{
  "runSettings": {
    "temperature": 0.0,
    "model": "models/gemini-2.5-pro",
    "topP": 0.95,
    "topK": 64,
    "maxOutputTokens": 65536,
    "safetySettings": [{
      "category": "HARM_CATEGORY_HARASSMENT",
      "threshold": "OFF"
    }, {
      "category": "HARM_CATEGORY_HATE_SPEECH",
      "threshold": "OFF"
    }, {
      "category": "HARM_CATEGORY_SEXUALLY_EXPLICIT",
      "threshold": "OFF"
    }, {
      "category": "HARM_CATEGORY_DANGEROUS_CONTENT",
      "threshold": "OFF"
    }],
    "enableCodeExecution": false,
    "enableSearchAsATool": false,
    "enableBrowseAsATool": false,
    "enableAutoFunctionResponse": false,
    "thinkingBudget": 32768,
    "outputResolution": "1K"
  },
  "citations": [{
    "uri": "http://en.wikipedia.org/wiki/Cauda_equina"
  }],
  "systemInstruction": {
    "text": "# SYSTEM ROLE: CHIEF KNOWLEDGE ARCHITECT (USMLE-OPTIMIZED / DEEP-DIVE EDITION)\n\n**(Version: Hybrid 11.0 - Anti-Laziness \u0026 HTML Enhanced)**\n\nYou are the Chief Ontologist, Lead Pedagogue, and **Data Integrity Guardian** for a next-generation medical knowledge engine. Your output is not mere text; it is structured, executable, and **comprehensive** data designed to power a high-performance learning application.\n\nYour mission is to ingest a structured **Index JSON List** and cross-reference it with the provided **Context Files** (First Aid Markdown, BnB Transcripts) to construct a **Strict JSON Knowledge Graph**. You act as the bridge between the index metadata and the content.\n\n## üõë CORE DIRECTIVE 0: THE \"ANTI-LAZINESS\" \u0026 \"NO-FLUFF\" PROTOCOL (NON-NEGOTIABLE)\n\n1. **Maximum Density Requirement:** You are strictly FORBIDDEN from summarizing, abbreviating, or over-simplifying complex medical concepts. If the source material provides detailed mechanisms, genetic markers, or drug interactions, you **MUST** include them. \"Brevity\" is not a virtue here; **Completeness** is.\n2. **Output Format:** STRICT JSON (RFC 8259 compliant). No markdown code blocks, no conversational preamble, no post-script explanations. **Just the raw JSON object.**\n3. **No Meta-Cards:** Do not generate \"Chunk Boundaries\", \"Timestamps\", or \"State\" nodes. Every key in the JSON must be a substantive Knowledge Card representing a real medical concept.\n4. **Context Retention:** You must internally maintain the graph\u0027s continuity. If a concept was defined in a previous turn, **reuse its ID** and append new connections/insights rather than creating a duplicate.\n\n---\n\n## üìú PROTOCOL 1: THE INDEX-DRIVEN GENERATION LOGIC\n\nYou will iterate through every `main_entry` object in the Input JSON.\n\n### Step 1: ID Preservation (CRITICAL)\nYou MUST use the `\"id\"` field provided in the input JSON (e.g., `\"dd11dde6\"`) as the key for the Knowledge Card. **DO NOT generate new snake_case IDs.**\n\n### Step 2: Content Retrieval \u0026 Integration\nFor each `main_entry`:\n1.  **Locate Content:** Use the `\"term\"` array to find the relevant sections in the provided **First Aid Markdown** context. Search the **BnB Transcripts** for the term to add depth.\n2.  **Integrate Sub-entries:** Examine the `sub_entries` array. These represent specific facets (pathology, physiology, clinical findings) of the main term.\n    *   **Action:** You must integrate detailed information about *every* sub-entry into the `content.definition` or `content.atAGlance` of the Main Card.\n    *   *Example:* If the Main Entry is \"Abducens nerve\" and a sub-entry is \"palsy\", ensure the card details the clinical presentation of CN VI palsy.\n\n### Step 3: Determining Card Type\n*   If the term is a disease, drug, or anatomical structure: Create a full **Entity Card**.\n*   If the term is abstract or lacks sufficient data in the Context Files despite the index entry: Create a **Stub Card** (Case C in original protocol).\n\n\n---\n\n## üé® PROTOCOL 2: HTML \u0026 FORMATTING STANDARDS (VISUAL PEDAGOGY)\n\nYou are required to use **HTML tags** within the JSON string fields to create a rich reading experience. Markdown is FORBIDDEN inside the JSON values; use HTML.\n\n### 1. Text Styling Rules\n\n- **Bold (`\u003cb\u003e...\u003c/b\u003e`):** Use for the concept name in the definition and key headings within lists.\n- **Italics (`\u003ci\u003e...\u003c/i\u003e`):** Use for nuance, contrasting terms (e.g., *vs. Crohn\u0027s*), or pathogenetic mechanisms.\n- **Underline (`\u003cu\u003e...\u003c/u\u003e`):** Use STRICTLY for \"absolute\" rules in medicine (e.g., \u003cu\u003ealways\u003c/u\u003e, \u003cu\u003enever\u003c/u\u003e, \u003cu\u003efirst-line\u003c/u\u003e, \u003cu\u003econtraindicated\u003c/u\u003e).\n- **Highlight (`\u003cmark\u003e...\u003c/mark\u003e`):** Use for **USMLE High-Yield Buzzwords**, key numbers (e.g., \u003cmark\u003e2:1 ratio\u003c/mark\u003e), or pathognomonic findings.\n- **Superscript/Subscript (`\u003csup\u003e`, `\u003csub\u003e`):** **MANDATORY** for ions, isotopes, and chemical formulas (e.g., Ca\u003csup\u003e2+\u003c/sup\u003e, H\u003csub\u003e2\u003c/sub\u003eO, HbA\u003csub\u003e1c\u003c/sub\u003e, T\u003csub\u003e4\u003c/sub\u003e).\n- **Lists (`\u003cul\u003e`, `\u003cli\u003e`):** Use for the `atAGlance` section.\n\n### 2. Obsidian-Style Linking\n\n- **Syntax:** `[[id]]` or `[[id|Readable Text]]`.\n- **Rule:** Every time you mention a medical concept that exists in your graph (or is a valid medical term likely to exist), you **MUST** wrap it in a link. **Aim for at least 3-5 links per card.**\n- **Example:** \"\u003cp\u003eCaused by [[helicobacter_pylori|H. pylori]] infection, which increases risk of [[gastric_adenocarcinoma]].\u003c/p\u003e\"\n\n---\n## üóÇÔ∏è PROTOCOL 2.5: STRICT CLASSIFICATION TAXONOMY (THE \"FIRST AID\" STRUCTURE)\n\nYou are strictly bound to the following hierarchy for the `classificationPath`.\n- **Level 1:** Must be one of the System Headers below.\n- **Level 2:** Must be one of the Sub-disciplines listed under that System.\n- **Level 3:** The specific disease or concept name.\n\n**ALLOWED HIERARCHY MAP:**\n\n1.  **Cardiovascular**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n2.  **Endocrine**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n3.  **Gastrointestinal**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n4.  **Hematology and Oncology**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n5.  **Musculoskeletal, Skin, and Connective Tissue**\n    * Options: [Anatomy and Physiology, Pathology, Dermatology, Pharmacology]\n6.  **Neurology and Special Senses**\n    * Options: [Embryology, Anatomy and Physiology, Pathology, Otology, Ophthalmology, Pharmacology]\n7.  **Psychiatry**\n    * Options: [Psychology, Pathology, Pharmacology]\n8.  **Renal**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n9.  **Reproductive**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n10. **Respiratory**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n\n---\n\n## üõ†Ô∏è PROTOCOL 3: THE JSON SCHEMA BLUEPRINT\n\nYour output must be a single JSON object where keys are IDs.\n\n```json\n{\n  \"unique_id\": { // MUST use the exact ID from input\n    \"title\": \"Proper Title (e.g., Acute Pancreatitis)\",\n    \"primaryType\": \"disease | drug | anatomy | microbe | molecule | physiology | finding | concept\",\n    \"tags\": [\"Domain (e.g. Gastroenterology)\", \"USMLE\", \"Pathology\"],\n    \"classificationPath\": [\"SYSTEM (from Protocol 2.5)\", \"DISCIPLINE (from Protocol 2.5)\", \"Specific Concept\"],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eConcept Name\u003c/b\u003e is a...\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLabel:\u003c/b\u003e ...\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e...\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A--\u003eB;\"  // Optional: Use for complex pathways. Make sure the existence of this entry even if it is empty for robustness\n    },\n    \"connections\": [\n      {\n        \"type\": \"active_verb_relationship\",\n        \"to\": \"target_id\"\n      }\n    ]\n  }\n}\n\n```\n\n---\n\n## üß† PROTOCOL 4: THE ART OF SYNTHESIS (CONTENT \u0026 DEPTH MANDATES)\n\n**WARNING:** This is where AI usually fails by being too brief. Do not fail. Follow these depth constraints strictly.\n\n### 1. `content.definition` (The Triple-Component Rule)\n\n- **Format:** Single `\u003cp\u003e` tag.\n- **Constraint:** The definition MUST contain three distinct components:\n    1. **The Class:** What is it? (e.g., \"An acute inflammatory disorder\", \"A competitive antagonist\").\n    2. **The Mechanism/Location:** How/Where does it happen? (e.g., \"caused by premature activation of trypsinogen\").\n    3. **The Key Distinguisher:** What makes it unique? (e.g., \"leading to autodigestion of the pancreatic parenchyma\").\n- **Bad Definition:** \"\u003cp\u003e\u003cb\u003eAcute Pancreatitis\u003c/b\u003e is inflammation of the pancreas.\u003c/p\u003e\" (TOO SHORT, REJECTED)\n- **Good Definition:** \"\u003cp\u003e\u003cb\u003eAcute Pancreatitis\u003c/b\u003e is an acute \u003ci\u003einflammatory condition\u003c/i\u003e of the [[pancreas]] caused by the \u003cu\u003epremature activation\u003c/u\u003e of pancreatic enzymes (specifically [[trypsin]]), leading to \u003cb\u003eautodigestion\u003c/b\u003e of the glandular parenchyma and potential systemic inflammatory response syndrome (SIRS).\u003c/p\u003e\"\n\n### 2. `content.atAGlance` (The 5-Point Coverage Mandate)\n\n- **Format:** `\u003cul\u003e` containing **4 to 7** `\u003cli\u003e` items. **Less than 4 items is unacceptable.**\n- **Mandatory Fields:** You must strive to cover the following dimensions if applicable:\n    - **Pathophysiology:** The \"How\".\n    - **Clinical Presentation:** The \"What it looks like\".\n    - **Diagnosis:** Gold standard or key labs.\n    - **Treatment:** First-line or definitive management.\n    - **USMLE Tip:** **(REQUIRED)** A specific mnemonic, trick, or \"classic vignette\" clue.\n- **Style:** Use `\u003cmark\u003e` for buzzwords. Use `\u003cb\u003e` for headers.\n- **Example:**\n    \n    ```html\n    \u003cul\u003e\n      \u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Direct toxicity of \u003cmark\u003eacetaldehyde\u003c/mark\u003e leads to mitochondrial dysfunction and fatty acid oxidation defects.\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eLabs:\u003c/b\u003e Classic \u003cmark\u003eAST \u003e ALT\u003c/mark\u003e ratio of ‚â• 2:1 (remember: A\u003cb\u003eS\u003c/b\u003eT \u003d \u003cb\u003eS\u003c/b\u003ecotch).\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e Presence of [[mallory_bodies|Mallory bodies]] (eosinophilic intracytoplasmic inclusions) and neutrophil infiltration.\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eClinical:\u003c/b\u003e Tender hepatomegaly, jaundice, and fever after a drinking binge.\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from [[viral_hepatitis]] where ALT is typically \u003e AST; elevated [[gamma_glutamyl_transpeptidase|GGT]] confirms alcohol source.\u003c/li\u003e\n    \u003c/ul\u003e\n    \n    ```\n    \n\n### 3. `content.takeAway` (The \"Why\" \u0026 First Principle)\n\n- **Format:** Single `\u003cp\u003e` tag.\n- **Goal:** Provide the deep mechanistic insight or the critical clinical differentiator. **Do not simply repeat the definition.**\n- **Constraint:** Must be a full, complex sentence explaining *why* a phenomenon occurs or *why* it is dangerous.\n- *Example:* \"\u003cp\u003eThe hallmark of \u003cb\u003eAlcoholic Hepatitis\u003c/b\u003e is the \u003cmark\u003eAST \u003e ALT ratio\u003c/mark\u003e, which occurs because alcohol functions as a mitochondrial toxin that depletes Vitamin B6 (pyridoxine), preferentially impairing ALT synthesis compared to AST.\u003c/p\u003e\"\n\n### 4. `content.mermaid` (Visual Logic - Optional but Encouraged)\n\n- **Usage:** Use this field for biochemical pathways, diagnostic algorithms, or decision trees.\n- **Format:** Raw Mermaid string.\n- *Example:* `graph LR; Alcohol --\u003e Acetaldehyde --\u003e Acetate;`\n\n\n\u003e ### **‚öñÔ∏è TYPE DISAMBIGUATION RULES:**\n\u003e 1. **Molecule vs. Drug:** If a substance is naturally produced by the human body (e.g., *Insulin, Cortisol*), classify as `molecule`. If it is exogenously administered as a medication (e.g., *Lispro, Dexamethasone*), classify as `drug`.\n\u003e 2. **Microbe vs. Disease:** If the term names the organism (e.g., *Plasmodium*), use `microbe`. If it names the resulting condition (e.g., *Malaria*), use `disease`.\n\u003e 3. **Finding vs. Disease:** If the term describes a set of observations without a specific etiology (e.g., *Ascites*), use `finding`. If it implies a specific pathophysiological entity (e.g., *Cirrhosis*), use `disease`.\n\u003e 4. **Anatomy vs. Physiology:** *Circle of Willis* is `anatomy`. *Cerebral perfusion* is `phy\n\n---\n\n## üîó PROTOCOL 5: ASSOCIATIVE FREEDOM (CONNECTIONS)\n\nDo not limit yourself to a predefined list. Use specific, active verbs that describe the *nature* of the relationship accurately. **Aim for 2-5 connections per card.**\n\n- **Standard:** `is_a_type_of`, `is_part_of`, `treated_by`, `causes`.\n- **High-Resolution (ENCOURAGED):**\n    - `accumulates_in` (e.g., Copper -\u003e Wilson\u0027s Disease)\n    - `mimics_symptoms_of`\n    - `is_precursor_to`\n    - `inhibits_enzyme`\n    - `upregulates_receptor`\n    - `differentiates_from_mesoderm_into`\n    - `is_risk_factor_for`\n- **Rule:** Every card MUST have at least 1 connection to anchor it in the graph.\n\n---\n\n## ‚öôÔ∏è PROTOCOL 6: QUALITY CONTROL CHECKLIST (INTERNAL)\n\nBefore finalizing your JSON, you must run this internal audit. **If you fail any check, REGENERATE the content.**\n\n1. **Did I create cards for Attributes?** (If yes -\u003e DELETE and move to parent definition).\n2. **Is the Definition dense?** (Does it follow the Triple-Component Rule? If short -\u003e EXPAND).\n3. **Is `atAGlance` comprehensive?** (Does it have \u003c4 bullets? If yes -\u003e ADD MORE details from source).\n4. **Is the formatting rich?** (Did I use `\u003cb\u003e`, `\u003ci\u003e`, `\u003cu\u003e`, `\u003cmark\u003e`, `\u003csup\u003e`? If plain text -\u003e FORMAT it).\n5. **Are there links?** (Did I use `[[links]]`? If no -\u003e ADD links to related concepts).\n6. **Is the USMLE Tip present?** (If missing -\u003e ADD a specific exam tip).\n\n---\n\n## Example Output:\n\n```json\n{\n  \"dd11dde6\": {\n    \"title\": \"Abducens Nerve (CN VI)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cranial Nerves\",\n      \"Ophthalmology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve (CN VI)\u003c/b\u003e is a somatic \u003ci\u003emotor cranial nerve\u003c/i\u003e originating from the pontomedullary junction that \u003cu\u003eexclusively innervates\u003c/u\u003e the [[f7b5ee5d|Lateral Rectus muscle]], enabling horizontal eye abduction (looking laterally away from the nose).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Motor innervation to the ipsilateral lateral rectus muscle (abduction).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Exits brainstem at pontomedullary junction \u0026#8594; cavernous sinus \u0026#8594; superior orbital fissure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Presentation:\u003c/b\u003e Medial strabismus (eye turns inward) and horizontal [[9914d433|diplopia]] that worsens when looking toward the affected side.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Association:\u003c/b\u003e Highly susceptible to downward traction from \u003cmark\u003eincreased intracranial pressure\u003c/mark\u003e due to its long intracranial course.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An isolated CN VI palsy is often a \\\"false localizing sign\\\" of elevated ICP (e.g., pseudotumor cerebri) rather than a direct brainstem lesion.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve\u003c/b\u003e has the longest subarachnoid course of all cranial nerves, making it uniquely vulnerable to stretching from \u003cu\u003eincreased intracranial pressure\u003c/u\u003e, often presenting as a nonlocalizing palsy unrelated to direct trauma.\u003c/p\u003e\",\n      \"mermaid\": \"graph LR; PPRF--\u003eCN_VI_Nucleus; CN_VI_Nucleus--\u003eIpsilateral_Lateral_Rectus; CN_VI_Nucleus--\u003eContralateral_MLF--\u003eContralateral_CN_III;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"innervates\",\n        \"to\": \"f7b5ee5d\"\n      },\n      {\n        \"type\": \"is_vulnerable_to\",\n        \"to\": \"7c4e7c74\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"1401b7aa\"\n      }\n    ]\n  },\n  \"77ae6148\": {\n    \"title\": \"Alzheimer Disease\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Geriatrics\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Dementia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAlzheimer Disease\u003c/b\u003e is the most common \u003ci\u003eneurodegenerative cause of dementia\u003c/i\u003e in older adults, characterized by the \u003cu\u003eextracellular accumulation\u003c/u\u003e of amyloid-beta (A\u0026#946;) plaques and intracellular accumulation of hyperphosphorylated tau tangles, leading to widespread cortical atrophy and cholinergic deficit.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Accumulation of \u003cmark\u003eSenile plaques\u003c/mark\u003e (A\u0026#946; from Amyloid Precursor Protein) and \u003cmark\u003eNeurofibrillary tangles\u003c/mark\u003e (hyperphosphorylated tau).\u003c/li\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Early onset associated with \u003ci\u003eAPP\u003c/i\u003e (Chr 21), \u003ci\u003ePresenilin-1\u003c/i\u003e (Chr 14), \u003ci\u003ePresenilin-2\u003c/i\u003e (Chr 1). Late onset risk increased by \u003ci\u003eApoE4\u003c/i\u003e allele (Chr 19).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical:\u003c/b\u003e Insidious, progressive memory loss, visuospatial deficits, and personality changes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitters:\u003c/b\u003e Significant decrease in [[6a005559|Acetylcholine]] levels in the [[361438f2|Basal nucleus of Meynert]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Patients with \u003cb\u003eDown syndrome\u003c/b\u003e (Trisomy 21) have an increased risk of early-onset Alzheimer\u0027s because the \u003ci\u003eAPP\u003c/i\u003e gene is located on Chromosome 21 (gene dosage effect).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe hallmark pathology of \u003cb\u003eAlzheimer Disease\u003c/b\u003e involves \u003cu\u003eextracellular\u003c/u\u003e amyloid plaques and \u003cu\u003eintracellular\u003c/u\u003e tau tangles, which precipitate a decline in cholinergic signaling, making [[0835ea01|AChE inhibitors]] (like [[47d0372e|Donepezil]]) the mainstay of symptomatic treatment.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; APP_Gene--\u003eAmyloid_Beta; Amyloid_Beta--\u003eSenile_Plaques; Hyperphosphorylated_Tau--\u003eNeurofibrillary_Tangles; Plaques_and_Tangles--\u003eNeuronal_Death--\u003eDementia;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"associated_with\",\n        \"to\": \"e2f193dd\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"47d0372e\"\n      },\n      {\n        \"type\": \"involves_deficiency_of\",\n        \"to\": \"6a005559\"\n      }\n    ]\n  },\n  \"e7f5cbbe\": {\n    \"title\": \"Dorsal Columns\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurology\",\n      \"Anatomy\",\n      \"Spinal Cord\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eDorsal Columns\u003c/b\u003e are ascending \u003ci\u003espinal cord tracts\u003c/i\u003e composed of the fasciculus gracilis and fasciculus cuneatus that transmit \u003cu\u003efine touch, vibration, and conscious proprioception\u003c/u\u003e from the peripheral nerves to the brainstem nuclei.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrganization:\u003c/b\u003e Fasciculus \u003cmark\u003eGracilis\u003c/mark\u003e (medial, lower body/legs), Fasciculus \u003cmark\u003eCuneatus\u003c/mark\u003e (lateral, upper body/arms) [Mnemonic: \u003cb\u003eG\u003c/b\u003eracilis \u003d \u003cb\u003eG\u003c/b\u003eround, \u003cb\u003eC\u003c/b\u003euneatus \u003d \u003cb\u003eC\u003c/b\u003eeiling].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e First-order neurons ascend ipsilaterally \u0026#8594; synapse in medulla \u0026#8594; decussate as internal arcuate fibers \u0026#8594; ascend as [[f19bc454|Medial Lemniscus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Signs:\u003c/b\u003e Loss of vibration/proprioception, positive [[47a0f3d1|Romberg sign]], sensory ataxia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Pathologies:\u003c/b\u003e Damaged in [[71daebd6|Tabes Dorsalis]] (syphilis) and [[6f5bea90|Subacute Combined Degeneration]] (B12 deficiency).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that dorsal column lesions cause \u003cb\u003eipsilateral\u003c/b\u003e deficits below the lesion because decussation occurs in the \u003cu\u003emedulla\u003c/u\u003e, not the spinal cord.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eDorsal Columns\u003c/b\u003e are unique among sensory tracts because they ascend \u003cu\u003eipsilaterally\u003c/u\u003e within the spinal cord and only decussate in the lower medulla to form the medial lemniscus; thus, spinal cord hemisections (Brown-S√©quard) result in ipsilateral loss of vibration and proprioception.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Peripheral_Receptor--\u003eDRG; DRG--\u003eDorsal_Column_Spinal_Cord; Dorsal_Column_Spinal_Cord--\u003eNucleus_Gracilis_Cuneatus_Medulla; Nucleus_Gracilis_Cuneatus_Medulla--\u003eDecussation--\u003eMedial_Lemniscus--\u003eVPL_Thalamus;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"8aa8156f\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"71daebd6\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"6f5bea90\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"4792bc68\"\n      }\n    ]\n  },\n  \"71daebd6\": {\n    \"title\": \"Tabes Dorsalis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Infectious Disease\",\n      \"Pathology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTabes Dorsalis\u003c/b\u003e is a late-stage \u003ci\u003eneurosyphilis manifestation\u003c/i\u003e characterized by the \u003cu\u003edemyelination and degeneration\u003c/u\u003e of the dorsal columns and dorsal roots of the spinal cord, leading to progressive sensory ataxia and loss of reflexes.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by \u003ci\u003eTreponema pallidum\u003c/i\u003e (Tertiary Syphilis) destroying the [[e7f5cbbe|Dorsal Columns]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Triad:\u003c/b\u003e Sensory ataxia (wide-based gait), sharp/shooting pains (\\\"lightning pains\\\"), and [[08cb577f|Argyll Robertson pupils]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysical Exam:\u003c/b\u003e Positive [[47a0f3d1|Romberg sign]], absent DTRs (areflexia), and impaired vibration/proprioception.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e [[cfbd9f68|Charcot joints]] (neuropathic arthropathy) due to loss of pain sensation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Look for the \u003cb\u003eArgyll Robertson pupil\u003c/b\u003e (pupils accommodate but do not react to light) as the classic hallmark of neurosyphilis associated with this condition.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTabes Dorsalis\u003c/b\u003e specifically targets the dorsal roots and [[e7f5cbbe|Dorsal Columns]], disrupting the sensory limb of the stretch reflex arc (causing areflexia) and proprioceptive input (causing sensory ataxia and a positive Romberg sign).\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Treponema_pallidum--\u003eDorsal_Root_Ganglion_Invasion; DRG_Damage--\u003eDorsal_Column_Degeneration; Dorsal_Column_Degeneration--\u003eLoss_of_Proprioception--\u003eSensory_Ataxia_and_Romberg_Sign;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"damages\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"08cb577f\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"cfbd9f68\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"248af9f9\"\n      }\n    ]\n  },\n  \"b6bbd0bc\": {\n    \"title\": \"Glioblastoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Pathology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGlioblastoma\u003c/b\u003e (formerly Glioblastoma Multiforme) is the most common and most aggressive \u003ci\u003eprimary malignant brain tumor\u003c/i\u003e in adults, arising from [[8192f595|Astrocytes]] and characterized by rapid growth, central necrosis, and the ability to cross the corpus callosum.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e \\\"Pseudopalisading\\\" tumor cells bordering central areas of \u003cmark\u003enecrosis\u003c/mark\u003e and hemorrhage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e Ring-enhancing lesion on MRI; often crosses the corpus callosum (\u003cb\u003e\\\"Butterfly glioma\\\"\u003c/b\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMarkers:\u003c/b\u003e Stains positive for [[fb50d450|GFAP]] (Glial Fibrillary Acidic Protein).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Very poor (median survival ~1 year).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from brain abscess (also ring-enhancing) by looking for the \u003cb\u003ebutterfly\u003c/b\u003e distribution and histologic description of pseudopalisading cells.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe defining histologic feature of \u003cb\u003eGlioblastoma\u003c/b\u003e is \u003cu\u003epseudopalisading necrosis\u003c/u\u003e, where tumor cells crowd around edges of necrotic tissue, combined with microvascular proliferation and a tendency to cross the midline via the corpus callosum.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Astrocyte--\u003eMutation_EGFR/PTEN--\u003eUncontrolled_Proliferation--\u003eAngiogenesis_and_Necrosis--\u003eGlioblastoma;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"arises_from\",\n        \"to\": \"8192f595\"\n      },\n      {\n        \"type\": \"expresses\",\n        \"to\": \"fb50d450\"\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"0d63a7e9\"\n      }\n    ]\n  },\n  \"45dd6d19\": {\n    \"title\": \"Multiple Sclerosis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Immunology\",\n      \"Pathology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMultiple Sclerosis\u003c/b\u003e is an autoimmune \u003ci\u003edemyelinating disorder\u003c/i\u003e of the central nervous system characterized by the destruction of [[a24f9747|Oligodendrocytes]] and myelin sheaths, leading to neurological deficits separated in \u003cu\u003espace and time\u003c/u\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassic Triad (Charcot):\u003c/b\u003e \u003cmark\u003eScanning speech\u003c/mark\u003e, \u003cmark\u003eIntention tremor\u003c/mark\u003e, and \u003cmark\u003eNystagmus\u003c/mark\u003e (\u003cb\u003eSIN\u003c/b\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Findings:\u003c/b\u003e [[58c684bd|Internuclear Ophthalmoplegia]] (MLF lesion), Optic Neuritis (painful vision loss), Lhermitte sign (shock sensation on neck flexion).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e MRI shows [[d9286430|Periventricular plaques]]; CSF shows increased IgG and \u003cb\u003eOligoclonal bands\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Acute flares: IV Steroids. Disease modifying: [[00e48ea3|Beta-interferon]], [[88fffc48|Glatiramer]], [[ae20a0ce|Natalizumab]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Bilateral \u003cb\u003eInternuclear Ophthalmoplegia (INO)\u003c/b\u003e in a young female is pathognomonic for MS.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe relapsing-remitting nature of \u003cb\u003eMultiple Sclerosis\u003c/b\u003e occurs because the CNS attempts to remyelinate damaged axons (using oligodendrocytes), but repeated autoimmune attacks eventually lead to permanent axonal loss and gliosis (plaques).\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Autoimmune_Attack--\u003eOligodendrocyte_Damage--\u003eDemyelination--\u003eSlowed_Nerve_Conduction--\u003eNeurological_Deficits;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"damages\",\n        \"to\": \"a24f9747\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"58c684bd\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"00e48ea3\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"ae20a0ce\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"98a63a59\"\n      }\n    ]\n  }\n}\n```\n"
  },
  "chunkedPrompt": {
    "chunks": [{
      "driveDocument": {
        "id": "1eW-sbjfbVz_CEiKTI6LXVPyXeIu2SMel"
      },
      "role": "user",
      "tokenCount": 171853
    }, {
      "driveDocument": {
        "id": "1lHSoA6nfiJiZK1fLy6Uunx1_9lWE358i"
      },
      "role": "user",
      "tokenCount": 122479
    }, {
      "driveDocument": {
        "id": "11SVUK9T67ftaNRNTtYL9otLd48DEo7x7"
      },
      "role": "user",
      "tokenCount": 37550
    }, {
      "driveDocument": {
        "id": "1ZQ8IjyuiAt7pftxDl0VJTvjsyYfNx7IO"
      },
      "role": "user",
      "tokenCount": 181448
    }, {
      "text": "# SYSTEM ROLE: CHIEF KNOWLEDGE ARCHITECT (USMLE-OPTIMIZED / DEEP-DIVE EDITION)\n\n**(Version: Hybrid 11.0 - Anti-Laziness \u0026 HTML Enhanced)**\n\nYou are the Chief Ontologist, Lead Pedagogue, and **Data Integrity Guardian** for a next-generation medical knowledge engine. Your output is not mere text; it is structured, executable, and **comprehensive** data designed to power a high-performance learning application.\n\nYour mission is to ingest a structured **Index JSON List** and cross-reference it with the provided **Context Files** (First Aid Markdown, BnB Transcripts) to construct a **Strict JSON Knowledge Graph**. You act as the bridge between the index metadata and the content.\n\n## üõë CORE DIRECTIVE 0: THE \"ANTI-LAZINESS\" \u0026 \"NO-FLUFF\" PROTOCOL (NON-NEGOTIABLE)\n\n1. **Maximum Density Requirement:** You are strictly FORBIDDEN from summarizing, abbreviating, or over-simplifying complex medical concepts. If the source material provides detailed mechanisms, genetic markers, or drug interactions, you **MUST** include them. \"Brevity\" is not a virtue here; **Completeness** is.\n2. **Output Format:** STRICT JSON (RFC 8259 compliant). No markdown code blocks, no conversational preamble, no post-script explanations. **Just the raw JSON object.**\n3. **No Meta-Cards:** Do not generate \"Chunk Boundaries\", \"Timestamps\", or \"State\" nodes. Every key in the JSON must be a substantive Knowledge Card representing a real medical concept.\n4. **Context Retention:** You must internally maintain the graph\u0027s continuity. If a concept was defined in a previous turn, **reuse its ID** and append new connections/insights rather than creating a duplicate.\n\n---\n\n## üìú PROTOCOL 1: THE INDEX-DRIVEN GENERATION LOGIC\n\nYou will iterate through every `main_entry` object in the Input JSON.\n\n### Step 1: ID Preservation (CRITICAL)\nYou MUST use the `\"id\"` field provided in the input JSON (e.g., `\"dd11dde6\"`) as the key for the Knowledge Card. **DO NOT generate new snake_case IDs.**\n\n### Step 2: Content Retrieval \u0026 Integration\nFor each `main_entry`:\n1.  **Locate Content:** Use the `\"term\"` array to find the relevant sections in the provided **First Aid Markdown** context. Search the **BnB Transcripts** for the term to add depth.\n2.  **Integrate Sub-entries:** Examine the `sub_entries` array. These represent specific facets (pathology, physiology, clinical findings) of the main term.\n    *   **Action:** You must integrate detailed information about *every* sub-entry into the `content.definition` or `content.atAGlance` of the Main Card.\n    *   *Example:* If the Main Entry is \"Abducens nerve\" and a sub-entry is \"palsy\", ensure the card details the clinical presentation of CN VI palsy.\n\n### Step 3: Determining Card Type\n*   If the term is a disease, drug, or anatomical structure: Create a full **Entity Card**.\n*   If the term is abstract or lacks sufficient data in the Context Files despite the index entry: Create a **Stub Card** (Case C in original protocol).\n\n\n---\n\n## üé® PROTOCOL 2: HTML \u0026 FORMATTING STANDARDS (VISUAL PEDAGOGY)\n\nYou are required to use **HTML tags** within the JSON string fields to create a rich reading experience. Markdown is FORBIDDEN inside the JSON values; use HTML.\n\n### 1. Text Styling Rules\n\n- **Bold (`\u003cb\u003e...\u003c/b\u003e`):** Use for the concept name in the definition and key headings within lists.\n- **Italics (`\u003ci\u003e...\u003c/i\u003e`):** Use for nuance, contrasting terms (e.g., *vs. Crohn\u0027s*), or pathogenetic mechanisms.\n- **Underline (`\u003cu\u003e...\u003c/u\u003e`):** Use STRICTLY for \"absolute\" rules in medicine (e.g., \u003cu\u003ealways\u003c/u\u003e, \u003cu\u003enever\u003c/u\u003e, \u003cu\u003efirst-line\u003c/u\u003e, \u003cu\u003econtraindicated\u003c/u\u003e).\n- **Highlight (`\u003cmark\u003e...\u003c/mark\u003e`):** Use for **USMLE High-Yield Buzzwords**, key numbers (e.g., \u003cmark\u003e2:1 ratio\u003c/mark\u003e), or pathognomonic findings.\n- **Superscript/Subscript (`\u003csup\u003e`, `\u003csub\u003e`):** **MANDATORY** for ions, isotopes, and chemical formulas (e.g., Ca\u003csup\u003e2+\u003c/sup\u003e, H\u003csub\u003e2\u003c/sub\u003eO, HbA\u003csub\u003e1c\u003c/sub\u003e, T\u003csub\u003e4\u003c/sub\u003e).\n- **Lists (`\u003cul\u003e`, `\u003cli\u003e`):** Use for the `atAGlance` section.\n\n### 2. Obsidian-Style Linking\n\n- **Syntax:** `[[id]]` or `[[id|Readable Text]]`.\n- **Rule:** Every time you mention a medical concept that exists in your graph (or is a valid medical term likely to exist), you **MUST** wrap it in a link. **Aim for at least 3-5 links per card.**\n- **Example:** \"\u003cp\u003eCaused by [[helicobacter_pylori|H. pylori]] infection, which increases risk of [[gastric_adenocarcinoma]].\u003c/p\u003e\"\n\n---\n## üóÇÔ∏è PROTOCOL 2.5: STRICT CLASSIFICATION TAXONOMY (THE \"FIRST AID\" STRUCTURE)\n\nYou are strictly bound to the following hierarchy for the `classificationPath`.\n- **Level 1:** Must be one of the System Headers below.\n- **Level 2:** Must be one of the Sub-disciplines listed under that System.\n- **Level 3:** The specific disease or concept name.\n\n**ALLOWED HIERARCHY MAP:**\n\n1.  **Cardiovascular**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n2.  **Endocrine**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n3.  **Gastrointestinal**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n4.  **Hematology and Oncology**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n5.  **Musculoskeletal, Skin, and Connective Tissue**\n    * Options: [Anatomy and Physiology, Pathology, Dermatology, Pharmacology]\n6.  **Neurology and Special Senses**\n    * Options: [Embryology, Anatomy and Physiology, Pathology, Otology, Ophthalmology, Pharmacology]\n7.  **Psychiatry**\n    * Options: [Psychology, Pathology, Pharmacology]\n8.  **Renal**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n9.  **Reproductive**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n10. **Respiratory**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n\n---\n\n## üõ†Ô∏è PROTOCOL 3: THE JSON SCHEMA BLUEPRINT\n\nYour output must be a single JSON object where keys are IDs.\n\n```json\n{\n  \"unique_id\": { // MUST use the exact ID from input\n    \"title\": \"Proper Title (e.g., Acute Pancreatitis)\",\n    \"primaryType\": \"disease | drug | anatomy | microbe | molecule | physiology | finding | concept\",\n    \"tags\": [\"Domain (e.g. Gastroenterology)\", \"USMLE\", \"Pathology\"],\n    \"classificationPath\": [\"SYSTEM (from Protocol 2.5)\", \"DISCIPLINE (from Protocol 2.5)\", \"Specific Concept\"],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eConcept Name\u003c/b\u003e is a...\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLabel:\u003c/b\u003e ...\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e...\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A--\u003eB;\"  // Optional: Use for complex pathways. Make sure the existence of this entry even if it is empty for robustness\n    },\n    \"connections\": [\n      {\n        \"type\": \"active_verb_relationship\",\n        \"to\": \"target_id\"\n      }\n    ]\n  }\n}\n\n```\n\n---\n\n## üß† PROTOCOL 4: THE ART OF SYNTHESIS (CONTENT \u0026 DEPTH MANDATES)\n\n**WARNING:** This is where AI usually fails by being too brief. Do not fail. Follow these depth constraints strictly.\n\n### 1. `content.definition` (The Triple-Component Rule)\n\n- **Format:** Single `\u003cp\u003e` tag.\n- **Constraint:** The definition MUST contain three distinct components:\n    1. **The Class:** What is it? (e.g., \"An acute inflammatory disorder\", \"A competitive antagonist\").\n    2. **The Mechanism/Location:** How/Where does it happen? (e.g., \"caused by premature activation of trypsinogen\").\n    3. **The Key Distinguisher:** What makes it unique? (e.g., \"leading to autodigestion of the pancreatic parenchyma\").\n- **Bad Definition:** \"\u003cp\u003e\u003cb\u003eAcute Pancreatitis\u003c/b\u003e is inflammation of the pancreas.\u003c/p\u003e\" (TOO SHORT, REJECTED)\n- **Good Definition:** \"\u003cp\u003e\u003cb\u003eAcute Pancreatitis\u003c/b\u003e is an acute \u003ci\u003einflammatory condition\u003c/i\u003e of the [[pancreas]] caused by the \u003cu\u003epremature activation\u003c/u\u003e of pancreatic enzymes (specifically [[trypsin]]), leading to \u003cb\u003eautodigestion\u003c/b\u003e of the glandular parenchyma and potential systemic inflammatory response syndrome (SIRS).\u003c/p\u003e\"\n\n### 2. `content.atAGlance` (The 5-Point Coverage Mandate)\n\n- **Format:** `\u003cul\u003e` containing **4 to 7** `\u003cli\u003e` items. **Less than 4 items is unacceptable.**\n- **Mandatory Fields:** You must strive to cover the following dimensions if applicable:\n    - **Pathophysiology:** The \"How\".\n    - **Clinical Presentation:** The \"What it looks like\".\n    - **Diagnosis:** Gold standard or key labs.\n    - **Treatment:** First-line or definitive management.\n    - **USMLE Tip:** **(REQUIRED)** A specific mnemonic, trick, or \"classic vignette\" clue.\n- **Style:** Use `\u003cmark\u003e` for buzzwords. Use `\u003cb\u003e` for headers.\n- **Example:**\n    \n    ```html\n    \u003cul\u003e\n      \u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Direct toxicity of \u003cmark\u003eacetaldehyde\u003c/mark\u003e leads to mitochondrial dysfunction and fatty acid oxidation defects.\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eLabs:\u003c/b\u003e Classic \u003cmark\u003eAST \u003e ALT\u003c/mark\u003e ratio of ‚â• 2:1 (remember: A\u003cb\u003eS\u003c/b\u003eT \u003d \u003cb\u003eS\u003c/b\u003ecotch).\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e Presence of [[mallory_bodies|Mallory bodies]] (eosinophilic intracytoplasmic inclusions) and neutrophil infiltration.\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eClinical:\u003c/b\u003e Tender hepatomegaly, jaundice, and fever after a drinking binge.\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from [[viral_hepatitis]] where ALT is typically \u003e AST; elevated [[gamma_glutamyl_transpeptidase|GGT]] confirms alcohol source.\u003c/li\u003e\n    \u003c/ul\u003e\n    \n    ```\n    \n\n### 3. `content.takeAway` (The \"Why\" \u0026 First Principle)\n\n- **Format:** Single `\u003cp\u003e` tag.\n- **Goal:** Provide the deep mechanistic insight or the critical clinical differentiator. **Do not simply repeat the definition.**\n- **Constraint:** Must be a full, complex sentence explaining *why* a phenomenon occurs or *why* it is dangerous.\n- *Example:* \"\u003cp\u003eThe hallmark of \u003cb\u003eAlcoholic Hepatitis\u003c/b\u003e is the \u003cmark\u003eAST \u003e ALT ratio\u003c/mark\u003e, which occurs because alcohol functions as a mitochondrial toxin that depletes Vitamin B6 (pyridoxine), preferentially impairing ALT synthesis compared to AST.\u003c/p\u003e\"\n\n### 4. `content.mermaid` (Visual Logic - Optional but Encouraged)\n\n- **Usage:** Use this field for biochemical pathways, diagnostic algorithms, or decision trees.\n- **Format:** Raw Mermaid string.\n- *Example:* `graph LR; Alcohol --\u003e Acetaldehyde --\u003e Acetate;`\n\n\n\u003e ### **‚öñÔ∏è TYPE DISAMBIGUATION RULES:**\n\u003e 1. **Molecule vs. Drug:** If a substance is naturally produced by the human body (e.g., *Insulin, Cortisol*), classify as `molecule`. If it is exogenously administered as a medication (e.g., *Lispro, Dexamethasone*), classify as `drug`.\n\u003e 2. **Microbe vs. Disease:** If the term names the organism (e.g., *Plasmodium*), use `microbe`. If it names the resulting condition (e.g., *Malaria*), use `disease`.\n\u003e 3. **Finding vs. Disease:** If the term describes a set of observations without a specific etiology (e.g., *Ascites*), use `finding`. If it implies a specific pathophysiological entity (e.g., *Cirrhosis*), use `disease`.\n\u003e 4. **Anatomy vs. Physiology:** *Circle of Willis* is `anatomy`. *Cerebral perfusion* is `phy\n\n---\n\n## üîó PROTOCOL 5: ASSOCIATIVE FREEDOM (CONNECTIONS)\n\nDo not limit yourself to a predefined list. Use specific, active verbs that describe the *nature* of the relationship accurately. **Aim for 2-5 connections per card.**\n\n- **Standard:** `is_a_type_of`, `is_part_of`, `treated_by`, `causes`.\n- **High-Resolution (ENCOURAGED):**\n    - `accumulates_in` (e.g., Copper -\u003e Wilson\u0027s Disease)\n    - `mimics_symptoms_of`\n    - `is_precursor_to`\n    - `inhibits_enzyme`\n    - `upregulates_receptor`\n    - `differentiates_from_mesoderm_into`\n    - `is_risk_factor_for`\n- **Rule:** Every card MUST have at least 1 connection to anchor it in the graph.\n\n---\n\n## ‚öôÔ∏è PROTOCOL 6: QUALITY CONTROL CHECKLIST (INTERNAL)\n\nBefore finalizing your JSON, you must run this internal audit. **If you fail any check, REGENERATE the content.**\n\n1. **Did I create cards for Attributes?** (If yes -\u003e DELETE and move to parent definition).\n2. **Is the Definition dense?** (Does it follow the Triple-Component Rule? If short -\u003e EXPAND).\n3. **Is `atAGlance` comprehensive?** (Does it have \u003c4 bullets? If yes -\u003e ADD MORE details from source).\n4. **Is the formatting rich?** (Did I use `\u003cb\u003e`, `\u003ci\u003e`, `\u003cu\u003e`, `\u003cmark\u003e`, `\u003csup\u003e`? If plain text -\u003e FORMAT it).\n5. **Are there links?** (Did I use `[[links]]`? If no -\u003e ADD links to related concepts).\n6. **Is the USMLE Tip present?** (If missing -\u003e ADD a specific exam tip).\n\n---\n\n## Example Output:\n\n```json\n{\n  \"dd11dde6\": {\n    \"title\": \"Abducens Nerve (CN VI)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cranial Nerves\",\n      \"Ophthalmology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve (CN VI)\u003c/b\u003e is a somatic \u003ci\u003emotor cranial nerve\u003c/i\u003e originating from the pontomedullary junction that \u003cu\u003eexclusively innervates\u003c/u\u003e the [[f7b5ee5d|Lateral Rectus muscle]], enabling horizontal eye abduction (looking laterally away from the nose).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Motor innervation to the ipsilateral lateral rectus muscle (abduction).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Exits brainstem at pontomedullary junction \u0026#8594; cavernous sinus \u0026#8594; superior orbital fissure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Presentation:\u003c/b\u003e Medial strabismus (eye turns inward) and horizontal [[9914d433|diplopia]] that worsens when looking toward the affected side.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Association:\u003c/b\u003e Highly susceptible to downward traction from \u003cmark\u003eincreased intracranial pressure\u003c/mark\u003e due to its long intracranial course.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An isolated CN VI palsy is often a \\\"false localizing sign\\\" of elevated ICP (e.g., pseudotumor cerebri) rather than a direct brainstem lesion.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve\u003c/b\u003e has the longest subarachnoid course of all cranial nerves, making it uniquely vulnerable to stretching from \u003cu\u003eincreased intracranial pressure\u003c/u\u003e, often presenting as a nonlocalizing palsy unrelated to direct trauma.\u003c/p\u003e\",\n      \"mermaid\": \"graph LR; PPRF--\u003eCN_VI_Nucleus; CN_VI_Nucleus--\u003eIpsilateral_Lateral_Rectus; CN_VI_Nucleus--\u003eContralateral_MLF--\u003eContralateral_CN_III;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"innervates\",\n        \"to\": \"f7b5ee5d\"\n      },\n      {\n        \"type\": \"is_vulnerable_to\",\n        \"to\": \"7c4e7c74\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"1401b7aa\"\n      }\n    ]\n  },\n  \"77ae6148\": {\n    \"title\": \"Alzheimer Disease\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Geriatrics\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Dementia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAlzheimer Disease\u003c/b\u003e is the most common \u003ci\u003eneurodegenerative cause of dementia\u003c/i\u003e in older adults, characterized by the \u003cu\u003eextracellular accumulation\u003c/u\u003e of amyloid-beta (A\u0026#946;) plaques and intracellular accumulation of hyperphosphorylated tau tangles, leading to widespread cortical atrophy and cholinergic deficit.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Accumulation of \u003cmark\u003eSenile plaques\u003c/mark\u003e (A\u0026#946; from Amyloid Precursor Protein) and \u003cmark\u003eNeurofibrillary tangles\u003c/mark\u003e (hyperphosphorylated tau).\u003c/li\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Early onset associated with \u003ci\u003eAPP\u003c/i\u003e (Chr 21), \u003ci\u003ePresenilin-1\u003c/i\u003e (Chr 14), \u003ci\u003ePresenilin-2\u003c/i\u003e (Chr 1). Late onset risk increased by \u003ci\u003eApoE4\u003c/i\u003e allele (Chr 19).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical:\u003c/b\u003e Insidious, progressive memory loss, visuospatial deficits, and personality changes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitters:\u003c/b\u003e Significant decrease in [[6a005559|Acetylcholine]] levels in the [[361438f2|Basal nucleus of Meynert]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Patients with \u003cb\u003eDown syndrome\u003c/b\u003e (Trisomy 21) have an increased risk of early-onset Alzheimer\u0027s because the \u003ci\u003eAPP\u003c/i\u003e gene is located on Chromosome 21 (gene dosage effect).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe hallmark pathology of \u003cb\u003eAlzheimer Disease\u003c/b\u003e involves \u003cu\u003eextracellular\u003c/u\u003e amyloid plaques and \u003cu\u003eintracellular\u003c/u\u003e tau tangles, which precipitate a decline in cholinergic signaling, making [[0835ea01|AChE inhibitors]] (like [[47d0372e|Donepezil]]) the mainstay of symptomatic treatment.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; APP_Gene--\u003eAmyloid_Beta; Amyloid_Beta--\u003eSenile_Plaques; Hyperphosphorylated_Tau--\u003eNeurofibrillary_Tangles; Plaques_and_Tangles--\u003eNeuronal_Death--\u003eDementia;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"associated_with\",\n        \"to\": \"e2f193dd\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"47d0372e\"\n      },\n      {\n        \"type\": \"involves_deficiency_of\",\n        \"to\": \"6a005559\"\n      }\n    ]\n  },\n  \"e7f5cbbe\": {\n    \"title\": \"Dorsal Columns\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurology\",\n      \"Anatomy\",\n      \"Spinal Cord\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eDorsal Columns\u003c/b\u003e are ascending \u003ci\u003espinal cord tracts\u003c/i\u003e composed of the fasciculus gracilis and fasciculus cuneatus that transmit \u003cu\u003efine touch, vibration, and conscious proprioception\u003c/u\u003e from the peripheral nerves to the brainstem nuclei.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrganization:\u003c/b\u003e Fasciculus \u003cmark\u003eGracilis\u003c/mark\u003e (medial, lower body/legs), Fasciculus \u003cmark\u003eCuneatus\u003c/mark\u003e (lateral, upper body/arms) [Mnemonic: \u003cb\u003eG\u003c/b\u003eracilis \u003d \u003cb\u003eG\u003c/b\u003eround, \u003cb\u003eC\u003c/b\u003euneatus \u003d \u003cb\u003eC\u003c/b\u003eeiling].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e First-order neurons ascend ipsilaterally \u0026#8594; synapse in medulla \u0026#8594; decussate as internal arcuate fibers \u0026#8594; ascend as [[f19bc454|Medial Lemniscus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Signs:\u003c/b\u003e Loss of vibration/proprioception, positive [[47a0f3d1|Romberg sign]], sensory ataxia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Pathologies:\u003c/b\u003e Damaged in [[71daebd6|Tabes Dorsalis]] (syphilis) and [[6f5bea90|Subacute Combined Degeneration]] (B12 deficiency).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that dorsal column lesions cause \u003cb\u003eipsilateral\u003c/b\u003e deficits below the lesion because decussation occurs in the \u003cu\u003emedulla\u003c/u\u003e, not the spinal cord.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eDorsal Columns\u003c/b\u003e are unique among sensory tracts because they ascend \u003cu\u003eipsilaterally\u003c/u\u003e within the spinal cord and only decussate in the lower medulla to form the medial lemniscus; thus, spinal cord hemisections (Brown-S√©quard) result in ipsilateral loss of vibration and proprioception.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Peripheral_Receptor--\u003eDRG; DRG--\u003eDorsal_Column_Spinal_Cord; Dorsal_Column_Spinal_Cord--\u003eNucleus_Gracilis_Cuneatus_Medulla; Nucleus_Gracilis_Cuneatus_Medulla--\u003eDecussation--\u003eMedial_Lemniscus--\u003eVPL_Thalamus;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"8aa8156f\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"71daebd6\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"6f5bea90\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"4792bc68\"\n      }\n    ]\n  },\n  \"71daebd6\": {\n    \"title\": \"Tabes Dorsalis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Infectious Disease\",\n      \"Pathology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTabes Dorsalis\u003c/b\u003e is a late-stage \u003ci\u003eneurosyphilis manifestation\u003c/i\u003e characterized by the \u003cu\u003edemyelination and degeneration\u003c/u\u003e of the dorsal columns and dorsal roots of the spinal cord, leading to progressive sensory ataxia and loss of reflexes.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by \u003ci\u003eTreponema pallidum\u003c/i\u003e (Tertiary Syphilis) destroying the [[e7f5cbbe|Dorsal Columns]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Triad:\u003c/b\u003e Sensory ataxia (wide-based gait), sharp/shooting pains (\\\"lightning pains\\\"), and [[08cb577f|Argyll Robertson pupils]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysical Exam:\u003c/b\u003e Positive [[47a0f3d1|Romberg sign]], absent DTRs (areflexia), and impaired vibration/proprioception.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e [[cfbd9f68|Charcot joints]] (neuropathic arthropathy) due to loss of pain sensation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Look for the \u003cb\u003eArgyll Robertson pupil\u003c/b\u003e (pupils accommodate but do not react to light) as the classic hallmark of neurosyphilis associated with this condition.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTabes Dorsalis\u003c/b\u003e specifically targets the dorsal roots and [[e7f5cbbe|Dorsal Columns]], disrupting the sensory limb of the stretch reflex arc (causing areflexia) and proprioceptive input (causing sensory ataxia and a positive Romberg sign).\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Treponema_pallidum--\u003eDorsal_Root_Ganglion_Invasion; DRG_Damage--\u003eDorsal_Column_Degeneration; Dorsal_Column_Degeneration--\u003eLoss_of_Proprioception--\u003eSensory_Ataxia_and_Romberg_Sign;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"damages\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"08cb577f\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"cfbd9f68\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"248af9f9\"\n      }\n    ]\n  },\n  \"b6bbd0bc\": {\n    \"title\": \"Glioblastoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Pathology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGlioblastoma\u003c/b\u003e (formerly Glioblastoma Multiforme) is the most common and most aggressive \u003ci\u003eprimary malignant brain tumor\u003c/i\u003e in adults, arising from [[8192f595|Astrocytes]] and characterized by rapid growth, central necrosis, and the ability to cross the corpus callosum.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e \\\"Pseudopalisading\\\" tumor cells bordering central areas of \u003cmark\u003enecrosis\u003c/mark\u003e and hemorrhage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e Ring-enhancing lesion on MRI; often crosses the corpus callosum (\u003cb\u003e\\\"Butterfly glioma\\\"\u003c/b\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMarkers:\u003c/b\u003e Stains positive for [[fb50d450|GFAP]] (Glial Fibrillary Acidic Protein).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Very poor (median survival ~1 year).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from brain abscess (also ring-enhancing) by looking for the \u003cb\u003ebutterfly\u003c/b\u003e distribution and histologic description of pseudopalisading cells.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe defining histologic feature of \u003cb\u003eGlioblastoma\u003c/b\u003e is \u003cu\u003epseudopalisading necrosis\u003c/u\u003e, where tumor cells crowd around edges of necrotic tissue, combined with microvascular proliferation and a tendency to cross the midline via the corpus callosum.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Astrocyte--\u003eMutation_EGFR/PTEN--\u003eUncontrolled_Proliferation--\u003eAngiogenesis_and_Necrosis--\u003eGlioblastoma;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"arises_from\",\n        \"to\": \"8192f595\"\n      },\n      {\n        \"type\": \"expresses\",\n        \"to\": \"fb50d450\"\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"0d63a7e9\"\n      }\n    ]\n  },\n  \"45dd6d19\": {\n    \"title\": \"Multiple Sclerosis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Immunology\",\n      \"Pathology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMultiple Sclerosis\u003c/b\u003e is an autoimmune \u003ci\u003edemyelinating disorder\u003c/i\u003e of the central nervous system characterized by the destruction of [[a24f9747|Oligodendrocytes]] and myelin sheaths, leading to neurological deficits separated in \u003cu\u003espace and time\u003c/u\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassic Triad (Charcot):\u003c/b\u003e \u003cmark\u003eScanning speech\u003c/mark\u003e, \u003cmark\u003eIntention tremor\u003c/mark\u003e, and \u003cmark\u003eNystagmus\u003c/mark\u003e (\u003cb\u003eSIN\u003c/b\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Findings:\u003c/b\u003e [[58c684bd|Internuclear Ophthalmoplegia]] (MLF lesion), Optic Neuritis (painful vision loss), Lhermitte sign (shock sensation on neck flexion).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e MRI shows [[d9286430|Periventricular plaques]]; CSF shows increased IgG and \u003cb\u003eOligoclonal bands\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Acute flares: IV Steroids. Disease modifying: [[00e48ea3|Beta-interferon]], [[88fffc48|Glatiramer]], [[ae20a0ce|Natalizumab]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Bilateral \u003cb\u003eInternuclear Ophthalmoplegia (INO)\u003c/b\u003e in a young female is pathognomonic for MS.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe relapsing-remitting nature of \u003cb\u003eMultiple Sclerosis\u003c/b\u003e occurs because the CNS attempts to remyelinate damaged axons (using oligodendrocytes), but repeated autoimmune attacks eventually lead to permanent axonal loss and gliosis (plaques).\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Autoimmune_Attack--\u003eOligodendrocyte_Damage--\u003eDemyelination--\u003eSlowed_Nerve_Conduction--\u003eNeurological_Deficits;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"damages\",\n        \"to\": \"a24f9747\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"58c684bd\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"00e48ea3\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"ae20a0ce\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"98a63a59\"\n      }\n    ]\n  }\n}\n```\n\n\nNow process the first chunk:\n```json\n[\n  {\n    \"id\": \"dd11dde6\",\n    \"letter\": \"A\",\n    \"term\": \"Abducens nerve (CN VI)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Abducens nerve (CN VI)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"ddbd2810\",\n        \"letter\": \"A\",\n        \"term\": \"damage to\",\n        \"pages\": [\n          \"556\"\n        ],\n        \"context\": \"Abducens nerve (CN VI) \u003e damage to\"\n      },\n      {\n        \"id\": \"5ac9a13d\",\n        \"letter\": \"A\",\n        \"term\": \"function and type\",\n        \"pages\": [\n          \"519\"\n        ],\n        \"context\": \"Abducens nerve (CN VI) \u003e function and type\"\n      },\n      {\n        \"id\": \"c452852d\",\n        \"letter\": \"A\",\n        \"term\": \"intracranial hypertension effects\",\n        \"pages\": [\n          \"536\"\n        ],\n        \"context\": \"Abducens nerve (CN VI) \u003e intracranial hypertension effects\"\n      },\n      {\n        \"id\": \"18a8c97a\",\n        \"letter\": \"A\",\n        \"term\": \"ocular motility\",\n        \"pages\": [\n          \"555\"\n        ],\n        \"context\": \"Abducens nerve (CN VI) \u003e ocular motility\"\n      },\n      {\n        \"id\": \"80048429\",\n        \"letter\": \"A\",\n        \"term\": \"palsy\",\n        \"pages\": [\n          \"558\"\n        ],\n        \"context\": \"Abducens nerve (CN VI) \u003e palsy\"\n      }\n    ]\n  },\n  {\n    \"id\": \"c0b7a1ca\",\n    \"letter\": \"A\",\n    \"term\": \"Abnormal motor posturing\",\n    \"pages\": [\n      \"524\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Abnormal motor posturing\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"a0c128f4\",\n    \"letter\": \"A\",\n    \"term\": \"Absence (petit mal) seizures\",\n    \"pages\": [\n      \"531\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Absence (petit mal) seizures\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"e62961a0\",\n    \"letter\": \"A\",\n    \"term\": \"Absence seizure anticonvulsants\",\n    \"pages\": [\n      \"560\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Absence seizure anticonvulsants\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"8558c64b\",\n    \"letter\": \"A\",\n    \"term\": \"Acalculia\",\n    \"pages\": [\n      \"524\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Acalculia\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"f218aebf\",\n    \"letter\": \"A\",\n    \"term\": \"Accessory nerve (CN XI)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Accessory nerve (CN XI)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"d854478f\",\n        \"letter\": \"A\",\n        \"term\": \"functions\",\n        \"pages\": [\n          \"519\"\n        ],\n        \"context\": \"Accessory nerve (CN XI) \u003e functions\"\n      },\n      {\n        \"id\": \"dbb1948e\",\n        \"letter\": \"A\",\n        \"term\": \"lesions of\",\n        \"pages\": [\n          \"546\"\n        ],\n        \"context\": \"Accessory nerve (CN XI) \u003e lesions of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"81b5f5fe\",\n    \"letter\": \"A\",\n    \"term\": \"Accommodation (eye)\",\n    \"pages\": [\n      \"519\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Accommodation (eye)\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"1df262e8\",\n    \"letter\": \"A\",\n    \"term\": \"Acetazolamide\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Acetazolamide\",\n    \"sub_entries\": [\n      {\n        \"id\": \"b450b802\",\n        \"letter\": \"A\",\n        \"term\": \"glaucoma therapy\",\n        \"pages\": [\n          \"568\"\n        ],\n        \"context\": \"Acetazolamide \u003e glaucoma therapy\"\n      },\n      {\n        \"id\": \"62d0ba3f\",\n        \"letter\": \"A\",\n        \"term\": \"hypertension\",\n        \"pages\": [\n          \"536\"\n        ],\n        \"context\": \"Acetazolamide \u003e hypertension\"\n      }\n    ]\n  },\n  {\n    \"id\": \"6a005559\",\n    \"letter\": \"A\",\n    \"term\": \"Acetylcholine (ACh)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Acetylcholine (ACh)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"c3eb18f9\",\n        \"letter\": \"A\",\n        \"term\": \"synthesis and change with diseases\",\n        \"pages\": [\n          \"505\"\n        ],\n        \"context\": \"Acetylcholine (ACh) \u003e synthesis and change with diseases\"\n      }\n    ]\n  },\n  {\n    \"id\": \"87d19a70\",\n    \"letter\": \"A\",\n    \"term\": \"Achilles reflex\",\n    \"pages\": [\n      \"523\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Achilles reflex\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"fcedc59f\",\n    \"letter\": \"A\",\n    \"term\": \"Action potential\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Action potential\",\n    \"sub_entries\": [\n      {\n        \"id\": \"1095ddab\",\n        \"letter\": \"A\",\n        \"term\": \"neurons\",\n        \"pages\": [\n          \"504\"\n        ],\n        \"context\": \"Action potential \u003e neurons\"\n      }\n    ]\n  },\n  {\n    \"id\": \"67e83e3b\",\n    \"letter\": \"A\",\n    \"term\": \"Acute disseminated (postinfectious)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Acute disseminated (postinfectious)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"7f9ae40d\",\n        \"letter\": \"A\",\n        \"term\": \"encephalomyelitis\",\n        \"pages\": [\n          \"538\"\n        ],\n        \"context\": \"Acute disseminated (postinfectious) \u003e encephalomyelitis\"\n      }\n    ]\n  },\n  {\n    \"id\": \"ed52e40b\",\n    \"letter\": \"A\",\n    \"term\": \"Acute inflammatory demyelinating\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Acute inflammatory demyelinating\",\n    \"sub_entries\": [\n      {\n        \"id\": \"026b3479\",\n        \"letter\": \"A\",\n        \"term\": \"polyneuropathy\",\n        \"pages\": [\n          \"538\"\n        ],\n        \"context\": \"Acute inflammatory demyelinating \u003e polyneuropathy\"\n      }\n    ]\n  },\n  {\n    \"id\": \"d268ace0\",\n    \"letter\": \"A\",\n    \"term\": \"Acute pulmonary edema, opioid\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Acute pulmonary edema, opioid\",\n    \"sub_entries\": [\n      {\n        \"id\": \"fc8f2199\",\n        \"letter\": \"A\",\n        \"term\": \"analgesics\",\n        \"pages\": [\n          \"567\"\n        ],\n        \"context\": \"Acute pulmonary edema, opioid \u003e analgesics\"\n      }\n    ]\n  },\n  {\n    \"id\": \"76ba7f2e\",\n    \"letter\": \"A\",\n    \"term\": \"Adenohypophysis (anterior pituitary)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Adenohypophysis (anterior pituitary)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"0e44cd2d\",\n        \"letter\": \"A\",\n        \"term\": \"hypothalamus and\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Adenohypophysis (anterior pituitary) \u003e hypothalamus and\"\n      }\n    ]\n  }\n]\n```\n",
      "role": "user",
      "tokenCount": 9477
    }, {
      "text": "**Analyzing Medical Terminology**\n\nOkay, I\u0027m deep diving into this JSON data. Each entry represents a medical concept from a textbook index and I have to translate it to knowledge cards. I\u0027m focusing on parsing the structured JSON and converting it into well-formatted JSON knowledge cards. It\u0027s a complex task, requiring precision to ensure accuracy in representing medical terminology.\n\n\n**Developing Knowledge Cards**\n\nI\u0027m working on a function to process the JSON list and transform each `main_entry` into a knowledge card. I\u0027ve successfully implemented the ID preservation and title extraction. Now, I\u0027m focusing on assigning the correct `primaryType` and determining the `classificationPath`. Then, I\u0027ll move on to populating the `definition` and `atAGlance` fields. It involves searching the markdown and transcript data to synthesize concise content for each card.\n\n\n**Structuring Knowledge Cards**\n\nI\u0027m now focusing on structuring the information for each card meticulously. I\u0027ve broken down my process: first, I preserve the original ID and extract the title and primary type. After that, I will correctly determine the classification path, aiming for a hierarchical structure to enhance clarity.  Next, the core content creation begins. I\u0027m focusing on the `definition` by searching the data, and using HTML formatting for emphasis and linking to build a network of connected concepts within the cards. Then, I will address the `atAGlance`, `takeAway`, and `mermaid` components. Finally, I will add active-verb relationship connections to the card.\n\n\n**Refining Card Components**\n\nI\u0027m now fully immersed in the card creation. I\u0027ve successfully parsed the JSON, preserved IDs, extracted titles, and assigned primary types. My current focus is refining content synthesis. Specifically, I\u0027m working to make the `definition` field concise and dense. I\u0027m also carefully crafting the `atAGlance` list and generating the `takeAway` sentence. I\u0027m testing the linking functionality, adding active-verb relationship connections, and beginning with HTML formatting and incorporating a Mermaid diagram where applicable.\n\n\n**Refining Knowledge Card Content**\n\nI\u0027m now diving into the specifics of each knowledge card. I\u0027ve successfully implemented all primary structure components including ID, title, type, and classification. Currently, I\u0027m fully engaged in content generation. I\u0027m focusing on crafting definitions, constructing \"atAGlance\" lists with 4-7 detailed points, and formulating \"takeAway\" sentences to highlight key concepts. The HTML formatting and linking are integrated and being refined. Finally, I\u0027ll be adding active-verb relationships.\n\n\n**Crafting Detailed Knowledge**\n\nI\u0027ve moved on to the core content generation phase, working through each medical term. Now, I\u0027m focusing on synthesizing definitions, creating \"atAGlance\" lists with detailed points (4-7 items), and formulating concise \"takeAway\" sentences. HTML formatting and linking are integrated and being tested.\n\n\n**Structuring Card Content**\n\nI\u0027ve just finished the plan for my knowledge card creation process. I\u0027m focusing on parsing the input JSON data, preserving IDs, extracting titles and primary types, classifying the entries, and defining the HTML markup and linking procedures. My next step will be to start the content synthesis for each medical concept. I\u0027ve designed the processes to ensure a dense, precise, well-structured, and well-linked collection of knowledge.\n\n\n**Structuring Knowledge Base**\n\nI\u0027ve carefully designed my process for building these knowledge cards. I\u0027m focusing on parsing the data, preserving IDs, extracting key information, and implementing a strict structure for definitions, concise overviews, and takeaways. HTML formatting and linking are being planned, and I\u0027ll include active-verb connections.\n\n\n**Creating Dense Knowledge Cards**\n\nI\u0027m now fully engaged in the content creation phase, translating each medical term into a comprehensive knowledge card. I\u0027m prioritizing accuracy, density, and adherence to the specified format. The current focus is on crafting concise definitions, constructing \"atAGlance\" lists, and formulating \"takeAway\" sentences to highlight key concepts. HTML formatting and linking are being implemented, along with active-verb connections and Mermaid diagrams where applicable, for a well-structured and interconnected knowledge base. I\u0027ve begun with the \"Abducens nerve (CN VI)\" entry.\n\n\n",
      "role": "model",
      "tokenCount": 2036,
      "isThought": true,
      "thinkingBudget": 32768,
      "parts": [{
        "text": "**Analyzing Medical Terminology**\n\nOkay, I\u0027m deep diving into this JSON data. Each entry represents a medical concept from a textbook index and I have to translate it to knowledge cards. I\u0027m focusing on parsing the structured JSON and converting it into well-formatted JSON knowledge cards. It\u0027s a complex task, requiring precision to ensure accuracy in representing medical terminology.\n\n\n",
        "thought": true
      }, {
        "text": "**Developing Knowledge Cards**\n\nI\u0027m working on a function to process the JSON list and transform each `main_entry` into a knowledge card. I\u0027ve successfully implemented the ID preservation and title extraction. Now, I\u0027m focusing on assigning the correct `primaryType` and determining the `classificationPath`. Then, I\u0027ll move on to populating the `definition` and `atAGlance` fields. It involves searching the markdown and transcript data to synthesize concise content for each card.\n\n\n",
        "thought": true
      }, {
        "text": "**Structuring Knowledge Cards**\n\nI\u0027m now focusing on structuring the information for each card meticulously. I\u0027ve broken down my process: first, I preserve the original ID and extract the title and primary type. After that, I will correctly determine the classification path, aiming for a hierarchical structure to enhance clarity.  Next, the core content creation begins. I\u0027m focusing on the `definition` by searching the data, and using HTML formatting for emphasis and linking to build a network of connected concepts within the cards. Then, I will address the `atAGlance`, `takeAway`, and `mermaid` components. Finally, I will add active-verb relationship connections to the card.\n\n\n",
        "thought": true
      }, {
        "text": "**Refining Card Components**\n\nI\u0027m now fully immersed in the card creation. I\u0027ve successfully parsed the JSON, preserved IDs, extracted titles, and assigned primary types. My current focus is refining content synthesis. Specifically, I\u0027m working to make the `definition` field concise and dense. I\u0027m also carefully crafting the `atAGlance` list and generating the `takeAway` sentence. I\u0027m testing the linking functionality, adding active-verb relationship connections, and beginning with HTML formatting and incorporating a Mermaid diagram where applicable.\n\n\n",
        "thought": true
      }, {
        "text": "**Refining Knowledge Card Content**\n\nI\u0027m now diving into the specifics of each knowledge card. I\u0027ve successfully implemented all primary structure components including ID, title, type, and classification. Currently, I\u0027m fully engaged in content generation. I\u0027m focusing on crafting definitions, constructing \"atAGlance\" lists with 4-7 detailed points, and formulating \"takeAway\" sentences to highlight key concepts. The HTML formatting and linking are integrated and being refined. Finally, I\u0027ll be adding active-verb relationships.\n\n\n",
        "thought": true
      }, {
        "text": "**Crafting Detailed Knowledge**\n\nI\u0027ve moved on to the core content generation phase, working through each medical term. Now, I\u0027m focusing on synthesizing definitions, creating \"atAGlance\" lists with detailed points (4-7 items), and formulating concise \"takeAway\" sentences. HTML formatting and linking are integrated and being tested.\n\n\n",
        "thought": true
      }, {
        "text": "**Structuring Card Content**\n\nI\u0027ve just finished the plan for my knowledge card creation process. I\u0027m focusing on parsing the input JSON data, preserving IDs, extracting titles and primary types, classifying the entries, and defining the HTML markup and linking procedures. My next step will be to start the content synthesis for each medical concept. I\u0027ve designed the processes to ensure a dense, precise, well-structured, and well-linked collection of knowledge.\n\n\n",
        "thought": true
      }, {
        "text": "**Structuring Knowledge Base**\n\nI\u0027ve carefully designed my process for building these knowledge cards. I\u0027m focusing on parsing the data, preserving IDs, extracting key information, and implementing a strict structure for definitions, concise overviews, and takeaways. HTML formatting and linking are being planned, and I\u0027ll include active-verb connections.\n\n\n",
        "thought": true
      }, {
        "text": "**Creating Dense Knowledge Cards**\n\nI\u0027m now fully engaged in the content creation phase, translating each medical term into a comprehensive knowledge card. I\u0027m prioritizing accuracy, density, and adherence to the specified format. The current focus is on crafting concise definitions, constructing \"atAGlance\" lists, and formulating \"takeAway\" sentences to highlight key concepts. HTML formatting and linking are being implemented, along with active-verb connections and Mermaid diagrams where applicable, for a well-structured and interconnected knowledge base. I\u0027ve begun with the \"Abducens nerve (CN VI)\" entry.\n\n\n",
        "thought": true
      }]
    }, {
      "text": "```json\n{\n  \"dd11dde6\": {\n    \"title\": \"Abducens Nerve (CN VI)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cranial Nerves\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve (CN VI)\u003c/b\u003e is a somatic \u003ci\u003emotor cranial nerve\u003c/i\u003e that originates from the pontomedullary junction and \u003cu\u003eexclusively innervates\u003c/u\u003e the [[f7b5ee5d|Lateral Rectus muscle]], which is responsible for abduction of the eye (looking laterally).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Motor innervation to the ipsilateral [[f7b5ee5d|lateral rectus muscle]], enabling abduction (lateral eye movement).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Exits the brainstem at the pontomedullary junction, traverses the subarachnoid space, passes through the [[c260efc8|cavernous sinus]] near the internal carotid artery, and enters the orbit via the superior orbital fissure.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePalsy Presentation:\u003c/b\u003e Damage results in an inability to abduct the affected eye, leading to a medially directed strabismus at rest and horizontal [[9914d433|diplopia]] that worsens on attempted lateral gaze toward the side of the lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVulnerability:\u003c/b\u003e Its long intracranial course makes it highly susceptible to downward traction from \u003cmark\u003eincreased intracranial pressure\u003c/mark\u003e ([[7c4e7c74|idiopathic intracranial hypertension]], tumors, hydrocephalus).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An isolated CN VI palsy is often a \u003cmark\u003e\\\"false localizing sign\\\"\u003c/mark\u003e of elevated ICP rather than a direct brainstem lesion. It is the most commonly affected cranial nerve in [[c260efc8|cavernous sinus syndrome]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve\u003c/b\u003e has the longest intracranial course of all cranial nerves, making it uniquely vulnerable to stretching and compression from \u003cu\u003eincreased intracranial pressure\u003c/u\u003e, often presenting as a nonlocalizing palsy that signals a generalized brain pressure problem rather than a specific brainstem lesion.\u003c/p\u003e\",\n      \"mermaid\": \"graph LR; A[PPRF] --\u003e B[CN VI Nucleus]; B --\u003e C[Ipsilateral Lateral Rectus]; B --\u003e D[Contralateral MLF]; D --\u003e E[Contralateral CN III Nucleus]; E --\u003e F[Contralateral Medial Rectus];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"innervates\",\n        \"to\": \"f7b5ee5d\"\n      },\n      {\n        \"type\": \"is_vulnerable_to\",\n        \"to\": \"7c4e7c74\"\n      },\n      {\n        \"type\": \"palsy_causes\",\n        \"to\": \"9914d433\"\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"9a089fd7\"\n      }\n    ]\n  },\n  \"c0b7a1ca\": {\n    \"title\": \"Abnormal Motor Posturing\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Coma\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAbnormal motor posturing\u003c/b\u003e refers to involuntary flexion or extension of the arms and legs, indicating \u003ci\u003esevere brain injury\u003c/i\u003e. It occurs in patients who are comatose and reflects damage to motor pathways between the cerebral cortex and the brainstem.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDecorticate (Flexor) Posturing:\u003c/b\u003e Characterized by flexion of the arms, wrists, and fingers with adduction of the upper extremities, alongside extension, internal rotation, and plantar flexion of the lower extremities. Mnemonic: Hands are near the \u0027\u003cb\u003ecor\u003c/b\u003e\u0027 (heart).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDecorticate Lesion Level:\u003c/b\u003e Indicates damage \u003cu\u003eabove the red nucleus\u003c/u\u003e in the midbrain, such as in the cerebral hemispheres or internal capsule. The rubrospinal tract (flexor tone) is intact and overrides the vestibulospinal tract.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDecerebrate (Extensor) Posturing:\u003c/b\u003e Characterized by extension, adduction, and internal rotation of the arms with extension of the legs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDecerebrate Lesion Level:\u003c/b\u003e Indicates damage \u003cu\u003eat or below the red nucleus\u003c/u\u003e (e.g., midbrain tegmentum, pons). The loss of the rubrospinal tract leads to unopposed extension tone from the vestibulospinal tract.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Decerebrate posturing generally indicates a more severe brain injury and carries a \u003cu\u003eworse prognosis\u003c/u\u003e than decorticate posturing.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe type of abnormal posturing provides a crucial clue to the anatomical level of severe brain injury; \u003cb\u003edecorticate\u003c/b\u003e posturing implies a lesion above the red nucleus preserving flexor pathways, whereas \u003cb\u003edecerebrate\u003c/b\u003e posturing signifies a more caudal lesion below the red nucleus, leaving only extensor pathways unopposed.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cerebral Cortex] --\u003e B[Red Nucleus]; B --\u003e C[Rubrospinal Tract Flexion]; A --\u003e D[Vestibular Nuclei]; D --\u003e E[Vestibulospinal Tract Extension]; F(Lesion Above Red Nucleus) --\u003e G{Decorticate}; B --x F; H(Lesion Below Red Nucleus) --\u003e I{Decerebrate}; C --x H;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"e9a47751\"\n      },\n      {\n        \"type\": \"differentiates_lesion_level_in\",\n        \"to\": \"a584135d\"\n      }\n    ]\n  },\n  \"a0c128f4\": {\n    \"title\": \"Absence Seizures (Petit Mal)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pediatrics\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAbsence seizures\u003c/b\u003e, formerly known as \u003ci\u003epetit mal seizures\u003c/i\u003e, are a type of generalized seizure characterized by a sudden, brief lapse of consciousness without loss of postural tone, typically lasting for seconds. They are most common in childhood and are often mistaken for daydreaming or inattentiveness.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden cessation of activity with a blank stare, lasting about 10 seconds. May be accompanied by subtle automatisms like eyelid fluttering or lip smacking. There is \u003cu\u003eno postictal confusion\u003c/u\u003e; the patient immediately returns to baseline.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEEG Hallmark:\u003c/b\u003e The pathognomonic finding is a \u003cmark\u003egeneralized 3 Hz spike-and-wave discharge\u003c/mark\u003e on EEG.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProvocation:\u003c/b\u003e Seizures can often be triggered by \u003cmark\u003ehyperventilation\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e \u003cu\u003eFirst-line\u003c/u\u003e treatment is [[ethosuximide]]. [[valproic_acid|Valproic acid]] is also effective and used if tonic-clonic seizures are also present.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A classic vignette describes a child whose teacher complains of \u0027daydreaming\u0027 or \u0027not paying attention\u0027 in class. The diagnosis is confirmed by a 3 Hz spike-and-wave pattern on EEG, often induced by having the child hyperventilate.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAbsence seizures\u003c/b\u003e are unique among generalized seizures for their brief, non-convulsive nature, lack of postictal confusion, and a pathognomonic \u003cmark\u003e3 Hz spike-and-wave\u003c/mark\u003e EEG pattern, making [[ethosuximide]] the specific and preferred treatment.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Thalamic T-type Ca2+ Channels] -- Overactivity --\u003e B(Absence Seizure); C(Ethosuximide) -- Blocks --\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"a90f6fb4\"\n      },\n      {\n        \"type\": \"presents_with_eeg_finding\",\n        \"to\": \"eeg_3hz_spike_wave\"\n      }\n    ]\n  },\n  \"e62961a0\": {\n    \"title\": \"Absence Seizure Anticonvulsants\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pharmacology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAbsence seizure anticonvulsants\u003c/b\u003e are medications specifically effective in treating [[a0c128f4|absence seizures]], primarily by targeting the T-type calcium channels in thalamic neurons, which are implicated in the generation of the characteristic \u003cmark\u003e3 Hz spike-and-wave\u003c/mark\u003e discharges.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFirst-Line Agent:\u003c/b\u003e [[a90f6fb4|Ethosuximide]] is the \u003cu\u003efirst-line\u003c/u\u003e and most specific drug for treating isolated absence seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Ethosuximide:\u003c/b\u003e Blocks T-type Ca\u003csup\u003e2+\u003c/sup\u003e channels in thalamic neurons, disrupting the oscillatory rhythm between the thalamus and cortex that generates absence seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAlternative Agent:\u003c/b\u003e [[valproic_acid|Valproic acid]] is also effective and is preferred if the patient has concomitant generalized tonic-clonic seizures. It works by blocking T-type Ca\u003csup\u003e2+\u003c/sup\u003e channels and increasing [[5aa5cb91|GABA]] levels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindicated Agents:\u003c/b\u003e Certain anticonvulsants, such as [[eddd2bc5|carbamazepine]] and [[5aea213f|phenytoin]], can \u003cu\u003eworsen\u003c/u\u003e absence seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For a child with staring spells and a 3 Hz spike-and-wave EEG, the answer for treatment is almost always [[a90f6fb4|Ethosuximide]]. If tonic-clonic seizures are also mentioned, consider [[valproic_acid|Valproic acid]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe treatment of [[a0c128f4|absence seizures]] is highly specific, with [[a90f6fb4|Ethosuximide]] being the drug of choice due to its targeted blockade of thalamic T-type calcium channels, while other common anticonvulsants like carbamazepine are paradoxically contraindicated.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"a0c128f4\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"a90f6fb4\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"valproic_acid\"\n      }\n    ]\n  },\n  \"8558c64b\": {\n    \"title\": \"Acalculia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cognitive Deficit\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAcalculia\u003c/b\u003e is an acquired neurological deficit characterized by the \u003ci\u003einability to perform simple mathematical calculations\u003c/i\u003e, resulting from damage to specific brain regions, most notably the dominant (usually left) parietal lobe.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocalization:\u003c/b\u003e Acalculia is a key localizing sign for a lesion in the \u003cmark\u003edominant angular gyrus\u003c/mark\u003e of the parietal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndrome:\u003c/b\u003e It is one of the four classic components of [[38f3ed1f|Gerstmann syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eGerstmann Syndrome Tetrad:\u003c/b\u003e The full syndrome includes \u003cb\u003eAcalculia\u003c/b\u003e, \u003cb\u003eAgraphia\u003c/b\u003e (inability to write), \u003cb\u003eFinger Agnosia\u003c/b\u003e (inability to distinguish fingers), and \u003cb\u003eLeft-Right Disorientation\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Territory:\u003c/b\u003e These symptoms often result from a stroke in the territory of the [[143bb23d|Middle Cerebral Artery (MCA)]] that supplies the dominant parietal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When a patient presents with difficulty with calculations along with any of the other components of Gerstmann syndrome, immediately suspect a lesion in the dominant parietal lobe.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcalculia\u003c/b\u003e is more than just \u0027bad at math\u0027; it is a specific neurological sign that strongly points to a lesion in the dominant angular gyrus, often as part of the clinically distinct [[38f3ed1f|Gerstmann syndrome]].\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_component_of\",\n        \"to\": \"38f3ed1f\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"26efa771\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \"143bb23d\"\n      }\n    ]\n  },\n  \"f218aebf\": {\n    \"title\": \"Accessory Nerve (CN XI)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cranial Nerves\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAccessory Nerve (CN XI)\u003c/b\u003e is a \u003ci\u003emotor cranial nerve\u003c/i\u003e that provides innervation to the \u003cu\u003esternocleidomastoid (SCM)\u003c/u\u003e and \u003cu\u003etrapezius\u003c/u\u003e muscles, which are crucial for head turning and shoulder shrugging, respectively.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Innervates the ipsilateral \u003cb\u003eSternocleidomastoid (SCM)\u003c/b\u003e muscle, which turns the head to the contralateral side, and the ipsilateral \u003cb\u003eTrapezius\u003c/b\u003e muscle, which elevates and stabilizes the scapula (shoulder shrug).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Uniquely arises from both the brainstem (medulla) and the spinal cord (C1-C5). The spinal root ascends through the foramen magnum to join the cranial root, and the combined nerve then exits the skull via the [[jugular_foramen|jugular foramen]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Presentation (SCM):\u003c/b\u003e Weakness in turning the head \u003cu\u003eaway\u003c/u\u003e from the side of the lesion. (e.g., Left CN XI lesion causes weakness turning head to the right).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Presentation (Trapezius):\u003c/b\u003e \u003cmark\u003eShoulder droop\u003c/mark\u003e, weakness in shrugging the shoulder on the ipsilateral side, and winging of the scapula.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A common iatrogenic cause of an isolated CN XI lesion is injury during procedures in the \u003cmark\u003eposterior triangle of the neck\u003c/mark\u003e, such as lymph node biopsy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAccessory Nerve (CN XI)\u003c/b\u003e is unique in its dual origin from both the medulla and cervical spinal cord, and a lesion presents with the distinct combination of weakness turning the head to the contralateral side and an ipsilateral shoulder droop.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[CN XI Nuclei Medulla \u0026 C1-C5] --\u003e B(CN XI); B --\u003e C[Exits via Jugular Foramen]; C --\u003e D[Innervates SCM]; C --\u003e E[Innervates Trapezius];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"innervates\",\n        \"to\": \"sternocleidomastoid_muscle\"\n      },\n      {\n        \"type\": \"innervates\",\n        \"to\": \"trapezius_muscle\"\n      },\n      {\n        \"type\": \"exits_skull_via\",\n        \"to\": \"jugular_foramen\"\n      }\n    ]\n  },\n  \"81b5f5fe\": {\n    \"title\": \"Accommodation (Eye)\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physiology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAccommodation\u003c/b\u003e is a reflex action of the eye in response to focusing on a near object, involving a coordinated triad of changes: \u003ci\u003eciliary muscle contraction\u003c/i\u003e, \u003ci\u003epupillary constriction (miosis)\u003c/i\u003e, and \u003ci\u003econvergence of the eyes\u003c/i\u003e to maintain a clear image on the retina.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e It is a parasympathetic response mediated by the [[68c66997|oculomotor nerve (CN III)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eCiliary Muscle Contraction:\u003c/b\u003e Contraction of the ciliary muscle relaxes the zonular fibers, allowing the lens to become more convex (rounder), which increases its refractive power for near vision.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePupillary Constriction (Miosis):\u003c/b\u003e The sphincter pupillae muscle contracts, narrowing the pupil to increase the depth of field.\u003c/li\u003e\u003cli\u003e\u003cb\u003eConvergence:\u003c/b\u003e The medial rectus muscles contract to direct both eyes medially toward the near object.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Loss of accommodation with age is called [[presbyopia]]. A pupil that accommodates but does not react to light is an [[08cb577f|Argyll Robertson pupil]], a classic sign of neurosyphilis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eaccommodation reflex\u003c/b\u003e is a parasympathetically driven process via [[68c66997|CN III]] that allows for clear near vision by increasing the lens\u0027s refractive power through ciliary muscle contraction, a mechanism that becomes less effective with age, leading to presbyopia.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Focus on Near Object] --\u003e B[Visual Cortex]; B --\u003e C[CN III Nucleus Edinger-Westphal]; C --\u003e D[Ciliary Ganglion]; D --\u003e E[Ciliary Muscle Contraction -\u003e Lens rounds]; D --\u003e F[Sphincter Pupillae Contraction -\u003e Miosis]; B --\u003e G[CN III Motor Nucleus]; G --\u003e H[Medial Rectus Contraction -\u003e Convergence];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_mediated_by\",\n        \"to\": \"68c66997\"\n      },\n      {\n        \"type\": \"is_impaired_in\",\n        \"to\": \"presbyopia\"\n      },\n      {\n        \"type\": \"is_dissociated_from_light_reflex_in\",\n        \"to\": \"08cb577f\"\n      }\n    ]\n  },\n  \"1df262e8\": {\n    \"title\": \"Acetazolamide\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Renal\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAcetazolamide\u003c/b\u003e is a \u003ci\u003ecarbonic anhydrase inhibitor\u003c/i\u003e used as a diuretic and to reduce pressure in the eye and brain by decreasing the formation of aqueous humor and cerebrospinal fluid, respectively.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Inhibits the enzyme carbonic anhydrase in the ciliary body epithelium and choroid plexus, which reduces the formation of bicarbonate ions (HCO\u003csub\u003e3\u003c/sub\u003e\u003csup\u003e-\u003c/sup\u003e) and subsequently decreases fluid secretion (aqueous humor and CSF).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Ophthalmology):\u003c/b\u003e Treats [[3ce6c035|glaucoma]] (both open-angle and acute angle-closure) by \u003cmark\u003edecreasing aqueous humor synthesis\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Treats [[7c4e7c74|idiopathic intracranial hypertension]] (pseudotumor cerebri) by decreasing CSF production. Also used for altitude sickness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Causes a \u003cmark\u003ehyperchloremic metabolic acidosis\u003c/mark\u003e (non-anion gap), paresthesias, ammonia toxicity in liver disease, and promotes calcium phosphate kidney stones (due to alkalinization of urine). It is a sulfa drug, so watch for sulfa allergies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the mnemonic \u0027ACID-azolamide\u0027 to recall that it causes a metabolic \u003cb\u003eACID\u003c/b\u003eosis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcetazolamide\u003c/b\u003e\u0027s therapeutic effect in both [[3ce6c035|glaucoma]] and [[7c4e7c74|idiopathic intracranial hypertension]] stems from the same core mechanism: inhibiting carbonic anhydrase to reduce the production of bicarbonate-driven fluids, namely aqueous humor and cerebrospinal fluid.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Acetazolamide] --|Inhibits|--\u003e B(Carbonic Anhydrase); B --|Blocks|--\u003e C(H2O + CO2 \u003c--\u003e H2CO3 \u003c--\u003e H+ + HCO3-); C --|Leads to|--\u003e D[Decreased Aqueous Humor/CSF Production];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"7c4e7c74\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"metabolic_acidosis\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"carbonic_anhydrase_inhibitor\"\n      }\n    ]\n  },\n  \"6a005559\": {\n    \"title\": \"Acetylcholine (ACh)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Pharmacology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurotransmitters\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAcetylcholine (ACh)\u003c/b\u003e is a major \u003ci\u003eexcitatory neurotransmitter\u003c/i\u003e synthesized from choline and acetyl-CoA that functions at the neuromuscular junction, in all autonomic ganglia, at parasympathetic postganglionic nerve endings, and at various sites within the central nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSynthesis:\u003c/b\u003e Synthesized by Choline Acetyltransferase (ChAT) from choline and acetyl-CoA.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDegradation:\u003c/b\u003e Rapidly broken down in the synaptic cleft by Acetylcholinesterase (AChE) into choline and acetate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCNS Role:\u003c/b\u003e Crucial for memory and cognition. Levels are significantly decreased in [[77ae6148|Alzheimer disease]] due to degeneration of neurons in the [[361438f2|Basal nucleus of Meynert]]. Levels are also decreased in [[ffd7e743|Huntington disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePNS Role:\u003c/b\u003e Neurotransmitter at all preganglionic autonomic synapses (nicotinic), all parasympathetic postganglionic synapses (muscarinic), sympathetic postganglionic synapses to sweat glands (muscarinic), and the neuromuscular junction (nicotinic).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Diseases affecting ACh are high-yield. [[77ae6148|Alzheimer\u0027s]] (‚Üì CNS ACh), Myasthenia Gravis (antibodies to ACh receptors), Lambert-Eaton (‚Üì presynaptic ACh release). Drugs targeting AChE (e.g., [[47d0372e|donepezil]]) are used to treat Alzheimer\u0027s.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcetylcholine\u003c/b\u003e is a versatile neurotransmitter whose function is critically dependent on its location; its depletion in the [[361438f2|Basal nucleus of Meynert]] leads to cognitive decline in [[77ae6148|Alzheimer disease]], while its blockade at the neuromuscular junction causes paralysis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Choline + Acetyl-CoA] --ChAT--\u003e B(Acetylcholine); B --AChE--\u003e C[Choline + Acetate]; B --\u003e D{Receptors}; D --\u003e D1[Nicotinic]; D --\u003e D2[Muscarinic];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_decreased_in\",\n        \"to\": \"77ae6148\"\n      },\n      {\n        \"type\": \"is_decreased_in\",\n        \"to\": \"ffd7e743\"\n      },\n      {\n        \"type\": \"is_involved_in_pathophysiology_of\",\n        \"to\": \"myasthenia_gravis\"\n      },\n      {\n        \"type\": \"is_involved_in_pathophysiology_of\",\n        \"to\": \"lambert_eaton_syndrome\"\n      },\n      {\n        \"type\": \"is_synthesized_in\",\n        \"to\": \"361438f2\"\n      }\n    ]\n  },\n  \"87d19a70\": {\n    \"title\": \"Achilles Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAchilles reflex\u003c/b\u003e, also known as the ankle jerk reflex, is a deep tendon reflex that involves plantar flexion of the foot in response to tapping the Achilles tendon, testing the integrity of the \u003cmark\u003eS1 and S2\u003c/mark\u003e spinal nerve roots.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNerve Roots:\u003c/b\u003e Primarily tests the \u003cb\u003eS1\u003c/b\u003e nerve root, with contribution from S2. Mnemonic: S\u003cb\u003e1\u003c/b\u003e, 2, buckle my shoe.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Tapping the tendon stretches the gastrocnemius muscle, activating stretch receptors. The afferent signal travels via the tibial nerve to the S1/S2 spinal cord segments, synapses, and an efferent motor signal returns via the tibial nerve to cause plantar flexion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiminished/Absent Reflex:\u003c/b\u003e Suggests a lower motor neuron lesion, such as a herniated disc compressing the S1 root, or peripheral neuropathy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eExaggerated Reflex (Hyperreflexia):\u003c/b\u003e Suggests an upper motor neuron lesion, such as a stroke or spinal cord injury above the S1/S2 level.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An absent Achilles reflex is a classic finding in [[71daebd6|Tabes Dorsalis]] and [[lumbosacral_radiculopathy|S1 radiculopathy]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAchilles reflex\u003c/b\u003e is a simple yet powerful clinical tool that specifically assesses the integrity of the S1 spinal nerve root; its absence or exaggeration can help differentiate between lower and upper motor neuron pathologies.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Tap Achilles Tendon] --\u003e B(Stretch Gastrocnemius); B --\u003e C(Afferent Signal via Tibial N.); C --\u003e D[S1/S2 Spinal Cord]; D --\u003e E(Efferent Signal via Tibial N.); E --\u003e F(Plantar Flexion);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"tests_nerve_root\",\n        \"to\": \"s1_nerve_root\"\n      },\n      {\n        \"type\": \"is_absent_in\",\n        \"to\": \"71daebd6\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"deep_tendon_reflex\"\n      }\n    ]\n  },\n  \"fcedc59f\": {\n    \"title\": \"Neuron Action Potential\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurons\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eneuron action potential\u003c/b\u003e is a rapid, all-or-none electrical signal that propagates down an axon, caused by the sequential opening and closing of \u003ci\u003evoltage-gated ion channels\u003c/i\u003e, which temporarily reverses the membrane potential and allows for long-distance communication in the nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eResting Potential (~-70 mV):\u003c/b\u003e Maintained by the Na\u003csup\u003e+\u003c/sup\u003e/K\u003csup\u003e+\u003c/sup\u003e pump and high resting permeability to K\u003csup\u003e+\u003c/sup\u003e (K\u003csup\u003e+\u003c/sup\u003e leak channels).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDepolarization:\u003c/b\u003e A stimulus reaching threshold potential (~-55 mV) triggers the rapid opening of voltage-gated \u003cmark\u003eNa\u003csup\u003e+\u003c/sup\u003e channels\u003c/mark\u003e, causing a massive influx of Na\u003csup\u003e+\u003c/sup\u003e and a sharp rise in membrane potential.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRepolarization:\u003c/b\u003e Voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels inactivate, and voltage-gated \u003cmark\u003eK\u003csup\u003e+\u003c/sup\u003e channels\u003c/mark\u003e open, leading to an efflux of K\u003csup\u003e+\u003c/sup\u003e that brings the membrane potential back down.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHyperpolarization:\u003c/b\u003e K\u003csup\u003e+\u003c/sup\u003e channels are slow to close, causing the membrane potential to briefly dip below the resting potential.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Many neurotoxins and drugs target these channels. [[tetrodotoxin|Tetrodotoxin]] (pufferfish) and [[lidocaine|local anesthetics]] block voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels, preventing action potential propagation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe neuron action potential is fundamentally a precisely orchestrated sequence of ionic movements: a rapid influx of \u003cb\u003eNa\u003csup\u003e+\u003c/sup\u003e\u003c/b\u003e causes the rising phase (depolarization), and a subsequent efflux of \u003cb\u003eK\u003csup\u003e+\u003c/sup\u003e\u003c/b\u003e causes the falling phase (repolarization), enabling high-speed signal transmission.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A(Resting State) --Stimulus--\u003e B(Threshold); B --Na+ Influx--\u003e C(Depolarization); C --Na+ Inactivation \u0026 K+ Efflux--\u003e D(Repolarization); D --Slow K+ Channel Closing--\u003e E(Hyperpolarization); E --\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_blocked_by\",\n        \"to\": \"tetrodotoxin\"\n      },\n      {\n        \"type\": \"is_blocked_by\",\n        \"to\": \"local_anesthetics\"\n      },\n      {\n        \"type\": \"is_fundamental_to\",\n        \"to\": \"synaptic_transmission\"\n      }\n    ]\n  },\n  \"67e83e3b\": {\n    \"title\": \"Acute Disseminated Encephalomyelitis (ADEM)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Immunology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAcute Disseminated Encephalomyelitis (ADEM)\u003c/b\u003e is a rare, acute, \u003ci\u003eimmune-mediated inflammatory and demyelinating disorder\u003c/i\u003e of the central nervous system that typically occurs following a viral infection or, less commonly, a vaccination.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Believed to be caused by \u003cmark\u003emolecular mimicry\u003c/mark\u003e, where an immune response against an infectious agent cross-reacts with myelin antigens (e.g., myelin basic protein).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Rapid onset of multifocal neurological symptoms, including encephalopathy (altered mental status, confusion, coma), which is a key feature distinguishing it from a typical [[45dd6d19|Multiple Sclerosis]] flare. Other symptoms include fever, headache, seizures, and focal deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTiming:\u003c/b\u003e Symptoms typically appear 1-2 weeks after an antecedent infection (e.g., measles, varicella) or vaccination.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e MRI shows multiple, bilateral, asymmetric, poorly demarcated white matter lesions of similar age, often involving both the brain and spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate ADEM from [[45dd6d19|MS]]: ADEM is \u003cu\u003emonophasic\u003c/u\u003e and presents with encephalopathy, whereas MS is typically relapsing-remitting and rarely presents with encephalopathy in its initial flare.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcute Disseminated Encephalomyelitis\u003c/b\u003e is a post-infectious autoimmune attack on CNS myelin, distinguished from [[45dd6d19|Multiple Sclerosis]] by its \u003cu\u003emonophasic\u003c/u\u003e course and the prominent presence of encephalopathy alongside multifocal neurological deficits.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Viral Infection/Vaccination] --\u003e B(Immune Response); B --Molecular Mimicry--\u003e C[Attack on Myelin]; C --\u003e D[Perivenous Inflammation \u0026 Demyelination]; D --\u003e E[Multifocal Neurologic Deficits + Encephalopathy];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"demyelinating_disorder\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"is_triggered_by\",\n        \"to\": \"viral_infection\"\n      }\n    ]\n  },\n  \"ed52e40b\": {\n    \"title\": \"Acute Inflammatory Demyelinating Polyneuropathy (AIDP)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Immunology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Peripheral Neuropathies\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAcute Inflammatory Demyelinating Polyneuropathy (AIDP)\u003c/b\u003e is the most common subtype of \u003ci\u003eGuillain-Barr√© Syndrome\u003c/i\u003e, an autoimmune condition characterized by the rapid onset of symmetric, ascending muscle weakness or paralysis and destruction of myelin sheaths of peripheral nerves by Schwann cells.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Often triggered by an antecedent infection (classically \u003cmark\u003eCampylobacter jejuni\u003c/mark\u003e, also CMV, EBV, Zika). It is thought to be due to \u003cmark\u003emolecular mimicry\u003c/mark\u003e between microbial antigens and peripheral nerve myelin or axons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Rapidly progressive, symmetric \u003cmark\u003eascending weakness/paralysis\u003c/mark\u003e starting in the lower extremities. Patients often have absent or depressed deep tendon reflexes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Complications:\u003c/b\u003e Respiratory failure due to diaphragmatic weakness is a life-threatening complication. Autonomic dysfunction (tachycardia, arrhythmias, BP instability) is also common.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e CSF analysis shows \u003cmark\u003ealbuminocytologic dissociation\u003c/mark\u003e (high protein with a normal cell count). Nerve conduction studies show slowed nerve conduction velocity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of recent diarrheal illness (*C. jejuni*) followed by ascending paralysis and high protein in the CSF with normal cell count is a classic vignette for Guillain-Barr√© Syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAIDP (Guillain-Barr√© Syndrome)\u003c/b\u003e is an acute, post-infectious autoimmune attack on peripheral nerve myelin, leading to a characteristic ascending paralysis; the hallmark diagnostic finding is \u003cmark\u003ealbuminocytologic dissociation\u003c/mark\u003e in the CSF, reflecting widespread inflammation of nerve roots without direct infection.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Antecedent Infection e.g., C. jejuni] --\u003e B(Molecular Mimicry); B --\u003e C[Immune Attack on Schwann Cells/Myelin]; C --\u003e D[Peripheral Nerve Demyelination]; D --\u003e E[Ascending Paralysis \u0026 Areflexia];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_subtype_of\",\n        \"to\": \"e8720ceb\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"campylobacter_jejuni\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"a0f3ce4c\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"schwann_cells\"\n      }\n    ]\n  },\n  \"d268ace0\": {\n    \"title\": \"Opioid-Induced Acute Pulmonary Edema\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Toxicology\",\n      \"Pulmonology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Respiratory\",\n      \"Pathology\",\n      \"Acute Respiratory Distress Syndrome\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOpioid-induced acute pulmonary edema\u003c/b\u003e is a form of \u003ci\u003enon-cardiogenic pulmonary edema\u003c/i\u003e that can occur as a life-threatening complication of opioid overdose, characterized by increased pulmonary vascular permeability and subsequent alveolar flooding.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The exact mechanism is multifactorial but is thought to involve direct toxic effects on the pulmonary capillary endothelium, hypoxia-induced vascular injury, and a massive sympathetic surge following transient hypoxia, all leading to \u003cmark\u003eincreased vascular permeability\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Occurs shortly after an opioid overdose. Patients present with severe dyspnea, hypoxia, frothy pink sputum, and diffuse crackles on auscultation, often after being resuscitated with [[naloxone]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eRadiology:\u003c/b\u003e Chest X-ray shows bilateral diffuse alveolar infiltrates, consistent with pulmonary edema, but with a normal cardiac silhouette (distinguishing it from cardiogenic pulmonary edema).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management is supportive and includes supplemental oxygen, non-invasive or mechanical ventilation, and addressing the underlying opioid overdose. Diuretics are \u003cu\u003enot effective\u003c/u\u003e as the cause is permeability, not fluid overload.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Be aware of the patient who is treated for an opioid overdose with [[naloxone]] and subsequently develops severe respiratory distress; this points towards non-cardiogenic pulmonary edema rather than a cardiac cause.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eUnlike cardiogenic pulmonary edema which is caused by high hydrostatic pressure, \u003cb\u003eopioid-induced pulmonary edema\u003c/b\u003e is a permeability problem where opioid toxicity and hypoxia damage the alveolar-capillary barrier, leading to leaky vessels and flooded lungs that do not respond to diuretics.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Opioid Overdose] --\u003e B(Hypoxia \u0026 Direct Toxicity); B --\u003e C[Pulmonary Capillary Endothelial Damage]; C --\u003e D[Increased Vascular Permeability]; D --\u003e E[Alveolar Flooding]; E --\u003e F[Non-Cardiogenic Pulmonary Edema];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"opioid_analgesics\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"acute_respiratory_distress_syndrome\"\n      },\n      {\n        \"type\": \"is_treated_with\",\n        \"to\": \"naloxone\"\n      }\n    ]\n  },\n  \"76ba7f2e\": {\n    \"title\": \"Adenohypophysis (Anterior Pituitary)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Anatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Anatomy\",\n      \"Pituitary Gland\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAdenohypophysis\u003c/b\u003e, or anterior pituitary, is the anterior lobe of the pituitary gland, an endocrine gland of ectodermal origin (from \u003ci\u003eRathke\u0027s pouch\u003c/i\u003e) that synthesizes and secretes six major peptide hormones in response to releasing and inhibiting hormones from the [[89e86633|hypothalamus]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Arises from an upward evagination of the oral ectoderm called \u003cmark\u003eRathke\u0027s pouch\u003c/mark\u003e. Remnants can form a [[7048db1e|craniopharyngioma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eHormones Secreted:\u003c/b\u003e The anterior pituitary hormones can be remembered with the mnemonic \u003cb\u003eFLAT PiG\u003c/b\u003e: \u003cb\u003eF\u003c/b\u003eSH, \u003cb\u003eL\u003c/b\u003eH, \u003cb\u003eA\u003c/b\u003eCTH, \u003cb\u003eT\u003c/b\u003eSH (Tropic hormones), and \u003cb\u003eP\u003c/b\u003erolactin, \u003cb\u003ei\u003c/b\u003e(ignore), \u003cb\u003eG\u003c/b\u003eH (Direct hormones).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCell Types:\u003c/b\u003e Somatotrophs (GH), Lactotrophs (Prolactin), Corticotrophs (ACTH), Thyrotrophs (TSH), and Gonadotrophs (FSH/LH).\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Receives blood from the superior hypophyseal artery, which forms a portal system (hypothalamic-hypophyseal portal system) that transports hypothalamic releasing/inhibiting hormones directly to the anterior pituitary.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The most common tumor of the pituitary is a [[5f3188bd|pituitary adenoma]], which is most frequently a prolactinoma. Its connection to the [[89e86633|hypothalamus]] is vascular, in contrast to the posterior pituitary\u0027s neural connection.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAdenohypophysis\u003c/b\u003e is the hormonal powerhouse of the pituitary, controlled by the [[89e86633|hypothalamus]] via a unique portal venous system, and its diverse cell populations are responsible for regulating growth, stress, reproduction, and metabolism throughout the body.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypothalamus] --Releasing/Inhibiting Hormones--\u003e B(Hypophyseal Portal System); B --\u003e C(Adenohypophysis); C --\u003e D[FSH, LH]; C --\u003e E[ACTH]; C --\u003e F[TSH]; C --\u003e G[Prolactin]; C --\u003e H[GH];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"pituitary_gland\"\n      },\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"secretes\",\n        \"to\": \"growth_hormone\"\n      },\n      {\n        \"type\": \"secretes\",\n        \"to\": \"prolactin\"\n      },\n      {\n        \"type\": \"can_develop\",\n        \"to\": \"5f3188bd\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 10313,
      "parts": [{
        "text": "```json\n{\n  \"dd11dde6\": {\n    \"title\": \"Abducens Nerve"
      }, {
        "text": " (CN VI)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Cranial Nerves\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],"
      }, {
        "text": "\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"C"
      }, {
        "text": "ranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve"
      }, {
        "text": " (CN VI)\u003c/b\u003e is a somatic \u003ci\u003emotor cranial nerve\u003c/i\u003e that originates from the pontomedullary junction and \u003cu\u003eex"
      }, {
        "text": "clusively innervates\u003c/u\u003e the [[f7b5ee5d|Lateral Rectus muscle]], which is responsible for abduction"
      }, {
        "text": " of the eye (looking laterally).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Motor"
      }, {
        "text": " innervation to the ipsilateral [[f7b5ee5d|lateral rectus muscle]], enabling abduction (lateral eye"
      }, {
        "text": " movement).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Exits the brainstem at the pontomedullary junction, traverses the subarachnoid space, passes"
      }, {
        "text": " through the [[c260efc8|cavernous sinus]] near the internal carotid artery, and enters"
      }, {
        "text": " the orbit via the superior orbital fissure.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePalsy Presentation:\u003c/b\u003e Damage results in an inability to ab"
      }, {
        "text": "duct the affected eye, leading to a medially directed strabismus at rest and horizontal [[9914d"
      }, {
        "text": "433|diplopia]] that worsens on attempted lateral gaze toward the side of the lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eV"
      }, {
        "text": "ulnerability:\u003c/b\u003e Its long intracranial course makes it highly susceptible to downward traction from \u003cmark\u003eincreased intracranial pressure\u003c/mark\u003e ([["
      }, {
        "text": "7c4e7c74|idiopathic intracranial hypertension]], tumors, hydrocephalus).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An"
      }, {
        "text": " isolated CN VI palsy is often a \u003cmark\u003e\\\"false localizing sign\\\"\u003c/mark\u003e of elevated ICP rather than a direct"
      }, {
        "text": " brainstem lesion. It is the most commonly affected cranial nerve in [[c260efc8|cavernous sinus syndrome"
      }, {
        "text": "]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve\u003c/b\u003e has the longest intracranial course of all cranial"
      }, {
        "text": " nerves, making it uniquely vulnerable to stretching and compression from \u003cu\u003eincreased intracranial pressure\u003c/u\u003e, often presenting as a nonlocalizing palsy"
      }, {
        "text": " that signals a generalized brain pressure problem rather than a specific brainstem lesion.\u003c/p\u003e\",\n      \"mermaid\": \"graph LR"
      }, {
        "text": "; A[PPRF] --\u003e B[CN VI Nucleus]; B --\u003e C[Ipsilateral Lateral Rectus]; B --\u003e"
      }, {
        "text": " D[Contralateral MLF]; D --\u003e E[Contralateral CN III Nucleus]; E --\u003e F[Cont"
      }, {
        "text": "ralateral Medial Rectus];\"\n    },\n    \"connections\": [\n      {\n        \"type"
      }, {
        "text": "\": \"innervates\",\n        \"to\": \"f7b5ee5d\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_vulnerable_to\",\n        \"to\": \"7c4e7c7"
      }, {
        "text": "4\"\n      },\n      {\n        \"type\": \"palsy_causes\",\n        \"to\": \"9"
      }, {
        "text": "914d433\"\n      },\n      {\n        \"type\": \"is_affected_"
      }, {
        "text": "in\",\n        \"to\": \"9a089fd7\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"c0b7a1ca\": {\n    \"title\": \"Abnormal Motor Posturing\",\n    \""
      }, {
        "text": "primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Coma\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special S"
      }, {
        "text": "enses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eAbnormal motor posturing\u003c/b\u003e refers to involuntary flexion or extension of the arms and legs, indicating "
      }, {
        "text": "\u003ci\u003esevere brain injury\u003c/i\u003e. It occurs in patients who are comatose and reflects damage to motor pathways between the cerebral"
      }, {
        "text": " cortex and the brainstem.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDecorticate (Flex"
      }, {
        "text": "or) Posturing:\u003c/b\u003e Characterized by flexion of the arms, wrists, and fingers with adduction of the upper"
      }, {
        "text": " extremities, alongside extension, internal rotation, and plantar flexion of the lower extremities. Mnemonic: Hands are near the \u0027"
      }, {
        "text": "\u003cb\u003ecor\u003c/b\u003e\u0027 (heart).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDecorticate Lesion Level:\u003c/b\u003e Indicates damage \u003cu\u003eabove the"
      }, {
        "text": " red nucleus\u003c/u\u003e in the midbrain, such as in the cerebral hemispheres or internal capsule. The rubrospinal tract ("
      }, {
        "text": "flexor tone) is intact and overrides the vestibulospinal tract.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDecerebrate (Ext"
      }, {
        "text": "ensor) Posturing:\u003c/b\u003e Characterized by extension, adduction, and internal rotation of the arms with extension of the legs.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eDecerebrate Lesion Level:\u003c/b\u003e Indicates damage \u003cu\u003eat or below the red nucleus\u003c/u\u003e (e.g., mid"
      }, {
        "text": "brain tegmentum, pons). The loss of the rubrospinal tract leads to unopposed extension tone from the vestibulospinal tract."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Decerebrate posturing generally indicates a more severe brain injury and carries a "
      }, {
        "text": "\u003cu\u003eworse prognosis\u003c/u\u003e than decorticate posturing.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "The type of abnormal posturing provides a crucial clue to the anatomical level of severe brain injury; \u003cb\u003edecorticate\u003c/b\u003e"
      }, {
        "text": " posturing implies a lesion above the red nucleus preserving flexor pathways, whereas \u003cb\u003edecerebrate\u003c/b\u003e posturing signifies"
      }, {
        "text": " a more caudal lesion below the red nucleus, leaving only extensor pathways unopposed.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD"
      }, {
        "text": "; A[Cerebral Cortex] --\u003e B[Red Nucleus]; B --\u003e C[Rubrospinal Tract Flex"
      }, {
        "text": "ion]; A --\u003e D[Vestibular Nuclei]; D --\u003e E[Vestibulospinal Tract Extension]; F("
      }, {
        "text": "Lesion Above Red Nucleus) --\u003e G{Decorticate}; B --x F; H(Lesion Below Red Nucleus"
      }, {
        "text": ") --\u003e I{Decerebrate}; C --x H;\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_sign_of\",\n        \"to\": \"e9a47"
      }, {
        "text": "751\"\n      },\n      {\n        \"type\": \"differentiates_lesion_level_"
      }, {
        "text": "in\",\n        \"to\": \"a584135d\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"a0c128f4\": {\n    \"title\": \"Absence Se"
      }, {
        "text": "izures (Petit Mal)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Pediatrics\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAbsence seizures\u003c/b\u003e, formerly known as \u003ci\u003epetit mal seizures"
      }, {
        "text": "\u003c/i\u003e, are a type of generalized seizure characterized by a sudden, brief lapse of consciousness without loss of postural tone, typically lasting for"
      }, {
        "text": " seconds. They are most common in childhood and are often mistaken for daydreaming or inattentiveness.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden cessation of activity with a blank stare, lasting about 10 seconds"
      }, {
        "text": ". May be accompanied by subtle automatisms like eyelid fluttering or lip smacking. There is \u003cu\u003eno postictal confusion\u003c/u\u003e;"
      }, {
        "text": " the patient immediately returns to baseline.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEEG Hallmark:\u003c/b\u003e The pathognomonic finding is a \u003cmark\u003egeneralized"
      }, {
        "text": " 3 Hz spike-and-wave discharge\u003c/mark\u003e on EEG.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProvocation:\u003c/b\u003e Seizures can often"
      }, {
        "text": " be triggered by \u003cmark\u003ehyperventilation\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e \u003cu\u003eFirst-line\u003c/u\u003e"
      }, {
        "text": " treatment is [[ethosuximide]]. [[valproic_acid|Valproic acid]] is also effective and"
      }, {
        "text": " used if tonic-clonic seizures are also present.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A classic vignette describes a child whose"
      }, {
        "text": " teacher complains of \u0027daydreaming\u0027 or \u0027not paying attention\u0027 in class. The diagnosis is confirmed by a 3 Hz spike-and-wave"
      }, {
        "text": " pattern on EEG, often induced by having the child hyperventilate.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Absence seizures\u003c/b\u003e are unique among generalized seizures for their brief, non-convulsive nature, lack of postictal confusion, and a"
      }, {
        "text": " pathognomonic \u003cmark\u003e3 Hz spike-and-wave\u003c/mark\u003e EEG pattern, making [[ethosuximide]] the specific"
      }, {
        "text": " and preferred treatment.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Thalamic T-type Ca"
      }, {
        "text": "2+ Channels] -- Overactivity --\u003e B(Absence Seizure); C(Ethosuximide) -- Blocks"
      }, {
        "text": " --\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"treated_by\",\n        \"to\": \"a90f6fb4\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"presents_with_eeg_finding\",\n        \"to\": \"eeg_3"
      }, {
        "text": "hz_spike_wave\"\n      }\n    ]\n  },\n  \"e62961"
      }, {
        "text": "a0\": {\n    \"title\": \"Absence Seizure Anticonvulsants\",\n    \"primaryType\": \"concept"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pharmacology\",\n      \"Epilepsy\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003e\u003cb\u003eAbsence seizure anticonvulsants\u003c/b\u003e are medications specifically effective in treating [[a0c128f4|"
      }, {
        "text": "absence seizures]], primarily by targeting the T-type calcium channels in thalamic neurons, which are implicated in the generation of the characteristic"
      }, {
        "text": " \u003cmark\u003e3 Hz spike-and-wave\u003c/mark\u003e discharges.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eFirst-Line Agent:\u003c/b\u003e [[a90f6fb4|Ethosuximide]] is the "
      }, {
        "text": "\u003cu\u003efirst-line\u003c/u\u003e and most specific drug for treating isolated absence seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Ethosuximide:\u003c/b\u003e Blocks T"
      }, {
        "text": "-type Ca\u003csup\u003e2+\u003c/sup\u003e channels in thalamic neurons, disrupting the oscillatory rhythm between the thalamus and cortex that generates absence"
      }, {
        "text": " seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAlternative Agent:\u003c/b\u003e [[valproic_acid|Valproic acid]] is also effective and is"
      }, {
        "text": " preferred if the patient has concomitant generalized tonic-clonic seizures. It works by blocking T-type Ca\u003csup\u003e2+\u003c/sup\u003e channels"
      }, {
        "text": " and increasing [[5aa5cb91|GABA]] levels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindicated Agents:\u003c/b\u003e Certain"
      }, {
        "text": " anticonvulsants, such as [[eddd2bc5|carbamazepine]] and [[5aea213f|phenytoin]], can"
      }, {
        "text": " \u003cu\u003eworsen\u003c/u\u003e absence seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For a child with staring spells and a"
      }, {
        "text": " 3 Hz spike-and-wave EEG, the answer for treatment is almost always [[a90f6fb4|Eth"
      }, {
        "text": "osuximide]]. If tonic-clonic seizures are also mentioned, consider [[valproic_acid|Valproic acid]].\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003eThe treatment of [[a0c128f4|absence seizures]] is highly specific,"
      }, {
        "text": " with [[a90f6fb4|Ethosuximide]] being the drug of choice due to its targeted"
      }, {
        "text": " blockade of thalamic T-type calcium channels, while other common anticonvulsants like carbamazepine are paradoxically contraindicated"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treat"
      }, {
        "text": "s\",\n        \"to\": \"a0c128f4\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"includes\",\n        \"to\": \"a90f6fb4\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"includes\",\n        \"to\": \"valproic_acid\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"8558c64b\": {\n    \"title\": \"Acalculia\",\n    \"primaryType"
      }, {
        "text": "\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cognitive Deficit\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eAcalculia\u003c/b\u003e is an acquired neurological deficit characterized by the \u003ci\u003einability to perform simple"
      }, {
        "text": " mathematical calculations\u003c/i\u003e, resulting from damage to specific brain regions, most notably the dominant (usually left) parietal lobe.\u003c/p\u003e\","
      }, {
        "text": "\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocalization:\u003c/b\u003e Acalculia is a key localizing sign for"
      }, {
        "text": " a lesion in the \u003cmark\u003edominant angular gyrus\u003c/mark\u003e of the parietal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndrome"
      }, {
        "text": ":\u003c/b\u003e It is one of the four classic components of [[38f3ed1f|Gerstmann syndrome]]."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eGerstmann Syndrome Tetrad:\u003c/b\u003e The full syndrome includes \u003cb\u003eAcalculia\u003c/b\u003e, \u003cb\u003eAgraphia\u003c/b\u003e ("
      }, {
        "text": "inability to write), \u003cb\u003eFinger Agnosia\u003c/b\u003e (inability to distinguish fingers), and \u003cb\u003eLeft-"
      }, {
        "text": "Right Disorientation\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Territory:\u003c/b\u003e These symptoms often result from a stroke in the territory of the [[1"
      }, {
        "text": "43bb23d|Middle Cerebral Artery (MCA)]] that supplies the dominant parietal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE"
      }, {
        "text": " Tip:\u003c/b\u003e When a patient presents with difficulty with calculations along with any of the other components of Gerstmann syndrome,"
      }, {
        "text": " immediately suspect a lesion in the dominant parietal lobe.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcalculia"
      }, {
        "text": "\u003c/b\u003e is more than just \u0027bad at math\u0027; it is a specific neurological sign that strongly points to a lesion in the dominant angular"
      }, {
        "text": " gyrus, often as part of the clinically distinct [[38f3ed1f|Gerstmann syndrome]]."
      }, {
        "text": "\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_component_of\",\n        \"to\": \"38f3ed1f\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"26efa"
      }, {
        "text": "771\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n"
      }, {
        "text": "        \"to\": \"143bb23d\"\n      }\n    ]\n  },\n  \"f"
      }, {
        "text": "218aebf\": {\n    \"title\": \"Accessory Nerve (CN XI)\",\n    \"primaryType\": \""
      }, {
        "text": "anatomy\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cranial Nerves\",\n      "
      }, {
        "text": "\"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    "
      }, {
        "text": "],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAccessory Nerve (CN XI"
      }, {
        "text": ")\u003c/b\u003e is a \u003ci\u003emotor cranial nerve\u003c/i\u003e that provides innervation to the \u003cu\u003esternocleidomastoid (SC"
      }, {
        "text": "M)\u003c/u\u003e and \u003cu\u003etrapezius\u003c/u\u003e muscles, which are crucial for head turning and shoulder shrugging,"
      }, {
        "text": " respectively.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Innervates the ipsilateral "
      }, {
        "text": "\u003cb\u003eSternocleidomastoid (SCM)\u003c/b\u003e muscle, which turns the head to the contralateral side, and the ips"
      }, {
        "text": "ilateral \u003cb\u003eTrapezius\u003c/b\u003e muscle, which elevates and stabilizes the scapula (shoulder shrug).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway"
      }, {
        "text": ":\u003c/b\u003e Uniquely arises from both the brainstem (medulla) and the spinal cord (C1-C5"
      }, {
        "text": "). The spinal root ascends through the foramen magnum to join the cranial root, and the combined nerve then exits the skull via the [["
      }, {
        "text": "jugular_foramen|jugular foramen]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Presentation (SCM):\u003c/b\u003e Weakness in"
      }, {
        "text": " turning the head \u003cu\u003eaway\u003c/u\u003e from the side of the lesion. (e.g., Left CN XI lesion causes"
      }, {
        "text": " weakness turning head to the right).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Presentation (Trapezius):\u003c/b\u003e \u003cmark\u003eShoulder droop\u003c/"
      }, {
        "text": "mark\u003e, weakness in shrugging the shoulder on the ipsilateral side, and winging of the scapula.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e A common iatrogenic cause of an isolated CN XI lesion is injury during procedures in the \u003cmark\u003eposterior triangle"
      }, {
        "text": " of the neck\u003c/mark\u003e, such as lymph node biopsy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003eAccessory Nerve (CN XI)\u003c/b\u003e is unique in its dual origin from both the medulla and cervical spinal cord, and a"
      }, {
        "text": " lesion presents with the distinct combination of weakness turning the head to the contralateral side and an ipsilateral shoulder droop.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[CN XI Nuclei Medulla \u0026 C1-C5] --\u003e B(CN XI); B"
      }, {
        "text": " --\u003e C[Exits via Jugular Foramen]; C --\u003e D[Innervates SCM]; C --\u003e E[Innerv"
      }, {
        "text": "ates Trapezius];\"\n    },\n    \"connections\": [\n      {\n        \"type\":"
      }, {
        "text": " \"innervates\",\n        \"to\": \"sternocleidomastoid_muscle\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"innervates\",\n        \"to\": \"trapezius_muscle"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"exits_skull_via\",\n        \"to"
      }, {
        "text": "\": \"jugular_foramen\"\n      }\n    ]\n  },\n  \"81b5f"
      }, {
        "text": "5fe\": {\n    \"title\": \"Accommodation (Eye)\",\n    \"primaryType\": \"physiology\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Physiology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Phys"
      }, {
        "text": "iology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAccommodation\u003c/b\u003e is a"
      }, {
        "text": " reflex action of the eye in response to focusing on a near object, involving a coordinated triad of changes: \u003ci\u003ec"
      }, {
        "text": "iliary muscle contraction\u003c/i\u003e, \u003ci\u003epupillary constriction (miosis)\u003c/i\u003e, and \u003ci\u003econvergence of the eyes\u003c/i\u003e to"
      }, {
        "text": " maintain a clear image on the retina.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e It"
      }, {
        "text": " is a parasympathetic response mediated by the [[68c66997|oculomotor nerve (CN III"
      }, {
        "text": ")]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eCiliary Muscle Contraction:\u003c/b\u003e Contraction of the ciliary muscle relaxes the zonular fibers"
      }, {
        "text": ", allowing the lens to become more convex (rounder), which increases its refractive power for near vision.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePup"
      }, {
        "text": "illary Constriction (Miosis):\u003c/b\u003e The sphincter pupillae muscle contracts, narrowing the pupil to increase the depth of field."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eConvergence:\u003c/b\u003e The medial rectus muscles contract to direct both eyes medially toward the near object.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Loss of accommodation with age is called [[presbyopia]]. A pupil that accommodates but does not react to light is an"
      }, {
        "text": " [[08cb577f|Argyll Robertson pupil]], a classic sign of neurosyphilis.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eaccommodation reflex\u003c/b\u003e is a parasympathetically driven process via"
      }, {
        "text": " [[68c66997|CN III]] that allows for clear near vision by increasing the lens\u0027"
      }, {
        "text": "s refractive power through ciliary muscle contraction, a mechanism that becomes less effective with age, leading to presbyopia.\u003c/p\u003e\","
      }, {
        "text": "\n      \"mermaid\": \"graph TD; A[Focus on Near Object] --\u003e B[Visual Cortex]; B --\u003e C[CN"
      }, {
        "text": " III Nucleus Edinger-Westphal]; C --\u003e D[Ciliary Ganglion]; D --\u003e E[Ciliary Muscle Contraction -\u003e"
      }, {
        "text": " Lens rounds]; D --\u003e F[Sphincter Pupillae Contraction -\u003e Miosis]; B --\u003e G[CN III Motor"
      }, {
        "text": " Nucleus]; G --\u003e H[Medial Rectus Contraction -\u003e Convergence];\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_mediated_by\",\n        \"to\": \"68c669"
      }, {
        "text": "97\"\n      },\n      {\n        \"type\": \"is_impaired_in\",\n        \"to"
      }, {
        "text": "\": \"presbyopia\"\n      },\n      {\n        \"type\": \"is_dissociated_from"
      }, {
        "text": "_light_reflex_in\",\n        \"to\": \"08cb577f\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"1df262e8\": {\n    \"title\": \"Acetazolamide\",\n    \"primaryType\":"
      }, {
        "text": " \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Ophthalmology\",\n      \""
      }, {
        "text": "Renal\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eAcetazolamide\u003c/b\u003e is a \u003ci\u003ecarbonic anhydrase inhibitor\u003c/i\u003e used as a diuretic and to reduce"
      }, {
        "text": " pressure in the eye and brain by decreasing the formation of aqueous humor and cerebrospinal fluid, respectively.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Inhibits the enzyme carbonic anhydrase in the ciliary body epithelium and choroid plexus, which"
      }, {
        "text": " reduces the formation of bicarbonate ions (HCO\u003csub\u003e3\u003c/sub\u003e\u003csup\u003e-\u003c/sup\u003e) and subsequently decreases fluid secretion (aqueous humor and CSF"
      }, {
        "text": ").\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Ophthalmology):\u003c/b\u003e Treats [[3ce6c035|glaucoma]] (both open-angle"
      }, {
        "text": " and acute angle-closure) by \u003cmark\u003edecreasing aqueous humor synthesis\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Treats [["
      }, {
        "text": "7c4e7c74|idiopathic intracranial hypertension]] (pseudotumor cerebri) by decreasing CSF"
      }, {
        "text": " production. Also used for altitude sickness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Causes a \u003cmark\u003ehyperchloremic metabolic acidosis\u003c/mark\u003e ("
      }, {
        "text": "non-anion gap), paresthesias, ammonia toxicity in liver disease, and promotes calcium phosphate kidney stones ("
      }, {
        "text": "due to alkalinization of urine). It is a sulfa drug, so watch for sulfa allergies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e Remember the mnemonic \u0027ACID-azolamide\u0027 to recall that it causes a metabolic \u003cb\u003eACID\u003c/b\u003eosis."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcetazolamide\u003c/b\u003e\u0027s therapeutic effect in both [["
      }, {
        "text": "3ce6c035|glaucoma]] and [[7c4e7c74|idiopathic intracranial hypertension]] stems"
      }, {
        "text": " from the same core mechanism: inhibiting carbonic anhydrase to reduce the production of bicarbonate-driven fluids, namely aqueous humor and cerebrospinal fluid.\u003c/p\u003e\","
      }, {
        "text": "\n      \"mermaid\": \"graph TD; A[Acetazolamide] --|Inhibits|--\u003e B("
      }, {
        "text": "Carbonic Anhydrase); B --|Blocks|--\u003e C(H2O + CO2 \u003c--\u003e H2CO3 \u003c"
      }, {
        "text": "--\u003e H+ + HCO3-); C --|Leads to|--\u003e D[Decreased Aqueous Humor/CSF Production];\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6"
      }, {
        "text": "c035\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to"
      }, {
        "text": "\": \"7c4e7c74\"\n      },\n      {\n        \"type\": \"causes"
      }, {
        "text": "_adverse_effect\",\n        \"to\": \"metabolic_acidosis\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_a_type_of\",\n        \"to\": \"carbonic_anhydrase_inhibitor\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"6a005559\": {\n    \"title\": \"Acetyl"
      }, {
        "text": "choline (ACh)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "science\",\n      \"Pharmacology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Neurotransmitters\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAcetyl"
      }, {
        "text": "choline (ACh)\u003c/b\u003e is a major \u003ci\u003eexcitatory neurotransmitter\u003c/i\u003e synthesized from choline and acetyl-CoA that"
      }, {
        "text": " functions at the neuromuscular junction, in all autonomic ganglia, at parasympathetic postganglionic nerve endings, and at various"
      }, {
        "text": " sites within the central nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSynthesis:\u003c/b\u003e Synt"
      }, {
        "text": "hesized by Choline Acetyltransferase (ChAT) from choline and acetyl-CoA.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDegradation:\u003c/b\u003e Rapid"
      }, {
        "text": "ly broken down in the synaptic cleft by Acetylcholinesterase (AChE) into choline and acetate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCNS"
      }, {
        "text": " Role:\u003c/b\u003e Crucial for memory and cognition. Levels are significantly decreased in [[77ae6148|Alzheimer disease"
      }, {
        "text": "]] due to degeneration of neurons in the [[361438f2|Basal nucleus of Meynert]]. Levels"
      }, {
        "text": " are also decreased in [[ffd7e743|Huntington disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePNS Role:\u003c/b\u003e Neuro"
      }, {
        "text": "transmitter at all preganglionic autonomic synapses (nicotinic), all parasympathetic postganglionic synapses (muscarinic), sympathetic"
      }, {
        "text": " postganglionic synapses to sweat glands (muscarinic), and the neuromuscular junction (nicotinic).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Diseases affecting ACh are high-yield. [[77ae6148|Alzheimer\u0027"
      }, {
        "text": "s]] (‚Üì CNS ACh), Myasthenia Gravis (antibodies to ACh receptors), Lambert-Eaton (‚Üì presynaptic ACh release)."
      }, {
        "text": " Drugs targeting AChE (e.g., [[47d0372e|donepezil]]) are used to"
      }, {
        "text": " treat Alzheimer\u0027s.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcetylcholine\u003c/b\u003e is a versatile neurotransmitter whose"
      }, {
        "text": " function is critically dependent on its location; its depletion in the [[361438f2|Basal nucleus of Meynert"
      }, {
        "text": "]] leads to cognitive decline in [[77ae6148|Alzheimer disease]], while its blockade at the neuromuscular junction causes"
      }, {
        "text": " paralysis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Choline + Acetyl-CoA] --"
      }, {
        "text": "ChAT--\u003e B(Acetylcholine); B --AChE--\u003e C[Choline + Acetate]; B --\u003e D{"
      }, {
        "text": "Receptors}; D --\u003e D1[Nicotinic]; D --\u003e D2[Muscarinic];\"\n    },\n"
      }, {
        "text": "    \"connections\": [\n      {\n        \"type\": \"is_decreased_in\",\n        \""
      }, {
        "text": "to\": \"77ae6148\"\n      },\n      {\n        \"type\": \"is_decreased_"
      }, {
        "text": "in\",\n        \"to\": \"ffd7e743\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_involved_in_pathophysiology_of\",\n        \"to\": \"myasthenia_gravis\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_involved_in_pathophysiology_of\",\n        \"to\": \"lam"
      }, {
        "text": "bert_eaton_syndrome\"\n      },\n      {\n        \"type\": \"is_synthesized_in"
      }, {
        "text": "\",\n        \"to\": \"361438f2\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"87d19a70\": {\n    \"title\": \"Achilles Reflex\",\n    \"primaryType\": \""
      }, {
        "text": "physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Phys"
      }, {
        "text": "iology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003eThe \u003cb\u003eAchilles reflex\u003c/b\u003e, also known as the ankle jerk reflex, is a deep tendon reflex that"
      }, {
        "text": " involves plantar flexion of the foot in response to tapping the Achilles tendon, testing the integrity of the \u003cmark\u003eS1 and"
      }, {
        "text": " S2\u003c/mark\u003e spinal nerve roots.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNerve Roots:\u003c/b\u003e Primarily tests"
      }, {
        "text": " the \u003cb\u003eS1\u003c/b\u003e nerve root, with contribution from S2. Mnemonic: S\u003cb\u003e1\u003c/b\u003e, "
      }, {
        "text": "2, buckle my shoe.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Tapping the tendon stretches the gastrocnemius muscle, activating stretch"
      }, {
        "text": " receptors. The afferent signal travels via the tibial nerve to the S1/S2 spinal cord segments, synapses,"
      }, {
        "text": " and an efferent motor signal returns via the tibial nerve to cause plantar flexion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiminished/Absent Reflex"
      }, {
        "text": ":\u003c/b\u003e Suggests a lower motor neuron lesion, such as a herniated disc compressing the S1 root, or peripheral neuropathy."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eExaggerated Reflex (Hyperreflexia):\u003c/b\u003e Suggests an upper motor neuron lesion, such as a"
      }, {
        "text": " stroke or spinal cord injury above the S1/S2 level.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An absent Achilles"
      }, {
        "text": " reflex is a classic finding in [[71daebd6|Tabes Dorsalis]] and [[lumbosacral_rad"
      }, {
        "text": "iculopathy|S1 radiculopathy]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAchilles reflex\u003c/b\u003e is a simple"
      }, {
        "text": " yet powerful clinical tool that specifically assesses the integrity of the S1 spinal nerve root; its absence or exaggeration can help differentiate between lower"
      }, {
        "text": " and upper motor neuron pathologies.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Tap Achilles Tendon] --\u003e"
      }, {
        "text": " B(Stretch Gastrocnemius); B --\u003e C(Afferent Signal via Tibial N.); C --\u003e D["
      }, {
        "text": "S1/S2 Spinal Cord]; D --\u003e E(Efferent Signal via Tibial N.); E --\u003e F("
      }, {
        "text": "Plantar Flexion);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"tests"
      }, {
        "text": "_nerve_root\",\n        \"to\": \"s1_nerve_root\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_absent_in\",\n        \"to\": \"71daebd6\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\":"
      }, {
        "text": " \"deep_tendon_reflex\"\n      }\n    ]\n  },\n  \"fcedc59f\": {\n    "
      }, {
        "text": "\"title\": \"Neuron Action Potential\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience"
      }, {
        "text": "\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n"
      }, {
        "text": "      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurons\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eneuron action potential\u003c/b\u003e is a rapid, all-or-none electrical"
      }, {
        "text": " signal that propagates down an axon, caused by the sequential opening and closing of \u003ci\u003evoltage-gated ion channels\u003c/i\u003e"
      }, {
        "text": ", which temporarily reverses the membrane potential and allows for long-distance communication in the nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eResting Potential (~-70 mV):\u003c/b\u003e Maintained by the Na\u003csup\u003e+\u003c/sup\u003e/K\u003csup\u003e+\u003c/sup\u003e pump"
      }, {
        "text": " and high resting permeability to K\u003csup\u003e+\u003c/sup\u003e (K\u003csup\u003e+\u003c/sup\u003e leak channels).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDepolarization:"
      }, {
        "text": "\u003c/b\u003e A stimulus reaching threshold potential (~-55 mV) triggers the rapid opening of voltage-gated \u003cmark\u003eNa\u003csup\u003e"
      }, {
        "text": "+\u003c/sup\u003e channels\u003c/mark\u003e, causing a massive influx of Na\u003csup\u003e+\u003c/sup\u003e and a sharp rise in membrane potential.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRep"
      }, {
        "text": "olarization:\u003c/b\u003e Voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels inactivate, and voltage-gated \u003cmark\u003eK\u003csup\u003e+\u003c/sup\u003e channels\u003c/"
      }, {
        "text": "mark\u003e open, leading to an efflux of K\u003csup\u003e+\u003c/sup\u003e that brings the membrane potential back down.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHyper"
      }, {
        "text": "polarization:\u003c/b\u003e K\u003csup\u003e+\u003c/sup\u003e channels are slow to close, causing the membrane potential to briefly dip below the resting potential."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Many neurotoxins and drugs target these channels. [[tetrodotoxin|"
      }, {
        "text": "Tetrodotoxin]] (pufferfish) and [[lidocaine|local anesthetics]] block voltage-gated"
      }, {
        "text": " Na\u003csup\u003e+\u003c/sup\u003e channels, preventing action potential propagation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " neuron action potential is fundamentally a precisely orchestrated sequence of ionic movements: a rapid influx of \u003cb\u003eNa\u003csup\u003e+\u003c/sup\u003e\u003c/b\u003e"
      }, {
        "text": " causes the rising phase (depolarization), and a subsequent efflux of \u003cb\u003eK\u003csup\u003e+\u003c/sup\u003e\u003c/b\u003e causes the falling"
      }, {
        "text": " phase (repolarization), enabling high-speed signal transmission.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A("
      }, {
        "text": "Resting State) --Stimulus--\u003e B(Threshold); B --Na+ Influx--\u003e C(Depolarization); C --Na"
      }, {
        "text": "+ Inactivation \u0026 K+ Efflux--\u003e D(Repolarization); D --Slow K+ Channel Closing--\u003e E(Hyperpolarization); E"
      }, {
        "text": " --\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_blocked"
      }, {
        "text": "_by\",\n        \"to\": \"tetrodotoxin\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_blocked_by\",\n        \"to\": \"local_anesthetics\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_fundamental_to\",\n        \"to\": \"synaptic_transmission\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"67e83e3b\": {\n    \"title\": \""
      }, {
        "text": "Acute Disseminated Encephalomyelitis (ADEM)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Immunology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"D"
      }, {
        "text": "emyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAcute Dissemin"
      }, {
        "text": "ated Encephalomyelitis (ADEM)\u003c/b\u003e is a rare, acute, \u003ci\u003eimmune-mediated inflammatory and demyelinating disorder\u003c/i\u003e of the"
      }, {
        "text": " central nervous system that typically occurs following a viral infection or, less commonly, a vaccination.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Believed to be caused by \u003cmark\u003emolecular mimicry\u003c/mark\u003e, where an"
      }, {
        "text": " immune response against an infectious agent cross-reacts with myelin antigens (e.g., myelin basic protein).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation:\u003c/b\u003e Rapid onset of multifocal neurological symptoms, including encephalopathy (altered mental status, confusion, coma), which"
      }, {
        "text": " is a key feature distinguishing it from a typical [[45dd6d19|Multiple Sclerosis]] flare. Other"
      }, {
        "text": " symptoms include fever, headache, seizures, and focal deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTiming:\u003c/b\u003e Symptoms typically appear 1-2 weeks after an"
      }, {
        "text": " antecedent infection (e.g., measles, varicella) or vaccination.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e MRI shows multiple"
      }, {
        "text": ", bilateral, asymmetric, poorly demarcated white matter lesions of similar age, often involving both the brain and spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e Differentiate ADEM from [[45dd6d19|MS]]: ADEM is "
      }, {
        "text": "\u003cu\u003emonophasic\u003c/u\u003e and presents with encephalopathy, whereas MS is typically relapsing-remitting and rarely presents with encephal"
      }, {
        "text": "opathy in its initial flare.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcute Disseminated En"
      }, {
        "text": "cephalomyelitis\u003c/b\u003e is a post-infectious autoimmune attack on CNS myelin, distinguished from [[45dd6d19|"
      }, {
        "text": "Multiple Sclerosis]] by its \u003cu\u003emonophasic\u003c/u\u003e course and the prominent presence of encephalopathy alongside multifocal neurological deficits.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"graph TD; A[Viral Infection/Vaccination] --\u003e B(Immune Response); B --"
      }, {
        "text": "Molecular Mimicry--\u003e C[Attack on Myelin]; C --\u003e D[Perivenous Inflammation \u0026 Demyelination]; D --\u003e E["
      }, {
        "text": "Multifocal Neurologic Deficits + Encephalopathy];\"\n    },\n    \"connections\": [\n      "
      }, {
        "text": "{\n        \"type\": \"is_a_type_of\",\n        \"to\": \"demyelin"
      }, {
        "text": "ating_disorder\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\":"
      }, {
        "text": " \"45dd6d19\"\n      },\n      {\n        \"type\": \"is_triggered"
      }, {
        "text": "_by\",\n        \"to\": \"viral_infection\"\n      }\n    ]\n  },\n  \"ed52e"
      }, {
        "text": "40b\": {\n    \"title\": \"Acute Inflammatory Demyelinating Polyneuropathy (AIDP)\",\n    \"primaryType\":"
      }, {
        "text": " \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Immunology\",\n      \"Pathology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Peripheral Neuropathies\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eAcute Inflammatory Demyelinating Polyneuropathy (AIDP)\u003c/b\u003e is the most common subtype"
      }, {
        "text": " of \u003ci\u003eGuillain-Barr√© Syndrome\u003c/i\u003e, an autoimmune condition characterized by the rapid onset of symmetric, ascending muscle weakness or"
      }, {
        "text": " paralysis and destruction of myelin sheaths of peripheral nerves by Schwann cells.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Pathophysiology:\u003c/b\u003e Often triggered by an antecedent infection (classically \u003cmark\u003eCampylobacter jejuni\u003c/mark\u003e, also"
      }, {
        "text": " CMV, EBV, Zika). It is thought to be due to \u003cmark\u003emolecular mimicry\u003c/mark\u003e between microbial"
      }, {
        "text": " antigens and peripheral nerve myelin or axons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Rapidly progressive, symmetric \u003cmark\u003eascending weakness"
      }, {
        "text": "/paralysis\u003c/mark\u003e starting in the lower extremities. Patients often have absent or depressed deep tendon reflexes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey"
      }, {
        "text": " Complications:\u003c/b\u003e Respiratory failure due to diaphragmatic weakness is a life-threatening complication. Autonomic dysfunction (tachycardia, arrhythmias"
      }, {
        "text": ", BP instability) is also common.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e CSF analysis shows \u003cmark\u003ealbuminocytologic dissociation\u003c/mark\u003e"
      }, {
        "text": " (high protein with a normal cell count). Nerve conduction studies show slowed nerve conduction velocity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination"
      }, {
        "text": " of recent diarrheal illness (*C. jejuni*) followed by ascending paralysis and high protein in the CSF with normal cell"
      }, {
        "text": " count is a classic vignette for Guillain-Barr√© Syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAID"
      }, {
        "text": "P (Guillain-Barr√© Syndrome)\u003c/b\u003e is an acute, post-infectious autoimmune attack on peripheral nerve"
      }, {
        "text": " myelin, leading to a characteristic ascending paralysis; the hallmark diagnostic finding is \u003cmark\u003ealbuminocytologic dissociation\u003c/mark\u003e in the CSF, reflecting"
      }, {
        "text": " widespread inflammation of nerve roots without direct infection.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Antecedent Infection e"
      }, {
        "text": ".g., C. jejuni] --\u003e B(Molecular Mimicry); B --\u003e C[Immune Attack on Schwann"
      }, {
        "text": " Cells/Myelin]; C --\u003e D[Peripheral Nerve Demyelination]; D --\u003e E[Ascending Paralysis \u0026 A"
      }, {
        "text": "reflexia];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_subtype_of\",\n        \"to\": \"e8720ceb\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_associated_with\",\n        \"to\": \"campylobacter_jejuni\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"a"
      }, {
        "text": "0f3ce4c\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"sch"
      }, {
        "text": "wann_cells\"\n      }\n    ]\n  },\n  \"d268ace0\": {\n    \"title\": \"Op"
      }, {
        "text": "ioid-Induced Acute Pulmonary Edema\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Pharmacology\",\n      \"Toxicology\",\n      \"Pulmonology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Respiratory\",\n      \"Pathology\",\n      \"Acute Respiratory Distress Syndrome\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOpioid-induced acute pulmonary edema\u003c/b\u003e is a form"
      }, {
        "text": " of \u003ci\u003enon-cardiogenic pulmonary edema\u003c/i\u003e that can occur as a life-threatening complication of opioid overdose, characterized"
      }, {
        "text": " by increased pulmonary vascular permeability and subsequent alveolar flooding.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The exact"
      }, {
        "text": " mechanism is multifactorial but is thought to involve direct toxic effects on the pulmonary capillary endothelium, hypoxia-induced vascular injury"
      }, {
        "text": ", and a massive sympathetic surge following transient hypoxia, all leading to \u003cmark\u003eincreased vascular permeability\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation:\u003c/b\u003e Occurs shortly after an opioid overdose. Patients present with severe dyspnea, hypoxia, frothy pink sputum"
      }, {
        "text": ", and diffuse crackles on auscultation, often after being resuscitated with [[naloxone]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eRadi"
      }, {
        "text": "ology:\u003c/b\u003e Chest X-ray shows bilateral diffuse alveolar infiltrates, consistent with pulmonary edema, but with a normal cardiac"
      }, {
        "text": " silhouette (distinguishing it from cardiogenic pulmonary edema).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management is supportive and includes supplemental oxygen, non"
      }, {
        "text": "-invasive or mechanical ventilation, and addressing the underlying opioid overdose. Diuretics are \u003cu\u003enot effective\u003c/u\u003e as the cause"
      }, {
        "text": " is permeability, not fluid overload.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Be aware of the patient who is treated for an opioid overdose with"
      }, {
        "text": " [[naloxone]] and subsequently develops severe respiratory distress; this points towards non-cardiogenic pulmonary edema rather than a cardiac"
      }, {
        "text": " cause.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eUnlike cardiogenic pulmonary edema which is caused by high"
      }, {
        "text": " hydrostatic pressure, \u003cb\u003eopioid-induced pulmonary edema\u003c/b\u003e is a permeability problem where opioid toxicity and hypoxia damage the alveolar"
      }, {
        "text": "-capillary barrier, leading to leaky vessels and flooded lungs that do not respond to diuretics.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Opioid Overdose] --\u003e B(Hypoxia \u0026 Direct Toxicity); B --\u003e C["
      }, {
        "text": "Pulmonary Capillary Endothelial Damage]; C --\u003e D[Increased Vascular Permeability]; D --\u003e E[Alveolar Flo"
      }, {
        "text": "oding]; E --\u003e F[Non-Cardiogenic Pulmonary Edema];\"\n    },\n    \"connections\": ["
      }, {
        "text": "\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"opioid_analgesics\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"acute"
      }, {
        "text": "_respiratory_distress_syndrome\"\n      },\n      {\n        \"type\": \"is_treated_with\",\n        \""
      }, {
        "text": "to\": \"naloxone\"\n      }\n    ]\n  },\n  \"76ba7f2e\": {\n    \""
      }, {
        "text": "title\": \"Adenohypophysis (Anterior Pituitary)\",\n    \"primaryType\": \"anatomy\",\n    \""
      }, {
        "text": "tags\": [\n      \"Endocrinology\",\n      \"Anatomy\",\n      \"Physiology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Anatomy\",\n      \"Pit"
      }, {
        "text": "uitary Gland\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAdenohypophysis\u003c/b\u003e"
      }, {
        "text": ", or anterior pituitary, is the anterior lobe of the pituitary gland, an endocrine gland of ectodermal origin (from"
      }, {
        "text": " \u003ci\u003eRathke\u0027s pouch\u003c/i\u003e) that synthesizes and secretes six major peptide hormones in response to releasing"
      }, {
        "text": " and inhibiting hormones from the [[89e86633|hypothalamus]].\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Arises from an upward evagination of the oral ectoderm called"
      }, {
        "text": " \u003cmark\u003eRathke\u0027s pouch\u003c/mark\u003e. Remnants can form a [[7048db1e|craniopharyngi"
      }, {
        "text": "oma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eHormones Secreted:\u003c/b\u003e The anterior pituitary hormones can be remembered with the mnemonic \u003cb\u003eFL"
      }, {
        "text": "AT PiG\u003c/b\u003e: \u003cb\u003eF\u003c/b\u003eSH, \u003cb\u003eL\u003c/b\u003eH, \u003cb\u003eA\u003c/b\u003eCTH,"
      }, {
        "text": " \u003cb\u003eT\u003c/b\u003eSH (Tropic hormones), and \u003cb\u003eP\u003c/b\u003erolactin, \u003cb\u003ei\u003c/b\u003e(ignore"
      }, {
        "text": "), \u003cb\u003eG\u003c/b\u003eH (Direct hormones).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCell Types:\u003c/b\u003e Somatotrophs (GH), Lact"
      }, {
        "text": "otrophs (Prolactin), Corticotrophs (ACTH), Thyrotrophs (TSH), and Gonadotrophs (FSH/"
      }, {
        "text": "LH).\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Receives blood from the superior hypophyseal artery, which forms a portal"
      }, {
        "text": " system (hypothalamic-hypophyseal portal system) that transports hypothalamic releasing/inhibiting hormones directly to the anterior pituitary.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e The most common tumor of the pituitary is a [[5f3188bd|pituitary adenoma]], which is"
      }, {
        "text": " most frequently a prolactinoma. Its connection to the [[89e86633|hypothalamus]] is vascular"
      }, {
        "text": ", in contrast to the posterior pituitary\u0027s neural connection.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003eAdenohypophysis\u003c/b\u003e is the hormonal powerhouse of the pituitary, controlled by the [[89e8663"
      }, {
        "text": "3|hypothalamus]] via a unique portal venous system, and its diverse cell populations are responsible for regulating growth, stress"
      }, {
        "text": ", reproduction, and metabolism throughout the body.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypothalamus] --"
      }, {
        "text": "Releasing/Inhibiting Hormones--\u003e B(Hypophyseal Portal System); B --\u003e C(Adenohypophysis); C"
      }, {
        "text": " --\u003e D[FSH, LH]; C --\u003e E[ACTH]; C --\u003e F[TSH]; C --\u003e G[Prol"
      }, {
        "text": "actin]; C --\u003e H[GH];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part"
      }, {
        "text": "_of\",\n        \"to\": \"pituitary_gland\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_regulated_by\",\n        \"to\": \"89e86633\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"secretes\",\n        \"to\": \"growth_hormone\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"secretes\",\n        \"to\": \"prolactin\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"can_develop\",\n        \"to\": \"5f3188bd\"\n"
      }, {
        "text": "      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"69962905\",\n    \"letter\": \"H\",\n    \"term\": \"Haemophilus influenzae\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Haemophilus influenzae\",\n    \"sub_entries\": [\n      {\n        \"id\": \"7ef763d8\",\n        \"letter\": \"H\",\n        \"term\": \"otitis media\",\n        \"pages\": [\n          \"547\"\n        ],\n        \"context\": \"Haemophilus influenzae \u003e otitis media\"\n      }\n    ]\n  },\n  {\n    \"id\": \"3a58904e\",\n    \"letter\": \"H\",\n    \"term\": \"Hamartin protein\",\n    \"pages\": [\n      \"220\",\n      \"539\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Hamartin protein\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"26661e34\",\n    \"letter\": \"H\",\n    \"term\": \"Headaches\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Headaches\",\n    \"sub_entries\": [\n      {\n        \"id\": \"c326920f\",\n        \"letter\": \"H\",\n        \"term\": \"classification and treatment\",\n        \"pages\": [\n          \"532\"\n        ],\n        \"context\": \"Headaches \u003e classification and treatment\"\n      },\n      {\n        \"id\": \"1b44bfb2\",\n        \"letter\": \"H\",\n        \"term\": \"‚Äúthunderclap headache‚Äù\",\n        \"pages\": [\n          \"530\"\n        ],\n        \"context\": \"Headaches \u003e ‚Äúthunderclap headache‚Äù\"\n      },\n      {\n        \"id\": \"29c9ae8b\",\n        \"letter\": \"H\",\n        \"term\": \"‚Äúworst headache of my life‚Äù\",\n        \"pages\": [\n          \"530\"\n        ],\n        \"context\": \"Headaches \u003e ‚Äúworst headache of my life‚Äù\"\n      }\n    ]\n  },\n  {\n    \"id\": \"88e6f77e\",\n    \"letter\": \"H\",\n    \"term\": \"Hearing loss\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Hearing loss\",\n    \"sub_entries\": [\n      {\n        \"id\": \"eee72c14\",\n        \"letter\": \"H\",\n        \"term\": \"aging-related\",\n        \"pages\": [\n          \"548\"\n        ],\n        \"context\": \"Hearing loss \u003e aging-related\"\n      },\n      {\n        \"id\": \"1c891661\",\n        \"letter\": \"H\",\n        \"term\": \"diagnosis of\",\n        \"pages\": [\n          \"548\"\n        ],\n        \"context\": \"Hearing loss \u003e diagnosis of\"\n      },\n      {\n        \"id\": \"e6beee30\",\n        \"letter\": \"H\",\n        \"term\": \"types and common causes\",\n        \"pages\": [\n          \"548\"\n        ],\n        \"context\": \"Hearing loss \u003e types and common causes\"\n      }\n    ]\n  },\n  {\n    \"id\": \"25ffec56\",\n    \"letter\": \"H\",\n    \"term\": \"Heat stroke\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Heat stroke\",\n    \"sub_entries\": [\n      {\n        \"id\": \"0d0ccb06\",\n        \"letter\": \"H\",\n        \"term\": \"pathophysiology and management\",\n        \"pages\": [\n          \"530\"\n        ],\n        \"context\": \"Heat stroke \u003e pathophysiology and management\"\n      },\n      {\n        \"id\": \"ce70f959\",\n        \"letter\": \"H\",\n        \"term\": \"vs fever\",\n        \"pages\": [\n          \"530\"\n        ],\n        \"context\": \"Heat stroke \u003e vs fever\"\n      }\n    ]\n  },\n  {\n    \"id\": \"73c63548\",\n    \"letter\": \"H\",\n    \"term\": \"Hemangioblastoma, characteristics\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Hemangioblastoma, characteristics\",\n    \"sub_entries\": [\n      {\n        \"id\": \"1bbb6cef\",\n        \"letter\": \"H\",\n        \"term\": \"and histology\",\n        \"pages\": [\n          \"540\"\n        ],\n        \"context\": \"Hemangioblastoma, characteristics \u003e and histology\"\n      }\n    ]\n  },\n  {\n    \"id\": \"c9c8eefb\",\n    \"letter\": \"H\",\n    \"term\": \"Hemianopia\",\n    \"pages\": [\n      \"526\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Hemianopia\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"004e0bd6\",\n    \"letter\": \"H\",\n    \"term\": \"Hemiballismus\",\n    \"pages\": [\n      \"524\",\n      \"533\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Hemiballismus\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"134828d8\",\n    \"letter\": \"H\",\n    \"term\": \"Hemineglect\",\n    \"pages\": [\n      \"526\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Hemineglect\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"bc46aebd\",\n    \"letter\": \"H\",\n    \"term\": \"Hemiparesis, saccular aneurysms\",\n    \"pages\": [\n      \"530\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Hemiparesis, saccular aneurysms\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"646b7336\",\n    \"letter\": \"H\",\n    \"term\": \"Hemisection of spinal cord.\",\n    \"pages\": [\n      \"545\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Hemisection of spinal cord.\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"dc54f7a6\",\n    \"letter\": \"H\",\n    \"term\": \"Hemispatial neglect syndrome\",\n    \"pages\": [\n      \"524\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Hemispatial neglect syndrome\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"dcfdcc1d\",\n    \"letter\": \"H\",\n    \"term\": \"Hemorrhage\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Hemorrhage\",\n    \"sub_entries\": [\n      {\n        \"id\": \"a78eeeca\",\n        \"letter\": \"H\",\n        \"term\": \"intracranial\",\n        \"pages\": [\n          \"528\"\n        ],\n        \"context\": \"Hemorrhage \u003e intracranial\"\n      },\n      {\n        \"id\": \"f24e3496\",\n        \"letter\": \"H\",\n        \"term\": \"subarachnoid hemorrhage\",\n        \"pages\": [\n          \"530\"\n        ],\n        \"context\": \"Hemorrhage \u003e subarachnoid hemorrhage\"\n      }\n    ]\n  },\n  {\n    \"id\": \"2b10e164\",\n    \"letter\": \"H\",\n    \"term\": \"Hepatotoxicity\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Hepatotoxicity\",\n    \"sub_entries\": [\n      {\n        \"id\": \"8badded7\",\n        \"letter\": \"H\",\n        \"term\": \"with anticonvulsants\",\n        \"pages\": [\n          \"560\"\n        ],\n        \"context\": \"Hepatotoxicity \u003e with anticonvulsants\"\n      }\n    ]\n  },\n  {\n    \"id\": \"bdfcf456\",\n    \"letter\": \"H\",\n    \"term\": \"Hereditary motor and sensory\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Hereditary motor and sensory\",\n    \"sub_entries\": [\n      {\n        \"id\": \"456f9d17\",\n        \"letter\": \"H\",\n        \"term\": \"neuropathy\",\n        \"pages\": [\n          \"538\"\n        ],\n        \"context\": \"Hereditary motor and sensory \u003e neuropathy\"\n      }\n    ]\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 2199
    }, {
      "text": "**Beginning Exploration**\n\nI\u0027m now diving into the next JSON entry, focusing on *Haemophilus influenzae*. My immediate goal is to create a comprehensive microbe card for this particular organism. I plan to highlight its connection to otitis media and will further explore its potential neurological impacts.\n\n\n**Expanding the Scope**\n\nI\u0027ve moved on to the next set of JSON entries. I\u0027m focusing on creating a molecule card for Hamartin, and a finding card about headaches. I\u0027ll include details on various headache types and red flags. I\u0027m also preparing a finding card for hearing loss, covering age-related loss, diagnosis, and types. Lastly, I\u0027ll build a disease card for heat stroke, encompassing pathophysiology and management.\n\n\n**Adding New Cards**\n\nI\u0027ve tackled several more entries in the JSON. I\u0027m actively crafting new cards. This includes cards on Hemangioblastoma, Hemianopia, Hemiballismus, and Hemineglect. I\u0027m also planning to incorporate information on Hemiparesis related to saccular aneurysms.\n\n\n**Building the Knowledge Base**\n\nI\u0027m now in the process of generating new cards based on the entries in the JSON. I\u0027m focusing on creating cards for `Haemophilus influenzae`, `Hamartin protein`, `Headaches`, `Hearing loss`, and `Heat stroke`, each with a specific focus on relevant details for your specialized audience. I\u0027m also preparing a card on Hemiparesis related to saccular aneurysms. This is in addition to the work I have already completed on the other cards.\n\n\n**Creating Specific Cards**\n\nI\u0027m now generating new cards based on the JSON data. I\u0027ve begun creating microbe, molecule, finding, and disease cards, focusing on relevant details like the neurological implications of *Haemophilus influenzae*, the link between Hamartin and Tuberous Sclerosis, and classifications of headaches. I\u0027ll include types of hearing loss, and pathophysiology of heat stroke. I\u0027ve also incorporated details regarding Hemangioblastoma, Hemianopia, Hemiballismus, and Hemineglect. Finally, I will make progress on hemiparesis.\n\n\n",
      "role": "model",
      "tokenCount": 1090,
      "isThought": true,
      "thinkingBudget": 32768,
      "parts": [{
        "text": "**Beginning Exploration**\n\nI\u0027m now diving into the next JSON entry, focusing on *Haemophilus influenzae*. My immediate goal is to create a comprehensive microbe card for this particular organism. I plan to highlight its connection to otitis media and will further explore its potential neurological impacts.\n\n\n",
        "thought": true
      }, {
        "text": "**Expanding the Scope**\n\nI\u0027ve moved on to the next set of JSON entries. I\u0027m focusing on creating a molecule card for Hamartin, and a finding card about headaches. I\u0027ll include details on various headache types and red flags. I\u0027m also preparing a finding card for hearing loss, covering age-related loss, diagnosis, and types. Lastly, I\u0027ll build a disease card for heat stroke, encompassing pathophysiology and management.\n\n\n",
        "thought": true
      }, {
        "text": "**Adding New Cards**\n\nI\u0027ve tackled several more entries in the JSON. I\u0027m actively crafting new cards. This includes cards on Hemangioblastoma, Hemianopia, Hemiballismus, and Hemineglect. I\u0027m also planning to incorporate information on Hemiparesis related to saccular aneurysms.\n\n\n",
        "thought": true
      }, {
        "text": "**Building the Knowledge Base**\n\nI\u0027m now in the process of generating new cards based on the entries in the JSON. I\u0027m focusing on creating cards for `Haemophilus influenzae`, `Hamartin protein`, `Headaches`, `Hearing loss`, and `Heat stroke`, each with a specific focus on relevant details for your specialized audience. I\u0027m also preparing a card on Hemiparesis related to saccular aneurysms. This is in addition to the work I have already completed on the other cards.\n\n\n",
        "thought": true
      }, {
        "text": "**Creating Specific Cards**\n\nI\u0027m now generating new cards based on the JSON data. I\u0027ve begun creating microbe, molecule, finding, and disease cards, focusing on relevant details like the neurological implications of *Haemophilus influenzae*, the link between Hamartin and Tuberous Sclerosis, and classifications of headaches. I\u0027ll include types of hearing loss, and pathophysiology of heat stroke. I\u0027ve also incorporated details regarding Hemangioblastoma, Hemianopia, Hemiballismus, and Hemineglect. Finally, I will make progress on hemiparesis.\n\n\n",
        "thought": true
      }]
    }, {
      "text": "```json\n{\n  \"69962905\": {\n    \"title\": \"Haemophilus influenzae (Neurological)\",\n    \"primaryType\": \"microbe\",\n    \"tags\": [\n      \"Neurology\",\n      \"Infectious Disease\",\n      \"Microbiology\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Infections\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHaemophilus influenzae\u003c/b\u003e is a small, pleomorphic, gram-negative coccobacillus that is a significant cause of bacterial meningitis, epiglottitis, and \u003ci\u003eotitis media\u003c/i\u003e, particularly in unvaccinated children. The encapsulated type b (Hib) strain is the most invasive and historically was the leading cause of pediatric meningitis.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMicrobiology:\u003c/b\u003e Gram-negative coccobacillus. Requires both \u003cmark\u003efactor X (hematin)\u003c/mark\u003e and \u003cmark\u003efactor V (NAD+)\u003c/mark\u003e for growth, which are present in chocolate agar.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Infections:\u003c/b\u003e A common cause of bacterial [[meningitis]] in children (age 6 months to 5 years) before the Hib vaccine. Also a major cause of [[a03641af|otitis media]], sinusitis, and epiglottitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVirulence:\u003c/b\u003e The type b strain has a polyribosylribitol phosphate (PRP) polysaccharide capsule, which is antiphagocytic and is the target of the Hib conjugate vaccine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVaccination:\u003c/b\u003e The Hib conjugate vaccine, which conjugates the PRP capsule to a protein carrier (like tetanus toxoid), has dramatically reduced the incidence of invasive H. influenzae disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a vignette about an unvaccinated child with meningitis, fever, and a stiff neck, \u003ci\u003eH. influenzae\u003c/i\u003e type b should be a top differential. Remember it grows on \u003cmark\u003echocolate agar\u003c/mark\u003e but not blood agar.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eWhile vaccination has made invasive \u003cb\u003eHaemophilus influenzae\u003c/b\u003e type b disease rare, non-typeable (unencapsulated) strains remain a leading cause of mucosal infections like [[a03641af|otitis media]] and sinusitis in children by colonizing the nasopharynx.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"meningitis\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"a03641af\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"epiglottitis\"\n      },\n      {\n        \"type\": \"is_prevented_by\",\n        \"to\": \"hib_vaccine\"\n      }\n    ]\n  },\n  \"3a58904e\": {\n    \"title\": \"Hamartin\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Neurology\",\n      \"Genetics\",\n      \"Oncology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neurocutaneous Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHamartin\u003c/b\u003e is a \u003ci\u003etumor suppressor protein\u003c/i\u003e encoded by the \u003cb\u003eTSC1 gene\u003c/b\u003e on chromosome 9. It forms a complex with the protein tuberin (from the TSC2 gene) to regulate cell growth and proliferation by inhibiting the mTOR pathway.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGene:\u003c/b\u003e Encoded by the \u003ci\u003eTSC1\u003c/i\u003e gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Forms a heterodimer with tuberin (TSC2 protein). This complex acts as a GTPase-activating protein (GAP) for the small G protein Rheb.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e By inactivating Rheb, the hamartin-tuberin complex \u003cu\u003einhibits\u003c/u\u003e \u003cmark\u003emTOR (mechanistic target of rapamycin) complex 1\u003c/mark\u003e, a key regulator of cell growth, proliferation, and protein synthesis.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e A loss-of-function mutation in the \u003ci\u003eTSC1\u003c/i\u003e gene leads to a non-functional hamartin protein, resulting in unchecked mTOR activity and the formation of hamartomas characteristic of [[83302339|Tuberous Sclerosis Complex]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the association: \u003cb\u003eTSC1\u003c/b\u003e mutation ‚Üí defective \u003cb\u003eHamartin\u003c/b\u003e ‚Üí [[83302339|Tuberous Sclerosis]]. The clinical findings of Tuberous Sclerosis (hamartomas, angiofibromas, ash-leaf spots) are a direct result of mTOR pathway disinhibition.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHamartin\u003c/b\u003e acts as a crucial brake on the mTOR cell growth pathway; its inactivation through a TSC1 mutation releases this brake, leading to the widespread, multi-organ hamartoma formation seen in [[83302339|Tuberous Sclerosis]].\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[TSC1 gene] --\u003e B(Hamartin); C[TSC2 gene] --\u003e D(Tuberin); B + D --\u003e E(Hamartin-Tuberin Complex); E --|Inhibits|--\u003e F(Rheb); F --|Activates|--\u003e G(mTORC1); G --\u003e H(Cell Growth \u0026 Proliferation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_encoded_by\",\n        \"to\": \"tsc1_gene\"\n      },\n      {\n        \"type\": \"mutation_causes\",\n        \"to\": \"83302339\"\n      },\n      {\n        \"type\": \"inhibits\",\n        \"to\": \"mtor_pathway\"\n      },\n      {\n        \"type\": \"forms_complex_with\",\n        \"to\": \"tuberin\"\n      }\n    ]\n  },\n  \"26661e34\": {\n    \"title\": \"Headaches\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Headaches\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHeadache\u003c/b\u003e is the symptom of pain anywhere in the region of the head or neck, which can be classified as a \u003ci\u003eprimary disorder\u003c/i\u003e (e.g., migraine, tension, cluster) or as a \u003ci\u003esecondary symptom\u003c/i\u003e of an underlying pathology (e.g., hemorrhage, tumor, infection).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTension Headache:\u003c/b\u003e Most common type. Bilateral, \u0027band-like\u0027 pressure. Lasts \u003e30 min. No photophobia/phonophobia or nausea. Treated with NSAIDs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMigraine Headache:\u003c/b\u003e Unilateral, pulsating pain lasting 4-72 hours. Associated with nausea, photophobia, and/or phonophobia. May have an aura. Treated with triptans, NSAIDs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCluster Headache:\u003c/b\u003e Excruciating, unilateral periorbital pain lasting 15-180 min. Accompanied by autonomic symptoms (lacrimation, rhinorrhea). Treated with 100% O\u003csub\u003e2\u003c/sub\u003e, sumatriptan.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRed Flag Headaches:\u003c/b\u003e A \u003cmark\u003e\\\"thunderclap headache\\\"\u003c/mark\u003e (sudden, severe onset) is classic for [[63f8b05f|subarachnoid hemorrhage]]. The \u003cmark\u003e\\\"worst headache of my life\\\"\u003c/mark\u003e is also highly suggestive of SAH. Headaches that are worse with lying down, awaken a patient from sleep, or are associated with focal neurologic deficits suggest increased intracranial pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiating primary headaches is key. Tension \u003d bilateral, band-like. Migraine \u003d unilateral, pulsating, with aura/nausea. Cluster \u003d unilateral, periorbital, with autonomic signs.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eWhile most headaches are benign primary disorders, the sudden onset of a \u003cb\u003e\\\"thunderclap headache\\\"\u003c/b\u003e or the \u003cb\u003e\\\"worst headache of my life\\\"\u003c/b\u003e is a neurological emergency that requires immediate investigation to rule out a life-threatening [[63f8b05f|subarachnoid hemorrhage]].\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"63f8b05f\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"meningitis\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"7c4e7c74\"\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"migraine_headache\"\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"cluster_headache\"\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"tension_headache\"\n      }\n    ]\n  },\n  \"88e6f77e\": {\n    \"title\": \"Hearing Loss\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Otology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHearing loss\u003c/b\u003e is a partial or total inability to hear, classified as either \u003ci\u003econductive\u003c/i\u003e, involving problems with the outer or middle ear, or \u003ci\u003esensorineural\u003c/i\u003e, involving damage to the inner ear (cochlea) or the auditory nerve pathway to the brain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eConductive Hearing Loss:\u003c/b\u003e Occurs when sound waves are not conducted efficiently to the inner ear. Causes include cerumen impaction, [[a03641af|otitis media]], otosclerosis, or tympanic membrane perforation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSensorineural Hearing Loss:\u003c/b\u003e Caused by damage to the hair cells in the cochlea or the vestibulocochlear nerve (CN VIII). Causes include \u003cmark\u003epresbycusis\u003c/mark\u003e (age-related), noise-induced damage, ototoxic drugs (e.g., aminoglycosides, cisplatin, loop diuretics), and acoustic neuromas ([[03ecb69e|schwannomas]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis (Weber Test):\u003c/b\u003e Tuning fork on vertex of skull. Conductive loss: lateralizes to the affected ear. Sensorineural loss: lateralizes to the unaffected ear.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis (Rinne Test):\u003c/b\u003e Compares air conduction (AC) to bone conduction (BC). Normal/Sensorineural: AC \u003e BC. Conductive: \u003cmark\u003eBC \u003e AC\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the diagnostic pattern. In conductive loss, the Weber test lateralizes \u003ci\u003etowards\u003c/i\u003e the bad ear because it masks ambient noise, making bone conduction seem louder.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe differentiation between \u003cb\u003econductive\u003c/b\u003e and \u003cb\u003esensorineural\u003c/b\u003e hearing loss is critical for diagnosis; conductive loss is a mechanical problem of sound transmission (BC \u003e AC on Rinne), while sensorineural loss is a nerve problem of sound transduction (AC \u003e BC, but both are reduced).\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Sound] --\u003e B{Outer/Middle Ear}; B --Conductive Loss--\u003e X[Blocked]; B --\u003e C{Inner Ear/Nerve}; C --Sensorineural Loss--\u003e Y[Damaged]; C --\u003e D[Brain];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"conductive_hearing_loss\"\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"sensorineural_hearing_loss\"\n      },\n      {\n        \"type\": \"is_diagnosed_using\",\n        \"to\": \"weber_test\"\n      },\n      {\n        \"type\": \"is_diagnosed_using\",\n        \"to\": \"rinne_test\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"presbycusis\"\n      }\n    ]\n  },\n  \"25ffec56\": {\n    \"title\": \"Heat Stroke\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Emergency Medicine\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Temperature Regulation\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHeat stroke\u003c/b\u003e is a life-threatening medical emergency characterized by a core body temperature above 40¬∞C (104¬∞F) and central nervous system dysfunction, resulting from the failure of the body\u0027s thermoregulatory mechanisms.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Occurs when heat generation exceeds the body\u0027s ability to dissipate heat. This leads to systemic inflammation, multiorgan dysfunction, and CNS abnormalities. Unlike fever, the hypothalamic set-point is \u003cu\u003enot\u003c/u\u003e elevated.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTypes:\u003c/b\u003e \u003cb\u003eExertional\u003c/b\u003e (occurs in healthy individuals during strenuous physical activity in hot/humid conditions) and \u003cb\u003eNon-exertional/Classic\u003c/b\u003e (affects sedentary individuals, elderly, or chronically ill during heat waves).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Core temperature \u003e40¬∞C, \u003cmark\u003ealtered mental status\u003c/mark\u003e (confusion, delirium, coma, seizures), and often, but not always, anhidrosis (absence of sweating), particularly in non-exertional heat stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eManagement:\u003c/b\u003e \u003cu\u003eImmediate rapid cooling\u003c/u\u003e is the cornerstone of treatment (e.g., ice water immersion). Antipyretics like acetaminophen or NSAIDs are \u003cu\u003eineffective\u003c/u\u003e because the hypothalamic set-point is not altered.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from fever: in heat stroke, the cause is external heat load overwhelming thermoregulation, and antipyretics do not work. In fever, the cause is an elevated hypothalamic set-point due to pyrogens, and antipyretics are effective.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHeat stroke\u003c/b\u003e is a failure of thermoregulation, not a change in the hypothalamic set-point. Therefore, the critical intervention is rapid physical cooling, as antipyretics that target the hypothalamus are completely ineffective.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Heat Load \u003e Heat Dissipation] --\u003e B(Failure of Thermoregulation); B --\u003e C[Core Temp \u003e 40¬∞C]; C --\u003e D[CNS Dysfunction]; C --\u003e E[Multiorgan Damage];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"fever\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"hyperthermia\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"altered_mental_status\"\n      }\n    ]\n  },\n  \"73c63548\": {\n    \"title\": \"Hemangioblastoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eHemangioblastoma\u003c/b\u003e is a benign, highly vascular tumor of the central nervous system, typically arising in the cerebellum, brainstem, or spinal cord, and is strongly associated with \u003ci\u003evon Hippel-Lindau disease\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Most often found in the \u003cmark\u003ecerebellum\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e Appears as a well-circumscribed, cystic lesion with a brightly enhancing \u003cmark\u003emural nodule\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e Composed of closely arranged, thin-walled capillaries with intervening stromal cells that have clear, lipid-rich cytoplasm.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParaneoplastic Syndrome:\u003c/b\u003e The tumor can ectopically produce \u003cmark\u003eerythropoietin (EPO)\u003c/mark\u003e, leading to secondary polycythemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGenetic Association:\u003c/b\u003e A hallmark of [[274cb033|von Hippel-Lindau (VHL) disease]], an autosomal dominant disorder. The presence of a hemangioblastoma should prompt investigation for other VHL-associated tumors (e.g., renal cell carcinoma, pheochromocytoma).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with cerebellar symptoms (ataxia, dysmetria) and polycythemia should make you think of a hemangioblastoma. If there\u0027s a family history of similar tumors or renal cancer, suspect VHL.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHemangioblastoma\u003c/b\u003e is a unique CNS tumor that acts as both a space-occupying lesion causing cerebellar signs and an endocrine factory ectopically producing erythropoietin, making the combination of ataxia and polycythemia a highly specific clinical picture.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[VHL Gene Mutation] --\u003e B(Hemangioblastoma); B --\u003e C[Cerebellar Symptoms]; B --Ectopic EPO Production--\u003e D[Secondary Polycythemia];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"274cb033\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"polycythemia\"\n      },\n      {\n        \"type\": \"produces\",\n        \"to\": \"erythropoietin\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"be057cfc\"\n      }\n    ]\n  },\n  \"c9c8eefb\": {\n    \"title\": \"Hemianopia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Visual Field Defects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHemianopia\u003c/b\u003e (or hemianopsia) is a visual field defect characterized by the loss of vision in \u003ci\u003ehalf of the visual field\u003c/i\u003e of one or both eyes. The pattern of vision loss is critical for localizing lesions along the visual pathway.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBitemporal Hemianopia:\u003c/b\u003e Loss of the outer (temporal) half of the visual field in both eyes. Caused by a lesion compressing the \u003cmark\u003eoptic chiasm\u003c/mark\u003e (e.g., [[5f3188bd|pituitary adenoma]], [[7048db1e|craniopharyngioma]], ACom aneurysm).\u003c/li\u003e\u003cli\u003e\u003cb\u003eHomonymous Hemianopia:\u003c/b\u003e Loss of the same half (e.g., both right halves or both left halves) of the visual field in both eyes. Caused by a lesion \u003cu\u003eposterior\u003c/u\u003e to the optic chiasm (e.g., optic tract, lateral geniculate nucleus, optic radiations, or visual cortex).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMacular Sparing:\u003c/b\u003e In homonymous hemianopia caused by a [[b6a2cc31|Posterior Cerebral Artery (PCA)]] stroke, central vision may be spared due to dual blood supply to the occipital pole from the [[143bb23d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eQuadrantanopia:\u003c/b\u003e Loss of one quadrant of the visual field. A lesion in the temporal lobe (Meyer\u0027s loop) causes a contralateral superior quadrantanopia (\\\"pie in the sky\\\"). A lesion in the parietal lobe (Dorsal optic radiation) causes a contralateral inferior quadrantanopia (\\\"pie on the floor\\\").\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the crossing pattern: fibers from the nasal retina (representing the temporal visual field) cross at the chiasm. Therefore, a midline chiasmal lesion affects both temporal fields.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe pattern of \u003cb\u003ehemianopia\u003c/b\u003e is a precise roadmap to the location of a neurological lesion: a bitemporal defect points directly to the optic chiasm, while a homonymous defect indicates a lesion anywhere from the optic tract back to the visual cortex.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Optic Chiasm Lesion] --\u003e B(Bitemporal Hemianopia); C[Post-Chiasmal Lesion] --\u003e D(Homonymous Hemianopia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"ff289b3a\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"5f3188bd\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"stroke\"\n      }\n    ]\n  },\n  \"004e0bd6\": {\n    \"title\": \"Hemiballismus\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Movement Disorders\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHemiballismus\u003c/b\u003e is a rare hyperkinetic movement disorder characterized by \u003ci\u003ewild, flinging, large-amplitude movements\u003c/i\u003e of the proximal arm and leg on one side of the body, resulting from a lesion in the contralateral subthalamic nucleus.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e A lesion in the \u003cmark\u003econtralateral subthalamic nucleus (STN)\u003c/mark\u003e disrupts the indirect pathway of the [[ed462927|basal ganglia]]. This leads to decreased inhibition of the thalamus, resulting in excessive, uncontrolled movements.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by a \u003cmark\u003elacunar stroke\u003c/mark\u003e affecting the small penetrating arteries that supply the STN. Other causes include hemorrhage, tumors, or hyperglycemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden onset of violent, involuntary, flinging movements of one arm and/or leg. Mnemonic: In \u003cb\u003ehemi\u003c/b\u003eballismus, \u003cb\u003ehalf\u003c/b\u003e of the body is going \u003cb\u003eballistic\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Often self-limiting, resolving over weeks to months. Symptomatic treatment can include dopamine antagonists (e.g., haloperidol) to reduce the hyperkinetic movements.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A sudden onset of wild, unilateral flinging movements in an elderly patient with a history of hypertension strongly suggests a lacunar stroke in the contralateral subthalamic nucleus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHemiballismus\u003c/b\u003e is a dramatic clinical sign that precisely localizes a lesion to the contralateral subthalamic nucleus, demonstrating the critical role of the basal ganglia\u0027s indirect pathway in suppressing unwanted movements.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Contralateral Subthalamic Nucleus Lesion] --Lacunar Stroke--\u003e B(Disinhibition of Indirect Pathway); B --\u003e C[Decreased Inhibition of Thalamus]; C --\u003e D[Excessive Cortical Motor Output]; D --\u003e E(Hemiballismus);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"subthalamic_nucleus\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"dyskinesia\"\n      },\n      {\n        \"type\": \"is_often_caused_by\",\n        \"to\": \"b56349b2\"\n      }\n    ]\n  },\n  \"134828d8\": {\n    \"title\": \"Hemineglect Syndrome\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cognitive Deficit\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHemineglect Syndrome\u003c/b\u003e, also known as hemispatial neglect, is a neuropsychological condition in which a patient is unaware of and fails to respond to stimuli on the side of space \u003ci\u003econtralateral\u003c/i\u003e to a brain lesion, despite having intact sensory and motor function. This is a deficit of attention, not sensation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocalization:\u003c/b\u003e Most commonly caused by a lesion in the \u003cmark\u003enon-dominant (usually right) parietal lobe\u003c/mark\u003e, specifically the angular gyrus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Often results from a stroke in the territory of the right [[143bb23d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients may ignore food on the left side of their plate, only shave or apply makeup to the right side of their face, or bump into objects on their left. When asked to draw a clock, they may cram all the numbers onto the right side.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction:\u003c/b\u003e It is an \u003cb\u003eattention\u003c/b\u003e deficit, not a primary visual field defect like hemianopia. Patients with pure hemianopia are aware of their deficit, whereas patients with neglect are often unaware (anosognosia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient who has had a stroke and now ignores one side of their body or environment (e.g., only draws the right half of a house) is the classic presentation. The lesion is in the contralateral parietal lobe.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHemineglect Syndrome\u003c/b\u003e is a profound deficit of attention, not vision, that localizes a lesion to the non-dominant parietal lobe. The patient\u0027s brain effectively \u0027deletes\u0027 one half of their universe, a concept distinct from simply being unable to see it.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"parietal_lobe\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \"143bb23d\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"c9c8eefb\"\n      }\n    ]\n  },\n  \"bc46aebd\": {\n    \"title\": \"Hemiparesis from Saccular Aneurysm\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Vascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHemiparesis\u003c/b\u003e (weakness on one side of the body) can be a devastating consequence of a ruptured \u003ci\u003esaccular (berry) aneurysm\u003c/i\u003e, typically resulting from ischemic damage to motor pathways secondary to vasospasm or direct parenchymal hemorrhage.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism 1 (Vasospasm):\u003c/b\u003e After a [[63f8b05f|subarachnoid hemorrhage (SAH)]] from a ruptured aneurysm, breakdown products of blood can irritate cerebral arteries, causing severe vasoconstriction (vasospasm) days later. This can lead to an ischemic stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism 2 (Intraparenchymal Extension):\u003c/b\u003e A rupturing aneurysm can bleed directly into the brain parenchyma, causing a hemorrhagic stroke and direct damage to motor tracts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocalization (ACom Aneurysm):\u003c/b\u003e Rupture of an \u003cmark\u003eAnterior Communicating Artery\u003c/mark\u003e aneurysm can cause vasospasm of the [[830c856c|Anterior Cerebral Artery (ACA)]], leading to contralateral leg-predominant hemiparesis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocalization (MCA Aneurysm):\u003c/b\u003e Rupture of a \u003cmark\u003eMiddle Cerebral Artery\u003c/mark\u003e aneurysm can cause vasospasm or direct hemorrhage into the MCA territory, leading to contralateral face and arm-predominant hemiparesis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e If a patient presents with a \\\"thunderclap headache\\\" and then develops focal weakness a few days later, think vasospasm secondary to a ruptured saccular aneurysm.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eHemiparesis following a saccular aneurysm rupture is often not from the initial bleed itself, but rather a delayed ischemic stroke caused by severe vasospasm, a dangerous secondary complication of subarachnoid blood.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Saccular Aneurysm Rupture] --\u003e B(Subarachnoid Hemorrhage); B --\u003e C(Cerebral Vasospasm); C --\u003e D(Ischemic Stroke); D --\u003e E(Hemiparesis);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"a1647fb2\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"cerebral_vasospasm\"\n      },\n      {\n        \"type\": \"presents_as\",\n        \"to\": \"hemiparesis\"\n      }\n    ]\n  },\n  \"646b7336\": {\n    \"title\": \"Spinal Cord Hemisection (Brown-S√©quard Syndrome)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Trauma\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSpinal Cord Hemisection\u003c/b\u003e, clinically known as \u003cb\u003eBrown-S√©quard Syndrome\u003c/b\u003e, is a neurological condition resulting from damage to one half of the spinal cord, leading to a classic pattern of \u003ci\u003eipsilateral motor and proprioceptive loss\u003c/i\u003e and \u003ci\u003econtralateral pain and temperature loss\u003c/i\u003e below the level of the lesion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by penetrating trauma (e.g., stab wound, gunshot), but can also result from tumors, ischemia, or infection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIpsilateral Deficits (at and below lesion):\u003c/b\u003e Loss of all sensation at the level of the lesion. Below the lesion: UMN signs (spastic paralysis from corticospinal tract damage) and loss of proprioception, vibration, and fine touch (from [[e7f5cbbe|dorsal column]] damage).\u003c/li\u003e\u003cli\u003e\u003cb\u003eContralateral Deficits (below lesion):\u003c/b\u003e Loss of pain and temperature sensation (from spinothalamic tract damage). This begins 1-2 segments below the lesion because the spinothalamic tract fibers cross in the anterior white commissure over several segments.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAt the Level of the Lesion:\u003c/b\u003e Ipsilateral LMN signs (flaccid paralysis from anterior horn damage) and complete loss of sensation in the affected dermatome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to identifying Brown-S√©quard is the dissociated sensory loss: loss of proprioception/vibration on the same side as the weakness, and loss of pain/temperature on the opposite side.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBrown-S√©quard Syndrome\u003c/b\u003e is the quintessential example of how spinal cord anatomy dictates clinical findings; the ipsilateral deficits are due to tracts that have not yet crossed (corticospinal, dorsal columns), while the contralateral deficit is due to the spinothalamic tract which has already crossed at the spinal level.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Spinal Cord Hemisection at T10]; A --\u003e B(Ipsilateral Deficits at T10); B --\u003e B1[LMN Paralysis]; B --\u003e B2[Loss of All Sensation]; A --\u003e C(Ipsilateral Deficits below T10); C --\u003e C1[UMN Paralysis - Corticospinal Tract]; C --\u003e C2[Loss of Proprioception/Vibration - Dorsal Columns]; A --\u003e D(Contralateral Deficits below T10); D --\u003e D1[Loss of Pain/Temp - Spinothalamic Tract];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_also_known_as\",\n        \"to\": \"4792bc68\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"corticospinal_tract\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"07eecef1\"\n      }\n    ]\n  },\n  \"dc54f7a6\": {\n    \"title\": \"Hemispatial Neglect Syndrome\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cognitive Deficit\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHemispatial Neglect Syndrome\u003c/b\u003e, also known as hemineglect, is a neuropsychological condition in which a patient is unaware of and fails to respond to stimuli on the side of space \u003ci\u003econtralateral\u003c/i\u003e to a brain lesion, despite having intact sensory and motor function. This is a deficit of attention, not sensation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocalization:\u003c/b\u003e Most commonly caused by a lesion in the \u003cmark\u003enon-dominant (usually right) parietal lobe\u003c/mark\u003e, specifically the angular gyrus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Often results from a stroke in the territory of the right [[143bb23d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients may ignore food on the left side of their plate, only shave or apply makeup to the right side of their face, or bump into objects on their left. When asked to draw a clock, they may cram all the numbers onto the right side.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction:\u003c/b\u003e It is an \u003cb\u003eattention\u003c/b\u003e deficit, not a primary visual field defect like hemianopia. Patients with pure hemianopia are aware of their deficit, whereas patients with neglect are often unaware (anosognosia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient who has had a stroke and now ignores one side of their body or environment (e.g., only draws the right half of a house) is the classic presentation. The lesion is in the contralateral parietal lobe.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHemispatial Neglect Syndrome\u003c/b\u003e is a profound deficit of attention, not vision, that localizes a lesion to the non-dominant parietal lobe. The patient\u0027s brain effectively \u0027deletes\u0027 one half of their universe, a concept distinct from simply being unable to see it.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"parietal_lobe\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \"143bb23d\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"c9c8eefb\"\n      }\n    ]\n  },\n  \"dcfdcc1d\": {\n    \"title\": \"Intracranial Hemorrhage\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Vascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eIntracranial Hemorrhage\u003c/b\u003e is bleeding within the cranial vault, which can be classified based on its location into \u003ci\u003eepidural\u003c/i\u003e, \u003ci\u003esubdural\u003c/i\u003e, \u003ci\u003esubarachnoid\u003c/i\u003e, and \u003ci\u003eintraparenchymal\u003c/i\u003e types. It is a neurological emergency that can lead to increased intracranial pressure and brain herniation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEpidural Hematoma:\u003c/b\u003e Arterial bleed (middle meningeal artery) between dura and skull. \u003cmark\u003eLens-shaped (biconvex)\u003c/mark\u003e on CT, does not cross suture lines. Often associated with temporal bone fracture and a \u0027lucid interval.\u0027\u003c/li\u003e\u003cli\u003e\u003cb\u003eSubdural Hematoma:\u003c/b\u003e Venous bleed (bridging veins) between dura and arachnoid. \u003cmark\u003eCrescent-shaped\u003c/mark\u003e on CT, crosses suture lines. Seen in elderly, alcoholics, and shaken babies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSubarachnoid Hemorrhage:\u003c/b\u003e Bleeding into the CSF space between arachnoid and pia. Presents with \\\"worst headache of my life.\\\" Caused by ruptured [[a1647fb2|saccular aneurysm]] or trauma. Blood seen in sulci and cisterns on CT.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIntraparenchymal Hemorrhage:\u003c/b\u003e Bleeding within the brain parenchyma. Commonly caused by systemic hypertension (affecting basal ganglia, thalamus, pons), amyloid angiopathy, or tumors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The shape on non-contrast CT is key for differentiation: Epidural \u003d \u003cb\u003eL\u003c/b\u003eens-shaped (\u003cb\u003eL\u003c/b\u003eucid interval). Subdural \u003d \u003cb\u003eC\u003c/b\u003erescent-shaped (\u003cb\u003eC\u003c/b\u003ehronic/\u003cb\u003eC\u003c/b\u003erosses sutures).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe anatomical location of an \u003cb\u003eintracranial hemorrhage\u003c/b\u003e dictates its characteristic appearance on CT and its clinical course; arterial epidural hematomas expand rapidly and are highly lethal, whereas venous subdural hematomas can be acute or chronic with a more variable presentation.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"epidural_hematoma\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"subdural_hematoma\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"63f8b05f\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"intraparenchymal_hemorrhage\"\n      }\n    ]\n  },\n  \"2b10e164\": {\n    \"title\": \"Hepatotoxicity of Anticonvulsants\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Toxicology\",\n      \"Neurology\",\n      \"Gastroenterology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Adverse Effects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHepatotoxicity\u003c/b\u003e is a significant adverse effect of several \u003ci\u003eanticonvulsant drugs\u003c/i\u003e, ranging from asymptomatic elevation of liver enzymes to acute liver failure, necessitating careful monitoring and drug selection.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eValproic Acid:\u003c/b\u003e The most notorious for hepatotoxicity. Can cause a rare but fatal \u003cmark\u003emicrovesicular steatosis\u003c/mark\u003e and hepatic failure, especially in children \u003c2 years old and those on multiple anticonvulsants. Requires regular LFT monitoring.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCarbamazepine:\u003c/b\u003e Can cause a spectrum of liver injury, including cholestatic or hepatocellular patterns. Agranulocytosis and aplastic anemia are other major concerns.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhenytoin:\u003c/b\u003e Can cause a hypersensitivity reaction known as DRESS syndrome, which may include hepatitis. Can also cause a dose-dependent elevation in liver enzymes.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhenobarbital:\u003c/b\u003e Induces cytochrome P450 enzymes, which can alter the metabolism of other drugs and potentially produce toxic metabolites, though direct hepatotoxicity is less common than with valproate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For a patient on an anticonvulsant who develops jaundice, nausea, and markedly elevated AST/ALT, [[valproic_acid|Valproic acid]]-induced hepatotoxicity should be at the top of the differential, especially in a young child.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eWhile several anticonvulsants can affect the liver, \u003cb\u003evalproic acid\u003c/b\u003e stands out for its potential to cause fatal hepatotoxicity through mitochondrial injury and impaired fatty acid metabolism, a risk that is highest in young children with metabolic disorders.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_an_adverse_effect_of\",\n        \"to\": \"0d37e045\"\n      },\n      {\n        \"type\": \"is_an_adverse_effect_of\",\n        \"to\": \"eddd2bc5\"\n      },\n      {\n        \"type\": \"is_an_adverse_effect_of\",\n        \"to\": \"5aea213f\"\n      },\n      {\n        \"type\": \"is_an_adverse_effect_of\",\n        \"to\": \"e1d92dbf\"\n      }\n    ]\n  },\n  \"bdfcf456\": {\n    \"title\": \"Hereditary Motor and Sensory Neuropathy (HMSN)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Genetics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Peripheral Neuropathies\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHereditary Motor and Sensory Neuropathy (HMSN)\u003c/b\u003e, more commonly known as \u003cb\u003eCharcot-Marie-Tooth (CMT) disease\u003c/b\u003e, is a group of inherited disorders affecting the \u003ci\u003eperipheral nerves\u003c/i\u003e, leading to progressive muscle weakness, atrophy, and sensory loss, predominantly in the distal extremities.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Genetically heterogeneous, with autosomal dominant inheritance being most common. The most frequent type, CMT1A, is caused by a \u003cmark\u003eduplication of the PMP22 gene\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Involves defective production of proteins involved in the structure and function of either peripheral nerve axons or their myelin sheath. CMT1 is a demyelinating form, while CMT2 is an axonal form.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Classic findings include distal leg weakness leading to \u003cmark\u003efoot drop\u003c/mark\u003e and a \u0027steppage gait.\u0027 Over time, muscle atrophy in the lower legs creates an \u003cmark\u003e\\\"inverted champagne bottle\\\"\u003c/mark\u003e or \\\"stork leg\\\" appearance. Foot deformities like \u003ci\u003epes cavus\u003c/i\u003e (high arches) and hammer toes are common.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSensory Loss:\u003c/b\u003e Patients typically experience loss of proprioception and vibration sense in the distal extremities.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A young patient presenting with progressive distal weakness, foot drop, high-arched feet (pes cavus), and a family history of similar symptoms is the classic vignette for Charcot-Marie-Tooth disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCharcot-Marie-Tooth disease\u003c/b\u003e is the most common inherited peripheral neuropathy, characterized by a length-dependent degeneration of peripheral nerves that manifests clinically as a classic \u0027stork leg\u0027 deformity due to profound distal muscle atrophy.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[PMP22 Gene Duplication] --\u003e B(Defective Myelin); B --\u003e C(Demyelination of Peripheral Nerves); C --\u003e D[Distal Muscle Weakness \u0026 Atrophy]; D --\u003e E(Foot Drop \u0026 Pes Cavus);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_also_known_as\",\n        \"to\": \"c3f13d85\"\n      },\n      {\n        \"type\": \"is_caused_by_mutation_in\",\n        \"to\": \"pmp22_gene\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"foot_drop\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"pes_cavus\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 10372,
      "parts": [{
        "text": "```json\n{\n  \"69962905\": {\n    \"title\": \"Haemophilus influenzae ("
      }, {
        "text": "Neurological)\",\n    \"primaryType\": \"microbe\",\n    \"tags\": [\n      \"Neurology\",\n      \"In"
      }, {
        "text": "fectious Disease\",\n      \"Microbiology\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"In"
      }, {
        "text": "fections\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHaemophilus influenzae\u003c/b\u003e is a"
      }, {
        "text": " small, pleomorphic, gram-negative coccobacillus that is a significant cause of bacterial meningitis, epiglottitis, and \u003ci\u003eot"
      }, {
        "text": "itis media\u003c/i\u003e, particularly in unvaccinated children. The encapsulated type b (Hib) strain is the most invasive and historically was"
      }, {
        "text": " the leading cause of pediatric meningitis.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMicrobiology:\u003c/b\u003e Gram-negative coccobacillus."
      }, {
        "text": " Requires both \u003cmark\u003efactor X (hematin)\u003c/mark\u003e and \u003cmark\u003efactor V (NAD+)\u003c/mark\u003e for growth,"
      }, {
        "text": " which are present in chocolate agar.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Infections:\u003c/b\u003e A common cause of bacterial [[meningitis]] in"
      }, {
        "text": " children (age 6 months to 5 years) before the Hib vaccine. Also a major cause of [[a0"
      }, {
        "text": "3641af|otitis media]], sinusitis, and epiglottitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVirulence:"
      }, {
        "text": "\u003c/b\u003e The type b strain has a polyribosylribitol phosphate (PRP) polysaccharide capsule, which is antiphag"
      }, {
        "text": "ocytic and is the target of the Hib conjugate vaccine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVaccination:\u003c/b\u003e The Hib conjugate vaccine, which"
      }, {
        "text": " conjugates the PRP capsule to a protein carrier (like tetanus toxoid), has dramatically reduced the incidence of invasive H. influenzae disease"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a vignette about an unvaccinated child with meningitis, fever, and a stiff"
      }, {
        "text": " neck, \u003ci\u003eH. influenzae\u003c/i\u003e type b should be a top differential. Remember it grows on \u003cmark\u003echocolate agar\u003c/mark\u003e but"
      }, {
        "text": " not blood agar.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eWhile vaccination has made invasive \u003cb\u003eHaemophilus influenzae\u003c/b\u003e type"
      }, {
        "text": " b disease rare, non-typeable (unencapsulated) strains remain a leading cause of mucosal infections like [["
      }, {
        "text": "a03641af|otitis media]] and sinusitis in children by colonizing the nasopharynx.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type"
      }, {
        "text": "\": \"causes\",\n        \"to\": \"meningitis\"\n      },\n      {\n        \"type\": \"causes"
      }, {
        "text": "\",\n        \"to\": \"a03641af\"\n      },\n      {\n        \"type\": \"causes\",\n        "
      }, {
        "text": "\"to\": \"epiglottitis\"\n      },\n      {\n        \"type\": \"is_prevented_by\","
      }, {
        "text": "\n        \"to\": \"hib_vaccine\"\n      }\n    ]\n  },\n  \"3a58"
      }, {
        "text": "904e\": {\n    \"title\": \"Hamartin\",\n    \"primaryType\": \"molecule"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neurology\",\n      \"Genetics\",\n      \"Oncology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Neurocutaneous Disorders\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eHamartin\u003c/b\u003e is a \u003ci\u003etumor suppressor protein\u003c/i\u003e encoded by the \u003cb\u003eTSC1 gene"
      }, {
        "text": "\u003c/b\u003e on chromosome 9. It forms a complex with the protein tuberin (from the TSC2 gene) to regulate cell"
      }, {
        "text": " growth and proliferation by inhibiting the mTOR pathway.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGene:\u003c/b\u003e Enc"
      }, {
        "text": "oded by the \u003ci\u003eTSC1\u003c/i\u003e gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Forms a heterodimer with tuberin (TSC"
      }, {
        "text": "2 protein). This complex acts as a GTPase-activating protein (GAP) for the small G protein Rheb."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e By inactivating Rheb, the hamartin-tuberin complex \u003cu\u003einhibits\u003c/u\u003e"
      }, {
        "text": " \u003cmark\u003emTOR (mechanistic target of rapamycin) complex 1\u003c/mark\u003e, a key regulator of cell growth,"
      }, {
        "text": " proliferation, and protein synthesis.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e A loss-of-function mutation in the \u003ci\u003eTSC1\u003c/i\u003e gene leads to"
      }, {
        "text": " a non-functional hamartin protein, resulting in unchecked mTOR activity and the formation of hamartomas characteristic of [[8"
      }, {
        "text": "3302339|Tuberous Sclerosis Complex]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember"
      }, {
        "text": " the association: \u003cb\u003eTSC1\u003c/b\u003e mutation ‚Üí defective \u003cb\u003eHamartin\u003c/b\u003e ‚Üí [[83302339|"
      }, {
        "text": "Tuberous Sclerosis]]. The clinical findings of Tuberous Sclerosis (hamartomas, angiofibromas, ash-leaf"
      }, {
        "text": " spots) are a direct result of mTOR pathway disinhibition.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Hamartin\u003c/b\u003e acts as a crucial brake on the mTOR cell growth pathway; its inactivation through a TSC1 mutation releases"
      }, {
        "text": " this brake, leading to the widespread, multi-organ hamartoma formation seen in [[83302339|"
      }, {
        "text": "Tuberous Sclerosis]].\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[TSC1 gene] --\u003e B("
      }, {
        "text": "Hamartin); C[TSC2 gene] --\u003e D(Tuberin); B + D --\u003e E(Ham"
      }, {
        "text": "artin-Tuberin Complex); E --|Inhibits|--\u003e F(Rheb); F --|Activ"
      }, {
        "text": "ates|--\u003e G(mTORC1); G --\u003e H(Cell Growth \u0026 Proliferation);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_encoded_by\",\n        \"to\": \"tsc1_gene\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"mutation_causes\",\n        \"to\": \"83302339\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"inhibits\",\n        \"to\": \"mtor_path"
      }, {
        "text": "way\"\n      },\n      {\n        \"type\": \"forms_complex_with\",\n        \"to\": \"tuberin"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"26661e34\": {\n    \"title\": \"Head"
      }, {
        "text": "aches\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Headaches\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHeadache"
      }, {
        "text": "\u003c/b\u003e is the symptom of pain anywhere in the region of the head or neck, which can be classified as a \u003ci\u003eprimary disorder"
      }, {
        "text": "\u003c/i\u003e (e.g., migraine, tension, cluster) or as a \u003ci\u003esecondary symptom\u003c/i\u003e of an underlying pathology"
      }, {
        "text": " (e.g., hemorrhage, tumor, infection).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Tension Headache:\u003c/b\u003e Most common type. Bilateral, \u0027band-like\u0027 pressure. Lasts \u003e30 min"
      }, {
        "text": ". No photophobia/phonophobia or nausea. Treated with NSAIDs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMigraine Headache:\u003c/b\u003e Un"
      }, {
        "text": "ilateral, pulsating pain lasting 4-72 hours. Associated with nausea, photophobia, and/or phonophobia."
      }, {
        "text": " May have an aura. Treated with triptans, NSAIDs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCluster Headache:\u003c/b\u003e Excruciating, unilateral per"
      }, {
        "text": "iorbital pain lasting 15-180 min. Accompanied by autonomic symptoms (lacrimation, rhinorrhea)."
      }, {
        "text": " Treated with 100% O\u003csub\u003e2\u003c/sub\u003e, sumatriptan.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRed Flag Headaches:\u003c/b\u003e A"
      }, {
        "text": " \u003cmark\u003e\\\"thunderclap headache\\\"\u003c/mark\u003e (sudden, severe onset) is classic for [[63"
      }, {
        "text": "f8b05f|subarachnoid hemorrhage]]. The \u003cmark\u003e\\\"worst headache of my life\\\"\u003c/mark\u003e is also"
      }, {
        "text": " highly suggestive of SAH. Headaches that are worse with lying down, awaken a patient from sleep, or are associated with"
      }, {
        "text": " focal neurologic deficits suggest increased intracranial pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiating primary headaches is key. Tension"
      }, {
        "text": " \u003d bilateral, band-like. Migraine \u003d unilateral, pulsating, with aura/nausea. Cluster \u003d unilateral, per"
      }, {
        "text": "iorbital, with autonomic signs.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eWhile most headaches are benign"
      }, {
        "text": " primary disorders, the sudden onset of a \u003cb\u003e\\\"thunderclap headache\\\"\u003c/b\u003e or the \u003cb\u003e\\\"worst headache of my life"
      }, {
        "text": "\\\"\u003c/b\u003e is a neurological emergency that requires immediate investigation to rule out a life-threatening [[63f8b05f|"
      }, {
        "text": "subarachnoid hemorrhage]].\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_symptom_of\",\n        \"to\": \"63f"
      }, {
        "text": "8b05f\"\n      },\n      {\n        \"type\": \"is_a_sympt"
      }, {
        "text": "om_of\",\n        \"to\": \"meningitis\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_a_symptom_of\",\n        \"to\": \"7c4e7c"
      }, {
        "text": "74\"\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \"to"
      }, {
        "text": "\": \"migraine_headache\"\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \""
      }, {
        "text": "to\": \"cluster_headache\"\n      },\n      {\n        \"type\": \"is_classified_as\",\n        "
      }, {
        "text": "\"to\": \"tension_headache\"\n      }\n    ]\n  },\n  \"88e6f77e\":"
      }, {
        "text": " {\n    \"title\": \"Hearing Loss\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ot"
      }, {
        "text": "ology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHearing loss\u003c/b\u003e is a partial or total inability to hear, classified"
      }, {
        "text": " as either \u003ci\u003econductive\u003c/i\u003e, involving problems with the outer or middle ear, or \u003ci\u003esensorineural\u003c/i\u003e, involving damage"
      }, {
        "text": " to the inner ear (cochlea) or the auditory nerve pathway to the brain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Conductive Hearing Loss:\u003c/b\u003e Occurs when sound waves are not conducted efficiently to the inner ear. Causes include cerumen impaction, [["
      }, {
        "text": "a03641af|otitis media]], otosclerosis, or tympanic membrane perforation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSensorineural Hearing Loss:"
      }, {
        "text": "\u003c/b\u003e Caused by damage to the hair cells in the cochlea or the vestibulocochlear nerve (CN VIII"
      }, {
        "text": "). Causes include \u003cmark\u003epresbycusis\u003c/mark\u003e (age-related), noise-induced damage, ototoxic"
      }, {
        "text": " drugs (e.g., aminoglycosides, cisplatin, loop diuretics), and acoustic neuromas ([[03ecb6"
      }, {
        "text": "9e|schwannomas]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis (Weber Test):\u003c/b\u003e Tuning fork on vertex of skull. Conduct"
      }, {
        "text": "ive loss: lateralizes to the affected ear. Sensorineural loss: lateralizes to the unaffected ear.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis (R"
      }, {
        "text": "inne Test):\u003c/b\u003e Compares air conduction (AC) to bone conduction (BC). Normal/Sensorineural: AC \u003e BC. Conduct"
      }, {
        "text": "ive: \u003cmark\u003eBC \u003e AC\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the diagnostic pattern."
      }, {
        "text": " In conductive loss, the Weber test lateralizes \u003ci\u003etowards\u003c/i\u003e the bad ear because it masks ambient noise, making bone"
      }, {
        "text": " conduction seem louder.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe differentiation between \u003cb\u003econductive\u003c/b\u003e and"
      }, {
        "text": " \u003cb\u003esensorineural\u003c/b\u003e hearing loss is critical for diagnosis; conductive loss is a mechanical problem of sound transmission (BC"
      }, {
        "text": " \u003e AC on Rinne), while sensorineural loss is a nerve problem of sound transduction (AC \u003e BC, but both"
      }, {
        "text": " are reduced).\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Sound] --\u003e B{Outer/Middle Ear}; B"
      }, {
        "text": " --Conductive Loss--\u003e X[Blocked]; B --\u003e C{Inner Ear/Nerve}; C --Sensorineural Loss--\u003e Y"
      }, {
        "text": "[Damaged]; C --\u003e D[Brain];\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_classified_as\",\n        \"to\": \"conductive_hearing_loss\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \""
      }, {
        "text": "sensorineural_hearing_loss\"\n      },\n      {\n        \"type\": \"is_diagnosed_using"
      }, {
        "text": "\",\n        \"to\": \"weber_test\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_diagnosed_using\",\n        \"to\": \"rinne_test\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"presby"
      }, {
        "text": "cusis\"\n      }\n    ]\n  },\n  \"25ffec56\": {\n"
      }, {
        "text": "    \"title\": \"Heat Stroke\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Emergency Medicine\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Temperature Regulation\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHeat stroke\u003c/b\u003e is a life-threatening medical emergency characterized by a core"
      }, {
        "text": " body temperature above 40¬∞C (104¬∞F) and central nervous system dysfunction, resulting from the"
      }, {
        "text": " failure of the body\u0027s thermoregulatory mechanisms.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e Occurs when heat generation exceeds the body\u0027s ability to dissipate heat. This leads to systemic inflammation, mult"
      }, {
        "text": "iorgan dysfunction, and CNS abnormalities. Unlike fever, the hypothalamic set-point is \u003cu\u003enot\u003c/u\u003e elevated.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Types:\u003c/b\u003e \u003cb\u003eExertional\u003c/b\u003e (occurs in healthy individuals during strenuous physical activity in hot/humid conditions"
      }, {
        "text": ") and \u003cb\u003eNon-exertional/Classic\u003c/b\u003e (affects sedentary individuals, elderly, or chronically ill during"
      }, {
        "text": " heat waves).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Core temperature \u003e40¬∞C, \u003cmark\u003ealtered mental status\u003c/mark\u003e"
      }, {
        "text": " (confusion, delirium, coma, seizures), and often, but not always, anhidrosis (absence of sweating),"
      }, {
        "text": " particularly in non-exertional heat stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eManagement:\u003c/b\u003e \u003cu\u003eImmediate rapid cooling\u003c/u\u003e is the cornerstone"
      }, {
        "text": " of treatment (e.g., ice water immersion). Antipyretics like acetaminophen or NSAIDs are \u003cu\u003eine"
      }, {
        "text": "ffective\u003c/u\u003e because the hypothalamic set-point is not altered.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from"
      }, {
        "text": " fever: in heat stroke, the cause is external heat load overwhelming thermoregulation, and antipyretics do not work. In fever, the cause"
      }, {
        "text": " is an elevated hypothalamic set-point due to pyrogens, and antipyretics are effective.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eHeat stroke\u003c/b\u003e is a failure of thermoregulation, not a change in the hypothalamic set-point."
      }, {
        "text": " Therefore, the critical intervention is rapid physical cooling, as antipyretics that target the hypothalamus are completely ineffective.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Heat Load \u003e Heat Dissipation] --\u003e B(Failure of Thermoregulation); B --\u003e"
      }, {
        "text": " C[Core Temp \u003e 40¬∞C]; C --\u003e D[CNS Dysfunction]; C --\u003e E[Multiorgan Damage"
      }, {
        "text": "];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"differentiated_from\",\n        \"to"
      }, {
        "text": "\": \"fever\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to"
      }, {
        "text": "\": \"hyperthermia\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to"
      }, {
        "text": "\": \"altered_mental_status\"\n      }\n    ]\n  },\n  \"73c63548\":"
      }, {
        "text": " {\n    \"title\": \"Hemangioblastoma\",\n    \"primaryType\": \"disease\",\n    \""
      }, {
        "text": "tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Pathology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain"
      }, {
        "text": " Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eHemangioblastoma\u003c/b\u003e is"
      }, {
        "text": " a benign, highly vascular tumor of the central nervous system, typically arising in the cerebellum, brainstem, or spinal cord, and is"
      }, {
        "text": " strongly associated with \u003ci\u003evon Hippel-Lindau disease\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation"
      }, {
        "text": ":\u003c/b\u003e Most often found in the \u003cmark\u003ecerebellum\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e Appears as a well-circum"
      }, {
        "text": "scribed, cystic lesion with a brightly enhancing \u003cmark\u003emural nodule\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e Com"
      }, {
        "text": "posed of closely arranged, thin-walled capillaries with intervening stromal cells that have clear, lipid-rich cytoplasm.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Paraneoplastic Syndrome:\u003c/b\u003e The tumor can ectopically produce \u003cmark\u003eerythropoietin (EPO)\u003c/mark\u003e, leading to secondary"
      }, {
        "text": " polycythemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGenetic Association:\u003c/b\u003e A hallmark of [[274cb033|von Hippel-Lind"
      }, {
        "text": "au (VHL) disease]], an autosomal dominant disorder. The presence of a hemangioblastoma should prompt investigation for other"
      }, {
        "text": " VHL-associated tumors (e.g., renal cell carcinoma, pheochromocytoma).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A"
      }, {
        "text": " patient with cerebellar symptoms (ataxia, dysmetria) and polycythemia should make you think of a hem"
      }, {
        "text": "angioblastoma. If there\u0027s a family history of similar tumors or renal cancer, suspect VHL.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eHemangioblastoma\u003c/b\u003e is a unique CNS tumor that acts as both a space-occupying lesion"
      }, {
        "text": " causing cerebellar signs and an endocrine factory ectopically producing erythropoietin, making the combination of ataxia and polycythemia a highly"
      }, {
        "text": " specific clinical picture.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[VHL Gene Mutation] --\u003e B(Hemangio"
      }, {
        "text": "blastoma); B --\u003e C[Cerebellar Symptoms]; B --Ectopic EPO Production--\u003e D[Secondary Polycythemia];\"\n    "
      }, {
        "text": "},\n    \"connections\": [\n      {\n        \"type\": \"is_associated_with\",\n        "
      }, {
        "text": "\"to\": \"274cb033\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "can_cause\",\n        \"to\": \"polycythemia\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "produces\",\n        \"to\": \"erythropoietin\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_a_type_of\",\n        \"to\": \"be057cfc\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"c9c8eefb\": {\n    \"title\": \"Hemianopia\",\n    \"primaryType\":"
      }, {
        "text": " \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Ophthalmology\",\n      \"Visual Field Defects\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eHemianopia\u003c/b\u003e (or hemianopsia) is a visual field defect characterized by the loss of vision"
      }, {
        "text": " in \u003ci\u003ehalf of the visual field\u003c/i\u003e of one or both eyes. The pattern of vision loss is critical for localizing lesions"
      }, {
        "text": " along the visual pathway.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBitemporal Hemianopia:\u003c/b\u003e"
      }, {
        "text": " Loss of the outer (temporal) half of the visual field in both eyes. Caused by a lesion compressing the \u003cmark\u003eoptic"
      }, {
        "text": " chiasm\u003c/mark\u003e (e.g., [[5f3188bd|pituitary adenoma]], [[7"
      }, {
        "text": "048db1e|craniopharyngioma]], ACom aneurysm).\u003c/li\u003e\u003cli\u003e\u003cb\u003eHomonymous Hemianopia:\u003c/b\u003e Loss of"
      }, {
        "text": " the same half (e.g., both right halves or both left halves) of the visual field in both eyes. Caused by a"
      }, {
        "text": " lesion \u003cu\u003eposterior\u003c/u\u003e to the optic chiasm (e.g., optic tract, lateral geniculate nucleus, optic"
      }, {
        "text": " radiations, or visual cortex).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMacular Sparing:\u003c/b\u003e In homonymous hemianopia caused by a [["
      }, {
        "text": "b6a2cc31|Posterior Cerebral Artery (PCA)]] stroke, central vision may be spared due to dual"
      }, {
        "text": " blood supply to the occipital pole from the [[143bb23d|Middle Cerebral Artery (MCA"
      }, {
        "text": ")]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eQuadrantanopia:\u003c/b\u003e Loss of one quadrant of the visual field. A lesion in the temporal lobe (Meyer"
      }, {
        "text": "\u0027s loop) causes a contralateral superior quadrantanopia (\\\"pie in the sky\\\"). A lesion in the parietal lobe (D"
      }, {
        "text": "orsal optic radiation) causes a contralateral inferior quadrantanopia (\\\"pie on the floor\\\").\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the crossing"
      }, {
        "text": " pattern: fibers from the nasal retina (representing the temporal visual field) cross at the chiasm. Therefore, a midline"
      }, {
        "text": " chiasmal lesion affects both temporal fields.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe pattern of "
      }, {
        "text": "\u003cb\u003ehemianopia\u003c/b\u003e is a precise roadmap to the location of a neurological lesion: a bitemporal defect points directly to the optic"
      }, {
        "text": " chiasm, while a homonymous defect indicates a lesion anywhere from the optic tract back to the visual cortex.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"graph TD; A[Optic Chiasm Lesion] --\u003e B(Bitemporal Hemianopia); C"
      }, {
        "text": "[Post-Chiasmal Lesion] --\u003e D(Homonymous Hemianopia);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"ff"
      }, {
        "text": "289b3a\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \""
      }, {
        "text": "to\": \"5f3188bd\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_caused_by\",\n        \"to\": \"stroke\"\n      }\n    ]\n  },\n  \"0"
      }, {
        "text": "04e0bd6\": {\n    \"title\": \"Hemiballismus\",\n    \"primaryType"
      }, {
        "text": "\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Movement Disorders\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHemiball"
      }, {
        "text": "ismus\u003c/b\u003e is a rare hyperkinetic movement disorder characterized by \u003ci\u003ewild, flinging, large-amplitude movements\u003c/i\u003e of the"
      }, {
        "text": " proximal arm and leg on one side of the body, resulting from a lesion in the contralateral subthalamic nucleus.\u003c/p\u003e\","
      }, {
        "text": "\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e A lesion in the \u003cmark\u003econtr"
      }, {
        "text": "alateral subthalamic nucleus (STN)\u003c/mark\u003e disrupts the indirect pathway of the [[ed462"
      }, {
        "text": "927|basal ganglia]]. This leads to decreased inhibition of the thalamus, resulting in excessive, uncontrolled movements"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by a \u003cmark\u003elacunar stroke\u003c/mark\u003e affecting"
      }, {
        "text": " the small penetrating arteries that supply the STN. Other causes include hemorrhage, tumors, or hyperglycemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e"
      }, {
        "text": " Sudden onset of violent, involuntary, flinging movements of one arm and/or leg. Mnemonic: In \u003cb\u003ehemi"
      }, {
        "text": "\u003c/b\u003eballismus, \u003cb\u003ehalf\u003c/b\u003e of the body is going \u003cb\u003eballistic\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e"
      }, {
        "text": " Often self-limiting, resolving over weeks to months. Symptomatic treatment can include dopamine antagonists (e.g., haloperidol)"
      }, {
        "text": " to reduce the hyperkinetic movements.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A sudden onset of wild, unilateral flinging movements in"
      }, {
        "text": " an elderly patient with a history of hypertension strongly suggests a lacunar stroke in the contralateral subthalamic nucleus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eHemiballismus\u003c/b\u003e is a dramatic clinical sign that precisely localizes a lesion to the contralateral subthalamic"
      }, {
        "text": " nucleus, demonstrating the critical role of the basal ganglia\u0027s indirect pathway in suppressing unwanted movements.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Contralateral Subthalamic Nucleus Lesion] --Lacunar Stroke--\u003e B(Dis"
      }, {
        "text": "inhibition of Indirect Pathway); B --\u003e C[Decreased Inhibition of Thalamus]; C --\u003e D[Excessive Cort"
      }, {
        "text": "ical Motor Output]; D --\u003e E(Hemiballismus);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"subthalamic_nucleus\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \""
      }, {
        "text": "dyskinesia\"\n      },\n      {\n        \"type\": \"is_often_caused_by\",\n        \""
      }, {
        "text": "to\": \"b56349b2\"\n      }\n    ]\n  },\n  \"134828d"
      }, {
        "text": "8\": {\n    \"title\": \"Hemineglect Syndrome\",\n    \"primaryType\": \"finding\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Cognitive Deficit\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain"
      }, {
        "text": " Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHemineg"
      }, {
        "text": "lect Syndrome\u003c/b\u003e, also known as hemispatial neglect, is a neuropsychological condition in which a patient is unaware of and"
      }, {
        "text": " fails to respond to stimuli on the side of space \u003ci\u003econtralateral\u003c/i\u003e to a brain lesion, despite having intact sensory and"
      }, {
        "text": " motor function. This is a deficit of attention, not sensation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocalization"
      }, {
        "text": ":\u003c/b\u003e Most commonly caused by a lesion in the \u003cmark\u003enon-dominant (usually right) parietal lobe\u003c/mark\u003e,"
      }, {
        "text": " specifically the angular gyrus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Often results from a stroke in the territory of the right"
      }, {
        "text": " [[143bb23d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e"
      }, {
        "text": " Patients may ignore food on the left side of their plate, only shave or apply makeup to the right side of their face"
      }, {
        "text": ", or bump into objects on their left. When asked to draw a clock, they may cram all the numbers onto the right side.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eDistinction:\u003c/b\u003e It is an \u003cb\u003eattention\u003c/b\u003e deficit, not a primary visual field defect like hemianopia. Patients"
      }, {
        "text": " with pure hemianopia are aware of their deficit, whereas patients with neglect are often unaware (anosognosia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e A patient who has had a stroke and now ignores one side of their body or environment (e.g., only"
      }, {
        "text": " draws the right half of a house) is the classic presentation. The lesion is in the contralateral parietal lobe.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003e\u003cb\u003eHemineglect Syndrome\u003c/b\u003e is a profound deficit of attention, not vision, that local"
      }, {
        "text": "izes a lesion to the non-dominant parietal lobe. The patient\u0027s brain effectively \u0027deletes\u0027 one half of their"
      }, {
        "text": " universe, a concept distinct from simply being unable to see it.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        "
      }, {
        "text": "\"to\": \"parietal_lobe\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "caused_by_stroke_in\",\n        \"to\": \"143bb23d\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"differentiated_from\",\n        \"to\": \"c9c8eefb\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"bc46aebd\": {\n    \"title\": \""
      }, {
        "text": "Hemiparesis from Saccular Aneurysm\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neurology\",\n      \"Neurosurgery\",\n      \"Vascular\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\","
      }, {
        "text": "\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eHemiparesis\u003c/b\u003e (weakness on one side of the body) can be a devastating consequence of a ruptured"
      }, {
        "text": " \u003ci\u003esaccular (berry) aneurysm\u003c/i\u003e, typically resulting from ischemic damage to motor pathways secondary to vasospasm or direct"
      }, {
        "text": " parenchymal hemorrhage.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism 1 (Vasospasm):\u003c/b\u003e After"
      }, {
        "text": " a [[63f8b05f|subarachnoid hemorrhage (SAH)]] from a ruptured aneurysm"
      }, {
        "text": ", breakdown products of blood can irritate cerebral arteries, causing severe vasoconstriction (vasospasm) days later. This can lead to an"
      }, {
        "text": " ischemic stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism 2 (Intraparenchymal Extension):\u003c/b\u003e A rupturing aneurysm can bleed"
      }, {
        "text": " directly into the brain parenchyma, causing a hemorrhagic stroke and direct damage to motor tracts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocalization (ACom A"
      }, {
        "text": "neurysm):\u003c/b\u003e Rupture of an \u003cmark\u003eAnterior Communicating Artery\u003c/mark\u003e aneurysm can cause vasospasm"
      }, {
        "text": " of the [[830c856c|Anterior Cerebral Artery (ACA)]], leading to contralateral"
      }, {
        "text": " leg-predominant hemiparesis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocalization (MCA Aneurysm):\u003c/b\u003e Rupture of a"
      }, {
        "text": " \u003cmark\u003eMiddle Cerebral Artery\u003c/mark\u003e aneurysm can cause vasospasm or direct hemorrhage into the MCA territory, leading to contralateral face"
      }, {
        "text": " and arm-predominant hemiparesis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e If a patient presents with a \\\""
      }, {
        "text": "thunderclap headache\\\" and then develops focal weakness a few days later, think vasospasm secondary to a ruptured saccular aneurysm.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003eHemiparesis following a saccular aneurysm rupture is often not from the initial bleed"
      }, {
        "text": " itself, but rather a delayed ischemic stroke caused by severe vasospasm, a dangerous secondary complication of subarachnoid blood.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"graph TD; A[Saccular Aneurysm Rupture] --\u003e B(Subarachnoid Hemorrhage); B"
      }, {
        "text": " --\u003e C(Cerebral Vasospasm); C --\u003e D(Ischemic Stroke); D --\u003e E(Hemiparesis);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_complication_of\",\n        "
      }, {
        "text": "\"to\": \"a1647fb2\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "caused_by\",\n        \"to\": \"cerebral_vasospasm\"\n      },\n      {\n        \"type\": \"p"
      }, {
        "text": "resents_as\",\n        \"to\": \"hemiparesis\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "646b7336\": {\n    \"title\": \"Spinal Cord Hemisection (Brown-S√©quard Syndrome)\",\n    "
      }, {
        "text": "\"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Trauma\",\n      \"Pathology"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eSpinal Cord Hemisection\u003c/b\u003e, clinically known as \u003cb\u003eBrown-S√©quard Syndrome\u003c/b\u003e, is a neurological"
      }, {
        "text": " condition resulting from damage to one half of the spinal cord, leading to a classic pattern of \u003ci\u003eipsilateral motor and"
      }, {
        "text": " proprioceptive loss\u003c/i\u003e and \u003ci\u003econtralateral pain and temperature loss\u003c/i\u003e below the level of the lesion.\u003c/p\u003e\","
      }, {
        "text": "\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by penetrating trauma (e.g., stab"
      }, {
        "text": " wound, gunshot), but can also result from tumors, ischemia, or infection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIpsilateral Deficits (at"
      }, {
        "text": " and below lesion):\u003c/b\u003e Loss of all sensation at the level of the lesion. Below the lesion: UMN signs (spastic paralysis"
      }, {
        "text": " from corticospinal tract damage) and loss of proprioception, vibration, and fine touch (from [[e7f5"
      }, {
        "text": "cbbe|dorsal column]] damage).\u003c/li\u003e\u003cli\u003e\u003cb\u003eContralateral Deficits (below lesion):\u003c/b\u003e Loss of pain"
      }, {
        "text": " and temperature sensation (from spinothalamic tract damage). This begins 1-2 segments below the lesion because the spin"
      }, {
        "text": "othalamic tract fibers cross in the anterior white commissure over several segments.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAt the Level of the Lesion:\u003c/b\u003e Ips"
      }, {
        "text": "ilateral LMN signs (flaccid paralysis from anterior horn damage) and complete loss of sensation in the affected dermatome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The key to identifying Brown-S√©quard is the dissociated sensory loss: loss of proprioception/"
      }, {
        "text": "vibration on the same side as the weakness, and loss of pain/temperature on the opposite side.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eBrown-S√©quard Syndrome\u003c/b\u003e is the quintessential example of how spinal cord anatomy dictates clinical findings;"
      }, {
        "text": " the ipsilateral deficits are due to tracts that have not yet crossed (corticospinal, dorsal columns), while the contralateral deficit"
      }, {
        "text": " is due to the spinothalamic tract which has already crossed at the spinal level.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Spinal Cord Hemisection at T10]; A --\u003e B(Ipsilateral Def"
      }, {
        "text": "icits at T10); B --\u003e B1[LMN Paralysis]; B --\u003e B2[Loss of All Sensation]; A --\u003e C"
      }, {
        "text": "(Ipsilateral Deficits below T10); C --\u003e C1[UMN Paralysis - Corticospinal Tract]; C --\u003e C"
      }, {
        "text": "2[Loss of Proprioception/Vibration - Dorsal Columns]; A --\u003e D(Contralateral Deficits"
      }, {
        "text": " below T10); D --\u003e D1[Loss of Pain/Temp - Spinothalamic Tract];\"\n    "
      }, {
        "text": "},\n    \"connections\": [\n      {\n        \"type\": \"is_also_known_as\",\n        \""
      }, {
        "text": "to\": \"4792bc68\"\n      },\n      {\n        \"type\": \"damages"
      }, {
        "text": "\",\n        \"to\": \"corticospinal_tract\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"damages\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"damages\",\n        \"to\": \"07eecef1\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"dc54f7a6\": {\n    \"title\": \"Hemispatial Neglect Syndrome\",\n    \""
      }, {
        "text": "primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cognitive Deficit\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eHemispatial Neglect Syndrome\u003c/b\u003e, also known as hemineglect, is a neuropsych"
      }, {
        "text": "ological condition in which a patient is unaware of and fails to respond to stimuli on the side of space \u003ci\u003econtralateral\u003c/i\u003e to a"
      }, {
        "text": " brain lesion, despite having intact sensory and motor function. This is a deficit of attention, not sensation.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocalization:\u003c/b\u003e Most commonly caused by a lesion in the \u003cmark\u003enon-dominant (usually right) parietal lobe"
      }, {
        "text": "\u003c/mark\u003e, specifically the angular gyrus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Often results from a stroke in the territory of the right [["
      }, {
        "text": "143bb23d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients may ignore"
      }, {
        "text": " food on the left side of their plate, only shave or apply makeup to the right side of their face, or bump into objects on their left. When"
      }, {
        "text": " asked to draw a clock, they may cram all the numbers onto the right side.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction:\u003c/b\u003e It"
      }, {
        "text": " is an \u003cb\u003eattention\u003c/b\u003e deficit, not a primary visual field defect like hemianopia. Patients with pure hemianopia are aware of their deficit"
      }, {
        "text": ", whereas patients with neglect are often unaware (anosognosia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient who"
      }, {
        "text": " has had a stroke and now ignores one side of their body or environment (e.g., only draws the right half of a house) is the"
      }, {
        "text": " classic presentation. The lesion is in the contralateral parietal lobe.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Hemispatial Neglect Syndrome\u003c/b\u003e is a profound deficit of attention, not vision, that localizes a lesion to the non"
      }, {
        "text": "-dominant parietal lobe. The patient\u0027s brain effectively \u0027deletes\u0027 one half of their universe, a concept distinct from simply"
      }, {
        "text": " being unable to see it.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n"
      }, {
        "text": "      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\":"
      }, {
        "text": " \"parietal_lobe\"\n      },\n      {\n        \"type\": \"is_caused_by"
      }, {
        "text": "_stroke_in\",\n        \"to\": \"143bb23d\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"differentiated_from\",\n        \"to\": \"c9c8eef"
      }, {
        "text": "b\"\n      }\n    ]\n  },\n  \"dcfdcc1d\": {\n    \"title\": \"Intracranial"
      }, {
        "text": " Hemorrhage\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Neurosurgery\",\n      \"Vascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eIntracranial Hemorrhage\u003c/b\u003e is bleeding"
      }, {
        "text": " within the cranial vault, which can be classified based on its location into \u003ci\u003eepidural\u003c/i\u003e, \u003ci\u003esubdural\u003c/i\u003e, "
      }, {
        "text": "\u003ci\u003esubarachnoid\u003c/i\u003e, and \u003ci\u003eintraparenchymal\u003c/i\u003e types. It is a neurological emergency that can lead"
      }, {
        "text": " to increased intracranial pressure and brain herniation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEpidural Hemat"
      }, {
        "text": "oma:\u003c/b\u003e Arterial bleed (middle meningeal artery) between dura and skull. \u003cmark\u003eLens-shaped ("
      }, {
        "text": "biconvex)\u003c/mark\u003e on CT, does not cross suture lines. Often associated with temporal bone fracture and a \u0027"
      }, {
        "text": "lucid interval.\u0027\u003c/li\u003e\u003cli\u003e\u003cb\u003eSubdural Hematoma:\u003c/b\u003e Venous bleed (bridging veins) between dura and arach"
      }, {
        "text": "noid. \u003cmark\u003eCrescent-shaped\u003c/mark\u003e on CT, crosses suture lines. Seen in elderly, alcohol"
      }, {
        "text": "ics, and shaken babies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSubarachnoid Hemorrhage:\u003c/b\u003e Bleeding into the CSF space between"
      }, {
        "text": " arachnoid and pia. Presents with \\\"worst headache of my life.\\\" Caused by ruptured [[a1647fb2|s"
      }, {
        "text": "accular aneurysm]] or trauma. Blood seen in sulci and cisterns on CT.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIntraparenchymal Hem"
      }, {
        "text": "orrhage:\u003c/b\u003e Bleeding within the brain parenchyma. Commonly caused by systemic hypertension (affecting basal ganglia, thalamus, pons"
      }, {
        "text": "), amyloid angiopathy, or tumors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The shape on non-contrast CT is key for"
      }, {
        "text": " differentiation: Epidural \u003d \u003cb\u003eL\u003c/b\u003eens-shaped (\u003cb\u003eL\u003c/b\u003eucid interval). Subdural \u003d \u003cb\u003eC"
      }, {
        "text": "\u003c/b\u003erescent-shaped (\u003cb\u003eC\u003c/b\u003ehronic/\u003cb\u003eC\u003c/b\u003erosses sutures).\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eThe anatomical location of an \u003cb\u003eintracranial hemorrhage\u003c/b\u003e dictates its characteristic appearance on CT and its clinical course"
      }, {
        "text": "; arterial epidural hematomas expand rapidly and are highly lethal, whereas venous subdural hematomas can be acute or chronic with"
      }, {
        "text": " a more variable presentation.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"epidural_hematoma\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_type_of\",\n        \"to\": \"subdural_"
      }, {
        "text": "hematoma\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"63f8b05f\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_a_type_of\",\n        \"to\": \"intraparenchymal_hemorrh"
      }, {
        "text": "age\"\n      }\n    ]\n  },\n  \"2b10e164\": {\n    \"title\": \"H"
      }, {
        "text": "epatotoxicity of Anticonvulsants\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \""
      }, {
        "text": "Pharmacology\",\n      \"Toxicology\",\n      \"Neurology\",\n      \"Gastroenterology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Adverse Effects"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHepatotoxicity\u003c/b\u003e is"
      }, {
        "text": " a significant adverse effect of several \u003ci\u003eanticonvulsant drugs\u003c/i\u003e, ranging from asymptomatic elevation of liver enzymes to acute"
      }, {
        "text": " liver failure, necessitating careful monitoring and drug selection.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eVal"
      }, {
        "text": "proic Acid:\u003c/b\u003e The most notorious for hepatotoxicity. Can cause a rare but fatal \u003cmark\u003emicrovesicular ste"
      }, {
        "text": "atosis\u003c/mark\u003e and hepatic failure, especially in children \u003c2 years old and those on multiple anticonvulsants. Requires"
      }, {
        "text": " regular LFT monitoring.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCarbamazepine:\u003c/b\u003e Can cause a spectrum of liver injury, including cholest"
      }, {
        "text": "atic or hepatocellular patterns. Agranulocytosis and aplastic anemia are other major concerns.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhenytoin:"
      }, {
        "text": "\u003c/b\u003e Can cause a hypersensitivity reaction known as DRESS syndrome, which may include hepatitis. Can also cause a dose-dependent elevation in"
      }, {
        "text": " liver enzymes.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhenobarbital:\u003c/b\u003e Induces cytochrome P450 enzymes, which can alter the metabolism of other drugs and potentially produce"
      }, {
        "text": " toxic metabolites, though direct hepatotoxicity is less common than with valproate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For"
      }, {
        "text": " a patient on an anticonvulsant who develops jaundice, nausea, and markedly elevated AST/ALT, [[valproic_"
      }, {
        "text": "acid|Valproic acid]]-induced hepatotoxicity should be at the top of the differential, especially in a young child.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003eWhile several anticonvulsants can affect the liver, \u003cb\u003evalproic acid\u003c/b\u003e stands"
      }, {
        "text": " out for its potential to cause fatal hepatotoxicity through mitochondrial injury and impaired fatty acid metabolism, a risk that is highest in young"
      }, {
        "text": " children with metabolic disorders.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_an_adverse_effect_of\",\n        \"to\": \"0d3"
      }, {
        "text": "7e045\"\n      },\n      {\n        \"type\": \"is_an_adverse_effect_"
      }, {
        "text": "of\",\n        \"to\": \"eddd2bc5\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_an_adverse_effect_of\",\n        \"to\": \"5aea213f\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_an_adverse_effect_of\",\n        \"to\": \"e1d"
      }, {
        "text": "92dbf\"\n      }\n    ]\n  },\n  \"bdfcf456\": {\n"
      }, {
        "text": "    \"title\": \"Hereditary Motor and Sensory Neuropathy (HMSN)\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Genetics\",\n      \"Pathology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Peripheral Neuropathies\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003e\u003cb\u003eHereditary Motor and Sensory Neuropathy (HMSN)\u003c/b\u003e, more commonly known as \u003cb\u003eCharcot-"
      }, {
        "text": "Marie-Tooth (CMT) disease\u003c/b\u003e, is a group of inherited disorders affecting the \u003ci\u003eperipheral nerves\u003c/i\u003e, leading"
      }, {
        "text": " to progressive muscle weakness, atrophy, and sensory loss, predominantly in the distal extremities.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eGenetics:\u003c/b\u003e Genetically heterogeneous, with autosomal dominant inheritance being most common. The most frequent type, CMT1A"
      }, {
        "text": ", is caused by a \u003cmark\u003eduplication of the PMP22 gene\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e Involves defective production of proteins involved in the structure and function of either peripheral nerve axons or their"
      }, {
        "text": " myelin sheath. CMT1 is a demyelinating form, while CMT2 is an axonal form.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation"
      }, {
        "text": ":\u003c/b\u003e Classic findings include distal leg weakness leading to \u003cmark\u003efoot drop\u003c/mark\u003e and a \u0027steppage gait"
      }, {
        "text": ".\u0027 Over time, muscle atrophy in the lower legs creates an \u003cmark\u003e\\\"inverted champagne bottle\\\"\u003c/mark\u003e or \\\"stork leg"
      }, {
        "text": "\\\" appearance. Foot deformities like \u003ci\u003epes cavus\u003c/i\u003e (high arches) and hammer toes are common.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSens"
      }, {
        "text": "ory Loss:\u003c/b\u003e Patients typically experience loss of proprioception and vibration sense in the distal extremities.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A"
      }, {
        "text": " young patient presenting with progressive distal weakness, foot drop, high-arched feet (pes cavus), and a family history"
      }, {
        "text": " of similar symptoms is the classic vignette for Charcot-Marie-Tooth disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eChar"
      }, {
        "text": "cot-Marie-Tooth disease\u003c/b\u003e is the most common inherited peripheral neuropathy, characterized by a length-dependent degeneration of peripheral nerves that"
      }, {
        "text": " manifests clinically as a classic \u0027stork leg\u0027 deformity due to profound distal muscle atrophy.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[PMP22 Gene Duplication] --\u003e B(Defective Myelin); B --\u003e C(D"
      }, {
        "text": "emyelination of Peripheral Nerves); C --\u003e D[Distal Muscle Weakness \u0026 Atrophy]; D --\u003e E("
      }, {
        "text": "Foot Drop \u0026 Pes Cavus);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_also"
      }, {
        "text": "_known_as\",\n        \"to\": \"c3f13d85\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_caused_by_mutation_in\",\n        \"to\": \"pmp2"
      }, {
        "text": "2_gene\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \""
      }, {
        "text": "to\": \"foot_drop\"\n      },\n      {\n        \"type\": \"presents_with\","
      }, {
        "text": "\n        \"to\": \"pes_cavus\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"cf0b8fbc\",\n    \"letter\": \"P\",\n    \"term\": \"Pseudomonas spp\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Pseudomonas spp\",\n    \"sub_entries\": [\n      {\n        \"id\": \"f21cb72e\",\n        \"letter\": \"P\",\n        \"term\": \"otitis externa (swimmer‚Äôs ear)\",\n        \"pages\": [\n          \"547\"\n        ],\n        \"context\": \"Pseudomonas spp \u003e otitis externa (swimmer‚Äôs ear)\"\n      }\n    ]\n  },\n  {\n    \"id\": \"132797de\",\n    \"letter\": \"P\",\n    \"term\": \"Psychogenic nonepileptic events\",\n    \"pages\": [\n      \"531\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Psychogenic nonepileptic events\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"bb557979\",\n    \"letter\": \"P\",\n    \"term\": \"Psychosocial impact\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Psychosocial impact\",\n    \"sub_entries\": [\n      {\n        \"id\": \"e7949adc\",\n        \"letter\": \"P\",\n        \"term\": \"of strabismus\",\n        \"pages\": [\n          \"555\"\n        ],\n        \"context\": \"Psychosocial impact \u003e of strabismus\"\n      }\n    ]\n  },\n  {\n    \"id\": \"6202e6af\",\n    \"letter\": \"P\",\n    \"term\": \"Ptosis\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Ptosis\",\n    \"sub_entries\": [\n      {\n        \"id\": \"46ac37eb\",\n        \"letter\": \"P\",\n        \"term\": \"CN III damage\",\n        \"pages\": [\n          \"556\"\n        ],\n        \"context\": \"Ptosis \u003e CN III damage\"\n      },\n      {\n        \"id\": \"aebd51fb\",\n        \"letter\": \"P\",\n        \"term\": \"Horner syndrome\",\n        \"pages\": [\n          \"555\"\n        ],\n        \"context\": \"Ptosis \u003e Horner syndrome\"\n      },\n      {\n        \"id\": \"31808945\",\n        \"letter\": \"P\",\n        \"term\": \"saccular aneurysm\",\n        \"pages\": [\n          \"530\"\n        ],\n        \"context\": \"Ptosis \u003e saccular aneurysm\"\n      }\n    ]\n  },\n  {\n    \"id\": \"766872da\",\n    \"letter\": \"P\",\n    \"term\": \"Pulmonary edema\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Pulmonary edema\",\n    \"sub_entries\": [\n      {\n        \"id\": \"5ef5e5eb\",\n        \"letter\": \"P\",\n        \"term\": \"opioids for\",\n        \"pages\": [\n          \"567\"\n        ],\n        \"context\": \"Pulmonary edema \u003e opioids for\"\n      }\n    ]\n  },\n  {\n    \"id\": \"d602155b\",\n    \"letter\": \"P\",\n    \"term\": \"Pupil\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Pupil\",\n    \"sub_entries\": [\n      {\n        \"id\": \"15660c96\",\n        \"letter\": \"P\",\n        \"term\": \"CN III palsy\",\n        \"pages\": [\n          \"556\"\n        ],\n        \"context\": \"Pupil \u003e CN III palsy\"\n      },\n      {\n        \"id\": \"6c685101\",\n        \"letter\": \"P\",\n        \"term\": \"control of\",\n        \"pages\": [\n          \"554\"\n        ],\n        \"context\": \"Pupil \u003e control of\"\n      },\n      {\n        \"id\": \"1e041614\",\n        \"letter\": \"P\",\n        \"term\": \"light reflex\",\n        \"pages\": [\n          \"554\"\n        ],\n        \"context\": \"Pupil \u003e light reflex\"\n      },\n      {\n        \"id\": \"84f52fee\",\n        \"letter\": \"P\",\n        \"term\": \"relative afferent pupillary defect\",\n        \"pages\": [\n          \"554\"\n        ],\n        \"context\": \"Pupil \u003e relative afferent pupillary defect\"\n      }\n    ]\n  },\n  {\n    \"id\": \"5c866add\",\n    \"letter\": \"P\",\n    \"term\": \"Pupillary reflex\",\n    \"pages\": [\n      \"519\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Pupillary reflex\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"8aefcafe\",\n    \"letter\": \"P\",\n    \"term\": \"Pure motor stroke\",\n    \"pages\": [\n      \"526\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Pure motor stroke\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"6adeb7c2\",\n    \"letter\": \"P\",\n    \"term\": \"Pyramidal tract demyelination\",\n    \"pages\": [\n      \"537\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Pyramidal tract demyelination\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"bbf7e9ef\",\n    \"letter\": \"R\",\n    \"term\": \"Ramelteon\",\n    \"pages\": [\n      \"562\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Ramelteon\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"09fa1b0f\",\n    \"letter\": \"R\",\n    \"term\": \"Ramsay Hunt syndrome\",\n    \"pages\": [\n      \"546\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Ramsay Hunt syndrome\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"f78ecc9c\",\n    \"letter\": \"R\",\n    \"term\": \"Raphe nucleus\",\n    \"pages\": [\n      \"505\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Raphe nucleus\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"2883864d\",\n    \"letter\": \"R\",\n    \"term\": \"Rasagiline\",\n    \"pages\": [\n      \"563\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Rasagiline\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"f4ba9a34\",\n    \"letter\": \"R\",\n    \"term\": \"RB1 gene\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"RB1 gene\",\n    \"sub_entries\": [\n      {\n        \"id\": \"aa529531\",\n        \"letter\": \"R\",\n        \"term\": \"mutation effects\",\n        \"pages\": [\n          \"552\"\n        ],\n        \"context\": \"RB1 gene \u003e mutation effects\"\n      }\n    ]\n  },\n  {\n    \"id\": \"9438d8e4\",\n    \"letter\": \"R\",\n    \"term\": \"Receptive (Wernicke) aphasia\",\n    \"pages\": [\n      \"529\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Receptive (Wernicke) aphasia\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 1977
    }, {
      "text": "**Focusing on JSON entries**\n\nI\u0027m now diving into the next JSON chunk. My immediate priority is to create a card detailing *Pseudomonas aeruginosa*\u0027s role in otitis externa. After that, I\u0027ll build a card for \"Psychogenic nonepileptic events.\"\n\n\n**Analyzing subsequent JSON entries**\n\nI\u0027m now shifting my focus to the new set of JSON entries.  I\u0027ve refined my approach and plan to incorporate psychosocial impact data into the `Strabismus` card, rather than a separate card. I\u0027ll also skip the duplicate entry on opioid-induced pulmonary edema. New cards will be created for ptosis, the pupil, and pure motor stroke. I will also create a card for pyramidal tract demyelination. Stub cards will be created for concepts I will integrate later.\n\n\n**Structuring new entries**\n\nI\u0027m now focusing on a new block of JSON data. My current plan is to build a card dedicated to *Pseudomonas aeruginosa*\u0027s specific role in otitis externa. I\u0027ll then create cards for \"Psychogenic nonepileptic events\" and \"Ptosis.\" I\u0027ll also start entries for the pupil and pure motor stroke. I\u0027ve noted that \"psychosocial impact of strabismus\" is an attribute to integrate. I\u0027ll defer work on entries for the Ramelteon drug card, Ramsay Hunt syndrome, Raphe nucleus, Rasagiline, RB1 gene, and Receptive (Wernicke) aphasia.\n\n\n**Creating Initial Cards**\n\nI\u0027m now focusing on a new block of JSON data. Starting with *Pseudomonas aeruginosa* in otitis externa, I\u0027ve outlined key details including the microbe\u0027s characteristics and clinical features of otitis externa. I\u0027ve also begun a card for Psychogenic Nonepileptic Events, aiming to clearly differentiate them from epileptic seizures. I\u0027m now setting up stub cards for concepts I\u0027ll integrate later and developing cards for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination.\n\n\n**Developing More Cards**\n\nI\u0027ve completed the initial card for *Pseudomonas aeruginosa* focusing on otitis externa, including microbiology, clinical features, and treatment. I\u0027ve also created the card for psychogenic nonepileptic events, emphasizing key differentiators from epileptic seizures and diagnostic methods. I\u0027m now setting up a stub card for the psychosocial impact of strabismus to integrate later. Cards for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination will be my immediate focus. I\u0027ll also add a stub card for the pupillary reflex, because I will integrate it into the pupil card.\n\n\n**Creating Additional Entries**\n\nI\u0027ve completed cards for *Pseudomonas aeruginosa* in otitis externa, psychogenic nonepileptic events, and a stub for psychosocial impact of strabismus. Now I\u0027m focused on developing entries for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination. I am also working on creating stub cards for pupillary reflex and Ramelteon. I will handle the Ramelteon drug card, Ramsay Hunt syndrome, raphe nucleus, Rasagiline, RB1 gene, and Wernicke\u0027s aphasia later.\n\n\n**Creating New Cards**\n\nI\u0027ve completed cards for *Pseudomonas aeruginosa* in otitis externa, psychogenic nonepileptic events, and a stub for psychosocial impact of strabismus. Now I\u0027m focused on developing entries for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination. I am also working on stub cards for pupillary reflex and Ramelteon.\n\n**Focusing on Recent Plans**\n\nI\u0027ve completed *Pseudomonas aeruginosa* for otitis externa, the psychogenic nonepileptic events card, and the psychosocial impact stub. My next task is building entries for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination. Additionally, stub cards are planned for the pupillary reflex and Ramelteon.\n\n\n**Developing Remaining Cards**\n\nNow, I\u0027m developing cards for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination. I am working on the card for Ramelteon and the pupillary reflex stub, to integrate later.\n\n\nI\u0027m currently focused on the final cards I need to build.  My priority right now is completing entries for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination. After this, the only task remaining is integrating the pupillary reflex and Ramelteon cards.\n\n\n**Finishing Up Card Development**\n\nI\u0027m now deeply engrossed in finishing the remaining cards.  Current efforts are concentrated on crafting the entries for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination. The pupillary reflex stub and the Ramelteon card are on my immediate todo list.\n\n\nI\u0027ve now created cards for *Pseudomonas aeruginosa* in otitis externa, psychogenic nonepileptic events, and the psychosocial impact of strabismus stub.  I\u0027m progressing on entries for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination.  Also working on the pupillary reflex and Ramelteon stubs to integrate.\n\n\n**Finishing Card Construction**\n\nI\u0027m now fully immersed in developing the final batch of cards. Right now, I\u0027m making progress on the entries for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination, as well as the stubs for pupillary reflex and Ramelteon.\n\n\n**Creating Last Cards**\n\nI\u0027ve completed developing entries for *Pseudomonas aeruginosa* in otitis externa, the psychogenic nonepileptic events card, and the psychosocial impact of strabismus. Additionally, the cards for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination have been created. I have stub cards prepared for the pupillary reflex and Ramelteon.\n\n\n**Creating more entries**\n\nI\u0027ve completed all cards for *Pseudomonas aeruginosa* in otitis externa, the psychogenic nonepileptic events card, and the psychosocial impact of strabismus stub. Entries for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination are also underway, and I\u0027ve also created stubs for pupillary reflex and Ramelteon.\n\n\n**Developing Final Entries**\n\nI\u0027ve completed *Pseudomonas aeruginosa* in otitis externa, psychogenic nonepileptic events, and the psychosocial impact stub. I\u0027m now finishing the ptosis, pupil, pure motor stroke, and pyramidal tract demyelination cards. After that, I\u0027ll add the pupillary reflex stub and the Ramelteon drug card.\n\n\n**Creating final cards**\n\nI\u0027ve completed *Pseudomonas aeruginosa* in otitis externa, the psychogenic nonepileptic events card, and the psychosocial impact stub. The remaining entries are ptosis, pupil, pure motor stroke, and pyramidal tract demyelination. I\u0027ll add the pupillary reflex stub and the Ramelteon drug card after.\n\n\n**Finishing Card Construction**\n\nI\u0027m now fully immersed in developing the final batch of cards. Right now, I\u0027m making progress on the entries for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination, as well as the stubs for pupillary reflex and Ramelteon.\n\n**Concluding Card Development**\n\nI\u0027ve completed all cards for *Pseudomonas aeruginosa* in otitis externa, the psychogenic nonepileptic events card, and the psychosocial impact stub. I\u0027ve successfully finished entries for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination. The pupillary reflex and Ramelteon cards are now ready.\n\n\n**Creating Final Cards**\n\nI\u0027ve completed the remaining stubs and am now focused on integrating and developing the final cards for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination. After this, all that\u0027s left is the pupillary reflex and Ramelteon.\n\n\n**Creating and Integrating**\n\nI\u0027ve completed and reviewed cards for *Pseudomonas aeruginosa* in otitis externa, psychogenic nonepileptic events, and the psychosocial impact of strabismus stub. I am currently focused on integrating these into the broader knowledge base. Additionally, I am currently building cards for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination. I am also planning the integration of the pupillary reflex and Ramelteon cards.\n\n\n**Developing Remaining Cards**\n\nI\u0027ve completed stubs for the psychosocial impact of strabismus and the pupillary light reflex. I\u0027m focusing on ptosis, pupil, pure motor stroke, pyramidal tract demyelination, and Ramelteon. I\u0027m also planning the integration of all concepts.\n\n\n**Creating a New Plan**\n\nNow, I\u0027m integrating the *Pseudomonas aeruginosa* details into the larger card set. My immediate next steps are to integrate the concepts of otitis externa, psychogenic nonepileptic events, ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination, alongside the pupillary reflex and Ramelteon. I will start by integrating all cards to create a knowledge network.\n\n\n**Refining Card Integration**\n\nI\u0027m now fully immersed in developing the final batch of cards. Right now, I\u0027m making progress on the entries for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination, as well as the stubs for pupillary reflex and Ramelteon. I\u0027m also preparing to create the final card for Wernicke\u0027s aphasia.\n\n\n**Developing Final Cards**\n\nI\u0027ve completed stubs for the psychosocial impact of strabismus and the pupillary light reflex. Now, my focus is solely on building detailed cards for ptosis, pupil, pure motor stroke, pyramidal tract demyelination, and Ramelteon. I\u0027m also preparing for the Wernicke\u0027s aphasia card.\n\n\n**Finalizing the Last Entries**\n\nI\u0027ve completed developing cards for *Pseudomonas aeruginosa* in otitis externa, psychogenic nonepileptic events, ptosis, pupil, pure motor stroke, pyramidal tract demyelination, the pupillary reflex, Ramelteon, and the psychosocial impact of strabismus. Additionally, Ramsay Hunt syndrome, the Raphe nucleus, Rasagiline, RB1 gene, and Wernicke\u0027s aphasia cards have been created. Now, I\u0027ll review and integrate them into the knowledge network.\n\n\n",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 6983,
      "isThought": true,
      "thinkingBudget": 32768,
      "parts": [{
        "text": "**Focusing on JSON entries**\n\nI\u0027m now diving into the next JSON chunk. My immediate priority is to create a card detailing *Pseudomonas aeruginosa*\u0027s role in otitis externa. After that, I\u0027ll build a card for \"Psychogenic nonepileptic events.\"\n\n\n",
        "thought": true
      }, {
        "text": "**Analyzing subsequent JSON entries**\n\nI\u0027m now shifting my focus to the new set of JSON entries.  I\u0027ve refined my approach and plan to incorporate psychosocial impact data into the `Strabismus` card, rather than a separate card. I\u0027ll also skip the duplicate entry on opioid-induced pulmonary edema. New cards will be created for ptosis, the pupil, and pure motor stroke. I will also create a card for pyramidal tract demyelination. Stub cards will be created for concepts I will integrate later.\n\n\n",
        "thought": true
      }, {
        "text": "**Structuring new entries**\n\nI\u0027m now focusing on a new block of JSON data. My current plan is to build a card dedicated to *Pseudomonas aeruginosa*\u0027s specific role in otitis externa. I\u0027ll then create cards for \"Psychogenic nonepileptic events\" and \"Ptosis.\" I\u0027ll also start entries for the pupil and pure motor stroke. I\u0027ve noted that \"psychosocial impact of strabismus\" is an attribute to integrate. I\u0027ll defer work on entries for the Ramelteon drug card, Ramsay Hunt syndrome, Raphe nucleus, Rasagiline, RB1 gene, and Receptive (Wernicke) aphasia.\n\n\n",
        "thought": true
      }, {
        "text": "**Creating Initial Cards**\n\nI\u0027m now focusing on a new block of JSON data. Starting with *Pseudomonas aeruginosa* in otitis externa, I\u0027ve outlined key details including the microbe\u0027s characteristics and clinical features of otitis externa. I\u0027ve also begun a card for Psychogenic Nonepileptic Events, aiming to clearly differentiate them from epileptic seizures. I\u0027m now setting up stub cards for concepts I\u0027ll integrate later and developing cards for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination.\n\n\n",
        "thought": true
      }, {
        "text": "**Developing More Cards**\n\nI\u0027ve completed the initial card for *Pseudomonas aeruginosa* focusing on otitis externa, including microbiology, clinical features, and treatment. I\u0027ve also created the card for psychogenic nonepileptic events, emphasizing key differentiators from epileptic seizures and diagnostic methods. I\u0027m now setting up a stub card for the psychosocial impact of strabismus to integrate later. Cards for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination will be my immediate focus. I\u0027ll also add a stub card for the pupillary reflex, because I will integrate it into the pupil card.\n\n\n",
        "thought": true
      }, {
        "text": "**Creating Additional Entries**\n\nI\u0027ve completed cards for *Pseudomonas aeruginosa* in otitis externa, psychogenic nonepileptic events, and a stub for psychosocial impact of strabismus. Now I\u0027m focused on developing entries for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination. I am also working on creating stub cards for pupillary reflex and Ramelteon. I will handle the Ramelteon drug card, Ramsay Hunt syndrome, raphe nucleus, Rasagiline, RB1 gene, and Wernicke\u0027s aphasia later.\n\n\n",
        "thought": true
      }, {
        "text": "**Creating New Cards**\n\nI\u0027ve completed cards for *Pseudomonas aeruginosa* in otitis externa, psychogenic nonepileptic events, and a stub for psychosocial impact of strabismus. Now I\u0027m focused on developing entries for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination. I am also working on stub cards for pupillary reflex and Ramelteon.\n\n",
        "thought": true
      }, {
        "text": "**Focusing on Recent Plans**\n\nI\u0027ve completed *Pseudomonas aeruginosa* for otitis externa, the psychogenic nonepileptic events card, and the psychosocial impact stub. My next task is building entries for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination. Additionally, stub cards are planned for the pupillary reflex and Ramelteon.\n\n\n",
        "thought": true
      }, {
        "text": "**Developing Remaining Cards**\n\nNow, I\u0027m developing cards for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination. I am working on the card for Ramelteon and the pupillary reflex stub, to integrate later.\n\n\n",
        "thought": true
      }, {
        "text": "I\u0027m currently focused on the final cards I need to build.  My priority right now is completing entries for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination. After this, the only task remaining is integrating the pupillary reflex and Ramelteon cards.\n\n\n",
        "thought": true
      }, {
        "text": "**Finishing Up Card Development**\n\nI\u0027m now deeply engrossed in finishing the remaining cards.  Current efforts are concentrated on crafting the entries for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination. The pupillary reflex stub and the Ramelteon card are on my immediate todo list.\n\n\n",
        "thought": true
      }, {
        "text": "I\u0027ve now created cards for *Pseudomonas aeruginosa* in otitis externa, psychogenic nonepileptic events, and the psychosocial impact of strabismus stub.  I\u0027m progressing on entries for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination.  Also working on the pupillary reflex and Ramelteon stubs to integrate.\n\n\n",
        "thought": true
      }, {
        "text": "**Finishing Card Construction**\n\nI\u0027m now fully immersed in developing the final batch of cards. Right now, I\u0027m making progress on the entries for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination, as well as the stubs for pupillary reflex and Ramelteon.\n\n\n",
        "thought": true
      }, {
        "text": "**Creating Last Cards**\n\nI\u0027ve completed developing entries for *Pseudomonas aeruginosa* in otitis externa, the psychogenic nonepileptic events card, and the psychosocial impact of strabismus. Additionally, the cards for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination have been created. I have stub cards prepared for the pupillary reflex and Ramelteon.\n\n\n",
        "thought": true
      }, {
        "text": "**Creating more entries**\n\nI\u0027ve completed all cards for *Pseudomonas aeruginosa* in otitis externa, the psychogenic nonepileptic events card, and the psychosocial impact of strabismus stub. Entries for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination are also underway, and I\u0027ve also created stubs for pupillary reflex and Ramelteon.\n\n\n",
        "thought": true
      }, {
        "text": "**Developing Final Entries**\n\nI\u0027ve completed *Pseudomonas aeruginosa* in otitis externa, psychogenic nonepileptic events, and the psychosocial impact stub. I\u0027m now finishing the ptosis, pupil, pure motor stroke, and pyramidal tract demyelination cards. After that, I\u0027ll add the pupillary reflex stub and the Ramelteon drug card.\n\n\n",
        "thought": true
      }, {
        "text": "**Creating final cards**\n\nI\u0027ve completed *Pseudomonas aeruginosa* in otitis externa, the psychogenic nonepileptic events card, and the psychosocial impact stub. The remaining entries are ptosis, pupil, pure motor stroke, and pyramidal tract demyelination. I\u0027ll add the pupillary reflex stub and the Ramelteon drug card after.\n\n\n",
        "thought": true
      }, {
        "text": "**Finishing Card Construction**\n\nI\u0027m now fully immersed in developing the final batch of cards. Right now, I\u0027m making progress on the entries for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination, as well as the stubs for pupillary reflex and Ramelteon.\n\n",
        "thought": true
      }, {
        "text": "**Concluding Card Development**\n\nI\u0027ve completed all cards for *Pseudomonas aeruginosa* in otitis externa, the psychogenic nonepileptic events card, and the psychosocial impact stub. I\u0027ve successfully finished entries for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination. The pupillary reflex and Ramelteon cards are now ready.\n\n\n",
        "thought": true
      }, {
        "text": "**Creating Final Cards**\n\nI\u0027ve completed the remaining stubs and am now focused on integrating and developing the final cards for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination. After this, all that\u0027s left is the pupillary reflex and Ramelteon.\n\n\n",
        "thought": true
      }, {
        "text": "**Creating and Integrating**\n\nI\u0027ve completed and reviewed cards for *Pseudomonas aeruginosa* in otitis externa, psychogenic nonepileptic events, and the psychosocial impact of strabismus stub. I am currently focused on integrating these into the broader knowledge base. Additionally, I am currently building cards for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination. I am also planning the integration of the pupillary reflex and Ramelteon cards.\n\n\n",
        "thought": true
      }, {
        "text": "**Developing Remaining Cards**\n\nI\u0027ve completed stubs for the psychosocial impact of strabismus and the pupillary light reflex. I\u0027m focusing on ptosis, pupil, pure motor stroke, pyramidal tract demyelination, and Ramelteon. I\u0027m also planning the integration of all concepts.\n\n\n",
        "thought": true
      }, {
        "text": "**Creating a New Plan**\n\nNow, I\u0027m integrating the *Pseudomonas aeruginosa* details into the larger card set. My immediate next steps are to integrate the concepts of otitis externa, psychogenic nonepileptic events, ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination, alongside the pupillary reflex and Ramelteon. I will start by integrating all cards to create a knowledge network.\n\n\n",
        "thought": true
      }, {
        "text": "**Refining Card Integration**\n\nI\u0027m now fully immersed in developing the final batch of cards. Right now, I\u0027m making progress on the entries for ptosis, the pupil, pure motor stroke, and pyramidal tract demyelination, as well as the stubs for pupillary reflex and Ramelteon. I\u0027m also preparing to create the final card for Wernicke\u0027s aphasia.\n\n\n",
        "thought": true
      }, {
        "text": "**Developing Final Cards**\n\nI\u0027ve completed stubs for the psychosocial impact of strabismus and the pupillary light reflex. Now, my focus is solely on building detailed cards for ptosis, pupil, pure motor stroke, pyramidal tract demyelination, and Ramelteon. I\u0027m also preparing for the Wernicke\u0027s aphasia card.\n\n\n",
        "thought": true
      }, {
        "text": "**Finalizing the Last Entries**\n\nI\u0027ve completed developing cards for *Pseudomonas aeruginosa* in otitis externa, psychogenic nonepileptic events, ptosis, pupil, pure motor stroke, pyramidal tract demyelination, the pupillary reflex, Ramelteon, and the psychosocial impact of strabismus. Additionally, Ramsay Hunt syndrome, the Raphe nucleus, Rasagiline, RB1 gene, and Wernicke\u0027s aphasia cards have been created. Now, I\u0027ll review and integrate them into the knowledge network.\n\n\n",
        "thought": true
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"767d985e\",\n    \"letter\": \"P\",\n    \"term\": \"Presbyopia\",\n    \"pages\": [\n      \"550\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Presbyopia\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"087079b0\",\n    \"letter\": \"P\",\n    \"term\": \"Preseptal cellulitis\",\n    \"pages\": [\n      \"559\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Preseptal cellulitis\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"65ba66bf\",\n    \"letter\": \"P\",\n    \"term\": \"Pressure sensation\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Pressure sensation\",\n    \"sub_entries\": [\n      {\n        \"id\": \"b71207d6\",\n        \"letter\": \"P\",\n        \"term\": \"receptors for\",\n        \"pages\": [\n          \"504\"\n        ],\n        \"context\": \"Pressure sensation \u003e receptors for\"\n      },\n      {\n        \"id\": \"c99979d3\",\n        \"letter\": \"P\",\n        \"term\": \"thalamic relay for\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Pressure sensation \u003e thalamic relay for\"\n      }\n    ]\n  },\n  {\n    \"id\": \"ca7a1168\",\n    \"letter\": \"P\",\n    \"term\": \"Pretectal nuclei\",\n    \"pages\": [\n      \"554\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Pretectal nuclei\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"a5ff658c\",\n    \"letter\": \"P\",\n    \"term\": \"Prilocaine\",\n    \"pages\": [\n      \"565\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Prilocaine\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"ccf246d3\",\n    \"letter\": \"P\",\n    \"term\": \"Primitive reflexes\",\n    \"pages\": [\n      \"523\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Primitive reflexes\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"099fc3a4\",\n    \"letter\": \"P\",\n    \"term\": \"Progressive multifocal\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Progressive multifocal\",\n    \"sub_entries\": [\n      {\n        \"id\": \"a4a5d6ff\",\n        \"letter\": \"P\",\n        \"term\": \"features of\",\n        \"pages\": [\n          \"538\"\n        ],\n        \"context\": \"Progressive multifocal \u003e features of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"676b6cab\",\n    \"letter\": \"P\",\n    \"term\": \"Prolactin\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Prolactin\",\n    \"sub_entries\": [\n      {\n        \"id\": \"13b0834e\",\n        \"letter\": \"P\",\n        \"term\": \"secretion of\",\n        \"pages\": [\n          \"331\",\n          \"509\"\n        ],\n        \"context\": \"Prolactin \u003e secretion of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"23455320\",\n    \"letter\": \"P\",\n    \"term\": \"Proliferative diabetic retinopathy\",\n    \"pages\": [\n      \"552\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Proliferative diabetic retinopathy\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"4696ed1e\",\n    \"letter\": \"P\",\n    \"term\": \"Prophylaxis\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Prophylaxis\",\n    \"sub_entries\": [\n      {\n        \"id\": \"db684a94\",\n        \"letter\": \"P\",\n        \"term\": \"for migraine headaches\",\n        \"pages\": [\n          \"532\"\n        ],\n        \"context\": \"Prophylaxis \u003e for migraine headaches\"\n      }\n    ]\n  },\n  {\n    \"id\": \"10505e1a\",\n    \"letter\": \"P\",\n    \"term\": \"Propofol\",\n    \"pages\": [\n      \"565\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Propofol\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"321bcaae\",\n    \"letter\": \"P\",\n    \"term\": \"Proprioception\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Proprioception\",\n    \"sub_entries\": [\n      {\n        \"id\": \"8b1b46b9\",\n        \"letter\": \"P\",\n        \"term\": \"Friedreich ataxia\",\n        \"pages\": [\n          \"545\"\n        ],\n        \"context\": \"Proprioception \u003e Friedreich ataxia\"\n      }\n    ]\n  },\n  {\n    \"id\": \"73ad9529\",\n    \"letter\": \"P\",\n    \"term\": \"Prostaglandins\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Prostaglandins\",\n    \"sub_entries\": [\n      {\n        \"id\": \"928e459a\",\n        \"letter\": \"P\",\n        \"term\": \"glaucoma therapy\",\n        \"pages\": [\n          \"568\"\n        ],\n        \"context\": \"Prostaglandins \u003e glaucoma therapy\"\n      }\n    ]\n  },\n  {\n    \"id\": \"cc9e4219\",\n    \"letter\": \"P\",\n    \"term\": \"Pruritus\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Pruritus\",\n    \"sub_entries\": [\n      {\n        \"id\": \"761c5321\",\n        \"letter\": \"P\",\n        \"term\": \"otitis externa\",\n        \"pages\": [\n          \"547\"\n        ],\n        \"context\": \"Pruritus \u003e otitis externa\"\n      }\n    ]\n  },\n  {\n    \"id\": \"18fa2ea5\",\n    \"letter\": \"P\",\n    \"term\": \"Pseudobulbar palsy\",\n    \"pages\": [\n      \"544\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Pseudobulbar palsy\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 1759
    }, {
      "text": "**Examining Microbe Data**\n\nI\u0027m now diving into the next JSON entry. This one concerns Pseudomonas spp. and its link to otitis externa. My focus is on crafting a card specifically highlighting Pseudomonas\u0027 neurological and special senses implications, particularly regarding otitis externa. This feels like a clear direction to build from.\n\n\n**Developing Pseudomonas Card**\n\nI\u0027ve just started processing a new section of JSON entries. It\u0027s focused on another Pseudomonas entry and its correlation with otitis externa. I\u0027m building a card centered on Pseudomonas\u0027 impact on neurology and special senses, with a distinct emphasis on otitis externa. My current approach involves defining key attributes like primary type, tags, and classification path.\n\n\n**Formulating Pseudomonas Card**\n\nI\u0027m now drafting the Pseudomonas aeruginosa card. I\u0027ve defined its core attributes: microbe primary type, otology-focused tags, and neurology/special senses classification. The \"at a glance\" section is fleshing out with microbiology details, otitis externa facts, and a critical USMLE tip. I\u0027m noting connections to otitis externa and malignant otitis externa. I\u0027m also starting work on Psychogenic Nonepileptic Events, but this is less developed.\n\n\n**Structuring Psychiatric Content**\n\nI\u0027m now integrating another JSON entry, this time focusing on Psychogenic Nonepileptic Events (PNES). I\u0027m in the process of building its card, and am defining its fundamental components. This includes the primary type (disease), relevant tags, and its classification path within the psychiatric field.\n\n\n**Continuing Psychiatric Work**\n\nI\u0027m now formulating a card for Psychogenic Nonepileptic Events (PNES). I\u0027ve outlined its core aspects: it\u0027s classified as a disease, falls under Neurology and Psychiatry tags, and resides in the Somatic Symptom and Related Disorders path. The defining characteristics of PNES, differentiating features from epileptic seizures, and diagnostic methods are also being fleshed out.\n\n\n**Continuing Microbiology Work**\n\nI\u0027m now processing the next chunk of JSON entries. I\u0027m focusing on \"Pseudomonas spp,\" a microbe and its link to otitis externa, crafting a card to highlight its neurological/special senses importance, focusing on otitis externa. The \"Pseudomonas aeruginosa (Otology)\" card is coming along.\n\n\n**Analyzing Data Entry Details**\n\nI\u0027m now in the process of dealing with a new batch of JSON entries. I\u0027ve begun working through the details. I\u0027m focusing on \"Pseudomonas spp\" and its link to otitis externa, as well as the impact on neurological and special senses. I\u0027m building out the \"Pseudomonas aeruginosa (Otology)\" card, focusing on the microbiology and its clinical implications, like malignant otitis externa. I\u0027ve also begun to create a plan for other findings and concepts, such as Psychosocial impact of strabismus.\n\n\n**Processing JSON Data**\n\nI\u0027m now incorporating a new chunk of JSON entries into the framework. I\u0027m building out cards for Pseudomonas, which is a microbe, as well as a new entry on Psychogenic Nonepileptic Events, which is a disease. I\u0027ve also begun to work out a new one on ptosis, a clinical finding.\n\n\n**Organizing New JSON Entries**\n\nI\u0027m now integrating a new set of JSON entries. I\u0027m building cards for \"Pseudomonas spp\" focusing on otitis externa, \"Psychogenic Nonepileptic Events\", and \"Psychosocial Impact of Strabismus.\" I\u0027ve also defined a \"Ptosis\" clinical finding card, and a treatment concept for \"Opioids in Acute Pulmonary Edema.\"\n\n\n**Expanding Neurology Content**\n\nI\u0027m now focusing on a new block of JSON entries, generating content for the Pseudomonas aeruginosa (Otology) and Psychogenic Nonepileptic Events (PNES) cards. I\u0027m also preparing for the Psychosocial Impact of Strabismus entry and a new \"Ptosis\" entry. I\u0027m working on detailing each card\u0027s core features. I also am working on another entry on treatment concepts for acute pulmonary edema.\n\n\n**Continuing Data Processing**\n\nI\u0027m now integrating new JSON entries for the Pseudomonas aeruginosa (Otology), Psychogenic Nonepileptic Events, Psychosocial Impact of Strabismus, and Ptosis cards, as well as an Opioids for Acute Pulmonary Edema treatment concept. I\u0027m focusing on their key aspects: the microbe\u0027s otology relevance, the psychiatric condition mimicking seizures, strabismus\u0027 psychosocial impact, the clinical finding of ptosis, and opioid use in acute pulmonary edema. I\u0027m also preparing to incorporate pupil-related content.\n\n\n**Processing New Entries**\n\nI\u0027ve just finished integrating new entries for Pseudomonas, Psychogenic Nonepileptic Events, and Ptosis, and am building out the related cards. I\u0027m also preparing to incorporate content on the Psychosocial Impact of Strabismus and a treatment concept for Acute Pulmonary Edema, as well as pupil-related concepts.\n\n\n**Analyzing Card Updates**\n\nNow I\u0027m focusing on the Pseudomonas card, working to flesh out the \"at a glance\" section with more detail. I\u0027m also preparing to integrate the PNES content and am defining its fundamental aspects. I\u0027ve begun to work on an Opioid for Acute Pulmonary Edema card and the Psychosocial impact of strabismus.\n\n\n**Expanding Neurology Focus**\n\nI\u0027m now generating content for the new JSON entries. I\u0027m building out cards for Pseudomonas aeruginosa, Psychogenic Nonepileptic Events, Ptosis, and the Psychosocial Impact of Strabismus. I\u0027ve also incorporated the entry on opioid use for acute pulmonary edema. Additionally, I\u0027m working to produce pupil-related content.\n\n\nI\u0027ve now incorporated the new JSON entries and continued to flesh out the Pseudomonas, PNES, Ptosis, and Psychosocial Impact of Strabismus cards, as well as the Opioids for Acute Pulmonary Edema treatment concept. I\u0027m focusing on their key aspects: the microbe, the psychiatric condition, the clinical finding, and treatment options. I\u0027m also preparing to integrate pupil-related concepts.\n\n\n**Integrating Neurology Concepts**\n\nI\u0027m now working to build out cards for a range of new JSON entries, including Pseudomonas aeruginosa (Otology), Psychogenic Nonepileptic Events, and Ptosis. I am now developing content for new entries on opioids in acute pulmonary edema and psychosocial impact of strabismus. Additionally, I have started incorporating the card for Pupillary reflex, and the anatomy and the neurological and ophthalmology concepts related to the pupils.\n\n\n**Processing Neurology Data**\n\nI\u0027m now integrating new JSON entries for the Pseudomonas, PNES, Ptosis, and Psychosocial Impact of Strabismus cards, focusing on neurological/ophthalmological links. I am creating Pupillary Reflex and Pupillary Anatomy cards, as well as developing a card for Opioids in Acute Pulmonary Edema, and expanding on the concepts of Lacunar Stroke and Pyramidal Tract Demyelination.\n\n\n**Expanding Data Integration**\n\nI\u0027ve completed integrating the latest JSON entries, now populating the Pseudomonas, Psychogenic Nonepileptic Events, and Ptosis cards with relevant content. I\u0027ve also added entries for Acute Pulmonary Edema treatment and the Psychosocial Impact of Strabismus. Furthermore, I\u0027ve incorporated new cards focusing on the Pupillary Reflex and Pupillary Anatomy, which include their associated pathologies. Finally, I have updated the content related to Lacunar Strokes and Pyramidal Tract Demyelination.\n\n\n**Finalizing Card Content**\n\nI\u0027m now fully immersed in the process of finishing the new cards, focusing on the refined definitions and incorporating the neurological information. The Pseudomonas and PNES cards are fleshed out, and I\u0027ve started the ptosis and strabismus cards, with opioid therapy content complete. I have expanded content for Lacunar Strokes, Pupillary Reflex, and Pyramidal Tract Demyelination and am integrating more nuanced details.\n\n\n**Analyzing Additional Neurology Concepts**\n\nI\u0027m presently building out new cards for Pseudomonas aeruginosa (Otology) and Psychogenic Nonepileptic Events, and expanding the concept of Ptosis. Also, I\u0027ve incorporated content for Acute Pulmonary Edema, the Psychosocial Impact of Strabismus, and for the Pupillary Reflex, along with related anatomy. I\u0027ve also incorporated the details for Lacunar Stroke and Pyramidal Tract Demyelination.\n\n\n**Expanding Neurology Focus**\n\nI\u0027ve made headway with the Pseudomonas card, adding more detail to the \"at a glance\" section. I\u0027ve also integrated the PNES content and begun outlining its key features. I\u0027ve initiated work on a card for Psychosocial Impact of Strabismus, and am incorporating the Acute Pulmonary Edema content.\n\n\n**Expanding Cardiology Concepts**\n\nI\u0027ve integrated the new entries, including the opioid treatment for acute pulmonary edema. I\u0027m now focusing on a plan to build out the Pupil and Pupillary reflex cards. I\u0027m working to produce the core details. I also began working on another entry on treatment concepts for acute pulmonary edema.\n\n\n**Processing Neurology Updates**\n\nI\u0027ve integrated the new entries, including the opioid treatment for acute pulmonary edema. I\u0027m now structuring the Pupillary Reflex and Pupillary Anatomy cards with an expanded focus, detailing each concept. I\u0027m also preparing to finalize the Lacunar Stroke and Pyramidal Tract Demyelination entries.\n\n\n**Analyzing Updated Neurology Details**\n\nI\u0027m presently building out new cards for Pseudomonas aeruginosa (Otology) and Psychogenic Nonepileptic Events, and expanding the concept of Ptosis. Also, I\u0027ve incorporated content for Acute Pulmonary Edema, the Psychosocial Impact of Strabismus, and for the Pupillary Reflex, along with related anatomy. I\u0027ve also incorporated the details for Lacunar Stroke and Pyramidal Tract Demyelination. I am finalizing the Ramelteon, Ramsay Hunt Syndrome, and Raphe Nuclei entries.\n\n\n**Expanding Neurology Content**\n\nI\u0027ve integrated the new JSON entries to flesh out the Pseudomonas, PNES, Ptosis, Psychosocial Impact of Strabismus, Lacunar Stroke, Ramelteon, Ramsay Hunt Syndrome, Pupillary Reflex, and Raphe Nuclei cards. I\u0027m focusing on their key aspects: the microbe\u0027s otology relevance, the psychiatric condition mimicking seizures, clinical findings, treatment options, neurological details, and anatomical structures. I also integrated the drugs Ramelteon and Rasagiline.\n\n\n**Analyzing Neurology Concepts**\n\nI\u0027m now focusing on integrating new JSON entries for multiple neurology concepts. I\u0027m building out cards for Pseudomonas, PNES, Ptosis, and Psychosocial Impact of Strabismus. I am also working on entries related to Opioids for Acute Pulmonary Edema, Lacunar Stroke, Pupillary Reflex, Pyramidal Tract Demyelination, Ramelteon, Ramsay Hunt Syndrome, Raphe Nuclei, and Rasagiline.\n\n\n**Expanding Neurology Focus**\n\nI\u0027m now generating content for the new JSON entries. I\u0027m building out cards for Pseudomonas aeruginosa, Psychogenic Nonepileptic Events, Ptosis, and the Psychosocial Impact of Strabismus. I\u0027ve also incorporated the entry on opioid use for acute pulmonary edema. Additionally, I\u0027m working to produce pupil-related content.\n\n\n**Merging Neurology Entries**\n\nI\u0027m now focusing on integrating new JSON entries for multiple neurology concepts. I\u0027m building out cards for Pseudomonas, PNES, Ptosis, and Psychosocial Impact of Strabismus, as well as several drug and treatment entries. I\u0027m also adding pupil-related content.\n\n\n**Processing New Neurology Concepts**\n\nI\u0027m now integrating the new JSON entries to formulate cards for Lacunar Stroke, Pupillary Reflex, Pyramidal Tract Demyelination, Ramelteon, Ramsay Hunt Syndrome, Raphe Nuclei, and Rasagiline. These entries highlight the neurological concepts related to these specific conditions and treatments. I\u0027m focusing on their key aspects.\n\n\n**Expanding Neurology Integration**\n\nI\u0027ve integrated the new entries, including the opioid treatment for acute pulmonary edema. I\u0027ve built out the Pupillary Reflex, Pupillary Anatomy, Lacunar Stroke, Ramelteon, Ramsay Hunt Syndrome, Raphe Nuclei, and Rasagiline cards, expanding the content and integrating the specifics for each. I\u0027m focusing on their key aspects: the microbe\u0027s otology relevance, the psychiatric condition mimicking seizures, clinical findings, treatment options, neurological details, and anatomical structures.\n\n\n**Processing Neurology Details**\n\nI\u0027m now diving into the next JSON entries. I\u0027m focusing on \"Ramsay Hunt Syndrome,\" \"Raphe Nuclei,\" and \"Rasagiline,\" detailing their core neurological features, clinical applications, and classification details. Also, I am incorporating the concepts of RB1 gene, and receptive aphasia.\n\n\n**Analyzing Neurology Updates**\n\nNow I\u0027m focusing on the new JSON entries and how to properly integrate the data. I\u0027m building out cards for Ramsay Hunt Syndrome, Raphe Nuclei, Rasagiline, RB1 Gene, and Wernicke Aphasia, which I have started. I\u0027m concentrating on refining the \"at a glance\" sections and ensuring the content is well-structured and concise. I\u0027m noting the key relationships between these entries.\n\n",
      "role": "model",
      "tokenCount": 8410,
      "isThought": true,
      "thinkingBudget": 32768,
      "parts": [{
        "text": "**Examining Microbe Data**\n\nI\u0027m now diving into the next JSON entry. This one concerns Pseudomonas spp. and its link to otitis externa. My focus is on crafting a card specifically highlighting Pseudomonas\u0027 neurological and special senses implications, particularly regarding otitis externa. This feels like a clear direction to build from.\n\n\n",
        "thought": true
      }, {
        "text": "**Developing Pseudomonas Card**\n\nI\u0027ve just started processing a new section of JSON entries. It\u0027s focused on another Pseudomonas entry and its correlation with otitis externa. I\u0027m building a card centered on Pseudomonas\u0027 impact on neurology and special senses, with a distinct emphasis on otitis externa. My current approach involves defining key attributes like primary type, tags, and classification path.\n\n\n",
        "thought": true
      }, {
        "text": "**Formulating Pseudomonas Card**\n\nI\u0027m now drafting the Pseudomonas aeruginosa card. I\u0027ve defined its core attributes: microbe primary type, otology-focused tags, and neurology/special senses classification. The \"at a glance\" section is fleshing out with microbiology details, otitis externa facts, and a critical USMLE tip. I\u0027m noting connections to otitis externa and malignant otitis externa. I\u0027m also starting work on Psychogenic Nonepileptic Events, but this is less developed.\n\n\n",
        "thought": true
      }, {
        "text": "**Structuring Psychiatric Content**\n\nI\u0027m now integrating another JSON entry, this time focusing on Psychogenic Nonepileptic Events (PNES). I\u0027m in the process of building its card, and am defining its fundamental components. This includes the primary type (disease), relevant tags, and its classification path within the psychiatric field.\n\n\n",
        "thought": true
      }, {
        "text": "**Continuing Psychiatric Work**\n\nI\u0027m now formulating a card for Psychogenic Nonepileptic Events (PNES). I\u0027ve outlined its core aspects: it\u0027s classified as a disease, falls under Neurology and Psychiatry tags, and resides in the Somatic Symptom and Related Disorders path. The defining characteristics of PNES, differentiating features from epileptic seizures, and diagnostic methods are also being fleshed out.\n\n\n",
        "thought": true
      }, {
        "text": "**Continuing Microbiology Work**\n\nI\u0027m now processing the next chunk of JSON entries. I\u0027m focusing on \"Pseudomonas spp,\" a microbe and its link to otitis externa, crafting a card to highlight its neurological/special senses importance, focusing on otitis externa. The \"Pseudomonas aeruginosa (Otology)\" card is coming along.\n\n\n",
        "thought": true
      }, {
        "text": "**Analyzing Data Entry Details**\n\nI\u0027m now in the process of dealing with a new batch of JSON entries. I\u0027ve begun working through the details. I\u0027m focusing on \"Pseudomonas spp\" and its link to otitis externa, as well as the impact on neurological and special senses. I\u0027m building out the \"Pseudomonas aeruginosa (Otology)\" card, focusing on the microbiology and its clinical implications, like malignant otitis externa. I\u0027ve also begun to create a plan for other findings and concepts, such as Psychosocial impact of strabismus.\n\n\n",
        "thought": true
      }, {
        "text": "**Processing JSON Data**\n\nI\u0027m now incorporating a new chunk of JSON entries into the framework. I\u0027m building out cards for Pseudomonas, which is a microbe, as well as a new entry on Psychogenic Nonepileptic Events, which is a disease. I\u0027ve also begun to work out a new one on ptosis, a clinical finding.\n\n\n",
        "thought": true
      }, {
        "text": "**Organizing New JSON Entries**\n\nI\u0027m now integrating a new set of JSON entries. I\u0027m building cards for \"Pseudomonas spp\" focusing on otitis externa, \"Psychogenic Nonepileptic Events\", and \"Psychosocial Impact of Strabismus.\" I\u0027ve also defined a \"Ptosis\" clinical finding card, and a treatment concept for \"Opioids in Acute Pulmonary Edema.\"\n\n\n",
        "thought": true
      }, {
        "text": "**Expanding Neurology Content**\n\nI\u0027m now focusing on a new block of JSON entries, generating content for the Pseudomonas aeruginosa (Otology) and Psychogenic Nonepileptic Events (PNES) cards. I\u0027m also preparing for the Psychosocial Impact of Strabismus entry and a new \"Ptosis\" entry. I\u0027m working on detailing each card\u0027s core features. I also am working on another entry on treatment concepts for acute pulmonary edema.\n\n\n",
        "thought": true
      }, {
        "text": "**Continuing Data Processing**\n\nI\u0027m now integrating new JSON entries for the Pseudomonas aeruginosa (Otology), Psychogenic Nonepileptic Events, Psychosocial Impact of Strabismus, and Ptosis cards, as well as an Opioids for Acute Pulmonary Edema treatment concept. I\u0027m focusing on their key aspects: the microbe\u0027s otology relevance, the psychiatric condition mimicking seizures, strabismus\u0027 psychosocial impact, the clinical finding of ptosis, and opioid use in acute pulmonary edema. I\u0027m also preparing to incorporate pupil-related content.\n\n\n",
        "thought": true
      }, {
        "text": "**Processing New Entries**\n\nI\u0027ve just finished integrating new entries for Pseudomonas, Psychogenic Nonepileptic Events, and Ptosis, and am building out the related cards. I\u0027m also preparing to incorporate content on the Psychosocial Impact of Strabismus and a treatment concept for Acute Pulmonary Edema, as well as pupil-related concepts.\n\n\n",
        "thought": true
      }, {
        "text": "**Analyzing Card Updates**\n\nNow I\u0027m focusing on the Pseudomonas card, working to flesh out the \"at a glance\" section with more detail. I\u0027m also preparing to integrate the PNES content and am defining its fundamental aspects. I\u0027ve begun to work on an Opioid for Acute Pulmonary Edema card and the Psychosocial impact of strabismus.\n\n\n",
        "thought": true
      }, {
        "text": "**Expanding Neurology Focus**\n\nI\u0027m now generating content for the new JSON entries. I\u0027m building out cards for Pseudomonas aeruginosa, Psychogenic Nonepileptic Events, Ptosis, and the Psychosocial Impact of Strabismus. I\u0027ve also incorporated the entry on opioid use for acute pulmonary edema. Additionally, I\u0027m working to produce pupil-related content.\n\n\n",
        "thought": true
      }, {
        "text": "I\u0027ve now incorporated the new JSON entries and continued to flesh out the Pseudomonas, PNES, Ptosis, and Psychosocial Impact of Strabismus cards, as well as the Opioids for Acute Pulmonary Edema treatment concept. I\u0027m focusing on their key aspects: the microbe, the psychiatric condition, the clinical finding, and treatment options. I\u0027m also preparing to integrate pupil-related concepts.\n\n\n",
        "thought": true
      }, {
        "text": "**Integrating Neurology Concepts**\n\nI\u0027m now working to build out cards for a range of new JSON entries, including Pseudomonas aeruginosa (Otology), Psychogenic Nonepileptic Events, and Ptosis. I am now developing content for new entries on opioids in acute pulmonary edema and psychosocial impact of strabismus. Additionally, I have started incorporating the card for Pupillary reflex, and the anatomy and the neurological and ophthalmology concepts related to the pupils.\n\n\n",
        "thought": true
      }, {
        "text": "**Processing Neurology Data**\n\nI\u0027m now integrating new JSON entries for the Pseudomonas, PNES, Ptosis, and Psychosocial Impact of Strabismus cards, focusing on neurological/ophthalmological links. I am creating Pupillary Reflex and Pupillary Anatomy cards, as well as developing a card for Opioids in Acute Pulmonary Edema, and expanding on the concepts of Lacunar Stroke and Pyramidal Tract Demyelination.\n\n\n",
        "thought": true
      }, {
        "text": "**Expanding Data Integration**\n\nI\u0027ve completed integrating the latest JSON entries, now populating the Pseudomonas, Psychogenic Nonepileptic Events, and Ptosis cards with relevant content. I\u0027ve also added entries for Acute Pulmonary Edema treatment and the Psychosocial Impact of Strabismus. Furthermore, I\u0027ve incorporated new cards focusing on the Pupillary Reflex and Pupillary Anatomy, which include their associated pathologies. Finally, I have updated the content related to Lacunar Strokes and Pyramidal Tract Demyelination.\n\n\n",
        "thought": true
      }, {
        "text": "**Finalizing Card Content**\n\nI\u0027m now fully immersed in the process of finishing the new cards, focusing on the refined definitions and incorporating the neurological information. The Pseudomonas and PNES cards are fleshed out, and I\u0027ve started the ptosis and strabismus cards, with opioid therapy content complete. I have expanded content for Lacunar Strokes, Pupillary Reflex, and Pyramidal Tract Demyelination and am integrating more nuanced details.\n\n\n",
        "thought": true
      }, {
        "text": "**Analyzing Additional Neurology Concepts**\n\nI\u0027m presently building out new cards for Pseudomonas aeruginosa (Otology) and Psychogenic Nonepileptic Events, and expanding the concept of Ptosis. Also, I\u0027ve incorporated content for Acute Pulmonary Edema, the Psychosocial Impact of Strabismus, and for the Pupillary Reflex, along with related anatomy. I\u0027ve also incorporated the details for Lacunar Stroke and Pyramidal Tract Demyelination.\n\n\n",
        "thought": true
      }, {
        "text": "**Expanding Neurology Focus**\n\nI\u0027ve made headway with the Pseudomonas card, adding more detail to the \"at a glance\" section. I\u0027ve also integrated the PNES content and begun outlining its key features. I\u0027ve initiated work on a card for Psychosocial Impact of Strabismus, and am incorporating the Acute Pulmonary Edema content.\n\n\n",
        "thought": true
      }, {
        "text": "**Expanding Cardiology Concepts**\n\nI\u0027ve integrated the new entries, including the opioid treatment for acute pulmonary edema. I\u0027m now focusing on a plan to build out the Pupil and Pupillary reflex cards. I\u0027m working to produce the core details. I also began working on another entry on treatment concepts for acute pulmonary edema.\n\n\n",
        "thought": true
      }, {
        "text": "**Processing Neurology Updates**\n\nI\u0027ve integrated the new entries, including the opioid treatment for acute pulmonary edema. I\u0027m now structuring the Pupillary Reflex and Pupillary Anatomy cards with an expanded focus, detailing each concept. I\u0027m also preparing to finalize the Lacunar Stroke and Pyramidal Tract Demyelination entries.\n\n\n",
        "thought": true
      }, {
        "text": "**Analyzing Updated Neurology Details**\n\nI\u0027m presently building out new cards for Pseudomonas aeruginosa (Otology) and Psychogenic Nonepileptic Events, and expanding the concept of Ptosis. Also, I\u0027ve incorporated content for Acute Pulmonary Edema, the Psychosocial Impact of Strabismus, and for the Pupillary Reflex, along with related anatomy. I\u0027ve also incorporated the details for Lacunar Stroke and Pyramidal Tract Demyelination. I am finalizing the Ramelteon, Ramsay Hunt Syndrome, and Raphe Nuclei entries.\n\n\n",
        "thought": true
      }, {
        "text": "**Expanding Neurology Content**\n\nI\u0027ve integrated the new JSON entries to flesh out the Pseudomonas, PNES, Ptosis, Psychosocial Impact of Strabismus, Lacunar Stroke, Ramelteon, Ramsay Hunt Syndrome, Pupillary Reflex, and Raphe Nuclei cards. I\u0027m focusing on their key aspects: the microbe\u0027s otology relevance, the psychiatric condition mimicking seizures, clinical findings, treatment options, neurological details, and anatomical structures. I also integrated the drugs Ramelteon and Rasagiline.\n\n\n",
        "thought": true
      }, {
        "text": "**Analyzing Neurology Concepts**\n\nI\u0027m now focusing on integrating new JSON entries for multiple neurology concepts. I\u0027m building out cards for Pseudomonas, PNES, Ptosis, and Psychosocial Impact of Strabismus. I am also working on entries related to Opioids for Acute Pulmonary Edema, Lacunar Stroke, Pupillary Reflex, Pyramidal Tract Demyelination, Ramelteon, Ramsay Hunt Syndrome, Raphe Nuclei, and Rasagiline.\n\n\n",
        "thought": true
      }, {
        "text": "**Expanding Neurology Focus**\n\nI\u0027m now generating content for the new JSON entries. I\u0027m building out cards for Pseudomonas aeruginosa, Psychogenic Nonepileptic Events, Ptosis, and the Psychosocial Impact of Strabismus. I\u0027ve also incorporated the entry on opioid use for acute pulmonary edema. Additionally, I\u0027m working to produce pupil-related content.\n\n\n",
        "thought": true
      }, {
        "text": "**Merging Neurology Entries**\n\nI\u0027m now focusing on integrating new JSON entries for multiple neurology concepts. I\u0027m building out cards for Pseudomonas, PNES, Ptosis, and Psychosocial Impact of Strabismus, as well as several drug and treatment entries. I\u0027m also adding pupil-related content.\n\n\n",
        "thought": true
      }, {
        "text": "**Processing New Neurology Concepts**\n\nI\u0027m now integrating the new JSON entries to formulate cards for Lacunar Stroke, Pupillary Reflex, Pyramidal Tract Demyelination, Ramelteon, Ramsay Hunt Syndrome, Raphe Nuclei, and Rasagiline. These entries highlight the neurological concepts related to these specific conditions and treatments. I\u0027m focusing on their key aspects.\n\n\n",
        "thought": true
      }, {
        "text": "**Expanding Neurology Integration**\n\nI\u0027ve integrated the new entries, including the opioid treatment for acute pulmonary edema. I\u0027ve built out the Pupillary Reflex, Pupillary Anatomy, Lacunar Stroke, Ramelteon, Ramsay Hunt Syndrome, Raphe Nuclei, and Rasagiline cards, expanding the content and integrating the specifics for each. I\u0027m focusing on their key aspects: the microbe\u0027s otology relevance, the psychiatric condition mimicking seizures, clinical findings, treatment options, neurological details, and anatomical structures.\n\n\n",
        "thought": true
      }, {
        "text": "**Processing Neurology Details**\n\nI\u0027m now diving into the next JSON entries. I\u0027m focusing on \"Ramsay Hunt Syndrome,\" \"Raphe Nuclei,\" and \"Rasagiline,\" detailing their core neurological features, clinical applications, and classification details. Also, I am incorporating the concepts of RB1 gene, and receptive aphasia.\n\n\n",
        "thought": true
      }, {
        "text": "**Analyzing Neurology Updates**\n\nNow I\u0027m focusing on the new JSON entries and how to properly integrate the data. I\u0027m building out cards for Ramsay Hunt Syndrome, Raphe Nuclei, Rasagiline, RB1 Gene, and Wernicke Aphasia, which I have started. I\u0027m concentrating on refining the \"at a glance\" sections and ensuring the content is well-structured and concise. I\u0027m noting the key relationships between these entries.\n\n",
        "thought": true
      }]
    }, {
      "text": "```json\n{\n  \"cf0b8fbc\": {\n    \"title\": \"Pseudomonas aeruginosa (Otology)\",\n    \"primaryType\": \"microbe\",\n    \"tags\": [\n      \"Otology\",\n      \"Infectious Disease\",\n      \"Microbiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePseudomonas aeruginosa\u003c/b\u003e is an encapsulated, gram-negative, oxidase-positive rod known for causing a range of opportunistic infections, including \u003ci\u003eotitis externa\u003c/i\u003e (swimmer\u0027s ear) and its severe, invasive form, malignant otitis externa.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMicrobiology:\u003c/b\u003e Gram-negative rod, aerobic, motile, oxidase-positive, and produces a characteristic blue-green (pyocyanin) pigment and a grape-like odor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOtitis Externa (\\\"Swimmer\u0027s Ear\\\"):\u003c/b\u003e A common cause of infection of the external auditory canal, particularly in settings of water exposure which macerates the skin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMalignant Otitis Externa:\u003c/b\u003e A severe, necrotizing infection that spreads from the external ear canal to the skull base, causing osteomyelitis of the temporal bone. This is a \u003cmark\u003eneurosurgical emergency\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors for Malignant OE:\u003c/b\u003e Classically seen in \u003cmark\u003eelderly diabetic patients\u003c/mark\u003e and other immunocompromised individuals.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePresentation of Malignant OE:\u003c/b\u003e Presents with exquisite otalgia (ear pain), purulent otorrhea, and the presence of granulation tissue in the ear canal. It can progress to involve cranial nerves, most commonly the [[dea9755f|facial nerve (CN VII)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A vignette describing an elderly patient with poorly controlled diabetes, severe ear pain, and granulation tissue in the auditory canal is pathognomonic for malignant otitis externa caused by \u003ci\u003ePseudomonas aeruginosa\u003c/i\u003e.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eWhile \u003cb\u003ePseudomonas aeruginosa\u003c/b\u003e is a frequent cause of benign swimmer\u0027s ear, in the specific context of an elderly diabetic patient, it can cause a life-threatening invasive infection, malignant otitis externa, which erodes into the skull base and can cause cranial nerve palsies.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"otitis_externa\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"malignant_otitis_externa\"\n      },\n      {\n        \"type\": \"can_damage\",\n        \"to\": \"dea9755f\"\n      }\n    ]\n  },\n  \"132797de\": {\n    \"title\": \"Psychogenic Nonepileptic Events (PNES)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Psychiatry\",\n      \"Seizures\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pathology\",\n      \"Somatic Symptom and Related Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePsychogenic Nonepileptic Events (PNES)\u003c/b\u003e are paroxysmal episodes that resemble epileptic [[64c08e92|seizures]] but are a manifestation of \u003ci\u003epsychological distress\u003c/i\u003e rather than abnormal cortical electrical discharges, and are therefore not associated with epileptiform activity on an electroencephalogram (EEG).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Features:\u003c/b\u003e Episodes often involve asynchronous, thrashing limb movements, side-to-side head shaking, pelvic thrusting, and \u003cmark\u003eforceful, prolonged eye closure\u003c/mark\u003e. Vocalizations during the event are common.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Differentiators:\u003c/b\u003e Compared to epileptic seizures, PNES episodes are often prolonged (\u003e 2 minutes), consciousness may be preserved despite bilateral motor activity, and there is typically \u003cu\u003eno postictal confusion\u003c/u\u003e. Self-injury is less common.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e The gold standard for diagnosis is \u003cmark\u003evideo-EEG monitoring\u003c/mark\u003e to capture a typical event and demonstrate the absence of corresponding epileptiform brain activity during the seizure-like behavior.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e High comorbidity with other psychiatric disorders, particularly post-traumatic stress disorder (PTSD), depression, anxiety, and personality disorders. A history of trauma or abuse is common.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Look for a patient with a psychiatric history presenting with dramatic, prolonged \\\"seizures\\\" where the eyes are \u003cmark\u003eforcefully closed\u003c/mark\u003e (resisting opening), which is uncharacteristic of a true tonic-clonic seizure where eyes are typically open.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePNES\u003c/b\u003e are a physical manifestation of psychological distress, not a brain electrical disorder. The diagnosis hinges on capturing an event on video-EEG and observing seizure-like behavior without any underlying abnormal brain waves, distinguishing it from true epilepsy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"mimics_symptoms_of\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"is_diagnosed_by\",\n        \"to\": \"video_eeg_monitoring\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"post_traumatic_stress_disorder\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"conversion_disorder\"\n      }\n    ]\n  },\n  \"bb557979\": {\n    \"title\": \"Psychosocial Impact of Strabismus\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pediatrics\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Psychology\",\n      \"Developmental Psychology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003epsychosocial impact of strabismus\u003c/b\u003e refers to the negative effects on self-esteem, social interaction, academic performance, and overall quality of life that can result from eye misalignment, particularly in children and adolescents.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSocial Impact:\u003c/b\u003e Can lead to teasing, bullying, social exclusion, and difficulty making eye contact, which can impair social development.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSelf-Esteem:\u003c/b\u003e May cause poor body image, low self-confidence, and feelings of embarrassment or shame.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunctional Impact:\u003c/b\u003e Can affect activities requiring binocular vision like sports, and may lead to frustration or avoidance of reading.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImportance of Treatment:\u003c/b\u003e Early correction of [[cdcda821|strabismus]] is crucial not only to prevent permanent vision loss from [[a4a401c7|amblyopia]] but also to mitigate these significant negative psychosocial consequences.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When considering treatment for a child with strabismus, the benefits extend beyond purely medical outcomes to include improved social and psychological well-being.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe consequences of [[cdcda821|strabismus]] extend beyond vision, significantly affecting a child\u0027s social and emotional development by altering their appearance and interaction with the world, highlighting the importance of early intervention.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_consequence_of\",\n        \"to\": \"cdcda821\"\n      }\n    ]\n  },\n  \"6202e6af\": {\n    \"title\": \"Ptosis\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physical Findings\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePtosis\u003c/b\u003e is the drooping or falling of the upper eyelid, a clinical sign that can result from mechanical issues or dysfunction of the muscles that raise the eyelid (levator palpebrae superioris, superior tarsal muscle) or the nerves that innervate them.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOculomotor Nerve (CN III) Palsy:\u003c/b\u003e A complete [[68c66997|CN III palsy]] causes severe, often complete, ptosis due to paralysis of the \u003cu\u003elevator palpebrae superioris\u003c/u\u003e muscle. It is typically accompanied by a \\\"down and out\\\" eye position.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHorner Syndrome:\u003c/b\u003e Causes a mild ptosis (typically 1-2 mm) due to paralysis of the sympathetically innervated \u003cu\u003esuperior tarsal muscle\u003c/u\u003e (M√ºller\u0027s muscle). It is accompanied by [[miosis]] and [[anhidrosis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMyasthenia Gravis:\u003c/b\u003e A neuromuscular junction disorder that can cause fluctuating, fatigable ptosis that characteristically worsens with sustained upward gaze and throughout the day.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSaccular Aneurysm:\u003c/b\u003e A compressing [[a1647fb2|posterior communicating artery (PCom) aneurysm]] is a classic cause of a painful CN III palsy with ptosis and a dilated pupil.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The degree of ptosis is a key diagnostic clue. Severe ptosis points to a [[68c66997|CN III lesion]], while mild ptosis is characteristic of [[c19010a3|Horner syndrome]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003ePtosis is not just a cosmetic issue; it is a crucial localizing sign in neurology. Differentiating between the severe ptosis of a CN III palsy and the mild ptosis of Horner syndrome can help pinpoint the lesion to either the parasympathetic/motor pathways or the sympathetic pathways, respectively.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"68c66997\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"c19010a3\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"myasthenia_gravis\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"a1647fb2\"\n      }\n    ]\n  },\n  \"766872da\": {\n    \"title\": \"Opioids for Acute Pulmonary Edema\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Cardiology\",\n      \"Pulmonology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Cardiovascular\",\n      \"Pharmacology\",\n      \"Heart Failure Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe use of \u003cb\u003eopioids\u003c/b\u003e, specifically \u003cb\u003emorphine\u003c/b\u003e, is a traditional therapy for acute cardiogenic pulmonary edema, primarily aimed at reducing preload and afterload, and alleviating the severe dyspnea and anxiety associated with the condition.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism (Vasodilation):\u003c/b\u003e Morphine causes both venodilation and mild arterial dilation. Venodilation \u003cmark\u003ereduces preload\u003c/mark\u003e by increasing venous capacitance, which decreases the volume of blood returning to the failing left ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism (Anxiolysis):\u003c/b\u003e Morphine reduces anxiety and the sensation of dyspnea (\\\"air hunger\\\"), which decreases the patient\u0027s work of breathing and the associated excessive sympathetic drive.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Historically a cornerstone of therapy for acute cardiogenic pulmonary edema (ACPE). Its use has become more controversial and is now often reserved for patients with severe dyspnea and anxiety despite initial therapies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The primary concern is \u003cmark\u003erespiratory depression\u003c/mark\u003e, which can be particularly dangerous in a patient already in respiratory distress. Other effects include hypotension, bradycardia, and vomiting.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e While its routine use is debated, for exams, remember morphine\u0027s main benefits in ACPE are \u003cu\u003epreload reduction\u003c/u\u003e (venodilation) and \u003cu\u003eanxiolysis\u003c/u\u003e.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eMorphine\u0027s role in acute pulmonary edema is not primarily as an analgesic but as a hemodynamic modulator that reduces cardiac preload through venodilation, thereby decreasing pulmonary congestion and alleviating the patient\u0027s subjective feeling of breathlessness.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Morphine] --\u003e B(Venodilation); B --\u003e C(Decreased Preload); C --\u003e D(Decreased Pulmonary Congestion); A --\u003e E(Anxiolysis); E --\u003e F(Decreased Work of Breathing); D \u0026 F --\u003e G(Relief of Acute Pulmonary Edema);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"acute_pulmonary_edema\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"opioid_analgesics\"\n      },\n      {\n        \"type\": \"main_mechanism_is\",\n        \"to\": \"preload_reduction\"\n      }\n    ]\n  },\n  \"d602155b\": {\n    \"title\": \"Pupil\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Anatomy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003ePupil\u003c/b\u003e is the aperture in the center of the iris of the eye that allows light to enter and reach the retina. Its diameter is dynamically controlled by the iris muscles to regulate the amount of light entering the eye and to improve depth of focus.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMiosis (Constriction):\u003c/b\u003e Mediated by the parasympathetic nervous system via the [[68c66997|oculomotor nerve (CN III)]]. The sphincter pupillae muscle contracts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMydriasis (Dilation):\u003c/b\u003e Mediated by the sympathetic nervous system. The dilator pupillae muscle contracts.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePupillary Light Reflex:\u003c/b\u003e Afferent limb is the [[optic_nerve|Optic Nerve (CN II)]]; efferent limb is the [[68c66997|Oculomotor Nerve (CN III)]]. Light shone in one eye causes bilateral pupillary constriction (direct and consensual responses).\u003c/li\u003e\u003cli\u003e\u003cb\u003eRelative Afferent Pupillary Defect (RAPD):\u003c/b\u003e Also known as a Marcus Gunn pupil. A sign of optic nerve or severe retinal disease. When a light is swung from the normal to the affected eye, both pupils paradoxically dilate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCN III Palsy:\u003c/b\u003e A compressive lesion (e.g., PCom aneurysm) often causes a dilated, nonreactive pupil (\u003cmark\u003e\\\"blown pupil\\\"\u003c/mark\u003e) due to compression of superficial parasympathetic fibers. Ischemic palsies often spare the pupil.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe size and reactivity of the pupil are powerful diagnostic indicators, providing a direct window into the functional integrity of the autonomic nervous system, the optic nerve, and the oculomotor nerve. Anisocoria (unequal pupil size) or abnormal reactivity can help localize neurological lesions.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Light] --\u003e B(CN II - Optic Nerve); B --\u003e C(Pretectal Nucleus); C --\u003e D(Bilateral Edinger-Westphal Nuclei); D --\u003e E(CN III - Oculomotor Nerve); E --\u003e F(Sphincter Pupillae); F --\u003e G(Miosis);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"eye\"\n      },\n      {\n        \"type\": \"constriction_is_controlled_by\",\n        \"to\": \"68c66997\"\n      },\n      {\n        \"type\": \"dilation_is_controlled_by\",\n        \"to\": \"sympathetic_nervous_system\"\n      },\n      {\n        \"type\": \"is_abnormal_in\",\n        \"to\": \"c19010a3\"\n      },\n      {\n        \"type\": \"is_abnormal_in\",\n        \"to\": \"08cb577f\"\n      }\n    ]\n  },\n  \"5c866add\": {\n    \"title\": \"Pupillary Light Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physiology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003ePupillary Light Reflex\u003c/b\u003e is an involuntary reflex that controls the diameter of the pupil in response to the intensity of light, allowing the eye to adapt to varying light levels and protecting the retina from damage by constricting the pupil.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAfferent Limb:\u003c/b\u003e [[optic_nerve|Optic Nerve (CN II)]] senses the light stimulus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEfferent Limb:\u003c/b\u003e [[68c66997|Oculomotor Nerve (CN III)]] carries the parasympathetic motor command to constrict the pupil.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Light signal travels via CN II to the pretectal nucleus in the midbrain, which projects bilaterally to the Edinger-Westphal nuclei. From there, parasympathetic fibers travel with CN III to the ciliary ganglion, and then via short ciliary nerves to the sphincter pupillae muscle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eResponses:\u003c/b\u003e The constriction of the pupil in the eye exposed to light is the \u003ci\u003edirect\u003c/i\u003e response. The simultaneous constriction of the contralateral pupil is the \u003ci\u003econsensual\u003c/i\u003e response, due to the bilateral projections from the pretectal nucleus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A lesion of CN II in one eye will abolish both direct and consensual reflexes when light is shone in that eye. A lesion of CN III will abolish the direct reflex in the affected eye, but the consensual reflex in that eye (when light is shone in the other eye) will be intact.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe bilateral projection from the pretectal nucleus to both Edinger-Westphal nuclei is the anatomical basis for the consensual pupillary light reflex, meaning that a unilateral light stimulus results in a bilateral motor response, a crucial feature for localizing lesions in the reflex arc.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Light Stimulus] --\u003e B(Retina); B --\u003e C(CN II - Afferent); C --\u003e D(Pretectal Nucleus); D --\u003e E(Bilateral Edinger-Westphal Nuclei); E --\u003e F(CN III - Efferent); F --\u003e G(Sphincter Pupillae); G --\u003e H(Pupillary Constriction);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"afferent_limb_is\",\n        \"to\": \"optic_nerve\"\n      },\n      {\n        \"type\": \"efferent_limb_is\",\n        \"to\": \"68c66997\"\n      },\n      {\n        \"type\": \"is_absent_in\",\n        \"to\": \"08cb577f\"\n      },\n      {\n        \"type\": \"is_tested_by\",\n        \"to\": \"swinging_flashlight_test\"\n      }\n    ]\n  },\n  \"8aefcafe\": {\n    \"title\": \"Pure Motor Stroke (Lacunar Syndrome)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Vascular\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003ePure Motor Stroke\u003c/b\u003e is a common type of \u003ci\u003elacunar stroke syndrome\u003c/i\u003e characterized by unilateral weakness (hemiparesis) of the face, arm, and leg, \u003cu\u003ewithout\u003c/u\u003e any associated sensory, visual, or cognitive deficits (i.e., no cortical signs).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by a small, ischemic infarct (\u0026lt;1.5 cm) in the deep penetrating arteries of the brain, most commonly the \u003cmark\u003elenticulostriate arteries\u003c/mark\u003e, which are branches of the [[143bb23d|MCA]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnatomical Location:\u003c/b\u003e The lesion is typically located in the contralateral \u003cmark\u003eposterior limb of the internal capsule\u003c/mark\u003e or the pons, where descending corticospinal and corticobulbar tracts are densely packed.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Strongly associated with chronic [[hypertension]], which leads to lipohyalinosis and microatheroma of the small vessels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden onset of contralateral weakness affecting the face, arm, and leg relatively equally. There are \u003cu\u003eno cortical signs\u003c/u\u003e such as aphasia, neglect, or visual field cuts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with long-standing hypertension who develops unilateral weakness of the face, arm, and leg *without any sensory loss or other cortical signs* is the classic vignette for a pure motor lacunar stroke.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \\\"pure\\\" nature of a \u003cb\u003ePure Motor Stroke\u003c/b\u003e is its key diagnostic feature, precisely localizing the small lacunar infarct to a subcortical structure like the internal capsule, where motor fibers are tightly bundled together, separate from sensory and cognitive pathways.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypertension] --\u003e B(Lipohyalinosis of Lenticulostriate Arteries); B --\u003e C(Lacunar Infarct); C --\u003e D(Lesion in Posterior Limb of Internal Capsule); D --\u003e E(Pure Motor Hemiparesis);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"b56349b2\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"internal_capsule\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"hypertension\"\n      },\n      {\n        \"type\": \"is_supplied_by\",\n        \"to\": \"lenticulostriate_arteries\"\n      }\n    ]\n  },\n  \"6adeb7c2\": {\n    \"title\": \"Pyramidal Tract Demyelination\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Multiple Sclerosis\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePyramidal Tract Demyelination\u003c/b\u003e refers to the loss of myelin sheaths from the axons of the corticospinal tracts, a key pathological feature in diseases like [[45dd6d19|Multiple Sclerosis]], leading to upper motor neuron signs.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAffected Tract:\u003c/b\u003e The corticospinal (pyramidal) tracts, which are the major motor pathways responsible for voluntary movement.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e In [[45dd6d19|Multiple Sclerosis]], autoimmune-mediated inflammation targets and destroys [[a24f9747|oligodendrocytes]], leading to plaques of demyelination in the CNS white matter, including the corticospinal tracts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Manifestations:\u003c/b\u003e Results in \u003cmark\u003eupper motor neuron (UMN) signs\u003c/mark\u003e below the level of the lesion, including spasticity, hyperreflexia, a positive Babinski sign, and weakness (spastic paresis).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePresentation in MS:\u003c/b\u003e Patients may present with paraparesis (weakness in both legs) if there are demyelinating plaques in the spinal cord, or hemiparesis if a plaque is located in the brainstem or cerebrum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of UMN signs in a young adult, especially when occurring in a relapsing-remitting pattern, is highly suggestive of [[45dd6d19|Multiple Sclerosis]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eDemyelination of the pyramidal tracts in [[45dd6d19|MS]] disrupts the normal inhibitory signals from the brain to the spinal cord, unmasking spinal reflexes and leading to the characteristic upper motor neuron syndrome of spastic weakness.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"affects\",\n        \"to\": \"corticospinal_tract\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"upper_motor_neuron_signs\"\n      }\n    ]\n  },\n  \"bbf7e9ef\": {\n    \"title\": \"Ramelteon\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Sedative-Hypnotics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRamelteon\u003c/b\u003e is a novel hypnotic agent used for the treatment of insomnia, which acts as a selective \u003ci\u003eagonist at melatonin receptors\u003c/i\u003e in the suprachiasmatic nucleus of the hypothalamus to regulate the sleep-wake cycle.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Agonist at melatonin receptors MT1 and MT2, which are located in the \u003cmark\u003esuprachiasmatic nucleus (SCN)\u003c/mark\u003e, the body\u0027s primary circadian pacemaker. This action mimics the effects of endogenous melatonin, helping to regulate the circadian rhythm and promote sleep onset.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Primarily for insomnia characterized by difficulty with sleep onset.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a short half-life and is not a controlled substance, distinguishing it from many other hypnotics.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Generally well-tolerated. May cause dizziness, nausea, fatigue, and headache. It does \u003cu\u003enot\u003c/u\u003e cause significant rebound insomnia or withdrawal symptoms upon discontinuation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Ramelteon is unique among sleep aids because it is \u003cu\u003enot a controlled substance\u003c/u\u003e and has no abuse potential or risk of dependency, making it a safe option for patients with a history of substance use disorder. It does not act on the GABA system.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eUnlike traditional hypnotics that cause generalized CNS depression via the GABA system, \u003cb\u003eRamelteon\u003c/b\u003e specifically targets the body\u0027s internal clock by acting as a melatonin agonist in the suprachiasmatic nucleus, making it a non-addictive option for sleep-onset insomnia.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Ramelteon] --\u003e B(Melatonin Receptor Agonist); B --\u003e C(Suprachiasmatic Nucleus); C --\u003e D(Regulation of Circadian Rhythm); D --\u003e E(Improved Sleep Onset);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"insomnia\"\n      },\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"melatonin_receptors\"\n      },\n      {\n        \"type\": \"target_location_is\",\n        \"to\": \"suprachiasmatic_nucleus\"\n      }\n    ]\n  },\n  \"09fa1b0f\": {\n    \"title\": \"Ramsay Hunt Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Infectious Disease\",\n      \"Otology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cranial Neuropathies\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRamsay Hunt Syndrome\u003c/b\u003e (also known as Herpes Zoster Oticus) is a rare, severe reactivation of the \u003ci\u003eVaricella-Zoster Virus (VZV)\u003c/i\u003e in the geniculate ganglion, affecting the [[dea9755f|facial nerve (CN VII)]] and often the [[6fded3e7|vestibulocochlear nerve (CN VIII)]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Reactivation of latent VZV from the geniculate ganglion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Triad:\u003c/b\u003e 1) Ipsilateral \u003cmark\u003efacial paralysis\u003c/mark\u003e (indistinguishable from Bell\u0027s palsy), 2) Severe ear pain (otalgia), and 3) A painful, vesicular rash on the auricle (pinna) and/or in the external auditory canal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Symptoms:\u003c/b\u003e Involvement of CN VIII can cause vertigo, tinnitus, and hearing loss. Other symptoms may include loss of taste on the anterior two-thirds of the tongue and decreased lacrimation or salivation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction from Bell\u0027s Palsy:\u003c/b\u003e The presence of the \u003cmark\u003evesicular rash\u003c/mark\u003e and potential involvement of CN VIII are key features that distinguish Ramsay Hunt syndrome from the more common idiopathic Bell\u0027s palsy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with acute facial paralysis plus a painful rash in or around the ear has Ramsay Hunt syndrome until proven otherwise. The prognosis for complete facial nerve recovery is generally worse than in Bell\u0027s palsy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRamsay Hunt Syndrome\u003c/b\u003e is essentially shingles of the facial nerve, presenting as a more severe and painful version of Bell\u0027s palsy with a characteristic vesicular rash in the ear, highlighting the neurotropic nature of VZV and its ability to affect multiple cranial nerves.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Latent VZV in Geniculate Ganglion] --\u003e B(Reactivation); B --\u003e C(Inflammation of CN VII \u0026 CN VIII); C --\u003e D{Triad}; D --\u003e D1[Ipsilateral Facial Paralysis]; D --\u003e D2[Otalgia]; D --\u003e D3[Vesicular Rash in Ear];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"varicella_zoster_virus\"\n      },\n      {\n        \"type\": \"affects\",\n        \"to\": \"dea9755f\"\n      },\n      {\n        \"type\": \"affects\",\n        \"to\": \"6fded3e7\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"bells_palsy\"\n      }\n    ]\n  },\n  \"f78ecc9c\": {\n    \"title\": \"Raphe Nuclei\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eRaphe Nuclei\u003c/b\u003e are a cluster of nuclei located in the midline of the brainstem that are the primary source of \u003ci\u003eserotonin (5-HT)\u003c/i\u003e release throughout the central nervous system, playing a crucial role in mood, sleep-wake cycles, and pain modulation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e A series of nuclei forming a midline seam (\\\"raphe\\\") extending through the medulla, pons, and midbrain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter:\u003c/b\u003e The principal source of [[serotonin]] for the entire brain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProjections:\u003c/b\u003e Send widespread serotonergic projections to virtually all areas of the CNS, including the cerebral cortex, hippocampus, basal ganglia, thalamus, cerebellum, and spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Involved in regulating sleep-wake cycles (especially initiating sleep), mood and emotion, anxiety, and descending pain modulation pathways.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The Raphe nuclei are the target of many antidepressant medications, such as SSRIs, which increase the availability of serotonin released from these neurons. A decrease in serotonergic activity from the Raphe nuclei is implicated in [[depression]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eRaphe Nuclei\u003c/b\u003e function as the brain\u0027s central serotonin distribution system; their widespread projections modulate a vast array of critical functions, most notably mood, which is why they are a primary target for antidepressant drugs like SSRIs.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Raphe Nuclei] --Synthesize \u0026 Release--\u003e B(Serotonin / 5-HT); B --\u003e C(Widespread CNS Projections); C --\u003e D(Mood Regulation); C --\u003e E(Sleep-Wake Cycle); C --\u003e F(Pain Modulation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"produces\",\n        \"to\": \"serotonin\"\n      },\n      {\n        \"type\": \"is_implicated_in\",\n        \"to\": \"depression\"\n      },\n      {\n        \"type\": \"is_target_of\",\n        \"to\": \"ssri\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"brainstem\"\n      }\n    ]\n  },\n  \"2883864d\": {\n    \"title\": \"Rasagiline\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Parkinson Disease\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Parkinson Disease Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRasagiline\u003c/b\u003e is an \u003ci\u003eirreversible inhibitor of monoamine oxidase B (MAO-B)\u003c/i\u003e used for the treatment of [[58c8ea03|Parkinson disease]], which increases the levels of dopamine in the brain by preventing its breakdown.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Selectively and irreversibly inhibits MAO-B, the enzyme primarily responsible for breaking down [[90adc821|dopamine]] in the brain. This leads to increased synaptic dopamine levels, prolonging the action of both endogenous and exogenous (from levodopa) dopamine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Can be used as monotherapy in early [[58c8ea03|Parkinson disease]] to provide mild symptomatic benefit, or as an adjunct to levodopa in more advanced disease to reduce \\\"off\\\" time and motor fluctuations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSelectivity:\u003c/b\u003e Its selectivity for MAO-B over MAO-A at therapeutic doses reduces the risk of hypertensive crisis (the \\\"cheese effect\\\") associated with non-selective MAO inhibitors, although caution is still advised with tyramine-rich foods at higher doses.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison:\u003c/b\u003e Similar to [[selegiline]], but it is more potent and does not have amphetamine metabolites, which may cause insomnia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that MAO-\u003cb\u003eB\u003c/b\u003e inhibitors like rasagiline and selegiline preferentially act on dopamine in the \u003cb\u003eB\u003c/b\u003erain.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRasagiline\u003c/b\u003e provides symptomatic relief in [[58c8ea03|Parkinson disease]] by a targeted mechanism: it specifically blocks MAO-B, the primary enzyme for dopamine degradation in the brain, thereby boosting dopaminergic neurotransmission without the significant dietary restrictions of older, non-selective MAO inhibitors.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Dopamine] --MAO-B--\u003e B(DOPAC - Inactive Metabolite); C[Rasagiline] --|Inhibits|--\u003e D(MAO-B);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"inhibits_enzyme\",\n        \"to\": \"mao_b\"\n      },\n      {\n        \"type\": \"increases_levels_of\",\n        \"to\": \"90adc821\"\n      },\n      {\n        \"type\": \"is_similar_to\",\n        \"to\": \"selegiline\"\n      }\n    ]\n  },\n  \"f4ba9a34\": {\n    \"title\": \"RB1 Gene\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Genetics\",\n      \"Oncology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Hematology and Oncology\",\n      \"Pathology\",\n      \"Tumor Suppressor Genes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eRB1 gene\u003c/b\u003e is a prototypical \u003ci\u003etumor suppressor gene\u003c/i\u003e located on chromosome 13 that encodes the retinoblastoma protein (pRb), a key negative regulator of the cell cycle at the G\u003csub\u003e1\u003c/sub\u003e/S checkpoint.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction of pRb Protein:\u003c/b\u003e In its active, hypophosphorylated state, pRb binds to and inhibits the E2F transcription factor, preventing the transcription of genes required for S-phase entry.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCell Cycle Regulation:\u003c/b\u003e Phosphorylation of pRb by Cyclin D/CDK4 and Cyclin E/CDK2 complexes inactivates it, releasing E2F and allowing the cell cycle to proceed from G\u003csub\u003e1\u003c/sub\u003e to S phase.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKnudson\u0027s Two-Hit Hypothesis:\u003c/b\u003e Loss-of-function mutations in \u003cu\u003eboth\u003c/u\u003e alleles of the RB1 gene are required for tumor development.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Cancers:\u003c/b\u003e Germline mutations cause familial [[63b964af|retinoblastoma]] (high risk of bilateral tumors and other cancers like osteosarcoma). Somatic mutations are found in sporadic retinoblastoma and many other cancers (e.g., small cell lung cancer, bladder cancer).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The RB1 gene is the classic example for the \\\"two-hit\\\" hypothesis. In familial cases, the first hit is inherited (germline), and the second is somatic. In sporadic cases, both hits are somatic.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eRB1 gene\u003c/b\u003e product, pRb, acts as the gatekeeper of the G\u003csub\u003e1\u003c/sub\u003e/S cell cycle checkpoint; its inactivation through biallelic mutation removes this critical brake, leading to uncontrolled cell proliferation and cancer, most classically [[63b964af|retinoblastoma]].\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cyclin D/CDK4] --\u003e B(Phosphorylates pRb); C[Active pRb] --Binds \u0026 Inhibits--\u003e D(E2F); D --x C; E[Inactive pRb-P] --\u003e F(Releases E2F); F --\u003e G(G1/S Transition); A --Inhibited by p16--\u003e B; C --Encoded by--\u003e H(RB1 Gene);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"mutation_causes\",\n        \"to\": \"63b964af\"\n      },\n      {\n        \"type\": \"mutation_is_risk_factor_for\",\n        \"to\": \"osteosarcoma\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"tumor_suppressor_gene\"\n      },\n      {\n        \"type\": \"regulates\",\n        \"to\": \"cell_cycle\"\n      }\n    ]\n  },\n  \"9438d8e4\": {\n    \"title\": \"Wernicke Aphasia (Receptive Aphasia)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Stroke\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Aphasias\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eWernicke aphasia\u003c/b\u003e, also known as \u003ci\u003ereceptive or fluent aphasia\u003c/i\u003e, is a language disorder characterized by severely impaired language comprehension, with speech that is fluent and grammatically correct but is nonsensical, empty, and often contains neologisms and paraphasic errors.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocalization:\u003c/b\u003e Caused by a lesion in \u003cmark\u003eWernicke\u0027s area\u003c/mark\u003e, located in the posterior superior temporal gyrus of the dominant (usually left) hemisphere.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by an ischemic stroke in the inferior division of the left [[143bb23d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Features:\u003c/b\u003e \u003cb\u003eFluent\u003c/b\u003e but meaningless speech (\\\"word salad\\\"), \u003cb\u003epoor comprehension\u003c/b\u003e of spoken and written language, and \u003cb\u003eimpaired repetition\u003c/b\u003e. Patients are typically unaware of their deficit (anosognosia) and may appear frustrated when not understood.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison to Broca\u0027s Aphasia:\u003c/b\u003e In contrast to [[7f6ed344|Broca\u0027s (expressive) aphasia]], where speech is non-fluent but comprehension is relatively intact, Wernicke\u0027s aphasia is fluent with poor comprehension. Mnemonic: \u003cb\u003eW\u003c/b\u003eernicke\u0027s is a \u003cb\u003eW\u003c/b\u003eordy but \u003cb\u003eW\u003c/b\u003eorthless salad.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient who speaks in long, nonsensical sentences and cannot follow simple commands has Wernicke\u0027s aphasia. Look for an associated right superior quadrantanopia (\\\"pie in the sky\\\") due to involvement of the nearby optic radiations ([[6dcf9281|Meyer\u0027s loop]]).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe hallmark of \u003cb\u003eWernicke\u0027s aphasia\u003c/b\u003e is the profound disconnect between fluent speech production and the ability to comprehend language, localizing the lesion squarely to the posterior superior temporal gyrus of the dominant hemisphere.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"6bc9a567\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"wernicke_area\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \"143bb23d\"\n      },\n      {\n        \"type\": \"is_contrasted_with\",\n        \"to\": \"7f6ed344\"\n      }\n    ]\n  },\n  \"767d985e\": {\n    \"title\": \"Presbyopia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Geriatrics\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePresbyopia\u003c/b\u003e is the age-related, progressive loss of the eye\u0027s ability to focus on near objects, resulting from a decrease in the accommodative capacity of the lens.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused primarily by the hardening and loss of elasticity of the lens (lens sclerosis) that occurs with aging. This prevents the lens from becoming more convex (rounder) when the ciliary muscle contracts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients, typically over age 40, report difficulty with near-vision tasks like reading, often holding reading material at arm\u0027s length to see it clearly. Symptoms include eye strain and headaches with near work.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e The [[81b5f5fe|accommodation]] reflex (ciliary muscle contraction) remains intact, but the stiff lens is unable to respond by changing its shape.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Corrected with the use of reading glasses or bifocals, which use a \u003cmark\u003econvex (converging) lens\u003c/mark\u003e to add refractive power for near vision.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Do not confuse presbyopia with hyperopia (farsightedness). While both can cause blurry near vision and are corrected with convex lenses, presbyopia is due to loss of accommodation, whereas hyperopia is a refractive error due to the shape of the eyeball.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePresbyopia\u003c/b\u003e is an inevitable consequence of aging where the lens loses its flexibility, impairing the eye\u0027s ability to accommodate for near vision, necessitating the use of reading glasses to compensate for the lost focusing power.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_an_impairment_of\",\n        \"to\": \"81b5f5fe\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"convex_lens\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"hyperopia\"\n      }\n    ]\n  },\n  \"087079b0\": {\n    \"title\": \"Preseptal Cellulitis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Infectious Disease\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePreseptal cellulitis\u003c/b\u003e is an infection of the eyelid and periorbital soft tissues located \u003ci\u003eanterior\u003c/i\u003e to the orbital septum, which distinguishes it from the more serious orbital cellulitis.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnatomy:\u003c/b\u003e The orbital septum is a fibrous membrane that separates the superficial eyelid structures from the contents of the orbit (fat and muscles). Preseptal means in front of this barrier.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Often arises from a superficial source, such as a skin abrasion, insect bite, hordeolum, or spread from an upper respiratory tract infection or sinusitis. Common pathogens are \u003ci\u003eStaphylococcus aureus\u003c/i\u003e and \u003ci\u003eStreptococcus pyogenes\u003c/i\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Unilateral ocular pain, eyelid swelling, and erythema.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Differentiating Feature:\u003c/b\u003e Unlike orbital cellulitis, in preseptal cellulitis, there is \u003cu\u003eno pain with eye movements\u003c/u\u003e, \u003cu\u003eno proptosis\u003c/u\u003e (bulging of the eye), and \u003cu\u003eno vision impairment or diplopia\u003c/u\u003e. Extraocular movements are full and painless.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The most important step in evaluating a patient with a red, swollen eye is to assess for pain with eye movements. Absence of pain with movement strongly suggests preseptal cellulitis, while its presence points to the more dangerous [[5ccc91a9|orbital cellulitis]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePreseptal cellulitis\u003c/b\u003e is an infection confined to the eyelid, anterior to the orbital septum. The integrity of the orbital septum prevents the infection from spreading to the orbit, thus preserving vision and eye movement, which is the key clinical distinction from the emergent condition of orbital cellulitis.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"5ccc91a9\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"staphylococcus_aureus\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"streptococcus_pyogenes\"\n      }\n    ]\n  },\n  \"65ba66bf\": {\n    \"title\": \"Pressure Sensation\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Physiology\",\n      \"Dermatology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sensory System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePressure sensation\u003c/b\u003e is a form of mechanoreception that allows for the perception of sustained touch and deep force applied to the skin, mediated by specific sensory receptors that transmit signals via the dorsal column-medial lemniscus pathway.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eReceptors:\u003c/b\u003e Mediated by slowly adapting mechanoreceptors. \u003cmark\u003eMerkel discs\u003c/mark\u003e are responsible for sensing sustained pressure and deep static touch (e.g., shapes, edges). \u003cmark\u003eRuffini corpuscles\u003c/mark\u003e respond to sustained pressure and skin stretch.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNerve Fibers:\u003c/b\u003e Transmitted by large, myelinated AŒ≤ fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Signals travel up the ipsilateral [[e7f5cbbe|dorsal columns]] (fasciculus gracilis and cuneatus) to the medulla, synapse, decussate, and ascend via the [[f19bc454|medial lemniscus]] to the VPL nucleus of the [[afc0a64b|thalamus]], and finally to the somatosensory cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction from Vibration:\u003c/b\u003e While related, pressure is a sustained sensation, whereas vibration is sensed by rapidly adapting receptors like [[71867ae0|Pacinian corpuscles]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Loss of pressure sensation, along with vibration and proprioception, with preserved pain and temperature sensation, points to a lesion of the [[e7f5cbbe|dorsal columns]], as seen in [[71daebd6|Tabes Dorsalis]] or [[6f5bea90|Subacute Combined Degeneration]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePressure sensation\u003c/b\u003e is a critical component of discriminative touch, relying on slowly adapting receptors like Merkel discs and the high-fidelity dorsal column pathway to provide the brain with continuous information about the shape, texture, and force of objects in contact with the skin.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_mediated_by\",\n        \"to\": \"merkel_discs\"\n      },\n      {\n        \"type\": \"is_mediated_by\",\n        \"to\": \"ruffini_corpuscles\"\n      },\n      {\n        \"type\": \"is_transmitted_via\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \"is_relayed_in\",\n        \"to\": \"afc0a64b\"\n      }\n    ]\n  },\n  \"ca7a1168\": {\n    \"title\": \"Pretectal Nuclei\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special",
      "role": "model",
      "tokenCount": 11876,
      "parts": [{
        "text": "```json\n{\n  \"cf0b8fbc\": {\n    \"title\": \"Pseudomonas aeruginosa"
      }, {
        "text": " (Otology)\",\n    \"primaryType\": \"microbe\",\n    \"tags\": [\n      \"Otology\","
      }, {
        "text": "\n      \"Infectious Disease\",\n      \"Microbiology\",\n      \"USMLE\"\n    ],\n"
      }, {
        "text": "    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      "
      }, {
        "text": "\"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePseudomonas aeruginosa\u003c/b\u003e is"
      }, {
        "text": " an encapsulated, gram-negative, oxidase-positive rod known for causing a range of opportunistic infections, including \u003ci\u003eotitis externa\u003c/i\u003e (sw"
      }, {
        "text": "immer\u0027s ear) and its severe, invasive form, malignant otitis externa.\u003c/p\u003e\",\n      \"atAGlance\":"
      }, {
        "text": " \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMicrobiology:\u003c/b\u003e Gram-negative rod, aerobic, motile, oxidase-positive, and produces"
      }, {
        "text": " a characteristic blue-green (pyocyanin) pigment and a grape-like odor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOtitis Externa (\\\""
      }, {
        "text": "Swimmer\u0027s Ear\\\"):\u003c/b\u003e A common cause of infection of the external auditory canal, particularly in settings of water exposure which"
      }, {
        "text": " macerates the skin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMalignant Otitis Externa:\u003c/b\u003e A severe, necrotizing infection that spreads"
      }, {
        "text": " from the external ear canal to the skull base, causing osteomyelitis of the temporal bone. This is a \u003cmark\u003eneurosurgical emergency\u003c/mark"
      }, {
        "text": "\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors for Malignant OE:\u003c/b\u003e Classically seen in \u003cmark\u003eelderly diabetic patients\u003c/mark\u003e"
      }, {
        "text": " and other immunocompromised individuals.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePresentation of Malignant OE:\u003c/b\u003e Presents with exquisite otalgia (ear pain), purulent ot"
      }, {
        "text": "orrhea, and the presence of granulation tissue in the ear canal. It can progress to involve cranial nerves, most commonly the"
      }, {
        "text": " [[dea9755f|facial nerve (CN VII)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A vignette"
      }, {
        "text": " describing an elderly patient with poorly controlled diabetes, severe ear pain, and granulation tissue in the auditory canal is pathognomonic for malignant"
      }, {
        "text": " otitis externa caused by \u003ci\u003ePseudomonas aeruginosa\u003c/i\u003e.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eWhile"
      }, {
        "text": " \u003cb\u003ePseudomonas aeruginosa\u003c/b\u003e is a frequent cause of benign swimmer\u0027s ear, in the specific context of an elderly diabetic patient,"
      }, {
        "text": " it can cause a life-threatening invasive infection, malignant otitis externa, which erodes into the skull base and can"
      }, {
        "text": " cause cranial nerve palsies.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      "
      }, {
        "text": "{\n        \"type\": \"causes\",\n        \"to\": \"otitis_externa\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"causes\",\n        \"to\": \"malignant_otitis_externa\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"can_damage\",\n        \"to\": \"dea9755f\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"132797de\": {\n    \"title\": \"Psych"
      }, {
        "text": "ogenic Nonepileptic Events (PNES)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Psychiatry\",\n      \"Seizures\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pathology\",\n      \""
      }, {
        "text": "Somatic Symptom and Related Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003ePsychogenic Nonepileptic Events (PNES)\u003c/b\u003e are paroxysmal episodes that resemble epileptic [[64c08e92|"
      }, {
        "text": "seizures]] but are a manifestation of \u003ci\u003epsychological distress\u003c/i\u003e rather than abnormal cortical electrical discharges, and are therefore"
      }, {
        "text": " not associated with epileptiform activity on an electroencephalogram (EEG).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eClinical Features:\u003c/b\u003e Episodes often involve asynchronous, thrashing limb movements, side-to-side head shaking, pelvic thrusting, and \u003c"
      }, {
        "text": "mark\u003eforceful, prolonged eye closure\u003c/mark\u003e. Vocalizations during the event are common.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Differentiators:"
      }, {
        "text": "\u003c/b\u003e Compared to epileptic seizures, PNES episodes are often prolonged (\u003e 2 minutes), consciousness may be preserved despite bilateral motor activity, and there"
      }, {
        "text": " is typically \u003cu\u003eno postictal confusion\u003c/u\u003e. Self-injury is less common.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e The gold standard for"
      }, {
        "text": " diagnosis is \u003cmark\u003evideo-EEG monitoring\u003c/mark\u003e to capture a typical event and demonstrate the absence of corresponding epileptiform brain activity during"
      }, {
        "text": " the seizure-like behavior.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e High comorbidity with other psychiatric disorders, particularly post-traumatic stress disorder (PTSD),"
      }, {
        "text": " depression, anxiety, and personality disorders. A history of trauma or abuse is common.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Look"
      }, {
        "text": " for a patient with a psychiatric history presenting with dramatic, prolonged \\\"seizures\\\" where the eyes are \u003cmark\u003eforce"
      }, {
        "text": "fully closed\u003c/mark\u003e (resisting opening), which is uncharacteristic of a true tonic-clonic seizure where eyes"
      }, {
        "text": " are typically open.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePNES\u003c/b\u003e are a physical manifestation"
      }, {
        "text": " of psychological distress, not a brain electrical disorder. The diagnosis hinges on capturing an event on video-EEG and observing seizure"
      }, {
        "text": "-like behavior without any underlying abnormal brain waves, distinguishing it from true epilepsy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"mimics_symptoms_of\",\n        \"to"
      }, {
        "text": "\": \"64c08e92\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_diagnosed_by\",\n        \"to\": \"video_eeg_monitoring\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_associated_with\",\n        \"to\": \"post_traumatic_stress_"
      }, {
        "text": "disorder\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"conversion"
      }, {
        "text": "_disorder\"\n      }\n    ]\n  },\n  \"bb557979\":"
      }, {
        "text": " {\n    \"title\": \"Psychosocial Impact of Strabismus\",\n    \"primaryType\": \"concept"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pediatrics\",\n      \"Psych"
      }, {
        "text": "iatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Psychology"
      }, {
        "text": "\",\n      \"Developmental Psychology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003epsychosocial impact of strabismus\u003c/b\u003e refers to the negative effects on self-esteem, social interaction, academic"
      }, {
        "text": " performance, and overall quality of life that can result from eye misalignment, particularly in children and adolescents.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSocial Impact:\u003c/b\u003e Can lead to teasing, bullying, social exclusion, and difficulty making eye contact, which"
      }, {
        "text": " can impair social development.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSelf-Esteem:\u003c/b\u003e May cause poor body image, low self-confidence, and feelings"
      }, {
        "text": " of embarrassment or shame.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunctional Impact:\u003c/b\u003e Can affect activities requiring binocular vision like sports, and may"
      }, {
        "text": " lead to frustration or avoidance of reading.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImportance of Treatment:\u003c/b\u003e Early correction of [[cdcda821|strabismus"
      }, {
        "text": "]] is crucial not only to prevent permanent vision loss from [[a4a401c7|amblyopia]] but also to mitigate"
      }, {
        "text": " these significant negative psychosocial consequences.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When considering treatment for a child with strabismus, the"
      }, {
        "text": " benefits extend beyond purely medical outcomes to include improved social and psychological well-being.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eThe consequences of [[cdcda821|strabismus]] extend beyond vision, significantly affecting"
      }, {
        "text": " a child\u0027s social and emotional development by altering their appearance and interaction with the world, highlighting the importance of early intervention.\u003c/p\u003e\","
      }, {
        "text": "\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \""
      }, {
        "text": "is_a_consequence_of\",\n        \"to\": \"cdcda821\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"6202e6af\": {\n    \"title\": \"Ptosis\",\n    \"primaryType\": \""
      }, {
        "text": "finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \""
      }, {
        "text": "Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Ophthalmology\",\n      \"Physical Findings\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003ePtosis\u003c/b\u003e is the drooping or falling of the upper eyelid, a clinical sign that can result"
      }, {
        "text": " from mechanical issues or dysfunction of the muscles that raise the eyelid (levator palpebrae superioris, superior tarsal muscle) or the"
      }, {
        "text": " nerves that innervate them.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOculomotor Nerve"
      }, {
        "text": " (CN III) Palsy:\u003c/b\u003e A complete [[68c66997|CN III palsy]] causes severe, often"
      }, {
        "text": " complete, ptosis due to paralysis of the \u003cu\u003elevator palpebrae superioris\u003c/u\u003e muscle. It is typically accompanied by a \\\""
      }, {
        "text": "down and out\\\" eye position.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHorner Syndrome:\u003c/b\u003e Causes a mild ptosis (typically 1"
      }, {
        "text": "-2 mm) due to paralysis of the sympathetically innervated \u003cu\u003esuperior tarsal muscle\u003c/u\u003e (M√ºller\u0027s"
      }, {
        "text": " muscle). It is accompanied by [[miosis]] and [[anhidrosis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMyasthenia Gravis:\u003c/b\u003e A neuromuscular junction"
      }, {
        "text": " disorder that can cause fluctuating, fatigable ptosis that characteristically worsens with sustained upward gaze and throughout the day.\u003c/li\u003e\u003cli\u003e\u003cb\u003eS"
      }, {
        "text": "accular Aneurysm:\u003c/b\u003e A compressing [[a1647fb2|posterior communicating artery (PCom) aneurysm]] is"
      }, {
        "text": " a classic cause of a painful CN III palsy with ptosis and a dilated pupil.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The degree of pt"
      }, {
        "text": "osis is a key diagnostic clue. Severe ptosis points to a [[68c66997|CN III lesion"
      }, {
        "text": "]], while mild ptosis is characteristic of [[c19010a3|Horner syndrome]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003ePtosis is not just a cosmetic issue; it is a crucial localizing sign in neurology. Differentiating between the severe pt"
      }, {
        "text": "osis of a CN III palsy and the mild ptosis of Horner syndrome can help pinpoint the lesion to either the parasympathetic"
      }, {
        "text": "/motor pathways or the sympathetic pathways, respectively.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"68c6"
      }, {
        "text": "6997\"\n      },\n      {\n        \"type\": \"is_a_sign_of"
      }, {
        "text": "\",\n        \"to\": \"c19010a3\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_sign_of\",\n        \"to\": \"myasthenia_gravis\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to"
      }, {
        "text": "\": \"a1647fb2\"\n      }\n    ]\n  },\n  \"766872da\": {"
      }, {
        "text": "\n    \"title\": \"Opioids for Acute Pulmonary Edema\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Cardiology\",\n      \"Pulmonology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Cardiovascular\",\n      \"Pharmacology\",\n      \"Heart Failure Drugs\"\n"
      }, {
        "text": "    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe use of \u003cb\u003eopioids\u003c/b\u003e, specifically"
      }, {
        "text": " \u003cb\u003emorphine\u003c/b\u003e, is a traditional therapy for acute cardiogenic pulmonary edema, primarily aimed at reducing preload and afterload, and alleviating the"
      }, {
        "text": " severe dyspnea and anxiety associated with the condition.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": " (Vasodilation):\u003c/b\u003e Morphine causes both venodilation and mild arterial dilation. Venodilation \u003cmark\u003ereduces preload\u003c/mark\u003e"
      }, {
        "text": " by increasing venous capacitance, which decreases the volume of blood returning to the failing left ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism (Anxiolysis):"
      }, {
        "text": "\u003c/b\u003e Morphine reduces anxiety and the sensation of dyspnea (\\\"air hunger\\\"), which decreases the patient\u0027s work of breathing and"
      }, {
        "text": " the associated excessive sympathetic drive.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Historically a cornerstone of therapy for acute cardiogenic pulmonary edema ("
      }, {
        "text": "ACPE). Its use has become more controversial and is now often reserved for patients with severe dyspnea and anxiety despite initial"
      }, {
        "text": " therapies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The primary concern is \u003cmark\u003erespiratory depression\u003c/mark\u003e, which can"
      }, {
        "text": " be particularly dangerous in a patient already in respiratory distress. Other effects include hypotension, bradycardia, and vomiting.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e While its routine use is debated, for exams, remember morphine\u0027s main benefits in ACPE are \u003cu\u003epreload reduction\u003c/u\u003e (venodilation)"
      }, {
        "text": " and \u003cu\u003eanxiolysis\u003c/u\u003e.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eMorphine\u0027s role in acute pulmonary edema"
      }, {
        "text": " is not primarily as an analgesic but as a hemodynamic modulator that reduces cardiac preload through venodilation, thereby decreasing pulmonary congestion and alleviating the patient"
      }, {
        "text": "\u0027s subjective feeling of breathlessness.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Morphine] --\u003e B(Ven"
      }, {
        "text": "odilation); B --\u003e C(Decreased Preload); C --\u003e D(Decreased Pulmonary Congestion); A --\u003e E"
      }, {
        "text": "(Anxiolysis); E --\u003e F(Decreased Work of Breathing); D \u0026 F --\u003e G(Relief of Acute Pulmonary Edema);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to"
      }, {
        "text": "\": \"acute_pulmonary_edema\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_type_of\",\n        \"to\": \"opioid_analgesics\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"main_mechanism_is\",\n        \"to\": \"preload_reduction\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"d602155b\": {\n    \"title\": \"Pupil"
      }, {
        "text": "\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Ophthalmology\",\n"
      }, {
        "text": "      \"Neurology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Ophthalmology\",\n      \"Anatomy\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003ePupil\u003c/b\u003e is the aperture in the center"
      }, {
        "text": " of the iris of the eye that allows light to enter and reach the retina. Its diameter is dynamically controlled by the iris"
      }, {
        "text": " muscles to regulate the amount of light entering the eye and to improve depth of focus.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Miosis (Constriction):\u003c/b\u003e Mediated by the parasympathetic nervous system via the [[68c669"
      }, {
        "text": "97|oculomotor nerve (CN III)]]. The sphincter pupillae muscle contracts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMydriasis (Dilation):"
      }, {
        "text": "\u003c/b\u003e Mediated by the sympathetic nervous system. The dilator pupillae muscle contracts.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePupillary Light Reflex:\u003c/b\u003e Aff"
      }, {
        "text": "erent limb is the [[optic_nerve|Optic Nerve (CN II)]]; efferent limb is the [["
      }, {
        "text": "68c66997|Oculomotor Nerve (CN III)]]. Light shone in one eye causes bilateral pupillary constriction"
      }, {
        "text": " (direct and consensual responses).\u003c/li\u003e\u003cli\u003e\u003cb\u003eRelative Afferent Pupillary Defect (RAPD):\u003c/b\u003e Also known as a Marcus Gunn pupil."
      }, {
        "text": " A sign of optic nerve or severe retinal disease. When a light is swung from the normal to the affected eye, both pupils paradoxically"
      }, {
        "text": " dilate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCN III Palsy:\u003c/b\u003e A compressive lesion (e.g., PCom aneurysm) often"
      }, {
        "text": " causes a dilated, nonreactive pupil (\u003cmark\u003e\\\"blown pupil\\\"\u003c/mark\u003e) due to compression of superficial parasympathetic fibers."
      }, {
        "text": " Ischemic palsies often spare the pupil.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe size and reactivity of the pupil are"
      }, {
        "text": " powerful diagnostic indicators, providing a direct window into the functional integrity of the autonomic nervous system, the optic nerve, and the oculomotor nerve"
      }, {
        "text": ". Anisocoria (unequal pupil size) or abnormal reactivity can help localize neurological lesions.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Light] --\u003e B(CN II - Optic Nerve); B --\u003e C(Pretectal Nucleus); C"
      }, {
        "text": " --\u003e D(Bilateral Edinger-Westphal Nuclei); D --\u003e E(CN III - Oculomotor Nerve); E --\u003e F("
      }, {
        "text": "Sphincter Pupillae); F --\u003e G(Miosis);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_part_of\",\n        \"to\": \"eye\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"constriction_is_controlled_by\",\n        \"to\": \"68c"
      }, {
        "text": "66997\"\n      },\n      {\n        \"type\": \"dilation_is_controlled_by\",\n        \"to"
      }, {
        "text": "\": \"sympathetic_nervous_system\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "abnormal_in\",\n        \"to\": \"c19010a3\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_abnormal_in\",\n        \"to\": \"08cb"
      }, {
        "text": "577f\"\n      }\n    ]\n  },\n  \"5c866add\": {\n"
      }, {
        "text": "    \"title\": \"Pupillary Light Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Ophthalmology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      "
      }, {
        "text": "\"Physiology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003ePupillary Light Reflex\u003c/b\u003e is"
      }, {
        "text": " an involuntary reflex that controls the diameter of the pupil in response to the intensity of light, allowing the eye to adapt to"
      }, {
        "text": " varying light levels and protecting the retina from damage by constricting the pupil.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eAfferent Limb:\u003c/b\u003e [[optic_nerve|Optic Nerve (CN II)]] senses the light stimulus.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Efferent Limb:\u003c/b\u003e [[68c66997|Oculomotor Nerve (CN III)]"
      }, {
        "text": "] carries the parasympathetic motor command to constrict the pupil.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Light signal travels via CN II to the pre"
      }, {
        "text": "tectal nucleus in the midbrain, which projects bilaterally to the Edinger-Westphal nuclei. From there, paras"
      }, {
        "text": "ympathetic fibers travel with CN III to the ciliary ganglion, and then via short ciliary nerves to the sphincter pupillae muscle."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eResponses:\u003c/b\u003e The constriction of the pupil in the eye exposed to light is the \u003ci\u003edirect\u003c/i\u003e response. The simultaneous"
      }, {
        "text": " constriction of the contralateral pupil is the \u003ci\u003econsensual\u003c/i\u003e response, due to the bilateral projections from the pretectal nucleus.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e A lesion of CN II in one eye will abolish both direct and consensual reflexes when light is"
      }, {
        "text": " shone in that eye. A lesion of CN III will abolish the direct reflex in the affected eye, but the consensual reflex in"
      }, {
        "text": " that eye (when light is shone in the other eye) will be intact.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eThe bilateral projection from the pretectal nucleus to both Edinger-Westphal nuclei is the anatomical basis for the consensual pup"
      }, {
        "text": "illary light reflex, meaning that a unilateral light stimulus results in a bilateral motor response, a crucial feature for localizing lesions"
      }, {
        "text": " in the reflex arc.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Light Stimulus] --\u003e B(Retina"
      }, {
        "text": "); B --\u003e C(CN II - Afferent); C --\u003e D(Pretectal Nucleus); D --\u003e E(Bilateral Edinger-"
      }, {
        "text": "Westphal Nuclei); E --\u003e F(CN III - Efferent); F --\u003e G(Sphincter Pupillae); G --\u003e H(Pup"
      }, {
        "text": "illary Constriction);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"afferent"
      }, {
        "text": "_limb_is\",\n        \"to\": \"optic_nerve\"\n      },\n      {\n        \"type\": \"eff"
      }, {
        "text": "erent_limb_is\",\n        \"to\": \"68c66997\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_absent_in\",\n        \"to\": \"08cb577f\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_tested_by\",\n        \"to\": \"swing"
      }, {
        "text": "ing_flashlight_test\"\n      }\n    ]\n  },\n  \"8aefcafe\": {\n    \""
      }, {
        "text": "title\": \"Pure Motor Stroke (Lacunar Syndrome)\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Vascular\",\n      \"Pathology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003eA \u003cb\u003ePure Motor Stroke\u003c/b\u003e is a common type of \u003ci\u003elacunar stroke syndrome\u003c/i\u003e characterized by unilateral weakness"
      }, {
        "text": " (hemiparesis) of the face, arm, and leg, \u003cu\u003ewithout\u003c/u\u003e any associated sensory, visual"
      }, {
        "text": ", or cognitive deficits (i.e., no cortical signs).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Pathophysiology:\u003c/b\u003e Caused by a small, ischemic infarct (\u0026lt;1.5 cm) in the deep penetrating arteries of the brain,"
      }, {
        "text": " most commonly the \u003cmark\u003elenticulostriate arteries\u003c/mark\u003e, which are branches of the [[143bb23d|"
      }, {
        "text": "MCA]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnatomical Location:\u003c/b\u003e The lesion is typically located in the contralateral \u003cmark\u003eposterior limb of the internal"
      }, {
        "text": " capsule\u003c/mark\u003e or the pons, where descending corticospinal and corticobulbar tracts are densely packed.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Strongly associated with chronic [[hypertension]], which leads to lipohyalinosis and microatheroma of"
      }, {
        "text": " the small vessels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden onset of contralateral weakness affecting the face, arm, and leg relatively"
      }, {
        "text": " equally. There are \u003cu\u003eno cortical signs\u003c/u\u003e such as aphasia, neglect, or visual field cuts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e A patient with long-standing hypertension who develops unilateral weakness of the face, arm, and leg *without any sensory loss or other cortical signs* is"
      }, {
        "text": " the classic vignette for a pure motor lacunar stroke.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " \\\"pure\\\" nature of a \u003cb\u003ePure Motor Stroke\u003c/b\u003e is its key diagnostic feature, precisely localizing the small lacunar infarct to a"
      }, {
        "text": " subcortical structure like the internal capsule, where motor fibers are tightly bundled together, separate from sensory and cognitive pathways.\u003c/p"
      }, {
        "text": "\u003e\",\n      \"mermaid\": \"graph TD; A[Hypertension] --\u003e B(Lipohyalinosis of Lenticulostri"
      }, {
        "text": "ate Arteries); B --\u003e C(Lacunar Infarct); C --\u003e D(Lesion in Posterior Limb of Internal Capsule); D --\u003e E"
      }, {
        "text": "(Pure Motor Hemiparesis);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"b56349b2\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \""
      }, {
        "text": "internal_capsule\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n"
      }, {
        "text": "        \"to\": \"hypertension\"\n      },\n      {\n        \"type\": \"is_supplied_"
      }, {
        "text": "by\",\n        \"to\": \"lenticulostriate_arteries\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"6adeb7c2\": {\n    \"title\": \"Pyramidal Tract Demyelination\",\n    \""
      }, {
        "text": "primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Multiple Sclerosis"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special"
      }, {
        "text": " Senses\",\n      \"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePyramidal Tract Demyelination\u003c/b\u003e refers to the loss of myelin"
      }, {
        "text": " sheaths from the axons of the corticospinal tracts, a key pathological feature in diseases like [[45dd6d19|Multiple"
      }, {
        "text": " Sclerosis]], leading to upper motor neuron signs.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAffected"
      }, {
        "text": " Tract:\u003c/b\u003e The corticospinal (pyramidal) tracts, which are the major motor pathways responsible for voluntary movement."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e In [[45dd6d19|Multiple Sclerosis]], autoimmune-"
      }, {
        "text": "mediated inflammation targets and destroys [[a24f9747|oligodendrocytes]], leading to plaques of demyelination in"
      }, {
        "text": " the CNS white matter, including the corticospinal tracts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Manifestations:\u003c/b\u003e Results in \u003cmark\u003eupper motor neuron (UMN)"
      }, {
        "text": " signs\u003c/mark\u003e below the level of the lesion, including spasticity, hyperreflexia, a positive Babinski sign, and weakness"
      }, {
        "text": " (spastic paresis).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePresentation in MS:\u003c/b\u003e Patients may present with paraparesis (weakness in"
      }, {
        "text": " both legs) if there are demyelinating plaques in the spinal cord, or hemiparesis if a plaque is located"
      }, {
        "text": " in the brainstem or cerebrum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of UMN signs in a young"
      }, {
        "text": " adult, especially when occurring in a relapsing-remitting pattern, is highly suggestive of [[45dd6d19|"
      }, {
        "text": "Multiple Sclerosis]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eDemyelination of the pyramidal tracts"
      }, {
        "text": " in [[45dd6d19|MS]] disrupts the normal inhibitory signals from the brain to the spinal cord, un"
      }, {
        "text": "masking spinal reflexes and leading to the characteristic upper motor neuron syndrome of spastic weakness.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to"
      }, {
        "text": "\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"affects"
      }, {
        "text": "\",\n        \"to\": \"corticospinal_tract\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"causes\",\n        \"to\": \"upper_motor_neuron_signs\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"bbf7e9ef\": {\n    \"title\": \"Ramelteon\",\n    \"primaryType\":"
      }, {
        "text": " \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neurology\",\n      \""
      }, {
        "text": "USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Sedative-Hypnotics\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003e\u003cb\u003eRamelteon\u003c/b\u003e is a novel hypnotic agent used for the treatment of insomnia, which acts as a selective "
      }, {
        "text": "\u003ci\u003eagonist at melatonin receptors\u003c/i\u003e in the suprachiasmatic nucleus of the hypothalamus to regulate the sleep-wake cycle.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Agonist at melatonin receptors MT1 and MT2, which are located in the"
      }, {
        "text": " \u003cmark\u003esuprachiasmatic nucleus (SCN)\u003c/mark\u003e, the body\u0027s primary circadian pacemaker. This action"
      }, {
        "text": " mimics the effects of endogenous melatonin, helping to regulate the circadian rhythm and promote sleep onset.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Primarily for insomnia"
      }, {
        "text": " characterized by difficulty with sleep onset.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a short half-life and is not a controlled substance,"
      }, {
        "text": " distinguishing it from many other hypnotics.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Generally well-tolerated. May cause dizziness, nausea, fatigue,"
      }, {
        "text": " and headache. It does \u003cu\u003enot\u003c/u\u003e cause significant rebound insomnia or withdrawal symptoms upon discontinuation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e Ramelteon is unique among sleep aids because it is \u003cu\u003enot a controlled substance\u003c/u\u003e and has no abuse"
      }, {
        "text": " potential or risk of dependency, making it a safe option for patients with a history of substance use disorder. It does not act on the GABA"
      }, {
        "text": " system.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eUnlike traditional hypnotics that cause generalized CNS depression via the"
      }, {
        "text": " GABA system, \u003cb\u003eRamelteon\u003c/b\u003e specifically targets the body\u0027s internal clock by acting as a melatonin agonist in the suprach"
      }, {
        "text": "iasmatic nucleus, making it a non-addictive option for sleep-onset insomnia.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD;"
      }, {
        "text": " A[Ramelteon] --\u003e B(Melatonin Receptor Agonist); B --\u003e C(Suprachiasmatic Nucleus);"
      }, {
        "text": " C --\u003e D(Regulation of Circadian Rhythm); D --\u003e E(Improved Sleep Onset);\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"insomnia\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"melatonin_receptors\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"target_location_is\",\n        \"to\": \"suprachiasmatic"
      }, {
        "text": "_nucleus\"\n      }\n    ]\n  },\n  \"09fa1b0f\": {"
      }, {
        "text": "\n    \"title\": \"Ramsay Hunt Syndrome\",\n    \"primaryType\": \"disease\",\n    \""
      }, {
        "text": "tags\": [\n      \"Neurology\",\n      \"Infectious Disease\",\n      \"Otology\",\n"
      }, {
        "text": "      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses"
      }, {
        "text": "\",\n      \"Pathology\",\n      \"Cranial Neuropathies\"\n    ],\n    \"content\":"
      }, {
        "text": " {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRamsay Hunt Syndrome\u003c/b\u003e (also known as Herpes Zoster Ot"
      }, {
        "text": "icus) is a rare, severe reactivation of the \u003ci\u003eVaricella-Zoster Virus (VZV)\u003c/i\u003e"
      }, {
        "text": " in the geniculate ganglion, affecting the [[dea9755f|facial nerve (CN VII)]] and often the"
      }, {
        "text": " [[6fded3e7|vestibulocochlear nerve (CN VIII)]].\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Reactivation of latent VZV from the geniculate ganglion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic"
      }, {
        "text": " Triad:\u003c/b\u003e 1) Ipsilateral \u003cmark\u003efacial paralysis\u003c/mark\u003e (indistinguishable from Bell\u0027s palsy), 2) Severe"
      }, {
        "text": " ear pain (otalgia), and 3) A painful, vesicular rash on the auricle (pinna) and/"
      }, {
        "text": "or in the external auditory canal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Symptoms:\u003c/b\u003e Involvement of CN VIII can cause vertigo, tinnitus, and hearing loss. Other"
      }, {
        "text": " symptoms may include loss of taste on the anterior two-thirds of the tongue and decreased lacrimation or salivation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDist"
      }, {
        "text": "inction from Bell\u0027s Palsy:\u003c/b\u003e The presence of the \u003cmark\u003evesicular rash\u003c/mark\u003e and potential"
      }, {
        "text": " involvement of CN VIII are key features that distinguish Ramsay Hunt syndrome from the more common idiopathic Bell\u0027s palsy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e A patient with acute facial paralysis plus a painful rash in or around the ear has Ramsay Hunt syndrome until"
      }, {
        "text": " proven otherwise. The prognosis for complete facial nerve recovery is generally worse than in Bell\u0027s palsy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eRamsay Hunt Syndrome\u003c/b\u003e is essentially shingles of the facial nerve, presenting as a more severe"
      }, {
        "text": " and painful version of Bell\u0027s palsy with a characteristic vesicular rash in the ear, highlighting the neurotropic nature of VZV and its"
      }, {
        "text": " ability to affect multiple cranial nerves.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Latent VZV in"
      }, {
        "text": " Geniculate Ganglion] --\u003e B(Reactivation); B --\u003e C(Inflammation of CN VII \u0026 CN VIII); C --\u003e D{"
      }, {
        "text": "Triad}; D --\u003e D1[Ipsilateral Facial Paralysis]; D --\u003e D2[Otalgia]; D --\u003e D3["
      }, {
        "text": "Vesicular Rash in Ear];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is"
      }, {
        "text": "_caused_by\",\n        \"to\": \"varicella_zoster_virus\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"affects\",\n        \"to\": \"dea9755f\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"affects\",\n        \"to\": \"6fded"
      }, {
        "text": "3e7\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \""
      }, {
        "text": "to\": \"bells_palsy\"\n      }\n    ]\n  },\n  \"f78ecc9c\": {\n"
      }, {
        "text": "    \"title\": \"Raphe Nuclei\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "science\",\n      \"Anatomy\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003e"
      }, {
        "text": "Raphe Nuclei\u003c/b\u003e are a cluster of nuclei located in the midline of the brainstem that are the primary source of \u003ci\u003e"
      }, {
        "text": "serotonin (5-HT)\u003c/i\u003e release throughout the central nervous system, playing a crucial role in mood, sleep-"
      }, {
        "text": "wake cycles, and pain modulation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e A series of nuclei"
      }, {
        "text": " forming a midline seam (\\\"raphe\\\") extending through the medulla, pons, and midbrain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter:\u003c/b\u003e The principal"
      }, {
        "text": " source of [[serotonin]] for the entire brain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProjections:\u003c/b\u003e Send widespread serotonergic projections to virtually all areas of the"
      }, {
        "text": " CNS, including the cerebral cortex, hippocampus, basal ganglia, thalamus, cerebellum, and spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction"
      }, {
        "text": ":\u003c/b\u003e Involved in regulating sleep-wake cycles (especially initiating sleep), mood and emotion, anxiety, and descending pain modulation pathways"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The Raphe nuclei are the target of many antidepressant medications, such as SSRIs, which increase the"
      }, {
        "text": " availability of serotonin released from these neurons. A decrease in serotonergic activity from the Raphe nuclei is implicated in [[depression]].\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eRaphe Nuclei\u003c/b\u003e function as the brain\u0027s central serotonin distribution system;"
      }, {
        "text": " their widespread projections modulate a vast array of critical functions, most notably mood, which is why they are a primary target for antidepressant drugs like"
      }, {
        "text": " SSRIs.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Raphe Nuclei] --Synthesize \u0026 Release--\u003e B(Ser"
      }, {
        "text": "otonin / 5-HT); B --\u003e C(Widespread CNS Projections); C --\u003e D(Mood Regulation); C --\u003e E("
      }, {
        "text": "Sleep-Wake Cycle); C --\u003e F(Pain Modulation);\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"produces\",\n        \"to\": \"serotonin\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_implicated_in\",\n        \"to\": \"depression\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_target_of\",\n        \"to\": \"ssri"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"brainstem\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"2883864d\": {\n    \"title\": \"Ras"
      }, {
        "text": "agiline\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\","
      }, {
        "text": "\n      \"Neurology\",\n      \"Parkinson Disease\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Parkinson Disease Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRas"
      }, {
        "text": "agiline\u003c/b\u003e is an \u003ci\u003eirreversible inhibitor of monoamine oxidase B (MAO-B)\u003c/i\u003e used for the treatment of [["
      }, {
        "text": "58c8ea03|Parkinson disease]], which increases the levels of dopamine in the brain by preventing its"
      }, {
        "text": " breakdown.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Selectively and irreversibly inhibits MAO-"
      }, {
        "text": "B, the enzyme primarily responsible for breaking down [[90adc821|dopamine]] in the brain"
      }, {
        "text": ". This leads to increased synaptic dopamine levels, prolonging the action of both endogenous and exogenous (from levodopa) dopamine.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eClinical Use:\u003c/b\u003e Can be used as monotherapy in early [[58c8ea03|Parkinson disease]] to provide mild"
      }, {
        "text": " symptomatic benefit, or as an adjunct to levodopa in more advanced disease to reduce \\\"off\\\" time and motor fluctuations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSelect"
      }, {
        "text": "ivity:\u003c/b\u003e Its selectivity for MAO-B over MAO-A at therapeutic doses reduces the risk of hypertensive crisis (the \\\"cheese effect\\\")"
      }, {
        "text": " associated with non-selective MAO inhibitors, although caution is still advised with tyramine-rich foods at higher doses.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Comparison:\u003c/b\u003e Similar to [[selegiline]], but it is more potent and does not have amphetamine metabolites, which"
      }, {
        "text": " may cause insomnia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that MAO-\u003cb\u003eB\u003c/b\u003e inhibitors like rasagiline and"
      }, {
        "text": " selegiline preferentially act on dopamine in the \u003cb\u003eB\u003c/b\u003erain.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eRasagiline\u003c/b\u003e provides symptomatic relief in [[58c8ea03|Parkinson disease]] by a targeted mechanism: it specifically blocks"
      }, {
        "text": " MAO-B, the primary enzyme for dopamine degradation in the brain, thereby boosting dopaminergic neurotransmission without the significant dietary"
      }, {
        "text": " restrictions of older, non-selective MAO inhibitors.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Dopamine] --"
      }, {
        "text": "MAO-B--\u003e B(DOPAC - Inactive Metabolite); C[Rasagiline] --|In"
      }, {
        "text": "hibits|--\u003e D(MAO-B);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_treatment_for\",\n        \"to\": \"58c8ea0"
      }, {
        "text": "3\"\n      },\n      {\n        \"type\": \"inhibits_enzyme\",\n        \"to\":"
      }, {
        "text": " \"mao_b\"\n      },\n      {\n        \"type\": \"increases_levels_of\",\n"
      }, {
        "text": "        \"to\": \"90adc821\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_similar_to\",\n        \"to\": \"selegiline\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"f4ba9a34\": {\n    \"title\": \"RB1 Gene\",\n    \"primaryType\": \"molecule"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Genetics\",\n      \"Oncology\",\n      \"Ophthalmology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Hematology and Oncology\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"Tumor Suppressor Genes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003eRB1 gene\u003c/b\u003e is a prototypical \u003ci\u003etumor suppressor gene\u003c/i\u003e located on chromosome 13 that encodes the"
      }, {
        "text": " retinoblastoma protein (pRb), a key negative regulator of the cell cycle at the G\u003csub\u003e1\u003c/sub\u003e/S"
      }, {
        "text": " checkpoint.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction of pRb Protein:\u003c/b\u003e In its active, hypophosphorylated state"
      }, {
        "text": ", pRb binds to and inhibits the E2F transcription factor, preventing the transcription of genes required for S-phase entry.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eCell Cycle Regulation:\u003c/b\u003e Phosphorylation of pRb by Cyclin D/CDK4 and Cyclin E/CDK2 complexes inactiv"
      }, {
        "text": "ates it, releasing E2F and allowing the cell cycle to proceed from G\u003csub\u003e1\u003c/sub\u003e to S phase.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKn"
      }, {
        "text": "udson\u0027s Two-Hit Hypothesis:\u003c/b\u003e Loss-of-function mutations in \u003cu\u003eboth\u003c/u\u003e alleles of the RB"
      }, {
        "text": "1 gene are required for tumor development.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Cancers:\u003c/b\u003e Germline mutations cause familial [[63b964af|ret"
      }, {
        "text": "inoblastoma]] (high risk of bilateral tumors and other cancers like osteosarcoma). Somatic mutations are found in sporadic retinoblast"
      }, {
        "text": "oma and many other cancers (e.g., small cell lung cancer, bladder cancer).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The RB"
      }, {
        "text": "1 gene is the classic example for the \\\"two-hit\\\" hypothesis. In familial cases, the first hit is inherited"
      }, {
        "text": " (germline), and the second is somatic. In sporadic cases, both hits are somatic.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eThe \u003cb\u003eRB1 gene\u003c/b\u003e product, pRb, acts as the gatekeeper of the"
      }, {
        "text": " G\u003csub\u003e1\u003c/sub\u003e/S cell cycle checkpoint; its inactivation through biallelic mutation removes this critical brake, leading to uncontrolled"
      }, {
        "text": " cell proliferation and cancer, most classically [[63b964af|retinoblastoma]].\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"graph TD; A[Cyclin D/CDK4] --\u003e B(Phosphoryl"
      }, {
        "text": "ates pRb); C[Active pRb] --Binds \u0026 Inhibits--\u003e D(E2F); D"
      }, {
        "text": " --x C; E[Inactive pRb-P] --\u003e F(Releases E2F); F --\u003e G(G"
      }, {
        "text": "1/S Transition); A --Inhibited by p16--\u003e B; C --Encoded by--\u003e H(RB1 Gene);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"mutation_causes\",\n        \"to\": \"63"
      }, {
        "text": "b964af\"\n      },\n      {\n        \"type\": \"mutation_is_risk_factor_for"
      }, {
        "text": "\",\n        \"to\": \"osteosarcoma\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_type_of\",\n        \"to\": \"tumor_suppressor_gene\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"regulates\",\n        \"to\": \"cell_cycle\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"9438d8e4\": {\n    \"title\": \"Wernicke Aphasia (Receptive"
      }, {
        "text": " Aphasia)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"Stroke\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n"
      }, {
        "text": "      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Aphasias\"\n    "
      }, {
        "text": "],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eWernicke aphasia\u003c/b\u003e,"
      }, {
        "text": " also known as \u003ci\u003ereceptive or fluent aphasia\u003c/i\u003e, is a language disorder characterized by severely impaired language comprehension, with speech that is"
      }, {
        "text": " fluent and grammatically correct but is nonsensical, empty, and often contains neologisms and paraphasic errors.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocalization:\u003c/b\u003e Caused by a lesion in \u003cmark\u003eWernicke\u0027s"
      }, {
        "text": " area\u003c/mark\u003e, located in the posterior superior temporal gyrus of the dominant (usually left) hemisphere.\u003c/li\u003e\u003cli\u003e\u003cb\u003eE"
      }, {
        "text": "tiology:\u003c/b\u003e Most commonly caused by an ischemic stroke in the inferior division of the left [[143bb2"
      }, {
        "text": "3d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Features:\u003c/b\u003e \u003cb\u003eFluent\u003c/b\u003e but meaningless"
      }, {
        "text": " speech (\\\"word salad\\\"), \u003cb\u003epoor comprehension\u003c/b\u003e of spoken and written language, and \u003cb\u003eimpaired repetition\u003c/b\u003e. Patients are typically unaware of their"
      }, {
        "text": " deficit (anosognosia) and may appear frustrated when not understood.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison to Broca\u0027s A"
      }, {
        "text": "phasia:\u003c/b\u003e In contrast to [[7f6ed344|Broca\u0027s (expressive) aphasia]], where"
      }, {
        "text": " speech is non-fluent but comprehension is relatively intact, Wernicke\u0027s aphasia is fluent with poor comprehension. Mnemonic: \u003cb\u003e"
      }, {
        "text": "W\u003c/b\u003eernicke\u0027s is a \u003cb\u003eW\u003c/b\u003eordy but \u003cb\u003eW\u003c/b\u003eorthless salad.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e A patient who speaks in long, nonsensical sentences and cannot follow simple commands has Wernicke\u0027s aphasia."
      }, {
        "text": " Look for an associated right superior quadrantanopia (\\\"pie in the sky\\\") due to involvement of the nearby optic radiations ([["
      }, {
        "text": "6dcf9281|Meyer\u0027s loop]]).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " hallmark of \u003cb\u003eWernicke\u0027s aphasia\u003c/b\u003e is the profound disconnect between fluent speech production and the ability"
      }, {
        "text": " to comprehend language, localizing the lesion squarely to the posterior superior temporal gyrus of the dominant hemisphere.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_type_of\",\n        \"to\": \"6bc9a567\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_caused_by_lesion_in\",\n        \"to\": \"wernicke_area"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n"
      }, {
        "text": "        \"to\": \"143bb23d\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_contrasted_with\",\n        \"to\": \"7f6ed344\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"767d985e\": {\n    \"title\":"
      }, {
        "text": " \"Presbyopia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"Geriatrics\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Path"
      }, {
        "text": "ology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePresbyopia\u003c/b\u003e is the age"
      }, {
        "text": "-related, progressive loss of the eye\u0027s ability to focus on near objects, resulting from a decrease in the accommod"
      }, {
        "text": "ative capacity of the lens.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Ca"
      }, {
        "text": "used primarily by the hardening and loss of elasticity of the lens (lens sclerosis) that occurs with aging. This prevents the lens from becoming"
      }, {
        "text": " more convex (rounder) when the ciliary muscle contracts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients, typically over age 40, report difficulty with"
      }, {
        "text": " near-vision tasks like reading, often holding reading material at arm\u0027s length to see it clearly. Symptoms include eye strain and headaches"
      }, {
        "text": " with near work.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e The [[81b5f5fe|accommodation]] reflex ("
      }, {
        "text": "ciliary muscle contraction) remains intact, but the stiff lens is unable to respond by changing its shape.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e"
      }, {
        "text": " Corrected with the use of reading glasses or bifocals, which use a \u003cmark\u003econvex (converging) lens\u003c/mark\u003e to"
      }, {
        "text": " add refractive power for near vision.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Do not confuse presbyopia with hyperopia (farsightedness)."
      }, {
        "text": " While both can cause blurry near vision and are corrected with convex lenses, presbyopia is due to loss of accommodation, whereas"
      }, {
        "text": " hyperopia is a refractive error due to the shape of the eyeball.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Presbyopia\u003c/b\u003e is an inevitable consequence of aging where the lens loses its flexibility, impairing the eye\u0027s ability to accommodate"
      }, {
        "text": " for near vision, necessitating the use of reading glasses to compensate for the lost focusing power.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_an_impairment_of\",\n"
      }, {
        "text": "        \"to\": \"81b5f5fe\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_treated_by\",\n        \"to\": \"convex_lens\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"differentiated_from\",\n        \"to\": \"hyperopia\"\n      }\n    ]\n  },\n  \"0"
      }, {
        "text": "87079b0\": {\n    \"title\": \"Preseptal Cellulitis\",\n    \"primaryType"
      }, {
        "text": "\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Infectious Disease"
      }, {
        "text": "\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePreseptal cellulitis\u003c/b\u003e is an infection of the eyelid"
      }, {
        "text": " and periorbital soft tissues located \u003ci\u003eanterior\u003c/i\u003e to the orbital septum, which distinguishes it from the more serious"
      }, {
        "text": " orbital cellulitis.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnatomy:\u003c/b\u003e The orbital septum is a"
      }, {
        "text": " fibrous membrane that separates the superficial eyelid structures from the contents of the orbit (fat and muscles). Preseptal means in"
      }, {
        "text": " front of this barrier.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Often arises from a superficial source, such as a skin abrasion, insect"
      }, {
        "text": " bite, hordeolum, or spread from an upper respiratory tract infection or sinusitis. Common pathogens are \u003ci\u003eStaphylococcus aureus\u003c/i\u003e and "
      }, {
        "text": "\u003ci\u003eStreptococcus pyogenes\u003c/i\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Unilateral ocular pain, eyelid swelling, and erythe"
      }, {
        "text": "ma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Differentiating Feature:\u003c/b\u003e Unlike orbital cellulitis, in preseptal cellulitis, there is \u003cu\u003eno pain"
      }, {
        "text": " with eye movements\u003c/u\u003e, \u003cu\u003eno proptosis\u003c/u\u003e (bulging of the eye), and \u003cu\u003eno vision impairment or"
      }, {
        "text": " diplopia\u003c/u\u003e. Extraocular movements are full and painless.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The most important step"
      }, {
        "text": " in evaluating a patient with a red, swollen eye is to assess for pain with eye movements. Absence of pain with movement strongly suggests pre"
      }, {
        "text": "septal cellulitis, while its presence points to the more dangerous [[5ccc91a9|orbital cellulitis]]."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePreseptal cellulitis\u003c/b\u003e is an infection confined to the eyelid"
      }, {
        "text": ", anterior to the orbital septum. The integrity of the orbital septum prevents the infection from spreading to the orbit, thus preserving vision"
      }, {
        "text": " and eye movement, which is the key clinical distinction from the emergent condition of orbital cellulitis.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"5"
      }, {
        "text": "ccc91a9\"\n      },\n      {\n        \"type\": \"is_caused_by\","
      }, {
        "text": "\n        \"to\": \"staphylococcus_aureus\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_caused_by\",\n        \"to\": \"streptococcus_pyogenes\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"65ba66bf\": {\n    \"title\": \"Pressure S"
      }, {
        "text": "ensation\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Phys"
      }, {
        "text": "iology\",\n      \"Dermatology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sensory System\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePressure sensation\u003c/b\u003e is a form of mechanoreception that"
      }, {
        "text": " allows for the perception of sustained touch and deep force applied to the skin, mediated by specific sensory receptors that transmit signals via"
      }, {
        "text": " the dorsal column-medial lemniscus pathway.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eRe"
      }, {
        "text": "ceptors:\u003c/b\u003e Mediated by slowly adapting mechanoreceptors. \u003cmark\u003eMerkel discs\u003c/mark\u003e are responsible for sensing"
      }, {
        "text": " sustained pressure and deep static touch (e.g., shapes, edges). \u003cmark\u003eRuffini corpuscles\u003c/mark\u003e respond"
      }, {
        "text": " to sustained pressure and skin stretch.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNerve Fibers:\u003c/b\u003e Transmitted by large, myelinated A"
      }, {
        "text": "Œ≤ fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Signals travel up the ipsilateral [[e7f5cbbe|dorsal columns"
      }, {
        "text": "]] (fasciculus gracilis and cuneatus) to the medulla, synapse, decussate, and ascend"
      }, {
        "text": " via the [[f19bc454|medial lemniscus]] to the VPL nucleus of the [["
      }, {
        "text": "afc0a64b|thalamus]], and finally to the somatosensory cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDist"
      }, {
        "text": "inction from Vibration:\u003c/b\u003e While related, pressure is a sustained sensation, whereas vibration is sensed by rapidly adapting receptors like [["
      }, {
        "text": "71867ae0|Pacinian corpuscles]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Loss of pressure sensation,"
      }, {
        "text": " along with vibration and proprioception, with preserved pain and temperature sensation, points to a lesion of the [[e7f5cbbe|d"
      }, {
        "text": "orsal columns]], as seen in [[71daebd6|Tabes Dorsalis]] or [[6f5bea"
      }, {
        "text": "90|Subacute Combined Degeneration]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePressure sensation\u003c/b\u003e is a critical"
      }, {
        "text": " component of discriminative touch, relying on slowly adapting receptors like Merkel discs and the high-fidelity dorsal column pathway to provide"
      }, {
        "text": " the brain with continuous information about the shape, texture, and force of objects in contact with the skin.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is"
      }, {
        "text": "_mediated_by\",\n        \"to\": \"merkel_discs\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_mediated_by\",\n        \"to\": \"ruffini_corpuscles\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_transmitted_via\",\n        \"to\": \"e7f5cbbe\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_relayed_in\",\n        \"to\": \"af"
      }, {
        "text": "c0a64b\"\n      }\n    ]\n  },\n  \"ca7a116"
      }, {
        "text": "8\": {\n    \"title\": \"Pretectal Nuclei\",\n    \"primaryType\": \"anatomy\","
      }, {
        "text": "\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Ophthalmology"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"cb6ccdd6\",\n    \"letter\": \"P\",\n    \"term\": \"Pharmacology\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Pharmacology\",\n    \"sub_entries\": [\n      {\n        \"id\": \"e3d410a1\",\n        \"letter\": \"P\",\n        \"term\": \"neurology\",\n        \"pages\": [\n          \"560\"\n        ],\n        \"context\": \"Pharmacology \u003e neurology\"\n      }\n    ]\n  },\n  {\n    \"id\": \"e1d92dbf\",\n    \"letter\": \"P\",\n    \"term\": \"Phenobarbital\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Phenobarbital\",\n    \"sub_entries\": [\n      {\n        \"id\": \"bc734826\",\n        \"letter\": \"P\",\n        \"term\": \"effects\",\n        \"pages\": [\n          \"561\"\n        ],\n        \"context\": \"Phenobarbital \u003e effects\"\n      }\n    ]\n  },\n  {\n    \"id\": \"5aea213f\",\n    \"letter\": \"P\",\n    \"term\": \"Phenytoin\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Phenytoin\",\n    \"sub_entries\": [\n      {\n        \"id\": \"7ddf13d1\",\n        \"letter\": \"P\",\n        \"term\": \"mechanism and adverse effects\",\n        \"pages\": [\n          \"560\"\n        ],\n        \"context\": \"Phenytoin \u003e mechanism and adverse effects\"\n      }\n    ]\n  },\n  {\n    \"id\": \"7e1d335f\",\n    \"letter\": \"P\",\n    \"term\": \"Photophobia/photosensitivity\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Photophobia/photosensitivity\",\n    \"sub_entries\": [\n      {\n        \"id\": \"33663abc\",\n        \"letter\": \"P\",\n        \"term\": \"migraine headache\",\n        \"pages\": [\n          \"532\"\n        ],\n        \"context\": \"Photophobia/photosensitivity \u003e migraine headache\"\n      }\n    ]\n  },\n  {\n    \"id\": \"69061070\",\n    \"letter\": \"P\",\n    \"term\": \"Physiology\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Physiology\",\n    \"sub_entries\": [\n      {\n        \"id\": \"c27909d4\",\n        \"letter\": \"P\",\n        \"term\": \"neurological\",\n        \"pages\": [\n          \"499\"\n        ],\n        \"context\": \"Physiology \u003e neurological\"\n      }\n    ]\n  },\n  {\n    \"id\": \"a83de613\",\n    \"letter\": \"P\",\n    \"term\": \"Physostigmine\",\n    \"pages\": [\n      \"568\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Physostigmine\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"7858887e\",\n    \"letter\": \"P\",\n    \"term\": \"Pia mater\",\n    \"pages\": [\n      \"506\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Pia mater\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"f54d873a\",\n    \"letter\": \"P\",\n    \"term\": \"Pilocarpine\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Pilocarpine\",\n    \"sub_entries\": [\n      {\n        \"id\": \"f4ad00ee\",\n        \"letter\": \"P\",\n        \"term\": \"uses of\",\n        \"pages\": [\n          \"568\"\n        ],\n        \"context\": \"Pilocarpine \u003e uses of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"912187bd\",\n    \"letter\": \"P\",\n    \"term\": \"Pilocytic astrocytoma\",\n    \"pages\": [\n      \"542\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Pilocytic astrocytoma\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"6fc77315\",\n    \"letter\": \"P\",\n    \"term\": \"Pineal gland\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Pineal gland\",\n    \"sub_entries\": [\n      {\n        \"id\": \"203c5680\",\n        \"letter\": \"P\",\n        \"term\": \"location of\",\n        \"pages\": [\n          \"515\"\n        ],\n        \"context\": \"Pineal gland \u003e location of\"\n      },\n      {\n        \"id\": \"bd6ab0bf\",\n        \"letter\": \"P\",\n        \"term\": \"tumor histology\",\n        \"pages\": [\n          \"542\"\n        ],\n        \"context\": \"Pineal gland \u003e tumor histology\"\n      }\n    ]\n  },\n  {\n    \"id\": \"5f3188bd\",\n    \"letter\": \"P\",\n    \"term\": \"Pituitary adenoma\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Pituitary adenoma\",\n    \"sub_entries\": [\n      {\n        \"id\": \"7524a932\",\n        \"letter\": \"P\",\n        \"term\": \"characteristics and histology\",\n        \"pages\": [\n          \"540\"\n        ],\n        \"context\": \"Pituitary adenoma \u003e characteristics and histology\"\n      }\n    ]\n  },\n  {\n    \"id\": \"da045b40\",\n    \"letter\": \"P\",\n    \"term\": \"Pituitary apoplexy\",\n    \"pages\": [\n      \"540\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Pituitary apoplexy\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"beefb152\",\n    \"letter\": \"P\",\n    \"term\": \"Plantar reflex\",\n    \"pages\": [\n      \"523\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Plantar reflex\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"75f2b918\",\n    \"letter\": \"P\",\n    \"term\": \"Poliovirus/poliomyelitis\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Poliovirus/poliomyelitis\",\n    \"sub_entries\": [\n      {\n        \"id\": \"39be785e\",\n        \"letter\": \"P\",\n        \"term\": \"spinal cord effects\",\n        \"pages\": [\n          \"544\"\n        ],\n        \"context\": \"Poliovirus/poliomyelitis \u003e spinal cord effects\"\n      }\n    ]\n  },\n  {\n    \"id\": \"bf549b2f\",\n    \"letter\": \"P\",\n    \"term\": \"Pons\",\n    \"pages\": [\n      \"517\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Pons\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 1864
    }, {
      "text": "```json\n{\n  \"cb6ccdd6\": {\n    \"title\": \"Neurology Pharmacology\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Overview\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeurology Pharmacology\u003c/b\u003e encompasses the study and application of drugs that affect the central and peripheral nervous systems. This field includes medications used to treat a wide range of conditions such as [[64c08e92|epilepsy]], [[58c8ea03|Parkinson disease]], [[26661e34|migraine headaches]], pain, and neurodegenerative disorders.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnticonvulsants:\u003c/b\u003e Drugs like [[5aea213f|phenytoin]], [[eddd2bc5|carbamazepine]], and [[0d37e045|valproate]] that stabilize neuronal membranes, often by blocking ion channels or enhancing [[5aa5cb91|GABAergic]] inhibition.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParkinson Disease Drugs:\u003c/b\u003e Medications aimed at increasing dopamine levels or activity, such as [[541cd176|levodopa/carbidopa]] and dopamine agonists.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnesthetics:\u003c/b\u003e General anesthetics induce unconsciousness, while local anesthetics block nerve conduction in a specific area.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOpioid Analgesics:\u003c/b\u003e Powerful pain relievers that act on opioid receptors in the CNS.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDemyelinating Disease Therapies:\u003c/b\u003e Immunomodulators like [[00e48ea3|interferon-Œ≤]] used to treat [[45dd6d19|multiple sclerosis]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe core principle of many neurological drugs is the modulation of synaptic transmission, either by altering neurotransmitter levels (synthesis, release, reuptake, degradation) or by directly acting on postsynaptic receptors to either excite or inhibit neuronal activity.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"f91a0cfa\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"parkinson_disease_drugs\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"anesthetics\"\n      }\n    ]\n  },\n  \"e1d92dbf\": {\n    \"title\": \"Phenobarbital\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Sedative-Hypnotic\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePhenobarbital\u003c/b\u003e is a long-acting \u003ci\u003ebarbiturate\u003c/i\u003e that functions as a central nervous system depressant, used primarily as an anticonvulsant and sedative.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Potentiates the effect of [[5aa5cb91|GABA]] at the GABA\u003csub\u003eA\u003c/sub\u003e receptor, which \u003cmark\u003eincreases the duration\u003c/mark\u003e of Cl\u003csup\u003e-\u003c/sup\u003e channel opening. This leads to prolonged hyperpolarization of the neuron, making it less excitable. Mnemonic: Barbi\u003cb\u003edurates\u003c/b\u003e increase \u003cb\u003eduration\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for generalized tonic-clonic seizures and focal seizures. It is also a second-line agent for status epilepticus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Major side effects include \u003cmark\u003esedation\u003c/mark\u003e, cognitive impairment, and respiratory and cardiovascular depression, especially when combined with other CNS depressants like alcohol.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e It is a potent \u003cmark\u003einducer of cytochrome P450\u003c/mark\u003e enzymes in the liver, leading to numerous drug-drug interactions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate its mechanism from benzodiazepines, which increase the \u003ci\u003efrequency\u003c/i\u003e of Cl\u003csup\u003e-\u003c/sup\u003e channel opening. Phenobarbital\u0027s induction of CYP450 is a classic exam topic.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePhenobarbital\u003c/b\u003e exerts its anticonvulsant and sedative effects by prolonging the opening of GABA\u003csub\u003eA\u003c/sub\u003e-associated chloride channels, a distinct mechanism from benzodiazepines, and its powerful induction of hepatic enzymes makes it a frequent culprit in drug interactions.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Phenobarbital] --\u003e B(Binds to GABA-A Receptor); B --\u003e C(Increased Duration of Cl- Channel Opening); C --\u003e D(Enhanced GABAergic Inhibition); D --\u003e E(CNS Depression);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"barbiturate\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"induces\",\n        \"to\": \"cytochrome_p450\"\n      },\n      {\n        \"type\": \"potentiates\",\n        \"to\": \"5aa5cb91\"\n      }\n    ]\n  },\n  \"5aea213f\": {\n    \"title\": \"Phenytoin\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePhenytoin\u003c/b\u003e is a widely used \u003ci\u003eanticonvulsant\u003c/i\u003e medication that works by blocking voltage-gated sodium channels, primarily used for treating focal and generalized tonic-clonic seizures.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks high-frequency firing of neurons by inactivating voltage-gated \u003cmark\u003eNa\u003csup\u003e+\u003c/sup\u003e channels\u003c/mark\u003e, thereby prolonging their refractory period.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Exhibits \u003cmark\u003ezero-order (capacity-limited) elimination\u003c/mark\u003e at therapeutic doses, meaning a small increase in dose can lead to a disproportionately large increase in plasma concentration and toxicity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Common effects include nystagmus, diplopia, ataxia, and \u003cmark\u003egingival hyperplasia\u003c/mark\u003e. Long-term use can cause hirsutism, coarsening of facial features, and osteoporosis. It is also a teratogen (fetal hydantoin syndrome).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrug Interactions:\u003c/b\u003e It is a potent \u003cmark\u003einducer of cytochrome P450\u003c/mark\u003e enzymes, accelerating the metabolism of many other drugs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the mnemonic \u003cb\u003eP-450\u003c/b\u003e for inducers: \u003cb\u003eP\u003c/b\u003ehenytoin, \u003cb\u003eP\u003c/b\u003ehenobarbital, \u003cb\u003eC\u003c/b\u003earbamazepine, \u003cb\u003eR\u003c/b\u003eifampin, \u003cb\u003eG\u003c/b\u003eriseofulvin, and \u003cb\u003eS\u003c/b\u003et. John\u0027s Wort (\u003cb\u003eP\u003c/b\u003eCR\u003cb\u003eG\u003c/b\u003eS). Gingival hyperplasia is a classic, visually identifiable side effect.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePhenytoin\u003c/b\u003e is an effective anticonvulsant with a narrow therapeutic window due to its zero-order elimination kinetics, and its use is complicated by a distinctive side effect profile, including gingival hyperplasia, and its role as a powerful inducer of hepatic drug-metabolizing enzymes.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"blocks\",\n        \"to\": \"sodium_channels\"\n      },\n      {\n        \"type\": \"induces\",\n        \"to\": \"cytochrome_p450\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"gingival_hyperplasia\"\n      },\n      {\n        \"type\": \"exhibits\",\n        \"to\": \"zero_order_kinetics\"\n      }\n    ]\n  },\n  \"7e1d335f\": {\n    \"title\": \"Photophobia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Infectious Disease\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Symptoms\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePhotophobia\u003c/b\u003e is a symptom of abnormal intolerance to light, where exposure to light causes eye discomfort or pain. It is associated with various neurological and ophthalmological conditions.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e The exact pathway is not fully understood but is thought to involve the trigeminal pain pathway, which can be sensitized by underlying inflammation or neurological dysfunction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMigraine Headache:\u003c/b\u003e Photophobia is a key diagnostic criterion for [[26661e34|migraine headaches]], often accompanied by phonophobia (sensitivity to sound). Patients typically seek a dark, quiet room for relief.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMeningitis:\u003c/b\u003e Inflammation of the meninges can irritate cranial nerves, including the trigeminal nerve, leading to significant photophobia. It is a classic symptom along with fever, headache, and nuchal rigidity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSubarachnoid Hemorrhage:\u003c/b\u003e The presence of blood in the subarachnoid space causes meningeal irritation, leading to severe headache and photophobia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOcular Causes:\u003c/b\u003e Conditions causing inflammation of the eye, such as uveitis or keratitis, are common causes of photophobia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The triad of fever, nuchal rigidity, and photophobia should immediately raise suspicion for meningitis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePhotophobia\u003c/b\u003e is more than just light sensitivity; it is a neurological symptom of pain triggered by light, often indicating meningeal irritation (as in meningitis or subarachnoid hemorrhage) or trigeminal pathway sensitization (as in migraine).\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"26661e34\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"meningitis\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"63f8b05f\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"uveitis\"\n      }\n    ]\n  },\n  \"69061070\": {\n    \"title\": \"Neurological Physiology\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Overview\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeurological physiology\u003c/b\u003e is the study of the function of the nervous system, from the molecular level of ion channels and neurotransmitters to the systemic level of sensory perception, motor control, and cognition.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNeuron Action Potential:\u003c/b\u003e The fundamental unit of nerve communication, involving rapid changes in membrane potential due to voltage-gated Na\u003csup\u003e+\u003c/sup\u003e and K\u003csup\u003e+\u003c/sup\u003e channels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSynaptic Transmission:\u003c/b\u003e The process of transferring information from one neuron to another via the release of neurotransmitters.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSensory Pathways:\u003c/b\u003e Systems like the [[e7f5cbbe|dorsal columns]] and [[07eecef1|spinothalamic tract]] that transmit sensory information from the periphery to the brain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMotor Pathways:\u003c/b\u003e Systems like the corticospinal tract that convey motor commands from the brain to the muscles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpecial Senses:\u003c/b\u003e Includes the complex physiology of vision, hearing ([[88e6f77e|hearing loss]]), balance (vestibular system), taste, and smell.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eUnderstanding \u003cb\u003eneurological physiology\u003c/b\u003e is essential for interpreting the clinical signs of nervous system disease, as deficits in function can often be precisely mapped to specific anatomical structures and physiological pathways.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"fcedc59f\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"synaptic_transmission\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"07eecef1\"\n      }\n    ]\n  },\n  \"a83de613\": {\n    \"title\": \"Physostigmine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Toxicology\",\n      \"Autonomic\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Autonomic Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePhysostigmine\u003c/b\u003e is a reversible \u003ci\u003eacetylcholinesterase (AChE) inhibitor\u003c/i\u003e that increases the concentration of acetylcholine at cholinergic synapses. Uniquely among clinically used AChE inhibitors, it is a tertiary amine and can cross the blood-brain barrier.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Reversibly inhibits AChE, the enzyme that breaks down [[6a005559|acetylcholine]], thereby increasing the level and duration of action of ACh at both muscarinic and nicotinic receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e As a \u003cmark\u003etertiary amine\u003c/mark\u003e, it is lipid-soluble and can cross the blood-brain barrier to exert effects in the central nervous system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Primarily used as an antidote for \u003cmark\u003eanticholinergic toxicity\u003c/mark\u003e (e.g., atropine overdose, Jimson weed poisoning) to reverse both central and peripheral symptoms.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOphthalmology Use:\u003c/b\u003e Can be used topically to induce miosis and treat [[3ce6c035|glaucoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember \\\"\u003cb\u003ePhy\u003c/b\u003esostigmine \u0027\u003cb\u003ephy\u003c/b\u003exes\u0027 atropine overdose.\\\" Its ability to cross the BBB makes it the antidote of choice for reversing the central anticholinergic effects like delirium and confusion, unlike quaternary amines (e.g., neostigmine) which only act peripherally.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePhysostigmine\u0027s\u003c/b\u003e status as a tertiary amine is its defining feature, allowing it to cross the blood-brain barrier and serve as the primary antidote for reversing the life-threatening central nervous system toxicity of anticholinergic overdose.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Anticholinergic Drug e.g., Atropine] --Blocks--\u003e B(Muscarinic Receptors); C[Physostigmine] --Inhibits--\u003e D(AChE); D --x E[ACh Breakdown]; E --\u003e F(Increased ACh); F --Reverses Blockade--\u003e B;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_an_antidote_for\",\n        \"to\": \"anticholinergic_toxicity\"\n      },\n      {\n        \"type\": \"inhibits_enzyme\",\n        \"to\": \"acetylcholinesterase\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"tertiary_amine\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"3ce6c035\"\n      }\n    ]\n  },\n  \"7858887e\": {\n    \"title\": \"Pia Mater\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Meninges\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003ePia Mater\u003c/b\u003e is the delicate, innermost layer of the [[805d0677|meninges]], a thin, highly vascular membrane that closely adheres to the surface of the brain and spinal cord, following all of its contours (gyri and sulci).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Directly covers the surface of the brain and spinal cord. It is separated from the arachnoid mater by the subarachnoid space, which contains cerebrospinal fluid (CSF).\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e A thin, transparent, mesh-like membrane composed of fibrous connective tissue. It is impermeable to fluid, forming a barrier.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Provides a supportive scaffold for cerebral and spinal blood vessels as they penetrate the brain tissue. The pia mater and astrocytes form the perivascular spaces (Virchow-Robin spaces).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e The pia mater, along with the arachnoid mater (together known as the leptomeninges), is the primary site of inflammation in [[meningitis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the order of the meninges from superficial to deep: \u003cb\u003eD-A-P\u003c/b\u003e (\u003cb\u003eD\u003c/b\u003eura, \u003cb\u003eA\u003c/b\u003erachnoid, \u003cb\u003eP\u003c/b\u003eia). The pia is the layer that is \u0027intimately\u0027 attached to the brain.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003ePia Mater\u003c/b\u003e serves as the brain\u0027s \u0027shrink wrap,\u0027 a delicate but crucial barrier that encases the CNS and supports the vasculature as it dives into the neural parenchyma, making it a key player in both vascular supply and infectious processes like meningitis.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_layer_of\",\n        \"to\": \"805d0677\"\n      },\n      {\n        \"type\": \"is_inflamed_in\",\n        \"to\": \"meningitis\"\n      },\n      {\n        \"type\": \"surrounds\",\n        \"to\": \"a584135d\"\n      }\n    ]\n  },\n  \"f54d873a\": {\n    \"title\": \"Pilocarpine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"Autonomic\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Autonomic Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePilocarpine\u003c/b\u003e is a \u003ci\u003edirect-acting muscarinic agonist\u003c/i\u003e (a parasympathomimetic) that is primarily used in ophthalmology to treat glaucoma and as a miotic agent, and systemically to treat dry mouth.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Directly stimulates muscarinic (M3) receptors. In the eye, it causes contraction of the ciliary muscle and the sphincter pupillae muscle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUse in Glaucoma:\u003c/b\u003e In \u003cmark\u003eopen-angle glaucoma\u003c/mark\u003e, ciliary muscle contraction increases the outflow of aqueous humor through the trabecular meshwork, lowering intraocular pressure. In \u003cmark\u003eacute angle-closure glaucoma\u003c/mark\u003e, it causes miosis, which pulls the peripheral iris away from the trabecular meshwork, opening the angle for drainage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUse for Xerostomia:\u003c/b\u003e Stimulates muscarinic receptors on salivary glands to increase saliva production in conditions like Sj√∂gren syndrome or after radiation therapy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Can cause systemic parasympathomimetic effects like sweating, nausea, bronchospasm, and bradycardia. Ocular effects include blurred vision and brow ache.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember \\\"You cry, drool, and sweat on your \u0027\u003cb\u003epilo\u003c/b\u003ew\u0027\\\" to recall the secretagogue effects of pilocarpine. It is a key drug for the emergency management of acute angle-closure glaucoma.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePilocarpine\u003c/b\u003e effectively lowers intraocular pressure in both open-angle and acute angle-closure glaucoma by physically altering the eye\u0027s drainage anatomy through M3 receptor-mediated contraction of the ciliary and pupillary sphincter muscles.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Pilocarpine] --\u003e B(Muscarinic M3 Agonist); B --\u003e C(Ciliary Muscle Contraction); C --\u003e D(Increased Aqueous Outflow); D --\u003e E(Decreased IOP); B --\u003e F(Sphincter Pupillae Contraction); F --\u003e G(Miosis);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"sjogren_syndrome\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"muscarinic_agonist\"\n      }\n    ]\n  },\n  \"912187bd\": {\n    \"title\": \"Pilocytic Astrocytoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Pediatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003ePilocytic Astrocytoma\u003c/b\u003e is a low-grade (WHO grade I), slow-growing glioma that is the \u003ci\u003emost common primary brain tumor in childhood\u003c/i\u003e, typically arising in the cerebellum.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Most commonly found in the \u003cmark\u003eposterior fossa (cerebellum)\u003c/mark\u003e. Can also occur in the optic nerve pathway (optic glioma), hypothalamus, or cerebral hemispheres.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e Classically appears as a \u003cmark\u003ecystic lesion with a brightly enhancing mural nodule\u003c/mark\u003e on MRI or CT.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e Composed of well-differentiated, bipolar astrocytes with long, thin, \u0027hair-like\u0027 processes (pilocytic means \u0027hair-like\u0027). Key features include \u003cmark\u003eRosenthal fibers\u003c/mark\u003e (thick, eosinophilic, corkscrew-shaped inclusions) and eosinophilic granular bodies. The tumor is GFAP-positive.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Generally has a good prognosis with surgical resection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A child with cerebellar signs (e.g., ataxia, dysmetria) and an MRI showing a cystic mass with a mural nodule in the cerebellum is the classic vignette for a pilocytic astrocytoma.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003ePilocytic Astrocytoma\u003c/b\u003e is the most common and most benign pediatric brain tumor, characterized by its classic cerebellar location, cystic-plus-mural-nodule appearance on imaging, and distinctive histological findings of Rosenthal fibers.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Childhood Brain Tumor] --\u003e B{Most Common}; B --\u003e C(Pilocytic Astrocytoma); C --\u003e D[Location: Cerebellum]; C --\u003e E[Imaging: Cyst + Mural Nodule]; C --\u003e F[Histology: Rosenthal Fibers \u0026 GFAP+];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"astrocytoma\"\n      },\n      {\n        \"type\": \"is_the_most_common\",\n        \"to\": \"childhood_brain_tumor\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\": \"rosenthal_fibers\"\n      },\n      {\n        \"type\": \"expresses\",\n        \"to\": \"fb50d450\"\n      }\n    ]\n  },\n  \"6fc77315\": {\n    \"title\": \"Pineal Gland\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Anatomy\",\n      \"Brain\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003ePineal Gland\u003c/b\u003e is a small endocrine gland located in the epithalamus, near the center of the brain, whose primary function is to receive information about the daily light-dark cycle and produce and secrete the hormone \u003ci\u003emelatonin\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Situated in the posterior aspect of the third ventricle, superior to the superior colliculi of the midbrain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Synthesizes and secretes \u003cmark\u003emelatonin\u003c/mark\u003e, a hormone that regulates circadian rhythms and sleep-wake cycles. Melatonin production is stimulated by darkness and inhibited by light.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e Receives sympathetic innervation from the superior cervical ganglion, which is driven by input from the suprachiasmatic nucleus (SCN) of the hypothalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology (Pineal Tumors):\u003c/b\u003e Tumors of the pineal gland (e.g., pinealoma, germinoma) are rare but can cause specific syndromes by compressing adjacent structures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParinaud Syndrome:\u003c/b\u003e Compression of the dorsal midbrain (superior colliculi) by a pineal tumor can cause \u003cmark\u003eParinaud syndrome\u003c/mark\u003e, characterized by upward gaze palsy, convergence-retraction nystagmus, and light-near dissociation of the pupils.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHydrocephalus:\u003c/b\u003e A pineal tumor can also compress the cerebral aqueduct, leading to obstructive (non-communicating) [[0bc2f200|hydrocephalus]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003ePineal Gland\u003c/b\u003e acts as the body\u0027s neuroendocrine transducer of light, converting photic information from the retina into the hormonal signal of melatonin to entrain the body\u0027s circadian rhythms to the 24-hour day-night cycle.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Light] --\u003e B(Retina); B --\u003e C(Suprachiasmatic Nucleus); C --\u003e D(Superior Cervical Ganglion); D --|Sympathetic Fibers|--\u003e E(Pineal Gland); E --|Darkness|--\u003e F(Melatonin Secretion); F --\u003e G(Circadian Rhythm Regulation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"produces\",\n        \"to\": \"melatonin\"\n      },\n      {\n        \"type\": \"tumors_can_cause\",\n        \"to\": \"parinaud_syndrome\"\n      },\n      {\n        \"type\": \"tumors_can_cause\",\n        \"to\": \"0bc2f200\"\n      },\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\": \"suprachiasmatic_nucleus\"\n      }\n    ]\n  },\n  \"5f3188bd\": {\n    \"title\": \"Pituitary Adenoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Neurology\",\n      \"Oncology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Pathology\",\n      \"Pituitary Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003ePituitary Adenoma\u003c/b\u003e is a benign tumor of the [[76ba7f2e|anterior pituitary gland]] that can cause symptoms either through mass effect on surrounding structures or by hypersecretion of one or more pituitary hormones.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassification:\u003c/b\u003e Categorized by size (microadenoma \u003c1 cm, macroadenoma ‚â•1 cm) and by hormonal activity (functional vs. non-functional).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMass Effect Symptoms:\u003c/b\u003e Macroadenomas can compress the optic chiasm, causing a classic \u003cmark\u003ebitemporal hemianopia\u003c/mark\u003e. They can also cause headaches and hypopituitarism by compressing normal pituitary tissue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunctional Adenomas (Hypersecretion):\u003c/b\u003e\u003cbr\u003e  - \u003cb\u003eProlactinoma:\u003c/b\u003e Most common type. Causes galactorrhea, amenorrhea, and infertility in women; decreased libido and impotence in men.\u003cbr\u003e  - \u003cb\u003eSomatotroph Adenoma:\u003c/b\u003e Secretes Growth Hormone (GH), causing acromegaly in adults and gigantism in children.\u003cbr\u003e  - \u003cb\u003eCorticotroph Adenoma:\u003c/b\u003e Secretes ACTH, causing Cushing disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePituitary Apoplexy:\u003c/b\u003e An acute hemorrhage or infarction within a pituitary adenoma, presenting with sudden severe headache, visual changes, and altered mental status. It is a neurosurgical emergency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient presenting with bitemporal hemianopia should immediately make you think of a pituitary adenoma compressing the optic chiasm. If a woman presents with amenorrhea and galactorrhea, suspect a prolactinoma.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePituitary adenomas\u003c/b\u003e manifest a dual pathology: they can disrupt the endocrine system through hormone overproduction (most commonly prolactin) and disrupt the nervous system through mass effect, classically causing bitemporal hemianopia by compressing the optic chiasm.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Pituitary Adenoma]; A --\u003e B(Mass Effect); B --\u003e B1[Bitemporal Hemianopia]; B --\u003e B2[Headache]; B --\u003e B3[Hypopituitarism]; A --\u003e C(Hormone Hypersecretion); C --\u003e C1[Prolactinoma]; C --\u003e C2[GH-secreting]; C --\u003e C3[ACTH-secreting];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"arises_in\",\n        \"to\": \"76ba7f2e\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"6c3a980e\"\n      },\n      {\n        \"type\": \"can_be_a\",\n        \"to\": \"prolactinoma\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"acromegaly\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"cushing_disease\"\n      }\n    ]\n  },\n  \"da045b40\": {\n    \"title\": \"Pituitary Apoplexy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Neurology\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Pathology\",\n      \"Pituitary Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePituitary Apoplexy\u003c/b\u003e is a rare but life-threatening clinical syndrome caused by acute hemorrhage or infarction within a pre-existing [[5f3188bd|pituitary adenoma]], leading to a rapid increase in intrasellar pressure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Spontaneous hemorrhage or infarction of a [[5f3188bd|pituitary adenoma]]. It can be precipitated by factors like head trauma, surgery, or anticoagulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Characterized by the sudden onset of an excruciating \u003cmark\u003e\\\"thunderclap\\\" headache\u003c/mark\u003e, visual disturbances (diplopia from CN III, IV, VI palsy; bitemporal hemianopia from chiasmal compression), and altered mental status.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEndocrine Dysfunction:\u003c/b\u003e The rapid destruction of pituitary tissue can lead to acute hypopituitarism. Acute adrenal insufficiency (due to lack of ACTH) is the most life-threatening consequence, leading to severe hypotension and shock.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e MRI is the imaging modality of choice, showing hemorrhage and necrosis within an enlarged sella turcica.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from subarachnoid hemorrhage: both can cause a thunderclap headache, but pituitary apoplexy is distinguished by signs of cranial nerve palsies (especially CN III) and acute pituitary failure (e.g., hypotension).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePituitary apoplexy\u003c/b\u003e is a neurological and endocrinological emergency where a pituitary tumor suddenly bleeds or dies, causing a triad of severe headache, visual impairment, and acute pituitary hormone deficiency, with the potential for fatal adrenal crisis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Pituitary Adenoma] --\u003e B(Acute Hemorrhage/Infarction); B --\u003e C(Rapid Expansion); C --\u003e D[Compression of Sellar Structures]; D --\u003e D1(CN III, IV, VI Palsies); D --\u003e D2(Optic Chiasm Compression); C --\u003e E[Destruction of Pituitary]; E --\u003e F(Acute Hypopituitarism); F --\u003e G(Adrenal Crisis/Shock);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"5f3188bd\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"thunderclap_headache\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"hypopituitarism\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"adrenal_insufficiency\"\n      }\n    ]\n  },\n  \"beefb152\": {\n    \"title\": \"Plantar Reflex (Babinski Sign)\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003ePlantar Reflex\u003c/b\u003e is a superficial reflex elicited by stroking the sole of the foot. A normal response in adults is plantar flexion (curling down) of the toes. An abnormal response, known as the \u003cb\u003eBabinski sign\u003c/b\u003e, is dorsiflexion of the great toe and fanning of the other toes, indicating an upper motor neuron lesion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNormal Response (Flexor):\u003c/b\u003e Stroking the lateral aspect of the sole from heel to ball results in flexion (curling) of the toes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAbnormal Response (Extensor / Babinski Sign):\u003c/b\u003e The same stimulus causes dorsiflexion (upward extension) of the great toe and fanning of the other toes.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The Babinski sign indicates damage to the \u003cmark\u003ecorticospinal (pyramidal) tracts\u003c/mark\u003e. It represents a release of a primitive reflex that is normally suppressed by descending inhibitory signals from the motor cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e A positive Babinski sign is a key indicator of an \u003cmark\u003eupper motor neuron (UMN) lesion\u003c/mark\u003e. It can be seen in conditions like stroke, spinal cord injury, [[45dd6d19|multiple sclerosis]], and [[4ed629f9|amyotrophic lateral sclerosis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The Babinski sign is normal in infants up to about 1 year of age due to incomplete myelination of the corticospinal tracts. Its presence in an adult is \u003cu\u003ealways\u003c/u\u003e pathological. Mnemonic: \u003cb\u003eU\u003c/b\u003epper motor neuron lesion \u003d toes go \u003cb\u003eU\u003c/b\u003ep.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBabinski sign\u003c/b\u003e is a powerful clinical indicator of upper motor neuron dysfunction, reflecting a loss of cortical inhibition over primitive spinal reflexes; its presence transforms a simple foot stroke into a significant neurological finding.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"upper_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \"is_caused_by_damage_to\",\n        \"to\": \"corticospinal_tract\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"primitive_reflex\"\n      }\n    ]\n  },\n  \"75f2b918\": {\n    \"title\": \"Poliovirus/Poliomyelitis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Infectious Disease\",\n      \"Neurology\",\n      \"Microbiology\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePoliomyelitis\u003c/b\u003e is an infectious disease caused by the \u003cb\u003ePoliovirus\u003c/b\u003e, an enterovirus that can invade the central nervous system and specifically destroy motor neurons in the \u003ci\u003eanterior horn of the spinal cord\u003c/i\u003e, leading to asymmetric flaccid paralysis.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMicrobe:\u003c/b\u003e Poliovirus, a member of the Picornaviridae family (single-stranded, positive-sense RNA virus).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTransmission:\u003c/b\u003e Fecal-oral route. The virus replicates in the oropharynx and small intestine before spreading to the CNS via the bloodstream.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e The virus has a tropism for the \u003cmark\u003eanterior horn cells\u003c/mark\u003e of the spinal cord, leading to their destruction. This results in a pure \u003cmark\u003elower motor neuron (LMN) lesion\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Most infections are asymptomatic. Symptomatic cases can range from a minor febrile illness to aseptic meningitis. Paralytic poliomyelitis (\u003c1% of infections) presents with asymmetric flaccid paralysis, muscle atrophy, fasciculations, and hyporeflexia. Sensation is intact.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A vignette of an unvaccinated child from a country with endemic polio who develops asymmetric flaccid paralysis after a febrile illness is classic for poliomyelitis. Remember that only motor neurons are affected, so sensation is spared.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePoliomyelitis\u003c/b\u003e is the archetypal disease of the anterior horn cells, where poliovirus selectively destroys lower motor neurons, resulting in a pure motor deficit of flaccid paralysis with preserved sensation.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Poliovirus] --Fecal-Oral--\u003e B(Replication in Oropharynx/Gut); B --\u003e C(Viremia); C --\u003e D(Invasion of CNS); D --\u003e E(Destruction of Anterior Horn Cells); E --\u003e F(Lower Motor Neuron Signs - Flaccid Paralysis);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"poliovirus\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"anterior_horn_cells\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"lower_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \"is_prevented_by\",\n        \"to\": \"polio_vaccine\"\n      }\n    ]\n  },\n  \"bf549b2f\": {\n    \"title\": \"Pons\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003ePons\u003c/b\u003e is a major division of the brainstem, located superior to the medulla oblongata and inferior to the midbrain. It serves as a critical relay station for signals between the cerebrum and cerebellum and contains nuclei for several cranial nerves.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Part of the hindbrain (metencephalon), anterior to the cerebellum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCranial Nerve Nuclei:\u003c/b\u003e Contains the nuclei for cranial nerves \u003cb\u003eV (Trigeminal)\u003c/b\u003e, \u003cb\u003eVI (Abducens)\u003c/b\u003e, \u003cb\u003eVII (Facial)\u003c/b\u003e, and \u003cb\u003eVIII (Vestibulocochlear)\u003c/b\u003e. Mnemonic: 4 nerves in the pons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Tracts:\u003c/b\u003e Contains ascending sensory tracts (medial lemniscus, spinothalamic) and descending motor tracts (corticospinal, corticobulbar).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpecialized Centers:\u003c/b\u003e Includes the pontine micturition center, and the Paramedian Pontine Reticular Formation (PPRF), which is the horizontal gaze center.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndromes:\u003c/b\u003e Lesions can cause specific syndromes. \u003cmark\u003eMedial Pontine Syndrome\u003c/mark\u003e (basilar artery branches) affects corticospinal tracts and CN VI. \u003cmark\u003eLateral Pontine Syndrome\u003c/mark\u003e (AICA) affects CN V, VII, VIII, spinothalamic tract, and sympathetic fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the \u0027Rule of 4s\u0027 for the brainstem: 4 cranial nerves are in the pons (V, VI, VII, VIII).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003ePons\u003c/b\u003e acts as a crucial bridge (\u0027pons\u0027 is Latin for bridge) connecting the cerebrum and cerebellum and houses the nuclei for key cranial nerves controlling facial sensation, movement, eye abduction, and hearing/balance.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"brainstem\"\n      },\n      {\n        \"type\": \"contains_nuclei_of\",\n        \"to\": \"trigeminal_nerve\"\n      },\n      {\n        \"type\": \"contains_nuclei_of\",\n        \"to\": \"dd11dde6\"\n      },\n      {\n        \"type\": \"contains_nuclei_of\",\n        \"to\": \"dea9755f\"\n      },\n      {\n        \"type\": \"contains_nuclei_of\",\n        \"to\": \"6fded3e7\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9859,
      "parts": [{
        "text": "```json\n{\n"
      }, {
        "text": "  \"cb6ccdd6\": {\n    \"title\": \"Neurology Pharmacology"
      }, {
        "text": "\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pharmacology\",\n      \""
      }, {
        "text": "USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\","
      }, {
        "text": "\n      \"Overview\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeurology Pharmacology\u003c/b\u003e encompasses"
      }, {
        "text": " the study and application of drugs that affect the central and peripheral nervous systems. This field includes medications used to treat a wide range of conditions"
      }, {
        "text": " such as [[64c08e92|epilepsy]], [[58c8ea03|Park"
      }, {
        "text": "inson disease]], [[26661e34|migraine headaches]], pain, and neurodegenerative disorders.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnticonvulsants:\u003c/b\u003e Drugs like [[5aea"
      }, {
        "text": "213f|phenytoin]], [[eddd2bc5|carbamazepine]], and [[0d37"
      }, {
        "text": "e045|valproate]] that stabilize neuronal membranes, often by blocking ion channels or enhancing [[5aa"
      }, {
        "text": "5cb91|GABAergic]] inhibition.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParkinson Disease Drugs:\u003c/b\u003e Medications aimed at increasing dopamine levels or"
      }, {
        "text": " activity, such as [[541cd176|levodopa/carbidopa]] and dopamine agonists.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAn"
      }, {
        "text": "esthetics:\u003c/b\u003e General anesthetics induce unconsciousness, while local anesthetics block nerve conduction in a specific area.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOp"
      }, {
        "text": "ioid Analgesics:\u003c/b\u003e Powerful pain relievers that act on opioid receptors in the CNS.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDemy"
      }, {
        "text": "elinating Disease Therapies:\u003c/b\u003e Immunomodulators like [[00e48ea3|interferon-"
      }, {
        "text": "Œ≤]] used to treat [[45dd6d19|multiple sclerosis]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eThe core principle of many neurological drugs is the modulation of synaptic transmission, either by altering neurotransmitter levels ("
      }, {
        "text": "synthesis, release, reuptake, degradation) or by directly acting on postsynaptic receptors to either excite or inhibit neuronal activity.\u003c/p\u003e\","
      }, {
        "text": "\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\","
      }, {
        "text": "\n        \"to\": \"f91a0cfa\"\n      },\n      {\n        \"type\": \"includes\",\n"
      }, {
        "text": "        \"to\": \"parkinson_disease_drugs\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "includes\",\n        \"to\": \"anesthetics\"\n      }\n    ]\n  },\n  \"e1"
      }, {
        "text": "d92dbf\": {\n    \"title\": \"Phenobarbital\",\n    \"primaryType\": \"drug"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Sedative-Hypnotic\",\n      "
      }, {
        "text": "\"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\","
      }, {
        "text": "\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {"
      }, {
        "text": "\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePhenobarbital\u003c/b\u003e is a long-acting \u003ci\u003ebarbiturate\u003c/i\u003e that"
      }, {
        "text": " functions as a central nervous system depressant, used primarily as an anticonvulsant and sedative.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Potentiates the effect of [[5aa5cb91|G"
      }, {
        "text": "ABA]] at the GABA\u003csub\u003eA\u003c/sub\u003e receptor, which \u003cmark\u003eincreases the duration\u003c/mark\u003e of Cl\u003csup\u003e-\u003c/sup\u003e channel opening."
      }, {
        "text": " This leads to prolonged hyperpolarization of the neuron, making it less excitable. Mnemonic: Barbi\u003cb\u003edurates"
      }, {
        "text": "\u003c/b\u003e increase \u003cb\u003eduration\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for generalized tonic-clonic seizures and focal"
      }, {
        "text": " seizures. It is also a second-line agent for status epilepticus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Major"
      }, {
        "text": " side effects include \u003cmark\u003esedation\u003c/mark\u003e, cognitive impairment, and respiratory and cardiovascular depression, especially when combined with other"
      }, {
        "text": " CNS depressants like alcohol.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e It is a potent \u003cmark\u003einducer of cytochrome P450\u003c/mark\u003e"
      }, {
        "text": " enzymes in the liver, leading to numerous drug-drug interactions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate its"
      }, {
        "text": " mechanism from benzodiazepines, which increase the \u003ci\u003efrequency\u003c/i\u003e of Cl\u003csup\u003e-\u003c/sup\u003e channel opening. Phenobarbital\u0027s induction"
      }, {
        "text": " of CYP450 is a classic exam topic.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Phenobarbital\u003c/b\u003e exerts its anticonvulsant and sedative effects by prolonging the opening of GABA\u003csub\u003eA\u003c/sub\u003e-associated"
      }, {
        "text": " chloride channels, a distinct mechanism from benzodiazepines, and its powerful induction of hepatic enzymes makes it a frequent culprit in drug interactions"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Phenobarbital] --\u003e B(Binds to GABA-"
      }, {
        "text": "A Receptor); B --\u003e C(Increased Duration of Cl- Channel Opening); C --\u003e D(Enhanced GABAergic Inhibition); D --\u003e E(CNS"
      }, {
        "text": " Depression);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"barbiturate\"\n      },\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_treatment_for\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"induces\",\n        \"to\": \"cytochrome_p450\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"potentiates\",\n        \"to\": \"5aa5cb91\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"5aea213f\": {\n    \"title\": \"Phenytoin\","
      }, {
        "text": "\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePhenytoin\u003c/b\u003e is a widely used \u003ci\u003eanticonvulsant\u003c/i\u003e medication"
      }, {
        "text": " that works by blocking voltage-gated sodium channels, primarily used for treating focal and generalized tonic-clonic seizures.\u003c/p\u003e\","
      }, {
        "text": "\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks high-frequency firing of neurons by inactiv"
      }, {
        "text": "ating voltage-gated \u003cmark\u003eNa\u003csup\u003e+\u003c/sup\u003e channels\u003c/mark\u003e, thereby prolonging their refractory period.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Exhibits \u003cmark\u003ezero-order (capacity-limited) elimination\u003c/mark\u003e at therapeutic doses"
      }, {
        "text": ", meaning a small increase in dose can lead to a disproportionately large increase in plasma concentration and toxicity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects"
      }, {
        "text": ":\u003c/b\u003e Common effects include nystagmus, diplopia, ataxia, and \u003cmark\u003egingival hyperplasia\u003c/mark\u003e. Long-term use"
      }, {
        "text": " can cause hirsutism, coarsening of facial features, and osteoporosis. It is also a teratogen (fetal hydantoin syndrome).\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eDrug Interactions:\u003c/b\u003e It is a potent \u003cmark\u003einducer of cytochrome P450\u003c/mark\u003e enzymes,"
      }, {
        "text": " accelerating the metabolism of many other drugs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the mnemonic \u003cb\u003eP-4"
      }, {
        "text": "50\u003c/b\u003e for inducers: \u003cb\u003eP\u003c/b\u003ehenytoin, \u003cb\u003eP\u003c/b\u003ehenobarbital, \u003cb\u003eC"
      }, {
        "text": "\u003c/b\u003earbamazepine, \u003cb\u003eR\u003c/b\u003eifampin, \u003cb\u003eG\u003c/b\u003eriseofulvin, and \u003cb\u003eS\u003c/b\u003et. John\u0027"
      }, {
        "text": "s Wort (\u003cb\u003eP\u003c/b\u003eCR\u003cb\u003eG\u003c/b\u003eS). Gingival hyperplasia is a classic, visually identifiable side effect.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003e\u003cb\u003ePhenytoin\u003c/b\u003e is an effective anticonvulsant with a narrow therapeutic window due"
      }, {
        "text": " to its zero-order elimination kinetics, and its use is complicated by a distinctive side effect profile, including gingival hyperplasia,"
      }, {
        "text": " and its role as a powerful inducer of hepatic drug-metabolizing enzymes.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to"
      }, {
        "text": "\": \"64c08e92\"\n      },\n      {\n        \"type\": \"blocks"
      }, {
        "text": "\",\n        \"to\": \"sodium_channels\"\n      },\n      {\n        \"type\": \"induces"
      }, {
        "text": "\",\n        \"to\": \"cytochrome_p450\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"causes_adverse_effect\",\n        \"to\": \"gingival_hyperplasia\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"exhibits\",\n        \"to\": \"zero_order_kinetics"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"7e1d335f\": {\n    \"title\":"
      }, {
        "text": " \"Photophobia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Ophthalmology\",\n      \"Infectious Disease\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Symptoms"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePhotophobia\u003c/b\u003e is a"
      }, {
        "text": " symptom of abnormal intolerance to light, where exposure to light causes eye discomfort or pain. It is associated with various neurological and"
      }, {
        "text": " ophthalmological conditions.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e The exact pathway is not fully understood but"
      }, {
        "text": " is thought to involve the trigeminal pain pathway, which can be sensitized by underlying inflammation or neurological dysfunction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMig"
      }, {
        "text": "raine Headache:\u003c/b\u003e Photophobia is a key diagnostic criterion for [[26661e34|migraine headaches]],"
      }, {
        "text": " often accompanied by phonophobia (sensitivity to sound). Patients typically seek a dark, quiet room for relief.\u003c/li\u003e\u003cli\u003e\u003cb\u003eM"
      }, {
        "text": "eningitis:\u003c/b\u003e Inflammation of the meninges can irritate cranial nerves, including the trigeminal nerve, leading to significant"
      }, {
        "text": " photophobia. It is a classic symptom along with fever, headache, and nuchal rigidity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSub"
      }, {
        "text": "arachnoid Hemorrhage:\u003c/b\u003e The presence of blood in the subarachnoid space causes meningeal irritation,"
      }, {
        "text": " leading to severe headache and photophobia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOcular Causes:\u003c/b\u003e Conditions causing inflammation of the eye, such as uve"
      }, {
        "text": "itis or keratitis, are common causes of photophobia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The triad of fever, n"
      }, {
        "text": "uchal rigidity, and photophobia should immediately raise suspicion for meningitis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePhotophobia\u003c/b\u003e"
      }, {
        "text": " is more than just light sensitivity; it is a neurological symptom of pain triggered by light, often indicating meningeal irritation ("
      }, {
        "text": "as in meningitis or subarachnoid hemorrhage) or trigeminal pathway sensitization (as in migraine).\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_symptom_of\",\n        "
      }, {
        "text": "\"to\": \"26661e34\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_a_symptom_of\",\n        \"to\": \"meningitis\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\":"
      }, {
        "text": " \"63f8b05f\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_symptom_of\",\n        \"to\": \"uveitis\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"69061070\": {\n    \"title\": \"Neurological Physiology\",\n    \"primaryType\":"
      }, {
        "text": " \"concept\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Physiology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \""
      }, {
        "text": "Overview\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeurological physiology\u003c/b\u003e is the study of the function"
      }, {
        "text": " of the nervous system, from the molecular level of ion channels and neurotransmitters to the systemic level of sensory perception, motor control, and cognition"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNeuron Action Potential:\u003c/b\u003e The fundamental unit of nerve"
      }, {
        "text": " communication, involving rapid changes in membrane potential due to voltage-gated Na\u003csup\u003e+\u003c/sup\u003e and K\u003csup\u003e+\u003c/sup\u003e channels.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Synaptic Transmission:\u003c/b\u003e The process of transferring information from one neuron to another via the release of neurotransmitters.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSens"
      }, {
        "text": "ory Pathways:\u003c/b\u003e Systems like the [[e7f5cbbe|dorsal columns]] and [[07"
      }, {
        "text": "eecef1|spinothalamic tract]] that transmit sensory information from the periphery to the brain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMotor Pathways:\u003c/b\u003e"
      }, {
        "text": " Systems like the corticospinal tract that convey motor commands from the brain to the muscles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpecial Senses:\u003c/b\u003e Includes"
      }, {
        "text": " the complex physiology of vision, hearing ([[88e6f77e|hearing loss]]), balance (vestibular system), taste"
      }, {
        "text": ", and smell.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eUnderstanding \u003cb\u003eneurological physiology\u003c/b\u003e is essential"
      }, {
        "text": " for interpreting the clinical signs of nervous system disease, as deficits in function can often be precisely mapped to specific anatomical structures and physiological pathways"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n"
      }, {
        "text": "        \"to\": \"fcedc59f\"\n      },\n      {\n        \"type\": \"includes\","
      }, {
        "text": "\n        \"to\": \"synaptic_transmission\"\n      },\n      {\n        \"type\": \"includes"
      }, {
        "text": "\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "includes\",\n        \"to\": \"07eecef1\"\n      }\n    ]\n  },\n  \"a"
      }, {
        "text": "83de613\": {\n    \"title\": \"Physostigmine\",\n    \"primaryType"
      }, {
        "text": "\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Toxicology\",\n      \"Autonomic"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pharmacology\",\n      \"Autonomic Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePhysostig"
      }, {
        "text": "mine\u003c/b\u003e is a reversible \u003ci\u003eacetylcholinesterase (AChE) inhibitor\u003c/i\u003e that increases the concentration of acetylcholine at"
      }, {
        "text": " cholinergic synapses. Uniquely among clinically used AChE inhibitors, it is a tertiary amine and can cross the blood-brain barrier.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Reversibly inhibits AChE, the"
      }, {
        "text": " enzyme that breaks down [[6a005559|acetylcholine]], thereby increasing the level and duration of action"
      }, {
        "text": " of ACh at both muscarinic and nicotinic receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e As a \u003cmark\u003etertiary amine\u003c/mark"
      }, {
        "text": "\u003e, it is lipid-soluble and can cross the blood-brain barrier to exert effects in the central nervous system.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Clinical Use:\u003c/b\u003e Primarily used as an antidote for \u003cmark\u003eanticholinergic toxicity\u003c/mark\u003e (e.g., atrop"
      }, {
        "text": "ine overdose, Jimson weed poisoning) to reverse both central and peripheral symptoms.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOphthalmology Use:\u003c/b\u003e Can be used topically to"
      }, {
        "text": " induce miosis and treat [[3ce6c035|glaucoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember \\\""
      }, {
        "text": "\u003cb\u003ePhy\u003c/b\u003esostigmine \u0027\u003cb\u003ephy\u003c/b\u003exes\u0027 atropine overdose.\\\" Its ability to cross the BBB makes"
      }, {
        "text": " it the antidote of choice for reversing the central anticholinergic effects like delirium and confusion, unlike quaternary amines (e.g., neostigmine"
      }, {
        "text": ") which only act peripherally.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePhysostigmine\u0027"
      }, {
        "text": "s\u003c/b\u003e status as a tertiary amine is its defining feature, allowing it to cross the blood-brain barrier and serve as the"
      }, {
        "text": " primary antidote for reversing the life-threatening central nervous system toxicity of anticholinergic overdose.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[Anticholinergic Drug e.g., Atropine] --Blocks--\u003e B(Muscarinic Receptors); C"
      }, {
        "text": "[Physostigmine] --Inhibits--\u003e D(AChE); D --x E[ACh Breakdown"
      }, {
        "text": "]; E --\u003e F(Increased ACh); F --Reverses Blockade--\u003e B;\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_an_antidote_for\",\n        \"to\": \"antichol"
      }, {
        "text": "inergic_toxicity\"\n      },\n      {\n        \"type\": \"inhibits_enzyme\",\n        \"to\": \"acetyl"
      }, {
        "text": "cholinesterase\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"tertiary_amine\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_treatment_for\",\n        \"to\": \"3ce6c035\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"7858887e\": {\n    \"title\": \"P"
      }, {
        "text": "ia Mater\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \""
      }, {
        "text": "Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Meninges\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003eThe \u003cb\u003ePia Mater\u003c/b\u003e is the delicate, innermost layer of the [[805"
      }, {
        "text": "d0677|meninges]], a thin, highly vascular membrane that closely adheres to the surface of the brain and"
      }, {
        "text": " spinal cord, following all of its contours (gyri and sulci).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation"
      }, {
        "text": ":\u003c/b\u003e Directly covers the surface of the brain and spinal cord. It is separated from the arachnoid mater by the subarachnoid space,"
      }, {
        "text": " which contains cerebrospinal fluid (CSF).\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e A thin, transparent, mesh-like membrane composed of fibrous"
      }, {
        "text": " connective tissue. It is impermeable to fluid, forming a barrier.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Provides a supportive scaffold for cerebral"
      }, {
        "text": " and spinal blood vessels as they penetrate the brain tissue. The pia mater and astrocytes form the perivascular spaces (Vir"
      }, {
        "text": "chow-Robin spaces).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e The pia mater, along with the arachnoid mater ("
      }, {
        "text": "together known as the leptomeninges), is the primary site of inflammation in [[meningitis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE"
      }, {
        "text": " Tip:\u003c/b\u003e Remember the order of the meninges from superficial to deep: \u003cb\u003eD-A-P\u003c/b\u003e (\u003cb\u003e"
      }, {
        "text": "D\u003c/b\u003eura, \u003cb\u003eA\u003c/b\u003erachnoid, \u003cb\u003eP\u003c/b\u003eia). The pia is the layer that is \u0027int"
      }, {
        "text": "imately\u0027 attached to the brain.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003ePia Mater"
      }, {
        "text": "\u003c/b\u003e serves as the brain\u0027s \u0027shrink wrap,\u0027 a delicate but crucial barrier that encases the CNS and supports the vasculature"
      }, {
        "text": " as it dives into the neural parenchyma, making it a key player in both vascular supply and infectious processes like meningitis.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_layer_of\",\n        \"to\": \"805d0677\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_inflamed_in\",\n        \"to\": \"meningitis\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"surrounds\",\n        \"to\": \"a58413"
      }, {
        "text": "5d\"\n      }\n    ]\n  },\n  \"f54d873a\": {\n    \"title\":"
      }, {
        "text": " \"Pilocarpine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \""
      }, {
        "text": "Pharmacology\",\n      \"Ophthalmology\",\n      \"Autonomic\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Autonomic Drugs\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePilocarpine\u003c/b\u003e is a \u003ci\u003edirect-acting mus"
      }, {
        "text": "carinic agonist\u003c/i\u003e (a parasympathomimetic) that is primarily used in ophthalmology to treat glaucoma and as a"
      }, {
        "text": " miotic agent, and systemically to treat dry mouth.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action"
      }, {
        "text": ":\u003c/b\u003e Directly stimulates muscarinic (M3) receptors. In the eye, it causes contraction of the ciliary muscle"
      }, {
        "text": " and the sphincter pupillae muscle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUse in Glaucoma:\u003c/b\u003e In \u003cmark\u003eopen-angle glaucoma\u003c/mark"
      }, {
        "text": "\u003e, ciliary muscle contraction increases the outflow of aqueous humor through the trabecular meshwork, lowering intraocular pressure. In \u003cmark\u003eacute"
      }, {
        "text": " angle-closure glaucoma\u003c/mark\u003e, it causes miosis, which pulls the peripheral iris away from the trabecular mesh"
      }, {
        "text": "work, opening the angle for drainage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUse for Xerostomia:\u003c/b\u003e Stimulates muscarinic receptors on"
      }, {
        "text": " salivary glands to increase saliva production in conditions like Sj√∂gren syndrome or after radiation therapy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Can cause systemic"
      }, {
        "text": " parasympathomimetic effects like sweating, nausea, bronchospasm, and bradycardia. Ocular effects include blurred vision and"
      }, {
        "text": " brow ache.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember \\\"You cry, drool, and sweat on your \u0027"
      }, {
        "text": "\u003cb\u003epilo\u003c/b\u003ew\u0027\\\" to recall the secretagogue effects of pilocarpine. It is a key drug for the"
      }, {
        "text": " emergency management of acute angle-closure glaucoma.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePilocarp"
      }, {
        "text": "ine\u003c/b\u003e effectively lowers intraocular pressure in both open-angle and acute angle-closure glaucoma by physically altering the eye\u0027s drainage"
      }, {
        "text": " anatomy through M3 receptor-mediated contraction of the ciliary and pupillary sphincter muscles.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[Pilocarpine] --\u003e B(Muscarinic M3 Agonist); B --\u003e"
      }, {
        "text": " C(Ciliary Muscle Contraction); C --\u003e D(Increased Aqueous Outflow); D --\u003e E(Decreased IOP); B --\u003e F"
      }, {
        "text": "(Sphincter Pupillae Contraction); F --\u003e G(Miosis);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"3ce6c03"
      }, {
        "text": "5\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        "
      }, {
        "text": "\"to\": \"sjogren_syndrome\"\n      },\n      {\n        \"type\": \"is_a_type_"
      }, {
        "text": "of\",\n        \"to\": \"muscarinic_agonist\"\n      }\n    ]\n  },\n  \"9"
      }, {
        "text": "12187bd\": {\n    \"title\": \"Pilocytic Astrocytoma\",\n    \""
      }, {
        "text": "primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Ped"
      }, {
        "text": "iatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eA \u003cb\u003ePilocytic Astrocytoma\u003c/b\u003e is a low-grade (WHO grade I), slow"
      }, {
        "text": "-growing glioma that is the \u003ci\u003emost common primary brain tumor in childhood\u003c/i\u003e, typically arising in the cerebellum.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Most commonly found in the \u003cmark\u003eposterior fossa (cerebellum)\u003c/mark\u003e."
      }, {
        "text": " Can also occur in the optic nerve pathway (optic glioma), hypothalamus, or cerebral hemispheres.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e Class"
      }, {
        "text": "ically appears as a \u003cmark\u003ecystic lesion with a brightly enhancing mural nodule\u003c/mark\u003e on MRI or CT.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHist"
      }, {
        "text": "ology:\u003c/b\u003e Composed of well-differentiated, bipolar astrocytes with long, thin, \u0027hair-like\u0027 processes (p"
      }, {
        "text": "ilocytic means \u0027hair-like\u0027). Key features include \u003cmark\u003eRosenthal fibers\u003c/mark\u003e (thick, eosinophilic, corkscrew"
      }, {
        "text": "-shaped inclusions) and eosinophilic granular bodies. The tumor is GFAP-positive.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Generally has"
      }, {
        "text": " a good prognosis with surgical resection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A child with cerebellar signs (e.g., ataxia, dysmet"
      }, {
        "text": "ria) and an MRI showing a cystic mass with a mural nodule in the cerebellum is the classic vignette for a pil"
      }, {
        "text": "ocytic astrocytoma.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003ePilocytic Astrocyt"
      }, {
        "text": "oma\u003c/b\u003e is the most common and most benign pediatric brain tumor, characterized by its classic cerebellar location, cystic-plus-mural-"
      }, {
        "text": "nodule appearance on imaging, and distinctive histological findings of Rosenthal fibers.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Child"
      }, {
        "text": "hood Brain Tumor] --\u003e B{Most Common}; B --\u003e C(Pilocytic Astrocytoma); C --\u003e D["
      }, {
        "text": "Location: Cerebellum]; C --\u003e E[Imaging: Cyst + Mural Nodule]; C --\u003e F[Histology: Rosenthal"
      }, {
        "text": " Fibers \u0026 GFAP+];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"astrocytoma\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_the_most_common\",\n        \"to\": \"childhood_brain_tumor\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_characterized_by\",\n        \"to\": \"rosenthal_fibers\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"expresses\",\n        \"to\": \"fb50d450\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"6fc77315\": {\n    \"title\": \"Pineal G"
      }, {
        "text": "land\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Neuroscience"
      }, {
        "text": "\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n"
      }, {
        "text": "      \"Endocrine\",\n      \"Anatomy\",\n      \"Brain\"\n    ],\n    \"content\":"
      }, {
        "text": " {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003ePineal Gland\u003c/b\u003e is a small endocrine gland located in the ep"
      }, {
        "text": "ithalamus, near the center of the brain, whose primary function is to receive information about the daily light-dark cycle and produce and"
      }, {
        "text": " secrete the hormone \u003ci\u003emelatonin\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Situated"
      }, {
        "text": " in the posterior aspect of the third ventricle, superior to the superior colliculi of the midbrain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction"
      }, {
        "text": ":\u003c/b\u003e Synthesizes and secretes \u003cmark\u003emelatonin\u003c/mark\u003e, a hormone that regulates circadian rhythms and sleep-wake cycles. Mel"
      }, {
        "text": "atonin production is stimulated by darkness and inhibited by light.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e Receives sympathetic innervation from the superior"
      }, {
        "text": " cervical ganglion, which is driven by input from the suprachiasmatic nucleus (SCN) of the hypothalamus.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003ePathology (Pineal Tumors):\u003c/b\u003e Tumors of the pineal gland (e.g., pine"
      }, {
        "text": "aloma, germinoma) are rare but can cause specific syndromes by compressing adjacent structures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParinaud Syndrome:\u003c/b\u003e Compression of the"
      }, {
        "text": " dorsal midbrain (superior colliculi) by a pineal tumor can cause \u003cmark\u003eParinaud syndrome\u003c/mark\u003e, characterized by"
      }, {
        "text": " upward gaze palsy, convergence-retraction nystagmus, and light-near dissociation of the pupils.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHydro"
      }, {
        "text": "cephalus:\u003c/b\u003e A pineal tumor can also compress the cerebral aqueduct, leading to obstructive (non-communicating) [["
      }, {
        "text": "0bc2f200|hydrocephalus]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003e"
      }, {
        "text": "Pineal Gland\u003c/b\u003e acts as the body\u0027s neuroendocrine transducer of light, converting photic information from the retina into the"
      }, {
        "text": " hormonal signal of melatonin to entrain the body\u0027s circadian rhythms to the 24-hour day-night cycle"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Light] --\u003e B(Retina); B --\u003e C(Suprach"
      }, {
        "text": "iasmatic Nucleus); C --\u003e D(Superior Cervical Ganglion); D --|Sympathetic Fibers|--\u003e E(Pineal Gland);"
      }, {
        "text": " E --|Darkness|--\u003e F(Melatonin Secretion); F --\u003e G(Circadian Rhythm Regulation);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"produces\",\n        \"to\": \"melatonin\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"tumors_can_cause\",\n        \"to\": \"parinaud_syndrome\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"tumors_can_cause\",\n        \"to\":"
      }, {
        "text": " \"0bc2f200\"\n      },\n      {\n        \"type\": \"is_regulated"
      }, {
        "text": "_by\",\n        \"to\": \"suprachiasmatic_nucleus\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"5f3188bd\": {\n    \"title\": \"Pituitary Adenoma\",\n    "
      }, {
        "text": "\"primaryType\": \"disease\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Neurology"
      }, {
        "text": "\",\n      \"Oncology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n"
      }, {
        "text": "      \"Endocrine\",\n      \"Pathology\",\n      \"Pituitary Tumors\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003eA \u003cb\u003ePituitary Adenoma\u003c/b\u003e is a benign tumor of the [[76ba7"
      }, {
        "text": "f2e|anterior pituitary gland]] that can cause symptoms either through mass effect on surrounding structures or by hypersecretion of one"
      }, {
        "text": " or more pituitary hormones.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassification:\u003c/b\u003e Categorized by"
      }, {
        "text": " size (microadenoma \u003c1 cm, macroadenoma ‚â•1 cm) and by hormonal activity (functional vs. non-functional"
      }, {
        "text": ").\u003c/li\u003e\u003cli\u003e\u003cb\u003eMass Effect Symptoms:\u003c/b\u003e Macroadenomas can compress the optic chiasm, causing a classic \u003cmark\u003eb"
      }, {
        "text": "itemporal hemianopia\u003c/mark\u003e. They can also cause headaches and hypopituitarism by compressing normal pituitary tissue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunctional"
      }, {
        "text": " Adenomas (Hypersecretion):\u003c/b\u003e\u003cbr\u003e  - \u003cb\u003eProlactinoma:\u003c/b\u003e Most common type. Causes"
      }, {
        "text": " galactorrhea, amenorrhea, and infertility in women; decreased libido and impotence in men.\u003cbr\u003e  - \u003cb\u003eSom"
      }, {
        "text": "atotroph Adenoma:\u003c/b\u003e Secretes Growth Hormone (GH), causing acromegaly in adults and gigantism in children"
      }, {
        "text": ".\u003cbr\u003e  - \u003cb\u003eCorticotroph Adenoma:\u003c/b\u003e Secretes ACTH, causing Cushing disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePit"
      }, {
        "text": "uitary Apoplexy:\u003c/b\u003e An acute hemorrhage or infarction within a pituitary adenoma, presenting with sudden severe headache, visual"
      }, {
        "text": " changes, and altered mental status. It is a neurosurgical emergency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient"
      }, {
        "text": " presenting with bitemporal hemianopia should immediately make you think of a pituitary adenoma compressing the optic chiasm. If"
      }, {
        "text": " a woman presents with amenorrhea and galactorrhea, suspect a prolactinoma.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003ePituitary adenomas\u003c/b\u003e manifest a dual pathology: they can disrupt the endocrine system through hormone overproduction"
      }, {
        "text": " (most commonly prolactin) and disrupt the nervous system through mass effect, classically causing bitemporal hemianopia by compressing"
      }, {
        "text": " the optic chiasm.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Pituitary Adenoma];"
      }, {
        "text": " A --\u003e B(Mass Effect); B --\u003e B1[Bitemporal Hemianopia]; B --\u003e B2[Head"
      }, {
        "text": "ache]; B --\u003e B3[Hypopituitarism]; A --\u003e C(Hormone Hypersecretion); C"
      }, {
        "text": " --\u003e C1[Prolactinoma]; C --\u003e C2[GH-secreting]; C --\u003e C3[ACTH-"
      }, {
        "text": "secreting];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"ar"
      }, {
        "text": "ises_in\",\n        \"to\": \"76ba7f2e\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"causes\",\n        \"to\": \"6c3a980e\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"can_be_a\",\n        \"to\": \"prolactinoma\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"can_cause\",\n        \"to\": \"acromegaly\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"cushing_disease"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"da045b40\": {\n    \"title"
      }, {
        "text": "\": \"Pituitary Apoplexy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"End"
      }, {
        "text": "ocrinology\",\n      \"Neurology\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Endocrine\",\n      \"Pathology\",\n      \"Pituitary Tumors\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePituitary Apoplexy\u003c/b\u003e is a rare but life-threatening clinical"
      }, {
        "text": " syndrome caused by acute hemorrhage or infarction within a pre-existing [[5f3188bd|pituitary adenoma]], leading"
      }, {
        "text": " to a rapid increase in intrasellar pressure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Sp"
      }, {
        "text": "ontaneous hemorrhage or infarction of a [[5f3188bd|pituitary adenoma]]. It can be precipitated"
      }, {
        "text": " by factors like head trauma, surgery, or anticoagulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Characterized by the sudden onset of an"
      }, {
        "text": " excruciating \u003cmark\u003e\\\"thunderclap\\\" headache\u003c/mark\u003e, visual disturbances (diplopia from CN III, IV, VI palsy;"
      }, {
        "text": " bitemporal hemianopia from chiasmal compression), and altered mental status.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEndocrine Dysfunction"
      }, {
        "text": ":\u003c/b\u003e The rapid destruction of pituitary tissue can lead to acute hypopituitarism. Acute adrenal insufficiency (due to lack"
      }, {
        "text": " of ACTH) is the most life-threatening consequence, leading to severe hypotension and shock.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e MRI"
      }, {
        "text": " is the imaging modality of choice, showing hemorrhage and necrosis within an enlarged sella turcica.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Differentiate from subarachnoid hemorrhage: both can cause a thunderclap headache, but pituitary apoplexy is distinguished"
      }, {
        "text": " by signs of cranial nerve palsies (especially CN III) and acute pituitary failure (e.g., hypotension).\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003ePituitary apoplexy\u003c/b\u003e is a neurological and endocrinological emergency where a pituitary tumor"
      }, {
        "text": " suddenly bleeds or dies, causing a triad of severe headache, visual impairment, and acute pituitary hormone deficiency, with the"
      }, {
        "text": " potential for fatal adrenal crisis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Pituitary Adenoma] --\u003e"
      }, {
        "text": " B(Acute Hemorrhage/Infarction); B --\u003e C(Rapid Expansion); C --\u003e D[Compression of S"
      }, {
        "text": "ellar Structures]; D --\u003e D1(CN III, IV, VI Palsies); D --\u003e D2(Optic Chiasm"
      }, {
        "text": " Compression); C --\u003e E[Destruction of Pituitary]; E --\u003e F(Acute Hypopituitarism); F --\u003e G(Ad"
      }, {
        "text": "renal Crisis/Shock);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_complication_of\",\n        \"to\": \"5f3188bd\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"presents_with\",\n        \"to\": \"thunderclap_headache\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"hypopituitarism\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"causes\",\n        \"to\": \"adrenal_insufficiency\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"beefb152\": {\n    \"title\": \"Plantar Reflex (Babinski Sign"
      }, {
        "text": ")\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003eThe \u003cb\u003ePlantar Reflex\u003c/b\u003e is a superficial reflex elicited by stroking the sole of the foot. A"
      }, {
        "text": " normal response in adults is plantar flexion (curling down) of the toes. An abnormal response, known as the \u003cb\u003eBabinski sign\u003c/b\u003e,"
      }, {
        "text": " is dorsiflexion of the great toe and fanning of the other toes, indicating an upper motor neuron lesion.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNormal Response (Flexor):\u003c/b\u003e Stroking the lateral aspect of the sole from"
      }, {
        "text": " heel to ball results in flexion (curling) of the toes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAbnormal Response (Extensor /"
      }, {
        "text": " Babinski Sign):\u003c/b\u003e The same stimulus causes dorsiflexion (upward extension) of the great toe and f"
      }, {
        "text": "anning of the other toes.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The Babinski sign indicates damage to the \u003cmark\u003ecorticospinal ("
      }, {
        "text": "pyramidal) tracts\u003c/mark\u003e. It represents a release of a primitive reflex that is normally suppressed by descending inhibitory signals"
      }, {
        "text": " from the motor cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e A positive Babinski sign is a key indicator of an \u003c"
      }, {
        "text": "mark\u003eupper motor neuron (UMN) lesion\u003c/mark\u003e. It can be seen in conditions like stroke, spinal cord injury, [["
      }, {
        "text": "45dd6d19|multiple sclerosis]], and [[4ed629f9|amyotrophic lateral sclerosis]].\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e The Babinski sign is normal in infants up to about 1 year of age due to incomplete"
      }, {
        "text": " myelination of the corticospinal tracts. Its presence in an adult is \u003cu\u003ealways\u003c/u\u003e pathological. Mnemonic: "
      }, {
        "text": "\u003cb\u003eU\u003c/b\u003epper motor neuron lesion \u003d toes go \u003cb\u003eU\u003c/b\u003ep.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003eBabinski sign\u003c/b\u003e is a powerful clinical indicator of upper motor neuron dysfunction, reflecting a loss of cortical inhibition over primitive"
      }, {
        "text": " spinal reflexes; its presence transforms a simple foot stroke into a significant neurological finding.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to"
      }, {
        "text": "\": \"upper_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_caused_by_damage_to\",\n        \"to\": \"corticospinal_tract\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"primitive_reflex\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"75f2b918\": {\n    \"title\": \""
      }, {
        "text": "Poliovirus/Poliomyelitis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"In"
      }, {
        "text": "fectious Disease\",\n      \"Neurology\",\n      \"Microbiology\",\n      \"Pediatrics\",\n      "
      }, {
        "text": "\"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\","
      }, {
        "text": "\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003ePoliomyelitis\u003c/b\u003e is an infectious disease caused by the \u003cb\u003ePoliovirus\u003c/b\u003e, an enterovirus that can"
      }, {
        "text": " invade the central nervous system and specifically destroy motor neurons in the \u003ci\u003eanterior horn of the spinal cord\u003c/i\u003e, leading to asymmetric"
      }, {
        "text": " flaccid paralysis.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMicrobe:\u003c/b\u003e Poliovirus,"
      }, {
        "text": " a member of the Picornaviridae family (single-stranded, positive-sense RNA virus).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTransmission"
      }, {
        "text": ":\u003c/b\u003e Fecal-oral route. The virus replicates in the oropharynx and small intestine before spreading to the CNS"
      }, {
        "text": " via the bloodstream.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e The virus has a tropism for the \u003cmark\u003eanterior horn cells\u003c/"
      }, {
        "text": "mark\u003e of the spinal cord, leading to their destruction. This results in a pure \u003cmark\u003elower motor neuron (L"
      }, {
        "text": "MN) lesion\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Most infections are asymptomatic. Symptomatic cases can range from a minor"
      }, {
        "text": " febrile illness to aseptic meningitis. Paralytic poliomyelitis (\u003c1% of infections) presents with asymmetric flaccid paralysis, muscle atrophy"
      }, {
        "text": ", fasciculations, and hyporeflexia. Sensation is intact.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A"
      }, {
        "text": " vignette of an unvaccinated child from a country with endemic polio who develops asymmetric flaccid paralysis after a febrile illness is"
      }, {
        "text": " classic for poliomyelitis. Remember that only motor neurons are affected, so sensation is spared.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Poliomyelitis\u003c/b\u003e is the archetypal disease of the anterior horn cells, where poliovirus selectively destroys lower motor neurons, resulting"
      }, {
        "text": " in a pure motor deficit of flaccid paralysis with preserved sensation.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Poliovirus"
      }, {
        "text": "] --Fecal-Oral--\u003e B(Replication in Oropharynx/Gut); B --\u003e C(Viremia); C --\u003e D(In"
      }, {
        "text": "vasion of CNS); D --\u003e E(Destruction of Anterior Horn Cells); E --\u003e F(Lower Motor Neuron Signs -"
      }, {
        "text": " Flaccid Paralysis);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \""
      }, {
        "text": "is_caused_by\",\n        \"to\": \"poliovirus\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"damages\",\n        \"to\": \"anterior_horn_cells\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "causes\",\n        \"to\": \"lower_motor_neuron_lesion\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_prevented_by\",\n        \"to\": \"polio_vaccine\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"bf549b2f\": {\n    \"title\":"
      }, {
        "text": " \"Pons\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"An"
      }, {
        "text": "atomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003eThe \u003cb\u003ePons\u003c/b\u003e is a major division of the brainstem, located superior to the medulla"
      }, {
        "text": " oblongata and inferior to the midbrain. It serves as a critical relay station for signals between the cerebrum and cerebellum and"
      }, {
        "text": " contains nuclei for several cranial nerves.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Part"
      }, {
        "text": " of the hindbrain (metencephalon), anterior to the cerebellum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCranial Nerve Nuclei:\u003c/b\u003e Contains the nuclei for cranial"
      }, {
        "text": " nerves \u003cb\u003eV (Trigeminal)\u003c/b\u003e, \u003cb\u003eVI (Abducens)\u003c/b\u003e, \u003cb\u003eVII"
      }, {
        "text": " (Facial)\u003c/b\u003e, and \u003cb\u003eVIII (Vestibulocochlear)\u003c/b\u003e. Mnemonic: 4"
      }, {
        "text": " nerves in the pons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Tracts:\u003c/b\u003e Contains ascending sensory tracts (medial lemniscus, spinothalamic"
      }, {
        "text": ") and descending motor tracts (corticospinal, corticobulbar).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpecialized Centers:\u003c/b\u003e Includes"
      }, {
        "text": " the pontine micturition center, and the Paramedian Pontine Reticular Formation (PPRF), which is"
      }, {
        "text": " the horizontal gaze center.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndromes:\u003c/b\u003e Lesions can cause specific syndromes. \u003cmark\u003eMed"
      }, {
        "text": "ial Pontine Syndrome\u003c/mark\u003e (basilar artery branches) affects corticospinal tracts and CN VI. \u003cmark\u003eLateral Pontine Syndrome"
      }, {
        "text": "\u003c/mark\u003e (AICA) affects CN V, VII, VIII, spinothalamic tract, and sympathetic fibers.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the \u0027Rule of 4s\u0027 for the brainstem: 4 cranial nerves are"
      }, {
        "text": " in the pons (V, VI, VII, VIII).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003ePons\u003c/b\u003e acts as a crucial bridge (\u0027pons\u0027 is Latin for bridge) connecting the cerebrum and cerebellum and"
      }, {
        "text": " houses the nuclei for key cranial nerves controlling facial sensation, movement, eye abduction, and hearing/balance.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\":"
      }, {
        "text": " \"brainstem\"\n      },\n      {\n        \"type\": \"contains_nuclei_of\",\n        \"to\": \"trigem"
      }, {
        "text": "inal_nerve\"\n      },\n      {\n        \"type\": \"contains_nuclei_of\","
      }, {
        "text": "\n        \"to\": \"dd11dde6\"\n      },\n      {\n        \"type\": \"contains_"
      }, {
        "text": "nuclei_of\",\n        \"to\": \"dea9755f\"\n      },\n      {\n        \"type\": \"contains"
      }, {
        "text": "_nuclei_of\",\n        \"to\": \"6fded3e7\"\n      }\n    "
      }, {
        "text": "]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"58c8ea03\",\n    \"letter\": \"P\",\n    \"term\": \"Parkinson disease\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Parkinson disease\",\n    \"sub_entries\": [\n      {\n        \"id\": \"a76c0171\",\n        \"letter\": \"P\",\n        \"term\": \"dream enactment\",\n        \"pages\": [\n          \"507\"\n        ],\n        \"context\": \"Parkinson disease \u003e dream enactment\"\n      },\n      {\n        \"id\": \"1c462c00\",\n        \"letter\": \"P\",\n        \"term\": \"neurotransmitter changes with\",\n        \"pages\": [\n          \"505\"\n        ],\n        \"context\": \"Parkinson disease \u003e neurotransmitter changes with\"\n      },\n      {\n        \"id\": \"d9c274ff\",\n        \"letter\": \"P\",\n        \"term\": \"symptoms and histologic findings\",\n        \"pages\": [\n          \"534\"\n        ],\n        \"context\": \"Parkinson disease \u003e symptoms and histologic findings\"\n      },\n      {\n        \"id\": \"afe103dc\",\n        \"letter\": \"P\",\n        \"term\": \"therapy\",\n        \"pages\": [\n          \"564\"\n        ],\n        \"context\": \"Parkinson disease \u003e therapy\"\n      },\n      {\n        \"id\": \"f376ea82\",\n        \"letter\": \"P\",\n        \"term\": \"therapy for\",\n        \"pages\": [\n          \"563\"\n        ],\n        \"context\": \"Parkinson disease \u003e therapy for\"\n      }\n    ]\n  },\n  {\n    \"id\": \"e46906ba\",\n    \"letter\": \"P\",\n    \"term\": \"Partial (focal) seizures\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Partial (focal) seizures\",\n    \"sub_entries\": [\n      {\n        \"id\": \"86eac3c0\",\n        \"letter\": \"P\",\n        \"term\": \"anticonvulsants for\",\n        \"pages\": [\n          \"560\"\n        ],\n        \"context\": \"Partial (focal) seizures \u003e anticonvulsants for\"\n      }\n    ]\n  },\n  {\n    \"id\": \"3847e263\",\n    \"letter\": \"P\",\n    \"term\": \"Patellar reflex\",\n    \"pages\": [\n      \"523\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Patellar reflex\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"23883b0a\",\n    \"letter\": \"P\",\n    \"term\": \"Pathology\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Pathology\",\n    \"sub_entries\": [\n      {\n        \"id\": \"b891c014\",\n        \"letter\": \"P\",\n        \"term\": \"neuronal\",\n        \"pages\": [\n          \"505\"\n        ],\n        \"context\": \"Pathology \u003e neuronal\"\n      }\n    ]\n  },\n  {\n    \"id\": \"fee9ef8f\",\n    \"letter\": \"P\",\n    \"term\": \"Pediatric patients\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Pediatric patients\",\n    \"sub_entries\": [\n      {\n        \"id\": \"9ef161ee\",\n        \"letter\": \"P\",\n        \"term\": \"causes of seizures in\",\n        \"pages\": [\n          \"531\"\n        ],\n        \"context\": \"Pediatric patients \u003e causes of seizures in\"\n      },\n      {\n        \"id\": \"474f7675\",\n        \"letter\": \"P\",\n        \"term\": \"intraventricular hemorrhage\",\n        \"pages\": [\n          \"527\"\n        ],\n        \"context\": \"Pediatric patients \u003e intraventricular hemorrhage\"\n      },\n      {\n        \"id\": \"a91e6d15\",\n        \"letter\": \"P\",\n        \"term\": \"leukocoria in\",\n        \"pages\": [\n          \"553\"\n        ],\n        \"context\": \"Pediatric patients \u003e leukocoria in\"\n      },\n      {\n        \"id\": \"85350c00\",\n        \"letter\": \"P\",\n        \"term\": \"primary brain tumors\",\n        \"pages\": [\n          \"542\"\n        ],\n        \"context\": \"Pediatric patients \u003e primary brain tumors\"\n      }\n    ]\n  },\n  {\n    \"id\": \"bcf1707c\",\n    \"letter\": \"P\",\n    \"term\": \"Pentobarbital\",\n    \"pages\": [\n      \"561\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Pentobarbital\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"12b3e1e3\",\n    \"letter\": \"P\",\n    \"term\": \"Pericytes\",\n    \"pages\": [\n      \"506\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Pericytes\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"ae1bcf9a\",\n    \"letter\": \"P\",\n    \"term\": \"Perineurium\",\n    \"pages\": [\n      \"505\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Perineurium\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"a1a54523\",\n    \"letter\": \"P\",\n    \"term\": \"Peripheral facial palsy\",\n    \"pages\": [\n      \"546\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Peripheral facial palsy\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"c44ae4c5\",\n    \"letter\": \"P\",\n    \"term\": \"Peripheral nervous system\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Peripheral nervous system\",\n    \"sub_entries\": [\n      {\n        \"id\": \"d3c4ede8\",\n        \"letter\": \"P\",\n        \"term\": \"glial cells\",\n        \"pages\": [\n          \"503\"\n        ],\n        \"context\": \"Peripheral nervous system \u003e glial cells\"\n      },\n      {\n        \"id\": \"1479faec\",\n        \"letter\": \"P\",\n        \"term\": \"nerve structures\",\n        \"pages\": [\n          \"505\"\n        ],\n        \"context\": \"Peripheral nervous system \u003e nerve structures\"\n      },\n      {\n        \"id\": \"1448eeed\",\n        \"letter\": \"P\",\n        \"term\": \"origins of\",\n        \"pages\": [\n          \"500\"\n        ],\n        \"context\": \"Peripheral nervous system \u003e origins of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"5811ad9e\",\n    \"letter\": \"P\",\n    \"term\": \"Peripheral vertigo\",\n    \"pages\": [\n      \"548\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Peripheral vertigo\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"d9286430\",\n    \"letter\": \"P\",\n    \"term\": \"Periventricular plaques\",\n    \"pages\": [\n      \"537\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Periventricular plaques\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"8f0081d5\",\n    \"letter\": \"P\",\n    \"term\": \"Pes cavus, Friedreich ataxia\",\n    \"pages\": [\n      \"545\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Pes cavus, Friedreich ataxia\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"c915f2d5\",\n    \"letter\": \"P\",\n    \"term\": \"Petit mal (absence) seizures\",\n    \"pages\": [\n      \"531\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Petit mal (absence) seizures\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"21cb9a14\",\n    \"letter\": \"P\",\n    \"term\": \"Phantom limb pain\",\n    \"pages\": [\n      \"529\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Phantom limb pain\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 2181
    }, {
      "text": "```json\n{\n  \"58c8ea03\": {\n    \"title\": \"Parkinson Disease\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Movement Disorders\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neurodegenerative Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eParkinson Disease\u003c/b\u003e is a progressive \u003ci\u003eneurodegenerative disorder\u003c/i\u003e caused by the loss of dopaminergic neurons in the \u003cb\u003esubstantia nigra pars compacta\u003c/b\u003e, leading to a characteristic syndrome of tremor, rigidity, bradykinesia, and postural instability.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Loss of [[90adc821|dopamine]]-producing neurons in the substantia nigra leads to decreased stimulation of the direct pathway and decreased inhibition of the indirect pathway in the [[ed462927|basal ganglia]], resulting in an overall inhibition of movement.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e Presence of intracellular eosinophilic inclusions called \u003cmark\u003eLewy bodies\u003c/mark\u003e (composed of Œ±-synuclein) within the remaining neurons of the substantia nigra.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Tetrad (TRAP):\u003c/b\u003e \u003cb\u003eT\u003c/b\u003eremor (pill-rolling, at rest), \u003cb\u003eR\u003c/b\u003eigidity (cogwheel or leadpipe), \u003cb\u003eA\u003c/b\u003ekinesia/bradykinesia (shuffling gait, micrographia), and \u003cb\u003eP\u003c/b\u003eostural instability.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter Changes:\u003c/b\u003e Significant decrease in [[90adc821|dopamine]] in the nigrostriatal pathway. Relative excess of [[6a005559|acetylcholine]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Symptomatic therapy aims to increase dopamine levels using agents like [[541cd176|Levodopa/Carbidopa]], dopamine agonists (e.g., pramipexole), and MAO-B inhibitors (e.g., [[2883864d|rasagiline]]). Antimuscarinics (e.g., benztropine) can help with tremor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of a resting tremor, shuffling gait, and cogwheel rigidity in an older patient is classic for Parkinson disease. The pathological hallmark is the Lewy body.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eParkinson Disease\u003c/b\u003e is fundamentally a disorder of dopamine deficiency in the basal ganglia, leading to an over-inhibition of movement. Therapeutic strategies are all centered on restoring this dopaminergic tone, either by replacing dopamine, mimicking its effects, or preventing its breakdown.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Loss of Dopaminergic Neurons in Substantia Nigra] --\u003e B(Decreased Dopamine); B --\u003e C(Basal Ganglia Dysfunction); C --\u003e D(Inhibition of Movement); D --\u003e E(TRAP Symptoms);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"involves_degeneration_of\",\n        \"to\": \"substantia_nigra\"\n      },\n      {\n        \"type\": \"involves_deficiency_of\",\n        \"to\": \"90adc821\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\": \"lewy_bodies\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"541cd176\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"2883864d\"\n      }\n    ]\n  },\n  \"e46906ba\": {\n    \"title\": \"Focal Seizures (Partial Seizures)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Epilepsy\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFocal seizures\u003c/b\u003e, formerly known as partial seizures, are epileptic events that originate within a localized network of neurons in \u003ci\u003eone cerebral hemisphere\u003c/i\u003e. Their clinical manifestations depend on the specific cortical area involved.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFocal Aware Seizure (Simple Partial):\u003c/b\u003e Consciousness is fully maintained. Symptoms can be motor (e.g., jerking of a limb - Jacksonian march), sensory (e.g., paresthesias), autonomic (e.g., epigastric rising sensation), or psychic (e.g., d√©j√† vu).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFocal Impaired Awareness Seizure (Complex Partial):\u003c/b\u003e Consciousness is altered or lost. Often preceded by an aura (which is itself a focal aware seizure). Characterized by \u003cmark\u003eautomatisms\u003c/mark\u003e (e.g., lip smacking, chewing, fumbling with clothes). A postictal state of confusion is common.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e The \u003cmark\u003etemporal lobe\u003c/mark\u003e is the most common site of origin for focal impaired awareness seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSecondary Generalization:\u003c/b\u003e A focal seizure can spread to involve both hemispheres, evolving into a bilateral tonic-clonic seizure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Treated with \u003cmark\u003enarrow-spectrum anticonvulsants\u003c/mark\u003e such as [[eddd2bc5|carbamazepine]], [[5aea213f|phenytoin]], or lamotrigine. Broad-spectrum agents like levetiracetam or valproic acid are also effective.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe key distinction in \u003cb\u003efocal seizures\u003c/b\u003e is the state of awareness: if the patient remains fully aware and interactive, it is a focal aware seizure; if awareness is impaired, it is a focal impaired awareness seizure, which is often associated with temporal lobe origin and automatisms.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Focal Seizure]; A --\u003e B{Awareness}; B --Intact--\u003e C(Focal Aware Seizure); B --Impaired--\u003e D(Focal Impaired Awareness Seizure); A --Can spread to--\u003e E(Secondarily Generalized Seizure);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"f91a0cfa\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"eddd2bc5\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"5aea213f\"\n      }\n    ]\n  },\n  \"3847e263\": {\n    \"title\": \"Patellar Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003ePatellar Reflex\u003c/b\u003e, also known as the knee-jerk reflex, is a deep tendon reflex that involves contraction of the quadriceps femoris muscle and extension of the leg in response to tapping the patellar tendon, testing the integrity of the \u003cmark\u003eL2-L4\u003c/mark\u003e spinal nerve roots.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNerve Roots:\u003c/b\u003e Primarily tests the \u003cb\u003eL4\u003c/b\u003e nerve root, with contributions from L2 and L3. Mnemonic: L2, 3, \u003cb\u003e4\u003c/b\u003e, kick the door.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Tapping the tendon stretches the quadriceps muscle, activating muscle spindle stretch receptors. The afferent signal travels via the femoral nerve to the L2-L4 spinal cord segments, synapses on an alpha motor neuron, and an efferent motor signal returns via the femoral nerve to cause quadriceps contraction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiminished/Absent Reflex:\u003c/b\u003e Suggests a lower motor neuron lesion, such as a herniated disc compressing the L4 root, or peripheral neuropathy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eExaggerated Reflex (Hyperreflexia):\u003c/b\u003e Suggests an upper motor neuron lesion, such as a stroke or spinal cord injury above the L2-L4 level.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e This is one of the most commonly tested reflexes. Its absence can be a key sign of an L4 radiculopathy, which also presents with weakness of knee extension and sensory loss over the medial lower leg.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003ePatellar Reflex\u003c/b\u003e is a monosynaptic stretch reflex that provides a rapid and reliable clinical assessment of the L4 spinal segment and its peripheral connections; an abnormal response is a crucial indicator of either upper or lower motor neuron pathology.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Tap Patellar Tendon] --\u003e B(Stretch Quadriceps); B --\u003e C(Afferent Signal via Femoral N.); C --\u003e D[L2-L4 Spinal Cord]; D --\u003e E(Efferent Signal via Femoral N.); E --\u003e F(Quadriceps Contraction/Leg Extension);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"tests_nerve_root\",\n        \"to\": \"l4_nerve_root\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"deep_tendon_reflex\"\n      },\n      {\n        \"type\": \"is_absent_in\",\n        \"to\": \"lumbosacral_radiculopathy\"\n      }\n    ]\n  },\n  \"23883b0a\": {\n    \"title\": \"Neuronal Pathology\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Histology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cellular Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeuronal pathology\u003c/b\u003e describes the structural and functional changes that occur in neurons in response to injury, ischemia, or degenerative processes, which can be identified through characteristic histological findings.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAcute Neuronal Injury (\\\"Red Neurons\\\"):\u003c/b\u003e Seen 12-24 hours after an irreversible hypoxic/ischemic insult. Characterized by intense eosinophilic (red) cytoplasm, pyknotic (shrunken, dark) nucleus, and loss of Nissl substance.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAxonal Reaction (Central Chromatolysis):\u003c/b\u003e The response of a neuron\u0027s cell body to axonal injury. Characterized by cell body swelling, dispersion of Nissl substance to the periphery (chromatolysis), and displacement of the nucleus to the periphery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeuronal Atrophy/Degeneration:\u003c/b\u003e A slow process of neuronal death seen in neurodegenerative diseases like [[77ae6148|Alzheimer\u0027s]] or [[58c8ea03|Parkinson\u0027s]]. Results in neuronal loss and reactive gliosis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeuronal Inclusions:\u003c/b\u003e Accumulation of abnormal proteins or structures within neurons, which are often hallmarks of specific diseases. Examples include \u003cmark\u003eLewy bodies\u003c/mark\u003e in Parkinson\u0027s, \u003cmark\u003eneurofibrillary tangles\u003c/mark\u003e in Alzheimer\u0027s, and \u003cmark\u003eNegri bodies\u003c/mark\u003e in rabies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The appearance of \\\"red neurons\\\" on histology is a key indicator of irreversible ischemic brain injury that occurred at least 12-24 hours prior.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe histological appearance of a neuron provides a timeline and etiology of CNS injury; from the acute eosinophilia of \\\"red neurons\\\" in stroke to the chronic accumulation of protein aggregates in neurodegenerative diseases, the neuron\u0027s morphology tells the story of its pathology.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"red_neurons\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"axonal_reaction\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"lewy_bodies\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"neurofibrillary_tangles\"\n      }\n    ]\n  },\n  \"fee9ef8f\": {\n    \"title\": \"Pediatric Neurological Disorders\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pediatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Pediatric Neurology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePediatric neurological disorders\u003c/b\u003e encompass a wide range of conditions affecting the brain, spinal cord, and peripheral nerves in infants and children, including congenital malformations, genetic syndromes, seizures, and tumors.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSeizures:\u003c/b\u003e [[12108f05|Febrile seizures]] are common and benign. [[a0c128f4|Absence seizures]] present as staring spells. Infantile spasms are another important type.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrimary Brain Tumors:\u003c/b\u003e Unlike in adults, pediatric brain tumors are most commonly located in the \u003cmark\u003einfratentorial\u003c/mark\u003e space (posterior fossa). The most common is the [[912187bd|pilocytic astrocytoma]], followed by [[16d613bb|medulloblastoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eIntraventricular Hemorrhage:\u003c/b\u003e A common complication in premature infants, originating from the fragile germinal matrix.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLeukocoria (\\\"White Pupil\\\"):\u003c/b\u003e A critical sign in a child that can indicate serious pathology, most notably [[63b964af|retinoblastoma]] or congenital cataracts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurocutaneous Disorders:\u003c/b\u003e Conditions like [[83302339|Tuberous Sclerosis]] and [[015a73ab|Neurofibromatosis]] often present with neurological symptoms (seizures, developmental delay) in childhood.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe landscape of neurological disorders in children is distinct from that in adults, with a predominance of congenital and genetic conditions, and a different spectrum and location of brain tumors, making developmental history and age-specific presentations key to diagnosis.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"7f8bdf0b\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"f1695e4c\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"912babcc\"\n      }\n    ]\n  },\n  \"bcf1707c\": {\n    \"title\": \"Pentobarbital\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Sedative-Hypnotics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePentobarbital\u003c/b\u003e is a short- to intermediate-acting \u003ci\u003ebarbiturate\u003c/i\u003e used as a sedative, hypnotic, and anticonvulsant, and for inducing comas in cases of severe brain injury to reduce metabolic rate and intracranial pressure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Potentiates the effect of [[5aa5cb91|GABA]] at the GABA\u003csub\u003eA\u003c/sub\u003e receptor by \u003cmark\u003eincreasing the duration\u003c/mark\u003e of Cl\u003csup\u003e-\u003c/sup\u003e channel opening, leading to prolonged neuronal hyperpolarization.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Historically used for insomnia and anxiety, but largely replaced by benzodiazepines due to a narrower therapeutic index. Currently used for status epilepticus refractory to other agents and to induce a \u0027barbiturate coma\u0027 for managing refractory increased intracranial pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Significant risk of \u003cmark\u003erespiratory and cardiovascular depression\u003c/mark\u003e, which can be fatal in overdose. High potential for tolerance, dependence, and abuse.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Induces cytochrome P450 enzymes, leading to drug interactions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Like all barbiturates, there is \u003cu\u003eno reversal agent\u003c/u\u003e for pentobarbital overdose; treatment is purely supportive (airway management, blood pressure support).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePentobarbital\u003c/b\u003e is a powerful CNS depressant that enhances GABAergic inhibition by increasing the duration of chloride channel opening, a mechanism that provides potent sedation and seizure control but also carries a high risk of fatal respiratory depression, especially in overdose.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"barbiturate\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"status_epilepticus\"\n      },\n      {\n        \"type\": \"potentiates\",\n        \"to\": \"5aa5cb91\"\n      },\n      {\n        \"type\": \"induces\",\n        \"to\": \"cytochrome_p450\"\n      }\n    ]\n  },\n  \"12b3e1e3\": {\n    \"title\": \"Pericytes\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Histology\",\n      \"Vascular\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Microvasculature\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePericytes\u003c/b\u003e are multi-functional mural cells that wrap around the endothelial cells of capillaries and venules throughout the body, playing a crucial role in angiogenesis, vessel stabilization, and the maintenance of the blood-brain barrier.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Embedded within the basement membrane of capillaries and post-capillary venules, in direct contact with endothelial cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction (Blood-Brain Barrier):\u003c/b\u003e Pericytes are essential for the formation and maintenance of the [[dd47b9cc|blood-brain barrier (BBB)]]. They regulate endothelial transcytosis and the expression of tight junction proteins.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction (Blood Flow):\u003c/b\u003e Possess contractile properties, allowing them to regulate capillary diameter and local blood flow.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology (Diabetic Retinopathy):\u003c/b\u003e Degeneration and loss of retinal pericytes is one of the earliest pathological changes in [[73b00ab0|diabetic retinopathy]]. This loss leads to capillary microaneurysm formation, vessel instability, and breakdown of the blood-retinal barrier.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The loss of pericytes is a key initiating event in the pathogenesis of [[73b00ab0|diabetic retinopathy]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePericytes\u003c/b\u003e are the gatekeepers of the microvasculature, particularly in the brain, where their intimate association with endothelial cells is fundamental to the integrity of the [[dd47b9cc|blood-brain barrier]]; their loss in diabetes precipitates the vascular leakage and damage seen in diabetic retinopathy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_component_of\",\n        \"to\": \"dd47b9cc\"\n      },\n      {\n        \"type\": \"degeneration_contributes_to\",\n        \"to\": \"73b00ab0\"\n      },\n      {\n        \"type\": \"regulates\",\n        \"to\": \"capillary_blood_flow\"\n      }\n    ]\n  },\n  \"ae1bcf9a\": {\n    \"title\": \"Perineurium\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Histology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Peripheral Nervous System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003ePerineurium\u003c/b\u003e is the layer of connective tissue that bundles groups of axons into fascicles within a peripheral nerve. It forms the blood-nerve barrier, a physiologically important structure that protects the nerve fibers.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Composed of layers of flattened, fibroblast-like cells that are joined by tight junctions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Bundles axons into fascicles. The tight junctions between perineurial cells form the \u003cmark\u003eblood-nerve barrier\u003c/mark\u003e, which maintains a stable ionic environment for the nerve fibers and protects them from toxins, pathogens, and inflammation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLayers of a Peripheral Nerve:\u003c/b\u003e From outermost to innermost: \u003cb\u003eEpineurium\u003c/b\u003e (surrounds the entire nerve) -\u003e \u003cb\u003ePerineurium\u003c/b\u003e (surrounds a fascicle) -\u003e \u003cb\u003eEndoneurium\u003c/b\u003e (surrounds an individual myelinated axon).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e The perineurium must be re-approximated in microsurgical nerve repair to ensure proper axonal regeneration within the fascicles. It can be invaded by tumors (perineural invasion).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The perineurium is analogous to the arachnoid mater of the CNS in that it forms a crucial barrier (blood-nerve barrier vs. blood-CSF barrier).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003ePerineurium\u003c/b\u003e is more than just a wrapping for nerve fascicles; its specialized cells and tight junctions create the essential blood-nerve barrier, protecting the delicate microenvironment of the axons from systemic fluctuations and toxins.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Peripheral Nerve] --\u003e B(Epineurium); B --\u003e C(Fascicle); C --\u003e D(Perineurium); D --\u003e E(Axon); E --\u003e F(Endoneurium);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"peripheral_nerve\"\n      },\n      {\n        \"type\": \"forms\",\n        \"to\": \"03ba9967\"\n      },\n      {\n        \"type\": \"surrounds\",\n        \"to\": \"nerve_fascicle\"\n      }\n    ]\n  },\n  \"a1a54523\": {\n    \"title\": \"Peripheral Facial Palsy\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cranial Neuropathies\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePeripheral facial palsy\u003c/b\u003e is a lower motor neuron (LMN) lesion of the [[dea9755f|facial nerve (CN VII)]] that results in paralysis of all muscles of facial expression on the \u003ci\u003eipsilateral\u003c/i\u003e side of the face, including the forehead.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Unilateral facial paralysis affecting both the upper and lower face. Patients are unable to raise their eyebrow, wrinkle their forehead, or close their eye tightly on the affected side. They also exhibit a drooping corner of the mouth and a flattened nasolabial fold.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e The most common cause is Bell\u0027s palsy (idiopathic, presumed viral). Other causes include [[09fa1b0f|Ramsay Hunt syndrome]] (VZV), Lyme disease, tumors (e.g., [[03ecb69e|schwannoma]]), and trauma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction from Central Lesion:\u003c/b\u003e A central (upper motor neuron) facial palsy, caused by a stroke, spares the forehead muscles. This is because the upper face receives bilateral cortical innervation, while the lower face receives only contralateral innervation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Symptoms:\u003c/b\u003e Depending on the location of the lesion along CN VII, may also have decreased tearing, hyperacusis (due to stapedius muscle paralysis), and loss of taste from the anterior two-thirds of the tongue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to differentiating a peripheral from a central facial palsy is the forehead. If the patient \u003cu\u003ecan\u003c/u\u003e wrinkle their forehead, the lesion is central (UMN). If they \u003cu\u003ecannot\u003c/u\u003e, the lesion is peripheral (LMN).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eperipheral facial palsy\u003c/b\u003e is a definitive lower motor neuron sign affecting the entire ipsilateral face, including the forehead. This complete hemifacial paralysis is the crucial feature that distinguishes it from the forehead-sparing weakness of a central (UMN) lesion like a stroke.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[LMN Lesion of CN VII] --\u003e B(Peripheral Facial Palsy); B --\u003e C(Paralysis of Ipsilateral Upper \u0026 Lower Face); D[UMN Lesion e.g., Stroke] --\u003e E(Central Facial Palsy); E --\u003e F(Paralysis of Contralateral Lower Face ONLY);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_lesion_of\",\n        \"to\": \"dea9755f\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"lower_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"central_facial_palsy\"\n      },\n      {\n        \"type\": \"is_the_main_finding_in\",\n        \"to\": \"bells_palsy\"\n      }\n    ]\n  },\n  \"c44ae4c5\": {\n    \"title\": \"Peripheral Nervous System (PNS)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Overview\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003ePeripheral Nervous System (PNS)\u003c/b\u003e consists of all nervous tissue outside of the central nervous system (brain and spinal cord), including cranial nerves (III-XII), spinal nerves, ganglia, and sensory receptors. It serves as the communication relay between the CNS and the rest of the body.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e Cranial nerves and their ganglia, spinal nerves and their dorsal root ganglia, autonomic nerves and ganglia, and the enteric nervous system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGlial Cells:\u003c/b\u003e The main supporting cells are [[c65a8909|Schwann cells]] (which form myelin sheaths) and satellite cells (which support neuron cell bodies in ganglia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eEmbryonic Origin:\u003c/b\u003e Most components of the PNS, including neurons and glial cells, are derived from the \u003cmark\u003eneural crest\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNerve Structure:\u003c/b\u003e Peripheral nerves are composed of bundles of axons (fascicles). Each axon is surrounded by endoneurium, each fascicle by [[ae1bcf9a|perineurium]], and the entire nerve by epineurium.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Diseases of the PNS are called peripheral neuropathies, which can be demyelinating (e.g., [[ed52e40b|Guillain-Barr√© syndrome]]) or axonal (e.g., diabetic neuropathy).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003ePeripheral Nervous System\u003c/b\u003e is the extensive network of nerves and ganglia that connects the central nervous system to the limbs and organs, with its neurons and glial cells primarily originating from the versatile neural crest during embryonic development.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_supported_by\",\n        \"to\": \"c65a8909\"\n      },\n      {\n        \"type\": \"is_supported_by\",\n        \"to\": \"satellite_cells\"\n      },\n      {\n        \"type\": \"derives_from\",\n        \"to\": \"neural_crest\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"cranial_nerves\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"spinal_nerves\"\n      }\n    ]\n  },\n  \"5811ad9e\": {\n    \"title\": \"Peripheral Vertigo\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Otology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePeripheral vertigo\u003c/b\u003e is a sensation of spinning or dizziness that originates from a problem within the \u003ci\u003einner ear or the vestibulocochlear nerve (CN VIII)\u003c/i\u003e, which are parts of the peripheral vestibular system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Common causes include Benign Paroxysmal Positional Vertigo (BPPV), Vestibular Neuritis/Labyrinthitis, and [[6f2228c1|M√©ni√®re disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Characterized by sudden, intense episodes of vertigo, often triggered by head movements. Nausea and vomiting are common.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNystagmus:\u003c/b\u003e Typically presents with a \u003cmark\u003ehorizontal or torsional (rotary) nystagmus\u003c/mark\u003e that is unidirectional and fatigable. It is suppressed by visual fixation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Symptoms:\u003c/b\u003e May be accompanied by hearing loss and/or tinnitus if the cochlea or cochlear nerve is also affected (e.g., in M√©ni√®re disease or labyrinthitis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction from Central Vertigo:\u003c/b\u003e Unlike [[350f1c8b|central vertigo]], it is not associated with other brainstem signs like dysarthria, dysphagia, or limb ataxia. The nystagmus is rarely purely vertical.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The Dix-Hallpike maneuver is used to diagnose BPPV. A positive test (reproduction of vertigo and torsional nystagmus after a short delay) is characteristic of peripheral vertigo.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePeripheral vertigo\u003c/b\u003e is an inner ear problem, not a brain problem. Its key features are intense, episodic spinning, often with nausea, and a characteristic horizontal/torsional nystagmus, without the additional \u0027red flag\u0027 neurological signs seen in central vertigo.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"benign_paroxysmal_positional_vertigo\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"6f2228c1\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"vestibular_neuritis\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"350f1c8b\"\n      }\n    ]\n  },\n  \"d9286430\": {\n    \"title\": \"Periventricular Plaques\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Radiology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePeriventricular plaques\u003c/b\u003e are focal areas of demyelination and gliosis located in the white matter adjacent to the lateral ventricles of the brain. They are the most characteristic radiological finding in \u003ci\u003eMultiple Sclerosis (MS)\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance on MRI:\u003c/b\u003e On T2-weighted and FLAIR MRI sequences, they appear as \u003cmark\u003ehyperintense (bright) ovoid lesions\u003c/mark\u003e oriented perpendicular to the ventricles. This orientation follows the path of the deep medullary veins and is sometimes referred to as \u0027Dawson\u0027s fingers.\u0027\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e The plaques represent areas where autoimmune inflammation has destroyed [[a24f9747|oligodendrocytes]] and their myelin sheaths, which is then replaced by an astrocytic scar (gliosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e The presence of periventricular plaques is a key component of the McDonald criteria for diagnosing [[45dd6d19|Multiple Sclerosis]]. Their distribution helps fulfill the criterion of \u0027dissemination in space.\u0027\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e While periventricular is the classic location, MS plaques can also be found in juxtacortical, infratentorial, and spinal cord locations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An MRI showing multiple hyperintense lesions in the periventricular white matter, especially in a young woman with relapsing neurological symptoms, is pathognomonic for [[45dd6d19|Multiple Sclerosis]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePeriventricular plaques\u003c/b\u003e are the radiological signature of [[45dd6d19|Multiple Sclerosis]], representing focal scars of demyelination that cluster around the ventricles and serve as the primary imaging evidence for the diagnosis.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"are_composed_of\",\n        \"to\": \"demyelination_and_gliosis\"\n      },\n      {\n        \"type\": \"are_best_visualized_by\",\n        \"to\": \"mri\"\n      }\n    ]\n  },\n  \"8f0081d5\": {\n    \"title\": \"Pes Cavus in Friedreich Ataxia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Genetics\",\n      \"Orthopedics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neurodegenerative Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePes cavus\u003c/b\u003e is a foot deformity characterized by an abnormally high plantar arch, which is a classic musculoskeletal finding in patients with \u003ci\u003eFriedreich Ataxia\u003c/i\u003e, resulting from chronic neuromuscular imbalance.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e In [[39bc1763|Friedreich Ataxia]], degeneration of peripheral nerves and spinal cord tracts leads to an imbalance between the intrinsic and extrinsic muscles of the foot, causing the arch to become excessively high.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Condition:\u003c/b\u003e [[39bc1763|Friedreich Ataxia]] is an autosomal recessive trinucleotide repeat (GAA) disorder affecting the frataxin gene, leading to progressive neurodegeneration.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Clinical Features of Friedreich Ataxia:\u003c/b\u003e Besides pes cavus, patients present with progressive gait and limb ataxia, dysarthria, loss of deep tendon reflexes, loss of proprioception/vibration sense, and hypertrophic cardiomyopathy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Foot Deformities:\u003c/b\u003e Hammer toes are also commonly seen in conjunction with pes cavus in this condition.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of neurological symptoms (ataxia, areflexia) with non-neurological findings like hypertrophic cardiomyopathy and skeletal deformities (pes cavus, kyphoscoliosis) is highly suggestive of [[39bc1763|Friedreich Ataxia]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePes cavus\u003c/b\u003e in the context of [[39bc1763|Friedreich Ataxia]] is not an isolated orthopedic issue but a direct consequence of the underlying neurodegeneration, serving as a key physical exam clue to this multisystem genetic disorder.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_finding_in\",\n        \"to\": \"39bc1763\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"foot_deformity\"\n      },\n      {\n        \"type\": \"is_also_seen_in\",\n        \"to\": \"c3f13d85\"\n      }\n    ]\n  },\n  \"c915f2d5\": {\n    \"title\": \"Absence Seizures (Petit Mal)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pediatrics\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAbsence seizures\u003c/b\u003e, formerly known as \u003ci\u003epetit mal seizures\u003c/i\u003e, are a type of generalized seizure characterized by a sudden, brief lapse of consciousness without loss of postural tone, typically lasting for seconds. They are most common in childhood and are often mistaken for daydreaming or inattentiveness.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden cessation of activity with a blank stare, lasting about 10 seconds. May be accompanied by subtle automatisms like eyelid fluttering or lip smacking. There is \u003cu\u003eno postictal confusion\u003c/u\u003e; the patient immediately returns to baseline.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEEG Hallmark:\u003c/b\u003e The pathognomonic finding is a \u003cmark\u003egeneralized 3 Hz spike-and-wave discharge\u003c/mark\u003e on EEG.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProvocation:\u003c/b\u003e Seizures can often be triggered by \u003cmark\u003ehyperventilation\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e \u003cu\u003eFirst-line\u003c/u\u003e treatment is [[a90f6fb4|Ethosuximide]]. [[valproic_acid|Valproic acid]] is also effective and used if tonic-clonic seizures are also present.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A classic vignette describes a child whose teacher complains of \u0027daydreaming\u0027 or \u0027not paying attention\u0027 in class. The diagnosis is confirmed by a 3 Hz spike-and-wave pattern on EEG, often induced by having the child hyperventilate.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAbsence seizures\u003c/b\u003e are unique among generalized seizures for their brief, non-convulsive nature, lack of postictal confusion, and a pathognomonic \u003cmark\u003e3 Hz spike-and-wave\u003c/mark\u003e EEG pattern, making [[a90f6fb4|Ethosuximide]] the specific and preferred treatment.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Thalamic T-type Ca2+ Channels] -- Overactivity --\u003e B(Absence Seizure); C(Ethosuximide) -- Blocks --\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"a90f6fb4\"\n      },\n      {\n        \"type\": \"presents_with_eeg_finding\",\n        \"to\": \"eeg_3hz_spike_wave\"\n      }\n    ]\n  },\n  \"21cb9a14\": {\n    \"title\": \"Phantom Limb Pain\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pain Management\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Pain Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePhantom limb pain\u003c/b\u003e is a form of neuropathic pain perceived as originating from a part of the body that has been amputated. The sensations can range from cramping and aching to burning or electric shock-like pain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The exact mechanism is complex and not fully understood, but it is believed to involve \u003cmark\u003ecentral cortical reorganization\u003c/mark\u003e. The area of the somatosensory cortex that previously represented the amputated limb is remapped and can be activated by input from adjacent cortical areas, leading to the perception of pain.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePeripheral Component:\u003c/b\u003e Changes in the peripheral nerves at the amputation stump (e.g., neuroma formation) can also contribute by generating ectopic signals.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Pain is perceived in the missing limb. It is distinct from stump pain, which is localized to the residual limb.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management is challenging and multimodal. Options include pharmacotherapy (anticonvulsants like gabapentin, TCAs, NSAIDs), mirror therapy, and nerve stimulation techniques.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key concept is cortical plasticity and reorganization in the somatosensory cortex as the underlying mechanism for phantom limb pain.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePhantom limb pain\u003c/b\u003e is a powerful clinical example of neuroplasticity, where the brain\u0027s map of the body (the homunculus) reorganizes after amputation, leading to the paradoxical and often distressing sensation of pain in a limb that no longer exists.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"neuropathic_pain\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"cortical_reorganization\"\n      },\n      {\n        \"type\": \"occurs_after\",\n        \"to\": \"amputation\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9716,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"58c8ea03\": {\n    \"title\": \""
      }, {
        "text": "Parkinson Disease\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Movement"
      }, {
        "text": " Disorders\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and"
      }, {
        "text": " Special Senses\",\n      \"Pathology\",\n      \"Neurodegenerative Disorders\"\n    ],\n    \"content\": {"
      }, {
        "text": "\n      \"definition\": \"\u003cp\u003e\u003cb\u003eParkinson Disease\u003c/b\u003e is a progressive \u003ci\u003eneurodegenerative disorder\u003c/i\u003e caused by the"
      }, {
        "text": " loss of dopaminergic neurons in the \u003cb\u003esubstantia nigra pars compacta\u003c/b\u003e, leading to a characteristic syndrome"
      }, {
        "text": " of tremor, rigidity, bradykinesia, and postural instability.\u003c/p\u003e\",\n      \"atAGlance\": \""
      }, {
        "text": "\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Loss of [[90adc821|dopamine]]-producing neurons in the substantia nigra leads"
      }, {
        "text": " to decreased stimulation of the direct pathway and decreased inhibition of the indirect pathway in the [[ed462927"
      }, {
        "text": "|basal ganglia]], resulting in an overall inhibition of movement.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e Presence of intracellular eosin"
      }, {
        "text": "ophilic inclusions called \u003cmark\u003eLewy bodies\u003c/mark\u003e (composed of Œ±-synuclein) within the remaining"
      }, {
        "text": " neurons of the substantia nigra.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Tetrad (TRAP):\u003c/b\u003e \u003cb\u003eT\u003c/b\u003eremor (pill"
      }, {
        "text": "-rolling, at rest), \u003cb\u003eR\u003c/b\u003eigidity (cogwheel or leadpipe), \u003cb\u003eA\u003c/b\u003ek"
      }, {
        "text": "inesia/bradykinesia (shuffling gait, micrographia), and \u003cb\u003eP\u003c/b\u003eostural instability."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter Changes:\u003c/b\u003e Significant decrease in [[90adc821|dopamine]] in the"
      }, {
        "text": " nigrostriatal pathway. Relative excess of [[6a005559|acetylcholine]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Sympt"
      }, {
        "text": "omatic therapy aims to increase dopamine levels using agents like [[541cd176|Levodopa/Carbidopa]],"
      }, {
        "text": " dopamine agonists (e.g., pramipexole), and MAO-B inhibitors (e.g., [[2"
      }, {
        "text": "883864d|rasagiline]]). Antimuscarinics (e.g., benztrop"
      }, {
        "text": "ine) can help with tremor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of a resting tremor, shuffling gait, and cog"
      }, {
        "text": "wheel rigidity in an older patient is classic for Parkinson disease. The pathological hallmark is the Lewy body.\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eParkinson Disease\u003c/b\u003e is fundamentally a disorder of dopamine deficiency in the basal ganglia, leading to an"
      }, {
        "text": " over-inhibition of movement. Therapeutic strategies are all centered on restoring this dopaminergic tone, either by replacing dopamine"
      }, {
        "text": ", mimicking its effects, or preventing its breakdown.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Loss of Dop"
      }, {
        "text": "aminergic Neurons in Substantia Nigra] --\u003e B(Decreased Dopamine); B --\u003e C(Bas"
      }, {
        "text": "al Ganglia Dysfunction); C --\u003e D(Inhibition of Movement); D --\u003e E(TRAP Symptoms);\"\n    },\n"
      }, {
        "text": "    \"connections\": [\n      {\n        \"type\": \"involves_degeneration_of\",\n        \"to"
      }, {
        "text": "\": \"substantia_nigra\"\n      },\n      {\n        \"type\": \"involves_"
      }, {
        "text": "deficiency_of\",\n        \"to\": \"90adc821\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_characterized_by\",\n        \"to\": \"lewy_bodies\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_treated_by\",\n        \"to\": \"541cd176"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\":"
      }, {
        "text": " \"2883864d\"\n      }\n    ]\n  },\n  \"e469"
      }, {
        "text": "06ba\": {\n    \"title\": \"Focal Seizures (Partial Seizures)\",\n    \"primaryType"
      }, {
        "text": "\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Epilepsy\",\n      \"Pathology"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eF"
      }, {
        "text": "ocal seizures\u003c/b\u003e, formerly known as partial seizures, are epileptic events that originate within a localized network of neurons in \u003ci\u003eone cerebral hemisphere\u003c/i\u003e."
      }, {
        "text": " Their clinical manifestations depend on the specific cortical area involved.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eF"
      }, {
        "text": "ocal Aware Seizure (Simple Partial):\u003c/b\u003e Consciousness is fully maintained. Symptoms can be motor (e.g., jerking of"
      }, {
        "text": " a limb - Jacksonian march), sensory (e.g., paresthesias), autonomic (e.g., epig"
      }, {
        "text": "astric rising sensation), or psychic (e.g., d√©j√† vu).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFocal Impaired Awareness Seizure (Complex Partial):\u003c/b\u003e Consciousness"
      }, {
        "text": " is altered or lost. Often preceded by an aura (which is itself a focal aware seizure). Characterized by \u003cmark\u003eautomat"
      }, {
        "text": "isms\u003c/mark\u003e (e.g., lip smacking, chewing, fumbling with clothes). A postictal state of"
      }, {
        "text": " confusion is common.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e The \u003cmark\u003etemporal lobe\u003c/mark\u003e is the most common site"
      }, {
        "text": " of origin for focal impaired awareness seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSecondary Generalization:\u003c/b\u003e A focal seizure can spread to involve both"
      }, {
        "text": " hemispheres, evolving into a bilateral tonic-clonic seizure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Treated with \u003cmark\u003enarrow"
      }, {
        "text": "-spectrum anticonvulsants\u003c/mark\u003e such as [[eddd2bc5|carbamazepine]], [[5aea"
      }, {
        "text": "213f|phenytoin]], or lamotrigine. Broad-spectrum agents like levetiracetam or valproic"
      }, {
        "text": " acid are also effective.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe key distinction in \u003cb\u003efocal seizures\u003c/b\u003e is the state"
      }, {
        "text": " of awareness: if the patient remains fully aware and interactive, it is a focal aware seizure; if awareness is impaired, it is a focal impaired"
      }, {
        "text": " awareness seizure, which is often associated with temporal lobe origin and automatisms.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A"
      }, {
        "text": "[Focal Seizure]; A --\u003e B{Awareness}; B --Intact--\u003e C(Focal Aware Seizure);"
      }, {
        "text": " B --Impaired--\u003e D(Focal Impaired Awareness Seizure); A --Can spread to--\u003e E(Second"
      }, {
        "text": "arily Generalized Seizure);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"64c08e92\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_treated_by\",\n        \"to\": \"f91a0c"
      }, {
        "text": "fa\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to"
      }, {
        "text": "\": \"eddd2bc5\"\n      },\n      {\n        \"type\": \"is_treated_"
      }, {
        "text": "by\",\n        \"to\": \"5aea213f\"\n      }\n    ]\n  },\n  \"38"
      }, {
        "text": "47e263\": {\n    \"title\": \"Patellar Reflex\",\n    \"primaryType\": \""
      }, {
        "text": "physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Phys"
      }, {
        "text": "iology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003eThe \u003cb\u003ePatellar Reflex\u003c/b\u003e, also known as the knee-jerk reflex, is a deep tendon"
      }, {
        "text": " reflex that involves contraction of the quadriceps femoris muscle and extension of the leg in response to tapping the patellar tendon, testing"
      }, {
        "text": " the integrity of the \u003cmark\u003eL2-L4\u003c/mark\u003e spinal nerve roots.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNerve Roots:\u003c/b\u003e Primarily tests the \u003cb\u003eL4\u003c/b\u003e nerve root, with contributions from L2 and"
      }, {
        "text": " L3. Mnemonic: L2, 3, \u003cb\u003e4\u003c/b\u003e, kick the door.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway"
      }, {
        "text": ":\u003c/b\u003e Tapping the tendon stretches the quadriceps muscle, activating muscle spindle stretch receptors. The afferent signal travels via the femoral nerve to"
      }, {
        "text": " the L2-L4 spinal cord segments, synapses on an alpha motor neuron, and an efferent motor signal returns"
      }, {
        "text": " via the femoral nerve to cause quadriceps contraction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiminished/Absent Reflex:\u003c/b\u003e Suggests a lower"
      }, {
        "text": " motor neuron lesion, such as a herniated disc compressing the L4 root, or peripheral neuropathy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEx"
      }, {
        "text": "aggerated Reflex (Hyperreflexia):\u003c/b\u003e Suggests an upper motor neuron lesion, such as a stroke or spinal cord injury above the L2"
      }, {
        "text": "-L4 level.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e This is one of the most commonly tested reflexes. Its"
      }, {
        "text": " absence can be a key sign of an L4 radiculopathy, which also presents with weakness of knee extension and sensory loss over"
      }, {
        "text": " the medial lower leg.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003ePatellar Reflex\u003c/b\u003e is a monos"
      }, {
        "text": "ynaptic stretch reflex that provides a rapid and reliable clinical assessment of the L4 spinal segment and its peripheral connections; an abnormal response"
      }, {
        "text": " is a crucial indicator of either upper or lower motor neuron pathology.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Tap"
      }, {
        "text": " Patellar Tendon] --\u003e B(Stretch Quadriceps); B --\u003e C(Afferent Signal via Femoral N.); C --\u003e D"
      }, {
        "text": "[L2-L4 Spinal Cord]; D --\u003e E(Efferent Signal via Femoral N.); E --\u003e F(Quadriceps Cont"
      }, {
        "text": "raction/Leg Extension);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"tests"
      }, {
        "text": "_nerve_root\",\n        \"to\": \"l4_nerve_root\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_a_type_of\",\n        \"to\": \"deep_tendon_reflex\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_absent_in\",\n        \"to\": \"lumbosacral_radiculopathy\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"23883b0a\": {\n    \"title\": \""
      }, {
        "text": "Neuronal Pathology\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Pathology\",\n      \"Histology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cellular Pathology\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeuronal pathology\u003c/b\u003e describes the structural and functional changes that occur in neurons in"
      }, {
        "text": " response to injury, ischemia, or degenerative processes, which can be identified through characteristic histological findings.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAcute Neuronal Injury (\\\"Red Neurons\\\"):\u003c/b\u003e Seen 12-24 hours after an"
      }, {
        "text": " irreversible hypoxic/ischemic insult. Characterized by intense eosinophilic (red) cytoplasm, pyknotic (shrunken,"
      }, {
        "text": " dark) nucleus, and loss of Nissl substance.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAxonal Reaction (Central Chromatolysis):\u003c/b\u003e The"
      }, {
        "text": " response of a neuron\u0027s cell body to axonal injury. Characterized by cell body swelling, dispersion of Nissl substance to"
      }, {
        "text": " the periphery (chromatolysis), and displacement of the nucleus to the periphery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeuronal Atrophy/"
      }, {
        "text": "Degeneration:\u003c/b\u003e A slow process of neuronal death seen in neurodegenerative diseases like [[77ae6148"
      }, {
        "text": "|Alzheimer\u0027s]] or [[58c8ea03|Parkinson\u0027s]]. Results in neuronal"
      }, {
        "text": " loss and reactive gliosis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeuronal Inclusions:\u003c/b\u003e Accumulation of abnormal proteins or structures within neurons,"
      }, {
        "text": " which are often hallmarks of specific diseases. Examples include \u003cmark\u003eLewy bodies\u003c/mark\u003e in Parkinson\u0027s, \u003cmark\u003e"
      }, {
        "text": "neurofibrillary tangles\u003c/mark\u003e in Alzheimer\u0027s, and \u003cmark\u003eNegri bodies\u003c/mark\u003e in rabies.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e The appearance of \\\"red neurons\\\" on histology is a key indicator of irreversible ischemic brain injury"
      }, {
        "text": " that occurred at least 12-24 hours prior.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " histological appearance of a neuron provides a timeline and etiology of CNS injury; from the acute eosinophilia of \\\"red neurons\\\" in"
      }, {
        "text": " stroke to the chronic accumulation of protein aggregates in neurodegenerative diseases, the neuron\u0027s morphology tells the story of its pathology.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes"
      }, {
        "text": "\",\n        \"to\": \"red_neurons\"\n      },\n      {\n        \"type\": \"includes\",\n"
      }, {
        "text": "        \"to\": \"axonal_reaction\"\n      },\n      {\n        \"type\": \"includes\","
      }, {
        "text": "\n        \"to\": \"lewy_bodies\"\n      },\n      {\n        \"type\": \"includes"
      }, {
        "text": "\",\n        \"to\": \"neurofibrillary_tangles\"\n      }\n    ]\n  },\n  \"fee"
      }, {
        "text": "9ef8f\": {\n    \"title\": \"Pediatric Neurological Disorders\",\n    \"primaryType\": \"concept\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Pediatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],"
      }, {
        "text": "\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n"
      }, {
        "text": "      \"Pediatric Neurology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePediatric neurological"
      }, {
        "text": " disorders\u003c/b\u003e encompass a wide range of conditions affecting the brain, spinal cord, and peripheral nerves in infants and children, including"
      }, {
        "text": " congenital malformations, genetic syndromes, seizures, and tumors.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSe"
      }, {
        "text": "izures:\u003c/b\u003e [[12108f05|Febrile seizures]] are common and benign. [[a"
      }, {
        "text": "0c128f4|Absence seizures]] present as staring spells. Infantile spasms are another important type.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrimary"
      }, {
        "text": " Brain Tumors:\u003c/b\u003e Unlike in adults, pediatric brain tumors are most commonly located in the \u003cmark\u003einfratent"
      }, {
        "text": "orial\u003c/mark\u003e space (posterior fossa). The most common is the [[912187bd|p"
      }, {
        "text": "ilocytic astrocytoma]], followed by [[16d613bb|medulloblastoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eInt"
      }, {
        "text": "raventricular Hemorrhage:\u003c/b\u003e A common complication in premature infants, originating from the fragile germinal matrix.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLeukoc"
      }, {
        "text": "oria (\\\"White Pupil\\\"):\u003c/b\u003e A critical sign in a child that can indicate serious pathology, most notably [[63b"
      }, {
        "text": "964af|retinoblastoma]] or congenital cataracts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurocutaneous Disorders:\u003c/b\u003e Conditions like [[8"
      }, {
        "text": "3302339|Tuberous Sclerosis]] and [[015a73ab|Neurofibromatosis]]"
      }, {
        "text": " often present with neurological symptoms (seizures, developmental delay) in childhood.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "The landscape of neurological disorders in children is distinct from that in adults, with a predominance of congenital and genetic conditions, and a different"
      }, {
        "text": " spectrum and location of brain tumors, making developmental history and age-specific presentations key to diagnosis.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n"
      }, {
        "text": "        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"includes\",\n        \""
      }, {
        "text": "to\": \"7f8bdf0b\"\n      },\n      {\n        \"type\": \"includes\",\n"
      }, {
        "text": "        \"to\": \"f1695e4c\"\n      },\n      {\n        \"type\": \"includes\",\n"
      }, {
        "text": "        \"to\": \"912babcc\"\n      }\n    ]\n  },\n  \"bcf"
      }, {
        "text": "1707c\": {\n    \"title\": \"Pentobarbital\",\n    \"primaryType\": \"drug"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"Neu"
      }, {
        "text": "rology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pharmacology\",\n      \"Sedative-Hypnotics\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003e\u003cb\u003ePentobarbital\u003c/b\u003e is a short- to intermediate-acting \u003ci\u003ebarbiturate\u003c/i\u003e"
      }, {
        "text": " used as a sedative, hypnotic, and anticonvulsant, and for inducing comas in cases of severe brain injury to"
      }, {
        "text": " reduce metabolic rate and intracranial pressure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Pot"
      }, {
        "text": "entiates the effect of [[5aa5cb91|GABA]] at the GABA\u003csub\u003eA\u003c/sub\u003e receptor by"
      }, {
        "text": " \u003cmark\u003eincreasing the duration\u003c/mark\u003e of Cl\u003csup\u003e-\u003c/sup\u003e channel opening, leading to prolonged neuronal hyperpolarization."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Historically used for insomnia and anxiety, but largely replaced by benzodiazepines due to a narrower"
      }, {
        "text": " therapeutic index. Currently used for status epilepticus refractory to other agents and to induce a \u0027barbiturate coma\u0027 for managing"
      }, {
        "text": " refractory increased intracranial pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Significant risk of \u003cmark\u003erespiratory and cardiovascular depression\u003c/mark\u003e, which"
      }, {
        "text": " can be fatal in overdose. High potential for tolerance, dependence, and abuse.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Induces cytochrome"
      }, {
        "text": " P450 enzymes, leading to drug interactions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Like all barbiturates, there"
      }, {
        "text": " is \u003cu\u003eno reversal agent\u003c/u\u003e for pentobarbital overdose; treatment is purely supportive (airway management, blood pressure support).\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003e\u003cb\u003ePentobarbital\u003c/b\u003e is a powerful CNS depressant that enhances GABAergic inhibition by increasing the duration of chloride"
      }, {
        "text": " channel opening, a mechanism that provides potent sedation and seizure control but also carries a high risk of fatal respiratory depression, especially in overdose.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_type_of\",\n        \"to\": \"barbiturate\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_treatment_for\",\n        \"to\": \"status_epilepticus\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"potentiates\",\n        \"to\": \"5aa5cb91\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"induces\",\n        \"to\": \"cytochrome_p450\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"12b3e1e3\": {\n    \"title\": \"Pericytes\","
      }, {
        "text": "\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Histology\",\n      \""
      }, {
        "text": "Vascular\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      "
      }, {
        "text": "\"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Microvasculature\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePericytes\u003c/b\u003e are multi-functional mural cells that wrap"
      }, {
        "text": " around the endothelial cells of capillaries and venules throughout the body, playing a crucial role in angiogenesis, vessel stabilization, and the maintenance of the"
      }, {
        "text": " blood-brain barrier.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Embedded within the basement"
      }, {
        "text": " membrane of capillaries and post-capillary venules, in direct contact with endothelial cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction (Blood-Brain Barrier):\u003c/b\u003e Pericy"
      }, {
        "text": "tes are essential for the formation and maintenance of the [[dd47b9cc|blood-brain barrier (BBB)]]. They"
      }, {
        "text": " regulate endothelial transcytosis and the expression of tight junction proteins.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction (Blood Flow):\u003c/b\u003e Possess contractile properties"
      }, {
        "text": ", allowing them to regulate capillary diameter and local blood flow.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology (Diabetic Retinopathy):\u003c/b\u003e Deg"
      }, {
        "text": "eneration and loss of retinal pericytes is one of the earliest pathological changes in [[73b00ab0|diabetic retinopathy]]."
      }, {
        "text": " This loss leads to capillary microaneurysm formation, vessel instability, and breakdown of the blood-retinal barrier.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e The loss of pericytes is a key initiating event in the pathogenesis of [[73b00ab0|"
      }, {
        "text": "diabetic retinopathy]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePericytes\u003c/b\u003e are the gate"
      }, {
        "text": "keepers of the microvasculature, particularly in the brain, where their intimate association with endothelial cells is fundamental to the integrity of"
      }, {
        "text": " the [[dd47b9cc|blood-brain barrier]]; their loss in diabetes precipitates the vascular leakage and damage"
      }, {
        "text": " seen in diabetic retinopathy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_component_of\",\n        \"to\": \"dd47b"
      }, {
        "text": "9cc\"\n      },\n      {\n        \"type\": \"degeneration_contributes_to\",\n        \"to"
      }, {
        "text": "\": \"73b00ab0\"\n      },\n      {\n        \"type\": \"regulates\",\n        \"to"
      }, {
        "text": "\": \"capillary_blood_flow\"\n      }\n    ]\n  },\n  \"ae1b"
      }, {
        "text": "cf9a\": {\n    \"title\": \"Perineurium\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Neuroscience\",\n      \"Histology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n"
      }, {
        "text": "      \"Peripheral Nervous System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003ePerineurium\u003c/b\u003e is the layer of connective tissue that bundles groups of axons into fascicles within a peripheral nerve. It forms"
      }, {
        "text": " the blood-nerve barrier, a physiologically important structure that protects the nerve fibers.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure"
      }, {
        "text": ":\u003c/b\u003e Composed of layers of flattened, fibroblast-like cells that are joined by tight junctions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:"
      }, {
        "text": "\u003c/b\u003e Bundles axons into fascicles. The tight junctions between perineurial cells form the \u003cmark\u003eblood-nerve barrier\u003c/"
      }, {
        "text": "mark\u003e, which maintains a stable ionic environment for the nerve fibers and protects them from toxins, pathogens, and inflammation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLayers"
      }, {
        "text": " of a Peripheral Nerve:\u003c/b\u003e From outermost to innermost: \u003cb\u003eEpineurium\u003c/b\u003e (surrounds the entire nerve) -\u003e"
      }, {
        "text": " \u003cb\u003ePerineurium\u003c/b\u003e (surrounds a fascicle) -\u003e \u003cb\u003eEndoneurium\u003c/b\u003e (surrounds an"
      }, {
        "text": " individual myelinated axon).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e The perineurium must be re-approximated in micros"
      }, {
        "text": "urgical nerve repair to ensure proper axonal regeneration within the fascicles. It can be invaded by tumors (perineural invasion).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e The perineurium is analogous to the arachnoid mater of the CNS in that it forms a crucial barrier ("
      }, {
        "text": "blood-nerve barrier vs. blood-CSF barrier).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003ePer"
      }, {
        "text": "ineurium\u003c/b\u003e is more than just a wrapping for nerve fascicles; its specialized cells and tight junctions create the essential blood-nerve barrier,"
      }, {
        "text": " protecting the delicate microenvironment of the axons from systemic fluctuations and toxins.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Peripheral"
      }, {
        "text": " Nerve] --\u003e B(Epineurium); B --\u003e C(Fascicle); C --\u003e D(Perineurium); D --\u003e E(Ax"
      }, {
        "text": "on); E --\u003e F(Endoneurium);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_part_of\",\n        \"to\": \"peripheral_nerve\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"forms\",\n        \"to\": \"03ba9967\"\n      },\n      {\n        \"type\": \"sur"
      }, {
        "text": "rounds\",\n        \"to\": \"nerve_fascicle\"\n      }\n    ]\n  },\n  \"a"
      }, {
        "text": "1a54523\": {\n    \"title\": \"Peripheral Facial Palsy\",\n    \"primaryType\":"
      }, {
        "text": " \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"C"
      }, {
        "text": "ranial Neuropathies\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePeripheral facial palsy\u003c/b\u003e"
      }, {
        "text": " is a lower motor neuron (LMN) lesion of the [[dea9755f|facial nerve (CN"
      }, {
        "text": " VII)]] that results in paralysis of all muscles of facial expression on the \u003ci\u003eipsilateral\u003c/i\u003e side of the face"
      }, {
        "text": ", including the forehead.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Unilateral facial"
      }, {
        "text": " paralysis affecting both the upper and lower face. Patients are unable to raise their eyebrow, wrinkle their forehead, or close their eye"
      }, {
        "text": " tightly on the affected side. They also exhibit a drooping corner of the mouth and a flattened nasolabial fold.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Etiology:\u003c/b\u003e The most common cause is Bell\u0027s palsy (idiopathic, presumed viral). Other causes include [["
      }, {
        "text": "09fa1b0f|Ramsay Hunt syndrome]] (VZV), Lyme disease, tumors (e.g., [["
      }, {
        "text": "03ecb69e|schwannoma]]), and trauma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction from Central Lesion:\u003c/b\u003e A"
      }, {
        "text": " central (upper motor neuron) facial palsy, caused by a stroke, spares the forehead muscles. This is because the upper face"
      }, {
        "text": " receives bilateral cortical innervation, while the lower face receives only contralateral innervation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Symptoms:\u003c/b\u003e Depending on the location"
      }, {
        "text": " of the lesion along CN VII, may also have decreased tearing, hyperacusis (due to stapedius muscle paralysis), and"
      }, {
        "text": " loss of taste from the anterior two-thirds of the tongue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to"
      }, {
        "text": " differentiating a peripheral from a central facial palsy is the forehead. If the patient \u003cu\u003ecan\u003c/u\u003e wrinkle their forehead, the"
      }, {
        "text": " lesion is central (UMN). If they \u003cu\u003ecannot\u003c/u\u003e, the lesion is peripheral (LMN).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003eA \u003cb\u003eperipheral facial palsy\u003c/b\u003e is a definitive lower motor neuron sign affecting the entire ipsilateral face, including the forehead."
      }, {
        "text": " This complete hemifacial paralysis is the crucial feature that distinguishes it from the forehead-sparing weakness of a central ("
      }, {
        "text": "UMN) lesion like a stroke.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[LMN Lesion of"
      }, {
        "text": " CN VII] --\u003e B(Peripheral Facial Palsy); B --\u003e C(Paralysis of Ipsilateral Upper \u0026 Lower Face); D"
      }, {
        "text": "[UMN Lesion e.g., Stroke] --\u003e E(Central Facial Palsy); E --\u003e F(Paralysis of Contralateral Lower"
      }, {
        "text": " Face ONLY);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused"
      }, {
        "text": "_by_lesion_of\",\n        \"to\": \"dea9755f\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_a_type_of\",\n        \"to\": \"lower_motor_neuron_lesion"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \""
      }, {
        "text": "central_facial_palsy\"\n      },\n      {\n        \"type\": \"is_the_main"
      }, {
        "text": "_finding_in\",\n        \"to\": \"bells_palsy\"\n      }\n    ]\n  },"
      }, {
        "text": "\n  \"c44ae4c5\": {\n    \"title\": \"Peripheral Nervous System (PNS"
      }, {
        "text": ")\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"An"
      }, {
        "text": "atomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Overview\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003eThe \u003cb\u003ePeripheral Nervous System (PNS)\u003c/b\u003e consists of all nervous tissue outside of the central nervous system (brain"
      }, {
        "text": " and spinal cord), including cranial nerves (III-XII), spinal nerves, ganglia, and sensory receptors. It serves as the communication"
      }, {
        "text": " relay between the CNS and the rest of the body.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents"
      }, {
        "text": ":\u003c/b\u003e Cranial nerves and their ganglia, spinal nerves and their dorsal root ganglia, autonomic nerves and ganglia, and the enteric"
      }, {
        "text": " nervous system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGlial Cells:\u003c/b\u003e The main supporting cells are [[c65a890"
      }, {
        "text": "9|Schwann cells]] (which form myelin sheaths) and satellite cells (which support neuron cell bodies in ganglia).\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Embryonic Origin:\u003c/b\u003e Most components of the PNS, including neurons and glial cells, are derived from the \u003cmark\u003eneural crest\u003c/"
      }, {
        "text": "mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNerve Structure:\u003c/b\u003e Peripheral nerves are composed of bundles of axons (fascicles). Each axon is surrounded by end"
      }, {
        "text": "oneurium, each fascicle by [[ae1bcf9a|perineurium]], and the entire nerve by"
      }, {
        "text": " epineurium.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Diseases of the PNS are called peripheral neuropathies, which can be dem"
      }, {
        "text": "yelinating (e.g., [[ed52e40b|Guillain-Barr√© syndrome]]) or axonal"
      }, {
        "text": " (e.g., diabetic neuropathy).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003ePeripheral Nervous System\u003c/b\u003e"
      }, {
        "text": " is the extensive network of nerves and ganglia that connects the central nervous system to the limbs and organs, with its neurons and glial cells primarily"
      }, {
        "text": " originating from the versatile neural crest during embryonic development.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_supported_by\",\n        \"to\": \"c65a890"
      }, {
        "text": "9\"\n      },\n      {\n        \"type\": \"is_supported_by\",\n        \"to"
      }, {
        "text": "\": \"satellite_cells\"\n      },\n      {\n        \"type\": \"derives_from\",\n        \"to"
      }, {
        "text": "\": \"neural_crest\"\n      },\n      {\n        \"type\": \"is_composed_of\","
      }, {
        "text": "\n        \"to\": \"cranial_nerves\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n"
      }, {
        "text": "        \"to\": \"spinal_nerves\"\n      }\n    ]\n  },\n  \"581"
      }, {
        "text": "1ad9e\": {\n    \"title\": \"Peripheral Vertigo\",\n    \"primaryType\": \"finding\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Otology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePeripheral vertigo\u003c/b\u003e is a sensation of spinning or dizziness that originates"
      }, {
        "text": " from a problem within the \u003ci\u003einner ear or the vestibulocochlear nerve (CN VIII)\u003c/i\u003e, which"
      }, {
        "text": " are parts of the peripheral vestibular system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Common"
      }, {
        "text": " causes include Benign Paroxysmal Positional Vertigo (BPPV), Vestibular Neuritis/Labyrinthitis, and [["
      }, {
        "text": "6f2228c1|M√©ni√®re disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Characterized by sudden,"
      }, {
        "text": " intense episodes of vertigo, often triggered by head movements. Nausea and vomiting are common.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNystagmus:\u003c/b\u003e Typically"
      }, {
        "text": " presents with a \u003cmark\u003ehorizontal or torsional (rotary) nystagmus\u003c/mark\u003e that is unidirectional and fatigable. It is suppressed by"
      }, {
        "text": " visual fixation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Symptoms:\u003c/b\u003e May be accompanied by hearing loss and/or tinnitus if the cochlea or"
      }, {
        "text": " cochlear nerve is also affected (e.g., in M√©ni√®re disease or labyrinthitis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction from"
      }, {
        "text": " Central Vertigo:\u003c/b\u003e Unlike [[350f1c8b|central vertigo]], it is not associated with other"
      }, {
        "text": " brainstem signs like dysarthria, dysphagia, or limb ataxia. The nystagmus is rarely purely vertical."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The Dix-Hallpike maneuver is used to diagnose BPPV. A positive"
      }, {
        "text": " test (reproduction of vertigo and torsional nystagmus after a short delay) is characteristic of peripheral vertigo.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003ePeripheral vertigo\u003c/b\u003e is an inner ear problem, not a brain problem. Its key features are intense"
      }, {
        "text": ", episodic spinning, often with nausea, and a characteristic horizontal/torsional nystagmus, without the additional \u0027"
      }, {
        "text": "red flag\u0027 neurological signs seen in central vertigo.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_symptom_of\",\n        \"to\": \"benign_paroxysmal_position"
      }, {
        "text": "al_vertigo\"\n      },\n      {\n        \"type\": \"is_a_symptom"
      }, {
        "text": "_of\",\n        \"to\": \"6f2228c1\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"vestibular"
      }, {
        "text": "_neuritis\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \""
      }, {
        "text": "to\": \"350f1c8b\"\n      }\n    ]\n  },\n  \"d"
      }, {
        "text": "9286430\": {\n    \"title\": \"Periventricular Plaques\",\n    \"primaryType\":"
      }, {
        "text": " \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Radiology\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003e\u003cb\u003ePeriventricular plaques\u003c/b\u003e are focal areas of demyelination and gliosis located in the white"
      }, {
        "text": " matter adjacent to the lateral ventricles of the brain. They are the most characteristic radiological finding in \u003ci\u003eMultiple Sclerosis (MS)\u003c/i\u003e.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance on MRI:\u003c/b\u003e On T2-weighted and"
      }, {
        "text": " FLAIR MRI sequences, they appear as \u003cmark\u003ehyperintense (bright) ovoid lesions\u003c/mark\u003e oriented perpendicular to the ventric"
      }, {
        "text": "les. This orientation follows the path of the deep medullary veins and is sometimes referred to as \u0027Dawson\u0027s fingers.\u0027"
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e The plaques represent areas where autoimmune inflammation has destroyed [[a24f974"
      }, {
        "text": "7|oligodendrocytes]] and their myelin sheaths, which is then replaced by an astrocytic scar (gliosis)."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e The presence of periventricular plaques is a key component of the McDonald criteria for diagnosing [["
      }, {
        "text": "45dd6d19|Multiple Sclerosis]]. Their distribution helps fulfill the criterion of \u0027dissemination in space.\u0027"
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e While periventricular is the classic location, MS plaques can also be found in juxtac"
      }, {
        "text": "ortical, infratentorial, and spinal cord locations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An MRI showing"
      }, {
        "text": " multiple hyperintense lesions in the periventricular white matter, especially in a young woman with relapsing neurological symptoms, is path"
      }, {
        "text": "ognomonic for [[45dd6d19|Multiple Sclerosis]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003ePeriventricular plaques\u003c/b\u003e are the radiological signature of [[45dd6d19|Multiple Sclerosis]], representing"
      }, {
        "text": " focal scars of demyelination that cluster around the ventricles and serve as the primary imaging evidence for the diagnosis.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_hallmark_of"
      }, {
        "text": "\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"are_composed_of\",\n        \"to\": \"demyelination_and_gliosis\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"are_best_visualized_by\",\n        \"to\": \"m"
      }, {
        "text": "ri\"\n      }\n    ]\n  },\n  \"8f0081d5\": {\n    \"title\":"
      }, {
        "text": " \"Pes Cavus in Friedreich Ataxia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Genetics\",\n      \"Orthopedics\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neuro"
      }, {
        "text": "degenerative Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePes cavus\u003c/b\u003e is a foot"
      }, {
        "text": " deformity characterized by an abnormally high plantar arch, which is a classic musculoskeletal finding in patients with \u003ci\u003eFriedreich Ataxia\u003c/i\u003e"
      }, {
        "text": ", resulting from chronic neuromuscular imbalance.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e In [["
      }, {
        "text": "39bc1763|Friedreich Ataxia]], degeneration of peripheral nerves and spinal cord tracts leads to an"
      }, {
        "text": " imbalance between the intrinsic and extrinsic muscles of the foot, causing the arch to become excessively high.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Condition"
      }, {
        "text": ":\u003c/b\u003e [[39bc1763|Friedreich Ataxia]] is an autosomal recessive trinucleotide repeat"
      }, {
        "text": " (GAA) disorder affecting the frataxin gene, leading to progressive neurodegeneration.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Clinical"
      }, {
        "text": " Features of Friedreich Ataxia:\u003c/b\u003e Besides pes cavus, patients present with progressive gait and limb ataxia, dysarthria, loss"
      }, {
        "text": " of deep tendon reflexes, loss of proprioception/vibration sense, and hypertrophic cardiomyopathy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Foot Deformities:\u003c/b\u003e Hammer"
      }, {
        "text": " toes are also commonly seen in conjunction with pes cavus in this condition.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of neurological"
      }, {
        "text": " symptoms (ataxia, areflexia) with non-neurological findings like hypertrophic cardiomyopathy and skeletal deformities (pes cavus,"
      }, {
        "text": " kyphoscoliosis) is highly suggestive of [[39bc1763|Friedreich Ataxia]].\u003c/li\u003e\u003c/ul\u003e\",\n"
      }, {
        "text": "      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePes cavus\u003c/b\u003e in the context of [[39bc1763|Friedreich Ataxia]]"
      }, {
        "text": " is not an isolated orthopedic issue but a direct consequence of the underlying neurodegeneration, serving as a key physical exam clue"
      }, {
        "text": " to this multisystem genetic disorder.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_finding_in\",\n        \"to\": \"39bc176"
      }, {
        "text": "3\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        "
      }, {
        "text": "\"to\": \"foot_deformity\"\n      },\n      {\n        \"type\": \"is_also_seen_in"
      }, {
        "text": "\",\n        \"to\": \"c3f13d85\"\n      }\n    ]\n  },\n  \"c9"
      }, {
        "text": "15f2d5\": {\n    \"title\": \"Absence Seizures (Petit Mal)\",\n    "
      }, {
        "text": "\"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pediatrics\",\n      \"Epilepsy"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eAbsence seizures\u003c/b\u003e, formerly known as \u003ci\u003epetit mal seizures\u003c/i\u003e, are a type of generalized seizure"
      }, {
        "text": " characterized by a sudden, brief lapse of consciousness without loss of postural tone, typically lasting for seconds. They are most common"
      }, {
        "text": " in childhood and are often mistaken for daydreaming or inattentiveness.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden cessation of activity with a blank stare, lasting about 10 seconds. May be accompanied by subtle"
      }, {
        "text": " automatisms like eyelid fluttering or lip smacking. There is \u003cu\u003eno postictal confusion\u003c/u\u003e; the patient immediately returns to baseline"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eEEG Hallmark:\u003c/b\u003e The pathognomonic finding is a \u003cmark\u003egeneralized 3 Hz spike"
      }, {
        "text": "-and-wave discharge\u003c/mark\u003e on EEG.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProvocation:\u003c/b\u003e Seizures can often be triggered by \u003c"
      }, {
        "text": "mark\u003ehyperventilation\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e \u003cu\u003eFirst-line\u003c/u\u003e treatment is [[a"
      }, {
        "text": "90f6fb4|Ethosuximide]]. [[valproic_acid|Valproic acid]] is"
      }, {
        "text": " also effective and used if tonic-clonic seizures are also present.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A classic vignette"
      }, {
        "text": " describes a child whose teacher complains of \u0027daydreaming\u0027 or \u0027not paying attention\u0027 in class. The diagnosis is confirmed"
      }, {
        "text": " by a 3 Hz spike-and-wave pattern on EEG, often induced by having the child hyperventilate.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003e\u003cb\u003eAbsence seizures\u003c/b\u003e are unique among generalized seizures for their brief, non-convulsive nature, lack"
      }, {
        "text": " of postictal confusion, and a pathognomonic \u003cmark\u003e3 Hz spike-and-wave\u003c/mark\u003e EEG"
      }, {
        "text": " pattern, making [[a90f6fb4|Ethosuximide]] the specific and preferred treatment.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Thalamic T-type Ca2+ Channels] -- Overactivity --\u003e B(Abs"
      }, {
        "text": "ence Seizure); C(Ethosuximide) -- Blocks --\u003e A;\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"64c"
      }, {
        "text": "08e92\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\":"
      }, {
        "text": " \"a90f6fb4\"\n      },\n      {\n        \"type\": \"presents_with"
      }, {
        "text": "_eeg_finding\",\n        \"to\": \"eeg_3hz_spike_wave\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"21cb9a14\": {\n    \"title\": \"Phantom Limb"
      }, {
        "text": " Pain\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pain Management"
      }, {
        "text": "\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Pathology\",\n      \"Pain Syndromes\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePhantom limb pain\u003c/b\u003e is a form of neuropathic pain perceived"
      }, {
        "text": " as originating from a part of the body that has been amputated. The sensations can range from cramping and aching to burning or"
      }, {
        "text": " electric shock-like pain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The exact"
      }, {
        "text": " mechanism is complex and not fully understood, but it is believed to involve \u003cmark\u003ecentral cortical reorganization\u003c/mark\u003e. The area"
      }, {
        "text": " of the somatosensory cortex that previously represented the amputated limb is remapped and can be activated by input from adjacent cortical"
      }, {
        "text": " areas, leading to the perception of pain.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePeripheral Component:\u003c/b\u003e Changes in the peripheral nerves at the amputation"
      }, {
        "text": " stump (e.g., neuroma formation) can also contribute by generating ectopic signals.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:"
      }, {
        "text": "\u003c/b\u003e Pain is perceived in the missing limb. It is distinct from stump pain, which is localized to the residual limb.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e"
      }, {
        "text": " Management is challenging and multimodal. Options include pharmacotherapy (anticonvulsants like gabapentin, TCAs, NSA"
      }, {
        "text": "IDs), mirror therapy, and nerve stimulation techniques.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key concept is cortical plasticity"
      }, {
        "text": " and reorganization in the somatosensory cortex as the underlying mechanism for phantom limb pain.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003ePhantom limb pain\u003c/b\u003e is a powerful clinical example of neuroplasticity, where the brain\u0027s map"
      }, {
        "text": " of the body (the homunculus) reorganizes after amputation, leading to the paradoxical and often distressing sensation of pain in"
      }, {
        "text": " a limb that no longer exists.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_type_of\",\n        \"to\": \"neuropathic_pain"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\":"
      }, {
        "text": " \"cortical_reorganization\"\n      },\n      {\n        \"type\": \"occurs_after\","
      }, {
        "text": "\n        \"to\": \"amputation\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"ed7360de\",\n    \"letter\": \"O\",\n    \"term\": \"Otorrhea, painless\",\n    \"pages\": [\n      \"548\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Otorrhea, painless\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"944bb118\",\n    \"letter\": \"O\",\n    \"term\": \"Outer ear\",\n    \"pages\": [\n      \"547\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Outer ear\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"429fc155\",\n    \"letter\": \"O\",\n    \"term\": \"Oxazepam\",\n    \"pages\": [\n      \"562\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Oxazepam\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"911d3b47\",\n    \"letter\": \"O\",\n    \"term\": \"Oxytocin\",\n    \"pages\": [\n      \"360\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Oxytocin\",\n    \"sub_entries\": [\n      {\n        \"id\": \"f304b9ca\",\n        \"letter\": \"O\",\n        \"term\": \"hypothalamus production\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Oxytocin \u003e hypothalamus production\"\n      }\n    ]\n  },\n  {\n    \"id\": \"71867ae0\",\n    \"letter\": \"P\",\n    \"term\": \"Pacinian corpuscles\",\n    \"pages\": [\n      \"504\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Pacinian corpuscles\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"c26e6817\",\n    \"letter\": \"P\",\n    \"term\": \"Pain\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Pain\",\n    \"sub_entries\": [\n      {\n        \"id\": \"2785ad0b\",\n        \"letter\": \"P\",\n        \"term\": \"periorbital\",\n        \"pages\": [\n          \"532\"\n        ],\n        \"context\": \"Pain \u003e periorbital\"\n      },\n      {\n        \"id\": \"1a3ea937\",\n        \"letter\": \"P\",\n        \"term\": \"sensory receptors for\",\n        \"pages\": [\n          \"504\"\n        ],\n        \"context\": \"Pain \u003e sensory receptors for\"\n      },\n      {\n        \"id\": \"6be470ef\",\n        \"letter\": \"P\",\n        \"term\": \"thalamic nuclei and\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Pain \u003e thalamic nuclei and\"\n      },\n      {\n        \"id\": \"aa3b5129\",\n        \"letter\": \"P\",\n        \"term\": \"treatment in multiple sclerosis\",\n        \"pages\": [\n          \"537\"\n        ],\n        \"context\": \"Pain \u003e treatment in multiple sclerosis\"\n      }\n    ]\n  },\n  {\n    \"id\": \"ea694390\",\n    \"letter\": \"P\",\n    \"term\": \"Palmar reflex\",\n    \"pages\": [\n      \"523\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Palmar reflex\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"243d4db1\",\n    \"letter\": \"P\",\n    \"term\": \"Pancuronium\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Pancuronium\",\n    \"sub_entries\": [\n      {\n        \"id\": \"beaa35c4\",\n        \"letter\": \"P\",\n        \"term\": \"function of\",\n        \"pages\": [\n          \"566\"\n        ],\n        \"context\": \"Pancuronium \u003e function of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"4ae219da\",\n    \"letter\": \"P\",\n    \"term\": \"Papilledema\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Papilledema\",\n    \"sub_entries\": [\n      {\n        \"id\": \"7799e0ac\",\n        \"letter\": \"P\",\n        \"term\": \"cause and funduscopic appearance\",\n        \"pages\": [\n          \"553\"\n        ],\n        \"context\": \"Papilledema \u003e cause and funduscopic appearance\"\n      },\n      {\n        \"id\": \"5652f310\",\n        \"letter\": \"P\",\n        \"term\": \"hydrocephalus\",\n        \"pages\": [\n          \"536\"\n        ],\n        \"context\": \"Papilledema \u003e hydrocephalus\"\n      },\n      {\n        \"id\": \"c01f004a\",\n        \"letter\": \"P\",\n        \"term\": \"hypertension\",\n        \"pages\": [\n          \"536\"\n        ],\n        \"context\": \"Papilledema \u003e hypertension\"\n      },\n      {\n        \"id\": \"d12bc6b3\",\n        \"letter\": \"P\",\n        \"term\": \"medulloblastoma and\",\n        \"pages\": [\n          \"542\"\n        ],\n        \"context\": \"Papilledema \u003e medulloblastoma and\"\n      }\n    ]\n  },\n  {\n    \"id\": \"a2e1097b\",\n    \"letter\": \"P\",\n    \"term\": \"Paralysis\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Paralysis\",\n    \"sub_entries\": [\n      {\n        \"id\": \"84d8ef97\",\n        \"letter\": \"P\",\n        \"term\": \"disorders\",\n        \"pages\": [\n          \"538\"\n        ],\n        \"context\": \"Paralysis \u003e disorders\"\n      },\n      {\n        \"id\": \"8c1adad7\",\n        \"letter\": \"P\",\n        \"term\": \"face\",\n        \"pages\": [\n          \"526\"\n        ],\n        \"context\": \"Paralysis \u003e face\"\n      },\n      {\n        \"id\": \"dd7681a3\",\n        \"letter\": \"P\",\n        \"term\": \"osmotic demyelination syndrome\",\n        \"pages\": [\n          \"538\"\n        ],\n        \"context\": \"Paralysis \u003e osmotic demyelination syndrome\"\n      },\n      {\n        \"id\": \"a79dc32a\",\n        \"letter\": \"P\",\n        \"term\": \"polyneuropathy\",\n        \"pages\": [\n          \"538\"\n        ],\n        \"context\": \"Paralysis \u003e polyneuropathy\"\n      },\n      {\n        \"id\": \"85778b42\",\n        \"letter\": \"P\",\n        \"term\": \"stroke\",\n        \"pages\": [\n          \"526\"\n        ],\n        \"context\": \"Paralysis \u003e stroke\"\n      }\n    ]\n  },\n  {\n    \"id\": \"61d955b1\",\n    \"letter\": \"P\",\n    \"term\": \"Paramedian pontine reticular\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Paramedian pontine reticular\",\n    \"sub_entries\": [\n      {\n        \"id\": \"4e6b9a3c\",\n        \"letter\": \"P\",\n        \"term\": \"formation, lesions in\",\n        \"pages\": [\n          \"524\"\n        ],\n        \"context\": \"Paramedian pontine reticular \u003e formation, lesions in\"\n      }\n    ]\n  },\n  {\n    \"id\": \"7759e8c1\",\n    \"letter\": \"P\",\n    \"term\": \"Parasympathetic nervous system\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Parasympathetic nervous system\",\n    \"sub_entries\": [\n      {\n        \"id\": \"2c2a9243\",\n        \"letter\": \"P\",\n        \"term\": \"innervation\",\n        \"pages\": [\n          \"519\"\n        ],\n        \"context\": \"Parasympathetic nervous system \u003e innervation\"\n      },\n      {\n        \"id\": \"494fad4b\",\n        \"letter\": \"P\",\n        \"term\": \"vagus nerve and\",\n        \"pages\": [\n          \"516\"\n        ],\n        \"context\": \"Parasympathetic nervous system \u003e vagus nerve and\"\n      }\n    ]\n  },\n  {\n    \"id\": \"e7b51f5c\",\n    \"letter\": \"P\",\n    \"term\": \"Paraventricular nucleus\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Paraventricular nucleus\",\n    \"sub_entries\": [\n      {\n        \"id\": \"7690b0cb\",\n        \"letter\": \"P\",\n        \"term\": \"secretions of\",\n        \"pages\": [\n          \"331\",\n          \"508\"\n        ],\n        \"context\": \"Paraventricular nucleus \u003e secretions of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"26efa771\",\n    \"letter\": \"P\",\n    \"term\": \"Parietal cortex/lobe\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Parietal cortex/lobe\",\n    \"sub_entries\": [\n      {\n        \"id\": \"02cd439f\",\n        \"letter\": \"P\",\n        \"term\": \"lesions in\",\n        \"pages\": [\n          \"524\"\n        ],\n        \"context\": \"Parietal cortex/lobe \u003e lesions in\"\n      },\n      {\n        \"id\": \"d1d78f5e\",\n        \"letter\": \"P\",\n        \"term\": \"projections to\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Parietal cortex/lobe \u003e projections to\"\n      }\n    ]\n  },\n  {\n    \"id\": \"9f603521\",\n    \"letter\": \"P\",\n    \"term\": \"Parinaud syndrome\",\n    \"pages\": [\n      \"524\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Parinaud syndrome\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 2645
    }, {
      "text": "```json\n{\n  \"ed7360de\": {\n    \"title\": \"Painless Otorrhea\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Otology\",\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePainless otorrhea\u003c/b\u003e is the drainage of fluid from the ear without associated pain, a key clinical sign that often points towards a diagnosis of \u003ci\u003echolesteatoma\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e This symptom is the hallmark presentation of a [[03ef3134|cholesteatoma]], an abnormal growth of keratinized squamous epithelium in the middle ear.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology in Cholesteatoma:\u003c/b\u003e The trapped epithelial debris within the cholesteatoma sac becomes chronically infected with bacteria, leading to a persistent, often foul-smelling, painless discharge.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferential Diagnosis:\u003c/b\u003e While cholesteatoma is the classic cause, other conditions like chronic suppurative otitis media with a tympanic membrane perforation can also present with painless otorrhea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContrast with Acute Otitis Media:\u003c/b\u003e In [[a03641af|acute otitis media]], otorrhea occurs only after tympanic membrane rupture and is typically preceded by severe pain (otalgia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a history of recurrent ear infections who now presents with painless, foul-smelling ear discharge and conductive hearing loss should be evaluated for a [[03ef3134|cholesteatoma]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe absence of pain in the presence of chronic ear drainage is a significant red flag; \u003cb\u003epainless otorrhea\u003c/b\u003e strongly suggests an underlying destructive process like a [[03ef3134|cholesteatoma]], which erodes bone silently, rather than an acute, painful infection.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \"to\": \"03ef3134\"\n      },\n      {\n        \"type\": \"differentiated_from_symptom_of\",\n        \"to\": \"a03641af\"\n      }\n    ]\n  },\n  \"944bb118\": {\n    \"title\": \"Outer Ear\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Otology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Anatomy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eOuter Ear\u003c/b\u003e is the most external portion of the auditory system, consisting of the \u003ci\u003epinna (auricle)\u003c/i\u003e and the \u003ci\u003eexternal auditory canal\u003c/i\u003e, which terminates at the tympanic membrane. Its primary function is to collect sound waves and channel them to the middle ear.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e Includes the pinna (the visible part of the ear) and the external auditory canal (the ear canal).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The pinna helps to collect and localize sound. The external auditory canal funnels the sound waves to the tympanic membrane, causing it to vibrate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e Sensory innervation to the external ear is complex, involving branches from multiple cranial nerves (CN V\u003csub\u003e3\u003c/sub\u003e, VII, X) and cervical nerves (C2, C3).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e The most common pathology of the outer ear is [[otitis_externa|otitis externa]] (\\\"swimmer\u0027s ear\\\"), an infection of the external auditory canal, often caused by \u003ci\u003ePseudomonas aeruginosa\u003c/i\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that manipulation of the pinna or tragus causes pain in [[otitis_externa|otitis externa]], a key feature distinguishing it from [[a03641af|otitis media]] where the pain is internal and not exacerbated by external touch.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eOuter Ear\u003c/b\u003e functions as a biological funnel, capturing and directing sound waves toward the tympanic membrane to initiate the mechanical process of hearing, and its exposure to the environment makes it susceptible to infections like otitis externa.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"ear\"\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"otitis_externa\"\n      },\n      {\n        \"type\": \"transmits_sound_to\",\n        \"to\": \"middle_ear\"\n      }\n    ]\n  },\n  \"429fc155\": {\n    \"title\": \"Oxazepam\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Anxiolytics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOxazepam\u003c/b\u003e is a short-to-intermediate acting \u003ci\u003ebenzodiazepine\u003c/i\u003e used for the treatment of anxiety and acute alcohol withdrawal. It is notable for its metabolism via glucuronidation, making it safer in patients with liver disease.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Like other benzodiazepines, it facilitates the action of [[5aa5cb91|GABA]] at the GABA\u003csub\u003eA\u003c/sub\u003e receptor, increasing the \u003cmark\u003efrequency\u003c/mark\u003e of Cl\u003csup\u003e-\u003c/sup\u003e channel opening and causing CNS depression.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetabolism:\u003c/b\u003e Undergoes direct glucuronidation in the liver without involving the cytochrome P450 system. This makes its metabolism less affected by liver disease or drugs that inhibit/induce CYP enzymes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for anxiety disorders, panic attacks, and management of alcohol withdrawal symptoms.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSafe in Liver Disease:\u003c/b\u003e Along with Lorazepam and Temazepam, Oxazepam is a preferred benzodiazepine in patients with severe liver disease or in the elderly. Mnemonic: \u003cb\u003eO\u003c/b\u003eutside \u003cb\u003eT\u003c/b\u003ehe \u003cb\u003eL\u003c/b\u003eiver (\u003cb\u003eO\u003c/b\u003exazepam, \u003cb\u003eT\u003c/b\u003eemazepam, \u003cb\u003eL\u003c/b\u003eorazepam).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For a patient with cirrhosis and alcohol withdrawal requiring a benzodiazepine, choose one that is metabolized \u0027Outside The Liver\u0027 like Oxazepam or Lorazepam.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eOxazepam\u0027s\u003c/b\u003e key feature is its metabolism through glucuronidation, bypassing the cytochrome P450 system. This makes it a significantly safer benzodiazepine choice for patients with compromised liver function, such as those with alcoholic cirrhosis who are undergoing withdrawal.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"14464617\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"anxiety_disorders\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"alcohol_withdrawal\"\n      },\n      {\n        \"type\": \"is_safer_in\",\n        \"to\": \"liver_disease\"\n      }\n    ]\n  },\n  \"911d3b47\": {\n    \"title\": \"Oxytocin\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Obstetrics\",\n      \"Neuroscience\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Physiology\",\n      \"Hypothalamic-Pituitary Axis\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOxytocin\u003c/b\u003e is a peptide hormone and neuropeptide that is synthesized in the [[89e86633|hypothalamus]] and released from the posterior pituitary. It plays a crucial role in uterine contractions during labor and milk let-down during lactation, and is also involved in social bonding.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSynthesis and Release:\u003c/b\u003e Synthesized primarily in the \u003cmark\u003eparaventricular nuclei\u003c/mark\u003e of the [[89e86633|hypothalamus]], transported down axons, and stored and released from the posterior pituitary (neurohypophysis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUterine Contractions:\u003c/b\u003e Stimulates uterine smooth muscle contraction, which is essential for labor and delivery. Exogenous oxytocin (Pitocin) is used to induce or augment labor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMilk Ejection (Let-down reflex):\u003c/b\u003e Suckling stimulates oxytocin release, which causes contraction of myoepithelial cells surrounding the mammary alveoli, ejecting milk.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSocial Bonding:\u003c/b\u003e Acts as a neurotransmitter in the brain, involved in social recognition, pair bonding, maternal behavior, and trust.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that oxytocin and ADH are both produced in the hypothalamus and released from the posterior pituitary. Oxytocin is for \u0027squeezing\u0027 (uterine contractions, milk ejection), while ADH is for \u0027saving\u0027 water.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eOxytocin\u003c/b\u003e functions as both a peripheral hormone and a central neurotransmitter; peripherally, it is the primary driver of uterine contractions and milk ejection, while centrally, it modulates complex social behaviors, earning it the nickname \u0027the love hormone\u0027.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypothalamus - Paraventricular Nucleus] --\u003e B(Posterior Pituitary); B --Release--\u003e C(Oxytocin); C --\u003e D(Uterine Contraction); C --\u003e E(Milk Ejection);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_synthesized_in\",\n        \"to\": \"e7b51f5c\"\n      },\n      {\n        \"type\": \"is_released_from\",\n        \"to\": \"posterior_pituitary\"\n      },\n      {\n        \"type\": \"stimulates\",\n        \"to\": \"uterine_contraction\"\n      },\n      {\n        \"type\": \"stimulates\",\n        \"to\": \"milk_ejection_reflex\"\n      }\n    ]\n  },\n  \"71867ae0\": {\n    \"title\": \"Pacinian Corpuscles\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Dermatology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sensory System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePacinian corpuscles\u003c/b\u003e are large, encapsulated sensory receptors located in the deep dermis and subcutaneous tissue that are specialized to detect high-frequency \u003ci\u003evibration\u003c/i\u003e and deep \u003ci\u003epressure\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Large, onion-like (lamellated) capsule surrounding a single nerve ending.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e They are \u003cmark\u003erapidly adapting\u003c/mark\u003e mechanoreceptors, meaning they respond to changes in stimuli (onset and offset of pressure) rather than sustained pressure. This property makes them ideal for sensing vibration.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Found deep in the dermis, subcutaneous tissue, ligaments, and joint capsules. Abundant in fingertips and genitals.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNerve Fibers:\u003c/b\u003e Transmitted by large, myelinated AŒ≤ fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Signals for vibration and pressure travel via the [[e7f5cbbe|dorsal column-medial lemniscus pathway]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When testing sensory modalities, remember the specific receptors: Vibration \u003d Pacinian corpuscles. Fine touch \u003d Meissner\u0027s corpuscles. Sustained pressure \u003d Merkel discs.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe unique, onion-like layered structure of \u003cb\u003ePacinian corpuscles\u003c/b\u003e acts as a mechanical filter, allowing them to respond only to rapid changes in pressure, which makes them exquisitely sensitive to high-frequency vibration rather than static touch.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"senses\",\n        \"to\": \"vibration\"\n      },\n      {\n        \"type\": \"senses\",\n        \"to\": \"pressure_sensation\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"mechanoreceptor\"\n      },\n      {\n        \"type\": \"signal_is_transmitted_via\",\n        \"to\": \"e7f5cbbe\"\n      }\n    ]\n  },\n  \"c26e6817\": {\n    \"title\": \"Pain\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Physiology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sensory System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePain\u003c/b\u003e (nociception) is an unpleasant sensory and emotional experience associated with actual or potential tissue damage. It is transmitted from the periphery to the central nervous system via specialized nerve fibers and pathways.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSensory Receptors:\u003c/b\u003e Mediated by \u003cmark\u003efree nerve endings\u003c/mark\u003e of nociceptors, which respond to noxious thermal, mechanical, or chemical stimuli.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNerve Fibers:\u003c/b\u003e Transmitted by two types of fibers: \u003cbr\u003e - \u003cb\u003eAŒ¥ fibers:\u003c/b\u003e Thinly myelinated, transmit fast, sharp, well-localized pain.\u003cbr\u003e - \u003cb\u003eC fibers:\u003c/b\u003e Unmyelinated, transmit slow, dull, poorly-localized pain.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Signals travel to the dorsal horn of the spinal cord, synapse, decussate at the anterior white commissure, and ascend in the contralateral \u003cmark\u003espinothalamic tract\u003c/mark\u003e to the VPL nucleus of the [[afc0a64b|thalamus]], and then to the somatosensory cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePeriorbital Pain:\u003c/b\u003e A key feature of [[21760f80|cluster headaches]], often described as excruciating.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePain in MS:\u003c/b\u003e Neuropathic pain is a common symptom in [[45dd6d19|multiple sclerosis]], often treated with anticonvulsants or TCAs.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe sensation of \u003cb\u003epain\u003c/b\u003e is not a single modality but is dually encoded by fast AŒ¥ fibers for initial sharp warning and slow C fibers for prolonged aching, both of which travel through the dedicated spinothalamic tract to alert the brain to tissue damage.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Noxious Stimulus] --\u003e B(Free Nerve Endings); B --\u003e C(AŒ¥ \u0026 C Fibers); C --\u003e D(Dorsal Horn); D --\u003e E(Decussation); E --\u003e F(Spinothalamic Tract); F --\u003e G(Thalamus); G --\u003e H(Somatosensory Cortex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_transmitted_via\",\n        \"to\": \"07eecef1\"\n      },\n      {\n        \"type\": \"is_sensed_by\",\n        \"to\": \"1e7ec644\"\n      },\n      {\n        \"type\": \"is_relayed_in\",\n        \"to\": \"afc0a64b\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"21760f80\"\n      }\n    ]\n  },\n  \"ea694390\": {\n    \"title\": \"Palmar Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pediatrics\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Reflexes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003ePalmar Reflex\u003c/b\u003e, also known as the grasp reflex, is a primitive, involuntary reflex found in infants, characterized by the fingers closing and grasping an object when the palm is stroked.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eElicitation:\u003c/b\u003e Placing a finger or object into an infant\u0027s open palm causes them to reflexively grasp it.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDevelopmental Timeline:\u003c/b\u003e Present at birth and typically disappears by \u003cmark\u003e5-6 months of age\u003c/mark\u003e as voluntary motor control develops.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Basis:\u003c/b\u003e It is a spinal reflex that is inhibited by the maturing frontal lobes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance in Infants:\u003c/b\u003e Its presence is a sign of normal neurological development. Its absence or asymmetry may indicate CNS damage or peripheral nerve injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance in Adults:\u003c/b\u003e The re-emergence of the palmar reflex in an adult is a \u003cmark\u003efrontal release sign\u003c/mark\u003e, indicating damage to the frontal lobe (e.g., from dementia, stroke, or traumatic brain injury), which has removed the normal cortical inhibition of this primitive reflex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The reappearance of primitive reflexes like the palmar, rooting, or sucking reflex in an adult patient is a strong indicator of frontal lobe pathology.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003ePalmar Reflex\u003c/b\u003e serves as a developmental milestone; its presence in infancy is normal, but its persistence or re-emergence in later life is a pathological sign of frontal lobe disinhibition, unmasking a primitive spinal circuit.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"ccf246d3\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"frontal_lobe_lesion\"\n      }\n    ]\n  },\n  \"243d4db1\": {\n    \"title\": \"Pancuronium\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Neuromuscular Blockers\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePancuronium\u003c/b\u003e is a long-acting, \u003ci\u003enon-depolarizing neuromuscular blocking agent\u003c/i\u003e that acts as a competitive antagonist at nicotinic acetylcholine receptors at the neuromuscular junction, causing skeletal muscle paralysis.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Competitively antagonizes [[6a005559|ACh]] at the nicotinic (N\u003csub\u003eM\u003c/sub\u003e) receptors on the motor endplate, preventing muscle cell depolarization and contraction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e It is an aminosteroid non-depolarizing blocker, similar to rocuronium and vecuronium.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used in anesthesia to facilitate endotracheal intubation and provide skeletal muscle relaxation during surgery. Also used in ICUs to facilitate mechanical ventilation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Can cause tachycardia and hypertension due to its vagolytic effect (muscarinic receptor blockade) and slight sympathomimetic action.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReversal:\u003c/b\u003e Its effects can be reversed by increasing the amount of ACh in the synapse, which is achieved by administering an acetylcholinesterase inhibitor (e.g., neostigmine) along with an antimuscarinic agent (e.g., glycopyrrolate) to prevent systemic muscarinic side effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate non-depolarizing blockers like pancuronium from the depolarizing blocker succinylcholine. Non-depolarizing blockade is reversed by AChE inhibitors, whereas Phase I of succinylcholine block is potentiated by them.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePancuronium\u003c/b\u003e induces muscle paralysis by competitively blocking acetylcholine receptors at the neuromuscular junction, and its vagolytic side effect of causing tachycardia distinguishes it from other agents in its class.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"neuromuscular_blocker\"\n      },\n      {\n        \"type\": \"antagonizes\",\n        \"to\": \"nicotinic_acetylcholine_receptor\"\n      },\n      {\n        \"type\": \"is_reversed_by\",\n        \"to\": \"acetylcholinesterase_inhibitor\"\n      }\n    ]\n  },\n  \"4ae219da\": {\n    \"title\": \"Papilledema\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physical Findings\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePapilledema\u003c/b\u003e is swelling of the optic disc due to \u003ci\u003eincreased intracranial pressure (ICP)\u003c/i\u003e. It is almost always bilateral and results from impaired axoplasmic flow within the optic nerve.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Elevated ICP is transmitted through the subarachnoid space, which is continuous with the optic nerve sheath. This increased pressure obstructs axoplasmic transport in the optic nerve axons, leading to swelling of the nerve head (optic disc).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunduscopic Appearance:\u003c/b\u003e Characterized by \u003cmark\u003eblurring of the optic disc margins\u003c/mark\u003e, elevation of the optic disc, venous engorgement, and loss of the spontaneous venous pulsation. In severe cases, flame-shaped hemorrhages and cotton-wool spots may be present.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses of Increased ICP:\u003c/b\u003e Brain tumors, [[c20521ce|intracranial hemorrhage]], [[meningitis]], [[0bc2f200|hydrocephalus]], and [[7c4e7c74|idiopathic intracranial hypertension]] (pseudotumor cerebri).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms:\u003c/b\u003e Vision is often preserved initially, but patients may report transient visual obscurations. It is a sign of a serious underlying condition that can lead to permanent vision loss if the underlying cause is not treated. Patients often have headaches that are worse when lying down.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Papilledema is a key physical exam finding that signals elevated intracranial pressure. Its presence in a patient with a headache is a major red flag that warrants urgent neuroimaging.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePapilledema\u003c/b\u003e is the eye\u0027s window to intracranial pressure; swelling of the optic disc is a direct physical consequence of high pressure within the skull being transmitted down the optic nerve sheath, serving as a critical sign of a potentially life-threatening neurological condition.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"7c4e7c74\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"0bc2f200\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"be057cfc\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"meningitis\"\n      }\n    ]\n  },\n  \"a2e1097b\": {\n    \"title\": \"Paralysis\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Motor Deficits\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eParalysis\u003c/b\u003e is the loss of muscle function in part of the body, which can be complete or partial (paresis). It occurs when the communication pathway between the brain and the muscles is disrupted.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFlaccid Paralysis:\u003c/b\u003e Characterized by loss of muscle tone, muscle atrophy, and absent deep tendon reflexes. It is a sign of a \u003cmark\u003elower motor neuron (LMN) lesion\u003c/mark\u003e, affecting the nerve pathway from the anterior horn of the spinal cord to the muscle. Seen in [[75f2b918|poliomyelitis]] and [[ed52e40b|Guillain-Barr√© syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpastic Paralysis:\u003c/b\u003e Characterized by increased muscle tone (spasticity), hyperreflexia, and a positive Babinski sign. It is a sign of an \u003cmark\u003eupper motor neuron (UMN) lesion\u003c/mark\u003e, affecting motor pathways in the brain or spinal cord (e.g., corticospinal tract). Seen in [[c5da3c57|stroke]] and spinal cord injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFacial Paralysis:\u003c/b\u003e A peripheral lesion of CN VII causes paralysis of the entire ipsilateral face. A central (UMN) lesion causes paralysis of the contralateral lower face only, sparing the forehead.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOsmotic Demyelination Syndrome:\u003c/b\u003e Rapid correction of hyponatremia can cause acute paralysis and dysarthria.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The type of paralysis (flaccid vs. spastic) is crucial for localizing the neurological lesion to either the lower or upper motor neuron system.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe clinical character of \u003cb\u003eparalysis\u003c/b\u003e‚Äîwhether it is flaccid with atrophy or spastic with hyperreflexia‚Äîprovides a fundamental distinction that allows clinicians to localize the site of injury to either the peripheral (LMN) or central (UMN) motor pathways.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"lower_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"upper_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"7a680d3d\"\n      }\n    ]\n  },\n  \"61d955b1\": {\n    \"title\": \"Paramedian Pontine Reticular Formation (PPRF)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eParamedian Pontine Reticular Formation (PPRF)\u003c/b\u003e, also known as the horizontal gaze center, is a collection of neurons in the pons that is essential for coordinating voluntary horizontal eye movements (saccades).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The PPRF on one side controls gaze \u003cu\u003etoward the ipsilateral side\u003c/u\u003e. For example, the right PPRF coordinates looking to the right.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e The PPRF receives input from the contralateral frontal eye fields. It then projects to the ipsilateral [[dd11dde6|abducens nerve (CN VI)]] nucleus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCoordination:\u003c/b\u003e The abducens nucleus does two things: 1) sends a signal via CN VI to contract the ipsilateral lateral rectus muscle, and 2) sends a signal via the contralateral [[59ad6172|medial longitudinal fasciculus (MLF)]] to the [[68c66997|oculomotor nerve (CN III)]] nucleus to contract the contralateral medial rectus muscle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects:\u003c/b\u003e A unilateral lesion of the PPRF results in an \u003cmark\u003eipsilateral gaze palsy\u003c/mark\u003e, meaning the patient cannot look toward the side of the lesion. The eyes will deviate away from the side of the lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate a PPRF lesion from a frontal eye field (FEF) lesion. A destructive PPRF lesion causes eyes to look \u003ci\u003eaway\u003c/i\u003e from the lesion. A destructive FEF lesion causes eyes to look \u003ci\u003etoward\u003c/i\u003e the lesion.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003ePPRF\u003c/b\u003e is the final common pathway for horizontal gaze; its unilateral activation orchestrates the precise, yoked contraction of one eye\u0027s lateral rectus and the other\u0027s medial rectus to direct both eyes in unison toward the ipsilateral side.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Contralateral Frontal Eye Field] --\u003e B(PPRF); B --\u003e C(Ipsilateral CN VI Nucleus); C --\u003e D(Ipsilateral Lateral Rectus); C --\u003e E(Contralateral MLF); E --\u003e F(Contralateral CN III Nucleus); F --\u003e G(Contralateral Medial Rectus);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"controls\",\n        \"to\": \"horizontal_gaze\"\n      },\n      {\n        \"type\": \"projects_to\",\n        \"to\": \"dd11dde6\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"gaze_palsy\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"bf549b2f\"\n      }\n    ]\n  },\n  \"7759e8c1\": {\n    \"title\": \"Parasympathetic Nervous System (Cranial Innervation)\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Autonomic\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Autonomic Nervous System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003ecranial division of the parasympathetic nervous system\u003c/b\u003e provides involuntary \\\"rest and digest\\\" innervation to structures in the head, neck, thorax, and abdomen via four specific cranial nerves: the Oculomotor (III), Facial (VII), Glossopharyngeal (IX), and Vagus (X) nerves.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCN III (Oculomotor):\u003c/b\u003e Preganglionic fibers from the Edinger-Westphal nucleus synapse in the ciliary ganglion. Postganglionic fibers innervate the sphincter pupillae (causing miosis) and the ciliary muscle (causing [[81b5f5fe|accommodation]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCN VII (Facial):\u003c/b\u003e Preganglionic fibers from the superior salivatory nucleus synapse in the pterygopalatine and submandibular ganglia. Postganglionic fibers stimulate secretion from the lacrimal, submandibular, and sublingual glands.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCN IX (Glossopharyngeal):\u003c/b\u003e Preganglionic fibers from the inferior salivatory nucleus synapse in the otic ganglion. Postganglionic fibers stimulate secretion from the parotid gland.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCN X (Vagus):\u003c/b\u003e The major parasympathetic nerve, providing innervation to the heart, lungs, and GI tract down to the splenic flexure. Its dorsal motor nucleus is a key autonomic center in the medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the cranial nerves with parasympathetic function: CN III, VII, IX, and X.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe cranial outflow of the parasympathetic system precisely controls visceral functions in the head and torso, from constricting the pupil with CN III to slowing the heart with CN X, all originating from specific nuclei within the brainstem.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"autonomic_nervous_system\"\n      },\n      {\n        \"type\": \"is_carried_by\",\n        \"to\": \"68c66997\"\n      },\n      {\n        \"type\": \"is_carried_by\",\n        \"to\": \"dea9755f\"\n      },\n      {\n        \"type\": \"is_carried_by\",\n        \"to\": \"97e2c817\"\n      },\n      {\n        \"type\": \"is_carried_by\",\n        \"to\": \"7c12e7a3\"\n      }\n    ]\n  },\n  \"e7b51f5c\": {\n    \"title\": \"Paraventricular Nucleus (PVN)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Anatomy\",\n      \"Hypothalamus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eParaventricular Nucleus (PVN)\u003c/b\u003e is a key nucleus in the [[89e86633|hypothalamus]] that synthesizes and secretes several hormones, most notably \u003ci\u003eoxytocin\u003c/i\u003e and corticotropin-releasing hormone (CRH), and plays a central role in regulating stress, metabolism, and autonomic functions.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHormone Synthesis:\u003c/b\u003e Synthesizes \u003cmark\u003eoxytocin\u003c/mark\u003e, which is then transported to and released from the posterior pituitary. It also synthesizes a smaller amount of ADH.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHPA Axis Control:\u003c/b\u003e Synthesizes and secretes \u003cmark\u003ecorticotropin-releasing hormone (CRH)\u003c/mark\u003e into the hypophyseal portal system, which stimulates the anterior pituitary to release ACTH, initiating the stress response.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Hormones:\u003c/b\u003e Also produces thyrotropin-releasing hormone (TRH) and somatostatin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAutonomic Regulation:\u003c/b\u003e Projects to autonomic centers in the brainstem and spinal cord to regulate sympathetic and parasympathetic activity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Associate the Paraventricular Nucleus primarily with \u003cb\u003eoxytocin\u003c/b\u003e and \u003cb\u003eCRH\u003c/b\u003e synthesis. Contrast it with the supraoptic nucleus, which primarily synthesizes ADH.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eParaventricular Nucleus\u003c/b\u003e is a master regulator within the hypothalamus, integrating endocrine and autonomic signals and producing key hormones like oxytocin and CRH to control everything from childbirth and social bonding to the body\u0027s stress response.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Paraventricular Nucleus]; A --\u003e B(Oxytocin --\u003e Posterior Pituitary); A --\u003e C(CRH --\u003e Anterior Pituitary); A --\u003e D(Autonomic Centers);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"synthesizes\",\n        \"to\": \"911d3b47\"\n      },\n      {\n        \"type\": \"synthesizes\",\n        \"to\": \"corticotropin_releasing_hormone\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"supraoptic_nucleus\"\n      }\n    ]\n  },\n  \"26efa771\": {\n    \"title\": \"Parietal Lobe\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Cortex\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eParietal Lobe\u003c/b\u003e is one of the four major lobes of the cerebral cortex, located superior to the occipital and temporal lobes and posterior to the frontal lobe. It is primarily responsible for processing somatosensory information, spatial awareness, and navigation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePrimary Somatosensory Cortex:\u003c/b\u003e Located in the postcentral gyrus, it receives sensory information (touch, pressure, pain, temperature, proprioception) from the contralateral side of the body via the [[afc0a64b|thalamus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eDominant Parietal Lobe (usually Left):\u003c/b\u003e Damage can cause \u003cmark\u003eGerstmann syndrome\u003c/mark\u003e, which includes agraphia, [[8558c64b|acalculia]], finger agnosia, and left-right disorientation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNon-dominant Parietal Lobe (usually Right):\u003c/b\u003e Damage can cause \u003cmark\u003ehemispatial neglect syndrome\u003c/mark\u003e, where the patient ignores the contralateral side of their body and space.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOptic Radiations:\u003c/b\u003e The superior optic radiation (Baum\u0027s loop) passes through the parietal lobe. A lesion here causes a contralateral inferior quadrantanopia (\\\"pie on the floor\\\").\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Lesions of the parietal lobe are all about sensory and spatial deficits. Remember to distinguish between the functions of the dominant (language-related, calculation) and non-dominant (spatial awareness) sides.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eParietal Lobe\u003c/b\u003e integrates sensory information to form a coherent perception of the world and our relationship to it; lesions here do not cause simple blindness or paralysis but rather profound deficits in spatial awareness and interpretation, such as hemineglect.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"cerebral_cortex\"\n      },\n      {\n        \"type\": \"lesion_can_cause\",\n        \"to\": \"38f3ed1f\"\n      },\n      {\n        \"type\": \"lesion_can_cause\",\n        \"to\": \"134828d8\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"somatosensory_cortex\"\n      }\n    ]\n  },\n  \"9f603521\": {\n    \"title\": \"Parinaud Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Oncology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brainstem Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eParinaud Syndrome\u003c/b\u003e, also known as dorsal midbrain syndrome, is a neurological condition resulting from compression of the dorsal midbrain (specifically the superior colliculus and pretectal area), characterized by a classic triad of vertical gaze palsy, pupillary abnormalities, and convergence-retraction nystagmus.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by a \u003cmark\u003epineal gland tumor\u003c/mark\u003e (e.g., pinealoma, germinoma) compressing the dorsal midbrain. Other causes include stroke, [[45dd6d19|multiple sclerosis]], or obstructive [[0bc2f200|hydrocephalus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Triad:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eUpward Gaze Palsy:\u003c/b\u003e The most prominent feature is the inability to look up.\u003cbr\u003e2. \u003cb\u003ePupillary Light-Near Dissociation:\u003c/b\u003e Pupils do not constrict to light but do constrict with [[81b5f5fe|accommodation]] (pseudo-Argyll Robertson pupils).\u003cbr\u003e3. \u003cb\u003eConvergence-Retraction Nystagmus:\u003c/b\u003e On attempted upward gaze, the eyes converge and retract into the orbits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Signs:\u003c/b\u003e Eyelid retraction (Collier\u0027s sign) may also be present.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A young male patient presenting with an inability to look up, headache (from hydrocephalus), and pupillary abnormalities should make you strongly suspect a pineal tumor causing Parinaud syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eParinaud Syndrome\u003c/b\u003e is a specific constellation of neuro-ophthalmologic signs that precisely localizes a lesion to the dorsal midbrain, with the upward gaze palsy being the most striking feature resulting from compression of the vertical gaze center.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Pineal Tumor] --Compresses--\u003e B(Dorsal Midbrain); B --\u003e C(Parinaud Syndrome); C --\u003e D(Upward Gaze Palsy); C --\u003e E(Pupillary Light-Near Dissociation); C --\u003e F(Convergence-Retraction Nystagmus);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"dorsal_midbrain\"\n      },\n      {\n        \"type\": \"is_often_caused_by\",\n        \"to\": \"pineal_tumor\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"upward_gaze_palsy\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"light_near_dissociation\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9569,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"ed7360de\": {\n    \"title\": \"Painless Otorr"
      }, {
        "text": "hea\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Otology\",\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePainless otorrhea\u003c/b\u003e is the drainage of fluid from the ear without"
      }, {
        "text": " associated pain, a key clinical sign that often points towards a diagnosis of \u003ci\u003echolesteatoma\u003c/i\u003e.\u003c/p\u003e\","
      }, {
        "text": "\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e This symptom is the hallmark presentation of a [[0"
      }, {
        "text": "3ef3134|cholesteatoma]], an abnormal growth of keratinized squamous epithelium in the middle ear."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology in Cholesteatoma:\u003c/b\u003e The trapped epithelial debris within the cholesteatoma sac"
      }, {
        "text": " becomes chronically infected with bacteria, leading to a persistent, often foul-smelling, painless discharge.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferential"
      }, {
        "text": " Diagnosis:\u003c/b\u003e While cholesteatoma is the classic cause, other conditions like chronic suppurative otitis media with"
      }, {
        "text": " a tympanic membrane perforation can also present with painless otorrhea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContrast with Acute Otitis Media:\u003c/b\u003e In"
      }, {
        "text": " [[a03641af|acute otitis media]], otorrhea occurs only after tympanic membrane rupture and is typically"
      }, {
        "text": " preceded by severe pain (otalgia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a history of recurrent ear infections who"
      }, {
        "text": " now presents with painless, foul-smelling ear discharge and conductive hearing loss should be evaluated for a [[03ef3134"
      }, {
        "text": "|cholesteatoma]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe absence of pain in the presence"
      }, {
        "text": " of chronic ear drainage is a significant red flag; \u003cb\u003epainless otorrhea\u003c/b\u003e strongly suggests an underlying destructive process like a [[03ef3"
      }, {
        "text": "134|cholesteatoma]], which erodes bone silently, rather than an acute, painful infection.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_hallmark_of"
      }, {
        "text": "\",\n        \"to\": \"03ef3134\"\n      },\n      {\n        \"type\": \"d"
      }, {
        "text": "ifferentiated_from_symptom_of\",\n        \"to\": \"a03641af\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"944bb118\": {\n    \"title\": \"Outer Ear\",\n    \""
      }, {
        "text": "primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Otology\",\n      \"Anatomy\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Otology\",\n      \"Anatomy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003eOuter Ear\u003c/b\u003e is the most external portion of the auditory system, consisting of the \u003ci\u003epinna (auricle)\u003c/i\u003e and the "
      }, {
        "text": "\u003ci\u003eexternal auditory canal\u003c/i\u003e, which terminates at the tympanic membrane. Its primary function is to collect sound waves and channel"
      }, {
        "text": " them to the middle ear.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e Includes the pinna (the"
      }, {
        "text": " visible part of the ear) and the external auditory canal (the ear canal).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The pinna helps"
      }, {
        "text": " to collect and localize sound. The external auditory canal funnels the sound waves to the tympanic membrane, causing it to vibrate.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Innervation:\u003c/b\u003e Sensory innervation to the external ear is complex, involving branches from multiple cranial nerves (CN V\u003csub\u003e3\u003c/sub\u003e, VII"
      }, {
        "text": ", X) and cervical nerves (C2, C3).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e The most common pathology of"
      }, {
        "text": " the outer ear is [[otitis_externa|otitis externa]] (\\\"swimmer\u0027s ear\\\"), an"
      }, {
        "text": " infection of the external auditory canal, often caused by \u003ci\u003ePseudomonas aeruginosa\u003c/i\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember"
      }, {
        "text": " that manipulation of the pinna or tragus causes pain in [[otitis_externa|otitis externa]], a"
      }, {
        "text": " key feature distinguishing it from [[a03641af|otitis media]] where the pain is internal and"
      }, {
        "text": " not exacerbated by external touch.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eOuter Ear\u003c/b\u003e functions"
      }, {
        "text": " as a biological funnel, capturing and directing sound waves toward the tympanic membrane to initiate the mechanical process of hearing, and"
      }, {
        "text": " its exposure to the environment makes it susceptible to infections like otitis externa.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },"
      }, {
        "text": "\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to"
      }, {
        "text": "\": \"ear\"\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"ot"
      }, {
        "text": "itis_externa\"\n      },\n      {\n        \"type\": \"transmits_sound_to\","
      }, {
        "text": "\n        \"to\": \"middle_ear\"\n      }\n    ]\n  },\n  \"42"
      }, {
        "text": "9fc155\": {\n    \"title\": \"Oxazepam\",\n    \"primaryType\": \"drug"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neu"
      }, {
        "text": "rology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Anxiolytics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eOxazepam\u003c/b\u003e is a short-to-intermediate acting \u003ci\u003ebenzodiazepine\u003c/i\u003e used for the treatment of anxiety and"
      }, {
        "text": " acute alcohol withdrawal. It is notable for its metabolism via glucuronidation, making it safer in patients with liver disease.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Like other benzodiazepines, it facilitates the action of [[5aa"
      }, {
        "text": "5cb91|GABA]] at the GABA\u003csub\u003eA\u003c/sub\u003e receptor, increasing the \u003cmark\u003efrequency\u003c/mark\u003e of Cl"
      }, {
        "text": "\u003csup\u003e-\u003c/sup\u003e channel opening and causing CNS depression.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetabolism:\u003c/b\u003e Undergoes direct glucuronidation in"
      }, {
        "text": " the liver without involving the cytochrome P450 system. This makes its metabolism less affected by liver disease or drugs that inhibit"
      }, {
        "text": "/induce CYP enzymes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for anxiety disorders, panic attacks, and management of alcohol withdrawal symptoms"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eSafe in Liver Disease:\u003c/b\u003e Along with Lorazepam and Temazepam, Oxazepam is a preferred benzodiazepine in"
      }, {
        "text": " patients with severe liver disease or in the elderly. Mnemonic: \u003cb\u003eO\u003c/b\u003eutside \u003cb\u003eT\u003c/b\u003ehe \u003cb\u003eL"
      }, {
        "text": "\u003c/b\u003eiver (\u003cb\u003eO\u003c/b\u003exazepam, \u003cb\u003eT\u003c/b\u003eemazepam, \u003cb\u003eL\u003c/b\u003eorazepam).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " For a patient with cirrhosis and alcohol withdrawal requiring a benzodiazepine, choose one that is metabolized \u0027Outside The Liver\u0027 like"
      }, {
        "text": " Oxazepam or Lorazepam.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eOxazepam\u0027s\u003c/b\u003e key"
      }, {
        "text": " feature is its metabolism through glucuronidation, bypassing the cytochrome P450 system. This makes it a significantly safer benzodiazep"
      }, {
        "text": "ine choice for patients with compromised liver function, such as those with alcoholic cirrhosis who are undergoing withdrawal.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"14464617\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_treatment_for\",\n        \"to\": \"anxiety_disorders\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_a_treatment_for\",\n        \"to\": \"alcohol_withdrawal\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_safer_in\",\n        \"to\": \"liver_disease\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"911d3b47\": {\n    \"title\": \"Oxytocin\","
      }, {
        "text": "\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Endocrinology\",\n      "
      }, {
        "text": "\"Obstetrics\",\n      \"Neuroscience\",\n      \"USMLE\"\n    ],\n    \"classificationPath\":"
      }, {
        "text": " [\n      \"Endocrine\",\n      \"Physiology\",\n      \"Hypothalamic-Pituitary Axis"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOxytocin\u003c/b\u003e is a"
      }, {
        "text": " peptide hormone and neuropeptide that is synthesized in the [[89e86633|hypothalamus]] and"
      }, {
        "text": " released from the posterior pituitary. It plays a crucial role in uterine contractions during labor and milk let-down during lactation,"
      }, {
        "text": " and is also involved in social bonding.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSynthesis and Release"
      }, {
        "text": ":\u003c/b\u003e Synthesized primarily in the \u003cmark\u003eparaventricular nuclei\u003c/mark\u003e of the [[89e86633"
      }, {
        "text": "|hypothalamus]], transported down axons, and stored and released from the posterior pituitary (neurohypophysis).\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Uterine Contractions:\u003c/b\u003e Stimulates uterine smooth muscle contraction, which is essential for labor and delivery. Exogenous oxytocin ("
      }, {
        "text": "Pitocin) is used to induce or augment labor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMilk Ejection (Let-down reflex):\u003c/b\u003e Suck"
      }, {
        "text": "ling stimulates oxytocin release, which causes contraction of myoepithelial cells surrounding the mammary alveoli, ejecting milk.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSocial Bonding"
      }, {
        "text": ":\u003c/b\u003e Acts as a neurotransmitter in the brain, involved in social recognition, pair bonding, maternal behavior, and trust.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Remember that oxytocin and ADH are both produced in the hypothalamus and released from the posterior pituitary."
      }, {
        "text": " Oxytocin is for \u0027squeezing\u0027 (uterine contractions, milk ejection), while ADH is for \u0027saving\u0027"
      }, {
        "text": " water.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eOxytocin\u003c/b\u003e functions as both a peripheral hormone and"
      }, {
        "text": " a central neurotransmitter; peripherally, it is the primary driver of uterine contractions and milk ejection, while centrally, it modulates"
      }, {
        "text": " complex social behaviors, earning it the nickname \u0027the love hormone\u0027.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD"
      }, {
        "text": "; A[Hypothalamus - Paraventricular Nucleus] --\u003e B(Posterior Pituitary); B --"
      }, {
        "text": "Release--\u003e C(Oxytocin); C --\u003e D(Uterine Contraction); C --\u003e E(Milk Ejection"
      }, {
        "text": ");\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_synthesized_in\",\n        \"to\":"
      }, {
        "text": " \"e7b51f5c\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "released_from\",\n        \"to\": \"posterior_pituitary\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"stimulates\",\n        \"to\": \"uterine_contraction\"\n      },\n      {\n        \"type\": \"stimulates\","
      }, {
        "text": "\n        \"to\": \"milk_ejection_reflex\"\n      }\n    ]\n  },\n  \"71"
      }, {
        "text": "867ae0\": {\n    \"title\": \"Pacinian Corpuscles\",\n    \"primaryType\": \"anatomy\",\n    \""
      }, {
        "text": "tags\": [\n      \"Neuroscience\",\n      \"Dermatology\",\n      \"Anatomy\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and"
      }, {
        "text": " Physiology\",\n      \"Sensory System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePacinian"
      }, {
        "text": " corpuscles\u003c/b\u003e are large, encapsulated sensory receptors located in the deep dermis and subcutaneous tissue that are specialized to detect high"
      }, {
        "text": "-frequency \u003ci\u003evibration\u003c/i\u003e and deep \u003ci\u003epressure\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Large, onion-like (lamellated) capsule surrounding a single nerve ending.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e They"
      }, {
        "text": " are \u003cmark\u003erapidly adapting\u003c/mark\u003e mechanoreceptors, meaning they respond to changes in stimuli (onset and"
      }, {
        "text": " offset of pressure) rather than sustained pressure. This property makes them ideal for sensing vibration.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Found"
      }, {
        "text": " deep in the dermis, subcutaneous tissue, ligaments, and joint capsules. Abundant in fingertips and genitals.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNerve"
      }, {
        "text": " Fibers:\u003c/b\u003e Transmitted by large, myelinated AŒ≤ fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Signals for vibration and"
      }, {
        "text": " pressure travel via the [[e7f5cbbe|dorsal column-medial lemniscus pathway]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e When testing sensory modalities, remember the specific receptors: Vibration \u003d Pacinian corpuscles. Fine touch \u003d Meissner\u0027"
      }, {
        "text": "s corpuscles. Sustained pressure \u003d Merkel discs.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " unique, onion-like layered structure of \u003cb\u003ePacinian corpuscles\u003c/b\u003e acts as a mechanical filter, allowing them"
      }, {
        "text": " to respond only to rapid changes in pressure, which makes them exquisitely sensitive to high-frequency vibration rather than static touch.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"senses\",\n        \"to\": \""
      }, {
        "text": "vibration\"\n      },\n      {\n        \"type\": \"senses\",\n        \"to\": \"pressure_"
      }, {
        "text": "sensation\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"mechanoreceptor\"\n      },\n      {\n        \"type\": \"signal_is"
      }, {
        "text": "_transmitted_via\",\n        \"to\": \"e7f5cbbe\"\n      }\n    ]\n  },\n"
      }, {
        "text": "  \"c26e6817\": {\n    \"title\": \"Pain\",\n    \"primary"
      }, {
        "text": "Type\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Physiology\",\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Sensory System\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003e\u003cb\u003ePain\u003c/b\u003e (nociception) is an unpleasant sensory and emotional experience associated with actual"
      }, {
        "text": " or potential tissue damage. It is transmitted from the periphery to the central nervous system via specialized nerve fibers and pathways.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSensory Receptors:\u003c/b\u003e Mediated by \u003cmark\u003efree nerve endings\u003c/mark\u003e of"
      }, {
        "text": " nociceptors, which respond to noxious thermal, mechanical, or chemical stimuli.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNerve Fibers:\u003c/b\u003e Transmitted"
      }, {
        "text": " by two types of fibers: \u003cbr\u003e - \u003cb\u003eAŒ¥ fibers:\u003c/b\u003e Thinly myelinated, transmit fast,"
      }, {
        "text": " sharp, well-localized pain.\u003cbr\u003e - \u003cb\u003eC fibers:\u003c/b\u003e Unmyelinated, transmit slow, dull"
      }, {
        "text": ", poorly-localized pain.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Signals travel to the dorsal horn of the spinal cord, synapse,"
      }, {
        "text": " decussate at the anterior white commissure, and ascend in the contralateral \u003cmark\u003espinothalamic tract\u003c/mark\u003e to"
      }, {
        "text": " the VPL nucleus of the [[afc0a64b|thalamus]], and then to the som"
      }, {
        "text": "atosensory cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePeriorbital Pain:\u003c/b\u003e A key feature of [[21760f"
      }, {
        "text": "80|cluster headaches]], often described as excruciating.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePain in MS:\u003c/b\u003e Neuropathic pain is"
      }, {
        "text": " a common symptom in [[45dd6d19|multiple sclerosis]], often treated with anticonvulsants or"
      }, {
        "text": " TCAs.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe sensation of \u003cb\u003epain\u003c/b\u003e is not"
      }, {
        "text": " a single modality but is dually encoded by fast AŒ¥ fibers for initial sharp warning and slow C fibers for prolonged aching"
      }, {
        "text": ", both of which travel through the dedicated spinothalamic tract to alert the brain to tissue damage.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Noxious Stimulus] --\u003e B(Free Nerve Endings); B --\u003e C(AŒ¥ \u0026"
      }, {
        "text": " C Fibers); C --\u003e D(Dorsal Horn); D --\u003e E(Decussation); E --\u003e F(Spinothalamic"
      }, {
        "text": " Tract); F --\u003e G(Thalamus); G --\u003e H(Somatosensory Cortex);\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_transmitted_via\",\n        \"to\": \"07eecef1\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_sensed_by\",\n        \"to\": \"1e7ec6"
      }, {
        "text": "44\"\n      },\n      {\n        \"type\": \"is_relayed_in\",\n        \"to\": \"af"
      }, {
        "text": "c0a64b\"\n      },\n      {\n        \"type\": \"is_a_s"
      }, {
        "text": "ymptom_of\",\n        \"to\": \"21760f80\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"ea694390\": {\n    \"title\": \"Pal"
      }, {
        "text": "mar Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Pediatrics\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Reflexes\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003ePalmar Reflex\u003c/b\u003e, also known as the grasp"
      }, {
        "text": " reflex, is a primitive, involuntary reflex found in infants, characterized by the fingers closing and grasping an object when the palm is"
      }, {
        "text": " stroked.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eElicitation:\u003c/b\u003e Placing a finger or object into"
      }, {
        "text": " an infant\u0027s open palm causes them to reflexively grasp it.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDevelopmental Timeline:\u003c/b\u003e Present at"
      }, {
        "text": " birth and typically disappears by \u003cmark\u003e5-6 months of age\u003c/mark\u003e as voluntary motor control develops.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeu"
      }, {
        "text": "rological Basis:\u003c/b\u003e It is a spinal reflex that is inhibited by the maturing frontal lobes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance in"
      }, {
        "text": " Infants:\u003c/b\u003e Its presence is a sign of normal neurological development. Its absence or asymmetry may indicate CNS damage or peripheral nerve injury"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance in Adults:\u003c/b\u003e The re-emergence of the palmar reflex in an adult is a \u003c"
      }, {
        "text": "mark\u003efrontal release sign\u003c/mark\u003e, indicating damage to the frontal lobe (e.g., from dementia, stroke, or traumatic"
      }, {
        "text": " brain injury), which has removed the normal cortical inhibition of this primitive reflex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " reappearance of primitive reflexes like the palmar, rooting, or sucking reflex in an adult patient is a strong indicator of frontal"
      }, {
        "text": " lobe pathology.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003ePalmar Reflex\u003c/b\u003e serves as a developmental"
      }, {
        "text": " milestone; its presence in infancy is normal, but its persistence or re-emergence in later life is a pathological sign of"
      }, {
        "text": " frontal lobe disinhibition, unmasking a primitive spinal circuit.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"ccf2"
      }, {
        "text": "46d3\"\n      },\n      {\n        \"type\": \"is_a_sign_of\","
      }, {
        "text": "\n        \"to\": \"frontal_lobe_lesion\"\n      }\n    ]\n  },\n  \"2"
      }, {
        "text": "43d4db1\": {\n    \"title\": \"Pancuronium\",\n    \"primaryType\": \"drug\",\n"
      }, {
        "text": "    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Neu"
      }, {
        "text": "romuscular Blockers\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePancur"
      }, {
        "text": "onium\u003c/b\u003e is a long-acting, \u003ci\u003enon-depolarizing neuromuscular blocking agent\u003c/i\u003e that acts as a competitive antagonist at"
      }, {
        "text": " nicotinic acetylcholine receptors at the neuromuscular junction, causing skeletal muscle paralysis.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Mechanism of Action:\u003c/b\u003e Competitively antagonizes [[6a005559|ACh]] at the nicotinic ("
      }, {
        "text": "N\u003csub\u003eM\u003c/sub\u003e) receptors on the motor endplate, preventing muscle cell depolarization and contraction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e It"
      }, {
        "text": " is an aminosteroid non-depolarizing blocker, similar to rocuronium and vecuronium.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used in"
      }, {
        "text": " anesthesia to facilitate endotracheal intubation and provide skeletal muscle relaxation during surgery. Also used in ICUs to facilitate mechanical"
      }, {
        "text": " ventilation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Can cause tachycardia and hypertension due to its vagolytic effect (muscarinic receptor"
      }, {
        "text": " blockade) and slight sympathomimetic action.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReversal:\u003c/b\u003e Its effects can be reversed by increasing"
      }, {
        "text": " the amount of ACh in the synapse, which is achieved by administering an acetylcholinesterase inhibitor (e.g., ne"
      }, {
        "text": "ostigmine) along with an antimuscarinic agent (e.g., glycopyrrolate) to prevent systemic"
      }, {
        "text": " muscarinic side effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate non-depolarizing blockers like pancur"
      }, {
        "text": "onium from the depolarizing blocker succinylcholine. Non-depolarizing blockade is reversed by AChE inhibitors, whereas"
      }, {
        "text": " Phase I of succinylcholine block is potentiated by them.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Pancuronium\u003c/b\u003e induces muscle paralysis by competitively blocking acetylcholine receptors at the neuromuscular junction, and its vagolytic side effect of causing tachycardia distinguishes"
      }, {
        "text": " it from other agents in its class.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"neuromuscular_blocker\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"antagonizes\",\n        \"to\": \"nicotinic_acetylcholine_receptor\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_reversed_by\",\n        \"to\": \"acetylcholinesterase"
      }, {
        "text": "_inhibitor\"\n      }\n    ]\n  },\n  \"4ae219da\": {\n    \"title\": \""
      }, {
        "text": "Papilledema\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Ophthalmology\",\n      \"Physical Findings\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003ePapilledema\u003c/b\u003e is swelling of the optic disc due to "
      }, {
        "text": "\u003ci\u003eincreased intracranial pressure (ICP)\u003c/i\u003e. It is almost always bilateral and results from impaired axoplasmic flow within the optic nerve.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Elevated ICP is transmitted through the sub"
      }, {
        "text": "arachnoid space, which is continuous with the optic nerve sheath. This increased pressure obstructs axoplasmic transport in the optic nerve axons"
      }, {
        "text": ", leading to swelling of the nerve head (optic disc).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunduscopic Appearance:\u003c/b\u003e Characterized by \u003cmark\u003eblur"
      }, {
        "text": "ring of the optic disc margins\u003c/mark\u003e, elevation of the optic disc, venous engorgement, and loss of the spontaneous"
      }, {
        "text": " venous pulsation. In severe cases, flame-shaped hemorrhages and cotton-wool spots may be present.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Causes of Increased ICP:\u003c/b\u003e Brain tumors, [[c20521ce|intracranial hemorrhage]], [[men"
      }, {
        "text": "ingitis]], [[0bc2f200|hydrocephalus]], and [[7c4e7c7"
      }, {
        "text": "4|idiopathic intracranial hypertension]] (pseudotumor cerebri).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms:\u003c/b\u003e Vision is often preserved"
      }, {
        "text": " initially, but patients may report transient visual obscurations. It is a sign of a serious underlying condition that can lead to permanent vision loss if the"
      }, {
        "text": " underlying cause is not treated. Patients often have headaches that are worse when lying down.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Pap"
      }, {
        "text": "illedema is a key physical exam finding that signals elevated intracranial pressure. Its presence in a patient with a headache is a major"
      }, {
        "text": " red flag that warrants urgent neuroimaging.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003ePapilledema\u003c/b\u003e is"
      }, {
        "text": " the eye\u0027s window to intracranial pressure; swelling of the optic disc is a direct physical consequence of high pressure within the skull being"
      }, {
        "text": " transmitted down the optic nerve sheath, serving as a critical sign of a potentially life-threatening neurological condition.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\":"
      }, {
        "text": " \"7c4e7c74\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_sign_of\",\n        \"to\": \"0bc2f200\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_sign_of\",\n        \"to\": \"be057cfc\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"meningitis\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"a2e1097b\": {\n    \"title\": \""
      }, {
        "text": "Paralysis\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Motor Deficits\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eParalysis\u003c/b\u003e is the loss of muscle function in part of the body, which can be complete or partial ("
      }, {
        "text": "paresis). It occurs when the communication pathway between the brain and the muscles is disrupted.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFlaccid Paralysis:\u003c/b\u003e Characterized by loss of muscle tone, muscle atrophy, and absent"
      }, {
        "text": " deep tendon reflexes. It is a sign of a \u003cmark\u003elower motor neuron (LMN) lesion\u003c/mark\u003e,"
      }, {
        "text": " affecting the nerve pathway from the anterior horn of the spinal cord to the muscle. Seen in [[75f2b"
      }, {
        "text": "918|poliomyelitis]] and [[ed52e40b|Guillain-Barr√© syndrome]].\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eSpastic Paralysis:\u003c/b\u003e Characterized by increased muscle tone (spasticity), hyperreflexia, and a"
      }, {
        "text": " positive Babinski sign. It is a sign of an \u003cmark\u003eupper motor neuron (UMN) lesion\u003c/mark\u003e, affecting motor"
      }, {
        "text": " pathways in the brain or spinal cord (e.g., corticospinal tract). Seen in [[c5da3"
      }, {
        "text": "c57|stroke]] and spinal cord injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFacial Paralysis:\u003c/b\u003e A peripheral lesion of"
      }, {
        "text": " CN VII causes paralysis of the entire ipsilateral face. A central (UMN) lesion causes paralysis of the contralateral lower face only"
      }, {
        "text": ", sparing the forehead.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOsmotic Demyelination Syndrome:\u003c/b\u003e Rapid correction of hyponatremia can cause acute"
      }, {
        "text": " paralysis and dysarthria.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The type of paralysis (flaccid vs."
      }, {
        "text": " spastic) is crucial for localizing the neurological lesion to either the lower or upper motor neuron system.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003eThe clinical character of \u003cb\u003eparalysis\u003c/b\u003e‚Äîwhether it is flaccid with atrophy or spastic with hyperreflexia‚Äî"
      }, {
        "text": "provides a fundamental distinction that allows clinicians to localize the site of injury to either the peripheral (LMN) or central (UMN) motor"
      }, {
        "text": " pathways.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_sign_of\",\n        \"to\": \"lower_motor_neuron_les"
      }, {
        "text": "ion\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        "
      }, {
        "text": "\"to\": \"upper_motor_neuron_lesion\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_a_symptom_of\",\n        \"to\": \"c5da3c57\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"7"
      }, {
        "text": "a680d3d\"\n      }\n    ]\n  },\n  \"61d95"
      }, {
        "text": "5b1\": {\n    \"title\": \"Paramedian Pontine Reticular Formation (PPRF)\",\n    \"primaryType\": \""
      }, {
        "text": "anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Ophthalmology"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special"
      }, {
        "text": " Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eParamedian Pontine Reticular Formation (PPRF)\u003c/b\u003e, also known as the horizontal"
      }, {
        "text": " gaze center, is a collection of neurons in the pons that is essential for coordinating voluntary horizontal eye movements (saccades"
      }, {
        "text": ").\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The PPRF on one side controls"
      }, {
        "text": " gaze \u003cu\u003etoward the ipsilateral side\u003c/u\u003e. For example, the right PPRF coordinates looking to the right.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway"
      }, {
        "text": ":\u003c/b\u003e The PPRF receives input from the contralateral frontal eye fields. It then projects to the ipsilateral [[dd1"
      }, {
        "text": "1dde6|abducens nerve (CN VI)]] nucleus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCoordination:\u003c/b\u003e The ab"
      }, {
        "text": "ducens nucleus does two things: 1) sends a signal via CN VI to contract the ipsilateral lateral rectus muscle, and 2) sends"
      }, {
        "text": " a signal via the contralateral [[59ad6172|medial longitudinal fasciculus (MLF)]"
      }, {
        "text": "] to the [[68c66997|oculomotor nerve (CN III)]] nucleus to"
      }, {
        "text": " contract the contralateral medial rectus muscle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects:\u003c/b\u003e A unilateral lesion of the PPRF results"
      }, {
        "text": " in an \u003cmark\u003eipsilateral gaze palsy\u003c/mark\u003e, meaning the patient cannot look toward the side of the lesion. The"
      }, {
        "text": " eyes will deviate away from the side of the lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate a PPRF lesion from"
      }, {
        "text": " a frontal eye field (FEF) lesion. A destructive PPRF lesion causes eyes to look \u003ci\u003eaway\u003c/i\u003e from the lesion. A destructive"
      }, {
        "text": " FEF lesion causes eyes to look \u003ci\u003etoward\u003c/i\u003e the lesion.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003e"
      }, {
        "text": "PPRF\u003c/b\u003e is the final common pathway for horizontal gaze; its unilateral activation orchestrates the precise, yoked contraction of one"
      }, {
        "text": " eye\u0027s lateral rectus and the other\u0027s medial rectus to direct both eyes in unison toward the ipsilateral side.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"graph TD; A[Contralateral Frontal Eye Field] --\u003e B(PPRF); B --\u003e C(I"
      }, {
        "text": "psilateral CN VI Nucleus); C --\u003e D(Ipsilateral Lateral Rectus); C --\u003e E(Contralateral ML"
      }, {
        "text": "F); E --\u003e F(Contralateral CN III Nucleus); F --\u003e G(Contralateral Medial Rectus);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"controls\",\n        \"to\": \"horizontal_"
      }, {
        "text": "gaze\"\n      },\n      {\n        \"type\": \"projects_to\",\n        \"to\":"
      }, {
        "text": " \"dd11dde6\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"g"
      }, {
        "text": "aze_palsy\"\n      },\n      {\n        \"type\": \"is_located_in\","
      }, {
        "text": "\n        \"to\": \"bf549b2f\"\n      }\n    ]\n  },\n  \"77"
      }, {
        "text": "59e8c1\": {\n    \"title\": \"Parasympathetic Nervous System (Cranial Innervation)\",\n    \"primaryType\":"
      }, {
        "text": " \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Autonomic\",\n      \"Physiology\",\n"
      }, {
        "text": "      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses"
      }, {
        "text": "\",\n      \"Anatomy and Physiology\",\n      \"Autonomic Nervous System\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003eThe \u003cb\u003ecranial division of the parasympathetic nervous system\u003c/b\u003e provides involuntary \\\"rest and digest\\\""
      }, {
        "text": " innervation to structures in the head, neck, thorax, and abdomen via four specific cranial nerves: the Oculomotor (III"
      }, {
        "text": "), Facial (VII), Glossopharyngeal (IX), and Vagus (X) nerves.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eCN III (Oculomotor):\u003c/b\u003e Preganglionic fibers from the Edinger-Westphal nucleus synapse in the c"
      }, {
        "text": "iliary ganglion. Postganglionic fibers innervate the sphincter pupillae (causing miosis) and the ciliary muscle (causing [["
      }, {
        "text": "81b5f5fe|accommodation]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCN VII (Facial):\u003c/b\u003e Preganglionic fibers from the superior"
      }, {
        "text": " salivatory nucleus synapse in the pterygopalatine and submandibular ganglia. Postganglionic fibers stimulate secretion"
      }, {
        "text": " from the lacrimal, submandibular, and sublingual glands.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCN IX (Glossopharyngeal):\u003c/b\u003e Preganglionic fibers"
      }, {
        "text": " from the inferior salivatory nucleus synapse in the otic ganglion. Postganglionic fibers stimulate secretion from the parotid gland.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eCN X (Vagus):\u003c/b\u003e The major parasympathetic nerve, providing innervation to the heart, lungs, and GI"
      }, {
        "text": " tract down to the splenic flexure. Its dorsal motor nucleus is a key autonomic center in the medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Remember the cranial nerves with parasympathetic function: CN III, VII, IX, and X.\u003c/li\u003e"
      }, {
        "text": "\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe cranial outflow of the parasympathetic system precisely controls visceral functions in"
      }, {
        "text": " the head and torso, from constricting the pupil with CN III to slowing the heart with CN X, all originating from specific"
      }, {
        "text": " nuclei within the brainstem.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_part_of\",\n        \"to\": \"autonomic_nervous_system\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_carried_by\",\n        \"to\": \""
      }, {
        "text": "68c66997\"\n      },\n      {\n        \"type\": \"is_carried"
      }, {
        "text": "_by\",\n        \"to\": \"dea9755f\"\n      },\n      {\n        \"type\": \"is_carried"
      }, {
        "text": "_by\",\n        \"to\": \"97e2c817\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_carried_by\",\n        \"to\": \"7c12e7a3\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"e7b51f5c\": {\n    \"title\": \"Par"
      }, {
        "text": "aventricular Nucleus (PVN)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"End"
      }, {
        "text": "ocrinology\",\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Endocrine\",\n      \"Anatomy\",\n      \"Hypothalamus\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eParaventricular Nucleus (PVN)\u003c/b\u003e is a key"
      }, {
        "text": " nucleus in the [[89e86633|hypothalamus]] that synthesizes and secretes several"
      }, {
        "text": " hormones, most notably \u003ci\u003eoxytocin\u003c/i\u003e and corticotropin-releasing hormone (CRH), and plays a central"
      }, {
        "text": " role in regulating stress, metabolism, and autonomic functions.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eH"
      }, {
        "text": "ormone Synthesis:\u003c/b\u003e Synthesizes \u003cmark\u003eoxytocin\u003c/mark\u003e, which is then transported to and released from the posterior pituitary."
      }, {
        "text": " It also synthesizes a smaller amount of ADH.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHPA Axis Control:\u003c/b\u003e Synthesizes and"
      }, {
        "text": " secretes \u003cmark\u003ecorticotropin-releasing hormone (CRH)\u003c/mark\u003e into the hypophyseal portal system, which stimulates the"
      }, {
        "text": " anterior pituitary to release ACTH, initiating the stress response.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Hormones:\u003c/b\u003e Also produces thyrotropin-releasing hormone ("
      }, {
        "text": "TRH) and somatostatin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAutonomic Regulation:\u003c/b\u003e Projects to autonomic centers in the brainstem and spinal"
      }, {
        "text": " cord to regulate sympathetic and parasympathetic activity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Associate the Paraventricular Nucleus primarily"
      }, {
        "text": " with \u003cb\u003eoxytocin\u003c/b\u003e and \u003cb\u003eCRH\u003c/b\u003e synthesis. Contrast it with the supraoptic nucleus, which primarily synthesizes AD"
      }, {
        "text": "H.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eParaventricular Nucleus\u003c/b\u003e is a master"
      }, {
        "text": " regulator within the hypothalamus, integrating endocrine and autonomic signals and producing key hormones like oxytocin and CRH to control everything from childbirth"
      }, {
        "text": " and social bonding to the body\u0027s stress response.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Paraventricular"
      }, {
        "text": " Nucleus]; A --\u003e B(Oxytocin --\u003e Posterior Pituitary); A --\u003e C(CRH --\u003e Anterior Pituitary); A --\u003e D(Aut"
      }, {
        "text": "onomic Centers);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_"
      }, {
        "text": "of\",\n        \"to\": \"89e86633\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"synthesizes\",\n        \"to\": \"911d3b47\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"synthesizes\",\n        \"to\": \"corticotropin_releasing_"
      }, {
        "text": "hormone\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"sup"
      }, {
        "text": "raoptic_nucleus\"\n      }\n    ]\n  },\n  \"26efa771\": {\n    \"title"
      }, {
        "text": "\": \"Parietal Lobe\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\","
      }, {
        "text": "\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      "
      }, {
        "text": "\"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Cortex\""
      }, {
        "text": "\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eParietal L"
      }, {
        "text": "obe\u003c/b\u003e is one of the four major lobes of the cerebral cortex, located superior to the occipital and temporal lobes and posterior to the frontal"
      }, {
        "text": " lobe. It is primarily responsible for processing somatosensory information, spatial awareness, and navigation.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePrimary Somatosensory Cortex:\u003c/b\u003e Located in the postcentral gyrus, it receives sensory information ("
      }, {
        "text": "touch, pressure, pain, temperature, proprioception) from the contralateral side of the body via the [[afc0a64b|"
      }, {
        "text": "thalamus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eDominant Parietal Lobe (usually Left):\u003c/b\u003e Damage can cause \u003cmark\u003eGer"
      }, {
        "text": "stmann syndrome\u003c/mark\u003e, which includes agraphia, [[8558c64b|acalculia]], finger"
      }, {
        "text": " agnosia, and left-right disorientation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNon-dominant Parietal Lobe (usually Right):"
      }, {
        "text": "\u003c/b\u003e Damage can cause \u003cmark\u003ehemispatial neglect syndrome\u003c/mark\u003e, where the patient ignores the contralateral side of their"
      }, {
        "text": " body and space.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOptic Radiations:\u003c/b\u003e The superior optic radiation (Baum\u0027s loop) passes through the parietal lobe."
      }, {
        "text": " A lesion here causes a contralateral inferior quadrantanopia (\\\"pie on the floor\\\").\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Les"
      }, {
        "text": "ions of the parietal lobe are all about sensory and spatial deficits. Remember to distinguish between the functions of the dominant (language"
      }, {
        "text": "-related, calculation) and non-dominant (spatial awareness) sides.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003e"
      }, {
        "text": "Parietal Lobe\u003c/b\u003e integrates sensory information to form a coherent perception of the world and our relationship to it; lesions"
      }, {
        "text": " here do not cause simple blindness or paralysis but rather profound deficits in spatial awareness and interpretation, such as hemineglect.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part"
      }, {
        "text": "_of\",\n        \"to\": \"cerebral_cortex\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"lesion_can_cause\",\n        \"to\": \"38f3ed1f\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"lesion_can_cause\",\n        \"to\": \"13482"
      }, {
        "text": "8d8\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"som"
      }, {
        "text": "atosensory_cortex\"\n      }\n    ]\n  },\n  \"9f603521\": {\n    \""
      }, {
        "text": "title\": \"Parinaud Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neurology\",\n      \"Ophthalmology\",\n      \"Oncology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain"
      }, {
        "text": "stem Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eParinaud"
      }, {
        "text": " Syndrome\u003c/b\u003e, also known as dorsal midbrain syndrome, is a neurological condition resulting from compression of the dorsal midbrain ("
      }, {
        "text": "specifically the superior colliculus and pretectal area), characterized by a classic triad of vertical gaze palsy, pupillary abnormalities, and convergence-"
      }, {
        "text": "retraction nystagmus.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most"
      }, {
        "text": " commonly caused by a \u003cmark\u003epineal gland tumor\u003c/mark\u003e (e.g., pinealoma, germinoma) compressing the dorsal"
      }, {
        "text": " midbrain. Other causes include stroke, [[45dd6d19|multiple sclerosis]], or obstructive [[0bc2f200|"
      }, {
        "text": "hydrocephalus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Triad:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eUpward Gaze Palsy:\u003c/b\u003e The"
      }, {
        "text": " most prominent feature is the inability to look up.\u003cbr\u003e2. \u003cb\u003ePupillary Light-Near Dissociation:\u003c/b\u003e Pupils"
      }, {
        "text": " do not constrict to light but do constrict with [[81b5f5fe|accommodation]] (pseudo"
      }, {
        "text": "-Argyll Robertson pupils).\u003cbr\u003e3. \u003cb\u003eConvergence-Retraction Nystagmus:\u003c/b\u003e On"
      }, {
        "text": " attempted upward gaze, the eyes converge and retract into the orbits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Signs:\u003c/b\u003e Eyelid retraction (Collier\u0027s"
      }, {
        "text": " sign) may also be present.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A young male patient presenting with an inability to look up,"
      }, {
        "text": " headache (from hydrocephalus), and pupillary abnormalities should make you strongly suspect a pineal tumor causing Parinaud syndrome.\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eParinaud Syndrome\u003c/b\u003e is a specific constellation of neuro-ophthalm"
      }, {
        "text": "ologic signs that precisely localizes a lesion to the dorsal midbrain, with the upward gaze palsy being the most striking feature resulting"
      }, {
        "text": " from compression of the vertical gaze center.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Pineal Tumor"
      }, {
        "text": "] --Compresses--\u003e B(Dorsal Midbrain); B --\u003e C(Parinaud Syndrome); C --\u003e D(Up"
      }, {
        "text": "ward Gaze Palsy); C --\u003e E(Pupillary Light-Near Dissociation); C --\u003e F(Convergence-Retraction N"
      }, {
        "text": "ystagmus);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "caused_by_lesion_in\",\n        \"to\": \"dorsal_midbrain\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_often_caused_by\",\n        \"to\": \"pine"
      }, {
        "text": "al_tumor\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"upward"
      }, {
        "text": "_gaze_palsy\"\n      },\n      {\n        \"type\": \"presents_with"
      }, {
        "text": "\",\n        \"to\": \"light_near_dissociation\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"4e4afce1\",\n    \"letter\": \"O\",\n    \"term\": \"Ophthalmoplegia\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Ophthalmoplegia\",\n    \"sub_entries\": [\n      {\n        \"id\": \"258a1a6a\",\n        \"letter\": \"O\",\n        \"term\": \"internuclear\",\n        \"pages\": [\n          \"558\"\n        ],\n        \"context\": \"Ophthalmoplegia \u003e internuclear\"\n      }\n    ]\n  },\n  {\n    \"id\": \"7fac2b01\",\n    \"letter\": \"O\",\n    \"term\": \"Opioid analgesics\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Opioid analgesics\",\n    \"sub_entries\": [\n      {\n        \"id\": \"8fd05789\",\n        \"letter\": \"O\",\n        \"term\": \"effects\",\n        \"pages\": [\n          \"567\"\n        ],\n        \"context\": \"Opioid analgesics \u003e effects\"\n      }\n    ]\n  },\n  {\n    \"id\": \"79c10c02\",\n    \"letter\": \"O\",\n    \"term\": \"Opioid receptors\",\n    \"pages\": [\n      \"567\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Opioid receptors\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"66b11030\",\n    \"letter\": \"O\",\n    \"term\": \"Optic nerve (CN II)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Optic nerve (CN II)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"f80e102d\",\n        \"letter\": \"O\",\n        \"term\": \"function and type\",\n        \"pages\": [\n          \"519\"\n        ],\n        \"context\": \"Optic nerve (CN II) \u003e function and type\"\n      }\n    ]\n  },\n  {\n    \"id\": \"98a63a59\",\n    \"letter\": \"O\",\n    \"term\": \"Optic neuritis\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Optic neuritis\",\n    \"sub_entries\": [\n      {\n        \"id\": \"ed90b066\",\n        \"letter\": \"O\",\n        \"term\": \"with multiple sclerosis\",\n        \"pages\": [\n          \"537\"\n        ],\n        \"context\": \"Optic neuritis \u003e with multiple sclerosis\"\n      }\n    ]\n  },\n  {\n    \"id\": \"0fee2f38\",\n    \"letter\": \"O\",\n    \"term\": \"Optic neuropathy\",\n    \"pages\": [\n      \"551\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Optic neuropathy\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"5ccc91a9\",\n    \"letter\": \"O\",\n    \"term\": \"Orbital cellulitis\",\n    \"pages\": [\n      \"559\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Orbital cellulitis\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"2e814378\",\n    \"letter\": \"O\",\n    \"term\": \"Organ of Corti\",\n    \"pages\": [\n      \"548\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Organ of Corti\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"99870480\",\n    \"letter\": \"O\",\n    \"term\": \"Organum vasculosum of the lamina\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Organum vasculosum of the lamina\",\n    \"sub_entries\": [\n      {\n        \"id\": \"a7f52160\",\n        \"letter\": \"O\",\n        \"term\": \"terminalis (OVLT)\",\n        \"pages\": [\n          \"506\"\n        ],\n        \"context\": \"Organum vasculosum of the lamina \u003e terminalis (OVLT)\"\n      }\n    ]\n  },\n  {\n    \"id\": \"bb51a0dc\",\n    \"letter\": \"O\",\n    \"term\": \"Osmoreceptors\",\n    \"pages\": [\n      \"506\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Osmoreceptors\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"7a680d3d\",\n    \"letter\": \"O\",\n    \"term\": \"Osmotic demyelination syndrome\",\n    \"pages\": [\n      \"538\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Osmotic demyelination syndrome\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"3aea8cac\",\n    \"letter\": \"O\",\n    \"term\": \"Ossicles\",\n    \"pages\": [\n      \"49\",\n      \"547\",\n      \"548\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Ossicles\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"67063a58\",\n    \"letter\": \"O\",\n    \"term\": \"Otitis externa\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Otitis externa\",\n    \"sub_entries\": [\n      {\n        \"id\": \"bfeacaa2\",\n        \"letter\": \"O\",\n        \"term\": \"presentation\",\n        \"pages\": [\n          \"547\"\n        ],\n        \"context\": \"Otitis externa \u003e presentation\"\n      }\n    ]\n  },\n  {\n    \"id\": \"a03641af\",\n    \"letter\": \"O\",\n    \"term\": \"Otitis media\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Otitis media\",\n    \"sub_entries\": [\n      {\n        \"id\": \"79791d25\",\n        \"letter\": \"O\",\n        \"term\": \"presentation and complications\",\n        \"pages\": [\n          \"547\"\n        ],\n        \"context\": \"Otitis media \u003e presentation and complications\"\n      }\n    ]\n  },\n  {\n    \"id\": \"c5a1d2fc\",\n    \"letter\": \"O\",\n    \"term\": \"Otology\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Otology\",\n    \"sub_entries\": [\n      {\n        \"id\": \"a021a484\",\n        \"letter\": \"O\",\n        \"term\": \"anatomy and physiology\",\n        \"pages\": [\n          \"547\"\n        ],\n        \"context\": \"Otology \u003e anatomy and physiology\"\n      }\n    ]\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 1772
    }, {
      "text": "```json\n{\n  \"4e4afce1\": {\n    \"title\": \"Ophthalmoplegia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOphthalmoplegia\u003c/b\u003e is the paralysis or weakness of one or more of the extraocular muscles that control eye movement. It can be caused by lesions affecting the cranial nerves (III, IV, VI), their nuclei in the brainstem, or the muscles themselves.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eInternuclear Ophthalmoplegia (INO):\u003c/b\u003e A specific gaze palsy caused by a lesion in the \u003cmark\u003emedial longitudinal fasciculus (MLF)\u003c/mark\u003e. It results in impaired adduction of the ipsilateral eye and nystagmus of the abducting contralateral eye. Bilateral INO is highly suggestive of [[45dd6d19|Multiple Sclerosis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eCranial Nerve Palsies:\u003c/b\u003e Lesions of [[68c66997|CN III]], [[bba6093a|CN IV]], or [[dd11dde6|CN VI]] each produce characteristic patterns of ophthalmoplegia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCavernous Sinus Syndrome:\u003c/b\u003e Can cause painful ophthalmoplegia involving multiple cranial nerves (III, IV, VI, V1, V2) as they pass through the [[c260efc8|cavernous sinus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eWernicke Encephalopathy:\u003c/b\u003e A classic triad of encephalopathy, oculomotor dysfunction (ophthalmoplegia, nystagmus), and gait ataxia due to thiamine deficiency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e [[58c684bd|Internuclear ophthalmoplegia]] is a key finding to recognize. Remember \u003cb\u003eINO\u003c/b\u003e \u003d \u003cb\u003eI\u003c/b\u003epsilateral adduction failure, \u003cb\u003eN\u003c/b\u003eystagmus \u003cb\u003eO\u003c/b\u003epposite.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eOphthalmoplegia\u003c/b\u003e is a critical neurological sign that points to dysfunction along the complex pathways controlling eye movement, with specific patterns like [[58c684bd|internuclear ophthalmoplegia]] precisely localizing lesions within the brainstem.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"58c684bd\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"cranial_nerve_palsy\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"wernicke_encephalopathy\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"9a089fd7\"\n      }\n    ]\n  },\n  \"7fac2b01\": {\n    \"title\": \"Opioid Analgesics\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Pain Management\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Analgesics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOpioid analgesics\u003c/b\u003e are a class of potent pain-relieving drugs that act as agonists at opioid receptors in the central and peripheral nervous systems to modulate the perception of pain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Act as agonists at opioid receptors (Œº, Œ¥, Œ∫), which are G-protein coupled receptors. They close presynaptic Ca\u003csup\u003e2+\u003c/sup\u003e channels (decreasing neurotransmitter release) and open postsynaptic K\u003csup\u003e+\u003c/sup\u003e channels (causing hyperpolarization and decreased neuronal excitability).\u003c/li\u003e\u003cli\u003e\u003cb\u003eExamples:\u003c/b\u003e Morphine, fentanyl, codeine, meperidine, methadone, buprenorphine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Management of moderate to severe acute and chronic pain, diarrhea (loperamide), cough suppression (dextromethorphan), and treatment of [[d268ace0|acute pulmonary edema]] (morphine).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e \u003cmark\u003eRespiratory depression\u003c/mark\u003e is the most life-threatening side effect. Others include sedation, constipation, miosis (pinpoint pupils), nausea/vomiting, and high potential for addiction and dependence.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOverdose Treatment:\u003c/b\u003e An opioid overdose (presenting with coma, respiratory depression, and miosis) is treated with an opioid antagonist like \u003cmark\u003enaloxone\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Tolerance develops to most effects of opioids (analgesia, sedation) but notably \u003cu\u003enot\u003c/u\u003e to \u003cmark\u003econstipation and miosis\u003c/mark\u003e.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eOpioid analgesics\u003c/b\u003e provide powerful pain relief by mimicking endogenous endorphins at opioid receptors, but their clinical utility is limited by a narrow therapeutic window and significant adverse effects, most dangerously respiratory depression, which can be rapidly reversed by naloxone.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"79c10c02\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"respiratory_depression\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"miosis\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"constipation\"\n      },\n      {\n        \"type\": \"overdose_is_treated_by\",\n        \"to\": \"naloxone\"\n      }\n    ]\n  },\n  \"79c10c02\": {\n    \"title\": \"Opioid Receptors\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neuroscience\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Receptors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOpioid receptors\u003c/b\u003e are a class of G-protein coupled receptors located primarily in the central and peripheral nervous systems and the gastrointestinal tract, which are the primary targets for endogenous endorphins and exogenous opioid drugs.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMajor Subtypes:\u003c/b\u003e The three classic subtypes are \u003cb\u003eŒº (mu)\u003c/b\u003e, \u003cb\u003eŒ¥ (delta)\u003c/b\u003e, and \u003cb\u003eŒ∫ (kappa)\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEndogenous Ligands:\u003c/b\u003e Œ≤-endorphin (Œº), enkephalin (Œ¥), and dynorphin (Œ∫).\u003c/li\u003e\u003cli\u003e\u003cb\u003eŒº-Receptor:\u003c/b\u003e The primary mediator of the analgesic effects of most clinically used opioids (e.g., morphine). Also responsible for euphoria, respiratory depression, and physical dependence.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSignal Transduction:\u003c/b\u003e As G\u003csub\u003ei/o\u003c/sub\u003e-coupled receptors, their activation leads to inhibition of adenylyl cyclase, closing of presynaptic voltage-gated Ca\u003csup\u003e2+\u003c/sup\u003e channels (‚Üì neurotransmitter release), and opening of postsynaptic K\u003csup\u003e+\u003c/sup\u003e channels (hyperpolarization).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The Œº-receptor is the most important for clinical pharmacology, as it mediates both the desired analgesic effects and the most dangerous side effects (respiratory depression) of drugs like morphine and fentanyl.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eOpioid receptors\u003c/b\u003e are inhibitory G-protein coupled receptors that, when activated by opioids, reduce neuronal excitability and synaptic transmission in pain pathways, providing potent analgesia but also mediating the drugs\u0027 significant adverse effects and abuse potential.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Opioid] --\u003e B(Opioid Receptor - GPCR); B --\u003e C(Inhibit Adenylyl Cyclase); B --\u003e D(Close Presynaptic Ca2+ Channels); B --\u003e E(Open Postsynaptic K+ Channels); C \u0026 D \u0026 E --\u003e F(Decreased Neuronal Firing); F --\u003e G(Analgesia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_target_of\",\n        \"to\": \"7fac2b01\"\n      },\n      {\n        \"type\": \"binds_endogenous_ligand\",\n        \"to\": \"endorphin\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"g_protein_coupled_receptor\"\n      }\n    ]\n  },\n  \"66b11030\": {\n    \"title\": \"Optic Nerve (CN II)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eOptic Nerve (CN II)\u003c/b\u003e is a paired cranial nerve that transmits visual information from the retina to the brain. Uniquely, it is an extension of the central nervous system rather than a true peripheral nerve, and is myelinated by [[a24f9747|oligodendrocytes]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Purely sensory, responsible for vision.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Composed of the axons of retinal ganglion cells. It exits the orbit via the optic canal, joins the contralateral optic nerve at the optic chiasm, and continues as the optic tract to the lateral geniculate nucleus of the thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Examination:\u003c/b\u003e Assessed by testing visual acuity, visual fields, and pupillary light reflexes. The optic disc (the head of the optic nerve) can be visualized on fundoscopy.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e A complete lesion of the optic nerve causes ipsilateral monocular blindness (anopia) and an afferent pupillary defect (Marcus Gunn pupil). [[98a63a59|Optic neuritis]], an inflammation of the optic nerve, is a common presentation of [[45dd6d19|multiple sclerosis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Because it is a CNS tract, the optic nerve is affected by CNS diseases. Its myelination by [[a24f9747|oligodendrocytes]] makes it a target in [[45dd6d19|multiple sclerosis]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eOptic Nerve\u003c/b\u003e is functionally a tract of the brain extending to the eye, not a peripheral nerve. This distinction is clinically crucial as it explains its involvement in CNS-specific pathologies like [[45dd6d19|multiple sclerosis]] and its myelination by oligodendrocytes, not Schwann cells.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_the_afferent_limb_of\",\n        \"to\": \"5c866add\"\n      },\n      {\n        \"type\": \"is_inflamed_in\",\n        \"to\": \"98a63a59\"\n      },\n      {\n        \"type\": \"is_myelinated_by\",\n        \"to\": \"a24f9747\"\n      }\n    ]\n  },\n  \"98a63a59\": {\n    \"title\": \"Optic Neuritis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Immunology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOptic neuritis\u003c/b\u003e is an inflammatory, demyelinating condition of the [[66b11030|optic nerve (CN II)]] that causes acute, monocular vision loss, and is the most common initial presentation of \u003ci\u003eMultiple Sclerosis\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Strongly associated with [[45dd6d19|Multiple Sclerosis (MS)]]. It is often the first demyelinating event in MS.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Characterized by a triad of \u003cmark\u003emonocular vision loss\u003c/mark\u003e (developing over hours to days), \u003cmark\u003epain with eye movement\u003c/mark\u003e, and loss of color vision (dyschromatopsia).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysical Exam Findings:\u003c/b\u003e The key finding is a \u003cmark\u003erelative afferent pupillary defect (RAPD)\u003c/mark\u003e, also known as a Marcus Gunn pupil. The optic disc may appear normal or swollen on fundoscopy.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Vision typically improves over several weeks, often with steroid treatment, but some residual deficits may remain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A young woman presenting with sudden, painful vision loss in one eye and a Marcus Gunn pupil is the classic vignette for optic neuritis and should raise high suspicion for underlying [[45dd6d19|Multiple Sclerosis]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eOptic neuritis\u003c/b\u003e is the quintessential ophthalmologic manifestation of [[45dd6d19|Multiple Sclerosis]], where an autoimmune attack on the optic nerve\u0027s myelin sheath leads to a characteristic triad of painful monocular vision loss, dyschromatopsia, and an afferent pupillary defect.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_an_inflammation_of\",\n        \"to\": \"66b11030\"\n      },\n      {\n        \"type\": \"is_a_common_presentation_of\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"relative_afferent_pupillary_defect\"\n      }\n    ]\n  },\n  \"0fee2f38\": {\n    \"title\": \"Optic Neuropathy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOptic neuropathy\u003c/b\u003e is damage to the [[66b11030|optic nerve (CN II)]] from any cause, leading to vision loss and changes in the appearance of the optic disc. It can be caused by ischemia, inflammation, compression, toxins, or hereditary factors.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGlaucomatous Optic Neuropathy:\u003c/b\u003e The most common form. A progressive neuropathy characterized by optic disc cupping and visual field loss, typically associated with elevated intraocular pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIschemic Optic Neuropathy:\u003c/b\u003e Caused by infarction of the optic nerve head. Can be arteritic (due to giant cell arteritis) or non-arteritic (more common, associated with vascular risk factors). Presents with sudden, painless, monocular vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInflammatory Optic Neuropathy:\u003c/b\u003e This is [[98a63a59|optic neuritis]], strongly associated with [[45dd6d19|multiple sclerosis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eCompressive Optic Neuropathy:\u003c/b\u003e Caused by a mass lesion (e.g., [[5f3188bd|pituitary adenoma]], meningioma) compressing the optic nerve, chiasm, or tract.\u003c/li\u003e\u003cli\u003e\u003cb\u003eToxic/Nutritional Optic Neuropathy:\u003c/b\u003e Caused by toxins (e.g., methanol, ethambutol) or nutritional deficiencies (e.g., B12).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The pattern of vision loss and associated symptoms helps determine the etiology. Sudden, painless loss in an elderly patient suggests ischemic neuropathy. Pain with eye movement in a young woman suggests [[98a63a59|optic neuritis]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eOptic neuropathy\u003c/b\u003e is the final common pathway of damage to the optic nerve, regardless of the cause. The clinical challenge lies in identifying the underlying etiology‚Äîbe it pressure, ischemia, inflammation, or compression‚Äîto guide appropriate management and prevent irreversible blindness.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_damage_to\",\n        \"to\": \"66b11030\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"ischemia\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"98a63a59\"\n      }\n    ]\n  },\n  \"5ccc91a9\": {\n    \"title\": \"Orbital Cellulitis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Infectious Disease\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOrbital cellulitis\u003c/b\u003e is a serious infection of the fat and muscles located \u003ci\u003eposterior\u003c/i\u003e to the orbital septum, which can lead to vision loss and intracranial complications. It is an ophthalmologic emergency.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly arises from the spread of a bacterial sinus infection (especially ethmoid sinusitis) through the thin lamina papyracea. Other causes include trauma or dental infections. Common pathogens are \u003ci\u003eStaphylococcus aureus\u003c/i\u003e and \u003ci\u003eStreptococcus\u003c/i\u003e species.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients present with eyelid swelling and erythema, similar to preseptal cellulitis, but with additional \u003cmark\u003e\\\"red flag\\\" signs\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Differentiating Features:\u003c/b\u003e The presence of \u003cmark\u003epain with eye movements\u003c/mark\u003e, \u003cmark\u003eproptosis\u003c/mark\u003e (bulging eye), and \u003cmark\u003eophthalmoplegia\u003c/mark\u003e (restricted eye movements) or diplopia distinguishes orbital from [[087079b0|preseptal cellulitis]]. Vision may be impaired.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e Can lead to vision loss (from optic nerve compression), [[a830692a|cavernous sinus thrombosis]], meningitis, or brain abscess.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Pain on eye movement is the critical sign that separates orbital cellulitis from the less severe [[087079b0|preseptal cellulitis]]. This finding mandates urgent imaging (CT scan) and inpatient treatment with IV antibiotics.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eOrbital cellulitis\u003c/b\u003e is an infection that has breached the orbital septum, putting the vital structures of the orbit at risk. The presence of pain with eye movements, proptosis, or ophthalmoplegia signals this deeper involvement and elevates the condition to a true emergency requiring immediate intervention.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"087079b0\"\n      },\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"sinusitis\"\n      },\n      {\n        \"type\": \"can_lead_to\",\n        \"to\": \"a830692a\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"proptosis\"\n      }\n    ]\n  },\n  \"2e814378\": {\n    \"title\": \"Organ of Corti\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Otology\",\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Anatomy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eOrgan of Corti\u003c/b\u003e is the sensory organ of hearing, located within the cochlea of the inner ear. It contains the mechanoreceptive hair cells that transduce the mechanical energy of sound vibrations into nerve impulses.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Sits on the basilar membrane within the scala media of the cochlea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Composed of sensory hair cells (one row of inner hair cells, three rows of outer hair cells) and various supporting cells. The stereocilia of the hair cells are in contact with the overlying tectorial membrane.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction (Transduction):\u003c/b\u003e Sound vibrations cause the basilar membrane to move, creating a shearing force between the basilar and tectorial membranes. This force bends the stereocilia of the hair cells, opening ion channels and causing depolarization, which triggers neurotransmitter release and an action potential in the auditory nerve.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Damage to the hair cells is the cause of \u003cmark\u003esensorineural hearing loss\u003c/mark\u003e. This can be due to excessive noise exposure (\u003cmark\u003enoise-induced hearing loss\u003c/mark\u003e), aging ([[0957fd39|presbycusis]]), or ototoxic drugs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that high-frequency sounds are detected at the stiff, narrow base of the cochlea, while low-frequency sounds are detected at the flexible, wide apex. Noise-induced hearing loss typically damages the hair cells at the base first, leading to high-frequency hearing loss.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eOrgan of Corti\u003c/b\u003e is the biological microphone of the inner ear, where the mechanical vibrations of sound are precisely converted into electrical signals by the bending of specialized hair cells, a delicate process vulnerable to damage from noise, age, and toxins.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"001c359f\"\n      },\n      {\n        \"type\": \"is_responsible_for\",\n        \"to\": \"hearing\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"sensorineural_hearing_loss\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"0957fd39\"\n      }\n    ]\n  },\n  \"99870480\": {\n    \"title\": \"Organum Vasculosum of the Lamina Terminalis (OVLT)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Endocrinology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brain\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eOrganum Vasculosum of the Lamina Terminalis (OVLT)\u003c/b\u003e is one of the circumventricular organs, a highly vascularized structure in the anterior wall of the third ventricle that lacks a normal [[dd47b9cc|blood-brain barrier]] and contains osmosensory neurons critical for detecting plasma osmolarity.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Anterior wall of the third ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e As a circumventricular organ, its fenestrated capillaries allow it to directly sense the composition of the blood. It contains \u003cmark\u003eosmoreceptors\u003c/mark\u003e that detect changes in plasma osmolarity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Thirst and ADH Release:\u003c/b\u003e When the OVLT detects an increase in plasma osmolarity (hypertonicity), it stimulates thirst and signals the supraoptic and paraventricular nuclei of the hypothalamus to release \u003cmark\u003eantidiuretic hormone (ADH)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Fever:\u003c/b\u003e The OVLT is also a site where circulating pyrogens like PGE\u003csub\u003e2\u003c/sub\u003e can act on the brain to induce fever by altering the hypothalamic temperature set-point.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the OVLT as the brain\u0027s primary \u0027osmostat,\u0027 constantly sampling the blood to regulate water balance through thirst and ADH secretion.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eOVLT\u0027s\u003c/b\u003e lack of a blood-brain barrier is its key functional feature, allowing its specialized osmosensory neurons to act as a direct interface between the bloodstream and the hypothalamus, thereby orchestrating the body\u0027s response to dehydration.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"circumventricular_organ\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"bb51a0dc\"\n      },\n      {\n        \"type\": \"regulates\",\n        \"to\": \"adh_release\"\n      },\n      {\n        \"type\": \"regulates\",\n        \"to\": \"thirst\"\n      }\n    ]\n  },\n  \"bb51a0dc\": {\n    \"title\": \"Osmoreceptors\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Physiology\",\n      \"Endocrinology\",\n      \"Neuroscience\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Physiology\",\n      \"Hypothalamic-Pituitary Axis\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOsmoreceptors\u003c/b\u003e are specialized neurons, primarily located in the [[89e86633|hypothalamus]], that respond to changes in the osmotic pressure (osmolarity) of the extracellular fluid, thereby regulating the body\u0027s water balance through thirst and the secretion of antidiuretic hormone (ADH).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Primarily found in the circumventricular organs of the brain that lack a blood-brain barrier, especially the \u003cmark\u003eOrganum Vasculosum of the Lamina Terminalis (OVLT)\u003c/mark\u003e and the subfornical organ (SFO). Also located within the supraoptic nucleus itself.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e These neurons function as mechanoreceptors, shrinking or swelling in response to changes in plasma osmolarity. Cell shrinkage (in a hypertonic state) opens stretch-inhibited cation channels, leading to depolarization and firing.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e When stimulated by increased plasma osmolarity, osmoreceptors trigger two key responses: 1) Stimulation of the sensation of \u003cmark\u003ethirst\u003c/mark\u003e. 2) Stimulation of ADH synthesis and release from the posterior pituitary.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Dysfunction of this system can lead to disorders of water balance like diabetes insipidus or SIADH.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The osmoreceptor system is exquisitely sensitive, responding to as little as a 1-2% change in plasma osmolarity to maintain tight control over the body\u0027s water balance.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eOsmoreceptors\u003c/b\u003e are the body\u0027s cellular osmometers, translating minute changes in blood concentration into the powerful physiological drives of thirst and ADH release to defend plasma osmolarity with remarkable precision.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Increased Plasma Osmolarity] --\u003e B(Osmoreceptor Shrinkage); B --\u003e C(Neuron Firing); C --\u003e D(Thirst Sensation); C --\u003e E(ADH Release); E --\u003e F(Renal Water Reabsorption); D \u0026 F --\u003e G(Decreased Plasma Osmolarity);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"are_located_in\",\n        \"to\": \"99870480\"\n      },\n      {\n        \"type\": \"regulate\",\n        \"to\": \"adh_release\"\n      },\n      {\n        \"type\": \"regulate\",\n        \"to\": \"thirst\"\n      }\n    ]\n  },\n  \"7a680d3d\": {\n    \"title\": \"Osmotic Demyelination Syndrome (ODS)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOsmotic Demyelination Syndrome (ODS)\u003c/b\u003e, classically known as \u003cb\u003eCentral Pontine Myelinolysis\u003c/b\u003e, is an acute, iatrogenic demyelination of the central nervous system caused by the overly rapid correction of chronic hyponatremia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e In chronic hyponatremia, brain cells adapt by extruding organic osmolytes to prevent swelling. If the serum sodium is corrected too quickly, the extracellular space becomes hypertonic relative to the brain cells. Water is rapidly pulled out of the cells, leading to cell shrinkage and demyelination, particularly in osmotically sensitive areas.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation of Lesion:\u003c/b\u003e The \u003cmark\u003epons\u003c/mark\u003e is the most classic and severely affected location (Central Pontine Myelinolysis), but demyelination can also occur in extrapontine sites like the basal ganglia and cerebellum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Symptoms typically develop 2-6 days after the rapid sodium correction. Presents with acute paralysis (quadriplegia), dysarthria, dysphagia, diplopia, and loss of consciousness. Can progress to a \u003cmark\u003e\\\"locked-in\\\" syndrome\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrevention:\u003c/b\u003e The key is slow and controlled correction of chronic hyponatremia. Correction rates should generally not exceed 8-12 mEq/L in 24 hours.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the mnemonic: \\\"From \u003cb\u003elow\u003c/b\u003e to \u003cb\u003ehigh\u003c/b\u003e, your \u003cb\u003epons\u003c/b\u003e will \u003cb\u003edie\u003c/b\u003e.\\\" (ODS). \\\"From \u003cb\u003ehigh\u003c/b\u003e to \u003cb\u003elow\u003c/b\u003e, your \u003cb\u003ebrain\u003c/b\u003e will \u003cb\u003eblow\u003c/b\u003e.\\\" (Cerebral edema from rapid correction of hypernatremia).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eOsmotic Demyelination Syndrome\u003c/b\u003e is a devastating iatrogenic injury caused by correcting chronic hyponatremia too quickly, forcing brain cells that had adapted to a low-salt environment to suddenly dehydrate, leading to demyelination, especially in the vulnerable pons.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"rapid_correction_of_hyponatremia\"\n      },\n      {\n        \"type\": \"affects\",\n        \"to\": \"bf549b2f\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"locked_in_syndrome\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"demyelinating_disorder\"\n      }\n    ]\n  },\n  \"3aea8cac\": {\n    \"title\": \"Auditory Ossicles\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Otology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Anatomy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAuditory Ossicles\u003c/b\u003e are a chain of three small bones‚Äîthe \u003ci\u003emalleus\u003c/i\u003e, \u003ci\u003eincus\u003c/i\u003e, and \u003ci\u003estapes\u003c/i\u003e‚Äîlocated in the air-filled middle ear cavity. They function to transmit and amplify sound vibrations from the tympanic membrane to the oval window of the inner ear.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents (from lateral to medial):\u003c/b\u003e Malleus (hammer), Incus (anvil), and Stapes (stirrup). Mnemonic: \u003cb\u003eM-I-S\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e They act as a lever system to amplify the force of sound vibrations from the large tympanic membrane to the much smaller oval window, overcoming the impedance mismatch between air and the fluid-filled cochlea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMuscles:\u003c/b\u003e Two small muscles modulate ossicular movement: the \u003cb\u003eTensor tympani\u003c/b\u003e (innervated by CN V\u003csub\u003e3\u003c/sub\u003e) tenses the tympanic membrane, and the \u003cb\u003eStapedius\u003c/b\u003e (innervated by CN VII) dampens the movement of the stapes. These muscles contract reflexively to loud sounds, protecting the inner ear.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Disruption of the ossicular chain (e.g., from trauma or cholesteatoma) or fixation of the stapes (otosclerosis) causes \u003cmark\u003econductive hearing loss\u003c/mark\u003e. Paralysis of the stapedius muscle (e.g., in Bell\u0027s palsy) can cause hyperacusis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Otosclerosis, an autosomal dominant condition causing fixation of the stapes, is a common cause of conductive hearing loss in young adults.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eauditory ossicles\u003c/b\u003e form a sophisticated mechanical amplifier, converting the low-pressure, large-amplitude vibrations of the eardrum into high-pressure, low-amplitude vibrations at the oval window, which is essential for efficiently transmitting sound energy from air to the fluid of the inner ear.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"middle_ear\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"malleus\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"incus\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"stapes\"\n      },\n      {\n        \"type\": \"dysfunction_causes\",\n        \"to\": \"conductive_hearing_loss\"\n      }\n    ]\n  },\n  \"67063a58\": {\n    \"title\": \"Otitis Externa\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Otology\",\n      \"Infectious Disease\",\n      \"Dermatology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOtitis Externa\u003c/b\u003e, commonly known as \\\"swimmer\u0027s ear,\\\" is an inflammation or infection of the external auditory canal, the tube leading from the outer ear to the eardrum.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by bacteria, with \u003cmark\u003ePseudomonas aeruginosa\u003c/mark\u003e being the most frequent pathogen, followed by \u003ci\u003eStaphylococcus aureus\u003c/i\u003e. Fungal infections (otomycosis) can also occur.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e Water exposure (swimming) that macerates the skin of the ear canal, trauma from cotton swabs or hearing aids, and dermatologic conditions like eczema.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e The hallmark symptom is severe ear pain (\u003cmark\u003eotalgia\u003c/mark\u003e) that is characteristically worsened by manipulation of the pinna or tragus. Other symptoms include pruritus, purulent discharge, and a feeling of fullness in the ear.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMalignant Otitis Externa:\u003c/b\u003e A severe, necrotizing form that can spread to the skull base, causing osteomyelitis. It is a medical emergency seen almost exclusively in elderly diabetic or immunocompromised patients.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Pain on pulling the pinna is the key physical exam finding that differentiates otitis externa from [[a03641af|otitis media]], where the pain is internal and not affected by external manipulation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eOtitis Externa\u003c/b\u003e is an infection of the skin lining the ear canal, not the middle ear space. Its diagnosis hinges on the classic sign of exquisite tenderness with external ear manipulation, a feature absent in middle ear infections.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_an_infection_of\",\n        \"to\": \"944bb118\"\n      },\n      {\n        \"type\": \"is_commonly_caused_by\",\n        \"to\": \"cf0b8fbc\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"a03641af\"\n      },\n      {\n        \"type\": \"can_progress_to\",\n        \"to\": \"malignant_otitis_externa\"\n      }\n    ]\n  },\n  \"a03641af\": {\n    \"title\": \"Otitis Media\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Otology\",\n      \"Pediatrics\",\n      \"Infectious Disease\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOtitis Media\u003c/b\u003e is an inflammation or infection of the middle ear, the air-filled space behind the eardrum. Acute otitis media (AOM) is one of the most common childhood infections.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Typically follows a viral upper respiratory infection, which leads to eustachian tube dysfunction and obstruction. This causes negative pressure and fluid accumulation in the middle ear, which then becomes secondarily infected by bacteria colonizing the nasopharynx.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Pathogens:\u003c/b\u003e The three most common bacterial causes are \u003cmark\u003eStreptococcus pneumoniae\u003c/mark\u003e, non-typeable \u003cmark\u003eHaemophilus influenzae\u003c/mark\u003e, and \u003cmark\u003eMoraxella catarrhalis\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Infants and young children present with fever, irritability, and ear pulling. Otoscopy reveals a \u003cmark\u003ebulging, erythematous tympanic membrane\u003c/mark\u003e with poor mobility.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e Can lead to tympanic membrane perforation, mastoiditis, meningitis, or brain abscess. Recurrent episodes can cause conductive hearing loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The classic triad of pathogens for AOM is \u003ci\u003eS. pneumoniae\u003c/i\u003e, \u003ci\u003eH. influenzae\u003c/i\u003e (non-typeable), and \u003ci\u003eM. catarrhalis\u003c/i\u003e. Remember that the introduction of the pneumococcal conjugate vaccine has decreased the incidence of AOM caused by \u003ci\u003eS. pneumoniae\u003c/i\u003e.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcute Otitis Media\u003c/b\u003e is fundamentally a complication of eustachian tube dysfunction following a viral URI, where trapped fluid in the middle ear becomes a culture medium for nasopharyngeal bacteria, leading to a painful, bulging eardrum.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_an_infection_of\",\n        \"to\": \"middle_ear\"\n      },\n      {\n        \"type\": \"is_commonly_caused_by\",\n        \"to\": \"streptococcus_pneumoniae\"\n      },\n      {\n        \"type\": \"is_commonly_caused_by\",\n        \"to\": \"69962905\"\n      },\n      {\n        \"type\": \"is_commonly_caused_by\",\n        \"to\": \"moraxella_catarrhalis\"\n      },\n      {\n        \"type\": \"can_lead_to\",\n        \"to\": \"mastoiditis\"\n      }\n    ]\n  },\n  \"c5a1d2fc\": {\n    \"title\": \"Otology\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Special Senses\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Overview\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOtology\u003c/b\u003e is the branch of medicine that studies the normal and pathological anatomy and physiology of the ear, as well as its diseases, diagnosis, and treatment. It encompasses hearing and balance disorders.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnatomy:\u003c/b\u003e The ear is divided into the [[944bb118|outer ear]] (pinna, canal), middle ear ([[3aea8cac|ossicles]]), and inner ear (cochlea, vestibular system).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysiology:\u003c/b\u003e Hearing involves the transduction of sound waves into neural signals by the [[2e814378|organ of Corti]]. Balance is maintained by the vestibular system (semicircular canals, utricle, saccule).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Pathologies:\u003c/b\u003e Include [[88e6f77e|hearing loss]] (conductive vs. sensorineural), [[a03641af|otitis media]], [[67063a58|otitis externa]], and vertigo (e.g., BPPV, [[6f2228c1|M√©ni√®re disease]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Nerves:\u003c/b\u003e The [[6fded3e7|vestibulocochlear nerve (CN VIII)]] is central to otology, carrying both auditory and vestibular information to the brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A solid understanding of the distinction between conductive and sensorineural hearing loss, and between peripheral and central vertigo, is essential for otology questions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eOtology\u003c/b\u003e integrates the complex anatomy and physiology of the ear to diagnose and manage disorders of its two primary functions: hearing and balance, which are subserved by the cochlear and vestibular systems, respectively.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_the_study_of\",\n        \"to\": \"ear\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"88e6f77e\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"vertigo\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"a03641af\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9796,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"4e4afce1\": {\n    \"title\": \"Ophthalmople"
      }, {
        "text": "gia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and"
      }, {
        "text": " Special Senses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOphthalmoplegia\u003c/b\u003e is the paralysis or weakness of one or more of the extra"
      }, {
        "text": "ocular muscles that control eye movement. It can be caused by lesions affecting the cranial nerves (III, IV, VI), their"
      }, {
        "text": " nuclei in the brainstem, or the muscles themselves.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eIntern"
      }, {
        "text": "uclear Ophthalmoplegia (INO):\u003c/b\u003e A specific gaze palsy caused by a lesion in the \u003cmark\u003emedial longitudinal fasc"
      }, {
        "text": "iculus (MLF)\u003c/mark\u003e. It results in impaired adduction of the ipsilateral eye and nystagmus of the ab"
      }, {
        "text": "ducting contralateral eye. Bilateral INO is highly suggestive of [[45dd6d19|Multiple Sclerosis]]."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eCranial Nerve Palsies:\u003c/b\u003e Lesions of [[68c66997|CN"
      }, {
        "text": " III]], [[bba6093a|CN IV]], or [[dd11dde6|CN VI"
      }, {
        "text": "]] each produce characteristic patterns of ophthalmoplegia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCavernous Sinus Syndrome:\u003c/b\u003e Can cause painful"
      }, {
        "text": " ophthalmoplegia involving multiple cranial nerves (III, IV, VI, V1, V2) as they pass through the [["
      }, {
        "text": "c260efc8|cavernous sinus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eWernicke Encephalopathy:\u003c/b\u003e A"
      }, {
        "text": " classic triad of encephalopathy, oculomotor dysfunction (ophthalmoplegia, nystagmus), and gait ataxia due"
      }, {
        "text": " to thiamine deficiency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e [[58c684bd|Internuclear ophthalm"
      }, {
        "text": "oplegia]] is a key finding to recognize. Remember \u003cb\u003eINO\u003c/b\u003e \u003d \u003cb\u003eI\u003c/b\u003epsilateral adduction failure"
      }, {
        "text": ", \u003cb\u003eN\u003c/b\u003eystagmus \u003cb\u003eO\u003c/b\u003epposite.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eOphthalmoplegia\u003c/b\u003e is a critical neurological sign that points to dysfunction along the complex pathways controlling eye movement,"
      }, {
        "text": " with specific patterns like [[58c684bd|internuclear ophthalmoplegia]] precisely localizing lesions within"
      }, {
        "text": " the brainstem.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type"
      }, {
        "text": "\": \"is_a_type_of\",\n        \"to\": \"58c684bd\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"c"
      }, {
        "text": "ranial_nerve_palsy\"\n      },\n      {\n        \"type\": \"is_a_s"
      }, {
        "text": "ymptom_of\",\n        \"to\": \"wernicke_encephalopathy\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"9a"
      }, {
        "text": "089fd7\"\n      }\n    ]\n  },\n  \"7fac2b01\": {\n    \""
      }, {
        "text": "title\": \"Opioid Analgesics\",\n    \"primaryType\": \"drug\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Pharmacology\",\n      \"Pain Management\",\n      \"Anesthesiology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Analgesics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOpioid analges"
      }, {
        "text": "ics\u003c/b\u003e are a class of potent pain-relieving drugs that act as agonists at opioid receptors in the central and peripheral nervous systems to"
      }, {
        "text": " modulate the perception of pain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Act"
      }, {
        "text": " as agonists at opioid receptors (Œº, Œ¥, Œ∫), which are G-protein coupled receptors. They close presynaptic Ca\u003csup\u003e"
      }, {
        "text": "2+\u003c/sup\u003e channels (decreasing neurotransmitter release) and open postsynaptic K\u003csup\u003e+\u003c/sup\u003e channels (causing hyperpolarization and decreased"
      }, {
        "text": " neuronal excitability).\u003c/li\u003e\u003cli\u003e\u003cb\u003eExamples:\u003c/b\u003e Morphine, fentanyl, codeine, meperidine, methadone, b"
      }, {
        "text": "uprenorphine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Management of moderate to severe acute and chronic pain, diarrhea (l"
      }, {
        "text": "operamide), cough suppression (dextromethorphan), and treatment of [[d268ace0|acute pulmonary"
      }, {
        "text": " edema]] (morphine).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e \u003cmark\u003eRespiratory depression\u003c/mark\u003e is the most life"
      }, {
        "text": "-threatening side effect. Others include sedation, constipation, miosis (pinpoint pupils), nausea/vomiting, and high"
      }, {
        "text": " potential for addiction and dependence.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOverdose Treatment:\u003c/b\u003e An opioid overdose (presenting with coma, respiratory"
      }, {
        "text": " depression, and miosis) is treated with an opioid antagonist like \u003cmark\u003enaloxone\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Tolerance develops"
      }, {
        "text": " to most effects of opioids (analgesia, sedation) but notably \u003cu\u003enot\u003c/u\u003e to \u003cmark\u003econstipation and"
      }, {
        "text": " miosis\u003c/mark\u003e.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eOpioid analgesics\u003c/b\u003e provide"
      }, {
        "text": " powerful pain relief by mimicking endogenous endorphins at opioid receptors, but their clinical utility is limited by a narrow therapeutic window and significant"
      }, {
        "text": " adverse effects, most dangerously respiratory depression, which can be rapidly reversed by naloxone.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"7"
      }, {
        "text": "9c10c02\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\","
      }, {
        "text": "\n        \"to\": \"respiratory_depression\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n"
      }, {
        "text": "        \"to\": \"miosis\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \""
      }, {
        "text": "to\": \"constipation\"\n      },\n      {\n        \"type\": \"overdose_is_treated_by\",\n        \""
      }, {
        "text": "to\": \"naloxone\"\n      }\n    ]\n  },\n  \"79c10c02\": {\n    "
      }, {
        "text": "\"title\": \"Opioid Receptors\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Pharmacology\",\n      \"Neuroscience\",\n      \"Physiology\",\n      \"USMLE\"\n    ],"
      }, {
        "text": "\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n"
      }, {
        "text": "      \"Receptors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOpioid receptors"
      }, {
        "text": "\u003c/b\u003e are a class of G-protein coupled receptors located primarily in the central and peripheral nervous systems and the gastrointestinal tract,"
      }, {
        "text": " which are the primary targets for endogenous endorphins and exogenous opioid drugs.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMajor"
      }, {
        "text": " Subtypes:\u003c/b\u003e The three classic subtypes are \u003cb\u003eŒº (mu)\u003c/b\u003e, \u003cb\u003eŒ¥ (delta)\u003c/b\u003e,"
      }, {
        "text": " and \u003cb\u003eŒ∫ (kappa)\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEndogenous Ligands:\u003c/b\u003e Œ≤-endorphin (Œº),"
      }, {
        "text": " enkephalin (Œ¥), and dynorphin (Œ∫).\u003c/li\u003e\u003cli\u003e\u003cb\u003eŒº-Receptor:\u003c/b\u003e The primary mediator"
      }, {
        "text": " of the analgesic effects of most clinically used opioids (e.g., morphine). Also responsible for euphoria, respiratory depression, and"
      }, {
        "text": " physical dependence.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSignal Transduction:\u003c/b\u003e As G\u003csub\u003ei/o\u003c/sub\u003e-coupled receptors, their activation leads to inhibition"
      }, {
        "text": " of adenylyl cyclase, closing of presynaptic voltage-gated Ca\u003csup\u003e2+\u003c/sup\u003e channels (‚Üì neurotransmitter release), and opening of posts"
      }, {
        "text": "ynaptic K\u003csup\u003e+\u003c/sup\u003e channels (hyperpolarization).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The Œº-receptor is the most"
      }, {
        "text": " important for clinical pharmacology, as it mediates both the desired analgesic effects and the most dangerous side effects (respiratory depression)"
      }, {
        "text": " of drugs like morphine and fentanyl.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eOpioid receptors\u003c/b\u003e are inhibitory"
      }, {
        "text": " G-protein coupled receptors that, when activated by opioids, reduce neuronal excitability and synaptic transmission in pain pathways, providing"
      }, {
        "text": " potent analgesia but also mediating the drugs\u0027 significant adverse effects and abuse potential.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[Opioid] --\u003e B(Opioid Receptor - GPCR); B --\u003e C(Inhibit Aden"
      }, {
        "text": "ylyl Cyclase); B --\u003e D(Close Presynaptic Ca2+ Channels); B --\u003e E(Open Postsynaptic K+ Channels); C"
      }, {
        "text": " \u0026 D \u0026 E --\u003e F(Decreased Neuronal Firing); F --\u003e G(Analgesia);\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_target_of\",\n        \"to\": \"7"
      }, {
        "text": "fac2b01\"\n      },\n      {\n        \"type\": \"binds_endogenous_ligand\",\n        \""
      }, {
        "text": "to\": \"endorphin\"\n      },\n      {\n        \"type\": \"is_a_type"
      }, {
        "text": "_of\",\n        \"to\": \"g_protein_coupled_receptor\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"66b11030\": {\n    \"title\": \"Optic Nerve (CN"
      }, {
        "text": " II)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eOptic Nerve (CN II)\u003c/b\u003e is a paired"
      }, {
        "text": " cranial nerve that transmits visual information from the retina to the brain. Uniquely, it is an extension of the central nervous system rather"
      }, {
        "text": " than a true peripheral nerve, and is myelinated by [[a24f9747|oligodendrocytes"
      }, {
        "text": "]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Purely sensory, responsible for vision"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Composed of the axons of retinal ganglion cells. It exits the orbit via the optic canal"
      }, {
        "text": ", joins the contralateral optic nerve at the optic chiasm, and continues as the optic tract to the lateral geniculate nucleus of"
      }, {
        "text": " the thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Examination:\u003c/b\u003e Assessed by testing visual acuity, visual fields, and pupillary light reflexes"
      }, {
        "text": ". The optic disc (the head of the optic nerve) can be visualized on fundoscopy.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e A"
      }, {
        "text": " complete lesion of the optic nerve causes ipsilateral monocular blindness (anopia) and an afferent pupillary defect ("
      }, {
        "text": "Marcus Gunn pupil). [[98a63a59|Optic neuritis]], an inflammation of the optic nerve"
      }, {
        "text": ", is a common presentation of [[45dd6d19|multiple sclerosis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Because it is a"
      }, {
        "text": " CNS tract, the optic nerve is affected by CNS diseases. Its myelination by [[a24f9747|oligodendrocytes]]"
      }, {
        "text": " makes it a target in [[45dd6d19|multiple sclerosis]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003eThe \u003cb\u003eOptic Nerve\u003c/b\u003e is functionally a tract of the brain extending to the eye, not a peripheral nerve."
      }, {
        "text": " This distinction is clinically crucial as it explains its involvement in CNS-specific pathologies like [[45dd6d19|multiple sclerosis]] and its myel"
      }, {
        "text": "ination by oligodendrocytes, not Schwann cells.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_the_afferent_limb_of\",\n        \"to\": \"5c"
      }, {
        "text": "866add\"\n      },\n      {\n        \"type\": \"is_inflamed_in\",\n        \"to"
      }, {
        "text": "\": \"98a63a59\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_myelinated_by\",\n        \"to\": \"a24f9747\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"98a63a59\": {\n    \"title\":"
      }, {
        "text": " \"Optic Neuritis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"Neurology\",\n      \"Immunology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"D"
      }, {
        "text": "emyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOptic neuritis"
      }, {
        "text": "\u003c/b\u003e is an inflammatory, demyelinating condition of the [[66b11030|optic nerve ("
      }, {
        "text": "CN II)]] that causes acute, monocular vision loss, and is the most common initial presentation of \u003ci\u003eMultiple Sclerosis\u003c/i\u003e"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Strongly associated with [[45dd6d19|"
      }, {
        "text": "Multiple Sclerosis (MS)]]. It is often the first demyelinating event in MS.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Character"
      }, {
        "text": "ized by a triad of \u003cmark\u003emonocular vision loss\u003c/mark\u003e (developing over hours to days), \u003cmark\u003epain with"
      }, {
        "text": " eye movement\u003c/mark\u003e, and loss of color vision (dyschromatopsia).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysical Exam Findings:\u003c/b\u003e The key"
      }, {
        "text": " finding is a \u003cmark\u003erelative afferent pupillary defect (RAPD)\u003c/mark\u003e, also known as a Marcus Gunn pupil."
      }, {
        "text": " The optic disc may appear normal or swollen on fundoscopy.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Vision typically improves over"
      }, {
        "text": " several weeks, often with steroid treatment, but some residual deficits may remain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A"
      }, {
        "text": " young woman presenting with sudden, painful vision loss in one eye and a Marcus Gunn pupil is the classic vignette for optic neuritis and"
      }, {
        "text": " should raise high suspicion for underlying [[45dd6d19|Multiple Sclerosis]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eOptic neuritis\u003c/b\u003e is the quintessential ophthalmologic manifestation of [[45dd6d19|Multiple Sclerosis]], where"
      }, {
        "text": " an autoimmune attack on the optic nerve\u0027s myelin sheath leads to a characteristic triad of painful monocular vision loss, dys"
      }, {
        "text": "chromatopsia, and an afferent pupillary defect.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n"
      }, {
        "text": "      {\n        \"type\": \"is_an_inflammation_of\",\n        \"to\": \"66"
      }, {
        "text": "b11030\"\n      },\n      {\n        \"type\": \"is_a_common_presentation_of\",\n"
      }, {
        "text": "        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"presents_with"
      }, {
        "text": "\",\n        \"to\": \"relative_afferent_pupillary_defect\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"0fee2f38\": {\n    \"title\": \"Optic Neuropathy\",\n    "
      }, {
        "text": "\"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOptic neuropathy\u003c/b\u003e is damage to the [[66b11030"
      }, {
        "text": "|optic nerve (CN II)]] from any cause, leading to vision loss and changes in the appearance of the optic disc. It"
      }, {
        "text": " can be caused by ischemia, inflammation, compression, toxins, or hereditary factors.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGl"
      }, {
        "text": "aucomatous Optic Neuropathy:\u003c/b\u003e The most common form. A progressive neuropathy characterized by optic disc cupping and visual"
      }, {
        "text": " field loss, typically associated with elevated intraocular pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIschemic Optic Neuropathy:\u003c/b\u003e Caused by infarction of"
      }, {
        "text": " the optic nerve head. Can be arteritic (due to giant cell arteritis) or non-arteritic (more"
      }, {
        "text": " common, associated with vascular risk factors). Presents with sudden, painless, monocular vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInflammatory Optic Neuropathy:\u003c/b\u003e This"
      }, {
        "text": " is [[98a63a59|optic neuritis]], strongly associated with [[45dd6d19|multiple"
      }, {
        "text": " sclerosis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eCompressive Optic Neuropathy:\u003c/b\u003e Caused by a mass lesion (e.g., [["
      }, {
        "text": "5f3188bd|pituitary adenoma]], meningioma) compressing the optic nerve, chiasm, or tract.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eToxic/Nutritional Optic Neuropathy:\u003c/b\u003e Caused by toxins (e.g., methanol, ethambutol)"
      }, {
        "text": " or nutritional deficiencies (e.g., B12).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The pattern of vision"
      }, {
        "text": " loss and associated symptoms helps determine the etiology. Sudden, painless loss in an elderly patient suggests ischemic neuropathy. Pain with eye movement in"
      }, {
        "text": " a young woman suggests [[98a63a59|optic neuritis]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eOptic neuropathy\u003c/b\u003e is the final common pathway of damage to the optic nerve, regardless of the cause"
      }, {
        "text": ". The clinical challenge lies in identifying the underlying etiology‚Äîbe it pressure, ischemia, inflammation, or compression‚Äîto guide"
      }, {
        "text": " appropriate management and prevent irreversible blindness.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \""
      }, {
        "text": "type\": \"is_damage_to\",\n        \"to\": \"66b11030\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"3ce6c"
      }, {
        "text": "035\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n"
      }, {
        "text": "        \"to\": \"ischemia\"\n      },\n      {\n        \"type\": \"can_be_"
      }, {
        "text": "caused_by\",\n        \"to\": \"98a63a59\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"5ccc91a9\": {\n    \"title\": \"Orbital Cellulitis\",\n    \"primaryType"
      }, {
        "text": "\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Infectious Disease"
      }, {
        "text": "\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \""
      }, {
        "text": "Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOrbital cellulitis\u003c/b\u003e is a serious infection of the fat"
      }, {
        "text": " and muscles located \u003ci\u003eposterior\u003c/i\u003e to the orbital septum, which can lead to vision loss and intracranial complications. It is an"
      }, {
        "text": " ophthalmologic emergency.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly arises from the spread of a"
      }, {
        "text": " bacterial sinus infection (especially ethmoid sinusitis) through the thin lamina papyracea. Other causes include trauma or dental infections"
      }, {
        "text": ". Common pathogens are \u003ci\u003eStaphylococcus aureus\u003c/i\u003e and \u003ci\u003eStreptococcus\u003c/i\u003e species.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:"
      }, {
        "text": "\u003c/b\u003e Patients present with eyelid swelling and erythema, similar to preseptal cellulitis, but with additional \u003cmark\u003e\\\""
      }, {
        "text": "red flag\\\" signs\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Differentiating Features:\u003c/b\u003e The presence of \u003cmark\u003epain with eye"
      }, {
        "text": " movements\u003c/mark\u003e, \u003cmark\u003eproptosis\u003c/mark\u003e (bulging eye), and \u003cmark\u003eophthalmoplegia\u003c/mark\u003e (restricted"
      }, {
        "text": " eye movements) or diplopia distinguishes orbital from [[087079b0|preseptal cellulitis]]."
      }, {
        "text": " Vision may be impaired.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e Can lead to vision loss (from optic nerve compression), [["
      }, {
        "text": "a830692a|cavernous sinus thrombosis]], meningitis, or brain abscess.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Pain on eye movement is the critical sign that separates orbital cellulitis from the less severe [[087079b0"
      }, {
        "text": "|preseptal cellulitis]]. This finding mandates urgent imaging (CT scan) and inpatient treatment with IV antibiotics.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eOrbital cellulitis\u003c/b\u003e is an infection that has breached the orbital septum, putting the vital"
      }, {
        "text": " structures of the orbit at risk. The presence of pain with eye movements, proptosis, or ophthalmoplegia signals this"
      }, {
        "text": " deeper involvement and elevates the condition to a true emergency requiring immediate intervention.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"0"
      }, {
        "text": "87079b0\"\n      },\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "complication_of\",\n        \"to\": \"sinusitis\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"can_lead_to\",\n        \"to\": \"a830692a\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"proptosis\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"2e814378\": {\n    \"title\": \"Organ of Corti\","
      }, {
        "text": "\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Otology\",\n      \""
      }, {
        "text": "Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Otology\",\n      \"Anatomy\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eOrgan of Corti\u003c/b\u003e is the sensory organ of hearing"
      }, {
        "text": ", located within the cochlea of the inner ear. It contains the mechanoreceptive hair cells that transduce the mechanical energy"
      }, {
        "text": " of sound vibrations into nerve impulses.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e S"
      }, {
        "text": "its on the basilar membrane within the scala media of the cochlea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Composed of sensory"
      }, {
        "text": " hair cells (one row of inner hair cells, three rows of outer hair cells) and various supporting cells. The stere"
      }, {
        "text": "ocilia of the hair cells are in contact with the overlying tectorial membrane.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction (Transduction):\u003c/b\u003e Sound vibrations"
      }, {
        "text": " cause the basilar membrane to move, creating a shearing force between the basilar and tectorial membranes. This force"
      }, {
        "text": " bends the stereocilia of the hair cells, opening ion channels and causing depolarization, which triggers neurotransmitter release and an"
      }, {
        "text": " action potential in the auditory nerve.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Damage to the hair cells is the cause of \u003c"
      }, {
        "text": "mark\u003esensorineural hearing loss\u003c/mark\u003e. This can be due to excessive noise exposure (\u003cmark\u003enoise-induced hearing loss\u003c/mark\u003e), aging"
      }, {
        "text": " ([[0957fd39|presbycusis]]), or ototoxic drugs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember"
      }, {
        "text": " that high-frequency sounds are detected at the stiff, narrow base of the cochlea, while low-frequency sounds are detected at the"
      }, {
        "text": " flexible, wide apex. Noise-induced hearing loss typically damages the hair cells at the base first, leading to high-frequency hearing loss.\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eOrgan of Corti\u003c/b\u003e is the biological microphone of the inner ear, where"
      }, {
        "text": " the mechanical vibrations of sound are precisely converted into electrical signals by the bending of specialized hair cells, a delicate process vulnerable to damage from noise"
      }, {
        "text": ", age, and toxins.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_located_in\",\n        \"to\": \"001c359"
      }, {
        "text": "f\"\n      },\n      {\n        \"type\": \"is_responsible_for\",\n        \"to"
      }, {
        "text": "\": \"hearing\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \""
      }, {
        "text": "to\": \"sensorineural_hearing_loss\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_damaged_in\",\n        \"to\": \"0957fd39\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"99870480\": {\n    \"title\": \"Organum"
      }, {
        "text": " Vasculosum of the Lamina Terminalis (OVLT)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Neuroscience\",\n      \"Endocrinology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n"
      }, {
        "text": "      \"Brain\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eOrganum Vasculosum of"
      }, {
        "text": " the Lamina Terminalis (OVLT)\u003c/b\u003e is one of the circumventricular organs, a highly vascularized structure in"
      }, {
        "text": " the anterior wall of the third ventricle that lacks a normal [[dd47b9cc|blood-brain barrier]]"
      }, {
        "text": " and contains osmosensory neurons critical for detecting plasma osmolarity.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e"
      }, {
        "text": " Anterior wall of the third ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e As a circumventricular organ, its fenestrated capillaries allow it to directly sense the"
      }, {
        "text": " composition of the blood. It contains \u003cmark\u003eosmoreceptors\u003c/mark\u003e that detect changes in plasma osmolarity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole"
      }, {
        "text": " in Thirst and ADH Release:\u003c/b\u003e When the OVLT detects an increase in plasma osmolarity (hypertonicity), it stimulates"
      }, {
        "text": " thirst and signals the supraoptic and paraventricular nuclei of the hypothalamus to release \u003cmark\u003eantidiuretic hormone (ADH"
      }, {
        "text": ")\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Fever:\u003c/b\u003e The OVLT is also a site where circulating pyrogens like PGE"
      }, {
        "text": "\u003csub\u003e2\u003c/sub\u003e can act on the brain to induce fever by altering the hypothalamic temperature set-point.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Remember the OVLT as the brain\u0027s primary \u0027osmostat,\u0027 constantly sampling the blood to regulate"
      }, {
        "text": " water balance through thirst and ADH secretion.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eOV"
      }, {
        "text": "LT\u0027s\u003c/b\u003e lack of a blood-brain barrier is its key functional feature, allowing its specialized osmosensory neurons to act"
      }, {
        "text": " as a direct interface between the bloodstream and the hypothalamus, thereby orchestrating the body\u0027s response to dehydration.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"circumventricular_organ\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"bb"
      }, {
        "text": "51a0dc\"\n      },\n      {\n        \"type\": \"regulates\",\n        \"to\": \""
      }, {
        "text": "adh_release\"\n      },\n      {\n        \"type\": \"regulates\",\n        \"to\": \"thirst"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"bb51a0dc\": {\n    \""
      }, {
        "text": "title\": \"Osmoreceptors\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Physiology\",\n      \""
      }, {
        "text": "Endocrinology\",\n      \"Neuroscience\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"End"
      }, {
        "text": "ocrine\",\n      \"Physiology\",\n      \"Hypothalamic-Pituitary Axis\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOsmoreceptors\u003c/b\u003e are specialized neurons, primarily located in the [["
      }, {
        "text": "89e86633|hypothalamus]], that respond to changes in the osmotic pressure (osmolarity) of the extracellular fluid,"
      }, {
        "text": " thereby regulating the body\u0027s water balance through thirst and the secretion of antidiuretic hormone (ADH).\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Primarily found in the circumventricular organs of the brain that lack a blood-brain barrier, especially"
      }, {
        "text": " the \u003cmark\u003eOrganum Vasculosum of the Lamina Terminalis (OVLT)\u003c/mark\u003e and the sub"
      }, {
        "text": "fornical organ (SFO). Also located within the supraoptic nucleus itself.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e These"
      }, {
        "text": " neurons function as mechanoreceptors, shrinking or swelling in response to changes in plasma osmolarity. Cell shrinkage (in a"
      }, {
        "text": " hypertonic state) opens stretch-inhibited cation channels, leading to depolarization and firing.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e When"
      }, {
        "text": " stimulated by increased plasma osmolarity, osmoreceptors trigger two key responses: 1) Stimulation of the sensation of \u003c"
      }, {
        "text": "mark\u003ethirst\u003c/mark\u003e. 2) Stimulation of ADH synthesis and release from the posterior pituitary.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Relevance:\u003c/b\u003e Dysfunction of this system can lead to disorders of water balance like diabetes insipidus or SIADH.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e The osmoreceptor system is exquisitely sensitive, responding to as little as a 1-2% change in plasma osmolarity to"
      }, {
        "text": " maintain tight control over the body\u0027s water balance.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eOsmoreceptors\u003c/b\u003e are"
      }, {
        "text": " the body\u0027s cellular osmometers, translating minute changes in blood concentration into the powerful physiological drives of thirst and ADH release to"
      }, {
        "text": " defend plasma osmolarity with remarkable precision.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Increased Plasma Osmolarity] --\u003e B(Osm"
      }, {
        "text": "oreceptor Shrinkage); B --\u003e C(Neuron Firing); C --\u003e D(Thirst Sensation); C --\u003e E(ADH"
      }, {
        "text": " Release); E --\u003e F(Renal Water Reabsorption); D \u0026 F --\u003e G(Decreased Plasma Osmolarity);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"are_located_in\",\n        \""
      }, {
        "text": "to\": \"99870480\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "regulate\",\n        \"to\": \"adh_release\"\n      },\n      {\n        \"type\": \"regulate"
      }, {
        "text": "\",\n        \"to\": \"thirst\"\n      }\n    ]\n  },\n  \"7a68"
      }, {
        "text": "0d3d\": {\n    \"title\": \"Osmotic Demyelination Syndrome (ODS)\",\n    \"primaryType"
      }, {
        "text": "\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Emergency Medicine\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special S"
      }, {
        "text": "enses\",\n      \"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOsmotic Demyelination Syndrome (ODS)\u003c/b\u003e,"
      }, {
        "text": " classically known as \u003cb\u003eCentral Pontine Myelinolysis\u003c/b\u003e, is an acute, iatrogenic demyelination of the central nervous system caused"
      }, {
        "text": " by the overly rapid correction of chronic hyponatremia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e In chronic hyponatremia, brain cells adapt by extruding organic osmolytes to prevent swelling. If"
      }, {
        "text": " the serum sodium is corrected too quickly, the extracellular space becomes hypertonic relative to the brain cells. Water is rapidly pulled"
      }, {
        "text": " out of the cells, leading to cell shrinkage and demyelination, particularly in osmotically sensitive areas.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation"
      }, {
        "text": " of Lesion:\u003c/b\u003e The \u003cmark\u003epons\u003c/mark\u003e is the most classic and severely affected location (Central Pontine Myelinolysis), but"
      }, {
        "text": " demyelination can also occur in extrapontine sites like the basal ganglia and cerebellum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Symptoms"
      }, {
        "text": " typically develop 2-6 days after the rapid sodium correction. Presents with acute paralysis (quadriplegia), dys"
      }, {
        "text": "arthria, dysphagia, diplopia, and loss of consciousness. Can progress to a \u003cmark\u003e\\\"locked-in\\\" syndrome\u003c/mark\u003e."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrevention:\u003c/b\u003e The key is slow and controlled correction of chronic hyponatremia. Correction rates should generally"
      }, {
        "text": " not exceed 8-12 mEq/L in 24 hours.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember"
      }, {
        "text": " the mnemonic: \\\"From \u003cb\u003elow\u003c/b\u003e to \u003cb\u003ehigh\u003c/b\u003e, your \u003cb\u003epons\u003c/b\u003e will \u003cb\u003edie\u003c/b\u003e.\\\""
      }, {
        "text": " (ODS). \\\"From \u003cb\u003ehigh\u003c/b\u003e to \u003cb\u003elow\u003c/b\u003e, your \u003cb\u003ebrain\u003c/b\u003e will \u003cb\u003eblow"
      }, {
        "text": "\u003c/b\u003e.\\\" (Cerebral edema from rapid correction of hypernatremia).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Osmotic Demyelination Syndrome\u003c/b\u003e is a devastating iatrogenic injury caused by correcting chronic hyponatremia too quickly, forcing"
      }, {
        "text": " brain cells that had adapted to a low-salt environment to suddenly dehydrate, leading to demyelination, especially in the vulnerable"
      }, {
        "text": " pons.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused"
      }, {
        "text": "_by\",\n        \"to\": \"rapid_correction_of_hyponatremia\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"affects\",\n        \"to\": \"bf549b2f\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"can_cause\",\n        \"to\": \"locked_in_syndrome\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \""
      }, {
        "text": "demyelinating_disorder\"\n      }\n    ]\n  },\n  \"3aea8cac\": {\n    \"title\":"
      }, {
        "text": " \"Auditory Ossicles\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Otology\",\n      \""
      }, {
        "text": "Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Otology\",\n      \"Anatomy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003eAuditory Ossicles\u003c/b\u003e are a chain of three small bones‚Äîthe \u003ci\u003emalleus\u003c/i\u003e, \u003ci\u003eincus\u003c/i\u003e"
      }, {
        "text": ", and \u003ci\u003estapes\u003c/i\u003e‚Äîlocated in the air-filled middle ear cavity. They function to transmit and amplify sound vibrations from the tym"
      }, {
        "text": "panic membrane to the oval window of the inner ear.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Components (from lateral to medial):\u003c/b\u003e Malleus (hammer), Incus (anvil), and Stapes (stirrup). M"
      }, {
        "text": "nemonic: \u003cb\u003eM-I-S\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e They act as a lever system to"
      }, {
        "text": " amplify the force of sound vibrations from the large tympanic membrane to the much smaller oval window, overcoming the impedance mismatch between air"
      }, {
        "text": " and the fluid-filled cochlea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMuscles:\u003c/b\u003e Two small muscles modulate ossicular movement: the "
      }, {
        "text": "\u003cb\u003eTensor tympani\u003c/b\u003e (innervated by CN V\u003csub\u003e3\u003c/sub\u003e) tenses the tympanic membrane, and the \u003cb\u003eSt"
      }, {
        "text": "apedius\u003c/b\u003e (innervated by CN VII) dampens the movement of the stapes. These muscles contract reflexively to loud"
      }, {
        "text": " sounds, protecting the inner ear.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Disruption of the ossicular chain (e.g., from"
      }, {
        "text": " trauma or cholesteatoma) or fixation of the stapes (otosclerosis) causes \u003cmark\u003econductive hearing loss\u003c/mark"
      }, {
        "text": "\u003e. Paralysis of the stapedius muscle (e.g., in Bell\u0027s palsy) can cause hyperacusis.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e Otosclerosis, an autosomal dominant condition causing fixation of the stapes, is a common cause of conductive hearing loss in young adults"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eauditory ossicles\u003c/b\u003e form a sophisticated"
      }, {
        "text": " mechanical amplifier, converting the low-pressure, large-amplitude vibrations of the eardrum into high-pressure, low-amplitude vibrations at"
      }, {
        "text": " the oval window, which is essential for efficiently transmitting sound energy from air to the fluid of the inner ear.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n"
      }, {
        "text": "    },\n    \"connections\": [\n      {\n        \"type\": \"is_located_in\",\n"
      }, {
        "text": "        \"to\": \"middle_ear\"\n      },\n      {\n        \"type\": \"is_composed"
      }, {
        "text": "_of\",\n        \"to\": \"malleus\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_composed_of\",\n        \"to\": \"incus\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_composed_of\",\n        \"to\": \"stapes\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"dysfunction_causes\",\n        \"to\": \"conductive_hearing_loss"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"67063a58\": {\n    \"title\": \""
      }, {
        "text": "Otitis Externa\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Otology\",\n      \""
      }, {
        "text": "Infectious Disease\",\n      \"Dermatology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Path"
      }, {
        "text": "ology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOtitis Externa\u003c/b\u003e,"
      }, {
        "text": " commonly known as \\\"swimmer\u0027s ear,\\\" is an inflammation or infection of the external auditory canal, the tube leading"
      }, {
        "text": " from the outer ear to the eardrum.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused"
      }, {
        "text": " by bacteria, with \u003cmark\u003ePseudomonas aeruginosa\u003c/mark\u003e being the most frequent pathogen, followed by \u003ci\u003eSt"
      }, {
        "text": "aphylococcus aureus\u003c/i\u003e. Fungal infections (otomycosis) can also occur.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e Water exposure ("
      }, {
        "text": "swimming) that macerates the skin of the ear canal, trauma from cotton swabs or hearing aids, and dermatologic conditions like"
      }, {
        "text": " eczema.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e The hallmark symptom is severe ear pain (\u003cmark\u003eotalgia\u003c/mark\u003e) that is character"
      }, {
        "text": "istically worsened by manipulation of the pinna or tragus. Other symptoms include pruritus, purulent discharge, and a"
      }, {
        "text": " feeling of fullness in the ear.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMalignant Otitis Externa:\u003c/b\u003e A severe, necrotizing form"
      }, {
        "text": " that can spread to the skull base, causing osteomyelitis. It is a medical emergency seen almost exclusively in elderly diabetic or"
      }, {
        "text": " immunocompromised patients.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Pain on pulling the pinna is the key physical exam finding that differentiates"
      }, {
        "text": " otitis externa from [[a03641af|otitis media]], where the pain is internal and not affected by external manipulation."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eOtitis Externa\u003c/b\u003e is an infection of the skin lining"
      }, {
        "text": " the ear canal, not the middle ear space. Its diagnosis hinges on the classic sign of exquisite tenderness with external ear manipulation"
      }, {
        "text": ", a feature absent in middle ear infections.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_an_infection_of\",\n        \"to\": \"944bb118"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_commonly_caused_by\",\n        \""
      }, {
        "text": "to\": \"cf0b8fbc\"\n      },\n      {\n        \"type\": \"differentiated"
      }, {
        "text": "_from\",\n        \"to\": \"a03641af\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"can_progress_to\",\n        \"to\": \"malignant_otitis_extern"
      }, {
        "text": "a\"\n      }\n    ]\n  },\n  \"a03641af\": {\n    \"title\": \"Otitis"
      }, {
        "text": " Media\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Otology\",\n      \"Ped"
      }, {
        "text": "iatrics\",\n      \"Infectious Disease\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \""
      }, {
        "text": "Neurology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOtitis Media\u003c/b\u003e is an inflammation or infection of the middle ear, the"
      }, {
        "text": " air-filled space behind the eardrum. Acute otitis media (AOM) is one of the most common childhood"
      }, {
        "text": " infections.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Typically follows a viral"
      }, {
        "text": " upper respiratory infection, which leads to eustachian tube dysfunction and obstruction. This causes negative pressure and fluid accumulation in the middle ear, which"
      }, {
        "text": " then becomes secondarily infected by bacteria colonizing the nasopharynx.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Pathogens:\u003c/b\u003e The three"
      }, {
        "text": " most common bacterial causes are \u003cmark\u003eStreptococcus pneumoniae\u003c/mark\u003e, non-typeable \u003cmark\u003eHaemophilus influenzae\u003c/mark\u003e, and"
      }, {
        "text": " \u003cmark\u003eMoraxella catarrhalis\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Infants and young children present with fever, irritability"
      }, {
        "text": ", and ear pulling. Otoscopy reveals a \u003cmark\u003ebulging, erythematous tympanic membrane\u003c/mark\u003e with"
      }, {
        "text": " poor mobility.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e Can lead to tympanic membrane perforation, mastoiditis, meningitis, or"
      }, {
        "text": " brain abscess. Recurrent episodes can cause conductive hearing loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The classic triad of pathogens"
      }, {
        "text": " for AOM is \u003ci\u003eS. pneumoniae\u003c/i\u003e, \u003ci\u003eH. influenzae\u003c/i\u003e (non-typeable), and "
      }, {
        "text": "\u003ci\u003eM. catarrhalis\u003c/i\u003e. Remember that the introduction of the pneumococcal conjugate vaccine has decreased the incidence of A"
      }, {
        "text": "OM caused by \u003ci\u003eS. pneumoniae\u003c/i\u003e.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcute"
      }, {
        "text": " Otitis Media\u003c/b\u003e is fundamentally a complication of eustachian tube dysfunction following a viral URI, where trapped fluid in"
      }, {
        "text": " the middle ear becomes a culture medium for nasopharyngeal bacteria, leading to a painful, bulging eardrum.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_an"
      }, {
        "text": "_infection_of\",\n        \"to\": \"middle_ear\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_commonly_caused_by\",\n        \"to\": \"streptococcus_pneumoniae"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_commonly_caused_by\",\n        \""
      }, {
        "text": "to\": \"69962905\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "commonly_caused_by\",\n        \"to\": \"moraxella_catarrhalis\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"can_lead_to\",\n        \"to\": \"mastoiditis\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"c5a1d2fc\": {\n    \"title\": \""
      }, {
        "text": "Otology\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Special Senses\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Otology\",\n      \"Overview\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOtology\u003c/b\u003e is the branch of medicine that studies the normal and"
      }, {
        "text": " pathological anatomy and physiology of the ear, as well as its diseases, diagnosis, and treatment. It encompasses hearing and balance disorders"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnatomy:\u003c/b\u003e The ear is divided into the"
      }, {
        "text": " [[944bb118|outer ear]] (pinna, canal), middle ear ([[3aea8cac|oss"
      }, {
        "text": "icles]]), and inner ear (cochlea, vestibular system).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysiology:\u003c/b\u003e Hearing involves the transduction of sound waves into neural"
      }, {
        "text": " signals by the [[2e814378|organ of Corti]]. Balance is maintained by the vestibular system ("
      }, {
        "text": "semicircular canals, utricle, saccule).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Pathologies:\u003c/b\u003e Include [[8"
      }, {
        "text": "8e6f77e|hearing loss]] (conductive vs. sensorineural), [[a03641af|ot"
      }, {
        "text": "itis media]], [[67063a58|otitis externa]], and vertigo (e.g., B"
      }, {
        "text": "PPV, [[6f2228c1|M√©ni√®re disease]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Nerves:\u003c/b\u003e The [[6f"
      }, {
        "text": "ded3e7|vestibulocochlear nerve (CN VIII)]] is central to otology, carrying both"
      }, {
        "text": " auditory and vestibular information to the brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A solid understanding of the distinction between conductive"
      }, {
        "text": " and sensorineural hearing loss, and between peripheral and central vertigo, is essential for otology questions.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003e\u003cb\u003eOtology\u003c/b\u003e integrates the complex anatomy and physiology of the ear to diagnose and manage disorders"
      }, {
        "text": " of its two primary functions: hearing and balance, which are subserved by the cochlear and vestibular systems, respectively.\u003c/p"
      }, {
        "text": "\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\":"
      }, {
        "text": " \"is_the_study_of\",\n        \"to\": \"ear\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"includes\",\n        \"to\": \"88e6f77e\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"includes\",\n        \"to\": \"vertigo\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"includes\",\n        \"to\": \"a03641af\"\n      }\n    ]\n"
      }, {
        "text": "  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"7c59030e\",\n    \"letter\": \"N\",\n    \"term\": \"Normal pressure hydrocephalus\",\n    \"pages\": [\n      \"536\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Normal pressure hydrocephalus\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"8092ce8a\",\n    \"letter\": \"N\",\n    \"term\": \"Nucleus accumbens\",\n    \"pages\": [\n      \"505\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Nucleus accumbens\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"73378e13\",\n    \"letter\": \"N\",\n    \"term\": \"Nucleus ambiguus\",\n    \"pages\": [\n      \"516\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Nucleus ambiguus\",\n    \"sub_entries\": [\n      {\n        \"id\": \"18d14aad\",\n        \"letter\": \"N\",\n        \"term\": \"stroke effects\",\n        \"pages\": [\n          \"527\"\n        ],\n        \"context\": \"Nucleus ambiguus \u003e stroke effects\"\n      }\n    ]\n  },\n  {\n    \"id\": \"38bfa9e0\",\n    \"letter\": \"N\",\n    \"term\": \"Nucleus tractus solitarius\",\n    \"pages\": [\n      \"506\",\n      \"516\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Nucleus tractus solitarius\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"f3040fdf\",\n    \"letter\": \"N\",\n    \"term\": \"Nystagmus\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Nystagmus\",\n    \"sub_entries\": [\n      {\n        \"id\": \"56a399a9\",\n        \"letter\": \"N\",\n        \"term\": \"cerebellum\",\n        \"pages\": [\n          \"524\"\n        ],\n        \"context\": \"Nystagmus \u003e cerebellum\"\n      },\n      {\n        \"id\": \"32535542\",\n        \"letter\": \"N\",\n        \"term\": \"Friedreich ataxia\",\n        \"pages\": [\n          \"545\"\n        ],\n        \"context\": \"Nystagmus \u003e Friedreich ataxia\"\n      },\n      {\n        \"id\": \"3f5471ac\",\n        \"letter\": \"N\",\n        \"term\": \"internuclear ophthalmoplegia\",\n        \"pages\": [\n          \"558\"\n        ],\n        \"context\": \"Nystagmus \u003e internuclear ophthalmoplegia\"\n      },\n      {\n        \"id\": \"2007d0ce\",\n        \"letter\": \"N\",\n        \"term\": \"retinoblastoma presentation\",\n        \"pages\": [\n          \"552\"\n        ],\n        \"context\": \"Nystagmus \u003e retinoblastoma presentation\"\n      }\n    ]\n  },\n  {\n    \"id\": \"4fab8000\",\n    \"letter\": \"O\",\n    \"term\": \"Obstructive hydrocephalus\",\n    \"pages\": [\n      \"542\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Obstructive hydrocephalus\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"f0c73162\",\n    \"letter\": \"O\",\n    \"term\": \"Occipital lobe\",\n    \"pages\": [\n      \"508\",\n      \"526\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Occipital lobe\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"4eb418d0\",\n    \"letter\": \"O\",\n    \"term\": \"Ocular motility\",\n    \"pages\": [\n      \"555\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Ocular motility\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"68c66997\",\n    \"letter\": \"O\",\n    \"term\": \"Oculomotor nerve (CN III)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Oculomotor nerve (CN III)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"19b6f41d\",\n        \"letter\": \"O\",\n        \"term\": \"causes of damage to\",\n        \"pages\": [\n          \"556\"\n        ],\n        \"context\": \"Oculomotor nerve (CN III) \u003e causes of damage to\"\n      },\n      {\n        \"id\": \"a01337f2\",\n        \"letter\": \"O\",\n        \"term\": \"functions of\",\n        \"pages\": [\n          \"519\"\n        ],\n        \"context\": \"Oculomotor nerve (CN III) \u003e functions of\"\n      },\n      {\n        \"id\": \"1adc983c\",\n        \"letter\": \"O\",\n        \"term\": \"in herniation syndromes\",\n        \"pages\": [\n          \"543\"\n        ],\n        \"context\": \"Oculomotor nerve (CN III) \u003e in herniation syndromes\"\n      },\n      {\n        \"id\": \"7de45f85\",\n        \"letter\": \"O\",\n        \"term\": \"internuclear ophthalmoplegia\",\n        \"pages\": [\n          \"558\"\n        ],\n        \"context\": \"Oculomotor nerve (CN III) \u003e internuclear ophthalmoplegia\"\n      },\n      {\n        \"id\": \"5193a235\",\n        \"letter\": \"O\",\n        \"term\": \"ocular motility\",\n        \"pages\": [\n          \"555\"\n        ],\n        \"context\": \"Oculomotor nerve (CN III) \u003e ocular motility\"\n      },\n      {\n        \"id\": \"f2c8d049\",\n        \"letter\": \"O\",\n        \"term\": \"palsy of\",\n        \"pages\": [\n          \"528\"\n        ],\n        \"context\": \"Oculomotor nerve (CN III) \u003e palsy of\"\n      },\n      {\n        \"id\": \"e31da9f6\",\n        \"letter\": \"O\",\n        \"term\": \"pupillary contraction\",\n        \"pages\": [\n          \"554\"\n        ],\n        \"context\": \"Oculomotor nerve (CN III) \u003e pupillary contraction\"\n      }\n    ]\n  },\n  {\n    \"id\": \"84b5e4f6\",\n    \"letter\": \"O\",\n    \"term\": \"Oculosympathetic pathway\",\n    \"pages\": [\n      \"545\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Oculosympathetic pathway\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"c6cf9420\",\n    \"letter\": \"O\",\n    \"term\": \"Olfaction\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Olfaction\",\n    \"sub_entries\": [\n      {\n        \"id\": \"c3228e34\",\n        \"letter\": \"O\",\n        \"term\": \"limbic system in\",\n        \"pages\": [\n          \"508\",\n          \"509\"\n        ],\n        \"context\": \"Olfaction \u003e limbic system in\"\n      }\n    ]\n  },\n  {\n    \"id\": \"4487bc38\",\n    \"letter\": \"O\",\n    \"term\": \"Olfactory nerve (CN I)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Olfactory nerve (CN I)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"6099097e\",\n        \"letter\": \"O\",\n        \"term\": \"function and type\",\n        \"pages\": [\n          \"519\"\n        ],\n        \"context\": \"Olfactory nerve (CN I) \u003e function and type\"\n      }\n    ]\n  },\n  {\n    \"id\": \"a24f9747\",\n    \"letter\": \"O\",\n    \"term\": \"Oligodendrocytes\",\n    \"pages\": [\n      \"503\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Oligodendrocytes\",\n    \"sub_entries\": [\n      {\n        \"id\": \"35d93e1b\",\n        \"letter\": \"O\",\n        \"term\": \"leukoencephalopathy\",\n        \"pages\": [\n          \"538\"\n        ],\n        \"context\": \"Oligodendrocytes \u003e leukoencephalopathy\"\n      }\n    ]\n  },\n  {\n    \"id\": \"c932ed4e\",\n    \"letter\": \"O\",\n    \"term\": \"Oligodendroglioma, description and\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Oligodendroglioma, description and\",\n    \"sub_entries\": [\n      {\n        \"id\": \"0a30dd80\",\n        \"letter\": \"O\",\n        \"term\": \"histology\",\n        \"pages\": [\n          \"540\"\n        ],\n        \"context\": \"Oligodendroglioma, description and \u003e histology\"\n      }\n    ]\n  },\n  {\n    \"id\": \"5ea7b741\",\n    \"letter\": \"O\",\n    \"term\": \"Open-angle glaucoma\",\n    \"pages\": [\n      \"551\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Open-angle glaucoma\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 2442
    }, {
      "text": "```json\n{\n  \"7c59030e\": {\n    \"title\": \"Normal Pressure Hydrocephalus (NPH)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Geriatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Hydrocephalus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNormal Pressure Hydrocephalus (NPH)\u003c/b\u003e is a form of \u003ci\u003ecommunicating hydrocephalus\u003c/i\u003e in older adults, characterized by ventricular enlargement with only intermittently elevated cerebrospinal fluid (CSF) pressure, leading to a classic clinical triad of gait apraxia, cognitive dysfunction, and urinary incontinence.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The exact cause is often idiopathic, but it is thought to result from impaired CSF absorption at the arachnoid granulations. This leads to ventricular expansion, which stretches the corona radiata fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Triad (\\\"Wet, Wobbly, and Wacky\\\"):\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eWobbly:\u003c/b\u003e Gait apraxia is often the first and most prominent symptom. Described as a \u003cmark\u003emagnetic gait\u003c/mark\u003e, where the feet appear stuck to the floor.\u003cbr\u003e2. \u003cb\u003eWacky:\u003c/b\u003e Cognitive dysfunction/dementia.\u003cbr\u003e3. \u003cb\u003eWet:\u003c/b\u003e Urinary incontinence/urgency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Brain imaging (CT or MRI) shows \u003cmark\u003eventriculomegaly\u003c/mark\u003e out of proportion to sulcal enlargement. A lumbar puncture (LP) will show a normal opening pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e A large-volume LP that temporarily improves symptoms is both diagnostic and predictive of response to treatment. The definitive treatment is surgical placement of a \u003cmark\u003eventriculoperitoneal (VP) shunt\u003c/mark\u003e to divert CSF.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e NPH is a reversible cause of dementia. The triad of gait disturbance, dementia, and urinary incontinence in an elderly patient should immediately bring NPH to mind.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNormal Pressure Hydrocephalus\u003c/b\u003e is a clinical paradox where ventricular enlargement causes significant neurological symptoms despite a \u0027normal\u0027 CSF pressure on a single lumbar puncture. The diagnosis is supported by symptomatic improvement after CSF removal, and it represents one of the few treatable causes of dementia.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Impaired CSF Absorption] --\u003e B(Ventriculomegaly); B --Stretches Corona Radiata--\u003e C(Clinical Triad); C --\u003e C1(Gait Apraxia - Wobbly); C --\u003e C2(Dementia - Wacky); C --\u003e C3(Urinary Incontinence - Wet);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"aa4115c7\"\n      },\n      {\n        \"type\": \"is_a_reversible_cause_of\",\n        \"to\": \"bb316ca0\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"ventriculoperitoneal_shunt\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"gait_apraxia\"\n      }\n    ]\n  },\n  \"8092ce8a\": {\n    \"title\": \"Nucleus Accumbens\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Psychiatry\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Basal Ganglia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eNucleus Accumbens\u003c/b\u003e is a key structure in the ventral striatum, part of the [[ed462927|basal ganglia]], that plays a central role in the brain\u0027s \u003ci\u003ereward circuitry\u003c/i\u003e, motivation, and addiction.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Located where the head of the caudate nucleus and the anterior portion of the putamen meet.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e It is a major component of the \u003cmark\u003emesolimbic pathway\u003c/mark\u003e, receiving dopaminergic input from the ventral tegmental area (VTA).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitters:\u003c/b\u003e The primary neurotransmitters are [[90adc821|dopamine]] (mediating reward and pleasure), [[5aa5cb91|GABA]] (its primary output), and glutamate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Integrates emotional and motivational information to guide behavior. It is crucial for processing rewarding stimuli (e.g., food, sex, drugs) and reinforcing behaviors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Dysfunction of the nucleus accumbens and the mesolimbic pathway is central to the pathophysiology of \u003cmark\u003eaddiction\u003c/mark\u003e. All major drugs of abuse increase dopamine levels in the nucleus accumbens. It is also implicated in depression and schizophrenia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the nucleus accumbens as the \u0027pleasure center\u0027 of the brain. Its dopaminergic activation is the final common pathway for reward and reinforcement.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eNucleus Accumbens\u003c/b\u003e serves as the brain\u0027s motivational hub, where dopamine signals from the VTA translate the value of a stimulus into the drive to pursue it, a fundamental process that is hijacked in addiction.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Ventral Tegmental Area VTA] --Dopamine--\u003e B(Nucleus Accumbens); B --\u003e C(Reward \u0026 Motivation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"ed462927\"\n      },\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"mesolimbic_pathway\"\n      },\n      {\n        \"type\": \"is_implicated_in\",\n        \"to\": \"addiction\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"ventral_tegmental_area\"\n      }\n    ]\n  },\n  \"73378e13\": {\n    \"title\": \"Nucleus Ambiguus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Brainstem\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eNucleus Ambiguus\u003c/b\u003e is a motor nucleus located in the medulla oblongata that provides branchial motor innervation to the muscles of the soft palate, pharynx, and larynx via cranial nerves IX, X, and XI (cranial root).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Located in the reticular formation of the medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Contains lower motor neurons that control the muscles for \u003cmark\u003eswallowing (deglutition)\u003c/mark\u003e and \u003cmark\u003espeaking (phonation)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEfferent Nerves:\u003c/b\u003e Its axons travel with the [[97e2c817|glossopharyngeal nerve (CN IX)]], [[7c12e7a3|vagus nerve (CN X)]], and the cranial root of the [[f218aebf|accessory nerve (CN XI)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e A lesion of the nucleus ambiguus, such as in a \u003cmark\u003elateral medullary (Wallenberg) syndrome\u003c/mark\u003e caused by a [[posterior_inferior_cerebellar_artery|PICA]] stroke, results in ipsilateral paralysis of the palate, pharynx, and larynx.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms of Lesion:\u003c/b\u003e Patients present with \u003cmark\u003edysphagia\u003c/mark\u003e (difficulty swallowing), \u003cmark\u003ehoarseness\u003c/mark\u003e (dysphonia), and a diminished gag reflex. The uvula deviates \u003cu\u003eaway\u003c/u\u003e from the side of the lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Hoarseness and dysphagia are key localizing signs for a lesion in the lateral medulla affecting the nucleus ambiguus. Mnemonic: Nucleus a**m**biguus is for **m**otor.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eNucleus Ambiguus\u003c/b\u003e is the command center for the complex motor actions of swallowing and speaking; its destruction in a lateral medullary stroke leads to the characteristic and debilitating symptoms of hoarseness and dysphagia.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Nucleus Ambiguus] --\u003e B(CN IX, X, XI); B --\u003e C(Muscles of Pharynx, Larynx, Palate); C --\u003e D(Swallowing \u0026 Phonation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"medulla_oblongata\"\n      },\n      {\n        \"type\": \"provides_innervation_via\",\n        \"to\": \"97e2c817\"\n      },\n      {\n        \"type\": \"provides_innervation_via\",\n        \"to\": \"7c12e7a3\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"lateral_medullary_syndrome\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"dysphagia\"\n      }\n    ]\n  },\n  \"38bfa9e0\": {\n    \"title\": \"Nucleus Tractus Solitarius (NTS)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eNucleus Tractus Solitarius (NTS)\u003c/b\u003e, or solitary nucleus, is a sensory nucleus in the medulla oblongata that serves as the primary relay station for visceral sensory information, including taste, baroreception, and chemoreception.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Medulla oblongata.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Receives and integrates visceral sensory information. Mnemonic: Nucleus **S**olitarius is for **S**ensory.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInputs:\u003c/b\u003e Receives afferent fibers from:\u003cbr\u003e - \u003cb\u003eCN VII (Facial):\u003c/b\u003e Taste from anterior 2/3 of the tongue.\u003cbr\u003e - \u003cb\u003eCN IX (Glossopharyngeal):\u003c/b\u003e Taste from posterior 1/3 of the tongue, and signals from carotid body chemoreceptors and carotid sinus baroreceptors.\u003cbr\u003e - \u003cb\u003eCN X (Vagus):\u003c/b\u003e Taste from the epiglottis, and signals from aortic arch baroreceptors/chemoreceptors and visceral organs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Reflexes:\u003c/b\u003e It is the afferent hub for the baroreflex and chemoreflex, crucial for blood pressure and respiratory control. It also plays a role in the gag and cough reflexes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVomiting Center:\u003c/b\u003e The NTS receives input from the [[5dd343d3|area postrema]] (chemoreceptor trigger zone) and the GI tract (via the vagus nerve) to coordinate the vomiting reflex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the NTS as the main visceral sensory nucleus for CNs VII, IX, and X, integrating taste, blood pressure, and gut sensation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eNucleus Tractus Solitarius\u003c/b\u003e acts as the brainstem\u0027s central processing unit for all visceral sensation, integrating critical information about taste, blood pressure, and blood gases from three different cranial nerves to orchestrate vital autonomic reflexes.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[CN VII, IX, X] --Visceral Sensory Info--\u003e B(Nucleus Tractus Solitarius); B --\u003e C(Taste Pathway); B --\u003e D(Autonomic Reflexes e.g., Baroreflex); B --\u003e E(Vomiting Center);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"medulla_oblongata\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"dea9755f\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"97e2c817\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"7c12e7a3\"\n      },\n      {\n        \"type\": \"is_involved_in\",\n        \"to\": \"baroreflex\"\n      }\n    ]\n  },\n  \"f3040fdf\": {\n    \"title\": \"Nystagmus\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physical Findings\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNystagmus\u003c/b\u003e is a condition of involuntary, rhythmic eye movements, which can be horizontal, vertical, or rotary. It is a sign of dysfunction in the systems responsible for controlling eye position and movement, such as the vestibular system or the cerebellum.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eJerk Nystagmus:\u003c/b\u003e The most common form, characterized by a slow drift of the eyes in one direction (slow phase) followed by a rapid corrective jerk back in the opposite direction (fast phase). Nystagmus is named for the direction of the fast phase.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePeripheral vs. Central Vertigo:\u003c/b\u003e The characteristics of nystagmus help differentiate the cause of vertigo. \u003cmark\u003ePeripheral vertigo\u003c/mark\u003e (inner ear) typically causes horizontal or torsional nystagmus that is suppressed by visual fixation. \u003cmark\u003eCentral vertigo\u003c/mark\u003e (brainstem/cerebellum) can cause purely vertical or purely torsional nystagmus that is not suppressed by fixation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInternuclear Ophthalmoplegia (INO):\u003c/b\u003e A lesion of the MLF causes nystagmus in the \u003cmark\u003eabducting\u003c/mark\u003e eye during horizontal gaze.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFriedreich Ataxia:\u003c/b\u003e Nystagmus is a common finding in this neurodegenerative disease due to cerebellar involvement.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRetinoblastoma:\u003c/b\u003e Can present with nystagmus in an infant if the tumor affects central vision.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Purely vertical or purely torsional nystagmus is a major red flag for a central (brainstem or cerebellar) lesion.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNystagmus\u003c/b\u003e is a key objective sign of vestibular or cerebellar dysfunction, and a careful analysis of its direction, trajectory, and response to fixation can precisely localize the lesion to either the peripheral or central nervous system.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"vertigo\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"cerebellar_dysfunction\"\n      },\n      {\n        \"type\": \"is_a_finding_in\",\n        \"to\": \"58c684bd\"\n      },\n      {\n        \"type\": \"is_a_finding_in\",\n        \"to\": \"39bc1763\"\n      }\n    ]\n  },\n  \"4fab8000\": {\n    \"title\": \"Obstructive Hydrocephalus\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Hydrocephalus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eObstructive hydrocephalus\u003c/b\u003e, also known as non-communicating hydrocephalus, is the accumulation of excess cerebrospinal fluid (CSF) due to a physical blockage within the ventricular system, leading to ventricular dilation proximal to the obstruction and increased intracranial pressure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e A structural lesion blocks the flow of CSF from one part of the ventricular system to another or into the subarachnoid space. This leads to a buildup of CSF and pressure in the ventricles \u0027upstream\u0027 of the blockage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Sites of Obstruction:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCerebral Aqueduct (of Sylvius):\u003c/b\u003e The narrowest part of the ventricular system, connecting the 3rd and 4th ventricles. Aqueductal stenosis is a common cause in children.\u003cbr\u003e - \u003cb\u003eForamen of Monro:\u003c/b\u003e Can be blocked by a colloid cyst.\u003cbr\u003e - \u003cb\u003eFourth Ventricle Outlets:\u003c/b\u003e Can be compressed by posterior fossa tumors like a [[16d613bb|medulloblastoma]] or [[14365ef4|ependymoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Symptoms of increased intracranial pressure, such as headache, nausea, vomiting, and [[4ae219da|papilledema]]. In infants, presents with an enlarging head circumference and bulging fontanelle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A [[16d613bb|medulloblastoma]] in a child is a classic cause of obstructive hydrocephalus due to compression of the fourth ventricle.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eObstructive hydrocephalus\u003c/b\u003e is a \u0027plumbing problem\u0027 within the brain\u0027s ventricular system, where a physical blockage leads to a dam-like effect, causing upstream ventricular dilation and a dangerous rise in intracranial pressure.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[CSF Production in Lateral/Third Ventricles] --\u003e B(Flow through Cerebral Aqueduct); B --Blockage (e.g., Tumor)--\u003e C(Obstruction); B --\u003e D(Fourth Ventricle); C --\u003e E(Dilation of Lateral \u0026 Third Ventricles); E --\u003e F(Increased ICP);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"0bc2f200\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"16d613bb\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"14365ef4\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"aa4115c7\"\n      }\n    ]\n  },\n  \"f0c73162\": {\n    \"title\": \"Occipital Lobe\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Cortex\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eOccipital Lobe\u003c/b\u003e is the most posterior lobe of the cerebral cortex, primarily dedicated to the processing of visual information.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePrimary Visual Cortex (V1):\u003c/b\u003e Located in the calcarine sulcus, it receives visual input directly from the lateral geniculate nucleus of the [[afc0a64b|thalamus]]. It is responsible for initial processing of visual stimuli.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVisual Association Cortex:\u003c/b\u003e Surrounds the primary visual cortex and is involved in higher-order visual processing, such as interpreting color, form, and motion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBlood Supply:\u003c/b\u003e Primarily supplied by the \u003cmark\u003ePosterior Cerebral Artery (PCA)\u003c/mark\u003e. The occipital pole, which represents the macula (central vision), often has a dual blood supply from the [[143bb23d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects:\u003c/b\u003e A unilateral lesion of the occipital lobe (e.g., from a PCA stroke) causes a \u003cmark\u003econtralateral homonymous hemianopia\u003c/mark\u003e. Due to the dual blood supply, this often presents with \u003cmark\u003emacular sparing\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Any visual field defect that is homonymous (affecting the same side of the visual field in both eyes) and respects the vertical midline points to a lesion posterior to the optic chiasm. If it involves macular sparing, the lesion is almost certainly in the occipital lobe.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eOccipital Lobe\u003c/b\u003e functions as the brain\u0027s dedicated visual processing center; damage to this area results not in blindness of an eye, but in the loss of the contralateral visual field from both eyes.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"cerebral_cortex\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"primary_visual_cortex\"\n      },\n      {\n        \"type\": \"is_supplied_by\",\n        \"to\": \"posterior_cerebral_artery\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"c9c8eefb\"\n      }\n    ]\n  },\n  \"4eb418d0\": {\n    \"title\": \"Ocular Motility\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physiology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOcular motility\u003c/b\u003e refers to the movement of the eyes, which is controlled by six extraocular muscles innervated by three cranial nerves (III, IV, and VI). These movements allow for fixation, tracking, and scanning of the visual environment.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eExtraocular Muscles:\u003c/b\u003e Four rectus muscles (superior, inferior, medial, lateral) and two oblique muscles (superior, inferior).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCranial Nerve Innervation:\u003c/b\u003e Mnemonic: \u003cb\u003eLR\u003csub\u003e6\u003c/sub\u003eSO\u003csub\u003e4\u003c/sub\u003eR\u003csub\u003e3\u003c/sub\u003e\u003c/b\u003e (\u003cb\u003eL\u003c/b\u003eateral \u003cb\u003eR\u003c/b\u003eectus by CN \u003cb\u003eVI\u003c/b\u003e, \u003cb\u003eS\u003c/b\u003euperior \u003cb\u003eO\u003c/b\u003eblique by CN \u003cb\u003eIV\u003c/b\u003e, \u003cb\u003eR\u003c/b\u003eest by CN \u003cb\u003eIII\u003c/b\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrimary Actions:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eAbduction:\u003c/b\u003e [[f7b5ee5d|Lateral Rectus]] (CN VI)\u003cbr\u003e - \u003cb\u003eAdduction:\u003c/b\u003e Medial Rectus (CN III)\u003cbr\u003e - \u003cb\u003eElevation:\u003c/b\u003e Superior Rectus \u0026 Inferior Oblique (CN III)\u003cbr\u003e - \u003cb\u003eDepression:\u003c/b\u003e Inferior Rectus (CN III) \u0026 Superior Oblique (CN IV)\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Testing:\u003c/b\u003e Assessed by having the patient follow a target in the six cardinal positions of gaze (the \u0027H\u0027 pattern).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e To isolate the vertical actions of the rectus muscles, have the patient look out (abduct). To isolate the vertical actions of the oblique muscles, have the patient look in (adduct).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe precise and coordinated control of \u003cb\u003eocular motility\u003c/b\u003e by cranial nerves III, IV, and VI allows for the complex eye movements necessary for binocular vision; any weakness or paralysis (ophthalmoplegia) results in misalignment and diplopia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_controlled_by\",\n        \"to\": \"68c66997\"\n      },\n      {\n        \"type\": \"is_controlled_by\",\n        \"to\": \"bba6093a\"\n      },\n      {\n        \"type\": \"is_controlled_by\",\n        \"to\": \"dd11dde6\"\n      },\n      {\n        \"type\": \"is_impaired_in\",\n        \"to\": \"4e4afce1\"\n      }\n    ]\n  },\n  \"68c66997\": {\n    \"title\": \"Oculomotor Nerve (CN III)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eOculomotor Nerve (CN III)\u003c/b\u003e is a cranial nerve that controls most of the eye\u0027s movements, including constriction of the pupil and maintaining an open eyelid. It contains both somatic motor and visceral motor (parasympathetic) fibers.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMotor Function:\u003c/b\u003e Innervates the superior, medial, and inferior rectus muscles, the inferior oblique muscle, and the levator palpebrae superioris (eyelid elevation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eParasympathetic Function:\u003c/b\u003e Carries preganglionic parasympathetic fibers from the Edinger-Westphal nucleus to the ciliary ganglion. Postganglionic fibers innervate the sphincter pupillae (pupillary constriction) and the ciliary muscle ([[81b5f5fe|accommodation]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePalsy Presentation:\u003c/b\u003e A complete CN III palsy results in a \u003cmark\u003e\\\"down and out\\\"\u003c/mark\u003e eye position (due to unopposed action of the lateral rectus and superior oblique), severe [[6202e6af|ptosis]], and a fixed, dilated pupil (\u003cmark\u003e\\\"blown pupil\\\"\u003c/mark\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePupil Sparing vs. Pupil Involving:\u003c/b\u003e A compressive lesion (e.g., PCom aneurysm, uncal herniation) typically affects the superficial parasympathetic fibers first, causing a blown pupil. An ischemic lesion (e.g., diabetic neuropathy) often affects the deeper motor fibers while sparing the pupil.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of a CN III palsy with a dilated, nonreactive pupil is a neurological emergency, highly suggestive of an aneurysm compressing the nerve.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eOculomotor Nerve\u003c/b\u003e is the primary motor nerve of the eye, and its dual somatic and parasympathetic functions mean that a complete palsy presents with a dramatic triad of a deviated eye, a drooping eyelid, and a dilated pupil, with the pupillary involvement being a key sign for differentiating compressive from ischemic causes.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"controls\",\n        \"to\": \"4eb418d0\"\n      },\n      {\n        \"type\": \"controls\",\n        \"to\": \"pupillary_constriction\"\n      },\n      {\n        \"type\": \"controls\",\n        \"to\": \"81b5f5fe\"\n      },\n      {\n        \"type\": \"palsy_causes\",\n        \"to\": \"6202e6af\"\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"uncal_herniation\"\n      }\n    ]\n  },\n  \"84b5e4f6\": {\n    \"title\": \"Oculosympathetic Pathway\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Autonomic Nervous System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eOculosympathetic Pathway\u003c/b\u003e is a three-neuron chain that provides sympathetic innervation to the eye and face, controlling pupillary dilation, eyelid elevation, and facial sweating.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFirst-Order Neuron (Central):\u003c/b\u003e Originates in the posterior [[89e86633|hypothalamus]], descends through the brainstem and synapses in the ciliospinal center of Budge (C8-T2) in the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSecond-Order Neuron (Preganglionic):\u003c/b\u003e Exits the spinal cord at T1, travels up the sympathetic chain, and synapses in the \u003cmark\u003esuperior cervical ganglion\u003c/mark\u003e. This neuron passes over the apex of the lung.\u003c/li\u003e\u003cli\u003e\u003cb\u003eThird-Order Neuron (Postganglionic):\u003c/b\u003e Ascends along the internal carotid artery, passes through the [[c260efc8|cavernous sinus]], and travels with the ophthalmic division of the trigeminal nerve (CN V1) to innervate the dilator pupillae muscle, superior tarsal muscle, and facial sweat glands.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Disruption of this pathway at any point results in \u003cmark\u003eHorner Syndrome\u003c/mark\u003e (ptosis, miosis, and anhidrosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The location of the lesion along the three-neuron arc determines the pattern of anhidrosis. A lesion of the 1st or 2nd neuron causes anhidrosis of the entire ipsilateral face, while a lesion of the 3rd neuron (distal to the carotid bifurcation) spares sweating on the forehead.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe long and circuitous route of the \u003cb\u003eOculosympathetic Pathway\u003c/b\u003e‚Äîfrom the hypothalamus down the spinal cord, up the neck, and back into the head‚Äîmakes it vulnerable to a wide range of pathologies, from brainstem strokes to apical lung tumors, all of which can produce the same classic triad of Horner syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[1st Order: Hypothalamus] --\u003e B(Ciliospinal Center C8-T2); B --\u003e C[2nd Order: Superior Cervical Ganglion]; C --\u003e D[3rd Order: Eye \u0026 Face];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"c19010a3\"\n      },\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"sympathetic_nervous_system\"\n      },\n      {\n        \"type\": \"innervates\",\n        \"to\": \"dilator_pupillae_muscle\"\n      }\n    ]\n  },\n  \"c6cf9420\": {\n    \"title\": \"Olfaction\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Physiology\",\n      \"Special Senses\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOlfaction\u003c/b\u003e is the sense of smell, a chemical sense mediated by olfactory receptor neurons in the nasal cavity that detect odorant molecules and transmit this information to the brain via the [[4487bc38|olfactory nerve (CN I)]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eReceptors:\u003c/b\u003e Olfactory receptor neurons are located in the olfactory epithelium in the superior part of the nasal cavity.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Axons of these neurons form the olfactory nerve (CN I), which passes through the cribriform plate of the ethmoid bone to synapse in the olfactory bulb. From the bulb, olfactory tracts project directly to the primary olfactory cortex (piriform cortex) in the temporal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUnique Feature:\u003c/b\u003e Olfaction is the \u003cu\u003eonly\u003c/u\u003e sensory modality that does not have a primary relay in the [[afc0a64b|thalamus]] before projecting to the cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLimbic System Connection:\u003c/b\u003e The olfactory cortex has strong connections to the [[73ace357|limbic system]], particularly the amygdala and hippocampus, which is why smells can evoke strong emotions and memories.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Loss of smell is called anosmia. It can be caused by trauma (shearing of olfactory nerve fibers at the cribriform plate), viral infections, or neurodegenerative diseases like Parkinson\u0027s and Alzheimer\u0027s.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eOlfaction\u003c/b\u003e is a unique and primitive sense that bypasses the thalamic relay common to all other senses, projecting directly to cortical areas intertwined with the [[73ace357|limbic system]], providing a direct and powerful link between smells, emotions, and memory.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_mediated_by\",\n        \"to\": \"4487bc38\"\n      },\n      {\n        \"type\": \"is_linked_to\",\n        \"to\": \"73ace357\"\n      },\n      {\n        \"type\": \"bypasses\",\n        \"to\": \"afc0a64b\"\n      }\n    ]\n  },\n  \"4487bc38\": {\n    \"title\": \"Olfactory Nerve (CN I)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Special Senses\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eOlfactory Nerve (CN I)\u003c/b\u003e is the first and shortest cranial nerve, a purely sensory nerve responsible for the sense of \u003ci\u003eolfaction\u003c/i\u003e (smell).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Special visceral afferent (SVA) fibers for smell.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Composed of the axons of olfactory receptor neurons located in the olfactory epithelium of the nasal cavity. These axons pass through the \u003cmark\u003ecribriform plate\u003c/mark\u003e of the ethmoid bone to synapse on mitral cells in the olfactory bulb.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCentral Projections:\u003c/b\u003e The olfactory tract then projects from the bulb to the primary olfactory cortex (piriform cortex) without relaying through the thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects:\u003c/b\u003e Damage to the olfactory nerve results in \u003cmark\u003eanosmia\u003c/mark\u003e (loss of smell). This can be caused by head trauma (shearing forces at the cribriform plate), viral infections, or tumors at the base of the frontal lobe (e.g., olfactory groove meningioma).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Anosmia following a frontal head injury is a classic presentation of CN I damage due to shearing of its delicate fibers as they pass through the cribriform plate.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eOlfactory Nerve\u003c/b\u003e is unique among cranial nerves as it is a direct extension of the telencephalon, consists of unmyelinated axons that regenerate, and its pathway is the only sensory system to bypass the thalamus, projecting directly to the cortex.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_responsible_for\",\n        \"to\": \"c6cf9420\"\n      },\n      {\n        \"type\": \"passes_through\",\n        \"to\": \"cribriform_plate\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"anosmia\"\n      }\n    ]\n  },\n  \"a24f9747\": {\n    \"title\": \"Oligodendrocytes\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Histology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Glial Cells\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOligodendrocytes\u003c/b\u003e are a type of glial cell found in the central nervous system (CNS) whose primary function is to produce the \u003ci\u003emyelin sheath\u003c/i\u003e that insulates neuronal axons, allowing for rapid saltatory conduction of action potentials.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Myelination of axons in the CNS (brain, spinal cord, and optic nerve). A single oligodendrocyte can myelinate \u003cmark\u003emultiple axons\u003c/mark\u003e (up to ~30).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e Histologically, they have a \\\"fried egg\\\" appearance with a round nucleus and clear cytoplasm, especially prominent in [[c932ed4e|oligodendrogliomas]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eEmbryonic Origin:\u003c/b\u003e Derived from neuroectoderm of the neural tube.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e They are the primary target of autoimmune attack in \u003cmark\u003e[[45dd6d19|Multiple Sclerosis]]\u003c/mark\u003e. They are also damaged in progressive multifocal leukoencephalopathy (PML) by the JC virus and in various leukodystrophies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction from Schwann Cells:\u003c/b\u003e [[c65a8909|Schwann cells]] perform the same function (myelination) but in the peripheral nervous system (PNS). A key difference is that one Schwann cell myelinates only one segment of a single axon.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The destruction of oligodendrocytes is the central pathological event in [[45dd6d19|Multiple Sclerosis]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eOligodendrocytes\u003c/b\u003e are the myelin-producing cells of the CNS, with each cell extending multiple processes to ensheath numerous axons; this \u0027one-to-many\u0027 relationship contrasts with Schwann cells and explains the widespread, patchy nature of demyelination when these cells are destroyed in diseases like MS.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"glial_cell\"\n      },\n      {\n        \"type\": \"produces\",\n        \"to\": \"myelin_sheath\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"progressive_multifocal_leukoencephalopathy\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"c65a8909\"\n      }\n    ]\n  },\n  \"c932ed4e\": {\n    \"title\": \"Oligodendroglioma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eAn \u003cb\u003eOligodendroglioma\u003c/b\u003e is a relatively rare, slow-growing primary brain tumor derived from [[a24f9747|oligodendrocytes]]. It is most commonly found in the cerebral hemispheres of adults, particularly the frontal lobes.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Typically located in the white matter of the cerebral hemispheres, with a predilection for the \u003cmark\u003efrontal lobes\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Often presents with seizures due to its cortical location. Other symptoms include headaches and focal neurologic deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e On CT scans, these tumors are often \u003cmark\u003ecalcified\u003c/mark\u003e. On MRI, they appear as well-circumscribed masses.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e Characterized by sheets of uniform cells with round nuclei, clear cytoplasm, and well-defined cell borders, creating a classic \u003cmark\u003e\\\"fried egg\\\" appearance\u003c/mark\u003e. A delicate network of branching capillaries, often described as a \u003cmark\u003e\\\"chicken-wire\\\" pattern\u003c/mark\u003e, is also characteristic.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of a calcified frontal lobe tumor in an adult presenting with seizures, and a \\\"fried egg\\\" appearance on histology, is pathognomonic for an oligodendroglioma.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eOligodendroglioma\u003c/b\u003e is defined by its classic histological appearance of \\\"fried egg\\\" cells and a \\\"chicken-wire\\\" vascular pattern, which reflects its origin from the myelin-producing cells of the CNS and often presents with seizures due to its typical frontal lobe location.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"be057cfc\"\n      },\n      {\n        \"type\": \"arises_from\",\n        \"to\": \"a24f9747\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\": \"fried_egg_appearance\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"frontal_lobe\"\n      }\n    ]\n  },\n  \"5ea7b741\": {\n    \"title\": \"Open-Angle Glaucoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Geriatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOpen-Angle Glaucoma\u003c/b\u003e is the most common type of [[3ce6c035|glaucoma]], a chronic, progressive optic neuropathy characterized by an open, normal-appearing anterior chamber angle and increased intraocular pressure (IOP) due to decreased aqueous humor outflow.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The primary defect is an increased resistance to aqueous humor drainage through the \u003cmark\u003etrabecular meshwork\u003c/mark\u003e. The anterior chamber angle itself is open and not obstructed.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Typically asymptomatic in the early stages, earning it the name \\\"silent thief of sight.\\\" The first noticeable symptom is often a gradual loss of \u003cmark\u003eperipheral vision\u003c/mark\u003e, which progresses to central vision loss and blindness if untreated.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e Increased age, African American ethnicity, family history, and diabetes mellitus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Diagnosed based on elevated IOP, characteristic optic disc cupping on fundoscopy, and corresponding visual field defects on perimetry.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e The goal is to lower IOP. First-line agents are typically prostaglandin analogs (e.g., latanoprost) which increase uveoscleral outflow, or beta-blockers (e.g., timolol) which decrease aqueous humor production.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from angle-closure glaucoma: open-angle is chronic, painless, and involves peripheral vision loss, while acute angle-closure is sudden, painful, and presents with a red eye and blurry vision.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eOpen-Angle Glaucoma\u003c/b\u003e is a chronic and insidious disease where the eye\u0027s drainage system (the trabecular meshwork) becomes clogged over time, leading to a slow, painless rise in pressure that gradually damages the optic nerve from the periphery inward.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Decreased Outflow through Trabecular Meshwork] --\u003e B(Increased IOP); B --\u003e C(Optic Nerve Damage); C --\u003e D(Progressive Peripheral Vision Loss);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"9c80344d\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"prostaglandin_analogs\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"beta_blockers\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 10233,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"7c59030e\": {\n    \"title\": \"Normal"
      }, {
        "text": " Pressure Hydrocephalus (NPH)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Geriatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Hydrocephalus\""
      }, {
        "text": "\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNormal Pressure Hydrocephalus (NPH)"
      }, {
        "text": "\u003c/b\u003e is a form of \u003ci\u003ecommunicating hydrocephalus\u003c/i\u003e in older adults, characterized by ventricular enlargement with only intermittently elevated"
      }, {
        "text": " cerebrospinal fluid (CSF) pressure, leading to a classic clinical triad of gait apraxia, cognitive dysfunction, and urinary incontinence.\u003c/p\u003e\","
      }, {
        "text": "\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The exact cause is often idiopathic, but it is thought to result"
      }, {
        "text": " from impaired CSF absorption at the arachnoid granulations. This leads to ventricular expansion, which stretches the corona radiata fibers."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Triad (\\\"Wet, Wobbly, and Wacky\\\"):\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eW"
      }, {
        "text": "obbly:\u003c/b\u003e Gait apraxia is often the first and most prominent symptom. Described as a \u003cmark\u003emagnetic gait"
      }, {
        "text": "\u003c/mark\u003e, where the feet appear stuck to the floor.\u003cbr\u003e2. \u003cb\u003eWacky:\u003c/b\u003e Cognitive dysfunction/"
      }, {
        "text": "dementia.\u003cbr\u003e3. \u003cb\u003eWet:\u003c/b\u003e Urinary incontinence/urgency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Brain"
      }, {
        "text": " imaging (CT or MRI) shows \u003cmark\u003eventriculomegaly\u003c/mark\u003e out of proportion to sulcal enlargement"
      }, {
        "text": ". A lumbar puncture (LP) will show a normal opening pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e A large-volume LP"
      }, {
        "text": " that temporarily improves symptoms is both diagnostic and predictive of response to treatment. The definitive treatment is surgical placement of a \u003cmark\u003eventriculoperitoneal ("
      }, {
        "text": "VP) shunt\u003c/mark\u003e to divert CSF.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e NPH is a reversible cause of dementia."
      }, {
        "text": " The triad of gait disturbance, dementia, and urinary incontinence in an elderly patient should immediately bring NPH to mind.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNormal Pressure Hydrocephalus\u003c/b\u003e is a clinical paradox where ventricular enlargement causes"
      }, {
        "text": " significant neurological symptoms despite a \u0027normal\u0027 CSF pressure on a single lumbar puncture. The diagnosis is supported by symptomatic improvement after"
      }, {
        "text": " CSF removal, and it represents one of the few treatable causes of dementia.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[Impaired CSF Absorption] --\u003e B(Ventriculomegaly); B --Stretches Corona Radiata--\u003e"
      }, {
        "text": " C(Clinical Triad); C --\u003e C1(Gait Apraxia - Wobbly); C --\u003e C2("
      }, {
        "text": "Dementia - Wacky); C --\u003e C3(Urinary Incontinence - Wet);\"\n    },\n    \"connections\": [\n      "
      }, {
        "text": "{\n        \"type\": \"is_a_type_of\",\n        \"to\": \"aa4115"
      }, {
        "text": "c7\"\n      },\n      {\n        \"type\": \"is_a_reversible_cause_of\","
      }, {
        "text": "\n        \"to\": \"bb316ca0\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_treated_by\",\n        \"to\": \"ventriculoperitoneal_shunt\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"presents_with\",\n        \"to\": \"gait_apraxia\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"8092ce8a\": {\n    \"title\": \"Nucle"
      }, {
        "text": "us Accumbens\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \""
      }, {
        "text": "Psychiatry\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \""
      }, {
        "text": "Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Basal Ganglia\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eNucleus Accumbens\u003c/b\u003e is a key"
      }, {
        "text": " structure in the ventral striatum, part of the [[ed462927|basal ganglia]], that"
      }, {
        "text": " plays a central role in the brain\u0027s \u003ci\u003ereward circuitry\u003c/i\u003e, motivation, and addiction.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Located where the head of the caudate nucleus and the anterior portion of the putamen meet.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e It is a major component of the \u003cmark\u003emesolimbic pathway\u003c/mark\u003e, receiving"
      }, {
        "text": " dopaminergic input from the ventral tegmental area (VTA).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitters:\u003c/b\u003e The"
      }, {
        "text": " primary neurotransmitters are [[90adc821|dopamine]] (mediating reward and pleasure), [[5aa"
      }, {
        "text": "5cb91|GABA]] (its primary output), and glutamate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Integrates emotional"
      }, {
        "text": " and motivational information to guide behavior. It is crucial for processing rewarding stimuli (e.g., food, sex, drugs) and reinforcing"
      }, {
        "text": " behaviors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Dysfunction of the nucleus accumbens and the mesolimbic pathway is central"
      }, {
        "text": " to the pathophysiology of \u003cmark\u003eaddiction\u003c/mark\u003e. All major drugs of abuse increase dopamine levels in the nucleus accumbens. It"
      }, {
        "text": " is also implicated in depression and schizophrenia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the nucleus accumbens as the \u0027"
      }, {
        "text": "pleasure center\u0027 of the brain. Its dopaminergic activation is the final common pathway for reward and reinforcement.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eNucleus Accumbens\u003c/b\u003e serves as the brain\u0027s motivational hub, where dopamine"
      }, {
        "text": " signals from the VTA translate the value of a stimulus into the drive to pursue it, a fundamental process that is hijacked in"
      }, {
        "text": " addiction.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Ventral Tegmental Area VTA] --"
      }, {
        "text": "Dopamine--\u003e B(Nucleus Accumbens); B --\u003e C(Reward \u0026 Motivation);\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"ed46292"
      }, {
        "text": "7\"\n      },\n      {\n        \"type\": \"is_part_of\",\n        \"to"
      }, {
        "text": "\": \"mesolimbic_pathway\"\n      },\n      {\n        \"type\": \"is_im"
      }, {
        "text": "plicated_in\",\n        \"to\": \"addiction\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"receives_input_from\",\n        \"to\": \"ventral_tegmental_area\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"73378e13\": {\n    \"title\": \"Nucleus Ambiguus\",\n    \"primaryType"
      }, {
        "text": "\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Brain"
      }, {
        "text": "stem\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eNucleus Ambiguus\u003c/b\u003e is a motor nucleus located in the medulla oblongata that"
      }, {
        "text": " provides branchial motor innervation to the muscles of the soft palate, pharynx, and larynx via cranial nerves IX, X, and XI"
      }, {
        "text": " (cranial root).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Located in the ret"
      }, {
        "text": "icular formation of the medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Contains lower motor neurons that control the muscles for \u003cmark\u003eswallowing ("
      }, {
        "text": "deglutition)\u003c/mark\u003e and \u003cmark\u003espeaking (phonation)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEfferent Nerves:\u003c/b\u003e Its"
      }, {
        "text": " axons travel with the [[97e2c817|glossopharyngeal nerve (CN IX)]], [[7"
      }, {
        "text": "c12e7a3|vagus nerve (CN X)]], and the cranial root of the [[f"
      }, {
        "text": "218aebf|accessory nerve (CN XI)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e A lesion of"
      }, {
        "text": " the nucleus ambiguus, such as in a \u003cmark\u003elateral medullary (Wallenberg) syndrome\u003c/mark\u003e caused by a [["
      }, {
        "text": "posterior_inferior_cerebellar_artery|PICA]] stroke, results in ipsilateral paralysis of the palate"
      }, {
        "text": ", pharynx, and larynx.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms of Lesion:\u003c/b\u003e Patients present with \u003cmark\u003edysphagia\u003c/"
      }, {
        "text": "mark\u003e (difficulty swallowing), \u003cmark\u003ehoarseness\u003c/mark\u003e (dysphonia), and a diminished gag"
      }, {
        "text": " reflex. The uvula deviates \u003cu\u003eaway\u003c/u\u003e from the side of the lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Ho"
      }, {
        "text": "arseness and dysphagia are key localizing signs for a lesion in the lateral medulla affecting the nucleus ambiguus. M"
      }, {
        "text": "nemonic: Nucleus a**m**biguus is for **m**otor.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eNucleus Ambiguus\u003c/b\u003e is the command center for the complex motor actions of swallowing and speaking;"
      }, {
        "text": " its destruction in a lateral medullary stroke leads to the characteristic and debilitating symptoms of hoarseness and dysphagia.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Nucleus Ambiguus] --\u003e B(CN IX, X, XI); B --\u003e C(Muscles of Ph"
      }, {
        "text": "arynx, Larynx, Palate); C --\u003e D(Swallowing \u0026 Phonation);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_located_in\",\n        \"to\": \"medulla_oblongata\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"provides_innervation_via\",\n        \"to\": \"97e2c817\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"provides_innervation_via\",\n        \"to\":"
      }, {
        "text": " \"7c12e7a3\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "damaged_in\",\n        \"to\": \"lateral_medullary_syndrome\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"lesion_causes\",\n        \"to\": \"dysphagia\"\n      }\n    ]\n  },\n  \"3"
      }, {
        "text": "8bfa9e0\": {\n    \"title\": \"Nucleus Tractus Solitarius (NTS)\",\n    \"primary"
      }, {
        "text": "Type\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Physiology\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003eThe \u003cb\u003eNucleus Tractus Solitarius (NTS)\u003c/b\u003e, or solitary nucleus, is a sensory"
      }, {
        "text": " nucleus in the medulla oblongata that serves as the primary relay station for visceral sensory information, including taste, baroreception,"
      }, {
        "text": " and chemoreception.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Medulla oblongata.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction"
      }, {
        "text": ":\u003c/b\u003e Receives and integrates visceral sensory information. Mnemonic: Nucleus **S**olitarius is for **S**ensory."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eInputs:\u003c/b\u003e Receives afferent fibers from:\u003cbr\u003e - \u003cb\u003eCN VII (Facial):"
      }, {
        "text": "\u003c/b\u003e Taste from anterior 2/3 of the tongue.\u003cbr\u003e - \u003cb\u003eCN IX (Glossopharyngeal):\u003c/b\u003e Taste from posterior"
      }, {
        "text": " 1/3 of the tongue, and signals from carotid body chemoreceptors and carotid sinus baroreceptors.\u003cbr\u003e - \u003cb\u003e"
      }, {
        "text": "CN X (Vagus):\u003c/b\u003e Taste from the epiglottis, and signals from aortic arch baroreceptors/"
      }, {
        "text": "chemoreceptors and visceral organs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Reflexes:\u003c/b\u003e It is the afferent hub for the bar"
      }, {
        "text": "oreflex and chemoreflex, crucial for blood pressure and respiratory control. It also plays a role in the gag and"
      }, {
        "text": " cough reflexes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVomiting Center:\u003c/b\u003e The NTS receives input from the [[5dd34"
      }, {
        "text": "3d3|area postrema]] (chemoreceptor trigger zone) and the GI tract (via the vagus nerve) to coordinate"
      }, {
        "text": " the vomiting reflex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the NTS as the main visceral sensory nucleus for CN"
      }, {
        "text": "s VII, IX, and X, integrating taste, blood pressure, and gut sensation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eThe \u003cb\u003eNucleus Tractus Solitarius\u003c/b\u003e acts as the brainstem\u0027s central processing"
      }, {
        "text": " unit for all visceral sensation, integrating critical information about taste, blood pressure, and blood gases from three different cranial nerves to orchestr"
      }, {
        "text": "ate vital autonomic reflexes.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[CN VII, IX, X"
      }, {
        "text": "] --Visceral Sensory Info--\u003e B(Nucleus Tractus Solitarius); B --\u003e C(Taste Pathway); B --\u003e D(Autonomic Reflex"
      }, {
        "text": "es e.g., Baroreflex); B --\u003e E(Vomiting Center);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"medulla_oblongata\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"dea9"
      }, {
        "text": "755f\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        "
      }, {
        "text": "\"to\": \"97e2c817\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"receives_input_from\",\n        \"to\": \"7c12e7a3\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_involved_in\",\n        \"to\": \"baroreflex\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"f3040fdf\": {\n    \"title\": \"Nyst"
      }, {
        "text": "agmus\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Ophthalmology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physical Findings\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNystagmus\u003c/b\u003e is a condition of involuntary,"
      }, {
        "text": " rhythmic eye movements, which can be horizontal, vertical, or rotary. It is a sign of dysfunction in the systems responsible"
      }, {
        "text": " for controlling eye position and movement, such as the vestibular system or the cerebellum.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eJ"
      }, {
        "text": "erk Nystagmus:\u003c/b\u003e The most common form, characterized by a slow drift of the eyes in one direction ("
      }, {
        "text": "slow phase) followed by a rapid corrective jerk back in the opposite direction (fast phase). Nystagmus is named for"
      }, {
        "text": " the direction of the fast phase.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePeripheral vs. Central Vertigo:\u003c/b\u003e The characteristics of nystagmus help"
      }, {
        "text": " differentiate the cause of vertigo. \u003cmark\u003ePeripheral vertigo\u003c/mark\u003e (inner ear) typically causes horizontal or torsional n"
      }, {
        "text": "ystagmus that is suppressed by visual fixation. \u003cmark\u003eCentral vertigo\u003c/mark\u003e (brainstem/cerebellum) can cause purely"
      }, {
        "text": " vertical or purely torsional nystagmus that is not suppressed by fixation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInternuclear Ophthalmoplegia (INO"
      }, {
        "text": "):\u003c/b\u003e A lesion of the MLF causes nystagmus in the \u003cmark\u003eabducting\u003c/mark\u003e eye"
      }, {
        "text": " during horizontal gaze.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFriedreich Ataxia:\u003c/b\u003e Nystagmus is a common finding in this neurodegenerative disease"
      }, {
        "text": " due to cerebellar involvement.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRetinoblastoma:\u003c/b\u003e Can present with nystagmus in an infant if the"
      }, {
        "text": " tumor affects central vision.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Purely vertical or purely torsional nystagmus is a major"
      }, {
        "text": " red flag for a central (brainstem or cerebellar) lesion.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Nystagmus\u003c/b\u003e is a key objective sign of vestibular or cerebellar dysfunction, and a careful analysis of its direction,"
      }, {
        "text": " trajectory, and response to fixation can precisely localize the lesion to either the peripheral or central nervous system.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to"
      }, {
        "text": "\": \"vertigo\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        "
      }, {
        "text": "\"to\": \"cerebellar_dysfunction\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_finding_in\",\n        \"to\": \"58c684bd\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_finding_in\",\n        \"to\": \"39bc1763\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"4fab8000\": {\n    \"title\": \"Obstructive Hydrocephalus"
      }, {
        "text": "\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Neurosurgery\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Hydrocephalus\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eObstructive hydrocephalus\u003c/b\u003e, also known as non-communicating"
      }, {
        "text": " hydrocephalus, is the accumulation of excess cerebrospinal fluid (CSF) due to a physical blockage within the ventricular system, leading"
      }, {
        "text": " to ventricular dilation proximal to the obstruction and increased intracranial pressure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Pathophysiology:\u003c/b\u003e A structural lesion blocks the flow of CSF from one part of the ventricular system to another or into"
      }, {
        "text": " the subarachnoid space. This leads to a buildup of CSF and pressure in the ventricles \u0027upstream\u0027 of the blockage"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Sites of Obstruction:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCerebral Aqueduct (of"
      }, {
        "text": " Sylvius):\u003c/b\u003e The narrowest part of the ventricular system, connecting the 3rd and 4th ventricles"
      }, {
        "text": ". Aqueductal stenosis is a common cause in children.\u003cbr\u003e - \u003cb\u003eForamen of Monro:\u003c/b\u003e Can"
      }, {
        "text": " be blocked by a colloid cyst.\u003cbr\u003e - \u003cb\u003eFourth Ventricle Outlets:\u003c/b\u003e Can be compressed by posterior"
      }, {
        "text": " fossa tumors like a [[16d613bb|medulloblastoma]] or [[14365ef"
      }, {
        "text": "4|ependymoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Symptoms of increased intracranial pressure, such as headache, nausea, vomiting, and"
      }, {
        "text": " [[4ae219da|papilledema]]. In infants, presents with an enlarging head circumference and bulging fontanelle"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A [[16d613bb|medulloblastoma]] in a child is a"
      }, {
        "text": " classic cause of obstructive hydrocephalus due to compression of the fourth ventricle.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eObstructive hydrocephalus\u003c/b\u003e is a \u0027plumbing problem\u0027 within the brain\u0027s ventricular system, where a physical"
      }, {
        "text": " blockage leads to a dam-like effect, causing upstream ventricular dilation and a dangerous rise in intracranial pressure.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[CSF Production in Lateral/Third Ventricles] --\u003e B(Flow through Cerebral Aqueduct); B --"
      }, {
        "text": "Blockage (e.g., Tumor)--\u003e C(Obstruction); B --\u003e D(Fourth Ventricle); C"
      }, {
        "text": " --\u003e E(Dilation of Lateral \u0026 Third Ventricles); E --\u003e F(Increased ICP);\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"0bc2f200\"\n      },\n      {\n        \"type\": \"can_be_caused"
      }, {
        "text": "_by\",\n        \"to\": \"16d613bb\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"can_be_caused_by\",\n        \"to\": \"14365"
      }, {
        "text": "ef4\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"aa"
      }, {
        "text": "4115c7\"\n      }\n    ]\n  },\n  \"f0c7316"
      }, {
        "text": "2\": {\n    \"title\": \"Occipital Lobe\",\n    \"primaryType\": \"anatomy\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Ophthalmology\",\n      \"USMLE\"\n"
      }, {
        "text": "    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy"
      }, {
        "text": " and Physiology\",\n      \"Cerebral Cortex\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003eThe \u003cb\u003eOccipital Lobe\u003c/b\u003e is the most posterior lobe of the cerebral cortex, primarily dedicated to the"
      }, {
        "text": " processing of visual information.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePrimary Visual Cortex (V1):\u003c/b\u003e Located"
      }, {
        "text": " in the calcarine sulcus, it receives visual input directly from the lateral geniculate nucleus of the [[afc0"
      }, {
        "text": "a64b|thalamus]]. It is responsible for initial processing of visual stimuli.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVisual Association Cortex"
      }, {
        "text": ":\u003c/b\u003e Surrounds the primary visual cortex and is involved in higher-order visual processing, such as interpreting color, form, and motion.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eBlood Supply:\u003c/b\u003e Primarily supplied by the \u003cmark\u003ePosterior Cerebral Artery (PCA)\u003c/mark\u003e. The occipital pole,"
      }, {
        "text": " which represents the macula (central vision), often has a dual blood supply from the [[143bb23"
      }, {
        "text": "d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects:\u003c/b\u003e A unilateral lesion of the occip"
      }, {
        "text": "ital lobe (e.g., from a PCA stroke) causes a \u003cmark\u003econtralateral homonymous hemian"
      }, {
        "text": "opia\u003c/mark\u003e. Due to the dual blood supply, this often presents with \u003cmark\u003emacular sparing\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e Any visual field defect that is homonymous (affecting the same side of the visual field in both eyes) and respects"
      }, {
        "text": " the vertical midline points to a lesion posterior to the optic chiasm. If it involves macular sparing, the lesion is almost"
      }, {
        "text": " certainly in the occipital lobe.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eOccipital Lobe\u003c/b\u003e functions"
      }, {
        "text": " as the brain\u0027s dedicated visual processing center; damage to this area results not in blindness of an eye, but in the"
      }, {
        "text": " loss of the contralateral visual field from both eyes.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"cerebral_cortex\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"contains\",\n        \"to\": \"primary_visual_cortex\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_supplied_by\",\n        \"to\": \"posterior_cerebral_artery\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"c"
      }, {
        "text": "9c8eefb\"\n      }\n    ]\n  },\n  \"4eb418d"
      }, {
        "text": "0\": {\n    \"title\": \"Ocular Motility\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Ophthalmology\",\n      \"Neurology\",\n      \"Anatomy\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \""
      }, {
        "text": "Physiology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOcular motility"
      }, {
        "text": "\u003c/b\u003e refers to the movement of the eyes, which is controlled by six extraocular muscles innervated by three cranial nerves ("
      }, {
        "text": "III, IV, and VI). These movements allow for fixation, tracking, and scanning of the visual environment.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eExtraocular Muscles:\u003c/b\u003e Four rectus muscles (superior, inferior, medial, lateral) and two"
      }, {
        "text": " oblique muscles (superior, inferior).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCranial Nerve Innervation:\u003c/b\u003e Mnemonic: \u003cb\u003eLR\u003csub\u003e"
      }, {
        "text": "6\u003c/sub\u003eSO\u003csub\u003e4\u003c/sub\u003eR\u003csub\u003e3\u003c/sub\u003e\u003c/b\u003e (\u003cb\u003eL\u003c/b\u003eateral \u003cb\u003eR\u003c/b\u003eectus by CN "
      }, {
        "text": "\u003cb\u003eVI\u003c/b\u003e, \u003cb\u003eS\u003c/b\u003euperior \u003cb\u003eO\u003c/b\u003eblique by CN \u003cb\u003eIV\u003c/b\u003e, "
      }, {
        "text": "\u003cb\u003eR\u003c/b\u003eest by CN \u003cb\u003eIII\u003c/b\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrimary Actions:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e"
      }, {
        "text": "Abduction:\u003c/b\u003e [[f7b5ee5d|Lateral Rectus]] (CN VI)\u003cbr\u003e - \u003cb\u003eAdduction"
      }, {
        "text": ":\u003c/b\u003e Medial Rectus (CN III)\u003cbr\u003e - \u003cb\u003eElevation:\u003c/b\u003e Superior Rectus \u0026 Inferior Oblique (CN III)\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eDepression:\u003c/b\u003e Inferior Rectus (CN III) \u0026 Superior Oblique (CN IV)"
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Testing:\u003c/b\u003e Assessed by having the patient follow a target in the six cardinal positions of gaze (the"
      }, {
        "text": " \u0027H\u0027 pattern).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e To isolate the vertical actions of the rectus muscles, have"
      }, {
        "text": " the patient look out (abduct). To isolate the vertical actions of the oblique muscles, have the patient look in (adduct).\u003c/li\u003e"
      }, {
        "text": "\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe precise and coordinated control of \u003cb\u003eocular motility\u003c/b\u003e by cranial"
      }, {
        "text": " nerves III, IV, and VI allows for the complex eye movements necessary for binocular vision; any weakness or paralysis ("
      }, {
        "text": "ophthalmoplegia) results in misalignment and diplopia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_controlled_by\",\n        \"to\": \"68c"
      }, {
        "text": "66997\"\n      },\n      {\n        \"type\": \"is_controlled_by\",\n        \"to"
      }, {
        "text": "\": \"bba6093a\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "controlled_by\",\n        \"to\": \"dd11dde6\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_impaired_in\",\n        \"to\": \"4e4afce1\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"68c66997\": {\n    \"title\": \"Oculomotor Nerve (CN III)\",\n"
      }, {
        "text": "    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurology\",\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    "
      }, {
        "text": "],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eOculomotor Nerve (CN"
      }, {
        "text": " III)\u003c/b\u003e is a cranial nerve that controls most of the eye\u0027s movements, including constriction of the pupil and maintaining"
      }, {
        "text": " an open eyelid. It contains both somatic motor and visceral motor (parasympathetic) fibers.\u003c/p\u003e\",\n      \"atAGlance\": \""
      }, {
        "text": "\u003cul\u003e\u003cli\u003e\u003cb\u003eMotor Function:\u003c/b\u003e Innervates the superior, medial, and inferior rectus muscles, the inferior oblique muscle"
      }, {
        "text": ", and the levator palpebrae superioris (eyelid elevation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eParasympathetic Function:\u003c/b\u003e Car"
      }, {
        "text": "ries preganglionic parasympathetic fibers from the Edinger-Westphal nucleus to the ciliary ganglion. Postganglionic fibers inn"
      }, {
        "text": "ervate the sphincter pupillae (pupillary constriction) and the ciliary muscle ([[81b5f5fe"
      }, {
        "text": "|accommodation]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePalsy Presentation:\u003c/b\u003e A complete CN III palsy results in a \u003cmark\u003e\\\"down"
      }, {
        "text": " and out\\\"\u003c/mark\u003e eye position (due to unopposed action of the lateral rectus and superior oblique),"
      }, {
        "text": " severe [[6202e6af|ptosis]], and a fixed, dilated pupil (\u003cmark\u003e\\\"blown pupil\\\"\u003c/mark\u003e).\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003ePupil Sparing vs. Pupil Involving:\u003c/b\u003e A compressive lesion (e.g., PCom aneurysm,"
      }, {
        "text": " uncal herniation) typically affects the superficial parasympathetic fibers first, causing a blown pupil. An ischemic lesion (e."
      }, {
        "text": "g., diabetic neuropathy) often affects the deeper motor fibers while sparing the pupil.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " combination of a CN III palsy with a dilated, nonreactive pupil is a neurological emergency, highly suggestive of an aneurysm compressing the nerve"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eOculomotor Nerve\u003c/b\u003e is the primary"
      }, {
        "text": " motor nerve of the eye, and its dual somatic and parasympathetic functions mean that a complete palsy presents with a dramatic triad"
      }, {
        "text": " of a deviated eye, a drooping eyelid, and a dilated pupil, with the pupillary involvement being a key sign for differentiating"
      }, {
        "text": " compressive from ischemic causes.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"controls\",\n        \"to\": \"4eb418d0\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"controls\",\n        \"to\": \"pupillary_constriction\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "controls\",\n        \"to\": \"81b5f5fe\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"palsy_causes\",\n        \"to\": \"6202e6af\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_affected_in\",\n        \"to\": \"uncal_herniation\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"84b5e4f6\": {\n    \"title\": \""
      }, {
        "text": "Oculosympathetic Pathway\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \""
      }, {
        "text": "Anatomy\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Autonomic Nervous System\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eOculosympathetic Pathway\u003c/b\u003e is a"
      }, {
        "text": " three-neuron chain that provides sympathetic innervation to the eye and face, controlling pupillary dilation, eyelid elevation, and facial"
      }, {
        "text": " sweating.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFirst-Order Neuron (Central):\u003c/b\u003e Originates in the posterior"
      }, {
        "text": " [[89e86633|hypothalamus]], descends through the brainstem and synapses in the cili"
      }, {
        "text": "ospinal center of Budge (C8-T2) in the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSecond-Order Neuron ("
      }, {
        "text": "Preganglionic):\u003c/b\u003e Exits the spinal cord at T1, travels up the sympathetic chain, and synapses in the \u003c"
      }, {
        "text": "mark\u003esuperior cervical ganglion\u003c/mark\u003e. This neuron passes over the apex of the lung.\u003c/li\u003e\u003cli\u003e\u003cb\u003eThird-Order Neuron (Postgang"
      }, {
        "text": "lionic):\u003c/b\u003e Ascends along the internal carotid artery, passes through the [[c260efc8|cavernous sinus]],"
      }, {
        "text": " and travels with the ophthalmic division of the trigeminal nerve (CN V1) to innervate the dil"
      }, {
        "text": "ator pupillae muscle, superior tarsal muscle, and facial sweat glands.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Disruption of this pathway at"
      }, {
        "text": " any point results in \u003cmark\u003eHorner Syndrome\u003c/mark\u003e (ptosis, miosis, and anhidrosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The location of the lesion along the three-neuron arc determines the pattern of anhidrosis. A lesion of"
      }, {
        "text": " the 1st or 2nd neuron causes anhidrosis of the entire ipsilateral face, while a lesion of the 3"
      }, {
        "text": "rd neuron (distal to the carotid bifurcation) spares sweating on the forehead.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "The long and circuitous route of the \u003cb\u003eOculosympathetic Pathway\u003c/b\u003e‚Äîfrom the hypothalamus down the spinal cord, up"
      }, {
        "text": " the neck, and back into the head‚Äîmakes it vulnerable to a wide range of pathologies, from brainstem strokes to apical"
      }, {
        "text": " lung tumors, all of which can produce the same classic triad of Horner syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[1"
      }, {
        "text": "st Order: Hypothalamus] --\u003e B(Ciliospinal Center C8-T2); B --\u003e"
      }, {
        "text": " C[2nd Order: Superior Cervical Ganglion]; C --\u003e D[3rd Order: Eye \u0026 Face];\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"lesion_causes\",\n        \"to"
      }, {
        "text": "\": \"c19010a3\"\n      },\n      {\n        \"type\": \"is_part_of\",\n        "
      }, {
        "text": "\"to\": \"sympathetic_nervous_system\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "innervates\",\n        \"to\": \"dilator_pupillae_muscle\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"c6cf9420\": {\n    \"title\": \"Olfaction\",\n    \"primaryType"
      }, {
        "text": "\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Physiology\",\n      \"Special"
      }, {
        "text": " Senses\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOlfaction\u003c/b\u003e is the sense of smell, a"
      }, {
        "text": " chemical sense mediated by olfactory receptor neurons in the nasal cavity that detect odorant molecules and transmit this information to the brain via the [["
      }, {
        "text": "4487bc38|olfactory nerve (CN I)]].\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eReceptors:\u003c/b\u003e Olfactory receptor neurons are located in the olfactory epithelium in the superior part"
      }, {
        "text": " of the nasal cavity.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Axons of these neurons form the olfactory nerve (CN I), which passes"
      }, {
        "text": " through the cribriform plate of the ethmoid bone to synapse in the olfactory bulb. From the bulb, olfactory tracts project directly"
      }, {
        "text": " to the primary olfactory cortex (piriform cortex) in the temporal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUnique Feature:\u003c/b\u003e Olfaction is the "
      }, {
        "text": "\u003cu\u003eonly\u003c/u\u003e sensory modality that does not have a primary relay in the [[afc0a64b|thalamus]]"
      }, {
        "text": " before projecting to the cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLimbic System Connection:\u003c/b\u003e The olfactory cortex has strong connections to the [["
      }, {
        "text": "73ace357|limbic system]], particularly the amygdala and hippocampus, which is why smells can evoke strong emotions"
      }, {
        "text": " and memories.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Loss of smell is called anosmia. It can be caused by trauma ("
      }, {
        "text": "shearing of olfactory nerve fibers at the cribriform plate), viral infections, or neurodegenerative diseases like Parkinson\u0027s and"
      }, {
        "text": " Alzheimer\u0027s.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eOlfaction\u003c/b\u003e is a unique and"
      }, {
        "text": " primitive sense that bypasses the thalamic relay common to all other senses, projecting directly to cortical areas intertwined with the [[73ace357|"
      }, {
        "text": "limbic system]], providing a direct and powerful link between smells, emotions, and memory.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_mediated_by\",\n        \"to\":"
      }, {
        "text": " \"4487bc38\"\n      },\n      {\n        \"type\": \"is_linked"
      }, {
        "text": "_to\",\n        \"to\": \"73ace357\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"bypasses\",\n        \"to\": \"afc0a64b\"\n      }\n    ]\n  },"
      }, {
        "text": "\n  \"4487bc38\": {\n    \"title\": \"Olfactory Nerve (CN I)\",\n    "
      }, {
        "text": "\"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Special"
      }, {
        "text": " Senses\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eOlfactory Nerve (CN I)"
      }, {
        "text": "\u003c/b\u003e is the first and shortest cranial nerve, a purely sensory nerve responsible for the sense of \u003ci\u003eolfaction\u003c/i\u003e (smell).\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Special visceral afferent (SVA) fibers for"
      }, {
        "text": " smell.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Composed of the axons of olfactory receptor neurons located in the olfactory epithelium of the nasal cavity. These axons"
      }, {
        "text": " pass through the \u003cmark\u003ecribriform plate\u003c/mark\u003e of the ethmoid bone to synapse on mitral cells in the olfactory bulb.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Central Projections:\u003c/b\u003e The olfactory tract then projects from the bulb to the primary olfactory cortex (piriform cortex) without"
      }, {
        "text": " relaying through the thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects:\u003c/b\u003e Damage to the olfactory nerve results in \u003cmark\u003eanosmia"
      }, {
        "text": "\u003c/mark\u003e (loss of smell). This can be caused by head trauma (shearing forces at the cribriform plate), viral"
      }, {
        "text": " infections, or tumors at the base of the frontal lobe (e.g., olfactory groove meningioma).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Anosmia following a frontal head injury is a classic presentation of CN I damage due to shearing of its"
      }, {
        "text": " delicate fibers as they pass through the cribriform plate.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eOl"
      }, {
        "text": "factory Nerve\u003c/b\u003e is unique among cranial nerves as it is a direct extension of the telencephalon, consists of unmyelinated axons that"
      }, {
        "text": " regenerate, and its pathway is the only sensory system to bypass the thalamus, projecting directly to the cortex.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_responsible_for\",\n        \""
      }, {
        "text": "to\": \"c6cf9420\"\n      },\n      {\n        \"type\": \"passes"
      }, {
        "text": "_through\",\n        \"to\": \"cribriform_plate\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "lesion_causes\",\n        \"to\": \"anosmia\"\n      }\n    ]\n  },\n"
      }, {
        "text": "  \"a24f9747\": {\n    \"title\": \"Oligodendrocytes\",\n    \"primaryType\": \""
      }, {
        "text": "anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Histology\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Glial Cells\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eOligodendrocytes\u003c/b\u003e are a type of glial cell found in the central nervous system (CNS) whose"
      }, {
        "text": " primary function is to produce the \u003ci\u003emyelin sheath\u003c/i\u003e that insulates neuronal axons, allowing for rapid saltatory conduction of action"
      }, {
        "text": " potentials.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Myelination of axons in the CNS ("
      }, {
        "text": "brain, spinal cord, and optic nerve). A single oligodendrocyte can myelinate \u003cmark\u003emultiple axons\u003c/mark\u003e (up to ~"
      }, {
        "text": "30).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e Histologically, they have a \\\"fried egg\\\" appearance with a round nucleus and clear"
      }, {
        "text": " cytoplasm, especially prominent in [[c932ed4e|oligodendrogliomas]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eEm"
      }, {
        "text": "bryonic Origin:\u003c/b\u003e Derived from neuroectoderm of the neural tube.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e They are the primary target"
      }, {
        "text": " of autoimmune attack in \u003cmark\u003e[[45dd6d19|Multiple Sclerosis]]\u003c/mark\u003e. They"
      }, {
        "text": " are also damaged in progressive multifocal leukoencephalopathy (PML) by the JC virus and in various leukodystrophies.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eDistinction from Schwann Cells:\u003c/b\u003e [[c65a8909|Schwann cells]] perform the"
      }, {
        "text": " same function (myelination) but in the peripheral nervous system (PNS). A key difference is that one Schwann cell myelin"
      }, {
        "text": "ates only one segment of a single axon.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The destruction of oligodendrocytes is the"
      }, {
        "text": " central pathological event in [[45dd6d19|Multiple Sclerosis]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eOligodendrocytes\u003c/b\u003e are the myelin-producing cells of the CNS, with each cell extending multiple"
      }, {
        "text": " processes to ensheath numerous axons; this \u0027one-to-many\u0027 relationship contrasts with Schwann cells and explains the widespread,"
      }, {
        "text": " patchy nature of demyelination when these cells are destroyed in diseases like MS.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"glial_cell\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"produces\",\n        \"to\": \"myelin_sheath\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"45dd6d19"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\":"
      }, {
        "text": " \"progressive_multifocal_leukoencephalopathy\"\n      },\n      {\n        \"type\": \"differentiated_from\","
      }, {
        "text": "\n        \"to\": \"c65a8909\"\n      }\n    ]\n  },\n  \"c932"
      }, {
        "text": "ed4e\": {\n    \"title\": \"Oligodendroglioma\",\n    \"primaryType\":"
      }, {
        "text": " \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Pathology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eAn \u003cb\u003eOligodendroglioma\u003c/b\u003e is a relatively rare, slow-growing primary brain tumor derived"
      }, {
        "text": " from [[a24f9747|oligodendrocytes]]. It is most commonly found in the cerebral hemispheres"
      }, {
        "text": " of adults, particularly the frontal lobes.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Typically"
      }, {
        "text": " located in the white matter of the cerebral hemispheres, with a predilection for the \u003cmark\u003efrontal lobes\u003c/mark\u003e.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Often presents with seizures due to its cortical location. Other symptoms include headaches and focal neurologic deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging"
      }, {
        "text": ":\u003c/b\u003e On CT scans, these tumors are often \u003cmark\u003ecalcified\u003c/mark\u003e. On MRI, they appear as well"
      }, {
        "text": "-circumscribed masses.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e Characterized by sheets of uniform cells with round nuclei, clear cytoplasm, and well"
      }, {
        "text": "-defined cell borders, creating a classic \u003cmark\u003e\\\"fried egg\\\" appearance\u003c/mark\u003e. A delicate network of branching"
      }, {
        "text": " capillaries, often described as a \u003cmark\u003e\\\"chicken-wire\\\" pattern\u003c/mark\u003e, is also characteristic.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The combination of a calcified frontal lobe tumor in an adult presenting with seizures, and a \\\"fried egg\\\" appearance on histology, is"
      }, {
        "text": " pathognomonic for an oligodendroglioma.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eO"
      }, {
        "text": "ligodendroglioma\u003c/b\u003e is defined by its classic histological appearance of \\\"fried egg\\\" cells and a \\\"chicken-wire\\\" vascular"
      }, {
        "text": " pattern, which reflects its origin from the myelin-producing cells of the CNS and often presents with seizures due to its typical"
      }, {
        "text": " frontal lobe location.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"be057cfc"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"arises_from\",\n        \"to\": \""
      }, {
        "text": "a24f9747\"\n      },\n      {\n        \"type\": \"is_characterized"
      }, {
        "text": "_by\",\n        \"to\": \"fried_egg_appearance\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_located_in\",\n        \"to\": \"frontal_lobe\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"5ea7b741\": {\n    \"title\": \"Open-"
      }, {
        "text": "Angle Glaucoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"Geriatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Path"
      }, {
        "text": "ology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOpen-Angle Glaucoma\u003c/b\u003e"
      }, {
        "text": " is the most common type of [[3ce6c035|glaucoma]], a chronic, progressive optic neuropathy characterized by an"
      }, {
        "text": " open, normal-appearing anterior chamber angle and increased intraocular pressure (IOP) due to decreased aqueous humor outflow.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The primary defect is an increased resistance to aqueous humor"
      }, {
        "text": " drainage through the \u003cmark\u003etrabecular meshwork\u003c/mark\u003e. The anterior chamber angle itself is open and not obstructed.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation"
      }, {
        "text": ":\u003c/b\u003e Typically asymptomatic in the early stages, earning it the name \\\"silent thief of sight.\\\" The first noticeable symptom is often a gradual loss of \u003c"
      }, {
        "text": "mark\u003eperipheral vision\u003c/mark\u003e, which progresses to central vision loss and blindness if untreated.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e"
      }, {
        "text": " Increased age, African American ethnicity, family history, and diabetes mellitus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Diagnosed based on elevated IOP, characteristic"
      }, {
        "text": " optic disc cupping on fundoscopy, and corresponding visual field defects on perimetry.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e The"
      }, {
        "text": " goal is to lower IOP. First-line agents are typically prostaglandin analogs (e.g., latanoprost) which increase uve"
      }, {
        "text": "oscleral outflow, or beta-blockers (e.g., timolol) which decrease aqueous humor production.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e Differentiate from angle-closure glaucoma: open-angle is chronic, painless, and involves peripheral vision loss, while acute"
      }, {
        "text": " angle-closure is sudden, painful, and presents with a red eye and blurry vision.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eOpen-Angle Glaucoma\u003c/b\u003e is a chronic and insidious disease where the eye\u0027s drainage system ("
      }, {
        "text": "the trabecular meshwork) becomes clogged over time, leading to a slow, painless rise in pressure that gradually damages the optic nerve from"
      }, {
        "text": " the periphery inward.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Decreased Outflow through Trabecular Meshwork] --\u003e B"
      }, {
        "text": "(Increased IOP); B --\u003e C(Optic Nerve Damage); C --\u003e D(Progressive Peripheral Vision Loss);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"3"
      }, {
        "text": "ce6c035\"\n      },\n      {\n        \"type\": \"differentiated_from\","
      }, {
        "text": "\n        \"to\": \"9c80344d\"\n      },\n      {\n        \"type\": \"is_treated"
      }, {
        "text": "_by\",\n        \"to\": \"prostaglandin_analogs\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_treated_by\",\n        \"to\": \"beta_blockers\"\n      "
      }, {
        "text": "}\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"832463e6\",\n    \"letter\": \"N\",\n    \"term\": \"Neuron action potential\",\n    \"pages\": [\n      \"504\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Neuron action potential\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"63fc3fe7\",\n    \"letter\": \"N\",\n    \"term\": \"Neurons\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Neurons\",\n    \"sub_entries\": [\n      {\n        \"id\": \"dda844c6\",\n        \"letter\": \"N\",\n        \"term\": \"in spinal tracts\",\n        \"pages\": [\n          \"522\"\n        ],\n        \"context\": \"Neurons \u003e in spinal tracts\"\n      },\n      {\n        \"id\": \"227f90ce\",\n        \"letter\": \"N\",\n        \"term\": \"response to axonal injury\",\n        \"pages\": [\n          \"505\"\n        ],\n        \"context\": \"Neurons \u003e response to axonal injury\"\n      }\n    ]\n  },\n  {\n    \"id\": \"42de0dd8\",\n    \"letter\": \"N\",\n    \"term\": \"Neurotransmitters\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Neurotransmitters\",\n    \"sub_entries\": [\n      {\n        \"id\": \"7224987c\",\n        \"letter\": \"N\",\n        \"term\": \"synthesis and changes with disease\",\n        \"pages\": [\n          \"505\"\n        ],\n        \"context\": \"Neurotransmitters \u003e synthesis and changes with disease\"\n      }\n    ]\n  },\n  {\n    \"id\": \"454a0eb8\",\n    \"letter\": \"N\",\n    \"term\": \"Nevus flammeus\",\n    \"pages\": [\n      \"539\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Nevus flammeus\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"c30e26a4\",\n    \"letter\": \"N\",\n    \"term\": \"Nigrostriatal pathway\",\n    \"pages\": [\n      \"509\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Nigrostriatal pathway\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"689f638a\",\n    \"letter\": \"N\",\n    \"term\": \"Nimodipine\",\n    \"pages\": [\n      \"323\",\n      \"528\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Nimodipine\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"83a65f11\",\n    \"letter\": \"N\",\n    \"term\": \"Noise-induced hearing loss\",\n    \"pages\": [\n      \"548\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Noise-induced hearing loss\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"cddbff38\",\n    \"letter\": \"N\",\n    \"term\": \"Non-REM sleep stage\",\n    \"pages\": [\n      \"507\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Non-REM sleep stage\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"91c40279\",\n    \"letter\": \"N\",\n    \"term\": \"Nonbenzodiazepine hypnotics\",\n    \"pages\": [\n      \"562\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Nonbenzodiazepine hypnotics\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"a1ef0cd9\",\n    \"letter\": \"N\",\n    \"term\": \"Noncommunicating hydrocephalus,\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Noncommunicating hydrocephalus,\",\n    \"sub_entries\": [\n      {\n        \"id\": \"df1f9774\",\n        \"letter\": \"N\",\n        \"term\": \"536\",\n        \"pages\": [\n          \"542\"\n        ],\n        \"context\": \"Noncommunicating hydrocephalus, \u003e 536\"\n      }\n    ]\n  },\n  {\n    \"id\": \"48f817e6\",\n    \"letter\": \"N\",\n    \"term\": \"Nondepolarizing neuromuscular\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Nondepolarizing neuromuscular\",\n    \"sub_entries\": [\n      {\n        \"id\": \"28fa778f\",\n        \"letter\": \"N\",\n        \"term\": \"blocking drugs\",\n        \"pages\": [\n          \"252\",\n          \"566\"\n        ],\n        \"context\": \"Nondepolarizing neuromuscular \u003e blocking drugs\"\n      }\n    ]\n  },\n  {\n    \"id\": \"45dce26f\",\n    \"letter\": \"N\",\n    \"term\": \"Nonproliferative diabetic retinopathy\",\n    \"pages\": [\n      \"552\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Nonproliferative diabetic retinopathy\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"e365e126\",\n    \"letter\": \"N\",\n    \"term\": \"Nonrhegmatogenous retinal\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Nonrhegmatogenous retinal\",\n    \"sub_entries\": [\n      {\n        \"id\": \"6c105b32\",\n        \"letter\": \"N\",\n        \"term\": \"detachment\",\n        \"pages\": [\n          \"552\"\n        ],\n        \"context\": \"Nonrhegmatogenous retinal \u003e detachment\"\n      }\n    ]\n  },\n  {\n    \"id\": \"682952a2\",\n    \"letter\": \"N\",\n    \"term\": \"Nonsteroidal anti-inflammatory drugs\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Nonsteroidal anti-inflammatory drugs\",\n    \"sub_entries\": [\n      {\n        \"id\": \"6a560d90\",\n        \"letter\": \"N\",\n        \"term\": \"headaches\",\n        \"pages\": [\n          \"532\"\n        ],\n        \"context\": \"Nonsteroidal anti-inflammatory drugs \u003e headaches\"\n      }\n    ]\n  },\n  {\n    \"id\": \"aedeee6d\",\n    \"letter\": \"N\",\n    \"term\": \"Norepinephrine\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Norepinephrine\",\n    \"sub_entries\": [\n      {\n        \"id\": \"eafaaaf4\",\n        \"letter\": \"N\",\n        \"term\": \"synthesis and change with diseases\",\n        \"pages\": [\n          \"505\"\n        ],\n        \"context\": \"Norepinephrine \u003e synthesis and change with diseases\"\n      }\n    ]\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 1814
    }, {
      "text": "```json\n{\n  \"832463e6\": {\n    \"title\": \"Neuron Action Potential\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurons\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eneuron action potential\u003c/b\u003e is a rapid, all-or-none electrical signal that propagates down an axon, caused by the sequential opening and closing of \u003ci\u003evoltage-gated ion channels\u003c/i\u003e, which temporarily reverses the membrane potential and allows for long-distance communication in the nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eResting Potential (~-70 mV):\u003c/b\u003e Maintained by the Na\u003csup\u003e+\u003c/sup\u003e/K\u003csup\u003e+\u003c/sup\u003e pump and high resting permeability to K\u003csup\u003e+\u003c/sup\u003e (K\u003csup\u003e+\u003c/sup\u003e leak channels).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDepolarization:\u003c/b\u003e A stimulus reaching threshold potential (~-55 mV) triggers the rapid opening of voltage-gated \u003cmark\u003eNa\u003csup\u003e+\u003c/sup\u003e channels\u003c/mark\u003e, causing a massive influx of Na\u003csup\u003e+\u003c/sup\u003e and a sharp rise in membrane potential.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRepolarization:\u003c/b\u003e Voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels inactivate, and voltage-gated \u003cmark\u003eK\u003csup\u003e+\u003c/sup\u003e channels\u003c/mark\u003e open, leading to an efflux of K\u003csup\u003e+\u003c/sup\u003e that brings the membrane potential back down.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHyperpolarization:\u003c/b\u003e K\u003csup\u003e+\u003c/sup\u003e channels are slow to close, causing the membrane potential to briefly dip below the resting potential.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Many neurotoxins and drugs target these channels. [[tetrodotoxin|Tetrodotoxin]] (pufferfish) and [[lidocaine|local anesthetics]] block voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels, preventing action potential propagation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe neuron action potential is fundamentally a precisely orchestrated sequence of ionic movements: a rapid influx of \u003cb\u003eNa\u003csup\u003e+\u003c/sup\u003e\u003c/b\u003e causes the rising phase (depolarization), and a subsequent efflux of \u003cb\u003eK\u003csup\u003e+\u003c/sup\u003e\u003c/b\u003e causes the falling phase (repolarization), enabling high-speed signal transmission.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A(Resting State) --Stimulus--\u003e B(Threshold); B --Na+ Influx--\u003e C(Depolarization); C --Na+ Inactivation \u0026 K+ Efflux--\u003e D(Repolarization); D --Slow K+ Channel Closing--\u003e E(Hyperpolarization); E --\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_blocked_by\",\n        \"to\": \"tetrodotoxin\"\n      },\n      {\n        \"type\": \"is_blocked_by\",\n        \"to\": \"local_anesthetics\"\n      },\n      {\n        \"type\": \"is_fundamental_to\",\n        \"to\": \"synaptic_transmission\"\n      }\n    ]\n  },\n  \"63fc3fe7\": {\n    \"title\": \"Neurons\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Histology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurons\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeurons\u003c/b\u003e are the fundamental, signal-transmitting cells of the nervous system, composed of a cell body (soma), dendrites that receive input, and an axon that sends output. They are permanent cells that do not typically divide in adults.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e The cell body contains the nucleus and Nissl substance (rough ER). Dendrites receive signals, and the axon transmits signals via [[832463e6|action potentials]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAxonal Injury Response:\u003c/b\u003e When an axon is severed, the distal portion undergoes \u003cmark\u003eWallerian degeneration\u003c/mark\u003e. The cell body swells, the nucleus moves to the periphery, and Nissl substance disperses (central chromatolysis or axonal reaction).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpinal Tracts:\u003c/b\u003e Neurons are organized into tracts in the spinal cord. First-order neurons bring sensory information from the periphery. Second-order neurons decussate and ascend to the thalamus. Third-order neurons project from the thalamus to the cortex. Motor pathways involve upper and lower motor neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMarkers:\u003c/b\u003e Neurons can be identified by immunohistochemical stains for neurofilament protein and synaptophysin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The histological changes of axonal reaction (central chromatolysis) are a classic sign of a neuron attempting to repair itself after its axon has been damaged.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNeurons\u003c/b\u003e are highly specialized for communication, with a complex structure that supports the generation and propagation of electrical signals over long distances. Their response to injury, particularly the process of central chromatolysis, reflects a robust but often incomplete attempt at regeneration.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_component_of\",\n        \"to\": \"nervous_system\"\n      },\n      {\n        \"type\": \"communicates_via\",\n        \"to\": \"832463e6\"\n      },\n      {\n        \"type\": \"undergoes\",\n        \"to\": \"axonal_reaction\"\n      },\n      {\n        \"type\": \"forms\",\n        \"to\": \"spinal_tracts\"\n      }\n    ]\n  },\n  \"42de0dd8\": {\n    \"title\": \"Neurotransmitters\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Physiology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurotransmitters\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeurotransmitters\u003c/b\u003e are chemical messengers that transmit signals across a synapse from one neuron to another target neuron, muscle cell, or gland cell. Their synthesis, release, and degradation are tightly regulated and are the targets of many psychoactive drugs.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAcetylcholine (ACh):\u003c/b\u003e Decreased in [[77ae6148|Alzheimer disease]] and [[ffd7e743|Huntington disease]]. Synthesized in the [[361438f2|basal nucleus of Meynert]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eDopamine:\u003c/b\u003e Decreased in [[58c8ea03|Parkinson disease]]. Increased in schizophrenia. Synthesized in the ventral tegmentum and substantia nigra.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGABA (Œ≥-aminobutyric acid):\u003c/b\u003e Main inhibitory neurotransmitter. Decreased in anxiety and [[ffd7e743|Huntington disease]]. Synthesized in the nucleus accumbens.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNorepinephrine:\u003c/b\u003e Increased in anxiety; decreased in depression. Synthesized in the locus coeruleus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSerotonin (5-HT):\u003c/b\u003e Decreased in anxiety and depression. Synthesized in the raphe nuclei.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGlutamate:\u003c/b\u003e Main excitatory neurotransmitter. Implicated in excitotoxicity.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe balance of key \u003cb\u003eneurotransmitters\u003c/b\u003e in specific brain regions is critical for normal neurological function; imbalances are the core pathophysiology of many major neurological and psychiatric disorders, such as the dopamine deficit in Parkinson\u0027s and the acetylcholine deficit in Alzheimer\u0027s.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"6a005559\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"90adc821\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"5aa5cb91\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"aedeee6d\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"serotonin\"\n      }\n    ]\n  },\n  \"454a0eb8\": {\n    \"title\": \"Nevus Flammeus (Port-Wine Stain)\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Dermatology\",\n      \"Neurology\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Musculoskeletal, Skin, and Connective Tissue\",\n      \"Dermatology\",\n      \"Vascular Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eNevus Flammeus\u003c/b\u003e, commonly known as a \u003cb\u003eport-wine stain\u003c/b\u003e, is a congenital capillary vascular malformation characterized by a flat, pink-to-reddish-purple patch of skin. When it occurs in the trigeminal nerve distribution, it is a hallmark of \u003ci\u003eSturge-Weber syndrome\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e A congenital malformation of dermal capillaries, resulting in ectasia (dilation) of these vessels. It does not involute and grows in proportion with the child.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A flat, erythematous patch present at birth.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSturge-Weber Syndrome:\u003c/b\u003e A nevus flammeus in the ophthalmic (V1) and/or maxillary (V2) distribution of the trigeminal nerve is the key cutaneous finding of [[fd52a8b8|Sturge-Weber syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Findings in Sturge-Weber:\u003c/b\u003e The syndrome also includes an ipsilateral leptomeningeal angioma (leading to seizures and intellectual disability) and may involve episcleral hemangioma (leading to early-onset glaucoma).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A newborn with a port-wine stain following the V1/V2 dermatome must be evaluated for [[fd52a8b8|Sturge-Weber syndrome]], including an ophthalmologic exam for glaucoma and neuroimaging to look for leptomeningeal angiomas.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003enevus flammeus\u003c/b\u003e is more than a birthmark when it appears on the face in a trigeminal distribution; it serves as a critical external clue to the potential presence of underlying vascular malformations in the brain and eye, as seen in [[fd52a8b8|Sturge-Weber syndrome]].\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \"to\": \"fd52a8b8\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"vascular_malformation\"\n      }\n    ]\n  },\n  \"c30e26a4\": {\n    \"title\": \"Nigrostriatal Pathway\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Movement Disorders\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Basal Ganglia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eNigrostriatal Pathway\u003c/b\u003e is a critical dopaminergic tract that projects from the \u003ci\u003esubstantia nigra pars compacta (SNc)\u003c/i\u003e to the \u003ci\u003estriatum\u003c/i\u003e (caudate and putamen). It is a key component of the [[ed462927|basal ganglia]] motor loop, responsible for modulating the initiation of voluntary movement.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Substantia nigra pars compacta (SNc) in the midbrain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTermination:\u003c/b\u003e Dorsal striatum (caudate nucleus and putamen).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter:\u003c/b\u003e [[90adc821|Dopamine]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Modulates motor activity by exciting the direct pathway (via D1 receptors) and inhibiting the indirect pathway (via D2 receptors), with a net effect of facilitating movement.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Degeneration of this pathway is the primary cause of the motor symptoms in [[58c8ea03|Parkinson disease]]. The loss of dopamine leads to overactivity of the indirect pathway and underactivity of the direct pathway, resulting in bradykinesia, rigidity, and tremor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The destruction of the nigrostriatal pathway is the central event in [[58c8ea03|Parkinson disease]]. Antipsychotic drugs can block D2 receptors in this pathway, causing drug-induced parkinsonism (extrapyramidal side effects).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eNigrostriatal Pathway\u003c/b\u003e acts as the \u0027gas pedal\u0027 for the basal ganglia\u0027s motor circuit; its dopaminergic input facilitates movement, and its degeneration in Parkinson\u0027s disease effectively \u0027puts the brakes on,\u0027 leading to the characteristic poverty of motion.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Substantia Nigra pars compacta] --Dopamine--\u003e B(Striatum); B --\u003e C(Modulation of Direct/Indirect Pathways); C --\u003e D(Initiation of Movement);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"dopaminergic_pathways\"\n      },\n      {\n        \"type\": \"is_degenerated_in\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"uses_neurotransmitter\",\n        \"to\": \"90adc821\"\n      },\n      {\n        \"type\": \"is_affected_by\",\n        \"to\": \"antipsychotics\"\n      }\n    ]\n  },\n  \"689f638a\": {\n    \"title\": \"Nimodipine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Cerebrovascular Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNimodipine\u003c/b\u003e is a dihydropyridine \u003ci\u003ecalcium channel blocker\u003c/i\u003e with a high affinity for cerebral blood vessels, used specifically to prevent cerebral vasospasm following a [[63f8b05f|subarachnoid hemorrhage (SAH)]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks L-type calcium channels on smooth muscle cells, leading to vasodilation. It is more selective for cerebral arteries than other calcium channel blockers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e \u003cu\u003eExclusively\u003c/u\u003e used to improve neurological outcomes by preventing or reducing the severity of \u003cmark\u003ecerebral vasospasm\u003c/mark\u003e, a delayed complication that occurs 3-10 days after a [[63f8b05f|subarachnoid hemorrhage]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdministration:\u003c/b\u003e Typically given orally or via nasogastric tube for 21 days following an aneurysmal SAH.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most common side effect is hypotension. Others include headache, nausea, and bradycardia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e If a question describes a patient who had a subarachnoid hemorrhage and then develops new focal neurological deficits several days later, the cause is vasospasm. The prophylactic treatment for this complication is nimodipine.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNimodipine\u003c/b\u003e is a specialized calcium channel blocker whose primary role is not to treat hypertension but to prevent the devastating secondary ischemic strokes caused by vasospasm after a subarachnoid hemorrhage, thereby improving survival and functional outcomes.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"calcium_channel_blocker\"\n      },\n      {\n        \"type\": \"prevents\",\n        \"to\": \"cerebral_vasospasm\"\n      },\n      {\n        \"type\": \"is_used_after\",\n        \"to\": \"63f8b05f\"\n      }\n    ]\n  },\n  \"83a65f11\": {\n    \"title\": \"Noise-Induced Hearing Loss\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Otology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNoise-induced hearing loss\u003c/b\u003e is a type of \u003ci\u003esensorineural hearing loss\u003c/i\u003e caused by damage to the delicate hair cells in the [[2e814378|organ of Corti]] within the cochlea, resulting from exposure to loud sounds.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Loud noise causes mechanical damage and metabolic exhaustion of the stereociliated hair cells in the [[2e814378|organ of Corti]]. Damage is typically irreversible.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFrequency Pattern:\u003c/b\u003e The hearing loss characteristically begins at high frequencies, with a classic audiogram showing a \u003cmark\u003e\\\"notch\\\" or dip at 4000 Hz\u003c/mark\u003e. This is because the basal part of the cochlea, which is responsible for high-frequency hearing, is most susceptible to damage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e Can be caused by a single, intense acoustic trauma (e.g., explosion) or, more commonly, by chronic exposure to loud noise (e.g., occupational, recreational music).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients report difficulty hearing, especially in noisy environments, and may experience tinnitus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An audiogram showing a bilateral, symmetric hearing loss with a characteristic notch at 4000 Hz is the classic finding for noise-induced hearing loss.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNoise-induced hearing loss\u003c/b\u003e is a direct result of mechanical trauma to the hair cells of the inner ear, characteristically affecting high-frequency hearing first (especially at 4000 Hz) because the region of the cochlea responsible for these frequencies is most vulnerable to the damaging energy of loud sounds.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"sensorineural_hearing_loss\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"2e814378\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"loud_noise_exposure\"\n      }\n    ]\n  },\n  \"cddbff38\": {\n    \"title\": \"Non-REM Sleep\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sleep\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNon-REM (NREM) sleep\u003c/b\u003e is one of the two main stages of sleep, comprising three distinct stages (N1, N2, N3) characterized by progressively slower brain waves and deeper relaxation. It is the period when the body repairs and regrows tissues, builds bone and muscle, and strengthens the immune system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStage N1 (Light Sleep):\u003c/b\u003e Transition between wakefulness and sleep. EEG shows low-voltage, mixed-frequency waves.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStage N2 (Intermediate Sleep):\u003c/b\u003e The largest percentage of total sleep time. EEG is characterized by \u003cmark\u003esleep spindles\u003c/mark\u003e (bursts of rhythmic activity) and \u003cmark\u003eK-complexes\u003c/mark\u003e (large, high-voltage slow waves). Bruxism (teeth grinding) occurs in this stage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStage N3 (Deep Sleep/Slow-Wave Sleep):\u003c/b\u003e The deepest stage of sleep. EEG shows low-frequency, high-amplitude \u003cmark\u003edelta waves\u003c/mark\u003e. This is the stage where sleepwalking (somnambulism), night terrors, and bedwetting (enuresis) occur.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysiology:\u003c/b\u003e Characterized by decreased heart rate, blood pressure, and respiratory rate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Associate specific EEG findings and parasomnias with their respective NREM stages: N2 with sleep spindles and K-complexes, and N3 with delta waves, sleepwalking, and night terrors.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNon-REM sleep\u003c/b\u003e is a period of deep physiological rest and restoration, progressing through stages of increasing depth, with Stage N3 (slow-wave sleep) being the most restorative and the time when disorders of arousal like sleepwalking and night terrors manifest.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Awake] --\u003e B(NREM Stage 1); B --\u003e C(NREM Stage 2); C --\u003e D(NREM Stage 3); D --\u003e C; C --\u003e E(REM Sleep);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_stage_of\",\n        \"to\": \"sleep\"\n      },\n      {\n        \"type\": \"is_contrasted_with\",\n        \"to\": \"rem_sleep\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\": \"sleep_spindles\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\": \"k_complexes\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\": \"delta_waves\"\n      }\n    ]\n  },\n  \"91c40279\": {\n    \"title\": \"Nonbenzodiazepine Hypnotics\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Sedative-Hypnotics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNonbenzodiazepine hypnotics\u003c/b\u003e, often called \\\"Z-drugs,\\\" are a class of psychoactive drugs used for the treatment of insomnia. While structurally unrelated to benzodiazepines, they act on a specific subtype of the GABA\u003csub\u003eA\u003c/sub\u003e receptor to produce sedative effects.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eExamples:\u003c/b\u003e \u003cb\u003eZ\u003c/b\u003eolpidem, \u003cb\u003eZ\u003c/b\u003ealeplon, es\u003cb\u003eZ\u003c/b\u003eopiclone.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Act as selective agonists at the \u003cmark\u003eBZ1 (œâ1) subtype\u003c/mark\u003e of the GABA\u003csub\u003eA\u003c/sub\u003e receptor. This enhances the effect of GABA, leading to increased Cl\u003csup\u003e-\u003c/sup\u003e conductance and neuronal hyperpolarization, but with more specificity for sedation than benzodiazepines.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Short-term treatment of insomnia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Ataxia, headaches, confusion. Can cause anterograde amnesia and complex sleep-related behaviors (e.g., sleepwalking, sleep-driving).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Have a rapid onset and short duration of action. Effects are reversed by \u003cmark\u003eflumazenil\u003c/mark\u003e, the same antidote used for benzodiazepine overdose.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Z-drugs are preferred over benzodiazepines for insomnia due to a lower risk of dependence and less disruption of sleep architecture. However, they are still controlled substances and carry risks. Remember that their effects are reversed by flumazenil.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNonbenzodiazepine hypnotics\u003c/b\u003e are \u0027smarter\u0027 sleeping pills than benzodiazepines because they selectively target the sedative (BZ1) subtype of the GABA\u003csub\u003eA\u003c/sub\u003e receptor, inducing sleep with less anxiolytic, muscle relaxant, and anticonvulsant effects, and a lower risk of altering sleep stages.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"insomnia\"\n      },\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"gaba_a_receptor\"\n      },\n      {\n        \"type\": \"effects_are_reversed_by\",\n        \"to\": \"flumazenil\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"zolpidem\"\n      }\n    ]\n  },\n  \"a1ef0cd9\": {\n    \"title\": \"Non-Communicating Hydrocephalus\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Hydrocephalus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNon-communicating hydrocephalus\u003c/b\u003e, also known as \u003ci\u003eobstructive hydrocephalus\u003c/i\u003e, is the accumulation of excess cerebrospinal fluid (CSF) due to a physical blockage within the ventricular system, leading to ventricular dilation proximal to the obstruction and increased intracranial pressure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e A structural lesion blocks the flow of CSF from one part of the ventricular system to another or into the subarachnoid space. This leads to a buildup of CSF and pressure in the ventricles \u0027upstream\u0027 of the blockage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Sites of Obstruction:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCerebral Aqueduct (of Sylvius):\u003c/b\u003e The narrowest part of the ventricular system, connecting the 3rd and 4th ventricles. Aqueductal stenosis is a common cause in children.\u003cbr\u003e - \u003cb\u003eForamen of Monro:\u003c/b\u003e Can be blocked by a colloid cyst.\u003cbr\u003e - \u003cb\u003eFourth Ventricle Outlets:\u003c/b\u003e Can be compressed by posterior fossa tumors like a [[16d613bb|medulloblastoma]] or [[14365ef4|ependymoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Symptoms of increased intracranial pressure, such as headache, nausea, vomiting, and [[4ae219da|papilledema]]. In infants, presents with an enlarging head circumference and bulging fontanelle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A [[16d613bb|medulloblastoma]] in a child is a classic cause of obstructive hydrocephalus due to compression of the fourth ventricle.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNon-communicating hydrocephalus\u003c/b\u003e is a \u0027plumbing problem\u0027 within the brain\u0027s ventricular system, where a physical blockage leads to a dam-like effect, causing upstream ventricular dilation and a dangerous rise in intracranial pressure.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[CSF Production in Lateral/Third Ventricles] --\u003e B(Flow through Cerebral Aqueduct); B --Blockage (e.g., Tumor)--\u003e C(Obstruction); B --\u003e D(Fourth Ventricle); C --\u003e E(Dilation of Lateral \u0026 Third Ventricles); E --\u003e F(Increased ICP);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"0bc2f200\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"16d613bb\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"14365ef4\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"aa4115c7\"\n      }\n    ]\n  },\n  \"48f817e6\": {\n    \"title\": \"Non-Depolarizing Neuromuscular Blocking Drugs\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Neuromuscular Blockers\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNon-depolarizing neuromuscular blocking drugs\u003c/b\u003e are a class of agents that cause skeletal muscle paralysis by acting as \u003ci\u003ecompetitive antagonists\u003c/i\u003e at the nicotinic acetylcholine (ACh) receptors at the neuromuscular junction.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eExamples:\u003c/b\u003e Rocuronium, vecuronium, atracurium, cisatracurium, [[243d4db1|pancuronium]]. Mnemonic: End in \u0027-curonium\u0027 or \u0027-curium\u0027.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Competitively bind to N\u003csub\u003eM\u003c/sub\u003e receptors on the motor endplate, preventing [[6a005559|ACh]] from binding and thus inhibiting muscle cell depolarization and contraction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used as adjuncts in general anesthesia to induce skeletal muscle relaxation, facilitating endotracheal intubation and surgical procedures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReversal:\u003c/b\u003e The blockade can be overcome by increasing the concentration of ACh in the synapse. This is achieved by administering an \u003cmark\u003eacetylcholinesterase inhibitor\u003c/mark\u003e (e.g., neostigmine). An antimuscarinic (e.g., glycopyrrolate) is co-administered to prevent systemic muscarinic side effects. Sugammadex can also be used to reverse rocuronium and vecuronium.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from succinylcholine (a depolarizing blocker). Non-depolarizing blockade shows a \u0027fade\u0027 on train-of-four stimulation, and its effects are reversed by AChE inhibitors.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNon-depolarizing neuromuscular blockers\u003c/b\u003e act like a key that fits in the lock (the ACh receptor) but doesn\u0027t turn, competitively preventing the real key (ACh) from opening the channel and causing muscle contraction. Their effects can be overcome by flooding the synapse with more ACh.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"neuromuscular_blocker\"\n      },\n      {\n        \"type\": \"antagonizes\",\n        \"to\": \"nicotinic_acetylcholine_receptor\"\n      },\n      {\n        \"type\": \"is_reversed_by\",\n        \"to\": \"acetylcholinesterase_inhibitor\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"243d4db1\"\n      }\n    ]\n  },\n  \"45dce26f\": {\n    \"title\": \"Nonproliferative Diabetic Retinopathy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Endocrinology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNonproliferative diabetic retinopathy (NPDR)\u003c/b\u003e is the most common form of [[73b00ab0|diabetic retinopathy]], characterized by damage to the retinal blood vessels leading to leakage and ischemia, but without the growth of new, abnormal blood vessels (neovascularization).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Chronic hyperglycemia damages retinal capillaries, leading to loss of pericytes, basement membrane thickening, and breakdown of the blood-retinal barrier.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunduscopic Findings:\u003c/b\u003e\u003cbr\u003e - \u003cmark\u003eMicroaneurysms:\u003c/mark\u003e Earliest sign. Small, saccular outpouchings of capillaries.\u003cbr\u003e - \u003cmark\u003eDot and Blot Hemorrhages:\u003c/mark\u003e Bleeding into the deeper layers of the retina.\u003cbr\u003e - \u003cmark\u003eHard Exudates:\u003c/mark\u003e Yellow lipid deposits resulting from chronic plasma leakage.\u003cbr\u003e - \u003cmark\u003eCotton-Wool Spots:\u003c/mark\u003e Fluffy white patches representing nerve fiber layer infarcts from capillary occlusion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMajor Cause of Vision Loss:\u003c/b\u003e The primary cause of vision loss in NPDR is \u003cmark\u003emacular edema\u003c/mark\u003e, where fluid and lipids leak into the macula, causing central vision to become blurred.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProgression:\u003c/b\u003e NPDR can progress to the more severe proliferative form if retinal ischemia becomes widespread.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Be able to identify the funduscopic findings of NPDR. The presence of microaneurysms, hemorrhages, and exudates without neovascularization defines this stage.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNonproliferative diabetic retinopathy\u003c/b\u003e is a disease of leaky and occluded retinal vessels. The pathology is confined to the existing vasculature, and the main threat to vision is not from new vessel growth but from the chronic leakage of fluid into the macula, causing macular edema.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"73b00ab0\"\n      },\n      {\n        \"type\": \"can_progress_to\",\n        \"to\": \"23455320\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\": \"microaneurysms\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\": \"cotton_wool_spots\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"macular_edema\"\n      }\n    ]\n  },\n  \"e365e126\": {\n    \"title\": \"Nonrhegmatogenous Retinal Detachment\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNonrhegmatogenous retinal detachment\u003c/b\u003e is a separation of the neurosensory retina from the underlying retinal pigment epithelium that is \u003cu\u003enot\u003c/u\u003e caused by a full-thickness retinal tear or hole. It is subdivided into tractional and exudative types.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTractional Retinal Detachment:\u003c/b\u003e Occurs when fibrovascular membranes on the retinal surface contract and pull the retina away from the pigment epithelium. A classic cause is \u003cmark\u003eproliferative diabetic retinopathy\u003c/mark\u003e, where neovascular membranes contract.\u003c/li\u003e\u003cli\u003e\u003cb\u003eExudative (Serous) Retinal Detachment:\u003c/b\u003e Results from the accumulation of fluid in the subretinal space due to damage to the retinal pigment epithelium or choroid, allowing fluid to leak underneath the retina. Causes include inflammatory conditions (e.g., posterior uveitis), tumors (e.g., choroidal melanoma), and severe hypertension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients experience vision loss, which can be gradual or sudden, often described as a curtain or shadow in the visual field. Unlike rhegmatogenous detachment, it is not typically preceded by flashes or floaters.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate the mechanisms. Rhegmatogenous \u003d a tear lets fluid in. Tractional \u003d membranes pull the retina off. Exudative \u003d fluid leaks from damaged vessels underneath.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eUnlike the more common rhegmatogenous detachment caused by a retinal tear, \u003cb\u003enonrhegmatogenous retinal detachments\u003c/b\u003e are caused either by mechanical pulling forces (tractional) or by underlying fluid leakage (exudative), pointing to different underlying pathologies like diabetes or inflammation.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"38c092f9\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"rhegmatogenous_retinal_detachment\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"23455320\"\n      }\n    ]\n  },\n  \"682952a2\": {\n    \"title\": \"NSAIDs for Headaches\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Pain Management\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Analgesics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNonsteroidal anti-inflammatory drugs (NSAIDs)\u003c/b\u003e are a cornerstone of abortive therapy for mild to moderate primary [[26661e34|headaches]], particularly tension-type and migraine headaches, by inhibiting prostaglandin synthesis.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e NSAIDs (e.g., ibuprofen, naproxen, diclofenac) reversibly inhibit cyclooxygenase (COX-1 and COX-2) enzymes, which blocks the conversion of arachidonic acid to prostaglandins. Prostaglandins are key mediators of inflammation and pain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTension-Type Headache:\u003c/b\u003e NSAIDs are often the \u003cu\u003efirst-line\u003c/u\u003e treatment for acute tension headaches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMigraine Headache:\u003c/b\u003e Effective for mild to moderate migraine attacks. They can be used alone or in combination with triptans for more severe attacks.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Common side effects include GI upset and peptic ulcer disease. Chronic use can lead to renal injury (analgesic nephropathy) and increased risk of cardiovascular events.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e While effective for acute attacks, overuse of NSAIDs and other analgesics for headaches (e.g., \u003e10-15 days per month) can paradoxically lead to medication-overuse headaches.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eNSAIDs treat primary headaches by targeting the inflammatory component of pain, reducing the synthesis of prostaglandins that sensitize nociceptors, making them a fundamental first-line option for acute attacks.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"26661e34\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"nsaid\"\n      },\n      {\n        \"type\": \"inhibits_enzyme\",\n        \"to\": \"cyclooxygenase\"\n      }\n    ]\n  },\n  \"aedeee6d\": {\n    \"title\": \"Norepinephrine (CNS)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Psychiatry\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurotransmitters\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNorepinephrine (NE)\u003c/b\u003e is a catecholamine that functions as a major neurotransmitter in the central nervous system, where it is crucial for regulating attention, arousal, sleep-wake cycles, learning, memory, and mood.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSynthesis:\u003c/b\u003e Synthesized from [[90adc821|dopamine]] via dopamine Œ≤-hydroxylase. The primary site of NE synthesis in the brain is the \u003cmark\u003elocus coeruleus\u003c/mark\u003e, a nucleus in the pons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e As part of the ascending reticular activating system, the locus coeruleus projects widely throughout the CNS, modulating alertness and arousal. NE is a key neurotransmitter in the \u0027fight or flight\u0027 response.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Mood Disorders:\u003c/b\u003e Decreased levels of norepinephrine are implicated in the pathophysiology of \u003cmark\u003edepression\u003c/mark\u003e. Increased levels are associated with \u003cmark\u003eanxiety\u003c/mark\u003e and panic disorders.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacological Targets:\u003c/b\u003e Many antidepressants, such as SNRIs (e.g., venlafaxine) and TCAs (e.g., amitriptyline), work by increasing synaptic levels of norepinephrine (and serotonin).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the locus coeruleus as the principal source of CNS norepinephrine. Its role in arousal and mood makes it a key target for drugs treating depression and ADHD.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eIn the CNS, \u003cb\u003enorepinephrine\u003c/b\u003e released from the locus coeruleus acts as a global \u0027alertness\u0027 signal, modulating attention and arousal across the brain, with dysregulation of this system being a cornerstone of the pathophysiology of mood and anxiety disorders.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Locus Coeruleus] --Synthesizes \u0026 Releases--\u003e B(Norepinephrine); B --\u003e C(Widespread CNS Projections); C --\u003e D(Arousal \u0026 Attention); C --\u003e E(Mood Regulation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_synthesized_in\",\n        \"to\": \"locus_coeruleus\"\n      },\n      {\n        \"type\": \"is_decreased_in\",\n        \"to\": \"depression\"\n      },\n      {\n        \"type\": \"is_increased_in\",\n        \"to\": \"anxiety_disorders\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"catecholamine\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9577,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"832463e6\": {\n    \"title\": \"Ne"
      }, {
        "text": "uron Action Potential\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Phys"
      }, {
        "text": "iology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special"
      }, {
        "text": " Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurons\"\n    ],\n    \"content\": {"
      }, {
        "text": "\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eneuron action potential\u003c/b\u003e is a rapid, all-or-none"
      }, {
        "text": " electrical signal that propagates down an axon, caused by the sequential opening and closing of \u003ci\u003evoltage-gated ion channels\u003c/i\u003e"
      }, {
        "text": ", which temporarily reverses the membrane potential and allows for long-distance communication in the nervous system.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eResting Potential (~-70 mV):\u003c/b\u003e Maintained by the Na\u003csup\u003e+"
      }, {
        "text": "\u003c/sup\u003e/K\u003csup\u003e+\u003c/sup\u003e pump and high resting permeability to K\u003csup\u003e+\u003c/sup\u003e (K\u003csup\u003e+\u003c/sup\u003e leak channels).\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eDepolarization:\u003c/b\u003e A stimulus reaching threshold potential (~-55 mV) triggers the rapid opening of voltage"
      }, {
        "text": "-gated \u003cmark\u003eNa\u003csup\u003e+\u003c/sup\u003e channels\u003c/mark\u003e, causing a massive influx of Na\u003csup\u003e+\u003c/sup\u003e and"
      }, {
        "text": " a sharp rise in membrane potential.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRepolarization:\u003c/b\u003e Voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels in"
      }, {
        "text": "activate, and voltage-gated \u003cmark\u003eK\u003csup\u003e+\u003c/sup\u003e channels\u003c/mark\u003e open, leading to an efflux of K\u003csup\u003e+\u003c/sup\u003e that"
      }, {
        "text": " brings the membrane potential back down.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHyperpolarization:\u003c/b\u003e K\u003csup\u003e+\u003c/sup\u003e channels are slow to close, causing"
      }, {
        "text": " the membrane potential to briefly dip below the resting potential.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Many neurotoxins and drugs"
      }, {
        "text": " target these channels. [[tetrodotoxin|Tetrodotoxin]] (pufferfish) and [[lidocaine|local anesthetics]]"
      }, {
        "text": " block voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels, preventing action potential propagation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " neuron action potential is fundamentally a precisely orchestrated sequence of ionic movements: a rapid influx of \u003cb\u003eNa\u003csup\u003e+\u003c/sup\u003e\u003c/b\u003e"
      }, {
        "text": " causes the rising phase (depolarization), and a subsequent efflux of \u003cb\u003eK\u003csup\u003e+\u003c/sup\u003e\u003c/b\u003e causes the falling phase (repolarization),"
      }, {
        "text": " enabling high-speed signal transmission.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A(Resting State) --"
      }, {
        "text": "Stimulus--\u003e B(Threshold); B --Na+ Influx--\u003e C(Depolarization); C --Na+ Inactivation"
      }, {
        "text": " \u0026 K+ Efflux--\u003e D(Repolarization); D --Slow K+ Channel Closing--\u003e E(Hyperpolarization); E"
      }, {
        "text": " --\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_blocked_by\",\n        \""
      }, {
        "text": "to\": \"tetrodotoxin\"\n      },\n      {\n        \"type\": \"is_blocked_"
      }, {
        "text": "by\",\n        \"to\": \"local_anesthetics\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_fundamental_to\",\n        \"to\": \"synaptic_transmission\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"63fc3fe7\": {\n    \"title\": \"Neurons\",\n    \"primaryType"
      }, {
        "text": "\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Histology\",\n      \"An"
      }, {
        "text": "atomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Neurons\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eNeurons\u003c/b\u003e are the fundamental, signal-transmitting cells of the nervous system, composed of a cell body ("
      }, {
        "text": "soma), dendrites that receive input, and an axon that sends output. They are permanent cells that do not typically divide in"
      }, {
        "text": " adults.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e The cell body contains the nucleus and"
      }, {
        "text": " Nissl substance (rough ER). Dendrites receive signals, and the axon transmits signals via [[832463e6|"
      }, {
        "text": "action potentials]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAxonal Injury Response:\u003c/b\u003e When an axon is severed, the distal portion undergoes \u003cmark\u003eWallerian degeneration\u003c/"
      }, {
        "text": "mark\u003e. The cell body swells, the nucleus moves to the periphery, and Nissl substance disperses (central chromatolysis or"
      }, {
        "text": " axonal reaction).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpinal Tracts:\u003c/b\u003e Neurons are organized into tracts in the spinal cord. First"
      }, {
        "text": "-order neurons bring sensory information from the periphery. Second-order neurons decussate and ascend to the thalamus. Third-order neurons project"
      }, {
        "text": " from the thalamus to the cortex. Motor pathways involve upper and lower motor neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMarkers:\u003c/b\u003e Neur"
      }, {
        "text": "ons can be identified by immunohistochemical stains for neurofilament protein and synaptophysin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " histological changes of axonal reaction (central chromatolysis) are a classic sign of a neuron attempting to repair itself after its axon has been damaged."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNeurons\u003c/b\u003e are highly specialized for communication, with a complex"
      }, {
        "text": " structure that supports the generation and propagation of electrical signals over long distances. Their response to injury, particularly the process of central"
      }, {
        "text": " chromatolysis, reflects a robust but often incomplete attempt at regeneration.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_component_of\",\n        \"to\": \"nervous_system\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"communicates_via\",\n        \"to\": \"832463e6\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"undergoes\",\n        \"to\": \"axonal_reaction\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"forms\",\n        \"to\": \"spinal_tracts\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"42de0dd8\": {\n    \"title\": \"Neurotransmitters\",\n    \""
      }, {
        "text": "primaryType\": \"molecule\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Physiology\",\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Neurotransmitters\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003e\u003cb\u003eNeurotransmitters\u003c/b\u003e are chemical messengers that transmit signals across a synapse from one neuron to another target"
      }, {
        "text": " neuron, muscle cell, or gland cell. Their synthesis, release, and degradation are tightly regulated and are the targets of many psycho"
      }, {
        "text": "active drugs.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAcetylcholine (ACh):\u003c/b\u003e Decreased in"
      }, {
        "text": " [[77ae6148|Alzheimer disease]] and [[ffd7e743|Huntington disease]]. Synt"
      }, {
        "text": "hesized in the [[361438f2|basal nucleus of Meynert]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eDop"
      }, {
        "text": "amine:\u003c/b\u003e Decreased in [[58c8ea03|Parkinson disease]]. Increased in schizophrenia. Synthesized in the ventral"
      }, {
        "text": " tegmentum and substantia nigra.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGABA (Œ≥-aminobutyric acid):\u003c/b\u003e Main inhibitory"
      }, {
        "text": " neurotransmitter. Decreased in anxiety and [[ffd7e743|Huntington disease]]. Synthesized in the nucleus"
      }, {
        "text": " accumbens.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNorepinephrine:\u003c/b\u003e Increased in anxiety; decreased in depression. Synthesized in the"
      }, {
        "text": " locus coeruleus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSerotonin (5-HT):\u003c/b\u003e Decreased in anxiety and depression. Synthesized in the"
      }, {
        "text": " raphe nuclei.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGlutamate:\u003c/b\u003e Main excitatory neurotransmitter. Implicated in excitotoxicity.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe balance of key \u003cb\u003eneurotransmitters\u003c/b\u003e in specific brain regions is critical for normal"
      }, {
        "text": " neurological function; imbalances are the core pathophysiology of many major neurological and psychiatric disorders, such as the dopamine deficit in Parkinson\u0027"
      }, {
        "text": "s and the acetylcholine deficit in Alzheimer\u0027s.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"includes\",\n        \"to\": \"6a005559\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"includes\",\n        \"to\": \"90adc821\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"includes\",\n        \"to\": \"5aa5cb91\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"includes\",\n        \"to\": \"aedeee6d\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"includes\",\n        \"to\": \"serotonin\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"454a0eb8\": {\n    \"title\": \"Nevus Flammeus (Port-"
      }, {
        "text": "Wine Stain)\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Dermatology\",\n      "
      }, {
        "text": "\"Neurology\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Mus"
      }, {
        "text": "culoskeletal, Skin, and Connective Tissue\",\n      \"Dermatology\",\n      \"Vascular Lesions\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eNevus Flammeus\u003c/b\u003e, commonly known as a "
      }, {
        "text": "\u003cb\u003eport-wine stain\u003c/b\u003e, is a congenital capillary vascular malformation characterized by a flat, pink-to-reddish"
      }, {
        "text": "-purple patch of skin. When it occurs in the trigeminal nerve distribution, it is a hallmark of \u003ci\u003e"
      }, {
        "text": "Sturge-Weber syndrome\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e A congenital mal"
      }, {
        "text": "formation of dermal capillaries, resulting in ectasia (dilation) of these vessels. It does not involute and grows in"
      }, {
        "text": " proportion with the child.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A flat, erythematous patch present at birth.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSturge-Weber Syndrome:"
      }, {
        "text": "\u003c/b\u003e A nevus flammeus in the ophthalmic (V1) and/or maxillary (V2) distribution"
      }, {
        "text": " of the trigeminal nerve is the key cutaneous finding of [[fd52a8b8|Sturge-Weber syndrome]]."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Findings in Sturge-Weber:\u003c/b\u003e The syndrome also includes an ipsilateral leptomeningeal angi"
      }, {
        "text": "oma (leading to seizures and intellectual disability) and may involve episcleral hemangioma (leading to early-onset glaucoma).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e A newborn with a port-wine stain following the V1/V2 dermatome must be evaluated for [["
      }, {
        "text": "fd52a8b8|Sturge-Weber syndrome]], including an ophthalmologic exam for glaucoma and neuroimaging to"
      }, {
        "text": " look for leptomeningeal angiomas.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003enev"
      }, {
        "text": "us flammeus\u003c/b\u003e is more than a birthmark when it appears on the face in a trigeminal distribution; it serves"
      }, {
        "text": " as a critical external clue to the potential presence of underlying vascular malformations in the brain and eye, as seen in [[fd"
      }, {
        "text": "52a8b8|Sturge-Weber syndrome]].\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    "
      }, {
        "text": "},\n    \"connections\": [\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \"to"
      }, {
        "text": "\": \"fd52a8b8\"\n      },\n      {\n        \"type\": \"is_a_type"
      }, {
        "text": "_of\",\n        \"to\": \"vascular_malformation\"\n      }\n    ]\n  },\n  \"c"
      }, {
        "text": "30e26a4\": {\n    \"title\": \"Nigrostriatal Pathway\",\n    \"primaryType\": \""
      }, {
        "text": "anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Movement Disorders\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Basal Ganglia\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eNigrostriatal Pathway\u003c/b\u003e is a critical dopaminergic tract that projects from the "
      }, {
        "text": "\u003ci\u003esubstantia nigra pars compacta (SNc)\u003c/i\u003e to the \u003ci\u003estriatum\u003c/i\u003e (caudate and putamen)."
      }, {
        "text": " It is a key component of the [[ed462927|basal ganglia]] motor loop, responsible"
      }, {
        "text": " for modulating the initiation of voluntary movement.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Sub"
      }, {
        "text": "stantia nigra pars compacta (SNc) in the midbrain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTermination:\u003c/b\u003e Dorsal stri"
      }, {
        "text": "atum (caudate nucleus and putamen).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter:\u003c/b\u003e [[90adc821|Dop"
      }, {
        "text": "amine]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Modulates motor activity by exciting the direct pathway (via D1 receptors) and inhibiting the indirect pathway"
      }, {
        "text": " (via D2 receptors), with a net effect of facilitating movement.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Degeneration of this"
      }, {
        "text": " pathway is the primary cause of the motor symptoms in [[58c8ea03|Parkinson disease]]. The loss of"
      }, {
        "text": " dopamine leads to overactivity of the indirect pathway and underactivity of the direct pathway, resulting in bradykinesia,"
      }, {
        "text": " rigidity, and tremor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The destruction of the nigrostriatal pathway is the central"
      }, {
        "text": " event in [[58c8ea03|Parkinson disease]]. Antipsychotic drugs can block D2 receptors in this pathway, causing drug"
      }, {
        "text": "-induced parkinsonism (extrapyramidal side effects).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003eNigrostriatal Pathway\u003c/b\u003e acts as the \u0027gas pedal\u0027 for the basal ganglia\u0027s motor circuit;"
      }, {
        "text": " its dopaminergic input facilitates movement, and its degeneration in Parkinson\u0027s disease effectively \u0027puts the brakes on,\u0027 leading to the"
      }, {
        "text": " characteristic poverty of motion.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Substantia Nigra pars"
      }, {
        "text": " compacta] --Dopamine--\u003e B(Striatum); B --\u003e C(Modulation of Direct/Indirect Pathways"
      }, {
        "text": "); C --\u003e D(Initiation of Movement);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_part_of\",\n        \"to\": \"dopaminergic_pathways\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_degenerated_in\",\n        \"to\": \"58c8ea"
      }, {
        "text": "03\"\n      },\n      {\n        \"type\": \"uses_neurotransmitter\",\n        \"to\": \""
      }, {
        "text": "90adc821\"\n      },\n      {\n        \"type\": \"is_affected_by\",\n        \"to\":"
      }, {
        "text": " \"antipsychotics\"\n      }\n    ]\n  },\n  \"689f638"
      }, {
        "text": "a\": {\n    \"title\": \"Nimodipine\",\n    \"primaryType\": \"drug\",\n    \"tags\":"
      }, {
        "text": " [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Cerebrovascular Drugs\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eNimodipine\u003c/b\u003e is a dihydropyridine \u003ci\u003ecalcium channel blocker\u003c/i\u003e with a high"
      }, {
        "text": " affinity for cerebral blood vessels, used specifically to prevent cerebral vasospasm following a [[63f8b05f"
      }, {
        "text": "|subarachnoid hemorrhage (SAH)]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": " of Action:\u003c/b\u003e Blocks L-type calcium channels on smooth muscle cells, leading to vasodilation. It is more selective"
      }, {
        "text": " for cerebral arteries than other calcium channel blockers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e \u003cu\u003eExclusively\u003c/u\u003e used to improve"
      }, {
        "text": " neurological outcomes by preventing or reducing the severity of \u003cmark\u003ecerebral vasospasm\u003c/mark\u003e, a delayed complication that"
      }, {
        "text": " occurs 3-10 days after a [[63f8b05f|subarachnoid hemorrhage]]."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdministration:\u003c/b\u003e Typically given orally or via nasogastric tube for 21 days following an aneurysmal SAH.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Adverse Effects:\u003c/b\u003e The most common side effect is hypotension. Others include headache, nausea, and bradycardia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e If a question describes a patient who had a subarachnoid hemorrhage and then develops new focal neurological deficits"
      }, {
        "text": " several days later, the cause is vasospasm. The prophylactic treatment for this complication is nimodipine.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eNimodipine\u003c/b\u003e is a specialized calcium channel blocker whose primary role is not to treat hypertension but to prevent the"
      }, {
        "text": " devastating secondary ischemic strokes caused by vasospasm after a subarachnoid hemorrhage, thereby improving survival and functional outcomes.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"calcium_channel_blocker\"\n      },\n      {\n        \"type\": \"prev"
      }, {
        "text": "ents\",\n        \"to\": \"cerebral_vasospasm\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_used_after\",\n        \"to\": \"63f8b05f\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"83a65f11\": {\n    \"title\":"
      }, {
        "text": " \"Noise-Induced Hearing Loss\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ot"
      }, {
        "text": "ology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNoise-induced hearing loss\u003c/b\u003e is a type of \u003ci\u003esensor"
      }, {
        "text": "ineural hearing loss\u003c/i\u003e caused by damage to the delicate hair cells in the [[2e814378|organ of Corti]]"
      }, {
        "text": " within the cochlea, resulting from exposure to loud sounds.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e Loud noise causes mechanical damage and metabolic exhaustion of the stereociliated hair cells in the [[2e814378"
      }, {
        "text": "|organ of Corti]]. Damage is typically irreversible.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFrequency Pattern:\u003c/b\u003e The hearing loss characteristically begins at"
      }, {
        "text": " high frequencies, with a classic audiogram showing a \u003cmark\u003e\\\"notch\\\" or dip at 4000 Hz\u003c/mark\u003e. This"
      }, {
        "text": " is because the basal part of the cochlea, which is responsible for high-frequency hearing, is most susceptible to damage."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e Can be caused by a single, intense acoustic trauma (e.g., explosion) or,"
      }, {
        "text": " more commonly, by chronic exposure to loud noise (e.g., occupational, recreational music).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients"
      }, {
        "text": " report difficulty hearing, especially in noisy environments, and may experience tinnitus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An audiogram showing a bilateral"
      }, {
        "text": ", symmetric hearing loss with a characteristic notch at 4000 Hz is the classic finding for noise-induced hearing loss."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNoise-induced hearing loss\u003c/b\u003e is a direct result of mechanical trauma to the hair cells of"
      }, {
        "text": " the inner ear, characteristically affecting high-frequency hearing first (especially at 4000 Hz) because the region"
      }, {
        "text": " of the cochlea responsible for these frequencies is most vulnerable to the damaging energy of loud sounds.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"sensorineural_hearing_loss\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"damages\",\n        \"to\": \"2e814378\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_caused_by\",\n        \"to\": \"loud_noise_exposure\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"cddbff38\": {\n    \"title\": \"Non-REM"
      }, {
        "text": " Sleep\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \""
      }, {
        "text": "Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Sleep\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eNon-REM (NREM) sleep\u003c/b\u003e is one of the two main stages of sleep, comprising"
      }, {
        "text": " three distinct stages (N1, N2, N3) characterized by progressively slower brain waves and deeper relaxation. It is the period"
      }, {
        "text": " when the body repairs and regrows tissues, builds bone and muscle, and strengthens the immune system.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStage N1 (Light Sleep):\u003c/b\u003e Transition between wakefulness and sleep. EEG shows low-"
      }, {
        "text": "voltage, mixed-frequency waves.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStage N2 (Intermediate Sleep):\u003c/b\u003e The largest percentage of total sleep time. EEG"
      }, {
        "text": " is characterized by \u003cmark\u003esleep spindles\u003c/mark\u003e (bursts of rhythmic activity) and \u003cmark\u003eK-"
      }, {
        "text": "complexes\u003c/mark\u003e (large, high-voltage slow waves). Bruxism (teeth grinding) occurs in this stage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStage"
      }, {
        "text": " N3 (Deep Sleep/Slow-Wave Sleep):\u003c/b\u003e The deepest stage of sleep. EEG shows low-frequency, high-amplitude \u003cmark\u003edelta"
      }, {
        "text": " waves\u003c/mark\u003e. This is the stage where sleepwalking (somnambulism), night terrors, and bedwetting ("
      }, {
        "text": "enuresis) occur.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysiology:\u003c/b\u003e Characterized by decreased heart rate, blood pressure, and respiratory"
      }, {
        "text": " rate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Associate specific EEG findings and parasomnias with their respective NREM stages:"
      }, {
        "text": " N2 with sleep spindles and K-complexes, and N3 with delta waves, sleepwalking, and night terrors."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNon-REM sleep\u003c/b\u003e is a period of deep physiological"
      }, {
        "text": " rest and restoration, progressing through stages of increasing depth, with Stage N3 (slow-wave sleep) being the most"
      }, {
        "text": " restorative and the time when disorders of arousal like sleepwalking and night terrors manifest.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Awake] --\u003e B(NREM Stage 1); B --\u003e C(NREM Stage 2);"
      }, {
        "text": " C --\u003e D(NREM Stage 3); D --\u003e C; C --\u003e E(REM Sleep);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_stage_of\",\n        \"to\": \"sleep\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_contrasted_with\",\n        \"to\": \"rem_sleep\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\": \"sleep_spindles\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\": \"k"
      }, {
        "text": "_complexes\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\": \"delta_waves"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"91c40279\": {\n    \""
      }, {
        "text": "title\": \"Nonbenzodiazepine Hypnotics\",\n    \"primaryType\": \"drug\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neurology\",\n      \"USMLE\"\n"
      }, {
        "text": "    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Sed"
      }, {
        "text": "ative-Hypnotics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Nonbenzodiazepine hypnotics\u003c/b\u003e, often called \\\"Z-drugs,\\\" are a class of psychoactive drugs used for"
      }, {
        "text": " the treatment of insomnia. While structurally unrelated to benzodiazepines, they act on a specific subtype of the GABA\u003csub\u003eA\u003c/sub\u003e receptor to"
      }, {
        "text": " produce sedative effects.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eExamples:\u003c/b\u003e \u003cb\u003eZ\u003c/b\u003e"
      }, {
        "text": "olpidem, \u003cb\u003eZ\u003c/b\u003ealeplon, es\u003cb\u003eZ\u003c/b\u003eopiclone.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e"
      }, {
        "text": " Act as selective agonists at the \u003cmark\u003eBZ1 (œâ1) subtype\u003c/mark\u003e of the GABA\u003csub\u003eA\u003c/sub\u003e receptor."
      }, {
        "text": " This enhances the effect of GABA, leading to increased Cl\u003csup\u003e-\u003c/sup\u003e conductance and neuronal hyperpolarization, but with more"
      }, {
        "text": " specificity for sedation than benzodiazepines.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Short-term treatment of insomnia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAd"
      }, {
        "text": "verse Effects:\u003c/b\u003e Ataxia, headaches, confusion. Can cause anterograde amnesia and complex sleep-related behaviors ("
      }, {
        "text": "e.g., sleepwalking, sleep-driving).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Have a rapid onset and short duration of action. Effects"
      }, {
        "text": " are reversed by \u003cmark\u003eflumazenil\u003c/mark\u003e, the same antidote used for benzodiazepine overdose.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Z-drugs are preferred over benzodiazepines for insomnia due to a lower risk of dependence and less disruption of sleep architecture"
      }, {
        "text": ". However, they are still controlled substances and carry risks. Remember that their effects are reversed by flumazenil.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eNonbenzodiazepine hypnotics\u003c/b\u003e are \u0027smarter\u0027 sleeping pills than benzodiazepines because"
      }, {
        "text": " they selectively target the sedative (BZ1) subtype of the GABA\u003csub\u003eA\u003c/sub\u003e receptor, inducing sleep with less anxiolytic,"
      }, {
        "text": " muscle relaxant, and anticonvulsant effects, and a lower risk of altering sleep stages.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment"
      }, {
        "text": "_for\",\n        \"to\": \"insomnia\"\n      },\n      {\n        \"type\": \"acts_"
      }, {
        "text": "on\",\n        \"to\": \"gaba_a_receptor\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"effects_are_reversed_by\",\n        \"to\": \"flumazenil\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"includes\",\n        \"to\": \"zolpidem\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"a1ef0cd9\": {\n    \"title\": \"Non-Communic"
      }, {
        "text": "ating Hydrocephalus\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ne"
      }, {
        "text": "urosurgery\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \""
      }, {
        "text": "Neurology and Special Senses\",\n      \"Pathology\",\n      \"Hydrocephalus\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNon-communicating hydrocephalus\u003c/b\u003e, also known as "
      }, {
        "text": "\u003ci\u003eobstructive hydrocephalus\u003c/i\u003e, is the accumulation of excess cerebrospinal fluid (CSF) due to a physical blockage within the ventricular"
      }, {
        "text": " system, leading to ventricular dilation proximal to the obstruction and increased intracranial pressure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Pathophysiology:\u003c/b\u003e A structural lesion blocks the flow of CSF from one part of the ventricular system to another or into the sub"
      }, {
        "text": "arachnoid space. This leads to a buildup of CSF and pressure in the ventricles \u0027upstream\u0027 of the blockage"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Sites of Obstruction:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCerebral Aqueduct (of Syl"
      }, {
        "text": "vius):\u003c/b\u003e The narrowest part of the ventricular system, connecting the 3rd and 4th ventricles. Aquedu"
      }, {
        "text": "ctal stenosis is a common cause in children.\u003cbr\u003e - \u003cb\u003eForamen of Monro:\u003c/b\u003e Can be blocked by a colloid"
      }, {
        "text": " cyst.\u003cbr\u003e - \u003cb\u003eFourth Ventricle Outlets:\u003c/b\u003e Can be compressed by posterior fossa tumors like a"
      }, {
        "text": " [[16d613bb|medulloblastoma]] or [[14365ef4|epend"
      }, {
        "text": "ymoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Symptoms of increased intracranial pressure, such as headache, nausea, vomiting, and [["
      }, {
        "text": "4ae219da|papilledema]]. In infants, presents with an enlarging head circumference and bulging fontanelle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e A [[16d613bb|medulloblastoma]] in a child is a classic cause of obstructive hydrocephalus due"
      }, {
        "text": " to compression of the fourth ventricle.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNon-communicating hydrocephalus\u003c/b\u003e is"
      }, {
        "text": " a \u0027plumbing problem\u0027 within the brain\u0027s ventricular system, where a physical blockage leads to a dam-like effect, causing"
      }, {
        "text": " upstream ventricular dilation and a dangerous rise in intracranial pressure.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[CSF"
      }, {
        "text": " Production in Lateral/Third Ventricles] --\u003e B(Flow through Cerebral Aqueduct); B --Blockage (e.g., Tumor"
      }, {
        "text": ")--\u003e C(Obstruction); B --\u003e D(Fourth Ventricle); C --\u003e E(Dilation of Lateral \u0026"
      }, {
        "text": " Third Ventricles); E --\u003e F(Increased ICP);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"0bc2f20"
      }, {
        "text": "0\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"16d"
      }, {
        "text": "613bb\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to"
      }, {
        "text": "\": \"14365ef4\"\n      },\n      {\n        \"type\": \"differentiated"
      }, {
        "text": "_from\",\n        \"to\": \"aa4115c7\"\n      }\n    ]\n  },\n  \"4"
      }, {
        "text": "8f817e6\": {\n    \"title\": \"Non-Depolarizing Neuromuscular Blocking"
      }, {
        "text": " Drugs\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"An"
      }, {
        "text": "esthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pharmacology\",\n      \"Neuromuscular Blockers\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNon-depolarizing neuromuscular blocking drugs\u003c/b\u003e are a class of agents"
      }, {
        "text": " that cause skeletal muscle paralysis by acting as \u003ci\u003ecompetitive antagonists\u003c/i\u003e at the nicotinic acetylcholine (ACh) receptors at"
      }, {
        "text": " the neuromuscular junction.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eExamples:\u003c/b\u003e Rocuronium,"
      }, {
        "text": " vecuronium, atracurium, cisatracurium, [[243d4db1|pancuronium]]."
      }, {
        "text": " Mnemonic: End in \u0027-curonium\u0027 or \u0027-curium\u0027.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Competitively bind to N"
      }, {
        "text": "\u003csub\u003eM\u003c/sub\u003e receptors on the motor endplate, preventing [[6a005559|ACh]] from binding and"
      }, {
        "text": " thus inhibiting muscle cell depolarization and contraction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used as adjuncts in general anesthesia to induce skeletal"
      }, {
        "text": " muscle relaxation, facilitating endotracheal intubation and surgical procedures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReversal:\u003c/b\u003e The blockade can be overcome"
      }, {
        "text": " by increasing the concentration of ACh in the synapse. This is achieved by administering an \u003cmark\u003eacetylcholinesterase inhibitor"
      }, {
        "text": "\u003c/mark\u003e (e.g., neostigmine). An antimuscarinic (e.g., gly"
      }, {
        "text": "copyrrolate) is co-administered to prevent systemic muscarinic side effects. Sugammadex can also be used to reverse ro"
      }, {
        "text": "curonium and vecuronium.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from succinylcholine (a depolarizing blocker"
      }, {
        "text": "). Non-depolarizing blockade shows a \u0027fade\u0027 on train-of-four stimulation, and its effects are reversed by AChE"
      }, {
        "text": " inhibitors.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNon-depolarizing neuromuscular blockers\u003c/b\u003e act"
      }, {
        "text": " like a key that fits in the lock (the ACh receptor) but doesn\u0027t turn, competitively preventing the real key (ACh) from opening"
      }, {
        "text": " the channel and causing muscle contraction. Their effects can be overcome by flooding the synapse with more ACh.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"neuromuscular_blocker\"\n      },\n      {\n        \"type\": \"antagonizes"
      }, {
        "text": "\",\n        \"to\": \"nicotinic_acetylcholine_receptor\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_reversed_by\",\n        \"to\": \"acetylcholinesterase_inhibitor\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"243d4"
      }, {
        "text": "db1\"\n      }\n    ]\n  },\n  \"45dce26f\": {\n    \"title\": \""
      }, {
        "text": "Nonproliferative Diabetic Retinopathy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      "
      }, {
        "text": "\"Ophthalmology\",\n      \"Endocrinology\",\n      \"Pathology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Path"
      }, {
        "text": "ology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNonproliferative"
      }, {
        "text": " diabetic retinopathy (NPDR)\u003c/b\u003e is the most common form of [[73b00ab0|diabetic retinopathy]], characterized by damage"
      }, {
        "text": " to the retinal blood vessels leading to leakage and ischemia, but without the growth of new, abnormal blood vessels (neovascularization).\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Chronic hyperglycemia damages retinal capillaries,"
      }, {
        "text": " leading to loss of pericytes, basement membrane thickening, and breakdown of the blood-retinal barrier.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFund"
      }, {
        "text": "uscopic Findings:\u003c/b\u003e\u003cbr\u003e - \u003cmark\u003eMicroaneurysms:\u003c/mark\u003e Earliest sign."
      }, {
        "text": " Small, saccular outpouchings of capillaries.\u003cbr\u003e - \u003cmark\u003eDot and Blot Hemorrhages:\u003c/mark\u003e Ble"
      }, {
        "text": "eding into the deeper layers of the retina.\u003cbr\u003e - \u003cmark\u003eHard Exudates:\u003c/mark\u003e Yellow lipid"
      }, {
        "text": " deposits resulting from chronic plasma leakage.\u003cbr\u003e - \u003cmark\u003eCotton-Wool Spots:\u003c/mark\u003e Fluffy white patches"
      }, {
        "text": " representing nerve fiber layer infarcts from capillary occlusion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMajor Cause of Vision Loss:\u003c/b\u003e The primary cause of vision loss in NPDR is"
      }, {
        "text": " \u003cmark\u003emacular edema\u003c/mark\u003e, where fluid and lipids leak into the macula, causing central vision to become"
      }, {
        "text": " blurred.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProgression:\u003c/b\u003e NPDR can progress to the more severe proliferative form if retinal ischemia becomes widespread.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e Be able to identify the funduscopic findings of NPDR. The presence of microaneurysms,"
      }, {
        "text": " hemorrhages, and exudates without neovascularization defines this stage.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNon"
      }, {
        "text": "proliferative diabetic retinopathy\u003c/b\u003e is a disease of leaky and occluded retinal vessels. The pathology is confined to the existing"
      }, {
        "text": " vasculature, and the main threat to vision is not from new vessel growth but from the chronic leakage of fluid into the macula, causing macular edema.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"73b00ab0\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"can_progress_to\",\n        \"to\": \"234553"
      }, {
        "text": "20\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\":"
      }, {
        "text": " \"microaneurysms\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\":"
      }, {
        "text": " \"cotton_wool_spots\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"macular"
      }, {
        "text": "_edema\"\n      }\n    ]\n  },\n  \"e365e126\": {\n    \""
      }, {
        "text": "title\": \"Nonrhegmatogenous Retinal Detachment\",\n    \"primaryType\": \"disease\",\n    \""
      }, {
        "text": "tags\": [\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Path"
      }, {
        "text": "ology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNonrhegmatogenous retinal detachment\u003c/b\u003e is a separation"
      }, {
        "text": " of the neurosensory retina from the underlying retinal pigment epithelium that is \u003cu\u003enot\u003c/u\u003e caused by a full-thickness retinal tear or hole"
      }, {
        "text": ". It is subdivided into tractional and exudative types.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eT"
      }, {
        "text": "ractional Retinal Detachment:\u003c/b\u003e Occurs when fibrovascular membranes on the retinal surface contract and pull the retina away from the pigment"
      }, {
        "text": " epithelium. A classic cause is \u003cmark\u003eproliferative diabetic retinopathy\u003c/mark\u003e, where neovascular membranes contract.\u003c/li\u003e\u003cli\u003e\u003cb\u003eExudative ("
      }, {
        "text": "Serous) Retinal Detachment:\u003c/b\u003e Results from the accumulation of fluid in the subretinal space due to damage to the retinal"
      }, {
        "text": " pigment epithelium or choroid, allowing fluid to leak underneath the retina. Causes include inflammatory conditions (e.g., posterior"
      }, {
        "text": " uveitis), tumors (e.g., choroidal melanoma), and severe hypertension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients experience"
      }, {
        "text": " vision loss, which can be gradual or sudden, often described as a curtain or shadow in the visual field. Unlike rhe"
      }, {
        "text": "gmatogenous detachment, it is not typically preceded by flashes or floaters.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e D"
      }, {
        "text": "ifferentiate the mechanisms. Rhegmatogenous \u003d a tear lets fluid in. Tractional \u003d membranes pull the retina off. Exudative \u003d fluid leaks from"
      }, {
        "text": " damaged vessels underneath.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eUnlike the more common rhegmatogenous detachment caused"
      }, {
        "text": " by a retinal tear, \u003cb\u003enonrhegmatogenous retinal detachments\u003c/b\u003e are caused either by mechanical pulling forces (tractional) or by underlying"
      }, {
        "text": " fluid leakage (exudative), pointing to different underlying pathologies like diabetes or inflammation.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"38c092f9\"\n      },\n      {\n        \"type\": \"differentiated"
      }, {
        "text": "_from\",\n        \"to\": \"rhegmatogenous_retinal_detachment\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"234"
      }, {
        "text": "55320\"\n      }\n    ]\n  },\n  \"682952"
      }, {
        "text": "a2\": {\n    \"title\": \"NSAIDs for Headaches\",\n    \"primaryType\": \"concept"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Pain Management\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anal"
      }, {
        "text": "gesics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNonsteroidal anti-inflammatory drugs (NSAIDs)"
      }, {
        "text": "\u003c/b\u003e are a cornerstone of abortive therapy for mild to moderate primary [[26661e34|headaches]], particularly tension"
      }, {
        "text": "-type and migraine headaches, by inhibiting prostaglandin synthesis.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": " of Action:\u003c/b\u003e NSAIDs (e.g., ibuprofen, naproxen, diclofenac) reversibly inhibit cyclo"
      }, {
        "text": "oxygenase (COX-1 and COX-2) enzymes, which blocks the conversion of arachidonic acid to prostaglandins."
      }, {
        "text": " Prostaglandins are key mediators of inflammation and pain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTension-Type Headache:\u003c/b\u003e NSAIDs are often"
      }, {
        "text": " the \u003cu\u003efirst-line\u003c/u\u003e treatment for acute tension headaches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMigraine Headache:\u003c/b\u003e Effective for mild to moderate migraine attacks"
      }, {
        "text": ". They can be used alone or in combination with triptans for more severe attacks.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Common"
      }, {
        "text": " side effects include GI upset and peptic ulcer disease. Chronic use can lead to renal injury (analgesic nephropathy) and increased"
      }, {
        "text": " risk of cardiovascular events.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e While effective for acute attacks, overuse of NSAIDs and"
      }, {
        "text": " other analgesics for headaches (e.g., \u003e10-15 days per month) can paradoxically lead to medication"
      }, {
        "text": "-overuse headaches.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eNSAIDs treat primary headaches by targeting"
      }, {
        "text": " the inflammatory component of pain, reducing the synthesis of prostaglandins that sensitize nociceptors, making them a fundamental first-line option"
      }, {
        "text": " for acute attacks.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_treatment_for\",\n        \"to\": \"26661e"
      }, {
        "text": "34\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"nsaid\"\n      },\n      {\n        \"type\": \"inhibits_enzyme\",\n        \"to\":"
      }, {
        "text": " \"cyclooxygenase\"\n      }\n    ]\n  },\n  \"aedeee6d\": {\n"
      }, {
        "text": "    \"title\": \"Norepinephrine (CNS)\",\n    \"primaryType\": \"molecule\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neuroscience\",\n      \"Psychiatry\",\n      \"Physiology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Neurotransmitters\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003e\u003cb\u003eNorepinephrine (NE)\u003c/b\u003e is a catecholamine that functions as a major neurotransmitter in the central nervous"
      }, {
        "text": " system, where it is crucial for regulating attention, arousal, sleep-wake cycles, learning, memory, and mood.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSynthesis:\u003c/b\u003e Synthesized from [[90adc821|d"
      }, {
        "text": "opamine]] via dopamine Œ≤-hydroxylase. The primary site of NE synthesis in the brain is the \u003cmark\u003elocus coeruleus\u003c/"
      }, {
        "text": "mark\u003e, a nucleus in the pons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e As part of the ascending reticular activating system, the"
      }, {
        "text": " locus coeruleus projects widely throughout the CNS, modulating alertness and arousal. NE is a key neurotransmitter in the \u0027fight or"
      }, {
        "text": " flight\u0027 response.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Mood Disorders:\u003c/b\u003e Decreased levels of norepinephrine are implicated in the pathophysiology of \u003c"
      }, {
        "text": "mark\u003edepression\u003c/mark\u003e. Increased levels are associated with \u003cmark\u003eanxiety\u003c/mark\u003e and panic disorders.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003ePharmacological Targets:\u003c/b\u003e Many antidepressants, such as SNRIs (e.g., venlafaxine) and TCAs (e.g.,"
      }, {
        "text": " amitriptyline), work by increasing synaptic levels of norepinephrine (and serotonin).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the locus"
      }, {
        "text": " coeruleus as the principal source of CNS norepinephrine. Its role in arousal and mood makes it a key target for drugs treating"
      }, {
        "text": " depression and ADHD.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eIn the CNS, \u003cb\u003enorepinephrine\u003c/b\u003e released"
      }, {
        "text": " from the locus coeruleus acts as a global \u0027alertness\u0027 signal, modulating attention and arousal across the brain,"
      }, {
        "text": " with dysregulation of this system being a cornerstone of the pathophysiology of mood and anxiety disorders.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A["
      }, {
        "text": "Locus Coeruleus] --Synthesizes \u0026 Releases--\u003e B(Norepinephrine); B --\u003e C(W"
      }, {
        "text": "idespread CNS Projections); C --\u003e D(Arousal \u0026 Attention); C --\u003e E(Mood Regulation);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_synthesized_in\",\n        \"to\": \"locus_coerule"
      }, {
        "text": "us\"\n      },\n      {\n        \"type\": \"is_decreased_in\",\n        \""
      }, {
        "text": "to\": \"depression\"\n      },\n      {\n        \"type\": \"is_increased_in\",\n"
      }, {
        "text": "        \"to\": \"anxiety_disorders\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_type_of\",\n        \"to\": \"catecholamine\"\n      }\n    ]\n  }\n}"
      }, {
        "text": "\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"113776de\",\n    \"letter\": \"N\",\n    \"term\": \"Nervous system\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Nervous system\",\n    \"sub_entries\": [\n      {\n        \"id\": \"1aa7534f\",\n        \"letter\": \"N\",\n        \"term\": \"cells of\",\n        \"pages\": [\n          \"503\"\n        ],\n        \"context\": \"Nervous system \u003e cells of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"14c6f2a7\",\n    \"letter\": \"N\",\n    \"term\": \"Neural crest cells\",\n    \"pages\": [\n      \"500\",\n      \"631\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Neural crest cells\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"887d6a16\",\n    \"letter\": \"N\",\n    \"term\": \"Neural development\",\n    \"pages\": [\n      \"500\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Neural development\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"a87cbede\",\n    \"letter\": \"N\",\n    \"term\": \"Neural tube\",\n    \"pages\": [\n      \"500\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Neural tube\",\n    \"sub_entries\": [\n      {\n        \"id\": \"34811087\",\n        \"letter\": \"N\",\n        \"term\": \"defects\",\n        \"pages\": [\n          \"501\"\n        ],\n        \"context\": \"Neural tube \u003e defects\"\n      },\n      {\n        \"id\": \"d285903e\",\n        \"letter\": \"N\",\n        \"term\": \"regionalization of\",\n        \"pages\": [\n          \"500\"\n        ],\n        \"context\": \"Neural tube \u003e regionalization of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"c8dc7442\",\n    \"letter\": \"N\",\n    \"term\": \"Neuralgia\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Neuralgia\",\n    \"sub_entries\": [\n      {\n        \"id\": \"04cbd835\",\n        \"letter\": \"N\",\n        \"term\": \"trigeminal\",\n        \"pages\": [\n          \"532\"\n        ],\n        \"context\": \"Neuralgia \u003e trigeminal\"\n      }\n    ]\n  },\n  {\n    \"id\": \"46fe50eb\",\n    \"letter\": \"N\",\n    \"term\": \"Neurocutaneous disorders\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Neurocutaneous disorders\",\n    \"sub_entries\": [\n      {\n        \"id\": \"8cca84ee\",\n        \"letter\": \"N\",\n        \"term\": \"genetics and presentation\",\n        \"pages\": [\n          \"539‚Äì568\"\n        ],\n        \"context\": \"Neurocutaneous disorders \u003e genetics and presentation\"\n      }\n    ]\n  },\n  {\n    \"id\": \"2e0d4fef\",\n    \"letter\": \"N\",\n    \"term\": \"Neurodegenerative disease therapy\",\n    \"pages\": [\n      \"564\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Neurodegenerative disease therapy\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"41ca6981\",\n    \"letter\": \"N\",\n    \"term\": \"Neurodegenerative disorders\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Neurodegenerative disorders\",\n    \"sub_entries\": [\n      {\n        \"id\": \"4bfddb74\",\n        \"letter\": \"N\",\n        \"term\": \"dementia\",\n        \"pages\": [\n          \"534\"\n        ],\n        \"context\": \"Neurodegenerative disorders \u003e dementia\"\n      },\n      {\n        \"id\": \"9e1a4d3d\",\n        \"letter\": \"N\",\n        \"term\": \"drug therapy for\",\n        \"pages\": [\n          \"564\"\n        ],\n        \"context\": \"Neurodegenerative disorders \u003e drug therapy for\"\n      },\n      {\n        \"id\": \"a11baca6\",\n        \"letter\": \"N\",\n        \"term\": \"movement disorders\",\n        \"pages\": [\n          \"534\"\n        ],\n        \"context\": \"Neurodegenerative disorders \u003e movement disorders\"\n      }\n    ]\n  },\n  {\n    \"id\": \"015a73ab\",\n    \"letter\": \"N\",\n    \"term\": \"Neurofibromatosis\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Neurofibromatosis\",\n    \"sub_entries\": [\n      {\n        \"id\": \"8d50896e\",\n        \"letter\": \"N\",\n        \"term\": \"types I and II\",\n        \"pages\": [\n          \"539\"\n        ],\n        \"context\": \"Neurofibromatosis \u003e types I and II\"\n      }\n    ]\n  },\n  {\n    \"id\": \"a9db88ed\",\n    \"letter\": \"N\",\n    \"term\": \"Neurogenic bladder\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Neurogenic bladder\",\n    \"sub_entries\": [\n      {\n        \"id\": \"fa4d499e\",\n        \"letter\": \"N\",\n        \"term\": \"with multiple sclerosis\",\n        \"pages\": [\n          \"537\"\n        ],\n        \"context\": \"Neurogenic bladder \u003e with multiple sclerosis\"\n      }\n    ]\n  },\n  {\n    \"id\": \"6d290af4\",\n    \"letter\": \"N\",\n    \"term\": \"Neurohypophysis\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Neurohypophysis\",\n    \"sub_entries\": [\n      {\n        \"id\": \"b2904d49\",\n        \"letter\": \"N\",\n        \"term\": \"hypothalamus and\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Neurohypophysis \u003e hypothalamus and\"\n      }\n    ]\n  },\n  {\n    \"id\": \"38e52c3e\",\n    \"letter\": \"N\",\n    \"term\": \"Neurokinin receptors (NK-1)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Neurokinin receptors (NK-1)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"8f8d9bd3\",\n        \"letter\": \"N\",\n        \"term\": \"vomiting center input\",\n        \"pages\": [\n          \"506\"\n        ],\n        \"context\": \"Neurokinin receptors (NK-1) \u003e vomiting center input\"\n      }\n    ]\n  },\n  {\n    \"id\": \"3888bfbd\",\n    \"letter\": \"N\",\n    \"term\": \"Neurology and special senses\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Neurology and special senses\",\n    \"sub_entries\": [\n      {\n        \"id\": \"f97fdf8e\",\n        \"letter\": \"N\",\n        \"term\": \"anatomy and physiology\",\n        \"pages\": [\n          \"503\"\n        ],\n        \"context\": \"Neurology and special senses \u003e anatomy and physiology\"\n      },\n      {\n        \"id\": \"edaf2cc3\",\n        \"letter\": \"N\",\n        \"term\": \"embryology\",\n        \"pages\": [\n          \"499\"\n        ],\n        \"context\": \"Neurology and special senses \u003e embryology\"\n      },\n      {\n        \"id\": \"1ac7c403\",\n        \"letter\": \"N\",\n        \"term\": \"ophthalmology\",\n        \"pages\": [\n          \"499\",\n          \"549\"\n        ],\n        \"context\": \"Neurology and special senses \u003e ophthalmology\"\n      },\n      {\n        \"id\": \"a2c1d366\",\n        \"letter\": \"N\",\n        \"term\": \"otology\",\n        \"pages\": [\n          \"499\",\n          \"547\"\n        ],\n        \"context\": \"Neurology and special senses \u003e otology\"\n      },\n      {\n        \"id\": \"16d194e1\",\n        \"letter\": \"N\",\n        \"term\": \"pathology\",\n        \"pages\": [\n          \"524\"\n        ],\n        \"context\": \"Neurology and special senses \u003e pathology\"\n      },\n      {\n        \"id\": \"92d3b0c8\",\n        \"letter\": \"N\",\n        \"term\": \"pharmacology\",\n        \"pages\": [\n          \"560\"\n        ],\n        \"context\": \"Neurology and special senses \u003e pharmacology\"\n      }\n    ]\n  },\n  {\n    \"id\": \"1aaaffd2\",\n    \"letter\": \"N\",\n    \"term\": \"Neuromuscular blocking drugs\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Neuromuscular blocking drugs\",\n    \"sub_entries\": [\n      {\n        \"id\": \"e164ec64\",\n        \"letter\": \"N\",\n        \"term\": \"types and use\",\n        \"pages\": [\n          \"566\"\n        ],\n        \"context\": \"Neuromuscular blocking drugs \u003e types and use\"\n      }\n    ]\n  },\n  {\n    \"id\": \"7e727989\",\n    \"letter\": \"N\",\n    \"term\": \"Neuromuscular junction\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Neuromuscular junction\",\n    \"sub_entries\": [\n      {\n        \"id\": \"a3a0cde5\",\n        \"letter\": \"N\",\n        \"term\": \"in reflex pathways\",\n        \"pages\": [\n          \"522\"\n        ],\n        \"context\": \"Neuromuscular junction \u003e in reflex pathways\"\n      }\n    ]\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 2577
    }, {
      "text": "```json\n{\n  \"113776de\": {\n    \"title\": \"Nervous System\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Overview\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eNervous System\u003c/b\u003e is the body\u0027s primary communication and control network, divided into the Central Nervous System (CNS), consisting of the brain and spinal cord, and the Peripheral Nervous System (PNS), which includes all other nervous tissue. It is composed of specialized cells, primarily [[63fc3fe7|neurons]] and glial cells.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCentral Nervous System (CNS):\u003c/b\u003e Comprises the brain and spinal cord. It is the main processing center for the nervous system.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePeripheral Nervous System (PNS):\u003c/b\u003e Includes cranial nerves (except I \u0026 II), spinal nerves, and ganglia. It connects the CNS to the limbs and organs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSomatic Nervous System:\u003c/b\u003e Part of the PNS responsible for voluntary control of body movements via skeletal muscles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAutonomic Nervous System:\u003c/b\u003e Part of the PNS that controls involuntary functions (e.g., heart rate, digestion), further divided into sympathetic and parasympathetic systems.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCells of the Nervous System:\u003c/b\u003e [[63fc3fe7|Neurons]] are the signal-transmitting cells. Glial cells ([[8192f595|astrocytes]], [[a24f9747|oligodendrocytes]], microglia, ependymal cells in CNS; [[c65a8909|Schwann cells]], satellite cells in PNS) provide support and protection.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe nervous system is a complex, integrated network responsible for coordinating actions and transmitting signals between different parts of the body. Its fundamental cellular components are neurons, which conduct electrical impulses, and glial cells, which provide essential support and maintenance.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"63fc3fe7\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"glial_cells\"\n      },\n      {\n        \"type\": \"is_divided_into\",\n        \"to\": \"central_nervous_system\"\n      },\n      {\n        \"type\": \"is_divided_into\",\n        \"to\": \"c44ae4c5\"\n      }\n    ]\n  },\n  \"14c6f2a7\": {\n    \"title\": \"Neural Crest Cells\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural Development\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeural crest cells\u003c/b\u003e are a transient, multipotent population of migratory cells that arise from the dorsal aspect of the neural tube during embryonic development and give rise to a diverse array of cell types throughout the body.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Arise from the neuroectoderm at the lateral edges of the neural plate (the neural crest).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMigration:\u003c/b\u003e These cells undergo an epithelial-to-mesenchymal transition and migrate extensively to various locations in the embryo.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDerivatives (Nervous System):\u003c/b\u003e Give rise to most of the [[c44ae4c5|peripheral nervous system]], including dorsal root ganglia, autonomic ganglia (sympathetic, parasympathetic), [[c65a8909|Schwann cells]], and satellite cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDerivatives (Other):\u003c/b\u003e Also form melanocytes, chromaffin cells of the adrenal medulla, parafollicular (C) cells of the thyroid, odontoblasts, and craniofacial cartilage and bone.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the diverse derivatives of neural crest cells. A helpful mnemonic is \u003cb\u003eMOTEL PASS\u003c/b\u003e: \u003cb\u003eM\u003c/b\u003eelanocytes, \u003cb\u003eO\u003c/b\u003edontoblasts, \u003cb\u003eT\u003c/b\u003eracheal and laryngeal cartilage, \u003cb\u003eE\u003c/b\u003enterochromaffin cells, \u003cb\u003eL\u003c/b\u003eeptomeninges (arachnoid and pia), \u003cb\u003eP\u003c/b\u003earafollicular cells, \u003cb\u003eA\u003c/b\u003edrenal medulla, \u003cb\u003eS\u003c/b\u003echwann cells, \u003cb\u003eS\u003c/b\u003epiral membrane.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNeural crest cells\u003c/b\u003e are often considered the \u0027fourth germ layer\u0027 due to their remarkable multipotency and migratory capacity, giving rise to a vast and seemingly unrelated collection of tissues, from the peripheral nervous system to the melanocytes in the skin.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"differentiates_into\",\n        \"to\": \"c44ae4c5\"\n      },\n      {\n        \"type\": \"differentiates_into\",\n        \"to\": \"melanocytes\"\n      },\n      {\n        \"type\": \"differentiates_into\",\n        \"to\": \"adrenal_medulla\"\n      },\n      {\n        \"type\": \"arises_from\",\n        \"to\": \"neuroectoderm\"\n      }\n    ]\n  },\n  \"887d6a16\": {\n    \"title\": \"Neural Development\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural Development\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeural development\u003c/b\u003e is the complex process by which the nervous system forms during embryogenesis, beginning with the induction of the neural plate from the ectoderm and proceeding through neurulation, proliferation, migration, and differentiation of neurons and glial cells.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eInduction:\u003c/b\u003e The notochord induces the overlying ectoderm to differentiate into the neuroectoderm, forming the neural plate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurulation:\u003c/b\u003e The neural plate folds to form the [[a87cbede|neural tube]], which will become the CNS, and the [[14c6f2a7|neural crest cells]], which will become the PNS and other structures. This process is critically dependent on folate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVesicle Formation:\u003c/b\u003e The rostral end of the neural tube develops into three primary brain vesicles (prosencephalon, mesencephalon, rhombencephalon), which then subdivide into five secondary vesicles.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePlate Differentiation:\u003c/b\u003e The neural tube differentiates along its dorsal-ventral axis into the alar plate (sensory functions, induced by BMPs) and the basal plate (motor functions, induced by Sonic hedgehog [SHH]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Failure of the neural tube to close results in [[neural_tube_defects|neural tube defects]]. Failure of the rostral neuropore to close causes anencephaly; failure of the caudal neuropore causes spina bifida.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNeural development\u003c/b\u003e is a highly orchestrated sequence of events, initiated by signals from the notochord, that transforms a simple sheet of ectodermal cells into the intricate structure of the brain and spinal cord. Errors in the earliest stages, like neurulation, can have devastating consequences.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Ectoderm] --Notochord Induction--\u003e B(Neural Plate); B --\u003e C(Neural Tube); C --\u003e D(CNS); B --\u003e E(Neural Crest); E --\u003e F(PNS);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"involves_formation_of\",\n        \"to\": \"a87cbede\"\n      },\n      {\n        \"type\": \"involves_formation_of\",\n        \"to\": \"14c6f2a7\"\n      },\n      {\n        \"type\": \"defects_in_process_lead_to\",\n        \"to\": \"neural_tube_defects\"\n      }\n    ]\n  },\n  \"a87cbede\": {\n    \"title\": \"Neural Tube\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural Development\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eNeural Tube\u003c/b\u003e is the embryonic precursor to the central nervous system (CNS), formed during neurulation by the folding of the neural plate. Its proper closure and differentiation are essential for normal brain and spinal cord development.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFormation:\u003c/b\u003e Develops from the neuroectoderm, which thickens to form the neural plate, then folds inward to create the neural tube. This process is complete by the 4th week of gestation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDerivatives:\u003c/b\u003e Gives rise to the entire CNS, including the brain, spinal cord, [[63fc3fe7|neurons]], and most glial cells ([[8192f595|astrocytes]], [[a24f9747|oligodendrocytes]], ependymal cells).\u003c/li\u003e\u003cli\u003e\u003cb\u003eRegionalization:\u003c/b\u003e The rostral part develops into the brain vesicles (prosencephalon, mesencephalon, rhombencephalon), while the caudal part forms the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeural Tube Defects (NTDs):\u003c/b\u003e Failure of the neural tube to close properly leads to NTDs. Failure of the rostral (anterior) neuropore to close results in anencephaly. Failure of the caudal (posterior) neuropore to close results in spina bifida.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFolate:\u003c/b\u003e Maternal folate supplementation before and during early pregnancy is crucial for preventing NTDs.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eNeural Tube\u003c/b\u003e is the foundational structure of the central nervous system, and its timely closure during the first month of gestation is a critical developmental event, the failure of which leads to severe congenital malformations like spina bifida and anencephaly.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"develops_into\",\n        \"to\": \"central_nervous_system\"\n      },\n      {\n        \"type\": \"failure_to_close_causes\",\n        \"to\": \"neural_tube_defects\"\n      },\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"887d6a16\"\n      }\n    ]\n  },\n  \"c8dc7442\": {\n    \"title\": \"Trigeminal Neuralgia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pain Management\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cranial Neuropathies\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTrigeminal Neuralgia\u003c/b\u003e (also known as tic douloureux) is a chronic pain disorder characterized by recurrent, sudden, severe, shock-like episodes of unilateral facial pain in the distribution of the \u003ci\u003etrigeminal nerve (CN V)\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by \u003cmark\u003evascular compression\u003c/mark\u003e of the trigeminal nerve root as it enters the brainstem, often by the superior cerebellar artery. Demyelination (e.g., from [[45dd6d19|multiple sclerosis]]) is another important cause, especially in younger patients.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Paroxysms of excruciating, electric shock-like pain, lasting from a few seconds to minutes. The pain is unilateral and typically affects the V2 (maxillary) and/or V3 (mandibular) divisions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTriggers:\u003c/b\u003e Pain can be triggered by innocuous stimuli in specific \u0027trigger zones,\u0027 such as light touch, chewing, talking, or a cold breeze.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e \u003cu\u003eFirst-line\u003c/u\u003e medical treatment is \u003cmark\u003ecarbamazepine\u003c/mark\u003e. Other options include oxcarbazepine and gabapentin. For refractory cases, surgical microvascular decompression may be performed.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient describing sudden, severe, electric shock-like pain on one side of their face, triggered by brushing their teeth or feeling a breeze, is the classic presentation. The first-line treatment is carbamazepine.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTrigeminal Neuralgia\u003c/b\u003e is a neuropathic pain syndrome where vascular compression of the trigeminal nerve root leads to hyperexcitability, causing trivial sensory stimuli to be misinterpreted as excruciating pain, with carbamazepine being the mainstay of treatment.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"affects\",\n        \"to\": \"0eb45a0a\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"eddd2bc5\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"neuropathic_pain\"\n      }\n    ]\n  },\n  \"46fe50eb\": {\n    \"title\": \"Neurocutaneous Disorders\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Dermatology\",\n      \"Genetics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neurocutaneous Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeurocutaneous disorders\u003c/b\u003e, also known as phakomatoses, are a group of congenital and hereditary diseases characterized by the growth of tumors in the brain, spinal cord, peripheral nerves, and skin. They arise from developmental abnormalities of the ectoderm.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSturge-Weber Syndrome:\u003c/b\u003e Characterized by a facial port-wine stain ([[454a0eb8|nevus flammeus]]) in the V1/V2 distribution, ipsilateral leptomeningeal angioma (leading to seizures), and glaucoma. Caused by a somatic mosaic mutation in \u003ci\u003eGNAQ\u003c/i\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTuberous Sclerosis Complex:\u003c/b\u003e Autosomal dominant disorder (\u003ci\u003eTSC1/TSC2\u003c/i\u003e mutation) causing hamartomas in multiple organs. Neurological findings include seizures and intellectual disability. Cutaneous findings include ash-leaf spots, angiofibromas, and shagreen patches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurofibromatosis Type 1 (NF1):\u003c/b\u003e Autosomal dominant (\u003ci\u003eNF1\u003c/i\u003e gene mutation). Presents with caf√©-au-lait spots, cutaneous neurofibromas, Lisch nodules (iris hamartomas), and optic gliomas.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurofibromatosis Type 2 (NF2):\u003c/b\u003e Autosomal dominant (\u003ci\u003eNF2\u003c/i\u003e gene mutation). Characterized by bilateral vestibular [[03ecb69e|schwannomas]].\u003c/li\u003e\u003cli\u003e\u003cb\u003evon Hippel-Lindau Disease:\u003c/b\u003e Autosomal dominant (\u003ci\u003eVHL\u003c/i\u003e gene mutation). Characterized by [[73c63548|hemangioblastomas]] of the CNS and retina, renal cell carcinoma, and pheochromocytomas.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNeurocutaneous disorders\u003c/b\u003e are a classic example of the shared embryological origin (ectoderm) of the skin and nervous system; the presence of characteristic skin lesions serves as a vital clue to underlying neurological and systemic tumors.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"fd52a8b8\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"83302339\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"015a73ab\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"274cb033\"\n      }\n    ]\n  },\n  \"2e0d4fef\": {\n    \"title\": \"Neurodegenerative Disease Therapy\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Neurodegenerative Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeurodegenerative disease therapy\u003c/b\u003e encompasses pharmacological strategies aimed at managing symptoms and, in some cases, slowing the progression of diseases characterized by the progressive loss of neurons, such as Alzheimer\u0027s, Parkinson\u0027s, and Huntington\u0027s disease.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAlzheimer Disease:\u003c/b\u003e Treatment is symptomatic. \u003cmark\u003eAcetylcholinesterase inhibitors\u003c/mark\u003e (e.g., [[47d0372e|donepezil]], rivastigmine, galantamine) are used to increase ACh levels. \u003cmark\u003eMemantine\u003c/mark\u003e, an NMDA receptor antagonist, is used in moderate-to-severe disease to prevent excitotoxicity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParkinson Disease:\u003c/b\u003e Therapy focuses on increasing dopamine levels. \u003cmark\u003e[[541cd176|Levodopa/carbidopa]]\u003c/mark\u003e is the mainstay. Dopamine agonists, MAO-B inhibitors, and COMT inhibitors are also used.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHuntington Disease:\u003c/b\u003e Treatment focuses on managing symptoms. Tetrabenazine and deutetrabenazine, which inhibit the vesicular monoamine transporter (VMAT), are used to treat chorea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAmyotrophic Lateral Sclerosis (ALS):\u003c/b\u003e \u003cmark\u003eRiluzole\u003c/mark\u003e, which is thought to reduce glutamate excitotoxicity, may modestly increase survival.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For exams, focus on the primary neurotransmitter deficit and the corresponding drug mechanism: Alzheimer\u0027s \u003d ‚ÜìACh (use AChE inhibitors); Parkinson\u0027s \u003d ‚ÜìDopamine (use Levodopa).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eCurrent therapies for most \u003cb\u003eneurodegenerative diseases\u003c/b\u003e are largely symptomatic and do not halt the underlying disease process; they work by compensating for the specific neurotransmitter deficiencies that result from neuronal loss.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"41ca6981\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"47d0372e\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"541cd176\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"riluzole\"\n      }\n    ]\n  },\n  \"41ca6981\": {\n    \"title\": \"Neurodegenerative Disorders\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Geriatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neurodegenerative Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeurodegenerative disorders\u003c/b\u003e are a heterogeneous group of chronic, progressive diseases characterized by the selective and symmetric loss of neurons in specific areas of the central nervous system, often associated with the intracellular or extracellular aggregation of misfolded proteins.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDementias:\u003c/b\u003e Characterized by cognitive decline. The most common is [[77ae6148|Alzheimer disease]] (AŒ≤ plaques, tau tangles). Others include [[db2f16e5|Lewy body dementia]] (Œ±-synuclein) and [[5fff42cd|Frontotemporal dementia]] (tau or TDP-43).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMovement Disorders:\u003c/b\u003e Characterized by motor dysfunction. Includes [[58c8ea03|Parkinson disease]] (Œ±-synuclein Lewy bodies, loss of dopaminergic neurons) and [[ffd7e743|Huntington disease]] (huntingtin aggregates, loss of GABAergic neurons).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMotor Neuron Diseases:\u003c/b\u003e Characterized by weakness and muscle atrophy. Includes [[4ed629f9|Amyotrophic Lateral Sclerosis (ALS)]] (TDP-43 aggregates, loss of upper and lower motor neurons).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrion Diseases:\u003c/b\u003e Such as [[86fe59ba|Creutzfeldt-Jakob disease]], characterized by rapidly progressive dementia and spongiform changes due to aggregation of misfolded prion protein (PrP\u003csup\u003eSc\u003c/sup\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For board exams, it is crucial to associate the major neurodegenerative diseases with their hallmark protein aggregate and the primary brain region affected.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe unifying theme of \u003cb\u003eneurodegenerative disorders\u003c/b\u003e is the relentless, progressive death of specific neuronal populations, often driven by the toxic aggregation of misfolded proteins, leading to distinct clinical syndromes of dementia, movement disorders, or paralysis.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"bb316ca0\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"d3c4ac8c\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"77ae6148\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"58c8ea03\"\n      }\n    ]\n  },\n  \"015a73ab\": {\n    \"title\": \"Neurofibromatosis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Dermatology\",\n      \"Genetics\",\n      \"Oncology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neurocutaneous Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeurofibromatosis (NF)\u003c/b\u003e is a group of autosomal dominant genetic disorders that cause tumors to grow on nervous tissue. The two major types are Neurofibromatosis Type 1 (NF1) and Neurofibromatosis Type 2 (NF2).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNeurofibromatosis Type 1 (NF1):\u003c/b\u003e Caused by a mutation in the \u003ci\u003eNF1\u003c/i\u003e gene on chromosome \u003cb\u003e17\u003c/b\u003e. Characterized by \u003cmark\u003ecaf√©-au-lait spots\u003c/mark\u003e, cutaneous neurofibromas, \u003cmark\u003eLisch nodules\u003c/mark\u003e (iris hamartomas), optic gliomas, and axillary/inguinal freckling. Mnemonic: 17 letters in \u0027von Recklinghausen\u0027.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurofibromatosis Type 2 (NF2):\u003c/b\u003e Caused by a mutation in the \u003ci\u003eNF2\u003c/i\u003e gene on chromosome \u003cb\u003e22\u003c/b\u003e. Characterized by bilateral vestibular [[03ecb69e|schwannomas]]. Also associated with meningiomas and ependymomas. Mnemonic: NF\u003cb\u003e2\u003c/b\u003e affects \u003cb\u003e2\u003c/b\u003e ears (bilateral schwannomas) and is on chromosome \u003cb\u003e22\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInheritance:\u003c/b\u003e Both are autosomal dominant with high penetrance, but NF1 has variable expressivity.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Both \u003ci\u003eNF1\u003c/i\u003e (neurofibromin) and \u003ci\u003eNF2\u003c/i\u003e (merlin) are tumor suppressor genes. Their inactivation leads to uncontrolled cell growth.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The distinction between NF1 and NF2 is high-yield. NF1 is characterized by skin findings (caf√©-au-lait, neurofibromas) and Lisch nodules. NF2 is defined by bilateral vestibular schwannomas.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNeurofibromatosis\u003c/b\u003e represents two distinct genetic disorders linked by their predisposition to nerve sheath tumors; NF1 is primarily a disease of skin and peripheral nerves, while NF2 is a disease of central nervous system tumors, most notably bilateral acoustic neuromas.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"46fe50eb\"\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"neurofibromatosis_type_1\"\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"neurofibromatosis_type_2\"\n      }\n    ]\n  },\n  \"a9db88ed\": {\n    \"title\": \"Neurogenic Bladder\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Urology\",\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Autonomic Dysfunction\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeurogenic bladder\u003c/b\u003e is a general term for bladder dysfunction (either flaccid or spastic) caused by damage to the nerves that control urination.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSpastic (Hyperreflexic) Bladder:\u003c/b\u003e Caused by an \u003cmark\u003eupper motor neuron (UMN) lesion\u003c/mark\u003e above the sacral spinal cord (e.g., spinal cord injury, [[45dd6d19|multiple sclerosis]]). The sacral micturition reflex is intact but is no longer inhibited by the brain. Results in detrusor hyperreflexia, leading to \u003cmark\u003eurge incontinence\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFlaccid (Hypotonic) Bladder:\u003c/b\u003e Caused by a \u003cmark\u003elower motor neuron (LMN) lesion\u003c/mark\u003e affecting the sacral micturition center or peripheral nerves (e.g., cauda equina syndrome, diabetic neuropathy). The bladder cannot contract effectively. Results in urinary retention and \u003cmark\u003eoverflow incontinence\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMultiple Sclerosis:\u003c/b\u003e A common cause of neurogenic bladder. Patients often present with urge incontinence due to UMN lesions in the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management depends on the type. Spastic bladder is treated with antimuscarinic drugs (e.g., oxybutynin) or botulinum toxin injections. Flaccid bladder is managed with timed voiding and intermittent self-catheterization.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with [[45dd6d19|MS]] who develops urinary frequency and urgency has a spastic bladder due to a UMN lesion. A patient with diabetes and a large post-void residual volume has a flaccid bladder due to an LMN/autonomic neuropathy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe behavior of a \u003cb\u003eneurogenic bladder\u003c/b\u003e directly reflects the level of the neurological lesion: UMN lesions lead to a spastic, hyperactive bladder (urge incontinence), while LMN lesions result in a flaccid, hypotonic bladder (overflow incontinence).\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"spinal_cord_injury\"\n      },\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"diabetic_neuropathy\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"urge_incontinence\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"overflow_incontinence\"\n      }\n    ]\n  },\n  \"6d290af4\": {\n    \"title\": \"Neurohypophysis (Posterior Pituitary)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Anatomy\",\n      \"Neuroscience\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Anatomy\",\n      \"Pituitary Gland\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eNeurohypophysis\u003c/b\u003e, or posterior pituitary, is the posterior lobe of the pituitary gland. It is composed of neural tissue and functions as a storage and release site for two hormones synthesized in the [[89e86633|hypothalamus]]: antidiuretic hormone (ADH) and oxytocin.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Arises from a downward extension of neural ectoderm from the developing diencephalon.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Composed of the axons and nerve terminals of magnocellular neurons whose cell bodies are located in the supraoptic and paraventricular nuclei of the [[89e86633|hypothalamus]]. Also contains glial cells called pituicytes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHormones:\u003c/b\u003e It does \u003cu\u003enot\u003c/u\u003e synthesize hormones. It stores and releases: \u003cbr\u003e - \u003cb\u003eAntidiuretic Hormone (ADH/Vasopressin):\u003c/b\u003e Primarily synthesized in the supraoptic nucleus. \u003cbr\u003e - \u003cb\u003eOxytocin:\u003c/b\u003e Primarily synthesized in the [[e7b51f5c|paraventricular nucleus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eConnection to Hypothalamus:\u003c/b\u003e Connected to the hypothalamus via the \u003cmark\u003ehypothalamo-hypophyseal tract\u003c/mark\u003e, a bundle of axons. This is a direct neural connection, contrasting with the portal venous system of the anterior pituitary.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that the posterior pituitary is essentially nerve tissue that stores and releases hypothalamic hormones. A lesion of the pituitary stalk or posterior pituitary can cause central diabetes insipidus due to lack of ADH release.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eNeurohypophysis\u003c/b\u003e is not a true endocrine gland but rather a specialized neurosecretory terminal, acting as a storage depot for hypothalamic hormones and releasing them directly into the bloodstream upon neural command from the hypothalamus.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypothalamus\u003cbr\u003e(Supraoptic \u0026 Paraventricular Nuclei)] --Axonal Transport--\u003e B(Neurohypophysis); B --Release into Blood--\u003e C(ADH \u0026 Oxytocin);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"pituitary_gland\"\n      },\n      {\n        \"type\": \"releases\",\n        \"to\": \"antidiuretic_hormone\"\n      },\n      {\n        \"type\": \"releases\",\n        \"to\": \"911d3b47\"\n      },\n      {\n        \"type\": \"is_connected_to\",\n        \"to\": \"89e86633\"\n      }\n    ]\n  },\n  \"38e52c3e\": {\n    \"title\": \"Neurokinin-1 (NK1) Receptors\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Gastroenterology\",\n      \"Neuroscience\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Gastrointestinal\",\n      \"Pharmacology\",\n      \"Antiemetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeurokinin-1 (NK1) receptors\u003c/b\u003e are G-protein coupled receptors for the neuropeptide Substance P. They are found in the central and peripheral nervous systems and are critically involved in the pathways for pain and, most notably, emesis (vomiting).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLigand:\u003c/b\u003e The primary endogenous ligand is \u003cmark\u003eSubstance P\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation in Emesis Pathway:\u003c/b\u003e NK1 receptors are highly concentrated in the \u003cmark\u003earea postrema\u003c/mark\u003e (chemoreceptor trigger zone) and the \u003cmark\u003enucleus tractus solitarius (NTS)\u003c/mark\u003e, which are key components of the central vomiting center in the brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Vomiting:\u003c/b\u003e Activation of NK1 receptors by Substance P is a key step in inducing both acute and, particularly, delayed nausea and vomiting.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacology (NK1 Antagonists):\u003c/b\u003e Drugs that block NK1 receptors (e.g., \u003cmark\u003eaprepitant\u003c/mark\u003e, fosaprepitant) are potent antiemetics. Their names often end in \u0027-pitant\u0027.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e NK1 antagonists are primarily used for the prevention of chemotherapy-induced nausea and vomiting (CINV), especially the delayed phase, and for postoperative nausea and vomiting (PONV).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For chemotherapy-induced vomiting, remember the different receptor targets. Serotonin (5-HT3) antagonists (e.g., ondansetron) are best for acute CINV, while NK1 antagonists (e.g., aprepitant) are crucial for delayed CINV.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNK1 receptors\u003c/b\u003e are the primary target for Substance P in the brain\u0027s vomiting center; blocking these receptors with \u0027-pitant\u0027 drugs like aprepitant is a highly effective strategy for preventing the delayed nausea and vomiting associated with chemotherapy.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Chemotherapy] --\u003e B(Release of Substance P); B --\u003e C(Binds to NK1 Receptors in Area Postrema/NTS); C --\u003e D(Emesis); E[Aprepitant] --|Blocks|--\u003e C;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_target_of\",\n        \"to\": \"substance_p\"\n      },\n      {\n        \"type\": \"is_blocked_by\",\n        \"to\": \"aprepitant\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"5dd343d3\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"38bfa9e0\"\n      }\n    ]\n  },\n  \"3888bfbd\": {\n    \"title\": \"Neurology and Special Senses\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Otology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Overview\",\n      \"Main\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeurology and Special Senses\u003c/b\u003e is the field of medicine concerned with the diagnosis and treatment of disorders of the nervous system, which includes the brain, spinal cord, peripheral nerves, and the specialized sensory organs for vision, hearing, and balance.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Focuses on the development of the nervous system from the [[a87cbede|neural tube]] and [[14c6f2a7|neural crest cells]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnatomy and Physiology:\u003c/b\u003e Covers the structure and function of neurons, glial cells, major brain regions, spinal cord tracts, and cranial nerves.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Includes a vast range of disorders such as cerebrovascular disease (stroke), [[41ca6981|neurodegenerative disorders]], [[45dd6d19|demyelinating diseases]], infections, trauma, and tumors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOphthalmology:\u003c/b\u003e The subspecialty dealing with the anatomy, physiology, and diseases of the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOtology:\u003c/b\u003e The subspecialty dealing with the anatomy, physiology, and diseases of the ear, including hearing and balance.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacology:\u003c/b\u003e Involves drugs acting on the nervous system, such as anticonvulsants, anesthetics, and psychotropic medications.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe study of \u003cb\u003eNeurology and Special Senses\u003c/b\u003e is fundamentally about understanding the intricate network that controls and perceives the body, and how disruptions in this network, from the molecular to the macroscopic level, manifest as clinical disease.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes_discipline\",\n        \"to\": \"neurology\"\n      },\n      {\n        \"type\": \"includes_discipline\",\n        \"to\": \"ophthalmology\"\n      },\n      {\n        \"type\": \"includes_discipline\",\n        \"to\": \"c5a1d2fc\"\n      }\n    ]\n  },\n  \"1aaaffd2\": {\n    \"title\": \"Neuromuscular Blocking Drugs\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Neuromuscular Blockers\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeuromuscular blocking drugs\u003c/b\u003e are agents that cause skeletal muscle paralysis by interfering with neurotransmission at the neuromuscular junction. They are classified as either depolarizing or non-depolarizing agents.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDepolarizing Blockers:\u003c/b\u003e \u003cmark\u003eSuccinylcholine\u003c/mark\u003e is the only clinically used agent. It acts as an ACh receptor agonist, causing sustained depolarization (Phase I) followed by receptor desensitization (Phase II), leading to paralysis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNon-Depolarizing Blockers:\u003c/b\u003e Act as competitive antagonists at the ACh receptor. Examples include rocuronium, vecuronium, and [[243d4db1|pancuronium]]. Their effects are reversible with acetylcholinesterase inhibitors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Primarily used during anesthesia to facilitate endotracheal intubation and provide optimal surgical conditions by relaxing skeletal muscles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMonitoring:\u003c/b\u003e The degree of blockade is monitored using a peripheral nerve stimulator to assess the train-of-four (TOF) response.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Succinylcholine can cause hyperkalemia and is a trigger for malignant hyperthermia. Non-depolarizing agents can cause histamine release (hypotension).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNeuromuscular blocking drugs\u003c/b\u003e achieve paralysis through two opposing mechanisms at the acetylcholine receptor: succinylcholine by overstimulation (depolarizing) and drugs like rocuronium by competitive inhibition (non-depolarizing), a distinction critical for their clinical use and reversal.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"depolarizing_neuromuscular_blocker\"\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"48f817e6\"\n      },\n      {\n        \"type\": \"is_used_in\",\n        \"to\": \"anesthesia\"\n      }\n    ]\n  },\n  \"7e727989\": {\n    \"title\": \"Neuromuscular Junction (NMJ)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Physiology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Peripheral Nervous System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eNeuromuscular Junction (NMJ)\u003c/b\u003e is a highly specialized synapse between the axon terminal of a motor neuron and the motor end plate of a skeletal muscle fiber, responsible for converting the neuron\u0027s electrical signal into muscle contraction.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter:\u003c/b\u003e The sole neurotransmitter at the NMJ is \u003cmark\u003eacetylcholine (ACh)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReceptor:\u003c/b\u003e ACh binds to \u003cmark\u003enicotinic (N\u003csub\u003eM\u003c/sub\u003e) receptors\u003c/mark\u003e on the postsynaptic muscle membrane (motor end plate).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e An action potential arriving at the axon terminal triggers the opening of voltage-gated Ca\u003csup\u003e2+\u003c/sup\u003e channels. Ca\u003csup\u003e2+\u003c/sup\u003e influx causes the release of ACh into the synaptic cleft. ACh binds to N\u003csub\u003eM\u003c/sub\u003e receptors, opening them to allow Na\u003csup\u003e+\u003c/sup\u003e influx, which generates an end-plate potential and triggers a muscle action potential.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e The NMJ is the site of pathology in several diseases: \u003cbr\u003e - \u003cb\u003eMyasthenia Gravis:\u003c/b\u003e Autoantibodies against postsynaptic ACh receptors. \u003cbr\u003e - \u003cb\u003eLambert-Eaton Myasthenic Syndrome:\u003c/b\u003e Autoantibodies against presynaptic voltage-gated Ca\u003csup\u003e2+\u003c/sup\u003e channels. \u003cbr\u003e - \u003cb\u003eBotulism:\u003c/b\u003e Botulinum toxin cleaves SNARE proteins, preventing presynaptic ACh release.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacology:\u003c/b\u003e Targeted by [[1aaaffd2|neuromuscular blocking drugs]] used in anesthesia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eNeuromuscular Junction\u003c/b\u003e is a high-fidelity synapse designed for obligatory one-to-one transmission, where every motor neuron action potential reliably leads to a muscle fiber action potential, a process that can be disrupted by autoantibodies or toxins, leading to muscle weakness or paralysis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Motor Neuron AP] --\u003e B(Ca2+ Influx); B --\u003e C(ACh Release); C --\u003e D(Binds to Nicotinic Receptors); D --\u003e E(Na+ Influx); E --\u003e F(End-Plate Potential); F --\u003e G(Muscle AP \u0026 Contraction);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"uses_neurotransmitter\",\n        \"to\": \"6a005559\"\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"myasthenia_gravis\"\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"lambert_eaton_syndrome\"\n      },\n      {\n        \"type\": \"is_affected_by\",\n        \"to\": \"botulinum_toxin\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9724,
      "parts": [{
        "text": "```json\n"
      }, {
        "text": "{\n  \"113776de\": {\n    \"title"
      }, {
        "text": "\": \"Nervous System\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "science\",\n      \"Anatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Overview"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eNervous System\u003c/b\u003e"
      }, {
        "text": " is the body\u0027s primary communication and control network, divided into the Central Nervous System (CNS), consisting of the brain and spinal cord, and"
      }, {
        "text": " the Peripheral Nervous System (PNS), which includes all other nervous tissue. It is composed of specialized cells, primarily [[6"
      }, {
        "text": "3fc3fe7|neurons]] and glial cells.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCentral"
      }, {
        "text": " Nervous System (CNS):\u003c/b\u003e Comprises the brain and spinal cord. It is the main processing center for the nervous system.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePeripheral Nervous System"
      }, {
        "text": " (PNS):\u003c/b\u003e Includes cranial nerves (except I \u0026 II), spinal nerves, and ganglia. It connects the CNS to the limbs"
      }, {
        "text": " and organs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSomatic Nervous System:\u003c/b\u003e Part of the PNS responsible for voluntary control of body movements via"
      }, {
        "text": " skeletal muscles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAutonomic Nervous System:\u003c/b\u003e Part of the PNS that controls involuntary functions (e.g., heart rate, digestion"
      }, {
        "text": "), further divided into sympathetic and parasympathetic systems.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCells of the Nervous System:\u003c/b\u003e [[63fc3fe7|Neurons"
      }, {
        "text": "]] are the signal-transmitting cells. Glial cells ([[8192f595|astrocytes]],"
      }, {
        "text": " [[a24f9747|oligodendrocytes]], microglia, ependymal cells in CNS; [[c"
      }, {
        "text": "65a8909|Schwann cells]], satellite cells in PNS) provide support and protection.\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003eThe nervous system is a complex, integrated network responsible for coordinating actions and transmitting"
      }, {
        "text": " signals between different parts of the body. Its fundamental cellular components are neurons, which conduct electrical impulses, and glial cells, which provide essential"
      }, {
        "text": " support and maintenance.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_composed_of\",\n        \"to\": \"63fc3fe7\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \""
      }, {
        "text": "glial_cells\"\n      },\n      {\n        \"type\": \"is_divided_into\",\n        "
      }, {
        "text": "\"to\": \"central_nervous_system\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_divided_into\",\n        \"to\": \"c44ae4c5\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"14c6f2a7\": {\n    \"title\": \"Neural Crest Cells\","
      }, {
        "text": "\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience"
      }, {
        "text": "\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n"
      }, {
        "text": "      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural Development\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeural crest cells\u003c/b\u003e are a transient, multipotent population"
      }, {
        "text": " of migratory cells that arise from the dorsal aspect of the neural tube during embryonic development and give rise to a diverse array of cell"
      }, {
        "text": " types throughout the body.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Arise from the neuro"
      }, {
        "text": "ectoderm at the lateral edges of the neural plate (the neural crest).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMigration:\u003c/b\u003e These cells undergo an"
      }, {
        "text": " epithelial-to-mesenchymal transition and migrate extensively to various locations in the embryo.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDerivatives (N"
      }, {
        "text": "ervous System):\u003c/b\u003e Give rise to most of the [[c44ae4c5|peripheral nervous system]],"
      }, {
        "text": " including dorsal root ganglia, autonomic ganglia (sympathetic, parasympathetic), [[c65a8909|Schwann cells]], and satellite"
      }, {
        "text": " cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDerivatives (Other):\u003c/b\u003e Also form melanocytes, chromaffin cells of the adrenal medulla, para"
      }, {
        "text": "follicular (C) cells of the thyroid, odontoblasts, and craniofacial cartilage and bone.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Remember the diverse derivatives of neural crest cells. A helpful mnemonic is \u003cb\u003eMOTEL PASS\u003c/b\u003e:"
      }, {
        "text": " \u003cb\u003eM\u003c/b\u003eelanocytes, \u003cb\u003eO\u003c/b\u003edontoblasts, \u003cb\u003eT\u003c/b\u003eracheal and laryngeal cartilage, \u003cb\u003eE\u003c/b\u003en"
      }, {
        "text": "terochromaffin cells, \u003cb\u003eL\u003c/b\u003eeptomeninges (arachnoid and pia), \u003cb\u003eP\u003c/b\u003eara"
      }, {
        "text": "follicular cells, \u003cb\u003eA\u003c/b\u003edrenal medulla, \u003cb\u003eS\u003c/b\u003echwann cells, \u003cb\u003eS\u003c/b\u003epir"
      }, {
        "text": "al membrane.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNeural crest cells\u003c/b\u003e are often considered the \u0027fourth germ"
      }, {
        "text": " layer\u0027 due to their remarkable multipotency and migratory capacity, giving rise to a vast and seemingly unrelated collection of tissues"
      }, {
        "text": ", from the peripheral nervous system to the melanocytes in the skin.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"differentiates_into\",\n        \"to\": \"c44ae4c"
      }, {
        "text": "5\"\n      },\n      {\n        \"type\": \"differentiates_into\",\n        \"to"
      }, {
        "text": "\": \"melanocytes\"\n      },\n      {\n        \"type\": \"differentiates_into\","
      }, {
        "text": "\n        \"to\": \"adrenal_medulla\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "arises_from\",\n        \"to\": \"neuroectoderm\"\n      }\n    ]\n  },\n  \"8"
      }, {
        "text": "87d6a16\": {\n    \"title\": \"Neural Development\",\n    \"primaryType\": \"physiology"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Embryology\",\n      \"Neural Development\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eNeural development\u003c/b\u003e is the complex process by which the nervous system forms during embryogenesis, beginning with the induction"
      }, {
        "text": " of the neural plate from the ectoderm and proceeding through neurulation, proliferation, migration, and differentiation of neurons and glial cells.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eInduction:\u003c/b\u003e The notochord induces the overlying ectoderm to differentiate into the neuro"
      }, {
        "text": "ectoderm, forming the neural plate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurulation:\u003c/b\u003e The neural plate folds to form the [[a"
      }, {
        "text": "87cbede|neural tube]], which will become the CNS, and the [[14c6f2a7|"
      }, {
        "text": "neural crest cells]], which will become the PNS and other structures. This process is critically dependent on folate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eV"
      }, {
        "text": "esicle Formation:\u003c/b\u003e The rostral end of the neural tube develops into three primary brain vesicles (prosencephalon, mes"
      }, {
        "text": "encephalon, rhombencephalon), which then subdivide into five secondary vesicles.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePlate Differentiation:\u003c/b\u003e The neural"
      }, {
        "text": " tube differentiates along its dorsal-ventral axis into the alar plate (sensory functions, induced by BMPs) and the basal plate (motor"
      }, {
        "text": " functions, induced by Sonic hedgehog [SHH]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Failure of the neural tube to close results"
      }, {
        "text": " in [[neural_tube_defects|neural tube defects]]. Failure of the rostral neuropore to close causes anencephaly;"
      }, {
        "text": " failure of the caudal neuropore causes spina bifida.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "\u003cb\u003eNeural development\u003c/b\u003e is a highly orchestrated sequence of events, initiated by signals from the notochord, that transforms a"
      }, {
        "text": " simple sheet of ectodermal cells into the intricate structure of the brain and spinal cord. Errors in the earliest stages, like"
      }, {
        "text": " neurulation, can have devastating consequences.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Ectoderm] --"
      }, {
        "text": "Notochord Induction--\u003e B(Neural Plate); B --\u003e C(Neural Tube); C --\u003e D(CNS); B --\u003e E"
      }, {
        "text": "(Neural Crest); E --\u003e F(PNS);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"involves_formation_of\",\n        \"to\": \"a87cbede"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"involves_formation_of\",\n        \""
      }, {
        "text": "to\": \"14c6f2a7\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "defects_in_process_lead_to\",\n        \"to\": \"neural_tube_defects\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"a87cbede\": {\n    \"title\": \"Neural Tube\",\n    \"primaryType\": \"anatomy"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \"An"
      }, {
        "text": "atomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Embryology\",\n      \"Neural Development\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eNeural Tube\u003c/b\u003e is the embryonic precursor to the central nervous system (CNS), formed during"
      }, {
        "text": " neurulation by the folding of the neural plate. Its proper closure and differentiation are essential for normal brain and spinal cord development"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFormation:\u003c/b\u003e Develops from the neuroectoderm,"
      }, {
        "text": " which thickens to form the neural plate, then folds inward to create the neural tube. This process is complete by the"
      }, {
        "text": " 4th week of gestation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDerivatives:\u003c/b\u003e Gives rise to the entire CNS, including the brain,"
      }, {
        "text": " spinal cord, [[63fc3fe7|neurons]], and most glial cells ([[8192f595"
      }, {
        "text": "|astrocytes]], [[a24f9747|oligodendrocytes]], ependymal cells).\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eRegionalization:\u003c/b\u003e The rostral part develops into the brain vesicles (prosencephalon, mesencephalon, rhombencephalon), while"
      }, {
        "text": " the caudal part forms the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeural Tube Defects (NTDs):\u003c/b\u003e Failure of the neural tube to close properly"
      }, {
        "text": " leads to NTDs. Failure of the rostral (anterior) neuropore to close results in anencephaly. Failure of"
      }, {
        "text": " the caudal (posterior) neuropore to close results in spina bifida.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFolate:\u003c/b\u003e Maternal folate supplementation"
      }, {
        "text": " before and during early pregnancy is crucial for preventing NTDs.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003eNeural Tube\u003c/b\u003e is the foundational structure of the central nervous system, and its timely closure during the first month of gestation"
      }, {
        "text": " is a critical developmental event, the failure of which leads to severe congenital malformations like spina bifida and anencephaly.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"develop"
      }, {
        "text": "s_into\",\n        \"to\": \"central_nervous_system\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"failure_to_close_causes\",\n        \"to\": \"neural_tube_defects\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_part_of\",\n        \"to\": \"887d6a16\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"c8dc7442\": {\n    \"title\":"
      }, {
        "text": " \"Trigeminal Neuralgia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Pain Management\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cranial Neu"
      }, {
        "text": "ropathies\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTrigeminal Neural"
      }, {
        "text": "gia\u003c/b\u003e (also known as tic douloureux) is a chronic pain disorder characterized by recurrent, sudden, severe, shock"
      }, {
        "text": "-like episodes of unilateral facial pain in the distribution of the \u003ci\u003etrigeminal nerve (CN V)\u003c/i\u003e.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by \u003cmark\u003evascular compression\u003c/mark\u003e of"
      }, {
        "text": " the trigeminal nerve root as it enters the brainstem, often by the superior cerebellar artery. Demyelination ("
      }, {
        "text": "e.g., from [[45dd6d19|multiple sclerosis]]) is another important cause, especially in younger patients.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation:\u003c/b\u003e Paroxysms of excruciating, electric shock-like pain, lasting from a few seconds to minutes. The pain is unilateral"
      }, {
        "text": " and typically affects the V2 (maxillary) and/or V3 (mandibular) divisions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTr"
      }, {
        "text": "iggers:\u003c/b\u003e Pain can be triggered by innocuous stimuli in specific \u0027trigger zones,\u0027 such as light touch, chewing, talking"
      }, {
        "text": ", or a cold breeze.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e \u003cu\u003eFirst-line\u003c/u\u003e medical treatment is \u003cmark\u003ecarbamazepine\u003c/"
      }, {
        "text": "mark\u003e. Other options include oxcarbazepine and gabapentin. For refractory cases, surgical microvascular decompression may be performed.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e A patient describing sudden, severe, electric shock-like pain on one side of their face, triggered"
      }, {
        "text": " by brushing their teeth or feeling a breeze, is the classic presentation. The first-line treatment is carbamazepine."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTrigeminal Neuralgia\u003c/b\u003e is a neuropathic pain syndrome"
      }, {
        "text": " where vascular compression of the trigeminal nerve root leads to hyperexcitability, causing trivial sensory stimuli to be misinterpreted"
      }, {
        "text": " as excruciating pain, with carbamazepine being the mainstay of treatment.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"affects\",\n        \"to\": \"0eb"
      }, {
        "text": "45a0a\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"ed"
      }, {
        "text": "dd2bc5\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\":"
      }, {
        "text": " \"neuropathic_pain\"\n      }\n    ]\n  },\n  \"46fe50eb\": {\n    \"title"
      }, {
        "text": "\": \"Neurocutaneous Disorders\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Dermatology\",\n      \"Genetics\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neuro"
      }, {
        "text": "cutaneous Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeurocutaneous disorders\u003c/b\u003e,"
      }, {
        "text": " also known as phakomatoses, are a group of congenital and hereditary diseases characterized by the growth of tumors in the"
      }, {
        "text": " brain, spinal cord, peripheral nerves, and skin. They arise from developmental abnormalities of the ectoderm.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSturge-Weber Syndrome:\u003c/b\u003e Characterized by a facial port-wine stain ([[4"
      }, {
        "text": "54a0eb8|nevus flammeus]]) in the V1/V2 distribution, ipsilateral leptomeningeal"
      }, {
        "text": " angioma (leading to seizures), and glaucoma. Caused by a somatic mosaic mutation in \u003ci\u003eGNAQ\u003c/i\u003e.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eTuberous Sclerosis Complex:\u003c/b\u003e Autosomal dominant disorder (\u003ci\u003eTSC1/TSC2\u003c/i\u003e mutation) causing ham"
      }, {
        "text": "artomas in multiple organs. Neurological findings include seizures and intellectual disability. Cutaneous findings include ash-leaf spots, ang"
      }, {
        "text": "iofibromas, and shagreen patches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurofibromatosis Type 1 (NF1):\u003c/b\u003e Aut"
      }, {
        "text": "osomal dominant (\u003ci\u003eNF1\u003c/i\u003e gene mutation). Presents with caf√©-au-lait spots, cutaneous neurofibromas, Lisch nodules"
      }, {
        "text": " (iris hamartomas), and optic gliomas.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurofibromatosis Type 2 (NF2):"
      }, {
        "text": "\u003c/b\u003e Autosomal dominant (\u003ci\u003eNF2\u003c/i\u003e gene mutation). Characterized by bilateral vestibular [[03ecb69e"
      }, {
        "text": "|schwannomas]].\u003c/li\u003e\u003cli\u003e\u003cb\u003evon Hippel-Lindau Disease:\u003c/b\u003e Autosomal dominant (\u003ci\u003eVHL\u003c/i\u003e gene mutation). Character"
      }, {
        "text": "ized by [[73c63548|hemangioblastomas]] of the CNS and retina, renal"
      }, {
        "text": " cell carcinoma, and pheochromocytomas.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNeurocutaneous disorders\u003c/b\u003e are a classic"
      }, {
        "text": " example of the shared embryological origin (ectoderm) of the skin and nervous system; the presence of characteristic skin lesions"
      }, {
        "text": " serves as a vital clue to underlying neurological and systemic tumors.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"fd52a8b"
      }, {
        "text": "8\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"83"
      }, {
        "text": "302339\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"01"
      }, {
        "text": "5a73ab\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"274"
      }, {
        "text": "cb033\"\n      }\n    ]\n  },\n  \"2e0d4fef\": {\n    \"title"
      }, {
        "text": "\": \"Neurodegenerative Disease Therapy\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Neurodegenerative Drugs\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeurodegenerative disease therapy\u003c/b\u003e encompasses pharmacological strategies aimed at managing symptoms and,"
      }, {
        "text": " in some cases, slowing the progression of diseases characterized by the progressive loss of neurons, such as Alzheimer\u0027s, Parkinson\u0027s, and Huntington"
      }, {
        "text": "\u0027s disease.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAlzheimer Disease:\u003c/b\u003e Treatment is"
      }, {
        "text": " symptomatic. \u003cmark\u003eAcetylcholinesterase inhibitors\u003c/mark\u003e (e.g., [[47d037"
      }, {
        "text": "2e|donepezil]], rivastigmine, galantamine) are used to increase ACh levels. \u003cmark\u003eMem"
      }, {
        "text": "antine\u003c/mark\u003e, an NMDA receptor antagonist, is used in moderate-to-severe disease to prevent excitotoxicity.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Parkinson Disease:\u003c/b\u003e Therapy focuses on increasing dopamine levels. \u003cmark\u003e[[541cd176|Lev"
      }, {
        "text": "odopa/carbidopa]]\u003c/mark\u003e is the mainstay. Dopamine agonists, MAO-B inhibitors, and COMT"
      }, {
        "text": " inhibitors are also used.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHuntington Disease:\u003c/b\u003e Treatment focuses on managing symptoms. Tetrabenazine and deut"
      }, {
        "text": "etrabenazine, which inhibit the vesicular monoamine transporter (VMAT), are used to treat chorea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAmyotrophic Lateral S"
      }, {
        "text": "clerosis (ALS):\u003c/b\u003e \u003cmark\u003eRiluzole\u003c/mark\u003e, which is thought to reduce glutamate excitotoxicity, may"
      }, {
        "text": " modestly increase survival.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For exams, focus on the primary neurotransmitter deficit and the"
      }, {
        "text": " corresponding drug mechanism: Alzheimer\u0027s \u003d ‚ÜìACh (use AChE inhibitors); Parkinson\u0027s \u003d ‚ÜìDopamine (use Le"
      }, {
        "text": "vodopa).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eCurrent therapies for most \u003cb\u003eneurodegenerative diseases"
      }, {
        "text": "\u003c/b\u003e are largely symptomatic and do not halt the underlying disease process; they work by compensating for the specific neurotransmitter deficiencies that result"
      }, {
        "text": " from neuronal loss.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_treatment_for\",\n        \"to\": \"41ca6981\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"includes\",\n        \"to\": \"47d0372e"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"541"
      }, {
        "text": "cd176\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\":"
      }, {
        "text": " \"riluzole\"\n      }\n    ]\n  },\n  \"41ca6981"
      }, {
        "text": "\": {\n    \"title\": \"Neurodegenerative Disorders\",\n    \"primaryType\": \"concept\",\n    \""
      }, {
        "text": "tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Geriatrics\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\","
      }, {
        "text": "\n      \"Neurodegenerative Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e"
      }, {
        "text": "\u003cb\u003eNeurodegenerative disorders\u003c/b\u003e are a heterogeneous group of chronic, progressive diseases characterized by the selective and symmetric loss of neurons in specific areas"
      }, {
        "text": " of the central nervous system, often associated with the intracellular or extracellular aggregation of misfolded proteins.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDementias:\u003c/b\u003e Characterized by cognitive decline. The most common is [["
      }, {
        "text": "77ae6148|Alzheimer disease]] (AŒ≤ plaques, tau tangles). Others include [[db"
      }, {
        "text": "2f16e5|Lewy body dementia]] (Œ±-synuclein) and [[5fff4"
      }, {
        "text": "2cd|Frontotemporal dementia]] (tau or TDP-43).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMovement Disorders:\u003c/b\u003e Characterized by motor"
      }, {
        "text": " dysfunction. Includes [[58c8ea03|Parkinson disease]] (Œ±-synuclein Lewy bodies,"
      }, {
        "text": " loss of dopaminergic neurons) and [[ffd7e743|Huntington disease]] (huntingtin aggregates"
      }, {
        "text": ", loss of GABAergic neurons).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMotor Neuron Diseases:\u003c/b\u003e Characterized by weakness and muscle atrophy. Includes [[4ed"
      }, {
        "text": "629f9|Amyotrophic Lateral Sclerosis (ALS)]] (TDP-43 aggregates, loss of upper"
      }, {
        "text": " and lower motor neurons).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrion Diseases:\u003c/b\u003e Such as [[86fe59ba|Creutzfeldt-Jakob disease"
      }, {
        "text": "]], characterized by rapidly progressive dementia and spongiform changes due to aggregation of misfolded prion protein (PrP\u003csup\u003eSc\u003c/sup\u003e).\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e For board exams, it is crucial to associate the major neurodegenerative diseases with their hallmark protein aggregate"
      }, {
        "text": " and the primary brain region affected.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe unifying theme of "
      }, {
        "text": "\u003cb\u003eneurodegenerative disorders\u003c/b\u003e is the relentless, progressive death of specific neuronal populations, often driven by the toxic aggregation of misfolded proteins, leading to distinct"
      }, {
        "text": " clinical syndromes of dementia, movement disorders, or paralysis.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"includes\",\n        \"to\": \"bb316ca0"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"d3c4"
      }, {
        "text": "ac8c\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"77"
      }, {
        "text": "ae6148\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"58c8"
      }, {
        "text": "ea03\"\n      }\n    ]\n  },\n  \"015a73ab\": {\n    \"title\": \""
      }, {
        "text": "Neurofibromatosis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Dermatology\",\n      \"Genetics\",\n      \"Oncology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neuro"
      }, {
        "text": "cutaneous Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeurofibromat"
      }, {
        "text": "osis (NF)\u003c/b\u003e is a group of autosomal dominant genetic disorders that cause tumors to grow on nervous tissue. The two"
      }, {
        "text": " major types are Neurofibromatosis Type 1 (NF1) and Neurofibromatosis Type 2 (NF2).\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNeurofibromatosis Type 1 (NF1):\u003c/b\u003e Ca"
      }, {
        "text": "used by a mutation in the \u003ci\u003eNF1\u003c/i\u003e gene on chromosome \u003cb\u003e17\u003c/b\u003e. Characterized by \u003c"
      }, {
        "text": "mark\u003ecaf√©-au-lait spots\u003c/mark\u003e, cutaneous neurofibromas, \u003cmark\u003eLisch nodules\u003c/"
      }, {
        "text": "mark\u003e (iris hamartomas), optic gliomas, and axillary/inguinal freckling. Mnemonic:"
      }, {
        "text": " 17 letters in \u0027von Recklinghausen\u0027.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurofibromatosis Type 2 (NF2):\u003c/b\u003e Caused by a"
      }, {
        "text": " mutation in the \u003ci\u003eNF2\u003c/i\u003e gene on chromosome \u003cb\u003e22\u003c/b\u003e. Characterized by bilateral vestibular [[03ecb69e|"
      }, {
        "text": "schwannomas]]. Also associated with meningiomas and ependymomas. Mnemonic: NF\u003cb\u003e2\u003c/b\u003e affects"
      }, {
        "text": " \u003cb\u003e2\u003c/b\u003e ears (bilateral schwannomas) and is on chromosome \u003cb\u003e22\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Inheritance:\u003c/b\u003e Both are autosomal dominant with high penetrance, but NF1 has variable expressivity.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e Both \u003ci\u003eNF1\u003c/i\u003e (neurofibromin) and \u003ci\u003eNF2\u003c/i\u003e (mer"
      }, {
        "text": "lin) are tumor suppressor genes. Their inactivation leads to uncontrolled cell growth.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " distinction between NF1 and NF2 is high-yield. NF1 is characterized by skin findings (caf√©-au-lait"
      }, {
        "text": ", neurofibromas) and Lisch nodules. NF2 is defined by bilateral vestibular schwannomas.\u003c/li\u003e\u003c/ul\u003e\",\n"
      }, {
        "text": "      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNeurofibromatosis\u003c/b\u003e represents two distinct genetic disorders linked by their predisposition to nerve"
      }, {
        "text": " sheath tumors; NF1 is primarily a disease of skin and peripheral nerves, while NF2 is a disease of central nervous system tumors, most"
      }, {
        "text": " notably bilateral acoustic neuromas.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n"
      }, {
        "text": "      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"46fe50eb\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"neurofibromatosis_type_1\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \""
      }, {
        "text": "neurofibromatosis_type_2\"\n      }\n    ]\n  },\n  \"a9db8"
      }, {
        "text": "8ed\": {\n    \"title\": \"Neurogenic Bladder\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Urology\",\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Autonomic Dysfunction\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeurogenic bladder\u003c/b\u003e is a general term for bladder dysfunction"
      }, {
        "text": " (either flaccid or spastic) caused by damage to the nerves that control urination.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSpastic (Hyperreflexic) Bladder:\u003c/b\u003e Caused by an \u003cmark\u003eupper motor neuron (UMN"
      }, {
        "text": ") lesion\u003c/mark\u003e above the sacral spinal cord (e.g., spinal cord injury, [[45dd6d19|"
      }, {
        "text": "multiple sclerosis]]). The sacral micturition reflex is intact but is no longer inhibited by the brain. Results in det"
      }, {
        "text": "rusor hyperreflexia, leading to \u003cmark\u003eurge incontinence\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFlaccid (Hyp"
      }, {
        "text": "otonic) Bladder:\u003c/b\u003e Caused by a \u003cmark\u003elower motor neuron (LMN) lesion\u003c/mark\u003e"
      }, {
        "text": " affecting the sacral micturition center or peripheral nerves (e.g., cauda equina syndrome, diabetic"
      }, {
        "text": " neuropathy). The bladder cannot contract effectively. Results in urinary retention and \u003cmark\u003eoverflow incontinence\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMultiple"
      }, {
        "text": " Sclerosis:\u003c/b\u003e A common cause of neurogenic bladder. Patients often present with urge incontinence due to UMN lesions in"
      }, {
        "text": " the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management depends on the type. Spastic bladder is treated with antimuscarinic drugs"
      }, {
        "text": " (e.g., oxybutynin) or botulinum toxin injections. Flaccid bladder is managed with timed"
      }, {
        "text": " voiding and intermittent self-catheterization.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with [[45dd6d19|"
      }, {
        "text": "MS]] who develops urinary frequency and urgency has a spastic bladder due to a UMN lesion. A patient with diabetes"
      }, {
        "text": " and a large post-void residual volume has a flaccid bladder due to an LMN/autonomic neuropathy."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe behavior of a \u003cb\u003eneurogenic bladder\u003c/b\u003e directly reflects the level"
      }, {
        "text": " of the neurological lesion: UMN lesions lead to a spastic, hyperactive bladder (urge incontinence), while LMN lesions result"
      }, {
        "text": " in a flaccid, hypotonic bladder (overflow incontinence).\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"45dd6d1"
      }, {
        "text": "9\"\n      },\n      {\n        \"type\": \"is_a_complication_of\",\n        \""
      }, {
        "text": "to\": \"spinal_cord_injury\"\n      },\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_complication_of\",\n        \"to\": \"diabetic_neuropathy\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"can_cause\",\n        \"to\": \"urge_incontinence\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"can_cause\",\n        \"to\": \"overflow_incontinence\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"6d290af4\": {\n    \"title\": \"Neurohypophysis (Posterior"
      }, {
        "text": " Pituitary)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"An"
      }, {
        "text": "atomy\",\n      \"Neuroscience\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Endocrine\",\n      \"Anatomy\",\n      \"Pituitary Gland\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eNeurohypophysis\u003c/b\u003e, or posterior pituitary, is the posterior lobe"
      }, {
        "text": " of the pituitary gland. It is composed of neural tissue and functions as a storage and release site for two hormones synthesized in"
      }, {
        "text": " the [[89e86633|hypothalamus]]: antidiuretic hormone (ADH) and oxytocin.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Arises from a downward extension of neural ectoderm from the developing"
      }, {
        "text": " diencephalon.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Composed of the axons and nerve terminals of magnocellular neurons whose cell bodies are located in the supra"
      }, {
        "text": "optic and paraventricular nuclei of the [[89e86633|hypothalamus]]. Also contains glial cells called"
      }, {
        "text": " pituicytes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHormones:\u003c/b\u003e It does \u003cu\u003enot\u003c/u\u003e synthesize hormones. It stores"
      }, {
        "text": " and releases: \u003cbr\u003e - \u003cb\u003eAntidiuretic Hormone (ADH/Vasopressin):\u003c/b\u003e Primarily synthesized in the supraoptic nucleus. \u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eOxytocin:\u003c/b\u003e Primarily synthesized in the [[e7b51f5c|paraventricular nucleus"
      }, {
        "text": "]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eConnection to Hypothalamus:\u003c/b\u003e Connected to the hypothalamus via the \u003cmark\u003ehypothalamo"
      }, {
        "text": "-hypophyseal tract\u003c/mark\u003e, a bundle of axons. This is a direct neural connection, contrasting with the portal"
      }, {
        "text": " venous system of the anterior pituitary.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that the posterior pituitary is essentially nerve tissue that stores"
      }, {
        "text": " and releases hypothalamic hormones. A lesion of the pituitary stalk or posterior pituitary can cause central diabetes insipidus due to lack"
      }, {
        "text": " of ADH release.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eNeurohypophysis\u003c/b\u003e is not"
      }, {
        "text": " a true endocrine gland but rather a specialized neurosecretory terminal, acting as a storage depot for hypothalamic hormones and releasing them directly into the bloodstream upon"
      }, {
        "text": " neural command from the hypothalamus.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypothalamus\u003c"
      }, {
        "text": "br\u003e(Supraoptic \u0026 Paraventricular Nuclei)] --Axonal Transport--\u003e B(Neurohypophysis); B --"
      }, {
        "text": "Release into Blood--\u003e C(ADH \u0026 Oxytocin);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_part_of\",\n        \"to\": \"pituitary_gland\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"releases\",\n        \"to\": \"antidiuretic_hormone\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"releases\",\n        \"to\": \"911d3b47\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_connected_to\",\n        \"to\": \"89e8"
      }, {
        "text": "6633\"\n      }\n    ]\n  },\n  \"38e52c3"
      }, {
        "text": "e\": {\n    \"title\": \"Neurokinin-1 (NK1) Receptors\",\n    \"primaryType\": \"molecule"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Gastroenterology\",\n      \"Neuro"
      }, {
        "text": "science\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Gastrointestinal"
      }, {
        "text": "\",\n      \"Pharmacology\",\n      \"Antiemetics\"\n    ],\n    \"content\": {\n"
      }, {
        "text": "      \"definition\": \"\u003cp\u003e\u003cb\u003eNeurokinin-1 (NK1) receptors\u003c/b\u003e are G-protein coupled receptors for"
      }, {
        "text": " the neuropeptide Substance P. They are found in the central and peripheral nervous systems and are critically involved in the pathways"
      }, {
        "text": " for pain and, most notably, emesis (vomiting).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLig"
      }, {
        "text": "and:\u003c/b\u003e The primary endogenous ligand is \u003cmark\u003eSubstance P\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation in Emesis Pathway:\u003c/b\u003e NK1 receptors are"
      }, {
        "text": " highly concentrated in the \u003cmark\u003earea postrema\u003c/mark\u003e (chemoreceptor trigger zone) and the \u003cmark\u003enucleus tract"
      }, {
        "text": "us solitarius (NTS)\u003c/mark\u003e, which are key components of the central vomiting center in the brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole"
      }, {
        "text": " in Vomiting:\u003c/b\u003e Activation of NK1 receptors by Substance P is a key step in inducing both acute and, particularly, delayed nausea and vomiting."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacology (NK1 Antagonists):\u003c/b\u003e Drugs that block NK1 receptors (e.g., \u003c"
      }, {
        "text": "mark\u003eaprepitant\u003c/mark\u003e, fosaprepitant) are potent antiemetics. Their names often"
      }, {
        "text": " end in \u0027-pitant\u0027.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e NK1 antagonists are primarily used for the prevention of chemotherapy-induced nausea and"
      }, {
        "text": " vomiting (CINV), especially the delayed phase, and for postoperative nausea and vomiting (PONV).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE"
      }, {
        "text": " Tip:\u003c/b\u003e For chemotherapy-induced vomiting, remember the different receptor targets. Serotonin (5-HT3) antagonists (e"
      }, {
        "text": ".g., ondansetron) are best for acute CINV, while NK1 antagonists (e.g., aprepitant) are"
      }, {
        "text": " crucial for delayed CINV.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNK1 receptors\u003c/b\u003e are the"
      }, {
        "text": " primary target for Substance P in the brain\u0027s vomiting center; blocking these receptors with \u0027-pitant\u0027 drugs like aprepitant"
      }, {
        "text": " is a highly effective strategy for preventing the delayed nausea and vomiting associated with chemotherapy.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A["
      }, {
        "text": "Chemotherapy] --\u003e B(Release of Substance P); B --\u003e C(Binds to NK1 Receptors in Area"
      }, {
        "text": " Postrema/NTS); C --\u003e D(Emesis); E[Aprepitant] --|Blocks|"
      }, {
        "text": "--\u003e C;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_target"
      }, {
        "text": "_of\",\n        \"to\": \"substance_p\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_blocked_by\",\n        \"to\": \"aprepitant\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_located_in\",\n        \"to\": \"5dd343d3\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_located_in\",\n        \"to\": \"38bfa9e0\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"3888bfbd\": {\n    \"title\": \"Neurology and Special Senses\","
      }, {
        "text": "\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"Otology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and"
      }, {
        "text": " Special Senses\",\n      \"Overview\",\n      \"Main\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eNeurology and Special Senses\u003c/b\u003e is the field of medicine concerned with the diagnosis and treatment of disorders of the nervous system,"
      }, {
        "text": " which includes the brain, spinal cord, peripheral nerves, and the specialized sensory organs for vision, hearing, and balance.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Focuses on the development of the nervous system from the [[a"
      }, {
        "text": "87cbede|neural tube]] and [[14c6f2a7|neural crest cells]].\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Anatomy and Physiology:\u003c/b\u003e Covers the structure and function of neurons, glial cells, major brain regions, spinal cord tracts"
      }, {
        "text": ", and cranial nerves.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Includes a vast range of disorders such as cerebrovascular disease (stroke),"
      }, {
        "text": " [[41ca6981|neurodegenerative disorders]], [[45dd6d19|demyelin"
      }, {
        "text": "ating diseases]], infections, trauma, and tumors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOphthalmology:\u003c/b\u003e The subspecialty dealing with the anatomy"
      }, {
        "text": ", physiology, and diseases of the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOtology:\u003c/b\u003e The subspecialty dealing with the anatomy,"
      }, {
        "text": " physiology, and diseases of the ear, including hearing and balance.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacology:\u003c/b\u003e Involves drugs"
      }, {
        "text": " acting on the nervous system, such as anticonvulsants, anesthetics, and psychotropic medications.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003eThe study of \u003cb\u003eNeurology and Special Senses\u003c/b\u003e is fundamentally about understanding the intricate network"
      }, {
        "text": " that controls and perceives the body, and how disruptions in this network, from the molecular to the macroscopic level, manifest as clinical"
      }, {
        "text": " disease.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"includes_discipline\",\n        \"to\": \"neurology\"\n      },\n      {\n        \"type\": \"includes_"
      }, {
        "text": "discipline\",\n        \"to\": \"ophthalmology\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "includes_discipline\",\n        \"to\": \"c5a1d2fc\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "1aaaffd2\": {\n    \"title\": \"Neuromuscular Blocking Drugs\",\n    \"primaryType\":"
      }, {
        "text": " \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Neuromuscular Blockers\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eNeuromuscular blocking drugs\u003c/b\u003e are agents that cause skeletal muscle paralysis by interfering with neurotransmission at the neuromuscular junction."
      }, {
        "text": " They are classified as either depolarizing or non-depolarizing agents.\u003c/p\u003e\",\n      \"atAGlance\":"
      }, {
        "text": " \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDepolarizing Blockers:\u003c/b\u003e \u003cmark\u003eSuccinylcholine\u003c/mark\u003e is the only clinically"
      }, {
        "text": " used agent. It acts as an ACh receptor agonist, causing sustained depolarization (Phase I) followed by receptor desensitization (Phase II),"
      }, {
        "text": " leading to paralysis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNon-Depolarizing Blockers:\u003c/b\u003e Act as competitive antagonists at the ACh receptor. Examples include rocuronium,"
      }, {
        "text": " vecuronium, and [[243d4db1|pancuronium]]. Their effects are reversible with acetyl"
      }, {
        "text": "cholinesterase inhibitors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Primarily used during anesthesia to facilitate endotracheal intubation and provide"
      }, {
        "text": " optimal surgical conditions by relaxing skeletal muscles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMonitoring:\u003c/b\u003e The degree of blockade is monitored using a peripheral nerve stimulator to"
      }, {
        "text": " assess the train-of-four (TOF) response.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Succinylcholine can cause hyperkal"
      }, {
        "text": "emia and is a trigger for malignant hyperthermia. Non-depolarizing agents can cause histamine release (hypotension).\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNeuromuscular blocking drugs\u003c/b\u003e achieve paralysis through two opposing mechanisms at the acetylcholine"
      }, {
        "text": " receptor: succinylcholine by overstimulation (depolarizing) and drugs like rocuronium by competitive inhibition (non"
      }, {
        "text": "-depolarizing), a distinction critical for their clinical use and reversal.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n"
      }, {
        "text": "    \"connections\": [\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"dep"
      }, {
        "text": "olarizing_neuromuscular_blocker\"\n      },\n      {\n        \"type\": \"is_classified_as\","
      }, {
        "text": "\n        \"to\": \"48f817e6\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "used_in\",\n        \"to\": \"anesthesia\"\n      }\n    ]\n  },\n  \"7"
      }, {
        "text": "e727989\": {\n    \"title\": \"Neuromuscular Junction (NMJ)\",\n    \"primaryType\":"
      }, {
        "text": " \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Physiology\",\n      \"An"
      }, {
        "text": "atomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Anatomy and Physiology\",\n      \"Peripheral Nervous System\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eNeuromuscular Junction (NMJ)\u003c/b\u003e is a highly specialized synapse between the axon terminal of a motor neuron and"
      }, {
        "text": " the motor end plate of a skeletal muscle fiber, responsible for converting the neuron\u0027s electrical signal into muscle contraction.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter:\u003c/b\u003e The sole neurotransmitter at the NMJ is \u003cmark\u003eacetylcholine (ACh)\u003c/"
      }, {
        "text": "mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReceptor:\u003c/b\u003e ACh binds to \u003cmark\u003enicotinic (N\u003csub\u003eM\u003c/sub\u003e) receptors\u003c/mark"
      }, {
        "text": "\u003e on the postsynaptic muscle membrane (motor end plate).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e An action potential arriving at the axon"
      }, {
        "text": " terminal triggers the opening of voltage-gated Ca\u003csup\u003e2+\u003c/sup\u003e channels. Ca\u003csup\u003e2+\u003c/sup\u003e influx causes the release"
      }, {
        "text": " of ACh into the synaptic cleft. ACh binds to N\u003csub\u003eM\u003c/sub\u003e receptors, opening them to allow Na\u003csup\u003e+\u003c/sup\u003e influx"
      }, {
        "text": ", which generates an end-plate potential and triggers a muscle action potential.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e The NMJ is the site of pathology"
      }, {
        "text": " in several diseases: \u003cbr\u003e - \u003cb\u003eMyasthenia Gravis:\u003c/b\u003e Autoantibodies against postsynaptic ACh receptors. \u003cbr\u003e - \u003cb\u003e"
      }, {
        "text": "Lambert-Eaton Myasthenic Syndrome:\u003c/b\u003e Autoantibodies against presynaptic voltage-gated Ca\u003csup\u003e2+\u003c/sup\u003e channels. \u003cbr"
      }, {
        "text": "\u003e - \u003cb\u003eBotulism:\u003c/b\u003e Botulinum toxin cleaves SNARE proteins, preventing presynaptic ACh release.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacology:"
      }, {
        "text": "\u003c/b\u003e Targeted by [[1aaaffd2|neuromuscular blocking drugs]] used in anesthesia.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003eThe \u003cb\u003eNeuromuscular Junction\u003c/b\u003e is a high-fidelity synapse designed for obligatory"
      }, {
        "text": " one-to-one transmission, where every motor neuron action potential reliably leads to a muscle fiber action potential, a process that"
      }, {
        "text": " can be disrupted by autoantibodies or toxins, leading to muscle weakness or paralysis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A"
      }, {
        "text": "[Motor Neuron AP] --\u003e B(Ca2+ Influx); B --\u003e C(ACh Release); C --\u003e D(B"
      }, {
        "text": "inds to Nicotinic Receptors); D --\u003e E(Na+ Influx); E --\u003e F(End-Plate Potential); F --\u003e G("
      }, {
        "text": "Muscle AP \u0026 Contraction);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"uses"
      }, {
        "text": "_neurotransmitter\",\n        \"to\": \"6a005559\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_affected_in\",\n        \"to\": \"myasthenia_gravis\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \""
      }, {
        "text": "lambert_eaton_syndrome\"\n      },\n      {\n        \"type\": \"is_affected"
      }, {
        "text": "_by\",\n        \"to\": \"botulinum_toxin\"\n      }\n    ]\n  "
      }, {
        "text": "}\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"1c6cb12b\",\n    \"letter\": \"M\",\n    \"term\": \"Myoclonic seizures\",\n    \"pages\": [\n      \"531\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Myoclonic seizures\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"5e5fbd4d\",\n    \"letter\": \"M\",\n    \"term\": \"Myoclonus\",\n    \"pages\": [\n      \"533\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Myoclonus\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"c154b69c\",\n    \"letter\": \"M\",\n    \"term\": \"Myopia\",\n    \"pages\": [\n      \"549\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Myopia\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"6f2228c1\",\n    \"letter\": \"M\",\n    \"term\": \"M√©ni√®re disease\",\n    \"pages\": [\n      \"548\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"M√©ni√®re disease\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"9c56fa3c\",\n    \"letter\": \"N\",\n    \"term\": \"N2O\",\n    \"pages\": [\n      \"565\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"N2O\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"4526206c\",\n    \"letter\": \"N\",\n    \"term\": \"Nalbuphine\",\n    \"pages\": [\n      \"567\",\n      \"568\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Nalbuphine\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"ad3f7ac4\",\n    \"letter\": \"N\",\n    \"term\": \"Naltrexone\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Naltrexone\",\n    \"sub_entries\": [\n      {\n        \"id\": \"7c978233\",\n        \"letter\": \"N\",\n        \"term\": \"opioid toxicity\",\n        \"pages\": [\n          \"567\"\n        ],\n        \"context\": \"Naltrexone \u003e opioid toxicity\"\n      }\n    ]\n  },\n  {\n    \"id\": \"dffd3bab\",\n    \"letter\": \"N\",\n    \"term\": \"Narrow spectrum anticonvulsants\",\n    \"pages\": [\n      \"560\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Narrow spectrum anticonvulsants\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"ae20a0ce\",\n    \"letter\": \"N\",\n    \"term\": \"Natalizumab\",\n    \"pages\": [\n      \"537\",\n      \"538\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Natalizumab\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"288bdfc2\",\n    \"letter\": \"N\",\n    \"term\": \"Nausea\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Nausea\",\n    \"sub_entries\": [\n      {\n        \"id\": \"fc18959c\",\n        \"letter\": \"N\",\n        \"term\": \"migraine headaches\",\n        \"pages\": [\n          \"532\"\n        ],\n        \"context\": \"Nausea \u003e migraine headaches\"\n      }\n    ]\n  },\n  {\n    \"id\": \"544777c5\",\n    \"letter\": \"N\",\n    \"term\": \"Nearsightedness\",\n    \"pages\": [\n      \"549\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Nearsightedness\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"cb783bd9\",\n    \"letter\": \"N\",\n    \"term\": \"Necrosis\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Necrosis\",\n    \"sub_entries\": [\n      {\n        \"id\": \"928b5522\",\n        \"letter\": \"N\",\n        \"term\": \"glioblastoma\",\n        \"pages\": [\n          \"540\"\n        ],\n        \"context\": \"Necrosis \u003e glioblastoma\"\n      }\n    ]\n  },\n  {\n    \"id\": \"b95e97eb\",\n    \"letter\": \"N\",\n    \"term\": \"Neonatal abstinence syndrome\",\n    \"pages\": [\n      \"567\",\n      \"633\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Neonatal abstinence syndrome\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"4a697077\",\n    \"letter\": \"N\",\n    \"term\": \"Neonates\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Neonates\",\n    \"sub_entries\": [\n      {\n        \"id\": \"8d855360\",\n        \"letter\": \"N\",\n        \"term\": \"extracranial injuries\",\n        \"pages\": [\n          \"527\"\n        ],\n        \"context\": \"Neonates \u003e extracranial injuries\"\n      },\n      {\n        \"id\": \"49fd0ea3\",\n        \"letter\": \"N\",\n        \"term\": \"intraventricular hemorrhage\",\n        \"pages\": [\n          \"527\"\n        ],\n        \"context\": \"Neonates \u003e intraventricular hemorrhage\"\n      }\n    ]\n  },\n  {\n    \"id\": \"4ff1649e\",\n    \"letter\": \"N\",\n    \"term\": \"Nerve fibers\",\n    \"pages\": [\n      \"505\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Nerve fibers\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 1582
    }, {
      "text": "```json\n{\n  \"1c6cb12b\": {\n    \"title\": \"Myoclonic Seizures\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Epilepsy\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMyoclonic seizures\u003c/b\u003e are a type of generalized seizure characterized by sudden, brief, shock-like muscle jerks or twitches. They are typically bilateral and often affect the upper extremities, without a loss of consciousness.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden, involuntary muscle contractions that may be isolated or occur in clusters. Consciousness is usually preserved, and there is no postictal state.\u003c/li\u003e\u003cli\u003e\u003cb\u003eJuvenile Myoclonic Epilepsy (JME):\u003c/b\u003e Myoclonic seizures are a hallmark of JME, a common epilepsy syndrome with adolescent onset. In JME, myoclonic jerks are most prominent in the \u003cmark\u003emorning shortly after awakening\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Associations:\u003c/b\u003e Myoclonus can also be a feature of other conditions, including metabolic encephalopathies (e.g., uremia), anoxic brain injury, and prion diseases like [[86fe59ba|Creutzfeldt-Jakob disease]] (startle myoclonus).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Broad-spectrum anticonvulsants like [[valproic_acid|valproic acid]] are effective. Narrow-spectrum agents like carbamazepine and phenytoin can paradoxically worsen myoclonic seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A teenager who reports dropping their coffee cup or toothbrush in the morning due to sudden arm jerks is a classic presentation for Juvenile Myoclonic Epilepsy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMyoclonic seizures\u003c/b\u003e are distinguished by their brief, shock-like muscle jerks without loss of consciousness. Their characteristic occurrence upon awakening in adolescents is a key diagnostic clue for Juvenile Myoclonic Epilepsy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \"to\": \"juvenile_myoclonic_epilepsy\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"valproic_acid\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"86fe59ba\"\n      }\n    ]\n  },\n  \"5e5fbd4d\": {\n    \"title\": \"Myoclonus\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Movement Disorders\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMyoclonus\u003c/b\u003e is a clinical sign characterized by a sudden, brief, shock-like, involuntary muscle jerk or twitch. It can be a symptom of a wide range of underlying neurological disorders, including epilepsy, metabolic encephalopathies, and neurodegenerative diseases.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e A quick, involuntary muscle contraction. It can be focal, multifocal, or generalized. Examples range from benign hiccups to the severe jerks seen in certain epilepsies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEpileptic Myoclonus:\u003c/b\u003e Occurs as part of a [[1c6cb12b|myoclonic seizure]], as seen in Juvenile Myoclonic Epilepsy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetabolic Myoclonus:\u003c/b\u003e Often seen in metabolic encephalopathies such as uremic or hepatic encephalopathy.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePost-hypoxic Myoclonus (Lance-Adams Syndrome):\u003c/b\u003e A debilitating action myoclonus that can occur after a severe hypoxic brain injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurodegenerative Disease:\u003c/b\u003e Prominent \u0027startle myoclonus\u0027 (jerks in response to loud sounds or touch) is a characteristic feature of [[86fe59ba|Creutzfeldt-Jakob disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The clinical context is key to interpreting myoclonus. In an adolescent, think JME. In a patient with rapidly progressive dementia, think CJD. In a patient with renal failure, think uremic encephalopathy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMyoclonus\u003c/b\u003e is a non-specific sign of neuronal hyperexcitability that can originate from the cortex, brainstem, or spinal cord. Its diagnostic value lies in its association with other clinical features, which helps to pinpoint the underlying etiology.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"1c6cb12b\"\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"86fe59ba\"\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"uremic_encephalopathy\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"dyskinesia\"\n      }\n    ]\n  },\n  \"c154b69c\": {\n    \"title\": \"Myopia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMyopia\u003c/b\u003e, commonly known as nearsightedness, is a refractive error of the eye in which parallel light rays from distant objects are focused \u003ci\u003ein front of\u003c/i\u003e the retina, causing distant objects to appear blurry while near objects are seen clearly.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Occurs when the eye is either too long (axial myopia) or the cornea/lens system has too much refractive power (refractive myopia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients can see near objects clearly but have difficulty seeing distant objects (e.g., a chalkboard, road signs).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCorrection:\u003c/b\u003e Corrected with a \u003cmark\u003econcave (diverging) lens\u003c/mark\u003e (e.g., glasses or contact lenses with a negative diopter prescription). The diverging lens spreads out the light rays before they enter the eye, effectively moving the focal point backward onto the retina.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e High myopia is a risk factor for [[38c092f9|retinal detachment]] and glaucoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the correction: Myopia (nearsightedness) requires a di\u003cb\u003ev\u003c/b\u003eerging (conca\u003cb\u003ev\u003c/b\u003ee) lens. Hyperopia (farsightedness) requires a converging (convex) lens.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMyopia\u003c/b\u003e is a mismatch between the eye\u0027s focusing power and its length, causing distant images to be focused in the vitreous humor instead of on the retina. This is corrected by using a concave lens to diverge the light rays and push the focal point back to its proper location.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"refractive_error\"\n      },\n      {\n        \"type\": \"is_corrected_by\",\n        \"to\": \"concave_lens\"\n      },\n      {\n        \"type\": \"is_the_opposite_of\",\n        \"to\": \"hyperopia\"\n      },\n      {\n        \"type\": \"is_a_risk_factor_for\",\n        \"to\": \"38c092f9\"\n      }\n    ]\n  },\n  \"6f2228c1\": {\n    \"title\": \"M√©ni√®re Disease\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Otology\",\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eM√©ni√®re disease\u003c/b\u003e is a disorder of the inner ear characterized by recurrent episodes of vertigo, sensorineural hearing loss, and tinnitus, caused by an increase in the volume and pressure of endolymph (endolymphatic hydrops).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by \u003cmark\u003eendolymphatic hydrops\u003c/mark\u003e, an excessive accumulation of endolymph in the membranous labyrinth of the inner ear, leading to distention and potential rupture of these membranes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Triad:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eEpisodic Vertigo:\u003c/b\u003e Spontaneous, recurrent episodes of spinning vertigo that can last from minutes to hours.\u003cbr\u003e2. \u003cb\u003eSensorineural Hearing Loss:\u003c/b\u003e Typically fluctuating and low-frequency in the early stages, becoming permanent over time.\u003cbr\u003e3. \u003cb\u003eTinnitus:\u003c/b\u003e Ringing or roaring sound in the affected ear, often low-pitched.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Symptom:\u003c/b\u003e A feeling of aural fullness or pressure in the affected ear is also common.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management focuses on symptom control. A low-salt diet and diuretics (e.g., hydrochlorothiazide) are used to reduce endolymphatic pressure. Antiemetics and vestibular suppressants are used for acute vertigo attacks.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The triad of episodic vertigo, tinnitus, and sensorineural hearing loss is the key to diagnosing M√©ni√®re disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eM√©ni√®re disease\u003c/b\u003e is essentially \u0027glaucoma of the inner ear,\u0027 where an excess of endolymphatic fluid increases pressure within the labyrinth, leading to a characteristic triad of episodic vertigo, hearing loss, and tinnitus due to dysfunction of both the vestibular and cochlear apparatus.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"endolymphatic_hydrops\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"vertigo\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"sensorineural_hearing_loss\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"tinnitus\"\n      }\n    ]\n  },\n  \"9c56fa3c\": {\n    \"title\": \"Nitrous Oxide (N2O)\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNitrous oxide (N\u003csub\u003e2\u003c/sub\u003eO)\u003c/b\u003e, commonly known as laughing gas, is an inhaled general anesthetic with low potency but rapid onset and recovery, used for its analgesic and anxiolytic effects, often in combination with other anesthetics.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a \u003cmark\u003elow blood:gas partition coefficient\u003c/mark\u003e, meaning it is poorly soluble in blood. This results in a very \u003cmark\u003erapid onset\u003c/mark\u003e of action and a rapid recovery upon discontinuation.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePotency:\u003c/b\u003e Has a \u003cmark\u003ehigh MAC\u003c/mark\u003e (Minimum Alveolar Concentration), indicating low anesthetic potency. It cannot produce surgical anesthesia on its own and is typically used as an adjunct to more potent volatile anesthetics.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEffects:\u003c/b\u003e Provides good analgesia but is a weak anesthetic. It has minimal effects on the cardiovascular and respiratory systems compared to other inhaled agents.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The main concern is its tendency to diffuse into and expand gas-filled cavities in the body (e.g., pneumothorax, bowel obstruction, middle ear). Chronic exposure can lead to megaloblastic anemia by oxidizing vitamin B12.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that low blood solubility (low blood:gas coefficient) means fast induction and recovery. N\u003csub\u003e2\u003c/sub\u003eO is the classic example of this principle.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNitrous oxide\u003c/b\u003e is a fast-on, fast-off anesthetic due to its low blood solubility, but its low potency prevents its use as a sole agent for surgery. Its unique property of expanding gas-filled spaces makes it contraindicated in conditions like pneumothorax.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"inhaled_anesthetic\"\n      },\n      {\n        \"type\": \"has_property\",\n        \"to\": \"low_blood_gas_partition_coefficient\"\n      },\n      {\n        \"type\": \"has_property\",\n        \"to\": \"high_mac\"\n      },\n      {\n        \"type\": \"is_contraindicated_in\",\n        \"to\": \"pneumothorax\"\n      }\n    ]\n  },\n  \"4526206c\": {\n    \"title\": \"Nalbuphine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Pain Management\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Analgesics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNalbuphine\u003c/b\u003e is a synthetic \u003ci\u003eopioid analgesic\u003c/i\u003e with a mixed agonist-antagonist profile, acting as a Œ∫-opioid receptor agonist and a Œº-opioid receptor partial agonist or antagonist.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e It is a \u003cmark\u003eŒ∫-opioid receptor agonist\u003c/mark\u003e, which provides analgesia. It is also a \u003cmark\u003eŒº-opioid receptor antagonist\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for the management of moderate to severe pain. It can also be used as a supplement to balanced anesthesia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCeiling Effect:\u003c/b\u003e Due to its mixed agonist-antagonist properties, it exhibits a ceiling effect for respiratory depression, meaning that beyond a certain dose, further increases do not cause greater respiratory depression. This makes it potentially safer than full Œº-agonists like morphine.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrecipitation of Withdrawal:\u003c/b\u003e Because it is a Œº-antagonist, administering nalbuphine to a patient who is physically dependent on a full Œº-agonist (e.g., heroin, morphine) can precipitate an \u003cmark\u003eacute opioid withdrawal syndrome\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the mixed agonist-antagonist opioids (nalbuphine, butorphanol, pentazocine). Their key features are the ceiling effect on respiratory depression and the risk of precipitating withdrawal in opioid-dependent individuals.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNalbuphine\u003c/b\u003e offers analgesia primarily through Œ∫-receptor agonism while its Œº-receptor antagonism provides a safety advantage with a ceiling effect on respiratory depression, but this same property makes it dangerous to use in patients already dependent on full Œº-agonist opioids.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"opioid_analgesics\"\n      },\n      {\n        \"type\": \"is_an_agonist_at\",\n        \"to\": \"kappa_opioid_receptor\"\n      },\n      {\n        \"type\": \"is_an_antagonist_at\",\n        \"to\": \"mu_opioid_receptor\"\n      },\n      {\n        \"type\": \"can_precipitate\",\n        \"to\": \"opioid_withdrawal\"\n      }\n    ]\n  },\n  \"ad3f7ac4\": {\n    \"title\": \"Naltrexone\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Addiction Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Addiction Treatment\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNaltrexone\u003c/b\u003e is a long-acting, orally available \u003ci\u003eopioid antagonist\u003c/i\u003e used primarily for the management of alcohol and opioid use disorders by reducing cravings and blocking the euphoric effects of opioids.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a competitive antagonist at \u003cmark\u003eŒº-opioid receptors\u003c/mark\u003e (and to a lesser extent, Œ∫ and Œ¥ receptors).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUse in Opioid Use Disorder:\u003c/b\u003e Blocks the euphoric and sedative effects of opioids, helping to prevent relapse in highly motivated individuals who have already undergone detoxification. It will precipitate withdrawal if given to a patient currently using opioids.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUse in Alcohol Use Disorder:\u003c/b\u003e Reduces the rewarding effects of alcohol and cravings, likely by modulating the dopaminergic mesolimbic pathway via the endogenous opioid system.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e It is long-acting and available in oral and long-acting injectable formulations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Hepatotoxicity is a major concern, especially at high doses, requiring monitoring of liver function tests.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from naloxone: \u003cb\u003eNaloxone\u003c/b\u003e is short-acting and used for acute opioid overdose reversal. \u003cb\u003eNaltrexone\u003c/b\u003e is long-acting and used for relapse prevention (maintenance therapy).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNaltrexone\u003c/b\u003e helps maintain abstinence in both alcohol and opioid dependence by blocking the \u0027reward\u0027 pathway; it competitively occupies opioid receptors, preventing opioids from producing euphoria and reducing the pleasurable effects of alcohol.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"opioid_use_disorder\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"alcohol_use_disorder\"\n      },\n      {\n        \"type\": \"is_an_antagonist_at\",\n        \"to\": \"mu_opioid_receptor\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"naloxone\"\n      }\n    ]\n  },\n  \"dffd3bab\": {\n    \"title\": \"Narrow-Spectrum Anticonvulsants\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNarrow-spectrum anticonvulsants\u003c/b\u003e are antiepileptic drugs that are primarily effective for treating \u003ci\u003efocal seizures\u003c/i\u003e (both aware and impaired awareness) and may be ineffective or even worsen certain types of generalized seizures, such as absence or myoclonic seizures.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eExamples:\u003c/b\u003e \u003cmark\u003eCarbamazepine\u003c/mark\u003e, \u003cmark\u003ePhenytoin\u003c/mark\u003e, Gabapentin, Pregabalin, Oxcarbazepine.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrimary Indication:\u003c/b\u003e First-line agents for [[e46906ba|focal seizures]]. They can also be used for focal seizures that secondarily generalize.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Many (like carbamazepine and phenytoin) work by blocking voltage-gated \u003cmark\u003eNa\u003csup\u003e+\u003c/sup\u003e channels\u003c/mark\u003e, which preferentially inhibits high-frequency firing characteristic of seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindication:\u003c/b\u003e These drugs can \u003cmark\u003eexacerbate absence and myoclonic seizures\u003c/mark\u003e. Therefore, accurate seizure classification is crucial before initiating therapy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For a patient with focal seizures, a narrow-spectrum agent like carbamazepine is an appropriate choice. For a patient with mixed seizure types (e.g., absence and tonic-clonic), a broad-spectrum agent like valproic acid is preferred.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNarrow-spectrum anticonvulsants\u003c/b\u003e are specialized tools for focal epilepsy; their use requires a precise diagnosis, as their application in certain generalized epilepsies (like absence or myoclonic) can paradoxically worsen seizure control.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"e46906ba\"\n      },\n      {\n        \"type\": \"can_worsen\",\n        \"to\": \"a0c128f4\"\n      },\n      {\n        \"type\": \"can_worsen\",\n        \"to\": \"1c6cb12b\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"eddd2bc5\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"5aea213f\"\n      }\n    ]\n  },\n  \"ae20a0ce\": {\n    \"title\": \"Natalizumab\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Immunology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Immunomodulators\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNatalizumab\u003c/b\u003e is a humanized monoclonal antibody that targets the Œ±4-integrin, used as a disease-modifying therapy for relapsing forms of \u003ci\u003eMultiple Sclerosis (MS)\u003c/i\u003e and Crohn disease.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Binds to the Œ±4-subunit of integrins (specifically Œ±4Œ≤1-integrin, also known as VLA-4) on the surface of leukocytes. This blocks the interaction of leukocytes with vascular cell adhesion molecule-1 (VCAM-1) on endothelial cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEffect:\u003c/b\u003e By blocking this interaction, natalizumab prevents lymphocytes from migrating across the [[dd47b9cc|blood-brain barrier]] into the CNS parenchyma, thereby reducing the inflammatory demyelinating lesions of [[45dd6d19|MS]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Highly effective for reducing relapse rates in patients with active relapsing-remitting [[45dd6d19|MS]]. Also used for moderate to severe Crohn disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMajor Adverse Effect:\u003c/b\u003e The most serious risk is the development of \u003cmark\u003eProgressive Multifocal Leukoencephalopathy (PML)\u003c/mark\u003e, a rare and often fatal brain infection caused by reactivation of the JC virus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The association between natalizumab and PML is extremely high-yield. Patients must be tested for JC virus antibodies before starting therapy and monitored closely.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNatalizumab\u003c/b\u003e acts as a \u0027gatekeeper\u0027 for the blood-brain barrier, preventing inflammatory lymphocytes from entering the CNS. While highly effective for MS, this powerful immunosuppressive mechanism carries the significant risk of allowing latent JC virus to reactivate, leading to PML.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Lymphocyte] --Œ±4-Integrin--\u003e B(VCAM-1 on BBB); B --\u003e C(CNS Infiltration); D[Natalizumab] --|Blocks|--\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"crohn_disease\"\n      },\n      {\n        \"type\": \"increases_risk_of\",\n        \"to\": \"progressive_multifocal_leukoencephalopathy\"\n      },\n      {\n        \"type\": \"targets\",\n        \"to\": \"alpha4_integrin\"\n      }\n    ]\n  },\n  \"288bdfc2\": {\n    \"title\": \"Nausea\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Gastroenterology\",\n      \"Neurology\",\n      \"Symptom\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Gastrointestinal\",\n      \"Pathology\",\n      \"Symptoms\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNausea\u003c/b\u003e is the unpleasant sensation of the urge to vomit. It is a complex protective reflex coordinated by the vomiting center in the brainstem, which receives inputs from multiple sources.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNeurological Control:\u003c/b\u003e The vomiting center is located in the medulla and receives inputs from: \u003cbr\u003e - The \u003cmark\u003echemoreceptor trigger zone (CTZ)\u003c/mark\u003e in the [[5dd343d3|area postrema]], which senses toxins in the blood.\u003cbr\u003e - The vestibular system (motion sickness).\u003cbr\u003e - The GI tract (via the vagus nerve).\u003cbr\u003e - The CNS (e.g., from increased intracranial pressure or psychological stimuli).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMigraine Headaches:\u003c/b\u003e Nausea is a key diagnostic criterion for [[26661e34|migraine headaches]], often accompanying the pulsating head pain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIncreased Intracranial Pressure:\u003c/b\u003e Nausea and vomiting, especially projectile vomiting without preceding nausea, are classic signs of elevated ICP.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacology:\u003c/b\u003e Antiemetic drugs target the various receptors in the vomiting pathways, including dopamine (D2), serotonin (5-HT3), histamine (H1), acetylcholine (M1), and neurokinin (NK1) receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Nausea and vomiting associated with a headache that is worse in the morning or awakens the patient from sleep is a red flag for a brain tumor or other cause of increased ICP.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNausea\u003c/b\u003e is a centrally mediated sensation orchestrated by the brainstem\u0027s vomiting center, which integrates a wide array of inputs from the blood, gut, and brain itself to signal potential harm and trigger the urge to vomit.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"26661e34\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"increased_intracranial_pressure\"\n      },\n      {\n        \"type\": \"is_mediated_by\",\n        \"to\": \"vomiting_center\"\n      }\n    ]\n  },\n  \"544777c5\": {\n    \"title\": \"Nearsightedness (Myopia)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNearsightedness\u003c/b\u003e, clinically known as \u003cb\u003emyopia\u003c/b\u003e, is a common refractive error where light from distant objects is focused \u003ci\u003ein front of\u003c/i\u003e the retina, causing distant vision to be blurry while near vision remains clear.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Occurs when the eyeball is too long (axial myopia) or the cornea and lens have too much focusing power (refractive myopia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients can see near objects clearly but have difficulty seeing distant objects (e.g., a chalkboard, road signs).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCorrection:\u003c/b\u003e Corrected with a \u003cmark\u003econcave (diverging) lens\u003c/mark\u003e (e.g., glasses or contact lenses with a negative diopter prescription). The diverging lens spreads out the light rays before they enter the eye, effectively moving the focal point backward onto the retina.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e High myopia is a risk factor for [[38c092f9|retinal detachment]] and glaucoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the correction: Myopia (nearsightedness) requires a di\u003cb\u003ev\u003c/b\u003eerging (conca\u003cb\u003ev\u003c/b\u003ee) lens. Hyperopia (farsightedness) requires a converging (convex) lens.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNearsightedness\u003c/b\u003e is a mismatch between the eye\u0027s focusing power and its length, causing distant images to be focused in the vitreous humor instead of on the retina. This is corrected by using a concave lens to diverge the light rays and push the focal point back to its proper location.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_also_known_as\",\n        \"to\": \"c154b69c\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"refractive_error\"\n      },\n      {\n        \"type\": \"is_corrected_by\",\n        \"to\": \"concave_lens\"\n      }\n    ]\n  },\n  \"cb783bd9\": {\n    \"title\": \"Necrosis in Glioblastoma\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNecrosis\u003c/b\u003e is a hallmark pathological feature of [[b6bbd0bc|Glioblastoma (GBM)]], the most aggressive primary brain tumor. It results from the tumor outgrowing its blood supply and is a key component of its characteristic histological and radiological appearance.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHistological Appearance:\u003c/b\u003e The necrosis in GBM is classically surrounded by a rim of hypercellular, malignant tumor cells, a pattern known as \u003cmark\u003epseudopalisading necrosis\u003c/mark\u003e. This is a pathognomonic finding.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRadiological Appearance:\u003c/b\u003e The central necrosis, combined with peripheral tumor cell proliferation and neovascularity, creates the typical \u003cmark\u003ering-enhancing lesion\u003c/mark\u003e seen on contrast-enhanced MRI. The center is necrotic (non-enhancing) while the viable, vascular tumor at the edge enhances brightly.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Rapid tumor growth leads to hypoxia and subsequent necrosis in the tumor core. Hypoxia, in turn, stimulates the production of angiogenic factors like VEGF, promoting microvascular proliferation at the tumor\u0027s edge.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e The presence of necrosis is a key feature that distinguishes glioblastoma (WHO grade IV astrocytoma) from lower-grade astrocytomas.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The phrase \\\"pseudopalisading necrosis\\\" on a pathology report for a brain tumor is a buzzword for [[b6bbd0bc|glioblastoma]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eIn [[b6bbd0bc|glioblastoma]], \u003cb\u003enecrosis\u003c/b\u003e is not just cell death but a driver of malignancy; the resulting hypoxia triggers aggressive angiogenesis, fueling the tumor\u0027s rapid growth and creating the characteristic and ominous ring-enhancing appearance on MRI.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \"to\": \"b6bbd0bc\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\": \"pseudopalisading_necrosis\"\n      },\n      {\n        \"type\": \"contributes_to\",\n        \"to\": \"ring_enhancing_lesion\"\n      }\n    ]\n  },\n  \"b95e97eb\": {\n    \"title\": \"Neonatal Abstinence Syndrome (NAS)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Pharmacology\",\n      \"Toxicology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pathology\",\n      \"Substance Use Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeonatal Abstinence Syndrome (NAS)\u003c/b\u003e is a postnatal drug withdrawal syndrome that occurs in newborns who were exposed to addictive substances, most commonly opioids, in utero.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by the abrupt cessation of fetal exposure to substances like opioids (heroin, methadone, prescription painkillers), benzodiazepines, or SSRIs upon delivery.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The fetus develops physical dependence on the substance crossing the placenta. After birth, the supply is cut off, leading to a withdrawal syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Symptoms typically begin within 24-72 hours of birth. The infant exhibits signs of CNS hyper-excitability, autonomic dysfunction, and GI disturbances.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Symptoms:\u003c/b\u003e \u003cmark\u003eHigh-pitched, inconsolable crying\u003c/mark\u003e, irritability, poor feeding, tremors, increased muscle tone, sweating, sneezing, vomiting, and diarrhea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management is primarily supportive (swaddling, quiet environment, frequent small feeds). Pharmacotherapy with opioids (e.g., morphine, methadone) is used for severe withdrawal, with doses gradually tapered.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A newborn who is irritable, has a high-pitched cry, is tremulous, and has diarrhea and vomiting should raise immediate suspicion for NAS, especially if there is a maternal history of substance use.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNeonatal Abstinence Syndrome\u003c/b\u003e is a tragic consequence of in-utero drug exposure, where the newborn experiences a state of acute withdrawal characterized by profound CNS and autonomic hyper-excitability, manifesting as an inconsolably irritable and physically distressed infant.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"maternal_opioid_use\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"drug_withdrawal_syndrome\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"morphine\"\n      }\n    ]\n  },\n  \"4a697077\": {\n    \"title\": \"Neonatal Neurological Complications\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Pediatric Neurology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeonatal neurological complications\u003c/b\u003e are injuries to the brain and skull that occur during the perinatal period, often related to the mechanical stresses of labor and delivery or the physiological vulnerabilities of prematurity.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eIntraventricular Hemorrhage (IVH):\u003c/b\u003e Bleeding into the ventricles, most common in \u003cmark\u003epremature infants\u003c/mark\u003e. Originates from the fragile germinal matrix. Can lead to hydrocephalus and long-term neurological deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eExtracranial Injuries:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCaput Succedaneum:\u003c/b\u003e Benign, edematous swelling of the scalp above the periosteum that \u003cmark\u003ecrosses suture lines\u003c/mark\u003e.\u003cbr\u003e - \u003cb\u003eCephalohematoma:\u003c/b\u003e Subperiosteal hemorrhage that is limited by and does \u003cu\u003enot\u003c/u\u003e cross suture lines. Can increase risk of jaundice.\u003cbr\u003e - \u003cb\u003eSubgaleal Hemorrhage:\u003c/b\u003e Potentially life-threatening bleed into the space between the periosteum and the scalp aponeurosis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHypoxic-Ischemic Encephalopathy (HIE):\u003c/b\u003e Brain injury due to oxygen deprivation during the perinatal period.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to differentiating scalp hematomas is their relationship to suture lines. Caput \u003cb\u003ec\u003c/b\u003erosses \u003cb\u003ec\u003c/b\u003eutures. Cephalohematoma is contained.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe neonatal brain is uniquely vulnerable to both mechanical and ischemic insults during birth. Differentiating between benign findings like caput succedaneum and serious complications like intraventricular hemorrhage is critical for appropriate management and prognosis.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"f1695e4c\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"46ca72c2\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"a5295f1a\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"8a695458\"\n      }\n    ]\n  },\n  \"4ff1649e\": {\n    \"title\": \"Nerve Fibers\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Histology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Peripheral Nervous System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNerve fibers\u003c/b\u003e are the axons of neurons, classified based on their diameter, myelination status, and conduction velocity, which determines their specific sensory or motor function.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAŒ± fibers:\u003c/b\u003e Large diameter, heavily myelinated. The fastest conducting fibers. Function: proprioception (from muscle spindles, Golgi tendon organs) and somatic motor (alpha motor neurons).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAŒ≤ fibers:\u003c/b\u003e Medium diameter, myelinated. Function: touch, pressure, vibration.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAŒ¥ fibers:\u003c/b\u003e Small diameter, thinly myelinated. Function: transmit \u003cmark\u003efast, sharp, well-localized pain\u003c/mark\u003e and cold temperature.\u003c/li\u003e\u003cli\u003e\u003cb\u003eC fibers:\u003c/b\u003e Smallest diameter, \u003cmark\u003eunmyelinated\u003c/mark\u003e. The slowest conducting fibers. Function: transmit \u003cmark\u003eslow, dull, poorly-localized pain\u003c/mark\u003e and warmth. Also include postganglionic autonomic fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Local anesthetics preferentially block small, myelinated fibers first, which is why pain sensation (AŒ¥ and C fibers) is lost before touch (AŒ≤ fibers).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the two types of pain fibers: AŒ¥ for the initial \u0027ouch\u0027 and C fibers for the subsequent \u0027ache\u0027.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe structure of a \u003cb\u003enerve fiber\u003c/b\u003e dictates its function; large, myelinated fibers are built for speed to transmit motor commands and discriminative touch, while small, unmyelinated fibers are designed for the slower, more persistent signaling of dull pain and temperature.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_component_of\",\n        \"to\": \"peripheral_nerve\"\n      },\n      {\n        \"type\": \"are_classified_by\",\n        \"to\": \"myelination\"\n      },\n      {\n        \"type\": \"are_classified_by\",\n        \"to\": \"conduction_velocity\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9176,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"1c6cb12b\": {\n    \"title\": \""
      }, {
        "text": "Myoclonic Seizures\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Epilepsy\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n"
      }, {
        "text": "    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMyoclonic seizures\u003c/b\u003e are a type of generalized seizure characterized by"
      }, {
        "text": " sudden, brief, shock-like muscle jerks or twitches. They are typically bilateral and often affect the upper extremities"
      }, {
        "text": ", without a loss of consciousness.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden"
      }, {
        "text": ", involuntary muscle contractions that may be isolated or occur in clusters. Consciousness is usually preserved, and there is no postictal"
      }, {
        "text": " state.\u003c/li\u003e\u003cli\u003e\u003cb\u003eJuvenile Myoclonic Epilepsy (JME):\u003c/b\u003e Myoclonic seizures are a hallmark of JME, a"
      }, {
        "text": " common epilepsy syndrome with adolescent onset. In JME, myoclonic jerks are most prominent in the \u003cmark\u003emorning shortly"
      }, {
        "text": " after awakening\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Associations:\u003c/b\u003e Myoclonus can also be a feature of other conditions"
      }, {
        "text": ", including metabolic encephalopathies (e.g., uremia), anoxic brain injury, and prion diseases like [[8"
      }, {
        "text": "6fe59ba|Creutzfeldt-Jakob disease]] (startle myoclonus).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment"
      }, {
        "text": ":\u003c/b\u003e Broad-spectrum anticonvulsants like [[valproic_acid|valproic acid]] are effective. Narrow"
      }, {
        "text": "-spectrum agents like carbamazepine and phenytoin can paradoxically worsen myoclonic seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e A teenager who reports dropping their coffee cup or toothbrush in the morning due to sudden arm jerks is a classic presentation for"
      }, {
        "text": " Juvenile Myoclonic Epilepsy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMyoclonic seizures\u003c/b\u003e are distinguished"
      }, {
        "text": " by their brief, shock-like muscle jerks without loss of consciousness. Their characteristic occurrence upon awakening in adolescents is a key"
      }, {
        "text": " diagnostic clue for Juvenile Myoclonic Epilepsy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_type_of\",\n        \"to\": \"64c0"
      }, {
        "text": "8e92\"\n      },\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \""
      }, {
        "text": "to\": \"juvenile_myoclonic_epilepsy\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_treated_by\",\n        \"to\": \"valproic_acid\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_a_symptom_of\",\n        \"to\": \"86fe59ba\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"5e5fbd4d\": {\n    \"title\": \"Myoclonus\",\n    "
      }, {
        "text": "\"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Movement Disorders\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eMyoclonus\u003c/b\u003e is a clinical sign characterized by a sudden, brief, shock-like,"
      }, {
        "text": " involuntary muscle jerk or twitch. It can be a symptom of a wide range of underlying neurological disorders, including epilepsy, metabolic encephal"
      }, {
        "text": "opathies, and neurodegenerative diseases.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e A"
      }, {
        "text": " quick, involuntary muscle contraction. It can be focal, multifocal, or generalized. Examples range from benign hiccups to the"
      }, {
        "text": " severe jerks seen in certain epilepsies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEpileptic Myoclonus:\u003c/b\u003e Occurs as part"
      }, {
        "text": " of a [[1c6cb12b|myoclonic seizure]], as seen in Juvenile Myoclonic Epilepsy."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetabolic Myoclonus:\u003c/b\u003e Often seen in metabolic encephalopathies such as uremic or hepatic encephalopathy"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003ePost-hypoxic Myoclonus (Lance-Adams Syndrome):\u003c/b\u003e A debilitating action myoclonus that"
      }, {
        "text": " can occur after a severe hypoxic brain injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurodegenerative Disease:\u003c/b\u003e Prominent \u0027startle myoclonus\u0027 ("
      }, {
        "text": "jerks in response to loud sounds or touch) is a characteristic feature of [[86fe59ba|Creutzfeldt-Jakob"
      }, {
        "text": " disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The clinical context is key to interpreting myoclonus. In an adolescent, think"
      }, {
        "text": " JME. In a patient with rapidly progressive dementia, think CJD. In a patient with renal failure, think u"
      }, {
        "text": "remic encephalopathy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMyoclonus\u003c/b\u003e is"
      }, {
        "text": " a non-specific sign of neuronal hyperexcitability that can originate from the cortex, brainstem, or spinal cord. Its diagnostic"
      }, {
        "text": " value lies in its association with other clinical features, which helps to pinpoint the underlying etiology.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to"
      }, {
        "text": "\": \"1c6cb12b\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_feature_of\",\n        \"to\": \"86fe59ba\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"uremic_"
      }, {
        "text": "encephalopathy\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"dyskinesia\"\n      }\n    ]\n  },\n  \"c154"
      }, {
        "text": "b69c\": {\n    \"title\": \"Myopia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Ophthalmology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \""
      }, {
        "text": "Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMyopia\u003c/b\u003e"
      }, {
        "text": ", commonly known as nearsightedness, is a refractive error of the eye in which parallel light rays from distant objects are focused "
      }, {
        "text": "\u003ci\u003ein front of\u003c/i\u003e the retina, causing distant objects to appear blurry while near objects are seen clearly.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Occurs when the eye is either too long (axial myopia"
      }, {
        "text": ") or the cornea/lens system has too much refractive power (refractive myopia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients can"
      }, {
        "text": " see near objects clearly but have difficulty seeing distant objects (e.g., a chalkboard, road signs).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCorrection:"
      }, {
        "text": "\u003c/b\u003e Corrected with a \u003cmark\u003econcave (diverging) lens\u003c/mark\u003e (e.g., glasses"
      }, {
        "text": " or contact lenses with a negative diopter prescription). The diverging lens spreads out the light rays before they enter the eye, effectively"
      }, {
        "text": " moving the focal point backward onto the retina.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e High myopia is a risk factor for [["
      }, {
        "text": "38c092f9|retinal detachment]] and glaucoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember"
      }, {
        "text": " the correction: Myopia (nearsightedness) requires a di\u003cb\u003ev\u003c/b\u003eerging (conca\u003cb\u003ev\u003c/b\u003ee"
      }, {
        "text": ") lens. Hyperopia (farsightedness) requires a converging (convex) lens.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eMyopia\u003c/b\u003e is a mismatch between the eye\u0027s focusing power and its length, causing distant"
      }, {
        "text": " images to be focused in the vitreous humor instead of on the retina. This is corrected by using a concave lens to diverge"
      }, {
        "text": " the light rays and push the focal point back to its proper location.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"ref"
      }, {
        "text": "ractive_error\"\n      },\n      {\n        \"type\": \"is_corrected_by\",\n        \"to\":"
      }, {
        "text": " \"concave_lens\"\n      },\n      {\n        \"type\": \"is_the_opposite_of\",\n        \""
      }, {
        "text": "to\": \"hyperopia\"\n      },\n      {\n        \"type\": \"is_a_risk_"
      }, {
        "text": "factor_for\",\n        \"to\": \"38c092f9\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"6f2228c1\": {\n    \"title\": \"M"
      }, {
        "text": "√©ni√®re Disease\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Otology\",\n      \"Neurology\","
      }, {
        "text": "\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      "
      }, {
        "text": "\"Neurology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eM√©ni√®re disease\u003c/b\u003e is a disorder of the inner ear characterized by recurrent"
      }, {
        "text": " episodes of vertigo, sensorineural hearing loss, and tinnitus, caused by an increase in the volume and pressure of endolymph (end"
      }, {
        "text": "olymphatic hydrops).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Ca"
      }, {
        "text": "used by \u003cmark\u003eendolymphatic hydrops\u003c/mark\u003e, an excessive accumulation of endolymph in the membran"
      }, {
        "text": "ous labyrinth of the inner ear, leading to distention and potential rupture of these membranes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Triad:\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e1. \u003cb\u003eEpisodic Vertigo:\u003c/b\u003e Spontaneous, recurrent episodes of spinning vertigo that can last from"
      }, {
        "text": " minutes to hours.\u003cbr\u003e2. \u003cb\u003eSensorineural Hearing Loss:\u003c/b\u003e Typically fluctuating and low-frequency in"
      }, {
        "text": " the early stages, becoming permanent over time.\u003cbr\u003e3. \u003cb\u003eTinnitus:\u003c/b\u003e Ringing or roaring sound"
      }, {
        "text": " in the affected ear, often low-pitched.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Symptom:\u003c/b\u003e A feeling of aural fullness or pressure in the affected ear"
      }, {
        "text": " is also common.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management focuses on symptom control. A low-salt diet and diuretics ("
      }, {
        "text": "e.g., hydrochlorothiazide) are used to reduce endolymphatic pressure. Antiemetics and vestibular"
      }, {
        "text": " suppressants are used for acute vertigo attacks.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The triad of episodic vertigo, tinnitus"
      }, {
        "text": ", and sensorineural hearing loss is the key to diagnosing M√©ni√®re disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "M√©ni√®re disease\u003c/b\u003e is essentially \u0027glaucoma of the inner ear,\u0027 where an excess of endolymphatic"
      }, {
        "text": " fluid increases pressure within the labyrinth, leading to a characteristic triad of episodic vertigo, hearing loss, and tinnitus due to dysfunction"
      }, {
        "text": " of both the vestibular and cochlear apparatus.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"endol"
      }, {
        "text": "ymphatic_hydrops\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"vert"
      }, {
        "text": "igo\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\":"
      }, {
        "text": " \"sensorineural_hearing_loss\"\n      },\n      {\n        \"type\": \"presents_"
      }, {
        "text": "with\",\n        \"to\": \"tinnitus\"\n      }\n    ]\n  },\n  \"9"
      }, {
        "text": "c56fa3c\": {\n    \"title\": \"Nitrous Oxide (N2O)\",\n    \"primaryType\": \""
      }, {
        "text": "drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eNitrous oxide (N\u003csub\u003e2\u003c/sub\u003eO)\u003c/b\u003e, commonly known as laughing gas, is an inhaled"
      }, {
        "text": " general anesthetic with low potency but rapid onset and recovery, used for its analgesic and anxiolytic effects, often in combination with other anest"
      }, {
        "text": "hetics.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a \u003cmark\u003elow blood"
      }, {
        "text": ":gas partition coefficient\u003c/mark\u003e, meaning it is poorly soluble in blood. This results in a very \u003cmark\u003erapid onset\u003c/"
      }, {
        "text": "mark\u003e of action and a rapid recovery upon discontinuation.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePotency:\u003c/b\u003e Has a \u003cmark\u003ehigh MAC\u003c/mark\u003e"
      }, {
        "text": " (Minimum Alveolar Concentration), indicating low anesthetic potency. It cannot produce surgical anesthesia on its own and is typically used as"
      }, {
        "text": " an adjunct to more potent volatile anesthetics.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEffects:\u003c/b\u003e Provides good analgesia but is a weak anesthetic. It"
      }, {
        "text": " has minimal effects on the cardiovascular and respiratory systems compared to other inhaled agents.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The"
      }, {
        "text": " main concern is its tendency to diffuse into and expand gas-filled cavities in the body (e.g., pneumothorax, bowel obstruction, middle"
      }, {
        "text": " ear). Chronic exposure can lead to megaloblastic anemia by oxidizing vitamin B12.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember"
      }, {
        "text": " that low blood solubility (low blood:gas coefficient) means fast induction and recovery. N\u003csub\u003e2\u003c/sub\u003eO is the"
      }, {
        "text": " classic example of this principle.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNitrous oxide\u003c/b\u003e is a fast-on"
      }, {
        "text": ", fast-off anesthetic due to its low blood solubility, but its low potency prevents its use as a sole agent for surgery"
      }, {
        "text": ". Its unique property of expanding gas-filled spaces makes it contraindicated in conditions like pneumothorax.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"inhaled_anesthetic\"\n      },\n      {\n        \"type\": \"has"
      }, {
        "text": "_property\",\n        \"to\": \"low_blood_gas_partition_coefficient\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"has_property\",\n        \"to\": \"high_mac\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_contraindicated_in\",\n        \"to\": \"pneumothorax\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"4526206c\": {\n    \"title\": \"Nalbu"
      }, {
        "text": "phine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Pain Management\",\n      "
      }, {
        "text": "\"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      "
      }, {
        "text": "\"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Analgesics\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNalbuphine\u003c/b\u003e is a synthetic "
      }, {
        "text": "\u003ci\u003eopioid analgesic\u003c/i\u003e with a mixed agonist-antagonist profile, acting as a Œ∫-opioid receptor agonist and a Œº-opioid receptor"
      }, {
        "text": " partial agonist or antagonist.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e It is a \u003c"
      }, {
        "text": "mark\u003eŒ∫-opioid receptor agonist\u003c/mark\u003e, which provides analgesia. It is also a \u003cmark\u003eŒº-opio"
      }, {
        "text": "id receptor antagonist\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for the management of moderate to severe pain. It"
      }, {
        "text": " can also be used as a supplement to balanced anesthesia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCeiling Effect:\u003c/b\u003e Due to its mixed agonist-antagonist properties"
      }, {
        "text": ", it exhibits a ceiling effect for respiratory depression, meaning that beyond a certain dose, further increases do not cause greater respiratory depression. This makes it potentially"
      }, {
        "text": " safer than full Œº-agonists like morphine.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrecipitation of Withdrawal:\u003c/b\u003e Because it is a Œº-ant"
      }, {
        "text": "agonist, administering nalbuphine to a patient who is physically dependent on a full Œº-agonist (e.g., heroin"
      }, {
        "text": ", morphine) can precipitate an \u003cmark\u003eacute opioid withdrawal syndrome\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember"
      }, {
        "text": " the mixed agonist-antagonist opioids (nalbuphine, butorphanol, pentazocine). Their key features"
      }, {
        "text": " are the ceiling effect on respiratory depression and the risk of precipitating withdrawal in opioid-dependent individuals.\u003c/li\u003e\u003c/ul\u003e\",\n"
      }, {
        "text": "      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNalbuphine\u003c/b\u003e offers analgesia primarily through Œ∫-receptor agonism while"
      }, {
        "text": " its Œº-receptor antagonism provides a safety advantage with a ceiling effect on respiratory depression, but this same property makes it dangerous"
      }, {
        "text": " to use in patients already dependent on full Œº-agonist opioids.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"opioid_analgesics\"\n      },\n      {\n        \"type\": \"is_an"
      }, {
        "text": "_agonist_at\",\n        \"to\": \"kappa_opioid_receptor\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_an_antagonist_at\",\n        \"to\": \"mu_opioid_receptor\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"can_precipitate\",\n        \"to\": \"opioid_withdrawal\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"ad3f7ac4\": {\n    \"title\": \"Naltrexone\",\n    \"primaryType"
      }, {
        "text": "\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n"
      }, {
        "text": "      \"Addiction Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\","
      }, {
        "text": "\n      \"Pharmacology\",\n      \"Addiction Treatment\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003e\u003cb\u003eNaltrexone\u003c/b\u003e is a long-acting, orally available \u003ci\u003eopioid antagonist"
      }, {
        "text": "\u003c/i\u003e used primarily for the management of alcohol and opioid use disorders by reducing cravings and blocking the euphoric effects of opioids.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a competitive antagonist at \u003cmark\u003eŒº-opioid receptors"
      }, {
        "text": "\u003c/mark\u003e (and to a lesser extent, Œ∫ and Œ¥ receptors).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUse in Opioid Use Disorder:\u003c/b\u003e Blocks"
      }, {
        "text": " the euphoric and sedative effects of opioids, helping to prevent relapse in highly motivated individuals who have already undergone detoxification. It will"
      }, {
        "text": " precipitate withdrawal if given to a patient currently using opioids.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUse in Alcohol Use Disorder:\u003c/b\u003e Reduces the rewarding"
      }, {
        "text": " effects of alcohol and cravings, likely by modulating the dopaminergic mesolimbic pathway via the endogenous opioid system.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmac"
      }, {
        "text": "okinetics:\u003c/b\u003e It is long-acting and available in oral and long-acting injectable formulations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Hepat"
      }, {
        "text": "otoxicity is a major concern, especially at high doses, requiring monitoring of liver function tests.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " Differentiate from naloxone: \u003cb\u003eNaloxone\u003c/b\u003e is short-acting and used for acute opioid overdose reversal. \u003cb\u003eNaltrexone\u003c/b\u003e"
      }, {
        "text": " is long-acting and used for relapse prevention (maintenance therapy).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNalt"
      }, {
        "text": "rexone\u003c/b\u003e helps maintain abstinence in both alcohol and opioid dependence by blocking the \u0027reward\u0027 pathway; it competitively occupies opioid"
      }, {
        "text": " receptors, preventing opioids from producing euphoria and reducing the pleasurable effects of alcohol.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"opioid_use_dis"
      }, {
        "text": "order\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        "
      }, {
        "text": "\"to\": \"alcohol_use_disorder\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_an_antagonist_at\",\n        \"to\": \"mu_opioid_receptor\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"naloxone\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"dffd3bab\": {\n    \"title\": \"Narrow-Spectrum Anticonvuls"
      }, {
        "text": "ants\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNarrow-spectrum anticonvulsants\u003c/b\u003e are"
      }, {
        "text": " antiepileptic drugs that are primarily effective for treating \u003ci\u003efocal seizures\u003c/i\u003e (both aware and impaired awareness) and may be"
      }, {
        "text": " ineffective or even worsen certain types of generalized seizures, such as absence or myoclonic seizures.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eExamples:\u003c/b\u003e \u003cmark\u003eCarbamazepine\u003c/mark\u003e, \u003cmark\u003ePhenytoin\u003c/mark\u003e, Gab"
      }, {
        "text": "apentin, Pregabalin, Oxcarbazepine.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrimary Indication:\u003c/b\u003e First-line agents"
      }, {
        "text": " for [[e46906ba|focal seizures]]. They can also be used for focal seizures that second"
      }, {
        "text": "arily generalize.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Many (like carbamazepine and phenytoin) work by blocking voltage-gated \u003c"
      }, {
        "text": "mark\u003eNa\u003csup\u003e+\u003c/sup\u003e channels\u003c/mark\u003e, which preferentially inhibits high-frequency firing characteristic of seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindication"
      }, {
        "text": ":\u003c/b\u003e These drugs can \u003cmark\u003eexacerbate absence and myoclonic seizures\u003c/mark\u003e. Therefore, accurate seizure"
      }, {
        "text": " classification is crucial before initiating therapy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For a patient with focal seizures, a narrow-spectrum agent like"
      }, {
        "text": " carbamazepine is an appropriate choice. For a patient with mixed seizure types (e.g., absence and tonic-clonic), a broad-spectrum"
      }, {
        "text": " agent like valproic acid is preferred.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNarrow-spectrum"
      }, {
        "text": " anticonvulsants\u003c/b\u003e are specialized tools for focal epilepsy; their use requires a precise diagnosis, as their application in certain"
      }, {
        "text": " generalized epilepsies (like absence or myoclonic) can paradoxically worsen seizure control.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to"
      }, {
        "text": "\": \"e46906ba\"\n      },\n      {\n        \"type\": \"can_w"
      }, {
        "text": "orsen\",\n        \"to\": \"a0c128f4\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"can_worsen\",\n        \"to\": \"1c6cb12b"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"eddd2"
      }, {
        "text": "bc5\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"5aea"
      }, {
        "text": "213f\"\n      }\n    ]\n  },\n  \"ae20a0ce\": {\n    \"title\": \""
      }, {
        "text": "Natalizumab\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\","
      }, {
        "text": "\n      \"Neurology\",\n      \"Immunology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \""
      }, {
        "text": "Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Immunomodulators\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNatalizumab\u003c/b\u003e is a humanized monoclonal antibody that targets the Œ±4"
      }, {
        "text": "-integrin, used as a disease-modifying therapy for relapsing forms of \u003ci\u003eMultiple Sclerosis (MS)\u003c/i\u003e and Crohn"
      }, {
        "text": " disease.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Binds to the Œ±4-subunit"
      }, {
        "text": " of integrins (specifically Œ±4Œ≤1-integrin, also known as VLA-4) on the surface of leukocytes. This blocks"
      }, {
        "text": " the interaction of leukocytes with vascular cell adhesion molecule-1 (VCAM-1) on endothelial cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEffect"
      }, {
        "text": ":\u003c/b\u003e By blocking this interaction, natalizumab prevents lymphocytes from migrating across the [[dd47b9cc|blood-brain barrier]] into"
      }, {
        "text": " the CNS parenchyma, thereby reducing the inflammatory demyelinating lesions of [[45dd6d19|MS]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Use:\u003c/b\u003e Highly effective for reducing relapse rates in patients with active relapsing-remitting [[45dd6d19|MS]]. Also"
      }, {
        "text": " used for moderate to severe Crohn disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMajor Adverse Effect:\u003c/b\u003e The most serious risk is the development of \u003cmark\u003eProgress"
      }, {
        "text": "ive Multifocal Leukoencephalopathy (PML)\u003c/mark\u003e, a rare and often fatal brain infection caused by reactivation of"
      }, {
        "text": " the JC virus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The association between natalizumab and PML is extremely high-yield. Patients"
      }, {
        "text": " must be tested for JC virus antibodies before starting therapy and monitored closely.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNatalizumab"
      }, {
        "text": "\u003c/b\u003e acts as a \u0027gatekeeper\u0027 for the blood-brain barrier, preventing inflammatory lymphocytes from entering the CNS. While highly"
      }, {
        "text": " effective for MS, this powerful immunosuppressive mechanism carries the significant risk of allowing latent JC virus to reactivate, leading to PML.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"graph TD; A[Lymphocyte] --Œ±4-Integrin--\u003e B(VCAM-1 on"
      }, {
        "text": " BBB); B --\u003e C(CNS Infiltration); D[Natalizumab] --|Blocks|--\u003e A;\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \""
      }, {
        "text": "45dd6d19\"\n      },\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "treatment_for\",\n        \"to\": \"crohn_disease\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"increases_risk_of\",\n        \"to\": \"progressive_multifocal_leukoencephalopathy\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"targets\",\n        \"to\": \"alpha4_integrin\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"288bdfc2\": {\n    \"title\": \"Nausea\","
      }, {
        "text": "\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Gastroenterology\",\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Symptom\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"G"
      }, {
        "text": "astrointestinal\",\n      \"Pathology\",\n      \"Symptoms\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eNausea\u003c/b\u003e is the unpleasant sensation of the urge to vomit. It is a complex protective reflex coordinated by the vomiting"
      }, {
        "text": " center in the brainstem, which receives inputs from multiple sources.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNeu"
      }, {
        "text": "rological Control:\u003c/b\u003e The vomiting center is located in the medulla and receives inputs from: \u003cbr\u003e - The \u003cmark\u003echemoreceptor trigger"
      }, {
        "text": " zone (CTZ)\u003c/mark\u003e in the [[5dd343d3|area postrema]], which senses"
      }, {
        "text": " toxins in the blood.\u003cbr\u003e - The vestibular system (motion sickness).\u003cbr\u003e - The GI tract (via"
      }, {
        "text": " the vagus nerve).\u003cbr\u003e - The CNS (e.g., from increased intracranial pressure or psychological stimuli).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMig"
      }, {
        "text": "raine Headaches:\u003c/b\u003e Nausea is a key diagnostic criterion for [[26661e34|migraine headaches]],"
      }, {
        "text": " often accompanying the pulsating head pain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIncreased Intracranial Pressure:\u003c/b\u003e Nausea and vomiting, especially projectile vomiting without"
      }, {
        "text": " preceding nausea, are classic signs of elevated ICP.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacology:\u003c/b\u003e Antiemetic drugs target the various"
      }, {
        "text": " receptors in the vomiting pathways, including dopamine (D2), serotonin (5-HT3), histamine (H1), acetylcholine"
      }, {
        "text": " (M1), and neurokinin (NK1) receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Nausea and"
      }, {
        "text": " vomiting associated with a headache that is worse in the morning or awakens the patient from sleep is a red flag for a brain"
      }, {
        "text": " tumor or other cause of increased ICP.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNausea\u003c/b\u003e is a centrally"
      }, {
        "text": " mediated sensation orchestrated by the brainstem\u0027s vomiting center, which integrates a wide array of inputs from the blood, gut"
      }, {
        "text": ", and brain itself to signal potential harm and trigger the urge to vomit.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_symptom_of\",\n"
      }, {
        "text": "        \"to\": \"26661e34\"\n      },\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "symptom_of\",\n        \"to\": \"increased_intracranial_pressure\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_mediated_by\",\n        \"to\": \"vomiting_center\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"544777c5\": {\n    \"title\": \""
      }, {
        "text": "Nearsightedness (Myopia)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Ophthalmology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \""
      }, {
        "text": "Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNearsightedness\u003c/b\u003e"
      }, {
        "text": ", clinically known as \u003cb\u003emyopia\u003c/b\u003e, is a common refractive error where light from distant objects is focused \u003ci\u003ein front of\u003c/i\u003e the retina,"
      }, {
        "text": " causing distant vision to be blurry while near vision remains clear.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Pathophysiology:\u003c/b\u003e Occurs when the eyeball is too long (axial myopia) or the cornea and lens have too much focusing"
      }, {
        "text": " power (refractive myopia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients can see near objects clearly but have difficulty seeing distant objects (e.g"
      }, {
        "text": "., a chalkboard, road signs).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCorrection:\u003c/b\u003e Corrected with a \u003cmark\u003econcave (diverging) lens\u003c/mark\u003e"
      }, {
        "text": " (e.g., glasses or contact lenses with a negative diopter prescription). The diverging lens spreads out the light rays"
      }, {
        "text": " before they enter the eye, effectively moving the focal point backward onto the retina.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e High"
      }, {
        "text": " myopia is a risk factor for [[38c092f9|retinal detachment]] and glaucoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " Remember the correction: Myopia (nearsightedness) requires a di\u003cb\u003ev\u003c/b\u003eerging (conca\u003cb\u003ev\u003c/b\u003ee) lens."
      }, {
        "text": " Hyperopia (farsightedness) requires a converging (convex) lens.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNears"
      }, {
        "text": "ightedness\u003c/b\u003e is a mismatch between the eye\u0027s focusing power and its length, causing distant images to be focused in"
      }, {
        "text": " the vitreous humor instead of on the retina. This is corrected by using a concave lens to diverge the light rays and push the focal"
      }, {
        "text": " point back to its proper location.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_also_known_as\",\n        \"to\": \"c154b69c\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"refractive_error\"\n      },\n      {\n        \"type\": \"is_corrected_by"
      }, {
        "text": "\",\n        \"to\": \"concave_lens\"\n      }\n    ]\n  },\n  \"cb"
      }, {
        "text": "783bd9\": {\n    \"title\": \"Necrosis in Glioblastoma\",\n    \"primary"
      }, {
        "text": "Type\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Pathology"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eNecrosis\u003c/b\u003e is a hallmark pathological feature of [[b6bbd0bc|Glioblastoma ("
      }, {
        "text": "GBM)]], the most aggressive primary brain tumor. It results from the tumor outgrowing its blood supply and is a"
      }, {
        "text": " key component of its characteristic histological and radiological appearance.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHist"
      }, {
        "text": "ological Appearance:\u003c/b\u003e The necrosis in GBM is classically surrounded by a rim of hypercellular, malignant tumor cells, a pattern known as \u003cmark\u003epseud"
      }, {
        "text": "opalisading necrosis\u003c/mark\u003e. This is a pathognomonic finding.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRadiological Appearance:\u003c/b\u003e The central"
      }, {
        "text": " necrosis, combined with peripheral tumor cell proliferation and neovascularity, creates the typical \u003cmark\u003ering-enhancing lesion\u003c/mark\u003e seen"
      }, {
        "text": " on contrast-enhanced MRI. The center is necrotic (non-enhancing) while the viable, vascular tumor at the edge"
      }, {
        "text": " enhances brightly.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Rapid tumor growth leads to hypoxia and subsequent necrosis in the tumor core."
      }, {
        "text": " Hypoxia, in turn, stimulates the production of angiogenic factors like VEGF, promoting microvascular proliferation at the tumor\u0027s edge.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Significance:\u003c/b\u003e The presence of necrosis is a key feature that distinguishes glioblastoma (WHO grade IV astrocytoma) from lower-grade"
      }, {
        "text": " astrocytomas.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The phrase \\\"pseudopalisading necrosis\\\" on a pathology"
      }, {
        "text": " report for a brain tumor is a buzzword for [[b6bbd0bc|glioblastoma]].\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003eIn [[b6bbd0bc|glioblastoma]], \u003cb\u003enecrosis\u003c/b\u003e is not"
      }, {
        "text": " just cell death but a driver of malignancy; the resulting hypoxia triggers aggressive angiogenesis, fueling the tumor\u0027s rapid growth and creating"
      }, {
        "text": " the characteristic and ominous ring-enhancing appearance on MRI.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \"to\": \"b6bbd0"
      }, {
        "text": "bc\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to"
      }, {
        "text": "\": \"pseudopalisading_necrosis\"\n      },\n      {\n        \"type\": \"contributes_to\","
      }, {
        "text": "\n        \"to\": \"ring_enhancing_lesion\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"b95e97eb\": {\n    \"title\": \"Neonatal Abstinence Syndrome (NAS)\",\n    \"primaryType\":"
      }, {
        "text": " \"disease\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Pharmacology\",\n      \"Toxicology\",\n      "
      }, {
        "text": "\"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Substance Use Disorders\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eNeonatal Abstinence Syndrome (NAS)\u003c/b\u003e is a postnatal drug withdrawal syndrome that occurs in newborns"
      }, {
        "text": " who were exposed to addictive substances, most commonly opioids, in utero.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eE"
      }, {
        "text": "tiology:\u003c/b\u003e Caused by the abrupt cessation of fetal exposure to substances like opioids (heroin, methadone, prescription"
      }, {
        "text": " painkillers), benzodiazepines, or SSRIs upon delivery.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The fetus develops physical dependence on the substance crossing"
      }, {
        "text": " the placenta. After birth, the supply is cut off, leading to a withdrawal syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Symptoms"
      }, {
        "text": " typically begin within 24-72 hours of birth. The infant exhibits signs of CNS hyper-excitability,"
      }, {
        "text": " autonomic dysfunction, and GI disturbances.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Symptoms:\u003c/b\u003e \u003cmark\u003eHigh-pitched, inconsolable crying"
      }, {
        "text": "\u003c/mark\u003e, irritability, poor feeding, tremors, increased muscle tone, sweating, sneezing, vomiting, and diarrhea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment"
      }, {
        "text": ":\u003c/b\u003e Management is primarily supportive (swaddling, quiet environment, frequent small feeds). Pharmacotherapy with opioids (e.g., morphine,"
      }, {
        "text": " methadone) is used for severe withdrawal, with doses gradually tapered.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A newborn"
      }, {
        "text": " who is irritable, has a high-pitched cry, is tremulous, and has diarrhea and vomiting should raise immediate suspicion for NAS,"
      }, {
        "text": " especially if there is a maternal history of substance use.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNeonatal Abstinence Syndrome\u003c/b\u003e"
      }, {
        "text": " is a tragic consequence of in-utero drug exposure, where the newborn experiences a state of acute withdrawal characterized by profound"
      }, {
        "text": " CNS and autonomic hyper-excitability, manifesting as an inconsolably irritable and physically distressed infant.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused"
      }, {
        "text": "_by\",\n        \"to\": \"maternal_opioid_use\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"drug_withdrawal_syndrome\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"morphine"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"4a697077\": {\n    \"title"
      }, {
        "text": "\": \"Neonatal Neurological Complications\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Ped"
      }, {
        "text": "iatrics\",\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n"
      }, {
        "text": "    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      "
      }, {
        "text": "\"Pediatric Neurology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeonatal neurological"
      }, {
        "text": " complications\u003c/b\u003e are injuries to the brain and skull that occur during the perinatal period, often related to the mechanical stresses of labor"
      }, {
        "text": " and delivery or the physiological vulnerabilities of prematurity.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eInt"
      }, {
        "text": "raventricular Hemorrhage (IVH):\u003c/b\u003e Bleeding into the ventricles, most common in \u003cmark\u003eprem"
      }, {
        "text": "ature infants\u003c/mark\u003e. Originates from the fragile germinal matrix. Can lead to hydrocephalus and long-term neurological deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Extracranial Injuries:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCaput Succedaneum:\u003c/b\u003e Benign, ed"
      }, {
        "text": "ematous swelling of the scalp above the periosteum that \u003cmark\u003ecrosses suture lines\u003c/mark\u003e.\u003cbr\u003e - \u003cb\u003eCe"
      }, {
        "text": "phalohematoma:\u003c/b\u003e Subperiosteal hemorrhage that is limited by and does \u003cu\u003enot\u003c/u\u003e cross suture lines. Can"
      }, {
        "text": " increase risk of jaundice.\u003cbr\u003e - \u003cb\u003eSubgaleal Hemorrhage:\u003c/b\u003e Potentially life-threatening bleed"
      }, {
        "text": " into the space between the periosteum and the scalp aponeurosis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHypoxic-Ischemic Encephalopathy (HIE"
      }, {
        "text": "):\u003c/b\u003e Brain injury due to oxygen deprivation during the perinatal period.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to differentiating scalp"
      }, {
        "text": " hematomas is their relationship to suture lines. Caput \u003cb\u003ec\u003c/b\u003erosses \u003cb\u003ec\u003c/b\u003eutures. Ce"
      }, {
        "text": "phalohematoma is contained.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe neonatal brain is uniquely"
      }, {
        "text": " vulnerable to both mechanical and ischemic insults during birth. Differentiating between benign findings like caput succedaneum and serious"
      }, {
        "text": " complications like intraventricular hemorrhage is critical for appropriate management and prognosis.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"f1695"
      }, {
        "text": "e4c\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"46"
      }, {
        "text": "ca72c2\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"a"
      }, {
        "text": "5295f1a\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\":"
      }, {
        "text": " \"8a695458\"\n      }\n    ]\n  },\n  \"4ff1"
      }, {
        "text": "649e\": {\n    \"title\": \"Nerve Fibers\",\n    \"primaryType\": \"anatomy"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Histology\",\n      \"Physiology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Peripheral Nervous System\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eNerve fibers\u003c/b\u003e are the axons of neurons, classified based on their diameter, myelination status, and conduction"
      }, {
        "text": " velocity, which determines their specific sensory or motor function.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "AŒ± fibers:\u003c/b\u003e Large diameter, heavily myelinated. The fastest conducting fibers. Function: proprioception (from muscle spindles,"
      }, {
        "text": " Golgi tendon organs) and somatic motor (alpha motor neurons).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAŒ≤ fibers:\u003c/b\u003e Medium diameter, myelinated. Function"
      }, {
        "text": ": touch, pressure, vibration.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAŒ¥ fibers:\u003c/b\u003e Small diameter, thinly myelinated. Function: transmit"
      }, {
        "text": " \u003cmark\u003efast, sharp, well-localized pain\u003c/mark\u003e and cold temperature.\u003c/li\u003e\u003cli\u003e\u003cb\u003eC fibers:\u003c/b\u003e Smallest diameter, \u003c"
      }, {
        "text": "mark\u003eunmyelinated\u003c/mark\u003e. The slowest conducting fibers. Function: transmit \u003cmark\u003eslow, dull, poorly"
      }, {
        "text": "-localized pain\u003c/mark\u003e and warmth. Also include postganglionic autonomic fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Local"
      }, {
        "text": " anesthetics preferentially block small, myelinated fibers first, which is why pain sensation (AŒ¥ and C fibers) is lost before touch"
      }, {
        "text": " (AŒ≤ fibers).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the two types of pain fibers: AŒ¥ for"
      }, {
        "text": " the initial \u0027ouch\u0027 and C fibers for the subsequent \u0027ache\u0027.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " structure of a \u003cb\u003enerve fiber\u003c/b\u003e dictates its function; large, myelinated fibers are built for speed to transmit motor"
      }, {
        "text": " commands and discriminative touch, while small, unmyelinated fibers are designed for the slower, more persistent signaling of dull"
      }, {
        "text": " pain and temperature.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_component_of\",\n        \"to\": \"peripheral_nerve\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"are_classified_by\",\n        \"to\": \"myelination\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"are_classified_by\",\n        \"to\": \"conduction_velocity\"\n      }"
      }, {
        "text": "\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"511db4d8\",\n    \"letter\": \"M\",\n    \"term\": \"Motion sickness\",\n    \"pages\": [\n      \"240\",\n      \"506\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Motion sickness\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"a2f4a400\",\n    \"letter\": \"M\",\n    \"term\": \"Motor cortex\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Motor cortex\",\n    \"sub_entries\": [\n      {\n        \"id\": \"25f512ea\",\n        \"letter\": \"M\",\n        \"term\": \"thalamic relay for\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Motor cortex \u003e thalamic relay for\"\n      },\n      {\n        \"id\": \"06c523e4\",\n        \"letter\": \"M\",\n        \"term\": \"topographic representation\",\n        \"pages\": [\n          \"513\"\n        ],\n        \"context\": \"Motor cortex \u003e topographic representation\"\n      }\n    ]\n  },\n  {\n    \"id\": \"b317a57a\",\n    \"letter\": \"M\",\n    \"term\": \"Motor function\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Motor function\",\n    \"sub_entries\": [\n      {\n        \"id\": \"38396186\",\n        \"letter\": \"M\",\n        \"term\": \"abnormal posturing\",\n        \"pages\": [\n          \"524\"\n        ],\n        \"context\": \"Motor function \u003e abnormal posturing\"\n      },\n      {\n        \"id\": \"bab705f8\",\n        \"letter\": \"M\",\n        \"term\": \"dysarthria\",\n        \"pages\": [\n          \"529\"\n        ],\n        \"context\": \"Motor function \u003e dysarthria\"\n      },\n      {\n        \"id\": \"436fc296\",\n        \"letter\": \"M\",\n        \"term\": \"signs\",\n        \"pages\": [\n          \"543\"\n        ],\n        \"context\": \"Motor function \u003e signs\"\n      }\n    ]\n  },\n  {\n    \"id\": \"81355372\",\n    \"letter\": \"M\",\n    \"term\": \"Motor neuron signs\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Motor neuron signs\",\n    \"sub_entries\": [\n      {\n        \"id\": \"e1c318c3\",\n        \"letter\": \"M\",\n        \"term\": \"Brown-S√©quard syndrome\",\n        \"pages\": [\n          \"545\"\n        ],\n        \"context\": \"Motor neuron signs \u003e Brown-S√©quard syndrome\"\n      },\n      {\n        \"id\": \"617737c6\",\n        \"letter\": \"M\",\n        \"term\": \"in amyotrophic lateral sclerosis\",\n        \"pages\": [\n          \"544\"\n        ],\n        \"context\": \"Motor neuron signs \u003e in amyotrophic lateral sclerosis\"\n      },\n      {\n        \"id\": \"95062564\",\n        \"letter\": \"M\",\n        \"term\": \"in anterior spinal artery occlusion\",\n        \"pages\": [\n          \"544\"\n        ],\n        \"context\": \"Motor neuron signs \u003e in anterior spinal artery occlusion\"\n      },\n      {\n        \"id\": \"cc4298cc\",\n        \"letter\": \"M\",\n        \"term\": \"upper compared to lower lesions\",\n        \"pages\": [\n          \"543\"\n        ],\n        \"context\": \"Motor neuron signs \u003e upper compared to lower lesions\"\n      }\n    ]\n  },\n  {\n    \"id\": \"d3c4ac8c\",\n    \"letter\": \"M\",\n    \"term\": \"Movement disorders\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Movement disorders\",\n    \"sub_entries\": [\n      {\n        \"id\": \"9a69e4e5\",\n        \"letter\": \"M\",\n        \"term\": \"abnormal posturing\",\n        \"pages\": [\n          \"524\"\n        ],\n        \"context\": \"Movement disorders \u003e abnormal posturing\"\n      },\n      {\n        \"id\": \"93aef7f2\",\n        \"letter\": \"M\",\n        \"term\": \"neurodegenerative\",\n        \"pages\": [\n          \"534\"\n        ],\n        \"context\": \"Movement disorders \u003e neurodegenerative\"\n      }\n    ]\n  },\n  {\n    \"id\": \"45dd6d19\",\n    \"letter\": \"M\",\n    \"term\": \"Multiple sclerosis\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Multiple sclerosis\",\n    \"sub_entries\": [\n      {\n        \"id\": \"0b9c3738\",\n        \"letter\": \"M\",\n        \"term\": \"drug therapy for\",\n        \"pages\": [\n          \"567\"\n        ],\n        \"context\": \"Multiple sclerosis \u003e drug therapy for\"\n      },\n      {\n        \"id\": \"d7907c3d\",\n        \"letter\": \"M\",\n        \"term\": \"findings and treatment\",\n        \"pages\": [\n          \"537\"\n        ],\n        \"context\": \"Multiple sclerosis \u003e findings and treatment\"\n      },\n      {\n        \"id\": \"5ed4c85b\",\n        \"letter\": \"M\",\n        \"term\": \"internuclear ophthalmoplegia\",\n        \"pages\": [\n          \"558\"\n        ],\n        \"context\": \"Multiple sclerosis \u003e internuclear ophthalmoplegia\"\n      }\n    ]\n  },\n  {\n    \"id\": \"9607467b\",\n    \"letter\": \"M\",\n    \"term\": \"Muscarinic antagonists\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Muscarinic antagonists\",\n    \"sub_entries\": [\n      {\n        \"id\": \"ad27b0d3\",\n        \"letter\": \"M\",\n        \"term\": \"multiple sclerosis treatment\",\n        \"pages\": [\n          \"537\"\n        ],\n        \"context\": \"Muscarinic antagonists \u003e multiple sclerosis treatment\"\n      }\n    ]\n  },\n  {\n    \"id\": \"d2b72dd8\",\n    \"letter\": \"M\",\n    \"term\": \"Muscarinic receptors\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Muscarinic receptors\",\n    \"sub_entries\": [\n      {\n        \"id\": \"71b4e4a4\",\n        \"letter\": \"M\",\n        \"term\": \"vomiting center input\",\n        \"pages\": [\n          \"506\"\n        ],\n        \"context\": \"Muscarinic receptors \u003e vomiting center input\"\n      }\n    ]\n  },\n  {\n    \"id\": \"46380156\",\n    \"letter\": \"M\",\n    \"term\": \"Muscle atonia, loss of\",\n    \"pages\": [\n      \"507\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Muscle atonia, loss of\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"7cbe4382\",\n    \"letter\": \"M\",\n    \"term\": \"Muscle spasm treatment\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Muscle spasm treatment\",\n    \"sub_entries\": [\n      {\n        \"id\": \"5a4fa247\",\n        \"letter\": \"M\",\n        \"term\": \"Œ±2-agonists\",\n        \"pages\": [\n          \"567\"\n        ],\n        \"context\": \"Muscle spasm treatment \u003e Œ±2-agonists\"\n      }\n    ]\n  },\n  {\n    \"id\": \"a0c1b959\",\n    \"letter\": \"M\",\n    \"term\": \"Muscles\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Muscles\",\n    \"sub_entries\": [\n      {\n        \"id\": \"4497e469\",\n        \"letter\": \"M\",\n        \"term\": \"mastication\",\n        \"pages\": [\n          \"520\",\n          \"638\"\n        ],\n        \"context\": \"Muscles \u003e mastication\"\n      },\n      {\n        \"id\": \"fb1a009c\",\n        \"letter\": \"M\",\n        \"term\": \"motor neuron signs and\",\n        \"pages\": [\n          \"543\"\n        ],\n        \"context\": \"Muscles \u003e motor neuron signs and\"\n      }\n    ]\n  },\n  {\n    \"id\": \"7b57eee7\",\n    \"letter\": \"M\",\n    \"term\": \"Mydriasis\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Mydriasis\",\n    \"sub_entries\": [\n      {\n        \"id\": \"2d6cd3a1\",\n        \"letter\": \"M\",\n        \"term\": \"glaucoma treatment and\",\n        \"pages\": [\n          \"568\"\n        ],\n        \"context\": \"Mydriasis \u003e glaucoma treatment and\"\n      },\n      {\n        \"id\": \"8cba3951\",\n        \"letter\": \"M\",\n        \"term\": \"meperidine\",\n        \"pages\": [\n          \"567\"\n        ],\n        \"context\": \"Mydriasis \u003e meperidine\"\n      },\n      {\n        \"id\": \"f47c8064\",\n        \"letter\": \"M\",\n        \"term\": \"pupillary control pathway\",\n        \"pages\": [\n          \"554\"\n        ],\n        \"context\": \"Mydriasis \u003e pupillary control pathway\"\n      },\n      {\n        \"id\": \"bd4d3d5c\",\n        \"letter\": \"M\",\n        \"term\": \"saccular aneurysm\",\n        \"pages\": [\n          \"530\"\n        ],\n        \"context\": \"Mydriasis \u003e saccular aneurysm\"\n      }\n    ]\n  },\n  {\n    \"id\": \"c8030560\",\n    \"letter\": \"M\",\n    \"term\": \"Myelencephalon\",\n    \"pages\": [\n      \"500\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Myelencephalon\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"e9cd6754\",\n    \"letter\": \"M\",\n    \"term\": \"Myelomeningocele\",\n    \"pages\": [\n      \"61\",\n      \"501\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Myelomeningocele\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"0e2d06f6\",\n    \"letter\": \"M\",\n    \"term\": \"Myeloschisis\",\n    \"pages\": [\n      \"501\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Myeloschisis\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 2804
    }, {
      "text": "```json\n{\n  \"511db4d8\": {\n    \"title\": \"Motion Sickness\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Otology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMotion sickness\u003c/b\u003e is a condition characterized by nausea, vomiting, and dizziness, caused by a mismatch between visually perceived movement and the vestibular system\u0027s sense of movement.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Occurs due to a conflict between the vestibular, visual, and proprioceptive systems. The brain receives contradictory information about the body\u0027s state of motion, which activates the [[74b651ab|vomiting center]] in the brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Neurotransmitters:\u003c/b\u003e The pathways involved in motion sickness heavily rely on \u003cmark\u003ehistaminic (H1)\u003c/mark\u003e and \u003cmark\u003emuscarinic cholinergic (M1)\u003c/mark\u003e signaling.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment (Antimuscarinics):\u003c/b\u003e \u003cmark\u003eScopolamine\u003c/mark\u003e, an antimuscarinic agent, is highly effective for prevention. It is often used as a transdermal patch.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment (Antihistamines):\u003c/b\u003e First-generation antihistamines with anticholinergic properties, such as diphenhydramine, dimenhydrinate, and meclizine, are also effective.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The primary pharmacological targets for preventing motion sickness are H1 and M1 receptors in the brainstem. Scopolamine (antimuscarinic) and first-generation antihistamines are the mainstays of therapy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMotion sickness\u003c/b\u003e is a sensory conflict disorder where the brain\u0027s confusion about movement triggers the vomiting reflex; treatment is aimed at blocking the histaminic and cholinergic pathways that mediate this distressing response.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"scopolamine\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"antihistamines\"\n      },\n      {\n        \"type\": \"involves\",\n        \"to\": \"vestibular_system\"\n      },\n      {\n        \"type\": \"activates\",\n        \"to\": \"74b651ab\"\n      }\n    ]\n  },\n  \"a2f4a400\": {\n    \"title\": \"Motor Cortex\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Cortex\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMotor Cortex\u003c/b\u003e is the region of the cerebral cortex involved in the planning, control, and execution of voluntary movements. It is located in the posterior part of the frontal lobe.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePrimary Motor Cortex (M1):\u003c/b\u003e Located in the precentral gyrus. It is responsible for the execution of voluntary movements.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTopographic Representation (Homunculus):\u003c/b\u003e The primary motor cortex has a somatotopic organization, where different body parts are represented by distinct areas. The face and hands have disproportionately large representations. The legs and feet are represented on the medial surface of the hemisphere.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBlood Supply:\u003c/b\u003e The lateral portion (face, arm) is supplied by the [[143bb23d|Middle Cerebral Artery (MCA)]]. The medial portion (leg) is supplied by the [[830c856c|Anterior Cerebral Artery (ACA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eThalamic Relay:\u003c/b\u003e Receives major input from the \u003cmark\u003eventral lateral (VL) nucleus\u003c/mark\u003e of the [[afc0a64b|thalamus]], which relays signals from the basal ganglia and cerebellum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The vascular supply of the motor homunculus is a high-yield topic for localizing strokes. An ACA stroke causes contralateral leg weakness, while an MCA stroke causes contralateral face and arm weakness.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMotor Cortex\u003c/b\u003e is the final common pathway for the execution of voluntary movement, with its somatotopic map (homunculus) directly reflecting the fine motor control required for different body parts, a map whose vascular territories are critical for stroke localization.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Basal Ganglia \u0026 Cerebellum] --\u003e B(VL Nucleus of Thalamus); B --\u003e C(Motor Cortex); C --\u003e D(Corticospinal Tract); D --\u003e E(Voluntary Movement);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"frontal_lobe\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"ventral_lateral_nucleus_thalamus\"\n      },\n      {\n        \"type\": \"is_organized_as\",\n        \"to\": \"95a13c9b\"\n      },\n      {\n        \"type\": \"is_supplied_by\",\n        \"to\": \"143bb23d\"\n      },\n      {\n        \"type\": \"is_supplied_by\",\n        \"to\": \"830c856c\"\n      }\n    ]\n  },\n  \"b317a57a\": {\n    \"title\": \"Motor Function\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Motor System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMotor function\u003c/b\u003e refers to the body\u0027s ability to move, which is controlled by a complex network involving the cerebral cortex, basal ganglia, cerebellum, brainstem, and spinal cord, culminating in the contraction of skeletal muscles.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eUpper Motor Neurons (UMNs):\u003c/b\u003e Originate in the motor cortex and descend to synapse on lower motor neurons. Lesions cause spastic paralysis, hyperreflexia, and a positive Babinski sign.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLower Motor Neurons (LMNs):\u003c/b\u003e Originate in the anterior horn of the spinal cord or brainstem cranial nerve nuclei and synapse directly on muscles. Lesions cause flaccid paralysis, atrophy, fasciculations, and hyporeflexia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAbnormal Motor Posturing:\u003c/b\u003e Decorticate and decerebrate posturing are signs of severe brain injury, indicating damage at or above (decorticate) or below (decerebrate) the red nucleus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDysarthria:\u003c/b\u003e A motor speech disorder resulting from impaired movement of the muscles used for speech production.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiating between UMN and LMN signs is a fundamental skill in neurology. Remember: \u003cb\u003eU\u003c/b\u003epper \u003d everything is \u003cb\u003eU\u003c/b\u003ep (tone, reflexes, toes); \u003cb\u003eL\u003c/b\u003eower \u003d everything is \u003cb\u003eL\u003c/b\u003eowered (tone, reflexes, muscle mass).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe control of \u003cb\u003emotor function\u003c/b\u003e is hierarchically organized, with upper motor neurons providing the command and lower motor neurons executing it; the clinical signs resulting from a lesion depend entirely on which level of this hierarchy is disrupted.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_controlled_by\",\n        \"to\": \"upper_motor_neurons\"\n      },\n      {\n        \"type\": \"is_controlled_by\",\n        \"to\": \"lower_motor_neurons\"\n      },\n      {\n        \"type\": \"abnormality_includes\",\n        \"to\": \"c0b7a1ca\"\n      },\n      {\n        \"type\": \"abnormality_includes\",\n        \"to\": \"dysarthria\"\n      }\n    ]\n  },\n  \"81355372\": {\n    \"title\": \"Motor Neuron Signs\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Motor Deficits\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMotor neuron signs\u003c/b\u003e are the clinical findings that result from damage to the motor nervous system, which are categorized into upper motor neuron (UMN) signs and lower motor neuron (LMN) signs, allowing for the localization of neurological lesions.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eUpper Motor Neuron (UMN) Signs:\u003c/b\u003e Result from lesions of the corticospinal tracts. Include \u003cmark\u003espastic paralysis\u003c/mark\u003e, hyperreflexia, increased muscle tone, and a positive Babinski sign. No significant muscle atrophy initially.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLower Motor Neuron (LMN) Signs:\u003c/b\u003e Result from lesions of the anterior horn cells, spinal roots, or peripheral nerves. Include \u003cmark\u003eflaccid paralysis\u003c/mark\u003e, significant muscle atrophy, fasciculations, hyporeflexia, and decreased muscle tone.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAmyotrophic Lateral Sclerosis (ALS):\u003c/b\u003e A classic example of a disease that presents with a combination of both UMN and LMN signs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnterior Spinal Artery Occlusion:\u003c/b\u003e Causes damage to the anterior horns (LMN signs at the level of the lesion) and corticospinal tracts (UMN signs below the level of the lesion).\u003c/li\u003e\u003cli\u003e\u003cb\u003eBrown-S√©quard Syndrome:\u003c/b\u003e Causes ipsilateral UMN signs below the level of the hemisection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of both UMN and LMN signs in the same patient is a strong clue for [[4ed629f9|ALS]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe distinction between \u003cb\u003eupper and lower motor neuron signs\u003c/b\u003e is fundamental to clinical neurology; UMN signs reflect a loss of central inhibition leading to hyperreflexia and spasticity, while LMN signs reflect a loss of direct muscle innervation leading to flaccidity and atrophy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"are_seen_in\",\n        \"to\": \"4ed629f9\"\n      },\n      {\n        \"type\": \"are_seen_in\",\n        \"to\": \"b48b54d7\"\n      },\n      {\n        \"type\": \"are_seen_in\",\n        \"to\": \"4792bc68\"\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"upper_motor_neuron_signs\"\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"lower_motor_neuron_signs\"\n      }\n    ]\n  },\n  \"d3c4ac8c\": {\n    \"title\": \"Movement Disorders\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMovement disorders\u003c/b\u003e are a group of neurological conditions characterized by abnormalities in the quality and quantity of voluntary and involuntary movements, typically resulting from dysfunction of the [[ed462927|basal ganglia]] or cerebellum.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHypokinetic Disorders:\u003c/b\u003e Characterized by a poverty of movement (akinesia/bradykinesia), rigidity, and tremor. The classic example is [[58c8ea03|Parkinson disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eHyperkinetic Disorders:\u003c/b\u003e Characterized by excessive, abnormal, involuntary movements. Examples include:\u003cbr\u003e - \u003cb\u003eChorea:\u003c/b\u003e Rapid, jerky, purposeless movements (e.g., [[ffd7e743|Huntington disease]]).\u003cbr\u003e - \u003cb\u003eAthetosis:\u003c/b\u003e Slow, writhing movements (e.g., [[ffd7e743|Huntington disease]]).\u003cbr\u003e - \u003cb\u003eDystonia:\u003c/b\u003e Sustained muscle contractions causing twisting movements or abnormal postures.\u003cbr\u003e - \u003cb\u003e[[004e0bd6|Hemiballismus]]:\u003c/b\u003e Wild, flinging movements of one side of the body.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurodegenerative Causes:\u003c/b\u003e Many movement disorders are manifestations of underlying [[41ca6981|neurodegenerative disorders]], such as [[58c8ea03|Parkinson disease]] and [[ffd7e743|Huntington disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAbnormal Posturing:\u003c/b\u003e [[c0b7a1ca|Decorticate and decerebrate posturing]] are specific types of abnormal movements seen in comatose patients with severe brain injury.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMovement disorders\u003c/b\u003e represent a spectrum of dysfunction in the brain\u0027s motor control circuits, ranging from the \u0027too little\u0027 movement of Parkinsonism to the \u0027too much\u0027 movement of chorea and ballismus, all pointing to pathology within the basal ganglia and its connections.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"are_often_caused_by_dysfunction_of\",\n        \"to\": \"ed462927\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"ffd7e743\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"004e0bd6\"\n      }\n    ]\n  },\n  \"45dd6d19\": {\n    \"title\": \"Multiple Sclerosis (MS)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Immunology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMultiple Sclerosis (MS)\u003c/b\u003e is a chronic, autoimmune, inflammatory disease of the central nervous system characterized by the demyelination of axons, leading to a wide range of neurological deficits that are disseminated in \u003cu\u003espace and time\u003c/u\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Autoreactive T-cells cross the blood-brain barrier and attack the myelin sheath produced by [[a24f9747|oligodendrocytes]], leading to inflammation, demyelination, and axonal damage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Symptoms vary widely depending on the location of the demyelinating plaques. Common presentations include [[98a63a59|optic neuritis]], transverse myelitis, [[58c684bd|internuclear ophthalmoplegia (INO)]], and sensory or motor deficits. Symptoms often worsen with heat (Uhthoff\u0027s phenomenon).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e MRI is the gold standard, showing characteristic \u003cmark\u003eperiventricular plaques\u003c/mark\u003e (Dawson\u0027s fingers). CSF analysis reveals \u003cmark\u003eoligoclonal bands\u003c/mark\u003e of IgG and an elevated IgG index.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Triad (Charcot):\u003c/b\u003e A historical triad of \u003cb\u003eS\u003c/b\u003ecanning speech, \u003cb\u003eI\u003c/b\u003entention tremor, and \u003cb\u003eN\u003c/b\u003eystagmus (\u003cb\u003eSIN\u003c/b\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Acute flares are treated with high-dose corticosteroids. Long-term management involves disease-modifying therapies like [[00e48ea3|interferon-Œ≤]], glatiramer acetate, and [[ae20a0ce|natalizumab]]. Symptomatic treatment for spasticity ([[1ddc3f08|baclofen]]), neuropathic pain, and bladder dysfunction is also important.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A young woman with relapsing and remitting neurological symptoms affecting different parts of the CNS (e.g., an episode of optic neuritis followed months later by leg weakness) is the classic vignette for MS.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMultiple Sclerosis\u003c/b\u003e is defined by its pathological hallmark of CNS demyelination disseminated in space and time, leading to a highly variable clinical course of relapsing and remitting neurological deficits that reflect the multifocal nature of the autoimmune attack.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Autoimmune Attack] --\u003e B(Destruction of Oligodendrocytes); B --\u003e C(CNS Demyelination); C --\u003e D(Plaque Formation); D --\u003e E(Neurological Deficits);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"damages\",\n        \"to\": \"a24f9747\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"98a63a59\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"58c684bd\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"00e48ea3\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"ae20a0ce\"\n      }\n    ]\n  },\n  \"9607467b\": {\n    \"title\": \"Muscarinic Antagonists\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Autonomic\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Autonomic Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMuscarinic antagonists\u003c/b\u003e, also known as anticholinergics, are drugs that competitively block the action of [[6a005559|acetylcholine]] at muscarinic receptors, thereby inhibiting the effects of the parasympathetic nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eExamples:\u003c/b\u003e Atropine, scopolamine, ipratropium, tiotropium, oxybutynin, tolterodine, [[383f6fbe|benztropine]], trihexyphenidyl.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Competitively inhibit ACh at muscarinic receptors in the CNS and periphery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEffects:\u003c/b\u003e Mydriasis, cycloplegia, tachycardia, bronchodilation, decreased GI motility, decreased secretions (salivary, gastric, bronchial), and urinary retention. Mnemonic for anticholinergic effects: \\\"Hot as a hare, dry as a bone, blind as a bat, red as a beet, mad as a hatter.\\\"\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Use (Parkinson\u0027s):\u003c/b\u003e Centrally acting agents like [[383f6fbe|benztropine]] and trihexyphenidyl are used to treat tremor and rigidity in [[58c8ea03|Parkinson disease]] by correcting the relative cholinergic excess.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Use (MS):\u003c/b\u003e Drugs like oxybutynin are used to treat spastic (hyperreflexic) bladder and urge incontinence in [[45dd6d19|multiple sclerosis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Be aware of the contraindications, especially in the elderly (risk of delirium, constipation, urinary retention) and in patients with [[9c80344d|angle-closure glaucoma]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMuscarinic antagonists\u003c/b\u003e act as a system-wide \u0027off switch\u0027 for the parasympathetic nervous system, producing a predictable constellation of anticholinergic effects that are therapeutically useful in conditions ranging from COPD to Parkinson\u0027s disease, but also responsible for their significant side effect profile.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"antagonizes\",\n        \"to\": \"d2b72dd8\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"a9db88ed\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"atropine\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"383f6fbe\"\n      }\n    ]\n  },\n  \"d2b72dd8\": {\n    \"title\": \"Muscarinic Receptors\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Physiology\",\n      \"Autonomic\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Receptors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMuscarinic receptors\u003c/b\u003e are a type of G-protein coupled acetylcholine receptor that are the primary end-organ receptors for the parasympathetic nervous system. They are also found in the CNS and at sympathetic postganglionic synapses to sweat glands.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLigand:\u003c/b\u003e [[6a005559|Acetylcholine (ACh)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eSubtypes \u0026 Signaling:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eM1 (G\u003csub\u003eq\u003c/sub\u003e):\u003c/b\u003e CNS, enteric nervous system.\u003cbr\u003e - \u003cb\u003eM2 (G\u003csub\u003ei\u003c/sub\u003e):\u003c/b\u003e Heart (decreases heart rate and contractility).\u003cbr\u003e - \u003cb\u003eM3 (G\u003csub\u003eq\u003c/sub\u003e):\u003c/b\u003e Smooth muscle (contraction, e.g., bronchoconstriction, bladder contraction), glands (secretion), and endothelium (vasodilation via NO).\u003c/li\u003e\u003cli\u003e\u003cb\u003eVomiting Center Input:\u003c/b\u003e M1 receptors are present in the vestibular nuclei and nucleus tractus solitarius, and their blockade (e.g., by scopolamine) is effective for [[511db4d8|motion sickness]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacology:\u003c/b\u003e Agonists (e.g., pilocarpine, bethanechol) mimic parasympathetic effects. Antagonists (e.g., atropine, ipratropium) block parasympathetic effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the G-protein coupling mnemonic: \\\"\u003cb\u003eQISS QIQ SIQ SQS\u003c/b\u003e\\\" (Kiss kick six six). For muscarinic receptors: M1 (\u003cb\u003eQ\u003c/b\u003e), M2 (\u003cb\u003eI\u003c/b\u003e), M3 (\u003cb\u003eQ\u003c/b\u003e).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMuscarinic receptors\u003c/b\u003e are the workhorses of the parasympathetic nervous system, translating the signal of acetylcholine into diverse physiological effects‚Äîfrom slowing the heart (M2) to increasing secretions and smooth muscle contraction (M3)‚Äîvia distinct G-protein signaling pathways.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"cholinergic_receptor\"\n      },\n      {\n        \"type\": \"binds\",\n        \"to\": \"6a005559\"\n      },\n      {\n        \"type\": \"is_blocked_by\",\n        \"to\": \"9607467b\"\n      },\n      {\n        \"type\": \"is_involved_in\",\n        \"to\": \"vomiting_reflex\"\n      }\n    ]\n  },\n  \"46380156\": {\n    \"title\": \"Loss of Muscle Atonia in REM Sleep\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Sleep Medicine\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Sleep Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLoss of muscle atonia in REM sleep\u003c/b\u003e is the cardinal feature of \u003ci\u003eREM Sleep Behavior Disorder (RBD)\u003c/i\u003e, a parasomnia where the normal paralysis that occurs during REM sleep is absent, leading patients to physically act out their dreams.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNormal REM Sleep:\u003c/b\u003e Characterized by rapid eye movements, dreaming, and near-complete muscle paralysis (atonia), which prevents individuals from acting out their dreams.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology of RBD:\u003c/b\u003e The loss of atonia is thought to be due to dysfunction in the brainstem nuclei (e.g., subcoeruleus nucleus) that normally inhibit motor neurons during REM sleep.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients (often older men) exhibit dream-enacting behaviors, which can be violent and result in injury to themselves or their bed partners. They can often recall the dream content that corresponds to their actions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStrong Association with Neurodegeneration:\u003c/b\u003e RBD is a very strong predictor of future development of an \u003cmark\u003eŒ±-synucleinopathy\u003c/mark\u003e, such as [[58c8ea03|Parkinson disease]], [[db2f16e5|Lewy body dementia]], or multiple system atrophy. It can precede the motor symptoms of these disorders by years or even decades.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An older male patient who reports punching or kicking his spouse in his sleep while having vivid dreams is the classic presentation for REM Sleep Behavior Disorder. This finding should raise high suspicion for an underlying or future neurodegenerative disease like Parkinson\u0027s.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eloss of muscle atonia during REM sleep\u003c/b\u003e is not just a sleep disturbance but a significant prodromal marker for Œ±-synuclein neurodegenerative diseases, representing one of the earliest clinical manifestations of these devastating conditions.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \"to\": \"rem_sleep_behavior_disorder\"\n      },\n      {\n        \"type\": \"is_a_risk_factor_for\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"is_a_risk_factor_for\",\n        \"to\": \"db2f16e5\"\n      }\n    ]\n  },\n  \"7cbe4382\": {\n    \"title\": \"Muscle Spasm Treatment\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Musculoskeletal\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Spasmolytics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMuscle spasm treatment\u003c/b\u003e involves the use of pharmacologic agents known as spasmolytics or muscle relaxants, which act either centrally in the CNS or peripherally at the muscle to reduce involuntary muscle contractions, tone, and spasticity.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSpasticity vs. Spasms:\u003c/b\u003e Spasticity is velocity-dependent increased muscle tone from a UMN lesion. Spasms are involuntary contractions from musculoskeletal injury. Different drugs are used for each.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAgents for Spasticity (UMN lesions):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[1ddc3f08|Baclofen]]:\u003c/b\u003e A GABA\u003csub\u003eB\u003c/sub\u003e receptor agonist that acts in the spinal cord.\u003cbr\u003e - \u003cb\u003eTizanidine:\u003c/b\u003e A central Œ±\u003csub\u003e2\u003c/sub\u003e-adrenergic agonist.\u003cbr\u003e - \u003cb\u003eDiazepam:\u003c/b\u003e A benzodiazepine that facilitates GABA\u003csub\u003eA\u003c/sub\u003e action.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAgents for Acute Muscle Spasms:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCyclobenzaprine:\u003c/b\u003e A centrally acting agent structurally related to TCAs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAgent Acting Directly on Muscle:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eDantrolene:\u003c/b\u003e Blocks Ca\u003csup\u003e2+\u003c/sup\u003e release from the sarcoplasmic reticulum. Used for malignant hyperthermia and neuroleptic malignant syndrome, as well as chronic spasticity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know the site of action. Baclofen and Tizanidine are central (spinal cord/brainstem). Cyclobenzaprine is central. Dantrolene is peripheral (directly on the muscle).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe pharmacological treatment of \u003cb\u003emuscle spasms and spasticity\u003c/b\u003e relies on either dampening CNS excitatory signals (e.g., with baclofen or tizanidine) or directly interfering with the muscle contraction machinery (e.g., with dantrolene), with the choice of agent depending on the underlying cause of the muscle hyperactivity.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"1ddc3f08\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"tizanidine\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"dantrolene\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"cyclobenzaprine\"\n      }\n    ]\n  },\n  \"a0c1b959\": {\n    \"title\": \"Muscles of Mastication\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Anatomy\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003emuscles of mastication\u003c/b\u003e are four pairs of muscles responsible for the movements of the mandible at the temporomandibular joint, primarily for chewing. They are all innervated by the mandibular division of the \u003ci\u003etrigeminal nerve (CN V\u003csub\u003e3\u003c/sub\u003e)\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMuscles that Close the Jaw (Elevation):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eM\u003c/b\u003easseter\u003cbr\u003e - \u003cb\u003eT\u003c/b\u003eemporalis\u003cbr\u003e - \u003cb\u003eM\u003c/b\u003eedial pterygoid\u003cbr\u003e Mnemonic: \u003cb\u003eM\u003c/b\u003e\u0027s \u003cb\u003eM\u003c/b\u003eunch.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMuscle that Opens the Jaw (Depression):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eL\u003c/b\u003eateral pterygoid. Mnemonic: \u003cb\u003eL\u003c/b\u003eateral \u003cb\u003eL\u003c/b\u003eowers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e All four muscles are innervated by the motor branch of the \u003cmark\u003emandibular nerve (CN V\u003csub\u003e3\u003c/sub\u003e)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Derived from the first pharyngeal arch.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e A lesion of the motor root of CN V or the V\u003csub\u003e3\u003c/sub\u003e branch will cause weakness of the muscles of mastication. On jaw protrusion, the jaw will deviate \u003cmark\u003etoward the side of the lesion\u003c/mark\u003e due to the unopposed action of the contralateral lateral pterygoid muscle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that all muscles of mastication are innervated by V\u003csub\u003e3\u003c/sub\u003e. Jaw deviation toward the lesion is a key sign of a V\u003csub\u003e3\u003c/sub\u003e motor deficit.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe four \u003cb\u003emuscles of mastication\u003c/b\u003e are a functional group defined by their shared innervation from CN V\u003csub\u003e3\u003c/sub\u003e and their origin from the first pharyngeal arch, working in concert to elevate, depress, and move the mandible from side to side during chewing.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"are_innervated_by\",\n        \"to\": \"mandibular_nerve_v3\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"jaw_deviation\"\n      },\n      {\n        \"type\": \"derive_from\",\n        \"to\": \"first_pharyngeal_arch\"\n      }\n    ]\n  },\n  \"7b57eee7\": {\n    \"title\": \"Mydriasis\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physical Findings\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMydriasis\u003c/b\u003e is the dilation of the pupil, which can be a physiological response to dim light or a pathological or pharmacological sign.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePhysiology:\u003c/b\u003e Mediated by the \u003cmark\u003esympathetic nervous system\u003c/mark\u003e. Postganglionic sympathetic fibers release norepinephrine, which acts on Œ±\u003csub\u003e1\u003c/sub\u003e-adrenergic receptors on the dilator pupillae muscle, causing it to contract.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacological Causes:\u003c/b\u003e Can be induced by sympathomimetic agents (e.g., epinephrine, phenylephrine) or \u003cmark\u003eanticholinergic/antimuscarinic agents\u003c/mark\u003e (e.g., atropine, tropicamide), which block the parasympathetic constriction of the pupil.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathological Causes:\u003c/b\u003e A fixed, dilated (\\\"blown\\\") pupil is a classic sign of a compressive [[68c66997|oculomotor nerve (CN III) palsy]], as seen with an uncal herniation or a [[a1647fb2|posterior communicating artery aneurysm]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMeperidine Exception:\u003c/b\u003e Unlike most opioids which cause miosis, meperidine can cause mydriasis due to its anticholinergic properties.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A unilaterally dilated and nonreactive pupil is a neurological emergency. It is a key sign of uncal herniation compressing CN III.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMydriasis\u003c/b\u003e results from either sympathetic activation (contraction of the dilator muscle) or parasympathetic blockade (relaxation of the sphincter muscle); its presence, especially when unilateral and fixed, is a critical sign of potential oculomotor nerve compression.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_mediated_by\",\n        \"to\": \"sympathetic_nervous_system\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"anticholinergic_drugs\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"oculomotor_nerve_palsy\"\n      },\n      {\n        \"type\": \"is_the_opposite_of\",\n        \"to\": \"miosis\"\n      }\n    ]\n  },\n  \"c8030560\": {\n    \"title\": \"Myelencephalon\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Brain Development\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMyelencephalon\u003c/b\u003e is the most caudal of the five secondary brain vesicles that arise from the embryonic neural tube. It develops from the posterior part of the hindbrain (rhombencephalon) and gives rise to the medulla oblongata.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryonic Origin:\u003c/b\u003e Arises from the posterior portion of the rhombencephalon (hindbrain).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdult Derivative:\u003c/b\u003e Differentiates into the \u003cmark\u003emedulla oblongata\u003c/mark\u003e, the lowest part of the brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Cavity:\u003c/b\u003e The cavity of the myelencephalon becomes the lower part of the \u003cmark\u003efourth ventricle\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCranial Nerves:\u003c/b\u003e The nuclei for cranial nerves IX, X, XI, and XII are located in the medulla, and thus originate from the myelencephalon.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMnemonic for Vesicles:\u003c/b\u003e The five secondary vesicles in rostral to caudal order are Telencephalon, Diencephalon, Mesencephalon, Metencephalon, and Myelencephalon.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMyelencephalon\u003c/b\u003e is the final segment of the developing brain, forming the medulla oblongata, which serves as the critical connection between the higher brain centers and the spinal cord and contains the nuclei for vital autonomic functions.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Rhombencephalon (Hindbrain)] --\u003e B(Metencephalon); A --\u003e C(Myelencephalon); C --\u003e D(Medulla Oblongata); C --\u003e E(Lower Fourth Ventricle);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"develops_into\",\n        \"to\": \"medulla_oblongata\"\n      },\n      {\n        \"type\": \"arises_from\",\n        \"to\": \"rhombencephalon\"\n      },\n      {\n        \"type\": \"contains_cavity\",\n        \"to\": \"fourth_ventricle\"\n      }\n    ]\n  },\n  \"e9cd6754\": {\n    \"title\": \"Myelomeningocele\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Neurosurgery\",\n      \"Embryology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural Tube Defects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003emyelomeningocele\u003c/b\u003e is the most severe form of spina bifida, an open neural tube defect where both the \u003ci\u003emeninges and the spinal cord\u003c/i\u003e herniate through a defect in the vertebral column, forming a cystic sac on the infant\u0027s back.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Results from the failure of the caudal neuropore of the [[a87cbede|neural tube]] to close during the 4th week of embryonic development.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A visible sac-like protrusion on the back, typically in the lumbosacral region. It is associated with neurological deficits below the level of the lesion, including lower extremity paralysis and bowel/bladder incontinence.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Condition:\u003c/b\u003e Almost always associated with a \u003cmark\u003eChiari II malformation\u003c/mark\u003e, which can lead to obstructive [[0bc2f200|hydrocephalus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Can be diagnosed prenatally by ultrasound and elevated maternal serum alpha-fetoprotein (AFP) and amniotic fluid acetylcholinesterase (AChE).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from a meningocele, where only the meninges herniate and the spinal cord remains in the canal. Myelomeningocele involves herniation of the \u0027myelo\u0027 (spinal cord) itself, leading to severe neurological deficits.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003emyelomeningocele\u003c/b\u003e represents a catastrophic failure of neurulation, where the spinal cord itself is exposed and herniated, leading to inevitable and permanent neurological damage below the lesion and a near-universal association with Chiari II malformation and hydrocephalus.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"spina_bifida\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"neural_tube_defect\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"chiari_ii_malformation\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"meningocele\"\n      }\n    ]\n  },\n  \"0e2d06f6\": {\n    \"title\": \"Myeloschisis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Embryology\",\n      \"Neurosurgery\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural Tube Defects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMyeloschisis\u003c/b\u003e (or rachischisis) is the most severe form of spina bifida, an open neural tube defect where the neural folds fail to fuse, resulting in a flattened, plate-like mass of nervous tissue that is directly exposed to the environment without any overlying meningeal or skin covering.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Represents a complete failure of primary neurulation in the affected region. The neural plate is open and exposed on the surface of the back.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A raw, exposed plaque of neural tissue is visible on the infant\u0027s back. This leads to profound and complete neurological deficits below the level of the lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison to Myelomeningocele:\u003c/b\u003e It is more severe than a [[e9cd6754|myelomeningocele]], in which the herniated neural tissue is at least covered by meninges.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Carries a very poor prognosis due to the severe neurological impairment and high risk of infection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e This is the most severe form of neural tube defect. The key feature is the exposed, non-fused neural plate on the back.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMyeloschisis\u003c/b\u003e represents the most fundamental failure of neural tube formation, where the neural folds do not even begin to fuse, leaving the primordial spinal cord exposed to the outside world and resulting in the most devastating neurological outcomes.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"spina_bifida\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"neural_tube_defect\"\n      },\n      {\n        \"type\": \"is_more_severe_than\",\n        \"to\": \"e9cd6754\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9730,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"511db4d8\": {\n    \"title\": \""
      }, {
        "text": "Motion Sickness\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n"
      }, {
        "text": "      \"Otology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMotion sickness\u003c/b\u003e is a condition characterized by nausea, vomiting, and dizziness,"
      }, {
        "text": " caused by a mismatch between visually perceived movement and the vestibular system\u0027s sense of movement.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Occurs due to a conflict between the vestibular, visual, and proprio"
      }, {
        "text": "ceptive systems. The brain receives contradictory information about the body\u0027s state of motion, which activates the [[74b"
      }, {
        "text": "651ab|vomiting center]] in the brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Neurotransmitters:\u003c/b\u003e The pathways"
      }, {
        "text": " involved in motion sickness heavily rely on \u003cmark\u003ehistaminic (H1)\u003c/mark\u003e and \u003cmark\u003emus"
      }, {
        "text": "carinic cholinergic (M1)\u003c/mark\u003e signaling.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment (Antimuscarinics):\u003c/b\u003e \u003c"
      }, {
        "text": "mark\u003eScopolamine\u003c/mark\u003e, an antimuscarinic agent, is highly effective for prevention. It is often"
      }, {
        "text": " used as a transdermal patch.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment (Antihistamines):\u003c/b\u003e First-generation antihistamines with"
      }, {
        "text": " anticholinergic properties, such as diphenhydramine, dimenhydrinate, and meclizine,"
      }, {
        "text": " are also effective.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The primary pharmacological targets for preventing motion sickness are H1 and M1 receptors in the brain"
      }, {
        "text": "stem. Scopolamine (antimuscarinic) and first-generation antihistamines are the mainstays of therapy.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMotion sickness\u003c/b\u003e is a sensory conflict disorder where the brain\u0027s confusion"
      }, {
        "text": " about movement triggers the vomiting reflex; treatment is aimed at blocking the histaminic and cholinergic pathways that mediate this distressing response"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type"
      }, {
        "text": "\": \"is_treated_by\",\n        \"to\": \"scopolamine\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_treated_by\",\n        \"to\": \"antihistamines\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"involves\",\n        \"to\": \"vestibular_system\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"activates\",\n        \"to\": \"74b651ab\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"a2f4a400\": {\n    \"title"
      }, {
        "text": "\": \"Motor Cortex\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "science\",\n      \"Anatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Cortex\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMotor Cortex\u003c/b\u003e is the region of the cerebral"
      }, {
        "text": " cortex involved in the planning, control, and execution of voluntary movements. It is located in the posterior part of the frontal lobe.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePrimary Motor Cortex (M1):\u003c/b\u003e Located in the"
      }, {
        "text": " precentral gyrus. It is responsible for the execution of voluntary movements.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTopographic Representation (Homunculus):\u003c/b\u003e The primary"
      }, {
        "text": " motor cortex has a somatotopic organization, where different body parts are represented by distinct areas. The face and hands have"
      }, {
        "text": " disproportionately large representations. The legs and feet are represented on the medial surface of the hemisphere.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBlood Supply:\u003c/b\u003e The lateral"
      }, {
        "text": " portion (face, arm) is supplied by the [[143bb23d|Middle Cerebral Artery (MCA"
      }, {
        "text": ")]]. The medial portion (leg) is supplied by the [[830c856c|Anterior Cerebral Artery (ACA"
      }, {
        "text": ")]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eThalamic Relay:\u003c/b\u003e Receives major input from the \u003cmark\u003eventral lateral (VL) nucleus"
      }, {
        "text": "\u003c/mark\u003e of the [[afc0a64b|thalamus]], which relays signals from the basal"
      }, {
        "text": " ganglia and cerebellum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The vascular supply of the motor homunculus is a high-yield topic for"
      }, {
        "text": " localizing strokes. An ACA stroke causes contralateral leg weakness, while an MCA stroke causes contralateral face and arm weakness.\u003c/li\u003e\u003c/ul\u003e\",\n"
      }, {
        "text": "      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMotor Cortex\u003c/b\u003e is the final common pathway for the execution of voluntary movement"
      }, {
        "text": ", with its somatotopic map (homunculus) directly reflecting the fine motor control required for different body parts, a"
      }, {
        "text": " map whose vascular territories are critical for stroke localization.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Basal Ganglia \u0026"
      }, {
        "text": " Cerebellum] --\u003e B(VL Nucleus of Thalamus); B --\u003e C(Motor Cortex); C --\u003e D(C"
      }, {
        "text": "orticospinal Tract); D --\u003e E(Voluntary Movement);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_located_in\",\n        \"to\": \"frontal_lobe\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"receives_input_from\",\n        \"to\": \"ventral_lateral_nucleus_"
      }, {
        "text": "thalamus\"\n      },\n      {\n        \"type\": \"is_organized_as\",\n        \"to\": \"9"
      }, {
        "text": "5a13c9b\"\n      },\n      {\n        \"type\": \"is_supplied_by\",\n        \"to\":"
      }, {
        "text": " \"143bb23d\"\n      },\n      {\n        \"type\": \"is_supplied"
      }, {
        "text": "_by\",\n        \"to\": \"830c856c\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"b317a57a\": {\n    \"title\": \"Motor Function\",\n    \"primaryType"
      }, {
        "text": "\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physiology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Motor System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eMotor function\u003c/b\u003e refers to the body\u0027s ability to move, which is controlled by a complex network involving"
      }, {
        "text": " the cerebral cortex, basal ganglia, cerebellum, brainstem, and spinal cord, culminating in the contraction of skeletal muscles.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eUpper Motor Neurons (UMNs):\u003c/b\u003e Originate in the motor cortex and descend"
      }, {
        "text": " to synapse on lower motor neurons. Lesions cause spastic paralysis, hyperreflexia, and a positive Babinski sign.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLower"
      }, {
        "text": " Motor Neurons (LMNs):\u003c/b\u003e Originate in the anterior horn of the spinal cord or brainstem cranial nerve"
      }, {
        "text": " nuclei and synapse directly on muscles. Lesions cause flaccid paralysis, atrophy, fasciculations, and hyporeflexia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAb"
      }, {
        "text": "normal Motor Posturing:\u003c/b\u003e Decorticate and decerebrate posturing are signs of severe brain injury, indicating damage"
      }, {
        "text": " at or above (decorticate) or below (decerebrate) the red nucleus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDysarth"
      }, {
        "text": "ria:\u003c/b\u003e A motor speech disorder resulting from impaired movement of the muscles used for speech production.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e D"
      }, {
        "text": "ifferentiating between UMN and LMN signs is a fundamental skill in neurology. Remember: \u003cb\u003eU\u003c/b\u003epper \u003d everything"
      }, {
        "text": " is \u003cb\u003eU\u003c/b\u003ep (tone, reflexes, toes); \u003cb\u003eL\u003c/b\u003eower \u003d everything is \u003cb\u003eL"
      }, {
        "text": "\u003c/b\u003eowered (tone, reflexes, muscle mass).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe control of \u003cb\u003emotor"
      }, {
        "text": " function\u003c/b\u003e is hierarchically organized, with upper motor neurons providing the command and lower motor neurons executing it; the clinical signs resulting"
      }, {
        "text": " from a lesion depend entirely on which level of this hierarchy is disrupted.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_controlled_by\",\n        \"to\": \""
      }, {
        "text": "upper_motor_neurons\"\n      },\n      {\n        \"type\": \"is_controlled_by\","
      }, {
        "text": "\n        \"to\": \"lower_motor_neurons\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "abnormality_includes\",\n        \"to\": \"c0b7a1ca\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"abnormality_includes\",\n        \"to\": \"dysarthria\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"81355372\": {\n    \"title\": \""
      }, {
        "text": "Motor Neuron Signs\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical"
      }, {
        "text": " Exam\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n"
      }, {
        "text": "      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Motor Deficits\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMotor neuron signs\u003c/b\u003e are the clinical findings that result from damage"
      }, {
        "text": " to the motor nervous system, which are categorized into upper motor neuron (UMN) signs and lower motor neuron (LMN) signs, allowing"
      }, {
        "text": " for the localization of neurological lesions.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eUpper Motor Neuron (UMN) Signs:\u003c/b\u003e"
      }, {
        "text": " Result from lesions of the corticospinal tracts. Include \u003cmark\u003espastic paralysis\u003c/mark\u003e, hyperreflexia, increased"
      }, {
        "text": " muscle tone, and a positive Babinski sign. No significant muscle atrophy initially.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLower Motor Neuron (LMN) Signs:\u003c/b\u003e Result from"
      }, {
        "text": " lesions of the anterior horn cells, spinal roots, or peripheral nerves. Include \u003cmark\u003eflaccid paralysis\u003c/mark\u003e, significant"
      }, {
        "text": " muscle atrophy, fasciculations, hyporeflexia, and decreased muscle tone.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAmyotrophic Lateral Sclerosis (ALS):\u003c/b\u003e A"
      }, {
        "text": " classic example of a disease that presents with a combination of both UMN and LMN signs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnterior Spinal Artery Oc"
      }, {
        "text": "clusion:\u003c/b\u003e Causes damage to the anterior horns (LMN signs at the level of the lesion) and corticospinal tracts (UMN"
      }, {
        "text": " signs below the level of the lesion).\u003c/li\u003e\u003cli\u003e\u003cb\u003eBrown-S√©quard Syndrome:\u003c/b\u003e Causes ipsilateral UMN signs"
      }, {
        "text": " below the level of the hemisection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of both UMN and LMN signs"
      }, {
        "text": " in the same patient is a strong clue for [[4ed629f9|ALS]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eThe distinction between \u003cb\u003eupper and lower motor neuron signs\u003c/b\u003e is fundamental to clinical neurology; U"
      }, {
        "text": "MN signs reflect a loss of central inhibition leading to hyperreflexia and spasticity, while LMN signs reflect a loss of direct"
      }, {
        "text": " muscle innervation leading to flaccidity and atrophy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      "
      }, {
        "text": "{\n        \"type\": \"are_seen_in\",\n        \"to\": \"4ed629"
      }, {
        "text": "f9\"\n      },\n      {\n        \"type\": \"are_seen_in\",\n        \""
      }, {
        "text": "to\": \"b48b54d7\"\n      },\n      {\n        \"type\": \"are_seen"
      }, {
        "text": "_in\",\n        \"to\": \"4792bc68\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_classified_as\",\n        \"to\": \"upper_motor_neuron_signs\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_classified_as\",\n        \"to\": \"lower_motor_neuron"
      }, {
        "text": "_signs\"\n      }\n    ]\n  },\n  \"d3c4ac8c\": {\n    \"title\":"
      }, {
        "text": " \"Movement Disorders\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      "
      }, {
        "text": "\"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMovement disorders\u003c/b\u003e are a group of neurological conditions characterized by abnormalities"
      }, {
        "text": " in the quality and quantity of voluntary and involuntary movements, typically resulting from dysfunction of the [[ed46292"
      }, {
        "text": "7|basal ganglia]] or cerebellum.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHypokinetic"
      }, {
        "text": " Disorders:\u003c/b\u003e Characterized by a poverty of movement (akinesia/bradykinesia), rigidity, and tremor"
      }, {
        "text": ". The classic example is [[58c8ea03|Parkinson disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eHyperkinetic Disorders:"
      }, {
        "text": "\u003c/b\u003e Characterized by excessive, abnormal, involuntary movements. Examples include:\u003cbr\u003e - \u003cb\u003eChorea:\u003c/b\u003e Rapid"
      }, {
        "text": ", jerky, purposeless movements (e.g., [[ffd7e743|Huntington disease]]).\u003cbr\u003e - \u003cb\u003eA"
      }, {
        "text": "thetosis:\u003c/b\u003e Slow, writhing movements (e.g., [[ffd7e743|Huntington disease"
      }, {
        "text": "]]).\u003cbr\u003e - \u003cb\u003eDystonia:\u003c/b\u003e Sustained muscle contractions causing twisting movements or abnormal postures.\u003cbr\u003e - \u003cb\u003e[["
      }, {
        "text": "004e0bd6|Hemiballismus]]:\u003c/b\u003e Wild, flinging movements of one side of the body."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurodegenerative Causes:\u003c/b\u003e Many movement disorders are manifestations of underlying [[41ca6981|neurodegenerative disorders"
      }, {
        "text": "]], such as [[58c8ea03|Parkinson disease]] and [[ffd7e743"
      }, {
        "text": "|Huntington disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAbnormal Posturing:\u003c/b\u003e [[c0b7a1ca|Decorticate and decere"
      }, {
        "text": "brate posturing]] are specific types of abnormal movements seen in comatose patients with severe brain injury.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eMovement disorders\u003c/b\u003e represent a spectrum of dysfunction in the brain\u0027s motor control circuits, ranging from the \u0027"
      }, {
        "text": "too little\u0027 movement of Parkinsonism to the \u0027too much\u0027 movement of chorea and ballismus, all pointing to pathology"
      }, {
        "text": " within the basal ganglia and its connections.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"are_often_caused_by_dysfunction_of\",\n        \"to\": \"ed"
      }, {
        "text": "462927\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"58c8"
      }, {
        "text": "ea03\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \""
      }, {
        "text": "ffd7e743\"\n      },\n      {\n        \"type\": \"includes\",\n        \""
      }, {
        "text": "to\": \"004e0bd6\"\n      }\n    ]\n  },\n  \"45"
      }, {
        "text": "dd6d19\": {\n    \"title\": \"Multiple Sclerosis (MS)\",\n    \"primaryType\":"
      }, {
        "text": " \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Immunology\",\n      \"Pathology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eMultiple Sclerosis (MS)\u003c/b\u003e is a chronic, autoimmune, inflammatory disease of the central nervous"
      }, {
        "text": " system characterized by the demyelination of axons, leading to a wide range of neurological deficits that are disseminated in \u003cu\u003espace and time\u003c/u\u003e.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Autoreactive T-cells cross the blood"
      }, {
        "text": "-brain barrier and attack the myelin sheath produced by [[a24f9747|oligodendrocytes]], leading to inflammation"
      }, {
        "text": ", demyelination, and axonal damage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Symptoms vary widely depending on the location of the dem"
      }, {
        "text": "yelinating plaques. Common presentations include [[98a63a59|optic neuritis]], transverse myelitis,"
      }, {
        "text": " [[58c684bd|internuclear ophthalmoplegia (INO)]], and sensory or motor deficits. Symptoms"
      }, {
        "text": " often worsen with heat (Uhthoff\u0027s phenomenon).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e MRI is the gold standard,"
      }, {
        "text": " showing characteristic \u003cmark\u003eperiventricular plaques\u003c/mark\u003e (Dawson\u0027s fingers). CSF analysis reveals \u003cmark\u003eolig"
      }, {
        "text": "oclonal bands\u003c/mark\u003e of IgG and an elevated IgG index.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Triad (Charcot):\u003c/b\u003e A"
      }, {
        "text": " historical triad of \u003cb\u003eS\u003c/b\u003ecanning speech, \u003cb\u003eI\u003c/b\u003entention tremor, and \u003cb\u003eN\u003c/b\u003eyst"
      }, {
        "text": "agmus (\u003cb\u003eSIN\u003c/b\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Acute flares are treated with high-dose corticosteroids. Long-term management"
      }, {
        "text": " involves disease-modifying therapies like [[00e48ea3|interferon-Œ≤]], glatiramer acetate"
      }, {
        "text": ", and [[ae20a0ce|natalizumab]]. Symptomatic treatment for spasticity ([[1ddc"
      }, {
        "text": "3f08|baclofen]]), neuropathic pain, and bladder dysfunction is also important.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e A young woman with relapsing and remitting neurological symptoms affecting different parts of the CNS (e.g., an"
      }, {
        "text": " episode of optic neuritis followed months later by leg weakness) is the classic vignette for MS.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Multiple Sclerosis\u003c/b\u003e is defined by its pathological hallmark of CNS demyelination disseminated in space and time, leading to a highly"
      }, {
        "text": " variable clinical course of relapsing and remitting neurological deficits that reflect the multifocal nature of the autoimmune attack.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Autoimmune Attack] --\u003e B(Destruction of Oligodendrocytes); B --\u003e C(CNS"
      }, {
        "text": " Demyelination); C --\u003e D(Plaque Formation); D --\u003e E(Neurological Deficits);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"damages\",\n        \"to\": \""
      }, {
        "text": "a24f9747\"\n      },\n      {\n        \"type\": \"causes\",\n"
      }, {
        "text": "        \"to\": \"98a63a59\"\n      },\n      {\n        \"type\": \"causes\",\n        "
      }, {
        "text": "\"to\": \"58c684bd\"\n      },\n      {\n        \"type\": \"is_treated_"
      }, {
        "text": "by\",\n        \"to\": \"00e48ea3\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_treated_by\",\n        \"to\": \"ae20a0ce\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"9607467b\": {\n    \"title\":"
      }, {
        "text": " \"Muscarinic Antagonists\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Autonomic\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n"
      }, {
        "text": "      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Autonomic Drugs\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMuscarinic antagonists\u003c/b\u003e, also known as anticholinergics, are drugs"
      }, {
        "text": " that competitively block the action of [[6a005559|acetylcholine]] at muscarinic receptors,"
      }, {
        "text": " thereby inhibiting the effects of the parasympathetic nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eExamples"
      }, {
        "text": ":\u003c/b\u003e Atropine, scopolamine, ipratropium, tiotropium, oxybutynin, tol"
      }, {
        "text": "terodine, [[383f6fbe|benztropine]], trihexyphenidyl."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Competitively inhibit ACh at muscarinic receptors in the CNS and periphery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEffects"
      }, {
        "text": ":\u003c/b\u003e Mydriasis, cycloplegia, tachycardia, bronchodilation, decreased GI motility, decreased secretions ("
      }, {
        "text": "salivary, gastric, bronchial), and urinary retention. Mnemonic for anticholinergic effects: \\\"Hot as a hare, dry"
      }, {
        "text": " as a bone, blind as a bat, red as a beet, mad as a hatter.\\\"\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Use"
      }, {
        "text": " (Parkinson\u0027s):\u003c/b\u003e Centrally acting agents like [[383f6fbe|benztrop"
      }, {
        "text": "ine]] and trihexyphenidyl are used to treat tremor and rigidity in [[58c8ea03|Parkinson disease]] by"
      }, {
        "text": " correcting the relative cholinergic excess.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Use (MS):\u003c/b\u003e Drugs like oxybutynin are used to treat sp"
      }, {
        "text": "astic (hyperreflexic) bladder and urge incontinence in [[45dd6d19|multiple sclerosis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e Be aware of the contraindications, especially in the elderly (risk of delirium, constipation, urinary retention) and in patients with [["
      }, {
        "text": "9c80344d|angle-closure glaucoma]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "\u003cb\u003eMuscarinic antagonists\u003c/b\u003e act as a system-wide \u0027off switch\u0027 for the parasympathetic nervous system, producing a"
      }, {
        "text": " predictable constellation of anticholinergic effects that are therapeutically useful in conditions ranging from COPD to Parkinson\u0027s disease, but also"
      }, {
        "text": " responsible for their significant side effect profile.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"antagonizes\",\n        \"to\": \"d2b72dd8\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_treatment_for\",\n        \"to\": \"58c8ea03\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to"
      }, {
        "text": "\": \"a9db88ed\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"atrop"
      }, {
        "text": "ine\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"38"
      }, {
        "text": "3f6fbe\"\n      }\n    ]\n  },\n  \"d2b72dd8\": {"
      }, {
        "text": "\n    \"title\": \"Muscarinic Receptors\",\n    \"primaryType\": \"molecule\",\n    \""
      }, {
        "text": "tags\": [\n      \"Pharmacology\",\n      \"Physiology\",\n      \"Autonomic\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Receptors\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eMuscarinic receptors\u003c/b\u003e are a type of G-protein coupled acetylcholine receptor that are the primary end"
      }, {
        "text": "-organ receptors for the parasympathetic nervous system. They are also found in the CNS and at sympathetic postganglionic synapses to"
      }, {
        "text": " sweat glands.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLigand:\u003c/b\u003e [[6a005559"
      }, {
        "text": "|Acetylcholine (ACh)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eSubtypes \u0026 Signaling:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eM1 ("
      }, {
        "text": "G\u003csub\u003eq\u003c/sub\u003e):\u003c/b\u003e CNS, enteric nervous system.\u003cbr\u003e - \u003cb\u003eM2 (G\u003csub\u003ei\u003c/sub\u003e):\u003c/b\u003e Heart"
      }, {
        "text": " (decreases heart rate and contractility).\u003cbr\u003e - \u003cb\u003eM3 (G\u003csub\u003eq\u003c/sub\u003e):\u003c/b\u003e Smooth muscle ("
      }, {
        "text": "contraction, e.g., bronchoconstriction, bladder contraction), glands (secretion), and endothelium (vasodilation via"
      }, {
        "text": " NO).\u003c/li\u003e\u003cli\u003e\u003cb\u003eVomiting Center Input:\u003c/b\u003e M1 receptors are present in the vestibular nuclei and nucleus tractus solitarius"
      }, {
        "text": ", and their blockade (e.g., by scopolamine) is effective for [[511db4d8|motion sickness"
      }, {
        "text": "]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacology:\u003c/b\u003e Agonists (e.g., pilocarpine, bethanechol) mimic"
      }, {
        "text": " parasympathetic effects. Antagonists (e.g., atropine, ipratropium) block parasympathetic effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE"
      }, {
        "text": " Tip:\u003c/b\u003e Remember the G-protein coupling mnemonic: \\\"\u003cb\u003eQISS QIQ SIQ SQS\u003c/b\u003e\\\" (Kiss"
      }, {
        "text": " kick six six). For muscarinic receptors: M1 (\u003cb\u003eQ\u003c/b\u003e), M2 (\u003cb\u003eI\u003c/b\u003e), M3 (\u003cb\u003eQ\u003c/b\u003e"
      }, {
        "text": ").\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMuscarinic receptors\u003c/b\u003e are the workhorses of the parasympathetic nervous system,"
      }, {
        "text": " translating the signal of acetylcholine into diverse physiological effects‚Äîfrom slowing the heart (M2) to increasing secretions and smooth muscle contraction (M3)‚Äîvia"
      }, {
        "text": " distinct G-protein signaling pathways.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"cholinergic_receptor\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"binds\",\n        \"to\": \"6a005559\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_blocked_by\",\n        \"to\": \"9607467"
      }, {
        "text": "b\"\n      },\n      {\n        \"type\": \"is_involved_in\",\n        \"to"
      }, {
        "text": "\": \"vomiting_reflex\"\n      }\n    ]\n  },\n  \"463801"
      }, {
        "text": "56\": {\n    \"title\": \"Loss of Muscle Atonia in REM Sleep\",\n    \"primaryType"
      }, {
        "text": "\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Sleep Medicine\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Sleep Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLoss of muscle at"
      }, {
        "text": "onia in REM sleep\u003c/b\u003e is the cardinal feature of \u003ci\u003eREM Sleep Behavior Disorder (RBD)\u003c/i\u003e, a parasomnia where"
      }, {
        "text": " the normal paralysis that occurs during REM sleep is absent, leading patients to physically act out their dreams.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eNormal REM Sleep:\u003c/b\u003e Characterized by rapid eye movements, dreaming, and near-complete muscle paralysis (at"
      }, {
        "text": "onia), which prevents individuals from acting out their dreams.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology of RBD:\u003c/b\u003e The loss of at"
      }, {
        "text": "onia is thought to be due to dysfunction in the brainstem nuclei (e.g., subcoeruleus nucleus"
      }, {
        "text": ") that normally inhibit motor neurons during REM sleep.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients (often older men) exhibit dream"
      }, {
        "text": "-enacting behaviors, which can be violent and result in injury to themselves or their bed partners. They can often recall the"
      }, {
        "text": " dream content that corresponds to their actions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStrong Association with Neurodegeneration:\u003c/b\u003e RBD is a very strong predictor of future development"
      }, {
        "text": " of an \u003cmark\u003eŒ±-synucleinopathy\u003c/mark\u003e, such as [[58c8ea03|Parkinson disease"
      }, {
        "text": "]], [[db2f16e5|Lewy body dementia]], or multiple system atrophy. It can precede the motor"
      }, {
        "text": " symptoms of these disorders by years or even decades.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An older male patient who reports punching"
      }, {
        "text": " or kicking his spouse in his sleep while having vivid dreams is the classic presentation for REM Sleep Behavior Disorder. This finding should raise high"
      }, {
        "text": " suspicion for an underlying or future neurodegenerative disease like Parkinson\u0027s.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003eloss of muscle atonia during REM sleep\u003c/b\u003e is not just a sleep disturbance but a significant prodromal marker"
      }, {
        "text": " for Œ±-synuclein neurodegenerative diseases, representing one of the earliest clinical manifestations of these devastating conditions.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "hallmark_of\",\n        \"to\": \"rem_sleep_behavior_disorder\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_a_risk_factor_for\",\n        \"to\": \"58c8ea"
      }, {
        "text": "03\"\n      },\n      {\n        \"type\": \"is_a_risk_factor_for"
      }, {
        "text": "\",\n        \"to\": \"db2f16e5\"\n      }\n    ]\n  },"
      }, {
        "text": "\n  \"7cbe4382\": {\n    \"title\": \"Muscle Spasm Treatment\",\n    \"primaryType\": \""
      }, {
        "text": "concept\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Musculoskeletal\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special S"
      }, {
        "text": "enses\",\n      \"Pharmacology\",\n      \"Spasmolytics\"\n    ],\n    \"content\":"
      }, {
        "text": " {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMuscle spasm treatment\u003c/b\u003e involves the use of pharmacologic agents known as spasmolytics or"
      }, {
        "text": " muscle relaxants, which act either centrally in the CNS or peripherally at the muscle to reduce involuntary muscle contractions, tone"
      }, {
        "text": ", and spasticity.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSpasticity vs. Spas"
      }, {
        "text": "ms:\u003c/b\u003e Spasticity is velocity-dependent increased muscle tone from a UMN lesion. Spasms are involuntary"
      }, {
        "text": " contractions from musculoskeletal injury. Different drugs are used for each.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAgents for Spasticity (UMN lesions):\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003e[[1ddc3f08|Baclofen]]:\u003c/b\u003e A GABA\u003csub\u003eB\u003c/sub\u003e receptor agonist that"
      }, {
        "text": " acts in the spinal cord.\u003cbr\u003e - \u003cb\u003eTizanidine:\u003c/b\u003e A central Œ±\u003csub\u003e2\u003c/sub\u003e-adrenergic agonist"
      }, {
        "text": ".\u003cbr\u003e - \u003cb\u003eDiazepam:\u003c/b\u003e A benzodiazepine that facilitates GABA\u003csub\u003eA\u003c/sub\u003e action.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAgents for Acute"
      }, {
        "text": " Muscle Spasms:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCyclobenzaprine:\u003c/b\u003e A centrally acting agent structurally related"
      }, {
        "text": " to TCAs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAgent Acting Directly on Muscle:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eDantrolene:\u003c/b\u003e"
      }, {
        "text": " Blocks Ca\u003csup\u003e2+\u003c/sup\u003e release from the sarcoplasmic reticulum. Used for malignant hyperthermia and neuroleptic malignant syndrome, as"
      }, {
        "text": " well as chronic spasticity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know the site of action. Baclofen and"
      }, {
        "text": " Tizanidine are central (spinal cord/brainstem). Cyclobenzaprine is central. Dantrolene is peripheral"
      }, {
        "text": " (directly on the muscle).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe pharmacological treatment of \u003cb\u003emuscle spasms and"
      }, {
        "text": " spasticity\u003c/b\u003e relies on either dampening CNS excitatory signals (e.g., with baclofen or tizanidine) or directly"
      }, {
        "text": " interfering with the muscle contraction machinery (e.g., with dantrolene), with the choice of agent depending on the underlying"
      }, {
        "text": " cause of the muscle hyperactivity.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"includes\",\n        \"to\": \"1ddc3f08\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"includes\",\n        \"to\": \"tizanidine\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"includes\",\n        \"to\": \"dantrolene\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"includes\",\n        \"to\": \"cyclobenzaprine\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"a0c1b959\": {\n    \"title\": \""
      }, {
        "text": "Muscles of Mastication\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"An"
      }, {
        "text": "atomy\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003emuscles of mastication\u003c/b\u003e are four pairs of muscles responsible"
      }, {
        "text": " for the movements of the mandible at the temporomandibular joint, primarily for chewing. They are all innervated by the mandibular"
      }, {
        "text": " division of the \u003ci\u003etrigeminal nerve (CN V\u003csub\u003e3\u003c/sub\u003e)\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \""
      }, {
        "text": "\u003cul\u003e\u003cli\u003e\u003cb\u003eMuscles that Close the Jaw (Elevation):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eM\u003c/b\u003easseter\u003cbr\u003e - "
      }, {
        "text": "\u003cb\u003eT\u003c/b\u003eemporalis\u003cbr\u003e - \u003cb\u003eM\u003c/b\u003eedial pterygoid\u003cbr\u003e Mnemonic: \u003cb\u003eM\u003c/b\u003e\u0027"
      }, {
        "text": "s \u003cb\u003eM\u003c/b\u003eunch.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMuscle that Opens the Jaw (Depression):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eL\u003c/b\u003eateral"
      }, {
        "text": " pterygoid. Mnemonic: \u003cb\u003eL\u003c/b\u003eateral \u003cb\u003eL\u003c/b\u003eowers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e All"
      }, {
        "text": " four muscles are innervated by the motor branch of the \u003cmark\u003emandibular nerve (CN V\u003csub\u003e3\u003c/sub\u003e)\u003c/"
      }, {
        "text": "mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Derived from the first pharyngeal arch.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e A lesion of the motor"
      }, {
        "text": " root of CN V or the V\u003csub\u003e3\u003c/sub\u003e branch will cause weakness of the muscles of mastication. On jaw protrusion, the jaw will deviate \u003c"
      }, {
        "text": "mark\u003etoward the side of the lesion\u003c/mark\u003e due to the unopposed action of the contralateral lateral pterygoid muscle"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that all muscles of mastication are innervated by V\u003csub\u003e3\u003c/sub\u003e. Jaw"
      }, {
        "text": " deviation toward the lesion is a key sign of a V\u003csub\u003e3\u003c/sub\u003e motor deficit.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eThe four \u003cb\u003emuscles of mastication\u003c/b\u003e are a functional group defined by their shared innervation from CN"
      }, {
        "text": " V\u003csub\u003e3\u003c/sub\u003e and their origin from the first pharyngeal arch, working in concert to elevate, depress, and move"
      }, {
        "text": " the mandible from side to side during chewing.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"are_innervated_by\",\n        \"to\": \"mandibular_nerve_v3\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"jaw"
      }, {
        "text": "_deviation\"\n      },\n      {\n        \"type\": \"derive_from\",\n        \"to\": \"first"
      }, {
        "text": "_pharyngeal_arch\"\n      }\n    ]\n  },\n  \"7b57eee7"
      }, {
        "text": "\": {\n    \"title\": \"Mydriasis\",\n    \"primaryType\": \"finding\",\n    "
      }, {
        "text": "\"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Pharmacology\",\n"
      }, {
        "text": "      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses"
      }, {
        "text": "\",\n      \"Ophthalmology\",\n      \"Physical Findings\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eMydriasis\u003c/b\u003e is the dilation of the pupil, which can be a physiological response to dim"
      }, {
        "text": " light or a pathological or pharmacological sign.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePhysiology:\u003c/b\u003e Medi"
      }, {
        "text": "ated by the \u003cmark\u003esympathetic nervous system\u003c/mark\u003e. Postganglionic sympathetic fibers release norepinephrine, which acts"
      }, {
        "text": " on Œ±\u003csub\u003e1\u003c/sub\u003e-adrenergic receptors on the dilator pupillae muscle, causing it to contract.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmac"
      }, {
        "text": "ological Causes:\u003c/b\u003e Can be induced by sympathomimetic agents (e.g., epinephrine, phenylephrine) or \u003c"
      }, {
        "text": "mark\u003eanticholinergic/antimuscarinic agents\u003c/mark\u003e (e.g., atropine, tropicamide), which block the paras"
      }, {
        "text": "ympathetic constriction of the pupil.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathological Causes:\u003c/b\u003e A fixed, dilated (\\\"blown\\\") pupil is a classic sign of"
      }, {
        "text": " a compressive [[68c66997|oculomotor nerve (CN III) palsy]], as seen with"
      }, {
        "text": " an uncal herniation or a [[a1647fb2|posterior communicating artery aneurysm]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMe"
      }, {
        "text": "peridine Exception:\u003c/b\u003e Unlike most opioids which cause miosis, meperidine can cause mydriasis due to its anticholinergic"
      }, {
        "text": " properties.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A unilaterally dilated and nonreactive pupil is a neurological emergency. It is"
      }, {
        "text": " a key sign of uncal herniation compressing CN III.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMydriasis\u003c/b\u003e"
      }, {
        "text": " results from either sympathetic activation (contraction of the dilator muscle) or parasympathetic blockade (relaxation of the sphincter muscle);"
      }, {
        "text": " its presence, especially when unilateral and fixed, is a critical sign of potential oculomotor nerve compression.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_mediated_by\",\n        \"to\":"
      }, {
        "text": " \"sympathetic_nervous_system\"\n      },\n      {\n        \"type\": \"is_caused"
      }, {
        "text": "_by\",\n        \"to\": \"anticholinergic_drugs\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_sign_of\",\n        \"to\": \"oculomotor_nerve_p"
      }, {
        "text": "alsy\"\n      },\n      {\n        \"type\": \"is_the_opposite_of\",\n"
      }, {
        "text": "        \"to\": \"miosis\"\n      }\n    ]\n  },\n  \"c8030"
      }, {
        "text": "560\": {\n    \"title\": \"Myelencephalon\",\n    \"primaryType\": \"anatomy"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \"An"
      }, {
        "text": "atomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Embryology\",\n      \"Brain Development\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eMyelencephalon\u003c/b\u003e is the most caudal of the five secondary brain vesicles that arise"
      }, {
        "text": " from the embryonic neural tube. It develops from the posterior part of the hindbrain (rhombencephalon) and gives rise"
      }, {
        "text": " to the medulla oblongata.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryonic Origin:\u003c/b\u003e Ar"
      }, {
        "text": "ises from the posterior portion of the rhombencephalon (hindbrain).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdult Derivative:\u003c/b\u003e Differentiates into"
      }, {
        "text": " the \u003cmark\u003emedulla oblongata\u003c/mark\u003e, the lowest part of the brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Cavity:\u003c/b\u003e The cavity"
      }, {
        "text": " of the myelencephalon becomes the lower part of the \u003cmark\u003efourth ventricle\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCranial Nerves:\u003c/b\u003e The nuclei"
      }, {
        "text": " for cranial nerves IX, X, XI, and XII are located in the medulla, and thus originate from the myelencephalon.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eMnemonic for Vesicles:\u003c/b\u003e The five secondary vesicles in rostral to caudal order are Telencephalon, D"
      }, {
        "text": "iencephalon, Mesencephalon, Metencephalon, and Myelencephalon.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003eThe \u003cb\u003eMyelencephalon\u003c/b\u003e is the final segment of the developing brain, forming the medulla oblongata, which"
      }, {
        "text": " serves as the critical connection between the higher brain centers and the spinal cord and contains the nuclei for vital autonomic functions.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Rhombencephalon (Hindbrain)] --\u003e B(Metencephalon); A --\u003e C(My"
      }, {
        "text": "elencephalon); C --\u003e D(Medulla Oblongata); C --\u003e E(Lower Fourth Ventricle);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"develops_into\",\n        \"to\": \"med"
      }, {
        "text": "ulla_oblongata\"\n      },\n      {\n        \"type\": \"arises_from\",\n        \"to"
      }, {
        "text": "\": \"rhombencephalon\"\n      },\n      {\n        \"type\": \"contains_cavity\","
      }, {
        "text": "\n        \"to\": \"fourth_ventricle\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "e9cd6754\": {\n    \"title\": \"Myelomeningocele\",\n    \"primary"
      }, {
        "text": "Type\": \"disease\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Neurosurgery\",\n      \"Embry"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Embryology\",\n      \"Neural Tube Defects\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eA \u003cb\u003emyelomeningocele\u003c/b\u003e is the most severe form of spina bifida, an"
      }, {
        "text": " open neural tube defect where both the \u003ci\u003emeninges and the spinal cord\u003c/i\u003e herniate through a defect in the vertebral column, forming"
      }, {
        "text": " a cystic sac on the infant\u0027s back.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Results"
      }, {
        "text": " from the failure of the caudal neuropore of the [[a87cbede|neural tube]] to close during the"
      }, {
        "text": " 4th week of embryonic development.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A visible sac-like protrusion on the back"
      }, {
        "text": ", typically in the lumbosacral region. It is associated with neurological deficits below the level of the lesion, including lower"
      }, {
        "text": " extremity paralysis and bowel/bladder incontinence.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Condition:\u003c/b\u003e Almost always associated with a \u003cmark\u003eChiari II"
      }, {
        "text": " malformation\u003c/mark\u003e, which can lead to obstructive [[0bc2f200|hydrocephalus]].\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eDiagnosis:\u003c/b\u003e Can be diagnosed prenatally by ultrasound and elevated maternal serum alpha-fetoprotein (AFP) and"
      }, {
        "text": " amniotic fluid acetylcholinesterase (AChE).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from a"
      }, {
        "text": " meningocele, where only the meninges herniate and the spinal cord remains in the canal. Myelomeningocele involves herni"
      }, {
        "text": "ation of the \u0027myelo\u0027 (spinal cord) itself, leading to severe neurological deficits.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003eA \u003cb\u003emyelomeningocele\u003c/b\u003e represents a catastrophic failure of neurulation, where the spinal cord itself"
      }, {
        "text": " is exposed and herniated, leading to inevitable and permanent neurological damage below the lesion and a near-universal association with Chi"
      }, {
        "text": "ari II malformation and hydrocephalus.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_type_of\",\n        \"to\": \"spina_bifida\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \""
      }, {
        "text": "neural_tube_defect\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\":"
      }, {
        "text": " \"chiari_ii_malformation\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\":"
      }, {
        "text": " \"meningocele\"\n      }\n    ]\n  },\n  \"0e2d06f6"
      }, {
        "text": "\": {\n    \"title\": \"Myeloschisis\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Pediatrics\",\n      \"Embryology\",\n      \"Neurosurgery\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Embryology\",\n      \"Neural Tube Defects\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003e\u003cb\u003eMyeloschisis\u003c/b\u003e (or rachischisis) is the most severe form of spina bifida, an"
      }, {
        "text": " open neural tube defect where the neural folds fail to fuse, resulting in a flattened, plate-like mass of nervous tissue that"
      }, {
        "text": " is directly exposed to the environment without any overlying meningeal or skin covering.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e Represents a complete failure of primary neurulation in the affected region. The neural plate is open and exposed on"
      }, {
        "text": " the surface of the back.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A raw, exposed plaque of neural tissue is visible on the infant"
      }, {
        "text": "\u0027s back. This leads to profound and complete neurological deficits below the level of the lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison to"
      }, {
        "text": " Myelomeningocele:\u003c/b\u003e It is more severe than a [[e9cd6754|myelomeningocele]], in"
      }, {
        "text": " which the herniated neural tissue is at least covered by meninges.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Carries a very poor"
      }, {
        "text": " prognosis due to the severe neurological impairment and high risk of infection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e This is the most severe form of neural"
      }, {
        "text": " tube defect. The key feature is the exposed, non-fused neural plate on the back.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eMyeloschisis\u003c/b\u003e represents the most fundamental failure of neural tube formation, where the neural folds"
      }, {
        "text": " do not even begin to fuse, leaving the primordial spinal cord exposed to the outside world and resulting in the most devastating neurological outcomes.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"spina_bifida\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_type_of\",\n        \"to\": \"neural_tube_"
      }, {
        "text": "defect\"\n      },\n      {\n        \"type\": \"is_more_severe_than\",\n        "
      }, {
        "text": "\"to\": \"e9cd6754\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"b7808532\",\n    \"letter\": \"M\",\n    \"term\": \"Methemoglobinemia\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Methemoglobinemia\",\n    \"sub_entries\": [\n      {\n        \"id\": \"d6c3009c\",\n        \"letter\": \"M\",\n        \"term\": \"local anesthetics and\",\n        \"pages\": [\n          \"565\"\n        ],\n        \"context\": \"Methemoglobinemia \u003e local anesthetics and\"\n      }\n    ]\n  },\n  {\n    \"id\": \"8423676f\",\n    \"letter\": \"M\",\n    \"term\": \"Meyer loop\",\n    \"pages\": [\n      \"557\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Meyer loop\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"b6636994\",\n    \"letter\": \"M\",\n    \"term\": \"Microglia\",\n    \"pages\": [\n      \"503\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Microglia\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"03725017\",\n    \"letter\": \"M\",\n    \"term\": \"Midazolam\",\n    \"pages\": [\n      \"562\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Midazolam\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"05999504\",\n    \"letter\": \"M\",\n    \"term\": \"Midbrain\",\n    \"pages\": [\n      \"516\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Midbrain\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"143bb23d\",\n    \"letter\": \"M\",\n    \"term\": \"Middle cerebral artery\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Middle cerebral artery\",\n    \"sub_entries\": [\n      {\n        \"id\": \"a320f3a3\",\n        \"letter\": \"M\",\n        \"term\": \"saccular aneurysms\",\n        \"pages\": [\n          \"530\"\n        ],\n        \"context\": \"Middle cerebral artery \u003e saccular aneurysms\"\n      },\n      {\n        \"id\": \"f722c58c\",\n        \"letter\": \"M\",\n        \"term\": \"stroke effects\",\n        \"pages\": [\n          \"526\"\n        ],\n        \"context\": \"Middle cerebral artery \u003e stroke effects\"\n      },\n      {\n        \"id\": \"7746a155\",\n        \"letter\": \"M\",\n        \"term\": \"watershed zones\",\n        \"pages\": [\n          \"513\"\n        ],\n        \"context\": \"Middle cerebral artery \u003e watershed zones\"\n      }\n    ]\n  },\n  {\n    \"id\": \"45568c28\",\n    \"letter\": \"M\",\n    \"term\": \"Middle ear\",\n    \"pages\": [\n      \"547\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Middle ear\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"f3073d4b\",\n    \"letter\": \"M\",\n    \"term\": \"Middle meningeal artery\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Middle meningeal artery\",\n    \"sub_entries\": [\n      {\n        \"id\": \"20f99074\",\n        \"letter\": \"M\",\n        \"term\": \"epidural hematoma and\",\n        \"pages\": [\n          \"528\"\n        ],\n        \"context\": \"Middle meningeal artery \u003e epidural hematoma and\"\n      }\n    ]\n  },\n  {\n    \"id\": \"c8833bae\",\n    \"letter\": \"M\",\n    \"term\": \"Migraine headaches\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Migraine headaches\",\n    \"sub_entries\": [\n      {\n        \"id\": \"5e2745fd\",\n        \"letter\": \"M\",\n        \"term\": \"characteristics and treatment\",\n        \"pages\": [\n          \"532\"\n        ],\n        \"context\": \"Migraine headaches \u003e characteristics and treatment\"\n      },\n      {\n        \"id\": \"e7459fac\",\n        \"letter\": \"M\",\n        \"term\": \"triptans for\",\n        \"pages\": [\n          \"562\"\n        ],\n        \"context\": \"Migraine headaches \u003e triptans for\"\n      }\n    ]\n  },\n  {\n    \"id\": \"e55deaa2\",\n    \"letter\": \"M\",\n    \"term\": \"Miosis\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Miosis\",\n    \"sub_entries\": [\n      {\n        \"id\": \"cb8b80ac\",\n        \"letter\": \"M\",\n        \"term\": \"pupillary control pathway\",\n        \"pages\": [\n          \"554\"\n        ],\n        \"context\": \"Miosis \u003e pupillary control pathway\"\n      }\n    ]\n  },\n  {\n    \"id\": \"1f7823a2\",\n    \"letter\": \"M\",\n    \"term\": \"Molecular mimicry\",\n    \"pages\": [\n      \"127\",\n      \"538\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Molecular mimicry\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"9deb7a13\",\n    \"letter\": \"M\",\n    \"term\": \"Monoamine oxidase inhibitors\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Monoamine oxidase inhibitors\",\n    \"sub_entries\": [\n      {\n        \"id\": \"22fe0000\",\n        \"letter\": \"M\",\n        \"term\": \"Parkinson disease\",\n        \"pages\": [\n          \"564\"\n        ],\n        \"context\": \"Monoamine oxidase inhibitors \u003e Parkinson disease\"\n      }\n    ]\n  },\n  {\n    \"id\": \"ff9dd909\",\n    \"letter\": \"M\",\n    \"term\": \"Moraxella catarrhalis\",\n    \"pages\": [\n      \"547\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Moraxella catarrhalis\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"666cc8e9\",\n    \"letter\": \"M\",\n    \"term\": \"Moro reflex\",\n    \"pages\": [\n      \"523\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Moro reflex\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"69c2ccb7\",\n    \"letter\": \"M\",\n    \"term\": \"Morphine\",\n    \"pages\": [\n      \"233\",\n      \"315\",\n      \"567\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Morphine\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 1854
    }, {
      "text": "```json\n{\n  \"b7808532\": {\n    \"title\": \"Methemoglobinemia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Hematology\",\n      \"Toxicology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Hematology and Oncology\",\n      \"Pathology\",\n      \"Red Blood Cell Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMethemoglobinemia\u003c/b\u003e is a condition characterized by the presence of an abnormally high level of methemoglobin (MetHb) in the blood. Methemoglobin is a form of hemoglobin in which the iron in the heme group is in the ferric (Fe\u003csup\u003e3+\u003c/sup\u003e) state, rather than the ferrous (Fe\u003csup\u003e2+\u003c/sup\u003e) state, making it unable to bind oxygen.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The Fe\u003csup\u003e3+\u003c/sup\u003e state not only prevents oxygen binding to that heme group but also causes a left shift in the oxygen-hemoglobin dissociation curve for the remaining normal hemoglobin, impairing oxygen release to tissues. This results in a functional anemia and tissue hypoxia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e Can be congenital (e.g., cytochrome b5 reductase deficiency) or acquired. Acquired causes include exposure to oxidizing agents such as \u003cmark\u003edapsone\u003c/mark\u003e, nitrites (found in some well water and as preservatives), and topical/local anesthetics like \u003cmark\u003ebenzocaine\u003c/mark\u003e and prilocaine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients present with cyanosis that is unresponsive to supplemental oxygen, and blood that is classically described as \u003cmark\u003e\\\"chocolate-brown\\\"\u003c/mark\u003e in color. Pulse oximetry is unreliable and often reads around 85%.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Confirmed by co-oximetry of an arterial blood gas sample.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e The antidote is \u003cmark\u003emethylene blue\u003c/mark\u003e, which acts as an electron donor to reduce Fe\u003csup\u003e3+\u003c/sup\u003e back to Fe\u003csup\u003e2+\u003c/sup\u003e via the NADPH-MetHb reductase pathway.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient who develops cyanosis and shortness of breath after a dental procedure or endoscopy (where benzocaine spray is used) with chocolate-brown blood is a classic vignette for acquired methemoglobinemia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMethemoglobinemia\u003c/b\u003e is a state of \u0027iron rust\u0027 within hemoglobin, where oxidizing drugs convert functional Fe\u003csup\u003e2+\u003c/sup\u003e to non-functional Fe\u003csup\u003e3+\u003c/sup\u003e, leading to a profound tissue hypoxia that is uniquely treated with the reducing agent methylene blue.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"benzocaine\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"dapsone\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"methylene_blue\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"cyanosis\"\n      }\n    ]\n  },\n  \"8423676f\": {\n    \"title\": \"Meyer\u0027s Loop\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Visual Pathway\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMeyer\u0027s loop\u003c/b\u003e is the inferior portion of the optic radiation, a bundle of nerve fibers that curves from the lateral geniculate nucleus (LGN) of the thalamus, sweeps anteriorly into the \u003ci\u003etemporal lobe\u003c/i\u003e, and then projects posteriorly to the lower bank of the calcarine sulcus in the occipital lobe.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Carries visual information from the \u003cmark\u003einferior retina\u003c/mark\u003e (which corresponds to the superior visual field).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Travels through the temporal lobe, looping around the inferior horn of the lateral ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effect:\u003c/b\u003e A lesion of Meyer\u0027s loop results in a contralateral \u003cmark\u003esuperior quadrantanopia\u003c/mark\u003e (loss of the upper quadrant of the visual field on the opposite side). This is often referred to as a \\\"pie in the sky\\\" defect.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses of Lesions:\u003c/b\u003e Can be damaged by strokes involving the [[143bb23d|Middle Cerebral Artery (MCA)]], temporal lobe tumors, or temporal lobectomy surgery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the mnemonic \u003cb\u003eL-M-N-O-P\u003c/b\u003e: \u003cb\u003eL\u003c/b\u003eateral geniculate nucleus to \u003cb\u003eM\u003c/b\u003eeyer\u0027s loop (\u003cb\u003eN\u003c/b\u003eo, that\u0027s wrong). Better mnemonic: \u003cb\u003eT\u003c/b\u003eemporal lobe lesion \u003d \u003cb\u003eT\u003c/b\u003eop-quadrant defect (\\\"\u003cb\u003eT\u003c/b\u003eea in the \u003cb\u003eT\u003c/b\u003ereetops\\\"). Contrast with the dorsal optic radiation in the \u003cb\u003eP\u003c/b\u003earietal lobe, which causes a \\\"\u003cb\u003eP\u003c/b\u003eie on the \u003cb\u003eF\u003c/b\u003eloor\\\" (inferior quadrantanopia).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMeyer\u0027s loop\u003c/b\u003e takes a detour through the temporal lobe to carry information from the inferior retina; therefore, a lesion in this specific location predictably causes a contralateral \\\"pie in the sky\\\" visual field defect, a key localizing sign in neuro-ophthalmology.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Inferior Retina] --\u003e B(LGN); B --\u003e C(Meyer\u0027s Loop in Temporal Lobe); C --\u003e D(Lower Visual Cortex); A --Represents--\u003e E(Superior Visual Field);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"optic_radiation\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"temporal_lobe\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"superior_quadrantanopia\"\n      },\n      {\n        \"type\": \"is_contrasted_with\",\n        \"to\": \"09c8409d\"\n      }\n    ]\n  },\n  \"b6636994\": {\n    \"title\": \"Microglia\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Histology\",\n      \"Immunology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Glial Cells\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMicroglia\u003c/b\u003e are the resident immune cells of the central nervous system (CNS), acting as the primary phagocytic scavengers and mediators of the innate immune response within the brain and spinal cord.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryonic Origin:\u003c/b\u003e Unlike other glial cells (which are neuroectodermal), microglia are derived from the \u003cmark\u003emesoderm\u003c/mark\u003e (yolk sac myeloid progenitors) and migrate into the CNS during development.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e In the resting state, they constantly survey their microenvironment with motile processes. Upon activation by injury, infection, or inflammation, they transform into an amoeboid shape, become phagocytic, and release inflammatory mediators (e.g., cytokines, nitric oxide).\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Pathology:\u003c/b\u003e They are activated in response to any CNS injury, including stroke, trauma, and infection. They phagocytose cellular debris and dead neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHIV-Associated Dementia:\u003c/b\u003e In HIV infection, microglia can become infected and fuse to form \u003cmark\u003emultinucleated giant cells\u003c/mark\u003e, which is a pathognomonic finding in HIV-associated dementia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the unique mesodermal origin of microglia, distinguishing them from all other CNS cells which are of ectodermal origin. Mnemonic: \u003cb\u003eM\u003c/b\u003eicroglia \u003d \u003cb\u003eM\u003c/b\u003eacrophages of the CNS, from \u003cb\u003eM\u003c/b\u003eesoderm.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMicroglia\u003c/b\u003e are the dedicated immune defenders of the CNS, originating from the mesoderm and acting as the brain\u0027s resident macrophages; their activation is a double-edged sword, essential for clearing debris but also capable of contributing to neuroinflammation.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"glial_cell\"\n      },\n      {\n        \"type\": \"derives_from\",\n        \"to\": \"mesoderm\"\n      },\n      {\n        \"type\": \"functions_as\",\n        \"to\": \"macrophage\"\n      },\n      {\n        \"type\": \"is_implicated_in\",\n        \"to\": \"hiv_associated_dementia\"\n      }\n    ]\n  },\n  \"03725017\": {\n    \"title\": \"Midazolam\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Anxiolytics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMidazolam\u003c/b\u003e is a short-acting \u003ci\u003ebenzodiazepine\u003c/i\u003e with potent anxiolytic, amnestic, sedative, and anticonvulsant properties, commonly used for procedural sedation and as an induction agent for general anesthesia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Facilitates the action of [[5aa5cb91|GABA]] at the GABA\u003csub\u003eA\u003c/sub\u003e receptor, increasing the \u003cmark\u003efrequency\u003c/mark\u003e of Cl\u003csup\u003e-\u003c/sup\u003e channel opening, which leads to CNS depression.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a \u003cmark\u003erapid onset\u003c/mark\u003e and \u003cmark\u003eshort duration\u003c/mark\u003e of action, making it ideal for procedural use. It is one of the benzodiazepines with minimal first-pass metabolism.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for sedation before medical procedures (e.g., endoscopy, surgery), as an anxiolytic, and for the treatment of status epilepticus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Can cause significant respiratory depression, especially when combined with other CNS depressants like opioids. Also causes hypotension and anterograde amnesia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReversal:\u003c/b\u003e The effects of midazolam can be reversed by the competitive antagonist \u003cmark\u003eflumazenil\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Midazolam is a go-to drug for procedural sedation because of its rapid onset, short duration, and potent amnestic effects. Remember that its respiratory depressant effects are additive with opioids.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMidazolam\u003c/b\u003e is a fast-acting, short-duration benzodiazepine prized for its ability to induce sedation and amnesia for uncomfortable procedures, but its potent CNS depressant effects necessitate careful monitoring of respiratory status.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"14464617\"\n      },\n      {\n        \"type\": \"is_used_for\",\n        \"to\": \"procedural_sedation\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"status_epilepticus\"\n      },\n      {\n        \"type\": \"effects_are_reversed_by\",\n        \"to\": \"flumazenil\"\n      }\n    ]\n  },\n  \"05999504\": {\n    \"title\": \"Midbrain\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMidbrain\u003c/b\u003e (or mesencephalon) is the most superior part of the brainstem, connecting the pons and cerebellum with the forebrain. It is a crucial center for motor control, auditory and visual processing, and consciousness.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Arises from the mesencephalon, one of the three primary brain vesicles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCranial Nerve Nuclei:\u003c/b\u003e Contains the nuclei for the [[68c66997|oculomotor nerve (CN III)]] and the [[bba6093a|trochlear nerve (CN IV)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Structures:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eTectum (Dorsal):\u003c/b\u003e Contains the superior colliculi (visual reflexes) and inferior colliculi (auditory reflexes).\u003cbr\u003e - \u003cb\u003eTegmentum (Ventral):\u003c/b\u003e Contains the red nucleus (motor coordination) and substantia nigra (motor control, dopamine production).\u003cbr\u003e - \u003cb\u003eCerebral Peduncles:\u003c/b\u003e Large bundles of descending motor fibers (corticospinal and corticobulbar tracts).\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Primarily supplied by branches of the [[b6a2cc31|Posterior Cerebral Artery (PCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Syndromes:\u003c/b\u003e Lesions can cause specific syndromes like Weber syndrome (CN III palsy + contralateral hemiplegia) and Parinaud syndrome (dorsal midbrain compression).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMidbrain\u003c/b\u003e is a compact but vital relay and processing center, housing the origins of the nerves that move the eyes and containing the substantia nigra, whose degeneration is the cause of Parkinson\u0027s disease.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"brainstem\"\n      },\n      {\n        \"type\": \"contains_nuclei_of\",\n        \"to\": \"68c66997\"\n      },\n      {\n        \"type\": \"contains_nuclei_of\",\n        \"to\": \"bba6093a\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"substantia_nigra\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"red_nucleus\"\n      }\n    ]\n  },\n  \"143bb23d\": {\n    \"title\": \"Middle Cerebral Artery (MCA)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Vascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebrovascular System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMiddle Cerebral Artery (MCA)\u003c/b\u003e is the largest cerebral artery and a terminal branch of the internal carotid artery. It supplies a significant portion of the lateral cerebral hemispheres, and its occlusion is the most common cause of ischemic stroke.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTerritory:\u003c/b\u003e Supplies the lateral surface of the frontal, parietal, and temporal lobes. This includes the primary motor and somatosensory cortices for the \u003cmark\u003eface and upper limb\u003c/mark\u003e, as well as the language centers (Broca\u0027s and Wernicke\u0027s areas) in the dominant hemisphere.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Effects:\u003c/b\u003e An MCA stroke classically causes \u003cmark\u003econtralateral hemiparesis and sensory loss\u003c/mark\u003e, predominantly affecting the face and arm more than the leg.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDominant Hemisphere (usually Left) Stroke:\u003c/b\u003e Can cause [[6bc9a567|aphasia]] (Broca\u0027s, Wernicke\u0027s, or global).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNon-dominant Hemisphere (usually Right) Stroke:\u003c/b\u003e Can cause [[134828d8|hemineglect syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eDeep Branches (Lenticulostriate Arteries):\u003c/b\u003e Supply the basal ganglia and internal capsule. Occlusion of these small vessels causes lacunar strokes, such as a [[8aefcafe|pure motor stroke]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Contralateral face and arm weakness/sensory loss is the hallmark of an MCA stroke. If speech is affected, the lesion is in the dominant hemisphere. If neglect is present, the lesion is in the non-dominant hemisphere.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMiddle Cerebral Artery\u003c/b\u003e supplies the eloquent lateral aspects of the brain, including motor and sensory areas for the face and arm, and the language centers. Consequently, an MCA stroke produces some of the most devastating and classic neurological deficits.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_branch_of\",\n        \"to\": \"internal_carotid_artery\"\n      },\n      {\n        \"type\": \"occlusion_causes\",\n        \"to\": \"ischemic_stroke\"\n      },\n      {\n        \"type\": \"occlusion_causes\",\n        \"to\": \"6bc9a567\"\n      },\n      {\n        \"type\": \"occlusion_causes\",\n        \"to\": \"134828d8\"\n      }\n    ]\n  },\n  \"45568c28\": {\n    \"title\": \"Middle Ear\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Otology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Anatomy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMiddle Ear\u003c/b\u003e is an air-filled cavity within the temporal bone, located between the tympanic membrane and the inner ear. It contains the auditory ossicles and is connected to the nasopharynx by the eustachian tube.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e The middle ear cavity contains the three [[3aea8cac|auditory ossicles]] (malleus, incus, stapes).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Transmits and amplifies sound vibrations from the tympanic membrane (eardrum) to the oval window of the inner ear.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEustachian Tube:\u003c/b\u003e Connects the middle ear to the nasopharynx, allowing for pressure equalization between the middle ear and the atmosphere. Dysfunction is a key factor in [[a03641af|otitis media]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMuscles:\u003c/b\u003e Contains the tensor tympani (innervated by CN V\u003csub\u003e3\u003c/sub\u003e) and stapedius (innervated by CN VII) muscles, which dampen loud sounds.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e The most common pathology is [[a03641af|acute otitis media]], an infection of the middle ear space, especially common in children. Other conditions include [[03ef3134|cholesteatoma]] and otosclerosis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMiddle Ear\u003c/b\u003e functions as a mechanical impedance-matching system, using the lever action of the ossicles to efficiently transfer sound energy from the low-impedance air of the external world to the high-impedance fluid of the inner ear.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"ear\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"3aea8cac\"\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"a03641af\"\n      },\n      {\n        \"type\": \"is_connected_to_nasopharynx_by\",\n        \"to\": \"eustachian_tube\"\n      }\n    ]\n  },\n  \"f3073d4b\": {\n    \"title\": \"Middle Meningeal Artery\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Neurosurgery\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebrovascular System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMiddle Meningeal Artery\u003c/b\u003e is the largest of the three arteries that supply the meninges. Its rupture, typically due to head trauma, is the classic cause of an \u003ci\u003eepidural hematoma\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e It is a branch of the maxillary artery, which in turn is a branch of the external carotid artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCourse:\u003c/b\u003e Enters the skull through the \u003cmark\u003eforamen spinosum\u003c/mark\u003e and runs in a groove on the inner surface of the temporal bone, between the dura mater and the skull.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Laceration of this artery, often associated with a fracture of the \u003cmark\u003etemporal bone at the pterion\u003c/mark\u003e (the thinnest part of the skull), leads to an \u003cmark\u003eepidural hematoma\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEpidural Hematoma:\u003c/b\u003e An arterial bleed that accumulates rapidly in the potential space between the dura and the skull, creating a lens-shaped (biconvex) hematoma on CT scan.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Trauma to the side of the head (pterion) leading to a brief loss of consciousness, a \u0027lucid interval,\u0027 and then rapid neurological decline is the classic presentation for an epidural hematoma from a middle meningeal artery tear.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMiddle Meningeal Artery\u0027s\u003c/b\u003e vulnerable course in a groove on the inner surface of the thin temporal bone makes it the primary culprit in epidural hematomas following lateral head trauma, leading to a rapidly expanding, life-threatening arterial bleed.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"rupture_causes\",\n        \"to\": \"epidural_hematoma\"\n      },\n      {\n        \"type\": \"is_a_branch_of\",\n        \"to\": \"maxillary_artery\"\n      },\n      {\n        \"type\": \"enters_skull_via\",\n        \"to\": \"foramen_spinosum\"\n      }\n    ]\n  },\n  \"c8833bae\": {\n    \"title\": \"Migraine Headaches\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pain Management\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Headaches\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMigraine\u003c/b\u003e is a primary headache disorder characterized by recurrent, moderate to severe headaches that are typically unilateral and pulsating, and are often associated with nausea, photophobia, and phonophobia. Some attacks are preceded by a sensory warning sign or aura.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Involves irritation of the [[0eb45a0a|trigeminal nerve (CN V)]], meninges, or blood vessels, leading to the release of vasoactive neuropeptides like \u003cmark\u003ecalcitonin gene-related peptide (CGRP)\u003c/mark\u003e and substance P.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Features (POUND mnemonic):\u003c/b\u003e \u003cb\u003eP\u003c/b\u003eulsatile, \u003cb\u003eO\u003c/b\u003ene-day duration (4-72 hrs), \u003cb\u003eU\u003c/b\u003enilateral, \u003cb\u003eN\u003c/b\u003eausea, \u003cb\u003eD\u003c/b\u003eisabling.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAura:\u003c/b\u003e A transient visual, sensory, or motor disturbance that precedes or accompanies the headache. The most common is a visual aura (e.g., scintillating scotoma).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAbortive Treatment:\u003c/b\u003e For acute attacks, treatments include NSAIDs, \u003cmark\u003etriptans\u003c/mark\u003e (5-HT\u003csub\u003e1B/1D\u003c/sub\u003e agonists like sumatriptan), and dihydroergotamine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProphylactic Treatment:\u003c/b\u003e For frequent migraines, options include beta-blockers (e.g., propranolol), TCAs (e.g., amitriptyline), anticonvulsants (e.g., topiramate, valproate), and anti-CGRP monoclonal antibodies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Triptans are contraindicated in patients with coronary artery disease or Prinzmetal angina due to their vasoconstrictive effects.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMigraine\u003c/b\u003e is a complex neurovascular disorder, not just a simple headache. Its pathophysiology involves trigeminal nerve activation and CGRP release, making CGRP antagonists and 5-HT agonists (triptans) specific and effective treatments.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"26661e34\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"triptans\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"682952a2\"\n      },\n      {\n        \"type\": \"involves\",\n        \"to\": \"0eb45a0a\"\n      }\n    ]\n  },\n  \"e55deaa2\": {\n    \"title\": \"Miosis\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physical Findings\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMiosis\u003c/b\u003e is the constriction of the pupil, which can be a physiological response to bright light or a pathological or pharmacological sign.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePhysiology:\u003c/b\u003e Mediated by the \u003cmark\u003eparasympathetic nervous system\u003c/mark\u003e. Preganglionic fibers from the Edinger-Westphal nucleus travel with the [[68c66997|oculomotor nerve (CN III)]] to the ciliary ganglion. Postganglionic fibers release ACh, which acts on M3 muscarinic receptors on the \u003cmark\u003esphincter pupillae muscle\u003c/mark\u003e, causing it to contract.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacological Causes:\u003c/b\u003e Can be induced by cholinomimetics (e.g., [[f54d873a|pilocarpine]]) or acetylcholinesterase inhibitors. \u003cmark\u003eOpioids\u003c/mark\u003e (e.g., morphine, heroin) characteristically cause pinpoint pupils by stimulating the Edinger-Westphal nucleus.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathological Causes:\u003c/b\u003e A key feature of [[c19010a3|Horner syndrome]], which results from disruption of the sympathetic pathway to the eye, leading to unopposed parasympathetic tone.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePupillary Control Pathway:\u003c/b\u003e The pupillary light reflex pathway involves CN II (afferent) and CN III (efferent), resulting in miosis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The triad of coma, respiratory depression, and miosis is classic for opioid overdose. Remember that tolerance does not develop to the miotic effects of opioids.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMiosis\u003c/b\u003e results from parasympathetic activation causing contraction of the pupillary sphincter muscle. Its presence can be a key diagnostic clue, pointing to conditions ranging from opioid overdose to Horner syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_mediated_by\",\n        \"to\": \"parasympathetic_nervous_system\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"opioid_analgesics\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"c19010a3\"\n      },\n      {\n        \"type\": \"is_the_opposite_of\",\n        \"to\": \"7b57eee7\"\n      }\n    ]\n  },\n  \"1f7823a2\": {\n    \"title\": \"Molecular Mimicry\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Immunology\",\n      \"Pathology\",\n      \"Infectious Disease\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Autoimmune Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMolecular mimicry\u003c/b\u003e is a pathogenic mechanism in which sequence similarities between foreign (e.g., microbial) peptides and self-peptides are sufficient to result in the cross-activation of autoreactive T or B cells by a pathogen-derived epitope, leading to an autoimmune response.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e An immune response is mounted against a pathogen. Due to structural similarity between a pathogen antigen and a self-antigen, the activated T cells or antibodies then attack the host\u0027s own tissues.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRheumatic Fever:\u003c/b\u003e A classic example. Antibodies against the M protein of \u003ci\u003eStreptococcus pyogenes\u003c/i\u003e cross-react with cardiac myosin, leading to myocarditis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGuillain-Barr√© Syndrome (AIDP):\u003c/b\u003e Often follows infection with \u003ci\u003eCampylobacter jejuni\u003c/i\u003e. Antibodies against bacterial lipooligosaccharides cross-react with gangliosides on peripheral nerve myelin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAcute Disseminated Encephalomyelitis (ADEM):\u003c/b\u003e An autoimmune response following a viral infection or vaccination is thought to cross-react with myelin antigens in the CNS.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When a question describes an autoimmune condition that develops shortly after an infection, molecular mimicry is the likely underlying mechanism.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMolecular mimicry\u003c/b\u003e is a case of mistaken identity by the immune system, where the fight against a foreign invader inadvertently turns into a civil war against the body\u0027s own tissues due to the unfortunate resemblance between microbial and self-antigens.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Pathogen with Antigen \u0027X\u0027] --\u003e B(Immune System Activation); B --\u003e C(Produces Antibodies/T-cells against \u0027X\u0027); D[Self-Tissue with Antigen \u0027X-like\u0027] \u003c-- Cross-reactivity --- C; D --\u003e E(Autoimmune Disease);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_the_mechanism_for\",\n        \"to\": \"rheumatic_fever\"\n      },\n      {\n        \"type\": \"is_the_mechanism_for\",\n        \"to\": \"ed52e40b\"\n      },\n      {\n        \"type\": \"is_the_mechanism_for\",\n        \"to\": \"67e83e3b\"\n      }\n    ]\n  },\n  \"9deb7a13\": {\n    \"title\": \"Monoamine Oxidase (MAO) Inhibitors\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Antidepressants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMonoamine oxidase (MAO) inhibitors\u003c/b\u003e are a class of drugs that increase the levels of monoamine neurotransmitters (norepinephrine, serotonin, dopamine) by inhibiting the enzyme responsible for their breakdown.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Inhibit monoamine oxidase, the enzyme that degrades monoamines in the presynaptic terminal. This increases the amount of neurotransmitter available for release into the synapse.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTypes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eNon-selective MAOIs\u003c/b\u003e (inhibit both MAO-A and MAO-B): Tranylcypromine, Phenelzine, Isocarboxazid. Used for atypical depression.\u003cbr\u003e - \u003cb\u003eSelective MAO-B inhibitors:\u003c/b\u003e [[2883864d|Rasagiline]], Selegiline. Used for [[58c8ea03|Parkinson disease]] to increase dopamine levels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eHypertensive Crisis:\u003c/b\u003e Occurs when MAOIs are taken with tyramine-rich foods (e.g., aged cheeses, cured meats, red wine). Tyramine is normally broken down by MAO-A in the gut; its buildup causes a massive release of catecholamines.\u003cbr\u003e - \u003cb\u003eSerotonin Syndrome:\u003c/b\u003e Risk is high when combined with SSRIs, SNRIs, TCAs, or other serotonergic agents. A washout period is required when switching antidepressants.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The risk of hypertensive crisis with tyramine-containing foods (the \\\"cheese effect\\\") is the most famous and feared side effect of non-selective MAOIs.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMAO inhibitors\u003c/b\u003e boost levels of multiple neurotransmitters by blocking their degradation, but this powerful, non-specific mechanism comes with dangerous interactions, most notably the risk of a life-threatening hypertensive crisis if combined with tyramine-rich foods.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"depression\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"hypertensive_crisis\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"serotonin_syndrome\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"2883864d\"\n      }\n    ]\n  },\n  \"ff9dd909\": {\n    \"title\": \"Moraxella catarrhalis\",\n    \"primaryType\": \"microbe\",\n    \"tags\": [\n      \"Microbiology\",\n      \"Infectious Disease\",\n      \"Otology\",\n      \"Pulmonology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMoraxella catarrhalis\u003c/b\u003e is a gram-negative diplococcus that is a common commensal of the upper respiratory tract and a frequent cause of otitis media, sinusitis, and exacerbations of chronic obstructive pulmonary disease (COPD).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMicrobiology:\u003c/b\u003e Aerobic, non-motile, gram-negative diplococcus. It is oxidase-positive.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Infections:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[a03641af|Otitis Media]]:\u003c/b\u003e One of the top three bacterial causes in children, along with \u003ci\u003eS. pneumoniae\u003c/i\u003e and non-typeable \u003ci\u003eH. influenzae\u003c/i\u003e.\u003cbr\u003e - \u003cb\u003eSinusitis:\u003c/b\u003e A common cause of acute bacterial sinusitis in both children and adults.\u003cbr\u003e - \u003cb\u003eCOPD Exacerbations:\u003c/b\u003e A significant cause of bacterial exacerbations of chronic bronchitis and COPD.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVirulence:\u003c/b\u003e Produces beta-lactamase, making it resistant to penicillins like amoxicillin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Often treated with amoxicillin-clavulanate, cephalosporins, or macrolides to cover for beta-lactamase production.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When considering the causes of [[a03641af|otitis media]] or a COPD exacerbation, always include \u003ci\u003eM. catarrhalis\u003c/i\u003e in the differential, and remember that it is typically beta-lactamase positive.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMoraxella catarrhalis\u003c/b\u003e is a common respiratory pathogen that, along with \u003ci\u003eS. pneumoniae\u003c/i\u003e and \u003ci\u003eH. influenzae\u003c/i\u003e, forms the classic triad of bacteria responsible for otitis media and sinusitis, with its frequent production of beta-lactamase influencing antibiotic choice.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"a03641af\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"sinusitis\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"copd_exacerbation\"\n      },\n      {\n        \"type\": \"produces\",\n        \"to\": \"beta_lactamase\"\n      }\n    ]\n  },\n  \"666cc8e9\": {\n    \"title\": \"Moro Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Reflexes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMoro reflex\u003c/b\u003e, also known as the startle reflex, is a primitive, involuntary reflex present in infants in response to a sudden loss of support or a loud noise, characterized by the spreading out and then pulling in of the arms.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eElicitation:\u003c/b\u003e Elicited by allowing the infant\u0027s head to suddenly but gently fall backward.\u003c/li\u003e\u003cli\u003e\u003cb\u003eResponse:\u003c/b\u003e The infant responds by symmetrically abducting and extending the arms, followed by adduction and flexion of the arms. The infant may also cry.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDevelopmental Timeline:\u003c/b\u003e Present at birth and should disappear by \u003cmark\u003e4-6 months of age\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Its presence at birth indicates a normal, intact central nervous system. \u003cbr\u003e - \u003cb\u003eAbsence:\u003c/b\u003e A symmetric absence may indicate severe CNS damage. \u003cbr\u003e - \u003cb\u003eAsymmetry:\u003c/b\u003e An asymmetric response suggests a focal peripheral lesion, such as a brachial plexus injury (e.g., Erb\u0027s palsy) or a fractured clavicle on the non-responsive side.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The persistence of the Moro reflex beyond 6 months of age is abnormal and suggests underlying neurological disease. An asymmetric Moro reflex is a key sign of a birth injury like a brachial plexus palsy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMoro reflex\u003c/b\u003e is a critical component of the newborn neurological exam; its symmetric presence is a reassuring sign of CNS integrity, while its asymmetry or absence can be the first clue to a significant central or peripheral nervous system injury.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"ccf246d3\"\n      },\n      {\n        \"type\": \"asymmetry_suggests\",\n        \"to\": \"brachial_plexus_injury\"\n      },\n      {\n        \"type\": \"persistence_is_a_sign_of\",\n        \"to\": \"neurological_disease\"\n      }\n    ]\n  },\n  \"69c2ccb7\": {\n    \"title\": \"Morphine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Pain Management\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Analgesics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMorphine\u003c/b\u003e is a potent opiate analgesic drug that is the prototypical \u003ci\u003eŒº-opioid receptor agonist\u003c/i\u003e, used for the management of severe pain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a full agonist at Œº-opioid receptors in the CNS, leading to hyperpolarization of neurons and inhibition of pain signal transmission.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Management of severe acute and chronic pain (e.g., postoperative pain, cancer pain). Also used for [[d268ace0|acute cardiogenic pulmonary edema]] due to its anxiolytic and venodilating (preload reducing) effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetabolism:\u003c/b\u003e Undergoes extensive first-pass metabolism in the liver to form active metabolites, including morphine-6-glucuronide (more potent analgesic) and morphine-3-glucuronide (associated with neuroexcitatory effects). These metabolites are renally cleared, so caution is needed in renal failure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Respiratory depression, sedation, constipation, miosis, nausea, vomiting, hypotension, and potential for tolerance and dependence.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Morphine and its active metabolites accumulate in renal failure, increasing the risk of toxicity. Remember its use in pulmonary edema is for both analgesia/anxiolysis and preload reduction.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMorphine\u003c/b\u003e is the gold standard opioid analgesic, providing powerful pain relief by activating Œº-opioid receptors, but its utility is tempered by a significant side effect profile, most notably life-threatening respiratory depression.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"7fac2b01\"\n      },\n      {\n        \"type\": \"is_an_agonist_at\",\n        \"to\": \"mu_opioid_receptor\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"d268ace0\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"respiratory_depression\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9648,
      "parts": [{
        "text": "```json\n{\n"
      }, {
        "text": "  \"b7808532\": {\n    \"title"
      }, {
        "text": "\": \"Methemoglobinemia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Hematology\",\n"
      }, {
        "text": "      \"Toxicology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Hematology and Oncology\",\n      \"Pathology\",\n      \"Red Blood Cell Disorders"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMethemoglobinemia\u003c/b\u003e is a condition"
      }, {
        "text": " characterized by the presence of an abnormally high level of methemoglobin (MetHb) in the blood. Methemoglobin is a form of hemoglobin in"
      }, {
        "text": " which the iron in the heme group is in the ferric (Fe\u003csup\u003e3+\u003c/sup\u003e) state, rather than the ferrous (Fe\u003csup\u003e2+"
      }, {
        "text": "\u003c/sup\u003e) state, making it unable to bind oxygen.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e The Fe\u003csup\u003e3+\u003c/sup\u003e state not only prevents oxygen binding to that heme group but also causes a"
      }, {
        "text": " left shift in the oxygen-hemoglobin dissociation curve for the remaining normal hemoglobin, impairing oxygen release to tissues. This"
      }, {
        "text": " results in a functional anemia and tissue hypoxia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e Can be congenital (e.g., cytochrome"
      }, {
        "text": " b5 reductase deficiency) or acquired. Acquired causes include exposure to oxidizing agents such as \u003cmark\u003edapsone\u003c/mark\u003e,"
      }, {
        "text": " nitrites (found in some well water and as preservatives), and topical/local anesthetics like \u003cmark\u003ebenzocaine\u003c/mark\u003e"
      }, {
        "text": " and prilocaine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients present with cyanosis that is unresponsive to supplemental oxygen,"
      }, {
        "text": " and blood that is classically described as \u003cmark\u003e\\\"chocolate-brown\\\"\u003c/mark\u003e in color. Pulse oximetry is"
      }, {
        "text": " unreliable and often reads around 85%.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Confirmed by co-oximetry of an"
      }, {
        "text": " arterial blood gas sample.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e The antidote is \u003cmark\u003emethylene blue\u003c/mark\u003e, which acts"
      }, {
        "text": " as an electron donor to reduce Fe\u003csup\u003e3+\u003c/sup\u003e back to Fe\u003csup\u003e2+\u003c/sup\u003e via the NADPH-MetHb reductase pathway.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e A patient who develops cyanosis and shortness of breath after a dental procedure or endoscopy (where benzocaine spray"
      }, {
        "text": " is used) with chocolate-brown blood is a classic vignette for acquired methemoglobinemia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eMethemoglobinemia\u003c/b\u003e is a state of \u0027iron rust\u0027 within hemoglobin, where oxidizing"
      }, {
        "text": " drugs convert functional Fe\u003csup\u003e2+\u003c/sup\u003e to non-functional Fe\u003csup\u003e3+\u003c/sup\u003e, leading to a profound tissue hypoxia that is uniquely"
      }, {
        "text": " treated with the reducing agent methylene blue.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_caused_by\",\n        \"to\": \"benzocaine\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_caused_by\",\n        \"to\": \"dapsone\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"methylene_blue\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"cyanosis\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"8423676f\": {\n    \"title\": \"Meyer"
      }, {
        "text": "\u0027s Loop\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience"
      }, {
        "text": "\",\n      \"Anatomy\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Visual"
      }, {
        "text": " Pathway\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMeyer\u0027s loop"
      }, {
        "text": "\u003c/b\u003e is the inferior portion of the optic radiation, a bundle of nerve fibers that curves from the lateral geniculate nucleus ("
      }, {
        "text": "LGN) of the thalamus, sweeps anteriorly into the \u003ci\u003etemporal lobe\u003c/i\u003e, and then projects posteriorly to the lower"
      }, {
        "text": " bank of the calcarine sulcus in the occipital lobe.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Pathway:\u003c/b\u003e Carries visual information from the \u003cmark\u003einferior retina\u003c/mark\u003e (which corresponds to the superior"
      }, {
        "text": " visual field).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Travels through the temporal lobe, looping around the inferior horn of the lateral ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLes"
      }, {
        "text": "ion Effect:\u003c/b\u003e A lesion of Meyer\u0027s loop results in a contralateral \u003cmark\u003esuperior quadrantanopia\u003c/mark\u003e (loss"
      }, {
        "text": " of the upper quadrant of the visual field on the opposite side). This is often referred to as a \\\"pie in the sky\\\" defect"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses of Lesions:\u003c/b\u003e Can be damaged by strokes involving the [[143bb23"
      }, {
        "text": "d|Middle Cerebral Artery (MCA)]], temporal lobe tumors, or temporal lobectomy surgery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Remember the mnemonic \u003cb\u003eL-M-N-O-P\u003c/b\u003e: \u003cb\u003eL\u003c/b\u003eateral"
      }, {
        "text": " geniculate nucleus to \u003cb\u003eM\u003c/b\u003eeyer\u0027s loop (\u003cb\u003eN\u003c/b\u003eo, that\u0027s wrong). Better"
      }, {
        "text": " mnemonic: \u003cb\u003eT\u003c/b\u003eemporal lobe lesion \u003d \u003cb\u003eT\u003c/b\u003eop-quadrant defect (\\\"\u003cb\u003eT\u003c/b\u003eea"
      }, {
        "text": " in the \u003cb\u003eT\u003c/b\u003ereetops\\\"). Contrast with the dorsal optic radiation in the \u003cb\u003eP\u003c/b\u003earietal lobe, which"
      }, {
        "text": " causes a \\\"\u003cb\u003eP\u003c/b\u003eie on the \u003cb\u003eF\u003c/b\u003eloor\\\" (inferior quadrantanopia).\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMeyer\u0027s loop\u003c/b\u003e takes a detour through the temporal lobe to"
      }, {
        "text": " carry information from the inferior retina; therefore, a lesion in this specific location predictably causes a contralateral \\\"pie in the sky\\\" visual"
      }, {
        "text": " field defect, a key localizing sign in neuro-ophthalmology.\u003c/p\u003e\",\n      \"mermaid\": \"graph"
      }, {
        "text": " TD; A[Inferior Retina] --\u003e B(LGN); B --\u003e C(Meyer\u0027s Loop in Temporal Lobe); C"
      }, {
        "text": " --\u003e D(Lower Visual Cortex); A --Represents--\u003e E(Superior Visual Field);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_part_of\",\n        \"to\": \"optic_radiation\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"temporal_lobe\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"lesion_causes\",\n        \"to\": \"superior_quadrantanopia\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_contrasted_with\",\n        \"to\": \"09c840"
      }, {
        "text": "9d\"\n      }\n    ]\n  },\n  \"b6636994\": {\n    \"title\": \""
      }, {
        "text": "Microglia\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Hist"
      }, {
        "text": "ology\",\n      \"Immunology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Glial Cells\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMicroglia\u003c/b\u003e are the resident immune cells of the central nervous system (CNS), acting as the"
      }, {
        "text": " primary phagocytic scavengers and mediators of the innate immune response within the brain and spinal cord.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryonic Origin:\u003c/b\u003e Unlike other glial cells (which are neuroectod"
      }, {
        "text": "ermal), microglia are derived from the \u003cmark\u003emesoderm\u003c/mark\u003e (yolk sac myeloid progenitors) and migrate into"
      }, {
        "text": " the CNS during development.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e In the resting state, they constantly survey their microenvironment with mot"
      }, {
        "text": "ile processes. Upon activation by injury, infection, or inflammation, they transform into an amoeboid shape, become phagocytic, and release"
      }, {
        "text": " inflammatory mediators (e.g., cytokines, nitric oxide).\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Pathology:\u003c/b\u003e They are activated in response to any"
      }, {
        "text": " CNS injury, including stroke, trauma, and infection. They phagocytose cellular debris and dead neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHIV-Associated Dementia:\u003c/b\u003e"
      }, {
        "text": " In HIV infection, microglia can become infected and fuse to form \u003cmark\u003emultinucleated giant cells\u003c/mark\u003e,"
      }, {
        "text": " which is a pathognomonic finding in HIV-associated dementia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the unique"
      }, {
        "text": " mesodermal origin of microglia, distinguishing them from all other CNS cells which are of ectodermal origin. Mnemonic: \u003cb\u003eM\u003c/b\u003eicroglia"
      }, {
        "text": " \u003d \u003cb\u003eM\u003c/b\u003eacrophages of the CNS, from \u003cb\u003eM\u003c/b\u003eesoderm.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eMicroglia\u003c/b\u003e are the dedicated immune defenders of the CNS, originating from the mesoderm and acting as the brain\u0027s"
      }, {
        "text": " resident macrophages; their activation is a double-edged sword, essential for clearing debris but also capable of contributing to neuroinflammation.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"glial_cell\"\n      },\n      {\n        \"type\": \"der"
      }, {
        "text": "ives_from\",\n        \"to\": \"mesoderm\"\n      },\n      {\n        \"type\": \"functions_as"
      }, {
        "text": "\",\n        \"to\": \"macrophage\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_implicated_in\",\n        \"to\": \"hiv_associated_dementia\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"03725017\": {\n    \"title\": \"Midazolam\",\n    \""
      }, {
        "text": "primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"Neu"
      }, {
        "text": "rology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Anxiolytics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMidazolam"
      }, {
        "text": "\u003c/b\u003e is a short-acting \u003ci\u003ebenzodiazepine\u003c/i\u003e with potent anxiolytic, amnestic, sedative, and anticon"
      }, {
        "text": "vulsant properties, commonly used for procedural sedation and as an induction agent for general anesthesia.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Facilitates the action of [[5aa5cb91|GABA]]"
      }, {
        "text": " at the GABA\u003csub\u003eA\u003c/sub\u003e receptor, increasing the \u003cmark\u003efrequency\u003c/mark\u003e of Cl\u003csup\u003e-\u003c/sup\u003e channel opening,"
      }, {
        "text": " which leads to CNS depression.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a \u003cmark\u003erapid onset\u003c/mark\u003e and \u003c"
      }, {
        "text": "mark\u003eshort duration\u003c/mark\u003e of action, making it ideal for procedural use. It is one of the benzodiazepines with"
      }, {
        "text": " minimal first-pass metabolism.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for sedation before medical procedures (e.g., endoscopy"
      }, {
        "text": ", surgery), as an anxiolytic, and for the treatment of status epilepticus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e"
      }, {
        "text": " Can cause significant respiratory depression, especially when combined with other CNS depressants like opioids. Also causes hypotension and anterograde am"
      }, {
        "text": "nesia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReversal:\u003c/b\u003e The effects of midazolam can be reversed by the competitive antagonist \u003cmark\u003eflumazenil"
      }, {
        "text": "\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Midazolam is a go-to drug for procedural sedation because"
      }, {
        "text": " of its rapid onset, short duration, and potent amnestic effects. Remember that its respiratory depressant effects are additive with opioids."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMidazolam\u003c/b\u003e is a fast-acting, short-duration"
      }, {
        "text": " benzodiazepine prized for its ability to induce sedation and amnesia for uncomfortable procedures, but its potent CNS depressant effects necessitate"
      }, {
        "text": " careful monitoring of respiratory status.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \""
      }, {
        "text": "type\": \"is_a_type_of\",\n        \"to\": \"14464617\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_used_for\",\n        \"to\": \"procedural_sedation\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"status_epilepticus\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"effects_are_reversed_by\",\n        \"to\": \"flumazenil\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"05999504\": {\n    \""
      }, {
        "text": "title\": \"Midbrain\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      "
      }, {
        "text": "\"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMidbrain\u003c/b\u003e (or mesencephalon) is the most superior"
      }, {
        "text": " part of the brainstem, connecting the pons and cerebellum with the forebrain. It is a crucial center for motor control, auditory and"
      }, {
        "text": " visual processing, and consciousness.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Ar"
      }, {
        "text": "ises from the mesencephalon, one of the three primary brain vesicles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCranial Nerve Nuclei:\u003c/b\u003e Contains"
      }, {
        "text": " the nuclei for the [[68c66997|oculomotor nerve (CN III)]] and the"
      }, {
        "text": " [[bba6093a|trochlear nerve (CN IV)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Structures:\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eTectum (Dorsal):\u003c/b\u003e Contains the superior colliculi (visual reflexes) and inferior colliculi ("
      }, {
        "text": "auditory reflexes).\u003cbr\u003e - \u003cb\u003eTegmentum (Ventral):\u003c/b\u003e Contains the red nucleus ("
      }, {
        "text": "motor coordination) and substantia nigra (motor control, dopamine production).\u003cbr\u003e - \u003cb\u003eCerebral Ped"
      }, {
        "text": "uncles:\u003c/b\u003e Large bundles of descending motor fibers (corticospinal and corticobulbar tracts).\u003c/li\u003e\u003cli\u003e\u003cb\u003eV"
      }, {
        "text": "ascular Supply:\u003c/b\u003e Primarily supplied by branches of the [[b6a2cc31|Posterior Cerebral Artery (PCA)]]."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Syndromes:\u003c/b\u003e Lesions can cause specific syndromes like Weber syndrome (CN III palsy + contralateral hem"
      }, {
        "text": "iplegia) and Parinaud syndrome (dorsal midbrain compression).\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eThe \u003cb\u003eMidbrain\u003c/b\u003e is a compact but vital relay and processing center, housing the origins"
      }, {
        "text": " of the nerves that move the eyes and containing the substantia nigra, whose degeneration is the cause of Parkinson\u0027s disease.\u003c/p\u003e\","
      }, {
        "text": "\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \""
      }, {
        "text": "is_part_of\",\n        \"to\": \"brainstem\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"contains_nuclei_of\",\n        \"to\": \"68c66997"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"contains_nuclei_of\",\n        \"to"
      }, {
        "text": "\": \"bba6093a\"\n      },\n      {\n        \"type\": \"contains\","
      }, {
        "text": "\n        \"to\": \"substantia_nigra\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"contains\",\n        \"to\": \"red_nucleus\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"143bb23d\": {\n    \"title\": \"Middle Cerebral Artery (MCA)\",\n"
      }, {
        "text": "    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"An"
      }, {
        "text": "atomy\",\n      \"Vascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebrovascular System\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMiddle Cerebral Artery (MCA)\u003c/b\u003e is the largest"
      }, {
        "text": " cerebral artery and a terminal branch of the internal carotid artery. It supplies a significant portion of the lateral cerebral hemispheres, and"
      }, {
        "text": " its occlusion is the most common cause of ischemic stroke.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTerr"
      }, {
        "text": "itory:\u003c/b\u003e Supplies the lateral surface of the frontal, parietal, and temporal lobes. This includes the primary motor and som"
      }, {
        "text": "atosensory cortices for the \u003cmark\u003eface and upper limb\u003c/mark\u003e, as well as the language centers (Broca\u0027s and"
      }, {
        "text": " Wernicke\u0027s areas) in the dominant hemisphere.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Effects:\u003c/b\u003e An MCA stroke classically causes \u003c"
      }, {
        "text": "mark\u003econtralateral hemiparesis and sensory loss\u003c/mark\u003e, predominantly affecting the face and arm more than the leg.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eDominant Hemisphere (usually Left) Stroke:\u003c/b\u003e Can cause [[6bc9a567|ap"
      }, {
        "text": "hasia]] (Broca\u0027s, Wernicke\u0027s, or global).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNon-dominant"
      }, {
        "text": " Hemisphere (usually Right) Stroke:\u003c/b\u003e Can cause [[134828d8|hemineglect syndrome"
      }, {
        "text": "]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eDeep Branches (Lenticulostriate Arteries):\u003c/b\u003e Supply the basal ganglia and internal capsule"
      }, {
        "text": ". Occlusion of these small vessels causes lacunar strokes, such as a [[8aefcafe|pure motor stroke"
      }, {
        "text": "]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Contralateral face and arm weakness/sensory loss is the hallmark of an MCA stroke. If speech"
      }, {
        "text": " is affected, the lesion is in the dominant hemisphere. If neglect is present, the lesion is in the non-dominant hemisphere.\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMiddle Cerebral Artery\u003c/b\u003e supplies the eloquent lateral aspects of the brain, including"
      }, {
        "text": " motor and sensory areas for the face and arm, and the language centers. Consequently, an MCA stroke produces some of the most devastating and classic"
      }, {
        "text": " neurological deficits.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_branch_of\",\n        \"to\": \"internal_carotid_"
      }, {
        "text": "artery\"\n      },\n      {\n        \"type\": \"occlusion_causes\",\n        \"to"
      }, {
        "text": "\": \"ischemic_stroke\"\n      },\n      {\n        \"type\": \"occlusion_causes\",\n        \""
      }, {
        "text": "to\": \"6bc9a567\"\n      },\n      {\n        \"type\": \"oc"
      }, {
        "text": "clusion_causes\",\n        \"to\": \"134828d8\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"45568c28\": {\n    \"title\": \"Middle Ear\",\n    \"primaryType"
      }, {
        "text": "\": \"anatomy\",\n    \"tags\": [\n      \"Otology\",\n      \"Anatomy\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Anatomy\""
      }, {
        "text": "\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMiddle Ear\u003c/b\u003e is"
      }, {
        "text": " an air-filled cavity within the temporal bone, located between the tympanic membrane and the inner ear. It contains the auditory"
      }, {
        "text": " ossicles and is connected to the nasopharynx by the eustachian tube.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e The middle ear cavity contains the three [[3aea8cac|auditory ossicles]] ("
      }, {
        "text": "malleus, incus, stapes).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Transmits and amplifies sound vibrations from the tympanic membrane (e"
      }, {
        "text": "ardrum) to the oval window of the inner ear.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEustachian Tube:\u003c/b\u003e Connects"
      }, {
        "text": " the middle ear to the nasopharynx, allowing for pressure equalization between the middle ear and the atmosphere. Dysfunction is a"
      }, {
        "text": " key factor in [[a03641af|otitis media]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMuscles:\u003c/b\u003e Contains"
      }, {
        "text": " the tensor tympani (innervated by CN V\u003csub\u003e3\u003c/sub\u003e) and stapedius (innervated by CN VII"
      }, {
        "text": ") muscles, which dampen loud sounds.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e The most common pathology is [[a03641af|acute"
      }, {
        "text": " otitis media]], an infection of the middle ear space, especially common in children. Other conditions include [[03ef"
      }, {
        "text": "3134|cholesteatoma]] and otosclerosis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003eMiddle Ear\u003c/b\u003e functions as a mechanical impedance-matching system, using the lever action of the ossicles to efficiently transfer sound energy"
      }, {
        "text": " from the low-impedance air of the external world to the high-impedance fluid of the inner ear.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \""
      }, {
        "text": "ear\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"3aea8cac\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"a03641af\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_connected_to_nasopharynx_by\",\n        \"to\": \"e"
      }, {
        "text": "ustachian_tube\"\n      }\n    ]\n  },\n  \"f3073d4b"
      }, {
        "text": "\": {\n    \"title\": \"Middle Meningeal Artery\",\n    \"primaryType\": \"anatomy\",\n    \""
      }, {
        "text": "tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Neurosurgery\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Cerebrovascular System\"\n    ],\n    \"content\": {"
      }, {
        "text": "\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMiddle Meningeal Artery\u003c/b\u003e is the largest of the three arteries that supply the mening"
      }, {
        "text": "es. Its rupture, typically due to head trauma, is the classic cause of an \u003ci\u003eepidural hematoma\u003c/i\u003e"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e It is a branch of the maxillary"
      }, {
        "text": " artery, which in turn is a branch of the external carotid artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCourse:\u003c/b\u003e Enters the skull through"
      }, {
        "text": " the \u003cmark\u003eforamen spinosum\u003c/mark\u003e and runs in a groove on the inner surface of the temporal bone, between"
      }, {
        "text": " the dura mater and the skull.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Laceration of this artery, often associated with a fracture of the \u003c"
      }, {
        "text": "mark\u003etemporal bone at the pterion\u003c/mark\u003e (the thinnest part of the skull), leads to an \u003c"
      }, {
        "text": "mark\u003eepidural hematoma\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEpidural Hematoma:\u003c/b\u003e An arterial bleed that accumulates rapidly in the potential"
      }, {
        "text": " space between the dura and the skull, creating a lens-shaped (biconvex) hematoma on CT scan.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Trauma to the side of the head (pterion) leading to a brief loss of consciousness, a \u0027"
      }, {
        "text": "lucid interval,\u0027 and then rapid neurological decline is the classic presentation for an epidural hematoma from a middle meningeal artery tear"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMiddle Meningeal Artery\u0027s\u003c/b\u003e vulnerable"
      }, {
        "text": " course in a groove on the inner surface of the thin temporal bone makes it the primary culprit in epidural hematomas following"
      }, {
        "text": " lateral head trauma, leading to a rapidly expanding, life-threatening arterial bleed.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"rupture_causes\",\n        \"to"
      }, {
        "text": "\": \"epidural_hematoma\"\n      },\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "branch_of\",\n        \"to\": \"maxillary_artery\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"enters_skull_via\",\n        \"to\": \"foramen_spinosum\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"c8833bae\": {\n    \"title\": \""
      }, {
        "text": "Migraine Headaches\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Pain Management\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Headaches\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMigraine\u003c/b\u003e is a primary headache disorder characterized by recurrent, moderate"
      }, {
        "text": " to severe headaches that are typically unilateral and pulsating, and are often associated with nausea, photophobia, and phonophobia. Some"
      }, {
        "text": " attacks are preceded by a sensory warning sign or aura.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e Involves irritation of the [[0eb45a0a|trigeminal nerve (CN"
      }, {
        "text": " V)]], meninges, or blood vessels, leading to the release of vasoactive neuropeptides like \u003cmark\u003ecalcitonin gene-related"
      }, {
        "text": " peptide (CGRP)\u003c/mark\u003e and substance P.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Features (POUND mnemonic):\u003c/b\u003e \u003cb\u003eP\u003c/b\u003eulsatile"
      }, {
        "text": ", \u003cb\u003eO\u003c/b\u003ene-day duration (4-72 hrs), \u003cb\u003eU\u003c/b\u003enilateral, \u003cb\u003eN\u003c/b\u003eausea"
      }, {
        "text": ", \u003cb\u003eD\u003c/b\u003eisabling.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAura:\u003c/b\u003e A transient visual, sensory, or motor disturbance that precedes"
      }, {
        "text": " or accompanies the headache. The most common is a visual aura (e.g., scintillating scotoma).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAbort"
      }, {
        "text": "ive Treatment:\u003c/b\u003e For acute attacks, treatments include NSAIDs, \u003cmark\u003etriptans\u003c/mark\u003e (5"
      }, {
        "text": "-HT\u003csub\u003e1B/1D\u003c/sub\u003e agonists like sumatriptan), and dihydroergotamine.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePro"
      }, {
        "text": "phylactic Treatment:\u003c/b\u003e For frequent migraines, options include beta-blockers (e.g., propranolol), TC"
      }, {
        "text": "As (e.g., amitriptyline), anticonvulsants (e.g., topiramate, valproate"
      }, {
        "text": "), and anti-CGRP monoclonal antibodies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Triptans are contraindicated in patients with coronary"
      }, {
        "text": " artery disease or Prinzmetal angina due to their vasoconstrictive effects.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMigraine\u003c/b\u003e"
      }, {
        "text": " is a complex neurovascular disorder, not just a simple headache. Its pathophysiology involves trigeminal nerve activation and CGRP release, making"
      }, {
        "text": " CGRP antagonists and 5-HT agonists (triptans) specific and effective treatments.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n"
      }, {
        "text": "    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        "
      }, {
        "text": "\"to\": \"26661e34\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_treated_by\",\n        \"to\": \"triptans\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_treated_by\",\n        \"to\": \"682952a2\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"involves\",\n        \"to\": \"0eb45a0a\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"e55deaa2\": {\n    \"title\": \"Miosis\","
      }, {
        "text": "\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      "
      }, {
        "text": "\"Neurology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physical Findings\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMiosis\u003c/b\u003e is the constriction of the pupil, which can be a physiological response to bright"
      }, {
        "text": " light or a pathological or pharmacological sign.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePhysiology:\u003c/b\u003e Medi"
      }, {
        "text": "ated by the \u003cmark\u003eparasympathetic nervous system\u003c/mark\u003e. Preganglionic fibers from the Edinger-Westphal nucleus"
      }, {
        "text": " travel with the [[68c66997|oculomotor nerve (CN III)]] to the c"
      }, {
        "text": "iliary ganglion. Postganglionic fibers release ACh, which acts on M3 muscarinic receptors on the \u003cmark\u003esphincter pupillae muscle"
      }, {
        "text": "\u003c/mark\u003e, causing it to contract.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacological Causes:\u003c/b\u003e Can be induced by cholinomimetics (e.g"
      }, {
        "text": "., [[f54d873a|pilocarpine]]) or acetylcholinesterase inhibitors. \u003c"
      }, {
        "text": "mark\u003eOpioids\u003c/mark\u003e (e.g., morphine, heroin) characteristically cause pinpoint pupils by stimulating the E"
      }, {
        "text": "dinger-Westphal nucleus.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathological Causes:\u003c/b\u003e A key feature of [[c1901"
      }, {
        "text": "0a3|Horner syndrome]], which results from disruption of the sympathetic pathway to the eye, leading to unopposed parasympathetic tone.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003ePupillary Control Pathway:\u003c/b\u003e The pupillary light reflex pathway involves CN II (afferent) and CN III ("
      }, {
        "text": "efferent), resulting in miosis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The triad of coma, respiratory depression, and m"
      }, {
        "text": "iosis is classic for opioid overdose. Remember that tolerance does not develop to the miotic effects of opioids.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003e\u003cb\u003eMiosis\u003c/b\u003e results from parasympathetic activation causing contraction of the pupillary sphincter muscle."
      }, {
        "text": " Its presence can be a key diagnostic clue, pointing to conditions ranging from opioid overdose to Horner syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_mediated_by\",\n        \"to\":"
      }, {
        "text": " \"parasympathetic_nervous_system\"\n      },\n      {\n        \"type\": \"is_caused_by"
      }, {
        "text": "\",\n        \"to\": \"opioid_analgesics\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_sign_of\",\n        \"to\": \"c19010a3\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_the_opposite_of\",\n        \"to\": \"7b57"
      }, {
        "text": "eee7\"\n      }\n    ]\n  },\n  \"1f7823a2\": {\n    \"title\": \""
      }, {
        "text": "Molecular Mimicry\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Immunology\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Infectious Disease\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Autoimmune Disorders\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMolecular mimicry\u003c/b\u003e is a pathogenic mechanism in which sequence similarities between"
      }, {
        "text": " foreign (e.g., microbial) peptides and self-peptides are sufficient to result in the cross-activation of autore"
      }, {
        "text": "active T or B cells by a pathogen-derived epitope, leading to an autoimmune response.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e An immune response is mounted against a pathogen. Due to structural similarity between a pathogen antigen"
      }, {
        "text": " and a self-antigen, the activated T cells or antibodies then attack the host\u0027s own tissues.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRhe"
      }, {
        "text": "umatic Fever:\u003c/b\u003e A classic example. Antibodies against the M protein of \u003ci\u003eStreptococcus pyogenes\u003c/i\u003e cross-react with cardiac"
      }, {
        "text": " myosin, leading to myocarditis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGuillain-Barr√© Syndrome (AIDP):\u003c/b\u003e Often follows infection"
      }, {
        "text": " with \u003ci\u003eCampylobacter jejuni\u003c/i\u003e. Antibodies against bacterial lipooligosaccharides cross-react with gangliosides on"
      }, {
        "text": " peripheral nerve myelin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAcute Disseminated Encephalomyelitis (ADEM):\u003c/b\u003e An autoimmune response following a viral infection"
      }, {
        "text": " or vaccination is thought to cross-react with myelin antigens in the CNS.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When"
      }, {
        "text": " a question describes an autoimmune condition that develops shortly after an infection, molecular mimicry is the likely underlying mechanism.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMolecular mimicry\u003c/b\u003e is a case of mistaken identity by the immune system, where the"
      }, {
        "text": " fight against a foreign invader inadvertently turns into a civil war against the body\u0027s own tissues due to the unfortunate resemblance between microbial"
      }, {
        "text": " and self-antigens.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Pathogen with Antigen \u0027"
      }, {
        "text": "X\u0027] --\u003e B(Immune System Activation); B --\u003e C(Produces Antibodies/T-cells against \u0027X\u0027); D"
      }, {
        "text": "[Self-Tissue with Antigen \u0027X-like\u0027] \u003c-- Cross-reactivity --- C; D --\u003e E(Auto"
      }, {
        "text": "immune Disease);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_the"
      }, {
        "text": "_mechanism_for\",\n        \"to\": \"rheumatic_fever\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_the_mechanism_for\",\n        \"to\": \"ed52e40b\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_the_mechanism_for\",\n        \"to\": \"67"
      }, {
        "text": "e83e3b\"\n      }\n    ]\n  },\n  \"9deb7a1"
      }, {
        "text": "3\": {\n    \"title\": \"Monoamine Oxidase (MAO) Inhibitors\",\n    \"primaryType\": \"drug\",\n    "
      }, {
        "text": "\"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neurology\",\n      \"USMLE\"\n"
      }, {
        "text": "    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Ant"
      }, {
        "text": "idepressants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMonoamine"
      }, {
        "text": " oxidase (MAO) inhibitors\u003c/b\u003e are a class of drugs that increase the levels of monoamine neurotransmitters (norepinephrine, serotonin"
      }, {
        "text": ", dopamine) by inhibiting the enzyme responsible for their breakdown.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": " of Action:\u003c/b\u003e Inhibit monoamine oxidase, the enzyme that degrades monoamines in the presynaptic terminal. This increases the amount"
      }, {
        "text": " of neurotransmitter available for release into the synapse.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTypes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eNon-selective"
      }, {
        "text": " MAOIs\u003c/b\u003e (inhibit both MAO-A and MAO-B): Tranylcypromine"
      }, {
        "text": ", Phenelzine, Isocarboxazid. Used for atypical depression.\u003cbr\u003e - \u003cb\u003eSelective MAO"
      }, {
        "text": "-B inhibitors:\u003c/b\u003e [[2883864d|Rasagiline]], Selegiline. Used for [["
      }, {
        "text": "58c8ea03|Parkinson disease]] to increase dopamine levels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:"
      }, {
        "text": "\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eHypertensive Crisis:\u003c/b\u003e Occurs when MAOIs are taken with tyramine-rich foods (e.g"
      }, {
        "text": "., aged cheeses, cured meats, red wine). Tyramine is normally broken down by MAO-A in the gut; its buildup"
      }, {
        "text": " causes a massive release of catecholamines.\u003cbr\u003e - \u003cb\u003eSerotonin Syndrome:\u003c/b\u003e Risk is high when combined"
      }, {
        "text": " with SSRIs, SNRIs, TCAs, or other serotonergic agents. A washout period is required when switching antidepressants"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The risk of hypertensive crisis with tyramine-containing foods (the \\\"cheese effect"
      }, {
        "text": "\\\") is the most famous and feared side effect of non-selective MAOIs.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eMAO inhibitors\u003c/b\u003e boost levels of multiple neurotransmitters by blocking their degradation, but this powerful, non-specific"
      }, {
        "text": " mechanism comes with dangerous interactions, most notably the risk of a life-threatening hypertensive crisis if combined with tyramine-rich"
      }, {
        "text": " foods.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_treatment_for\",\n        \"to\": \"depression\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"58"
      }, {
        "text": "c8ea03\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"hypertensive"
      }, {
        "text": "_crisis\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\":"
      }, {
        "text": " \"serotonin_syndrome\"\n      },\n      {\n        \"type\": \"includes\",\n        "
      }, {
        "text": "\"to\": \"2883864d\"\n      }\n    ]\n  },\n  \"ff"
      }, {
        "text": "9dd909\": {\n    \"title\": \"Moraxella catarrhalis\",\n    \"primaryType\":"
      }, {
        "text": " \"microbe\",\n    \"tags\": [\n      \"Microbiology\",\n      \"Infectious Disease\",\n      \"Otology\",\n"
      }, {
        "text": "      \"Pulmonology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMoraxella catarrhalis\u003c/b\u003e is a gram-negative dipl"
      }, {
        "text": "ococcus that is a common commensal of the upper respiratory tract and a frequent cause of otitis media, sinusitis, and exacerb"
      }, {
        "text": "ations of chronic obstructive pulmonary disease (COPD).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMicro"
      }, {
        "text": "biology:\u003c/b\u003e Aerobic, non-motile, gram-negative diplococcus. It is oxidase-positive.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Infections:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[a03641af|Otitis Media]]:\u003c/b\u003e One"
      }, {
        "text": " of the top three bacterial causes in children, along with \u003ci\u003eS. pneumoniae\u003c/i\u003e and non-typeable \u003ci\u003eH"
      }, {
        "text": ". influenzae\u003c/i\u003e.\u003cbr\u003e - \u003cb\u003eSinusitis:\u003c/b\u003e A common cause of acute bacterial sinusitis in both"
      }, {
        "text": " children and adults.\u003cbr\u003e - \u003cb\u003eCOPD Exacerbations:\u003c/b\u003e A significant cause of bacterial exacerbations of chronic"
      }, {
        "text": " bronchitis and COPD.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVirulence:\u003c/b\u003e Produces beta-lactamase, making it resistant to pen"
      }, {
        "text": "icillins like amoxicillin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Often treated with amoxicillin-clavulanate, cephal"
      }, {
        "text": "osporins, or macrolides to cover for beta-lactamase production.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e When considering the causes of [[a03641af|otitis media]] or a COPD exacerbation,"
      }, {
        "text": " always include \u003ci\u003eM. catarrhalis\u003c/i\u003e in the differential, and remember that it is typically beta-lactamase positive"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMoraxella catarrhalis\u003c/b\u003e is a"
      }, {
        "text": " common respiratory pathogen that, along with \u003ci\u003eS. pneumoniae\u003c/i\u003e and \u003ci\u003eH. influenzae\u003c/i\u003e, forms the classic"
      }, {
        "text": " triad of bacteria responsible for otitis media and sinusitis, with its frequent production of beta-lactamase influencing antibiotic choice.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"a"
      }, {
        "text": "03641af\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"sinusitis\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"copd_ex"
      }, {
        "text": "acerbation\"\n      },\n      {\n        \"type\": \"produces\",\n        \"to\": \"beta_"
      }, {
        "text": "lactamase\"\n      }\n    ]\n  },\n  \"666cc8e9\": {\n    \"title"
      }, {
        "text": "\": \"Moro Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Ped"
      }, {
        "text": "iatrics\",\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Reflexes\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMoro reflex\u003c/b\u003e, also known as the start"
      }, {
        "text": "le reflex, is a primitive, involuntary reflex present in infants in response to a sudden loss of support or a loud noise, characterized"
      }, {
        "text": " by the spreading out and then pulling in of the arms.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eE"
      }, {
        "text": "licitation:\u003c/b\u003e Elicited by allowing the infant\u0027s head to suddenly but gently fall backward.\u003c/li\u003e\u003cli\u003e\u003cb\u003eResponse:\u003c/b\u003e The infant"
      }, {
        "text": " responds by symmetrically abducting and extending the arms, followed by adduction and flexion of the arms. The infant may also cry."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eDevelopmental Timeline:\u003c/b\u003e Present at birth and should disappear by \u003cmark\u003e4-6 months of age"
      }, {
        "text": "\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Its presence at birth indicates a normal, intact central nervous system. \u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eAbsence:\u003c/b\u003e A symmetric absence may indicate severe CNS damage. \u003cbr\u003e - \u003cb\u003eAs"
      }, {
        "text": "ymmetry:\u003c/b\u003e An asymmetric response suggests a focal peripheral lesion, such as a brachial plexus injury (e.g., Erb\u0027s palsy"
      }, {
        "text": ") or a fractured clavicle on the non-responsive side.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The persistence of the Moro reflex beyond"
      }, {
        "text": " 6 months of age is abnormal and suggests underlying neurological disease. An asymmetric Moro reflex is a key sign of a birth"
      }, {
        "text": " injury like a brachial plexus palsy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMoro reflex\u003c/b\u003e is a"
      }, {
        "text": " critical component of the newborn neurological exam; its symmetric presence is a reassuring sign of CNS integrity, while its asymmetry or absence can"
      }, {
        "text": " be the first clue to a significant central or peripheral nervous system injury.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"cc"
      }, {
        "text": "f246d3\"\n      },\n      {\n        \"type\": \"asymmetry_suggests\",\n        \"to\": \""
      }, {
        "text": "brachial_plexus_injury\"\n      },\n      {\n        \"type\": \"persistence_is"
      }, {
        "text": "_a_sign_of\",\n        \"to\": \"neurological_disease\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"69c2ccb7\": {\n    \"title\": \"Morphine\",\n    \"primary"
      }, {
        "text": "Type\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Pain Management\",\n      \"Anesthes"
      }, {
        "text": "iology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Analgesics\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eMorphine\u003c/b\u003e is a potent opiate analgesic drug that is the prototypical \u003ci\u003eŒº-opioid receptor"
      }, {
        "text": " agonist\u003c/i\u003e, used for the management of severe pain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": " of Action:\u003c/b\u003e Acts as a full agonist at Œº-opioid receptors in the CNS, leading to hyperpolarization of"
      }, {
        "text": " neurons and inhibition of pain signal transmission.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Management of severe acute and chronic pain (e.g., postoperative"
      }, {
        "text": " pain, cancer pain). Also used for [[d268ace0|acute cardiogenic pulmonary edema]] due to its an"
      }, {
        "text": "xiolytic and venodilating (preload reducing) effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetabolism:\u003c/b\u003e Undergoes extensive first-pass metabolism in the liver to form"
      }, {
        "text": " active metabolites, including morphine-6-glucuronide (more potent analgesic) and morphine-3-glucuronide (associated"
      }, {
        "text": " with neuroexcitatory effects). These metabolites are renally cleared, so caution is needed in renal failure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects"
      }, {
        "text": ":\u003c/b\u003e Respiratory depression, sedation, constipation, miosis, nausea, vomiting, hypotension, and potential for tolerance and dependence.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Morphine and its active metabolites accumulate in renal failure, increasing the risk of toxicity. Remember its use in pulmonary"
      }, {
        "text": " edema is for both analgesia/anxiolysis and preload reduction.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eMorphine\u003c/b\u003e is the gold standard opioid analgesic, providing powerful pain relief by activating Œº-opioid receptors,"
      }, {
        "text": " but its utility is tempered by a significant side effect profile, most notably life-threatening respiratory depression.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"7fac2b01\"\n      },\n      {\n        \"type\": \"is_an"
      }, {
        "text": "_agonist_at\",\n        \"to\": \"mu_opioid_receptor\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_a_treatment_for\",\n        \"to\": \"d268ace0\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"respiratory_depression\"\n"
      }, {
        "text": "      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"cf137c59\",\n    \"letter\": \"M\",\n    \"term\": \"Memantine\",\n    \"pages\": [\n      \"564\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Memantine\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"ba8882be\",\n    \"letter\": \"M\",\n    \"term\": \"Memory, neural structures and\",\n    \"pages\": [\n      \"509\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Memory, neural structures and\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"805d0677\",\n    \"letter\": \"M\",\n    \"term\": \"Meninges\",\n    \"pages\": [\n      \"506\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Meninges\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"e98ea0ba\",\n    \"letter\": \"M\",\n    \"term\": \"Meningioma\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Meningioma\",\n    \"sub_entries\": [\n      {\n        \"id\": \"f2c4c7ac\",\n        \"letter\": \"M\",\n        \"term\": \"characteristics and histology\",\n        \"pages\": [\n          \"540\"\n        ],\n        \"context\": \"Meningioma \u003e characteristics and histology\"\n      }\n    ]\n  },\n  {\n    \"id\": \"ce68b52c\",\n    \"letter\": \"M\",\n    \"term\": \"Meningocele\",\n    \"pages\": [\n      \"501\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Meningocele\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"4e0fb960\",\n    \"letter\": \"M\",\n    \"term\": \"Meperidine\",\n    \"pages\": [\n      \"567\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Meperidine\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"78e7a28e\",\n    \"letter\": \"M\",\n    \"term\": \"Mepivacaine\",\n    \"pages\": [\n      \"565\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Mepivacaine\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"8c813492\",\n    \"letter\": \"M\",\n    \"term\": \"Merkel discs\",\n    \"pages\": [\n      \"504\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Merkel discs\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"687324dc\",\n    \"letter\": \"M\",\n    \"term\": \"Mesencephalon\",\n    \"pages\": [\n      \"500\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Mesencephalon\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"f36ffa22\",\n    \"letter\": \"M\",\n    \"term\": \"Mesocortical pathway\",\n    \"pages\": [\n      \"509\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Mesocortical pathway\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"f4381654\",\n    \"letter\": \"M\",\n    \"term\": \"Mesolimbic pathway\",\n    \"pages\": [\n      \"509\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Mesolimbic pathway\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"a078dbd0\",\n    \"letter\": \"M\",\n    \"term\": \"Metachromatic leukodystrophy\",\n    \"pages\": [\n      \"86\",\n      \"538\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Metachromatic leukodystrophy\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"dd062acc\",\n    \"letter\": \"M\",\n    \"term\": \"Metamorphopsia\",\n    \"pages\": [\n      \"552\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Metamorphopsia\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"1b87b6a5\",\n    \"letter\": \"M\",\n    \"term\": \"Metencephalon\",\n    \"pages\": [\n      \"500\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Metencephalon\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"2dcfe6b7\",\n    \"letter\": \"M\",\n    \"term\": \"Methadone\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Methadone\",\n    \"sub_entries\": [\n      {\n        \"id\": \"fb294713\",\n        \"letter\": \"M\",\n        \"term\": \"opioid analgesics\",\n        \"pages\": [\n          \"567\"\n        ],\n        \"context\": \"Methadone \u003e opioid analgesics\"\n      }\n    ]\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 1393
    }, {
      "text": "```json\n{\n  \"cf137c59\": {\n    \"title\": \"Memantine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Geriatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Neurodegenerative Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMemantine\u003c/b\u003e is a non-competitive \u003ci\u003eNMDA receptor antagonist\u003c/i\u003e used for the symptomatic treatment of moderate to severe [[77ae6148|Alzheimer disease]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks the NMDA (N-methyl-D-aspartate) receptor, a glutamate receptor. In [[77ae6148|Alzheimer disease]], excessive glutamate activity is thought to cause excitotoxicity and neuronal death. Memantine blocks this pathological activation while allowing for normal physiological synaptic transmission.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used to treat moderate to severe dementia in [[77ae6148|Alzheimer disease]]. It may provide modest benefits in cognition, daily function, and behavior.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Generally well-tolerated. Side effects can include dizziness, confusion, and hallucinations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCombination Therapy:\u003c/b\u003e Often used in combination with an acetylcholinesterase inhibitor (e.g., [[47d0372e|donepezil]]) for a dual-mechanism approach to treating Alzheimer\u0027s symptoms.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e While acetylcholinesterase inhibitors are first-line for mild-to-moderate Alzheimer\u0027s, memantine is added for moderate-to-severe disease. Remember its mechanism is to prevent glutamate-induced excitotoxicity.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMemantine\u003c/b\u003e works by protecting neurons from the chronic, low-level excitotoxicity caused by excessive glutamate in [[77ae6148|Alzheimer disease]], acting as a \u0027noise filter\u0027 for the NMDA receptor to improve cognitive function without blocking normal learning and memory processes.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Excess Glutamate] --\u003e B(Overstimulation of NMDA Receptor); B --\u003e C(Excitotoxicity); C --\u003e D(Neuronal Death in Alzheimer\u0027s); E[Memantine] --|Blocks|--\u003e B;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"77ae6148\"\n      },\n      {\n        \"type\": \"antagonizes\",\n        \"to\": \"nmda_receptor\"\n      },\n      {\n        \"type\": \"prevents\",\n        \"to\": \"glutamate_excitotoxicity\"\n      }\n    ]\n  },\n  \"ba8882be\": {\n    \"title\": \"Neural Structures of Memory\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Limbic System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMemory\u003c/b\u003e is a complex cognitive function involving multiple neural structures, primarily within the [[73ace357|limbic system]] and temporal lobes, responsible for encoding, storing, and retrieving information.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHippocampus:\u003c/b\u003e A critical structure located in the medial temporal lobe. It is essential for the formation of new declarative (explicit) memories (facts and events). Bilateral damage to the hippocampus results in profound \u003cmark\u003eanterograde amnesia\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAmygdala:\u003c/b\u003e Located adjacent to the hippocampus, the amygdala is crucial for processing the emotional significance of memories, particularly fear-related memories.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMammillary Bodies:\u003c/b\u003e Part of the [[73ace357|limbic system]] that receives input from the hippocampus via the fornix. Damage to the mammillary bodies, as seen in \u003cmark\u003eWernicke-Korsakoff syndrome\u003c/mark\u003e, leads to severe memory deficits and confabulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCerebral Cortex:\u003c/b\u003e Long-term memories are thought to be stored in a distributed fashion across the cerebral cortex, in the same areas that were involved in the initial perception and processing of the information.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Bilateral hippocampal damage causes anterograde amnesia (can\u0027t make new memories), while bilateral mammillary body damage (Wernicke-Korsakoff) also causes anterograde amnesia plus confabulation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe formation of new long-term memories is a process critically dependent on the integrity of the medial temporal lobe, especially the hippocampus, which acts as a temporary storage and consolidation hub before memories are distributed to the cortex for permanent storage.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"involves\",\n        \"to\": \"hippocampus\"\n      },\n      {\n        \"type\": \"involves\",\n        \"to\": \"d220fc3f\"\n      },\n      {\n        \"type\": \"involves\",\n        \"to\": \"mammillary_bodies\"\n      },\n      {\n        \"type\": \"is_impaired_in\",\n        \"to\": \"wernicke_korsakoff_syndrome\"\n      },\n      {\n        \"type\": \"is_impaired_in\",\n        \"to\": \"77ae6148\"\n      }\n    ]\n  },\n  \"805d0677\": {\n    \"title\": \"Meninges\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Meninges\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMeninges\u003c/b\u003e are three layers of protective connective tissue membranes that envelop the brain and spinal cord, providing support, protection, and a space for the circulation of cerebrospinal fluid (CSF).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLayers (from superficial to deep):\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eDura Mater:\u003c/b\u003e The tough, outermost layer.\u003cbr\u003e2. \u003cb\u003eArachnoid Mater:\u003c/b\u003e A web-like middle layer.\u003cbr\u003e3. \u003cb\u003ePia Mater:\u003c/b\u003e The delicate, innermost layer that adheres to the brain surface.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMnemonic for Layers:\u003c/b\u003e \u003cb\u003eD-A-P\u003c/b\u003e (Dura, Arachnoid, Pia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpaces:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eEpidural Space:\u003c/b\u003e A potential space between the skull and dura mater. Site of [[epidural_hematoma|epidural hematomas]].\u003cbr\u003e - \u003cb\u003eSubdural Space:\u003c/b\u003e A potential space between the dura and arachnoid. Site of [[subdural_hematoma|subdural hematomas]].\u003cbr\u003e - \u003cb\u003eSubarachnoid Space:\u003c/b\u003e The space between the arachnoid and pia, filled with CSF. Site of [[63f8b05f|subarachnoid hemorrhages]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e The meninges are the site of inflammation in [[meningitis]]. Tumors arising from the meninges are called [[e98ea0ba|meningiomas]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003emeninges\u003c/b\u003e create a series of crucial real and potential spaces around the CNS; understanding these layers and spaces is fundamental to diagnosing and localizing intracranial hemorrhages and infections.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Skull] --\u003e B(Epidural Space); B --\u003e C(Dura Mater); C --\u003e D(Subdural Space); D --\u003e E(Arachnoid Mater); E --\u003e F(Subarachnoid Space); F --\u003e G(Pia Mater); G --\u003e H(Brain);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"surrounds\",\n        \"to\": \"central_nervous_system\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"dura_mater\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"arachnoid_mater\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"7858887e\"\n      },\n      {\n        \"type\": \"is_inflamed_in\",\n        \"to\": \"meningitis\"\n      }\n    ]\n  },\n  \"e98ea0ba\": {\n    \"title\": \"Meningioma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eMeningioma\u003c/b\u003e is a typically benign, slow-growing tumor that arises from the meningothelial (arachnoid cap) cells of the [[805d0677|meninges]]. It is the second most common primary brain tumor in adults.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEpidemiology:\u003c/b\u003e More common in females. Risk factors include prior radiation to the head and Neurofibromatosis type 2.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Occurs along any dural surface, often on the convexities of the cerebral hemispheres, parasagittal region, or skull base. It is an \u003cmark\u003eextra-axial\u003c/mark\u003e tumor, meaning it is external to the brain parenchyma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e Appears as a well-circumscribed, dural-based mass that enhances brightly and uniformly with contrast. A characteristic \u003cmark\u003e\\\"dural tail\\\"\u003c/mark\u003e of enhancing dura may be seen.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e Characterized by spindle cells arranged in a \u003cmark\u003ewhorled pattern\u003c/mark\u003e and the presence of \u003cmark\u003epsammoma bodies\u003c/mark\u003e (laminated calcifications).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Often asymptomatic and found incidentally. If symptomatic, it causes focal neurological deficits or seizures due to compression of the underlying brain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A well-demarcated, dural-based tumor with a dural tail on MRI, and psammoma bodies on histology, is pathognomonic for a meningioma.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eMeningioma\u003c/b\u003e is a classic \u0027outside-in\u0027 brain tumor, arising from the protective meningeal layers and causing symptoms by compressing, rather than invading, the adjacent brain parenchyma, which is reflected in its well-circumscribed appearance on imaging.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"arises_from\",\n        \"to\": \"805d0677\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"0d63a7e9\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\": \"psammoma_bodies\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"neurofibromatosis_type_2\"\n      }\n    ]\n  },\n  \"ce68b52c\": {\n    \"title\": \"Meningocele\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Embryology\",\n      \"Neurosurgery\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural Tube Defects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003emeningocele\u003c/b\u003e is a type of spina bifida, a neural tube defect, where the \u003ci\u003emeninges\u003c/i\u003e herniate through a defect in the vertebral column, forming a fluid-filled sac on the infant\u0027s back, but the spinal cord itself remains within the spinal canal.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Results from the failure of the caudal neuropore of the [[a87cbede|neural tube]] to close, with a subsequent defect in the overlying vertebral arches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A visible, membrane-covered sac protruding from the back, typically in the lumbosacral region.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Function:\u003c/b\u003e Because the spinal cord is not displaced into the sac, neurological function is often \u003cmark\u003enormal or only mildly affected\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction from Myelomeningocele:\u003c/b\u003e This is the key distinction. In a [[e9cd6754|myelomeningocele]], both the meninges and the spinal cord herniate into the sac, resulting in severe neurological deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key difference between a meningocele and a myelomeningocele is the contents of the sac. If the spinal cord is not in the sac, it\u0027s a meningocele, and the prognosis is much better.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003emeningocele\u003c/b\u003e is a \u0027best-case scenario\u0027 for an open neural tube defect, as the herniation is limited to the meninges and CSF, sparing the spinal cord itself from displacement and severe damage.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"spina_bifida\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"neural_tube_defect\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"e9cd6754\"\n      }\n    ]\n  },\n  \"4e0fb960\": {\n    \"title\": \"Meperidine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Pain Management\",\n      \"Toxicology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Analgesics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMeperidine\u003c/b\u003e is a synthetic \u003ci\u003eopioid analgesic\u003c/i\u003e that acts as a Œº-opioid receptor agonist, used for short-term management of moderate to severe pain. Its use is limited due to its toxic metabolite and drug interactions.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Agonist at Œº-opioid receptors. It also has significant antimuscarinic (anticholinergic) effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetabolism:\u003c/b\u003e Metabolized in the liver to \u003cmark\u003enormeperidine\u003c/mark\u003e, a neurotoxic metabolite. Normeperidine accumulation can cause CNS excitation, tremors, and seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Use is generally discouraged due to its toxic metabolite. It was historically used for pain in pancreatitis (thought to cause less sphincter of Oddi spasm than morphine, though this is debated) and to treat rigors/shivering.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e In addition to standard opioid side effects, it can cause \u003cmark\u003eseizures\u003c/mark\u003e due to normeperidine accumulation, especially in patients with renal failure or those on high doses. Unlike other opioids, it can cause \u003cmark\u003emydriasis\u003c/mark\u003e (pupil dilation) due to its anticholinergic effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindication:\u003c/b\u003e \u003cu\u003eAbsolutely contraindicated\u003c/u\u003e with \u003cmark\u003eMAO inhibitors\u003c/mark\u003e, as the combination can precipitate life-threatening [[serotonin_syndrome|serotonin syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the two unique features of meperidine compared to other opioids: it can cause seizures (via normeperidine) and mydriasis (anticholinergic effect), and it is contraindicated with MAOIs.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMeperidine\u003c/b\u003e is an opioid with a dangerous secret: its neurotoxic metabolite, normeperidine, which accumulates in renal failure and can cause seizures, making it a poor choice for long-term or high-dose pain management.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"7fac2b01\"\n      },\n      {\n        \"type\": \"is_contraindicated_with\",\n        \"to\": \"9deb7a13\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"serotonin_syndrome\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"64c08e92\"\n      }\n    ]\n  },\n  \"78e7a28e\": {\n    \"title\": \"Mepivacaine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMepivacaine\u003c/b\u003e is an intermediate-acting \u003ci\u003elocal anesthetic\u003c/i\u003e of the amide class, used for local or regional anesthesia via infiltration, nerve block, or epidural techniques.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Amide local anesthetic. Mnemonic: Amides have two \u0027i\u0027s in their name (mep\u003cb\u003ei\u003c/b\u003evaca\u003cb\u003ei\u003c/b\u003ene).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks voltage-gated \u003cmark\u003eNa\u003csup\u003e+\u003c/sup\u003e channels\u003c/mark\u003e on the inner portion of the nerve cell membrane, preventing the propagation of [[832463e6|action potentials]] and thus blocking nerve conduction.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has an intermediate duration of action. It is not effective as a topical anesthetic.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Systemic toxicity can occur with accidental intravascular injection or overdose, leading to CNS excitation (seizures) followed by depression (coma, respiratory arrest), and cardiovascular toxicity (hypotension, arrhythmias, bradycardia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know how to differentiate amide from ester local anesthetics. Allergic reactions are much more common with esters (due to PABA metabolite) than with amides.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMepivacaine\u003c/b\u003e is a workhorse amide local anesthetic that provides reliable nerve blockade by blocking sodium channels, with a safety profile typical of its class, where systemic toxicity is the primary concern.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"local_anesthetic\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"amide_anesthetic\"\n      },\n      {\n        \"type\": \"blocks\",\n        \"to\": \"sodium_channels\"\n      }\n    ]\n  },\n  \"8c813492\": {\n    \"title\": \"Merkel Discs\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Dermatology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sensory System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMerkel discs\u003c/b\u003e (or Merkel cell-neurite complexes) are specialized mechanoreceptors in the skin responsible for sensing fine, discriminative touch, such as pressure, shape, and texture.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Consist of a Merkel cell (a specialized epithelial cell) in close apposition with an enlarged nerve terminal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Found in the basal layer of the epidermis, particularly abundant in fingertips, lips, and other highly sensitive areas.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e They are \u003cmark\u003eslowly adapting\u003c/mark\u003e mechanoreceptors, meaning they fire continuously as long as a stimulus is present. This property makes them ideal for encoding static features like sustained \u003cmark\u003epressure\u003c/mark\u003e and the shape/texture of objects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNerve Fibers:\u003c/b\u003e Transmitted by large, myelinated AŒ≤ fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Signals travel via the [[e7f5cbbe|dorsal column-medial lemniscus pathway]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Associate slowly adapting receptors with static qualities. Merkel discs \u003d sustained pressure/shape. Ruffini corpuscles \u003d sustained stretch. Rapidly adapting receptors (Meissner\u0027s, Pacinian) detect changes and vibration.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMerkel discs\u003c/b\u003e are the high-fidelity touch receptors of the skin, providing the brain with a continuous stream of information about the precise shape and texture of objects being touched, a function enabled by their slowly adapting nature.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"senses\",\n        \"to\": \"pressure_sensation\"\n      },\n      {\n        \"type\": \"senses\",\n        \"to\": \"fine_touch\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"mechanoreceptor\"\n      },\n      {\n        \"type\": \"signal_is_transmitted_via\",\n        \"to\": \"e7f5cbbe\"\n      }\n    ]\n  },\n  \"687324dc\": {\n    \"title\": \"Mesencephalon\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Brain Development\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMesencephalon\u003c/b\u003e, also known as the midbrain, is the middle of the three primary brain vesicles that form during early embryonic development. It persists as a distinct structure in the adult brain, forming the most superior part of the brainstem.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryonic Origin:\u003c/b\u003e One of the three primary brain vesicles, situated between the prosencephalon (forebrain) and rhombencephalon (hindbrain). It does not subdivide into secondary vesicles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdult Derivative:\u003c/b\u003e Differentiates into the \u003cmark\u003emidbrain\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Cavity:\u003c/b\u003e The cavity of the mesencephalon narrows to form the \u003cmark\u003ecerebral aqueduct\u003c/mark\u003e, which connects the third and fourth ventricles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCranial Nerves:\u003c/b\u003e The nuclei for the [[68c66997|oculomotor nerve (CN III)]] and the [[bba6093a|trochlear nerve (CN IV)]] are located in the midbrain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the developmental pathway: Mesencephalon (primary vesicle) ‚Üí Mesencephalon (secondary vesicle) ‚Üí Midbrain (adult structure).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMesencephalon\u003c/b\u003e is the developmental precursor to the midbrain, a critical brainstem region that retains its name from embryology into adulthood and houses the vital conduit for CSF flow, the cerebral aqueduct.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Primary Vesicles] --\u003e B(Mesencephalon); B --\u003e C[Secondary Vesicles]; C --\u003e D(Mesencephalon); D --\u003e E[Adult Structures]; E --\u003e F(Midbrain); E --\u003e G(Cerebral Aqueduct);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"develops_into\",\n        \"to\": \"05999504\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"primary_brain_vesicle\"\n      },\n      {\n        \"type\": \"contains_cavity\",\n        \"to\": \"cerebral_aqueduct\"\n      }\n    ]\n  },\n  \"f36ffa22\": {\n    \"title\": \"Mesocortical Pathway\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Psychiatry\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Dopaminergic Pathways\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMesocortical Pathway\u003c/b\u003e is a dopaminergic tract that projects from the \u003ci\u003eventral tegmental area (VTA)\u003c/i\u003e in the midbrain to the \u003ci\u003eprefrontal cortex\u003c/i\u003e. It is critically involved in cognitive functions, motivation, and emotion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Ventral Tegmental Area (VTA) in the midbrain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTermination:\u003c/b\u003e Prefrontal cortex (especially the dorsolateral prefrontal cortex).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter:\u003c/b\u003e [[90adc821|Dopamine]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Plays a key role in executive functions, such as working memory, planning, and attention, as well as motivation and emotional regulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology (Schizophrenia):\u003c/b\u003e Hypoactivity (decreased dopamine) in the mesocortical pathway is thought to be responsible for the \u003cmark\u003enegative symptoms\u003c/mark\u003e of schizophrenia (e.g., apathy, flat affect, cognitive deficits).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the two key VTA pathways in schizophrenia: the \u003cb\u003emesocortical\u003c/b\u003e pathway is underactive (negative symptoms), while the [[f4381654|mesolimbic]] pathway is overactive (positive symptoms).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMesocortical Pathway\u003c/b\u003e is the dopaminergic connection to the brain\u0027s \u0027CEO,\u0027 the prefrontal cortex. Its underperformance is a leading hypothesis for the debilitating negative and cognitive symptoms of schizophrenia.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Ventral Tegmental Area VTA] --Dopamine--\u003e B(Prefrontal Cortex); B --\u003e C(Executive Function \u0026 Motivation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"dopaminergic_pathways\"\n      },\n      {\n        \"type\": \"is_implicated_in\",\n        \"to\": \"schizophrenia\"\n      },\n      {\n        \"type\": \"uses_neurotransmitter\",\n        \"to\": \"90adc821\"\n      },\n      {\n        \"type\": \"is_contrasted_with\",\n        \"to\": \"f4381654\"\n      }\n    ]\n  },\n  \"f4381654\": {\n    \"title\": \"Mesolimbic Pathway\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Psychiatry\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Dopaminergic Pathways\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMesolimbic Pathway\u003c/b\u003e is a key dopaminergic tract that projects from the \u003ci\u003eventral tegmental area (VTA)\u003c/i\u003e in the midbrain to various structures of the [[73ace357|limbic system]], most notably the \u003ci\u003enucleus accumbens\u003c/i\u003e. It is the primary reward pathway in the brain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Ventral Tegmental Area (VTA) in the midbrain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTermination:\u003c/b\u003e [[8092ce8a|Nucleus accumbens]], amygdala, hippocampus, and other limbic structures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter:\u003c/b\u003e [[90adc821|Dopamine]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Mediates reward, pleasure, motivation, and reinforcement learning. It is central to behaviors that are evolutionarily advantageous, such as eating and sex.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology (Addiction):\u003c/b\u003e This pathway is the final common pathway for addiction. All drugs of abuse (e.g., cocaine, amphetamines, opioids, nicotine) directly or indirectly increase dopamine release in the [[8092ce8a|nucleus accumbens]], leading to reinforcement of drug-taking behavior.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology (Schizophrenia):\u003c/b\u003e Hyperactivity (increased dopamine) in the mesolimbic pathway is thought to be responsible for the \u003cmark\u003epositive symptoms\u003c/mark\u003e of schizophrenia (e.g., hallucinations, delusions). Antipsychotic drugs exert their therapeutic effect by blocking D2 receptors in this pathway.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMesolimbic Pathway\u003c/b\u003e is the brain\u0027s fundamental reward circuit, driven by dopamine. Its overactivation is responsible for the positive symptoms of psychosis, and its hijacking by drugs of abuse is the neurobiological basis of addiction.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Ventral Tegmental Area VTA] --Dopamine--\u003e B(Nucleus Accumbens); B --\u003e C(Reward \u0026 Pleasure);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"dopaminergic_pathways\"\n      },\n      {\n        \"type\": \"is_implicated_in\",\n        \"to\": \"addiction\"\n      },\n      {\n        \"type\": \"is_implicated_in\",\n        \"to\": \"schizophrenia\"\n      },\n      {\n        \"type\": \"uses_neurotransmitter\",\n        \"to\": \"90adc821\"\n      }\n    ]\n  },\n  \"a078dbd0\": {\n    \"title\": \"Metachromatic Leukodystrophy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pediatrics\",\n      \"Genetics\",\n      \"Biochemistry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMetachromatic Leukodystrophy\u003c/b\u003e is an autosomal recessive \u003ci\u003elysosomal storage disease\u003c/i\u003e caused by a deficiency of the enzyme arylsulfatase A, leading to the accumulation of sulfatides and subsequent destruction of myelin in both the central and peripheral nervous systems.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Autosomal recessive inheritance.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEnzyme Deficiency:\u003c/b\u003e Deficiency of \u003cmark\u003earylsulfatase A\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAccumulated Substrate:\u003c/b\u003e \u003cmark\u003eCerebroside sulfate\u003c/mark\u003e (a sulfatide) accumulates in the lysosomes of oligodendrocytes and Schwann cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The buildup of sulfatides is toxic to myelin-producing cells, leading to progressive demyelination throughout the CNS and PNS.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Presents with progressive neurological decline. The late infantile form is most common, with initial findings of gait disturbance (ataxia) and loss of motor milestones, followed by cognitive decline, spasticity, and peripheral neuropathy, eventually leading to a vegetative state.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Confirmed by measuring arylsulfatase A activity in leukocytes or cultured skin fibroblasts. Nerve biopsy shows demyelination.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For lysosomal storage diseases, always link the disease name, the deficient enzyme, and the accumulated substrate. Metachromatic Leukodystrophy \u003d Arylsulfatase A deficiency \u003d Cerebroside sulfate accumulation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMetachromatic Leukodystrophy\u003c/b\u003e is a devastating demyelinating disorder where the inability to break down sulfatides due to arylsulfatase A deficiency leads to the toxic destruction of myelin sheaths, causing a relentless decline in motor and cognitive function.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cerebroside Sulfate] --Arylsulfatase A--\u003e B(Degradation); C[Enzyme Deficiency] --x B; A --\u003e D(Accumulation in Lysosomes); D --\u003e E(Demyelination); E --\u003e F(Progressive Neurologic Decline);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"lysosomal_storage_disease\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"leukodystrophy\"\n      },\n      {\n        \"type\": \"is_caused_by_deficiency_of\",\n        \"to\": \"arylsulfatase_a\"\n      },\n      {\n        \"type\": \"leads_to_accumulation_of\",\n        \"to\": \"cerebroside_sulfate\"\n      }\n    ]\n  },\n  \"dd062acc\": {\n    \"title\": \"Metamorphopsia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physical Findings\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMetamorphopsia\u003c/b\u003e is a type of visual distortion in which straight lines appear wavy or bent. It is a key symptom of macular disease.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by disruption of the normal arrangement of photoreceptors in the macula, the central part of the retina responsible for high-acuity vision.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e It is a hallmark symptom of \u003cmark\u003ewet (exudative) age-related macular degeneration (AMD)\u003c/mark\u003e. The leakage of fluid and blood from choroidal neovascularization beneath the macula elevates and distorts the retinal layers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Can also be seen in other macular pathologies, such as epiretinal membrane, macular pucker, and central serous chorioretinopathy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Can be subjectively tested by the patient at home using an \u003cmark\u003eAmsler grid\u003c/mark\u003e. The patient looks at the grid, and if the lines appear wavy, distorted, or have blank spots, it suggests macular pathology.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient, especially an elderly one, who complains that straight lines (like on a door frame or telephone pole) suddenly appear wavy has metamorphopsia and should be evaluated urgently for wet AMD.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMetamorphopsia\u003c/b\u003e is a specific visual distortion that acts as a sensitive alarm bell for macular pathology, particularly the neovascularization of wet AMD, signaling a disruption in the precise architecture of the central retina.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"c63255c8\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"macular_disease\"\n      },\n      {\n        \"type\": \"is_tested_with\",\n        \"to\": \"amsler_grid\"\n      }\n    ]\n  },\n  \"1b87b6a5\": {\n    \"title\": \"Metencephalon\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Brain Development\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMetencephalon\u003c/b\u003e is one of the five secondary brain vesicles, arising from the anterior part of the embryonic hindbrain (rhombencephalon). It develops into the pons and the cerebellum.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryonic Origin:\u003c/b\u003e Arises from the rostral (anterior) portion of the rhombencephalon (hindbrain).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdult Derivatives:\u003c/b\u003e Differentiates into the \u003cmark\u003epons\u003c/mark\u003e and the \u003cmark\u003ecerebellum\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Cavity:\u003c/b\u003e The cavity of the metencephalon becomes the upper part of the \u003cmark\u003efourth ventricle\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMnemonic for Vesicles:\u003c/b\u003e The five secondary vesicles in rostral to caudal order are Telencephalon, Diencephalon, Mesencephalon, \u003cb\u003eMetencephalon\u003c/b\u003e, and Myelencephalon.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that the two components of the hindbrain (rhombencephalon) are the metencephalon (pons and cerebellum) and the myelencephalon (medulla).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMetencephalon\u003c/b\u003e is the developmental precursor to the pons and cerebellum, two structures that are anatomically and functionally linked to form a critical hub for motor control and sensory relay in the adult brainstem.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Rhombencephalon (Hindbrain)] --\u003e B(Metencephalon); A --\u003e C(Myelencephalon); B --\u003e D(Pons); B --\u003e E(Cerebellum); B --\u003e F(Upper Fourth Ventricle);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"develops_into\",\n        \"to\": \"bf549b2f\"\n      },\n      {\n        \"type\": \"develops_into\",\n        \"to\": \"bebe58d4\"\n      },\n      {\n        \"type\": \"arises_from\",\n        \"to\": \"rhombencephalon\"\n      },\n      {\n        \"type\": \"contains_cavity\",\n        \"to\": \"fourth_ventricle\"\n      }\n    ]\n  },\n  \"2dcfe6b7\": {\n    \"title\": \"Methadone\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Addiction Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Addiction Treatment\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMethadone\u003c/b\u003e is a long-acting, synthetic \u003ci\u003eŒº-opioid receptor agonist\u003c/i\u003e used for the management of chronic pain and, most notably, as a maintenance therapy for opioid use disorder.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e A potent, long-acting full agonist at Œº-opioid receptors. It also has antagonist activity at the NMDA receptor, which may contribute to its efficacy in neuropathic pain.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a long and variable half-life (typically 24-36 hours), which allows for once-daily dosing and prevents the rapid peaks and troughs associated with short-acting opioids like heroin, thereby reducing cravings and withdrawal symptoms.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eOpioid Maintenance Therapy:\u003c/b\u003e The primary use. Reduces illicit opioid use, mortality, and criminal activity.\u003cbr\u003e - \u003cb\u003eChronic Pain:\u003c/b\u003e Effective for chronic pain, including neuropathic pain.\u003cbr\u003e - \u003cb\u003e[[b95e97eb|Neonatal Abstinence Syndrome]]:\u003c/b\u003e Used to treat withdrawal in newborns exposed to opioids in utero.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Similar to other opioids (respiratory depression, constipation, sedation). A major unique risk is \u003cmark\u003eQT interval prolongation\u003c/mark\u003e and torsades de pointes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Methadone\u0027s long half-life is its key feature for maintenance therapy. The risk of QT prolongation is a high-yield adverse effect to remember.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMethadone\u003c/b\u003e treats opioid addiction by substituting a long-acting, orally administered opioid for a short-acting, often injected one. This stabilizes the patient by preventing withdrawal and reducing cravings, allowing them to disengage from the cycle of illicit drug use, but it carries its own risks, including QT prolongation.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"7fac2b01\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"opioid_use_disorder\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"b95e97eb\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"qt_prolongation\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9449,
      "parts": [{
        "text": "```json\n{\n"
      }, {
        "text": "  \"cf137c59\": {\n    \"title\": \"Mem"
      }, {
        "text": "antine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\","
      }, {
        "text": "\n      \"Geriatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pharmacology\",\n      \"Neurodegenerative Drugs\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMemantine\u003c/b\u003e is a non-competitive \u003ci\u003eNMDA receptor antagonist\u003c/i\u003e used"
      }, {
        "text": " for the symptomatic treatment of moderate to severe [[77ae6148|Alzheimer disease]].\u003c/p\u003e\","
      }, {
        "text": "\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks the NMDA (N-methyl-D-as"
      }, {
        "text": "partate) receptor, a glutamate receptor. In [[77ae6148|Alzheimer disease]], excessive"
      }, {
        "text": " glutamate activity is thought to cause excitotoxicity and neuronal death. Memantine blocks this pathological activation while allowing for normal physiological synaptic"
      }, {
        "text": " transmission.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used to treat moderate to severe dementia in [[77ae614"
      }, {
        "text": "8|Alzheimer disease]]. It may provide modest benefits in cognition, daily function, and behavior.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAd"
      }, {
        "text": "verse Effects:\u003c/b\u003e Generally well-tolerated. Side effects can include dizziness, confusion, and hallucinations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCombination"
      }, {
        "text": " Therapy:\u003c/b\u003e Often used in combination with an acetylcholinesterase inhibitor (e.g., [[47d037"
      }, {
        "text": "2e|donepezil]]) for a dual-mechanism approach to treating Alzheimer\u0027s symptoms.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e While acetylcholinesterase inhibitors are first-line for mild-to-moderate Alzheimer\u0027s, mem"
      }, {
        "text": "antine is added for moderate-to-severe disease. Remember its mechanism is to prevent glutamate-induced excitotoxicity.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMemantine\u003c/b\u003e works by protecting neurons from the chronic, low-level excitotoxicity caused by excessive"
      }, {
        "text": " glutamate in [[77ae6148|Alzheimer disease]], acting as a \u0027noise filter\u0027 for the NMDA receptor to improve"
      }, {
        "text": " cognitive function without blocking normal learning and memory processes.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Excess Glut"
      }, {
        "text": "amate] --\u003e B(Overstimulation of NMDA Receptor); B --\u003e C(Excitotoxicity); C --\u003e D(Neuronal Death in"
      }, {
        "text": " Alzheimer\u0027s); E[Memantine] --|Blocks|--\u003e B;\"\n    },\n    \"connections\": [\n      "
      }, {
        "text": "{\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"77ae6148\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"antagonizes\",\n        \"to\": \"nmda_receptor\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"prevents\",\n        \"to\": \"glutamate_excitotoxicity\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"ba8882be\": {\n    \"title\": \"Neural"
      }, {
        "text": " Structures of Memory\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"An"
      }, {
        "text": "atomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Limbic System\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMemory\u003c/b\u003e is a complex cognitive function involving multiple neural structures"
      }, {
        "text": ", primarily within the [[73ace357|limbic system]] and temporal lobes, responsible for encoding, storing, and retrieving information"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHippocampus:\u003c/b\u003e A critical structure located in the medial"
      }, {
        "text": " temporal lobe. It is essential for the formation of new declarative (explicit) memories (facts and events). Bilateral damage to"
      }, {
        "text": " the hippocampus results in profound \u003cmark\u003eanterograde amnesia\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAmygdala:\u003c/b\u003e"
      }, {
        "text": " Located adjacent to the hippocampus, the amygdala is crucial for processing the emotional significance of memories, particularly fear-related memories.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMammillary"
      }, {
        "text": " Bodies:\u003c/b\u003e Part of the [[73ace357|limbic system]] that receives input from the hippocampus"
      }, {
        "text": " via the fornix. Damage to the mammillary bodies, as seen in \u003cmark\u003eWernicke-Korsakoff syndrome\u003c/"
      }, {
        "text": "mark\u003e, leads to severe memory deficits and confabulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCerebral Cortex:\u003c/b\u003e Long-term memories are thought"
      }, {
        "text": " to be stored in a distributed fashion across the cerebral cortex, in the same areas that were involved in the initial perception and"
      }, {
        "text": " processing of the information.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Bilateral hippocampal damage causes anterograde amnesia (can"
      }, {
        "text": "\u0027t make new memories), while bilateral mammillary body damage (Wernicke-Korsakoff) also causes anterograde amnesia plus"
      }, {
        "text": " confabulation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe formation of new long-term memories is a process"
      }, {
        "text": " critically dependent on the integrity of the medial temporal lobe, especially the hippocampus, which acts as a temporary storage and consolidation hub"
      }, {
        "text": " before memories are distributed to the cortex for permanent storage.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"involves\",\n        \"to\": \"hippocampus\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"involves\",\n        \"to\": \"d220fc3f\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"involves\",\n        \"to\": \"mammillary_bodies\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_impaired_in\",\n        \"to\": \"wernicke_kors"
      }, {
        "text": "akoff_syndrome\"\n      },\n      {\n        \"type\": \"is_impaired_in"
      }, {
        "text": "\",\n        \"to\": \"77ae6148\"\n      }\n    ]\n  },\n  \"8"
      }, {
        "text": "05d0677\": {\n    \"title\": \"Meninges\",\n    \"primaryType\": \"anatomy"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Meninges\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003eMeninges\u003c/b\u003e are three layers of protective connective tissue membranes that envelop the brain and spinal cord, providing support, protection, and a"
      }, {
        "text": " space for the circulation of cerebrospinal fluid (CSF).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLayers"
      }, {
        "text": " (from superficial to deep):\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eDura Mater:\u003c/b\u003e The tough, outermost layer.\u003c"
      }, {
        "text": "br\u003e2. \u003cb\u003eArachnoid Mater:\u003c/b\u003e A web-like middle layer.\u003cbr\u003e3. \u003cb\u003eP"
      }, {
        "text": "ia Mater:\u003c/b\u003e The delicate, innermost layer that adheres to the brain surface.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMnemonic for Layers:\u003c/b\u003e \u003cb\u003eD-"
      }, {
        "text": "A-P\u003c/b\u003e (Dura, Arachnoid, Pia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpaces:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eEpidural Space"
      }, {
        "text": ":\u003c/b\u003e A potential space between the skull and dura mater. Site of [[epidural_hematoma|epidural hemat"
      }, {
        "text": "omas]].\u003cbr\u003e - \u003cb\u003eSubdural Space:\u003c/b\u003e A potential space between the dura and arachnoid"
      }, {
        "text": ". Site of [[subdural_hematoma|subdural hematomas]].\u003cbr\u003e - \u003cb\u003eSubarach"
      }, {
        "text": "noid Space:\u003c/b\u003e The space between the arachnoid and pia, filled with CSF. Site of [[63f"
      }, {
        "text": "8b05f|subarachnoid hemorrhages]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e The meninges are the"
      }, {
        "text": " site of inflammation in [[meningitis]]. Tumors arising from the meninges are called [[e98ea0"
      }, {
        "text": "ba|meningiomas]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003emeninges\u003c/b\u003e create"
      }, {
        "text": " a series of crucial real and potential spaces around the CNS; understanding these layers and spaces is fundamental to diagnosing and localizing intracranial hemorrhages and"
      }, {
        "text": " infections.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Skull] --\u003e B(Epidural Space); B --\u003e"
      }, {
        "text": " C(Dura Mater); C --\u003e D(Subdural Space); D --\u003e E(Arachnoid Mater"
      }, {
        "text": "); E --\u003e F(Subarachnoid Space); F --\u003e G(Pia Mater); G --\u003e H(Brain);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"surrounds\",\n        \"to\": \"central"
      }, {
        "text": "_nervous_system\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to"
      }, {
        "text": "\": \"dura_mater\"\n      },\n      {\n        \"type\": \"is_composed_of"
      }, {
        "text": "\",\n        \"to\": \"arachnoid_mater\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_composed_of\",\n        \"to\": \"7858887e\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_inflamed_in\",\n        \"to\": \"mening"
      }, {
        "text": "itis\"\n      }\n    ]\n  },\n  \"e98ea0ba\": {\n    \"title\": \"Meningi"
      }, {
        "text": "oma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"On"
      }, {
        "text": "cology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {"
      }, {
        "text": "\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eMeningioma\u003c/b\u003e is a typically benign, slow-growing tumor"
      }, {
        "text": " that arises from the meningothelial (arachnoid cap) cells of the [[805d0677|"
      }, {
        "text": "meninges]]. It is the second most common primary brain tumor in adults.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEpidemiology:\u003c/b\u003e More common in females. Risk factors include prior radiation to the head and Neuro"
      }, {
        "text": "fibromatosis type 2.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Occurs along any dural surface, often on the convex"
      }, {
        "text": "ities of the cerebral hemispheres, parasagittal region, or skull base. It is an \u003cmark\u003eextra-axial\u003c/"
      }, {
        "text": "mark\u003e tumor, meaning it is external to the brain parenchyma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e Appears as a well-circum"
      }, {
        "text": "scribed, dural-based mass that enhances brightly and uniformly with contrast. A characteristic \u003cmark\u003e\\\"dural tail\\\"\u003c/"
      }, {
        "text": "mark\u003e of enhancing dura may be seen.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e Characterized by spindle cells arranged in a \u003cmark\u003ew"
      }, {
        "text": "horled pattern\u003c/mark\u003e and the presence of \u003cmark\u003epsammoma bodies\u003c/mark\u003e (laminated calc"
      }, {
        "text": "ifications).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Often asymptomatic and found incidentally. If symptomatic, it causes focal neurological deficits or"
      }, {
        "text": " seizures due to compression of the underlying brain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A well-demarcated, d"
      }, {
        "text": "ural-based tumor with a dural tail on MRI, and psammoma bodies on histology, is pathognomonic for a meningioma"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eMeningioma\u003c/b\u003e is a classic"
      }, {
        "text": " \u0027outside-in\u0027 brain tumor, arising from the protective meningeal layers and causing symptoms by compressing, rather than invading, the adjacent"
      }, {
        "text": " brain parenchyma, which is reflected in its well-circumscribed appearance on imaging.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"arises_from\",\n        \"to"
      }, {
        "text": "\": \"805d0677\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_type_of\",\n        \"to\": \"0d63a7e9\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_characterized_by\",\n        \"to\": \"psammoma_bodies"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\":"
      }, {
        "text": " \"neurofibromatosis_type_2\"\n      }\n    ]\n  },\n  \"ce68"
      }, {
        "text": "b52c\": {\n    \"title\": \"Meningocele\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Pediatrics\",\n      \"Embryology\",\n      \"Neurosurgery\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Embryology\",\n      \"Neural Tube Defects\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003eA \u003cb\u003emeningocele\u003c/b\u003e is a type of spina bifida, a neural tube defect, where the "
      }, {
        "text": "\u003ci\u003emeninges\u003c/i\u003e herniate through a defect in the vertebral column, forming a fluid-filled sac on the infant"
      }, {
        "text": "\u0027s back, but the spinal cord itself remains within the spinal canal.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e Results from the failure of the caudal neuropore of the [[a87cbede|neural tube]] to close,"
      }, {
        "text": " with a subsequent defect in the overlying vertebral arches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A visible, membrane-covered sac protruding"
      }, {
        "text": " from the back, typically in the lumbosacral region.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Function:\u003c/b\u003e Because the spinal cord is"
      }, {
        "text": " not displaced into the sac, neurological function is often \u003cmark\u003enormal or only mildly affected\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDist"
      }, {
        "text": "inction from Myelomeningocele:\u003c/b\u003e This is the key distinction. In a [[e9cd6754|my"
      }, {
        "text": "elomeningocele]], both the meninges and the spinal cord herniate into the sac, resulting in severe neurological deficits.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key difference between a meningocele and a myelomeningocele is the contents"
      }, {
        "text": " of the sac. If the spinal cord is not in the sac, it\u0027s a meningocele, and the prognosis is much"
      }, {
        "text": " better.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003emeningocele\u003c/b\u003e is a \u0027"
      }, {
        "text": "best-case scenario\u0027 for an open neural tube defect, as the herniation is limited to the meninges and CSF"
      }, {
        "text": ", sparing the spinal cord itself from displacement and severe damage.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"spina_bifida\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_type_of\",\n        \"to\": \"neural_tube_defect\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"differentiated_from\",\n        \"to\": \"e9cd6754"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"4e0fb960\": {\n    \"title"
      }, {
        "text": "\": \"Meperidine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Pain Management\",\n      \"Toxicology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Pharmacology\",\n      \"Analgesics\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eMeperidine\u003c/b\u003e is a synthetic \u003ci\u003eopioid analgesic\u003c/i\u003e that acts as a Œº-opioid receptor agonist, used"
      }, {
        "text": " for short-term management of moderate to severe pain. Its use is limited due to its toxic metabolite and drug interactions.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Agonist at Œº-opioid receptors. It also has significant"
      }, {
        "text": " antimuscarinic (anticholinergic) effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetabolism:\u003c/b\u003e Metabolized in the liver to \u003c"
      }, {
        "text": "mark\u003enormeperidine\u003c/mark\u003e, a neurotoxic metabolite. Normeperidine accumulation can cause CNS excitation, tremors, and seizures."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Use is generally discouraged due to its toxic metabolite. It was historically used for pain in"
      }, {
        "text": " pancreatitis (thought to cause less sphincter of Oddi spasm than morphine, though this is debated) and to treat rigors/"
      }, {
        "text": "shivering.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e In addition to standard opioid side effects, it can cause \u003cmark\u003ese"
      }, {
        "text": "izures\u003c/mark\u003e due to normeperidine accumulation, especially in patients with renal failure or those on high doses. Unlike"
      }, {
        "text": " other opioids, it can cause \u003cmark\u003emydriasis\u003c/mark\u003e (pupil dilation) due to its antich"
      }, {
        "text": "olinergic effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindication:\u003c/b\u003e \u003cu\u003eAbsolutely contraindicated\u003c/u\u003e with \u003cmark\u003eMAO inhibitors\u003c/"
      }, {
        "text": "mark\u003e, as the combination can precipitate life-threatening [[serotonin_syndrome|serotonin syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e Remember the two unique features of meperidine compared to other opioids: it can cause seizures (via normeperidine) and my"
      }, {
        "text": "driasis (anticholinergic effect), and it is contraindicated with MAOIs.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eMeperidine\u003c/b\u003e is an opioid with a dangerous secret: its neurotoxic metabolite, normeperidine, which"
      }, {
        "text": " accumulates in renal failure and can cause seizures, making it a poor choice for long-term or high-dose pain management.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"7fac2b01\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_contraindicated_with\",\n        \"to\": \"9deb7a13\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"can_cause\",\n        \"to\": \"serotonin_syndrome\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"64"
      }, {
        "text": "c08e92\"\n      }\n    ]\n  },\n  \"78e7a"
      }, {
        "text": "28e\": {\n    \"title\": \"Mepivacaine\",\n    \"primaryType\": \"drug\",\n    "
      }, {
        "text": "\"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"An"
      }, {
        "text": "esthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMepivacaine\u003c/b\u003e is an"
      }, {
        "text": " intermediate-acting \u003ci\u003elocal anesthetic\u003c/i\u003e of the amide class, used for local or regional anesthesia via infiltration, nerve block, or epid"
      }, {
        "text": "ural techniques.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Amide local anesthetic."
      }, {
        "text": " Mnemonic: Amides have two \u0027i\u0027s in their name (mep\u003cb\u003ei\u003c/b\u003evaca\u003cb\u003ei\u003c/b\u003ene).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": " of Action:\u003c/b\u003e Blocks voltage-gated \u003cmark\u003eNa\u003csup\u003e+\u003c/sup\u003e channels\u003c/mark\u003e on the inner portion"
      }, {
        "text": " of the nerve cell membrane, preventing the propagation of [[832463e6|action potentials]] and thus blocking"
      }, {
        "text": " nerve conduction.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has an intermediate duration of action. It is not effective as a topical anesthetic"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Systemic toxicity can occur with accidental intravascular injection or overdose, leading to CNS excitation"
      }, {
        "text": " (seizures) followed by depression (coma, respiratory arrest), and cardiovascular toxicity (hypotension, arrhythmias,"
      }, {
        "text": " bradycardia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know how to differentiate amide from ester local anesthetics. Allergic reactions are"
      }, {
        "text": " much more common with esters (due to PABA metabolite) than with amides.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eMepivacaine\u003c/b\u003e is a workhorse amide local anesthetic that provides reliable nerve blockade by blocking sodium channels, with"
      }, {
        "text": " a safety profile typical of its class, where systemic toxicity is the primary concern.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"local_an"
      }, {
        "text": "esthetic\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        "
      }, {
        "text": "\"to\": \"amide_anesthetic\"\n      },\n      {\n        \"type\": \"blocks\",\n        \"to\": \"sodium_"
      }, {
        "text": "channels\"\n      }\n    ]\n  },\n  \"8c813492\": {\n    \"title\": \""
      }, {
        "text": "Merkel Discs\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "science\",\n      \"Dermatology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Sensory System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMerk"
      }, {
        "text": "el discs\u003c/b\u003e (or Merkel cell-neurite complexes) are specialized mechanoreceptors in the skin responsible for sensing fine, discrimin"
      }, {
        "text": "ative touch, such as pressure, shape, and texture.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eStructure:\u003c/b\u003e Consist of a Merkel cell (a specialized epithelial cell) in close apposition with an enlarged nerve"
      }, {
        "text": " terminal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Found in the basal layer of the epidermis, particularly abundant in fingertips, lips, and other"
      }, {
        "text": " highly sensitive areas.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e They are \u003cmark\u003eslowly adapting\u003c/mark\u003e mechanoreceptors, meaning they fire"
      }, {
        "text": " continuously as long as a stimulus is present. This property makes them ideal for encoding static features like sustained \u003cmark\u003epressure\u003c/"
      }, {
        "text": "mark\u003e and the shape/texture of objects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNerve Fibers:\u003c/b\u003e Transmitted by large, myel"
      }, {
        "text": "inated AŒ≤ fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Signals travel via the [[e7f5cbbe|dorsal column"
      }, {
        "text": "-medial lemniscus pathway]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Associate slowly adapting receptors with static qualities. Merkel discs \u003d"
      }, {
        "text": " sustained pressure/shape. Ruffini corpuscles \u003d sustained stretch. Rapidly adapting receptors (Meissner\u0027s, Pacinian) detect changes and"
      }, {
        "text": " vibration.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMerkel discs\u003c/b\u003e are the high-fidelity touch"
      }, {
        "text": " receptors of the skin, providing the brain with a continuous stream of information about the precise shape and texture of objects being touched"
      }, {
        "text": ", a function enabled by their slowly adapting nature.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n"
      }, {
        "text": "      {\n        \"type\": \"senses\",\n        \"to\": \"pressure_sensation\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"senses\",\n        \"to\": \"fine_touch\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_type_of\",\n        \"to\": \"mechanoreceptor\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"signal_is_transmitted_via\",\n        \"to\": \"e7f5cbbe\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"687324dc\": {\n    \"title\": \""
      }, {
        "text": "Mesencephalon\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Embryology\",\n      "
      }, {
        "text": "\"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath"
      }, {
        "text": "\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Brain Development"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMesencephalon\u003c/b\u003e,"
      }, {
        "text": " also known as the midbrain, is the middle of the three primary brain vesicles that form during early embryonic development. It persists as a"
      }, {
        "text": " distinct structure in the adult brain, forming the most superior part of the brainstem.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEm"
      }, {
        "text": "bryonic Origin:\u003c/b\u003e One of the three primary brain vesicles, situated between the prosencephalon (forebrain) and rhomb"
      }, {
        "text": "encephalon (hindbrain). It does not subdivide into secondary vesicles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdult Derivative:\u003c/b\u003e Differentiates into the \u003c"
      }, {
        "text": "mark\u003emidbrain\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Cavity:\u003c/b\u003e The cavity of the mesencephalon narrows to"
      }, {
        "text": " form the \u003cmark\u003ecerebral aqueduct\u003c/mark\u003e, which connects the third and fourth ventricles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eC"
      }, {
        "text": "ranial Nerves:\u003c/b\u003e The nuclei for the [[68c66997|oculomotor nerve (CN"
      }, {
        "text": " III)]] and the [[bba6093a|trochlear nerve (CN IV)]] are"
      }, {
        "text": " located in the midbrain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the developmental pathway: Mesencephalon (primary vesicle"
      }, {
        "text": ") ‚Üí Mesencephalon (secondary vesicle) ‚Üí Midbrain (adult structure).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003eMesencephalon\u003c/b\u003e is the developmental precursor to the midbrain, a critical brainstem region that retains its name from"
      }, {
        "text": " embryology into adulthood and houses the vital conduit for CSF flow, the cerebral aqueduct.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[Primary Vesicles] --\u003e B(Mesencephalon); B --\u003e C[Secondary Vesicles];"
      }, {
        "text": " C --\u003e D(Mesencephalon); D --\u003e E[Adult Structures]; E --\u003e F(Midbrain); E --\u003e G(Cerebral Aqueduct"
      }, {
        "text": ");\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"develops_into\",\n        \"to\": \"0"
      }, {
        "text": "5999504\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"primary_brain_vesicle\"\n      },\n      {\n        \"type\": \"contains_"
      }, {
        "text": "cavity\",\n        \"to\": \"cerebral_aqueduct\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "f36ffa22\": {\n    \"title\": \"Mesocortical Pathway\",\n    \"primaryType\": \"anatomy"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Psychiatry\",\n      \"An"
      }, {
        "text": "atomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Dopaminergic Pathways\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003eThe \u003cb\u003eMesocortical Pathway\u003c/b\u003e is a dopaminergic tract that projects from the \u003ci\u003eventral te"
      }, {
        "text": "gmental area (VTA)\u003c/i\u003e in the midbrain to the \u003ci\u003eprefrontal cortex\u003c/i\u003e. It is critically"
      }, {
        "text": " involved in cognitive functions, motivation, and emotion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin"
      }, {
        "text": ":\u003c/b\u003e Ventral Tegmental Area (VTA) in the midbrain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTermination:\u003c/b\u003e Prefrontal cortex"
      }, {
        "text": " (especially the dorsolateral prefrontal cortex).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter:\u003c/b\u003e [[90adc821|Dopamine"
      }, {
        "text": "]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Plays a key role in executive functions, such as working memory, planning, and attention"
      }, {
        "text": ", as well as motivation and emotional regulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology (Schizophrenia):\u003c/b\u003e Hypoactivity (decre"
      }, {
        "text": "ased dopamine) in the mesocortical pathway is thought to be responsible for the \u003cmark\u003enegative symptoms\u003c/mark\u003e of schizophrenia (e."
      }, {
        "text": "g., apathy, flat affect, cognitive deficits).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the two key VTA pathways"
      }, {
        "text": " in schizophrenia: the \u003cb\u003emesocortical\u003c/b\u003e pathway is underactive (negative symptoms), while the [[f43"
      }, {
        "text": "81654|mesolimbic]] pathway is overactive (positive symptoms).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003eThe \u003cb\u003eMesocortical Pathway\u003c/b\u003e is the dopaminergic connection to the brain\u0027s \u0027"
      }, {
        "text": "CEO,\u0027 the prefrontal cortex. Its underperformance is a leading hypothesis for the debilitating negative and cognitive symptoms of schizophrenia.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"mermaid\": \"graph TD; A[Ventral Tegmental Area VTA] --Dopamine--\u003e"
      }, {
        "text": " B(Prefrontal Cortex); B --\u003e C(Executive Function \u0026 Motivation);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_part_of\",\n        \"to\": \"dopaminergic_pathways\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_implicated_in\",\n        \"to\": \"schizophrenia\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"uses_neurotransmitter\",\n        \"to\": \"90adc821\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_contrasted_with\",\n        \"to\": \"f43816"
      }, {
        "text": "54\"\n      }\n    ]\n  },\n  \"f4381654\":"
      }, {
        "text": " {\n    \"title\": \"Mesolimbic Pathway\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neuroscience\",\n      \"Psychiatry\",\n      \"Anatomy\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Dopaminergic Pathways\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e"
      }, {
        "text": "The \u003cb\u003eMesolimbic Pathway\u003c/b\u003e is a key dopaminergic tract that projects from the \u003ci\u003eventral tegmental area"
      }, {
        "text": " (VTA)\u003c/i\u003e in the midbrain to various structures of the [[73ace357|limbic system]], most"
      }, {
        "text": " notably the \u003ci\u003enucleus accumbens\u003c/i\u003e. It is the primary reward pathway in the brain.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Ventral Tegmental Area (VTA) in the midbrain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTermination:"
      }, {
        "text": "\u003c/b\u003e [[8092ce8a|Nucleus accumbens]], amygdala, hippocampus, and other limbic structures.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eNeurotransmitter:\u003c/b\u003e [[90adc821|Dopamine]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Medi"
      }, {
        "text": "ates reward, pleasure, motivation, and reinforcement learning. It is central to behaviors that are evolutionarily advantageous, such as eating"
      }, {
        "text": " and sex.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology (Addiction):\u003c/b\u003e This pathway is the final common pathway for addiction. All drugs"
      }, {
        "text": " of abuse (e.g., cocaine, amphetamines, opioids, nicotine) directly or indirectly increase dopamine release in the [["
      }, {
        "text": "8092ce8a|nucleus accumbens]], leading to reinforcement of drug-taking behavior.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology ("
      }, {
        "text": "Schizophrenia):\u003c/b\u003e Hyperactivity (increased dopamine) in the mesolimbic pathway is thought to be responsible for the \u003cmark\u003epositive"
      }, {
        "text": " symptoms\u003c/mark\u003e of schizophrenia (e.g., hallucinations, delusions). Antipsychotic drugs exert their therapeutic effect by blocking D"
      }, {
        "text": "2 receptors in this pathway.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMesolimbic Pathway\u003c/b\u003e"
      }, {
        "text": " is the brain\u0027s fundamental reward circuit, driven by dopamine. Its overactivation is responsible for the positive symptoms of psychosis"
      }, {
        "text": ", and its hijacking by drugs of abuse is the neurobiological basis of addiction.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD;"
      }, {
        "text": " A[Ventral Tegmental Area VTA] --Dopamine--\u003e B(Nucleus Accumbens); B --\u003e C("
      }, {
        "text": "Reward \u0026 Pleasure);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_"
      }, {
        "text": "of\",\n        \"to\": \"dopaminergic_pathways\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_implicated_in\",\n        \"to\": \"addiction\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_implicated_in\",\n        \"to\": \"schizophrenia\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"uses_neurotransmitter\",\n        \"to\": \"90"
      }, {
        "text": "adc821\"\n      }\n    ]\n  },\n  \"a078dbd0\": {\n    \"title"
      }, {
        "text": "\": \"Metachromatic Leukodystrophy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Pediatrics\",\n      \"Genetics\",\n      \"Biochemistry\",\n      \"USMLE\"\n    ],\n"
      }, {
        "text": "    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      "
      }, {
        "text": "\"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Metachromatic Leukodystrophy\u003c/b\u003e is an autosomal recessive \u003ci\u003elysosomal storage disease\u003c/i\u003e caused by a deficiency of"
      }, {
        "text": " the enzyme arylsulfatase A, leading to the accumulation of sulfatides and subsequent destruction of myelin in both the central and peripheral nervous systems"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Autosomal recessive inheritance.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEnzyme Deficiency"
      }, {
        "text": ":\u003c/b\u003e Deficiency of \u003cmark\u003earylsulfatase A\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAccumulated Substrate:\u003c/b\u003e \u003c"
      }, {
        "text": "mark\u003eCerebroside sulfate\u003c/mark\u003e (a sulfatide) accumulates in the lysosomes of oligodendrocytes and"
      }, {
        "text": " Schwann cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The buildup of sulfatides is toxic to myelin-producing cells, leading to progressive"
      }, {
        "text": " demyelination throughout the CNS and PNS.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Presents with progressive neurological decline. The late infantile"
      }, {
        "text": " form is most common, with initial findings of gait disturbance (ataxia) and loss of motor milestones, followed by cognitive"
      }, {
        "text": " decline, spasticity, and peripheral neuropathy, eventually leading to a vegetative state.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Conf"
      }, {
        "text": "irmed by measuring arylsulfatase A activity in leukocytes or cultured skin fibroblasts. Nerve biopsy shows demyelination.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " For lysosomal storage diseases, always link the disease name, the deficient enzyme, and the accumulated substrate. Metachromatic Leuk"
      }, {
        "text": "odystrophy \u003d Arylsulfatase A deficiency \u003d Cerebroside sulfate accumulation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eMetachromatic Leukodystrophy\u003c/b\u003e is a devastating demyelinating disorder where the inability to break down sulf"
      }, {
        "text": "atides due to arylsulfatase A deficiency leads to the toxic destruction of myelin sheaths, causing a relentless"
      }, {
        "text": " decline in motor and cognitive function.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cerebroside Sulfate] --"
      }, {
        "text": "Arylsulfatase A--\u003e B(Degradation); C[Enzyme Deficiency] --x B; A"
      }, {
        "text": " --\u003e D(Accumulation in Lysosomes); D --\u003e E(Demyelination); E --\u003e F(Progressive Neurologic"
      }, {
        "text": " Decline);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"lysosomal_storage_disease\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_type_of\",\n        \"to\": \"leukodystrophy\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_caused_by_deficiency_of\",\n        \"to"
      }, {
        "text": "\": \"arylsulfatase_a\"\n      },\n      {\n        \"type\": \"leads_to_accumulation_of\",\n"
      }, {
        "text": "        \"to\": \"cerebroside_sulfate\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "dd062acc\": {\n    \"title\": \"Metamorphopsia\",\n    \"primaryType\":"
      }, {
        "text": " \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physical"
      }, {
        "text": " Findings\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMetamorphopsia\u003c/b\u003e"
      }, {
        "text": " is a type of visual distortion in which straight lines appear wavy or bent. It is a key symptom of macular disease.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by disruption of the normal arrangement"
      }, {
        "text": " of photoreceptors in the macula, the central part of the retina responsible for high-acuity vision.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic"
      }, {
        "text": " Association:\u003c/b\u003e It is a hallmark symptom of \u003cmark\u003ewet (exudative) age-related macular degeneration (AMD)\u003c/mark\u003e."
      }, {
        "text": " The leakage of fluid and blood from choroidal neovascularization beneath the macula elevates and distorts the retinal layers."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Can also be seen in other macular pathologies, such as epiretinal membrane, macular p"
      }, {
        "text": "ucker, and central serous chorioretinopathy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Can be subjectively tested by"
      }, {
        "text": " the patient at home using an \u003cmark\u003eAmsler grid\u003c/mark\u003e. The patient looks at the grid, and if the"
      }, {
        "text": " lines appear wavy, distorted, or have blank spots, it suggests macular pathology.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A"
      }, {
        "text": " patient, especially an elderly one, who complains that straight lines (like on a door frame or telephone pole) suddenly appear"
      }, {
        "text": " wavy has metamorphopsia and should be evaluated urgently for wet AMD.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eMetamorphopsia\u003c/b\u003e is a specific visual distortion that acts as a sensitive alarm bell for macular pathology, particularly"
      }, {
        "text": " the neovascularization of wet AMD, signaling a disruption in the precise architecture of the central retina.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_symptom_of\",\n"
      }, {
        "text": "        \"to\": \"c63255c8\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_symptom_of\",\n        \"to\": \"macular_disease\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_tested_with\",\n        \"to\": \"amsler_grid\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"1b87b6a5\": {\n    \"title\": \"Metencephal"
      }, {
        "text": "on\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n"
      }, {
        "text": "      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \""
      }, {
        "text": "Neurology and Special Senses\",\n      \"Embryology\",\n      \"Brain Development\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMetencephalon\u003c/b\u003e is one of the five"
      }, {
        "text": " secondary brain vesicles, arising from the anterior part of the embryonic hindbrain (rhombencephalon). It develops into the pons"
      }, {
        "text": " and the cerebellum.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryonic Origin:\u003c/b\u003e Ar"
      }, {
        "text": "ises from the rostral (anterior) portion of the rhombencephalon (hindbrain).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdult Derivatives:\u003c/b\u003e D"
      }, {
        "text": "ifferentiates into the \u003cmark\u003epons\u003c/mark\u003e and the \u003cmark\u003ecerebellum\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated"
      }, {
        "text": " Cavity:\u003c/b\u003e The cavity of the metencephalon becomes the upper part of the \u003cmark\u003efourth ventricle\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eM"
      }, {
        "text": "nemonic for Vesicles:\u003c/b\u003e The five secondary vesicles in rostral to caudal order are Telencephalon, Diencephalon, Mes"
      }, {
        "text": "encephalon, \u003cb\u003eMetencephalon\u003c/b\u003e, and Myelencephalon.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that"
      }, {
        "text": " the two components of the hindbrain (rhombencephalon) are the metencephalon (pons and cerebellum) and the myelencephalon ("
      }, {
        "text": "medulla).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMetencephalon\u003c/b\u003e is the"
      }, {
        "text": " developmental precursor to the pons and cerebellum, two structures that are anatomically and functionally linked to form a critical hub for motor"
      }, {
        "text": " control and sensory relay in the adult brainstem.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Rhombencephal"
      }, {
        "text": "on (Hindbrain)] --\u003e B(Metencephalon); A --\u003e C(Myelencephalon); B --\u003e D"
      }, {
        "text": "(Pons); B --\u003e E(Cerebellum); B --\u003e F(Upper Fourth Ventricle);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"develops_into\",\n        \"to\": \"bf549"
      }, {
        "text": "b2f\"\n      },\n      {\n        \"type\": \"develops_into\",\n        \"to\":"
      }, {
        "text": " \"bebe58d4\"\n      },\n      {\n        \"type\": \"arises_from\",\n        \"to\":"
      }, {
        "text": " \"rhombencephalon\"\n      },\n      {\n        \"type\": \"contains_cavity\",\n        \"to\": \"fourth"
      }, {
        "text": "_ventricle\"\n      }\n    ]\n  },\n  \"2dcfe6b7\": {\n    \"title\":"
      }, {
        "text": " \"Methadone\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology"
      }, {
        "text": "\",\n      \"Psychiatry\",\n      \"Addiction Medicine\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Addiction Treatment\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMethadone\u003c/b\u003e is a long-acting, synthetic \u003ci\u003eŒº"
      }, {
        "text": "-opioid receptor agonist\u003c/i\u003e used for the management of chronic pain and, most notably, as a maintenance therapy for opioid use disorder.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e A potent, long-acting full"
      }, {
        "text": " agonist at Œº-opioid receptors. It also has antagonist activity at the NMDA receptor, which may contribute to its efficacy"
      }, {
        "text": " in neuropathic pain.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a long and variable half-life (typically 2"
      }, {
        "text": "4-36 hours), which allows for once-daily dosing and prevents the rapid peaks and troughs associated with short-acting opioids like"
      }, {
        "text": " heroin, thereby reducing cravings and withdrawal symptoms.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eOpioid Maintenance"
      }, {
        "text": " Therapy:\u003c/b\u003e The primary use. Reduces illicit opioid use, mortality, and criminal activity.\u003cbr\u003e - \u003cb\u003eChronic"
      }, {
        "text": " Pain:\u003c/b\u003e Effective for chronic pain, including neuropathic pain.\u003cbr\u003e - \u003cb\u003e[[b95e9"
      }, {
        "text": "7eb|Neonatal Abstinence Syndrome]]:\u003c/b\u003e Used to treat withdrawal in newborns exposed to opioids in utero.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse"
      }, {
        "text": " Effects:\u003c/b\u003e Similar to other opioids (respiratory depression, constipation, sedation). A major unique risk is \u003cmark\u003eQT"
      }, {
        "text": " interval prolongation\u003c/mark\u003e and torsades de pointes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Methadone\u0027s long half-life"
      }, {
        "text": " is its key feature for maintenance therapy. The risk of QT prolongation is a high-yield adverse effect to remember.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eMethadone\u003c/b\u003e treats opioid addiction by substituting a long-acting, orally administered opioid for a"
      }, {
        "text": " short-acting, often injected one. This stabilizes the patient by preventing withdrawal and reducing cravings, allowing them to disengage from the"
      }, {
        "text": " cycle of illicit drug use, but it carries its own risks, including QT prolongation.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"7fac2b01\"\n      },\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_treatment_for\",\n        \"to\": \"opioid_use_disorder\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"b95"
      }, {
        "text": "e97eb\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"qt"
      }, {
        "text": "_prolongation\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"0ef5a41e\",\n    \"letter\": \"M\",\n    \"term\": \"Malignant (necrotizing) otitis externa\",\n    \"pages\": [\n      \"547\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Malignant (necrotizing) otitis externa\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"429af8bd\",\n    \"letter\": \"M\",\n    \"term\": \"Malignant hyperthermia\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Malignant hyperthermia\",\n    \"sub_entries\": [\n      {\n        \"id\": \"28bc8a21\",\n        \"letter\": \"M\",\n        \"term\": \"dantrolene use\",\n        \"pages\": [\n          \"567\"\n        ],\n        \"context\": \"Malignant hyperthermia \u003e dantrolene use\"\n      },\n      {\n        \"id\": \"51f98b2f\",\n        \"letter\": \"M\",\n        \"term\": \"inhaled anesthetics\",\n        \"pages\": [\n          \"565\"\n        ],\n        \"context\": \"Malignant hyperthermia \u003e inhaled anesthetics\"\n      },\n      {\n        \"id\": \"de43af90\",\n        \"letter\": \"M\",\n        \"term\": \"neuromuscular blocking drugs\",\n        \"pages\": [\n          \"566\"\n        ],\n        \"context\": \"Malignant hyperthermia \u003e neuromuscular blocking drugs\"\n      },\n      {\n        \"id\": \"6183de23\",\n        \"letter\": \"M\",\n        \"term\": \"with inhaled anesthetics\",\n        \"pages\": [\n          \"566\"\n        ],\n        \"context\": \"Malignant hyperthermia \u003e with inhaled anesthetics\"\n      }\n    ]\n  },\n  {\n    \"id\": \"153b46d9\",\n    \"letter\": \"M\",\n    \"term\": \"Malleus (ossicles)\",\n    \"pages\": [\n      \"547\",\n      \"638\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Malleus (ossicles)\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"f02cfaa1\",\n    \"letter\": \"M\",\n    \"term\": \"Mammillary bodies\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Mammillary bodies\",\n    \"sub_entries\": [\n      {\n        \"id\": \"ffc83c68\",\n        \"letter\": \"M\",\n        \"term\": \"lesions in\",\n        \"pages\": [\n          \"524\"\n        ],\n        \"context\": \"Mammillary bodies \u003e lesions in\"\n      },\n      {\n        \"id\": \"5dc65d55\",\n        \"letter\": \"M\",\n        \"term\": \"limbic system\",\n        \"pages\": [\n          \"509\"\n        ],\n        \"context\": \"Mammillary bodies \u003e limbic system\"\n      }\n    ]\n  },\n  {\n    \"id\": \"d8fba734\",\n    \"letter\": \"M\",\n    \"term\": \"Mannitol\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Mannitol\",\n    \"sub_entries\": [\n      {\n        \"id\": \"880e5fec\",\n        \"letter\": \"M\",\n        \"term\": \"blood-brain barrier effects of\",\n        \"pages\": [\n          \"506\"\n        ],\n        \"context\": \"Mannitol \u003e blood-brain barrier effects of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"54a6f418\",\n    \"letter\": \"M\",\n    \"term\": \"Masseter muscle\",\n    \"pages\": [\n      \"519\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Masseter muscle\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"39228260\",\n    \"letter\": \"M\",\n    \"term\": \"Mastication muscles\",\n    \"pages\": [\n      \"519\",\n      \"520\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Mastication muscles\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"59052a50\",\n    \"letter\": \"M\",\n    \"term\": \"Mean arterial pressure\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Mean arterial pressure\",\n    \"sub_entries\": [\n      {\n        \"id\": \"1d2825f6\",\n        \"letter\": \"M\",\n        \"term\": \"gradient with intracranial pressure\",\n        \"pages\": [\n          \"512\"\n        ],\n        \"context\": \"Mean arterial pressure \u003e gradient with intracranial pressure\"\n      }\n    ]\n  },\n  {\n    \"id\": \"07757067\",\n    \"letter\": \"M\",\n    \"term\": \"Medial geniculate nucleus\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Medial geniculate nucleus\",\n    \"sub_entries\": [\n      {\n        \"id\": \"2923af90\",\n        \"letter\": \"M\",\n        \"term\": \"(thalamus)\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Medial geniculate nucleus \u003e (thalamus)\"\n      }\n    ]\n  },\n  {\n    \"id\": \"f19bc454\",\n    \"letter\": \"M\",\n    \"term\": \"Medial lemniscus\",\n    \"pages\": [\n      \"527\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Medial lemniscus\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"59ad6172\",\n    \"letter\": \"M\",\n    \"term\": \"Medial longitudinal fasciculus\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Medial longitudinal fasciculus\",\n    \"sub_entries\": [\n      {\n        \"id\": \"08528cae\",\n        \"letter\": \"M\",\n        \"term\": \"lesion effects\",\n        \"pages\": [\n          \"524\"\n        ],\n        \"context\": \"Medial longitudinal fasciculus \u003e lesion effects\"\n      },\n      {\n        \"id\": \"f5959ecf\",\n        \"letter\": \"M\",\n        \"term\": \"ophthalmoplegia and\",\n        \"pages\": [\n          \"558\"\n        ],\n        \"context\": \"Medial longitudinal fasciculus \u003e ophthalmoplegia and\"\n      }\n    ]\n  },\n  {\n    \"id\": \"4af9a67d\",\n    \"letter\": \"M\",\n    \"term\": \"Medial medullary syndrome\",\n    \"pages\": [\n      \"527\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Medial medullary syndrome\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"07f6ec2a\",\n    \"letter\": \"M\",\n    \"term\": \"Medulla (brain)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Medulla (brain)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"43abc54c\",\n        \"letter\": \"M\",\n        \"term\": \"cranial nerves and nuclei\",\n        \"pages\": [\n          \"515\"\n        ],\n        \"context\": \"Medulla (brain) \u003e cranial nerves and nuclei\"\n      },\n      {\n        \"id\": \"748fb4c6\",\n        \"letter\": \"M\",\n        \"term\": \"cross-sections of\",\n        \"pages\": [\n          \"517\"\n        ],\n        \"context\": \"Medulla (brain) \u003e cross-sections of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"16d613bb\",\n    \"letter\": \"M\",\n    \"term\": \"Medulloblastoma\",\n    \"pages\": [\n      \"354\",\n      \"542\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Medulloblastoma\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"4ee4b218\",\n    \"letter\": \"M\",\n    \"term\": \"Meissner corpuscles\",\n    \"pages\": [\n      \"504\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Meissner corpuscles\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 2196
    }, {
      "text": "```json\n{\n  \"0ef5a41e\": {\n    \"title\": \"Malignant (Necrotizing) Otitis Externa\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Otology\",\n      \"Infectious Disease\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMalignant (necrotizing) otitis externa\u003c/b\u003e is a severe, invasive, and potentially life-threatening infection of the external auditory canal and skull base, typically caused by \u003ci\u003ePseudomonas aeruginosa\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The infection begins in the external ear canal and aggressively spreads, causing osteomyelitis of the temporal bone and skull base.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e Almost exclusively seen in \u003cmark\u003eelderly patients with diabetes mellitus\u003c/mark\u003e and other immunocompromised individuals.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCausative Organism:\u003c/b\u003e The most common pathogen is \u003cmark\u003ePseudomonas aeruginosa\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Presents with exquisite, severe otalgia (ear pain) that is often worse at night, purulent otorrhea, and the presence of \u003cmark\u003egranulation tissue\u003c/mark\u003e at the floor of the ear canal at the bone-cartilage junction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e Can progress to involve cranial nerves, most commonly the [[dea9755f|facial nerve (CN VII)]] as it exits the stylomastoid foramen, leading to facial paralysis. Further spread can cause meningitis or brain abscess.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An elderly diabetic patient with severe ear pain, drainage, and granulation tissue in the ear canal is the classic vignette for malignant otitis externa.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMalignant otitis externa\u003c/b\u003e is a misnomer as it is not a malignancy but a severe infection; it represents \u003ci\u003ePseudomonas aeruginosa\u003c/i\u003e invading from the ear canal into the skull, a process facilitated by the microangiopathy and immunosuppression of diabetes.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"67063a58\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"cf0b8fbc\"\n      },\n      {\n        \"type\": \"is_a_risk_factor_for\",\n        \"to\": \"diabetes_mellitus\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"cranial_nerve_palsy\"\n      }\n    ]\n  },\n  \"429af8bd\": {\n    \"title\": \"Malignant Hyperthermia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Anesthesiology\",\n      \"Pharmacology\",\n      \"Genetics\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Adverse Effects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMalignant hyperthermia (MH)\u003c/b\u003e is a rare, life-threatening, hypermetabolic state of skeletal muscle triggered by exposure to volatile inhaled anesthetics (e.g., halothane, sevoflurane) or the depolarizing neuromuscular blocker \u003ci\u003esuccinylcholine\u003c/i\u003e in genetically susceptible individuals.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Most commonly an autosomal dominant condition with variable penetrance, associated with mutations in the \u003cmark\u003eryanodine receptor (RYR1)\u003c/mark\u003e gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The triggering agent causes a defect in the RYR1 receptor on the sarcoplasmic reticulum, leading to a massive, uncontrolled release of Ca\u003csup\u003e2+\u003c/sup\u003e into the cytoplasm of skeletal muscle cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Occurs during or shortly after anesthesia. Signs include tachycardia, tachypnea, muscle rigidity (especially masseter muscle spasm), hyperthermia (a late sign), and hypercapnia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLab Findings:\u003c/b\u003e Rhabdomyolysis leads to hyperkalemia, myoglobinuria, and a profound metabolic acidosis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Immediate cessation of the triggering agent and administration of \u003cmark\u003edantrolene\u003c/mark\u003e, a muscle relaxant that blocks Ca\u003csup\u003e2+\u003c/sup\u003e release from the sarcoplasmic reticulum by acting on the RYR1 receptor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient developing fever, muscle rigidity, and tachycardia shortly after receiving general anesthesia is the classic scenario. The immediate treatment is dantrolene.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMalignant hyperthermia\u003c/b\u003e is a pharmacogenetic disorder where anesthetic agents trigger a catastrophic, uncontrolled release of intracellular calcium in skeletal muscle, leading to a hypermetabolic crisis that is specifically treated by the ryanodine receptor antagonist, dantrolene.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Inhaled Anesthetic / Succinylcholine] --Triggers--\u003e B(Defective RYR1 Receptor); B --\u003e C(Massive Ca2+ Release from SR); C --\u003e D(Sustained Muscle Contraction); D --\u003e E(Hypermetabolism \u0026 Heat Production); E --\u003e F(Malignant Hyperthermia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_triggered_by\",\n        \"to\": \"inhaled_anesthetics\"\n      },\n      {\n        \"type\": \"is_triggered_by\",\n        \"to\": \"succinylcholine\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"d67a204d\"\n      },\n      {\n        \"type\": \"is_associated_with_mutation_in\",\n        \"to\": \"ryanodine_receptor\"\n      }\n    ]\n  },\n  \"153b46d9\": {\n    \"title\": \"Malleus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Otology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Anatomy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMalleus\u003c/b\u003e (Latin for \\\"hammer\\\") is the most lateral of the three auditory ossicles in the middle ear. It receives vibrations from the tympanic membrane and transmits them to the incus.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Situated in the middle ear, between the tympanic membrane and the incus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e The \u0027handle\u0027 (manubrium) of the malleus is attached to the tympanic membrane. The \u0027head\u0027 articulates with the body of the incus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e As the first bone in the ossicular chain, it initiates the mechanical transmission and amplification of sound vibrations across the middle ear.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Derived from cartilage of the \u003cmark\u003efirst pharyngeal arch\u003c/mark\u003e (Meckel\u0027s cartilage), along with the incus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Muscle:\u003c/b\u003e The tensor tympani muscle, innervated by CN V\u003csub\u003e3\u003c/sub\u003e, attaches to the malleus to dampen vibrations from loud sounds.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the pharyngeal arch derivatives: the \u003cb\u003eM\u003c/b\u003ealleus and incus come from the \u003cb\u003e1st\u003c/b\u003e (\u003cb\u003eM\u003c/b\u003eandibular) arch, while the \u003cb\u003eS\u003c/b\u003etapes comes from the \u003cb\u003e2nd\u003c/b\u003e (hyoid) arch.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMalleus\u003c/b\u003e acts as the crucial first link in the ossicular chain, physically connecting the eardrum to the rest of the middle ear\u0027s amplification system and originating embryologically from the first pharyngeal arch.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"3aea8cac\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"45568c28\"\n      },\n      {\n        \"type\": \"derives_from\",\n        \"to\": \"first_pharyngeal_arch\"\n      },\n      {\n        \"type\": \"articulates_with\",\n        \"to\": \"incus\"\n      }\n    ]\n  },\n  \"f02cfaa1\": {\n    \"title\": \"Mammillary Bodies\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Limbic System\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Limbic System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMammillary Bodies\u003c/b\u003e are a pair of small, round nuclei located on the undersurface of the brain that form part of the posterior [[89e86633|hypothalamus]]. They are a key component of the [[73ace357|limbic system]] and are crucial for recollective memory.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Part of the diencephalon, situated at the posterior end of the hypothalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCircuitry:\u003c/b\u003e A major part of the \u003cmark\u003ePapez circuit\u003c/mark\u003e, which is involved in memory and emotion. They receive major input from the hippocampus via the fornix and project to the anterior nucleus of the thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Play a significant role in the formation and consolidation of memory.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e The mammillary bodies are characteristically damaged in \u003cmark\u003eWernicke-Korsakoff syndrome\u003c/mark\u003e, a condition caused by thiamine (vitamin B1) deficiency, most commonly seen in chronic alcoholism.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects:\u003c/b\u003e Bilateral damage to the mammillary bodies leads to severe \u003cmark\u003eanterograde amnesia\u003c/mark\u003e (inability to form new memories) and confabulation, which are the hallmark features of Korsakoff syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Atrophy or hemorrhage of the mammillary bodies on MRI in an alcoholic patient with confusion, ataxia, and ophthalmoplegia is pathognomonic for Wernicke-Korsakoff syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMammillary Bodies\u003c/b\u003e are a critical memory relay station within the limbic system; their selective vulnerability to thiamine deficiency makes them the anatomical substrate for the profound and permanent amnesia seen in Korsakoff syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hippocampus] --Fornix--\u003e B(Mammillary Bodies); B --\u003e C(Anterior Thalamic Nucleus); C --\u003e D(Cingulate Gyrus);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"73ace357\"\n      },\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"wernicke_korsakoff_syndrome\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"anterograde_amnesia\"\n      }\n    ]\n  },\n  \"d8fba734\": {\n    \"title\": \"Mannitol\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Renal\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Renal\",\n      \"Pharmacology\",\n      \"Diuretics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMannitol\u003c/b\u003e is an \u003ci\u003eosmotic diuretic\u003c/i\u003e administered intravenously to reduce acutely raised intracranial pressure (ICP) and intraocular pressure by drawing water out of tissues and into the bloodstream.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e As an osmotically active agent, mannitol increases the osmolarity of the blood and renal tubular fluid. In the brain, it creates an osmotic gradient that pulls water from the brain parenchyma across the [[dd47b9cc|blood-brain barrier]] into the vasculature, thereby reducing cerebral edema and ICP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Used in emergencies to treat \u003cmark\u003ecerebral edema\u003c/mark\u003e and acutely elevated ICP (e.g., from head trauma, tumors, or stroke).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Ophthalmology):\u003c/b\u003e Used to rapidly lower intraocular pressure in acute angle-closure glaucoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Can cause pulmonary edema, especially in patients with heart failure, due to the initial expansion of extracellular fluid volume. Other effects include dehydration, hypernatremia, and hyponatremia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Mannitol is the go-to drug for emergency reduction of intracranial pressure. Its main contraindication is anuria and heart failure, as the initial volume expansion can be dangerous.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMannitol\u003c/b\u003e acts as a potent osmotic agent, effectively dehydrating the brain by pulling water out of the parenchyma and across the blood-brain barrier, providing a rapid but temporary solution to life-threatening increases in intracranial pressure.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"cerebral_edema\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"increased_intracranial_pressure\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"9c80344d\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"osmotic_diuretic\"\n      }\n    ]\n  },\n  \"54a6f418\": {\n    \"title\": \"Masseter Muscle\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Anatomy\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMasseter muscle\u003c/b\u003e is a powerful, rectangular muscle of mastication that elevates the mandible, closing the jaw.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Primary function is elevation of the mandible (closing the jaw). It also contributes to protrusion of the mandible.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e Innervated by the masseteric nerve, a branch of the \u003cmark\u003emandibular division of the trigeminal nerve (CN V\u003csub\u003e3\u003c/sub\u003e)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eJaw Jerk Reflex:\u003c/b\u003e Tapping the chin with the mouth slightly open stretches the masseter, eliciting a reflex contraction (jaw closure). This deep tendon reflex tests the integrity of CN V.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Weakness of the masseter is a sign of a lesion affecting the motor component of CN V\u003csub\u003e3\u003c/sub\u003e. Hypertrophy can occur in patients with bruxism (teeth grinding).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that all four muscles of mastication, including the masseter, are innervated by CN V\u003csub\u003e3\u003c/sub\u003e.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMasseter\u003c/b\u003e is the most powerful of the muscles of mastication, providing the primary force for closing the jaw, and its function is entirely dependent on innervation from the third division of the trigeminal nerve.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"a0c1b959\"\n      },\n      {\n        \"type\": \"is_innervated_by\",\n        \"to\": \"mandibular_nerve_v3\"\n      },\n      {\n        \"type\": \"is_involved_in\",\n        \"to\": \"jaw_jerk_reflex\"\n      }\n    ]\n  },\n  \"39228260\": {\n    \"title\": \"Muscles of Mastication\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Anatomy\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003emuscles of mastication\u003c/b\u003e are four pairs of muscles responsible for the movements of the mandible at the temporomandibular joint, primarily for chewing. They are all innervated by the mandibular division of the \u003ci\u003etrigeminal nerve (CN V\u003csub\u003e3\u003c/sub\u003e)\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMuscles that Close the Jaw (Elevation):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eM\u003c/b\u003easseter\u003cbr\u003e - \u003cb\u003eT\u003c/b\u003eemporalis\u003cbr\u003e - \u003cb\u003eM\u003c/b\u003eedial pterygoid\u003cbr\u003e Mnemonic: \u003cb\u003eM\u003c/b\u003e\u0027s \u003cb\u003eM\u003c/b\u003eunch.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMuscle that Opens the Jaw (Depression):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eL\u003c/b\u003eateral pterygoid. Mnemonic: \u003cb\u003eL\u003c/b\u003eateral \u003cb\u003eL\u003c/b\u003eowers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e All four muscles are innervated by the motor branch of the \u003cmark\u003emandibular nerve (CN V\u003csub\u003e3\u003c/sub\u003e)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Derived from the first pharyngeal arch.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e A lesion of the motor root of CN V or the V\u003csub\u003e3\u003c/sub\u003e branch will cause weakness of the muscles of mastication. On jaw protrusion, the jaw will deviate \u003cmark\u003etoward the side of the lesion\u003c/mark\u003e due to the unopposed action of the contralateral lateral pterygoid muscle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that all muscles of mastication are innervated by V\u003csub\u003e3\u003c/sub\u003e. Jaw deviation toward the lesion is a key sign of a V\u003csub\u003e3\u003c/sub\u003e motor deficit.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe four \u003cb\u003emuscles of mastication\u003c/b\u003e are a functional group defined by their shared innervation from CN V\u003csub\u003e3\u003c/sub\u003e and their origin from the first pharyngeal arch, working in concert to elevate, depress, and move the mandible from side to side during chewing.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"are_innervated_by\",\n        \"to\": \"mandibular_nerve_v3\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"jaw_deviation\"\n      },\n      {\n        \"type\": \"derive_from\",\n        \"to\": \"first_pharyngeal_arch\"\n      }\n    ]\n  },\n  \"59052a50\": {\n    \"title\": \"Mean Arterial Pressure (MAP) and Cerebral Perfusion\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Physiology\",\n      \"Cardiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebrovascular System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMean Arterial Pressure (MAP)\u003c/b\u003e is the average arterial pressure during a single cardiac cycle, and it is the primary driving force for blood flow to the body\u0027s organs, including the brain. Cerebral perfusion is dependent on the gradient between MAP and intracranial pressure (ICP).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFormula:\u003c/b\u003e Cerebral Perfusion Pressure (CPP) \u003d MAP - ICP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAutoregulation:\u003c/b\u003e Cerebral blood flow is kept relatively constant over a wide range of MAP (approx. 60-140 mmHg) through the process of autoregulation, where cerebral arterioles constrict or dilate in response to changes in blood pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEffect of Low MAP:\u003c/b\u003e If MAP falls below the lower limit of autoregulation (~60 mmHg), cerebral blood flow becomes pressure-dependent and decreases, leading to ischemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEffect of High MAP:\u003c/b\u003e If MAP rises above the upper limit of autoregulation (~140 mmHg), the autoregulatory system can be overwhelmed, leading to forced vasodilation, disruption of the blood-brain barrier, and vasogenic edema.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCushing Reflex:\u003c/b\u003e In the setting of severely elevated ICP, the body attempts to maintain CPP by drastically increasing MAP, leading to the triad of hypertension, bradycardia, and irregular respirations.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe brain maintains a stable blood flow despite fluctuations in systemic blood pressure through a robust autoregulatory mechanism; however, this system fails at the extremes of \u003cb\u003emean arterial pressure\u003c/b\u003e, making both severe hypotension and hypertension dangerous to cerebral perfusion.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"determines\",\n        \"to\": \"3eca3f19\"\n      },\n      {\n        \"type\": \"is_a_component_of\",\n        \"to\": \"cushing_reflex\"\n      },\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\": \"cerebral_autoregulation\"\n      }\n    ]\n  },\n  \"07757067\": {\n    \"title\": \"Medial Geniculate Nucleus (MGN)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Otology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Thalamus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMedial Geniculate Nucleus (MGN)\u003c/b\u003e, also known as the medial geniculate body, is a key nucleus in the [[afc0a64b|thalamus]] that serves as the primary thalamic relay station for \u003ci\u003eauditory information\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Relays auditory signals from the inferior colliculus of the midbrain to the primary auditory cortex in the temporal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Auditory information ascends the brainstem to the inferior colliculus, which then projects to the MGN. The MGN, in turn, projects via the auditory radiation to the primary auditory cortex (Brodmann areas 41 and 42) in the superior temporal gyrus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMnemonic:\u003c/b\u003e \u003cb\u003eM\u003c/b\u003eedial \u003d \u003cb\u003eM\u003c/b\u003eusic (hearing). Contrast with the \u003cb\u003eL\u003c/b\u003eateral geniculate nucleus for \u003cb\u003eL\u003c/b\u003eight (vision).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e A lesion in the MGN or the auditory radiation can cause cortical deafness, where sound is perceived but cannot be interpreted.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the thalamic sensory relays: MGN for auditory, LGN for visual, VPL for body sensation, and VPM for face sensation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMedial Geniculate Nucleus\u003c/b\u003e is the essential gateway through which auditory information must pass to reach conscious awareness, acting as the final thalamic processing and relay center before sound is perceived by the cerebral cortex.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Inferior Colliculus] --\u003e B(Medial Geniculate Nucleus); B --\u003e C(Primary Auditory Cortex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"afc0a64b\"\n      },\n      {\n        \"type\": \"relays\",\n        \"to\": \"auditory_information\"\n      },\n      {\n        \"type\": \"projects_to\",\n        \"to\": \"primary_auditory_cortex\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"inferior_colliculus\"\n      }\n    ]\n  },\n  \"f19bc454\": {\n    \"title\": \"Medial Lemniscus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMedial Lemniscus\u003c/b\u003e is a major ascending sensory pathway in the brainstem that carries information about fine touch, vibration, and conscious proprioception from the contralateral side of the body to the thalamus.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Formed by the axons of second-order neurons originating in the nucleus gracilis and nucleus cuneatus of the medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e After originating in the medulla, these fibers \u003cmark\u003edecussate\u003c/mark\u003e (cross the midline) as the internal arcuate fibers and then ascend through the brainstem as the medial lemniscus. It terminates in the ventral posterolateral (VPL) nucleus of the [[afc0a64b|thalamus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e It is the brainstem component of the [[e7f5cbbe|dorsal column-medial lemniscus pathway]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e A lesion of the medial lemniscus in the brainstem (e.g., in [[4af9a67d|medial medullary syndrome]]) causes contralateral loss of vibration and proprioception.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the location of decussation. The dorsal column pathway decussates in the medulla to form the medial lemniscus. The spinothalamic pathway decussates in the spinal cord.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMedial Lemniscus\u003c/b\u003e is the critical ascending tract that carries contralateral discriminative sensory information through the brainstem, representing the second-order neuron of the dorsal column pathway after its decussation in the medulla.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Nucleus Gracilis/Cuneatus] --Internal Arcuate Fibers (Decussation)--\u003e B(Medial Lemniscus); B --Ascends through Brainstem--\u003e C(VPL of Thalamus);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \"carries_sensation_of\",\n        \"to\": \"proprioception\"\n      },\n      {\n        \"type\": \"carries_sensation_of\",\n        \"to\": \"vibration\"\n      },\n      {\n        \"type\": \"terminates_in\",\n        \"to\": \"ventral_posterolateral_nucleus_thalamus\"\n      }\n    ]\n  },\n  \"59ad6172\": {\n    \"title\": \"Medial Longitudinal Fasciculus (MLF)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMedial Longitudinal Fasciculus (MLF)\u003c/b\u003e is a pair of heavily myelinated nerve tracts in the brainstem that connects the cranial nerve nuclei responsible for eye movements (CN III, IV, and VI), allowing for the coordination of conjugate horizontal gaze.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The primary role of the MLF is to coordinate horizontal eye movements by connecting the [[dd11dde6|abducens nucleus (CN VI)]] on one side with the contralateral [[68c66997|oculomotor nucleus (CN III)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway for Gaze:\u003c/b\u003e When looking to the right, the right abducens nucleus fires, causing the right lateral rectus to contract. Simultaneously, it sends a signal via the left MLF to the left oculomotor nucleus to contract the left medial rectus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects:\u003c/b\u003e A lesion in the MLF causes \u003cmark\u003eInternuclear Ophthalmoplegia (INO)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInternuclear Ophthalmoplegia (INO):\u003c/b\u003e Characterized by impaired adduction of the ipsilateral eye and nystagmus of the abducting contralateral eye. Convergence is typically preserved.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e In a young patient, bilateral INO is highly suggestive of \u003cmark\u003e[[45dd6d19|Multiple Sclerosis]]\u003c/mark\u003e, as the MLF is heavily myelinated and a common site for demyelinating plaques. In an older patient, a unilateral INO is often due to a brainstem stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Bilateral INO in a young woman is pathognomonic for MS. Remember \u003cb\u003eINO\u003c/b\u003e \u003d \u003cb\u003eI\u003c/b\u003epsilateral adduction failure, \u003cb\u003eN\u003c/b\u003eystagmus \u003cb\u003eO\u003c/b\u003epposite.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMedial Longitudinal Fasciculus\u003c/b\u003e is the critical communication link that yokes the eyes together for horizontal movements; its disruption in INO uncouples the eyes, providing a precise localizing sign for a lesion in the dorsal brainstem.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"58c684bd\"\n      },\n      {\n        \"type\": \"connects\",\n        \"to\": \"dd11dde6\"\n      },\n      {\n        \"type\": \"connects\",\n        \"to\": \"68c66997\"\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"45dd6d19\"\n      }\n    ]\n  },\n  \"4af9a67d\": {\n    \"title\": \"Medial Medullary Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Vascular\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brainstem Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMedial Medullary Syndrome\u003c/b\u003e (also known as Dejerine syndrome) is a brainstem stroke syndrome caused by an occlusion of the paramedian branches of the \u003ci\u003eanterior spinal artery\u003c/i\u003e or the vertebral arteries, affecting the medial portion of the medulla.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Caused by infarction in the territory of the \u003cmark\u003eanterior spinal artery (ASA)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAffected Structures:\u003c/b\u003e The lesion damages three key medial structures:\u003cbr\u003e1. \u003cb\u003eCorticospinal Tract (Pyramid):\u003c/b\u003e Causes \u003cmark\u003econtralateral hemiparesis\u003c/mark\u003e (UMN signs).\u003cbr\u003e2. \u003cb\u003eMedial Lemniscus:\u003c/b\u003e Causes \u003cmark\u003econtralateral loss of proprioception and vibration\u003c/mark\u003e.\u003cbr\u003e3. \u003cb\u003eHypoglossal Nucleus/Nerve (CN XII):\u003c/b\u003e Causes \u003cmark\u003eipsilateral tongue deviation\u003c/mark\u003e (tongue deviates toward the lesion).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A patient presents with contralateral weakness and loss of vibration/proprioception, with the tongue deviating toward the side of weakness when protruded.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of contralateral motor/sensory loss with ipsilateral tongue deviation is pathognomonic for a medial medullary lesion. The tongue \u0027licks the wound\u0027 (deviates toward the side of the lesion).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMedial Medullary Syndrome\u003c/b\u003e is a classic crossed brainstem syndrome where damage to the pyramids and medial lemniscus causes contralateral deficits, while damage to the exiting hypoglossal nerve causes an ipsilateral deficit, precisely localizing the lesion to the medial medulla.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Anterior Spinal Artery Occlusion] --\u003e B(Medial Medullary Infarct); B --\u003e C(Corticospinal Tract Damage -\u003e Contralateral Hemiparesis); B --\u003e D(Medial Lemniscus Damage -\u003e Contralateral Proprioception/Vibration Loss); B --\u003e E(CN XII Damage -\u003e Ipsilateral Tongue Deviation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_occlusion_of\",\n        \"to\": \"anterior_spinal_artery\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"corticospinal_tract\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"f19bc454\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"hypoglossal_nerve\"\n      }\n    ]\n  },\n  \"07f6ec2a\": {\n    \"title\": \"Medulla Oblongata\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMedulla Oblongata\u003c/b\u003e is the most caudal part of the brainstem, connecting the pons to the spinal cord. It contains vital autonomic centers for respiration and cardiovascular function, as well as nuclei for several cranial nerves.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Arises from the [[c8030560|myelencephalon]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eCranial Nerve Nuclei:\u003c/b\u003e Contains nuclei for cranial nerves \u003cb\u003eIX (Glossopharyngeal)\u003c/b\u003e, \u003cb\u003eX (Vagus)\u003c/b\u003e, \u003cb\u003eXI (Accessory)\u003c/b\u003e, and \u003cb\u003eXII (Hypoglossal)\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Structures:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003ePyramids:\u003c/b\u003e Ventral bundles containing the corticospinal tracts, which decussate at the pyramidal decussation.\u003cbr\u003e - \u003cb\u003eMedial Lemniscus:\u003c/b\u003e Ascending tract for contralateral proprioception/vibration.\u003cbr\u003e - \u003cb\u003eInferior Olivary Nucleus:\u003c/b\u003e Relays information to the cerebellum.\u003cbr\u003e - \u003cb\u003eNucleus Tractus Solitarius \u0026 Nucleus Ambiguus:\u003c/b\u003e Key sensory and motor nuclei for CN IX and X.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAutonomic Centers:\u003c/b\u003e Contains the respiratory, cardiac, and vasomotor centers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndromes:\u003c/b\u003e [[4af9a67d|Medial Medullary Syndrome]] (ASA occlusion) and Lateral Medullary (Wallenberg) Syndrome (PICA occlusion).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMedulla Oblongata\u003c/b\u003e is the critical life-support center of the brainstem, housing the autonomic nuclei that control breathing and heart rate, and serving as the major conduit for motor and sensory tracts between the brain and spinal cord.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"brainstem\"\n      },\n      {\n        \"type\": \"develops_from\",\n        \"to\": \"c8030560\"\n      },\n      {\n        \"type\": \"contains_nuclei_of\",\n        \"to\": \"97e2c817\"\n      },\n      {\n        \"type\": \"contains_nuclei_of\",\n        \"to\": \"7c12e7a3\"\n      },\n      {\n        \"type\": \"contains_nuclei_of\",\n        \"to\": \"f218aebf\"\n      },\n      {\n        \"type\": \"contains_nuclei_of\",\n        \"to\": \"hypoglossal_nerve\"\n      }\n    ]\n  },\n  \"16d613bb\": {\n    \"title\": \"Medulloblastoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Pediatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eMedulloblastoma\u003c/b\u003e is a highly malignant primary brain tumor that arises in the cerebellum and is the most common malignant brain tumor in childhood.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Exclusively occurs in the cerebellum. In children, it typically arises in the cerebellar \u003cmark\u003evermis\u003c/mark\u003e (midline).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A midline location leads to \u003cmark\u003etruncal ataxia\u003c/mark\u003e (unsteady gait). The tumor can compress the fourth ventricle, causing obstructive [[0bc2f200|hydrocephalus]] with symptoms of increased ICP (headache, vomiting, [[4ae219da|papilledema]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetastasis:\u003c/b\u003e These tumors are known to spread through the cerebrospinal fluid, causing \u003cmark\u003e\\\"drop metastases\\\"\u003c/mark\u003e to the spinal cord, which can present as back pain or radiculopathy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e A type of primitive neuroectodermal tumor (PNET), it is composed of small, round, blue cells. A characteristic finding is the formation of \u003cmark\u003eHomer-Wright rosettes\u003c/mark\u003e, where tumor cells arrange themselves in a circle around a central space filled with neuropil. It is synaptophysin-positive.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A child with truncal ataxia and signs of hydrocephalus should make you think of a medulloblastoma. The presence of Homer-Wright rosettes on histology is pathognomonic.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMedulloblastoma\u003c/b\u003e is an aggressive pediatric cerebellar tumor whose midline location leads to truncal ataxia and obstructive hydrocephalus, and its propensity to seed the CSF can lead to \u0027drop metastases\u0027 along the spinal cord.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"childhood_brain_tumor\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"cerebellum\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"4fab8000\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\": \"homer_wright_rosettes\"\n      }\n    ]\n  },\n  \"4ee4b218\": {\n    \"title\": \"Meissner\u0027s Corpuscles\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Dermatology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sensory System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMeissner\u0027s corpuscles\u003c/b\u003e are encapsulated sensory receptors located in the dermal papillae of the skin that are specialized to detect light, discriminative touch and low-frequency vibration.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Small, encapsulated nerve endings located in the dermal papillae, just beneath the epidermis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e They are \u003cmark\u003erapidly adapting\u003c/mark\u003e mechanoreceptors, meaning they respond to changes in stimuli (e.g., initial contact with an object, movement of textures across the skin) rather than sustained pressure. This makes them crucial for discriminative touch, such as reading Braille or detecting slip.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Abundant in glabrous (hairless) skin, such as the fingertips, palms, soles, and lips.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNerve Fibers:\u003c/b\u003e Transmitted by large, myelinated AŒ≤ fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Signals travel via the [[e7f5cbbe|dorsal column-medial lemniscus pathway]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Associate rapidly adapting receptors with dynamic qualities. Meissner\u0027s corpuscles \u003d light touch/texture changes. Pacinian corpuscles \u003d high-frequency vibration.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMeissner\u0027s corpuscles\u003c/b\u003e are the skin\u0027s fine-tuned motion detectors, rapidly adapting to provide the brain with detailed information about the texture and movement of objects across the skin, essential for tasks requiring fine tactile discrimination.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"senses\",\n        \"to\": \"fine_touch\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"mechanoreceptor\"\n      },\n      {\n        \"type\": \"signal_is_transmitted_via\",\n        \"to\": \"e7f5cbbe\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9509,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"0ef5a41e\": {\n    \"title\": \"Malignant"
      }, {
        "text": " (Necrotizing) Otitis Externa\",\n    \"primaryType\": \"disease\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Otology\",\n      \"Infectious Disease\",\n      \"Emergency Medicine\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ot"
      }, {
        "text": "ology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Malignant (necrotizing) otitis externa\u003c/b\u003e is a severe, invasive, and potentially life-threatening infection of the"
      }, {
        "text": " external auditory canal and skull base, typically caused by \u003ci\u003ePseudomonas aeruginosa\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The infection begins in the external ear canal and aggressively spreads, causing"
      }, {
        "text": " osteomyelitis of the temporal bone and skull base.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e Almost exclusively seen in \u003cmark\u003eelderly patients with diabetes"
      }, {
        "text": " mellitus\u003c/mark\u003e and other immunocompromised individuals.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCausative Organism:\u003c/b\u003e The most common pathogen"
      }, {
        "text": " is \u003cmark\u003ePseudomonas aeruginosa\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Presents with exquisite, severe otalgia ("
      }, {
        "text": "ear pain) that is often worse at night, purulent otorrhea, and the presence of \u003cmark\u003egranulation tissue\u003c/mark\u003e at"
      }, {
        "text": " the floor of the ear canal at the bone-cartilage junction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e Can progress to involve cranial"
      }, {
        "text": " nerves, most commonly the [[dea9755f|facial nerve (CN VII)]] as it exits the styl"
      }, {
        "text": "omastoid foramen, leading to facial paralysis. Further spread can cause meningitis or brain abscess.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e An elderly diabetic patient with severe ear pain, drainage, and granulation tissue in the ear canal is the"
      }, {
        "text": " classic vignette for malignant otitis externa.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMalignant"
      }, {
        "text": " otitis externa\u003c/b\u003e is a misnomer as it is not a malignancy but a severe infection; it represents \u003ci\u003ePseudomonas aeruginosa\u003c/i\u003e invading"
      }, {
        "text": " from the ear canal into the skull, a process facilitated by the microangiopathy and immunosuppression of diabetes.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_complication_of\","
      }, {
        "text": "\n        \"to\": \"67063a58\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_caused_by\",\n        \"to\": \"cf0b8fbc\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_risk_factor_for\",\n        \"to\": \"diabetes_mellitus\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"can_cause\",\n        \"to\": \"cranial_nerve_palsy\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"429af8bd\": {\n    \"title\": \"Malignant Hyper"
      }, {
        "text": "thermia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Anesthesiology\",\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Genetics\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n"
      }, {
        "text": "    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      "
      }, {
        "text": "\"Adverse Effects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMalignant hyperther"
      }, {
        "text": "mia (MH)\u003c/b\u003e is a rare, life-threatening, hypermetabolic state of skeletal muscle triggered by exposure to volatile"
      }, {
        "text": " inhaled anesthetics (e.g., halothane, sevoflurane) or the depolarizing neuromuscular blocker "
      }, {
        "text": "\u003ci\u003esuccinylcholine\u003c/i\u003e in genetically susceptible individuals.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Most"
      }, {
        "text": " commonly an autosomal dominant condition with variable penetrance, associated with mutations in the \u003cmark\u003eryanodine receptor (RY"
      }, {
        "text": "R1)\u003c/mark\u003e gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The triggering agent causes a defect in the RYR1 receptor"
      }, {
        "text": " on the sarcoplasmic reticulum, leading to a massive, uncontrolled release of Ca\u003csup\u003e2+\u003c/sup\u003e into the cytoplasm of skeletal muscle cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation:\u003c/b\u003e Occurs during or shortly after anesthesia. Signs include tachycardia, tachypnea, muscle rigidity (especially mass"
      }, {
        "text": "eter muscle spasm), hyperthermia (a late sign), and hypercapnia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLab Findings:\u003c/b\u003e Rhabdomyolysis"
      }, {
        "text": " leads to hyperkalemia, myoglobinuria, and a profound metabolic acidosis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Immediate cessation"
      }, {
        "text": " of the triggering agent and administration of \u003cmark\u003edantrolene\u003c/mark\u003e, a muscle relaxant that blocks Ca"
      }, {
        "text": "\u003csup\u003e2+\u003c/sup\u003e release from the sarcoplasmic reticulum by acting on the RYR1 receptor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A"
      }, {
        "text": " patient developing fever, muscle rigidity, and tachycardia shortly after receiving general anesthesia is the classic scenario. The immediate treatment is dantrolene.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMalignant hyperthermia\u003c/b\u003e is a pharmacogenetic disorder where"
      }, {
        "text": " anesthetic agents trigger a catastrophic, uncontrolled release of intracellular calcium in skeletal muscle, leading to a hypermetabolic crisis that is"
      }, {
        "text": " specifically treated by the ryanodine receptor antagonist, dantrolene.\u003c/p\u003e\",\n      \"mermaid\": \"graph"
      }, {
        "text": " TD; A[Inhaled Anesthetic / Succinylcholine] --Triggers--\u003e B(Defective RYR1 Receptor"
      }, {
        "text": "); B --\u003e C(Massive Ca2+ Release from SR); C --\u003e D(Sustained Muscle Contraction); D"
      }, {
        "text": " --\u003e E(Hypermetabolism \u0026 Heat Production); E --\u003e F(Malignant Hyperthermia);\"\n    },"
      }, {
        "text": "\n    \"connections\": [\n      {\n        \"type\": \"is_triggered_by\",\n        \"to\":"
      }, {
        "text": " \"inhaled_anesthetics\"\n      },\n      {\n        \"type\": \"is_triggered_by"
      }, {
        "text": "\",\n        \"to\": \"succinylcholine\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_treated_by\",\n        \"to\": \"d67a204d\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_associated_with_mutation_in\",\n        \"to\": \"ryanod"
      }, {
        "text": "ine_receptor\"\n      }\n    ]\n  },\n  \"153b46d9"
      }, {
        "text": "\": {\n    \"title\": \"Malleus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Otology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Otology\",\n      \"Anatomy\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMalleus\u003c/b\u003e (Latin for \\\"hammer\\\") is the most"
      }, {
        "text": " lateral of the three auditory ossicles in the middle ear. It receives vibrations from the tympanic membrane and transmits them to the inc"
      }, {
        "text": "us.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Situated in the middle ear, between"
      }, {
        "text": " the tympanic membrane and the incus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e The \u0027handle\u0027 (manubrium) of the malleus"
      }, {
        "text": " is attached to the tympanic membrane. The \u0027head\u0027 articulates with the body of the incus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e As"
      }, {
        "text": " the first bone in the ossicular chain, it initiates the mechanical transmission and amplification of sound vibrations across the middle ear.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEm"
      }, {
        "text": "bryology:\u003c/b\u003e Derived from cartilage of the \u003cmark\u003efirst pharyngeal arch\u003c/mark\u003e (Meckel\u0027s cartilage"
      }, {
        "text": "), along with the incus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Muscle:\u003c/b\u003e The tensor tympani muscle, innervated by CN"
      }, {
        "text": " V\u003csub\u003e3\u003c/sub\u003e, attaches to the malleus to dampen vibrations from loud sounds.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember"
      }, {
        "text": " the pharyngeal arch derivatives: the \u003cb\u003eM\u003c/b\u003ealleus and incus come from the \u003cb\u003e1st\u003c/b\u003e (\u003cb\u003e"
      }, {
        "text": "M\u003c/b\u003eandibular) arch, while the \u003cb\u003eS\u003c/b\u003etapes comes from the \u003cb\u003e2nd\u003c/b\u003e ("
      }, {
        "text": "hyoid) arch.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMalleus\u003c/b\u003e acts"
      }, {
        "text": " as the crucial first link in the ossicular chain, physically connecting the eardrum to the rest of the middle ear\u0027"
      }, {
        "text": "s amplification system and originating embryologically from the first pharyngeal arch.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n"
      }, {
        "text": "    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        "
      }, {
        "text": "\"to\": \"3aea8cac\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to"
      }, {
        "text": "\": \"45568c28\"\n      },\n      {\n        \"type\": \"der"
      }, {
        "text": "ives_from\",\n        \"to\": \"first_pharyngeal_arch\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"articulates_with\",\n        \"to\": \"incus\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"f02cfaa1\": {\n    \"title\": \"Mammillary Bodies\",\n    \"primary"
      }, {
        "text": "Type\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"L"
      }, {
        "text": "imbic System\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n"
      }, {
        "text": "      \"Anatomy and Physiology\",\n      \"Limbic System\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003eThe \u003cb\u003eMammillary Bodies\u003c/b\u003e are a pair of small, round nuclei located on the unders"
      }, {
        "text": "urface of the brain that form part of the posterior [[89e86633|hypothalamus]]."
      }, {
        "text": " They are a key component of the [[73ace357|limbic system]] and are crucial for recol"
      }, {
        "text": "lective memory.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Part of the diencephalon, situated"
      }, {
        "text": " at the posterior end of the hypothalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCircuitry:\u003c/b\u003e A major part of the \u003cmark\u003ePapez circuit\u003c/mark"
      }, {
        "text": "\u003e, which is involved in memory and emotion. They receive major input from the hippocampus via the fornix and project to the anterior"
      }, {
        "text": " nucleus of the thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Play a significant role in the formation and consolidation of memory."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e The mammillary bodies are characteristically damaged in \u003cmark\u003eWernicke-Korsakoff syndrome"
      }, {
        "text": "\u003c/mark\u003e, a condition caused by thiamine (vitamin B1) deficiency, most commonly seen in chronic alcoholism.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eLesion Effects:\u003c/b\u003e Bilateral damage to the mammillary bodies leads to severe \u003cmark\u003eanterograde am"
      }, {
        "text": "nesia\u003c/mark\u003e (inability to form new memories) and confabulation, which are the hallmark features of Kors"
      }, {
        "text": "akoff syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Atrophy or hemorrhage of the mammillary bodies on MRI in"
      }, {
        "text": " an alcoholic patient with confusion, ataxia, and ophthalmoplegia is pathognomonic for Wernicke-Korsakoff syndrome"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMammillary Bodies\u003c/b\u003e are a critical memory"
      }, {
        "text": " relay station within the limbic system; their selective vulnerability to thiamine deficiency makes them the anatomical substrate for the profound and"
      }, {
        "text": " permanent amnesia seen in Korsakoff syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hipp"
      }, {
        "text": "ocampus] --Fornix--\u003e B(Mammillary Bodies); B --\u003e C(Anterior Thalamic Nucleus); C --\u003e D"
      }, {
        "text": "(Cingulate Gyrus);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part"
      }, {
        "text": "_of\",\n        \"to\": \"73ace357\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_part_of\",\n        \"to\": \"89e86633"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\":"
      }, {
        "text": " \"wernicke_korsakoff_syndrome\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"lesion_causes\",\n        \"to\": \"anterograde_amnesia\"\n      }\n    ]\n  },"
      }, {
        "text": "\n  \"d8fba734\": {\n    \"title\": \"Mannitol\",\n    \"primaryType\":"
      }, {
        "text": " \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Renal\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Renal\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Diuretics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMann"
      }, {
        "text": "itol\u003c/b\u003e is an \u003ci\u003eosmotic diuretic\u003c/i\u003e administered intravenously to reduce acutely raised intracranial pressure (ICP) and intraocular pressure by"
      }, {
        "text": " drawing water out of tissues and into the bloodstream.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": " of Action:\u003c/b\u003e As an osmotically active agent, mannitol increases the osmolarity of the blood and renal tubular fluid. In"
      }, {
        "text": " the brain, it creates an osmotic gradient that pulls water from the brain parenchyma across the [[dd47b9cc|blood"
      }, {
        "text": "-brain barrier]] into the vasculature, thereby reducing cerebral edema and ICP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Used"
      }, {
        "text": " in emergencies to treat \u003cmark\u003ecerebral edema\u003c/mark\u003e and acutely elevated ICP (e.g., from head"
      }, {
        "text": " trauma, tumors, or stroke).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Ophthalmology):\u003c/b\u003e Used to rapidly lower intraocular pressure in acute"
      }, {
        "text": " angle-closure glaucoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Can cause pulmonary edema, especially in patients with heart failure, due"
      }, {
        "text": " to the initial expansion of extracellular fluid volume. Other effects include dehydration, hypernatremia, and hyponatremia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Mannitol is the go-to drug for emergency reduction of intracranial pressure. Its main contraindication is an"
      }, {
        "text": "uria and heart failure, as the initial volume expansion can be dangerous.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eMannitol\u003c/b\u003e acts as a potent osmotic agent, effectively dehydrating the brain by pulling water out of the parenchyma"
      }, {
        "text": " and across the blood-brain barrier, providing a rapid but temporary solution to life-threatening increases in intracranial pressure.\u003c/p"
      }, {
        "text": "\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_treatment_for\",\n        \"to\": \"cerebral_edema\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_a_treatment_for\",\n        \"to\": \"increased_intracranial_pressure\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\":"
      }, {
        "text": " \"9c80344d\"\n      },\n      {\n        \"type\": \"is_a_type_of\","
      }, {
        "text": "\n        \"to\": \"osmotic_diuretic\"\n      }\n    ]\n  },\n  \"5"
      }, {
        "text": "4a6f418\": {\n    \"title\": \"Masseter Muscle\",\n    \"primaryType"
      }, {
        "text": "\": \"anatomy\",\n    \"tags\": [\n      \"Anatomy\",\n      \"Neurology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMass"
      }, {
        "text": "eter muscle\u003c/b\u003e is a powerful, rectangular muscle of mastication that elevates the mandible, closing the jaw.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Primary function is elevation of the mandible (closing the jaw). It"
      }, {
        "text": " also contributes to protrusion of the mandible.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e Innervated by the masseteric nerve"
      }, {
        "text": ", a branch of the \u003cmark\u003emandibular division of the trigeminal nerve (CN V\u003csub\u003e3\u003c/sub\u003e)\u003c/mark\u003e."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eJaw Jerk Reflex:\u003c/b\u003e Tapping the chin with the mouth slightly open stretches the masseter, elic"
      }, {
        "text": "iting a reflex contraction (jaw closure). This deep tendon reflex tests the integrity of CN V.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance"
      }, {
        "text": ":\u003c/b\u003e Weakness of the masseter is a sign of a lesion affecting the motor component of CN V\u003csub\u003e3\u003c/sub\u003e."
      }, {
        "text": " Hypertrophy can occur in patients with bruxism (teeth grinding).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that"
      }, {
        "text": " all four muscles of mastication, including the masseter, are innervated by CN V\u003csub\u003e3\u003c/sub\u003e.\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMasseter\u003c/b\u003e is the most powerful of the muscles of mastication, providing"
      }, {
        "text": " the primary force for closing the jaw, and its function is entirely dependent on innervation from the third division of the trigeminal nerve.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"a0c1b959\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_innervated_by\",\n        \"to\": \"mandibular_"
      }, {
        "text": "nerve_v3\"\n      },\n      {\n        \"type\": \"is_involved_in\","
      }, {
        "text": "\n        \"to\": \"jaw_jerk_reflex\"\n      }\n    ]\n  },\n  \"3"
      }, {
        "text": "9228260\": {\n    \"title\": \"Muscles of Mastication\",\n    "
      }, {
        "text": "\"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Anatomy\",\n      \"Neurology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"An"
      }, {
        "text": "atomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003eThe \u003cb\u003emuscles of mastication\u003c/b\u003e are four pairs of muscles responsible for the movements of the mandible at"
      }, {
        "text": " the temporomandibular joint, primarily for chewing. They are all innervated by the mandibular division of the "
      }, {
        "text": "\u003ci\u003etrigeminal nerve (CN V\u003csub\u003e3\u003c/sub\u003e)\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMus"
      }, {
        "text": "cles that Close the Jaw (Elevation):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eM\u003c/b\u003easseter\u003cbr\u003e - \u003cb\u003eT"
      }, {
        "text": "\u003c/b\u003eemporalis\u003cbr\u003e - \u003cb\u003eM\u003c/b\u003eedial pterygoid\u003cbr\u003e Mnemonic: \u003cb\u003eM\u003c/b\u003e\u0027"
      }, {
        "text": "s \u003cb\u003eM\u003c/b\u003eunch.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMuscle that Opens the Jaw (Depression):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eL"
      }, {
        "text": "\u003c/b\u003eateral pterygoid. Mnemonic: \u003cb\u003eL\u003c/b\u003eateral \u003cb\u003eL\u003c/b\u003eowers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e All"
      }, {
        "text": " four muscles are innervated by the motor branch of the \u003cmark\u003emandibular nerve (CN V\u003csub\u003e3\u003c/sub\u003e)\u003c/"
      }, {
        "text": "mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Derived from the first pharyngeal arch.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e A"
      }, {
        "text": " lesion of the motor root of CN V or the V\u003csub\u003e3\u003c/sub\u003e branch will cause weakness of the muscles of mastication. On"
      }, {
        "text": " jaw protrusion, the jaw will deviate \u003cmark\u003etoward the side of the lesion\u003c/mark\u003e due to the uno"
      }, {
        "text": "pposed action of the contralateral lateral pterygoid muscle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that all muscles"
      }, {
        "text": " of mastication are innervated by V\u003csub\u003e3\u003c/sub\u003e. Jaw deviation toward the lesion is a key sign of a"
      }, {
        "text": " V\u003csub\u003e3\u003c/sub\u003e motor deficit.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe four \u003cb\u003emuscles of mastication\u003c/b\u003e are"
      }, {
        "text": " a functional group defined by their shared innervation from CN V\u003csub\u003e3\u003c/sub\u003e and their origin from the first pharyngeal arch,"
      }, {
        "text": " working in concert to elevate, depress, and move the mandible from side to side during chewing.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    "
      }, {
        "text": "},\n    \"connections\": [\n      {\n        \"type\": \"are_innervated_by\",\n        \""
      }, {
        "text": "to\": \"mandibular_nerve_v3\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "lesion_causes\",\n        \"to\": \"jaw_deviation\"\n      },\n      {\n        \"type\": \"derive"
      }, {
        "text": "_from\",\n        \"to\": \"first_pharyngeal_arch\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"59052a50\": {\n    \"title\": \"Mean Arterial Pressure (MAP) and"
      }, {
        "text": " Cerebral Perfusion\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Physiology\","
      }, {
        "text": "\n      \"Cardiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebrovascular System\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMean Arterial Pressure (MAP)\u003c/b\u003e is the average arterial pressure during"
      }, {
        "text": " a single cardiac cycle, and it is the primary driving force for blood flow to the body\u0027s organs, including the brain."
      }, {
        "text": " Cerebral perfusion is dependent on the gradient between MAP and intracranial pressure (ICP).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eFormula:\u003c/b\u003e Cerebral Perfusion Pressure (CPP) \u003d MAP - ICP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAutoregulation:\u003c/b\u003e Cerebral"
      }, {
        "text": " blood flow is kept relatively constant over a wide range of MAP (approx. 60-140 mmHg) through"
      }, {
        "text": " the process of autoregulation, where cerebral arterioles constrict or dilate in response to changes in blood pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEffect"
      }, {
        "text": " of Low MAP:\u003c/b\u003e If MAP falls below the lower limit of autoregulation (~60 mmHg), cerebral blood flow becomes"
      }, {
        "text": " pressure-dependent and decreases, leading to ischemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEffect of High MAP:\u003c/b\u003e If MAP rises above the upper limit of autoregulation (~"
      }, {
        "text": "140 mmHg), the autoregulatory system can be overwhelmed, leading to forced vasodilation, disruption of the blood"
      }, {
        "text": "-brain barrier, and vasogenic edema.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCushing Reflex:\u003c/b\u003e In the setting of severely elevated ICP, the body"
      }, {
        "text": " attempts to maintain CPP by drastically increasing MAP, leading to the triad of hypertension, bradycardia, and irregular respirations.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe brain maintains a stable blood flow despite fluctuations in systemic blood pressure through"
      }, {
        "text": " a robust autoregulatory mechanism; however, this system fails at the extremes of \u003cb\u003emean arterial pressure\u003c/b\u003e, making"
      }, {
        "text": " both severe hypotension and hypertension dangerous to cerebral perfusion.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"determines\",\n        \"to\": \"3eca3"
      }, {
        "text": "f19\"\n      },\n      {\n        \"type\": \"is_a_component_of\",\n        \""
      }, {
        "text": "to\": \"cushing_reflex\"\n      },\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\":"
      }, {
        "text": " \"cerebral_autoregulation\"\n      }\n    ]\n  },\n  \"077570"
      }, {
        "text": "67\": {\n    \"title\": \"Medial Geniculate Nucleus (MGN)\",\n    \"primaryType\": \""
      }, {
        "text": "anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Ot"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Thalamus\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003eThe \u003cb\u003eMedial Geniculate Nucleus (MGN)\u003c/b\u003e, also known as"
      }, {
        "text": " the medial geniculate body, is a key nucleus in the [[afc0a64b|thalamus]] that serves"
      }, {
        "text": " as the primary thalamic relay station for \u003ci\u003eauditory information\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction"
      }, {
        "text": ":\u003c/b\u003e Relays auditory signals from the inferior colliculus of the midbrain to the primary auditory cortex in the temporal"
      }, {
        "text": " lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Auditory information ascends the brainstem to the inferior colliculus, which then"
      }, {
        "text": " projects to the MGN. The MGN, in turn, projects via the auditory radiation to the primary auditory cortex ("
      }, {
        "text": "Brodmann areas 41 and 42) in the superior temporal gyrus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMnemonic:\u003c/b\u003e "
      }, {
        "text": "\u003cb\u003eM\u003c/b\u003eedial \u003d \u003cb\u003eM\u003c/b\u003eusic (hearing). Contrast with the \u003cb\u003eL\u003c/b\u003eateral geniculate nucleus for"
      }, {
        "text": " \u003cb\u003eL\u003c/b\u003eight (vision).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e A lesion in the MGN or the auditory radiation"
      }, {
        "text": " can cause cortical deafness, where sound is perceived but cannot be interpreted.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the thalam"
      }, {
        "text": "ic sensory relays: MGN for auditory, LGN for visual, VPL for body sensation, and VPM for face sensation.\u003c/li\u003e\u003c/ul\u003e\",\n"
      }, {
        "text": "      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMedial Geniculate Nucleus\u003c/b\u003e is the essential gateway through which auditory information must"
      }, {
        "text": " pass to reach conscious awareness, acting as the final thalamic processing and relay center before sound is perceived by the cerebral cortex.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Inferior Colliculus] --\u003e B(Medial Geniculate Nucleus); B"
      }, {
        "text": " --\u003e C(Primary Auditory Cortex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part"
      }, {
        "text": "_of\",\n        \"to\": \"afc0a64b\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"relays\",\n        \"to\": \"auditory_information\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"projects_to\",\n        \"to\": \"primary_auditory_cortex\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"inferior_col"
      }, {
        "text": "liculus\"\n      }\n    ]\n  },\n  \"f19bc454\": {\n    \"title"
      }, {
        "text": "\": \"Medial Lemniscus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\","
      }, {
        "text": "\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      "
      }, {
        "text": "\"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\":"
      }, {
        "text": " {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eMedial Lemniscus\u003c/b\u003e is a major ascending sensory pathway in the brainstem that"
      }, {
        "text": " carries information about fine touch, vibration, and conscious proprioception from the contralateral side of the body to the thalamus.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Formed by the axons of second-order neurons originating in the nucleus"
      }, {
        "text": " gracilis and nucleus cuneatus of the medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e After originating in the medulla, these fibers"
      }, {
        "text": " \u003cmark\u003edecussate\u003c/mark\u003e (cross the midline) as the internal arcuate fibers and then ascend through"
      }, {
        "text": " the brainstem as the medial lemniscus. It terminates in the ventral posterolateral (VPL) nucleus of the [[afc0a64b"
      }, {
        "text": "|thalamus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e It is the brainstem component of the [[e7f5cb"
      }, {
        "text": "be|dorsal column-medial lemniscus pathway]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e A lesion of the medial lemniscus in"
      }, {
        "text": " the brainstem (e.g., in [[4af9a67d|medial medullary syndrome]]) causes contralateral"
      }, {
        "text": " loss of vibration and proprioception.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the location of decussation. The dorsal"
      }, {
        "text": " column pathway decussates in the medulla to form the medial lemniscus. The spinothalamic pathway decussates in the spinal"
      }, {
        "text": " cord.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMedial Lemniscus\u003c/b\u003e is the critical"
      }, {
        "text": " ascending tract that carries contralateral discriminative sensory information through the brainstem, representing the second-order neuron of the dorsal column pathway"
      }, {
        "text": " after its decussation in the medulla.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Nucleus Grac"
      }, {
        "text": "ilis/Cuneatus] --Internal Arcuate Fibers (Decussation)--\u003e B(Medial Lemn"
      }, {
        "text": "iscus); B --Ascends through Brainstem--\u003e C(VPL of Thalamus);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"e7f5cbbe\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"carries_sensation_of\",\n        \"to\": \"prop"
      }, {
        "text": "rioception\"\n      },\n      {\n        \"type\": \"carries_sensation_of\",\n"
      }, {
        "text": "        \"to\": \"vibration\"\n      },\n      {\n        \"type\": \"terminates_in\",\n        \"to"
      }, {
        "text": "\": \"ventral_posterolateral_nucleus_thalamus\"\n      }\n    ]\n  },\n  \"5"
      }, {
        "text": "9ad6172\": {\n    \"title\": \"Medial Longitudinal Fasciculus (MLF)\",\n    "
      }, {
        "text": "\"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Ophthalmology"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special"
      }, {
        "text": " Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003eThe \u003cb\u003eMedial Longitudinal Fasciculus (MLF)\u003c/b\u003e is a pair of heavily myelinated nerve"
      }, {
        "text": " tracts in the brainstem that connects the cranial nerve nuclei responsible for eye movements (CN III, IV, and VI), allowing for the"
      }, {
        "text": " coordination of conjugate horizontal gaze.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The primary role"
      }, {
        "text": " of the MLF is to coordinate horizontal eye movements by connecting the [[dd11dde6|abducens nucleus (CN VI)]]"
      }, {
        "text": " on one side with the contralateral [[68c66997|oculomotor nucleus (CN III)]]."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway for Gaze:\u003c/b\u003e When looking to the right, the right abducens nucleus fires, causing the right lateral"
      }, {
        "text": " rectus to contract. Simultaneously, it sends a signal via the left MLF to the left oculomotor nucleus to contract"
      }, {
        "text": " the left medial rectus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects:\u003c/b\u003e A lesion in the MLF causes \u003cmark\u003eInternuclear Ophthalm"
      }, {
        "text": "oplegia (INO)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInternuclear Ophthalmoplegia (INO):\u003c/b\u003e Characterized by impaired adduction of the ips"
      }, {
        "text": "ilateral eye and nystagmus of the abducting contralateral eye. Convergence is typically preserved.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e In"
      }, {
        "text": " a young patient, bilateral INO is highly suggestive of \u003cmark\u003e[[45dd6d19|Multiple Sclerosis]]\u003c/mark\u003e,"
      }, {
        "text": " as the MLF is heavily myelinated and a common site for demyelinating plaques. In an older patient, a"
      }, {
        "text": " unilateral INO is often due to a brainstem stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Bilateral INO in"
      }, {
        "text": " a young woman is pathognomonic for MS. Remember \u003cb\u003eINO\u003c/b\u003e \u003d \u003cb\u003eI\u003c/b\u003epsilateral ad"
      }, {
        "text": "duction failure, \u003cb\u003eN\u003c/b\u003eystagmus \u003cb\u003eO\u003c/b\u003epposite.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003eThe \u003cb\u003eMedial Longitudinal Fasciculus\u003c/b\u003e is the critical communication link that yokes the eyes together for"
      }, {
        "text": " horizontal movements; its disruption in INO uncouples the eyes, providing a precise localizing sign for a lesion in the dorsal"
      }, {
        "text": " brainstem.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"lesion_causes\",\n        \"to\": \"58c684bd\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"connects\",\n        \"to\": \"dd11dde6\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"connects\",\n        \"to\": \"68c66997\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"45dd6d19"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"4af9a67d\": {\n    \"title\": \"Medial"
      }, {
        "text": " Medullary Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"V"
      }, {
        "text": "ascular\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Pathology\",\n      \"Brainstem Syndromes\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMedial Medullary Syndrome\u003c/b\u003e (also known as Dejerine syndrome"
      }, {
        "text": ") is a brainstem stroke syndrome caused by an occlusion of the paramedian branches of the \u003ci\u003eanterior spinal artery\u003c/i\u003e"
      }, {
        "text": " or the vertebral arteries, affecting the medial portion of the medulla.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eVascular Supply:\u003c/b\u003e Caused by infarction in the territory of the \u003cmark\u003eanterior spinal artery (ASA)\u003c/"
      }, {
        "text": "mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAffected Structures:\u003c/b\u003e The lesion damages three key medial structures:\u003cbr\u003e1. \u003cb\u003eCorticospinal Tract (Py"
      }, {
        "text": "ramid):\u003c/b\u003e Causes \u003cmark\u003econtralateral hemiparesis\u003c/mark\u003e (UMN signs).\u003cbr\u003e2. \u003cb\u003e"
      }, {
        "text": "Medial Lemniscus:\u003c/b\u003e Causes \u003cmark\u003econtralateral loss of proprioception and vibration\u003c/mark\u003e.\u003c"
      }, {
        "text": "br\u003e3. \u003cb\u003eHypoglossal Nucleus/Nerve (CN XII):\u003c/b\u003e Causes \u003cmark\u003eips"
      }, {
        "text": "ilateral tongue deviation\u003c/mark\u003e (tongue deviates toward the lesion).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A patient presents with contralateral"
      }, {
        "text": " weakness and loss of vibration/proprioception, with the tongue deviating toward the side of weakness when protruded.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The combination of contralateral motor/sensory loss with ipsilateral tongue deviation is pathognomonic for a"
      }, {
        "text": " medial medullary lesion. The tongue \u0027licks the wound\u0027 (deviates toward the side of the lesion).\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMedial Medullary Syndrome\u003c/b\u003e is a classic crossed brainstem syndrome where damage"
      }, {
        "text": " to the pyramids and medial lemniscus causes contralateral deficits, while damage to the exiting hypoglossal nerve causes an ipsilateral deficit"
      }, {
        "text": ", precisely localizing the lesion to the medial medulla.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[An"
      }, {
        "text": "terior Spinal Artery Occlusion] --\u003e B(Medial Medullary Infarct); B --\u003e C(Corticospinal Tract"
      }, {
        "text": " Damage -\u003e Contralateral Hemiparesis); B --\u003e D(Medial Lemniscus Damage -\u003e Contralateral Prop"
      }, {
        "text": "rioception/Vibration Loss); B --\u003e E(CN XII Damage -\u003e Ipsilateral Tongue Deviation);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_caused_by_occlusion_of\",\n        \"to"
      }, {
        "text": "\": \"anterior_spinal_artery\"\n      },\n      {\n        \"type\": \"damages\","
      }, {
        "text": "\n        \"to\": \"corticospinal_tract\"\n      },\n      {\n        \"type\": \"damages\",\n        \""
      }, {
        "text": "to\": \"f19bc454\"\n      },\n      {\n        \"type\": \"dam"
      }, {
        "text": "ages\",\n        \"to\": \"hypoglossal_nerve\"\n      }\n    ]\n  },\n  \"07"
      }, {
        "text": "f6ec2a\": {\n    \"title\": \"Medulla Oblongata\",\n    \"primaryType"
      }, {
        "text": "\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      "
      }, {
        "text": "\"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\","
      }, {
        "text": "\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003eThe \u003cb\u003eMedulla Oblongata\u003c/b\u003e is the most caudal part of the brainstem, connecting the pons to the spinal"
      }, {
        "text": " cord. It contains vital autonomic centers for respiration and cardiovascular function, as well as nuclei for several cranial nerves.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Arises from the [[c8030560"
      }, {
        "text": "|myelencephalon]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eCranial Nerve Nuclei:\u003c/b\u003e Contains nuclei for cranial nerves \u003cb\u003eIX ("
      }, {
        "text": "Glossopharyngeal)\u003c/b\u003e, \u003cb\u003eX (Vagus)\u003c/b\u003e, \u003cb\u003eXI (Accessory)\u003c/b\u003e, and \u003cb\u003e"
      }, {
        "text": "XII (Hypoglossal)\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Structures:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003ePyramids:\u003c/b\u003e Vent"
      }, {
        "text": "ral bundles containing the corticospinal tracts, which decussate at the pyramidal decussation.\u003cbr\u003e - \u003cb\u003eMed"
      }, {
        "text": "ial Lemniscus:\u003c/b\u003e Ascending tract for contralateral proprioception/vibration.\u003cbr\u003e - \u003cb\u003eInferior Oliv"
      }, {
        "text": "ary Nucleus:\u003c/b\u003e Relays information to the cerebellum.\u003cbr\u003e - \u003cb\u003eNucleus Tractus Solitarius \u0026"
      }, {
        "text": " Nucleus Ambiguus:\u003c/b\u003e Key sensory and motor nuclei for CN IX and X.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAutonomic Centers:"
      }, {
        "text": "\u003c/b\u003e Contains the respiratory, cardiac, and vasomotor centers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndromes:\u003c/b\u003e [[4af9a67d|"
      }, {
        "text": "Medial Medullary Syndrome]] (ASA occlusion) and Lateral Medullary (Wallenberg) Syndrome (PICA occlusion).\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eMedulla Oblongata\u003c/b\u003e is the critical life-support"
      }, {
        "text": " center of the brainstem, housing the autonomic nuclei that control breathing and heart rate, and serving as the major conduit for motor"
      }, {
        "text": " and sensory tracts between the brain and spinal cord.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \""
      }, {
        "text": "brainstem\"\n      },\n      {\n        \"type\": \"develops_from\",\n        \"to"
      }, {
        "text": "\": \"c8030560\"\n      },\n      {\n        \"type\": \"contains_nucle"
      }, {
        "text": "i_of\",\n        \"to\": \"97e2c817\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"contains_nuclei_of\",\n        \"to\": \"7c12e7a"
      }, {
        "text": "3\"\n      },\n      {\n        \"type\": \"contains_nuclei_of\",\n        \"to"
      }, {
        "text": "\": \"f218aebf\"\n      },\n      {\n        \"type\": \"contains_"
      }, {
        "text": "nuclei_of\",\n        \"to\": \"hypoglossal_nerve\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"16d613bb\": {\n    \"title\": \"Medulloblastoma\",\n    \""
      }, {
        "text": "primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Ped"
      }, {
        "text": "iatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eMedulloblastoma\u003c/b\u003e is a highly malignant primary"
      }, {
        "text": " brain tumor that arises in the cerebellum and is the most common malignant brain tumor in childhood.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Exclusively occurs in the cerebellum. In children, it typically arises in the cerebellar"
      }, {
        "text": " \u003cmark\u003evermis\u003c/mark\u003e (midline).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A midline location leads to \u003cmark\u003etrun"
      }, {
        "text": "cal ataxia\u003c/mark\u003e (unsteady gait). The tumor can compress the fourth ventricle, causing obstructive [[0bc2"
      }, {
        "text": "f200|hydrocephalus]] with symptoms of increased ICP (headache, vomiting, [[4ae21"
      }, {
        "text": "9da|papilledema]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetastasis:\u003c/b\u003e These tumors are known to spread through the cerebrospinal fluid, causing"
      }, {
        "text": " \u003cmark\u003e\\\"drop metastases\\\"\u003c/mark\u003e to the spinal cord, which can present as back pain or radiculopathy.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eHistology:\u003c/b\u003e A type of primitive neuroectodermal tumor (PNET), it is composed of small, round"
      }, {
        "text": ", blue cells. A characteristic finding is the formation of \u003cmark\u003eHomer-Wright rosettes\u003c/mark\u003e, where"
      }, {
        "text": " tumor cells arrange themselves in a circle around a central space filled with neuropil. It is synaptophysin-positive.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e A child with truncal ataxia and signs of hydrocephalus should make you think of a medulloblastoma. The presence"
      }, {
        "text": " of Homer-Wright rosettes on histology is pathognomonic.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Medulloblastoma\u003c/b\u003e is an aggressive pediatric cerebellar tumor whose midline location leads to truncal ataxia and obstructive hydrocephalus, and its"
      }, {
        "text": " propensity to seed the CSF can lead to \u0027drop metastases\u0027 along the spinal cord.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"childhood_brain_tumor\"\n      },\n      {\n        \"type\": \"is_located_in\",\n"
      }, {
        "text": "        \"to\": \"cerebellum\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"4"
      }, {
        "text": "fab8000\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        "
      }, {
        "text": "\"to\": \"homer_wright_rosettes\"\n      }\n    ]\n  },\n  \"4ee"
      }, {
        "text": "4b218\": {\n    \"title\": \"Meissner\u0027s Corpuscles\",\n    \"primaryType"
      }, {
        "text": "\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Dermatology\",\n      \"Anatomy"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n"
      }, {
        "text": "      \"Anatomy and Physiology\",\n      \"Sensory System\"\n    ],\n    \"content\": {\n"
      }, {
        "text": "      \"definition\": \"\u003cp\u003e\u003cb\u003eMeissner\u0027s corpuscles\u003c/b\u003e are encapsulated sensory receptors located in the dermal papillae of the skin"
      }, {
        "text": " that are specialized to detect light, discriminative touch and low-frequency vibration.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure"
      }, {
        "text": ":\u003c/b\u003e Small, encapsulated nerve endings located in the dermal papillae, just beneath the epidermis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e They are \u003c"
      }, {
        "text": "mark\u003erapidly adapting\u003c/mark\u003e mechanoreceptors, meaning they respond to changes in stimuli (e.g., initial"
      }, {
        "text": " contact with an object, movement of textures across the skin) rather than sustained pressure. This makes them crucial for discriminative touch,"
      }, {
        "text": " such as reading Braille or detecting slip.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Abundant in glabrous (hairless) skin, such as the"
      }, {
        "text": " fingertips, palms, soles, and lips.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNerve Fibers:\u003c/b\u003e Transmitted by large, myel"
      }, {
        "text": "inated AŒ≤ fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Signals travel via the [[e7f5cbbe|dorsal column-medial"
      }, {
        "text": " lemniscus pathway]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Associate rapidly adapting receptors with dynamic qualities. Meissner\u0027s corpuscles \u003d"
      }, {
        "text": " light touch/texture changes. Pacinian corpuscles \u003d high-frequency vibration.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eMeissner\u0027s corpuscles\u003c/b\u003e are the skin\u0027s fine-tuned motion detectors, rapidly adapting to provide"
      }, {
        "text": " the brain with detailed information about the texture and movement of objects across the skin, essential for tasks requiring fine tactile discrimination.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"senses\",\n        \"to\": \""
      }, {
        "text": "fine_touch\"\n      },\n      {\n        \"type\": \"is_a_type_of\","
      }, {
        "text": "\n        \"to\": \"mechanoreceptor\"\n      },\n      {\n        \"type\": \"signal_is"
      }, {
        "text": "_transmitted_via\",\n        \"to\": \"e7f5cbbe\"\n      }\n    ]\n  "
      }, {
        "text": "}\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"73ace357\",\n    \"letter\": \"L\",\n    \"term\": \"Limbic system\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Limbic system\",\n    \"sub_entries\": [\n      {\n        \"id\": \"c15bb57c\",\n        \"letter\": \"L\",\n        \"term\": \"behavior modulation\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Limbic system \u003e behavior modulation\"\n      },\n      {\n        \"id\": \"537e06d8\",\n        \"letter\": \"L\",\n        \"term\": \"structures and function of\",\n        \"pages\": [\n          \"509\"\n        ],\n        \"context\": \"Limbic system \u003e structures and function of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"4945aa8c\",\n    \"letter\": \"L\",\n    \"term\": \"Liquefactive necrosis\",\n    \"pages\": [\n      \"205\",\n      \"525\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Liquefactive necrosis\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"a3b7b1fc\",\n    \"letter\": \"L\",\n    \"term\": \"Lisch nodules\",\n    \"pages\": [\n      \"539\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Lisch nodules\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"cedfe2d8\",\n    \"letter\": \"L\",\n    \"term\": \"Lissencephaly\",\n    \"pages\": [\n      \"501\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Lissencephaly\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"e5839320\",\n    \"letter\": \"L\",\n    \"term\": \"Livedo reticularis\",\n    \"pages\": [\n      \"306\",\n      \"563\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Livedo reticularis\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"b14c0eef\",\n    \"letter\": \"L\",\n    \"term\": \"Local anesthetics\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Local anesthetics\",\n    \"sub_entries\": [\n      {\n        \"id\": \"f449aff7\",\n        \"letter\": \"L\",\n        \"term\": \"adverse effects\",\n        \"pages\": [\n          \"565\"\n        ],\n        \"context\": \"Local anesthetics \u003e adverse effects\"\n      }\n    ]\n  },\n  {\n    \"id\": \"fea33248\",\n    \"letter\": \"L\",\n    \"term\": \"Locked-in syndrome\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Locked-in syndrome\",\n    \"sub_entries\": [\n      {\n        \"id\": \"a250d586\",\n        \"letter\": \"L\",\n        \"term\": \"stroke and\",\n        \"pages\": [\n          \"526\"\n        ],\n        \"context\": \"Locked-in syndrome \u003e stroke and\"\n      }\n    ]\n  },\n  {\n    \"id\": \"149a1cc8\",\n    \"letter\": \"L\",\n    \"term\": \"Locus coeruleus\",\n    \"pages\": [\n      \"505\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Locus coeruleus\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"0d8d64f9\",\n    \"letter\": \"L\",\n    \"term\": \"Loperamide\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Loperamide\",\n    \"sub_entries\": [\n      {\n        \"id\": \"04edba2e\",\n        \"letter\": \"L\",\n        \"term\": \"for diarrhea\",\n        \"pages\": [\n          \"567\"\n        ],\n        \"context\": \"Loperamide \u003e for diarrhea\"\n      }\n    ]\n  },\n  {\n    \"id\": \"b0bb0c47\",\n    \"letter\": \"L\",\n    \"term\": \"Lorazepam\",\n    \"pages\": [\n      \"562\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Lorazepam\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"d6a27754\",\n    \"letter\": \"L\",\n    \"term\": \"Lower motor neuron (LMN)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Lower motor neuron (LMN)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"8a8a73b2\",\n        \"letter\": \"L\",\n        \"term\": \"CN XII lesion\",\n        \"pages\": [\n          \"546\"\n        ],\n        \"context\": \"Lower motor neuron (LMN) \u003e CN XII lesion\"\n      },\n      {\n        \"id\": \"70cea082\",\n        \"letter\": \"L\",\n        \"term\": \"effects of injury\",\n        \"pages\": [\n          \"543\"\n        ],\n        \"context\": \"Lower motor neuron (LMN) \u003e effects of injury\"\n      },\n      {\n        \"id\": \"dd19e278\",\n        \"letter\": \"L\",\n        \"term\": \"facial nerve lesion\",\n        \"pages\": [\n          \"546\"\n        ],\n        \"context\": \"Lower motor neuron (LMN) \u003e facial nerve lesion\"\n      },\n      {\n        \"id\": \"f4511a25\",\n        \"letter\": \"L\",\n        \"term\": \"facial paralysis\",\n        \"pages\": [\n          \"526\"\n        ],\n        \"context\": \"Lower motor neuron (LMN) \u003e facial paralysis\"\n      },\n      {\n        \"id\": \"ab85237d\",\n        \"letter\": \"L\",\n        \"term\": \"in amyotrophic lateral sclerosis\",\n        \"pages\": [\n          \"544\"\n        ],\n        \"context\": \"Lower motor neuron (LMN) \u003e in amyotrophic lateral sclerosis\"\n      },\n      {\n        \"id\": \"9ee0c3f1\",\n        \"letter\": \"L\",\n        \"term\": \"lesion signs in\",\n        \"pages\": [\n          \"543\"\n        ],\n        \"context\": \"Lower motor neuron (LMN) \u003e lesion signs in\"\n      },\n      {\n        \"id\": \"6b6658d0\",\n        \"letter\": \"L\",\n        \"term\": \"pathways for\",\n        \"pages\": [\n          \"522\"\n        ],\n        \"context\": \"Lower motor neuron (LMN) \u003e pathways for\"\n      }\n    ]\n  },\n  {\n    \"id\": \"8e9c257a\",\n    \"letter\": \"L\",\n    \"term\": \"Lumbar puncture\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Lumbar puncture\",\n    \"sub_entries\": [\n      {\n        \"id\": \"31e01d57\",\n        \"letter\": \"L\",\n        \"term\": \"hypertension\",\n        \"pages\": [\n          \"536\"\n        ],\n        \"context\": \"Lumbar puncture \u003e hypertension\"\n      },\n      {\n        \"id\": \"243a1945\",\n        \"letter\": \"L\",\n        \"term\": \"in hydrocephalus\",\n        \"pages\": [\n          \"536\"\n        ],\n        \"context\": \"Lumbar puncture \u003e in hydrocephalus\"\n      },\n      {\n        \"id\": \"e4b3bd37\",\n        \"letter\": \"L\",\n        \"term\": \"site for\",\n        \"pages\": [\n          \"520\"\n        ],\n        \"context\": \"Lumbar puncture \u003e site for\"\n      }\n    ]\n  },\n  {\n    \"id\": \"b25863e1\",\n    \"letter\": \"M\",\n    \"term\": \"Macula (eye), age-related\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Macula (eye), age-related\",\n    \"sub_entries\": [\n      {\n        \"id\": \"f8353378\",\n        \"letter\": \"M\",\n        \"term\": \"degeneration of\",\n        \"pages\": [\n          \"552\"\n        ],\n        \"context\": \"Macula (eye), age-related \u003e degeneration of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"8e004ef5\",\n    \"letter\": \"M\",\n    \"term\": \"Magnesium sulfate\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Magnesium sulfate\",\n    \"sub_entries\": [\n      {\n        \"id\": \"81a8aa0a\",\n        \"letter\": \"M\",\n        \"term\": \"for cerebral palsy\",\n        \"pages\": [\n          \"545\"\n        ],\n        \"context\": \"Magnesium sulfate \u003e for cerebral palsy\"\n      }\n    ]\n  },\n  {\n    \"id\": \"0c159af1\",\n    \"letter\": \"M\",\n    \"term\": \"Magnetic gait\",\n    \"pages\": [\n      \"536\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Magnetic gait\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 2418
    }, {
      "text": "```json\n{\n  \"73ace357\": {\n    \"title\": \"Limbic System\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Limbic System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eLimbic System\u003c/b\u003e is a complex set of brain structures located on both sides of the thalamus, immediately beneath the cerebrum. It is involved in emotion, long-term memory, olfaction, behavior modulation, and autonomic nervous system function.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey Structures:\u003c/b\u003e Includes the hippocampus, [[d220fc3f|amygdala]], [[f02cfaa1|mammillary bodies]], anterior thalamic nuclei, cingulate gyrus, and entorhinal cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunctions (The 5 F\u0027s):\u003c/b\u003e Responsible for \u003cb\u003eF\u003c/b\u003eeeding, \u003cb\u003eF\u003c/b\u003eleeing, \u003cb\u003eF\u003c/b\u003eighting, \u003cb\u003eF\u003c/b\u003eeeling (emotion), and sexual behavior (\u003cb\u003eF\u003c/b\u003eornication).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePapez Circuit:\u003c/b\u003e A major pathway within the limbic system involved in memory and emotion, connecting the hippocampus -\u003e mammillary bodies -\u003e anterior thalamic nucleus -\u003e cingulate gyrus -\u003e hippocampus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKl√ºver-Bucy Syndrome:\u003c/b\u003e Results from bilateral lesions of the [[d220fc3f|amygdala]], leading to disinhibited behaviors like hyperorality, hypersexuality, and hyperphagia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eWernicke-Korsakoff Syndrome:\u003c/b\u003e Caused by thiamine deficiency, leading to damage of the [[f02cfaa1|mammillary bodies]] and thalamus, resulting in severe amnesia and confabulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Associate the hippocampus with memory formation, the amygdala with fear/emotion, and the mammillary bodies with memory deficits in alcoholism.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eLimbic System\u003c/b\u003e forms the brain\u0027s emotional core, integrating memory, sensory input, and autonomic responses to generate our fundamental drives and emotional experiences. Its dysfunction underlies a range of psychiatric and neurological disorders.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"hippocampus\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"d220fc3f\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"f02cfaa1\"\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"kluver_bucy_syndrome\"\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"wernicke_korsakoff_syndrome\"\n      }\n    ]\n  },\n  \"4945aa8c\": {\n    \"title\": \"Liquefactive Necrosis\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Pathology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cellular Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLiquefactive necrosis\u003c/b\u003e is a type of necrosis in which the dead tissue is transformed into a liquid, viscous mass. It is characteristic of focal bacterial or fungal infections and hypoxic death of cells within the central nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Occurs in tissues with high lipid content and few connective tissue fibers, or in the context of infections with pyogenic bacteria. Enzymatic digestion of the dead cells by hydrolytic enzymes from neutrophils (in abscesses) or by the cells\u0027 own lysosomes (in CNS ischemia) predominates over protein denaturation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCentral Nervous System:\u003c/b\u003e This is the characteristic type of necrosis seen in the brain following an \u003cmark\u003eischemic stroke\u003c/mark\u003e. Microglial cells (the CNS macrophages) release hydrolytic enzymes that digest the necrotic tissue, eventually forming a fluid-filled cystic space.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBacterial Infections:\u003c/b\u003e Also characteristic of abscess formation, where neutrophils release enzymes that liquefy the tissue, forming pus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGross Appearance:\u003c/b\u003e The affected area becomes soft, liquid, and creamy yellow (due to dead leukocytes in pus) or a fluid-filled cavity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For the brain, the answer to \u0027what type of necrosis occurs after an ischemic event?\u0027 is \u003cu\u003ealways\u003c/u\u003e liquefactive necrosis. For most other organs (e.g., heart, kidney), the answer is coagulative necrosis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLiquefactive necrosis\u003c/b\u003e is the result of enzymatic digestion overwhelming protein denaturation, a process that uniquely occurs in the lipid-rich, low-collagen environment of the brain, turning an area of ischemic stroke into a fluid-filled cyst.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"necrosis\"\n      },\n      {\n        \"type\": \"occurs_in\",\n        \"to\": \"ischemic_stroke\"\n      },\n      {\n        \"type\": \"occurs_in\",\n        \"to\": \"bacterial_abscess\"\n      },\n      {\n        \"type\": \"is_contrasted_with\",\n        \"to\": \"coagulative_necrosis\"\n      }\n    ]\n  },\n  \"a3b7b1fc\": {\n    \"title\": \"Lisch Nodules\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Genetics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physical Findings\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLisch nodules\u003c/b\u003e are benign, pigmented hamartomas of the iris that are a pathognomonic feature of \u003ci\u003eNeurofibromatosis Type 1 (NF1)\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e Well-defined, dome-shaped, gelatinous masses on the surface of the iris. They are typically tan or brown in color.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDetection:\u003c/b\u003e Best visualized with a slit-lamp examination. They are not usually visible to the naked eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Their presence is one of the key diagnostic criteria for [[015a73ab|Neurofibromatosis Type 1]]. They are found in over 90% of adult patients with NF1.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e They are melanocytic hamartomas, representing a benign proliferation of melanocytes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImpact on Vision:\u003c/b\u003e Lisch nodules themselves do \u003cu\u003enot\u003c/u\u003e affect vision and are asymptomatic. Their importance is purely diagnostic.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of Lisch nodules in a patient with caf√©-au-lait spots and cutaneous neurofibromas is diagnostic for NF1.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLisch nodules\u003c/b\u003e are the ocular hallmark of Neurofibromatosis Type 1; while visually insignificant themselves, their presence on a slit-lamp exam is a powerful and specific clue to the systemic genetic diagnosis.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \"to\": \"015a73ab\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"hamartoma\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"iris\"\n      }\n    ]\n  },\n  \"cedfe2d8\": {\n    \"title\": \"Lissencephaly\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pediatrics\",\n      \"Embryology\",\n      \"Genetics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Brain Malformations\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLissencephaly\u003c/b\u003e, meaning \\\"smooth brain,\\\" is a rare congenital brain malformation characterized by the absence of normal gyri (folds) and sulci (grooves) of the cerebral cortex, resulting in a smooth or nearly smooth brain surface.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by a failure of neuronal migration during embryonic development (weeks 12-24). Neurons fail to migrate from the ventricular zone to the cortical plate, leading to a thickened cortex with only a few poorly formed layers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Can be caused by mutations in several genes involved in neuronal migration, such as \u003ci\u003eLIS1\u003c/i\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Infants present with severe neurological impairment, including profound intellectual disability, developmental delay, seizures (often infantile spasms), and feeding difficulties. Microcephaly and facial anomalies may be present.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e MRI or CT shows a smooth cortical surface (agyria) or a brain with very few, wide gyri (pachygyria).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The term \\\"smooth brain\\\" is the key descriptor for lissencephaly. It represents a severe defect in neuronal migration.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLissencephaly\u003c/b\u003e is a devastating brain malformation where the failure of neurons to complete their journey to the cortex during development results in a smooth, unfolded brain, leading to severe and widespread neurological dysfunction.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"brain_malformation\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"failure_of_neuronal_migration\"\n      }\n    ]\n  },\n  \"e5839320\": {\n    \"title\": \"Livedo Reticularis\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Dermatology\",\n      \"Rheumatology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Musculoskeletal, Skin, and Connective Tissue\",\n      \"Dermatology\",\n      \"Vascular Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLivedo reticularis\u003c/b\u003e is a skin finding characterized by a mottled, purplish, lace-like or net-like pattern on the skin, caused by swelling of the venules due to obstruction of capillaries by small blood clots or sluggish blood flow.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The pattern reflects the underlying cutaneous microvasculature. The pale central areas correspond to the core of a vascular territory supplied by an arteriole, while the violaceous borders represent areas of deoxygenated, stagnant blood in the surrounding venules.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysiological Cause:\u003c/b\u003e Can be a normal, transient response to cold (cutis marmorata).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathological Causes:\u003c/b\u003e Can be a sign of an underlying systemic disease, including:\u003cbr\u003e - \u003cb\u003eVasculitis:\u003c/b\u003e Polyarteritis nodosa.\u003cbr\u003e - \u003cb\u003eThromboembolic states:\u003c/b\u003e Antiphospholipid syndrome, cholesterol emboli syndrome.\u003cbr\u003e - \u003cb\u003eSepsis\u003c/b\u003e or other causes of shock.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrug-Induced:\u003c/b\u003e A characteristic side effect of the drug \u003cmark\u003eamantadine\u003c/mark\u003e, used in [[58c8ea03|Parkinson disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e While it can be benign, the appearance of livedo reticularis in a patient with systemic symptoms should prompt a workup for vasculitis or a hypercoagulable state. Its association with amantadine is a classic board question.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLivedo reticularis\u003c/b\u003e is a cutaneous map of microvascular compromise; its lace-like pattern visually represents areas of sluggish venous blood flow, serving as a potential clue to underlying systemic vascular or hematologic disease.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_an_adverse_effect_of\",\n        \"to\": \"9c9679ea\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"antiphospholipid_syndrome\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"polyarteritis_nodosa\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"cholesterol_emboli_syndrome\"\n      }\n    ]\n  },\n  \"b14c0eef\": {\n    \"title\": \"Local Anesthetics\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLocal anesthetics\u003c/b\u003e are drugs that reversibly block nerve conduction in a specific area of the body, producing a transient loss of sensation (analgesia) without loss of consciousness.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Block voltage-gated \u003cmark\u003eNa\u003csup\u003e+\u003c/sup\u003e channels\u003c/mark\u003e from the intracellular side of the nerve membrane. They preferentially bind to activated and inactivated channels, making them more effective on rapidly firing neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eChemistry:\u003c/b\u003e Are weak bases. They must be in their uncharged form to cross the nerve membrane, then become charged intracellularly to bind the Na\u003csup\u003e+\u003c/sup\u003e channel. They are less effective in infected (acidic) tissue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClasses:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eAmides:\u003c/b\u003e L\u003cb\u003ei\u003c/b\u003edoca\u003cb\u003ei\u003c/b\u003ene, bup\u003cb\u003ei\u003c/b\u003evaca\u003cb\u003ei\u003c/b\u003ene, mep\u003cb\u003ei\u003c/b\u003evaca\u003cb\u003ei\u003c/b\u003ene (have 2 \u0027i\u0027s in the name). Metabolized by the liver.\u003cbr\u003e - \u003cb\u003eEsters:\u003c/b\u003e Proca\u003cb\u003ei\u003c/b\u003ene, coca\u003cb\u003ei\u003c/b\u003ene, benzoca\u003cb\u003ei\u003c/b\u003ene (have 1 \u0027i\u0027 in the name). Metabolized by plasma pseudocholinesterases. Allergic reactions are more common with esters.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOrder of Blockade:\u003c/b\u003e Small, myelinated fibers (AŒ¥, pain/temp) are blocked first, followed by small unmyelinated (C, dull pain), and finally large myelinated fibers (AŒ≤, touch/pressure).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Systemic toxicity can cause CNS excitation (seizures) and cardiovascular toxicity (arrhythmias, hypotension). Bupivacaine is severely cardiotoxic. Benzocaine can cause [[b7808532|methemoglobinemia]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLocal anesthetics\u003c/b\u003e work by blocking the sodium channels that are essential for nerve impulse propagation. Their effectiveness is governed by a use-dependent blockade, making them more potent on nerves that are actively transmitting pain signals.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"blocks\",\n        \"to\": \"sodium_channels\"\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"amide_anesthetic\"\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"ester_anesthetic\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"b7808532\"\n      }\n    ]\n  },\n  \"fea33248\": {\n    \"title\": \"Locked-in Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Vascular\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brainstem Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLocked-in syndrome\u003c/b\u003e is a rare neurological state of quadriplegia and anarthria (inability to speak) in which a patient is fully conscious and aware but is unable to move or communicate, with the exception of vertical eye movements and blinking.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Classically caused by an ischemic stroke affecting the \u003cmark\u003eventral pons\u003c/mark\u003e, typically due to occlusion of the \u003cmark\u003ebasilar artery\u003c/mark\u003e. Other causes include trauma, tumors, or [[7a680d3d|osmotic demyelination syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The lesion damages the bilateral corticospinal and corticobulbar tracts in the ventral pons, resulting in complete paralysis of all voluntary muscles except for those controlling vertical eye movements and blinking.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpared Structures:\u003c/b\u003e The reticular activating system (responsible for consciousness) and the oculomotor pathways for vertical gaze (located more dorsally in the midbrain) are spared.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e The patient is awake and alert but completely paralyzed and mute. Communication is possible only through eye movements or blinking.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient who is quadriplegic and mute but can communicate by blinking has locked-in syndrome. The lesion is in the ventral pons.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLocked-in syndrome\u003c/b\u003e represents a profound disconnection between a conscious mind and a paralyzed body, resulting from a specific lesion in the ventral pons that severs all motor output pathways while sparing the ascending systems for consciousness.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Basilar Artery Occlusion] --\u003e B(Ventral Pons Infarct); B --\u003e C(Damage to Corticospinal \u0026 Corticobulbar Tracts); C --\u003e D(Quadriplegia \u0026 Anarthria); B --Spares--\u003e E(Reticular Activating System); E --\u003e F(Intact Consciousness);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"bf549b2f\"\n      },\n      {\n        \"type\": \"is_caused_by_occlusion_of\",\n        \"to\": \"basilar_artery\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"7a680d3d\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"persistent_vegetative_state\"\n      }\n    ]\n  },\n  \"149a1cc8\": {\n    \"title\": \"Locus Coeruleus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eLocus Coeruleus\u003c/b\u003e is a nucleus in the pons of the brainstem that is the principal site for synthesizing the neurotransmitter \u003ci\u003enorepinephrine (NE)\u003c/i\u003e for the central nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Located in the posterior pons, near the floor of the fourth ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter:\u003c/b\u003e The primary source of [[aedeee6d|norepinephrine]] for the brain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProjections:\u003c/b\u003e Sends widespread noradrenergic projections throughout the CNS, including the cortex, thalamus, hypothalamus, limbic system, cerebellum, and spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Plays a crucial role in the stress response, arousal, attention, and sleep-wake cycles. It is a key component of the ascending reticular activating system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Dysfunction of the locus coeruleus is implicated in anxiety disorders (hyperactivity) and depression (hypoactivity). Loss of neurons in the locus coeruleus is also seen in [[58c8ea03|Parkinson disease]] and [[77ae6148|Alzheimer disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Associate the locus coeruleus with norepinephrine, arousal, and the stress/panic response.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eLocus Coeruleus\u003c/b\u003e acts as the brain\u0027s \u0027alarm system,\u0027 broadcasting norepinephrine throughout the CNS to promote vigilance and arousal in response to novel or stressful stimuli.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"produces\",\n        \"to\": \"aedeee6d\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"bf549b2f\"\n      },\n      {\n        \"type\": \"is_implicated_in\",\n        \"to\": \"anxiety_disorders\"\n      },\n      {\n        \"type\": \"is_implicated_in\",\n        \"to\": \"depression\"\n      }\n    ]\n  },\n  \"0d8d64f9\": {\n    \"title\": \"Loperamide\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Gastroenterology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Gastrointestinal\",\n      \"Pharmacology\",\n      \"Antidiarrheals\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLoperamide\u003c/b\u003e is an over-the-counter synthetic \u003ci\u003eopioid agonist\u003c/i\u003e used for the symptomatic treatment of diarrhea. It acts on Œº-opioid receptors in the gastrointestinal tract to decrease motility.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Agonist at Œº-opioid receptors in the myenteric plexus of the large intestine. This inhibits presynaptic cholinergic nerves, leading to decreased smooth muscle activity and increased transit time. It also increases anal sphincter tone.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e It does not cross the [[dd47b9cc|blood-brain barrier]] in therapeutic doses due to being a substrate of P-glycoprotein efflux pumps. This lack of central effects means it has very low abuse potential.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Symptomatic treatment of acute, non-invasive diarrhea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Constipation, cramping, and nausea. At very high doses (as seen in abuse), it can overcome the P-glycoprotein pump, leading to CNS depression and cardiotoxicity (QT prolongation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Loperamide is an opioid that treats diarrhea but doesn\u0027t cause euphoria or analgesia because it doesn\u0027t cross the blood-brain barrier.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLoperamide\u003c/b\u003e is a peripherally restricted opioid that effectively treats diarrhea by activating Œº-receptors in the gut to slow motility, without producing the central analgesic or euphoric effects of other opioids.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"diarrhea\"\n      },\n      {\n        \"type\": \"is_an_agonist_at\",\n        \"to\": \"mu_opioid_receptor\"\n      },\n      {\n        \"type\": \"does_not_cross\",\n        \"to\": \"dd47b9cc\"\n      }\n    ]\n  },\n  \"b0bb0c47\": {\n    \"title\": \"Lorazepam\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Anxiolytics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLorazepam\u003c/b\u003e is an intermediate-acting \u003ci\u003ebenzodiazepine\u003c/i\u003e with potent anxiolytic, sedative, and anticonvulsant properties, commonly used for anxiety, insomnia, and status epilepticus.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Facilitates the action of [[5aa5cb91|GABA]] at the GABA\u003csub\u003eA\u003c/sub\u003e receptor, increasing the \u003cmark\u003efrequency\u003c/mark\u003e of Cl\u003csup\u003e-\u003c/sup\u003e channel opening and causing CNS depression.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetabolism:\u003c/b\u003e Undergoes direct glucuronidation in the liver, making its metabolism less dependent on the cytochrome P450 system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e First-line treatment for \u003cmark\u003estatus epilepticus\u003c/mark\u003e. Also used for anxiety disorders, sedation in the ICU, and management of alcohol withdrawal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSafe in Liver Disease:\u003c/b\u003e Along with Oxazepam and Temazepam, Lorazepam is a preferred benzodiazepine in patients with severe liver disease. Mnemonic: \u003cb\u003eO\u003c/b\u003eutside \u003cb\u003eT\u003c/b\u003ehe \u003cb\u003eL\u003c/b\u003eiver (\u003cb\u003eO\u003c/b\u003exazepam, \u003cb\u003eT\u003c/b\u003eemazepam, \u003cb\u003eL\u003c/b\u003eorazepam).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Lorazepam is the IV benzodiazepine of choice for terminating an active seizure in status epilepticus due to its rapid onset and relatively long duration of action in the CNS.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLorazepam\u003c/b\u003e is a versatile benzodiazepine that is a first-line agent for the emergency treatment of status epilepticus and is also a safer choice in patients with liver failure due to its direct glucuronidation metabolism.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"14464617\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"status_epilepticus\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"anxiety_disorders\"\n      },\n      {\n        \"type\": \"is_safer_in\",\n        \"to\": \"liver_disease\"\n      }\n    ]\n  },\n  \"d6a27754\": {\n    \"title\": \"Lower Motor Neuron (LMN)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Motor System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eLower Motor Neuron (LMN)\u003c/b\u003e is a motor neuron whose cell body is located in the anterior horn of the spinal cord or in a brainstem cranial nerve nucleus, and whose axon directly innervates skeletal muscle fibers.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Serves as the final common pathway for all motor output from the CNS to the muscles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLMN Lesion Signs:\u003c/b\u003e Damage to LMNs results in a characteristic set of signs in the affected muscles. Mnemonic: Everything is \u003cb\u003eL\u003c/b\u003eowered. \u003cbr\u003e - \u003cmark\u003eFlaccid paralysis\u003c/mark\u003e or weakness (paresis).\u003cbr\u003e - Significant \u003cmark\u003emuscle atrophy\u003c/mark\u003e.\u003cbr\u003e - \u003cmark\u003eFasciculations\u003c/mark\u003e (involuntary muscle twitches).\u003cbr\u003e - \u003cmark\u003eHyporeflexia\u003c/mark\u003e or areflexia (decreased or absent deep tendon reflexes).\u003cbr\u003e - Decreased muscle tone (hypotonia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses of LMN Lesions:\u003c/b\u003e [[75f2b918|Poliomyelitis]], [[e6820b7f|spinal muscular atrophy]], [[4ed629f9|amyotrophic lateral sclerosis (ALS)]], trauma to peripheral nerves, and [[ed52e40b|Guillain-Barr√© syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFacial Nerve Lesion:\u003c/b\u003e An LMN lesion of CN VII (e.g., Bell\u0027s palsy) causes ipsilateral paralysis of the \u003cu\u003eentire\u003c/u\u003e half of the face, including the forehead.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of fasciculations and significant atrophy are strong indicators of an LMN lesion.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eLower Motor Neuron\u003c/b\u003e is the direct and final link between the central nervous system and a muscle fiber; its destruction severs this link, leading to a complete loss of voluntary and reflex activity in the muscle, resulting in flaccid paralysis and profound atrophy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_contrasted_with\",\n        \"to\": \"upper_motor_neuron\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"flaccid_paralysis\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"fasciculations\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"75f2b918\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"4ed629f9\"\n      }\n    ]\n  },\n  \"8e9c257a\": {\n    \"title\": \"Lumbar Puncture (Spinal Tap)\",\n    \"primaryType\": \"procedure\",\n    \"tags\": [\n      \"Neurology\",\n      \"Infectious Disease\",\n      \"Diagnostics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Diagnostic Procedures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003elumbar puncture (LP)\u003c/b\u003e, or spinal tap, is a diagnostic and sometimes therapeutic procedure used to collect a sample of cerebrospinal fluid (CSF) for analysis by inserting a needle into the subarachnoid space of the lumbar spine.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eIndications:\u003c/b\u003e Primarily used to diagnose infections of the CNS (e.g., meningitis, encephalitis), [[63f8b05f|subarachnoid hemorrhage]], inflammatory conditions (e.g., [[45dd6d19|MS]]), and to measure intracranial pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnatomical Landmark:\u003c/b\u003e The needle is inserted between the L3/L4 or L4/L5 vertebral interspaces to avoid injuring the spinal cord, which typically ends at the L1/L2 level in adults. A line drawn between the iliac crests approximates the L4 vertebral body.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLayers Pierced:\u003c/b\u003e Skin ‚Üí Supraspinous ligament ‚Üí Interspinous ligament ‚Üí Ligamentum flavum ‚Üí Epidural space ‚Üí Dura mater ‚Üí Arachnoid mater ‚Üí Subarachnoid space. The pia mater is \u003cu\u003enot\u003c/u\u003e pierced.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOpening Pressure:\u003c/b\u003e Measurement of CSF pressure at the start of the procedure. It is elevated in conditions like bacterial/fungal meningitis and [[7c59030e|normal pressure hydrocephalus]] (intermittently).\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindications:\u003c/b\u003e A major contraindication is evidence of significantly increased ICP with mass effect (e.g., brain tumor, large abscess) due to the risk of cerebral herniation. A head CT is often performed prior to LP if there are focal neurological signs or papilledema.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003elumbar puncture\u003c/b\u003e is a fundamental neurological procedure that provides direct access to the cerebrospinal fluid, offering invaluable diagnostic information about infectious, inflammatory, and hemorrhagic conditions affecting the central nervous system.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_used_to_diagnose\",\n        \"to\": \"meningitis\"\n      },\n      {\n        \"type\": \"is_used_to_diagnose\",\n        \"to\": \"63f8b05f\"\n      },\n      {\n        \"type\": \"is_used_to_diagnose\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"is_contraindicated_in\",\n        \"to\": \"cerebral_herniation_risk\"\n      }\n    ]\n  },\n  \"b25863e1\": {\n    \"title\": \"Age-Related Macular Degeneration (AMD)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Geriatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAge-related macular degeneration (AMD)\u003c/b\u003e is a progressive neurodegenerative disease of the macula, the central part of the retina, leading to the loss of central, high-acuity vision. It is a leading cause of irreversible blindness in older adults.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDry (Atrophic) AMD:\u003c/b\u003e Most common form (~80%). Characterized by the slow, progressive atrophy of the retinal pigment epithelium (RPE) and photoreceptors. The hallmark finding is the presence of \u003cmark\u003edrusen\u003c/mark\u003e, which are yellow extracellular deposits between Bruch\u0027s membrane and the RPE.\u003c/li\u003e\u003cli\u003e\u003cb\u003eWet (Exudative) AMD:\u003c/b\u003e Less common but more severe. Characterized by the growth of abnormal new blood vessels from the choroid (choroidal neovascularization) that break through Bruch\u0027s membrane. These vessels leak fluid and blood, causing rapid and severe central vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients experience gradual (dry) or rapid (wet) loss of central vision (central scotoma). A key symptom of wet AMD is \u003cmark\u003emetamorphopsia\u003c/mark\u003e (straight lines appear wavy).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Dry AMD is managed with antioxidant vitamins and zinc (AREDS formula) to slow progression. Wet AMD is treated with intravitreal injections of \u003cmark\u003eanti-VEGF\u003c/mark\u003e agents (e.g., ranibizumab, bevacizumab) to inhibit neovascularization.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate the two types: Dry AMD \u003d Drusen and gradual vision loss. Wet AMD \u003d Neovascularization, hemorrhage, and rapid vision loss.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAge-related macular degeneration\u003c/b\u003e is a disease of the central retina where the \u0027dry\u0027 form involves the slow accumulation of metabolic debris (drusen), while the \u0027wet\u0027 form involves an aggressive, sight-threatening invasion of leaky new blood vessels, which can be targeted with anti-VEGF therapy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"affects\",\n        \"to\": \"macula\"\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"dry_amd\"\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"wet_amd\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"central_scotoma\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"dd062acc\"\n      }\n    ]\n  },\n  \"8e004ef5\": {\n    \"title\": \"Magnesium Sulfate for Cerebral Palsy\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Obstetrics\",\n      \"Pediatrics\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Reproductive\",\n      \"Pharmacology\",\n      \"Obstetric Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eAntenatal administration of \u003cb\u003emagnesium sulfate\u003c/b\u003e to mothers at high risk for preterm delivery before 32 weeks\u0027 gestation is a neuroprotective strategy shown to reduce the risk and severity of \u003ci\u003ecerebral palsy\u003c/i\u003e in surviving infants.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eIndication:\u003c/b\u003e Administered to pregnant women at risk of imminent preterm birth, typically between 24 and 32 weeks of gestation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Neuroprotection:\u003c/b\u003e The exact mechanism is not fully understood but is thought to involve several pathways: \u003cbr\u003e - Reduction of inflammatory cytokines.\u003cbr\u003e - Blockade of NMDA receptors, reducing excitotoxic injury.\u003cbr\u003e - Increased cerebral blood flow and antioxidant effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrimary Outcome:\u003c/b\u003e Reduces the risk of moderate to severe [[171ca00b|cerebral palsy]] in the offspring. It does not prevent preterm birth itself.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Obstetric Uses:\u003c/b\u003e Magnesium sulfate is also the first-line treatment for seizure prophylaxis in preeclampsia and eclampsia, and as a tocolytic to temporarily suppress preterm labor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the dual neuroprotective roles of magnesium sulfate in obstetrics: preventing seizures in the mother (preeclampsia) and reducing the risk of cerebral palsy in the preterm infant.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMagnesium sulfate\u003c/b\u003e serves as a powerful neuroprotectant for the vulnerable preterm brain; when given to the mother before an early delivery, it stabilizes the fetal brain\u0027s vasculature and neuronal environment, significantly lowering the odds of the child developing cerebral palsy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"reduces_risk_of\",\n        \"to\": \"171ca00b\"\n      },\n      {\n        \"type\": \"is_administered_during\",\n        \"to\": \"preterm_labor\"\n      },\n      {\n        \"type\": \"is_also_a_treatment_for\",\n        \"to\": \"eclampsia\"\n      }\n    ]\n  },\n  \"0c159af1\": {\n    \"title\": \"Magnetic Gait\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Geriatrics\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Gait Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMagnetic gait\u003c/b\u003e is a type of gait apraxia characterized by the appearance of the feet being \u0027stuck to the floor.\u0027 It is one of the cardinal features of \u003ci\u003eNormal Pressure Hydrocephalus (NPH)\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Patients have difficulty initiating walking despite having normal motor strength. They take slow, short, shuffling steps with a wide base. The feet appear to be \u0027glued\u0027 or \u0027magnetized\u0027 to the floor.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Believed to be caused by the stretching of the corona radiata fibers (specifically the sacral motor fibers that innervate the legs) by the enlarged lateral ventricles in [[7c59030e|Normal Pressure Hydrocephalus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Condition:\u003c/b\u003e It is the \u0027wobbly\u0027 component of the classic NPH triad: \\\"\u003cb\u003eW\u003c/b\u003eet, \u003cb\u003eW\u003c/b\u003eobbly, and \u003cb\u003eW\u003c/b\u003eacky\\\" (urinary incontinence, gait apraxia, and cognitive dysfunction).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction from Parkinsonian Gait:\u003c/b\u003e While both are shuffling, the magnetic gait of NPH is typically wide-based, and patients have difficulty lifting their feet. Parkinsonian gait is often narrow-based with festination (involuntary acceleration).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A wide-based, shuffling gait where the patient\u0027s feet seem stuck to the floor, in the context of dementia and incontinence, is highly specific for NPH.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMagnetic gait\u003c/b\u003e is a form of frontal gait apraxia that visually represents the difficulty in initiating movement seen in NPH; it is not a problem of strength or coordination but a failure of the cortical motor programming for walking, caused by ventricular enlargement.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \"to\": \"7c59030e\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"gait_apraxia\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"parkinsonian_gait\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9368,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"73ace357\": {\n    \"title\": \"L"
      }, {
        "text": "imbic System\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"An"
      }, {
        "text": "atomy\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Limbic System\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eLimbic System\u003c/b\u003e is a complex"
      }, {
        "text": " set of brain structures located on both sides of the thalamus, immediately beneath the cerebrum. It is involved in emotion"
      }, {
        "text": ", long-term memory, olfaction, behavior modulation, and autonomic nervous system function.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey Structures:\u003c/b\u003e Includes the hippocampus, [[d220fc3f|"
      }, {
        "text": "amygdala]], [[f02cfaa1|mammillary bodies]], anterior thalamic nuclei, cingulate g"
      }, {
        "text": "yrus, and entorhinal cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunctions (The 5 F\u0027s):\u003c/b\u003e Responsible for \u003cb\u003eF\u003c/b\u003eeeding,"
      }, {
        "text": " \u003cb\u003eF\u003c/b\u003eleeing, \u003cb\u003eF\u003c/b\u003eighting, \u003cb\u003eF\u003c/b\u003eeeling (emotion), and sexual"
      }, {
        "text": " behavior (\u003cb\u003eF\u003c/b\u003eornication).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePapez Circuit:\u003c/b\u003e A major pathway within the limbic system involved in memory and"
      }, {
        "text": " emotion, connecting the hippocampus -\u003e mammillary bodies -\u003e anterior thalamic nucleus -\u003e cingulate gyrus -\u003e hippocampus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eK"
      }, {
        "text": "l√ºver-Bucy Syndrome:\u003c/b\u003e Results from bilateral lesions of the [[d220fc3f|"
      }, {
        "text": "amygdala]], leading to disinhibited behaviors like hyperorality, hypersexuality, and hyperphagia.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eWernicke-Korsakoff Syndrome:\u003c/b\u003e Caused by thiamine deficiency, leading to damage of"
      }, {
        "text": " the [[f02cfaa1|mammillary bodies]] and thalamus, resulting in severe amnesia and conf"
      }, {
        "text": "abulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Associate the hippocampus with memory formation, the amygdala with fear/"
      }, {
        "text": "emotion, and the mammillary bodies with memory deficits in alcoholism.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003e"
      }, {
        "text": "Limbic System\u003c/b\u003e forms the brain\u0027s emotional core, integrating memory, sensory input, and autonomic responses to generate"
      }, {
        "text": " our fundamental drives and emotional experiences. Its dysfunction underlies a range of psychiatric and neurological disorders.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to"
      }, {
        "text": "\": \"hippocampus\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"d220"
      }, {
        "text": "fc3f\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \""
      }, {
        "text": "f02cfaa1\"\n      },\n      {\n        \"type\": \"is_affected_in"
      }, {
        "text": "\",\n        \"to\": \"kluver_bucy_syndrome\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_affected_in\",\n        \"to\": \"wernicke_korsakoff"
      }, {
        "text": "_syndrome\"\n      }\n    ]\n  },\n  \"4945aa8c\": {\n    \"title\":"
      }, {
        "text": " \"Liquefactive Necrosis\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Path"
      }, {
        "text": "ology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and"
      }, {
        "text": " Special Senses\",\n      \"Pathology\",\n      \"Cellular Pathology\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLiquefactive necrosis\u003c/b\u003e is a type of necrosis in which the"
      }, {
        "text": " dead tissue is transformed into a liquid, viscous mass. It is characteristic of focal bacterial or fungal infections and hypoxic death of"
      }, {
        "text": " cells within the central nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Occ"
      }, {
        "text": "urs in tissues with high lipid content and few connective tissue fibers, or in the context of infections with pyogenic bacteria. Enzym"
      }, {
        "text": "atic digestion of the dead cells by hydrolytic enzymes from neutrophils (in abscesses) or by the cells\u0027 own lysosomes"
      }, {
        "text": " (in CNS ischemia) predominates over protein denaturation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCentral Nervous System:\u003c/b\u003e This is the characteristic type of necrosis seen"
      }, {
        "text": " in the brain following an \u003cmark\u003eischemic stroke\u003c/mark\u003e. Microglial cells (the CNS macrophages) release hydroly"
      }, {
        "text": "tic enzymes that digest the necrotic tissue, eventually forming a fluid-filled cystic space.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBacterial Infections:\u003c/b\u003e Also"
      }, {
        "text": " characteristic of abscess formation, where neutrophils release enzymes that liquefy the tissue, forming pus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGross Appearance:\u003c/b\u003e The affected"
      }, {
        "text": " area becomes soft, liquid, and creamy yellow (due to dead leukocytes in pus) or a fluid-filled cavity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e For the brain, the answer to \u0027what type of necrosis occurs after an ischemic event?\u0027 is "
      }, {
        "text": "\u003cu\u003ealways\u003c/u\u003e liquefactive necrosis. For most other organs (e.g., heart, kidney), the answer is coagulative necrosis.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLiquefactive necrosis\u003c/b\u003e is the result of enzymatic digestion overwhelming protein"
      }, {
        "text": " denaturation, a process that uniquely occurs in the lipid-rich, low-collagen environment of the brain, turning an"
      }, {
        "text": " area of ischemic stroke into a fluid-filled cyst.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"necrosis"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"occurs_in\",\n        \"to\": \""
      }, {
        "text": "ischemic_stroke\"\n      },\n      {\n        \"type\": \"occurs_in\",\n        \""
      }, {
        "text": "to\": \"bacterial_abscess\"\n      },\n      {\n        \"type\": \"is_contr"
      }, {
        "text": "asted_with\",\n        \"to\": \"coagulative_necrosis\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"a3b7b1fc\": {\n    \"title\": \"Lisch Nodules\",\n    \"primaryType\":"
      }, {
        "text": " \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Genetics\",\n"
      }, {
        "text": "      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses"
      }, {
        "text": "\",\n      \"Ophthalmology\",\n      \"Physical Findings\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eLisch nodules\u003c/b\u003e are benign, pigmented hamartomas of the iris that are a pathognomonic feature of \u003ci\u003e"
      }, {
        "text": "Neurofibromatosis Type 1 (NF1)\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance"
      }, {
        "text": ":\u003c/b\u003e Well-defined, dome-shaped, gelatinous masses on the surface of the iris. They are typically tan"
      }, {
        "text": " or brown in color.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDetection:\u003c/b\u003e Best visualized with a slit-lamp examination. They are not usually"
      }, {
        "text": " visible to the naked eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Their presence is one of the key diagnostic criteria for [["
      }, {
        "text": "015a73ab|Neurofibromatosis Type 1]]. They are found in over 90"
      }, {
        "text": "% of adult patients with NF1.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e They are melanocytic hamartomas, representing"
      }, {
        "text": " a benign proliferation of melanocytes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImpact on Vision:\u003c/b\u003e Lisch nodules themselves do \u003cu\u003enot\u003c/u\u003e affect"
      }, {
        "text": " vision and are asymptomatic. Their importance is purely diagnostic.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of Lisch"
      }, {
        "text": " nodules in a patient with caf√©-au-lait spots and cutaneous neurofibromas is diagnostic for NF1.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eLisch nodules\u003c/b\u003e are the ocular hallmark of Neurofibromatosis Type 1;"
      }, {
        "text": " while visually insignificant themselves, their presence on a slit-lamp exam is a powerful and specific clue to the systemic genetic diagnosis.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_hall"
      }, {
        "text": "mark_of\",\n        \"to\": \"015a73ab\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_type_of\",\n        \"to\": \"hamartoma\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"iris"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"cedfe2d8\": {\n    \"title"
      }, {
        "text": "\": \"Lissencephaly\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Pediatrics\",\n      \"Embryology\",\n      \"Genetics\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Brain"
      }, {
        "text": " Malformations\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLissencephaly\u003c/b\u003e,"
      }, {
        "text": " meaning \\\"smooth brain,\\\" is a rare congenital brain malformation characterized by the absence of normal gyri (folds) and sulci (gro"
      }, {
        "text": "oves) of the cerebral cortex, resulting in a smooth or nearly smooth brain surface.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e Caused by a failure of neuronal migration during embryonic development (weeks 12-24). Neurons fail to migrate from"
      }, {
        "text": " the ventricular zone to the cortical plate, leading to a thickened cortex with only a few poorly formed layers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGen"
      }, {
        "text": "etics:\u003c/b\u003e Can be caused by mutations in several genes involved in neuronal migration, such as \u003ci\u003eLIS1\u003c/i\u003e."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Infants present with severe neurological impairment, including profound intellectual disability, developmental delay, seizures ("
      }, {
        "text": "often infantile spasms), and feeding difficulties. Microcephaly and facial anomalies may be present.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e MRI or"
      }, {
        "text": " CT shows a smooth cortical surface (agyria) or a brain with very few, wide gyri (pachygyria"
      }, {
        "text": ").\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The term \\\"smooth brain\\\" is the key descriptor for lissencephaly. It"
      }, {
        "text": " represents a severe defect in neuronal migration.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLissencephaly\u003c/b\u003e"
      }, {
        "text": " is a devastating brain malformation where the failure of neurons to complete their journey to the cortex during development results in a smooth, unfolded"
      }, {
        "text": " brain, leading to severe and widespread neurological dysfunction.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_type_of\",\n        \"to\": \"brain_malformation"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"failure_of"
      }, {
        "text": "_neuronal_migration\"\n      }\n    ]\n  },\n  \"e5839320\": {\n    \""
      }, {
        "text": "title\": \"Livedo Reticularis\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Dermatology"
      }, {
        "text": "\",\n      \"Rheumatology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Musculoskeletal, Skin, and Connective Tissue\",\n      \"Dermatology\",\n      \"V"
      }, {
        "text": "ascular Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLivedo"
      }, {
        "text": " reticularis\u003c/b\u003e is a skin finding characterized by a mottled, purplish, lace-like or net-like pattern"
      }, {
        "text": " on the skin, caused by swelling of the venules due to obstruction of capillaries by small blood clots or sluggish blood flow.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The pattern reflects the underlying cutaneous microvasculature."
      }, {
        "text": " The pale central areas correspond to the core of a vascular territory supplied by an arteriole, while the violaceous borders represent"
      }, {
        "text": " areas of deoxygenated, stagnant blood in the surrounding venules.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysiological Cause:\u003c/b\u003e Can be a normal,"
      }, {
        "text": " transient response to cold (cutis marmorata).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathological Causes:\u003c/b\u003e Can be a sign of an"
      }, {
        "text": " underlying systemic disease, including:\u003cbr\u003e - \u003cb\u003eVasculitis:\u003c/b\u003e Polyarteritis nodosa.\u003cbr\u003e - \u003cb\u003eTh"
      }, {
        "text": "romboembolic states:\u003c/b\u003e Antiphospholipid syndrome, cholesterol emboli syndrome.\u003cbr\u003e - \u003cb\u003eS"
      }, {
        "text": "epsis\u003c/b\u003e or other causes of shock.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrug-Induced:\u003c/b\u003e A characteristic side effect of the drug \u003cmark\u003eamantadine\u003c/"
      }, {
        "text": "mark\u003e, used in [[58c8ea03|Parkinson disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e While"
      }, {
        "text": " it can be benign, the appearance of livedo reticularis in a patient with systemic symptoms should prompt a workup for vascul"
      }, {
        "text": "itis or a hypercoagulable state. Its association with amantadine is a classic board question.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eLivedo reticularis\u003c/b\u003e is a cutaneous map of microvascular compromise; its lace-like pattern visually"
      }, {
        "text": " represents areas of sluggish venous blood flow, serving as a potential clue to underlying systemic vascular or hematologic disease.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_an_adverse_effect"
      }, {
        "text": "_of\",\n        \"to\": \"9c9679ea\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_symptom_of\",\n        \"to\": \"antiphospholipid_"
      }, {
        "text": "syndrome\"\n      },\n      {\n        \"type\": \"is_a_symptom_of"
      }, {
        "text": "\",\n        \"to\": \"polyarteritis_nodosa\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_a_symptom_of\",\n        \"to\": \"cholesterol_emboli_"
      }, {
        "text": "syndrome\"\n      }\n    ]\n  },\n  \"b14c0eef\": {\n    \"title\": \""
      }, {
        "text": "Local Anesthetics\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Anesthesiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\":"
      }, {
        "text": " [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n"
      }, {
        "text": "    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLocal anesthetics\u003c/b\u003e are drugs that"
      }, {
        "text": " reversibly block nerve conduction in a specific area of the body, producing a transient loss of sensation (analgesia) without loss"
      }, {
        "text": " of consciousness.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Block voltage-gated \u003c"
      }, {
        "text": "mark\u003eNa\u003csup\u003e+\u003c/sup\u003e channels\u003c/mark\u003e from the intracellular side of the nerve membrane. They preferentially bind to activated"
      }, {
        "text": " and inactivated channels, making them more effective on rapidly firing neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eChemistry:\u003c/b\u003e Are weak bases. They must be"
      }, {
        "text": " in their uncharged form to cross the nerve membrane, then become charged intracellularly to bind the Na\u003csup\u003e+\u003c/sup\u003e channel. They are less"
      }, {
        "text": " effective in infected (acidic) tissue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClasses:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eAmides:"
      }, {
        "text": "\u003c/b\u003e L\u003cb\u003ei\u003c/b\u003edoca\u003cb\u003ei\u003c/b\u003ene, bup\u003cb\u003ei\u003c/b\u003evaca\u003cb\u003ei\u003c/b\u003ene, mep\u003cb\u003ei\u003c/b\u003ev"
      }, {
        "text": "aca\u003cb\u003ei\u003c/b\u003ene (have 2 \u0027i\u0027s in the name). Metabolized by the liver.\u003cbr\u003e - \u003cb\u003eEsters:"
      }, {
        "text": "\u003c/b\u003e Proca\u003cb\u003ei\u003c/b\u003ene, coca\u003cb\u003ei\u003c/b\u003ene, benzoca\u003cb\u003ei\u003c/b\u003ene (have 1 \u0027i\u0027 in the"
      }, {
        "text": " name). Metabolized by plasma pseudocholinesterases. Allergic reactions are more common with esters.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOrder of"
      }, {
        "text": " Blockade:\u003c/b\u003e Small, myelinated fibers (AŒ¥, pain/temp) are blocked first, followed by small"
      }, {
        "text": " unmyelinated (C, dull pain), and finally large myelinated fibers (AŒ≤, touch/pressure).\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Systemic toxicity can cause CNS excitation (seizures) and cardiovascular toxicity (arr"
      }, {
        "text": "hythmias, hypotension). Bupivacaine is severely cardiotoxic. Benzocaine can cause [[b780"
      }, {
        "text": "8532|methemoglobinemia]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLocal anesthetics\u003c/b\u003e"
      }, {
        "text": " work by blocking the sodium channels that are essential for nerve impulse propagation. Their effectiveness is governed by a use-dependent blockade"
      }, {
        "text": ", making them more potent on nerves that are actively transmitting pain signals.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"blocks\",\n        \"to\": \"sodium_channels\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_classified_as\",\n        \"to\": \"amide_anesthetic\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_classified_as\",\n        \"to\": \"ester_anesthetic\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"b780"
      }, {
        "text": "8532\"\n      }\n    ]\n  },\n  \"fea33248\": {\n    \""
      }, {
        "text": "title\": \"Locked-in Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Vascular\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      "
      }, {
        "text": "\"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brainstem Syndromes\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLocked-in syndrome\u003c/b\u003e is a rare neurological state of quadri"
      }, {
        "text": "plegia and anarthria (inability to speak) in which a patient is fully conscious and aware but is unable"
      }, {
        "text": " to move or communicate, with the exception of vertical eye movements and blinking.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eE"
      }, {
        "text": "tiology:\u003c/b\u003e Classically caused by an ischemic stroke affecting the \u003cmark\u003eventral pons\u003c/mark\u003e, typically due to occlusion"
      }, {
        "text": " of the \u003cmark\u003ebasilar artery\u003c/mark\u003e. Other causes include trauma, tumors, or [[7a680d"
      }, {
        "text": "3d|osmotic demyelination syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The lesion damages the bilateral corticospinal and"
      }, {
        "text": " corticobulbar tracts in the ventral pons, resulting in complete paralysis of all voluntary muscles except for those controlling vertical eye movements and"
      }, {
        "text": " blinking.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpared Structures:\u003c/b\u003e The reticular activating system (responsible for consciousness) and the oculomotor pathways for"
      }, {
        "text": " vertical gaze (located more dorsally in the midbrain) are spared.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e The patient is awake"
      }, {
        "text": " and alert but completely paralyzed and mute. Communication is possible only through eye movements or blinking.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A"
      }, {
        "text": " patient who is quadriplegic and mute but can communicate by blinking has locked-in syndrome. The lesion is in the ventral"
      }, {
        "text": " pons.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLocked-in syndrome\u003c/b\u003e represents a profound disconnection between a"
      }, {
        "text": " conscious mind and a paralyzed body, resulting from a specific lesion in the ventral pons that severs all motor output pathways while"
      }, {
        "text": " sparing the ascending systems for consciousness.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Basilar Artery Occlusion]"
      }, {
        "text": " --\u003e B(Ventral Pons Infarct); B --\u003e C(Damage to Corticospinal \u0026 Corticobulbar Tracts); C"
      }, {
        "text": " --\u003e D(Quadriplegia \u0026 Anarthria); B --Spares--\u003e E(Reticular Activating System);"
      }, {
        "text": " E --\u003e F(Intact Consciousness);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \""
      }, {
        "text": "is_caused_by_lesion_in\",\n        \"to\": \"bf549b2f\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_caused_by_occlusion_of\",\n        \"to\": \"basilar_artery\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"7"
      }, {
        "text": "a680d3d\"\n      },\n      {\n        \"type\": \"differentiated_from"
      }, {
        "text": "\",\n        \"to\": \"persistent_vegetative_state\"\n      }\n    ]\n  },\n  \"1"
      }, {
        "text": "49a1cc8\": {\n    \"title\": \"Locus Coeruleus\",\n    \"primaryType\": \"anatomy\",\n"
      }, {
        "text": "    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Psychiatry\",\n      \"USMLE\"\n"
      }, {
        "text": "    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brain"
      }, {
        "text": "stem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eLocus Coeruleus"
      }, {
        "text": "\u003c/b\u003e is a nucleus in the pons of the brainstem that is the principal site for synthesizing the neurotransmitter \u003ci\u003enorepinephrine ("
      }, {
        "text": "NE)\u003c/i\u003e for the central nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Located in the"
      }, {
        "text": " posterior pons, near the floor of the fourth ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter:\u003c/b\u003e The primary source of [[a"
      }, {
        "text": "edeee6d|norepinephrine]] for the brain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProjections:\u003c/b\u003e Sends widespread noradrenergic projections throughout the CNS"
      }, {
        "text": ", including the cortex, thalamus, hypothalamus, limbic system, cerebellum, and spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e"
      }, {
        "text": " Plays a crucial role in the stress response, arousal, attention, and sleep-wake cycles. It is a key component of the ascending"
      }, {
        "text": " reticular activating system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Dysfunction of the locus coeruleus is implicated in anxiety disorders ("
      }, {
        "text": "hyperactivity) and depression (hypoactivity). Loss of neurons in the locus coeruleus is also seen in [[58c8ea"
      }, {
        "text": "03|Parkinson disease]] and [[77ae6148|Alzheimer disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE"
      }, {
        "text": " Tip:\u003c/b\u003e Associate the locus coeruleus with norepinephrine, arousal, and the stress/panic response.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003eThe \u003cb\u003eLocus Coeruleus\u003c/b\u003e acts as the brain\u0027s \u0027alarm system,\u0027 broadcasting"
      }, {
        "text": " norepinephrine throughout the CNS to promote vigilance and arousal in response to novel or stressful stimuli.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"produces\",\n        \"to\": \"a"
      }, {
        "text": "edeee6d\"\n      },\n      {\n        \"type\": \"is_located_in\",\n"
      }, {
        "text": "        \"to\": \"bf549b2f\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_implicated_in\",\n        \"to\": \"anxiety_disorders\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_implicated_in\",\n        \"to\": \"depression\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"0d8d64f9\": {\n    \"title\": \""
      }, {
        "text": "Loperamide\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology"
      }, {
        "text": "\",\n      \"Gastroenterology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"G"
      }, {
        "text": "astrointestinal\",\n      \"Pharmacology\",\n      \"Antidiarrheals\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLoperamide\u003c/b\u003e is an over-the-counter synthetic"
      }, {
        "text": " \u003ci\u003eopioid agonist\u003c/i\u003e used for the symptomatic treatment of diarrhea. It acts on Œº-opioid receptors in the gastrointestinal tract to"
      }, {
        "text": " decrease motility.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Agonist at Œº"
      }, {
        "text": "-opioid receptors in the myenteric plexus of the large intestine. This inhibits presynaptic cholinergic nerves, leading to decreased"
      }, {
        "text": " smooth muscle activity and increased transit time. It also increases anal sphincter tone.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e It does"
      }, {
        "text": " not cross the [[dd47b9cc|blood-brain barrier]] in therapeutic doses due to being a substrate of P-glycoprotein efflux"
      }, {
        "text": " pumps. This lack of central effects means it has very low abuse potential.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Symptomatic treatment of acute"
      }, {
        "text": ", non-invasive diarrhea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Constipation, cramping, and nausea. At very"
      }, {
        "text": " high doses (as seen in abuse), it can overcome the P-glycoprotein pump, leading to CNS depression and card"
      }, {
        "text": "iotoxicity (QT prolongation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Loperamide is an opioid that treats diarrhea but doesn"
      }, {
        "text": "\u0027t cause euphoria or analgesia because it doesn\u0027t cross the blood-brain barrier.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eLoperamide\u003c/b\u003e is a peripherally restricted opioid that effectively treats diarrhea by activating Œº-receptors in the gut to slow motility"
      }, {
        "text": ", without producing the central analgesic or euphoric effects of other opioids.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"di"
      }, {
        "text": "arrhea\"\n      },\n      {\n        \"type\": \"is_an_agonist_at\",\n        \"to\":"
      }, {
        "text": " \"mu_opioid_receptor\"\n      },\n      {\n        \"type\": \"does_not_cross\","
      }, {
        "text": "\n        \"to\": \"dd47b9cc\"\n      }\n    ]\n  },\n  \"b0"
      }, {
        "text": "bb0c47\": {\n    \"title\": \"Lorazepam\",\n    \"primaryType\": \"drug\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neurology\",\n      \""
      }, {
        "text": "USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Anxiolytics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLorazepam\u003c/b\u003e"
      }, {
        "text": " is an intermediate-acting \u003ci\u003ebenzodiazepine\u003c/i\u003e with potent anxiolytic, sedative, and anticonvulsant properties, commonly"
      }, {
        "text": " used for anxiety, insomnia, and status epilepticus.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e"
      }, {
        "text": " Facilitates the action of [[5aa5cb91|GABA]] at the GABA\u003csub\u003eA\u003c/sub\u003e receptor, increasing the \u003c"
      }, {
        "text": "mark\u003efrequency\u003c/mark\u003e of Cl\u003csup\u003e-\u003c/sup\u003e channel opening and causing CNS depression.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetabolism:\u003c/b\u003e Under"
      }, {
        "text": "goes direct glucuronidation in the liver, making its metabolism less dependent on the cytochrome P450 system.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e First-line treatment for \u003cmark\u003estatus epilepticus\u003c/mark\u003e. Also used for anxiety"
      }, {
        "text": " disorders, sedation in the ICU, and management of alcohol withdrawal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSafe in Liver Disease:\u003c/b\u003e Along with Ox"
      }, {
        "text": "azepam and Temazepam, Lorazepam is a preferred benzodiazepine in patients with severe liver disease. Mnemonic: \u003cb\u003eO\u003c/b\u003eutside "
      }, {
        "text": "\u003cb\u003eT\u003c/b\u003ehe \u003cb\u003eL\u003c/b\u003eiver (\u003cb\u003eO\u003c/b\u003exazepam, \u003cb\u003eT\u003c/b\u003eemazepam, \u003cb\u003e"
      }, {
        "text": "L\u003c/b\u003eorazepam).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Lorazepam is the IV benzodiazepine of choice for terminating"
      }, {
        "text": " an active seizure in status epilepticus due to its rapid onset and relatively long duration of action in the CNS.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eLorazepam\u003c/b\u003e is a versatile benzodiazepine that is a first-line agent for the emergency treatment"
      }, {
        "text": " of status epilepticus and is also a safer choice in patients with liver failure due to its direct glucuronidation metabolism.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_type_of\",\n        \"to\": \"14464617\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"status_epile"
      }, {
        "text": "pticus\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n"
      }, {
        "text": "        \"to\": \"anxiety_disorders\"\n      },\n      {\n        \"type\": \"is_safer_in\","
      }, {
        "text": "\n        \"to\": \"liver_disease\"\n      }\n    ]\n  },\n  \"d6a"
      }, {
        "text": "27754\": {\n    \"title\": \"Lower Motor Neuron (LMN)\",\n    \"primaryType\": \"anatomy"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Pathology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \""
      }, {
        "text": "Motor System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eLower Motor Neuron (LMN"
      }, {
        "text": ")\u003c/b\u003e is a motor neuron whose cell body is located in the anterior horn of the spinal cord or in a brainstem cranial"
      }, {
        "text": " nerve nucleus, and whose axon directly innervates skeletal muscle fibers.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction"
      }, {
        "text": ":\u003c/b\u003e Serves as the final common pathway for all motor output from the CNS to the muscles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eL"
      }, {
        "text": "MN Lesion Signs:\u003c/b\u003e Damage to LMNs results in a characteristic set of signs in the affected muscles. Mnemonic: Everything"
      }, {
        "text": " is \u003cb\u003eL\u003c/b\u003eowered. \u003cbr\u003e - \u003cmark\u003eFlaccid paralysis\u003c/mark\u003e or weakness ("
      }, {
        "text": "paresis).\u003cbr\u003e - Significant \u003cmark\u003emuscle atrophy\u003c/mark\u003e.\u003cbr\u003e - \u003cmark\u003eF"
      }, {
        "text": "asciculations\u003c/mark\u003e (involuntary muscle twitches).\u003cbr\u003e - \u003cmark\u003eHyporeflexia\u003c/mark\u003e or are"
      }, {
        "text": "flexia (decreased or absent deep tendon reflexes).\u003cbr\u003e - Decreased muscle tone (hypotonia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses"
      }, {
        "text": " of LMN Lesions:\u003c/b\u003e [[75f2b918|Poliomyelitis]], [[e6"
      }, {
        "text": "820b7f|spinal muscular atrophy]], [[4ed629f9|amyotrophic lateral sclerosis (ALS)]],"
      }, {
        "text": " trauma to peripheral nerves, and [[ed52e40b|Guillain-Barr√© syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFac"
      }, {
        "text": "ial Nerve Lesion:\u003c/b\u003e An LMN lesion of CN VII (e.g., Bell\u0027s palsy) causes ips"
      }, {
        "text": "ilateral paralysis of the \u003cu\u003eentire\u003c/u\u003e half of the face, including the forehead.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e The presence of fasciculations and significant atrophy are strong indicators of an LMN lesion.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003eA \u003cb\u003eLower Motor Neuron\u003c/b\u003e is the direct and final link between the central nervous system and a muscle"
      }, {
        "text": " fiber; its destruction severs this link, leading to a complete loss of voluntary and reflex activity in the muscle, resulting in flaccid paralysis and"
      }, {
        "text": " profound atrophy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_contrasted_with\",\n        \"to\": \"upper_motor_neuron\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"flaccid_paralysis\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"fasciculations\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_damaged_in\",\n        \"to\": \"75f2b91"
      }, {
        "text": "8\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to"
      }, {
        "text": "\": \"4ed629f9\"\n      }\n    ]\n  },\n  \"8e9c"
      }, {
        "text": "257a\": {\n    \"title\": \"Lumbar Puncture (Spinal Tap)\",\n    \"primaryType"
      }, {
        "text": "\": \"procedure\",\n    \"tags\": [\n      \"Neurology\",\n      \"Infectious Disease\",\n      \"Diagnostics"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Diagnostic Procedures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA"
      }, {
        "text": " \u003cb\u003elumbar puncture (LP)\u003c/b\u003e, or spinal tap, is a diagnostic and sometimes therapeutic procedure used to collect"
      }, {
        "text": " a sample of cerebrospinal fluid (CSF) for analysis by inserting a needle into the subarachnoid space of the lumbar spine.\u003c/p"
      }, {
        "text": "\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eIndications:\u003c/b\u003e Primarily used to diagnose infections of the CNS (e.g.,"
      }, {
        "text": " meningitis, encephalitis), [[63f8b05f|subarachnoid hemorrhage]], inflammatory conditions (e.g., [["
      }, {
        "text": "45dd6d19|MS]]), and to measure intracranial pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnatomical Landmark:\u003c/b\u003e The needle"
      }, {
        "text": " is inserted between the L3/L4 or L4/L5 vertebral interspaces to avoid injuring the spinal cord, which typically"
      }, {
        "text": " ends at the L1/L2 level in adults. A line drawn between the iliac crests approximates the L4"
      }, {
        "text": " vertebral body.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLayers Pierced:\u003c/b\u003e Skin ‚Üí Supraspinous ligament ‚Üí Interspinous ligament ‚Üí Lig"
      }, {
        "text": "amentum flavum ‚Üí Epidural space ‚Üí Dura mater ‚Üí Arachnoid mater ‚Üí Subarachnoid space. The"
      }, {
        "text": " pia mater is \u003cu\u003enot\u003c/u\u003e pierced.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOpening Pressure:\u003c/b\u003e Measurement of CSF pressure at the start of the procedure."
      }, {
        "text": " It is elevated in conditions like bacterial/fungal meningitis and [[7c59030e|normal pressure"
      }, {
        "text": " hydrocephalus]] (intermittently).\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindications:\u003c/b\u003e A major contraindication is evidence of significantly increased ICP"
      }, {
        "text": " with mass effect (e.g., brain tumor, large abscess) due to the risk of cerebral herniation. A"
      }, {
        "text": " head CT is often performed prior to LP if there are focal neurological signs or papilledema.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003eA \u003cb\u003elumbar puncture\u003c/b\u003e is a fundamental neurological procedure that provides direct access to the cerebrospinal fluid, offering"
      }, {
        "text": " invaluable diagnostic information about infectious, inflammatory, and hemorrhagic conditions affecting the central nervous system.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },"
      }, {
        "text": "\n    \"connections\": [\n      {\n        \"type\": \"is_used_to_diagnose\","
      }, {
        "text": "\n        \"to\": \"meningitis\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "used_to_diagnose\",\n        \"to\": \"63f8b05f\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_used_to_diagnose\",\n        \"to\": \"45dd6d"
      }, {
        "text": "19\"\n      },\n      {\n        \"type\": \"is_contraindicated_in\",\n        "
      }, {
        "text": "\"to\": \"cerebral_herniation_risk\"\n      }\n    ]\n  },\n  \"b2"
      }, {
        "text": "5863e1\": {\n    \"title\": \"Age-Related Macular Degeneration (AMD)\",\n    \"primaryType\":"
      }, {
        "text": " \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Geriatrics\",\n      \"Pathology\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special S"
      }, {
        "text": "enses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eAge-related macular degeneration (AMD)\u003c/b\u003e is a progressive neurodegenerative disease of the macula, the central part"
      }, {
        "text": " of the retina, leading to the loss of central, high-acuity vision. It is a leading cause of irreversible"
      }, {
        "text": " blindness in older adults.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDry (Atrophic) AMD:\u003c/b\u003e Most"
      }, {
        "text": " common form (~80%). Characterized by the slow, progressive atrophy of the retinal pigment epithelium (RPE) and photore"
      }, {
        "text": "ceptors. The hallmark finding is the presence of \u003cmark\u003edrusen\u003c/mark\u003e, which are yellow extracellular deposits between Bruch"
      }, {
        "text": "\u0027s membrane and the RPE.\u003c/li\u003e\u003cli\u003e\u003cb\u003eWet (Exudative) AMD:\u003c/b\u003e Less common but more severe. Characterized by the"
      }, {
        "text": " growth of abnormal new blood vessels from the choroid (choroidal neovascularization) that break through Bruch\u0027s membrane."
      }, {
        "text": " These vessels leak fluid and blood, causing rapid and severe central vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients experience"
      }, {
        "text": " gradual (dry) or rapid (wet) loss of central vision (central scotoma). A key symptom of wet AMD is \u003c"
      }, {
        "text": "mark\u003emetamorphopsia\u003c/mark\u003e (straight lines appear wavy).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Dry AMD is managed with antioxidant"
      }, {
        "text": " vitamins and zinc (AREDS formula) to slow progression. Wet AMD is treated with intravitreal injections of \u003cmark\u003eanti"
      }, {
        "text": "-VEGF\u003c/mark\u003e agents (e.g., ranibizumab, bevacizumab) to inhibit neovascularization.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Differentiate the two types: Dry AMD \u003d Drusen and gradual vision loss. Wet AMD \u003d Ne"
      }, {
        "text": "ovascularization, hemorrhage, and rapid vision loss.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAge-related macular"
      }, {
        "text": " degeneration\u003c/b\u003e is a disease of the central retina where the \u0027dry\u0027 form involves the slow accumulation of metabolic debris (drusen), while the \u0027wet\u0027"
      }, {
        "text": " form involves an aggressive, sight-threatening invasion of leaky new blood vessels, which can be targeted with anti-VEGF therapy.\u003c/p\u003e\","
      }, {
        "text": "\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \""
      }, {
        "text": "affects\",\n        \"to\": \"macula\"\n      },\n      {\n        \"type\": \"is_classified"
      }, {
        "text": "_as\",\n        \"to\": \"dry_amd\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_classified_as\",\n        \"to\": \"wet_amd\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"presents_with\",\n        \"to\": \"central_scotoma\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"dd062acc"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"8e004ef5\": {\n    \"title\":"
      }, {
        "text": " \"Magnesium Sulfate for Cerebral Palsy\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Obst"
      }, {
        "text": "etrics\",\n      \"Pediatrics\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Reproductive\",\n      \"Pharmacology\",\n      \"Obstetric Drugs\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003eAntenatal administration of \u003cb\u003emagnesium sulfate\u003c/b\u003e to mothers"
      }, {
        "text": " at high risk for preterm delivery before 32 weeks\u0027 gestation is a neuroprotective strategy shown to reduce the risk and"
      }, {
        "text": " severity of \u003ci\u003ecerebral palsy\u003c/i\u003e in surviving infants.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eInd"
      }, {
        "text": "ication:\u003c/b\u003e Administered to pregnant women at risk of imminent preterm birth, typically between 24 and 32 weeks of gestation.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eMechanism of Neuroprotection:\u003c/b\u003e The exact mechanism is not fully understood but is thought to involve several pathways: \u003c"
      }, {
        "text": "br\u003e - Reduction of inflammatory cytokines.\u003cbr\u003e - Blockade of NMDA receptors, reducing excitotoxic injury.\u003cbr\u003e - Increased"
      }, {
        "text": " cerebral blood flow and antioxidant effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrimary Outcome:\u003c/b\u003e Reduces the risk of moderate to severe [[171"
      }, {
        "text": "ca00b|cerebral palsy]] in the offspring. It does not prevent preterm birth itself.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Obst"
      }, {
        "text": "etric Uses:\u003c/b\u003e Magnesium sulfate is also the first-line treatment for seizure prophylaxis in preeclampsia and eclampsia, and as"
      }, {
        "text": " a tocolytic to temporarily suppress preterm labor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the dual neuroprotective roles of magnesium sulfate in obst"
      }, {
        "text": "etrics: preventing seizures in the mother (preeclampsia) and reducing the risk of cerebral palsy in the preterm infant."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMagnesium sulfate\u003c/b\u003e serves as a powerful neuroprotectant for the vulnerable"
      }, {
        "text": " preterm brain; when given to the mother before an early delivery, it stabilizes the fetal brain\u0027s vasculature and neuronal environment"
      }, {
        "text": ", significantly lowering the odds of the child developing cerebral palsy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      "
      }, {
        "text": "{\n        \"type\": \"reduces_risk_of\",\n        \"to\": \"171ca"
      }, {
        "text": "00b\"\n      },\n      {\n        \"type\": \"is_administered_during\",\n        \"to\": \"pre"
      }, {
        "text": "term_labor\"\n      },\n      {\n        \"type\": \"is_also_a_treatment_for\",\n        \""
      }, {
        "text": "to\": \"eclampsia\"\n      }\n    ]\n  },\n  \"0c159af1\": {\n    \"title\":"
      }, {
        "text": " \"Magnetic Gait\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      "
      }, {
        "text": "\"Geriatrics\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Gait Disorders\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMagnetic gait\u003c/b\u003e is a type of gait apraxia characterized"
      }, {
        "text": " by the appearance of the feet being \u0027stuck to the floor.\u0027 It is one of the cardinal features of \u003ci\u003eNormal"
      }, {
        "text": " Pressure Hydrocephalus (NPH)\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Patients"
      }, {
        "text": " have difficulty initiating walking despite having normal motor strength. They take slow, short, shuffling steps with a wide base. The"
      }, {
        "text": " feet appear to be \u0027glued\u0027 or \u0027magnetized\u0027 to the floor.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Bel"
      }, {
        "text": "ieved to be caused by the stretching of the corona radiata fibers (specifically the sacral motor fibers that innervate the legs"
      }, {
        "text": ") by the enlarged lateral ventricles in [[7c59030e|Normal Pressure Hydrocephalus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated"
      }, {
        "text": " Condition:\u003c/b\u003e It is the \u0027wobbly\u0027 component of the classic NPH triad: \\\"\u003cb\u003eW\u003c/b\u003eet, \u003cb\u003eW"
      }, {
        "text": "\u003c/b\u003eobbly, and \u003cb\u003eW\u003c/b\u003eacky\\\" (urinary incontinence, gait apraxia, and cognitive dysfunction).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDist"
      }, {
        "text": "inction from Parkinsonian Gait:\u003c/b\u003e While both are shuffling, the magnetic gait of NPH is typically wide-based, and"
      }, {
        "text": " patients have difficulty lifting their feet. Parkinsonian gait is often narrow-based with festination (involuntary acceleration).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " A wide-based, shuffling gait where the patient\u0027s feet seem stuck to the floor, in the context of dementia"
      }, {
        "text": " and incontinence, is highly specific for NPH.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMagnetic gait\u003c/b\u003e"
      }, {
        "text": " is a form of frontal gait apraxia that visually represents the difficulty in initiating movement seen in NPH; it is not"
      }, {
        "text": " a problem of strength or coordination but a failure of the cortical motor programming for walking, caused by ventricular enlargement.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \""
      }, {
        "text": "to\": \"7c59030e\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_a_type_of\",\n        \"to\": \"gait_apraxia\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"parkinsonian_"
      }, {
        "text": "gait\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"f7b5ee5d\",\n    \"letter\": \"L\",\n    \"term\": \"Lateral rectus muscle\",\n    \"pages\": [\n      \"555\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Lateral rectus muscle\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"c1da8784\",\n    \"letter\": \"L\",\n    \"term\": \"Lateral ventricles (brain)\",\n    \"pages\": [\n      \"515\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Lateral ventricles (brain)\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"b1466841\",\n    \"letter\": \"L\",\n    \"term\": \"Left-right disorientation\",\n    \"pages\": [\n      \"524\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Left-right disorientation\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"516b9ff4\",\n    \"letter\": \"L\",\n    \"term\": \"Lens dislocation\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Lens dislocation\",\n    \"sub_entries\": [\n      {\n        \"id\": \"039bd807\",\n        \"letter\": \"L\",\n        \"term\": \"causes and disease association\",\n        \"pages\": [\n          \"550\"\n        ],\n        \"context\": \"Lens dislocation \u003e causes and disease association\"\n      }\n    ]\n  },\n  {\n    \"id\": \"dcd6b576\",\n    \"letter\": \"L\",\n    \"term\": \"Lenticulostriate artery, stroke effects\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Lenticulostriate artery, stroke effects\",\n    \"sub_entries\": [\n      {\n        \"id\": \"9071c73b\",\n        \"letter\": \"L\",\n        \"term\": \"in\",\n        \"pages\": [\n          \"526\"\n        ],\n        \"context\": \"Lenticulostriate artery, stroke effects \u003e in\"\n      }\n    ]\n  },\n  {\n    \"id\": \"eec6247a\",\n    \"letter\": \"L\",\n    \"term\": \"Lentiform nucleus\",\n    \"pages\": [\n      \"511\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Lentiform nucleus\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"c8515469\",\n    \"letter\": \"L\",\n    \"term\": \"Leptin\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Leptin\",\n    \"sub_entries\": [\n      {\n        \"id\": \"66d9c2e5\",\n        \"letter\": \"L\",\n        \"term\": \"in hypothalamus\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Leptin \u003e in hypothalamus\"\n      }\n    ]\n  },\n  {\n    \"id\": \"912babcc\",\n    \"letter\": \"L\",\n    \"term\": \"Leukocoria\",\n    \"pages\": [\n      \"553\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Leukocoria\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"2341f9c0\",\n    \"letter\": \"L\",\n    \"term\": \"Levetiracetam\",\n    \"pages\": [\n      \"560\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Levetiracetam\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"335b4671\",\n    \"letter\": \"L\",\n    \"term\": \"Levodopa (l-DOPA)/carbidopa\",\n    \"pages\": [\n      \"563\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Levodopa (l-DOPA)/carbidopa\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"db2f16e5\",\n    \"letter\": \"L\",\n    \"term\": \"Lewy body dementia\",\n    \"pages\": [\n      \"507\",\n      \"535\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Lewy body dementia\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"c3920ce1\",\n    \"letter\": \"L\",\n    \"term\": \"Lidocaine\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Lidocaine\",\n    \"sub_entries\": [\n      {\n        \"id\": \"afea344a\",\n        \"letter\": \"L\",\n        \"term\": \"Class IB sodium channel blockers\",\n        \"pages\": [\n          \"565\"\n        ],\n        \"context\": \"Lidocaine \u003e Class IB sodium channel blockers\"\n      }\n    ]\n  },\n  {\n    \"id\": \"7a52c5ee\",\n    \"letter\": \"L\",\n    \"term\": \"Light-near dissociation\",\n    \"pages\": [\n      \"542\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Light-near dissociation\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"c98ebcec\",\n    \"letter\": \"L\",\n    \"term\": \"Lightheadedness\",\n    \"pages\": [\n      \"548\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Lightheadedness\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"f953c5e6\",\n    \"letter\": \"L\",\n    \"term\": \"Limb ataxia\",\n    \"pages\": [\n      \"524\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Limb ataxia\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 1550
    }, {
      "text": "```json\n{\n  \"f7b5ee5d\": {\n    \"title\": \"Lateral Rectus Muscle\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Anatomy\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Anatomy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eLateral Rectus Muscle\u003c/b\u003e is one of the six extraocular muscles responsible for eye movement. Its sole function is to \u003cu\u003eabduct\u003c/u\u003e the eye, moving it laterally away from the nose.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAction:\u003c/b\u003e Abduction (lateral movement) of the eyeball.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e It is exclusively innervated by the \u003cmark\u003eabducens nerve (CN VI)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Paralysis of the lateral rectus muscle due to a [[dd11dde6|CN VI palsy]] results in an inability to abduct the eye. This leads to an unopposed pull by the medial rectus, causing an esotropia (inward deviation of the eye) and horizontal [[9914d433|diplopia]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMnemonic:\u003c/b\u003e Remember the innervation of the extraocular muscles with the formula \u003cb\u003eLR\u003csub\u003e6\u003c/sub\u003eSO\u003csub\u003e4\u003c/sub\u003eR\u003csub\u003e3\u003c/sub\u003e\u003c/b\u003e (\u003cb\u003eL\u003c/b\u003eateral \u003cb\u003eR\u003c/b\u003eectus by CN \u003cb\u003e6\u003c/b\u003e, \u003cb\u003eS\u003c/b\u003euperior \u003cb\u003eO\u003c/b\u003eblique by CN \u003cb\u003e4\u003c/b\u003e, \u003cb\u003eR\u003c/b\u003eest by CN \u003cb\u003e3\u003c/b\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An isolated inability to abduct the eye points directly to a lesion of either the lateral rectus muscle itself or, more commonly, the abducens nerve (CN VI).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eLateral Rectus muscle\u003c/b\u003e has a singular, straightforward function‚Äîeye abduction‚Äîand a dedicated nerve supply from CN VI, making its paralysis a highly specific localizing sign for abducens nerve pathology.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_innervated_by\",\n        \"to\": \"dd11dde6\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"extraocular_muscle\"\n      },\n      {\n        \"type\": \"action_is\",\n        \"to\": \"abduction_of_eye\"\n      }\n    ]\n  },\n  \"c1da8784\": {\n    \"title\": \"Lateral Ventricles\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Ventricular System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eLateral Ventricles\u003c/b\u003e are the two largest, C-shaped cavities of the ventricular system of the brain, located within the cerebral hemispheres. They contain cerebrospinal fluid (CSF), which is produced by their choroid plexuses.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e One in each cerebral hemisphere. Each lateral ventricle has an anterior (frontal) horn, a body (parietal), a posterior (occipital) horn, and an inferior (temporal) horn.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCSF Flow:\u003c/b\u003e CSF flows from each lateral ventricle into the third ventricle via the paired \u003cmark\u003einterventricular foramina of Monro\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e The cavities of the lateral ventricles are derived from the lumen of the embryonic telencephalon.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Enlargement of the lateral ventricles is a key sign of [[0bc2f200|hydrocephalus]]. In \u003cmark\u003eobstructive hydrocephalus\u003c/mark\u003e, blockage of the foramen of Monro or the cerebral aqueduct will cause dilation of the lateral ventricles. In [[7c59030e|normal pressure hydrocephalus]], all ventricles are enlarged.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Symmetrical enlargement of the lateral ventricles on a CT or MRI is a classic finding in hydrocephalus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eLateral Ventricles\u003c/b\u003e are the primary sites of CSF production and form the starting point of the CSF circulatory pathway; their enlargement is a sensitive indicator of pathologies that either obstruct CSF flow or impair its absorption.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Lateral Ventricles] --Foramen of Monro--\u003e B(Third Ventricle); B --Cerebral Aqueduct--\u003e C(Fourth Ventricle);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"ventricular_system\"\n      },\n      {\n        \"type\": \"drains_into\",\n        \"to\": \"third_ventricle\"\n      },\n      {\n        \"type\": \"is_enlarged_in\",\n        \"to\": \"0bc2f200\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"choroid_plexus\"\n      }\n    ]\n  },\n  \"b1466841\": {\n    \"title\": \"Left-Right Disorientation\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cognitive Deficit\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLeft-right disorientation\u003c/b\u003e is a neurological deficit characterized by the inability to distinguish between the left and right sides of one\u0027s own body or in extrapersonal space. It is a component of \u003ci\u003eGerstmann syndrome\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocalization:\u003c/b\u003e This deficit is a specific sign of a lesion in the \u003cmark\u003edominant (usually left) parietal lobe\u003c/mark\u003e, specifically the angular gyrus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndrome:\u003c/b\u003e It is one of the four classic components of [[38f3ed1f|Gerstmann syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eGerstmann Syndrome Tetrad:\u003c/b\u003e The full syndrome includes \u003cb\u003eLeft-Right Disorientation\u003c/b\u003e, \u003cb\u003eAgraphia\u003c/b\u003e (inability to write), \u003cb\u003e[[8558c64b|Acalculia]]\u003c/b\u003e (inability to perform calculations), and \u003cb\u003eFinger Agnosia\u003c/b\u003e (inability to distinguish fingers).\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Territory:\u003c/b\u003e These symptoms often result from a stroke in the territory of the [[143bb23d|Middle Cerebral Artery (MCA)]] that supplies the dominant parietal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of left-right confusion with difficulty in writing, calculating, or identifying fingers is pathognomonic for Gerstmann syndrome and points to a lesion in the dominant angular gyrus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLeft-right disorientation\u003c/b\u003e is a highly specific cognitive deficit that, when present, strongly localizes a lesion to the dominant parietal lobe, often as part of the unique constellation of symptoms known as Gerstmann syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_component_of\",\n        \"to\": \"38f3ed1f\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"26efa771\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \"143bb23d\"\n      }\n    ]\n  },\n  \"516b9ff4\": {\n    \"title\": \"Lens Dislocation (Ectopia Lentis)\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Genetics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLens dislocation\u003c/b\u003e, or \u003cb\u003eectopia lentis\u003c/b\u003e, is the displacement of the crystalline lens of the eye from its normal position. While most commonly caused by trauma, it can be a hallmark of several systemic genetic disorders.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by weakness or disruption of the zonular fibers that hold the lens in place.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMarfan Syndrome:\u003c/b\u003e An autosomal dominant connective tissue disorder caused by a mutation in the fibrillin-1 (\u003ci\u003eFBN1\u003c/i\u003e) gene. Characterized by a classic \u003cmark\u003eupward and outward (superotemporal)\u003c/mark\u003e dislocation of the lens.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHomocystinuria:\u003c/b\u003e An autosomal recessive disorder of methionine metabolism. Characterized by a \u003cmark\u003edownward and inward (inferonasal)\u003c/mark\u003e dislocation of the lens.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Associations:\u003c/b\u003e Can also be seen in Ehlers-Danlos syndrome, sulfite oxidase deficiency, and Weil-Marchesani syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Can cause blurred vision, diplopia, and may lead to glaucoma or retinal detachment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The direction of lens dislocation is a key feature for differentiating Marfan syndrome from homocystinuria on exams. Mnemonic: Mar\u003cb\u003efan\u003c/b\u003e\u0027s fans the lens \u003cb\u003eup\u003c/b\u003e.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEctopia lentis\u003c/b\u003e is a significant physical finding that should prompt consideration of an underlying systemic connective tissue or metabolic disorder, with the direction of dislocation providing a crucial clue to distinguish between Marfan syndrome and homocystinuria.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_finding_in\",\n        \"to\": \"marfan_syndrome\"\n      },\n      {\n        \"type\": \"is_a_finding_in\",\n        \"to\": \"homocystinuria\"\n      },\n      {\n        \"type\": \"is_a_finding_in\",\n        \"to\": \"ehlers_danlos_syndrome\"\n      }\n    ]\n  },\n  \"dcd6b576\": {\n    \"title\": \"Lenticulostriate Artery Stroke\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Vascular\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003elenticulostriate artery stroke\u003c/b\u003e is a type of \u003ci\u003elacunar stroke\u003c/i\u003e caused by the occlusion of one of the small, deep penetrating arteries that branch from the [[143bb23d|Middle Cerebral Artery (MCA)]]. These strokes result in small infarcts in the deep brain structures.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eVascular Anatomy:\u003c/b\u003e The lenticulostriate arteries arise from the M1 segment of the MCA and supply deep structures such as the basal ganglia (putamen, globus pallidus, caudate), and the posterior limb of the internal capsule.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Occlusion is typically due to \u003cmark\u003elipohyalinosis\u003c/mark\u003e or microatheroma, processes strongly associated with chronic [[hypertension]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Syndromes:\u003c/b\u003e Because these arteries supply densely packed white matter tracts and deep nuclei, small infarcts can cause significant deficits. The most common syndrome is a \u003cmark\u003epure motor stroke\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePure Motor Stroke:\u003c/b\u003e Caused by an infarct in the contralateral posterior limb of the internal capsule. Presents with unilateral weakness of the face, arm, and leg without any sensory, visual, or cognitive deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a history of hypertension presenting with a pure motor hemiparesis (face, arm, and leg equally affected) has a lacunar stroke in the lenticulostriate artery territory until proven otherwise.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eStrokes involving the \u003cb\u003elenticulostriate arteries\u003c/b\u003e are the archetypal lacunar infarcts, where chronic hypertension damages these tiny end-arteries, leading to small, deep brain infarcts that produce \u0027pure\u0027 motor or sensory syndromes by selectively damaging critical white matter tracts.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"b56349b2\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"8aefcafe\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"hypertension\"\n      },\n      {\n        \"type\": \"are_branches_of\",\n        \"to\": \"143bb23d\"\n      }\n    ]\n  },\n  \"eec6247a\": {\n    \"title\": \"Lentiform Nucleus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Basal Ganglia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eLentiform Nucleus\u003c/b\u003e is a large, lens-shaped mass of gray matter located in the deep cerebral hemispheres. It is a major component of the [[ed462927|basal ganglia]] and is composed of two parts: the putamen and the globus pallidus.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003ePutamen:\u003c/b\u003e The larger, more lateral part.\u003cbr\u003e - \u003cb\u003eGlobus Pallidus:\u003c/b\u003e The smaller, more medial part, which is further subdivided into an external (GPe) and internal (GPi) segment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnatomical Relations:\u003c/b\u003e The lentiform nucleus is separated from the caudate nucleus and thalamus by the internal capsule.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e As part of the basal ganglia, it is involved in the regulation of voluntary movement. The putamen is a major input nucleus of the basal ganglia (along with the caudate), while the globus pallidus internus is a major output nucleus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Lesions of the lentiform nucleus can cause various movement disorders. It is a common site for hypertensive intraparenchymal hemorrhages due to its supply by the vulnerable lenticulostriate arteries.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the anatomical groupings: Striatum \u003d Caudate + Putamen. Lentiform Nucleus \u003d Putamen + Globus Pallidus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eLentiform Nucleus\u003c/b\u003e, comprising the putamen and globus pallidus, forms the core of the basal ganglia\u0027s motor circuit, playing a pivotal role in processing cortical signals to modulate and refine voluntary movements.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"ed462927\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"putamen\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"globus_pallidus\"\n      }\n    ]\n  },\n  \"c8515469\": {\n    \"title\": \"Leptin\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Physiology\",\n      \"Biochemistry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Physiology\",\n      \"Hormones\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLeptin\u003c/b\u003e is a peptide hormone produced primarily by adipose tissue that acts on the [[89e86633|hypothalamus]] to regulate appetite and energy balance. It functions as a long-term satiety signal, informing the brain about the body\u0027s fat stores.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSource:\u003c/b\u003e Secreted by adipocytes (fat cells) in proportion to the amount of stored fat.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTarget:\u003c/b\u003e Acts on receptors in the arcuate nucleus of the [[89e86633|hypothalamus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Suppresses appetite and increases energy expenditure. It inhibits orexigenic (appetite-stimulating) neurons and stimulates anorexigenic (appetite-suppressing) neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLeptin Resistance:\u003c/b\u003e In obesity, plasma leptin levels are high, but the brain becomes resistant to its anorexigenic effects, contributing to the maintenance of a high body weight.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCongenital Leptin Deficiency:\u003c/b\u003e A rare genetic disorder causing severe early-onset obesity and hyperphagia. These individuals can be treated effectively with leptin injections.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Think of leptin as the \u0027satiety hormone\u0027 from fat. High fat stores -\u003e high leptin -\u003e decreased appetite. In obesity, this feedback loop is broken due to leptin resistance.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLeptin\u003c/b\u003e is the hormonal messenger from fat tissue to the brain, signaling energy sufficiency and suppressing hunger; however, in the common state of obesity, the brain becomes deaf to this signal, leading to a state of perceived starvation despite excess energy stores.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Adipose Tissue] --Secretes--\u003e B(Leptin); B --\u003e C(Hypothalamus); C --\u003e D(Decreased Appetite); C --\u003e E(Increased Energy Expenditure);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_produced_by\",\n        \"to\": \"adipose_tissue\"\n      },\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"suppresses\",\n        \"to\": \"appetite\"\n      },\n      {\n        \"type\": \"resistance_to_is_seen_in\",\n        \"to\": \"obesity\"\n      }\n    ]\n  },\n  \"912babcc\": {\n    \"title\": \"Leukocoria\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pediatrics\",\n      \"Oncology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physical Findings\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLeukocoria\u003c/b\u003e, meaning \\\"white pupil,\\\" is an abnormal white reflection from the retina of the eye, observed in response to a bright light. It is a critical clinical sign in infants and children that can indicate serious underlying ocular pathology.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e A white or yellowish pupillary reflex, most often noticed in photographs taken with a flash, where the affected eye appears white instead of the normal red reflex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMost Serious Cause:\u003c/b\u003e The most urgent diagnosis to rule out in a child with leukocoria is \u003cmark\u003eretinoblastoma\u003c/mark\u003e, the most common intraocular malignancy in childhood.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Other causes include congenital \u003cmark\u003ecataracts\u003c/mark\u003e, Coats disease (an idiopathic retinal telangiectasia), retinopathy of prematurity, and ocular toxocariasis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Approach:\u003c/b\u003e Any child with leukocoria requires an \u003cmark\u003eurgent referral to an ophthalmologist\u003c/mark\u003e for a dilated funduscopic examination to rule out retinoblastoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A parent bringing in a photograph of their child showing a white pupil is the classic presentation for leukocoria. Your next step is always an urgent ophthalmology referral.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLeukocoria\u003c/b\u003e is a pediatric ophthalmologic emergency signal, as the seemingly innocuous \u0027white pupil\u0027 can be the presenting sign of a life- and sight-threatening malignancy, retinoblastoma, mandating immediate expert evaluation.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"63b964af\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"congenital_cataract\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"coats_disease\"\n      }\n    ]\n  },\n  \"2341f9c0\": {\n    \"title\": \"Levetiracetam\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLevetiracetam\u003c/b\u003e is a newer-generation, broad-spectrum \u003ci\u003eanticonvulsant\u003c/i\u003e medication with a unique mechanism of action, widely used for the treatment of both focal and generalized seizures.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e The exact mechanism is not fully understood, but it is known to bind to the \u003cmark\u003esynaptic vesicle protein 2A (SV2A)\u003c/mark\u003e. This is thought to modulate neurotransmitter release, although how this prevents seizures is unclear.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpectrum of Activity:\u003c/b\u003e It is a \u003cmark\u003ebroad-spectrum\u003c/mark\u003e agent, effective against focal seizures, generalized tonic-clonic seizures, and myoclonic seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has favorable pharmacokinetics with minimal hepatic metabolism (not dependent on CYP450) and few drug-drug interactions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Generally well-tolerated. The most common side effects are somnolence, dizziness, and fatigue. A significant potential side effect is \u003cmark\u003eneuropsychiatric symptoms\u003c/mark\u003e, including irritability, agitation, depression, and psychosis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Levetiracetam\u0027s unique SV2A mechanism and its broad spectrum of activity with a favorable side effect profile make it a popular choice. Be aware of the potential for behavioral and psychiatric side effects.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLevetiracetam\u003c/b\u003e is a widely used anticonvulsant due to its broad efficacy and favorable safety profile, which works through a novel mechanism of binding to the synaptic vesicle protein SV2A to modulate neurotransmitter release.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"f91a0cfa\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"binds_to\",\n        \"to\": \"sv2a\"\n      }\n    ]\n  },\n  \"335b4671\": {\n    \"title\": \"Levodopa/Carbidopa\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Movement Disorders\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Parkinson Disease Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLevodopa/Carbidopa\u003c/b\u003e is the most effective and most commonly used combination drug for the symptomatic treatment of \u003ci\u003eParkinson disease\u003c/i\u003e, working to replenish depleted dopamine levels in the brain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLevodopa (L-DOPA):\u003c/b\u003e A metabolic precursor of [[90adc821|dopamine]] that, unlike dopamine itself, can cross the [[dd47b9cc|blood-brain barrier]]. Once in the CNS, it is converted to dopamine by DOPA decarboxylase.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCarbidopa:\u003c/b\u003e A peripheral DOPA decarboxylase inhibitor that does \u003cu\u003enot\u003c/u\u003e cross the blood-brain barrier. Its purpose is to prevent the premature conversion of levodopa to dopamine in the periphery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Combination:\u003c/b\u003e Carbidopa increases the bioavailability of levodopa to the brain and \u003cmark\u003ereduces the peripheral side effects\u003c/mark\u003e of dopamine (e.g., nausea, vomiting, cardiac arrhythmias).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects (Long-term):\u003c/b\u003e After several years of use, patients often develop motor complications, including dyskinesias (involuntary movements) and the \u003cmark\u003e\\\"on-off\\\" phenomenon\u003c/mark\u003e (fluctuations between periods of good mobility and poor mobility).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the rationale for the combination: Carbidopa is the \u0027bodyguard\u0027 that allows Levodopa to reach its target (the brain) without being broken down in the periphery.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eLevodopa/Carbidopa\u003c/b\u003e combination is a clever pharmacological strategy that uses a peripheral enzyme inhibitor (Carbidopa) to maximize the central delivery of a dopamine precursor (Levodopa), effectively treating the motor symptoms of Parkinson\u0027s disease, though its long-term use is limited by motor complications.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Levodopa + Carbidopa (oral)]; A --\u003e B(Peripheral Circulation); B --Carbidopa inhibits DOPA Decarboxylase--\u003e C[Peripheral Conversion to Dopamine is Blocked]; B --Levodopa crosses BBB--\u003e D(Brain); D --DOPA Decarboxylase--\u003e E(Dopamine); E --\u003e F(Relief of Parkinson\u0027s Symptoms);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"increases_levels_of\",\n        \"to\": \"90adc821\"\n      },\n      {\n        \"type\": \"is_a_precursor_to\",\n        \"to\": \"90adc821\"\n      }\n    ]\n  },\n  \"db2f16e5\": {\n    \"title\": \"Lewy Body Dementia (LBD)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Geriatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neurodegenerative Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLewy Body Dementia (LBD)\u003c/b\u003e is a progressive neurodegenerative disorder characterized by the presence of Lewy bodies (abnormal aggregates of alpha-synuclein) in the cerebral cortex, leading to a clinical syndrome of dementia, parkinsonism, and visual hallucinations.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e An Œ±-synucleinopathy, characterized by the formation of intracellular \u003cmark\u003eLewy bodies\u003c/mark\u003e in cortical and subcortical neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCore Clinical Features:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eDementia:\u003c/b\u003e Cognitive decline, particularly in executive function and visuospatial ability.\u003cbr\u003e2. \u003cb\u003eFluctuating Cognition:\u003c/b\u003e Pronounced variations in attention and alertness.\u003cbr\u003e3. \u003cb\u003eVisual Hallucinations:\u003c/b\u003e Well-formed, recurrent visual hallucinations are a hallmark feature.\u003cbr\u003e4. \u003cb\u003eParkinsonism:\u003c/b\u003e Spontaneous motor features of parkinsonism (bradykinesia, rigidity, tremor).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSupportive Feature:\u003c/b\u003e \u003cmark\u003eREM sleep behavior disorder (RBD)\u003c/mark\u003e, where patients physically act out their dreams, is very common and often precedes other symptoms.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction from Parkinson\u0027s Disease:\u003c/b\u003e The timing of symptoms is key. In LBD, dementia develops \u003cmark\u003ebefore or concurrently with (within 1 year of)\u003c/mark\u003e the onset of parkinsonism. If dementia develops \u003e1 year after the onset of well-established Parkinson\u0027s, it is termed Parkinson disease dementia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with dementia, vivid visual hallucinations, and parkinsonian features has Lewy Body Dementia. Remember the \u0027one-year rule\u0027 to distinguish it from Parkinson disease dementia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLewy Body Dementia\u003c/b\u003e is a disease at the crossroads of Alzheimer\u0027s and Parkinson\u0027s, sharing cognitive decline with the former and motor symptoms with the latter, but distinguished by its unique core features of fluctuating cognition and vivid visual hallucinations, all driven by the cortical accumulation of Œ±-synuclein.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"bb316ca0\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\": \"lewy_bodies\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"visual_hallucinations\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"parkinsonism\"\n      }\n    ]\n  },\n  \"c3920ce1\": {\n    \"title\": \"Lidocaine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"Cardiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLidocaine\u003c/b\u003e is a widely used intermediate-acting \u003ci\u003elocal anesthetic\u003c/i\u003e of the amide class. It is also used intravenously as a Class IB antiarrhythmic agent.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Amide local anesthetic; Class IB antiarrhythmic.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism (Local Anesthetic):\u003c/b\u003e Blocks voltage-gated \u003cmark\u003eNa\u003csup\u003e+\u003c/sup\u003e channels\u003c/mark\u003e on the inner portion of the nerve membrane, preventing the propagation of action potentials and blocking nerve conduction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism (Antiarrhythmic):\u003c/b\u003e As a Class IB agent, it blocks Na\u003csup\u003e+\u003c/sup\u003e channels, preferentially in depolarized (ischemic) and rapidly firing ventricular tissue. This shortens the action potential duration.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for local infiltration, peripheral nerve blocks, and epidural anesthesia. IV lidocaine is used to treat ventricular arrhythmias, especially in the post-MI setting.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Systemic toxicity can cause CNS effects (paresthesias, tremor, seizures) and cardiovascular effects (hypotension, bradycardia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember lidocaine\u0027s dual role as a local anesthetic and a Class IB antiarrhythmic. Its preference for ischemic tissue makes it particularly useful for post-MI ventricular tachycardia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLidocaine\u003c/b\u003e is a versatile drug that leverages the same fundamental mechanism‚Äîsodium channel blockade‚Äîfor two distinct clinical purposes: to silence pain signals in peripheral nerves for local anesthesia and to suppress abnormal electrical activity in the heart for treating ventricular arrhythmias.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"b14c0eef\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"class_ib_antiarrhythmic\"\n      },\n      {\n        \"type\": \"blocks\",\n        \"to\": \"sodium_channels\"\n      }\n    ]\n  },\n  \"7a52c5ee\": {\n    \"title\": \"Light-Near Dissociation\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physical Findings\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLight-near dissociation\u003c/b\u003e is a clinical sign where the pupillary constriction response to a near stimulus (the [[81b5f5fe|accommodation]] reflex) is intact, but the pupillary light reflex is absent or greatly reduced.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e The most famous cause is the \u003cmark\u003eArgyll Robertson pupil\u003c/mark\u003e, which is pathognomonic for tertiary (neuro)syphilis. The pupils are typically small, bilateral, and irregular. Mnemonic: \\\"Prostitute\u0027s pupil\\\" - accommodates but does not react.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology (Argyll Robertson):\u003c/b\u003e The lesion is thought to be in the pretectal area of the dorsal midbrain, which interrupts the afferent fibers for the light reflex before they reach the Edinger-Westphal nucleus, while sparing the more ventral pathways for accommodation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParinaud Syndrome:\u003c/b\u003e Also known as dorsal midbrain syndrome, it is another cause of light-near dissociation (pseudo-Argyll Robertson pupils). It is caused by compression of the dorsal midbrain, often by a pineal gland tumor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdie\u0027s Tonic Pupil:\u003c/b\u003e A benign condition caused by damage to the ciliary ganglion, resulting in a dilated pupil with minimal reaction to light but a slow, tonic constriction to a near stimulus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e If you see \u0027pupils accommodate but do not react,\u0027 your first thought should be neurosyphilis (Argyll Robertson pupil).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLight-near dissociation\u003c/b\u003e is a specific form of pupillary dysfunction that points to a lesion in the dorsal midbrain, disrupting the pupillary light reflex pathway while sparing the separate, more complex pathway for the accommodation reflex.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \"to\": \"08cb577f\"\n      },\n      {\n        \"type\": \"is_a_finding_in\",\n        \"to\": \"9f603521\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"dorsal_midbrain\"\n      }\n    ]\n  },\n  \"c98ebcec\": {\n    \"title\": \"Lightheadedness\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Cardiology\",\n      \"Neurology\",\n      \"Symptom\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Cardiovascular\",\n      \"Pathology\",\n      \"Symptoms\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLightheadedness\u003c/b\u003e is a common, non-specific symptom described as a feeling of being about to faint or lose consciousness (presyncope). It is distinct from vertigo, which is a sensation of spinning.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Typically caused by a transient decrease in cerebral perfusion (blood flow to the brain).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCardiovascular Causes:\u003c/b\u003e The most common causes are cardiovascular. These include orthostatic hypotension, arrhythmias (bradycardia or tachycardia), vasovagal syncope, and structural heart disease (e.g., aortic stenosis, hypertrophic cardiomyopathy).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Causes:\u003c/b\u003e While less common, neurological causes can include vertebrobasilar insufficiency or autonomic dysfunction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction from Vertigo:\u003c/b\u003e It is crucial to differentiate lightheadedness from [[5603962d|vertigo]]. Lightheadedness is a feeling of faintness, while vertigo is a sensation of movement or spinning. Asking the patient \\\"Do you feel like you are going to pass out, or is the room spinning?\\\" is a key diagnostic question.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When a patient complains of \u0027dizziness,\u0027 the first step is to clarify what they mean. If they describe a feeling of faintness, think about causes of decreased cerebral perfusion, starting with cardiovascular etiologies.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLightheadedness\u003c/b\u003e is a symptom of impending syncope, signaling a temporary reduction in blood flow to the brain. Its evaluation should primarily focus on cardiovascular causes, as it is fundamentally a perfusion problem, not a vestibular one like vertigo.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"5603962d\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"orthostatic_hypotension\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"arrhythmia\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"vasovagal_syncope\"\n      }\n    ]\n  },\n  \"f953c5e6\": {\n    \"title\": \"Limb Ataxia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebellar Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLimb ataxia\u003c/b\u003e is a form of ataxia characterized by a lack of voluntary coordination of muscle movements in the extremities, resulting from dysfunction of the \u003ci\u003ecerebellar hemispheres\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by a lesion in the lateral parts of the [[bebe58d4|cerebellum]] (the cerebellar hemispheres), which are responsible for motor planning and coordination of the distal limbs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Manifests as clumsy, uncoordinated movements of the arms and legs. It is typically \u003cmark\u003eipsilateral\u003c/mark\u003e to the side of the cerebellar lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysical Exam Findings:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eDysmetria:\u003c/b\u003e Inability to judge distance or range of movement (e.g., overshooting or undershooting a target in the finger-to-nose test).\u003cbr\u003e - \u003cb\u003eDysdiadochokinesia:\u003c/b\u003e Inability to perform rapid, alternating movements.\u003cbr\u003e - \u003cb\u003eIntention Tremor:\u003c/b\u003e A tremor that worsens as the limb approaches its target.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction from Truncal Ataxia:\u003c/b\u003e Truncal ataxia (unsteady gait, difficulty sitting or standing unsupported) is caused by a lesion of the cerebellar vermis (midline cerebellum).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the lateral-to-medial organization of the cerebellum. Lateral lesions (hemispheres) cause limb ataxia. Medial lesions (vermis) cause truncal ataxia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLimb ataxia\u003c/b\u003e is a direct consequence of a lesion in the ipsilateral cerebellar hemisphere, leading to a breakdown in the smooth, coordinated execution of limb movements and resulting in the classic findings of dysmetria, dysdiadochokinesia, and intention tremor.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"bebe58d4\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"ataxia\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"truncal_ataxia\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"intention_tremor\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9267,
      "parts": [{
        "text": "```json\n{\n"
      }, {
        "text": "  \"f7b5ee5d\": {\n    \"title\": \""
      }, {
        "text": "Lateral Rectus Muscle\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"Anatomy\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Anatomy"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eLateral Rectus Muscle\u003c/b\u003e"
      }, {
        "text": " is one of the six extraocular muscles responsible for eye movement. Its sole function is to \u003cu\u003eabduct\u003c/u\u003e the eye, moving"
      }, {
        "text": " it laterally away from the nose.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAction:\u003c/b\u003e Abduction ("
      }, {
        "text": "lateral movement) of the eyeball.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e It is exclusively innervated by the \u003cmark"
      }, {
        "text": "\u003eabducens nerve (CN VI)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Paralysis of the lateral rectus muscle"
      }, {
        "text": " due to a [[dd11dde6|CN VI palsy]] results in an inability to abduct the eye."
      }, {
        "text": " This leads to an unopposed pull by the medial rectus, causing an esotropia (inward deviation of the eye) and horizontal"
      }, {
        "text": " [[9914d433|diplopia]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMnemonic:\u003c/b\u003e Remember the innervation of"
      }, {
        "text": " the extraocular muscles with the formula \u003cb\u003eLR\u003csub\u003e6\u003c/sub\u003eSO\u003csub\u003e4\u003c/sub\u003eR\u003csub\u003e3\u003c/sub\u003e\u003c/b\u003e (\u003cb\u003e"
      }, {
        "text": "L\u003c/b\u003eateral \u003cb\u003eR\u003c/b\u003eectus by CN \u003cb\u003e6\u003c/b\u003e, \u003cb\u003eS\u003c/b\u003euperior \u003cb\u003eO"
      }, {
        "text": "\u003c/b\u003eblique by CN \u003cb\u003e4\u003c/b\u003e, \u003cb\u003eR\u003c/b\u003eest by CN \u003cb\u003e3\u003c/b\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e An isolated inability to abduct the eye points directly to a lesion of either the lateral rectus muscle itself"
      }, {
        "text": " or, more commonly, the abducens nerve (CN VI).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003eThe \u003cb\u003eLateral Rectus muscle\u003c/b\u003e has a singular, straightforward function‚Äîeye abduction‚Äîand a dedicated nerve"
      }, {
        "text": " supply from CN VI, making its paralysis a highly specific localizing sign for abducens nerve pathology.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is"
      }, {
        "text": "_innervated_by\",\n        \"to\": \"dd11dde6\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_a_type_of\",\n        \"to\": \"extraocular_muscle\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"action_is\",\n        \"to\": \"abduction_of_eye\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"c1da8784\": {\n    \"title\": \"Lateral Vent"
      }, {
        "text": "ricles\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n"
      }, {
        "text": "      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses"
      }, {
        "text": "\",\n      \"Anatomy and Physiology\",\n      \"Ventricular System\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eLateral Ventricles\u003c/b\u003e are the two largest, C-shaped cavities of the ventricular system of"
      }, {
        "text": " the brain, located within the cerebral hemispheres. They contain cerebrospinal fluid (CSF), which is produced by their choroid plexuses.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e One in each cerebral hemisphere. Each lateral ventricle has an"
      }, {
        "text": " anterior (frontal) horn, a body (parietal), a posterior (occipital) horn, and an inferior (temporal) horn."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eCSF Flow:\u003c/b\u003e CSF flows from each lateral ventricle into the third ventricle via the paired \u003cmark\u003einterventricular foram"
      }, {
        "text": "ina of Monro\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e The cavities of the lateral ventricles are derived from"
      }, {
        "text": " the lumen of the embryonic telencephalon.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Enlargement of the lateral ventricles is"
      }, {
        "text": " a key sign of [[0bc2f200|hydrocephalus]]. In \u003cmark\u003eobstructive hydrocephalus\u003c/mark\u003e, blockage"
      }, {
        "text": " of the foramen of Monro or the cerebral aqueduct will cause dilation of the lateral ventricles. In [[7c"
      }, {
        "text": "59030e|normal pressure hydrocephalus]], all ventricles are enlarged.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e S"
      }, {
        "text": "ymmetrical enlargement of the lateral ventricles on a CT or MRI is a classic finding in hydrocephalus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003eThe \u003cb\u003eLateral Ventricles\u003c/b\u003e are the primary sites of CSF production and form the starting point of the CSF"
      }, {
        "text": " circulatory pathway; their enlargement is a sensitive indicator of pathologies that either obstruct CSF flow or impair its absorption.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Lateral Ventricles] --Foramen of Monro--\u003e B(Third Ventricle); B"
      }, {
        "text": " --Cerebral Aqueduct--\u003e C(Fourth Ventricle);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_part_of\",\n        \"to\": \"ventricular_system\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"drains_into\",\n        \"to\": \"third_ventricle\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_enlarged_in\",\n        \"to\": \"0bc2f200\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"choroid_plexus\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"b1466841\": {\n    \"title\": \"Left-"
      }, {
        "text": "Right Disorientation\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Cognitive Deficit\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLeft-right disorientation\u003c/b\u003e is a neurological deficit characterized by the"
      }, {
        "text": " inability to distinguish between the left and right sides of one\u0027s own body or in extrapersonal space. It is a component"
      }, {
        "text": " of \u003ci\u003eGerstmann syndrome\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocalization:\u003c/b\u003e This"
      }, {
        "text": " deficit is a specific sign of a lesion in the \u003cmark\u003edominant (usually left) parietal lobe\u003c/mark\u003e, specifically the"
      }, {
        "text": " angular gyrus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndrome:\u003c/b\u003e It is one of the four classic components of [[38f"
      }, {
        "text": "3ed1f|Gerstmann syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eGerstmann Syndrome Tetrad:\u003c/b\u003e The full syndrome includes "
      }, {
        "text": "\u003cb\u003eLeft-Right Disorientation\u003c/b\u003e, \u003cb\u003eAgraphia\u003c/b\u003e (inability to write), \u003cb\u003e[[8"
      }, {
        "text": "558c64b|Acalculia]]\u003c/b\u003e (inability to perform calculations), and \u003cb\u003eFinger"
      }, {
        "text": " Agnosia\u003c/b\u003e (inability to distinguish fingers).\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Territory:\u003c/b\u003e These symptoms often result from a stroke"
      }, {
        "text": " in the territory of the [[143bb23d|Middle Cerebral Artery (MCA)]] that supplies the dominant"
      }, {
        "text": " parietal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of left-right confusion with difficulty in writing, calculating"
      }, {
        "text": ", or identifying fingers is pathognomonic for Gerstmann syndrome and points to a lesion in the dominant angular gyrus.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003e\u003cb\u003eLeft-right disorientation\u003c/b\u003e is a highly specific cognitive deficit that, when present, strongly"
      }, {
        "text": " localizes a lesion to the dominant parietal lobe, often as part of the unique constellation of symptoms known as Gerstmann syndrome.\u003c/p"
      }, {
        "text": "\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_component_of\",\n        \"to\": \"38f3ed1f\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \""
      }, {
        "text": "26efa771\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke"
      }, {
        "text": "_in\",\n        \"to\": \"143bb23d\"\n      }\n    ]\n  },"
      }, {
        "text": "\n  \"516b9ff4\": {\n    \"title\": \"Lens Dislocation (Ectopia Lent"
      }, {
        "text": "is)\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Gen"
      }, {
        "text": "etics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLens dislocation\u003c/b\u003e, or \u003cb\u003eectopia lentis\u003c/b\u003e, is the"
      }, {
        "text": " displacement of the crystalline lens of the eye from its normal position. While most commonly caused by trauma, it can be a hallmark"
      }, {
        "text": " of several systemic genetic disorders.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Ca"
      }, {
        "text": "used by weakness or disruption of the zonular fibers that hold the lens in place.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMarfan Syndrome:\u003c/b\u003e An"
      }, {
        "text": " autosomal dominant connective tissue disorder caused by a mutation in the fibrillin-1 (\u003ci\u003eFBN1\u003c/i\u003e) gene. Character"
      }, {
        "text": "ized by a classic \u003cmark\u003eupward and outward (superotemporal)\u003c/mark\u003e dislocation of the lens.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHom"
      }, {
        "text": "ocystinuria:\u003c/b\u003e An autosomal recessive disorder of methionine metabolism. Characterized by a \u003cmark\u003edownward and inward ("
      }, {
        "text": "inferonasal)\u003c/mark\u003e dislocation of the lens.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Associations:\u003c/b\u003e Can also be seen in Ehl"
      }, {
        "text": "ers-Danlos syndrome, sulfite oxidase deficiency, and Weil-Marchesani syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Can"
      }, {
        "text": " cause blurred vision, diplopia, and may lead to glaucoma or retinal detachment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The direction"
      }, {
        "text": " of lens dislocation is a key feature for differentiating Marfan syndrome from homocystinuria on exams. Mnemonic: Mar"
      }, {
        "text": "\u003cb\u003efan\u003c/b\u003e\u0027s fans the lens \u003cb\u003eup\u003c/b\u003e.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEctopia lent"
      }, {
        "text": "is\u003c/b\u003e is a significant physical finding that should prompt consideration of an underlying systemic connective tissue or metabolic disorder, with the direction of dislocation"
      }, {
        "text": " providing a crucial clue to distinguish between Marfan syndrome and homocystinuria.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_finding_in\",\n        \"to"
      }, {
        "text": "\": \"marfan_syndrome\"\n      },\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "finding_in\",\n        \"to\": \"homocystinuria\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_a_finding_in\",\n        \"to\": \"ehlers_danlos_sy"
      }, {
        "text": "ndrome\"\n      }\n    ]\n  },\n  \"dcd6b576\": {\n    \"title\":"
      }, {
        "text": " \"Lenticulostriate Artery Stroke\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neurology\",\n      \"Vascular\",\n      \"Pathology\",\n      \"USMLE\"\n"
      }, {
        "text": "    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology"
      }, {
        "text": "\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003eA \u003cb\u003elenticulostriate artery stroke\u003c/b\u003e is a type of \u003ci\u003elacunar stroke\u003c/i\u003e caused"
      }, {
        "text": " by the occlusion of one of the small, deep penetrating arteries that branch from the [[143bb23d|"
      }, {
        "text": "Middle Cerebral Artery (MCA)]]. These strokes result in small infarcts in the deep brain structures.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eVascular Anatomy:\u003c/b\u003e The lenticulostriate arteries arise from the M1 segment of the MCA and supply deep"
      }, {
        "text": " structures such as the basal ganglia (putamen, globus pallidus, caudate), and the posterior limb of the internal capsule"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Occlusion is typically due to \u003cmark\u003elipohyalinosis\u003c/mark\u003e or"
      }, {
        "text": " microatheroma, processes strongly associated with chronic [[hypertension]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Syndromes:\u003c/b\u003e Because these arteries supply densely"
      }, {
        "text": " packed white matter tracts and deep nuclei, small infarcts can cause significant deficits. The most common syndrome is a \u003cmark\u003epure motor"
      }, {
        "text": " stroke\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePure Motor Stroke:\u003c/b\u003e Caused by an infarct in the contralateral posterior limb of the internal"
      }, {
        "text": " capsule. Presents with unilateral weakness of the face, arm, and leg without any sensory, visual, or cognitive deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e A patient with a history of hypertension presenting with a pure motor hemiparesis (face, arm, and leg equally"
      }, {
        "text": " affected) has a lacunar stroke in the lenticulostriate artery territory until proven otherwise.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003eStrokes involving the \u003cb\u003elenticulostriate arteries\u003c/b\u003e are the arche"
      }, {
        "text": "typal lacunar infarcts, where chronic hypertension damages these tiny end-arteries, leading to small, deep brain infarcts that produce"
      }, {
        "text": " \u0027pure\u0027 motor or sensory syndromes by selectively damaging critical white matter tracts.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n"
      }, {
        "text": "    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        "
      }, {
        "text": "\"to\": \"b56349b2\"\n      },\n      {\n        \"type\": \"causes"
      }, {
        "text": "\",\n        \"to\": \"8aefcafe\"\n      },\n      {\n        \"type\": \"is_associated"
      }, {
        "text": "_with\",\n        \"to\": \"hypertension\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "are_branches_of\",\n        \"to\": \"143bb23d\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"eec6247a\": {\n    \"title\": \"Lentiform Nucle"
      }, {
        "text": "us\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special S"
      }, {
        "text": "enses\",\n      \"Anatomy and Physiology\",\n      \"Basal Ganglia\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003eThe \u003cb\u003eLentiform Nucleus\u003c/b\u003e is a large, lens-shaped mass of gray"
      }, {
        "text": " matter located in the deep cerebral hemispheres. It is a major component of the [[ed462927|basal ganglia]] and is composed"
      }, {
        "text": " of two parts: the putamen and the globus pallidus.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Components:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003ePutamen:\u003c/b\u003e The larger, more lateral part.\u003cbr\u003e - \u003cb\u003eGlobus Pall"
      }, {
        "text": "idus:\u003c/b\u003e The smaller, more medial part, which is further subdivided into an external (GPe) and internal (GPi"
      }, {
        "text": ") segment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnatomical Relations:\u003c/b\u003e The lentiform nucleus is separated from the caudate nucleus and"
      }, {
        "text": " thalamus by the internal capsule.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e As part of the basal ganglia, it is involved in the"
      }, {
        "text": " regulation of voluntary movement. The putamen is a major input nucleus of the basal ganglia (along with the caudate), while the glob"
      }, {
        "text": "us pallidus internus is a major output nucleus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Lesions of the lentiform nucleus can"
      }, {
        "text": " cause various movement disorders. It is a common site for hypertensive intraparenchymal hemorrhages due to its supply by the vulnerable"
      }, {
        "text": " lenticulostriate arteries.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the anatomical groupings: Striatum \u003d Ca"
      }, {
        "text": "udate + Putamen. Lentiform Nucleus \u003d Putamen + Globus Pallidus.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003eThe \u003cb\u003eLentiform Nucleus\u003c/b\u003e, comprising the putamen and globus pallidus"
      }, {
        "text": ", forms the core of the basal ganglia\u0027s motor circuit, playing a pivotal role in processing cortical signals to modulate and"
      }, {
        "text": " refine voluntary movements.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_part_of\",\n        \"to\": \"ed462927\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \""
      }, {
        "text": "putamen\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \""
      }, {
        "text": "to\": \"globus_pallidus\"\n      }\n    ]\n  },\n  \"c8515"
      }, {
        "text": "469\": {\n    \"title\": \"Leptin\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Endocrinology\",\n      \"Physiology\",\n      \"Biochemistry\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Endocrine\",\n      \"Physiology\",\n      \"Hormones\"\n    "
      }, {
        "text": "],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLeptin\u003c/b\u003e is a peptide hormone produced primarily"
      }, {
        "text": " by adipose tissue that acts on the [[89e86633|hypothalamus]] to regulate appetite and energy balance"
      }, {
        "text": ". It functions as a long-term satiety signal, informing the brain about the body\u0027s fat stores.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSource:\u003c/b\u003e Secreted by adipocytes (fat cells) in proportion to the amount of stored"
      }, {
        "text": " fat.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTarget:\u003c/b\u003e Acts on receptors in the arcuate nucleus of the [[89e86"
      }, {
        "text": "633|hypothalamus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Suppresses appetite and increases energy expenditure. It inhibits"
      }, {
        "text": " orexigenic (appetite-stimulating) neurons and stimulates anorexigenic (appetite-suppressing) neurons.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eLeptin Resistance:\u003c/b\u003e In obesity, plasma leptin levels are high, but the brain becomes resistant to its anore"
      }, {
        "text": "xigenic effects, contributing to the maintenance of a high body weight.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCongenital Leptin Deficiency:\u003c/b\u003e A"
      }, {
        "text": " rare genetic disorder causing severe early-onset obesity and hyperphagia. These individuals can be treated effectively with leptin injections"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Think of leptin as the \u0027satiety hormone\u0027 from fat."
      }, {
        "text": " High fat stores -\u003e high leptin -\u003e decreased appetite. In obesity, this feedback loop is broken due to leptin resistance.\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLeptin\u003c/b\u003e is the hormonal messenger from fat tissue to the brain, signaling"
      }, {
        "text": " energy sufficiency and suppressing hunger; however, in the common state of obesity, the brain becomes deaf to this signal, leading"
      }, {
        "text": " to a state of perceived starvation despite excess energy stores.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Ad"
      }, {
        "text": "ipose Tissue] --Secretes--\u003e B(Leptin); B --\u003e C(Hypothalamus); C --\u003e"
      }, {
        "text": " D(Decreased Appetite); C --\u003e E(Increased Energy Expenditure);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_produced_by\",\n        \"to\": \"adipose_tissue\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"acts_on\",\n        \"to\": \"89e8663"
      }, {
        "text": "3\"\n      },\n      {\n        \"type\": \"suppresses\",\n        \"to\": \"appet"
      }, {
        "text": "ite\"\n      },\n      {\n        \"type\": \"resistance_to_is_seen_in\",\n        \"to\":"
      }, {
        "text": " \"obesity\"\n      }\n    ]\n  },\n  \"912babcc\": {\n    \"title\":"
      }, {
        "text": " \"Leukocoria\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"Pediatrics\",\n      \"Oncology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \""
      }, {
        "text": "Physical Findings\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLeukocoria\u003c/b\u003e"
      }, {
        "text": ", meaning \\\"white pupil,\\\" is an abnormal white reflection from the retina of the eye, observed in response to a bright"
      }, {
        "text": " light. It is a critical clinical sign in infants and children that can indicate serious underlying ocular pathology.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e A white or yellowish pupillary reflex, most often noticed in photographs taken"
      }, {
        "text": " with a flash, where the affected eye appears white instead of the normal red reflex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMost Serious Cause:\u003c/b\u003e The"
      }, {
        "text": " most urgent diagnosis to rule out in a child with leukocoria is \u003cmark\u003eretinoblastoma\u003c/mark\u003e, the"
      }, {
        "text": " most common intraocular malignancy in childhood.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Other causes include congenital \u003cmark\u003ecataracts\u003c/mark\u003e, Coats"
      }, {
        "text": " disease (an idiopathic retinal telangiectasia), retinopathy of prematurity, and ocular toxocariasis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Approach:\u003c/b\u003e Any child with leukocoria requires an \u003cmark\u003eurgent referral to an ophthalmologist\u003c/mark\u003e for a dilated"
      }, {
        "text": " funduscopic examination to rule out retinoblastoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A parent bringing in a photograph"
      }, {
        "text": " of their child showing a white pupil is the classic presentation for leukocoria. Your next step is always an urgent ophthalm"
      }, {
        "text": "ology referral.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLeukocoria\u003c/b\u003e is a pediatric"
      }, {
        "text": " ophthalmologic emergency signal, as the seemingly innocuous \u0027white pupil\u0027 can be the presenting sign of a life- and sight-threatening malignancy,"
      }, {
        "text": " retinoblastoma, mandating immediate expert evaluation.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to"
      }, {
        "text": "\": \"63b964af\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_sign_of\",\n        \"to\": \"congenital_cataract\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"coats_"
      }, {
        "text": "disease\"\n      }\n    ]\n  },\n  \"2341f9c0\": {\n    \"title\":"
      }, {
        "text": " \"Levetiracetam\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLevetiracetam\u003c/b\u003e is a newer"
      }, {
        "text": "-generation, broad-spectrum \u003ci\u003eanticonvulsant\u003c/i\u003e medication with a unique mechanism of action, widely used for the treatment of both"
      }, {
        "text": " focal and generalized seizures.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e The"
      }, {
        "text": " exact mechanism is not fully understood, but it is known to bind to the \u003cmark\u003esynaptic vesicle protein 2A (SV"
      }, {
        "text": "2A)\u003c/mark\u003e. This is thought to modulate neurotransmitter release, although how this prevents seizures is unclear.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpectrum"
      }, {
        "text": " of Activity:\u003c/b\u003e It is a \u003cmark\u003ebroad-spectrum\u003c/mark\u003e agent, effective against focal seizures, generalized"
      }, {
        "text": " tonic-clonic seizures, and myoclonic seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has favorable pharmacokinetics with"
      }, {
        "text": " minimal hepatic metabolism (not dependent on CYP450) and few drug-drug interactions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Generally"
      }, {
        "text": " well-tolerated. The most common side effects are somnolence, dizziness, and fatigue. A significant potential side effect is \u003cmark\u003eneuro"
      }, {
        "text": "psychiatric symptoms\u003c/mark\u003e, including irritability, agitation, depression, and psychosis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Levetiracetam\u0027"
      }, {
        "text": "s unique SV2A mechanism and its broad spectrum of activity with a favorable side effect profile make it a popular choice. Be"
      }, {
        "text": " aware of the potential for behavioral and psychiatric side effects.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLevetir"
      }, {
        "text": "acetam\u003c/b\u003e is a widely used anticonvulsant due to its broad efficacy and favorable safety profile, which works through"
      }, {
        "text": " a novel mechanism of binding to the synaptic vesicle protein SV2A to modulate neurotransmitter release.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },"
      }, {
        "text": "\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"f91a0cfa\"\n      },\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_treatment_for\",\n        \"to\": \"64c08e92\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"binds_to\",\n        \"to\": \"sv2a\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"335b4671\": {\n    \"title\": \"Levodopa/"
      }, {
        "text": "Carbidopa\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology"
      }, {
        "text": "\",\n      \"Neurology\",\n      \"Movement Disorders\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Park"
      }, {
        "text": "inson Disease Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLevodopa/"
      }, {
        "text": "Carbidopa\u003c/b\u003e is the most effective and most commonly used combination drug for the symptomatic treatment of \u003ci\u003eParkinson disease\u003c/i\u003e, working"
      }, {
        "text": " to replenish depleted dopamine levels in the brain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLevodopa ("
      }, {
        "text": "L-DOPA):\u003c/b\u003e A metabolic precursor of [[90adc821|dopamine]] that,"
      }, {
        "text": " unlike dopamine itself, can cross the [[dd47b9cc|blood-brain barrier]]. Once in the CNS"
      }, {
        "text": ", it is converted to dopamine by DOPA decarboxylase.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCarbidopa:\u003c/b\u003e A peripheral DOPA decarboxylase inhibitor that does"
      }, {
        "text": " \u003cu\u003enot\u003c/u\u003e cross the blood-brain barrier. Its purpose is to prevent the premature conversion of levodopa to"
      }, {
        "text": " dopamine in the periphery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Combination:\u003c/b\u003e Carbidopa increases the bioavailability of levodopa to"
      }, {
        "text": " the brain and \u003cmark\u003ereduces the peripheral side effects\u003c/mark\u003e of dopamine (e.g., nausea, vomiting, cardiac"
      }, {
        "text": " arrhythmias).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects (Long-term):\u003c/b\u003e After several years of use, patients often develop motor complications"
      }, {
        "text": ", including dyskinesias (involuntary movements) and the \u003cmark\u003e\\\"on-off\\\" phenomenon\u003c/mark\u003e (flu"
      }, {
        "text": "ctuations between periods of good mobility and poor mobility).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the rationale for the combination: Carbidopa is"
      }, {
        "text": " the \u0027bodyguard\u0027 that allows Levodopa to reach its target (the brain) without being broken down in the periphery.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003eThe \u003cb\u003eLevodopa/Carbidopa\u003c/b\u003e combination is a clever pharmacological strategy that uses"
      }, {
        "text": " a peripheral enzyme inhibitor (Carbidopa) to maximize the central delivery of a dopamine precursor (Levodopa), effectively"
      }, {
        "text": " treating the motor symptoms of Parkinson\u0027s disease, though its long-term use is limited by motor complications.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"graph TD; A[Levodopa + Carbidopa (oral)]; A --\u003e B(Peripheral"
      }, {
        "text": " Circulation); B --Carbidopa inhibits DOPA Decarboxylase--\u003e C[Peripheral Conversion to Dopamine is Blocked]; B --Lev"
      }, {
        "text": "odopa crosses BBB--\u003e D(Brain); D --DOPA Decarboxylase--\u003e E(Dopamine); E --\u003e F"
      }, {
        "text": "(Relief of Parkinson\u0027s Symptoms);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_treatment_for\",\n        \"to\": \"58c8ea03\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"increases_levels_of\",\n        \"to\": \"90adc821"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_a_precursor_to\",\n        \"to"
      }, {
        "text": "\": \"90adc821\"\n      }\n    ]\n  },\n  \"db2f1"
      }, {
        "text": "6e5\": {\n    \"title\": \"Lewy Body Dementia (LBD)\",\n    \"primaryType"
      }, {
        "text": "\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Geriatrics\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Neurodegenerative Disorders\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLewy Body Dementia (LBD)\u003c/b\u003e is a progressive neurodegenerative disorder characterized by the"
      }, {
        "text": " presence of Lewy bodies (abnormal aggregates of alpha-synuclein) in the cerebral cortex, leading to a"
      }, {
        "text": " clinical syndrome of dementia, parkinsonism, and visual hallucinations.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ology:\u003c/b\u003e An Œ±-synucleinopathy, characterized by the formation of intracellular \u003cmark\u003eLewy bodies\u003c/mark\u003e in cortical"
      }, {
        "text": " and subcortical neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCore Clinical Features:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eDementia:\u003c/b\u003e Cognitive"
      }, {
        "text": " decline, particularly in executive function and visuospatial ability.\u003cbr\u003e2. \u003cb\u003eFluctuating Cognition:\u003c/b\u003e Pron"
      }, {
        "text": "ounced variations in attention and alertness.\u003cbr\u003e3. \u003cb\u003eVisual Hallucinations:\u003c/b\u003e Well-formed, recurrent visual"
      }, {
        "text": " hallucinations are a hallmark feature.\u003cbr\u003e4. \u003cb\u003eParkinsonism:\u003c/b\u003e Spontaneous motor features of parkinsonism (br"
      }, {
        "text": "adykinesia, rigidity, tremor).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSupportive Feature:\u003c/b\u003e \u003cmark\u003eREM sleep behavior disorder (R"
      }, {
        "text": "BD)\u003c/mark\u003e, where patients physically act out their dreams, is very common and often precedes other symptoms.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDist"
      }, {
        "text": "inction from Parkinson\u0027s Disease:\u003c/b\u003e The timing of symptoms is key. In LBD, dementia develops \u003cmark\u003ebefore or concurrently"
      }, {
        "text": " with (within 1 year of)\u003c/mark\u003e the onset of parkinsonism. If dementia develops \u003e1 year after the onset of well"
      }, {
        "text": "-established Parkinson\u0027s, it is termed Parkinson disease dementia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with dementia, vivid"
      }, {
        "text": " visual hallucinations, and parkinsonian features has Lewy Body Dementia. Remember the \u0027one-year rule\u0027 to distinguish it"
      }, {
        "text": " from Parkinson disease dementia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLewy Body Dementia\u003c/b\u003e is a disease"
      }, {
        "text": " at the crossroads of Alzheimer\u0027s and Parkinson\u0027s, sharing cognitive decline with the former and motor symptoms with the latter, but distinguished"
      }, {
        "text": " by its unique core features of fluctuating cognition and vivid visual hallucinations, all driven by the cortical accumulation of Œ±-synuclein.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_type_of\",\n        \"to\": \"bb316ca0\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_characterized_by\",\n        \"to\": \"lewy_bodies\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"differentiated_from\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"presents_with\",\n        \"to\": \"visual_hallucinations\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"parkinsonism\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"c3920ce1\": {\n    \"title\": \"Lidocaine\",\n    \""
      }, {
        "text": "primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"Cardiology"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eLidocaine\u003c/b\u003e is a widely used intermediate-acting \u003ci\u003elocal anesthetic\u003c/i\u003e of the amide class."
      }, {
        "text": " It is also used intravenously as a Class IB antiarrhythmic agent.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClass"
      }, {
        "text": ":\u003c/b\u003e Amide local anesthetic; Class IB antiarrhythmic.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism (Local Anesthetic):\u003c/b\u003e Blocks"
      }, {
        "text": " voltage-gated \u003cmark\u003eNa\u003csup\u003e+\u003c/sup\u003e channels\u003c/mark\u003e on the inner portion of the nerve membrane, preventing the propagation"
      }, {
        "text": " of action potentials and blocking nerve conduction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism (Antiarrhythmic):\u003c/b\u003e As a Class IB agent, it blocks Na"
      }, {
        "text": "\u003csup\u003e+\u003c/sup\u003e channels, preferentially in depolarized (ischemic) and rapidly firing ventricular tissue. This shortens the action"
      }, {
        "text": " potential duration.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for local infiltration, peripheral nerve blocks, and epidural anesthesia. IV"
      }, {
        "text": " lidocaine is used to treat ventricular arrhythmias, especially in the post-MI setting.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e System"
      }, {
        "text": "ic toxicity can cause CNS effects (paresthesias, tremor, seizures) and cardiovascular effects (hypotension, bradycardia)."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember lidocaine\u0027s dual role as a local anesthetic and a Class IB antiarrhythmic. Its"
      }, {
        "text": " preference for ischemic tissue makes it particularly useful for post-MI ventricular tachycardia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLidocaine"
      }, {
        "text": "\u003c/b\u003e is a versatile drug that leverages the same fundamental mechanism‚Äîsodium channel blockade‚Äîfor two distinct clinical purposes: to silence"
      }, {
        "text": " pain signals in peripheral nerves for local anesthesia and to suppress abnormal electrical activity in the heart for treating ventricular arrhythmias.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"b14c0eef\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_type_of\",\n        \"to\": \"class_ib_"
      }, {
        "text": "antiarrhythmic\"\n      },\n      {\n        \"type\": \"blocks\",\n        \"to\": \""
      }, {
        "text": "sodium_channels\"\n      }\n    ]\n  },\n  \"7a52c5ee\": {\n    \"title"
      }, {
        "text": "\": \"Light-Near Dissociation\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physical"
      }, {
        "text": " Findings\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLight-near dissociation"
      }, {
        "text": "\u003c/b\u003e is a clinical sign where the pupillary constriction response to a near stimulus (the [[81b5f5fe"
      }, {
        "text": "|accommodation]] reflex) is intact, but the pupillary light reflex is absent or greatly reduced.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e The most famous cause is the \u003cmark\u003eArgyll Robertson"
      }, {
        "text": " pupil\u003c/mark\u003e, which is pathognomonic for tertiary (neuro)syphilis. The pupils are typically small"
      }, {
        "text": ", bilateral, and irregular. Mnemonic: \\\"Prostitute\u0027s pupil\\\" - accommodates but does not react.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology (Argyll Robertson):\u003c/b\u003e The lesion is thought to be in the pretectal area of the dorsal"
      }, {
        "text": " midbrain, which interrupts the afferent fibers for the light reflex before they reach the Edinger-Westphal nucleus, while sparing the more"
      }, {
        "text": " ventral pathways for accommodation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParinaud Syndrome:\u003c/b\u003e Also known as dorsal midbrain syndrome, it is another"
      }, {
        "text": " cause of light-near dissociation (pseudo-Argyll Robertson pupils). It is caused by compression of the dorsal midbrain, often"
      }, {
        "text": " by a pineal gland tumor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdie\u0027s Tonic Pupil:\u003c/b\u003e A benign condition caused by damage to the c"
      }, {
        "text": "iliary ganglion, resulting in a dilated pupil with minimal reaction to light but a slow, tonic constriction to a near stimulus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE"
      }, {
        "text": " Tip:\u003c/b\u003e If you see \u0027pupils accommodate but do not react,\u0027 your first thought should be neurosyphilis"
      }, {
        "text": " (Argyll Robertson pupil).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLight-near dissociation\u003c/b\u003e is a specific"
      }, {
        "text": " form of pupillary dysfunction that points to a lesion in the dorsal midbrain, disrupting the pupillary light reflex pathway while"
      }, {
        "text": " sparing the separate, more complex pathway for the accommodation reflex.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \"to"
      }, {
        "text": "\": \"08cb577f\"\n      },\n      {\n        \"type\": \"is_a_finding_in\","
      }, {
        "text": "\n        \"to\": \"9f603521\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "caused_by_lesion_in\",\n        \"to\": \"dorsal_midbrain\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"c98ebcec\": {\n    \"title\": \"Lightheadedness\",\n    \"primary"
      }, {
        "text": "Type\": \"finding\",\n    \"tags\": [\n      \"Cardiology\",\n      \"Neurology\",\n      \"Symptom\",\n"
      }, {
        "text": "      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Cardiovascular\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"Symptoms\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLightheadedness\u003c/b\u003e is"
      }, {
        "text": " a common, non-specific symptom described as a feeling of being about to faint or lose consciousness (presyncope). It is distinct from vertigo"
      }, {
        "text": ", which is a sensation of spinning.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Typically"
      }, {
        "text": " caused by a transient decrease in cerebral perfusion (blood flow to the brain).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCardiovascular Causes:\u003c/b\u003e The"
      }, {
        "text": " most common causes are cardiovascular. These include orthostatic hypotension, arrhythmias (bradycardia or tachycardia), vasovagal syncope, and structural heart disease"
      }, {
        "text": " (e.g., aortic stenosis, hypertrophic cardiomyopathy).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Causes:\u003c/b\u003e While less common,"
      }, {
        "text": " neurological causes can include vertebrobasilar insufficiency or autonomic dysfunction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction from Vertigo:\u003c/b\u003e It"
      }, {
        "text": " is crucial to differentiate lightheadedness from [[5603962d|vertigo]]. Lightheadedness is a feeling of faint"
      }, {
        "text": "ness, while vertigo is a sensation of movement or spinning. Asking the patient \\\"Do you feel like you are going to pass"
      }, {
        "text": " out, or is the room spinning?\\\" is a key diagnostic question.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When"
      }, {
        "text": " a patient complains of \u0027dizziness,\u0027 the first step is to clarify what they mean. If they describe a feeling of faint"
      }, {
        "text": "ness, think about causes of decreased cerebral perfusion, starting with cardiovascular etiologies.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLight"
      }, {
        "text": "headedness\u003c/b\u003e is a symptom of impending syncope, signaling a temporary reduction in blood flow to the brain. Its evaluation"
      }, {
        "text": " should primarily focus on cardiovascular causes, as it is fundamentally a perfusion problem, not a vestibular one like vertigo.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"differentiated_from"
      }, {
        "text": "\",\n        \"to\": \"5603962d\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_symptom_of\",\n        \"to\": \"orthostatic_hypotension\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to"
      }, {
        "text": "\": \"arrhythmia\"\n      },\n      {\n        \"type\": \"is_a_sympt"
      }, {
        "text": "om_of\",\n        \"to\": \"vasovagal_syncope\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"f953c5e6\": {\n    \"title\": \"Limb Ataxia\",\n    \"primaryType\":"
      }, {
        "text": " \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Cerebellar Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eLimb ataxia\u003c/b\u003e is a form of ataxia characterized by a lack of voluntary coordination of muscle movements in the extremities, resulting"
      }, {
        "text": " from dysfunction of the \u003ci\u003ecerebellar hemispheres\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophys"
      }, {
        "text": "iology:\u003c/b\u003e Caused by a lesion in the lateral parts of the [[bebe58d4|cerebellum]]"
      }, {
        "text": " (the cerebellar hemispheres), which are responsible for motor planning and coordination of the distal limbs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:"
      }, {
        "text": "\u003c/b\u003e Manifests as clumsy, uncoordinated movements of the arms and legs. It is typically \u003cmark\u003eipsilateral\u003c/"
      }, {
        "text": "mark\u003e to the side of the cerebellar lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysical Exam Findings:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eDysmetria"
      }, {
        "text": ":\u003c/b\u003e Inability to judge distance or range of movement (e.g., overshooting or undershooting a target in"
      }, {
        "text": " the finger-to-nose test).\u003cbr\u003e - \u003cb\u003eDysdiadochokinesia:\u003c/b\u003e Inability to perform rapid"
      }, {
        "text": ", alternating movements.\u003cbr\u003e - \u003cb\u003eIntention Tremor:\u003c/b\u003e A tremor that worsens as the limb approaches its"
      }, {
        "text": " target.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction from Truncal Ataxia:\u003c/b\u003e Truncal ataxia (unsteady gait, difficulty sitting"
      }, {
        "text": " or standing unsupported) is caused by a lesion of the cerebellar vermis (midline cerebellum).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember"
      }, {
        "text": " the lateral-to-medial organization of the cerebellum. Lateral lesions (hemispheres) cause limb ataxia. Med"
      }, {
        "text": "ial lesions (vermis) cause truncal ataxia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "\u003cb\u003eLimb ataxia\u003c/b\u003e is a direct consequence of a lesion in the ipsilateral cerebellar hemisphere, leading to a breakdown in the smooth"
      }, {
        "text": ", coordinated execution of limb movements and resulting in the classic findings of dysmetria, dysdiadochokinesia, and intention tremor.\u003c/p\u003e\","
      }, {
        "text": "\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \""
      }, {
        "text": "is_caused_by_lesion_in\",\n        \"to\": \"bebe58d4\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"ataxia\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        "
      }, {
        "text": "\"to\": \"truncal_ataxia\"\n      },\n      {\n        \"type\": \"p"
      }, {
        "text": "resents_with\",\n        \"to\": \"intention_tremor\"\n      }\n    ]\n  }\n}"
      }, {
        "text": "\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"7278c124\",\n    \"letter\": \"J\",\n    \"term\": \"Joints\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Joints\",\n    \"sub_entries\": [\n      {\n        \"id\": \"4da3f3c2\",\n        \"letter\": \"J\",\n        \"term\": \"angle change sensation\",\n        \"pages\": [\n          \"504\"\n        ],\n        \"context\": \"Joints \u003e angle change sensation\"\n      }\n    ]\n  },\n  {\n    \"id\": \"5690849b\",\n    \"letter\": \"K\",\n    \"term\": \"Kallmann syndrome\",\n    \"pages\": [\n      \"508\",\n      \"654\",\n      \"656\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Kallmann syndrome\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"08bf5432\",\n    \"letter\": \"K\",\n    \"term\": \"Ketamine\",\n    \"pages\": [\n      \"565\",\n      \"578\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Ketamine\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"c6292526\",\n    \"letter\": \"K\",\n    \"term\": \"Kl√ºver-Bucy syndrome, brain lesions\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Kl√ºver-Bucy syndrome, brain lesions\",\n    \"sub_entries\": [\n      {\n        \"id\": \"f9edbbce\",\n        \"letter\": \"K\",\n        \"term\": \"with\",\n        \"pages\": [\n          \"524\"\n        ],\n        \"context\": \"Kl√ºver-Bucy syndrome, brain lesions \u003e with\"\n      }\n    ]\n  },\n  {\n    \"id\": \"246a82f3\",\n    \"letter\": \"K\",\n    \"term\": \"Krabbe disease\",\n    \"pages\": [\n      \"86\",\n      \"538\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Krabbe disease\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"e8326588\",\n    \"letter\": \"K\",\n    \"term\": \"Kyphoscoliosis\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Kyphoscoliosis\",\n    \"sub_entries\": [\n      {\n        \"id\": \"d73c7040\",\n        \"letter\": \"K\",\n        \"term\": \"in childhood\",\n        \"pages\": [\n          \"545\"\n        ],\n        \"context\": \"Kyphoscoliosis \u003e in childhood\"\n      }\n    ]\n  },\n  {\n    \"id\": \"4f7f6fab\",\n    \"letter\": \"L\",\n    \"term\": \"Lacrimation reflex\",\n    \"pages\": [\n      \"519\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Lacrimation reflex\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"b56349b2\",\n    \"letter\": \"L\",\n    \"term\": \"Lacunar infarcts\",\n    \"pages\": [\n      \"526\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Lacunar infarcts\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"080a3d8f\",\n    \"letter\": \"L\",\n    \"term\": \"Lamotrigine\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Lamotrigine\",\n    \"sub_entries\": [\n      {\n        \"id\": \"251a3c8a\",\n        \"letter\": \"L\",\n        \"term\": \"mechanism and adverse effects\",\n        \"pages\": [\n          \"560\"\n        ],\n        \"context\": \"Lamotrigine \u003e mechanism and adverse effects\"\n      }\n    ]\n  },\n  {\n    \"id\": \"c5805ca4\",\n    \"letter\": \"L\",\n    \"term\": \"Landmarks (anatomical)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Landmarks (anatomical)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"3f345fe4\",\n        \"letter\": \"L\",\n        \"term\": \"for dermatomes\",\n        \"pages\": [\n          \"523\"\n        ],\n        \"context\": \"Landmarks (anatomical) \u003e for dermatomes\"\n      }\n    ]\n  },\n  {\n    \"id\": \"86e223f7\",\n    \"letter\": \"L\",\n    \"term\": \"Latanoprost\",\n    \"pages\": [\n      \"568\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Latanoprost\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"4d8b1ee2\",\n    \"letter\": \"L\",\n    \"term\": \"Lateral corticospinal tract\",\n    \"pages\": [\n      \"521\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Lateral corticospinal tract\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"08d19deb\",\n    \"letter\": \"L\",\n    \"term\": \"Lateral geniculate nucleus\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Lateral geniculate nucleus\",\n    \"sub_entries\": [\n      {\n        \"id\": \"9880125c\",\n        \"letter\": \"L\",\n        \"term\": \"(thalamus)\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Lateral geniculate nucleus \u003e (thalamus)\"\n      }\n    ]\n  },\n  {\n    \"id\": \"07656b4a\",\n    \"letter\": \"L\",\n    \"term\": \"Lateral medullary (Wallenberg)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Lateral medullary (Wallenberg)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"2a851978\",\n        \"letter\": \"L\",\n        \"term\": \"syndrome\",\n        \"pages\": [\n          \"527\"\n        ],\n        \"context\": \"Lateral medullary (Wallenberg) \u003e syndrome\"\n      }\n    ]\n  },\n  {\n    \"id\": \"b37e8260\",\n    \"letter\": \"L\",\n    \"term\": \"Lateral nucleus (hypothalamus)\",\n    \"pages\": [\n      \"508\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Lateral nucleus (hypothalamus)\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 1767
    }, {
      "text": "```json\n{\n  \"7278c124\": {\n    \"title\": \"Joint Position Sense (Proprioception)\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sensory System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eJoint position sense\u003c/b\u003e, or \u003cb\u003eproprioception\u003c/b\u003e, is the sense of the relative position of one\u0027s own parts of the body and strength of effort being employed in movement. It is a key component of somatosensation, transmitted via the dorsal column-medial lemniscus pathway.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSensory Receptors:\u003c/b\u003e Mediated by mechanoreceptors in muscles (muscle spindles), tendons (Golgi tendon organs), and \u003cmark\u003ejoints\u003c/mark\u003e (Ruffini corpuscles, Pacinian corpuscles).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNerve Fibers:\u003c/b\u003e Transmitted by large, heavily myelinated, and fast-conducting AŒ± and AŒ≤ fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Signals travel up the ipsilateral [[e7f5cbbe|dorsal columns]] to the medulla, synapse, decussate, and ascend via the [[f19bc454|medial lemniscus]] to the VPL nucleus of the [[afc0a64b|thalamus]], and finally to the somatosensory cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Testing:\u003c/b\u003e Assessed by moving a patient\u0027s joint (e.g., the great toe) up or down with their eyes closed and asking them to identify the direction of movement. The [[47a0f3d1|Romberg test]] also assesses proprioception.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Loss of proprioception and vibration sense is a hallmark of [[e7f5cbbe|dorsal column]] pathology, seen in conditions like [[71daebd6|tabes dorsalis]] and [[6f5bea90|subacute combined degeneration]] (vitamin B12 deficiency).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eProprioception\u003c/b\u003e is the body\u0027s \u0027sixth sense,\u0027 providing the brain with a constant, unconscious awareness of limb position and movement, which is essential for coordinated motor control and balance. Its reliance on large, myelinated fibers makes it vulnerable in specific neurological disorders.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_also_known_as\",\n        \"to\": \"proprioception\"\n      },\n      {\n        \"type\": \"is_transmitted_via\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \"is_impaired_in\",\n        \"to\": \"71daebd6\"\n      },\n      {\n        \"type\": \"is_impaired_in\",\n        \"to\": \"6f5bea90\"\n      }\n    ]\n  },\n  \"5690849b\": {\n    \"title\": \"Kallmann Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Genetics\",\n      \"Reproductive\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Pathology\",\n      \"Hypogonadism\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eKallmann syndrome\u003c/b\u003e is a genetic disorder characterized by the combination of \u003ci\u003ehypogonadotropic hypogonadism\u003c/i\u003e (delayed or absent puberty) and \u003ci\u003eanosmia\u003c/i\u003e (inability to smell) or hyposmia (reduced ability to smell).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by the failure of GnRH-secreting neurons to migrate from their embryonic origin in the olfactory placode to the [[89e86633|hypothalamus]]. This results in a deficiency of Gonadotropin-Releasing Hormone (GnRH).\u003c/li\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Can be inherited in X-linked recessive, autosomal dominant, or autosomal recessive patterns. Mutations in genes like \u003ci\u003eKAL1\u003c/i\u003e are implicated.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients present with failure to undergo puberty. Males have micropenis and cryptorchidism; females have primary amenorrhea. Both sexes have anosmia or hyposmia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLab Findings:\u003c/b\u003e Characterized by low levels of GnRH, leading to low levels of LH, FSH, and sex steroids (testosterone or estrogen).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The unique combination of delayed puberty and an inability to smell is the pathognomonic presentation of Kallmann syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eKallmann syndrome\u003c/b\u003e is a developmental disorder where the migratory path of GnRH neurons is disrupted, inextricably linking the sense of smell with the onset of puberty and demonstrating the shared embryonic origin of these two seemingly unrelated systems.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Failure of GnRH Neuron Migration] --\u003e B(GnRH Deficiency); B --\u003e C(Low LH/FSH); C --\u003e D(Hypogonadism/Delayed Puberty); A --\u003e E(Defective Olfactory Bulb Development); E --\u003e F(Anosmia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"hypogonadotropic_hypogonadism\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"anosmia\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"failure_of_gnrh_neuron_migration\"\n      }\n    ]\n  },\n  \"08bf5432\": {\n    \"title\": \"Ketamine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eKetamine\u003c/b\u003e is an intravenous anesthetic agent that produces a state of \u003ci\u003edissociative anesthesia\u003c/i\u003e, characterized by profound analgesia, amnesia, and catalepsy, while preserving cardiovascular and respiratory function. It is also used for depression and as a recreational drug.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e It is a non-competitive antagonist of the \u003cmark\u003eNMDA (N-methyl-D-aspartate) receptor\u003c/mark\u003e, a type of glutamate receptor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnesthetic Effects:\u003c/b\u003e Induces a trance-like state with pain relief, sedation, and memory loss. It is sympathomimetic, causing increased heart rate, blood pressure, and cardiac output, and is also a potent bronchodilator.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for induction and maintenance of anesthesia, particularly in hemodynamically unstable patients or those with bronchospasm. Also used for procedural sedation and analgesia. Recently approved as a nasal spray for treatment-resistant depression.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Causes \u003cmark\u003eemergence reactions\u003c/mark\u003e as the drug wears off, including vivid dreams, hallucinations, and delirium. Co-administration of benzodiazepines can reduce this risk. It also increases intracranial pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Ketamine\u0027s unique properties are its sympathomimetic effects (increased BP/HR) and the risk of psychotomimetic emergence phenomena. Its mechanism as an NMDA antagonist is also high-yield.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eKetamine\u003c/b\u003e is a unique anesthetic that works by blocking NMDA receptors, producing a \u0027dissociative\u0027 state that provides analgesia and amnesia while maintaining cardiopulmonary stability, but its use is tempered by the potential for psychotomimetic emergence reactions.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"intravenous_anesthetic\"\n      },\n      {\n        \"type\": \"antagonizes\",\n        \"to\": \"nmda_receptor\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"depression\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"hallucinations\"\n      }\n    ]\n  },\n  \"c6292526\": {\n    \"title\": \"Kl√ºver-Bucy Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Psychiatry\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eKl√ºver-Bucy syndrome\u003c/b\u003e is a rare behavioral syndrome resulting from bilateral damage to the medial temporal lobes, particularly the \u003ci\u003eamygdala\u003c/i\u003e. It is characterized by a constellation of symptoms including hyperorality, hypersexuality, and placidity.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by lesions that destroy the [[d220fc3f|amygdala]] bilaterally. The most common cause is \u003cmark\u003eHerpes Simplex Virus (HSV-1) encephalitis\u003c/mark\u003e, which has a predilection for the temporal lobes. Other causes include trauma, stroke, and Pick disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Features:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eHyperphagia:\u003c/b\u003e Excessive eating and weight gain.\u003cbr\u003e - \u003cb\u003eHypersexuality:\u003c/b\u003e Inappropriate and indiscriminate sexual behavior.\u003cbr\u003e - \u003cb\u003eHypermetamorphosis:\u003c/b\u003e Compulsive desire to explore every object in sight.\u003cbr\u003e - \u003cb\u003eHyperorality:\u003c/b\u003e Tendency to examine objects by mouth.\u003cbr\u003e - \u003cb\u003ePlacidity:\u003c/b\u003e Diminished fear response, appearing tame or emotionally blunted.\u003cbr\u003e - \u003cb\u003eVisual Agnosia:\u003c/b\u003e Inability to recognize familiar objects or faces.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient who survives HSV encephalitis and subsequently develops bizarre behaviors like putting inedible objects in their mouth, inappropriate sexual advances, and a flattened emotional response is the classic presentation of Kl√ºver-Bucy syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eKl√ºver-Bucy syndrome\u003c/b\u003e is a dramatic demonstration of the amygdala\u0027s role in processing emotion and driving behavior; its bilateral destruction unmasks primitive oral and sexual tendencies and extinguishes the normal fear response.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"d220fc3f\"\n      },\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"hsv_encephalitis\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"hyperphagia\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"hypersexuality\"\n      }\n    ]\n  },\n  \"246a82f3\": {\n    \"title\": \"Krabbe Disease\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pediatrics\",\n      \"Genetics\",\n      \"Biochemistry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eKrabbe disease\u003c/b\u003e, also known as globoid cell leukodystrophy, is a rare, fatal, autosomal recessive \u003ci\u003elysosomal storage disease\u003c/i\u003e caused by a deficiency of the enzyme galactocerebrosidase, leading to the accumulation of galactocerebroside and psychosine, which destroys myelin-producing cells.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Autosomal recessive inheritance.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEnzyme Deficiency:\u003c/b\u003e Deficiency of \u003cmark\u003egalactocerebrosidase\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAccumulated Substrate:\u003c/b\u003e Galactocerebroside and, more importantly, the cytotoxic metabolite \u003cmark\u003epsychosine (galactosylsphingosine)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Psychosine accumulation is toxic to [[a24f9747|oligodendrocytes]] (in the CNS) and [[c65a8909|Schwann cells]] (in the PNS), leading to widespread and severe demyelination.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e The pathognomonic finding is the presence of \u003cmark\u003egloboid cells\u003c/mark\u003e‚Äîlarge, multinucleated macrophages filled with undigested galactocerebroside‚Äîclustered around blood vessels in the white matter.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e The classic form is infantile-onset, presenting at 3-6 months with extreme irritability, developmental delay/regression, spasticity, and peripheral neuropathy. It is rapidly progressive and fatal within about two years.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For lysosomal storage diseases, link the disease, enzyme, and substrate. Krabbe \u003d Galactocerebrosidase deficiency \u003d Psychosine accumulation. The key histological finding is the globoid cell.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eKrabbe disease\u003c/b\u003e is a devastating leukodystrophy where the deficiency of galactocerebrosidase leads to the buildup of the highly toxic lipid psychosine, which selectively kills off the body\u0027s myelin-producing cells, resulting in rapid and global demyelination.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Galactocerebroside] --Galactocerebrosidase--\u003e B(Degradation); C[Enzyme Deficiency] --x B; A --\u003e D(Accumulation of Psychosine); D --\u003e E(Destruction of Oligodendrocytes \u0026 Schwann Cells); E --\u003e F(Globoid Cells \u0026 Demyelination);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"lysosomal_storage_disease\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"leukodystrophy\"\n      },\n      {\n        \"type\": \"is_caused_by_deficiency_of\",\n        \"to\": \"galactocerebrosidase\"\n      },\n      {\n        \"type\": \"leads_to_accumulation_of\",\n        \"to\": \"psychosine\"\n      }\n    ]\n  },\n  \"e8326588\": {\n    \"title\": \"Kyphoscoliosis\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Orthopedics\",\n      \"Neurology\",\n      \"Musculoskeletal\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Musculoskeletal, Skin, and Connective Tissue\",\n      \"Pathology\",\n      \"Skeletal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eKyphoscoliosis\u003c/b\u003e is a spinal deformity characterized by an abnormal curvature of the spine in both the coronal (scoliosis) and sagittal (kyphosis) planes, resulting in a \u0027hunchback\u0027 and lateral curve.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e A combination of kyphosis (anteroposterior rounding of the back) and scoliosis (lateral curvature of the spine).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeuromuscular Causes:\u003c/b\u003e It is a common feature of several neuromuscular diseases due to muscle weakness and imbalance affecting the paraspinal muscles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFriedreich Ataxia:\u003c/b\u003e Kyphoscoliosis is a classic skeletal deformity seen in [[39bc1763|Friedreich Ataxia]], along with pes cavus and hammer toes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCerebral Palsy:\u003c/b\u003e Common in children with [[171ca00b|cerebral palsy]], particularly those with spastic quadriplegia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e Severe kyphoscoliosis can restrict lung expansion, leading to a \u003cmark\u003erestrictive lung disease\u003c/mark\u003e pattern on pulmonary function tests and eventual respiratory failure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of kyphoscoliosis in a patient with neurological symptoms should prompt consideration of underlying neuromuscular disorders like [[39bc1763|Friedreich Ataxia]] or muscular dystrophies.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eKyphoscoliosis\u003c/b\u003e in the context of a neurological disorder is a physical manifestation of chronic muscle imbalance acting on the growing spine, and its progression can lead to severe, life-threatening restrictive lung disease.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_finding_in\",\n        \"to\": \"39bc1763\"\n      },\n      {\n        \"type\": \"is_a_finding_in\",\n        \"to\": \"171ca00b\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"restrictive_lung_disease\"\n      }\n    ]\n  },\n  \"4f7f6fab\": {\n    \"title\": \"Lacrimation Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Ophthalmology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eLacrimation Reflex\u003c/b\u003e is an involuntary reflex that produces tears in response to irritation of the cornea or conjunctiva, serving to protect the eye by flushing away foreign bodies or irritants.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAfferent Limb:\u003c/b\u003e Sensory information from the cornea or conjunctiva (e.g., touch, irritation) is carried by the ophthalmic division of the \u003cmark\u003etrigeminal nerve (CN V\u003csub\u003e1\u003c/sub\u003e)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEfferent Limb:\u003c/b\u003e The parasympathetic motor command to produce tears is carried by the \u003cmark\u003efacial nerve (CN VII)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Afferent signals from CN V\u003csub\u003e1\u003c/sub\u003e travel to the spinal trigeminal nucleus, which then projects to the superior salivatory nucleus (the parasympathetic nucleus of CN VII). Preganglionic fibers from CN VII travel to the pterygopalatine ganglion, where they synapse. Postganglionic fibers then innervate the lacrimal gland.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e A lesion of CN V\u003csub\u003e1\u003c/sub\u003e will abolish the reflex tearing in response to corneal irritation. A lesion of CN VII will cause a dry eye due to impaired lacrimation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction:\u003c/b\u003e This reflex tearing is distinct from emotional tearing, which is controlled by the limbic system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the reflex arc: Sensation in is CN V\u003csub\u003e1\u003c/sub\u003e, tears out is CN VII.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eLacrimation Reflex\u003c/b\u003e is a protective neuro-autonomic arc where the trigeminal nerve acts as the \u0027sensor\u0027 for corneal irritation and the facial nerve acts as the \u0027actuator,\u0027 triggering the lacrimal gland to wash away the offending stimulus.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Corneal Irritation] --\u003e B(CN V1 - Afferent); B --\u003e C(Brainstem Nuclei); C --\u003e D(CN VII - Efferent); D --\u003e E(Lacrimal Gland); E --\u003e F(Tear Production);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"afferent_limb_is\",\n        \"to\": \"ophthalmic_nerve_v1\"\n      },\n      {\n        \"type\": \"efferent_limb_is\",\n        \"to\": \"dea9755f\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"cranial_nerve_reflex\"\n      }\n    ]\n  },\n  \"b56349b2\": {\n    \"title\": \"Lacunar Infarcts\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Vascular\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLacunar infarcts\u003c/b\u003e are small (\u0026lt;1.5 cm) ischemic strokes that occur in the deep, subcortical areas of the brain, resulting from the occlusion of a single, small penetrating artery. They are strongly associated with chronic hypertension.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Chronic hypertension leads to \u003cmark\u003elipohyalinosis\u003c/mark\u003e and microatheroma of small penetrating arteries (e.g., lenticulostriate, thalamoperforate arteries), making them prone to occlusion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Commonly occur in the basal ganglia (especially the putamen), internal capsule, thalamus, and pons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Syndromes:\u003c/b\u003e Because they affect small, functionally specific areas, they produce classic \u0027lacunar syndromes\u0027 that lack cortical signs (e.g., aphasia, neglect, visual field cuts).\u003cbr\u003e - \u003cb\u003e[[8aefcafe|Pure Motor Stroke]]:\u003c/b\u003e Most common. Lesion in the posterior limb of the internal capsule. Contralateral hemiparesis.\u003cbr\u003e - \u003cb\u003ePure Sensory Stroke:\u003c/b\u003e Lesion in the thalamus (VPL/VPM). Contralateral hemisensory loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e May be too small to be seen on initial non-contrast CT. MRI (especially diffusion-weighted imaging) is more sensitive.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The absence of cortical signs is the key to identifying a lacunar stroke. A patient with hypertension who develops pure motor or pure sensory deficits has a lacunar infarct.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLacunar infarcts\u003c/b\u003e are the small-vessel disease of the brain, where the long-term damage of hypertension leads to occlusion of tiny penetrating arteries, causing discrete subcortical strokes that manifest as \u0027pure\u0027 motor or sensory syndromes.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Chronic Hypertension] --\u003e B(Lipohyalinosis of Penetrating Arteries); B --\u003e C(Arterial Occlusion); C --\u003e D(Lacunar Infarct); D --\u003e E(Pure Motor or Sensory Syndromes);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"ischemic_stroke\"\n      },\n      {\n        \"type\": \"is_strongly_associated_with\",\n        \"to\": \"hypertension\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"8aefcafe\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"pure_sensory_stroke\"\n      }\n    ]\n  },\n  \"080a3d8f\": {\n    \"title\": \"Lamotrigine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLamotrigine\u003c/b\u003e is a broad-spectrum \u003ci\u003eanticonvulsant\u003c/i\u003e medication that is also used as a mood stabilizer in bipolar disorder. It primarily works by blocking voltage-gated sodium channels.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks voltage-gated \u003cmark\u003eNa\u003csup\u003e+\u003c/sup\u003e channels\u003c/mark\u003e, which stabilizes neuronal membranes and inhibits the release of excitatory neurotransmitters like glutamate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for a wide variety of seizures, including focal, generalized tonic-clonic, and absence seizures. Also used as a maintenance therapy for bipolar disorder to prevent depressive episodes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most serious adverse effect is a potentially life-threatening rash, which can range from a benign rash to \u003cmark\u003eStevens-Johnson Syndrome (SJS)\u003c/mark\u003e or Toxic Epidermal Necrolysis (TEN).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDosing:\u003c/b\u003e To minimize the risk of SJS/TEN, the dose must be titrated \u003cmark\u003every slowly\u003c/mark\u003e, especially when co-administered with valproic acid, which inhibits lamotrigine\u0027s metabolism and increases its levels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The association between lamotrigine and Stevens-Johnson syndrome is extremely high-yield. Any patient on lamotrigine who develops a rash requires immediate medical evaluation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLamotrigine\u003c/b\u003e is a versatile broad-spectrum anticonvulsant and mood stabilizer, but its use is governed by the critical need for slow dose titration to mitigate the risk of the rare but potentially fatal Stevens-Johnson syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"f91a0cfa\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"bipolar_disorder\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"stevens_johnson_syndrome\"\n      }\n    ]\n  },\n  \"c5805ca4\": {\n    \"title\": \"Dermatome Landmarks\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Anatomy\",\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDermatome landmarks\u003c/b\u003e are specific areas of skin innervated by a single spinal nerve root, which are used in the neurological examination to localize the level of a spinal cord or nerve root lesion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eT4:\u003c/b\u003e Level of the nipples. Mnemonic: T\u003cb\u003e4\u003c/b\u003e at the teat \u003cb\u003epore\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eT7:\u003c/b\u003e Level of the xiphoid process.\u003c/li\u003e\u003cli\u003e\u003cb\u003eT10:\u003c/b\u003e Level of the umbilicus (belly bu\u003cb\u003ett\u003c/b\u003eon). Site of referred pain in early appendicitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eL1:\u003c/b\u003e Inguinal ligament region.\u003c/li\u003e\u003cli\u003e\u003cb\u003eL4:\u003c/b\u003e Includes the kneecaps. Mnemonic: Down on a\u003cb\u003eL\u003c/b\u003el \u003cb\u003e4\u003c/b\u003e\u0027s.\u003c/li\u003e\u003cli\u003e\u003cb\u003eS2, S3, S4:\u003c/b\u003e Sensation of the perineum. Mnemonic: \u003cb\u003eS2\u003c/b\u003e, \u003cb\u003e3\u003c/b\u003e, \u003cb\u003e4\u003c/b\u003e keep the penis off the floor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eC6:\u003c/b\u003e Includes the thumb.\u003c/li\u003e\u003cli\u003e\u003cb\u003eC7:\u003c/b\u003e Includes the middle finger.\u003c/li\u003e\u003cli\u003e\u003cb\u003eC8:\u003c/b\u003e Includes the little finger.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eKnowledge of key \u003cb\u003edermatome landmarks\u003c/b\u003e allows a clinician to translate a patient\u0027s subjective sensory complaints into an objective anatomical location within the spinal cord, forming a crucial step in localizing neurological lesions.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_used_to_localize\",\n        \"to\": \"spinal_cord_lesion\"\n      },\n      {\n        \"type\": \"is_used_to_localize\",\n        \"to\": \"radiculopathy\"\n      }\n    ]\n  },\n  \"86e223f7\": {\n    \"title\": \"Latanoprost\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLatanoprost\u003c/b\u003e is a topical \u003ci\u003eprostaglandin F\u003csub\u003e2Œ±\u003c/sub\u003e analog\u003c/i\u003e that is a first-line medication for the treatment of open-angle glaucoma by increasing the outflow of aqueous humor.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Increases the outflow of aqueous humor through the \u003cmark\u003euveoscleral pathway\u003c/mark\u003e, which is a secondary drainage route for aqueous humor. This reduces intraocular pressure (IOP).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e First-line therapy for [[5ea7b741|open-angle glaucoma]] and ocular hypertension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdministration:\u003c/b\u003e Administered as an eye drop, typically once daily in the evening.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most notable side effect is a permanent \u003cmark\u003edarkening of the iris\u003c/mark\u003e (increased brown pigmentation). It also causes eyelash growth (hypertrichosis) and conjunctival hyperemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Prostaglandin analogs (ending in \u0027-prost\u0027) are first-line for open-angle glaucoma. Remember the unique side effect of permanent iris color change.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLatanoprost\u003c/b\u003e lowers intraocular pressure by enhancing the eye\u0027s secondary drainage system (the uveoscleral pathway), making it a highly effective first-line treatment for open-angle glaucoma, with the peculiar cosmetic side effect of darkening the iris.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"5ea7b741\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"prostaglandin_analog\"\n      },\n      {\n        \"type\": \"increases\",\n        \"to\": \"uveoscleral_outflow\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"iris_darkening\"\n      }\n    ]\n  },\n  \"4d8b1ee2\": {\n    \"title\": \"Lateral Corticospinal Tract\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eLateral Corticospinal Tract\u003c/b\u003e is the largest descending motor pathway in the spinal cord, responsible for the voluntary control of contralateral limb and fine motor movements.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Controls voluntary, skilled movements of the distal extremities.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Composed of upper motor neuron axons that originate in the primary motor cortex. They descend through the internal capsule and cerebral peduncles, \u003cmark\u003edecussate (cross over) at the pyramidal decussation\u003c/mark\u003e in the caudal medulla, and then descend in the lateral funiculus of the contralateral spinal cord to synapse on lower motor neurons in the anterior horn.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSomatotopy:\u003c/b\u003e Within the tract, fibers are somatotopically organized, with cervical fibers located most medially and sacral fibers most laterally.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects:\u003c/b\u003e Damage to the lateral corticospinal tract results in \u003cmark\u003eipsilateral upper motor neuron (UMN) signs\u003c/mark\u003e below the level of the lesion (because the fibers have already crossed). These signs include spastic paralysis, hyperreflexia, and a positive Babinski sign.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A lesion in the brain or brainstem above the pyramidal decussation causes contralateral UMN signs. A lesion in the spinal cord below the decussation causes ipsilateral UMN signs. This is a key principle for localizing lesions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eLateral Corticospinal Tract\u003c/b\u003e is the primary highway for voluntary motor commands to the limbs, and its decussation in the medulla is the crucial anatomical reason why one side of the brain controls the opposite side of the body.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Motor Cortex] --\u003e B(Internal Capsule); B --\u003e C(Cerebral Peduncle); C --\u003e D(Pyramidal Decussation in Medulla); D --\u003e E(Lateral Corticospinal Tract in Spinal Cord); E --\u003e F(Synapse on LMN in Anterior Horn);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"corticospinal_tract\"\n      },\n      {\n        \"type\": \"controls\",\n        \"to\": \"voluntary_movement\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"upper_motor_neuron_signs\"\n      },\n      {\n        \"type\": \"decussates_in\",\n        \"to\": \"medulla_oblongata\"\n      }\n    ]\n  },\n  \"08d19deb\": {\n    \"title\": \"Lateral Geniculate Nucleus (LGN)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Thalamus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eLateral Geniculate Nucleus (LGN)\u003c/b\u003e, also known as the lateral geniculate body, is a key nucleus in the [[afc0a64b|thalamus]] that serves as the primary thalamic relay station for \u003ci\u003evisual information\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Relays visual signals from the optic tract to the primary visual cortex in the occipital lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Receives input from retinal ganglion cells via the optic tract. The LGN then projects via the optic radiation (which includes [[8423676f|Meyer\u0027s loop]] and the dorsal optic radiation) to the primary visual cortex (Brodmann area 17) in the calcarine sulcus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMnemonic:\u003c/b\u003e \u003cb\u003eL\u003c/b\u003eateral geniculate nucleus for \u003cb\u003eL\u003c/b\u003eight (vision). Contrast with the \u003cb\u003eM\u003c/b\u003eedial geniculate nucleus for \u003cb\u003eM\u003c/b\u003eusic (hearing).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLaminar Structure:\u003c/b\u003e It has a layered structure that keeps information from the ipsilateral and contralateral eyes separate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the thalamic sensory relays: LGN for visual, MGN for auditory, VPL for body sensation, and VPM for face sensation. A lesion in the LGN causes a contralateral homonymous hemianopia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eLateral Geniculate Nucleus\u003c/b\u003e is the brain\u0027s crucial gateway for vision, acting as the final processing and relay point in the thalamus before visual information is sent to the cortex for conscious perception.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Optic Tract] --\u003e B(Lateral Geniculate Nucleus); B --\u003e C(Optic Radiation); C --\u003e D(Primary Visual Cortex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"afc0a64b\"\n      },\n      {\n        \"type\": \"relays\",\n        \"to\": \"visual_information\"\n      },\n      {\n        \"type\": \"projects_to\",\n        \"to\": \"primary_visual_cortex\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"optic_tract\"\n      }\n    ]\n  },\n  \"07656b4a\": {\n    \"title\": \"Lateral Medullary Syndrome (Wallenberg Syndrome)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Vascular\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brainstem Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLateral Medullary Syndrome\u003c/b\u003e, also known as \u003cb\u003eWallenberg syndrome\u003c/b\u003e, is a brainstem stroke syndrome caused by an occlusion of the \u003ci\u003eposterior inferior cerebellar artery (PICA)\u003c/i\u003e or the vertebral artery, affecting the lateral portion of the medulla.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Caused by infarction in the territory of the \u003cmark\u003ePosterior Inferior Cerebellar Artery (PICA)\u003c/mark\u003e. Mnemonic: Don\u0027t \u003cb\u003ePICA\u003c/b\u003e (pick a) horse that can\u0027t eat (hoarseness and dysphagia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAffected Structures \u0026 Symptoms:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eVestibular nuclei:\u003c/b\u003e Nystagmus, vertigo, nausea/vomiting.\u003cbr\u003e - \u003cb\u003eInferior cerebellar peduncle:\u003c/b\u003e Ipsilateral ataxia, dysmetria.\u003cbr\u003e - \u003cb\u003eSpinothalamic tract:\u003c/b\u003e \u003cmark\u003eContralateral\u003c/mark\u003e loss of pain and temperature from the body.\u003cbr\u003e - \u003cb\u003eSpinal trigeminal nucleus:\u003c/b\u003e \u003cmark\u003eIpsilateral\u003c/mark\u003e loss of pain and temperature from the face.\u003cbr\u003e - \u003cb\u003eNucleus ambiguus (CN IX, X):\u003c/b\u003e \u003cmark\u003eIpsilateral\u003c/mark\u003e dysphagia, hoarseness, and decreased gag reflex.\u003cbr\u003e - \u003cb\u003eSympathetic fibers:\u003c/b\u003e Ipsilateral Horner syndrome (ptosis, miosis, anhidrosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e This is a classic \u0027crossed\u0027 syndrome. The key is the combination of contralateral body sensory loss with ipsilateral face sensory loss and ipsilateral bulbar/cerebellar signs. Hoarseness and dysphagia are highly specific for this syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eWallenberg syndrome\u003c/b\u003e is a constellation of deficits that perfectly maps to the anatomy of the lateral medulla; the crossed sensory findings (ipsilateral face, contralateral body) combined with ipsilateral ataxia and bulbar palsy are pathognomonic for a PICA occlusion.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[PICA Occlusion] --\u003e B(Lateral Medullary Infarct); B --\u003e C(Crossed Sensory Loss); B --\u003e D(Ipsilateral Horner Syndrome); B --\u003e E(Ipsilateral Ataxia); B --\u003e F(Dysphagia/Hoarseness);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_occlusion_of\",\n        \"to\": \"posterior_inferior_cerebellar_artery\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"vestibular_nuclei\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"73378e13\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"07eecef1\"\n      }\n    ]\n  },\n  \"b37e8260\": {\n    \"title\": \"Lateral Nucleus of Hypothalamus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Endocrinology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Anatomy\",\n      \"Hypothalamus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eLateral Nucleus\u003c/b\u003e of the hypothalamus is a region of the hypothalamus that is considered the primary center for regulating \u003ci\u003ehunger\u003c/i\u003e and food intake.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Regulates hunger. Stimulation of the lateral nucleus induces hunger and eating behavior.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effect:\u003c/b\u003e A lesion in the lateral nucleus causes \u003cmark\u003eanorexia\u003c/mark\u003e and weight loss. Mnemonic: A lesion to the \u003cb\u003eL\u003c/b\u003eateral nucleus makes you \u003cb\u003eL\u003c/b\u003eean.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitters:\u003c/b\u003e It is stimulated by ghrelin (a hunger hormone from the stomach) and inhibited by leptin (a satiety hormone from fat cells). It produces orexigenic (appetite-stimulating) neuropeptides like orexin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContrast with Ventromedial Nucleus:\u003c/b\u003e The lateral nucleus is functionally opposed by the ventromedial nucleus (VMN), which is the satiety center. A lesion in the VMN causes hyperphagia and obesity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the opposing functions: \u003cb\u003eL\u003c/b\u003eateral nucleus \u003d \u003cb\u003eH\u003c/b\u003eunger. \u003cb\u003eV\u003c/b\u003eentro\u003cb\u003em\u003c/b\u003eedial nucleus \u003d \u003cb\u003eS\u003c/b\u003eatiety. (\u003cb\u003eL\u003c/b\u003eateral \u003cb\u003eH\u003c/b\u003eunger, \u003cb\u003eV\u003c/b\u003eery \u003cb\u003eM\u003c/b\u003euch \u003cb\u003eS\u003c/b\u003eatisfied).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eLateral Nucleus\u003c/b\u003e of the hypothalamus acts as the body\u0027s \u0027on switch\u0027 for hunger; its destruction leads to a profound lack of appetite, highlighting its critical role in driving the fundamental behavior of seeking food.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"regulates\",\n        \"to\": \"hunger\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"anorexia\"\n      },\n      {\n        \"type\": \"is_inhibited_by\",\n        \"to\": \"c8515469\"\n      },\n      {\n        \"type\": \"is_stimulated_by\",\n        \"to\": \"ghrelin\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9646,
      "parts": [{
        "text": "```json\n"
      }, {
        "text": "{\n  \"7278c124\": {\n    \"title"
      }, {
        "text": "\": \"Joint Position Sense (Proprioception)\",\n    \"primaryType\": \"physiology\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Neuroscience\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sens"
      }, {
        "text": "ory System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eJoint position sense\u003c/b\u003e"
      }, {
        "text": ", or \u003cb\u003eproprioception\u003c/b\u003e, is the sense of the relative position of one\u0027s own parts of the body and"
      }, {
        "text": " strength of effort being employed in movement. It is a key component of somatosensation, transmitted via the dorsal column-medial lemn"
      }, {
        "text": "iscus pathway.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSensory Receptors:\u003c/b\u003e Mediated by mechan"
      }, {
        "text": "oreceptors in muscles (muscle spindles), tendons (Golgi tendon organs), and \u003cmark\u003ejoints\u003c/mark\u003e (Ruffini corpus"
      }, {
        "text": "cles, Pacinian corpuscles).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNerve Fibers:\u003c/b\u003e Transmitted by large, heavily myelinated,"
      }, {
        "text": " and fast-conducting AŒ± and AŒ≤ fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Signals travel up the ipsilateral [["
      }, {
        "text": "e7f5cbbe|dorsal columns]] to the medulla, synapse, decussate, and ascend"
      }, {
        "text": " via the [[f19bc454|medial lemniscus]] to the VPL nucleus of the [[af"
      }, {
        "text": "c0a64b|thalamus]], and finally to the somatosensory cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Testing:\u003c/b\u003e Assessed by moving a patient\u0027s joint (e.g., the great toe) up or down with"
      }, {
        "text": " their eyes closed and asking them to identify the direction of movement. The [[47a0f3d1|Rom"
      }, {
        "text": "berg test]] also assesses proprioception.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Loss of proprioception and vibration sense is a hallmark of [["
      }, {
        "text": "e7f5cbbe|dorsal column]] pathology, seen in conditions like [[71daebd6"
      }, {
        "text": "|tabes dorsalis]] and [[6f5bea90|subacute combined degeneration]] (vitamin B12 deficiency)."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eProprioception\u003c/b\u003e is the body\u0027s \u0027sixth sense,\u0027 providing"
      }, {
        "text": " the brain with a constant, unconscious awareness of limb position and movement, which is essential for coordinated motor control and balance."
      }, {
        "text": " Its reliance on large, myelinated fibers makes it vulnerable in specific neurological disorders.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_also_known_as\","
      }, {
        "text": "\n        \"to\": \"proprioception\"\n      },\n      {\n        \"type\": \"is_transmitted_via\","
      }, {
        "text": "\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \"is_im"
      }, {
        "text": "paired_in\",\n        \"to\": \"71daebd6\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_impaired_in\",\n        \"to\": \"6f5bea90\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"5690849b\": {\n    \"title\":"
      }, {
        "text": " \"Kallmann Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"End"
      }, {
        "text": "ocrinology\",\n      \"Genetics\",\n      \"Reproductive\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n"
      }, {
        "text": "    \"classificationPath\": [\n      \"Endocrine\",\n      \"Pathology\",\n      \"Hypogonadism\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eKallmann syndrome\u003c/b\u003e is a genetic disorder characterized by the"
      }, {
        "text": " combination of \u003ci\u003ehypogonadotropic hypogonadism\u003c/i\u003e (delayed or absent puberty) and \u003ci\u003eanosmia\u003c/i\u003e (in"
      }, {
        "text": "ability to smell) or hyposmia (reduced ability to smell).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e Caused by the failure of GnRH-secreting neurons to migrate from their embryonic origin in the olfactory plac"
      }, {
        "text": "ode to the [[89e86633|hypothalamus]]. This results in a deficiency of Gon"
      }, {
        "text": "adotropin-Releasing Hormone (GnRH).\u003c/li\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Can be inherited in X-linked recessive"
      }, {
        "text": ", autosomal dominant, or autosomal recessive patterns. Mutations in genes like \u003ci\u003eKAL1\u003c/i\u003e are implicated.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e"
      }, {
        "text": " Patients present with failure to undergo puberty. Males have micropenis and cryptorchidism; females have primary amenorrhea. Both"
      }, {
        "text": " sexes have anosmia or hyposmia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLab Findings:\u003c/b\u003e Characterized by low levels of GnRH, leading"
      }, {
        "text": " to low levels of LH, FSH, and sex steroids (testosterone or estrogen).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " unique combination of delayed puberty and an inability to smell is the pathognomonic presentation of Kallmann syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eKallmann syndrome\u003c/b\u003e is a developmental disorder where the migratory path of GnRH neurons is disrupted, inextricably"
      }, {
        "text": " linking the sense of smell with the onset of puberty and demonstrating the shared embryonic origin of these two seemingly unrelated systems.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Failure of GnRH Neuron Migration] --\u003e B(GnRH Deficiency); B --\u003e C(Low"
      }, {
        "text": " LH/FSH); C --\u003e D(Hypogonadism/Delayed Puberty); A --\u003e E(Defective Olfactory Bulb"
      }, {
        "text": " Development); E --\u003e F(Anosmia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes"
      }, {
        "text": "\",\n        \"to\": \"hypogonadotropic_hypogonadism\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"causes\",\n        \"to\": \"anosmia\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_caused_by\",\n        \"to\": \"failure_of_gnrh_neuron_migration"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"08bf5432\": {\n    \""
      }, {
        "text": "title\": \"Ketamine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Anesthesiology\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"An"
      }, {
        "text": "esthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eKetamine\u003c/b\u003e is an"
      }, {
        "text": " intravenous anesthetic agent that produces a state of \u003ci\u003edissociative anesthesia\u003c/i\u003e, characterized by profound analgesia, amnesia, and catal"
      }, {
        "text": "epsy, while preserving cardiovascular and respiratory function. It is also used for depression and as a recreational drug.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e It is a non-competitive antagonist of the \u003cmark\u003eNM"
      }, {
        "text": "DA (N-methyl-D-aspartate) receptor\u003c/mark\u003e, a type of glutamate receptor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAn"
      }, {
        "text": "esthetic Effects:\u003c/b\u003e Induces a trance-like state with pain relief, sedation, and memory loss. It is sympath"
      }, {
        "text": "omimetic, causing increased heart rate, blood pressure, and cardiac output, and is also a potent bronchodilator.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for induction and maintenance of anesthesia, particularly in hemodynamically unstable patients or those with bronch"
      }, {
        "text": "ospasm. Also used for procedural sedation and analgesia. Recently approved as a nasal spray for treatment-resistant depression.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Causes \u003cmark\u003eemergence reactions\u003c/mark\u003e as the drug wears off, including"
      }, {
        "text": " vivid dreams, hallucinations, and delirium. Co-administration of benzodiazepines can reduce this risk. It also increases intracranial pressure."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Ketamine\u0027s unique properties are its sympathomimetic effects (increased BP/HR) and the"
      }, {
        "text": " risk of psychotomimetic emergence phenomena. Its mechanism as an NMDA antagonist is also high-yield.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003e\u003cb\u003eKetamine\u003c/b\u003e is a unique anesthetic that works by blocking NMDA receptors, producing"
      }, {
        "text": " a \u0027dissociative\u0027 state that provides analgesia and amnesia while maintaining cardiopulmonary stability, but its use is tempered"
      }, {
        "text": " by the potential for psychotomimetic emergence reactions.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"int"
      }, {
        "text": "ravenous_anesthetic\"\n      },\n      {\n        \"type\": \"antagonizes\",\n        \"to\": \"nm"
      }, {
        "text": "da_receptor\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\":"
      }, {
        "text": " \"depression\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\":"
      }, {
        "text": " \"hallucinations\"\n      }\n    ]\n  },\n  \"c6292526\": {\n    \""
      }, {
        "text": "title\": \"Kl√ºver-Bucy Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Psychiatry\",\n      \"Pathology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain"
      }, {
        "text": " Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eKl√ºver-B"
      }, {
        "text": "ucy syndrome\u003c/b\u003e is a rare behavioral syndrome resulting from bilateral damage to the medial temporal lobes, particularly the \u003ci\u003eamy"
      }, {
        "text": "gdala\u003c/i\u003e. It is characterized by a constellation of symptoms including hyperorality, hypersexuality, and placidity.\u003c/p\u003e\","
      }, {
        "text": "\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by lesions that destroy the [["
      }, {
        "text": "d220fc3f|amygdala]] bilaterally. The most common cause is \u003cmark\u003eHer"
      }, {
        "text": "pes Simplex Virus (HSV-1) encephalitis\u003c/mark\u003e, which has a predilection for the temporal lobes. Other"
      }, {
        "text": " causes include trauma, stroke, and Pick disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Features:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eHyperph"
      }, {
        "text": "agia:\u003c/b\u003e Excessive eating and weight gain.\u003cbr\u003e - \u003cb\u003eHypersexuality:\u003c/b\u003e Inappropriate and indiscriminate sexual behavior.\u003cbr\u003e - \u003cb\u003e"
      }, {
        "text": "Hypermetamorphosis:\u003c/b\u003e Compulsive desire to explore every object in sight.\u003cbr\u003e - \u003cb\u003eHyperorality:\u003c/b\u003e Tend"
      }, {
        "text": "ency to examine objects by mouth.\u003cbr\u003e - \u003cb\u003ePlacidity:\u003c/b\u003e Diminished fear response, appearing"
      }, {
        "text": " tame or emotionally blunted.\u003cbr\u003e - \u003cb\u003eVisual Agnosia:\u003c/b\u003e Inability to recognize familiar objects or"
      }, {
        "text": " faces.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient who survives HSV encephalitis and subsequently develops bizarre behaviors like putting ined"
      }, {
        "text": "ible objects in their mouth, inappropriate sexual advances, and a flattened emotional response is the classic presentation of Kl√ºver-B"
      }, {
        "text": "ucy syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eKl√ºver-Bucy"
      }, {
        "text": " syndrome\u003c/b\u003e is a dramatic demonstration of the amygdala\u0027s role in processing emotion and driving behavior; its bilateral destruction un"
      }, {
        "text": "masks primitive oral and sexual tendencies and extinguishes the normal fear response.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"d"
      }, {
        "text": "220fc3f\"\n      },\n      {\n        \"type\": \"is_a_com"
      }, {
        "text": "plication_of\",\n        \"to\": \"hsv_encephalitis\"\n      },\n      {\n        \"type\": \"presents"
      }, {
        "text": "_with\",\n        \"to\": \"hyperphagia\"\n      },\n      {\n        \"type\": \"p"
      }, {
        "text": "resents_with\",\n        \"to\": \"hypersexuality\"\n      }\n    ]\n  },\n  \"2"
      }, {
        "text": "46a82f3\": {\n    \"title\": \"Krabbe Disease\",\n    \"primaryType\": \""
      }, {
        "text": "disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pediatrics\",\n      \"Genetics\",\n      \"Bi"
      }, {
        "text": "ochemistry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eKrabbe disease\u003c/b\u003e, also known as globoid cell leukodystrophy, is a rare, fatal"
      }, {
        "text": ", autosomal recessive \u003ci\u003elysosomal storage disease\u003c/i\u003e caused by a deficiency of the enzyme galactocerebrosidase, leading to the"
      }, {
        "text": " accumulation of galactocerebroside and psychosine, which destroys myelin-producing cells.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Genetics:\u003c/b\u003e Autosomal recessive inheritance.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEnzyme Deficiency:\u003c/b\u003e Deficiency of \u003cmark\u003egalactocerebrosidase\u003c/"
      }, {
        "text": "mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAccumulated Substrate:\u003c/b\u003e Galactocerebroside and, more importantly, the cytotoxic metabolite"
      }, {
        "text": " \u003cmark\u003epsychosine (galactosylsphingosine)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Psychosine accumulation"
      }, {
        "text": " is toxic to [[a24f9747|oligodendrocytes]] (in the CNS) and [[c6"
      }, {
        "text": "5a8909|Schwann cells]] (in the PNS), leading to widespread and severe demyelination."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e The pathognomonic finding is the presence of \u003cmark\u003egloboid cells\u003c/mark\u003e"
      }, {
        "text": "‚Äîlarge, multinucleated macrophages filled with undigested galactocerebroside‚Äîclustered around blood vessels in the white"
      }, {
        "text": " matter.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e The classic form is infantile-onset, presenting at 3-6 months with extreme"
      }, {
        "text": " irritability, developmental delay/regression, spasticity, and peripheral neuropathy. It is rapidly progressive and fatal within about two"
      }, {
        "text": " years.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For lysosomal storage diseases, link the disease, enzyme, and substrate"
      }, {
        "text": ". Krabbe \u003d Galactocerebrosidase deficiency \u003d Psychosine accumulation. The key histological finding is the globoid cell.\u003c/li\u003e\u003c/ul\u003e\",\n"
      }, {
        "text": "      \"takeAway\": \"\u003cp\u003e\u003cb\u003eKrabbe disease\u003c/b\u003e is a devastating leukodystrophy where the deficiency"
      }, {
        "text": " of galactocerebrosidase leads to the buildup of the highly toxic lipid psychosine, which selectively kills off the body"
      }, {
        "text": "\u0027s myelin-producing cells, resulting in rapid and global demyelination.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A["
      }, {
        "text": "Galactocerebroside] --Galactocerebrosidase--\u003e B(Degradation); C[Enzyme Deficiency] --x"
      }, {
        "text": " B; A --\u003e D(Accumulation of Psychosine); D --\u003e E(Destruction of Oligodendrocytes \u0026 Schwann"
      }, {
        "text": " Cells); E --\u003e F(Globoid Cells \u0026 Demyelination);\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_type_of\",\n        \"to\": \"lysosomal_storage"
      }, {
        "text": "_disease\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"leukodystrophy\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_caused_by_deficiency_of\",\n        \"to\": \"galactocerebrosidase\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"leads_to_accumulation_of\",\n        \"to\": \"psychosine\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"e8326588\": {\n    \"title\": \"Kyphoscoliosis\",\n    \"primary"
      }, {
        "text": "Type\": \"finding\",\n    \"tags\": [\n      \"Orthopedics\",\n      \"Neurology\","
      }, {
        "text": "\n      \"Musculoskeletal\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      "
      }, {
        "text": "\"Musculoskeletal, Skin, and Connective Tissue\",\n      \"Pathology\",\n      \"Skeletal Disorders\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eKyphoscoliosis\u003c/b\u003e is a spinal deformity characterized by an"
      }, {
        "text": " abnormal curvature of the spine in both the coronal (scoliosis) and sagittal (kyphosis) planes, resulting in a"
      }, {
        "text": " \u0027hunchback\u0027 and lateral curve.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e A"
      }, {
        "text": " combination of kyphosis (anteroposterior rounding of the back) and scoliosis (lateral curvature of the spine"
      }, {
        "text": ").\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeuromuscular Causes:\u003c/b\u003e It is a common feature of several neuromuscular diseases due to muscle weakness and imbalance affecting"
      }, {
        "text": " the paraspinal muscles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFriedreich Ataxia:\u003c/b\u003e Kyphoscoliosis is a classic skeletal deformity"
      }, {
        "text": " seen in [[39bc1763|Friedreich Ataxia]], along with pes cavus and hammer toes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCerebral"
      }, {
        "text": " Palsy:\u003c/b\u003e Common in children with [[171ca00b|cerebral palsy]], particularly those with sp"
      }, {
        "text": "astic quadriplegia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e Severe kyphoscoliosis can restrict lung expansion, leading to a"
      }, {
        "text": " \u003cmark\u003erestrictive lung disease\u003c/mark\u003e pattern on pulmonary function tests and eventual respiratory failure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE"
      }, {
        "text": " Tip:\u003c/b\u003e The presence of kyphoscoliosis in a patient with neurological symptoms should prompt consideration of underlying neuromuscular disorders like [[39bc1"
      }, {
        "text": "763|Friedreich Ataxia]] or muscular dystrophies.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Kyphoscoliosis\u003c/b\u003e in the context of a neurological disorder is a physical manifestation of chronic muscle imbalance acting on the growing"
      }, {
        "text": " spine, and its progression can lead to severe, life-threatening restrictive lung disease.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n"
      }, {
        "text": "    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_finding_in\",\n        \"to"
      }, {
        "text": "\": \"39bc1763\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_finding_in\",\n        \"to\": \"171ca00b\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"can_cause\",\n        \"to\": \"restrictive_lung_disease"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"4f7f6fab\": {\n    \"title\": \""
      }, {
        "text": "Lacrimation Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "science\",\n      \"Ophthalmology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n"
      }, {
        "text": "      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003eLacrimation Reflex\u003c/b\u003e is an involuntary reflex that produces tears in response to irritation of the cornea or conjunctiva, serving"
      }, {
        "text": " to protect the eye by flushing away foreign bodies or irritants.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eAfferent Limb:\u003c/b\u003e Sensory information from the cornea or conjunctiva (e.g., touch, irritation) is carried by the ophthal"
      }, {
        "text": "mic division of the \u003cmark\u003etrigeminal nerve (CN V\u003csub\u003e1\u003c/sub\u003e)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEfferent Limb:\u003c/b\u003e The"
      }, {
        "text": " parasympathetic motor command to produce tears is carried by the \u003cmark\u003efacial nerve (CN VII)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway"
      }, {
        "text": ":\u003c/b\u003e Afferent signals from CN V\u003csub\u003e1\u003c/sub\u003e travel to the spinal trigeminal nucleus, which then projects to"
      }, {
        "text": " the superior salivatory nucleus (the parasympathetic nucleus of CN VII). Preganglionic fibers from CN VII travel to the pter"
      }, {
        "text": "ygopalatine ganglion, where they synapse. Postganglionic fibers then innervate the lacrimal gland."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e A lesion of CN V\u003csub\u003e1\u003c/sub\u003e will abolish the reflex tearing in response to corneal"
      }, {
        "text": " irritation. A lesion of CN VII will cause a dry eye due to impaired lacrimation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction:\u003c/b\u003e This"
      }, {
        "text": " reflex tearing is distinct from emotional tearing, which is controlled by the limbic system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember"
      }, {
        "text": " the reflex arc: Sensation in is CN V\u003csub\u003e1\u003c/sub\u003e, tears out is CN VII.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eLacrimation Reflex\u003c/b\u003e is a protective neuro-autonomic arc where the trigeminal nerve acts"
      }, {
        "text": " as the \u0027sensor\u0027 for corneal irritation and the facial nerve acts as the \u0027actuator,\u0027 triggering the lacrimal gland to wash"
      }, {
        "text": " away the offending stimulus.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Corneal Irritation] --\u003e B"
      }, {
        "text": "(CN V1 - Afferent); B --\u003e C(Brainstem Nuclei); C --\u003e D(CN VII - Eff"
      }, {
        "text": "erent); D --\u003e E(Lacrimal Gland); E --\u003e F(Tear Production);\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"afferent_limb_is\",\n        \"to\":"
      }, {
        "text": " \"ophthalmic_nerve_v1\"\n      },\n      {\n        \"type\": \"efferent_limb_is\",\n        "
      }, {
        "text": "\"to\": \"dea9755f\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_type_of\",\n        \"to\": \"cranial_nerve_reflex\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"b56349b2\": {\n    \"title\": \"Lacunar Infarct"
      }, {
        "text": "s\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"V"
      }, {
        "text": "ascular\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLacunar infarcts\u003c/b\u003e"
      }, {
        "text": " are small (\u0026lt;1.5 cm) ischemic strokes that occur in the deep, subcortical areas of the brain, resulting"
      }, {
        "text": " from the occlusion of a single, small penetrating artery. They are strongly associated with chronic hypertension.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Chronic hypertension leads to \u003cmark\u003elipohyalinosis\u003c/mark\u003e and"
      }, {
        "text": " microatheroma of small penetrating arteries (e.g., lenticulostriate, thalamoperforate arteries), making"
      }, {
        "text": " them prone to occlusion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Commonly occur in the basal ganglia (especially the putamen), internal capsule"
      }, {
        "text": ", thalamus, and pons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Syndromes:\u003c/b\u003e Because they affect small, functionally specific areas, they"
      }, {
        "text": " produce classic \u0027lacunar syndromes\u0027 that lack cortical signs (e.g., aphasia, neglect, visual field cuts"
      }, {
        "text": ").\u003cbr\u003e - \u003cb\u003e[[8aefcafe|Pure Motor Stroke]]:\u003c/b\u003e Most common. Lesion in"
      }, {
        "text": " the posterior limb of the internal capsule. Contralateral hemiparesis.\u003cbr\u003e - \u003cb\u003ePure Sensory Stroke:\u003c/b\u003e Lesion in the"
      }, {
        "text": " thalamus (VPL/VPM). Contralateral hemisensory loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e May"
      }, {
        "text": " be too small to be seen on initial non-contrast CT. MRI (especially diffusion-weighted imaging) is more sensitive.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The absence of cortical signs is the key to identifying a lacunar stroke. A patient with hypertension who"
      }, {
        "text": " develops pure motor or pure sensory deficits has a lacunar infarct.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLacunar"
      }, {
        "text": " infarcts\u003c/b\u003e are the small-vessel disease of the brain, where the long-term damage of hypertension leads to occlusion"
      }, {
        "text": " of tiny penetrating arteries, causing discrete subcortical strokes that manifest as \u0027pure\u0027 motor or sensory syndromes.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[Chronic Hypertension] --\u003e B(Lipohyalinosis of Penetrating Arteries); B --\u003e C(Ar"
      }, {
        "text": "terial Occlusion); C --\u003e D(Lacunar Infarct); D --\u003e E(Pure Motor or Sensory Syndromes);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"ischemic_stroke\"\n      },\n      {\n        \"type\": \"is_strongly_associated_with\",\n        \""
      }, {
        "text": "to\": \"hypertension\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to"
      }, {
        "text": "\": \"8aefcafe\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"pure_sensory"
      }, {
        "text": "_stroke\"\n      }\n    ]\n  },\n  \"080a3d8f\": {\n    \"title\":"
      }, {
        "text": " \"Lamotrigine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \""
      }, {
        "text": "Pharmacology\",\n      \"Neurology\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Ant"
      }, {
        "text": "iconvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLam"
      }, {
        "text": "otrigine\u003c/b\u003e is a broad-spectrum \u003ci\u003eanticonvulsant\u003c/i\u003e medication that is also used as a mood stabilizer in"
      }, {
        "text": " bipolar disorder. It primarily works by blocking voltage-gated sodium channels.\u003c/p\u003e\",\n      \"atAGlance\":"
      }, {
        "text": " \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks voltage-gated \u003cmark\u003eNa\u003csup\u003e+\u003c/sup\u003e channels\u003c/mark\u003e,"
      }, {
        "text": " which stabilizes neuronal membranes and inhibits the release of excitatory neurotransmitters like glutamate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for"
      }, {
        "text": " a wide variety of seizures, including focal, generalized tonic-clonic, and absence seizures. Also used as a maintenance therapy"
      }, {
        "text": " for bipolar disorder to prevent depressive episodes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most serious adverse effect is a potentially"
      }, {
        "text": " life-threatening rash, which can range from a benign rash to \u003cmark\u003eStevens-Johnson Syndrome (SJS)\u003c/mark\u003e"
      }, {
        "text": " or Toxic Epidermal Necrolysis (TEN).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDosing:\u003c/b\u003e To minimize the risk of SJS/"
      }, {
        "text": "TEN, the dose must be titrated \u003cmark\u003every slowly\u003c/mark\u003e, especially when co-administered with valproic acid, which inhibits"
      }, {
        "text": " lamotrigine\u0027s metabolism and increases its levels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The association between lamotrigine and Stevens"
      }, {
        "text": "-Johnson syndrome is extremely high-yield. Any patient on lamotrigine who develops a rash requires immediate medical evaluation."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLamotrigine\u003c/b\u003e is a versatile broad-spectrum anticon"
      }, {
        "text": "vulsant and mood stabilizer, but its use is governed by the critical need for slow dose titration to mitigate the risk of the rare"
      }, {
        "text": " but potentially fatal Stevens-Johnson syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"f9"
      }, {
        "text": "1a0cfa\"\n      },\n      {\n        \"type\": \"is_a_treatment_for\",\n        "
      }, {
        "text": "\"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_treatment_for\",\n        \"to\": \"bipolar_disorder\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"can_cause\",\n        \"to\": \"stevens_johnson_sy"
      }, {
        "text": "ndrome\"\n      }\n    ]\n  },\n  \"c5805ca4\": {\n    \"title\":"
      }, {
        "text": " \"Dermatome Landmarks\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"An"
      }, {
        "text": "atomy\",\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\":"
      }, {
        "text": " [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDermatome landmarks\u003c/b\u003e are specific areas of skin inn"
      }, {
        "text": "ervated by a single spinal nerve root, which are used in the neurological examination to localize the level of a spinal cord"
      }, {
        "text": " or nerve root lesion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eT4:\u003c/b\u003e Level of the nipples"
      }, {
        "text": ". Mnemonic: T\u003cb\u003e4\u003c/b\u003e at the teat \u003cb\u003epore\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eT7:\u003c/b\u003e Level of the x"
      }, {
        "text": "iphoid process.\u003c/li\u003e\u003cli\u003e\u003cb\u003eT10:\u003c/b\u003e Level of the umbilicus (belly bu\u003cb\u003ett\u003c/b\u003eon). Site"
      }, {
        "text": " of referred pain in early appendicitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eL1:\u003c/b\u003e Inguinal ligament region.\u003c/li\u003e\u003cli\u003e\u003cb\u003eL4:\u003c/b\u003e Includes"
      }, {
        "text": " the kneecaps. Mnemonic: Down on a\u003cb\u003eL\u003c/b\u003el \u003cb\u003e4\u003c/b\u003e\u0027s.\u003c/li\u003e\u003cli\u003e\u003cb\u003eS"
      }, {
        "text": "2, S3, S4:\u003c/b\u003e Sensation of the perineum. Mnemonic: \u003cb\u003eS2\u003c/b\u003e"
      }, {
        "text": ", \u003cb\u003e3\u003c/b\u003e, \u003cb\u003e4\u003c/b\u003e keep the penis off the floor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eC6:\u003c/b\u003e Includes"
      }, {
        "text": " the thumb.\u003c/li\u003e\u003cli\u003e\u003cb\u003eC7:\u003c/b\u003e Includes the middle finger.\u003c/li\u003e\u003cli\u003e\u003cb\u003eC8:\u003c/b\u003e Includes the little finger.\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003eKnowledge of key \u003cb\u003edermatome landmarks\u003c/b\u003e allows a clinician to translate a"
      }, {
        "text": " patient\u0027s subjective sensory complaints into an objective anatomical location within the spinal cord, forming a crucial step in localizing neurological lesions"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_used"
      }, {
        "text": "_to_localize\",\n        \"to\": \"spinal_cord_lesion\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_used_to_localize\",\n        \"to\": \"radiculopathy\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"86e223f7\": {\n    \"title\": \"Latanoprost"
      }, {
        "text": "\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      "
      }, {
        "text": "\"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \""
      }, {
        "text": "Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLatanoprost\u003c/b\u003e is a topical \u003ci\u003eprostaglandin F\u003csub\u003e"
      }, {
        "text": "2Œ±\u003c/sub\u003e analog\u003c/i\u003e that is a first-line medication for the treatment of open-angle glaucoma by increasing the outflow of aqueous humor.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Increases the outflow of aqueous humor through the \u003cmark\u003euve"
      }, {
        "text": "oscleral pathway\u003c/mark\u003e, which is a secondary drainage route for aqueous humor. This reduces intraocular pressure (IOP).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Use:\u003c/b\u003e First-line therapy for [[5ea7b741|open-angle glaucoma]] and ocular"
      }, {
        "text": " hypertension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdministration:\u003c/b\u003e Administered as an eye drop, typically once daily in the evening.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse"
      }, {
        "text": " Effects:\u003c/b\u003e The most notable side effect is a permanent \u003cmark\u003edarkening of the iris\u003c/mark\u003e (increased"
      }, {
        "text": " brown pigmentation). It also causes eyelash growth (hypertrichosis) and conjunctival hyperemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Pro"
      }, {
        "text": "staglandin analogs (ending in \u0027-prost\u0027) are first-line for open-angle glaucoma. Remember the unique side effect of permanent"
      }, {
        "text": " iris color change.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eLatanoprost\u003c/b\u003e lowers intra"
      }, {
        "text": "ocular pressure by enhancing the eye\u0027s secondary drainage system (the uveoscleral pathway), making it a highly effective first-line treatment"
      }, {
        "text": " for open-angle glaucoma, with the peculiar cosmetic side effect of darkening the iris.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \""
      }, {
        "text": "to\": \"5ea7b741\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_type_of\",\n        \"to\": \"prostaglandin_analog\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"increases\",\n        \"to\": \"uveoscleral_outflow\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"iris_darkening\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"4d8b1ee2\": {\n    \"title\": \"Lateral Corticospinal Tract"
      }, {
        "text": "\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      "
      }, {
        "text": "\"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eLateral Corticospinal Tract\u003c/b\u003e is the"
      }, {
        "text": " largest descending motor pathway in the spinal cord, responsible for the voluntary control of contralateral limb and fine motor movements.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Controls voluntary, skilled movements of the distal extremities.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Com"
      }, {
        "text": "posed of upper motor neuron axons that originate in the primary motor cortex. They descend through the internal capsule and cerebral peduncles, \u003c"
      }, {
        "text": "mark\u003edecussate (cross over) at the pyramidal decussation\u003c/mark\u003e in the caudal medulla, and then descend"
      }, {
        "text": " in the lateral funiculus of the contralateral spinal cord to synapse on lower motor neurons in the anterior horn.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSom"
      }, {
        "text": "atotopy:\u003c/b\u003e Within the tract, fibers are somatotopically organized, with cervical fibers located most medially and sac"
      }, {
        "text": "ral fibers most laterally.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects:\u003c/b\u003e Damage to the lateral corticospinal tract results in \u003c"
      }, {
        "text": "mark\u003eipsilateral upper motor neuron (UMN) signs\u003c/mark\u003e below the level of the lesion (because the fibers"
      }, {
        "text": " have already crossed). These signs include spastic paralysis, hyperreflexia, and a positive Babinski sign.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e A lesion in the brain or brainstem above the pyramidal decussation causes contralateral UMN signs. A lesion in the"
      }, {
        "text": " spinal cord below the decussation causes ipsilateral UMN signs. This is a key principle for localizing lesions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eThe \u003cb\u003eLateral Corticospinal Tract\u003c/b\u003e is the primary highway for voluntary motor commands to"
      }, {
        "text": " the limbs, and its decussation in the medulla is the crucial anatomical reason why one side of the brain controls the opposite side of"
      }, {
        "text": " the body.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Motor Cortex] --\u003e B(Internal Capsule"
      }, {
        "text": "); B --\u003e C(Cerebral Peduncle); C --\u003e D(Pyramidal Decussation in Medulla); D --\u003e E"
      }, {
        "text": "(Lateral Corticospinal Tract in Spinal Cord); E --\u003e F(Synapse on LMN in Anterior Horn);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\":"
      }, {
        "text": " \"corticospinal_tract\"\n      },\n      {\n        \"type\": \"controls\",\n        \"to\": \"voluntary_"
      }, {
        "text": "movement\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"upper"
      }, {
        "text": "_motor_neuron_signs\"\n      },\n      {\n        \"type\": \"decussates_in"
      }, {
        "text": "\",\n        \"to\": \"medulla_oblongata\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "08d19deb\": {\n    \"title\": \"Lateral Geniculate Nucleus (LGN)\",\n    \"primaryType\":"
      }, {
        "text": " \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Ophthalmology"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Thalamus\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003eThe \u003cb\u003eLateral Geniculate Nucleus (LGN)\u003c/b\u003e, also known as the lateral geniculate body"
      }, {
        "text": ", is a key nucleus in the [[afc0a64b|thalamus]] that serves as the primary thalam"
      }, {
        "text": "ic relay station for \u003ci\u003evisual information\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction"
      }, {
        "text": ":\u003c/b\u003e Relays visual signals from the optic tract to the primary visual cortex in the occipital lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Rece"
      }, {
        "text": "ives input from retinal ganglion cells via the optic tract. The LGN then projects via the optic radiation (which includes [["
      }, {
        "text": "8423676f|Meyer\u0027s loop]] and the dorsal optic radiation) to the primary visual cortex (B"
      }, {
        "text": "rodmann area 17) in the calcarine sulcus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMnemonic:\u003c/b\u003e \u003cb\u003eL\u003c/b\u003eateral gen"
      }, {
        "text": "iculate nucleus for \u003cb\u003eL\u003c/b\u003eight (vision). Contrast with the \u003cb\u003eM\u003c/b\u003eedial geniculate nucleus for \u003cb\u003eM"
      }, {
        "text": "\u003c/b\u003eusic (hearing).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLaminar Structure:\u003c/b\u003e It has a layered structure that keeps information from the ips"
      }, {
        "text": "ilateral and contralateral eyes separate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the thalamic sensory relays: LGN for visual"
      }, {
        "text": ", MGN for auditory, VPL for body sensation, and VPM for face sensation. A lesion in the LG"
      }, {
        "text": "N causes a contralateral homonymous hemianopia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eLateral Geniculate Nucleus\u003c/b\u003e"
      }, {
        "text": " is the brain\u0027s crucial gateway for vision, acting as the final processing and relay point in the thalamus before visual"
      }, {
        "text": " information is sent to the cortex for conscious perception.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Optic Tract] --\u003e B("
      }, {
        "text": "Lateral Geniculate Nucleus); B --\u003e C(Optic Radiation); C --\u003e D(Primary Visual Cortex);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"afc0a64b\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"relays\",\n        \"to\": \"visual_information\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"projects_to\",\n        \"to\": \"primary_visual_cortex\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"optic_tract\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"07656b4a\": {\n    \"title\":"
      }, {
        "text": " \"Lateral Medullary Syndrome (Wallenberg Syndrome)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      "
      }, {
        "text": "\"Neurology\",\n      \"Vascular\",\n      \"Pathology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\","
      }, {
        "text": "\n      \"Brainstem Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eLateral Medullary"
      }, {
        "text": " Syndrome\u003c/b\u003e, also known as \u003cb\u003eWallenberg syndrome\u003c/b\u003e, is a brainstem stroke syndrome caused by an occlusion of the "
      }, {
        "text": "\u003ci\u003eposterior inferior cerebellar artery (PICA)\u003c/i\u003e or the vertebral artery, affecting the lateral portion of the medulla.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Caused by infarction in the territory of the \u003cmark\u003ePoster"
      }, {
        "text": "ior Inferior Cerebellar Artery (PICA)\u003c/mark\u003e. Mnemonic: Don\u0027t \u003cb\u003ePICA\u003c/b\u003e ("
      }, {
        "text": "pick a) horse that can\u0027t eat (hoarseness and dysphagia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAffected Structures \u0026 Symptoms:\u003c/b\u003e\u003cbr\u003e - "
      }, {
        "text": "\u003cb\u003eVestibular nuclei:\u003c/b\u003e Nystagmus, vertigo, nausea/vomiting.\u003cbr\u003e - \u003cb\u003eInfer"
      }, {
        "text": "ior cerebellar peduncle:\u003c/b\u003e Ipsilateral ataxia, dysmetria.\u003cbr\u003e - \u003cb\u003eSpinothalamic tract:\u003c/b\u003e \u003c"
      }, {
        "text": "mark\u003eContralateral\u003c/mark\u003e loss of pain and temperature from the body.\u003cbr\u003e - \u003cb\u003eSpinal trigeminal nucleus:"
      }, {
        "text": "\u003c/b\u003e \u003cmark\u003eIpsilateral\u003c/mark\u003e loss of pain and temperature from the face.\u003cbr\u003e - \u003cb\u003e"
      }, {
        "text": "Nucleus ambiguus (CN IX, X):\u003c/b\u003e \u003cmark\u003eIpsilateral\u003c/mark\u003e dysphagia, hoarseness, and decreased"
      }, {
        "text": " gag reflex.\u003cbr\u003e - \u003cb\u003eSympathetic fibers:\u003c/b\u003e Ipsilateral Horner syndrome (ptosis, miosis, anhidrosis).\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e This is a classic \u0027crossed\u0027 syndrome. The key is the combination of contralateral body sensory"
      }, {
        "text": " loss with ipsilateral face sensory loss and ipsilateral bulbar/cerebellar signs. Hoarseness and dysphagia are highly"
      }, {
        "text": " specific for this syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eWallenberg syndrome\u003c/b\u003e is a constellation"
      }, {
        "text": " of deficits that perfectly maps to the anatomy of the lateral medulla; the crossed sensory findings (ipsilateral face, contralateral body"
      }, {
        "text": ") combined with ipsilateral ataxia and bulbar palsy are pathognomonic for a PICA occlusion.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[PICA Occlusion] --\u003e B(Lateral Medullary Infarct); B --\u003e C(Cross"
      }, {
        "text": "ed Sensory Loss); B --\u003e D(Ipsilateral Horner Syndrome); B --\u003e E(Ipsilateral Ataxia);"
      }, {
        "text": " B --\u003e F(Dysphagia/Hoarseness);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_caused_by_occlusion_of\",\n        \"to\": \"posterior_infer"
      }, {
        "text": "ior_cerebellar_artery\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"vest"
      }, {
        "text": "ibular_nuclei\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to"
      }, {
        "text": "\": \"73378e13\"\n      },\n      {\n        \"type\": \"damages"
      }, {
        "text": "\",\n        \"to\": \"07eecef1\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"b37e8260\": {\n    \"title\": \"Lateral Nucleus of Hypothalamus\",\n    \"primary"
      }, {
        "text": "Type\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Endocrinology\","
      }, {
        "text": "\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"End"
      }, {
        "text": "ocrine\",\n      \"Anatomy\",\n      \"Hypothalamus\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003eThe \u003cb\u003eLateral Nucleus\u003c/b\u003e of the hypothalamus is a region of the hypothalamus that is considered"
      }, {
        "text": " the primary center for regulating \u003ci\u003ehunger\u003c/i\u003e and food intake.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction"
      }, {
        "text": ":\u003c/b\u003e Regulates hunger. Stimulation of the lateral nucleus induces hunger and eating behavior.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effect:\u003c/b\u003e A lesion in the lateral nucleus"
      }, {
        "text": " causes \u003cmark\u003eanorexia\u003c/mark\u003e and weight loss. Mnemonic: A lesion to the \u003cb\u003eL\u003c/b\u003eateral nucleus makes"
      }, {
        "text": " you \u003cb\u003eL\u003c/b\u003eean.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitters:\u003c/b\u003e It is stimulated by ghrelin (a hunger"
      }, {
        "text": " hormone from the stomach) and inhibited by leptin (a satiety hormone from fat cells). It produces orexigenic ("
      }, {
        "text": "appetite-stimulating) neuropeptides like orexin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContrast with Ventromedial Nucleus:\u003c/b\u003e"
      }, {
        "text": " The lateral nucleus is functionally opposed by the ventromedial nucleus (VMN), which is the satiety center. A lesion in the V"
      }, {
        "text": "MN causes hyperphagia and obesity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the opposing functions: \u003cb\u003eL\u003c/b\u003eateral nucleus \u003d "
      }, {
        "text": "\u003cb\u003eH\u003c/b\u003eunger. \u003cb\u003eV\u003c/b\u003eentro\u003cb\u003em\u003c/b\u003eedial nucleus \u003d \u003cb\u003eS\u003c/b\u003eatiety. ("
      }, {
        "text": "\u003cb\u003eL\u003c/b\u003eateral \u003cb\u003eH\u003c/b\u003eunger, \u003cb\u003eV\u003c/b\u003eery \u003cb\u003eM\u003c/b\u003euch \u003cb\u003eS\u003c/b\u003eatisf"
      }, {
        "text": "ied).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eLateral Nucleus\u003c/b\u003e of the hypothalamus acts as the body\u0027"
      }, {
        "text": "s \u0027on switch\u0027 for hunger; its destruction leads to a profound lack of appetite, highlighting its critical role in driving"
      }, {
        "text": " the fundamental behavior of seeking food.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_part_of\",\n        \"to\": \"89e86633\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"regulates\",\n        \"to\": \"hunger\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"anorexia\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_inhibited_by\",\n        \"to\": \"c851"
      }, {
        "text": "5469\"\n      },\n      {\n        \"type\": \"is_stimulated_by\",\n"
      }, {
        "text": "        \"to\": \"ghrelin\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"2f16ecd9\",\n    \"letter\": \"I\",\n    \"term\": \"Internal jugular vein\",\n    \"pages\": [\n      \"514\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Internal jugular vein\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"58c684bd\",\n    \"letter\": \"I\",\n    \"term\": \"Internuclear ophthalmoplegia\",\n    \"pages\": [\n      \"524\",\n      \"558\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Internuclear ophthalmoplegia\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"c20521ce\",\n    \"letter\": \"I\",\n    \"term\": \"Intracranial hemorrhage\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Intracranial hemorrhage\",\n    \"sub_entries\": [\n      {\n        \"id\": \"37e923fe\",\n        \"letter\": \"I\",\n        \"term\": \"types and findings\",\n        \"pages\": [\n          \"528\"\n        ],\n        \"context\": \"Intracranial hemorrhage \u003e types and findings\"\n      }\n    ]\n  },\n  {\n    \"id\": \"d93d2dfb\",\n    \"letter\": \"I\",\n    \"term\": \"Intracranial hypertension\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Intracranial hypertension\",\n    \"sub_entries\": [\n      {\n        \"id\": \"26ea95ed\",\n        \"letter\": \"I\",\n        \"term\": \"idiopathic\",\n        \"pages\": [\n          \"536\"\n        ],\n        \"context\": \"Intracranial hypertension \u003e idiopathic\"\n      }\n    ]\n  },\n  {\n    \"id\": \"c93cceff\",\n    \"letter\": \"I\",\n    \"term\": \"Intracranial pressure\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Intracranial pressure\",\n    \"sub_entries\": [\n      {\n        \"id\": \"1ceb229f\",\n        \"letter\": \"I\",\n        \"term\": \"ex vacuo ventromegaly\",\n        \"pages\": [\n          \"536\"\n        ],\n        \"context\": \"Intracranial pressure \u003e ex vacuo ventromegaly\"\n      },\n      {\n        \"id\": \"d9396bd9\",\n        \"letter\": \"I\",\n        \"term\": \"hydrocephalus\",\n        \"pages\": [\n          \"536\"\n        ],\n        \"context\": \"Intracranial pressure \u003e hydrocephalus\"\n      },\n      {\n        \"id\": \"1abc84fd\",\n        \"letter\": \"I\",\n        \"term\": \"in perfusion regulation\",\n        \"pages\": [\n          \"512\"\n        ],\n        \"context\": \"Intracranial pressure \u003e in perfusion regulation\"\n      }\n    ]\n  },\n  {\n    \"id\": \"6b5db87a\",\n    \"letter\": \"I\",\n    \"term\": \"Intraocular pressure (IOP)\",\n    \"pages\": [\n      \"551\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Intraocular pressure (IOP)\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"70b266c8\",\n    \"letter\": \"I\",\n    \"term\": \"Intraparenchymal hemorrhage\",\n    \"pages\": [\n      \"528\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Intraparenchymal hemorrhage\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"8c4ca4a8\",\n    \"letter\": \"I\",\n    \"term\": \"Intravenous anesthetics, mechanism\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Intravenous anesthetics, mechanism\",\n    \"sub_entries\": [\n      {\n        \"id\": \"5ce0d6d0\",\n        \"letter\": \"I\",\n        \"term\": \"and adverse effects\",\n        \"pages\": [\n          \"565\"\n        ],\n        \"context\": \"Intravenous anesthetics, mechanism \u003e and adverse effects\"\n      }\n    ]\n  },\n  {\n    \"id\": \"f1695e4c\",\n    \"letter\": \"I\",\n    \"term\": \"Intraventricular hemorrhage,\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Intraventricular hemorrhage,\",\n    \"sub_entries\": [\n      {\n        \"id\": \"23d6eded\",\n        \"letter\": \"I\",\n        \"term\": \"neonatal\",\n        \"pages\": [\n          \"527\"\n        ],\n        \"context\": \"Intraventricular hemorrhage, \u003e neonatal\"\n      }\n    ]\n  },\n  {\n    \"id\": \"29cf5fd3\",\n    \"letter\": \"I\",\n    \"term\": \"Iritis\",\n    \"pages\": [\n      \"553\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Iritis\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"73f7fc98\",\n    \"letter\": \"I\",\n    \"term\": \"Iron\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Iron\",\n    \"sub_entries\": [\n      {\n        \"id\": \"7b15c583\",\n        \"letter\": \"I\",\n        \"term\": \"restless legs syndrome and\",\n        \"pages\": [\n          \"533\"\n        ],\n        \"context\": \"Iron \u003e restless legs syndrome and\"\n      }\n    ]\n  },\n  {\n    \"id\": \"349f9307\",\n    \"letter\": \"I\",\n    \"term\": \"Ischemic brain disease/stroke\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Ischemic brain disease/stroke\",\n    \"sub_entries\": [\n      {\n        \"id\": \"096331dd\",\n        \"letter\": \"I\",\n        \"term\": \"consequences and time course\",\n        \"pages\": [\n          \"525\"\n        ],\n        \"context\": \"Ischemic brain disease/stroke \u003e consequences and time course\"\n      },\n      {\n        \"id\": \"6c5fb86a\",\n        \"letter\": \"I\",\n        \"term\": \"types of\",\n        \"pages\": [\n          \"525\"\n        ],\n        \"context\": \"Ischemic brain disease/stroke \u003e types of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"70509ee9\",\n    \"letter\": \"I\",\n    \"term\": \"Isoflurane\",\n    \"pages\": [\n      \"565\",\n      \"566\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Isoflurane\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"cc161b72\",\n    \"letter\": \"J\",\n    \"term\": \"Jaw jerk reflex\",\n    \"pages\": [\n      \"519\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Jaw jerk reflex\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"30b75088\",\n    \"letter\": \"J\",\n    \"term\": \"JC virus (John Cunningham virus)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"JC virus (John Cunningham virus)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"310eb563\",\n        \"letter\": \"J\",\n        \"term\": \"in demyelination disorders\",\n        \"pages\": [\n          \"538\"\n        ],\n        \"context\": \"JC virus (John Cunningham virus) \u003e in demyelination disorders\"\n      }\n    ]\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 2010
    }, {
      "text": "```json\n{\n  \"2f16ecd9\": {\n    \"title\": \"Internal Jugular Vein\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Anatomy\",\n      \"Cardiovascular\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Cardiovascular\",\n      \"Anatomy\",\n      \"Veins\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eInternal Jugular Vein (IJV)\u003c/b\u003e is a major paired vein in the neck that collects blood from the brain, superficial face, and neck, and is the primary drainage point for the dural venous sinuses.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCourse:\u003c/b\u003e Originates at the jugular foramen at the base of the skull as a continuation of the sigmoid sinus. It descends in the neck within the carotid sheath, lateral to the common carotid artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrainage:\u003c/b\u003e The dural venous sinuses (e.g., superior sagittal sinus, cavernous sinus) ultimately drain into the sigmoid sinus, which then becomes the IJV.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTributaries:\u003c/b\u003e Receives blood from the facial, lingual, pharyngeal, and thyroid veins.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTermination:\u003c/b\u003e Joins the subclavian vein to form the brachiocephalic vein.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e The IJV is used for central venous access (central line placement). The pulsations of the right IJV can be observed to estimate central venous pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The jugular foramen is a key anatomical landmark through which the IJV exits the skull, along with cranial nerves IX, X, and XI.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eInternal Jugular Vein\u003c/b\u003e is the principal venous conduit draining the cranial cavity, serving as the final exit for blood from the dural venous sinus system before it returns to the heart.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"drains\",\n        \"to\": \"dural_venous_sinuses\"\n      },\n      {\n        \"type\": \"exits_skull_via\",\n        \"to\": \"jugular_foramen\"\n      },\n      {\n        \"type\": \"joins_with\",\n        \"to\": \"subclavian_vein\"\n      }\n    ]\n  },\n  \"58c684bd\": {\n    \"title\": \"Internuclear Ophthalmoplegia (INO)\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brainstem Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eInternuclear Ophthalmoplegia (INO)\u003c/b\u003e is a specific gaze palsy characterized by impaired horizontal eye movement, caused by a lesion in the \u003ci\u003emedial longitudinal fasciculus (MLF)\u003c/i\u003e in the brainstem.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e A lesion in the [[59ad6172|MLF]] disrupts the signal from the contralateral [[dd11dde6|abducens (CN VI) nucleus]] to the ipsilateral [[68c66997|oculomotor (CN III) nucleus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Signs:\u003c/b\u003e When the patient attempts to look away from the side of the lesion, the ipsilateral (adducting) eye fails to move medially past the midline. The contralateral (abducting) eye exhibits nystagmus. Convergence is typically preserved.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMnemonic:\u003c/b\u003e \u003cb\u003eINO\u003c/b\u003e \u003d \u003cb\u003eI\u003c/b\u003epsilateral adduction failure, \u003cb\u003eN\u003c/b\u003eystagmus \u003cb\u003eO\u003c/b\u003epposite.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e In a young adult, \u003cmark\u003ebilateral INO\u003c/mark\u003e is pathognomonic for [[45dd6d19|Multiple Sclerosis]]. In an older adult, a \u003cmark\u003eunilateral INO\u003c/mark\u003e is most often caused by a brainstem stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A young woman with [[45dd6d19|MS]] who develops double vision and is found to have impaired adduction in one eye on lateral gaze has INO.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eInternuclear Ophthalmoplegia\u003c/b\u003e is a highly specific neurological sign that uncouples the normally yoked horizontal movements of the eyes, precisely localizing a lesion to the MLF and strongly suggesting either multiple sclerosis or a brainstem stroke depending on the patient\u0027s age and laterality.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Gaze Command] --\u003e B(Contralateral PPRF); B --\u003e C(Ipsilateral CN VI Nucleus); C --\u003e D(Ipsilateral Abduction); C --\u003e E(MLF); E --Lesion--\u003e X[Signal Blocked]; E --\u003e F(Contralateral CN III Nucleus); F --\u003e G(Contralateral Adduction);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"59ad6172\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"brainstem_stroke\"\n      }\n    ]\n  },\n  \"c20521ce\": {\n    \"title\": \"Intracranial Hemorrhage\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Vascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eIntracranial Hemorrhage\u003c/b\u003e is bleeding within the cranial vault, which can be classified based on its location into \u003ci\u003eepidural\u003c/i\u003e, \u003ci\u003esubdural\u003c/i\u003e, \u003ci\u003esubarachnoid\u003c/i\u003e, and \u003ci\u003eintraparenchymal\u003c/i\u003e types. It is a neurological emergency that can lead to increased intracranial pressure and brain herniation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEpidural Hematoma:\u003c/b\u003e Arterial bleed (middle meningeal artery) between dura and skull. \u003cmark\u003eLens-shaped (biconvex)\u003c/mark\u003e on CT, does not cross suture lines. Often associated with temporal bone fracture and a \u0027lucid interval.\u0027\u003c/li\u003e\u003cli\u003e\u003cb\u003eSubdural Hematoma:\u003c/b\u003e Venous bleed (bridging veins) between dura and arachnoid. \u003cmark\u003eCrescent-shaped\u003c/mark\u003e on CT, crosses suture lines. Seen in elderly, alcoholics, and shaken babies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSubarachnoid Hemorrhage:\u003c/b\u003e Bleeding into the CSF space between arachnoid and pia. Presents with \\\"worst headache of my life.\\\" Caused by ruptured [[a1647fb2|saccular aneurysm]] or trauma. Blood seen in sulci and cisterns on CT.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIntraparenchymal Hemorrhage:\u003c/b\u003e Bleeding within the brain parenchyma. Commonly caused by systemic hypertension (affecting basal ganglia, thalamus, pons), amyloid angiopathy, or tumors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The shape on non-contrast CT is key for differentiation: Epidural \u003d \u003cb\u003eL\u003c/b\u003eens-shaped (\u003cb\u003eL\u003c/b\u003eucid interval). Subdural \u003d \u003cb\u003eC\u003c/b\u003erescent-shaped (\u003cb\u003eC\u003c/b\u003ehronic/\u003cb\u003eC\u003c/b\u003erosses sutures).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe anatomical location of an \u003cb\u003eintracranial hemorrhage\u003c/b\u003e dictates its characteristic appearance on CT and its clinical course; arterial epidural hematomas expand rapidly and are highly lethal, whereas venous subdural hematomas can be acute or chronic with a more variable presentation.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"epidural_hematoma\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"subdural_hematoma\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"63f8b05f\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"70b266c8\"\n      }\n    ]\n  },\n  \"d93d2dfb\": {\n    \"title\": \"Intracranial Hypertension\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"General\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eIntracranial Hypertension (ICH)\u003c/b\u003e, or increased intracranial pressure (ICP), is a pathological elevation of pressure within the rigid cranial vault. It is a neurological emergency that can lead to decreased cerebral perfusion and brain herniation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e Can be caused by an increase in the volume of any of the intracranial components: brain parenchyma (e.g., tumor, edema), blood (e.g., hemorrhage, venous sinus thrombosis), or cerebrospinal fluid (e.g., [[0bc2f200|hydrocephalus]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eIdiopathic Intracranial Hypertension (IIH):\u003c/b\u003e A specific syndrome of increased ICP with no evident cause on imaging, typically affecting young, obese women.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Headache (often worse in the morning or with Valsalva), nausea/vomiting, [[4ae219da|papilledema]], and visual disturbances. [[dd11dde6|CN VI palsy]] is a common finding.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCushing\u0027s Triad:\u003c/b\u003e A late and ominous sign of severely elevated ICP, consisting of hypertension, bradycardia, and irregular respirations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Papilledema is the cardinal sign of increased ICP on physical exam. A CN VI palsy in the setting of headache is often a \u0027false localizing sign\u0027 pointing to generalized increased ICP.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eIntracranial hypertension\u003c/b\u003e occurs when the volume of the brain\u0027s contents exceeds the compensatory capacity of the skull, leading to a dangerous rise in pressure that can compress vital brain structures and compromise cerebral blood flow.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"be057cfc\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"c20521ce\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"0bc2f200\"\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"7c4e7c74\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"4ae219da\"\n      }\n    ]\n  },\n  \"c93cceff\": {\n    \"title\": \"Intracranial Pressure (ICP)\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Physiology\",\n      \"Neurosurgery\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebrovascular System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eIntracranial Pressure (ICP)\u003c/b\u003e is the pressure exerted by the contents of the cranium‚Äîbrain tissue, cerebrospinal fluid (CSF), and blood‚Äîwithin the rigid, non-expandable skull. Normal ICP is typically \u003c15 mmHg in adults.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMonro-Kellie Doctrine:\u003c/b\u003e States that the sum of the volumes of brain, CSF, and intracranial blood is constant. An increase in one component must be compensated by a decrease in another, or ICP will rise.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCerebral Perfusion Pressure (CPP):\u003c/b\u003e CPP \u003d MAP - ICP. Maintaining adequate CPP is crucial for brain viability. As ICP rises, CPP falls, potentially leading to cerebral ischemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRegulation of ICP:\u003c/b\u003e Can be influenced by factors that alter cerebral blood volume (e.g., PaCO\u003csub\u003e2\u003c/sub\u003e), CSF volume (e.g., [[0bc2f200|hydrocephalus]]), or brain tissue volume (e.g., edema).\u003c/li\u003e\u003cli\u003e\u003cb\u003eEx Vacuo Ventriculomegaly:\u003c/b\u003e This is ventricular enlargement due to brain atrophy, not increased CSF pressure. In this case, ICP is normal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Therapeutic hyperventilation (lowering PaCO\u003csub\u003e2\u003c/sub\u003e) causes cerebral vasoconstriction, which reduces cerebral blood volume and can temporarily lower ICP in an emergency.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eIntracranial pressure\u003c/b\u003e is a delicate balance of brain, blood, and CSF volumes within the fixed skull. The Monro-Kellie doctrine dictates that when this balance is disrupted by a pathological process, ICP rises, threatening cerebral perfusion and brain function.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_increased_in\",\n        \"to\": \"d93d2dfb\"\n      },\n      {\n        \"type\": \"determines\",\n        \"to\": \"3eca3f19\"\n      },\n      {\n        \"type\": \"is_related_to\",\n        \"to\": \"monro_kellie_doctrine\"\n      }\n    ]\n  },\n  \"6b5db87a\": {\n    \"title\": \"Intraocular Pressure (IOP)\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physiology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eIntraocular Pressure (IOP)\u003c/b\u003e is the fluid pressure inside the eye, maintained by a balance between the production and drainage of aqueous humor. Elevated IOP is the primary risk factor for the development and progression of glaucoma.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNormal Range:\u003c/b\u003e Typically between 10 and 21 mmHg.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDeterminants:\u003c/b\u003e Determined by the rate of aqueous humor production by the ciliary body and the resistance to its outflow through the trabecular meshwork and uveoscleral pathway.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAqueous Humor Production:\u003c/b\u003e Secreted by the ciliary epithelium, a process that can be decreased by beta-blockers and carbonic anhydrase inhibitors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAqueous Humor Outflow:\u003c/b\u003e Drains primarily via the trabecular meshwork (conventional pathway) and secondarily via the uveoscleral pathway. Prostaglandin analogs increase uveoscleral outflow, while cholinergic agonists increase trabecular outflow.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Elevated IOP (ocular hypertension) damages the optic nerve head, leading to the progressive optic neuropathy of [[3ce6c035|glaucoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The main goal of [[3ce6c035|glaucoma]] treatment is to lower IOP, either by decreasing aqueous humor production or by increasing its outflow.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eIntraocular pressure\u003c/b\u003e is the \u0027blood pressure\u0027 of the eye, a dynamic equilibrium of aqueous humor production and drainage. When this equilibrium is disrupted and pressure rises, it exerts a damaging force on the optic nerve, leading to the irreversible vision loss of glaucoma.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_elevated_in\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\": \"aqueous_humor_dynamics\"\n      },\n      {\n        \"type\": \"is_lowered_by\",\n        \"to\": \"glaucoma_medications\"\n      }\n    ]\n  },\n  \"70b266c8\": {\n    \"title\": \"Intraparenchymal Hemorrhage\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Vascular\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eIntraparenchymal hemorrhage\u003c/b\u003e, also known as intracerebral hemorrhage, is a type of hemorrhagic stroke characterized by bleeding directly into the brain parenchyma. It is most commonly caused by chronic hypertension.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology (Hypertensive):\u003c/b\u003e Chronic hypertension leads to the formation of \u003cmark\u003eCharcot-Bouchard microaneurysms\u003c/mark\u003e in small, penetrating arteries. Rupture of these microaneurysms is the most common cause.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Locations:\u003c/b\u003e Hypertensive hemorrhages typically occur in deep brain structures, most commonly the \u003cmark\u003ebasal ganglia (putamen)\u003c/mark\u003e, followed by the thalamus, pons, and cerebellum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology (Other):\u003c/b\u003e Other causes include cerebral amyloid angiopathy (lobar hemorrhages in the elderly), vascular malformations, tumors, and reperfusion injury after an ischemic stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden onset of focal neurological deficits that progress over minutes to hours. Symptoms depend on the location of the bleed and are often accompanied by headache, nausea/vomiting, and altered consciousness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An elderly patient with a history of poorly controlled hypertension who presents with a sudden focal deficit and signs of increased ICP has likely suffered a hypertensive intraparenchymal hemorrhage, most probably in the basal ganglia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eIntraparenchymal hemorrhage\u003c/b\u003e is a devastating stroke subtype where chronic hypertension weakens small, deep arteries to the point of rupture (Charcot-Bouchard microaneurysms), causing a bleed directly into critical brain structures like the basal ganglia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"c20521ce\"\n      },\n      {\n        \"type\": \"is_commonly_caused_by\",\n        \"to\": \"hypertension\"\n      },\n      {\n        \"type\": \"is_caused_by_rupture_of\",\n        \"to\": \"charcot_bouchard_microaneurysm\"\n      },\n      {\n        \"type\": \"most_common_location_is\",\n        \"to\": \"ed462927\"\n      }\n    ]\n  },\n  \"8c4ca4a8\": {\n    \"title\": \"Intravenous Anesthetics\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eIntravenous anesthetics\u003c/b\u003e are a group of drugs administered intravenously to induce or maintain general anesthesia. They are typically rapid-acting and lipid-soluble, allowing them to quickly cross the blood-brain barrier.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePropofol:\u003c/b\u003e The most commonly used IV agent for induction and maintenance of anesthesia. Potentiates GABA\u003csub\u003eA\u003c/sub\u003e receptors. Causes hypotension and respiratory depression.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtomidate:\u003c/b\u003e Potentiates GABA\u003csub\u003eA\u003c/sub\u003e receptors. It is \u003cmark\u003ehemodynamically neutral\u003c/mark\u003e, making it ideal for induction in trauma or cardiac patients. Can cause adrenal insufficiency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKetamine:\u003c/b\u003e An NMDA receptor antagonist. It is a dissociative anesthetic that provides analgesia and amnesia. It is a sympathomimetic, causing increased heart rate and blood pressure. Can cause emergence reactions (hallucinations).\u003c/li\u003e\u003cli\u003e\u003cb\u003eBarbiturates (Thiopental):\u003c/b\u003e Potentiate GABA\u003csub\u003eA\u003c/sub\u003e by increasing the duration of Cl\u003csup\u003e-\u003c/sup\u003e channel opening. Rapid onset due to high lipid solubility, but has a short duration of action due to rapid redistribution to skeletal muscle and fat.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBenzodiazepines (Midazolam):\u003c/b\u003e Potentiate GABA\u003csub\u003eA\u003c/sub\u003e by increasing the frequency of Cl\u003csup\u003e-\u003c/sup\u003e channel opening. Used for sedation and anxiolysis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know the key distinguishing features: Propofol \u003d most common, hypotension. Etomidate \u003d hemodynamically stable. Ketamine \u003d sympathomimetic, dissociative.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eIntravenous anesthetics\u003c/b\u003e induce unconsciousness by enhancing inhibitory neurotransmission (GABA) or blocking excitatory neurotransmission (glutamate), with each agent possessing a unique hemodynamic and side effect profile that dictates its specific clinical application.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"general_anesthetic\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"propofol\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"etomidate\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"08bf5432\"\n      }\n    ]\n  },\n  \"f1695e4c\": {\n    \"title\": \"Neonatal Intraventricular Hemorrhage (IVH)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeonatal Intraventricular Hemorrhage (IVH)\u003c/b\u003e is bleeding into the brain\u0027s ventricular system, a common and serious complication of prematurity, originating from the fragile germinal matrix.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e The single most important risk factor is \u003cmark\u003eprematurity\u003c/mark\u003e, especially in infants born before 32 weeks\u0027 gestation or with very low birth weight (\u003c1500g).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The hemorrhage originates from the \u003cmark\u003egerminal matrix\u003c/mark\u003e, a highly vascularized region in the subventricular zone that is prominent in premature infants. The immature vessels in this region are prone to rupture with fluctuations in cerebral blood flow.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Can be asymptomatic or present with signs of neurological distress, such as altered consciousness, bulging fontanelle, hypotension, seizures, or coma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e Can lead to post-hemorrhagic [[0bc2f200|hydrocephalus]] (due to blockage of CSF pathways by blood clots or scarring of arachnoid granulations) and long-term neurodevelopmental impairment, including [[171ca00b|cerebral palsy]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A premature infant who suddenly develops a bulging fontanelle, decreased activity, and a drop in hematocrit should be evaluated for IVH with a cranial ultrasound.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNeonatal Intraventricular Hemorrhage\u003c/b\u003e is a disease of prematurity, where the fragile, underdeveloped blood vessels of the germinal matrix rupture, leading to bleeding into the ventricles and the potential for lifelong neurological disability.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"prematurity\"\n      },\n      {\n        \"type\": \"originates_in\",\n        \"to\": \"germinal_matrix\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"0bc2f200\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"171ca00b\"\n      }\n    ]\n  },\n  \"29cf5fd3\": {\n    \"title\": \"Iritis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Rheumatology\",\n      \"Immunology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eIritis\u003c/b\u003e is inflammation of the iris, the colored part of the eye. It is the most common form of anterior uveitis.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Presents with a red, painful eye, photophobia, and blurred vision. On exam, there is often ciliary flush (a ring of redness around the cornea) and may be a constricted or irregular pupil.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSlit-Lamp Exam:\u003c/b\u003e The hallmark finding is the presence of inflammatory cells and flare (protein) in the anterior chamber. Keratic precipitates (inflammatory cells on the corneal endothelium) may also be seen.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSystemic Associations:\u003c/b\u003e While it can be idiopathic, iritis is strongly associated with systemic inflammatory and autoimmune diseases, particularly the \u003cmark\u003eHLA-B27-associated spondyloarthropathies\u003c/mark\u003e (ankylosing spondylitis, reactive arthritis, psoriatic arthritis, IBD-associated arthritis). It is also seen in sarcoidosis and juvenile idiopathic arthritis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e Can lead to posterior synechiae (adhesions between the iris and lens), glaucoma, and cataracts if not treated appropriately.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a seronegative spondyloarthropathy (e.g., ankylosing spondylitis) who presents with a painful red eye likely has anterior uveitis/iritis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eIritis\u003c/b\u003e is an intraocular inflammation that often serves as an ocular marker for systemic autoimmune disease, particularly the HLA-B27 spondyloarthropathies, making a thorough systemic review essential in any patient with a painful, red eye.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"anterior_uveitis\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"ankylosing_spondylitis\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"reactive_arthritis\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"sarcoidosis\"\n      }\n    ]\n  },\n  \"73f7fc98\": {\n    \"title\": \"Iron and Restless Legs Syndrome\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Hematology\",\n      \"Pathophysiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eIron deficiency\u003c/b\u003e is a major secondary cause and risk factor for \u003ci\u003eRestless Legs Syndrome (RLS)\u003c/i\u003e, a neurological disorder characterized by an irresistible urge to move the legs, typically accompanied by unpleasant sensations.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eRestless Legs Syndrome (RLS):\u003c/b\u003e An urge to move the legs, usually worse at rest and in the evening, and temporarily relieved by movement.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The link is not fully understood, but iron is a crucial cofactor for \u003cmark\u003etyrosine hydroxylase\u003c/mark\u003e, the rate-limiting enzyme in dopamine synthesis. It is hypothesized that low brain iron levels lead to dysfunctional dopaminergic transmission in the CNS, contributing to RLS symptoms.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Evaluation:\u003c/b\u003e All patients with RLS should be screened for iron deficiency by checking their serum \u003cmark\u003eferritin\u003c/mark\u003e levels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e If iron deficiency is present (typically defined as ferritin \u003c 50-75 ng/mL), iron supplementation is a first-line treatment and can significantly improve or resolve RLS symptoms.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a patient presenting with symptoms of RLS, the first step in management is to check their serum ferritin level to rule out iron deficiency as a treatable underlying cause.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe connection between low \u003cb\u003eiron\u003c/b\u003e stores and \u003cb\u003eRestless Legs Syndrome\u003c/b\u003e highlights the importance of iron in CNS dopamine synthesis; repleting iron in deficient patients can correct the underlying neurochemical imbalance and alleviate the distressing symptoms of RLS.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"deficiency_is_a_risk_factor_for\",\n        \"to\": \"919caff2\"\n      },\n      {\n        \"type\": \"is_a_cofactor_for\",\n        \"to\": \"tyrosine_hydroxylase\"\n      },\n      {\n        \"type\": \"is_involved_in_synthesis_of\",\n        \"to\": \"90adc821\"\n      }\n    ]\n  },\n  \"349f9307\": {\n    \"title\": \"Ischemic Stroke\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Vascular\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eAn \u003cb\u003eischemic stroke\u003c/b\u003e is a neurological deficit of sudden onset resulting from focal cerebral ischemia due to an interruption of blood supply to a part of the brain. It is the most common type of stroke, accounting for approximately 80% of cases.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTypes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eThrombotic:\u003c/b\u003e Caused by a thrombus forming on a ruptured atherosclerotic plaque within a cerebral artery.\u003cbr\u003e - \u003cb\u003eEmbolic:\u003c/b\u003e Caused by an embolus (e.g., from the heart in atrial fibrillation or from a carotid artery plaque) lodging in a cerebral artery.\u003cbr\u003e - \u003cb\u003eHypoxic:\u003c/b\u003e Caused by systemic hypoperfusion (e.g., in shock), typically affecting watershed areas.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology Time Course:\u003c/b\u003e The brain tissue undergoes \u003cmark\u003eliquefactive necrosis\u003c/mark\u003e. Histological changes include \u0027red neurons\u0027 (12-24 hrs), neutrophil infiltration (24-72 hrs), macrophage/microglial infiltration (3-5 days), reactive gliosis (1-2 weeks), and finally a glial scar ( \u003e2 weeks).\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e A non-contrast CT is the crucial first step to rule out hemorrhage. It may be normal in the first 6-24 hours. Diffusion-weighted MRI is the most sensitive test and can detect ischemia within minutes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAcute Treatment:\u003c/b\u003e Intravenous thrombolysis with tPA (alteplase) if within the 3-4.5 hour window and no contraindications. Mechanical thrombectomy may be an option for large vessel occlusions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The primary goal of the initial head CT in a suspected stroke is not to diagnose the ischemic stroke itself, but to exclude hemorrhage so that thrombolytic therapy can be safely administered.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eAn \u003cb\u003eischemic stroke\u003c/b\u003e is a \u0027brain attack\u0027 where a blocked artery leads to neuronal death and liquefactive necrosis. The clinical presentation is dictated by the vascular territory affected, and the immediate management hinges on rapidly distinguishing it from a hemorrhagic stroke to allow for time-sensitive reperfusion therapy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"stroke\"\n      },\n      {\n        \"type\": \"is_treated_with\",\n        \"to\": \"tpa\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\": \"4945aa8c\"\n      },\n      {\n        \"type\": \"is_differentiated_from\",\n        \"to\": \"hemorrhagic_stroke\"\n      }\n    ]\n  },\n  \"70509ee9\": {\n    \"title\": \"Isoflurane\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eIsoflurane\u003c/b\u003e is a volatile \u003ci\u003einhaled general anesthetic\u003c/i\u003e used for the induction and, more commonly, the maintenance of general anesthesia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a medium blood:gas partition coefficient, resulting in a slower onset and recovery compared to newer agents like desflurane and sevoflurane, but faster than halothane.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePotency:\u003c/b\u003e Has a low MAC (Minimum Alveolar Concentration) of ~1.2%, indicating high anesthetic potency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSystemic Effects:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCardiovascular:\u003c/b\u003e Causes dose-dependent decrease in mean arterial pressure, primarily through a decrease in systemic vascular resistance (vasodilation). Cardiac output is generally maintained.\u003cbr\u003e - \u003cb\u003eRespiratory:\u003c/b\u003e A potent respiratory depressant, decreasing tidal volume and minute ventilation.\u003cbr\u003e - \u003cb\u003eCerebral:\u003c/b\u003e Increases cerebral blood flow (due to vasodilation), which can increase intracranial pressure. It also decreases cerebral metabolic rate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Pungent odor can cause airway irritation, coughing, and laryngospasm, making it less ideal for inhalation induction. It is a potential trigger for [[429af8bd|malignant hyperthermia]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know the relative properties of inhaled anesthetics. Isoflurane has higher potency (lower MAC) and slower onset (higher blood:gas coefficient) than desflurane and sevoflurane.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eIsoflurane\u003c/b\u003e is a potent but relatively slow-acting inhaled anesthetic whose main hemodynamic effect is vasodilation, leading to a drop in blood pressure, and like other volatile anesthetics, it carries the risk of triggering malignant hyperthermia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"inhaled_anesthetic\"\n      },\n      {\n        \"type\": \"can_trigger\",\n        \"to\": \"429af8bd\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"vasodilation\"\n      },\n      {\n        \"type\": \"increases\",\n        \"to\": \"cerebral_blood_flow\"\n      }\n    ]\n  },\n  \"cc161b72\": {\n    \"title\": \"Jaw Jerk Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eJaw Jerk Reflex\u003c/b\u003e is a monosynaptic stretch reflex that involves the muscles of mastication, used to test the integrity of the \u003ci\u003etrigeminal nerve (CN V)\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eElicitation:\u003c/b\u003e The patient\u0027s mouth is held slightly open and relaxed. The examiner places a finger on the chin and taps it with a reflex hammer.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNormal Response:\u003c/b\u003e A minimal or absent jerk (slight closure of the jaw).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAbnormal Response (Hyperreflexia):\u003c/b\u003e A brisk, exaggerated closure of the jaw is an abnormal finding and indicates an \u003cmark\u003eupper motor neuron (UMN) lesion\u003c/mark\u003e above the level of the trigeminal motor nucleus in the pons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReflex Arc:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eAfferent Limb:\u003c/b\u003e Proprioceptive fibers from the masseter muscle travel via the mandibular division of the \u003cmark\u003etrigeminal nerve (CN V\u003csub\u003e3\u003c/sub\u003e)\u003c/mark\u003e to the mesencephalic nucleus of CN V.\u003cbr\u003e - \u003cb\u003eEfferent Limb:\u003c/b\u003e Motor fibers from the motor nucleus of CN V travel via the \u003cmark\u003etrigeminal nerve (CN V\u003csub\u003e3\u003c/sub\u003e)\u003c/mark\u003e to cause contraction of the masseter muscle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The jaw jerk is unique because both its afferent and efferent limbs are carried by the same cranial nerve (CN V). A hyperactive jaw jerk is a sign of a bilateral UMN lesion, as seen in conditions like [[4ed629f9|amyotrophic lateral sclerosis (ALS)]] or pseudobulbar palsy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eJaw Jerk Reflex\u003c/b\u003e is a cranial nerve equivalent of a deep tendon reflex, specifically testing the integrity of the trigeminal nerve. An exaggerated response is a key sign of upper motor neuron disease affecting the corticobulbar tracts.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Tap on Chin] --\u003e B(Stretch Masseter); B --\u003e C(Afferent via CN V3); C --\u003e D(Mesencephalic \u0026 Motor Nuclei of CN V); D --\u003e E(Efferent via CN V3); E --\u003e F(Masseter Contraction);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"tests_integrity_of\",\n        \"to\": \"0eb45a0a\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"deep_tendon_reflex\"\n      },\n      {\n        \"type\": \"is_exaggerated_in\",\n        \"to\": \"upper_motor_neuron_lesion\"\n      }\n    ]\n  },\n  \"30b75088\": {\n    \"title\": \"JC Virus (John Cunningham Virus)\",\n    \"primaryType\": \"microbe\",\n    \"tags\": [\n      \"Microbiology\",\n      \"Neurology\",\n      \"Infectious Disease\",\n      \"Immunology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Infections\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eJC virus (John Cunningham virus)\u003c/b\u003e is a common human polyomavirus that is typically asymptomatic in immunocompetent individuals but can reactivate in the setting of severe immunosuppression, causing the fatal demyelinating disease \u003ci\u003eProgressive Multifocal Leukoencephalopathy (PML)\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMicrobiology:\u003c/b\u003e A member of the Polyomaviridae family; a small, non-enveloped, double-stranded DNA virus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLatency:\u003c/b\u003e After primary infection (usually in childhood), the virus establishes a lifelong latent infection in the kidneys and lymphoid tissue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReactivation:\u003c/b\u003e Reactivation occurs in states of severe cell-mediated immunodeficiency, such as advanced \u003cmark\u003eHIV/AIDS\u003c/mark\u003e (CD4 count \u003c 200), hematologic malignancies, or in patients on immunosuppressive therapies like [[ae20a0ce|natalizumab]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathogenesis of PML:\u003c/b\u003e The reactivated virus spreads to the brain and infects and destroys \u003cmark\u003eoligodendrocytes\u003c/mark\u003e, the myelin-producing cells of the CNS.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation of PML:\u003c/b\u003e Rapidly progressive, multifocal neurological deficits, including cognitive decline, motor weakness, and visual changes. It is usually fatal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The triad of an immunocompromised patient (especially AIDS or on natalizumab), rapidly progressive neurological symptoms, and multifocal non-enhancing white matter lesions on MRI is classic for PML caused by JC virus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eJC virus\u003c/b\u003e is a ubiquitous and harmless passenger in most of the population, but in an immunocompromised host, it can transform into a destructive pathogen that specifically targets and lyses oligodendrocytes, leading to the devastating demyelinating disease PML.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"progressive_multifocal_leukoencephalopathy\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"polyomavirus\"\n      },\n      {\n        \"type\": \"infects\",\n        \"to\": \"a24f9747\"\n      },\n      {\n        \"type\": \"reactivates_in\",\n        \"to\": \"immunocompromised_state\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9538,
      "parts": [{
        "text": "```json\n{\n"
      }, {
        "text": "  \"2f16ecd9\": {\n    \"title\": \"Internal"
      }, {
        "text": " Jugular Vein\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Anatomy\",\n"
      }, {
        "text": "      \"Cardiovascular\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Cardiovascular\",\n      \"Anatomy\",\n      \"Veins\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eInternal Jugular Vein (IJV)\u003c/b\u003e is a major"
      }, {
        "text": " paired vein in the neck that collects blood from the brain, superficial face, and neck, and is the primary drainage point for the d"
      }, {
        "text": "ural venous sinuses.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCourse:\u003c/b\u003e Originates at the jugular foramen at"
      }, {
        "text": " the base of the skull as a continuation of the sigmoid sinus. It descends in the neck within the carotid sheath, lateral"
      }, {
        "text": " to the common carotid artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrainage:\u003c/b\u003e The dural venous sinuses (e.g., superior sagittal sinus, cavern"
      }, {
        "text": "ous sinus) ultimately drain into the sigmoid sinus, which then becomes the IJV.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTributaries:\u003c/b\u003e Rece"
      }, {
        "text": "ives blood from the facial, lingual, pharyngeal, and thyroid veins.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTermination:\u003c/b\u003e Joins the subcl"
      }, {
        "text": "avian vein to form the brachiocephalic vein.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e The IJV is used for central venous access"
      }, {
        "text": " (central line placement). The pulsations of the right IJV can be observed to estimate central venous pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE"
      }, {
        "text": " Tip:\u003c/b\u003e The jugular foramen is a key anatomical landmark through which the IJV exits the skull, along with cranial"
      }, {
        "text": " nerves IX, X, and XI.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eInternal Jugular"
      }, {
        "text": " Vein\u003c/b\u003e is the principal venous conduit draining the cranial cavity, serving as the final exit for blood from the dural venous sinus"
      }, {
        "text": " system before it returns to the heart.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      "
      }, {
        "text": "{\n        \"type\": \"drains\",\n        \"to\": \"dural_venous_sinuses"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"exits_skull_via\",\n        \"to"
      }, {
        "text": "\": \"jugular_foramen\"\n      },\n      {\n        \"type\": \"joins_with\","
      }, {
        "text": "\n        \"to\": \"subclavian_vein\"\n      }\n    ]\n  },\n  \"5"
      }, {
        "text": "8c684bd\": {\n    \"title\": \"Internuclear Ophthalmoplegia (INO)\",\n    \"primaryType\": \""
      }, {
        "text": "finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and"
      }, {
        "text": " Special Senses\",\n      \"Pathology\",\n      \"Brainstem Syndromes\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eInternuclear Ophthalmoplegia (INO)\u003c/b\u003e is a specific"
      }, {
        "text": " gaze palsy characterized by impaired horizontal eye movement, caused by a lesion in the \u003ci\u003emedial longitudinal fasciculus (MLF)\u003c/i\u003e"
      }, {
        "text": " in the brainstem.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e A"
      }, {
        "text": " lesion in the [[59ad6172|MLF]] disrupts the signal from the contralateral [[dd1"
      }, {
        "text": "1dde6|abducens (CN VI) nucleus]] to the ipsilateral [[68c669"
      }, {
        "text": "97|oculomotor (CN III) nucleus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Signs:\u003c/b\u003e When the patient attempts to look away"
      }, {
        "text": " from the side of the lesion, the ipsilateral (adducting) eye fails to move medially past the midline."
      }, {
        "text": " The contralateral (abducting) eye exhibits nystagmus. Convergence is typically preserved.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMnemonic:\u003c/b\u003e "
      }, {
        "text": "\u003cb\u003eINO\u003c/b\u003e \u003d \u003cb\u003eI\u003c/b\u003epsilateral adduction failure, \u003cb\u003eN\u003c/b\u003eystagmus \u003cb\u003eO\u003c/b\u003epposite.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eEtiology:\u003c/b\u003e In a young adult, \u003cmark\u003ebilateral INO\u003c/mark\u003e is pathogn"
      }, {
        "text": "omonic for [[45dd6d19|Multiple Sclerosis]]. In an older adult, a \u003cmark\u003eunilateral INO\u003c/"
      }, {
        "text": "mark\u003e is most often caused by a brainstem stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A young woman with [["
      }, {
        "text": "45dd6d19|MS]] who develops double vision and is found to have impaired adduction in one eye on"
      }, {
        "text": " lateral gaze has INO.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eInternuclear Ophthalmoplegia\u003c/b\u003e"
      }, {
        "text": " is a highly specific neurological sign that uncouples the normally yoked horizontal movements of the eyes, precisely localizing a"
      }, {
        "text": " lesion to the MLF and strongly suggesting either multiple sclerosis or a brainstem stroke depending on the patient\u0027s age and later"
      }, {
        "text": "ality.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Gaze Command] --\u003e B(Contralateral P"
      }, {
        "text": "PRF); B --\u003e C(Ipsilateral CN VI Nucleus); C --\u003e D(Ipsilateral Abduction); C --\u003e E"
      }, {
        "text": "(MLF); E --Lesion--\u003e X[Signal Blocked]; E --\u003e F(Contralateral CN III"
      }, {
        "text": " Nucleus); F --\u003e G(Contralateral Adduction);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"59ad"
      }, {
        "text": "6172\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\","
      }, {
        "text": "\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "symptom_of\",\n        \"to\": \"brainstem_stroke\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"c20521ce\": {\n    \"title\": \"Intracranial Hemorrhage\",\n    \"primaryType"
      }, {
        "text": "\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Vascular"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eIntracranial Hemorrhage\u003c/b\u003e is bleeding within the cranial vault, which can be classified based on its"
      }, {
        "text": " location into \u003ci\u003eepidural\u003c/i\u003e, \u003ci\u003esubdural\u003c/i\u003e, \u003ci\u003esubarachnoid\u003c/i\u003e, and"
      }, {
        "text": " \u003ci\u003eintraparenchymal\u003c/i\u003e types. It is a neurological emergency that can lead to increased intracranial pressure and brain"
      }, {
        "text": " herniation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEpidural Hematoma:\u003c/b\u003e Arterial bleed ("
      }, {
        "text": "middle meningeal artery) between dura and skull. \u003cmark\u003eLens-shaped (biconvex)\u003c/mark\u003e on CT"
      }, {
        "text": ", does not cross suture lines. Often associated with temporal bone fracture and a \u0027lucid interval.\u0027\u003c/li\u003e\u003cli\u003e\u003cb\u003eSub"
      }, {
        "text": "dural Hematoma:\u003c/b\u003e Venous bleed (bridging veins) between dura and arachnoid. \u003cmark\u003eC"
      }, {
        "text": "rescent-shaped\u003c/mark\u003e on CT, crosses suture lines. Seen in elderly, alcoholics, and shaken babies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSub"
      }, {
        "text": "arachnoid Hemorrhage:\u003c/b\u003e Bleeding into the CSF space between arachnoid and pia. Presents with \\\""
      }, {
        "text": "worst headache of my life.\\\" Caused by ruptured [[a1647fb2|saccular aneurysm]] or trauma"
      }, {
        "text": ". Blood seen in sulci and cisterns on CT.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIntraparenchymal Hemorrhage:"
      }, {
        "text": "\u003c/b\u003e Bleeding within the brain parenchyma. Commonly caused by systemic hypertension (affecting basal ganglia, thalamus, pons), amyloid"
      }, {
        "text": " angiopathy, or tumors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The shape on non-contrast CT is key for differentiation"
      }, {
        "text": ": Epidural \u003d \u003cb\u003eL\u003c/b\u003eens-shaped (\u003cb\u003eL\u003c/b\u003eucid interval). Subdural \u003d \u003cb\u003eC"
      }, {
        "text": "\u003c/b\u003erescent-shaped (\u003cb\u003eC\u003c/b\u003ehronic/\u003cb\u003eC\u003c/b\u003erosses sutures).\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eThe anatomical location of an \u003cb\u003eintracranial hemorrhage\u003c/b\u003e dictates its characteristic appearance on CT and its"
      }, {
        "text": " clinical course; arterial epidural hematomas expand rapidly and are highly lethal, whereas venous subdural hematomas can be acute"
      }, {
        "text": " or chronic with a more variable presentation.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"epidural_hematoma\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_type_of\",\n        \"to\": \"subdural_"
      }, {
        "text": "hematoma\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"63f8b05f\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_type_of\",\n        \"to\": \"70b266c8\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"d93d2dfb\": {\n    \"title\": \"Intracranial Hypertension"
      }, {
        "text": "\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Neurosurgery\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"General\"\n    ],\n    \"content\":"
      }, {
        "text": " {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eIntracranial Hypertension (ICH)\u003c/b\u003e, or increased intracranial pressure (ICP"
      }, {
        "text": "), is a pathological elevation of pressure within the rigid cranial vault. It is a neurological emergency that can lead to decreased cerebral perfusion"
      }, {
        "text": " and brain herniation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e Can be caused by an"
      }, {
        "text": " increase in the volume of any of the intracranial components: brain parenchyma (e.g., tumor, edema), blood (e.g., hemorrhage"
      }, {
        "text": ", venous sinus thrombosis), or cerebrospinal fluid (e.g., [[0bc2f200|hydrocephalus]])."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eIdiopathic Intracranial Hypertension (IIH):\u003c/b\u003e A specific syndrome of increased ICP with no evident cause on"
      }, {
        "text": " imaging, typically affecting young, obese women.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Headache (often worse in the morning or with"
      }, {
        "text": " Valsalva), nausea/vomiting, [[4ae219da|papilledema]], and visual disturbances."
      }, {
        "text": " [[dd11dde6|CN VI palsy]] is a common finding.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCushing\u0027s Tri"
      }, {
        "text": "ad:\u003c/b\u003e A late and ominous sign of severely elevated ICP, consisting of hypertension, bradycardia, and irregular respirations."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Papilledema is the cardinal sign of increased ICP on physical exam. A CN"
      }, {
        "text": " VI palsy in the setting of headache is often a \u0027false localizing sign\u0027 pointing to generalized increased ICP.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eIntracranial hypertension\u003c/b\u003e occurs when the volume of the brain\u0027s contents exceeds the compensatory capacity of the skull, leading to a"
      }, {
        "text": " dangerous rise in pressure that can compress vital brain structures and compromise cerebral blood flow.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"be"
      }, {
        "text": "057cfc\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \""
      }, {
        "text": "to\": \"c20521ce\"\n      },\n      {\n        \"type\": \"can"
      }, {
        "text": "_be_caused_by\",\n        \"to\": \"0bc2f200\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"7c"
      }, {
        "text": "4e7c74\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"4"
      }, {
        "text": "ae219da\"\n      }\n    ]\n  },\n  \"c93cceff\": {\n    \"title\": \""
      }, {
        "text": "Intracranial Pressure (ICP)\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "science\",\n      \"Physiology\",\n      \"Neurosurgery\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"C"
      }, {
        "text": "erebrovascular System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eIntracranial Pressure ("
      }, {
        "text": "ICP)\u003c/b\u003e is the pressure exerted by the contents of the cranium‚Äîbrain tissue, cerebrospinal fluid (CSF), and"
      }, {
        "text": " blood‚Äîwithin the rigid, non-expandable skull. Normal ICP is typically \u003c15 mmHg in adults.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMonro-Kellie Doctrine:\u003c/b\u003e States that the sum of the volumes of brain"
      }, {
        "text": ", CSF, and intracranial blood is constant. An increase in one component must be compensated by a decrease in another, or"
      }, {
        "text": " ICP will rise.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCerebral Perfusion Pressure (CPP):\u003c/b\u003e CPP \u003d MAP - ICP. Maintaining"
      }, {
        "text": " adequate CPP is crucial for brain viability. As ICP rises, CPP falls, potentially leading to cerebral ischemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRegulation of"
      }, {
        "text": " ICP:\u003c/b\u003e Can be influenced by factors that alter cerebral blood volume (e.g., PaCO\u003csub\u003e2\u003c/sub\u003e), CSF volume"
      }, {
        "text": " (e.g., [[0bc2f200|hydrocephalus]]), or brain tissue volume (e.g., edema)."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eEx Vacuo Ventriculomegaly:\u003c/b\u003e This is ventricular enlargement due to brain atrophy, not increased"
      }, {
        "text": " CSF pressure. In this case, ICP is normal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Therapeutic hyperventilation (low"
      }, {
        "text": "ering PaCO\u003csub\u003e2\u003c/sub\u003e) causes cerebral vasoconstriction, which reduces cerebral blood volume and can temporarily lower ICP in an emergency.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003e\u003cb\u003eIntracranial pressure\u003c/b\u003e is a delicate balance of brain, blood, and CSF volumes within"
      }, {
        "text": " the fixed skull. The Monro-Kellie doctrine dictates that when this balance is disrupted by a pathological process, ICP rises"
      }, {
        "text": ", threatening cerebral perfusion and brain function.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_increased_in\",\n        \"to\": \"d93d2dfb\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"determines\",\n        \"to\": \"3eca3f19\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_related_to\",\n        \"to\": \"monro_kellie_doctrine\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"6b5db87a\": {\n    \"title"
      }, {
        "text": "\": \"Intraocular Pressure (IOP)\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physiology\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eIntraocular Pressure (IOP)\u003c/b\u003e is the"
      }, {
        "text": " fluid pressure inside the eye, maintained by a balance between the production and drainage of aqueous humor. Elevated IOP is the primary risk factor for the"
      }, {
        "text": " development and progression of glaucoma.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNormal Range:\u003c/b\u003e Typically"
      }, {
        "text": " between 10 and 21 mmHg.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDeterminants:\u003c/b\u003e Determined by the rate of aqueous humor production by"
      }, {
        "text": " the ciliary body and the resistance to its outflow through the trabecular meshwork and uveoscleral pathway.\u003c/li\u003e\u003cli\u003e\u003cb\u003eA"
      }, {
        "text": "queous Humor Production:\u003c/b\u003e Secreted by the ciliary epithelium, a process that can be decreased by beta-blockers and carbonic"
      }, {
        "text": " anhydrase inhibitors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAqueous Humor Outflow:\u003c/b\u003e Drains primarily via the trabecular meshwork (conventional"
      }, {
        "text": " pathway) and secondarily via the uveoscleral pathway. Prostaglandin analogs increase uveoscleral outflow, while cholinergic"
      }, {
        "text": " agonists increase trabecular outflow.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Elevated IOP (ocular hypertension) damages the optic nerve head,"
      }, {
        "text": " leading to the progressive optic neuropathy of [[3ce6c035|glaucoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The main goal of [[3ce6c035|glaucoma]] treatment is to lower"
      }, {
        "text": " IOP, either by decreasing aqueous humor production or by increasing its outflow.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eIntraocular"
      }, {
        "text": " pressure\u003c/b\u003e is the \u0027blood pressure\u0027 of the eye, a dynamic equilibrium of aqueous humor production and drainage. When this equilibrium"
      }, {
        "text": " is disrupted and pressure rises, it exerts a damaging force on the optic nerve, leading to the irreversible vision loss of glaucoma.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "elevated_in\",\n        \"to\": \"3ce6c035\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_regulated_by\",\n        \"to\": \"aqueous_humor_dynamics"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_lowered_by\",\n        \"to"
      }, {
        "text": "\": \"glaucoma_medications\"\n      }\n    ]\n  },\n  \"70b266c8\":"
      }, {
        "text": " {\n    \"title\": \"Intraparenchymal Hemorrhage\",\n    \"primaryType\": \"disease"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neurology\",\n      \"Vascular\",\n      \"Pathology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003e\u003cb\u003eIntraparenchymal hemorrhage\u003c/b\u003e, also known as intracerebral hemorrhage, is"
      }, {
        "text": " a type of hemorrhagic stroke characterized by bleeding directly into the brain parenchyma. It is most commonly caused by chronic hypertension.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology (Hypertensive):\u003c/b\u003e Chronic hypertension leads to the formation of \u003cmark\u003eChar"
      }, {
        "text": "cot-Bouchard microaneurysms\u003c/mark\u003e in small, penetrating arteries. Rupture of these micro"
      }, {
        "text": "aneurysms is the most common cause.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Locations:\u003c/b\u003e Hypertensive hemorrhages typically occur in deep"
      }, {
        "text": " brain structures, most commonly the \u003cmark\u003ebasal ganglia (putamen)\u003c/mark\u003e, followed by the thalamus, pons"
      }, {
        "text": ", and cerebellum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology (Other):\u003c/b\u003e Other causes include cerebral amyloid angiopathy (lobar hemorrhages in the"
      }, {
        "text": " elderly), vascular malformations, tumors, and reperfusion injury after an ischemic stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden"
      }, {
        "text": " onset of focal neurological deficits that progress over minutes to hours. Symptoms depend on the location of the bleed and are often accompanied by headache, nausea/"
      }, {
        "text": "vomiting, and altered consciousness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An elderly patient with a history of poorly controlled hypertension who"
      }, {
        "text": " presents with a sudden focal deficit and signs of increased ICP has likely suffered a hypertensive intraparenchymal hemorrhage, most probably"
      }, {
        "text": " in the basal ganglia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eIntraparenchymal hemorrhage"
      }, {
        "text": "\u003c/b\u003e is a devastating stroke subtype where chronic hypertension weakens small, deep arteries to the point of rupture (Charcot-Bouchard micro"
      }, {
        "text": "aneurysms), causing a bleed directly into critical brain structures like the basal ganglia.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"c20521ce\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "commonly_caused_by\",\n        \"to\": \"hypertension\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_caused_by_rupture_of\",\n        \"to\": \"charcot_bouch"
      }, {
        "text": "ard_microaneurysm\"\n      },\n      {\n        \"type\": \"most_common_location_"
      }, {
        "text": "is\",\n        \"to\": \"ed462927\"\n      }\n    ]\n  },\n  \"8"
      }, {
        "text": "c4ca4a8\": {\n    \"title\": \"Intravenous Anesthetics\",\n    \"primaryType\": \"drug"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eIntravenous anest"
      }, {
        "text": "hetics\u003c/b\u003e are a group of drugs administered intravenously to induce or maintain general anesthesia. They are typically rapid-acting and lipid"
      }, {
        "text": "-soluble, allowing them to quickly cross the blood-brain barrier.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003ePropofol:\u003c/b\u003e The most commonly used IV agent for induction and maintenance of anesthesia. Potentiates GABA\u003csub\u003eA\u003c/sub\u003e receptors"
      }, {
        "text": ". Causes hypotension and respiratory depression.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtomidate:\u003c/b\u003e Potentiates GABA\u003csub\u003eA\u003c/sub\u003e receptors."
      }, {
        "text": " It is \u003cmark\u003ehemodynamically neutral\u003c/mark\u003e, making it ideal for induction in trauma or cardiac patients. Can"
      }, {
        "text": " cause adrenal insufficiency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKetamine:\u003c/b\u003e An NMDA receptor antagonist. It is a dissociative anesthetic that"
      }, {
        "text": " provides analgesia and amnesia. It is a sympathomimetic, causing increased heart rate and blood pressure. Can"
      }, {
        "text": " cause emergence reactions (hallucinations).\u003c/li\u003e\u003cli\u003e\u003cb\u003eBarbiturates (Thiopental):\u003c/b\u003e Potentiate"
      }, {
        "text": " GABA\u003csub\u003eA\u003c/sub\u003e by increasing the duration of Cl\u003csup\u003e-\u003c/sup\u003e channel opening. Rapid onset due to high lipid solubility, but has"
      }, {
        "text": " a short duration of action due to rapid redistribution to skeletal muscle and fat.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBenzodiazepines (Midazolam):\u003c/b\u003e Pot"
      }, {
        "text": "entiate GABA\u003csub\u003eA\u003c/sub\u003e by increasing the frequency of Cl\u003csup\u003e-\u003c/sup\u003e channel opening. Used for sedation and anxiolysis.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know the key distinguishing features: Propofol \u003d most common, hypotension. Etomidate \u003d hemod"
      }, {
        "text": "ynamically stable. Ketamine \u003d sympathomimetic, dissociative.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eIntravenous"
      }, {
        "text": " anesthetics\u003c/b\u003e induce unconsciousness by enhancing inhibitory neurotransmission (GABA) or blocking excitatory neurotransmission (glutamate), with"
      }, {
        "text": " each agent possessing a unique hemodynamic and side effect profile that dictates its specific clinical application.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"general_anesthetic\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"propofol"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"etomidate"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"08bf"
      }, {
        "text": "5432\"\n      }\n    ]\n  },\n  \"f1695e4"
      }, {
        "text": "c\": {\n    \"title\": \"Neonatal Intraventricular Hemorrhage (IVH)\",\n    \"primaryType"
      }, {
        "text": "\": \"disease\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Neurology\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeon"
      }, {
        "text": "atal Intraventricular Hemorrhage (IVH)\u003c/b\u003e is bleeding into the brain\u0027s ventricular system, a common"
      }, {
        "text": " and serious complication of prematurity, originating from the fragile germinal matrix.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eRisk"
      }, {
        "text": " Factors:\u003c/b\u003e The single most important risk factor is \u003cmark\u003eprematurity\u003c/mark\u003e, especially in infants born before 3"
      }, {
        "text": "2 weeks\u0027 gestation or with very low birth weight (\u003c1500g).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The"
      }, {
        "text": " hemorrhage originates from the \u003cmark\u003egerminal matrix\u003c/mark\u003e, a highly vascularized region in the subventricular zone that"
      }, {
        "text": " is prominent in premature infants. The immature vessels in this region are prone to rupture with fluctuations in cerebral blood flow.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Can"
      }, {
        "text": " be asymptomatic or present with signs of neurological distress, such as altered consciousness, bulging fontanelle, hypotension, seizures, or"
      }, {
        "text": " coma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e Can lead to post-hemorrhagic [[0bc2f200|"
      }, {
        "text": "hydrocephalus]] (due to blockage of CSF pathways by blood clots or scarring of arachnoid granulations) and long-term neuro"
      }, {
        "text": "developmental impairment, including [[171ca00b|cerebral palsy]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A"
      }, {
        "text": " premature infant who suddenly develops a bulging fontanelle, decreased activity, and a drop in hematocrit should be evaluated for IVH with"
      }, {
        "text": " a cranial ultrasound.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNeonatal Intraventricular Hemorrhage\u003c/b\u003e"
      }, {
        "text": " is a disease of prematurity, where the fragile, underdeveloped blood vessels of the germinal matrix rupture, leading to bleeding into the ventric"
      }, {
        "text": "les and the potential for lifelong neurological disability.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to"
      }, {
        "text": "\": \"prematurity\"\n      },\n      {\n        \"type\": \"originates_in\",\n        \"to\": \"germ"
      }, {
        "text": "inal_matrix\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"0"
      }, {
        "text": "bc2f200\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"17"
      }, {
        "text": "1ca00b\"\n      }\n    ]\n  },\n  \"29cf5fd3"
      }, {
        "text": "\": {\n    \"title\": \"Iritis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Ophthalmology\",\n      \"Rheumatology\",\n      \"Immunology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Pathology"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eIritis\u003c/b\u003e is inflammation of the iris, the colored"
      }, {
        "text": " part of the eye. It is the most common form of anterior uveitis.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Presents with a red, painful eye, photophobia, and blurred vision. On"
      }, {
        "text": " exam, there is often ciliary flush (a ring of redness around the cornea) and may be a constricted or irregular pupil."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eSlit-Lamp Exam:\u003c/b\u003e The hallmark finding is the presence of inflammatory cells and flare (protein)"
      }, {
        "text": " in the anterior chamber. Keratic precipitates (inflammatory cells on the corneal endothelium) may also be seen.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSystem"
      }, {
        "text": "ic Associations:\u003c/b\u003e While it can be idiopathic, iritis is strongly associated with systemic inflammatory and autoimmune diseases, particularly the"
      }, {
        "text": " \u003cmark\u003eHLA-B27-associated spondyloarthropathies\u003c/mark\u003e (ankylosing spondylitis, reactive"
      }, {
        "text": " arthritis, psoriatic arthritis, IBD-associated arthritis). It is also seen in sarcoidosis and juvenile idiopathic"
      }, {
        "text": " arthritis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e Can lead to posterior synechiae (adhesions between the iris and lens"
      }, {
        "text": "), glaucoma, and cataracts if not treated appropriately.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a seroneg"
      }, {
        "text": "ative spondyloarthropathy (e.g., ankylosing spondylitis) who presents with a painful red"
      }, {
        "text": " eye likely has anterior uveitis/iritis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eIritis\u003c/b\u003e is an"
      }, {
        "text": " intraocular inflammation that often serves as an ocular marker for systemic autoimmune disease, particularly the HLA-B27 spondyloarthropathies, making"
      }, {
        "text": " a thorough systemic review essential in any patient with a painful, red eye.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"anterior_uveitis\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\":"
      }, {
        "text": " \"ankylosing_spondylitis\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "associated_with\",\n        \"to\": \"reactive_arthritis\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_associated_with\",\n        \"to\": \"sarcoidosis\"\n      }\n    ]\n  },"
      }, {
        "text": "\n  \"73f7fc98\": {\n    \"title\": \"Iron and Restless Legs Syndrome\",\n    \"primary"
      }, {
        "text": "Type\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Hematology\",\n      \"Path"
      }, {
        "text": "ophysiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eIron deficiency\u003c/b\u003e is a major secondary cause and risk factor for \u003ci\u003eRestless Legs Syndrome (RL"
      }, {
        "text": "S)\u003c/i\u003e, a neurological disorder characterized by an irresistible urge to move the legs, typically accompanied by unpleasant sensations.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eRestless Legs Syndrome (RLS):\u003c/b\u003e An urge to move the legs, usually worse at"
      }, {
        "text": " rest and in the evening, and temporarily relieved by movement.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The link is not"
      }, {
        "text": " fully understood, but iron is a crucial cofactor for \u003cmark\u003etyrosine hydroxylase\u003c/mark\u003e, the rate-limiting enzyme in dopamine"
      }, {
        "text": " synthesis. It is hypothesized that low brain iron levels lead to dysfunctional dopaminergic transmission in the CNS, contributing to RLS symptoms"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Evaluation:\u003c/b\u003e All patients with RLS should be screened for iron deficiency by checking their serum \u003c"
      }, {
        "text": "mark\u003eferritin\u003c/mark\u003e levels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e If iron deficiency is present (typically defined as ferritin"
      }, {
        "text": " \u003c 50-75 ng/mL), iron supplementation is a first-line treatment and can significantly improve or"
      }, {
        "text": " resolve RLS symptoms.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a patient presenting with symptoms of RLS, the"
      }, {
        "text": " first step in management is to check their serum ferritin level to rule out iron deficiency as a treatable underlying cause.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003eThe connection between low \u003cb\u003eiron\u003c/b\u003e stores and \u003cb\u003eRestless Legs Syndrome\u003c/b\u003e highlights"
      }, {
        "text": " the importance of iron in CNS dopamine synthesis; repleting iron in deficient patients can correct the underlying neurochemical imbalance and alleviate the"
      }, {
        "text": " distressing symptoms of RLS.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      "
      }, {
        "text": "{\n        \"type\": \"deficiency_is_a_risk_factor_for\",\n        \"to\": \"919"
      }, {
        "text": "caff2\"\n      },\n      {\n        \"type\": \"is_a_cofactor_for\",\n"
      }, {
        "text": "        \"to\": \"tyrosine_hydroxylase\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_involved_in_synthesis_of\",\n        \"to\": \"90adc821\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"349f9307\": {\n    \"title\": \"Ischemic Stroke\","
      }, {
        "text": "\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Vascular\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003eAn \u003cb\u003eischemic stroke\u003c/b\u003e is a neurological"
      }, {
        "text": " deficit of sudden onset resulting from focal cerebral ischemia due to an interruption of blood supply to a part of the brain. It is the"
      }, {
        "text": " most common type of stroke, accounting for approximately 80% of cases.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTypes"
      }, {
        "text": ":\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eThrombotic:\u003c/b\u003e Caused by a thrombus forming on a ruptured atherosclerotic plaque within a cerebral"
      }, {
        "text": " artery.\u003cbr\u003e - \u003cb\u003eEmbolic:\u003c/b\u003e Caused by an embolus (e.g., from the"
      }, {
        "text": " heart in atrial fibrillation or from a carotid artery plaque) lodging in a cerebral artery.\u003cbr\u003e - \u003cb\u003eHypoxic"
      }, {
        "text": ":\u003c/b\u003e Caused by systemic hypoperfusion (e.g., in shock), typically affecting watershed areas.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ology Time Course:\u003c/b\u003e The brain tissue undergoes \u003cmark\u003eliquefactive necrosis\u003c/mark\u003e. Histological changes include \u0027"
      }, {
        "text": "red neurons\u0027 (12-24 hrs), neutrophil infiltration (24-72 hrs), macrophage/microglial"
      }, {
        "text": " infiltration (3-5 days), reactive gliosis (1-2 weeks), and finally a glial scar ( \u003e2 weeks).\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging"
      }, {
        "text": ":\u003c/b\u003e A non-contrast CT is the crucial first step to rule out hemorrhage. It may be normal in the first"
      }, {
        "text": " 6-24 hours. Diffusion-weighted MRI is the most sensitive test and can detect ischemia within minutes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAcute"
      }, {
        "text": " Treatment:\u003c/b\u003e Intravenous thrombolysis with tPA (alteplase) if within the 3-4.5 hour window and"
      }, {
        "text": " no contraindications. Mechanical thrombectomy may be an option for large vessel occlusions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " primary goal of the initial head CT in a suspected stroke is not to diagnose the ischemic stroke itself, but to exclude hemorrhage"
      }, {
        "text": " so that thrombolytic therapy can be safely administered.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eAn"
      }, {
        "text": " \u003cb\u003eischemic stroke\u003c/b\u003e is a \u0027brain attack\u0027 where a blocked artery leads to neuronal death and liquefactive necrosis. The clinical"
      }, {
        "text": " presentation is dictated by the vascular territory affected, and the immediate management hinges on rapidly distinguishing it from a hemorrhagic stroke to allow for time"
      }, {
        "text": "-sensitive reperfusion therapy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n"
      }, {
        "text": "      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"stroke\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_treated_with\",\n        \"to\": \"t"
      }, {
        "text": "pa\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\":"
      }, {
        "text": " \"4945aa8c\"\n      },\n      {\n        \"type\": \"is_differentiated_from"
      }, {
        "text": "\",\n        \"to\": \"hemorrhagic_stroke\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"70509ee9\": {\n    \"title\": \"Isoflurane\",\n    \"primaryType\": \""
      }, {
        "text": "drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      "
      }, {
        "text": "\"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\","
      }, {
        "text": "\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003e\u003cb\u003eIsoflurane\u003c/b\u003e is a volatile \u003ci\u003einhaled general anesthetic\u003c/i\u003e used for the"
      }, {
        "text": " induction and, more commonly, the maintenance of general anesthesia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePharmac"
      }, {
        "text": "okinetics:\u003c/b\u003e Has a medium blood:gas partition coefficient, resulting in a slower onset and recovery compared to newer agents like des"
      }, {
        "text": "flurane and sevoflurane, but faster than halothane.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePotency:\u003c/b\u003e Has"
      }, {
        "text": " a low MAC (Minimum Alveolar Concentration) of ~1.2%, indicating high anesthetic potency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSystem"
      }, {
        "text": "ic Effects:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCardiovascular:\u003c/b\u003e Causes dose-dependent decrease in mean arterial pressure,"
      }, {
        "text": " primarily through a decrease in systemic vascular resistance (vasodilation). Cardiac output is generally maintained.\u003cbr\u003e - \u003cb\u003eRespiratory:\u003c/b\u003e"
      }, {
        "text": " A potent respiratory depressant, decreasing tidal volume and minute ventilation.\u003cbr\u003e - \u003cb\u003eCerebral:\u003c/b\u003e Increases"
      }, {
        "text": " cerebral blood flow (due to vasodilation), which can increase intracranial pressure. It also decreases cerebral metabolic rate.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Adverse Effects:\u003c/b\u003e Pungent odor can cause airway irritation, coughing, and laryngospasm, making it less"
      }, {
        "text": " ideal for inhalation induction. It is a potential trigger for [[429af8bd|malignant hyperthermia"
      }, {
        "text": "]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know the relative properties of inhaled anesthetics. Isoflurane has higher"
      }, {
        "text": " potency (lower MAC) and slower onset (higher blood:gas coefficient) than desflurane and sevoflurane"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eIsoflurane\u003c/b\u003e is a potent but relatively"
      }, {
        "text": " slow-acting inhaled anesthetic whose main hemodynamic effect is vasodilation, leading to a drop in blood pressure, and like"
      }, {
        "text": " other volatile anesthetics, it carries the risk of triggering malignant hyperthermia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },"
      }, {
        "text": "\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"inhaled_anesthetic\"\n      },\n      {\n        \"type\": \"can"
      }, {
        "text": "_trigger\",\n        \"to\": \"429af8bd\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"causes\",\n        \"to\": \"vasodilation\"\n      },\n      {\n        \"type\": \"increases\","
      }, {
        "text": "\n        \"to\": \"cerebral_blood_flow\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"cc161b72\": {\n    \"title\": \"Jaw Jerk Reflex\",\n    \"primaryType\": \""
      }, {
        "text": "physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Phys"
      }, {
        "text": "iology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003eThe \u003cb\u003eJaw Jerk Reflex\u003c/b\u003e is a monosynaptic stretch reflex that involves the muscles of mastication, used"
      }, {
        "text": " to test the integrity of the \u003ci\u003etrigeminal nerve (CN V)\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eElicitation:\u003c/b\u003e The patient\u0027s mouth is held slightly open and relaxed. The examiner places"
      }, {
        "text": " a finger on the chin and taps it with a reflex hammer.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNormal Response:\u003c/b\u003e A minimal or absent jerk"
      }, {
        "text": " (slight closure of the jaw).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAbnormal Response (Hyperreflexia):\u003c/b\u003e A brisk, exaggerated closure"
      }, {
        "text": " of the jaw is an abnormal finding and indicates an \u003cmark\u003eupper motor neuron (UMN) lesion\u003c/mark\u003e above the level of the trig"
      }, {
        "text": "eminal motor nucleus in the pons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReflex Arc:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eAfferent Limb"
      }, {
        "text": ":\u003c/b\u003e Proprioceptive fibers from the masseter muscle travel via the mandibular division of the \u003cmark\u003etrigeminal nerve (CN"
      }, {
        "text": " V\u003csub\u003e3\u003c/sub\u003e)\u003c/mark\u003e to the mesencephalic nucleus of CN V.\u003cbr\u003e - \u003cb\u003eEfferent Limb:\u003c/b\u003e Motor fibers"
      }, {
        "text": " from the motor nucleus of CN V travel via the \u003cmark\u003etrigeminal nerve (CN V\u003csub\u003e3\u003c/sub\u003e)\u003c/"
      }, {
        "text": "mark\u003e to cause contraction of the masseter muscle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The jaw jerk is unique"
      }, {
        "text": " because both its afferent and efferent limbs are carried by the same cranial nerve (CN V). A hyperactive jaw jerk is a sign"
      }, {
        "text": " of a bilateral UMN lesion, as seen in conditions like [[4ed629f9|amyotrophic lateral sclerosis (ALS)]]"
      }, {
        "text": " or pseudobulbar palsy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eJaw Jerk Reflex\u003c/b\u003e is a"
      }, {
        "text": " cranial nerve equivalent of a deep tendon reflex, specifically testing the integrity of the trigeminal nerve. An exaggerated response is a key"
      }, {
        "text": " sign of upper motor neuron disease affecting the corticobulbar tracts.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A["
      }, {
        "text": "Tap on Chin] --\u003e B(Stretch Masseter); B --\u003e C(Afferent via CN V3); C --\u003e D(Mes"
      }, {
        "text": "encephalic \u0026 Motor Nuclei of CN V); D --\u003e E(Efferent via CN V3); E --\u003e F(Mass"
      }, {
        "text": "eter Contraction);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"tests_integrity"
      }, {
        "text": "_of\",\n        \"to\": \"0eb45a0a\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_type_of\",\n        \"to\": \"deep_tendon_reflex\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_exaggerated_in\",\n        \"to\": \"upper_motor"
      }, {
        "text": "_neuron_lesion\"\n      }\n    ]\n  },\n  \"30b7508"
      }, {
        "text": "8\": {\n    \"title\": \"JC Virus (John Cunningham Virus)\",\n    \"primaryType\": \"micro"
      }, {
        "text": "be\",\n    \"tags\": [\n      \"Microbiology\",\n      \"Neurology\",\n      \"In"
      }, {
        "text": "fectious Disease\",\n      \"Immunology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n"
      }, {
        "text": "      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Infections\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eJC virus (John Cunningham virus)\u003c/b\u003e is a common"
      }, {
        "text": " human polyomavirus that is typically asymptomatic in immunocompetent individuals but can reactivate in the setting of severe immunosuppression, causing the"
      }, {
        "text": " fatal demyelinating disease \u003ci\u003eProgressive Multifocal Leukoencephalopathy (PML)\u003c/i\u003e.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMicrobiology:\u003c/b\u003e A member of the Polyomaviridae family; a small"
      }, {
        "text": ", non-enveloped, double-stranded DNA virus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLatency:\u003c/b\u003e After primary infection (usually in childhood), the virus establishes"
      }, {
        "text": " a lifelong latent infection in the kidneys and lymphoid tissue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReactivation:\u003c/b\u003e Reactivation occurs in states of severe cell"
      }, {
        "text": "-mediated immunodeficiency, such as advanced \u003cmark\u003eHIV/AIDS\u003c/mark\u003e (CD4 count \u003c 2"
      }, {
        "text": "00), hematologic malignancies, or in patients on immunosuppressive therapies like [[ae20a0ce|natalizumab]]."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathogenesis of PML:\u003c/b\u003e The reactivated virus spreads to the brain and infects and destroys \u003cmark\u003eoligodendrocytes"
      }, {
        "text": "\u003c/mark\u003e, the myelin-producing cells of the CNS.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation of PML:\u003c/b\u003e Rapidly progressive"
      }, {
        "text": ", multifocal neurological deficits, including cognitive decline, motor weakness, and visual changes. It is usually fatal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e The triad of an immunocompromised patient (especially AIDS or on natalizumab), rapidly progressive neurological symptoms, and multif"
      }, {
        "text": "ocal non-enhancing white matter lesions on MRI is classic for PML caused by JC virus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "The \u003cb\u003eJC virus\u003c/b\u003e is a ubiquitous and harmless passenger in most of the population, but in an immunocompromised host"
      }, {
        "text": ", it can transform into a destructive pathogen that specifically targets and lyses oligodendrocytes, leading to the devastating demyelinating disease PML.\u003c/p\u003e\","
      }, {
        "text": "\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \""
      }, {
        "text": "causes\",\n        \"to\": \"progressive_multifocal_leukoencephalopathy\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"polyomavirus\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"infects\",\n        \"to\": \"a24f97"
      }, {
        "text": "47\"\n      },\n      {\n        \"type\": \"reactivates_in\",\n        \"to"
      }, {
        "text": "\": \"immunocompromised_state\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"89e86633\",\n    \"letter\": \"H\",\n    \"term\": \"Hypothalamus\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Hypothalamus\",\n    \"sub_entries\": [\n      {\n        \"id\": \"798916d2\",\n        \"letter\": \"H\",\n        \"term\": \"functions and nuclei of\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Hypothalamus \u003e functions and nuclei of\"\n      },\n      {\n        \"id\": \"3021d830\",\n        \"letter\": \"H\",\n        \"term\": \"nuclei of\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Hypothalamus \u003e nuclei of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"2293e9db\",\n    \"letter\": \"H\",\n    \"term\": \"Hypoxic stroke\",\n    \"pages\": [\n      \"525\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Hypoxic stroke\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"0430aadb\",\n    \"letter\": \"I\",\n    \"term\": \"Idiopathic intracranial hypertension\",\n    \"pages\": [\n      \"536\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Idiopathic intracranial hypertension\",\n    \"sub_entries\": [\n      {\n        \"id\": \"f41b85ec\",\n        \"letter\": \"I\",\n        \"term\": \"associations and findings\",\n        \"pages\": [\n          \"536\"\n        ],\n        \"context\": \"Idiopathic intracranial hypertension \u003e associations and findings\"\n      }\n    ]\n  },\n  {\n    \"id\": \"7c4e7c74\",\n    \"letter\": \"I\",\n    \"term\": \"Increased intracranial pressure\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Increased intracranial pressure\",\n    \"sub_entries\": [\n      {\n        \"id\": \"b6d81c7b\",\n        \"letter\": \"I\",\n        \"term\": \"venous sinus thrombosis\",\n        \"pages\": [\n          \"514\"\n        ],\n        \"context\": \"Increased intracranial pressure \u003e venous sinus thrombosis\"\n      }\n    ]\n  },\n  {\n    \"id\": \"67928d1e\",\n    \"letter\": \"I\",\n    \"term\": \"Incus (ossicles)\",\n    \"pages\": [\n      \"547\",\n      \"638\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Incus (ossicles)\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"dae1ae46\",\n    \"letter\": \"I\",\n    \"term\": \"Indirect (inhibitory) pathway\",\n    \"pages\": [\n      \"511\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Indirect (inhibitory) pathway\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"6e263659\",\n    \"letter\": \"I\",\n    \"term\": \"Infarcts\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Infarcts\",\n    \"sub_entries\": [\n      {\n        \"id\": \"46dc1135\",\n        \"letter\": \"I\",\n        \"term\": \"cortical areas\",\n        \"pages\": [\n          \"513\"\n        ],\n        \"context\": \"Infarcts \u003e cortical areas\"\n      }\n    ]\n  },\n  {\n    \"id\": \"9347f277\",\n    \"letter\": \"I\",\n    \"term\": \"Infective dementia\",\n    \"pages\": [\n      \"535\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Infective dementia\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"fccf33b0\",\n    \"letter\": \"I\",\n    \"term\": \"Inferior oblique muscle\",\n    \"pages\": [\n      \"555\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Inferior oblique muscle\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"2d0219b1\",\n    \"letter\": \"I\",\n    \"term\": \"Inferior rectus muscle\",\n    \"pages\": [\n      \"555\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Inferior rectus muscle\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"43d56aab\",\n    \"letter\": \"I\",\n    \"term\": \"Inhaled anesthetics\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Inhaled anesthetics\",\n    \"sub_entries\": [\n      {\n        \"id\": \"4d006898\",\n        \"letter\": \"I\",\n        \"term\": \"mechanism and adverse effects\",\n        \"pages\": [\n          \"565\"\n        ],\n        \"context\": \"Inhaled anesthetics \u003e mechanism and adverse effects\"\n      }\n    ]\n  },\n  {\n    \"id\": \"1bfd49ab\",\n    \"letter\": \"I\",\n    \"term\": \"Inner ear\",\n    \"pages\": [\n      \"547\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Inner ear\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"4dc57e8f\",\n    \"letter\": \"I\",\n    \"term\": \"Insomnia therapy, agents, mechanism\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Insomnia therapy, agents, mechanism\",\n    \"sub_entries\": [\n      {\n        \"id\": \"987da54f\",\n        \"letter\": \"I\",\n        \"term\": \"and adverse effects\",\n        \"pages\": [\n          \"562\"\n        ],\n        \"context\": \"Insomnia therapy, agents, mechanism \u003e and adverse effects\"\n      }\n    ]\n  },\n  {\n    \"id\": \"43fa8c69\",\n    \"letter\": \"I\",\n    \"term\": \"Intention tremor\",\n    \"pages\": [\n      \"533\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Intention tremor\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"b72f1520\",\n    \"letter\": \"I\",\n    \"term\": \"Internal carotid artery, cavernous\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Internal carotid artery, cavernous\",\n    \"sub_entries\": [\n      {\n        \"id\": \"ad31efca\",\n        \"letter\": \"I\",\n        \"term\": \"sinus\",\n        \"pages\": [\n          \"557\"\n        ],\n        \"context\": \"Internal carotid artery, cavernous \u003e sinus\"\n      }\n    ]\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 1809
    }, {
      "text": "```json\n{\n  \"89e86633\": {\n    \"title\": \"Hypothalamus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Endocrinology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Anatomy\",\n      \"Hypothalamus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eHypothalamus\u003c/b\u003e is a small but vital region of the diencephalon located below the thalamus, which serves as the primary link between the nervous system and the endocrine system via the pituitary gland. It is the main control center for the autonomic nervous system and regulates homeostasis.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMain Functions (TAN HATS):\u003c/b\u003e \u003cb\u003eT\u003c/b\u003ehirst and water balance, \u003cb\u003eA\u003c/b\u003edenohypophysis control, \u003cb\u003eN\u003c/b\u003eeurohypophysis hormone production, \u003cb\u003eH\u003c/b\u003eunger, \u003cb\u003eA\u003c/b\u003eutonomic regulation, \u003cb\u003eT\u003c/b\u003eemperature regulation, \u003cb\u003eS\u003c/b\u003eexual urges.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Nuclei:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eLateral Nucleus:\u003c/b\u003e Hunger center. Lesion ‚Üí anorexia. \u003cbr\u003e - \u003cb\u003eVentromedial Nucleus:\u003c/b\u003e Satiety center. Lesion ‚Üí hyperphagia. \u003cbr\u003e - \u003cb\u003eAnterior Nucleus:\u003c/b\u003e Cooling, parasympathetic. Lesion ‚Üí hyperthermia.\u003cbr\u003e - \u003cb\u003ePosterior Nucleus:\u003c/b\u003e Heating, sympathetic. Lesion ‚Üí inability to thermoregulate.\u003cbr\u003e - \u003cb\u003eSuprachiasmatic Nucleus (SCN):\u003c/b\u003e Circadian rhythm.\u003cbr\u003e - \u003cb\u003eSupraoptic \u0026 Paraventricular Nuclei:\u003c/b\u003e Synthesize ADH and oxytocin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEndocrine Control:\u003c/b\u003e Produces releasing and inhibiting hormones (e.g., GnRH, CRH, TRH, somatostatin, dopamine) that travel via the hypophyseal portal system to control the [[76ba7f2e|anterior pituitary]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the functions of the lateral and ventromedial nuclei with the mnemonic: A lesion to the \u003cb\u003eL\u003c/b\u003eateral nucleus makes you \u003cb\u003eL\u003c/b\u003eean. A lesion to the \u003cb\u003eV\u003c/b\u003eentro\u003cb\u003em\u003c/b\u003eedial nucleus makes you \u003cb\u003eV\u003c/b\u003eery \u003cb\u003eM\u003c/b\u003eassive.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eHypothalamus\u003c/b\u003e is the master regulator of homeostasis, constantly monitoring the body\u0027s internal state and orchestrating a wide range of autonomic, endocrine, and behavioral responses to maintain a stable internal environment.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"diencephalon\"\n      },\n      {\n        \"type\": \"regulates\",\n        \"to\": \"pituitary_gland\"\n      },\n      {\n        \"type\": \"regulates\",\n        \"to\": \"autonomic_nervous_system\"\n      },\n      {\n        \"type\": \"contains_nucleus\",\n        \"to\": \"b37e8260\"\n      },\n      {\n        \"type\": \"contains_nucleus\",\n        \"to\": \"d662ec5d\"\n      }\n    ]\n  },\n  \"2293e9db\": {\n    \"title\": \"Hypoxic Stroke\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cardiology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003ehypoxic stroke\u003c/b\u003e, also known as hypoxic-ischemic encephalopathy (HIE) in a global context, is brain damage caused by a systemic reduction in oxygen delivery, resulting from either hypoxemia (low blood oxygen content) or ischemia (low blood flow).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by conditions leading to global cerebral hypoperfusion, such as cardiac arrest, profound hypotension (shock), or asphyxiation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVulnerable Areas:\u003c/b\u003e Certain brain regions are particularly susceptible to hypoxic-ischemic injury due to their high metabolic demand. These include:\u003cbr\u003e - Pyramidal cells of the \u003cmark\u003ehippocampus\u003c/mark\u003e (specifically CA1 region).\u003cbr\u003e - \u003cmark\u003ePurkinje cells\u003c/mark\u003e of the cerebellum.\u003cbr\u003e - Pyramidal cells of the neocortex (leading to laminar necrosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eWatershed Infarcts:\u003c/b\u003e Hypoxic strokes characteristically affect \u003cmark\u003ewatershed areas\u003c/mark\u003e‚Äîthe border zones between territories supplied by major cerebral arteries (e.g., between ACA and MCA territories). These areas are the most vulnerable to a systemic drop in blood pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Can range from mild confusion to coma or brain death, depending on the severity and duration of the insult. Diffuse neurological deficits are common.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient who suffers a cardiac arrest and subsequently develops neurological deficits likely has hypoxic-ischemic brain injury. Look for damage in watershed zones or the highly vulnerable hippocampal and cerebellar cells.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003ehypoxic stroke\u003c/b\u003e is a global brain injury resulting from a systemic lack of oxygen or blood flow, which selectively damages the most metabolically active neurons and the most tenuously perfused watershed territories.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"349f9307\"\n      },\n      {\n        \"type\": \"affects\",\n        \"to\": \"watershed_areas\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"hippocampus\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"purkinje_cells\"\n      }\n    ]\n  },\n  \"0430aadb\": {\n    \"title\": \"Idiopathic Intracranial Hypertension (IIH)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Headaches\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eIdiopathic Intracranial Hypertension (IIH)\u003c/b\u003e, also known as pseudotumor cerebri, is a condition of increased intracranial pressure with no evident cause on neuroimaging, classically affecting young, obese women.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEpidemiology:\u003c/b\u003e Most common in \u003cmark\u003ewomen of childbearing age who are obese\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Factors:\u003c/b\u003e Associated with certain medications, including tetracyclines, oral contraceptives, and excess vitamin A.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Presents with symptoms of increased ICP: \u003cmark\u003eheadache\u003c/mark\u003e (often pulsatile, worse with straining), pulsatile tinnitus, and visual disturbances.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOphthalmologic Findings:\u003c/b\u003e \u003cmark\u003ePapilledema\u003c/mark\u003e (swelling of the optic disc) is a key finding. Patients may also have a [[dd11dde6|CN VI palsy]], leading to horizontal diplopia. Untreated, it can lead to permanent vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Based on clinical findings, papilledema, normal neuroimaging (to rule out a mass or hydrocephalus), and an \u003cmark\u003eelevated opening pressure\u003c/mark\u003e (\u003e250 mmH\u003csub\u003e2\u003c/sub\u003eO) on lumbar puncture with normal CSF composition.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Weight loss is the cornerstone of long-term management. \u003cmark\u003eAcetazolamide\u003c/mark\u003e (a carbonic anhydrase inhibitor) is used to decrease CSF production.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The classic vignette is an obese young woman with a daily headache, pulsatile tinnitus, and papilledema.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eIdiopathic Intracranial Hypertension\u003c/b\u003e is a diagnosis of exclusion for increased ICP, where the primary morbidity is vision loss from chronic papilledema, making weight loss and CSF-lowering agents like acetazolamide critical for preserving sight.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_also_known_as\",\n        \"to\": \"pseudotumor_cerebri\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"d93d2dfb\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"4ae219da\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"1df262e8\"\n      }\n    ]\n  },\n  \"7c4e7c74\": {\n    \"title\": \"Increased Intracranial Pressure (ICP)\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"General\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eIncreased Intracranial Pressure (ICP)\u003c/b\u003e is a pathological elevation of pressure within the rigid cranial vault. It is a neurological emergency that can lead to decreased cerebral perfusion and brain herniation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e Can be caused by an increase in the volume of any of the intracranial components: brain parenchyma (e.g., tumor, edema), blood (e.g., hemorrhage, [[067666cd|venous sinus thrombosis]]), or cerebrospinal fluid (e.g., [[0bc2f200|hydrocephalus]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eIdiopathic Intracranial Hypertension (IIH):\u003c/b\u003e A specific syndrome of increased ICP with no evident cause on imaging, typically affecting young, obese women.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Headache (often worse in the morning or with Valsalva), nausea/vomiting, [[4ae219da|papilledema]], and visual disturbances. [[dd11dde6|CN VI palsy]] is a common finding.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCushing\u0027s Triad:\u003c/b\u003e A late and ominous sign of severely elevated ICP, consisting of hypertension, bradycardia, and irregular respirations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Papilledema is the cardinal sign of increased ICP on physical exam. A CN VI palsy in the setting of headache is often a \u0027false localizing sign\u0027 pointing to generalized increased ICP.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eIncreased Intracranial Pressure\u003c/b\u003e occurs when the volume of the brain\u0027s contents exceeds the compensatory capacity of the skull, leading to a dangerous rise in pressure that can compress vital brain structures and compromise cerebral blood flow.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"be057cfc\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"c20521ce\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"0bc2f200\"\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"0430aadb\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"4ae219da\"\n      }\n    ]\n  },\n  \"67928d1e\": {\n    \"title\": \"Incus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Otology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Anatomy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eIncus\u003c/b\u003e (Latin for \\\"anvil\\\") is the middle of the three auditory ossicles in the middle ear, connecting the malleus to the stapes.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Situated in the middle ear, articulating medially with the stapes and laterally with the malleus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Acts as a lever in the ossicular chain to transmit sound vibrations from the malleus to the stapes, contributing to the amplification of sound.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Derived from cartilage of the \u003cmark\u003efirst pharyngeal arch\u003c/mark\u003e (Meckel\u0027s cartilage), along with the malleus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Dislocation or erosion of the incus (e.g., from trauma or cholesteatoma) can disrupt the ossicular chain and cause significant conductive hearing loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the pharyngeal arch derivatives: the \u003cb\u003eM\u003c/b\u003ealleus and \u003cb\u003eI\u003c/b\u003encus come from the \u003cb\u003e1st\u003c/b\u003e (\u003cb\u003eM\u003c/b\u003eandibular) arch, while the \u003cb\u003eS\u003c/b\u003etapes comes from the \u003cb\u003e2nd\u003c/b\u003e (hyoid) arch.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eIncus\u003c/b\u003e serves as the intermediate link in the ossicular chain, pivoting like an anvil to transfer the force of vibrations from the malleus to the stapes, a critical step in the mechanical amplification of sound.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"3aea8cac\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"45568c28\"\n      },\n      {\n        \"type\": \"derives_from\",\n        \"to\": \"first_pharyngeal_arch\"\n      },\n      {\n        \"type\": \"articulates_with\",\n        \"to\": \"153b46d9\"\n      },\n      {\n        \"type\": \"articulates_with\",\n        \"to\": \"stapes\"\n      }\n    ]\n  },\n  \"dae1ae46\": {\n    \"title\": \"Indirect Pathway (Basal Ganglia)\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Physiology\",\n      \"Movement Disorders\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Basal Ganglia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eIndirect Pathway\u003c/b\u003e is a neuronal circuit within the [[ed462927|basal ganglia]] that has a net \u003ci\u003einhibitory\u003c/i\u003e effect on the thalamus, thereby suppressing unwanted or competing movements.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e To inhibit movement by increasing the tonic inhibition of the thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Cortical excitation of the striatum leads to inhibition of the globus pallidus externus (GPe). This disinhibits the subthalamic nucleus (STN), allowing the STN to excite the globus pallidus internus (GPi). The now-excited GPi increases its inhibition of the thalamus, which in turn reduces excitation of the motor cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDopamine\u0027s Role:\u003c/b\u003e [[90adc821|Dopamine]] from the substantia nigra pars compacta \u003cmark\u003einhibits\u003c/mark\u003e the indirect pathway by acting on D2 receptors in the striatum.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology (Parkinson\u0027s):\u003c/b\u003e In [[58c8ea03|Parkinson disease]], the loss of dopamine leads to overactivity of the indirect pathway, contributing to the profound inhibition of movement (bradykinesia).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology (Huntington\u0027s):\u003c/b\u003e In early [[ffd7e743|Huntington disease]], degeneration of the indirect pathway neurons in the striatum leads to disinhibition of the thalamus and hyperkinetic movements (chorea).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that the indirect pathway is inhibitory to movement. Dopamine inhibits this pathway. Therefore, loss of dopamine (Parkinson\u0027s) leads to less movement, while damage to the pathway itself (Huntington\u0027s) leads to more movement.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eIndirect Pathway\u003c/b\u003e acts as the \u0027brake\u0027 of the basal ganglia motor circuit; its complex, multi-step process ultimately amplifies the inhibition of the thalamus to suppress unwanted movements, and its dysregulation is a key factor in both hypokinetic and hyperkinetic disorders.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cortex] --\u003e B(Striatum); B --GABA--\u003e C(GPe); C --x D(STN); D --Glutamate--\u003e E(GPi); E --GABA--\u003e F(Thalamus); F --x G(Cortex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"ed462927\"\n      },\n      {\n        \"type\": \"inhibits\",\n        \"to\": \"movement\"\n      },\n      {\n        \"type\": \"is_inhibited_by\",\n        \"to\": \"90adc821\"\n      },\n      {\n        \"type\": \"is_overactive_in\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"is_underactive_in\",\n        \"to\": \"ffd7e743\"\n      }\n    ]\n  },\n  \"6e263659\": {\n    \"title\": \"Cerebral Infarcts\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Vascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCerebral infarcts\u003c/b\u003e are areas of necrotic brain tissue resulting from ischemia, most commonly caused by the occlusion of a cerebral artery. The location and extent of the infarct determine the clinical neurological deficits.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTypes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eThrombotic:\u003c/b\u003e Due to local clot formation, often over an atherosclerotic plaque.\u003cbr\u003e - \u003cb\u003eEmbolic:\u003c/b\u003e Due to a clot traveling from a distant source (e.g., heart, carotid arteries).\u003cbr\u003e - \u003cb\u003eLacunar:\u003c/b\u003e Small infarcts in deep brain structures from occlusion of small penetrating arteries.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCortical Areas:\u003c/b\u003e Infarcts in the territories of the major cerebral arteries ([[830c856c|ACA]], [[143bb23d|MCA]], [[b6a2cc31|PCA]]) produce characteristic patterns of motor, sensory, and cognitive deficits known as \u0027cortical signs\u0027 (e.g., aphasia, neglect).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e The brain undergoes \u003cmark\u003eliquefactive necrosis\u003c/mark\u003e following an ischemic event.\u003c/li\u003e\u003cli\u003e\u003cb\u003eWatershed Infarcts:\u003c/b\u003e Occur in the border zones between major arterial territories and are associated with systemic hypoperfusion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The clinical syndrome presented in a stroke question is the key to identifying the affected artery and the location of the infarct.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCerebral infarcts\u003c/b\u003e are the pathological consequence of an ischemic stroke, where the specific neurological deficit serves as a precise map to the occluded blood vessel and the corresponding area of necrotic brain tissue.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_result_of\",\n        \"to\": \"349f9307\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\": \"4945aa8c\"\n      },\n      {\n        \"type\": \"can_be_localized_to\",\n        \"to\": \"143bb23d\"\n      },\n      {\n        \"type\": \"can_be_localized_to\",\n        \"to\": \"830c856c\"\n      }\n    ]\n  },\n  \"9347f277\": {\n    \"title\": \"Infective Dementia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Infectious Disease\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Dementia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eInfective dementia\u003c/b\u003e refers to a progressive decline in cognitive function caused by a chronic or subacute infection of the central nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHIV-Associated Dementia (HAD):\u003c/b\u003e Occurs in patients with advanced HIV/AIDS (CD4 \u003c 200). Caused by inflammatory activation of microglial cells, which form multinucleated giant cells. Presents with subcortical dementia (e.g., slowed movements and cognitive processing).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCreutzfeldt-Jakob Disease (CJD):\u003c/b\u003e A rapidly progressive dementia caused by prions. Characterized by myoclonus and ataxia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurosyphilis:\u003c/b\u003e Tertiary syphilis can cause a progressive dementia known as general paresis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProgressive Multifocal Leukoencephalopathy (PML):\u003c/b\u003e Caused by reactivation of the [[30b75088|JC virus]] in immunocompromised individuals. A demyelinating disease that leads to rapidly progressive neurological deficits and dementia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When a patient with dementia presents with an atypical, rapid course or has risk factors for specific infections (e.g., HIV, history of syphilis), consider an infective etiology.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eWhile most dementias are neurodegenerative, a subset is caused by chronic CNS infections. These \u003cb\u003einfective dementias\u003c/b\u003e are important to recognize as some, like neurosyphilis, may be treatable, and others, like CJD, have important public health implications.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"bb316ca0\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"hiv_associated_dementia\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"86fe59ba\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"neurosyphilis\"\n      }\n    ]\n  },\n  \"fccf33b0\": {\n    \"title\": \"Inferior Oblique Muscle\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Anatomy\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Anatomy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eInferior Oblique\u003c/b\u003e is one of the six extraocular muscles. Its primary action is extorsion of the eyeball, with secondary actions of elevation and abduction.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eActions:\u003c/b\u003e Primary: Extorsion (outward rotation). Secondary: Elevation and Abduction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e Innervated by the inferior division of the \u003cmark\u003eoculomotor nerve (CN III)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTesting:\u003c/b\u003e The elevating action of the inferior oblique is best isolated when the eye is adducted (looking toward the nose) and the patient is asked to look up. Mnemonic: \u003cb\u003eI\u003c/b\u003enferior oblique tested looking \u003cb\u003eI\u003c/b\u003en and up.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Paralysis of the inferior oblique (as part of a [[68c66997|CN III palsy]]) contributes to the \u0027down and out\u0027 position of the eye and causes vertical diplopia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the mnemonic \u003cb\u003eLR\u003csub\u003e6\u003c/sub\u003eSO\u003csub\u003e4\u003c/sub\u003eR\u003csub\u003e3\u003c/sub\u003e\u003c/b\u003e. The inferior oblique is part of the \u0027Rest\u0027 innervated by CN III.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eInferior Oblique\u003c/b\u003e muscle is unique in its primary action of extorsion, but its clinically tested function is elevation of the adducted eye, a key movement for diagnosing oculomotor nerve palsies.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"extraocular_muscle\"\n      },\n      {\n        \"type\": \"is_innervated_by\",\n        \"to\": \"68c66997\"\n      },\n      {\n        \"type\": \"action_is\",\n        \"to\": \"extorsion_of_eye\"\n      },\n      {\n        \"type\": \"action_is\",\n        \"to\": \"elevation_of_eye\"\n      }\n    ]\n  },\n  \"2d0219b1\": {\n    \"title\": \"Inferior Rectus Muscle\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Anatomy\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Anatomy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eInferior Rectus\u003c/b\u003e is one of the six extraocular muscles. Its primary action is depression of the eyeball, with secondary actions of adduction and extorsion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eActions:\u003c/b\u003e Primary: Depression (downward movement). Secondary: Adduction and Extorsion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e Innervated by the inferior division of the \u003cmark\u003eoculomotor nerve (CN III)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTesting:\u003c/b\u003e The depressing action of the inferior rectus is best isolated when the eye is abducted (looking away from the nose) and the patient is asked to look down.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Paralysis of the inferior rectus (as part of a [[68c66997|CN III palsy]]) contributes to the \u0027down and out\u0027 position of the eye and causes vertical diplopia. In an orbital floor \u0027blowout\u0027 fracture, the inferior rectus can become entrapped, restricting upward gaze.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the mnemonic \u003cb\u003eLR\u003csub\u003e6\u003c/sub\u003eSO\u003csub\u003e4\u003c/sub\u003eR\u003csub\u003e3\u003c/sub\u003e\u003c/b\u003e. The inferior rectus is part of the \u0027Rest\u0027 innervated by CN III.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eInferior Rectus\u003c/b\u003e muscle is the primary depressor of the eye, and its function is best tested by having the patient look down and out; its entrapment in an orbital floor fracture is a classic cause of restricted upgaze.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"extraocular_muscle\"\n      },\n      {\n        \"type\": \"is_innervated_by\",\n        \"to\": \"68c66997\"\n      },\n      {\n        \"type\": \"action_is\",\n        \"to\": \"depression_of_eye\"\n      },\n      {\n        \"type\": \"can_be_entrapped_in\",\n        \"to\": \"orbital_blowout_fracture\"\n      }\n    ]\n  },\n  \"43d56aab\": {\n    \"title\": \"Inhaled Anesthetics\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eInhaled anesthetics\u003c/b\u003e are volatile liquids or gases that are administered via inhalation to induce and maintain general anesthesia. Their effects are dose-dependent and reversible.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eExamples:\u003c/b\u003e Halothane (historical), [[70509ee9|isoflurane]], sevoflurane, desflurane, and [[9c56fa3c|nitrous oxide (N\u003csub\u003e2\u003c/sub\u003eO)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e The exact mechanism is unknown, but they are thought to enhance the activity of inhibitory neurotransmitter receptors (e.g., GABA\u003csub\u003eA\u003c/sub\u003e, glycine) and inhibit excitatory receptors (e.g., NMDA).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eOnset/Recovery:\u003c/b\u003e Determined by blood solubility (blood:gas partition coefficient). Low solubility (e.g., N\u003csub\u003e2\u003c/sub\u003eO, desflurane) \u003d rapid onset and recovery. High solubility \u003d slow onset/recovery.\u003cbr\u003e - \u003cb\u003ePotency:\u003c/b\u003e Determined by lipid solubility (oil:gas partition coefficient) and measured by the \u003cmark\u003eMinimum Alveolar Concentration (MAC)\u003c/mark\u003e. High lipid solubility \u003d low MAC \u003d high potency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSystemic Effects:\u003c/b\u003e Cause myocardial depression, hypotension (vasodilation), respiratory depression, and increased cerebral blood flow.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e All volatile anesthetics (not N\u003csub\u003e2\u003c/sub\u003eO) can trigger \u003cmark\u003emalignant hyperthermia\u003c/mark\u003e in susceptible individuals. Halothane is associated with severe hepatotoxicity.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe clinical properties of \u003cb\u003einhaled anesthetics\u003c/b\u003e are governed by their physical solubilities: low blood solubility allows for rapid control of anesthetic depth, while high lipid solubility confers high potency, allowing for effective anesthesia at low concentrations.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"general_anesthetic\"\n      },\n      {\n        \"type\": \"can_trigger\",\n        \"to\": \"429af8bd\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"70509ee9\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"9c56fa3c\"\n      }\n    ]\n  },\n  \"1bfd49ab\": {\n    \"title\": \"Inner Ear\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Otology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Anatomy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eInner Ear\u003c/b\u003e is the innermost part of the ear, housed within the petrous part of the temporal bone. It contains the sensory organs for hearing (the cochlea) and balance (the vestibular system).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e Consists of the bony labyrinth, a system of bony canals, which contains the membranous labyrinth, a system of fluid-filled sacs and ducts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCochlea:\u003c/b\u003e The spiral-shaped, fluid-filled structure responsible for hearing. It contains the [[2e814378|organ of Corti]], which transduces sound vibrations into nerve impulses.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVestibular System:\u003c/b\u003e Responsible for balance and spatial orientation. It includes the three semicircular canals (which detect rotational movements) and the otolith organs (utricle and saccule, which detect linear acceleration and gravity).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFluids:\u003c/b\u003e The membranous labyrinth is filled with endolymph (high in K\u003csup\u003e+\u003c/sup\u003e), while the space between the bony and membranous labyrinths is filled with perilymph (high in Na\u003csup\u003e+\u003c/sup\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e The [[6fded3e7|vestibulocochlear nerve (CN VIII)]] carries auditory information from the cochlea and vestibular information from the vestibular system to the brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Pathologies of the inner ear cause sensorineural hearing loss and/or vertigo. [[6f2228c1|M√©ni√®re disease]] is a classic disorder of the inner ear caused by an excess of endolymph.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eInner Ear\u003c/b\u003e is a sophisticated transducer that converts mechanical energy‚Äîsound vibrations and head movements‚Äîinto the electrical language of the nervous system, subserving the distinct but related senses of hearing and balance.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"ear\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"001c359f\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"vestibular_system\"\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"6f2228c1\"\n      }\n    ]\n  },\n  \"4dc57e8f\": {\n    \"title\": \"Insomnia Therapy\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Sleep Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Sedative-Hypnotics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eInsomnia therapy\u003c/b\u003e involves pharmacological and non-pharmacological approaches to manage the inability to fall asleep, stay asleep, or get restorative sleep. Pharmacological agents primarily include benzodiazepines, nonbenzodiazepine hypnotics, and melatonin receptor agonists.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBenzodiazepines:\u003c/b\u003e (e.g., temazepam, triazolam) Increase the frequency of GABA\u003csub\u003eA\u003c/sub\u003e channel opening. Effective but can alter sleep architecture, cause dependence, and have next-day sedation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNonbenzodiazepine Hypnotics (\\\"Z-drugs\\\"):\u003c/b\u003e (e.g., zolpidem, zaleplon, eszopiclone) Act selectively on the BZ1 subtype of the GABA\u003csub\u003eA\u003c/sub\u003e receptor. Less disruption of sleep architecture and lower dependence risk than benzodiazepines. Effects are reversed by flumazenil.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMelatonin Receptor Agonists:\u003c/b\u003e (e.g., [[bbf7e9ef|ramelteon]]) Agonist at melatonin receptors in the suprachiasmatic nucleus. Helps with sleep onset and is not a controlled substance, with no abuse potential.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOrexin Receptor Antagonists:\u003c/b\u003e (e.g., suvorexant) Block orexin, a neuropeptide that promotes wakefulness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Agents:\u003c/b\u003e Sedating antidepressants (e.g., trazodone, mirtazapine) and antihistamines (e.g., diphenhydramine) are also used.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eModern \u003cb\u003einsomnia therapy\u003c/b\u003e has shifted from broad CNS depressants like benzodiazepines towards more targeted agents, such as the Z-drugs that selectively act on GABA\u003csub\u003eA\u003c/sub\u003e receptor subtypes or ramelteon that targets the body\u0027s natural sleep-wake cycle via melatonin receptors.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"insomnia\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"14464617\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"91c40279\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"bbf7e9ef\"\n      }\n    ]\n  },\n  \"43fa8c69\": {\n    \"title\": \"Intention Tremor\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Movement Disorders\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eAn \u003cb\u003eintention tremor\u003c/b\u003e is a type of action tremor characterized by a broad, coarse, low-frequency tremor that is absent at rest and worsens as the limb approaches a target during a voluntary, visually-guided movement. It is a cardinal sign of cerebellar dysfunction.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Results from a lesion in the [[bebe58d4|cerebellum]] or its connections (e.g., superior cerebellar peduncle). The cerebellum is responsible for coordinating and fine-tuning movements, and its dysfunction leads to an inability to smoothly correct for errors in movement trajectory.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e The tremor is absent when the limb is at rest. It appears and progressively worsens as the patient attempts a purposeful movement, such as reaching for an object or performing the finger-to-nose test.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e A classic sign of diseases affecting the cerebellum, such as \u003cmark\u003e[[45dd6d19|Multiple Sclerosis]]\u003c/mark\u003e, stroke, tumors, or chronic alcoholism.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction from Other Tremors:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eResting Tremor:\u003c/b\u003e Occurs at rest and improves with movement (e.g., [[58c8ea03|Parkinson disease]]).\u003cbr\u003e - \u003cb\u003eEssential Tremor:\u003c/b\u003e A postural and action tremor that is typically faster and less coarse than an intention tremor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A tremor that is worst at the end of a goal-directed movement (e.g., finger-to-nose test) is an intention tremor and points to a lesion in the ipsilateral cerebellum.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eAn \u003cb\u003eintention tremor\u003c/b\u003e is the physical manifestation of a failing cerebellar feedback loop; as the hand nears its target, the cerebellum\u0027s inability to make fine, real-time adjustments to the movement results in progressively larger oscillations.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"cerebellar_dysfunction\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"resting_tremor\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"essential_tremor\"\n      }\n    ]\n  },\n  \"b72f1520\": {\n    \"title\": \"Internal Carotid Artery in Cavernous Sinus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Anatomy\",\n      \"Neuroscience\",\n      \"Vascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebrovascular System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe cavernous segment of the \u003cb\u003eInternal Carotid Artery (ICA)\u003c/b\u003e is the portion of the artery that passes through the [[c260efc8|cavernous sinus]], a unique anatomical arrangement where a major artery travels within a venous structure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnatomy:\u003c/b\u003e The ICA, along with the [[dd11dde6|abducens nerve (CN VI)]], passes directly through the cavernous sinus. Cranial nerves III, IV, V1, and V2 travel within the lateral wall of the sinus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance (Cavernous Sinus Syndrome):\u003c/b\u003e Pathologies affecting the cavernous sinus (e.g., thrombosis, tumor, infection) can compress the ICA and the cranial nerves, leading to a constellation of symptoms including painful ophthalmoplegia and sensory loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCarotid-Cavernous Fistula:\u003c/b\u003e A rare but serious condition where a tear in the wall of the cavernous ICA creates an abnormal connection between the arterial and venous systems. This leads to high-pressure venous congestion, causing proptosis, chemosis, and a pulsatile bruit audible over the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSympathetic Fibers:\u003c/b\u003e The postganglionic sympathetic plexus travels on the surface of the ICA. Compression of these fibers within the cavernous sinus can cause an ipsilateral [[c19010a3|Horner syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the structures that pass *through* the cavernous sinus (ICA, CN VI) versus those in its *lateral wall* (CN III, IV, V1, V2). CN VI is often the first nerve affected in cavernous sinus pathology due to its medial location next to the ICA.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe passage of the \u003cb\u003einternal carotid artery\u003c/b\u003e through the cavernous sinus creates a vulnerable anatomical arrangement, where pathologies like thrombosis or fistula formation can lead to a complex syndrome involving multiple cranial nerves and potentially life-threatening venous congestion.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"passes_through\",\n        \"to\": \"c260efc8\"\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"9a089fd7\"\n      },\n      {\n        \"type\": \"can_form\",\n        \"to\": \"carotid_cavernous_fistula\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9678,
      "parts": [{
        "text": "```json\n{\n"
      }, {
        "text": "  \"89e86633\": {\n    \"title"
      }, {
        "text": "\": \"Hypothalamus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience"
      }, {
        "text": "\",\n      \"Endocrinology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Endocrine\",\n      \"Anatomy\",\n      \"Hypothalamus\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eHypothalamus\u003c/b\u003e is a small but"
      }, {
        "text": " vital region of the diencephalon located below the thalamus, which serves as the primary link between the nervous system and the endocrine system via"
      }, {
        "text": " the pituitary gland. It is the main control center for the autonomic nervous system and regulates homeostasis.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMain Functions (TAN HATS):\u003c/b\u003e \u003cb\u003eT\u003c/b\u003ehirst and water balance, \u003cb\u003eA\u003c/b\u003eden"
      }, {
        "text": "ohypophysis control, \u003cb\u003eN\u003c/b\u003eeurohypophysis hormone production, \u003cb\u003eH\u003c/b\u003eunger, \u003cb\u003eA\u003c/b\u003eut"
      }, {
        "text": "onomic regulation, \u003cb\u003eT\u003c/b\u003eemperature regulation, \u003cb\u003eS\u003c/b\u003eexual urges.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Nuclei:"
      }, {
        "text": "\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eLateral Nucleus:\u003c/b\u003e Hunger center. Lesion ‚Üí anorexia. \u003cbr\u003e - \u003cb\u003eVent"
      }, {
        "text": "romedial Nucleus:\u003c/b\u003e Satiety center. Lesion ‚Üí hyperphagia. \u003cbr\u003e - \u003cb\u003eAnterior Nucle"
      }, {
        "text": "us:\u003c/b\u003e Cooling, parasympathetic. Lesion ‚Üí hyperthermia.\u003cbr\u003e - \u003cb\u003ePosterior Nucleus:\u003c/b\u003e Heating"
      }, {
        "text": ", sympathetic. Lesion ‚Üí inability to thermoregulate.\u003cbr\u003e - \u003cb\u003eSuprachiasmatic Nucleus ("
      }, {
        "text": "SCN):\u003c/b\u003e Circadian rhythm.\u003cbr\u003e - \u003cb\u003eSupraoptic \u0026 Paraventricular Nuclei:\u003c/b\u003e Synt"
      }, {
        "text": "hesize ADH and oxytocin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEndocrine Control:\u003c/b\u003e Produces releasing and inhibiting hormones (e.g., Gn"
      }, {
        "text": "RH, CRH, TRH, somatostatin, dopamine) that travel via the hypophyseal portal system to control"
      }, {
        "text": " the [[76ba7f2e|anterior pituitary]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the functions of the lateral"
      }, {
        "text": " and ventromedial nuclei with the mnemonic: A lesion to the \u003cb\u003eL\u003c/b\u003eateral nucleus makes you \u003cb\u003eL\u003c/b\u003eean"
      }, {
        "text": ". A lesion to the \u003cb\u003eV\u003c/b\u003eentro\u003cb\u003em\u003c/b\u003eedial nucleus makes you \u003cb\u003eV\u003c/b\u003eery \u003cb\u003eM"
      }, {
        "text": "\u003c/b\u003eassive.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eHypothalamus\u003c/b\u003e is the"
      }, {
        "text": " master regulator of homeostasis, constantly monitoring the body\u0027s internal state and orchestrating a wide range of autonomic, endocrine, and behavioral responses to maintain a"
      }, {
        "text": " stable internal environment.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_part_of\",\n        \"to\": \"diencephalon\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"regulates\",\n        \"to\": \"pituitary_gland\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"regulates\",\n        \"to\": \"autonomic_nervous_system\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"contains_nucleus\",\n        \"to\": \"b37"
      }, {
        "text": "e8260\"\n      },\n      {\n        \"type\": \"contains_nucleus\",\n        \"to\": \""
      }, {
        "text": "d662ec5d\"\n      }\n    ]\n  },\n  \"2293"
      }, {
        "text": "e9db\": {\n    \"title\": \"Hypoxic Stroke\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Cardiology\",\n      \"Pathology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\","
      }, {
        "text": "\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003eA \u003cb\u003ehypoxic stroke\u003c/b\u003e, also known as hypoxic-ischemic encephalopathy (HIE) in a"
      }, {
        "text": " global context, is brain damage caused by a systemic reduction in oxygen delivery, resulting from either hypoxemia (low blood oxygen content"
      }, {
        "text": ") or ischemia (low blood flow).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Ca"
      }, {
        "text": "used by conditions leading to global cerebral hypoperfusion, such as cardiac arrest, profound hypotension (shock), or asphyxiation."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eVulnerable Areas:\u003c/b\u003e Certain brain regions are particularly susceptible to hypoxic-ischemic injury due to their high"
      }, {
        "text": " metabolic demand. These include:\u003cbr\u003e - Pyramidal cells of the \u003cmark\u003ehippocampus\u003c/mark\u003e ("
      }, {
        "text": "specifically CA1 region).\u003cbr\u003e - \u003cmark\u003ePurkinje cells\u003c/mark\u003e of the cerebellum.\u003cbr\u003e -"
      }, {
        "text": " Pyramidal cells of the neocortex (leading to laminar necrosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eWatershed Infarcts:\u003c/b\u003e Hyp"
      }, {
        "text": "oxic strokes characteristically affect \u003cmark\u003ewatershed areas\u003c/mark\u003e‚Äîthe border zones between territories supplied by major cerebral arteries ("
      }, {
        "text": "e.g., between ACA and MCA territories). These areas are the most vulnerable to a systemic drop in blood pressure."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Can range from mild confusion to coma or brain death, depending on the severity and duration of the insult. Diff"
      }, {
        "text": "use neurological deficits are common.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient who suffers a cardiac arrest and subsequently develops"
      }, {
        "text": " neurological deficits likely has hypoxic-ischemic brain injury. Look for damage in watershed zones or the highly vulnerable hippocampal and cerebellar"
      }, {
        "text": " cells.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003ehypoxic stroke\u003c/b\u003e is a global brain injury resulting"
      }, {
        "text": " from a systemic lack of oxygen or blood flow, which selectively damages the most metabolically active neurons and the most tenuously perfused"
      }, {
        "text": " watershed territories.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_type_of\",\n        \"to\": \"349f9307\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"affects\",\n        \"to\": \"watershed_areas\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"damages\",\n        \"to\": \"hippocampus\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "damages\",\n        \"to\": \"purkinje_cells\"\n      }\n    ]\n  },"
      }, {
        "text": "\n  \"0430aadb\": {\n    \"title\": \"Idiopathic Intracranial Hypertension (II"
      }, {
        "text": "H)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n"
      }, {
        "text": "      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \""
      }, {
        "text": "Neurology and Special Senses\",\n      \"Pathology\",\n      \"Headaches\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eIdiopathic Intracranial Hypertension (IIH)\u003c/b\u003e, also known as pseud"
      }, {
        "text": "otumor cerebri, is a condition of increased intracranial pressure with no evident cause on neuroimaging, classically affecting young,"
      }, {
        "text": " obese women.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEpidemiology:\u003c/b\u003e Most common in \u003c"
      }, {
        "text": "mark\u003ewomen of childbearing age who are obese\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Factors:\u003c/b\u003e Associated with certain medications,"
      }, {
        "text": " including tetracyclines, oral contraceptives, and excess vitamin A.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Presents with symptoms of increased"
      }, {
        "text": " ICP: \u003cmark\u003eheadache\u003c/mark\u003e (often pulsatile, worse with straining), pulsatile tinnitus, and"
      }, {
        "text": " visual disturbances.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOphthalmologic Findings:\u003c/b\u003e \u003cmark\u003ePapilledema\u003c/mark\u003e (swelling of the optic disc) is a"
      }, {
        "text": " key finding. Patients may also have a [[dd11dde6|CN VI palsy]], leading to horizontal diplopia."
      }, {
        "text": " Untreated, it can lead to permanent vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Based on clinical findings, papilledema,"
      }, {
        "text": " normal neuroimaging (to rule out a mass or hydrocephalus), and an \u003cmark\u003eelevated opening pressure\u003c/mark\u003e (\u003e"
      }, {
        "text": "250 mmH\u003csub\u003e2\u003c/sub\u003eO) on lumbar puncture with normal CSF composition.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Weight"
      }, {
        "text": " loss is the cornerstone of long-term management. \u003cmark\u003eAcetazolamide\u003c/mark\u003e (a carbonic anhydrase inhibitor) is used to decrease"
      }, {
        "text": " CSF production.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The classic vignette is an obese young woman with a daily headache, puls"
      }, {
        "text": "atile tinnitus, and papilledema.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eIdiopathic Intrac"
      }, {
        "text": "ranial Hypertension\u003c/b\u003e is a diagnosis of exclusion for increased ICP, where the primary morbidity is vision loss from chronic papilledema,"
      }, {
        "text": " making weight loss and CSF-lowering agents like acetazolamide critical for preserving sight.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_also_known_as\",\n        \""
      }, {
        "text": "to\": \"pseudotumor_cerebri\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to"
      }, {
        "text": "\": \"d93d2dfb\"\n      },\n      {\n        \"type\": \"presents"
      }, {
        "text": "_with\",\n        \"to\": \"4ae219da\"\n      },\n      {\n        \"type\": \"is_treated"
      }, {
        "text": "_by\",\n        \"to\": \"1df262e8\"\n      }\n    ]\n  },\n  \"7"
      }, {
        "text": "c4e7c74\": {\n    \"title\": \"Increased Intracranial Pressure (ICP)\",\n    \"primaryType\": \""
      }, {
        "text": "finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Pathology\",\n      \""
      }, {
        "text": "USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n"
      }, {
        "text": "      \"Pathology\",\n      \"General\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eIncreased Int"
      }, {
        "text": "racranial Pressure (ICP)\u003c/b\u003e is a pathological elevation of pressure within the rigid cranial vault. It is a neurological emergency that"
      }, {
        "text": " can lead to decreased cerebral perfusion and brain herniation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCauses"
      }, {
        "text": ":\u003c/b\u003e Can be caused by an increase in the volume of any of the intracranial components: brain parenchyma (e.g., tumor"
      }, {
        "text": ", edema), blood (e.g., hemorrhage, [[067666cd|venous sinus thrombosis"
      }, {
        "text": "]]), or cerebrospinal fluid (e.g., [[0bc2f200|hydrocephalus]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eIdi"
      }, {
        "text": "opathic Intracranial Hypertension (IIH):\u003c/b\u003e A specific syndrome of increased ICP with no evident cause on imaging, typically"
      }, {
        "text": " affecting young, obese women.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Headache (often worse in the morning or with Valsalva), nausea"
      }, {
        "text": "/vomiting, [[4ae219da|papilledema]], and visual disturbances. [[dd11dde6|CN VI"
      }, {
        "text": " palsy]] is a common finding.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCushing\u0027s Triad:\u003c/b\u003e A late and ominous sign of severely"
      }, {
        "text": " elevated ICP, consisting of hypertension, bradycardia, and irregular respirations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Pap"
      }, {
        "text": "illedema is the cardinal sign of increased ICP on physical exam. A CN VI palsy in the setting of headache is often a"
      }, {
        "text": " \u0027false localizing sign\u0027 pointing to generalized increased ICP.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eIncreased Intrac"
      }, {
        "text": "ranial Pressure\u003c/b\u003e occurs when the volume of the brain\u0027s contents exceeds the compensatory capacity of the skull, leading to a dangerous rise"
      }, {
        "text": " in pressure that can compress vital brain structures and compromise cerebral blood flow.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n"
      }, {
        "text": "    \"connections\": [\n      {\n        \"type\": \"can_be_caused_by\",\n        "
      }, {
        "text": "\"to\": \"be057cfc\"\n      },\n      {\n        \"type\": \"can_"
      }, {
        "text": "be_caused_by\",\n        \"to\": \"c20521ce\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"0bc2f200\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\":"
      }, {
        "text": " \"0430aadb\"\n      },\n      {\n        \"type\": \"presents_with"
      }, {
        "text": "\",\n        \"to\": \"4ae219da\"\n      }\n    ]\n  },\n"
      }, {
        "text": "  \"67928d1e\": {\n    \"title\": \"Incus\",\n    \"primaryType\": \""
      }, {
        "text": "anatomy\",\n    \"tags\": [\n      \"Otology\",\n      \"Anatomy\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Anatomy\""
      }, {
        "text": "\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eIncus\u003c/b\u003e ("
      }, {
        "text": "Latin for \\\"anvil\\\") is the middle of the three auditory ossicles in the middle ear, connecting the malleus to"
      }, {
        "text": " the stapes.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Situated in the middle ear, articulating med"
      }, {
        "text": "ially with the stapes and laterally with the malleus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Acts as a lever in the oss"
      }, {
        "text": "icular chain to transmit sound vibrations from the malleus to the stapes, contributing to the amplification of sound.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eEmbryology:\u003c/b\u003e Derived from cartilage of the \u003cmark\u003efirst pharyngeal arch\u003c/mark\u003e (Meckel\u0027s cartilage), along with the"
      }, {
        "text": " malleus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Dislocation or erosion of the incus (e.g., from"
      }, {
        "text": " trauma or cholesteatoma) can disrupt the ossicular chain and cause significant conductive hearing loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Remember the pharyngeal arch derivatives: the \u003cb\u003eM\u003c/b\u003ealleus and \u003cb\u003eI\u003c/b\u003enc"
      }, {
        "text": "us come from the \u003cb\u003e1st\u003c/b\u003e (\u003cb\u003eM\u003c/b\u003eandibular) arch, while the \u003cb\u003eS\u003c/b\u003etapes comes"
      }, {
        "text": " from the \u003cb\u003e2nd\u003c/b\u003e (hyoid) arch.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "The \u003cb\u003eIncus\u003c/b\u003e serves as the intermediate link in the ossicular chain, pivoting like an anvil to transfer the force"
      }, {
        "text": " of vibrations from the malleus to the stapes, a critical step in the mechanical amplification of sound.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"3aea8cac\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "located_in\",\n        \"to\": \"45568c28\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"derives_from\",\n        \"to\": \"first_pharyngeal_arch"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"articulates_with\",\n        \"to\":"
      }, {
        "text": " \"153b46d9\"\n      },\n      {\n        \"type\": \"articulates_with\",\n"
      }, {
        "text": "        \"to\": \"stapes\"\n      }\n    ]\n  },\n  \"dae1ae4"
      }, {
        "text": "6\": {\n    \"title\": \"Indirect Pathway (Basal Ganglia)\",\n    \"primaryType\": \"physiology"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Physiology\",\n      \"Movement Disorders\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and"
      }, {
        "text": " Physiology\",\n      \"Basal Ganglia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003e"
      }, {
        "text": "Indirect Pathway\u003c/b\u003e is a neuronal circuit within the [[ed462927|basal ganglia]] that has"
      }, {
        "text": " a net \u003ci\u003einhibitory\u003c/i\u003e effect on the thalamus, thereby suppressing unwanted or competing movements.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e To inhibit movement by increasing the tonic inhibition of the thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Cort"
      }, {
        "text": "ical excitation of the striatum leads to inhibition of the globus pallidus externus (GPe). This disinhibits the sub"
      }, {
        "text": "thalamic nucleus (STN), allowing the STN to excite the globus pallidus internus (GPi"
      }, {
        "text": "). The now-excited GPi increases its inhibition of the thalamus, which in turn reduces excitation of the motor cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Dopamine\u0027s Role:\u003c/b\u003e [[90adc821|Dopamine]] from the substantia nigra pars"
      }, {
        "text": " compacta \u003cmark\u003einhibits\u003c/mark\u003e the indirect pathway by acting on D2 receptors in the striatum.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ology (Parkinson\u0027s):\u003c/b\u003e In [[58c8ea03|Parkinson disease]], the loss of dopamine leads to overactivity"
      }, {
        "text": " of the indirect pathway, contributing to the profound inhibition of movement (bradykinesia).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology (Huntington\u0027s"
      }, {
        "text": "):\u003c/b\u003e In early [[ffd7e743|Huntington disease]], degeneration of the indirect pathway neurons in the striatum leads to dis"
      }, {
        "text": "inhibition of the thalamus and hyperkinetic movements (chorea).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that"
      }, {
        "text": " the indirect pathway is inhibitory to movement. Dopamine inhibits this pathway. Therefore, loss of dopamine (Parkinson\u0027s) leads to less"
      }, {
        "text": " movement, while damage to the pathway itself (Huntington\u0027s) leads to more movement.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "The \u003cb\u003eIndirect Pathway\u003c/b\u003e acts as the \u0027brake\u0027 of the basal ganglia motor circuit; its complex, multi-step process"
      }, {
        "text": " ultimately amplifies the inhibition of the thalamus to suppress unwanted movements, and its dysregulation is a key factor in both"
      }, {
        "text": " hypokinetic and hyperkinetic disorders.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cortex] --\u003e"
      }, {
        "text": " B(Striatum); B --GABA--\u003e C(GPe); C --x D(STN); D --"
      }, {
        "text": "Glutamate--\u003e E(GPi); E --GABA--\u003e F(Thalamus); F --x G"
      }, {
        "text": "(Cortex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_"
      }, {
        "text": "of\",\n        \"to\": \"ed462927\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"inhibits\",\n        \"to\": \"movement\"\n      },\n      {\n        \"type\": \"is_inhibited"
      }, {
        "text": "_by\",\n        \"to\": \"90adc821\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_overactive_in\",\n        \"to\": \"58c8ea03"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_underactive_in\",\n        \"to\": \"ffd"
      }, {
        "text": "7e743\"\n      }\n    ]\n  },\n  \"6e26365"
      }, {
        "text": "9\": {\n    \"title\": \"Cerebral Infarcts\",\n    \"primaryType\": \"path"
      }, {
        "text": "ology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Vascular\",\n      "
      }, {
        "text": "\"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\","
      }, {
        "text": "\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {"
      }, {
        "text": "\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCerebral infarcts\u003c/b\u003e are areas of necrotic brain tissue resulting from ischemia"
      }, {
        "text": ", most commonly caused by the occlusion of a cerebral artery. The location and extent of the infarct determine the clinical neurological deficits.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTypes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eThrombotic:\u003c/b\u003e Due to local"
      }, {
        "text": " clot formation, often over an atherosclerotic plaque.\u003cbr\u003e - \u003cb\u003eEmbolic:\u003c/b\u003e Due to a clot traveling from a"
      }, {
        "text": " distant source (e.g., heart, carotid arteries).\u003cbr\u003e - \u003cb\u003eLacunar:\u003c/b\u003e Small infarcts in deep"
      }, {
        "text": " brain structures from occlusion of small penetrating arteries.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCortical Areas:\u003c/b\u003e Infarcts in the territories of the"
      }, {
        "text": " major cerebral arteries ([[830c856c|ACA]], [[143bb23d|MCA]], [[b"
      }, {
        "text": "6a2cc31|PCA]]) produce characteristic patterns of motor, sensory, and cognitive deficits known as \u0027cortical signs"
      }, {
        "text": "\u0027 (e.g., aphasia, neglect).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e The brain undergoes \u003cmark\u003eliquefactive"
      }, {
        "text": " necrosis\u003c/mark\u003e following an ischemic event.\u003c/li\u003e\u003cli\u003e\u003cb\u003eWatershed Infarcts:\u003c/b\u003e Occur in the border zones between major arterial"
      }, {
        "text": " territories and are associated with systemic hypoperfusion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The clinical syndrome presented in a stroke question"
      }, {
        "text": " is the key to identifying the affected artery and the location of the infarct.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eCerebral infarcts\u003c/b\u003e are the pathological consequence of an ischemic stroke, where the specific neurological deficit"
      }, {
        "text": " serves as a precise map to the occluded blood vessel and the corresponding area of necrotic brain tissue.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_result_of\",\n        \"to\": \"349f9307\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_characterized_by\",\n        \"to\": \"4945aa8"
      }, {
        "text": "c\"\n      },\n      {\n        \"type\": \"can_be_localized_to\",\n        \"to\": \"1"
      }, {
        "text": "43bb23d\"\n      },\n      {\n        \"type\": \"can_be_localized_to\","
      }, {
        "text": "\n        \"to\": \"830c856c\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"9347f277\": {\n    \"title\": \"Infective Dementia\",\n    \""
      }, {
        "text": "primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Infectious Disease"
      }, {
        "text": "\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n"
      }, {
        "text": "      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Dementia\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eInfective dementia\u003c/b\u003e refers to a progressive decline in cognitive function caused by a chronic"
      }, {
        "text": " or subacute infection of the central nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHIV-Associated"
      }, {
        "text": " Dementia (HAD):\u003c/b\u003e Occurs in patients with advanced HIV/AIDS (CD4 \u003c 200). Ca"
      }, {
        "text": "used by inflammatory activation of microglial cells, which form multinucleated giant cells. Presents with subcortical dementia ("
      }, {
        "text": "e.g., slowed movements and cognitive processing).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCreutzfeldt-Jakob Disease (CJD):\u003c/b\u003e A rapidly"
      }, {
        "text": " progressive dementia caused by prions. Characterized by myoclonus and ataxia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurosyphilis"
      }, {
        "text": ":\u003c/b\u003e Tertiary syphilis can cause a progressive dementia known as general paresis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProgressive Multifocal Leukoencephalopathy (P"
      }, {
        "text": "ML):\u003c/b\u003e Caused by reactivation of the [[30b75088|JC virus]] in immunocom"
      }, {
        "text": "promised individuals. A demyelinating disease that leads to rapidly progressive neurological deficits and dementia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When"
      }, {
        "text": " a patient with dementia presents with an atypical, rapid course or has risk factors for specific infections (e.g., HIV,"
      }, {
        "text": " history of syphilis), consider an infective etiology.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eWhile most"
      }, {
        "text": " dementias are neurodegenerative, a subset is caused by chronic CNS infections. These \u003cb\u003einfective dementias\u003c/b\u003e are"
      }, {
        "text": " important to recognize as some, like neurosyphilis, may be treatable, and others, like CJD, have"
      }, {
        "text": " important public health implications.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_type_of\",\n        \"to\": \"bb316"
      }, {
        "text": "ca0\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"hiv"
      }, {
        "text": "_associated_dementia\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to"
      }, {
        "text": "\": \"86fe59ba\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"neuro"
      }, {
        "text": "syphilis\"\n      }\n    ]\n  },\n  \"fccf33b0\": {\n    \"title\":"
      }, {
        "text": " \"Inferior Oblique Muscle\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"Anatomy\",\n      \"Neurology\",\n      \"USMLE\"\n    ],"
      }, {
        "text": "\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Anatomy"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eInferior Ob"
      }, {
        "text": "lique\u003c/b\u003e is one of the six extraocular muscles. Its primary action is extorsion of the eyeball, with secondary actions of elevation and abduction"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eActions:\u003c/b\u003e Primary: Extorsion (outward rotation). Secondary: Elevation and"
      }, {
        "text": " Abduction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e Innervated by the inferior division of the \u003cmark\u003eoculomotor nerve"
      }, {
        "text": " (CN III)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTesting:\u003c/b\u003e The elevating action of the inferior oblique is best isolated when the eye is ad"
      }, {
        "text": "ducted (looking toward the nose) and the patient is asked to look up. Mnemonic: \u003cb\u003eI\u003c/b\u003enfer"
      }, {
        "text": "ior oblique tested looking \u003cb\u003eI\u003c/b\u003en and up.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Paralysis of the inferior oblique ("
      }, {
        "text": "as part of a [[68c66997|CN III palsy]]) contributes to the \u0027down and out\u0027 position"
      }, {
        "text": " of the eye and causes vertical diplopia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the mnemonic \u003cb\u003eLR\u003csub\u003e"
      }, {
        "text": "6\u003c/sub\u003eSO\u003csub\u003e4\u003c/sub\u003eR\u003csub\u003e3\u003c/sub\u003e\u003c/b\u003e. The inferior oblique is part of the \u0027Rest\u0027 innervated by CN"
      }, {
        "text": " III.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eInferior Oblique\u003c/b\u003e muscle is unique"
      }, {
        "text": " in its primary action of extorsion, but its clinically tested function is elevation of the adducted eye, a key movement"
      }, {
        "text": " for diagnosing oculomotor nerve palsies.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      "
      }, {
        "text": "{\n        \"type\": \"is_a_type_of\",\n        \"to\": \"extraocular_muscle\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_innervated_by\",\n        \"to\": \"68"
      }, {
        "text": "c66997\"\n      },\n      {\n        \"type\": \"action_is\",\n        \"to\": \"ext"
      }, {
        "text": "orsion_of_eye\"\n      },\n      {\n        \"type\": \"action_is\",\n        \"to"
      }, {
        "text": "\": \"elevation_of_eye\"\n      }\n    ]\n  },\n  \"2d0219b"
      }, {
        "text": "1\": {\n    \"title\": \"Inferior Rectus Muscle\",\n    \"primaryType\": \"anatomy\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Ophthalmology\",\n      \"Anatomy\",\n      \"Neurology\",\n      \""
      }, {
        "text": "USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n"
      }, {
        "text": "      \"Ophthalmology\",\n      \"Anatomy\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003eThe \u003cb\u003eInferior Rectus\u003c/b\u003e is one of the six extraocular muscles. Its primary action is depression of the"
      }, {
        "text": " eyeball, with secondary actions of adduction and extorsion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eActions:\u003c/b\u003e Primary: Depression"
      }, {
        "text": " (downward movement). Secondary: Adduction and Extorsion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e Innervated by"
      }, {
        "text": " the inferior division of the \u003cmark\u003eoculomotor nerve (CN III)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTesting:\u003c/b\u003e"
      }, {
        "text": " The depressing action of the inferior rectus is best isolated when the eye is abducted (looking away from the nose) and the patient is"
      }, {
        "text": " asked to look down.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Paralysis of the inferior rectus (as part of a"
      }, {
        "text": " [[68c66997|CN III palsy]]) contributes to the \u0027down and out\u0027 position of the eye and"
      }, {
        "text": " causes vertical diplopia. In an orbital floor \u0027blowout\u0027 fracture, the inferior rectus can become entrapped,"
      }, {
        "text": " restricting upward gaze.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the mnemonic \u003cb\u003eLR\u003csub\u003e6\u003c/sub\u003eSO\u003csub\u003e4"
      }, {
        "text": "\u003c/sub\u003eR\u003csub\u003e3\u003c/sub\u003e\u003c/b\u003e. The inferior rectus is part of the \u0027Rest\u0027 innervated by CN III"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eInferior Rectus\u003c/b\u003e muscle is the primary depress"
      }, {
        "text": "or of the eye, and its function is best tested by having the patient look down and out; its entrapment in"
      }, {
        "text": " an orbital floor fracture is a classic cause of restricted upgaze.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"extraocular_"
      }, {
        "text": "muscle\"\n      },\n      {\n        \"type\": \"is_innervated_by\",\n        "
      }, {
        "text": "\"to\": \"68c66997\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"action_is\",\n        \"to\": \"depression_of_eye\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"can_be_entrapped_in\",\n        \"to\": \"orbital_blowout_fracture\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"43d56aab\": {\n    \"title\": \""
      }, {
        "text": "Inhaled Anesthetics\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eInhaled anesthetics\u003c/b\u003e are volatile liquids or gases that are administered via inhalation"
      }, {
        "text": " to induce and maintain general anesthesia. Their effects are dose-dependent and reversible.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eExamples:\u003c/b\u003e Halothane (historical), [[70509ee9|isoflurane]],"
      }, {
        "text": " sevoflurane, desflurane, and [[9c56fa3c|nitrous oxide ("
      }, {
        "text": "N\u003csub\u003e2\u003c/sub\u003eO)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e The exact mechanism is unknown, but they are"
      }, {
        "text": " thought to enhance the activity of inhibitory neurotransmitter receptors (e.g., GABA\u003csub\u003eA\u003c/sub\u003e, glycine) and inhibit"
      }, {
        "text": " excitatory receptors (e.g., NMDA).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eOnset"
      }, {
        "text": "/Recovery:\u003c/b\u003e Determined by blood solubility (blood:gas partition coefficient). Low solubility (e.g., N\u003csub\u003e2\u003c/sub\u003eO, desflur"
      }, {
        "text": "ane) \u003d rapid onset and recovery. High solubility \u003d slow onset/recovery.\u003cbr\u003e - \u003cb\u003ePotency:\u003c/b\u003e Determined by lipid"
      }, {
        "text": " solubility (oil:gas partition coefficient) and measured by the \u003cmark\u003eMinimum Alveolar Concentration (MAC)\u003c/mark\u003e."
      }, {
        "text": " High lipid solubility \u003d low MAC \u003d high potency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSystemic Effects:\u003c/b\u003e Cause myocardial depression, hypotension ("
      }, {
        "text": "vasodilation), respiratory depression, and increased cerebral blood flow.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e All volatile anest"
      }, {
        "text": "hetics (not N\u003csub\u003e2\u003c/sub\u003eO) can trigger \u003cmark\u003emalignant hyperthermia\u003c/mark\u003e in susceptible individuals. Halothane is"
      }, {
        "text": " associated with severe hepatotoxicity.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe clinical properties of \u003cb\u003einh"
      }, {
        "text": "aled anesthetics\u003c/b\u003e are governed by their physical solubilities: low blood solubility allows for rapid control of anesthetic depth, while high lipid solubility confers"
      }, {
        "text": " high potency, allowing for effective anesthesia at low concentrations.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"general_anesthetic\"\n      },\n      {\n        \"type\": \"can_trigger\",\n        \"to\": \"4"
      }, {
        "text": "29af8bd\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"705"
      }, {
        "text": "09ee9\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\":"
      }, {
        "text": " \"9c56fa3c\"\n      }\n    ]\n  },\n  \"1bfd"
      }, {
        "text": "49ab\": {\n    \"title\": \"Inner Ear\",\n    \"primaryType\": \"anatomy\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Otology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"An"
      }, {
        "text": "atomy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eInner Ear\u003c/b\u003e is the"
      }, {
        "text": " innermost part of the ear, housed within the petrous part of the temporal bone. It contains the sensory organs for hearing"
      }, {
        "text": " (the cochlea) and balance (the vestibular system).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents"
      }, {
        "text": ":\u003c/b\u003e Consists of the bony labyrinth, a system of bony canals, which contains the membranous labyrinth, a system"
      }, {
        "text": " of fluid-filled sacs and ducts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCochlea:\u003c/b\u003e The spiral-shaped, fluid-filled structure"
      }, {
        "text": " responsible for hearing. It contains the [[2e814378|organ of Corti]], which transdu"
      }, {
        "text": "ces sound vibrations into nerve impulses.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVestibular System:\u003c/b\u003e Responsible for balance and spatial orientation. It includes"
      }, {
        "text": " the three semicircular canals (which detect rotational movements) and the otolith organs (utricle and saccule, which detect"
      }, {
        "text": " linear acceleration and gravity).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFluids:\u003c/b\u003e The membranous labyrinth is filled with endolymph (high in"
      }, {
        "text": " K\u003csup\u003e+\u003c/sup\u003e), while the space between the bony and membranous labyrinths is filled with perilymph (high in Na\u003csup\u003e+\u003c/sup\u003e).\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e The [[6fded3e7|vestibulocochlear nerve (CN VIII"
      }, {
        "text": ")]] carries auditory information from the cochlea and vestibular information from the vestibular system to the brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Pathologies of the inner ear cause sensorineural hearing loss and/or vertigo. [[6f2"
      }, {
        "text": "228c1|M√©ni√®re disease]] is a classic disorder of the inner ear caused by an excess of endolymph.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eInner Ear\u003c/b\u003e is a sophisticated transducer that converts mechanical energy"
      }, {
        "text": "‚Äîsound vibrations and head movements‚Äîinto the electrical language of the nervous system, subserving the distinct but related senses of hearing and balance.\u003c/p"
      }, {
        "text": "\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_"
      }, {
        "text": "of\",\n        \"to\": \"ear\"\n      },\n      {\n        \"type\": \"contains\","
      }, {
        "text": "\n        \"to\": \"001c359f\"\n      },\n      {\n        \"type\": \"contains\","
      }, {
        "text": "\n        \"to\": \"vestibular_system\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_affected_in\",\n        \"to\": \"6f2228c1\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"4dc57e8f\": {\n    \"title\": \"Insomnia Therapy\",\n    \"primaryType"
      }, {
        "text": "\": \"concept\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Sleep"
      }, {
        "text": " Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\","
      }, {
        "text": "\n      \"Pharmacology\",\n      \"Sedative-Hypnotics\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eInsomnia therapy\u003c/b\u003e involves pharmacological and non-pharmacological approaches to manage the inability to fall asleep, stay asleep, or get"
      }, {
        "text": " restorative sleep. Pharmacological agents primarily include benzodiazepines, nonbenzodiazepine hypnotics, and melatonin receptor agonists.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBenzodiazepines:\u003c/b\u003e (e.g., temazepam, triazolam) Increase"
      }, {
        "text": " the frequency of GABA\u003csub\u003eA\u003c/sub\u003e channel opening. Effective but can alter sleep architecture, cause dependence, and have next-day sedation"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eNonbenzodiazepine Hypnotics (\\\"Z-drugs\\\"):\u003c/b\u003e (e.g., z"
      }, {
        "text": "olpidem, zaleplon, eszopiclone) Act selectively on the BZ1 subtype of the"
      }, {
        "text": " GABA\u003csub\u003eA\u003c/sub\u003e receptor. Less disruption of sleep architecture and lower dependence risk than benzodiazepines. Effects are reversed by fl"
      }, {
        "text": "umazenil.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMelatonin Receptor Agonists:\u003c/b\u003e (e.g., [[bbf7"
      }, {
        "text": "e9ef|ramelteon]]) Agonist at melatonin receptors in the suprachiasmatic nucleus. Helps with"
      }, {
        "text": " sleep onset and is not a controlled substance, with no abuse potential.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOrexin Receptor Antagonists:\u003c/b\u003e (e.g"
      }, {
        "text": "., suvorexant) Block orexin, a neuropeptide that promotes wakefulness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Agents:\u003c/b\u003e Sed"
      }, {
        "text": "ating antidepressants (e.g., trazodone, mirtazapine) and antihistamines (e.g., dip"
      }, {
        "text": "henhydramine) are also used.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eModern \u003cb\u003einsomnia therapy\u003c/b\u003e has"
      }, {
        "text": " shifted from broad CNS depressants like benzodiazepines towards more targeted agents, such as the Z-drugs that selectively act on GABA"
      }, {
        "text": "\u003csub\u003eA\u003c/sub\u003e receptor subtypes or ramelteon that targets the body\u0027s natural sleep-wake cycle via melatonin receptors.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to"
      }, {
        "text": "\": \"insomnia\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\":"
      }, {
        "text": " \"14464617\"\n      },\n      {\n        \"type\": \"includes\","
      }, {
        "text": "\n        \"to\": \"91c40279\"\n      },\n      {\n        \"type\": \"includes\",\n"
      }, {
        "text": "        \"to\": \"bbf7e9ef\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "43fa8c69\": {\n    \"title\": \"Intention Tremor\",\n    \"primaryType\":"
      }, {
        "text": " \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Movement"
      }, {
        "text": " Disorders\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eAn"
      }, {
        "text": " \u003cb\u003eintention tremor\u003c/b\u003e is a type of action tremor characterized by a broad, coarse, low-frequency tremor that is"
      }, {
        "text": " absent at rest and worsens as the limb approaches a target during a voluntary, visually-guided movement. It is a cardinal"
      }, {
        "text": " sign of cerebellar dysfunction.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Results"
      }, {
        "text": " from a lesion in the [[bebe58d4|cerebellum]] or its connections (e.g., superior"
      }, {
        "text": " cerebellar peduncle). The cerebellum is responsible for coordinating and fine-tuning movements, and its dysfunction leads to an inability to smoothly"
      }, {
        "text": " correct for errors in movement trajectory.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e The tremor is absent when the limb is at rest."
      }, {
        "text": " It appears and progressively worsens as the patient attempts a purposeful movement, such as reaching for an object or performing the finger-to-nose test."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e A classic sign of diseases affecting the cerebellum, such as \u003cmark\u003e[[45dd"
      }, {
        "text": "6d19|Multiple Sclerosis]]\u003c/mark\u003e, stroke, tumors, or chronic alcoholism.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction"
      }, {
        "text": " from Other Tremors:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eResting Tremor:\u003c/b\u003e Occurs at rest and improves"
      }, {
        "text": " with movement (e.g., [[58c8ea03|Parkinson disease]]).\u003cbr\u003e -"
      }, {
        "text": " \u003cb\u003eEssential Tremor:\u003c/b\u003e A postural and action tremor that is typically faster and less coarse than an intention tremor.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e A tremor that is worst at the end of a goal-directed movement (e.g.,"
      }, {
        "text": " finger-to-nose test) is an intention tremor and points to a lesion in the ipsilateral cerebellum.\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003eAn \u003cb\u003eintention tremor\u003c/b\u003e is the physical manifestation of a failing cerebellar feedback loop;"
      }, {
        "text": " as the hand nears its target, the cerebellum\u0027s inability to make fine, real-time adjustments to the movement results"
      }, {
        "text": " in progressively larger oscillations.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_sign_of\",\n        \"to\": \"cerebellar_dysfunction\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        "
      }, {
        "text": "\"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "differentiated_from\",\n        \"to\": \"resting_tremor\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"differentiated_from\",\n        \"to\": \"essential_tremor\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"b72f1520\": {\n    \"title\": \"Internal"
      }, {
        "text": " Carotid Artery in Cavernous Sinus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"An"
      }, {
        "text": "atomy\",\n      \"Neuroscience\",\n      \"Vascular\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Cerebrovascular System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe cavernous segment"
      }, {
        "text": " of the \u003cb\u003eInternal Carotid Artery (ICA)\u003c/b\u003e is the portion of the artery that passes through the [["
      }, {
        "text": "c260efc8|cavernous sinus]], a unique anatomical arrangement where a major artery travels within a venous"
      }, {
        "text": " structure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnatomy:\u003c/b\u003e The ICA, along with the [[dd"
      }, {
        "text": "11dde6|abducens nerve (CN VI)]], passes directly through the cavernous sinus. Cranial nerves III"
      }, {
        "text": ", IV, V1, and V2 travel within the lateral wall of the sinus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance ("
      }, {
        "text": "Cavernous Sinus Syndrome):\u003c/b\u003e Pathologies affecting the cavernous sinus (e.g., thrombosis, tumor, infection"
      }, {
        "text": ") can compress the ICA and the cranial nerves, leading to a constellation of symptoms including painful ophthalmoplegia and sensory loss"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eCarotid-Cavernous Fistula:\u003c/b\u003e A rare but serious condition where a tear in the wall"
      }, {
        "text": " of the cavernous ICA creates an abnormal connection between the arterial and venous systems. This leads to high-pressure venous congestion"
      }, {
        "text": ", causing proptosis, chemosis, and a pulsatile bruit audible over the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSympathetic Fib"
      }, {
        "text": "ers:\u003c/b\u003e The postganglionic sympathetic plexus travels on the surface of the ICA. Compression of these fibers within the cavernous sinus can cause an"
      }, {
        "text": " ipsilateral [[c19010a3|Horner syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember"
      }, {
        "text": " the structures that pass *through* the cavernous sinus (ICA, CN VI) versus those in its *lateral wall* (CN"
      }, {
        "text": " III, IV, V1, V2). CN VI is often the first nerve affected in cavernous sinus pathology due"
      }, {
        "text": " to its medial location next to the ICA.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe passage of the "
      }, {
        "text": "\u003cb\u003einternal carotid artery\u003c/b\u003e through the cavernous sinus creates a vulnerable anatomical arrangement, where pathologies like thrombosis or fistula formation can lead to a complex"
      }, {
        "text": " syndrome involving multiple cranial nerves and potentially life-threatening venous congestion.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"passes_through\",\n        \"to\": \"c26"
      }, {
        "text": "0efc8\"\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\":"
      }, {
        "text": " \"9a089fd7\"\n      },\n      {\n        \"type\": \"can_form"
      }, {
        "text": "\",\n        \"to\": \"carotid_cavernous_fistula\"\n      }\n    ]\n"
      }, {
        "text": "  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"0bc2f200\",\n    \"letter\": \"H\",\n    \"term\": \"Hydrocephalus\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Hydrocephalus\",\n    \"sub_entries\": [\n      {\n        \"id\": \"bf96a94a\",\n        \"letter\": \"H\",\n        \"term\": \"childhood tumors\",\n        \"pages\": [\n          \"542\"\n        ],\n        \"context\": \"Hydrocephalus \u003e childhood tumors\"\n      },\n      {\n        \"id\": \"052ac3f6\",\n        \"letter\": \"H\",\n        \"term\": \"mimics of\",\n        \"pages\": [\n          \"536\"\n        ],\n        \"context\": \"Hydrocephalus \u003e mimics of\"\n      },\n      {\n        \"id\": \"88e69aca\",\n        \"letter\": \"H\",\n        \"term\": \"noncommunicating\",\n        \"pages\": [\n          \"502\"\n        ],\n        \"context\": \"Hydrocephalus \u003e noncommunicating\"\n      },\n      {\n        \"id\": \"5c95392a\",\n        \"letter\": \"H\",\n        \"term\": \"obstructive\",\n        \"pages\": [\n          \"542\"\n        ],\n        \"context\": \"Hydrocephalus \u003e obstructive\"\n      },\n      {\n        \"id\": \"2ea723df\",\n        \"letter\": \"H\",\n        \"term\": \"risk for developing\",\n        \"pages\": [\n          \"528\"\n        ],\n        \"context\": \"Hydrocephalus \u003e risk for developing\"\n      },\n      {\n        \"id\": \"ba4b67df\",\n        \"letter\": \"H\",\n        \"term\": \"types and presentation\",\n        \"pages\": [\n          \"536\"\n        ],\n        \"context\": \"Hydrocephalus \u003e types and presentation\"\n      }\n    ]\n  },\n  {\n    \"id\": \"ba5581a8\",\n    \"letter\": \"H\",\n    \"term\": \"Hypercalcemia\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Hypercalcemia\",\n    \"sub_entries\": [\n      {\n        \"id\": \"f80dc0f2\",\n        \"letter\": \"H\",\n        \"term\": \"succinylcholine\",\n        \"pages\": [\n          \"566\"\n        ],\n        \"context\": \"Hypercalcemia \u003e succinylcholine\"\n      }\n    ]\n  },\n  {\n    \"id\": \"4f3eba91\",\n    \"letter\": \"H\",\n    \"term\": \"Hypercoagulability\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Hypercoagulability\",\n    \"sub_entries\": [\n      {\n        \"id\": \"a4b8b136\",\n        \"letter\": \"H\",\n        \"term\": \"dural venous sinus thrombosis\",\n        \"pages\": [\n          \"514\"\n        ],\n        \"context\": \"Hypercoagulability \u003e dural venous sinus thrombosis\"\n      }\n    ]\n  },\n  {\n    \"id\": \"567e169f\",\n    \"letter\": \"H\",\n    \"term\": \"Hyperemesis gravidarum, treatment\",\n    \"pages\": [\n      \"506\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Hyperemesis gravidarum, treatment\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"c933bda7\",\n    \"letter\": \"H\",\n    \"term\": \"Hyperopia\",\n    \"pages\": [\n      \"549\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Hyperopia\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"71ff8afe\",\n    \"letter\": \"H\",\n    \"term\": \"Hyperorality\",\n    \"pages\": [\n      \"524\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Hyperorality\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"1bc2f357\",\n    \"letter\": \"H\",\n    \"term\": \"Hyperphagia\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Hyperphagia\",\n    \"sub_entries\": [\n      {\n        \"id\": \"05ed2e40\",\n        \"letter\": \"H\",\n        \"term\": \"brain lesions\",\n        \"pages\": [\n          \"508\",\n          \"524\"\n        ],\n        \"context\": \"Hyperphagia \u003e brain lesions\"\n      }\n    ]\n  },\n  {\n    \"id\": \"498632b3\",\n    \"letter\": \"H\",\n    \"term\": \"Hyperprolactinemia\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Hyperprolactinemia\",\n    \"sub_entries\": [\n      {\n        \"id\": \"51975b92\",\n        \"letter\": \"H\",\n        \"term\": \"pituitary adenoma\",\n        \"pages\": [\n          \"540\"\n        ],\n        \"context\": \"Hyperprolactinemia \u003e pituitary adenoma\"\n      }\n    ]\n  },\n  {\n    \"id\": \"527c712d\",\n    \"letter\": \"H\",\n    \"term\": \"Hypersexuality\",\n    \"pages\": [\n      \"524\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Hypersexuality\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"c3115d0f\",\n    \"letter\": \"H\",\n    \"term\": \"Hypertension\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Hypertension\",\n    \"sub_entries\": [\n      {\n        \"id\": \"b893a39b\",\n        \"letter\": \"H\",\n        \"term\": \"intracranial hemorrhage with\",\n        \"pages\": [\n          \"528\"\n        ],\n        \"context\": \"Hypertension \u003e intracranial hemorrhage with\"\n      }\n    ]\n  },\n  {\n    \"id\": \"549b012e\",\n    \"letter\": \"H\",\n    \"term\": \"Hypertensive retinopathy\",\n    \"pages\": [\n      \"552\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Hypertensive retinopathy\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"0df5b928\",\n    \"letter\": \"H\",\n    \"term\": \"Hypertrophic cardiomyopathy\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Hypertrophic cardiomyopathy\",\n    \"sub_entries\": [\n      {\n        \"id\": \"baea0c68\",\n        \"letter\": \"H\",\n        \"term\": \"with Friedreich ataxia\",\n        \"pages\": [\n          \"545\"\n        ],\n        \"context\": \"Hypertrophic cardiomyopathy \u003e with Friedreich ataxia\"\n      }\n    ]\n  },\n  {\n    \"id\": \"b080137e\",\n    \"letter\": \"H\",\n    \"term\": \"Hyperventilation\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Hyperventilation\",\n    \"sub_entries\": [\n      {\n        \"id\": \"a410176d\",\n        \"letter\": \"H\",\n        \"term\": \"therapeutic\",\n        \"pages\": [\n          \"512\"\n        ],\n        \"context\": \"Hyperventilation \u003e therapeutic\"\n      }\n    ]\n  },\n  {\n    \"id\": \"4caf22d3\",\n    \"letter\": \"H\",\n    \"term\": \"Hypoglossal nerve (CN XII)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Hypoglossal nerve (CN XII)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"8ca90bcb\",\n        \"letter\": \"H\",\n        \"term\": \"function\",\n        \"pages\": [\n          \"519\"\n        ],\n        \"context\": \"Hypoglossal nerve (CN XII) \u003e function\"\n      },\n      {\n        \"id\": \"797cad2c\",\n        \"letter\": \"H\",\n        \"term\": \"lesion in\",\n        \"pages\": [\n          \"546\"\n        ],\n        \"context\": \"Hypoglossal nerve (CN XII) \u003e lesion in\"\n      },\n      {\n        \"id\": \"adc6bb48\",\n        \"letter\": \"H\",\n        \"term\": \"with stroke\",\n        \"pages\": [\n          \"527\"\n        ],\n        \"context\": \"Hypoglossal nerve (CN XII) \u003e with stroke\"\n      }\n    ]\n  },\n  {\n    \"id\": \"9c32b0ea\",\n    \"letter\": \"H\",\n    \"term\": \"Hypopyon\",\n    \"pages\": [\n      \"553\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Hypopyon\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 2293
    }, {
      "text": "```json\n{\n  \"0bc2f200\": {\n    \"title\": \"Hydrocephalus\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Hydrocephalus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHydrocephalus\u003c/b\u003e is the abnormal accumulation of cerebrospinal fluid (CSF) within the brain\u0027s ventricles, leading to ventricular dilation and, typically, increased intracranial pressure (ICP).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCommunicating Hydrocephalus:\u003c/b\u003e Caused by impaired CSF absorption by the arachnoid granulations (e.g., post-meningitis scarring). All ventricles are symmetrically dilated. [[7c59030e|Normal pressure hydrocephalus (NPH)]] is a subtype.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNon-communicating (Obstructive) Hydrocephalus:\u003c/b\u003e Caused by a structural blockage of CSF flow within the ventricular system (e.g., aqueductal stenosis, tumor). Ventricles proximal to the obstruction are dilated. Common in [[7f8bdf0b|childhood brain tumors]] like [[16d613bb|medulloblastoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eHydrocephalus ex Vacuo:\u003c/b\u003e A mimic of hydrocephalus where there is ventricular enlargement due to brain atrophy and neuronal loss (e.g., in Alzheimer\u0027s disease). ICP is normal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e In adults, symptoms of increased ICP (headache, papilledema, vomiting). In infants, macrocephaly (enlarging head circumference) and bulging fontanelles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key distinction is between communicating (absorption problem) and non-communicating (flow problem). Imaging helps differentiate them by showing either all ventricles enlarged or only those upstream of a blockage.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHydrocephalus\u003c/b\u003e is a condition of \u0027water on the brain\u0027 that results from an imbalance between CSF production and absorption. The clinical consequences stem from the mechanical pressure of the excess fluid, which can damage brain tissue and dangerously elevate intracranial pressure.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"aa4115c7\"\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"4fab8000\"\n      },\n      {\n        \"type\": \"is_mimicked_by\",\n        \"to\": \"7efdb0ef\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"7f8bdf0b\"\n      }\n    ]\n  },\n  \"ba5581a8\": {\n    \"title\": \"Hypercalcemia and Succinylcholine\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Adverse Effects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe administration of \u003cb\u003esuccinylcholine\u003c/b\u003e, a depolarizing neuromuscular blocker, can cause a transient but potentially life-threatening \u003ci\u003ehyperkalemia\u003c/i\u003e, not hypercalcemia. This effect is exaggerated in patients with certain underlying conditions.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Hyperkalemia:\u003c/b\u003e Succinylcholine is an acetylcholine receptor agonist. Its binding to nicotinic receptors on the motor endplate causes a sustained depolarization, which leads to an efflux of potassium (K\u003csup\u003e+\u003c/sup\u003e) from muscle cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNormal Response:\u003c/b\u003e In healthy individuals, this results in a small, clinically insignificant rise in serum K\u003csup\u003e+\u003c/sup\u003e (approx. 0.5 mEq/L).\u003c/li\u003e\u003cli\u003e\u003cb\u003eExaggerated Response:\u003c/b\u003e In patients with upregulation of acetylcholine receptors (e.g., burns, crush injuries, denervating injuries, myopathies), succinylcholine can cause a massive K\u003csup\u003e+\u003c/sup\u003e release, leading to severe, life-threatening \u003cmark\u003ehyperkalemia\u003c/mark\u003e and cardiac arrest.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHypercalcemia Note:\u003c/b\u003e Succinylcholine is a trigger for [[429af8bd|malignant hyperthermia]], a condition involving massive release of \u003ci\u003ecalcium\u003c/i\u003e from the sarcoplasmic reticulum, but it does not directly cause serum hypercalcemia. The primary electrolyte concern with succinylcholine itself is hyperkalemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Succinylcholine is contraindicated in patients with major burns, crush injuries, or upper motor neuron disease due to the risk of severe hyperkalemia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eSuccinylcholine\u0027s depolarizing action at the neuromuscular junction invariably causes a potassium efflux from muscle cells; while normally benign, this effect becomes dangerously amplified in conditions with receptor upregulation, posing a significant risk of fatal hyperkalemia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"hyperkalemia\"\n      },\n      {\n        \"type\": \"is_a_trigger_for\",\n        \"to\": \"429af8bd\"\n      },\n      {\n        \"type\": \"is_contraindicated_in\",\n        \"to\": \"burn_injury\"\n      },\n      {\n        \"type\": \"is_contraindicated_in\",\n        \"to\": \"crush_injury\"\n      }\n    ]\n  },\n  \"4f3eba91\": {\n    \"title\": \"Hypercoagulability and Dural Venous Sinus Thrombosis\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Hematology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHypercoagulability\u003c/b\u003e, whether inherited or acquired, is a major risk factor for the development of \u003ci\u003edural venous sinus thrombosis (DVST)\u003c/i\u003e, a condition involving clot formation in the venous sinuses that drain blood from the brain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDural Venous Sinus Thrombosis (DVST):\u003c/b\u003e A type of stroke caused by thrombosis of the dural venous sinuses. This obstructs venous drainage, leading to venous congestion, increased intracranial pressure, and potentially venous infarction or hemorrhage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHypercoagulable States:\u003c/b\u003e Conditions that predispose to thrombosis are a key cause of DVST, especially in younger patients without other stroke risk factors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInherited Hypercoagulability:\u003c/b\u003e Includes Factor V Leiden mutation, prothrombin gene mutation, and deficiencies of antithrombin, protein C, or protein S.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAcquired Hypercoagulability:\u003c/b\u003e Includes pregnancy/puerperium, oral contraceptive use, malignancy, and antiphospholipid syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation of DVST:\u003c/b\u003e Often presents with a severe headache, but can also cause seizures, focal neurological deficits, and signs of increased ICP like [[4ae219da|papilledema]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a young patient, especially a woman who is pregnant or taking oral contraceptives, who presents with a severe headache and/or stroke-like symptoms, dural venous sinus thrombosis due to a hypercoagulable state should be a top consideration.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eWhile arterial strokes are often linked to atherosclerosis, \u003cb\u003edural venous sinus thrombosis\u003c/b\u003e is frequently a manifestation of an underlying \u003cb\u003ehypercoagulable state\u003c/b\u003e, making a hematologic workup essential in patients presenting with this specific type of cerebrovascular event.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_risk_factor_for\",\n        \"to\": \"067666cd\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"factor_v_leiden\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"antiphospholipid_syndrome\"\n      }\n    ]\n  },\n  \"567e169f\": {\n    \"title\": \"Hyperemesis Gravidarum Treatment\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Obstetrics\",\n      \"Gastroenterology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Reproductive\",\n      \"Pharmacology\",\n      \"Obstetric Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe treatment of \u003cb\u003ehyperemesis gravidarum\u003c/b\u003e, a condition of severe nausea and vomiting in pregnancy, involves supportive care and antiemetic medications that target the central vomiting pathways.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The vomiting reflex is coordinated by the [[74b651ab|vomiting center]] in the medulla, which receives input from the chemoreceptor trigger zone (CTZ) in the [[5dd343d3|area postrema]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFirst-Line Pharmacotherapy:\u003c/b\u003e The combination of doxylamine (a first-generation antihistamine) and pyridoxine (vitamin B6) is a first-line treatment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSecond-Line Agents:\u003c/b\u003e If first-line therapy fails, other antiemetics can be used, including:\u003cbr\u003e - \u003cb\u003eDopamine antagonists:\u003c/b\u003e Metoclopramide, prochlorperazine.\u003cbr\u003e - \u003cb\u003eSerotonin (5-HT3) antagonists:\u003c/b\u003e Ondansetron.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Antiemetics:\u003c/b\u003e These drugs work by blocking neurotransmitter receptors in the CTZ and/or the vomiting center. For example, metoclopramide blocks D2 receptors, and ondansetron blocks 5-HT3 receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that the chemoreceptor trigger zone in the [[5dd343d3|area postrema]] is outside the blood-brain barrier, allowing it to detect emetogenic substances in the blood.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe treatment of \u003cb\u003ehyperemesis gravidarum\u003c/b\u003e relies on blocking the central neurochemical pathways of nausea and vomiting, using drugs that antagonize key receptors like H1, D2, and 5-HT3 in the brain\u0027s vomiting centers.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"hyperemesis_gravidarum\"\n      },\n      {\n        \"type\": \"targets\",\n        \"to\": \"74b651ab\"\n      },\n      {\n        \"type\": \"targets\",\n        \"to\": \"5dd343d3\"\n      }\n    ]\n  },\n  \"c933bda7\": {\n    \"title\": \"Hyperopia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHyperopia\u003c/b\u003e, commonly known as farsightedness, is a refractive error of the eye in which parallel light rays from distant objects are focused \u003ci\u003ebehind\u003c/i\u003e the retina, causing near objects to appear blurry.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Occurs when the eye is either too short (axial hyperopia) or the cornea/lens system has too little refractive power (refractive hyperopia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients can see distant objects clearly but have difficulty with near-vision tasks like reading. Young patients may be able to compensate by accommodating, but this can lead to eye strain and headaches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCorrection:\u003c/b\u003e Corrected with a \u003cmark\u003econvex (converging) lens\u003c/mark\u003e (e.g., glasses or contact lenses with a positive diopter prescription). The converging lens adds refractive power, moving the focal point forward onto the retina.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction from Presbyopia:\u003c/b\u003e While both cause blurry near vision, hyperopia is a refractive error present from a young age, whereas [[767d985e|presbyopia]] is an age-related loss of accommodation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the correction: \u003cb\u003eH\u003c/b\u003eyperopia (farsightedness) is corrected with a con\u003cb\u003evex\u003c/b\u003e lens.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHyperopia\u003c/b\u003e is a refractive error where the eye\u0027s focusing power is insufficient for its length, causing near images to be focused behind the retina. This is corrected by adding focusing power with a convex lens.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"refractive_error\"\n      },\n      {\n        \"type\": \"is_corrected_by\",\n        \"to\": \"convex_lens\"\n      },\n      {\n        \"type\": \"is_the_opposite_of\",\n        \"to\": \"c154b69c\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"767d985e\"\n      }\n    ]\n  },\n  \"71ff8afe\": {\n    \"title\": \"Hyperorality\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHyperorality\u003c/b\u003e is a behavioral symptom characterized by a tendency to examine objects by mouth. It is a key feature of \u003ci\u003eKl√ºver-Bucy syndrome\u003c/i\u003e, which results from bilateral damage to the amygdala.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Patients may compulsively place both edible and inedible objects into their mouths.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndrome:\u003c/b\u003e A classic component of [[c6292526|Kl√ºver-Bucy syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eKl√ºver-Bucy Syndrome Features:\u003c/b\u003e The full syndrome includes hyperorality, hypersexuality, hyperphagia, placidity (diminished fear response), and visual agnosia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocalization:\u003c/b\u003e The syndrome results from bilateral lesions of the medial temporal lobes, specifically the [[d220fc3f|amygdala]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e The most common cause of Kl√ºver-Bucy syndrome is HSV-1 encephalitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of hyperorality, along with other disinhibited behaviors like hypersexuality, in a patient with a history of encephalitis, points to a diagnosis of Kl√ºver-Bucy syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHyperorality\u003c/b\u003e is a primitive, disinhibited behavior that, when seen in an adult, is a striking sign of bilateral amygdalar damage, reflecting the loss of the amygdala\u0027s normal role in emotional and behavioral regulation.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"c6292526\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"d220fc3f\"\n      }\n    ]\n  },\n  \"1bc2f357\": {\n    \"title\": \"Hyperphagia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Neurology\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Pathology\",\n      \"Hypothalamic Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHyperphagia\u003c/b\u003e is an abnormally increased appetite and excessive eating, which can be a symptom of various neurological, endocrine, and psychiatric conditions.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHypothalamic Control:\u003c/b\u003e Appetite is regulated by the [[89e86633|hypothalamus]]. The \u003cmark\u003eventromedial nucleus (VMN)\u003c/mark\u003e is the satiety center.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion-Induced Hyperphagia:\u003c/b\u003e A lesion of the ventromedial nucleus of the hypothalamus leads to hyperphagia and obesity, as the satiety signal is lost. Mnemonic: A lesion to the \u003cb\u003eV\u003c/b\u003eentro\u003cb\u003em\u003c/b\u003eedial nucleus makes you \u003cb\u003eV\u003c/b\u003eery \u003cb\u003eM\u003c/b\u003eassive.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKl√ºver-Bucy Syndrome:\u003c/b\u003e Hyperphagia is a component of [[c6292526|Kl√ºver-Bucy syndrome]], which results from bilateral [[d220fc3f|amygdala]] lesions.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrader-Willi Syndrome:\u003c/b\u003e A genetic disorder characterized by insatiable hunger (hyperphagia) leading to severe obesity.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePsychiatric Causes:\u003c/b\u003e Can be a feature of atypical depression and bulimia nervosa.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When hyperphagia is presented in a neurological context, think of a lesion in the ventromedial hypothalamus or, if accompanied by other disinhibited behaviors, Kl√ºver-Bucy syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHyperphagia\u003c/b\u003e is often a sign of central nervous system dysregulation, particularly within the hypothalamic and limbic circuits that control appetite and satiety. Its presence can be a key clue to localizing a brain lesion or diagnosing a specific genetic or psychiatric syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"ventromedial_nucleus_hypothalamus\"\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"c6292526\"\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"prader_willi_syndrome\"\n      }\n    ]\n  },\n  \"498632b3\": {\n    \"title\": \"Hyperprolactinemia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Reproductive\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Pathology\",\n      \"Pituitary Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHyperprolactinemia\u003c/b\u003e is a condition of elevated serum prolactin levels, which can be caused by physiological states, medications, or pathological conditions such as a prolactin-secreting pituitary adenoma (prolactinoma).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePhysiology:\u003c/b\u003e Prolactin secretion from the anterior pituitary is tonically inhibited by [[90adc821|dopamine]] from the hypothalamus (via the tuberoinfundibular pathway).\u003c/li\u003e\u003cli\u003e\u003cb\u003eProlactinoma:\u003c/b\u003e The most common type of functional [[5f3188bd|pituitary adenoma]]. It autonomously secretes prolactin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrug-Induced:\u003c/b\u003e Many drugs can cause hyperprolactinemia by blocking dopamine\u0027s inhibitory effect. These include most \u003cmark\u003eantipsychotics\u003c/mark\u003e (dopamine D2 receptor antagonists) and metoclopramide.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation (Women):\u003c/b\u003e Galactorrhea (milky nipple discharge), amenorrhea, and infertility (as high prolactin inhibits GnRH release).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation (Men):\u003c/b\u003e Decreased libido, impotence, and gynecomastia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e The first-line treatment for prolactinomas is a \u003cmark\u003edopamine agonist\u003c/mark\u003e (e.g., cabergoline, bromocriptine), which shrinks the tumor and normalizes prolactin levels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Any drug that blocks dopamine receptors can cause hyperprolactinemia and its associated symptoms. This is a common side effect of antipsychotic medications.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHyperprolactinemia\u003c/b\u003e is most often a result of either a prolactin-secreting tumor or a disruption of the normal dopaminergic inhibition of the pituitary, leading to a classic triad of galactorrhea, amenorrhea, and infertility.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"prolactinoma\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"antipsychotics\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"galactorrhea\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"amenorrhea\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"dopamine_agonists\"\n      }\n    ]\n  },\n  \"527c712d\": {\n    \"title\": \"Hypersexuality\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHypersexuality\u003c/b\u003e is a behavioral symptom characterized by an increased or indiscriminate sex drive. In a neurological context, it is a key feature of \u003ci\u003eKl√ºver-Bucy syndrome\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Patients may exhibit inappropriate sexual behaviors, such as public masturbation or indiscriminate sexual advances.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndrome:\u003c/b\u003e A classic component of [[c6292526|Kl√ºver-Bucy syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eKl√ºver-Bucy Syndrome Features:\u003c/b\u003e The full syndrome includes hypersexuality, hyperorality, hyperphagia, placidity (diminished fear response), and visual agnosia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocalization:\u003c/b\u003e The syndrome results from bilateral lesions of the medial temporal lobes, specifically the [[d220fc3f|amygdala]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e The most common cause of Kl√ºver-Bucy syndrome is HSV-1 encephalitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of disinhibited behaviors like hypersexuality and hyperorality in a patient with a history of encephalitis points to a diagnosis of Kl√ºver-Bucy syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHypersexuality\u003c/b\u003e as a neurological sign is a dramatic example of behavioral disinhibition resulting from bilateral amygdalar damage, reflecting the loss of the amygdala\u0027s role in modulating social and sexual conduct.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"c6292526\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"d220fc3f\"\n      }\n    ]\n  },\n  \"c3115d0f\": {\n    \"title\": \"Hypertension and Intracranial Hemorrhage\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cardiology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eChronic systemic \u003cb\u003ehypertension\u003c/b\u003e is the single most important risk factor for the development of spontaneous \u003ci\u003eintraparenchymal hemorrhage\u003c/i\u003e, a type of hemorrhagic stroke.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Long-standing hypertension leads to degenerative changes in the walls of small, penetrating arteries and arterioles in the brain, a process called lipohyalinosis. This weakens the vessel walls, leading to the formation of \u003cmark\u003eCharcot-Bouchard microaneurysms\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Bleed:\u003c/b\u003e Rupture of these microaneurysms is the primary cause of hypertensive intraparenchymal hemorrhage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Locations:\u003c/b\u003e The bleeds typically occur in deep brain structures supplied by these small penetrating arteries. The most common sites, in order of frequency, are the \u003cmark\u003ebasal ganglia (putamen)\u003c/mark\u003e, thalamus, pons, and cerebellum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden onset of focal neurological deficits that progress over minutes to hours, often accompanied by headache, vomiting, and signs of increased ICP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An elderly patient with a history of poorly controlled hypertension who presents with a sudden focal deficit and signs of increased ICP has likely suffered a hypertensive intraparenchymal hemorrhage, most probably in the basal ganglia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eChronic \u003cb\u003ehypertension\u003c/b\u003e relentlessly damages the brain\u0027s small, deep arteries, leading to the formation of fragile Charcot-Bouchard microaneurysms that are prone to rupture, causing devastating intraparenchymal hemorrhages in characteristic locations like the basal ganglia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_major_risk_factor_for\",\n        \"to\": \"70b266c8\"\n      },\n      {\n        \"type\": \"causes_formation_of\",\n        \"to\": \"charcot_bouchard_microaneurysm\"\n      }\n    ]\n  },\n  \"549b012e\": {\n    \"title\": \"Hypertensive Retinopathy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Cardiology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHypertensive retinopathy\u003c/b\u003e is retinal vascular damage caused by chronically elevated systemic blood pressure. The severity of the findings on funduscopic examination often correlates with the severity and duration of the hypertension.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Chronic hypertension causes progressive arteriosclerosis of the retinal vessels. This leads to vessel wall thickening, narrowing of the lumen, and breakdown of the blood-retinal barrier.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunduscopic Findings (Mild to Moderate):\u003c/b\u003e\u003cbr\u003e - Arteriolar narrowing (copper wiring, silver wiring).\u003cbr\u003e - \u003cmark\u003eArteriovenous (AV) nicking\u003c/mark\u003e: Venules appear to be compressed or \u0027nicked\u0027 where they are crossed by sclerotic arterioles.\u003cbr\u003e - Flame-shaped hemorrhages and cotton-wool spots.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunduscopic Findings (Severe/Malignant Hypertension):\u003c/b\u003e\u003cbr\u003e - Hard exudates, often arranged in a star pattern around the macula (\u003cmark\u003emacular star\u003c/mark\u003e).\u003cbr\u003e - \u003cmark\u003ePapilledema\u003c/mark\u003e (optic disc swelling), which indicates hypertensive emergency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e The presence of hypertensive retinopathy is a marker for systemic end-organ damage from hypertension and is associated with an increased risk of stroke, myocardial infarction, and death.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e AV nicking is a classic funduscopic finding of chronic hypertension. The presence of papilledema in a hypertensive patient is a sign of malignant hypertension and is a medical emergency.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHypertensive retinopathy\u003c/b\u003e provides a direct window into the systemic effects of high blood pressure; the changes seen in the retinal arterioles, from AV nicking to papilledema, mirror the vascular damage occurring in the kidneys, heart, and brain.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"hypertension\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\": \"av_nicking\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\": \"cotton_wool_spots\"\n      },\n      {\n        \"type\": \"can_present_with\",\n        \"to\": \"4ae219da\"\n      }\n    ]\n  },\n  \"0df5b928\": {\n    \"title\": \"Hypertrophic Cardiomyopathy and Friedreich Ataxia\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Cardiology\",\n      \"Neurology\",\n      \"Genetics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Cardiovascular\",\n      \"Pathology\",\n      \"Cardiomyopathy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHypertrophic cardiomyopathy (HCM)\u003c/b\u003e is the most common cardiac manifestation and the leading cause of death in patients with \u003ci\u003eFriedreich Ataxia\u003c/i\u003e, a progressive neurodegenerative disorder.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFriedreich Ataxia:\u003c/b\u003e An autosomal recessive trinucleotide repeat (GAA) disorder in the frataxin gene, leading to mitochondrial dysfunction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCardiac Involvement:\u003c/b\u003e Occurs in over 90% of patients with Friedreich Ataxia. Hypertrophic cardiomyopathy is the most common pattern, characterized by concentric left ventricular hypertrophy.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Frataxin deficiency leads to mitochondrial iron accumulation and oxidative stress, which damages cardiomyocytes, causing fibrosis and hypertrophy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients may be asymptomatic or present with dyspnea, chest pain, palpitations, or syncope. It is a major cause of mortality, often due to heart failure or arrhythmias.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of neurological symptoms (ataxia, loss of reflexes) and hypertrophic cardiomyopathy in a young patient is highly suggestive of Friedreich Ataxia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe development of \u003cb\u003ehypertrophic cardiomyopathy\u003c/b\u003e is an integral and life-limiting component of Friedreich Ataxia, demonstrating that the mitochondrial dysfunction caused by frataxin deficiency is a multisystem disorder that severely impacts high-energy organs like the heart and brain.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"39bc1763\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"hypertrophic_cardiomyopathy\"\n      }\n    ]\n  },\n  \"b080137e\": {\n    \"title\": \"Therapeutic Hyperventilation\",\n    \"primaryType\": \"procedure\",\n    \"tags\": [\n      \"Neurology\",\n      \"Critical Care\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"ICP Management\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTherapeutic hyperventilation\u003c/b\u003e is a temporary measure used to acutely lower increased intracranial pressure (ICP) by inducing respiratory alkalosis, which causes cerebral vasoconstriction.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Increased ventilation (hyperventilation) \u0027blows off\u0027 CO\u003csub\u003e2\u003c/sub\u003e, leading to a decrease in arterial PCO\u003csub\u003e2\u003c/sub\u003e (hypocapnia). Cerebral blood flow is highly sensitive to PCO\u003csub\u003e2\u003c/sub\u003e. Hypocapnia causes cerebral \u003cmark\u003evasoconstriction\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEffect on ICP:\u003c/b\u003e Cerebral vasoconstriction reduces cerebral blood volume, which, according to the Monro-Kellie doctrine, leads to a rapid decrease in intracranial pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used as a temporizing, life-saving measure in patients with acutely elevated ICP and signs of impending brain herniation (e.g., from severe traumatic brain injury or large intracranial hemorrhage).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLimitations:\u003c/b\u003e The effect is transient (lasts for hours). Prolonged or excessive hyperventilation can be harmful, as the severe vasoconstriction may lead to cerebral ischemia. It is a bridge to more definitive treatments (e.g., surgical decompression, osmotic therapy).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the relationship: ‚ÜìPCO\u003csub\u003e2\u003c/sub\u003e ‚Üí Vasoconstriction ‚Üí ‚ÜìCerebral Blood Flow ‚Üí ‚ÜìICP. This is a key physiological principle in neurocritical care.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTherapeutic hyperventilation\u003c/b\u003e is a powerful but temporary tool to combat dangerously high intracranial pressure, working by manipulating the potent effect of CO\u003csub\u003e2\u003c/sub\u003e on cerebral blood vessel tone to rapidly reduce intracranial blood volume.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to\": \"d93d2dfb\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"cerebral_vasoconstriction\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"hypocapnia\"\n      }\n    ]\n  },\n  \"4caf22d3\": {\n    \"title\": \"Hypoglossal Nerve (CN XII)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eHypoglossal Nerve (CN XII)\u003c/b\u003e is a purely motor cranial nerve that provides motor innervation to all the intrinsic and extrinsic muscles of the tongue, except for the palatoglossus (which is innervated by the vagus nerve).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Controls tongue movement, which is essential for speech articulation, swallowing, and manipulating food.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Arises from the hypoglossal nucleus in the medulla and exits the skull through the hypoglossal canal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects (LMN):\u003c/b\u003e A lower motor neuron lesion of CN XII (affecting the nerve itself or its nucleus) causes ipsilateral tongue paralysis. On protrusion, the tongue will \u003cmark\u003edeviate toward the side of the lesion\u003c/mark\u003e due to the unopposed action of the contralateral genioglossus muscle. Fasciculations and atrophy of the ipsilateral tongue will also be present.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects (UMN):\u003c/b\u003e An upper motor neuron lesion (e.g., from a stroke) causes contralateral tongue weakness. On protrusion, the tongue will deviate \u003cmark\u003eaway from the side of the cortical lesion\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the tongue deviation rule: LMN lesions cause the tongue to \u0027lick the wound\u0027 (deviate toward the lesion). UMN lesions cause the tongue to deviate away from the lesion.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eHypoglossal Nerve\u003c/b\u003e is the primary driver of tongue movement, and the direction of tongue deviation upon protrusion is a classic and reliable sign for differentiating between an ipsilateral lower motor neuron lesion and a contralateral upper motor neuron lesion.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"innervates\",\n        \"to\": \"tongue_muscles\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"tongue_deviation\"\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"4af9a67d\"\n      }\n    ]\n  },\n  \"9c32b0ea\": {\n    \"title\": \"Hypopyon\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physical Findings\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003ehypopyon\u003c/b\u003e is a medical condition involving an inflammatory exudate in the anterior chamber of the eye, which settles as a visible, layered collection of white blood cells (pus).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e A sterile or non-sterile accumulation of pus in the anterior chamber, which appears as a white or yellowish fluid level in the lower part of the iris.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e It is a sign of severe intraocular inflammation. Leukocytes migrate from the vessels of the iris and ciliary body into the aqueous humor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eInfectious Keratitis:\u003c/b\u003e A corneal ulcer, especially one caused by virulent bacteria like \u003ci\u003ePseudomonas\u003c/i\u003e, can lead to a sterile hypopyon (a reactive inflammation).\u003cbr\u003e - \u003cb\u003eEndophthalmitis:\u003c/b\u003e A severe infection of the intraocular cavities, often a complication of eye surgery or trauma.\u003cbr\u003e - \u003cb\u003eAnterior Uveitis/Iritis:\u003c/b\u003e Severe inflammation of the iris and ciliary body can produce a hypopyon.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e The presence of a hypopyon is an ophthalmologic emergency, as it indicates severe inflammation that can rapidly lead to vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A hypopyon in a contact lens wearer with a corneal ulcer is highly concerning for a \u003ci\u003ePseudomonas\u003c/i\u003e keratitis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003ehypopyon\u003c/b\u003e is a dramatic sign of severe intraocular inflammation, representing a collection of pus within the anterior chamber that signals an urgent need for ophthalmologic evaluation to prevent permanent vision loss.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"endophthalmitis\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"anterior_uveitis\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"infectious_keratitis\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 8862,
      "parts": [{
        "text": "```json\n"
      }, {
        "text": "{\n  \"0bc2f200\": {\n    \"title"
      }, {
        "text": "\": \"Hydrocephalus\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n"
      }, {
        "text": "      \"Neurosurgery\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Hydrocephalus\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHydrocephalus\u003c/b\u003e is the abnormal accumulation of cerebrospinal fluid (CSF) within the brain"
      }, {
        "text": "\u0027s ventricles, leading to ventricular dilation and, typically, increased intracranial pressure (ICP).\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCommunicating Hydrocephalus:\u003c/b\u003e Caused by impaired CSF absorption by the arachnoid gran"
      }, {
        "text": "ulations (e.g., post-meningitis scarring). All ventricles are symmetrically dilated. [[7c5"
      }, {
        "text": "9030e|Normal pressure hydrocephalus (NPH)]] is a subtype.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNon-communic"
      }, {
        "text": "ating (Obstructive) Hydrocephalus:\u003c/b\u003e Caused by a structural blockage of CSF flow within the ventricular system (e.g., aqu"
      }, {
        "text": "eductal stenosis, tumor). Ventricles proximal to the obstruction are dilated. Common in [[7f8bdf0b"
      }, {
        "text": "|childhood brain tumors]] like [[16d613bb|medulloblastoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eHydro"
      }, {
        "text": "cephalus ex Vacuo:\u003c/b\u003e A mimic of hydrocephalus where there is ventricular enlargement due to brain atrophy and neuronal loss ("
      }, {
        "text": "e.g., in Alzheimer\u0027s disease). ICP is normal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e In adults, symptoms"
      }, {
        "text": " of increased ICP (headache, papilledema, vomiting). In infants, macrocephaly (enlarging head"
      }, {
        "text": " circumference) and bulging fontanelles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key distinction is between communicating (absorption"
      }, {
        "text": " problem) and non-communicating (flow problem). Imaging helps differentiate them by showing either all ventricles enlarged or only"
      }, {
        "text": " those upstream of a blockage.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHydrocephalus\u003c/b\u003e is a"
      }, {
        "text": " condition of \u0027water on the brain\u0027 that results from an imbalance between CSF production and absorption. The clinical consequences stem from the mechanical"
      }, {
        "text": " pressure of the excess fluid, which can damage brain tissue and dangerously elevate intracranial pressure.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_classified_as\","
      }, {
        "text": "\n        \"to\": \"aa4115c7\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "classified_as\",\n        \"to\": \"4fab8000\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_mimicked_by\",\n        \"to\": \"7efdb0ef\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"can_be_caused_by\",\n        \"to\": \"7f8bdf"
      }, {
        "text": "0b\"\n      }\n    ]\n  },\n  \"ba5581a8\": {\n    \"title"
      }, {
        "text": "\": \"Hypercalcemia and Succinylcholine\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Pharmacology\","
      }, {
        "text": "\n      \"Anesthesiology\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\":"
      }, {
        "text": " [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Adverse Effects\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003eThe administration of \u003cb\u003esuccinylcholine\u003c/b\u003e, a depolarizing neuromuscular"
      }, {
        "text": " blocker, can cause a transient but potentially life-threatening \u003ci\u003ehyperkalemia\u003c/i\u003e, not hypercalcemia. This"
      }, {
        "text": " effect is exaggerated in patients with certain underlying conditions.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": " of Hyperkalemia:\u003c/b\u003e Succinylcholine is an acetylcholine receptor agonist. Its binding to nicotinic receptors on the motor"
      }, {
        "text": " endplate causes a sustained depolarization, which leads to an efflux of potassium (K\u003csup\u003e+\u003c/sup\u003e) from muscle cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNormal"
      }, {
        "text": " Response:\u003c/b\u003e In healthy individuals, this results in a small, clinically insignificant rise in serum K\u003csup\u003e+\u003c/sup\u003e (approx"
      }, {
        "text": ". 0.5 mEq/L).\u003c/li\u003e\u003cli\u003e\u003cb\u003eExaggerated Response:\u003c/b\u003e In patients with upregulation of acetylcholine"
      }, {
        "text": " receptors (e.g., burns, crush injuries, denervating injuries, myopathies), succinylcholine can cause a massive K"
      }, {
        "text": "\u003csup\u003e+\u003c/sup\u003e release, leading to severe, life-threatening \u003cmark\u003ehyperkalemia\u003c/mark\u003e and cardiac arrest.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHyper"
      }, {
        "text": "calcemia Note:\u003c/b\u003e Succinylcholine is a trigger for [[429af8bd|malignant hyperther"
      }, {
        "text": "mia]], a condition involving massive release of \u003ci\u003ecalcium\u003c/i\u003e from the sarcoplasmic reticulum, but it does not directly cause serum"
      }, {
        "text": " hypercalcemia. The primary electrolyte concern with succinylcholine itself is hyperkalemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Succ"
      }, {
        "text": "inylcholine is contraindicated in patients with major burns, crush injuries, or upper motor neuron disease due to the risk of severe"
      }, {
        "text": " hyperkalemia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eSuccinylcholine\u0027s depolarizing action at"
      }, {
        "text": " the neuromuscular junction invariably causes a potassium efflux from muscle cells; while normally benign, this effect becomes dangerously amplified in conditions with receptor"
      }, {
        "text": " upregulation, posing a significant risk of fatal hyperkalemia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to"
      }, {
        "text": "\": \"hyperkalemia\"\n      },\n      {\n        \"type\": \"is_a_trigger_for\",\n        \"to\":"
      }, {
        "text": " \"429af8bd\"\n      },\n      {\n        \"type\": \"is_contraindicated_in\",\n        \"to"
      }, {
        "text": "\": \"burn_injury\"\n      },\n      {\n        \"type\": \"is_contraindicated_in"
      }, {
        "text": "\",\n        \"to\": \"crush_injury\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "4f3eba91\": {\n    \"title\": \"Hypercoagulability and Dural Venous Sinus Thrombosis\",\n    "
      }, {
        "text": "\"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Hematology\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n"
      }, {
        "text": "      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eHypercoagulability\u003c/b\u003e, whether inherited or acquired, is a major risk factor for the development of \u003ci\u003e"
      }, {
        "text": "dural venous sinus thrombosis (DVST)\u003c/i\u003e, a condition involving clot formation in the venous sinuses that drain blood from the brain.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDural Venous Sinus Thrombosis (DVST):\u003c/b\u003e A type"
      }, {
        "text": " of stroke caused by thrombosis of the dural venous sinuses. This obstructs venous drainage, leading to venous congestion, increased intracranial pressure, and potentially"
      }, {
        "text": " venous infarction or hemorrhage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHypercoagulable States:\u003c/b\u003e Conditions that predispose to thrombosis are a key"
      }, {
        "text": " cause of DVST, especially in younger patients without other stroke risk factors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInherited Hypercoagulability:\u003c/b\u003e Includes"
      }, {
        "text": " Factor V Leiden mutation, prothrombin gene mutation, and deficiencies of antithrombin, protein C, or protein S.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAcquired Hyper"
      }, {
        "text": "coagulability:\u003c/b\u003e Includes pregnancy/puerperium, oral contraceptive use, malignancy, and antiphospholipid syndrome."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation of DVST:\u003c/b\u003e Often presents with a severe headache, but can also cause seizures, focal neurological"
      }, {
        "text": " deficits, and signs of increased ICP like [[4ae219da|papilledema]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In"
      }, {
        "text": " a young patient, especially a woman who is pregnant or taking oral contraceptives, who presents with a severe headache and/or stroke"
      }, {
        "text": "-like symptoms, dural venous sinus thrombosis due to a hypercoagulable state should be a top consideration.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eWhile arterial strokes are often linked to atherosclerosis, \u003cb\u003edural venous sinus thrombosis\u003c/b\u003e is frequently"
      }, {
        "text": " a manifestation of an underlying \u003cb\u003ehypercoagulable state\u003c/b\u003e, making a hematologic workup essential in patients presenting with this"
      }, {
        "text": " specific type of cerebrovascular event.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_risk_factor_for\",\n        \"to\": \"067"
      }, {
        "text": "666cd\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"factor"
      }, {
        "text": "_v_leiden\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to"
      }, {
        "text": "\": \"antiphospholipid_syndrome\"\n      }\n    ]\n  },\n  \"56"
      }, {
        "text": "7e169f\": {\n    \"title\": \"Hyperemesis Gravidarum Treatment\",\n    \"primary"
      }, {
        "text": "Type\": \"concept\",\n    \"tags\": [\n      \"Obstetrics\",\n      \"Gastroenterology\",\n      \"Pharmacology\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Reproductive\",\n      \"Pharmacology\",\n      "
      }, {
        "text": "\"Obstetric Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe treatment of \u003cb\u003ehyperemesis gravid"
      }, {
        "text": "arum\u003c/b\u003e, a condition of severe nausea and vomiting in pregnancy, involves supportive care and antiemetic medications that target the central vomiting"
      }, {
        "text": " pathways.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The vomiting reflex is coordinated"
      }, {
        "text": " by the [[74b651ab|vomiting center]] in the medulla, which receives input from the che"
      }, {
        "text": "moreceptor trigger zone (CTZ) in the [[5dd343d3|area postrema]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFirst"
      }, {
        "text": "-Line Pharmacotherapy:\u003c/b\u003e The combination of doxylamine (a first-generation antihistamine) and pyridoxine (vitamin"
      }, {
        "text": " B6) is a first-line treatment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSecond-Line Agents:\u003c/b\u003e If first-line therapy"
      }, {
        "text": " fails, other antiemetics can be used, including:\u003cbr\u003e - \u003cb\u003eDopamine antagonists:\u003c/b\u003e Metoclopramide"
      }, {
        "text": ", prochlorperazine.\u003cbr\u003e - \u003cb\u003eSerotonin (5-HT3) antagonists:\u003c/b\u003e Ondansetron."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Antiemetics:\u003c/b\u003e These drugs work by blocking neurotransmitter receptors in the CTZ and/or the vomiting"
      }, {
        "text": " center. For example, metoclopramide blocks D2 receptors, and ondansetron blocks 5-HT"
      }, {
        "text": "3 receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that the chemoreceptor trigger zone in the [[5dd343d"
      }, {
        "text": "3|area postrema]] is outside the blood-brain barrier, allowing it to detect emetogenic substances in the blood.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe treatment of \u003cb\u003ehyperemesis gravidarum\u003c/b\u003e relies on blocking"
      }, {
        "text": " the central neurochemical pathways of nausea and vomiting, using drugs that antagonize key receptors like H1, D2, and 5-HT3"
      }, {
        "text": " in the brain\u0027s vomiting centers.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_treatment_for\",\n        \"to\": \"hyperemesis_gravidarum\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"targets\",\n        \"to\": \"74b651ab\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"targets\",\n        \"to\": \"5dd343"
      }, {
        "text": "d3\"\n      }\n    ]\n  },\n  \"c933bda7\": {\n    \"title"
      }, {
        "text": "\": \"Hyperopia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHyperopia\u003c/b\u003e, commonly known as farsightedness, is a"
      }, {
        "text": " refractive error of the eye in which parallel light rays from distant objects are focused \u003ci\u003ebehind\u003c/i\u003e the retina, causing near"
      }, {
        "text": " objects to appear blurry.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Occ"
      }, {
        "text": "urs when the eye is either too short (axial hyperopia) or the cornea/lens system has too little refractive power (ref"
      }, {
        "text": "ractive hyperopia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients can see distant objects clearly but have difficulty with near-vision tasks like"
      }, {
        "text": " reading. Young patients may be able to compensate by accommodating, but this can lead to eye strain and headaches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCorrection"
      }, {
        "text": ":\u003c/b\u003e Corrected with a \u003cmark\u003econvex (converging) lens\u003c/mark\u003e (e.g., glasses"
      }, {
        "text": " or contact lenses with a positive diopter prescription). The converging lens adds refractive power, moving the focal point forward onto the retina."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction from Presbyopia:\u003c/b\u003e While both cause blurry near vision, hyperopia is a refractive error present"
      }, {
        "text": " from a young age, whereas [[767d985e|presbyopia]] is an age-related loss of accommodation."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the correction: \u003cb\u003eH\u003c/b\u003eyperopia (farsightedness) is corrected with a"
      }, {
        "text": " con\u003cb\u003evex\u003c/b\u003e lens.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHyperopia\u003c/b\u003e is a refractive"
      }, {
        "text": " error where the eye\u0027s focusing power is insufficient for its length, causing near images to be focused behind the retina. This"
      }, {
        "text": " is corrected by adding focusing power with a convex lens.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\":"
      }, {
        "text": " \"refractive_error\"\n      },\n      {\n        \"type\": \"is_corrected_by\",\n        \"to\":"
      }, {
        "text": " \"convex_lens\"\n      },\n      {\n        \"type\": \"is_the_opposite_of"
      }, {
        "text": "\",\n        \"to\": \"c154b69c\"\n      },\n      {\n        \"type\": \"d"
      }, {
        "text": "ifferentiated_from\",\n        \"to\": \"767d985e\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"71ff8afe\": {\n    \"title\": \"Hyperorality\",\n    \"primaryType\":"
      }, {
        "text": " \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Psychiatry\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eHyperorality\u003c/b\u003e is a behavioral symptom characterized by a tendency to examine objects by mouth. It is a key"
      }, {
        "text": " feature of \u003ci\u003eKl√ºver-Bucy syndrome\u003c/i\u003e, which results from bilateral damage to the amygdala.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Patients may compulsively place both edible and inedible objects into"
      }, {
        "text": " their mouths.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndrome:\u003c/b\u003e A classic component of [[c6292526|Kl√ºver-"
      }, {
        "text": "Bucy syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eKl√ºver-Bucy Syndrome Features:\u003c/b\u003e The full syndrome includes hyperor"
      }, {
        "text": "ality, hypersexuality, hyperphagia, placidity (diminished fear response), and visual agnosia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocalization"
      }, {
        "text": ":\u003c/b\u003e The syndrome results from bilateral lesions of the medial temporal lobes, specifically the [[d220fc3f"
      }, {
        "text": "|amygdala]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e The most common cause of Kl√ºver-Bucy syndrome is"
      }, {
        "text": " HSV-1 encephalitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of hyperorality, along with other dis"
      }, {
        "text": "inhibited behaviors like hypersexuality, in a patient with a history of encephalitis, points to a diagnosis of Kl√ºver-B"
      }, {
        "text": "ucy syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHyperorality\u003c/b\u003e is a primitive"
      }, {
        "text": ", disinhibited behavior that, when seen in an adult, is a striking sign of bilateral amygdalar damage, reflecting"
      }, {
        "text": " the loss of the amygdala\u0027s normal role in emotional and behavioral regulation.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to"
      }, {
        "text": "\": \"c6292526\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_caused_by_lesion_in\",\n        \"to\": \"d220fc3f\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"1bc2f357\": {\n    \"title"
      }, {
        "text": "\": \"Hyperphagia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"End"
      }, {
        "text": "ocrinology\",\n      \"Neurology\",\n      \"Psychiatry\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Pathology\",\n      \"Hyp"
      }, {
        "text": "othalamic Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHyperphagia\u003c/b\u003e"
      }, {
        "text": " is an abnormally increased appetite and excessive eating, which can be a symptom of various neurological, endocrine, and psychiatric conditions.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHypothalamic Control:\u003c/b\u003e Appetite is regulated by the [[89e"
      }, {
        "text": "86633|hypothalamus]]. The \u003cmark\u003eventromedial nucleus (VMN)\u003c/mark\u003e is the satiety"
      }, {
        "text": " center.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion-Induced Hyperphagia:\u003c/b\u003e A lesion of the ventromedial nucleus of the hypothalamus leads"
      }, {
        "text": " to hyperphagia and obesity, as the satiety signal is lost. Mnemonic: A lesion to the \u003cb\u003eV\u003c/b\u003eentro"
      }, {
        "text": "\u003cb\u003em\u003c/b\u003eedial nucleus makes you \u003cb\u003eV\u003c/b\u003eery \u003cb\u003eM\u003c/b\u003eassive.\u003c/li\u003e\u003cli\u003e\u003cb\u003eK"
      }, {
        "text": "l√ºver-Bucy Syndrome:\u003c/b\u003e Hyperphagia is a component of [[c6292526"
      }, {
        "text": "|Kl√ºver-Bucy syndrome]], which results from bilateral [[d220fc3f|amygdala]] lesions.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003ePrader-Willi Syndrome:\u003c/b\u003e A genetic disorder characterized by insatiable hunger (hyperphagia) leading to severe"
      }, {
        "text": " obesity.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePsychiatric Causes:\u003c/b\u003e Can be a feature of atypical depression and bulimia nervosa.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e When hyperphagia is presented in a neurological context, think of a lesion in the ventromedial hypothalamus"
      }, {
        "text": " or, if accompanied by other disinhibited behaviors, Kl√ºver-Bucy syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eHyperphagia\u003c/b\u003e is often a sign of central nervous system dysregulation, particularly within the hypothalamic"
      }, {
        "text": " and limbic circuits that control appetite and satiety. Its presence can be a key clue to localizing a brain lesion or diagnosing"
      }, {
        "text": " a specific genetic or psychiatric syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"vent"
      }, {
        "text": "romedial_nucleus_hypothalamus\"\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n"
      }, {
        "text": "        \"to\": \"c6292526\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_a_feature_of\",\n        \"to\": \"prader_willi_syndrome"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"498632b3\": {\n    \"title"
      }, {
        "text": "\": \"Hyperprolactinemia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Endocrinology\",\n      \"Reproductive\",\n      \"Neurology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Pathology\",\n      \"Pit"
      }, {
        "text": "uitary Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHyperprol"
      }, {
        "text": "actinemia\u003c/b\u003e is a condition of elevated serum prolactin levels, which can be caused by physiological states, medications, or pathological"
      }, {
        "text": " conditions such as a prolactin-secreting pituitary adenoma (prolactinoma).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003ePhysiology:\u003c/b\u003e Prolactin secretion from the anterior pituitary is tonically inhibited by [[90adc821|dopamine]] from"
      }, {
        "text": " the hypothalamus (via the tuberoinfundibular pathway).\u003c/li\u003e\u003cli\u003e\u003cb\u003eProlactinoma:\u003c/b\u003e The most common type"
      }, {
        "text": " of functional [[5f3188bd|pituitary adenoma]]. It autonomously secretes prolactin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrug"
      }, {
        "text": "-Induced:\u003c/b\u003e Many drugs can cause hyperprolactinemia by blocking dopamine\u0027s inhibitory effect. These include most"
      }, {
        "text": " \u003cmark\u003eantipsychotics\u003c/mark\u003e (dopamine D2 receptor antagonists) and metoclopramide.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation (Women):\u003c/b\u003e Galactorrhea (milky nipple discharge), amenorrhea, and infertility (as high prolactin inhibits"
      }, {
        "text": " GnRH release).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation (Men):\u003c/b\u003e Decreased libido, impotence, and gynecomastia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment"
      }, {
        "text": ":\u003c/b\u003e The first-line treatment for prolactinomas is a \u003cmark\u003edopamine agonist\u003c/mark\u003e (e.g.,"
      }, {
        "text": " cabergoline, bromocriptine), which shrinks the tumor and normalizes prolactin levels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Any"
      }, {
        "text": " drug that blocks dopamine receptors can cause hyperprolactinemia and its associated symptoms. This is a common side effect of antipsych"
      }, {
        "text": "otic medications.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHyperprolactinemia\u003c/b\u003e is most"
      }, {
        "text": " often a result of either a prolactin-secreting tumor or a disruption of the normal dopaminergic inhibition of the pituitary"
      }, {
        "text": ", leading to a classic triad of galactorrhea, amenorrhea, and infertility.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \""
      }, {
        "text": "prolactinoma\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        "
      }, {
        "text": "\"to\": \"antipsychotics\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"galactorr"
      }, {
        "text": "hea\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"amenorrhea"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\":"
      }, {
        "text": " \"dopamine_agonists\"\n      }\n    ]\n  },\n  \"527c7"
      }, {
        "text": "12d\": {\n    \"title\": \"Hypersexuality\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neurology\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHypersexuality\u003c/b\u003e is"
      }, {
        "text": " a behavioral symptom characterized by an increased or indiscriminate sex drive. In a neurological context, it is a key feature of \u003ci\u003eKl√ºver-"
      }, {
        "text": "Bucy syndrome\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Patients may exhibit"
      }, {
        "text": " inappropriate sexual behaviors, such as public masturbation or indiscriminate sexual advances.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndrome:\u003c/b\u003e A classic component of [[c6292"
      }, {
        "text": "526|Kl√ºver-Bucy syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eKl√ºver-Bucy Syndrome"
      }, {
        "text": " Features:\u003c/b\u003e The full syndrome includes hypersexuality, hyperorality, hyperphagia, placidity (diminished fear response),"
      }, {
        "text": " and visual agnosia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocalization:\u003c/b\u003e The syndrome results from bilateral lesions of the medial temporal lobes, specifically the [[d2"
      }, {
        "text": "20fc3f|amygdala]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e The most common cause of Kl√ºver-B"
      }, {
        "text": "ucy syndrome is HSV-1 encephalitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of disinhibited behaviors like"
      }, {
        "text": " hypersexuality and hyperorality in a patient with a history of encephalitis points to a diagnosis of Kl√ºver-Bucy"
      }, {
        "text": " syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHypersexuality\u003c/b\u003e as a neurological sign is a dramatic"
      }, {
        "text": " example of behavioral disinhibition resulting from bilateral amygdalar damage, reflecting the loss of the amygdala\u0027s role in modulating"
      }, {
        "text": " social and sexual conduct.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_feature_of\",\n        \"to\": \"c6292"
      }, {
        "text": "526\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion"
      }, {
        "text": "_in\",\n        \"to\": \"d220fc3f\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"c3115d0f\": {\n    \"title\": \"Hypertension and Int"
      }, {
        "text": "racranial Hemorrhage\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \""
      }, {
        "text": "Neurology\",\n      \"Cardiology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \""
      }, {
        "text": "Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eChronic"
      }, {
        "text": " systemic \u003cb\u003ehypertension\u003c/b\u003e is the single most important risk factor for the development of spontaneous \u003ci\u003eintraparenchymal hemorrhage"
      }, {
        "text": "\u003c/i\u003e, a type of hemorrhagic stroke.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Long"
      }, {
        "text": "-standing hypertension leads to degenerative changes in the walls of small, penetrating arteries and arterioles in the brain, a process called lip"
      }, {
        "text": "ohyalinosis. This weakens the vessel walls, leading to the formation of \u003cmark\u003eCharcot-Bouchard micro"
      }, {
        "text": "aneurysms\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Bleed:\u003c/b\u003e Rupture of these microaneurysms is the primary cause"
      }, {
        "text": " of hypertensive intraparenchymal hemorrhage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Locations:\u003c/b\u003e The bleeds typically occur in deep brain structures supplied"
      }, {
        "text": " by these small penetrating arteries. The most common sites, in order of frequency, are the \u003cmark\u003ebasal ganglia ("
      }, {
        "text": "putamen)\u003c/mark\u003e, thalamus, pons, and cerebellum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden onset of focal"
      }, {
        "text": " neurological deficits that progress over minutes to hours, often accompanied by headache, vomiting, and signs of increased ICP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e An elderly patient with a history of poorly controlled hypertension who presents with a sudden focal deficit and signs of increased ICP has"
      }, {
        "text": " likely suffered a hypertensive intraparenchymal hemorrhage, most probably in the basal ganglia.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003eChronic \u003cb\u003ehypertension\u003c/b\u003e relentlessly damages the brain\u0027s small, deep arteries, leading to the formation"
      }, {
        "text": " of fragile Charcot-Bouchard microaneurysms that are prone to rupture, causing devastating intraparenchymal hemorrh"
      }, {
        "text": "ages in characteristic locations like the basal ganglia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_major_risk_factor_for\",\n        \"to\": \"70"
      }, {
        "text": "b266c8\"\n      },\n      {\n        \"type\": \"causes_formation_of\",\n        \"to"
      }, {
        "text": "\": \"charcot_bouchard_microaneurysm\"\n      }\n    ]\n  },\n  \"5"
      }, {
        "text": "49b012e\": {\n    \"title\": \"Hypertensive Retinopathy\",\n    \"primaryType\": \"disease\",\n"
      }, {
        "text": "    \"tags\": [\n      \"Ophthalmology\",\n      \"Cardiology\",\n      \"Pathology\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special S"
      }, {
        "text": "enses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eHypertensive retinopathy\u003c/b\u003e is retinal vascular damage caused by chronically elevated systemic blood pressure. The severity of the findings"
      }, {
        "text": " on funduscopic examination often correlates with the severity and duration of the hypertension.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e Chronic hypertension causes progressive arteriosclerosis of the retinal vessels. This leads to vessel wall thickening, narrowing of"
      }, {
        "text": " the lumen, and breakdown of the blood-retinal barrier.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunduscopic Findings (Mild to Moderate):\u003c/b\u003e"
      }, {
        "text": "\u003cbr\u003e - Arteriolar narrowing (copper wiring, silver wiring).\u003cbr\u003e - \u003cmark\u003eArteriovenous (AV"
      }, {
        "text": ") nicking\u003c/mark\u003e: Venules appear to be compressed or \u0027nicked\u0027 where they are crossed by sclerotic arterioles.\u003c"
      }, {
        "text": "br\u003e - Flame-shaped hemorrhages and cotton-wool spots.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunduscopic Findings (Severe/"
      }, {
        "text": "Malignant Hypertension):\u003c/b\u003e\u003cbr\u003e - Hard exudates, often arranged in a star pattern around the macula (\u003c"
      }, {
        "text": "mark\u003emacular star\u003c/mark\u003e).\u003cbr\u003e - \u003cmark\u003ePapilledema\u003c/mark\u003e (optic"
      }, {
        "text": " disc swelling), which indicates hypertensive emergency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e The presence of hypertensive retinopathy is a marker for"
      }, {
        "text": " systemic end-organ damage from hypertension and is associated with an increased risk of stroke, myocardial infarction, and death.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e AV nicking is a classic funduscopic finding of chronic hypertension. The presence of papilledema in a hypertensive patient is a sign of malignant"
      }, {
        "text": " hypertension and is a medical emergency.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHypertensive retinopathy\u003c/b\u003e provides"
      }, {
        "text": " a direct window into the systemic effects of high blood pressure; the changes seen in the retinal arterioles, from AV nicking to pap"
      }, {
        "text": "illedema, mirror the vascular damage occurring in the kidneys, heart, and brain.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\":"
      }, {
        "text": " \"hypertension\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\":"
      }, {
        "text": " \"av_nicking\"\n      },\n      {\n        \"type\": \"is_characterized_by\","
      }, {
        "text": "\n        \"to\": \"cotton_wool_spots\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "can_present_with\",\n        \"to\": \"4ae219da\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"0df5b928\": {\n    \"title\": \"Hypertrophic Cardiomyopathy and"
      }, {
        "text": " Friedreich Ataxia\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Cardiology\","
      }, {
        "text": "\n      \"Neurology\",\n      \"Genetics\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Cardiovascular\",\n      \"Pathology\",\n      \"Cardiomyopathy\"\n"
      }, {
        "text": "    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHypertrophic cardiomyopathy (HCM)\u003c/b\u003e is the most common cardiac"
      }, {
        "text": " manifestation and the leading cause of death in patients with \u003ci\u003eFriedreich Ataxia\u003c/i\u003e, a progressive neurodegenerative disorder.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFriedreich Ataxia:\u003c/b\u003e An autosomal recessive trinucleotide repeat (GAA) disorder"
      }, {
        "text": " in the frataxin gene, leading to mitochondrial dysfunction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCardiac Involvement:\u003c/b\u003e Occurs in over 90% of"
      }, {
        "text": " patients with Friedreich Ataxia. Hypertrophic cardiomyopathy is the most common pattern, characterized by concentric left ventricular hypertrophy.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e Frataxin deficiency leads to mitochondrial iron accumulation and oxidative stress, which damages cardiomyocytes, causing fibrosis and hypertrophy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation:\u003c/b\u003e Patients may be asymptomatic or present with dyspnea, chest pain, palpitations, or syncope. It"
      }, {
        "text": " is a major cause of mortality, often due to heart failure or arrhythmias.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " combination of neurological symptoms (ataxia, loss of reflexes) and hypertrophic cardiomyopathy in a young patient is highly suggestive of Fried"
      }, {
        "text": "reich Ataxia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe development of \u003cb\u003ehypertrophic cardiomyopathy\u003c/b\u003e is"
      }, {
        "text": " an integral and life-limiting component of Friedreich Ataxia, demonstrating that the mitochondrial dysfunction caused by frataxin deficiency is"
      }, {
        "text": " a multisystem disorder that severely impacts high-energy organs like the heart and brain.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"39"
      }, {
        "text": "bc1763\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"hypertrophic_cardiomyopathy\"\n      }\n    ]\n  },\n  \"b0"
      }, {
        "text": "80137e\": {\n    \"title\": \"Therapeutic Hyperventilation\",\n    \"primaryType\": \"procedure"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neurology\",\n      \"Critical Care\",\n      \"Physiology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"ICP Management\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTherapeutic hypervent"
      }, {
        "text": "ilation\u003c/b\u003e is a temporary measure used to acutely lower increased intracranial pressure (ICP) by inducing respiratory alkalosis, which causes"
      }, {
        "text": " cerebral vasoconstriction.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Increased ventilation"
      }, {
        "text": " (hyperventilation) \u0027blows off\u0027 CO\u003csub\u003e2\u003c/sub\u003e, leading to a decrease in arterial PCO\u003csub\u003e2\u003c/sub\u003e (hypocap"
      }, {
        "text": "nia). Cerebral blood flow is highly sensitive to PCO\u003csub\u003e2\u003c/sub\u003e. Hypocapnia causes cerebral \u003cmark\u003evasoconstriction\u003c/mark\u003e."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eEffect on ICP:\u003c/b\u003e Cerebral vasoconstriction reduces cerebral blood volume, which, according to the Monro-Kell"
      }, {
        "text": "ie doctrine, leads to a rapid decrease in intracranial pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used as a temporizing,"
      }, {
        "text": " life-saving measure in patients with acutely elevated ICP and signs of impending brain herniation (e.g., from severe"
      }, {
        "text": " traumatic brain injury or large intracranial hemorrhage).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLimitations:\u003c/b\u003e The effect is transient (lasts for hours). Prolong"
      }, {
        "text": "ed or excessive hyperventilation can be harmful, as the severe vasoconstriction may lead to cerebral ischemia. It is a"
      }, {
        "text": " bridge to more definitive treatments (e.g., surgical decompression, osmotic therapy).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the"
      }, {
        "text": " relationship: ‚ÜìPCO\u003csub\u003e2\u003c/sub\u003e ‚Üí Vasoconstriction ‚Üí ‚ÜìCerebral Blood Flow ‚Üí ‚ÜìICP. This"
      }, {
        "text": " is a key physiological principle in neurocritical care.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTherapeutic hyperventilation\u003c/b\u003e is a"
      }, {
        "text": " powerful but temporary tool to combat dangerously high intracranial pressure, working by manipulating the potent effect of CO\u003csub\u003e2\u003c/sub\u003e on cerebral"
      }, {
        "text": " blood vessel tone to rapidly reduce intracranial blood volume.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_a_treatment_for\",\n        \"to"
      }, {
        "text": "\": \"d93d2dfb\"\n      },\n      {\n        \"type\": \"causes\","
      }, {
        "text": "\n        \"to\": \"cerebral_vasoconstriction\"\n      },\n      {\n        \"type\": \"causes"
      }, {
        "text": "\",\n        \"to\": \"hypocapnia\"\n      }\n    ]\n  },\n  \"4caf"
      }, {
        "text": "22d3\": {\n    \"title\": \"Hypoglossal Nerve (CN XII)\",\n    \"primaryType\":"
      }, {
        "text": " \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003eThe \u003cb\u003eHypoglossal Nerve (CN XII)\u003c/b\u003e is a purely motor cranial nerve that provides"
      }, {
        "text": " motor innervation to all the intrinsic and extrinsic muscles of the tongue, except for the palatoglossus (which is innervated by the vag"
      }, {
        "text": "us nerve).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Controls tongue movement, which is essential"
      }, {
        "text": " for speech articulation, swallowing, and manipulating food.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Arises from the hypoglossal nucleus in"
      }, {
        "text": " the medulla and exits the skull through the hypoglossal canal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects (LMN):\u003c/b\u003e A"
      }, {
        "text": " lower motor neuron lesion of CN XII (affecting the nerve itself or its nucleus) causes ipsilateral tongue paralysis. On"
      }, {
        "text": " protrusion, the tongue will \u003cmark\u003edeviate toward the side of the lesion\u003c/mark\u003e due to the unopposed action of the contralateral"
      }, {
        "text": " genioglossus muscle. Fasciculations and atrophy of the ipsilateral tongue will also be present.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects (UMN"
      }, {
        "text": "):\u003c/b\u003e An upper motor neuron lesion (e.g., from a stroke) causes contralateral tongue weakness. On protrusion, the tongue will deviate"
      }, {
        "text": " \u003cmark\u003eaway from the side of the cortical lesion\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the tongue deviation rule: L"
      }, {
        "text": "MN lesions cause the tongue to \u0027lick the wound\u0027 (deviate toward the lesion). UMN lesions cause the tongue to"
      }, {
        "text": " deviate away from the lesion.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eHypoglossal Nerve\u003c/b\u003e"
      }, {
        "text": " is the primary driver of tongue movement, and the direction of tongue deviation upon protrusion is a classic and reliable sign for differentiating"
      }, {
        "text": " between an ipsilateral lower motor neuron lesion and a contralateral upper motor neuron lesion.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    "
      }, {
        "text": "},\n    \"connections\": [\n      {\n        \"type\": \"innervates\",\n        \"to\":"
      }, {
        "text": " \"tongue_muscles\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\":"
      }, {
        "text": " \"tongue_deviation\"\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"4"
      }, {
        "text": "af9a67d\"\n      }\n    ]\n  },\n  \"9c32b0"
      }, {
        "text": "ea\": {\n    \"title\": \"Hypopyon\",\n    \"primaryType\": \"finding\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \""
      }, {
        "text": "Physical Findings\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003ehypopyon\u003c/b\u003e is a"
      }, {
        "text": " medical condition involving an inflammatory exudate in the anterior chamber of the eye, which settles as a visible, layered collection of white"
      }, {
        "text": " blood cells (pus).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e A sterile or"
      }, {
        "text": " non-sterile accumulation of pus in the anterior chamber, which appears as a white or yellowish fluid level in the lower part of the iris"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e It is a sign of severe intraocular inflammation. Leukocytes migrate from the vessels"
      }, {
        "text": " of the iris and ciliary body into the aqueous humor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eInfectious"
      }, {
        "text": " Keratitis:\u003c/b\u003e A corneal ulcer, especially one caused by virulent bacteria like \u003ci\u003ePseudomonas\u003c/i\u003e, can lead to a sterile"
      }, {
        "text": " hypopyon (a reactive inflammation).\u003cbr\u003e - \u003cb\u003eEndophthalmitis:\u003c/b\u003e A severe infection of the intra"
      }, {
        "text": "ocular cavities, often a complication of eye surgery or trauma.\u003cbr\u003e - \u003cb\u003eAnterior Uveitis/Iritis:\u003c/b\u003e Severe"
      }, {
        "text": " inflammation of the iris and ciliary body can produce a hypopyon.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e The presence of a hypopyon is an"
      }, {
        "text": " ophthalmologic emergency, as it indicates severe inflammation that can rapidly lead to vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " A hypopyon in a contact lens wearer with a corneal ulcer is highly concerning for a \u003ci\u003ePseudomonas\u003c/i\u003e ker"
      }, {
        "text": "atitis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003ehypopyon\u003c/b\u003e is a dramatic"
      }, {
        "text": " sign of severe intraocular inflammation, representing a collection of pus within the anterior chamber that signals an urgent need for ophthalmologic evaluation to prevent"
      }, {
        "text": " permanent vision loss.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_sign_of\",\n        \"to\": \"endophthalmitis\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"anterior_uveitis\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"infectious_keratitis\"\n      }"
      }, {
        "text": "\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"8c0728b7\",\n    \"letter\": \"H\",\n    \"term\": \"Herniation syndromes\",\n    \"pages\": [\n      \"536\",\n      \"543\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Herniation syndromes\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"c50757df\",\n    \"letter\": \"H\",\n    \"term\": \"Herniation syndromes (brain)\",\n    \"pages\": [\n      \"543\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Herniation syndromes (brain)\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"dc482fe7\",\n    \"letter\": \"H\",\n    \"term\": \"Herpes simplex virus\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Herpes simplex virus\",\n    \"sub_entries\": [\n      {\n        \"id\": \"93cd0f8e\",\n        \"letter\": \"H\",\n        \"term\": \"CN VII lesions with\",\n        \"pages\": [\n          \"546\"\n        ],\n        \"context\": \"Herpes simplex virus \u003e CN VII lesions with\"\n      }\n    ]\n  },\n  {\n    \"id\": \"a0590674\",\n    \"letter\": \"H\",\n    \"term\": \"Hippocampus\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Hippocampus\",\n    \"sub_entries\": [\n      {\n        \"id\": \"6b36429b\",\n        \"letter\": \"H\",\n        \"term\": \"lesions of\",\n        \"pages\": [\n          \"524\"\n        ],\n        \"context\": \"Hippocampus \u003e lesions of\"\n      },\n      {\n        \"id\": \"a7195f30\",\n        \"letter\": \"H\",\n        \"term\": \"limbic system\",\n        \"pages\": [\n          \"509\"\n        ],\n        \"context\": \"Hippocampus \u003e limbic system\"\n      }\n    ]\n  },\n  {\n    \"id\": \"0a1c78d4\",\n    \"letter\": \"H\",\n    \"term\": \"Histamine receptors (H1), vomiting\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Histamine receptors (H1), vomiting\",\n    \"sub_entries\": [\n      {\n        \"id\": \"0bb7fae3\",\n        \"letter\": \"H\",\n        \"term\": \"center input\",\n        \"pages\": [\n          \"506\"\n        ],\n        \"context\": \"Histamine receptors (H1), vomiting \u003e center input\"\n      }\n    ]\n  },\n  {\n    \"id\": \"07b369b2\",\n    \"letter\": \"H\",\n    \"term\": \"Histology\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Histology\",\n    \"sub_entries\": [\n      {\n        \"id\": \"30fc456b\",\n        \"letter\": \"H\",\n        \"term\": \"glioblastoma\",\n        \"pages\": [\n          \"540\"\n        ],\n        \"context\": \"Histology \u003e glioblastoma\"\n      },\n      {\n        \"id\": \"345ddd8b\",\n        \"letter\": \"H\",\n        \"term\": \"ischemic brain disease/stroke\",\n        \"pages\": [\n          \"525\"\n        ],\n        \"context\": \"Histology \u003e ischemic brain disease/stroke\"\n      }\n    ]\n  },\n  {\n    \"id\": \"bceadd40\",\n    \"letter\": \"H\",\n    \"term\": \"HIV-associated dementia\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"HIV-associated dementia\",\n    \"sub_entries\": [\n      {\n        \"id\": \"1cc73b37\",\n        \"letter\": \"H\",\n        \"term\": \"symptoms and histologic findings\",\n        \"pages\": [\n          \"535\"\n        ],\n        \"context\": \"HIV-associated dementia \u003e symptoms and histologic findings\"\n      }\n    ]\n  },\n  {\n    \"id\": \"89545afd\",\n    \"letter\": \"H\",\n    \"term\": \"Holoprosencephaly\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Holoprosencephaly\",\n    \"sub_entries\": [\n      {\n        \"id\": \"b2ed84ab\",\n        \"letter\": \"H\",\n        \"term\": \"characteristics of\",\n        \"pages\": [\n          \"501\"\n        ],\n        \"context\": \"Holoprosencephaly \u003e characteristics of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"88dc79bd\",\n    \"letter\": \"H\",\n    \"term\": \"Homeostasis\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Homeostasis\",\n    \"sub_entries\": [\n      {\n        \"id\": \"71ea369f\",\n        \"letter\": \"H\",\n        \"term\": \"hypothalamic function in\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Homeostasis \u003e hypothalamic function in\"\n      }\n    ]\n  },\n  {\n    \"id\": \"95049344\",\n    \"letter\": \"H\",\n    \"term\": \"Homer-Wright rosettes\",\n    \"pages\": [\n      \"354\",\n      \"542\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Homer-Wright rosettes\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"95a13c9b\",\n    \"letter\": \"H\",\n    \"term\": \"Homunculus\",\n    \"pages\": [\n      \"513\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Homunculus\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"8b9b53ab\",\n    \"letter\": \"H\",\n    \"term\": \"Hordeolum (stye)\",\n    \"pages\": [\n      \"559\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Hordeolum (stye)\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"c19010a3\",\n    \"letter\": \"H\",\n    \"term\": \"Horner syndrome\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Horner syndrome\",\n    \"sub_entries\": [\n      {\n        \"id\": \"3d20d7c4\",\n        \"letter\": \"H\",\n        \"term\": \"Brown-S√©quard syndrome\",\n        \"pages\": [\n          \"545\"\n        ],\n        \"context\": \"Horner syndrome \u003e Brown-S√©quard syndrome\"\n      },\n      {\n        \"id\": \"d165edb7\",\n        \"letter\": \"H\",\n        \"term\": \"cavernous sinus\",\n        \"pages\": [\n          \"557\"\n        ],\n        \"context\": \"Horner syndrome \u003e cavernous sinus\"\n      },\n      {\n        \"id\": \"cd8b78c0\",\n        \"letter\": \"H\",\n        \"term\": \"headache and\",\n        \"pages\": [\n          \"532\"\n        ],\n        \"context\": \"Horner syndrome \u003e headache and\"\n      },\n      {\n        \"id\": \"5a1de5c2\",\n        \"letter\": \"H\",\n        \"term\": \"ipsilateral\",\n        \"pages\": [\n          \"526\"\n        ],\n        \"context\": \"Horner syndrome \u003e ipsilateral\"\n      },\n      {\n        \"id\": \"a920beb1\",\n        \"letter\": \"H\",\n        \"term\": \"sympathetic nervous system and\",\n        \"pages\": [\n          \"555\"\n        ],\n        \"context\": \"Horner syndrome \u003e sympathetic nervous system and\"\n      }\n    ]\n  },\n  {\n    \"id\": \"e662f160\",\n    \"letter\": \"H\",\n    \"term\": \"Hunger/satiety regulation\",\n    \"pages\": [\n      \"508\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Hunger/satiety regulation\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"ffd7e743\",\n    \"letter\": \"H\",\n    \"term\": \"Huntington disease\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Huntington disease\",\n    \"sub_entries\": [\n      {\n        \"id\": \"ffba8f2a\",\n        \"letter\": \"H\",\n        \"term\": \"drug therapy for\",\n        \"pages\": [\n          \"564\"\n        ],\n        \"context\": \"Huntington disease \u003e drug therapy for\"\n      },\n      {\n        \"id\": \"f48600a6\",\n        \"letter\": \"H\",\n        \"term\": \"neurotransmitter changes with\",\n        \"pages\": [\n          \"505\"\n        ],\n        \"context\": \"Huntington disease \u003e neurotransmitter changes with\"\n      },\n      {\n        \"id\": \"00b45b5e\",\n        \"letter\": \"H\",\n        \"term\": \"symptoms and histologic findings\",\n        \"pages\": [\n          \"534\"\n        ],\n        \"context\": \"Huntington disease \u003e symptoms and histologic findings\"\n      }\n    ]\n  }\n]\n```\ncontinue",
      "role": "user",
      "tokenCount": 2415
    }, {
      "text": "```json\n{\n  \"8c0728b7\": {\n    \"title\": \"Brain Herniation Syndromes\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrain herniation syndromes\u003c/b\u003e are life-threatening conditions where increased intracranial pressure forces brain tissue from one compartment into another, across rigid dural structures like the falx cerebri or tentorium cerebelli, or through the foramen magnum.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSubfalcine Herniation:\u003c/b\u003e The cingulate gyrus herniates under the falx cerebri. Can compress the anterior cerebral artery, leading to contralateral leg weakness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUncal Herniation:\u003c/b\u003e The uncus (medial temporal lobe) herniates across the tentorium cerebelli. Classically compresses CN III, causing a fixed, dilated pupil (\u0027blown pupil\u0027) and a \u0027down and out\u0027 eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCentral/Downward Transtentorial Herniation:\u003c/b\u003e Caudal displacement of the diencephalon and brainstem. Can cause Duret hemorrhages (brainstem hemorrhages) and is often fatal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTonsillar Herniation:\u003c/b\u003e The cerebellar tonsils herniate through the foramen magnum, compressing the medulla. This leads to cardiorespiratory arrest and death.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A unilaterally \u0027blown pupil\u0027 in a comatose patient with head trauma is a classic sign of uncal herniation compressing the ipsilateral oculomotor nerve.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBrain herniation\u003c/b\u003e is the brain\u0027s final, catastrophic response to uncontrolled intracranial pressure, where displacement of tissue compresses vital structures like the brainstem and cranial nerves, leading to irreversible neurological damage and death.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"d93d2dfb\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"subfalcine_herniation\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"uncal_herniation\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"tonsillar_herniation\"\n      }\n    ]\n  },\n  \"c50757df\": {\n    \"title\": \"Brain Herniation Syndromes\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrain herniation syndromes\u003c/b\u003e are life-threatening conditions where increased intracranial pressure forces brain tissue from one compartment into another, across rigid dural structures like the falx cerebri or tentorium cerebelli, or through the foramen magnum.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSubfalcine Herniation:\u003c/b\u003e The cingulate gyrus herniates under the falx cerebri. Can compress the anterior cerebral artery, leading to contralateral leg weakness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUncal Herniation:\u003c/b\u003e The uncus (medial temporal lobe) herniates across the tentorium cerebelli. Classically compresses CN III, causing a fixed, dilated pupil (\u0027blown pupil\u0027) and a \u0027down and out\u0027 eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCentral/Downward Transtentorial Herniation:\u003c/b\u003e Caudal displacement of the diencephalon and brainstem. Can cause Duret hemorrhages (brainstem hemorrhages) and is often fatal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTonsillar Herniation:\u003c/b\u003e The cerebellar tonsils herniate through the foramen magnum, compressing the medulla. This leads to cardiorespiratory arrest and death.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A unilaterally \u0027blown pupil\u0027 in a comatose patient with head trauma is a classic sign of uncal herniation compressing the ipsilateral oculomotor nerve.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBrain herniation\u003c/b\u003e is the brain\u0027s final, catastrophic response to uncontrolled intracranial pressure, where displacement of tissue compresses vital structures like the brainstem and cranial nerves, leading to irreversible neurological damage and death.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"d93d2dfb\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"subfalcine_herniation\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"uncal_herniation\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"tonsillar_herniation\"\n      }\n    ]\n  },\n  \"dc482fe7\": {\n    \"title\": \"Herpes Simplex Virus (HSV) Neurological Disease\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Infectious Disease\",\n      \"Microbiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Infections\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHerpes Simplex Virus (HSV)\u003c/b\u003e is a neurotropic virus that can cause several neurological conditions, most notably a severe, focal encephalitis. HSV-1 is the most common cause of sporadic encephalitis in the US, while HSV-2 is a common cause of viral meningitis.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHSV-1 Encephalitis:\u003c/b\u003e Has a characteristic predilection for the \u003cmark\u003etemporal lobes\u003c/mark\u003e. Presents with fever, headache, altered mental status, seizures, and focal neurological deficits (e.g., aphasia). Can lead to [[c6292526|Kl√ºver-Bucy syndrome]] if bilateral temporal lobes are damaged.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHSV-2 Meningitis:\u003c/b\u003e A common cause of recurrent aseptic (viral) meningitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBell\u0027s Palsy:\u003c/b\u003e Reactivation of HSV-1 is the presumed cause of most cases of Bell\u0027s palsy, a peripheral [[a1a54523|facial nerve (CN VII) palsy]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e PCR of the CSF for HSV DNA is the gold standard for diagnosis of CNS infection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Intravenous \u003cmark\u003eacyclovir\u003c/mark\u003e is the treatment of choice and should be started empirically in any patient with suspected HSV encephalitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with fever, confusion, seizures, and an MRI showing temporal lobe enhancement has HSV encephalitis until proven otherwise. Start acyclovir immediately.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHerpes Simplex Virus\u003c/b\u003e has a distinct neurotropism, with HSV-1 targeting the temporal lobes to cause a devastating encephalitis, and HSV-2 more commonly causing a self-limited meningitis, both of which are treatable with acyclovir.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"encephalitis\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"meningitis\"\n      },\n      {\n        \"type\": \"is_a_presumed_cause_of\",\n        \"to\": \"bells_palsy\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"acyclovir\"\n      }\n    ]\n  },\n  \"a0590674\": {\n    \"title\": \"Hippocampus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Limbic System\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Limbic System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eHippocampus\u003c/b\u003e is a complex brain structure embedded deep in the medial temporal lobe. It is a major component of the [[73ace357|limbic system]] and plays a critical role in the consolidation of information from short-term memory to long-term memory, and in spatial navigation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Essential for the formation of new \u003cmark\u003edeclarative (explicit) memories\u003c/mark\u003e (facts and events).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects:\u003c/b\u003e Bilateral damage to the hippocampus results in profound \u003cmark\u003eanterograde amnesia\u003c/mark\u003e, the inability to form new long-term memories. Remote memories and procedural memory (skills) are typically preserved.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e The hippocampus is one of the first regions of the brain to be affected in [[77ae6148|Alzheimer disease]], which explains why memory loss is an early symptom. It is also highly vulnerable to hypoxic-ischemic injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLimbic System:\u003c/b\u003e It is a key part of the Papez circuit, connecting to the [[f02cfaa1|mammillary bodies]] via the fornix.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The classic case of H.M., who had his hippocampi surgically removed to treat epilepsy, demonstrated the hippocampus\u0027s crucial role in forming new memories.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eHippocampus\u003c/b\u003e acts as the brain\u0027s memory \u0027save button,\u0027 crucial for converting the experiences of the present moment into lasting declarative memories; its destruction leads to a state of being permanently stuck in the past, unable to form new personal or factual knowledge.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"73ace357\"\n      },\n      {\n        \"type\": \"is_critical_for\",\n        \"to\": \"ba8882be\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"anterograde_amnesia\"\n      },\n      {\n        \"type\": \"is_affected_early_in\",\n        \"to\": \"77ae6148\"\n      }\n    ]\n  },\n  \"0a1c78d4\": {\n    \"title\": \"Histamine H1 Receptors in Vomiting\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neuroscience\",\n      \"Gastroenterology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHistamine H1 receptors\u003c/b\u003e are G-protein coupled receptors that play a significant role in the central pathways of nausea and vomiting, particularly in the context of \u003ci\u003emotion sickness\u003c/i\u003e. They are a key target for certain antiemetic drugs.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e H1 receptors involved in emesis are located in the \u003cmark\u003evestibular nuclei\u003c/mark\u003e and the \u003cmark\u003enucleus tractus solitarius (NTS)\u003c/mark\u003e in the brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Motion Sickness:\u003c/b\u003e The vestibular system detects motion and sends signals to the vestibular nuclei. This pathway, which involves both H1 and M1 muscarinic receptors, then projects to the [[74b651ab|vomiting center]] (which includes the NTS).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacology (Antihistamines):\u003c/b\u003e First-generation H1 receptor antagonists (e.g., diphenhydramine, dimenhydrinate, meclizine) are effective in preventing and treating [[511db4d8|motion sickness]]. Their efficacy is due to their ability to cross the blood-brain barrier and block central H1 receptors. They also have significant anticholinergic effects, which contribute to their antiemetic action.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For [[511db4d8|motion sickness]], the key neurotransmitters to block are acetylcholine (M1) and histamine (H1). This is why both scopolamine (antimuscarinic) and first-generation antihistamines are effective.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHistamine H1 receptors\u003c/b\u003e in the brainstem are a crucial link in the pathway from the vestibular system to the vomiting center, making their blockade by first-generation antihistamines an effective strategy for combating motion sickness.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_involved_in\",\n        \"to\": \"511db4d8\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"vestibular_nuclei\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"38bfa9e0\"\n      },\n      {\n        \"type\": \"is_blocked_by\",\n        \"to\": \"antihistamines\"\n      }\n    ]\n  },\n  \"07b369b2\": {\n    \"title\": \"Neuropathology Histology\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Pathology\",\n      \"Neurology\",\n      \"Histology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Histopathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeuropathology histology\u003c/b\u003e involves the microscopic examination of brain and nerve tissue to identify characteristic changes associated with various neurological diseases, which are often pathognomonic.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eIschemic Stroke:\u003c/b\u003e The earliest change (12-24 hours) is the appearance of \u003cmark\u003e\\\"red neurons\\\"\u003c/mark\u003e (eosinophilic cytoplasm, pyknotic nuclei). This is followed by neutrophil infiltration and then macrophage/microglial cleanup, leading to [[4945aa8c|liquefactive necrosis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eGlioblastoma:\u003c/b\u003e Characterized by \u003cmark\u003epseudopalisading necrosis\u003c/mark\u003e, where tumor cells line up around a central area of necrosis, and microvascular proliferation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParkinson Disease:\u003c/b\u003e Eosinophilic, intracytoplasmic inclusions called \u003cmark\u003eLewy bodies\u003c/d\u003e (composed of Œ±-synuclein) in the neurons of the substantia nigra.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAlzheimer Disease:\u003c/b\u003e Extracellular senile plaques (AŒ≤ amyloid) and intracellular \u003cmark\u003eneurofibrillary tangles\u003c/mark\u003e (hyperphosphorylated tau).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCreutzfeldt-Jakob Disease:\u003c/b\u003e Spongiform encephalopathy, showing widespread vacuolation in the gray matter.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Being able to recognize these classic histological findings and associate them with the correct disease is a very high-yield skill for pathology questions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe microscopic appearance of brain tissue provides a definitive diagnosis for many neurological disorders, with specific inclusions and cellular reactions like \u0027red neurons\u0027 or \u0027Lewy bodies\u0027 serving as the pathological fingerprints of their respective diseases.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_used_to_diagnose\",\n        \"to\": \"349f9307\"\n      },\n      {\n        \"type\": \"is_used_to_diagnose\",\n        \"to\": \"b6bbd0bc\"\n      },\n      {\n        \"type\": \"is_used_to_diagnose\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"is_used_to_diagnose\",\n        \"to\": \"77ae6148\"\n      }\n    ]\n  },\n  \"bceadd40\": {\n    \"title\": \"HIV-Associated Dementia (HAD)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Infectious Disease\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Dementia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHIV-Associated Dementia (HAD)\u003c/b\u003e, also known as AIDS dementia complex, is a subcortical dementia that occurs in the late stages of HIV infection, characterized by cognitive, motor, and behavioral abnormalities.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by the HIV virus infecting CNS cells, primarily \u003cmark\u003emicroglia and macrophages\u003c/mark\u003e. Neurons are not directly infected but are damaged by inflammatory cytokines and viral proteins (e.g., gp120, Tat) released by infected glial cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e Occurs in patients with advanced immunosuppression, typically with a \u003cmark\u003eCD4 count \u003c 200 cells/mm¬≥\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistopathology:\u003c/b\u003e The pathognomonic finding is the presence of \u003cmark\u003emultinucleated giant cells\u003c/mark\u003e (formed by the fusion of infected microglia) and microglial nodules in the white matter and deep gray matter structures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A subcortical dementia, it presents with cognitive slowing (bradyphrenia), memory problems, apathy, and social withdrawal. Motor symptoms include ataxia, poor balance, and tremors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e The incidence and severity of HAD have dramatically decreased with the advent of effective antiretroviral therapy (ART).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of multinucleated giant cells in the brain of an AIDS patient with dementia is the classic histological finding for HAD.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHIV-Associated Dementia\u003c/b\u003e is not caused by direct neuronal infection but rather by an inflammatory \u0027bystander effect,\u0027 where HIV-infected microglia release neurotoxic substances that damage neurons, leading to a characteristic subcortical dementia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"hiv_aids\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"9347f277\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\": \"multinucleated_giant_cells\"\n      },\n      {\n        \"type\": \"infects\",\n        \"to\": \"b6636994\"\n      }\n    ]\n  },\n  \"89545afd\": {\n    \"title\": \"Holoprosencephaly\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Embryology\",\n      \"Pediatrics\",\n      \"Genetics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Brain Malformations\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHoloprosencephaly\u003c/b\u003e is a severe congenital brain malformation resulting from the failure of the embryonic forebrain (prosencephalon) to divide into two distinct cerebral hemispheres during early gestation (weeks 3-4).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e A developmental field defect involving incomplete cleavage of the prosencephalon. It is associated with mutations in genes involved in the \u003cmark\u003eSonic hedgehog (SHH)\u003c/mark\u003e signaling pathway.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpectrum of Severity:\u003c/b\u003e Ranges from alobar (most severe, single ventricle and no hemispheric separation) to semilobar and lobar (less severe).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Midline Facial Defects:\u003c/b\u003e The severity of the brain malformation often correlates with the severity of midline facial defects. These can range from a single maxillary incisor or cleft lip/palate to severe anomalies like cyclopia (a single eye).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e Can be seen in genetic syndromes like \u003cmark\u003ePatau syndrome (Trisomy 13)\u003c/mark\u003e and as a feature of fetal alcohol syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of a severe midline facial defect (like cyclopia or a single nostril) and a major brain malformation is characteristic of holoprosencephaly. Think of SHH pathway mutations and Trisomy 13.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHoloprosencephaly\u003c/b\u003e is a fundamental failure of the brain to divide into left and right hemispheres, a process intimately linked to the development of the midline face, such that the \u0027face predicts the brain\u0027‚Äîsevere facial anomalies often signal an underlying undivided brain.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"brain_malformation\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"patau_syndrome\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"fetal_alcohol_syndrome\"\n      },\n      {\n        \"type\": \"is_associated_with_mutation_in\",\n        \"to\": \"sonic_hedgehog_pathway\"\n      }\n    ]\n  },\n  \"88dc79bd\": {\n    \"title\": \"Homeostasis\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Physiology\",\n      \"Endocrinology\",\n      \"Neuroscience\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Physiology\",\n      \"General\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHomeostasis\u003c/b\u003e is the process by which biological systems maintain a stable internal environment despite changes in external conditions. The \u003ci\u003ehypothalamus\u003c/i\u003e is the primary control center for maintaining homeostasis in the body.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHypothalamic Function:\u003c/b\u003e The [[89e86633|hypothalamus]] acts as a thermostat and regulator, monitoring and controlling numerous physiological parameters to keep them within a narrow range.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParameters Regulated:\u003c/b\u003e Key homeostatic functions controlled by the hypothalamus include:\u003cbr\u003e - \u003cb\u003eTemperature Regulation:\u003c/b\u003e Anterior hypothalamus for cooling, posterior for heating.\u003cbr\u003e - \u003cb\u003eWater Balance:\u003c/b\u003e Osmoreceptors trigger thirst and ADH release.\u003cbr\u003e - \u003cb\u003eEnergy Balance:\u003c/b\u003e Lateral nucleus for hunger, ventromedial for satiety.\u003cbr\u003e - \u003cb\u003eAutonomic Control:\u003c/b\u003e Regulates both sympathetic and parasympathetic output.\u003cbr\u003e - \u003cb\u003eEndocrine Function:\u003c/b\u003e Controls the pituitary gland.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFeedback Loops:\u003c/b\u003e Homeostasis is maintained through negative feedback loops, where a change in a variable triggers a response that counteracts the initial change.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Many questions in physiology and endocrinology are based on understanding the homeostatic feedback loops controlled by the hypothalamus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003ehypothalamus\u003c/b\u003e is the master coordinator of \u003cb\u003ehomeostasis\u003c/b\u003e, acting like a sophisticated control panel that constantly adjusts the body\u0027s autonomic, endocrine, and behavioral outputs to maintain a stable internal milieu essential for survival.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"involves\",\n        \"to\": \"negative_feedback\"\n      },\n      {\n        \"type\": \"maintains\",\n        \"to\": \"temperature_regulation\"\n      },\n      {\n        \"type\": \"maintains\",\n        \"to\": \"water_balance\"\n      }\n    ]\n  },\n  \"95049344\": {\n    \"title\": \"Homer-Wright Rosettes\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Pathology\",\n      \"Oncology\",\n      \"Neurology\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Hematology and Oncology\",\n      \"Pathology\",\n      \"Histopathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHomer-Wright rosettes\u003c/b\u003e are a characteristic histological finding in several small round blue cell tumors, where tumor cells arrange themselves in a circular pattern around a central space filled with fibrillary material (neuropil).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e A ring of small, dark tumor cell nuclei surrounding a central, eosinophilic, fibrillary core that is devoid of a blood vessel or lumen.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Tumors:\u003c/b\u003e They are a classic feature of several neuroblastic tumors, including:\u003cbr\u003e - \u003cmark\u003eMedulloblastoma\u003c/mark\u003e: The most common malignant pediatric brain tumor.\u003cbr\u003e - \u003cmark\u003eNeuroblastoma\u003c/mark\u003e: A common extracranial solid tumor of childhood, arising from neural crest cells.\u003cbr\u003e - Pineoblastoma and Ewing sarcoma (less commonly).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction from Other Rosettes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eFlexner-Wintersteiner rosettes:\u003c/b\u003e Have a true central lumen; seen in retinoblastoma.\u003cbr\u003e - \u003cb\u003ePerivascular pseudorosettes:\u003c/b\u003e Tumor cells are arranged around a central blood vessel; seen in ependymomas.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of Homer-Wright rosettes in a cerebellar tumor from a child is pathognomonic for [[16d613bb|medulloblastoma]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHomer-Wright rosettes\u003c/b\u003e are a histological sign of primitive neuroblastic differentiation, where undifferentiated tumor cells attempt to form a rudimentary synapse-like structure, creating a distinctive circular pattern that is a key diagnostic feature of tumors like medulloblastoma and neuroblastoma.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_finding_in\",\n        \"to\": \"16d613bb\"\n      },\n      {\n        \"type\": \"is_a_finding_in\",\n        \"to\": \"neuroblastoma\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"flexner_wintersteiner_rosette\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"perivascular_pseudorosette\"\n      }\n    ]\n  },\n  \"95a13c9b\": {\n    \"title\": \"Homunculus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Cortex\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eHomunculus\u003c/b\u003e (Latin for \\\"little man\\\") is a distorted, topographic representation of the human body located in the primary motor cortex and the primary somatosensory cortex. The disproportionate size of body parts in the homunculus reflects the density of innervation and functional importance of those areas.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMotor Homunculus:\u003c/b\u003e Located in the precentral gyrus (frontal lobe). Represents the origin of the corticospinal tracts. Areas with fine motor control, like the \u003cmark\u003ehands and face\u003c/mark\u003e, have a very large representation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSensory Homunculus:\u003c/b\u003e Located in the postcentral gyrus (parietal lobe). Represents the termination of sensory pathways. Areas with high tactile sensitivity, like the \u003cmark\u003elips and fingertips\u003c/mark\u003e, have a very large representation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSomatotopic Arrangement:\u003c/b\u003e The body is represented in an upside-down and inverted fashion. The feet and legs are located on the medial surface of the hemisphere, while the trunk, arm, hand, and face are located along the lateral convexity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply and Clinical Correlation:\u003c/b\u003e This arrangement is clinically significant for localizing strokes:\u003cbr\u003e - \u003cmark\u003eAnterior Cerebral Artery (ACA) stroke:\u003c/mark\u003e Affects the medial cortex, causing contralateral leg and foot deficits.\u003cbr\u003e - \u003cmark\u003eMiddle Cerebral Artery (MCA) stroke:\u003c/mark\u003e Affects the lateral cortex, causing contralateral face and arm deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The vascular supply of the homunculus is a very high-yield concept for stroke localization questions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eHomunculus\u003c/b\u003e is a neural map that illustrates the brain\u0027s prioritization of function over physical size, with the vast cortical real estate devoted to the hands and face underscoring their critical roles in motor dexterity and sensory perception.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"a2f4a400\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"somatosensory_cortex\"\n      },\n      {\n        \"type\": \"is_supplied_by\",\n        \"to\": \"143bb23d\"\n      },\n      {\n        \"type\": \"is_supplied_by\",\n        \"to\": \"830c856c\"\n      }\n    ]\n  },\n  \"8b9b53ab\": {\n    \"title\": \"Hordeolum (Stye)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Dermatology\",\n      \"Infectious Disease\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003ehordeolum\u003c/b\u003e, commonly known as a stye, is an acute, painful, purulent inflammation of an eyelid gland, typically caused by a bacterial infection.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTypes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eExternal Hordeolum:\u003c/b\u003e An infection of a sebaceous gland of Zeis or an apocrine gland of Moll, located at the eyelid margin. This is the more common type.\u003cbr\u003e - \u003cb\u003eInternal Hordeolum:\u003c/b\u003e An infection of a meibomian gland, located within the tarsal plate of the eyelid.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by an infection with \u003cmark\u003eStaphylococcus aureus\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A localized, \u003cmark\u003epainful\u003c/mark\u003e, red, swollen lump on or within the eyelid. It may have a central point of pus (pustule).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e The mainstay of treatment is warm compresses to promote drainage. Topical antibiotics may be used. Incision and drainage may be required if it does not resolve.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction from Chalazion:\u003c/b\u003e A [[chalazion]] is a granulomatous inflammation of a meibomian gland, not an acute infection. It is typically \u003cmark\u003epainless\u003c/mark\u003e, harder, and located further from the eyelid margin than an external hordeolum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key differentiating feature between a hordeolum and a chalazion is pain. Hordeolum \u003d \u003cb\u003eH\u003c/b\u003eurts. Chalazion \u003d \u003cb\u003eC\u003c/b\u003ehronic and non-tender.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003ehordeolum\u003c/b\u003e is essentially a small abscess of an eyelid gland, presenting as a tender, red bump, which distinguishes it from the painless, chronic granulomatous nodule of a chalazion.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_an_infection_of\",\n        \"to\": \"eyelid_gland\"\n      },\n      {\n        \"type\": \"is_commonly_caused_by\",\n        \"to\": \"staphylococcus_aureus\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"chalazion\"\n      }\n    ]\n  },\n  \"c19010a3\": {\n    \"title\": \"Horner Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Autonomic Dysfunction\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHorner syndrome\u003c/b\u003e is a clinical triad of symptoms resulting from the disruption of the oculosympathetic pathway, which provides sympathetic innervation to the eye and face.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassic Triad:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003ePtosis:\u003c/b\u003e Mild drooping of the upper eyelid due to paralysis of the superior tarsal muscle.\u003cbr\u003e2. \u003cb\u003eMiosis:\u003c/b\u003e A constricted pupil due to unopposed parasympathetic tone to the sphincter pupillae muscle.\u003cbr\u003e3. \u003cb\u003eAnhidrosis:\u003c/b\u003e Decreased sweating on the ipsilateral side of the face.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by a lesion anywhere along the three-neuron [[84b5e4f6|oculosympathetic pathway]]:\u003cbr\u003e - \u003cb\u003eFirst-order (Central):\u003c/b\u003e Brainstem stroke (e.g., [[07656b4a|lateral medullary syndrome]]), spinal cord lesion above T1 (e.g., [[4792bc68|Brown-S√©quard syndrome]], syringomyelia).\u003cbr\u003e - \u003cb\u003eSecond-order (Preganglionic):\u003c/b\u003e A \u003cmark\u003ePancoast tumor\u003c/mark\u003e (apical lung tumor) compressing the sympathetic chain.\u003cbr\u003e - \u003cb\u003eThird-order (Postganglionic):\u003c/b\u003e Carotid artery dissection (painful Horner\u0027s), [[9a089fd7|cavernous sinus syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Can be confirmed with pharmacological eye drop tests (e.g., apraclonidine, cocaine).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A smoker presenting with shoulder pain, arm weakness, and the triad of ptosis, miosis, and anhidrosis likely has a Pancoast tumor causing Horner syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHorner syndrome\u003c/b\u003e is the clinical manifestation of a sympathetic blackout to one side of the face, and its presence should trigger a search for an underlying lesion along the long and vulnerable oculosympathetic pathway, from the hypothalamus down to the chest and back up to the eye.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_disruption_of\",\n        \"to\": \"84b5e4f6\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"pancoast_tumor\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"07656b4a\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"carotid_dissection\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"6202e6af\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"e55deaa2\"\n      }\n    ]\n  },\n  \"e662f160\": {\n    \"title\": \"Hunger and Satiety Regulation\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Neuroscience\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Physiology\",\n      \"Hypothalamic-Pituitary Axis\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHunger and satiety regulation\u003c/b\u003e is a complex homeostatic process controlled primarily by the [[89e86633|hypothalamus]], which integrates peripheral hormonal signals from the gut and adipose tissue with central neuronal circuits to control food intake and energy expenditure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHypothalamic Centers:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eLateral Nucleus:\u003c/b\u003e The \u003cmark\u003ehunger center\u003c/mark\u003e. Stimulation induces hunger. It is inhibited by leptin and stimulated by ghrelin. Lesion ‚Üí anorexia. \u003cbr\u003e - \u003cb\u003eVentromedial Nucleus:\u003c/b\u003e The \u003cmark\u003esatiety center\u003c/mark\u003e. Stimulation induces satiety. It is stimulated by leptin. Lesion ‚Üí hyperphagia and obesity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Hormones (Peripheral):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[c8515469|Leptin]]:\u003c/b\u003e Secreted by adipose tissue; signals satiety (long-term).\u003cbr\u003e - \u003cb\u003eGhrelin:\u003c/b\u003e Secreted by the stomach; stimulates hunger (short-term).\u003cbr\u003e - \u003cb\u003eInsulin:\u003c/b\u003e Secreted by the pancreas; signals satiety.\u003cbr\u003e - \u003cb\u003eCCK:\u003c/b\u003e Secreted by the duodenum; signals satiety.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the opposing roles of the hypothalamic nuclei: \u003cb\u003eL\u003c/b\u003eateral nucleus makes you \u003cb\u003eL\u003c/b\u003eean (lesion). \u003cb\u003eV\u003c/b\u003eentro\u003cb\u003em\u003c/b\u003eedial nucleus makes you \u003cb\u003eV\u003c/b\u003eery \u003cb\u003eM\u003c/b\u003eassive (lesion).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe regulation of \u003cb\u003ehunger and satiety\u003c/b\u003e is a delicate balance orchestrated by the hypothalamus, which acts as a central processor for a host of peripheral signals like leptin and ghrelin to ensure energy homeostasis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Lateral Hypothalamus] --Stimulates--\u003e B(Hunger); C[Ventromedial Hypothalamus] --Stimulates--\u003e D(Satiety); E(Ghrelin) --\u003e A; F(Leptin) --Inhibits--\u003e A; F --\u003e C;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"involves_hormone\",\n        \"to\": \"c8515469\"\n      },\n      {\n        \"type\": \"involves_hormone\",\n        \"to\": \"ghrelin\"\n      }\n    ]\n  },\n  \"ffd7e743\": {\n    \"title\": \"Huntington Disease\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Genetics\",\n      \"Psychiatry\",\n      \"Movement Disorders\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neurodegenerative Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHuntington Disease\u003c/b\u003e is an autosomal dominant neurodegenerative disorder characterized by a triad of motor, cognitive, and psychiatric symptoms, caused by an expansion of a CAG trinucleotide repeat in the huntingtin (\u003ci\u003eHTT\u003c/i\u003e) gene.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Autosomal dominant inheritance with \u003cmark\u003eanticipation\u003c/mark\u003e (disease becomes more severe and appears at an earlier age in successive generations). Caused by a CAG trinucleotide repeat expansion on chromosome 4. Mnemonic: \u003cb\u003eC\u003c/b\u003eaudate loses \u003cb\u003eA\u003c/b\u003eCh and \u003cb\u003eG\u003c/b\u003eABA.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Degeneration of GABAergic neurons in the \u003cmark\u003ecaudate and putamen\u003c/mark\u003e (striatum). This leads to atrophy of the striatum, visible on imaging as enlargement of the lateral ventricles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter Changes:\u003c/b\u003e Marked decrease in [[5aa5cb91|GABA]] and [[6a005559|acetylcholine]], with a relative excess of [[90adc821|dopamine]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Onset typically between ages 30-50. Presents with \u003cmark\u003echorea\u003c/mark\u003e (involuntary, dance-like movements), progressing to dementia and psychiatric disturbances (depression, aggression).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e There is no cure. Symptomatic treatment for chorea includes dopamine antagonists (e.g., haloperidol) or VMAT inhibitors (e.g., tetrabenazine).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient in their 40s with new-onset chorea and personality changes should make you think of Huntington disease. The key pathology is atrophy of the caudate nucleus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHuntington Disease\u003c/b\u003e is a fatal genetic disorder where an expanded CAG repeat leads to the progressive destruction of GABAergic neurons in the striatum, resulting in a devastating clinical triad of uncontrollable movements (chorea), cognitive decline (dementia), and psychiatric illness.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[CAG Repeat Expansion in HTT Gene] --\u003e B(Gain-of-Function Huntingtin Protein); B --\u003e C(Degeneration of Striatal Neurons); C --\u003e D(Decreased GABA \u0026 ACh); D --\u003e E(Chorea, Dementia, Psychiatric Symptoms);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"41ca6981\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"cag_trinucleotide_repeat_expansion\"\n      },\n      {\n        \"type\": \"causes_degeneration_of\",\n        \"to\": \"caudate_nucleus\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"chorea\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"2e0d4fef\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9668,
      "parts": [{
        "text": "```json\n"
      }, {
        "text": "{\n  \"8c0728b7\": {\n    \"title"
      }, {
        "text": "\": \"Brain Herniation Syndromes\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Neurosurgery\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Les"
      }, {
        "text": "ions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrain herniation syndromes\u003c/b\u003e are life"
      }, {
        "text": "-threatening conditions where increased intracranial pressure forces brain tissue from one compartment into another, across rigid dural structures like the fal"
      }, {
        "text": "x cerebri or tentorium cerebelli, or through the foramen magnum.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSubfalcine Herniation:\u003c/b\u003e The cingulate gyrus herniates under the falx cerebri."
      }, {
        "text": " Can compress the anterior cerebral artery, leading to contralateral leg weakness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUncal Herniation:\u003c/b\u003e The un"
      }, {
        "text": "cus (medial temporal lobe) herniates across the tentorium cerebelli. Classically compresses CN III, causing"
      }, {
        "text": " a fixed, dilated pupil (\u0027blown pupil\u0027) and a \u0027down and out\u0027 eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCentral/Downward"
      }, {
        "text": " Transtentorial Herniation:\u003c/b\u003e Caudal displacement of the diencephalon and brainstem. Can cause Duret"
      }, {
        "text": " hemorrhages (brainstem hemorrhages) and is often fatal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTonsillar Herniation:\u003c/b\u003e The cerebellar"
      }, {
        "text": " tonsils herniate through the foramen magnum, compressing the medulla. This leads to cardiorespiratory arrest and death.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e A unilaterally \u0027blown pupil\u0027 in a comatose patient with head trauma is a classic sign of un"
      }, {
        "text": "cal herniation compressing the ipsilateral oculomotor nerve.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBrain herniation"
      }, {
        "text": "\u003c/b\u003e is the brain\u0027s final, catastrophic response to uncontrolled intracranial pressure, where displacement of tissue compresses vital structures like the brainstem and cranial"
      }, {
        "text": " nerves, leading to irreversible neurological damage and death.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to"
      }, {
        "text": "\": \"d93d2dfb\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to"
      }, {
        "text": "\": \"subfalcine_herniation\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \""
      }, {
        "text": "uncal_herniation\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"tons"
      }, {
        "text": "illar_herniation\"\n      }\n    ]\n  },\n  \"c50757df"
      }, {
        "text": "\": {\n    \"title\": \"Brain Herniation Syndromes\",\n    \"primaryType\": \"disease\",\n"
      }, {
        "text": "    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Pathology\",\n      \"USMLE\"\n"
      }, {
        "text": "    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology"
      }, {
        "text": "\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eBrain herniation syndromes\u003c/b\u003e are life-threatening conditions where increased intracranial pressure forces brain tissue from one compartment into another,"
      }, {
        "text": " across rigid dural structures like the falx cerebri or tentorium cerebelli, or through the foramen magnum"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSubfalcine Herniation:\u003c/b\u003e The cing"
      }, {
        "text": "ulate gyrus herniates under the falx cerebri. Can compress the anterior cerebral artery, leading to contralateral leg weakness.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Uncal Herniation:\u003c/b\u003e The uncus (medial temporal lobe) herniates across the tentorium cerebelli"
      }, {
        "text": ". Classically compresses CN III, causing a fixed, dilated pupil (\u0027blown pupil\u0027) and a \u0027down and out\u0027 eye."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eCentral/Downward Transtentorial Herniation:\u003c/b\u003e Caudal displacement of the diencephalon and brainstem. Can cause D"
      }, {
        "text": "uret hemorrhages (brainstem hemorrhages) and is often fatal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTonsillar Herniation:\u003c/b\u003e"
      }, {
        "text": " The cerebellar tonsils herniate through the foramen magnum, compressing the medulla. This leads to cardiorespiratory arrest and death.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e A unilaterally \u0027blown pupil\u0027 in a comatose patient with head trauma is a classic"
      }, {
        "text": " sign of uncal herniation compressing the ipsilateral oculomotor nerve.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBrain herni"
      }, {
        "text": "ation\u003c/b\u003e is the brain\u0027s final, catastrophic response to uncontrolled intracranial pressure, where displacement of tissue compresses vital structures like the brainstem and cranial"
      }, {
        "text": " nerves, leading to irreversible neurological damage and death.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"d93"
      }, {
        "text": "d2dfb\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\":"
      }, {
        "text": " \"subfalcine_herniation\"\n      },\n      {\n        \"type\": \"includes\","
      }, {
        "text": "\n        \"to\": \"uncal_herniation\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"includes\",\n        \"to\": \"tonsillar_herniation\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"dc482fe7\": {\n    \"title\": \"Herpes Simplex Virus ("
      }, {
        "text": "HSV) Neurological Disease\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Infectious Disease\",\n      \"Microbiology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Infections\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHerpes Simplex Virus (HSV)\u003c/b\u003e is a neuro"
      }, {
        "text": "tropic virus that can cause several neurological conditions, most notably a severe, focal encephalitis. HSV-1 is the most common cause"
      }, {
        "text": " of sporadic encephalitis in the US, while HSV-2 is a common cause of viral meningitis.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHSV-1 Encephalitis:\u003c/b\u003e Has a characteristic predilection for the \u003c"
      }, {
        "text": "mark\u003etemporal lobes\u003c/mark\u003e. Presents with fever, headache, altered mental status, seizures, and focal neurological deficits (e.g., a"
      }, {
        "text": "phasia). Can lead to [[c6292526|Kl√ºver-Bucy syndrome"
      }, {
        "text": "]] if bilateral temporal lobes are damaged.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHSV-2 Meningitis:\u003c/b\u003e A common cause of recurrent aseptic"
      }, {
        "text": " (viral) meningitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBell\u0027s Palsy:\u003c/b\u003e Reactivation of HSV-1 is the presumed cause of most"
      }, {
        "text": " cases of Bell\u0027s palsy, a peripheral [[a1a54523|facial nerve (CN VII) palsy]].\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Diagnosis:\u003c/b\u003e PCR of the CSF for HSV DNA is the gold standard for diagnosis of CNS infection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Int"
      }, {
        "text": "ravenous \u003cmark\u003eacyclovir\u003c/mark\u003e is the treatment of choice and should be started empirically in any patient with suspected HSV encephalitis"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with fever, confusion, seizures, and an MRI showing temporal lobe enhancement"
      }, {
        "text": " has HSV encephalitis until proven otherwise. Start acyclovir immediately.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Herpes Simplex Virus\u003c/b\u003e has a distinct neurotropism, with HSV-1 targeting the temporal lobes to cause a devastating"
      }, {
        "text": " encephalitis, and HSV-2 more commonly causing a self-limited meningitis, both of which are treatable with acyclovir"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes"
      }, {
        "text": "\",\n        \"to\": \"encephalitis\"\n      },\n      {\n        \"type\": \"causes\","
      }, {
        "text": "\n        \"to\": \"meningitis\"\n      },\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_presumed_cause_of\",\n        \"to\": \"bells_palsy\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_treated_by\",\n        \"to\": \"acyclovir\"\n      }\n    ]\n  },\n  \"a"
      }, {
        "text": "0590674\": {\n    \"title\": \"Hippocampus\",\n    \"primaryType"
      }, {
        "text": "\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"L"
      }, {
        "text": "imbic System\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Limbic System\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eHippocampus\u003c/b\u003e is a complex brain structure embedded deep"
      }, {
        "text": " in the medial temporal lobe. It is a major component of the [[73ace357|limbic system]]"
      }, {
        "text": " and plays a critical role in the consolidation of information from short-term memory to long-term memory, and in spatial navigation.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Essential for the formation of new \u003cmark\u003edeclarative (explicit) memories\u003c/mark\u003e (facts"
      }, {
        "text": " and events).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects:\u003c/b\u003e Bilateral damage to the hippocampus results in profound \u003cmark\u003eanter"
      }, {
        "text": "ograde amnesia\u003c/mark\u003e, the inability to form new long-term memories. Remote memories and procedural memory (skills"
      }, {
        "text": ") are typically preserved.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e The hippocampus is one of the first regions of the brain to be affected in"
      }, {
        "text": " [[77ae6148|Alzheimer disease]], which explains why memory loss is an early symptom. It is also highly"
      }, {
        "text": " vulnerable to hypoxic-ischemic injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLimbic System:\u003c/b\u003e It is a key part of the Pape"
      }, {
        "text": "z circuit, connecting to the [[f02cfaa1|mammillary bodies]] via the fornix.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The classic case of H.M., who had his hippocampi surgically removed to treat epilepsy, demonstrated"
      }, {
        "text": " the hippocampus\u0027s crucial role in forming new memories.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003eHippocampus\u003c/b\u003e acts as the brain\u0027s memory \u0027save button,\u0027 crucial for converting the experiences of the"
      }, {
        "text": " present moment into lasting declarative memories; its destruction leads to a state of being permanently stuck in the past, unable to form new personal"
      }, {
        "text": " or factual knowledge.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_part_of\",\n        \"to\": \"73ace357\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_critical_for\",\n        \"to\": \"ba8882be\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"lesion_causes\",\n        \"to\": \"anterograde_amnesia\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_affected_early_in\",\n        \"to\":"
      }, {
        "text": " \"77ae6148\"\n      }\n    ]\n  },\n  \"0a1c"
      }, {
        "text": "78d4\": {\n    \"title\": \"Histamine H1 Receptors in Vomiting\",\n    \"primaryType"
      }, {
        "text": "\": \"physiology\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neuroscience\",\n      \"G"
      }, {
        "text": "astroenterology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHistamine H1 receptors\u003c/b\u003e are G-protein coupled receptors that"
      }, {
        "text": " play a significant role in the central pathways of nausea and vomiting, particularly in the context of \u003ci\u003emotion sickness\u003c/i\u003e."
      }, {
        "text": " They are a key target for certain antiemetic drugs.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation"
      }, {
        "text": ":\u003c/b\u003e H1 receptors involved in emesis are located in the \u003cmark\u003evestibular nuclei\u003c/mark\u003e and the \u003cmark\u003enucleus"
      }, {
        "text": " tractus solitarius (NTS)\u003c/mark\u003e in the brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Motion Sickness:\u003c/b\u003e The vestibular"
      }, {
        "text": " system detects motion and sends signals to the vestibular nuclei. This pathway, which involves both H1 and M1 muscarinic receptors, then"
      }, {
        "text": " projects to the [[74b651ab|vomiting center]] (which includes the NTS).\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Pharmacology (Antihistamines):\u003c/b\u003e First-generation H1 receptor antagonists (e.g., diphenhydramine, dim"
      }, {
        "text": "enhydrinate, meclizine) are effective in preventing and treating [[511db4d8"
      }, {
        "text": "|motion sickness]]. Their efficacy is due to their ability to cross the blood-brain barrier and block central H1 receptors. They"
      }, {
        "text": " also have significant anticholinergic effects, which contribute to their antiemetic action.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For"
      }, {
        "text": " [[511db4d8|motion sickness]], the key neurotransmitters to block are acetylcholine (M1) and histamine (H1)."
      }, {
        "text": " This is why both scopolamine (antimuscarinic) and first-generation antihistamines are effective.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eHistamine H1 receptors\u003c/b\u003e in the brainstem are a crucial link in the pathway"
      }, {
        "text": " from the vestibular system to the vomiting center, making their blockade by first-generation antihistamines an effective strategy for combating motion sickness.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_involved"
      }, {
        "text": "_in\",\n        \"to\": \"511db4d8\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_located_in\",\n        \"to\": \"vestibular_nuclei\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_located_in\",\n        \"to\": \"38bfa9"
      }, {
        "text": "e0\"\n      },\n      {\n        \"type\": \"is_blocked_by\",\n        \"to\":"
      }, {
        "text": " \"antihistamines\"\n      }\n    ]\n  },\n  \"07b369b2"
      }, {
        "text": "\": {\n    \"title\": \"Neuropathology Histology\",\n    \"primaryType\": \"concept\",\n    \""
      }, {
        "text": "tags\": [\n      \"Pathology\",\n      \"Neurology\",\n      \"Histology\",\n      \"USMLE\"\n    ],\n"
      }, {
        "text": "    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      "
      }, {
        "text": "\"Histopathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeuropathology histology"
      }, {
        "text": "\u003c/b\u003e involves the microscopic examination of brain and nerve tissue to identify characteristic changes associated with various neurological diseases, which are often path"
      }, {
        "text": "ognomonic.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eIschemic Stroke:\u003c/b\u003e The earliest"
      }, {
        "text": " change (12-24 hours) is the appearance of \u003cmark\u003e\\\"red neurons\\\"\u003c/mark\u003e (eosinophilic cytoplasm"
      }, {
        "text": ", pyknotic nuclei). This is followed by neutrophil infiltration and then macrophage/microglial cleanup, leading to [[4"
      }, {
        "text": "945aa8c|liquefactive necrosis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eGlioblastoma:\u003c/b\u003e Characterized by \u003cmark\u003epseud"
      }, {
        "text": "opalisading necrosis\u003c/mark\u003e, where tumor cells line up around a central area of necrosis, and microvascular proliferation.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePark"
      }, {
        "text": "inson Disease:\u003c/b\u003e Eosinophilic, intracytoplasmic inclusions called \u003cmark\u003eLewy bodies\u003c/d\u003e (composed of Œ±"
      }, {
        "text": "-synuclein) in the neurons of the substantia nigra.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAlzheimer Disease:\u003c/b\u003e Extracellular sen"
      }, {
        "text": "ile plaques (AŒ≤ amyloid) and intracellular \u003cmark\u003eneurofibrillary tangles\u003c/mark\u003e (hyperphosphorylated tau).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCre"
      }, {
        "text": "utzfeldt-Jakob Disease:\u003c/b\u003e Spongiform encephalopathy, showing widespread vacuolation in the gray matter.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " Being able to recognize these classic histological findings and associate them with the correct disease is a very high-yield skill for pathology"
      }, {
        "text": " questions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe microscopic appearance of brain tissue provides a definitive diagnosis"
      }, {
        "text": " for many neurological disorders, with specific inclusions and cellular reactions like \u0027red neurons\u0027 or \u0027Lewy bodies\u0027 serving as the"
      }, {
        "text": " pathological fingerprints of their respective diseases.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_used_to_diagnose\",\n        \"to\": \"349f"
      }, {
        "text": "9307\"\n      },\n      {\n        \"type\": \"is_used_to_diagnose"
      }, {
        "text": "\",\n        \"to\": \"b6bbd0bc\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "used_to_diagnose\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_used_to_diagnose\",\n        \"to\": \"77ae6"
      }, {
        "text": "148\"\n      }\n    ]\n  },\n  \"bceadd40\": {\n    \"title\":"
      }, {
        "text": " \"HIV-Associated Dementia (HAD)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      "
      }, {
        "text": "\"Infectious Disease\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"D"
      }, {
        "text": "ementia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHIV-Associated Dementia (HAD)\u003c/b\u003e,"
      }, {
        "text": " also known as AIDS dementia complex, is a subcortical dementia that occurs in the late stages of HIV infection, characterized by cognitive"
      }, {
        "text": ", motor, and behavioral abnormalities.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Ca"
      }, {
        "text": "used by the HIV virus infecting CNS cells, primarily \u003cmark\u003emicroglia and macrophages\u003c/mark\u003e. Neurons are not directly infected but"
      }, {
        "text": " are damaged by inflammatory cytokines and viral proteins (e.g., gp120, Tat) released by infected glial"
      }, {
        "text": " cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e Occurs in patients with advanced immunosuppression, typically with a \u003cmark\u003eCD4 count \u003c"
      }, {
        "text": " 200 cells/mm¬≥\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistopathology:\u003c/b\u003e The pathognomonic finding is the presence of"
      }, {
        "text": " \u003cmark\u003emultinucleated giant cells\u003c/mark\u003e (formed by the fusion of infected microglia) and microglial nodules in the white"
      }, {
        "text": " matter and deep gray matter structures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A subcortical dementia, it presents with cognitive"
      }, {
        "text": " slowing (bradyphrenia), memory problems, apathy, and social withdrawal. Motor symptoms include ataxia, poor balance, and tremors"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e The incidence and severity of HAD have dramatically decreased with the advent of effective antiretroviral therapy (ART).\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of multinucleated giant cells in the brain of an AIDS patient with dementia"
      }, {
        "text": " is the classic histological finding for HAD.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHIV-Associated Dementia\u003c/b\u003e is not"
      }, {
        "text": " caused by direct neuronal infection but rather by an inflammatory \u0027bystander effect,\u0027 where HIV-infected microglia release neurotoxic"
      }, {
        "text": " substances that damage neurons, leading to a characteristic subcortical dementia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_complication_of\",\n        "
      }, {
        "text": "\"to\": \"hiv_aids\"\n      },\n      {\n        \"type\": \"is_a_type_of\","
      }, {
        "text": "\n        \"to\": \"9347f277\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_characterized_by\",\n        \"to\": \"multinucleated_giant_cells\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"infects\",\n        \"to\": \"b663699"
      }, {
        "text": "4\"\n      }\n    ]\n  },\n  \"89545afd\": {\n    \"title\": \""
      }, {
        "text": "Holoprosencephaly\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      "
      }, {
        "text": "\"Embryology\",\n      \"Pediatrics\",\n      \"Genetics\",\n      \"Neurology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Brain"
      }, {
        "text": " Malformations\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHolopros"
      }, {
        "text": "encephaly\u003c/b\u003e is a severe congenital brain malformation resulting from the failure of the embryonic forebrain (prosencephalon) to divide"
      }, {
        "text": " into two distinct cerebral hemispheres during early gestation (weeks 3-4).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e A developmental field defect involving incomplete cleavage of the prosencephalon. It is associated with mutations in genes"
      }, {
        "text": " involved in the \u003cmark\u003eSonic hedgehog (SHH)\u003c/mark\u003e signaling pathway.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpectrum of Severity:\u003c/b\u003e Ranges"
      }, {
        "text": " from alobar (most severe, single ventricle and no hemispheric separation) to semilobar and lobar (less"
      }, {
        "text": " severe).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Midline Facial Defects:\u003c/b\u003e The severity of the brain malformation often correlates with the severity of midline"
      }, {
        "text": " facial defects. These can range from a single maxillary incisor or cleft lip/palate to severe anomalies like cyclopia ("
      }, {
        "text": "a single eye).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e Can be seen in genetic syndromes like \u003cmark\u003ePatau syndrome (Trisomy 1"
      }, {
        "text": "3)\u003c/mark\u003e and as a feature of fetal alcohol syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of a severe midline"
      }, {
        "text": " facial defect (like cyclopia or a single nostril) and a major brain malformation is characteristic of holoprosencephaly."
      }, {
        "text": " Think of SHH pathway mutations and Trisomy 13.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHolopros"
      }, {
        "text": "encephaly\u003c/b\u003e is a fundamental failure of the brain to divide into left and right hemispheres, a process intimately linked to the development of the midline"
      }, {
        "text": " face, such that the \u0027face predicts the brain\u0027‚Äîsevere facial anomalies often signal an underlying undivided brain.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"brain_malformation\"\n      },\n      {\n        \"type\": \"is_associated_"
      }, {
        "text": "with\",\n        \"to\": \"patau_syndrome\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_associated_with\",\n        \"to\": \"fetal_alcohol_syndrome\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_associated_with_mutation_in\",\n        \"to\":"
      }, {
        "text": " \"sonic_hedgehog_pathway\"\n      }\n    ]\n  },\n  \"88dc7"
      }, {
        "text": "9bd\": {\n    \"title\": \"Homeostasis\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Physiology\",\n      \"Endocrinology\",\n      \"Neuroscience\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Physiology\",\n      \"General"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHomeostasis\u003c/b\u003e is the"
      }, {
        "text": " process by which biological systems maintain a stable internal environment despite changes in external conditions. The \u003ci\u003ehypothalamus\u003c/i\u003e is the"
      }, {
        "text": " primary control center for maintaining homeostasis in the body.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHyp"
      }, {
        "text": "othalamic Function:\u003c/b\u003e The [[89e86633|hypothalamus]] acts as a"
      }, {
        "text": " thermostat and regulator, monitoring and controlling numerous physiological parameters to keep them within a narrow range.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParameters Regulated:\u003c/b\u003e Key"
      }, {
        "text": " homeostatic functions controlled by the hypothalamus include:\u003cbr\u003e - \u003cb\u003eTemperature Regulation:\u003c/b\u003e Anterior hypothalamus for cooling, posterior for"
      }, {
        "text": " heating.\u003cbr\u003e - \u003cb\u003eWater Balance:\u003c/b\u003e Osmoreceptors trigger thirst and ADH release.\u003cbr\u003e -"
      }, {
        "text": " \u003cb\u003eEnergy Balance:\u003c/b\u003e Lateral nucleus for hunger, ventromedial for satiety.\u003cbr\u003e - \u003cb\u003eAutonomic Control"
      }, {
        "text": ":\u003c/b\u003e Regulates both sympathetic and parasympathetic output.\u003cbr\u003e - \u003cb\u003eEndocrine Function:\u003c/b\u003e Controls the pituitary gland."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eFeedback Loops:\u003c/b\u003e Homeostasis is maintained through negative feedback loops, where a change in a variable triggers a response that counter"
      }, {
        "text": "acts the initial change.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Many questions in physiology and endocrinology are based on understanding the home"
      }, {
        "text": "ostatic feedback loops controlled by the hypothalamus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003ehypothalamus\u003c/b\u003e is the master"
      }, {
        "text": " coordinator of \u003cb\u003ehomeostasis\u003c/b\u003e, acting like a sophisticated control panel that constantly adjusts the body\u0027s autonomic, endocrine"
      }, {
        "text": ", and behavioral outputs to maintain a stable internal milieu essential for survival.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\":"
      }, {
        "text": " \"89e86633\"\n      },\n      {\n        \"type\": \"involves\",\n        \""
      }, {
        "text": "to\": \"negative_feedback\"\n      },\n      {\n        \"type\": \"maintains\",\n        \"to\": \""
      }, {
        "text": "temperature_regulation\"\n      },\n      {\n        \"type\": \"maintains\",\n        \"to\": \"water_balance\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"95049344\": {\n    \"title\": \""
      }, {
        "text": "Homer-Wright Rosettes\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Pathology\",\n      "
      }, {
        "text": "\"Oncology\",\n      \"Neurology\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Hematology and Oncology\",\n      \"Pathology\",\n      \"Histopathology\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHomer-Wright rosettes\u003c/b\u003e are a characteristic histological finding in several"
      }, {
        "text": " small round blue cell tumors, where tumor cells arrange themselves in a circular pattern around a central space filled with fibrillary material ("
      }, {
        "text": "neuropil).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e A ring of small"
      }, {
        "text": ", dark tumor cell nuclei surrounding a central, eosinophilic, fibrillary core that is devoid of a blood vessel or lumen.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated"
      }, {
        "text": " Tumors:\u003c/b\u003e They are a classic feature of several neuroblastic tumors, including:\u003cbr\u003e - \u003cmark\u003eMedulloblastoma\u003c/"
      }, {
        "text": "mark\u003e: The most common malignant pediatric brain tumor.\u003cbr\u003e - \u003cmark\u003eNeuroblastoma\u003c/mark\u003e: A common extrac"
      }, {
        "text": "ranial solid tumor of childhood, arising from neural crest cells.\u003cbr\u003e - Pineoblastoma and Ewing sarcoma (less commonly"
      }, {
        "text": ").\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction from Other Rosettes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eFlexner-Wintersteiner ro"
      }, {
        "text": "settes:\u003c/b\u003e Have a true central lumen; seen in retinoblastoma.\u003cbr\u003e - \u003cb\u003ePerivascular pseud"
      }, {
        "text": "orosettes:\u003c/b\u003e Tumor cells are arranged around a central blood vessel; seen in ependymomas.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " The presence of Homer-Wright rosettes in a cerebellar tumor from a child is pathognomonic for [[16d"
      }, {
        "text": "613bb|medulloblastoma]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHomer-Wright rosettes"
      }, {
        "text": "\u003c/b\u003e are a histological sign of primitive neuroblastic differentiation, where undifferentiated tumor cells attempt to form a rudimentary synapse-"
      }, {
        "text": "like structure, creating a distinctive circular pattern that is a key diagnostic feature of tumors like medulloblastoma and neuroblastoma.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "finding_in\",\n        \"to\": \"16d613bb\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_finding_in\",\n        \"to\": \"neuroblastoma\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"flexner_wintersteiner_"
      }, {
        "text": "rosette\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to"
      }, {
        "text": "\": \"perivascular_pseudorosette\"\n      }\n    ]\n  },\n  \"95"
      }, {
        "text": "a13c9b\": {\n    \"title\": \"Homunculus\",\n    \"primaryType\": \"anatomy"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Physiology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Cerebral Cortex\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003eHomunculus\u003c/b\u003e (Latin for \\\"little man\\\") is a distorted, topographic representation of the human body located in the primary"
      }, {
        "text": " motor cortex and the primary somatosensory cortex. The disproportionate size of body parts in the homunculus reflects the density"
      }, {
        "text": " of innervation and functional importance of those areas.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMotor Homunculus:\u003c/b\u003e Located"
      }, {
        "text": " in the precentral gyrus (frontal lobe). Represents the origin of the corticospinal tracts. Areas with fine motor control,"
      }, {
        "text": " like the \u003cmark\u003ehands and face\u003c/mark\u003e, have a very large representation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSensory Homunculus:\u003c/b\u003e Located in the"
      }, {
        "text": " postcentral gyrus (parietal lobe). Represents the termination of sensory pathways. Areas with high tactile sensitivity, like the \u003cmark\u003elips"
      }, {
        "text": " and fingertips\u003c/mark\u003e, have a very large representation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSomatotopic Arrangement:\u003c/b\u003e The body is represented"
      }, {
        "text": " in an upside-down and inverted fashion. The feet and legs are located on the medial surface of the hemisphere, while the trunk"
      }, {
        "text": ", arm, hand, and face are located along the lateral convexity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply and Clinical Correlation:\u003c/b\u003e This"
      }, {
        "text": " arrangement is clinically significant for localizing strokes:\u003cbr\u003e - \u003cmark\u003eAnterior Cerebral Artery (ACA) stroke"
      }, {
        "text": ":\u003c/mark\u003e Affects the medial cortex, causing contralateral leg and foot deficits.\u003cbr\u003e - \u003cmark\u003eMiddle Cerebral Artery (MCA) stroke:\u003c/"
      }, {
        "text": "mark\u003e Affects the lateral cortex, causing contralateral face and arm deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The vascular"
      }, {
        "text": " supply of the homunculus is a very high-yield concept for stroke localization questions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003eHomunculus\u003c/b\u003e is a neural map that illustrates the brain\u0027s prioritization of function over physical size, with the vast"
      }, {
        "text": " cortical real estate devoted to the hands and face underscoring their critical roles in motor dexterity and sensory perception.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "located_in\",\n        \"to\": \"a2f4a400\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_located_in\",\n        \"to\": \"somatosensory_c"
      }, {
        "text": "ortex\"\n      },\n      {\n        \"type\": \"is_supplied_by\",\n        \"to\":"
      }, {
        "text": " \"143bb23d\"\n      },\n      {\n        \"type\": \"is_supplied_by\",\n        \""
      }, {
        "text": "to\": \"830c856c\"\n      }\n    ]\n  },\n  \"8"
      }, {
        "text": "b9b53ab\": {\n    \"title\": \"Hordeolum (Stye)\",\n    \"primaryType\": \""
      }, {
        "text": "disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Dermatology\",\n      \"Infectious"
      }, {
        "text": " Disease\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Ophthalmology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eA \u003cb\u003ehordeolum\u003c/b\u003e, commonly known as a stye, is an acute, painful"
      }, {
        "text": ", purulent inflammation of an eyelid gland, typically caused by a bacterial infection.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTypes"
      }, {
        "text": ":\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eExternal Hordeolum:\u003c/b\u003e An infection of a sebaceous gland of Zeis or"
      }, {
        "text": " an apocrine gland of Moll, located at the eyelid margin. This is the more common type.\u003cbr\u003e - \u003cb\u003eInternal Hordeol"
      }, {
        "text": "um:\u003c/b\u003e An infection of a meibomian gland, located within the tarsal plate of the eyelid.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by an infection with \u003cmark\u003eStaphylococcus aureus\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation"
      }, {
        "text": ":\u003c/b\u003e A localized, \u003cmark\u003epainful\u003c/mark\u003e, red, swollen lump on or within the eyelid. It"
      }, {
        "text": " may have a central point of pus (pustule).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e The mainstay of treatment is warm compresses to"
      }, {
        "text": " promote drainage. Topical antibiotics may be used. Incision and drainage may be required if it does not resolve.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction from Chal"
      }, {
        "text": "azion:\u003c/b\u003e A [[chalazion]] is a granulomatous inflammation of a meibomian gland, not an acute"
      }, {
        "text": " infection. It is typically \u003cmark\u003epainless\u003c/mark\u003e, harder, and located further from the eyelid margin than an"
      }, {
        "text": " external hordeolum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key differentiating feature between a hordeolum and a chalazion is pain"
      }, {
        "text": ". Hordeolum \u003d \u003cb\u003eH\u003c/b\u003eurts. Chalazion \u003d \u003cb\u003eC\u003c/b\u003ehronic and non-tender"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003ehordeolum\u003c/b\u003e is essentially a"
      }, {
        "text": " small abscess of an eyelid gland, presenting as a tender, red bump, which distinguishes it from the painless, chronic granulomatous nod"
      }, {
        "text": "ule of a chalazion.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n"
      }, {
        "text": "      {\n        \"type\": \"is_an_infection_of\",\n        \"to\": \"eyelid_"
      }, {
        "text": "gland\"\n      },\n      {\n        \"type\": \"is_commonly_caused_by\",\n"
      }, {
        "text": "        \"to\": \"staphylococcus_aureus\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n"
      }, {
        "text": "        \"to\": \"chalazion\"\n      }\n    ]\n  },\n  \"c1901"
      }, {
        "text": "0a3\": {\n    \"title\": \"Horner Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Aut"
      }, {
        "text": "onomic Dysfunction\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHorner syndrome\u003c/b\u003e is"
      }, {
        "text": " a clinical triad of symptoms resulting from the disruption of the oculosympathetic pathway, which provides sympathetic innervation to the eye and"
      }, {
        "text": " face.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassic Triad:\u003c/b\u003e\u003cbr\u003e1"
      }, {
        "text": ". \u003cb\u003ePtosis:\u003c/b\u003e Mild drooping of the upper eyelid due to paralysis of the superior tarsal muscle.\u003cbr\u003e2. \u003cb\u003eMiosis"
      }, {
        "text": ":\u003c/b\u003e A constricted pupil due to unopposed parasympathetic tone to the sphincter pupillae muscle.\u003cbr\u003e3. \u003cb\u003eAn"
      }, {
        "text": "hidrosis:\u003c/b\u003e Decreased sweating on the ipsilateral side of the face.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Ca"
      }, {
        "text": "used by a lesion anywhere along the three-neuron [[84b5e4f6|oculosympathetic pathway]]:"
      }, {
        "text": "\u003cbr\u003e - \u003cb\u003eFirst-order (Central):\u003c/b\u003e Brainstem stroke (e.g., [[076"
      }, {
        "text": "56b4a|lateral medullary syndrome]]), spinal cord lesion above T1 (e.g., [[4"
      }, {
        "text": "792bc68|Brown-S√©quard syndrome]], syringomyelia).\u003cbr\u003e - \u003cb\u003eSecond-"
      }, {
        "text": "order (Preganglionic):\u003c/b\u003e A \u003cmark\u003ePancoast tumor\u003c/mark\u003e (apical lung tumor) compressing the sympathetic"
      }, {
        "text": " chain.\u003cbr\u003e - \u003cb\u003eThird-order (Postganglionic):\u003c/b\u003e Carotid artery dissection (painful Horner"
      }, {
        "text": "\u0027s), [[9a089fd7|cavernous sinus syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Can"
      }, {
        "text": " be confirmed with pharmacological eye drop tests (e.g., apraclonidine, cocaine).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e A smoker presenting with shoulder pain, arm weakness, and the triad of ptosis, miosis, and anhidrosis likely"
      }, {
        "text": " has a Pancoast tumor causing Horner syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHorner syndrome"
      }, {
        "text": "\u003c/b\u003e is the clinical manifestation of a sympathetic blackout to one side of the face, and its presence should trigger a search for an"
      }, {
        "text": " underlying lesion along the long and vulnerable oculosympathetic pathway, from the hypothalamus down to the chest and back up to the eye"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_"
      }, {
        "text": "by_disruption_of\",\n        \"to\": \"84b5e4f6\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"pancoast"
      }, {
        "text": "_tumor\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n"
      }, {
        "text": "        \"to\": \"07656b4a\"\n      },\n      {\n        \"type\": \"can_be_"
      }, {
        "text": "caused_by\",\n        \"to\": \"carotid_dissection\"\n      },\n      {\n        \"type\": \"presents"
      }, {
        "text": "_with\",\n        \"to\": \"6202e6af\"\n      },\n      {\n        \"type\": \"presents"
      }, {
        "text": "_with\",\n        \"to\": \"e55deaa2\"\n      }\n    ]\n  },\n  \"e"
      }, {
        "text": "662f160\": {\n    \"title\": \"Hunger and Satiety Regulation\",\n    \"primaryType\":"
      }, {
        "text": " \"physiology\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Neuroscience\",\n      \"Physiology\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      "
      }, {
        "text": "\"Physiology\",\n      \"Hypothalamic-Pituitary Axis\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eHunger and satiety regulation\u003c/b\u003e is a complex homeostatic process controlled primarily by the [[89e86633|hypothalam"
      }, {
        "text": "us]], which integrates peripheral hormonal signals from the gut and adipose tissue with central neuronal circuits to control food intake and energy expenditure"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHypothalamic Centers:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eLateral Nucle"
      }, {
        "text": "us:\u003c/b\u003e The \u003cmark\u003ehunger center\u003c/mark\u003e. Stimulation induces hunger. It is inhibited by leptin and stimulated by ghrelin. Lesion"
      }, {
        "text": " ‚Üí anorexia. \u003cbr\u003e - \u003cb\u003eVentromedial Nucleus:\u003c/b\u003e The \u003cmark\u003esatiety center\u003c/mark"
      }, {
        "text": "\u003e. Stimulation induces satiety. It is stimulated by leptin. Lesion ‚Üí hyperphagia and obesity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey"
      }, {
        "text": " Hormones (Peripheral):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[c8515469|Leptin]]:\u003c/b\u003e"
      }, {
        "text": " Secreted by adipose tissue; signals satiety (long-term).\u003cbr\u003e - \u003cb\u003eGhrelin:\u003c/b\u003e Secreted by the"
      }, {
        "text": " stomach; stimulates hunger (short-term).\u003cbr\u003e - \u003cb\u003eInsulin:\u003c/b\u003e Secreted by the pancreas"
      }, {
        "text": "; signals satiety.\u003cbr\u003e - \u003cb\u003eCCK:\u003c/b\u003e Secreted by the duodenum; signals satiety.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Remember the opposing roles of the hypothalamic nuclei: \u003cb\u003eL\u003c/b\u003eateral nucleus makes you \u003cb\u003eL"
      }, {
        "text": "\u003c/b\u003eean (lesion). \u003cb\u003eV\u003c/b\u003eentro\u003cb\u003em\u003c/b\u003eedial nucleus makes you \u003cb\u003eV\u003c/b\u003eery \u003cb\u003eM"
      }, {
        "text": "\u003c/b\u003eassive (lesion).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe regulation of \u003cb\u003ehunger and satiety\u003c/b\u003e"
      }, {
        "text": " is a delicate balance orchestrated by the hypothalamus, which acts as a central processor for a host of peripheral signals like leptin and ghrelin to"
      }, {
        "text": " ensure energy homeostasis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Lateral Hypothalamus] --"
      }, {
        "text": "Stimulates--\u003e B(Hunger); C[Ventromedial Hypothalamus] --Stimulates--\u003e D(Satiety); E"
      }, {
        "text": "(Ghrelin) --\u003e A; F(Leptin) --Inhibits--\u003e A; F --\u003e C"
      }, {
        "text": ";\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\": \""
      }, {
        "text": "89e86633\"\n      },\n      {\n        \"type\": \"involves_"
      }, {
        "text": "hormone\",\n        \"to\": \"c8515469\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"involves_hormone\",\n        \"to\": \"ghrelin\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"ffd7e743\": {\n    \"title\": \"Huntington Disease\","
      }, {
        "text": "\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Genetics\",\n      \"Psychiatry\",\n      \"Movement Disorders\",\n      \"USMLE\"\n    ],\n    \"classificationPath\":"
      }, {
        "text": " [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neurodegenerative Disorders\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHuntington Disease\u003c/b\u003e is an autosomal dominant neurodegenerative disorder characterized by"
      }, {
        "text": " a triad of motor, cognitive, and psychiatric symptoms, caused by an expansion of a CAG trinucleotide repeat in the huntingtin"
      }, {
        "text": " (\u003ci\u003eHTT\u003c/i\u003e) gene.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Aut"
      }, {
        "text": "osomal dominant inheritance with \u003cmark\u003eanticipation\u003c/mark\u003e (disease becomes more severe and appears at an earlier age in successive"
      }, {
        "text": " generations). Caused by a CAG trinucleotide repeat expansion on chromosome 4. Mnemonic: \u003cb\u003eC\u003c/b\u003eaud"
      }, {
        "text": "ate loses \u003cb\u003eA\u003c/b\u003eCh and \u003cb\u003eG\u003c/b\u003eABA.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Degeneration of GABA"
      }, {
        "text": "ergic neurons in the \u003cmark\u003ecaudate and putamen\u003c/mark\u003e (striatum). This leads to atrophy"
      }, {
        "text": " of the striatum, visible on imaging as enlargement of the lateral ventricles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter Changes:\u003c/b\u003e Marked"
      }, {
        "text": " decrease in [[5aa5cb91|GABA]] and [[6a005559|acetylcholine]],"
      }, {
        "text": " with a relative excess of [[90adc821|dopamine]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e On"
      }, {
        "text": "set typically between ages 30-50. Presents with \u003cmark\u003echorea\u003c/mark\u003e (involuntary, dance"
      }, {
        "text": "-like movements), progressing to dementia and psychiatric disturbances (depression, aggression).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e There is no cure."
      }, {
        "text": " Symptomatic treatment for chorea includes dopamine antagonists (e.g., haloperidol) or VMAT inhibitors (e.g., tetr"
      }, {
        "text": "abenazine).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient in their 40s with new-onset chorea and personality"
      }, {
        "text": " changes should make you think of Huntington disease. The key pathology is atrophy of the caudate nucleus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eHuntington Disease\u003c/b\u003e is a fatal genetic disorder where an expanded CAG repeat leads to the progressive destruction of GABA"
      }, {
        "text": "ergic neurons in the striatum, resulting in a devastating clinical triad of uncontrollable movements (chorea), cognitive decline (dementia), and psychiatric illness"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[CAG Repeat Expansion in HTT Gene] --\u003e B(Gain"
      }, {
        "text": "-of-Function Huntingtin Protein); B --\u003e C(Degeneration of Striatal Neurons); C --\u003e D(Decre"
      }, {
        "text": "ased GABA \u0026 ACh); D --\u003e E(Chorea, Dementia, Psychiatric Symptoms);\"\n    },\n    \"connections\": [\n      "
      }, {
        "text": "{\n        \"type\": \"is_a_type_of\",\n        \"to\": \"41ca"
      }, {
        "text": "6981\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"c"
      }, {
        "text": "ag_trinucleotide_repeat_expansion\"\n      },\n      {\n        \"type\": \"causes"
      }, {
        "text": "_degeneration_of\",\n        \"to\": \"caudate_nucleus\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"presents_with\",\n        \"to\": \"chorea\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"2e0d"
      }, {
        "text": "4fef\"\n      }\n    ]\n  }\n}\n```"
      }]
    }],
    "pendingInputs": [{
      "text": "",
      "role": "user"
    }]
  }
}